PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brown, JT				Brown, JT			A jack of all trades	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1996	276	4					264	264		10.1001/jama.276.4.264	http://dx.doi.org/10.1001/jama.276.4.264			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UX583	8656522				2022-12-28	WOS:A1996UX58300001
J	Dayan, CM; Daniels, GH				Dayan, CM; Daniels, GH			Chronic autoimmune thyroiditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TERM FOLLOW-UP; ANTITHYROID PEROXIDASE ANTIBODIES; CHRONIC LYMPHOCYTIC THYROIDITIS; L-THYROXINE THERAPY; HLA-DR EXPRESSION; LONG-TERM; HASHIMOTO THYROIDITIS; GRAVES-DISEASE; MICROSOMAL ANTIBODIES; T-CELLS		MASSACHUSETTS GEN HOSP, THYROID UNIT, BOSTON, MA 02114 USA; UNIV BRISTOL, BRISTOL ROYAL INFIRM, DEPT MED, BRISTOL BS2 8HW, AVON, ENGLAND	Harvard University; Massachusetts General Hospital; Bristol Royal Infirmary; University of Bristol			Dayan, Colin/AAH-6242-2019	Dayan, Colin/0000-0002-6557-3462				AMINO N, 1976, CLIN ENDOCRINOL, V5, P115, DOI 10.1111/j.1365-2265.1976.tb02822.x; AOZASA K, 1986, CANCER-AM CANCER SOC, V58, P100, DOI 10.1002/1097-0142(19860701)58:1<100::AID-CNCR2820580118>3.0.CO;2-1; ATKINS MB, 1988, NEW ENGL J MED, V318, P1557, DOI 10.1056/NEJM198806163182401; BAGCHI N, 1990, ARCH INTERN MED, V150, P785, DOI 10.1001/archinte.150.4.785; BARBATO MP, 1978, MED J AUSTRALIA, V2, P511, DOI 10.5694/j.1326-5377.1978.tb131681.x; BHAKRI H, 1985, LANCET, V2, P457; BOGNER U, 1990, ACTA ENDOCRINOL-COP, V123, P431, DOI 10.1530/acta.0.1230431; BOTTAZZO GF, 1983, LANCET, V2, P1115; BOUKIS MA, 1983, J CLIN ENDOCR METAB, V57, P859, DOI 10.1210/jcem-57-4-859; BRAVERMAN LE, 1971, J CLIN ENDOCR METAB, V32, P515, DOI 10.1210/jcem-32-4-515; BURMAN P, 1986, J CLIN ENDOCR METAB, V63, P1086, DOI 10.1210/jcem-63-5-1086; CHIOVATO L, 1993, J CLIN ENDOCR METAB, V77, P1700, DOI 10.1210/jc.77.6.1700; CHIOVATO L, 1986, J ENDOCRINOL INVEST, V9, P299, DOI 10.1007/BF03346932; CHOPRA IJ, 1977, J CLIN ENDOCR METAB, V45, P45, DOI 10.1210/jcem-45-1-45; CHOW CC, 1991, CLIN ENDOCRINOL, V34, P413, DOI 10.1111/j.1365-2265.1991.tb00314.x; COOPER DS, 1984, ANN INTERN MED, V101, P18, DOI 10.7326/0003-4819-101-1-18; COSTA A, 1989, J ENDOCRINOL INVEST, V12, P355, DOI 10.1007/BF03350006; CZARNOCKA B, 1985, FEBS LETT, V190, P147, DOI 10.1016/0014-5793(85)80446-4; DAVIES TF, 1991, NEW ENGL J MED, V325, P238, DOI 10.1056/NEJM199107253250404; DAYAN CM, 1991, P NATL ACAD SCI USA, V88, P7415, DOI 10.1073/pnas.88.16.7415; DEKERDANET M, 1994, CLIN ENDOCRINOL, V41, P673; DELPRETE GF, 1986, CLIN EXP IMMUNOL, V65, P140; DONIACH D, 1979, CLIN ENDOCRINOL META, V8, P63, DOI 10.1016/S0300-595X(79)80010-9; DRABICK JJ, 1991, MIL MED, V156, P93, DOI 10.1093/milmed/156.2.93; DUMONT JE, 1987, ENDOCR REV, V8, P448, DOI 10.1210/edrv-8-4-448; EMERSON CH, 1973, J CLIN ENDOCR METAB, V36, P338, DOI 10.1210/jcem-36-2-338; EWINS DL, 1991, CLIN ENDOCRINOL, V35, P93, DOI 10.1111/j.1365-2265.1991.tb03502.x; GERSTEIN HC, 1990, ARCH INTERN MED, V150, P1397, DOI 10.1001/archinte.150.7.1397; GEUL KW, 1993, CLIN ENDOCRINOL, V39, P275, DOI 10.1111/j.1365-2265.1993.tb02366.x; GISSLINGER H, 1992, CLIN EXP IMMUNOL, V90, P363; GORDIN A, 1981, CLIN ENDOCRINOL, V15, P537, DOI 10.1111/j.1365-2265.1981.tb00699.x; HANAFUSA T, 1983, LANCET, V2, P1111; HARACH HR, 1985, ACTA ENDOCRINOL-COP, V108, P55, DOI 10.1530/acta.0.1080055; Hashimoto H., 1912, ARCH KLIN CHIR, V97, P219; HAY ID, 1985, MAYO CLIN PROC, V60, P836, DOI 10.1016/S0025-6196(12)64789-2; HAYASHI Y, 1985, J CLIN ENDOCR METAB, V61, P1172, DOI 10.1210/jcem-61-6-1172; HAYSLIP CC, 1988, AM J OBSTET GYNECOL, V159, P203, DOI 10.1016/0002-9378(88)90522-4; HEDLEY AJ, 1989, CLIN ENDOCRINOL, V31, P209, DOI 10.1111/j.1365-2265.1989.tb01244.x; HEGEDUS L, 1991, CLIN ENDOCRINOL, V35, P235, DOI 10.1111/j.1365-2265.1991.tb03528.x; HOEKMAN K, 1991, LANCET, V338, P541, DOI 10.1016/0140-6736(91)91103-2; HOLM LE, 1985, NEW ENGL J MED, V312, P601, DOI 10.1056/NEJM198503073121001; HONDA K, 1989, J CLIN ENDOCR METAB, V69, P1268, DOI 10.1210/jcem-69-6-1268; IMAGAWA A, 1995, J CLIN ENDOCR METAB, V80, P922, DOI 10.1210/jc.80.3.922; KATO I, 1985, JPN J CANCER RES, V76, P1085; KATZ SM, 1974, HUM PATHOL, V5, P161, DOI 10.1016/S0046-8177(74)80063-8; KENNEDY RL, 1992, CLIN ENDOCRINOL, V37, P471, DOI 10.1111/j.1365-2265.1992.tb01475.x; KHOURY EL, 1981, CLIN EXP IMMUNOL, V45, P316; KIKUCHI T, 1993, 80 YEARS HASHIMOTO D, P201; KOHNO Y, 1991, CLIN EXP IMMUNOL, V85, P459; KONISHI J, 1993, 80 YEARS HASHIMOTO D, P573; KONNO N, 1994, J CLIN ENDOCR METAB, V78, P393, DOI 10.1210/jc.78.2.393; KURIHARA H, 1993, 80 YEARS HASHIMOTO D, P249; LADENSON PW, 1994, THYROID, V4, pS18; LAURBERG P, 1994, J CLIN ENDOCR METAB, V79, P17, DOI 10.1210/jc.79.1.17; LAZARUS JH, 1984, ACTA ENDOCRINOL-COP, V106, P199, DOI 10.1530/acta.0.1060199; LAZARUS JH, 1981, PSYCHOL MED, V11, P85, DOI 10.1017/S0033291700053307; LIVOLSI VA, 1994, THYROID, V4, P333, DOI 10.1089/thy.1994.4.333; LONDEI M, 1985, SCIENCE, V228, P85, DOI 10.1126/science.3871967; MANDEL SJ, 1993, ANN INTERN MED, V119, P492, DOI 10.7326/0003-4819-119-6-199309150-00009; MARIOTTI S, 1992, LANCET, V339, P1506, DOI 10.1016/0140-6736(92)91265-A; MARIOTTI S, 1990, J CLIN ENDOCR METAB, V71, P661, DOI 10.1210/jcem-71-3-661; MATSUZUKA F, 1993, THYROID, V3, P93, DOI 10.1089/thy.1993.3.93; MAURER R, 1979, VIRCHOWS ARCH A, V383, P293, DOI 10.1007/BF00430248; MCINTOSH RS, 1993, J IMMUNOL, V151, P3884; NAGATAKI S, 1993, 80 YEARS HASHIMOTO D, P539; NORDMEYER JP, 1990, ACTA ENDOCRINOL-COP, V122, P391, DOI 10.1530/acta.0.1220391; NORDYKE RA, 1993, ARCH INTERN MED, V153, P862, DOI 10.1001/archinte.153.7.862; NYSTROM E, 1988, CLIN ENDOCRINOL, V29, P63, DOI 10.1111/j.1365-2265.1988.tb00250.x; OERTEL JE, 1987, SEMIN ONCOL, V14, P333; OKAYASU I, 1994, AM J CLIN PATHOL, V101, P698, DOI 10.1093/ajcp/101.6.698; OTHMAN S, 1990, CLIN ENDOCRINOL, V32, P559, DOI 10.1111/j.1365-2265.1990.tb00898.x; PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77; PHILLIPS D, 1991, J CLIN ENDOCR METAB, V72, P973, DOI 10.1210/jcem-72-5-973; PHILLIPS D, 1990, J CLIN ENDOCR METAB, V70, P742, DOI 10.1210/jcem-70-3-742; PRATT D, 1993, AM J OBSTET GYNECOL, V168, P837, DOI 10.1016/S0002-9378(12)90830-3; RALLISON, 1992, AM J MED, V92, P582; RALLISON ML, 1991, AM J MED, V91, P363, DOI 10.1016/0002-9343(91)90153-O; RAMTOOLA S, 1988, NUCL MED COMMUN, V9, P639, DOI 10.1097/00006231-198809000-00006; RAVINSKY E, 1988, ACTA CYTOL, V32, P854; RIEU M, 1994, CLIN ENDOCRINOL, V40, P529, DOI 10.1111/j.1365-2265.1994.tb02494.x; Roitt I. M., 1967, CLIN EXP IMMUNOL, V2, P727; ROITT IM, 1956, LANCET, V271, P820; ROMAN SH, 1992, J CLIN ENDOCR METAB, V74, P496, DOI 10.1210/jc.74.3.496; ROSENTHAL MJ, 1987, JAMA-J AM MED ASSOC, V258, P209, DOI 10.1001/jama.258.2.209; SAUTER NP, 1992, AM J MED, V92, P441, DOI 10.1016/0002-9343(92)90278-J; SAWIN CT, 1985, ARCH INTERN MED, V145, P1386, DOI 10.1001/archinte.145.8.1386; SOSTRE S, 1991, J ENDOCRINOL INVEST, V14, P115, DOI 10.1007/BF03350281; Stagnaro-Green A, 1993, THYROID TODAY, V16, P1; STAGNAROGREEN A, 1990, JAMA-J AM MED ASSOC, V264, P1422, DOI 10.1001/jama.264.11.1422; SUGRUE D, 1980, Q J MED, V49, P51; TACHI J, 1988, J CLIN ENDOCR METAB, V66, P480, DOI 10.1210/jcem-66-3-480; TAKASU N, 1992, NEW ENGL J MED, V326, P513, DOI 10.1056/NEJM199202203260803; TAKASU N, 1990, LANCET, V336, P1084, DOI 10.1016/0140-6736(90)92567-2; TAMAI H, 1994, J CLIN ENDOCR METAB, V78, P94, DOI 10.1210/jc.78.1.94; TAMAKI H, 1989, AM J PERINAT, V6, P296, DOI 10.1055/s-2007-999597; TAMAKI H, 1990, J CLIN ENDOCR METAB, V71, P1382, DOI 10.1210/jcem-71-5-1382; TANDON N, 1994, Q J MED, V87, P231; TANI E, 1989, ACTA CYTOL, V33, P48; TODD I, 1985, CLIN EXP IMMUNOL, V61, P265; TOMER Y, 1993, ENDOCR REV, V14, P107, DOI 10.1210/er.14.1.107; TRIP MD, 1991, AM J MED, V91, P507, DOI 10.1016/0002-9343(91)90187-3; Tsuboi K, 1993, 80 YEARS HASHIMOTO D, P69; TUNBRIDGE WMG, 1981, BRIT MED J, V282, P258, DOI 10.1136/bmj.282.6260.258; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; UTIGER RD, 1992, NEW ENGL J MED, V326, P562, DOI 10.1056/NEJM199202203260810; VALTONEN VV, 1986, ACTA MED SCAND, V219, P105; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; VARGAS MT, 1988, J CLIN ENDOCR METAB, V67, P327, DOI 10.1210/jcem-67-2-327; VICKERY AL, 1961, NEW ENGL J MED, V264, P226, DOI 10.1056/NEJM196102022640505; VOLPE R, 1992, AUTOIMMUNITY, V13, P3, DOI 10.3109/08916939209014629; Volpe R, 1991, WERNER INGBARS THYRO, P921; WATANABE U, 1994, AM J GASTROENTEROL, V89, P399; WEETMAN AP, 1989, CLIN EXP IMMUNOL, V77, P25; WEETMAN AP, 1994, ENDOCR REV, V15, P788, DOI 10.1210/er.15.6.788; WILLIAMS ED, 1962, J PATHOL BACTERIOL, V83, P255, DOI 10.1002/path.1700830127; WOOD LC, 1979, J CLIN INVEST, V64, P1429, DOI 10.1172/JCI109601; ZIMMERMAN RS, 1986, ANN INTERN MED, V104, P355, DOI 10.7326/0003-4819-104-3-355; 1993, AM J MED, V95, P534	118	571	599	2	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 11	1996	335	2					99	107		10.1056/NEJM199607113350206	http://dx.doi.org/10.1056/NEJM199607113350206			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW353	8649497				2022-12-28	WOS:A1996UW35300006
J	Betts, CD; Astarloa, L; Bloch, C; Zacarias, F; Chelala, C				Betts, CD; Astarloa, L; Bloch, C; Zacarias, F; Chelala, C			The changing face of AIDS in Argentina	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									MINIST HLTH & SOCIAL ACT ARGENTINA,NATL PROGRAM AGAINST HUMAN RETROVIRUS & AIDS,BUENOS AIRES,DF,ARGENTINA; PAN AMER HLTH ORG,WHO,REG AIDS STD PROGRAM,BUENOS AIRES,DF,ARGENTINA	Pan American Health Organization; World Health Organization								ASTARLOA L, 1995, P 10 LAT AM STD C 4; AVOLIO J, 1993, 9 INT C AIDS JUN 6 1; CAHN P, 1989, 5 INT C AIDS JUN 4 9; CASIRO A, 1989, 5 INT C AIDS JUN 4 9; FAY O, 1989, 5 INT C AIDS JUN 4 9; MULTARE S, 1992, 8 INT C AIDS JUL 19; *PAN AM HLTH ORG, 1995, AIDS SURV AM Q REP; *PAN AM HLTH ORG, 1994, 1992 AIDS HIV STD AN; RIOMOLDI I, 1992, 8 INT C AIDS JUL 19; *US BUR CENS, 1995, HIV AIDS SURV DAT BA	10	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1996	276	2					94	96		10.1001/jama.276.2.94	http://dx.doi.org/10.1001/jama.276.2.94			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UV485	8656518				2022-12-28	WOS:A1996UV48500007
J	Goldsborough, AS; Kornberg, TB				Goldsborough, AS; Kornberg, TB			Reduction of transcription by homologue asynapsis in Drosophila imaginal discs	NATURE			English	Article							GENE-COMPLEX; MELANOGASTER; TRANSVECTION; TRANS; EXPRESSION; MUTATIONS	THE interactions between enhancers and promoter elements that control gene expression are generally considered to act in cis only, but genetic studies suggest that they can also function in trans between non-contiguous DNA molecules. Termed transvection(1), such trans interactions have been proposed to be responsible for several examples of intragenic complementation in Drosophila(1-9). Transvection is thought to depend on the physical proximity of sister chromosomes(10,11), because it is inhibited when chromosome rearrangements reduce the pairing of homologues(1,3,5). This led to the suggestion that transvection occurs enhancer elements on one chromosome regulate expression on the other(7,12), with the pairing dependence resulting from a need for proximity between the two copies of the gene. Here we have analysed the levels of transcription from both alleles of the Drosophila Ultra-bithorax (Ubx) gene, and report that the predictions of this simple model are not supported. Our findings indicate a more complex level of trans regulation that may have implications for the aetiology of genetic disorders that are influenced by chromosome rearrangements.	UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco								ASHBURNE.M, 1967, NATURE, V214, P1159, DOI 10.1038/2141159b0; BABU P, 1980, DEV NEUROBIOLOGY DRO, P35; CASTELLIGAIR JE, 1990, GENETICS, V126, P177; DREESEN TD, 1991, GENE DEV, V5, P331, DOI 10.1101/gad.5.3.331; GELBART WM, 1982, P NATL ACAD SCI-BIOL, V79, P2636, DOI 10.1073/pnas.79.8.2636; GELBART WM, 1982, GENETICS, V102, P179; GEYER P, 1990, EMBO J, V9, P224; GOLDSBOROUGH AS, 1994, P NATL ACAD SCI USA, V91, P12696, DOI 10.1073/pnas.91.26.12696; JACK JW, 1979, P NATL ACAD SCI USA, V76, P1368, DOI 10.1073/pnas.76.3.1368; JUDD BH, 1988, CELL, V53, P841, DOI 10.1016/S0092-8674(88)90209-7; KORNHER JS, 1986, CELL, V44, P879, DOI 10.1016/0092-8674(86)90010-3; LEISERSON WM, 1994, GENETICS, V138, P1171; LEWIS EB, 1954, AM NAT, V88, P225, DOI 10.1086/281833; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MULLER HP, 1990, TRENDS GENET, V6, P300, DOI 10.1016/0168-9525(90)90236-Y; TARTOF KD, 1991, CELL, V65, P201, DOI 10.1016/0092-8674(91)90153-P; WHITE RAH, 1985, NATURE, V318, P567, DOI 10.1038/318567a0; ZACHAR Z, 1985, COLD SPRING HARB SYM, V50, P337, DOI 10.1101/SQB.1985.050.01.043	18	53	54	0	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 27	1996	381	6585					807	810		10.1038/381807a0	http://dx.doi.org/10.1038/381807a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU356	8657287				2022-12-28	WOS:A1996UU35600066
J	Gore, JM; Dalen, JE				Gore, JM; Dalen, JE			Cardiovascular disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									UNIV ARIZONA, HLTH SCI CTR, TUCSON, AZ USA	University of Arizona; University of Arizona Health Sciences	Gore, JM (corresponding author), UNIV MASSACHUSETTS, SCH MED, WORCESTER, MA 01655 USA.							[Anonymous], 1995, Lancet, V346, P1179; DALEN JE, 1995, CHEST, V108, pS225, DOI 10.1378/chest.108.4_Supplement.225S; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; GOLDSTEIN S, 1994, AM J CARDIOL, V74, P394, DOI 10.1016/0002-9149(94)90410-3; HAMPTON JR, 1995, LANCET, V346, P329; MARK DB, 1995, NEW ENGL J MED, V332, P1418, DOI 10.1056/NEJM199505253322106; Miller RS, 1996, JAMA-J AM MED ASSOC, V275, P708, DOI 10.1001/jama.275.9.708; Newman TB, 1996, JAMA-J AM MED ASSOC, V275, P55, DOI 10.1001/jama.275.1.55; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; SACKNERBERNSTEIN JD, 1995, JAMA-J AM MED ASSOC, V274, P1462, DOI 10.1001/jama.274.18.1462; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; STEVENSON WG, 1995, J AM COLL CARDIOL, V26, P1417, DOI 10.1016/0735-1097(95)00341-X; WEINTRAUB WS, 1995, CIRCULATION, V92, P2831, DOI 10.1161/01.CIR.92.10.2831; IN PRESS N ENGL J ME	14	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1797	1798		10.1001/jama.275.23.1797	http://dx.doi.org/10.1001/jama.275.23.1797			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642715				2022-12-28	WOS:A1996UQ15200014
J	Wilkins, RH				Wilkins, RH			Neurological surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Wilkins, RH (corresponding author), DUKE UNIV, MED CTR, DURHAM, NC 27710 USA.							APUZZO MLJ, 1992, NEUROSURGERY 3 MILLE; Cohen A., 1996, NEUROSURGERY, P539; COHEN AR, 1995, MINIMALLY INVASIVE T; Dickman CA, 1996, NEUROSURGERY, V38, P279, DOI 10.1097/00006123-199602000-00010; FRIED I, 1995, J NEUROSURG, V83, P854, DOI 10.3171/jns.1995.83.5.0854; GALLEN CC, 1995, J NEUROSURG, V82, P988, DOI 10.3171/jns.1995.82.6.0988; GOLFINOS JG, 1995, J NEUROSURG, V83, P197, DOI 10.3171/jns.1995.83.2.0197; HAMILTON AJ, 1995, NEUROSURGERY, V36, P311, DOI 10.1227/00006123-199502000-00010; KALFAS IH, 1995, J NEUROSURG, V83, P641, DOI 10.3171/jns.1995.83.4.0641; Kelly P J, 1995, Bull Am Coll Surg, V80, P13; Kelly PJ, 1991, TUMOR STEREOTAXIS; LEKSELL L, 1951, ACTA CHIR SCAND, V102, P316; Loeffler JS, 1993, STEREOTACTIC RADIOSU; LUNSFORD LD, 1992, NEUROSURG CLIN N AM, V3, P1; Maciunas RJ, 1993, INTERACTIVE IMAGE GU; MCAFEE PC, 1995, SPINE, V20, P1624, DOI 10.1097/00007632-199507150-00012; PUCE A, 1995, J NEUROSURG, V83, P262, DOI 10.3171/jns.1995.83.2.0262; SETHI DS, 1995, J LARYNGOL OTOL, V109, P956, DOI 10.1017/S0022215100131755; TURNER DA, 1995, YB NEUROLOGY NEUROSU, pR33; YETKIN FZ, 1995, AM J NEURORADIOL, V16, P2109	20	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1825	1826		10.1001/jama.275.23.1825	http://dx.doi.org/10.1001/jama.275.23.1825			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642731				2022-12-28	WOS:A1996UQ15200030
J	Clifford, K; Rai, R; Watson, H; Franks, S; Regan, L				Clifford, K; Rai, R; Watson, H; Franks, S; Regan, L			Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							POLYCYSTIC-OVARY-SYNDROME; GONADOTROPIN-RELEASING-HORMONE; RECURRENT EARLY MISCARRIAGE; LUTEINIZING-HORMONE; INVITRO FERTILIZATION; REPRODUCTIVE-PERFORMANCE; EARLY-PREGNANCY; WOMEN; CONCEPTION; OVULATION	Objective-To determine whether prepregnancy pituitary suppression of luteinising hormone secretion with a luteinising hormone releasing hormone analogue improves the outcome of pregnancy in ovulatory women with a history of recurrent miscarriage, polycystic ovaries, and hypersecretion of luteinising hormone. Design-Randomised controlled trial, Setting-Specialist recurrent miscarriage clinic. Subjects-106 women with a history of three or more consecutive first trimester miscarriages, polycystic ovaries, and hypersecretion of luteinising hormone. Interventions-Women were randomised before conception to receive pituitary suppression with a luteinising hormone releasing hormone analogue followed by low dose ovulation induction and luteal phase progesterone (group 1) or were allowed to ovulate spontaneously and then given luteal phase progesterone alone or luteal phase placebo alone (group 2). No drugs were prescribed in pregnancy. Main outcome measures-Conception and live birth rates over six: cycles, Results-Conception rates in the pituitary suppression and luteal phase support groups were 80% (40/50 women) and 82% (46/56) respectively (NS). Live birth rates were 65% (26/40) and 76% (35/46) respectively (NS). In the luteal phase support group there was no difference in the outcome of pregnancy between women given progesterone and those given placebo pessaries. Live birth rates from an intention to treat analysis were 52% (26/50 pregnancies) in the group given and 63% (35/56) in the pituitary suppression controls (NS). Conclusions-Prepregnancy suppression of high luteinising hormone concentrations in ovulatory women with recurrent miscarriage and hypersecretion of luteinising hormone does not improve the outcome of pregnancy, The outcome of pregnancy without pituitary suppression is excellent.	ST MARYS HOSP,SCH MED,DEPT OBSTET & GYNAECOL,LONDON W2 1PG,ENGLAND	Imperial College London								ABDALLA HI, 1990, FERTIL STERIL, V53, P473; ADAMS J, 1985, LANCET, V2, P1375; ANTOINE JM, 1990, HUM REPROD, V5, P565, DOI 10.1093/oxfordjournals.humrep.a137144; BALEN AH, 1993, HUM REPROD, V8, P959, DOI 10.1093/oxfordjournals.humrep.a138174; CLIFFORD K, 1994, HUM REPROD, V9, P1328, DOI 10.1093/oxfordjournals.humrep.a138703; CLIFFORD K, 1995, HUM REPROD, V10, P19; DEKEL N, 1990, SERONO S US, P17; HAMILTONFAIRLEY D, 1991, HUM REPROD, V6, P1095, DOI 10.1093/oxfordjournals.humrep.a137491; HOMBURG R, 1988, BRIT MED J, V297, P1024, DOI 10.1136/bmj.297.6655.1024; HOMBURG R, 1989, FERTIL STERIL, V51, P196; HOMBURG R, 1993, FERTIL STERIL, V59, P527; HOWLES CM, 1987, HUM REPROD, V2, P17, DOI 10.1093/oxfordjournals.humrep.a136482; LIDDELL HS, 1991, AUST NZ J OBSTET GYN, V31, P320, DOI 10.1111/j.1479-828X.1991.tb02811.x; POLSON DW, 1987, CLIN ENDOCRINOL OXF, V26, P746; PORTER RN, 1984, LANCET, V2, P1284, DOI 10.1016/S0140-6736(84)92840-X; PUNNONEN R, 1988, FERTIL STERIL, V49, P479; REGAN L, 1990, LANCET, V336, P1141, DOI 10.1016/0140-6736(90)92765-A; REGAN L, 1989, BRIT MED J, V299, P541, DOI 10.1136/bmj.299.6698.541; Regan L, 1988, EARLY PREGNANCY LOSS, P23; RESHEF E, 1990, J CLIN ENDOCR METAB, V70, P421, DOI 10.1210/jcem-70-2-421; RUTHERFORD AJ, 1988, BRIT MED J, V296, P1765, DOI 10.1136/bmj.296.6639.1765; SAGLE M, 1988, BMJ-BRIT MED J, V297, P1027, DOI 10.1136/bmj.297.6655.1027; SAUNDERS DM, 1992, HUM REPROD, V7, P1154, DOI 10.1093/oxfordjournals.humrep.a137812; STANGER JD, 1985, BRIT J OBSTET GYNAEC, V92, P385, DOI 10.1111/j.1471-0528.1985.tb01113.x; STRAYPEDERSEN B, 1984, AM J OBSTET GYNECOL, V148, P140, DOI 10.1016/S0002-9378(84)80164-7; TULPPALA M, 1993, BRIT J OBSTET GYNAEC, V100, P348, DOI 10.1111/j.1471-0528.1993.tb12978.x; VERMA S, 1991, HUM REPROD S1, V6, P60; WATSON H, 1993, HUM REPROD, V8, P829, DOI 10.1093/oxfordjournals.humrep.a138149	28	92	96	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 15	1996	312	7045					1508	1511		10.1136/bmj.312.7045.1508	http://dx.doi.org/10.1136/bmj.312.7045.1508			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR823	8646142	Green Published			2022-12-28	WOS:A1996UR82300020
J	Pettengill, GH; Ford, PG; Simpson, RA				Pettengill, GH; Ford, PG; Simpson, RA			Electrical properties of the Venus surface from bistatic radar observations	SCIENCE			English	Article							MAGELLAN; EMISSION	A bistatic radar experiment in 1994, involving reception on Earth of a specularly reflected, linearly polarized 13-centimeter-wavelength signal transmitted from the Magellan spacecraft in orbit around Venus, has established that the surface materials viewed at low and intermediate altitudes on Venus have a relative dielectric permittivity of 4.0 +/- 0.5. However, bistatic results far the Maxwell Montes highlands imply an electrically lossy surface with an imaginary dielectric permittivity of -i 100 +/- 50, probably associated with a specific conductivity of about 13 mhos per meter. Candidates for highlands surface composition include ferroelectrics, a thin frost of elemental tellurium, or a plating of magnetite or pyrites.	STANFORD UNIV,CTR RADAR ASTRON,STANFORD,CA 94305	Stanford University	Pettengill, GH (corresponding author), MIT,SPACE RES CTR,CAMBRIDGE,MA 02139, USA.							BECKER WM, 1966, CHEM SELENIUM TELLUR, pCH3; BRACKETT RA, 1985, J GEOPHYS RES, V100, P1553; FORD PG, 1983, SCIENCE, V220, P1379, DOI 10.1126/science.220.4604.1379; HAPKE B, 1990, ICARUS, V88, P407, DOI 10.1016/0019-1035(90)90091-M; KARGEL JS, 1993, ICARUS, V105, P6; Kraus J D, 1986, RADIO ASTRONOMY, P4; OLHOEFT GR, 1989, PHYS PROPERTIES ROCK, P257; PETTENGILL GH, 1982, SCIENCE, V217, P640, DOI 10.1126/science.217.4560.640; PETTENGILL GH, 1992, J GEOPHYS RES-PLANET, V97, P13091, DOI 10.1029/92JE01356; PETTENGILL GH, 1988, J GEOPHYS RES-SOLID, V93, P14881, DOI 10.1029/JB093iB12p14881; SAUNDERS RS, 1992, J GEOPHYS RES-PLANET, V97, P13067, DOI 10.1029/92JE01397; Seiff A, 1980, J GEOPHYS RES-SPACE, V85, P7903, DOI 10.1029/JA085iA13p07903; SHEPARD MK, 1994, GEOPHYS RES LETT, V21, P469, DOI 10.1029/94GL00392; SIMPSON RA, 1993, IEEE T GEOSCI REMOTE, V31, P465, DOI 10.1109/36.214923; Stratton J., 1941, ELECTROMAGNETIC THEO; TRYKA KA, 1992, J GEOPHYS RES-PLANET, V97, P13379, DOI 10.1029/92JE01163; TYLER GL, 1992, J GEOPHYS RES-PLANET, V97, P13115, DOI 10.1029/92JE00742; TYLER GL, 1991, SCIENCE, V252, P265, DOI 10.1126/science.252.5003.265; WILT RJ, 1992, THESIS MIT; WOOD JA, IN PRESS VENUS, V2; 1973, HDB CHEM PHYSICS, pD142; 1973, HDB CHEM PHYSICS, pF145	22	37	38	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1996	272	5268					1628	1631		10.1126/science.272.5268.1628	http://dx.doi.org/10.1126/science.272.5268.1628			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8662473				2022-12-28	WOS:A1996UR09300038
J	Liu, F; Hata, A; Baker, JC; Doody, J; Carcamo, J; Harland, RM; Massague, J				Liu, F; Hata, A; Baker, JC; Doody, J; Carcamo, J; Harland, RM; Massague, J			A human Mad protein acting as a BMP-regulated transcriptional activator	NATURE			English	Article							BONE MORPHOGENETIC PROTEIN-4; VENTRALIZING FACTOR; MAMMALIAN-CELLS; INDUCTION; MESODERM	THE TGF-beta/activin/BMP cytokine family signals through serine/threonine kinase receptors, but how the receptors transduce the signal is unknown. The Mad (Mothers against decapentaplegic) gene from Drosophila(1) and the related Sma genes from Caenorhabditis elegans(2) have been genetically implicated in signalling by members of the bone-morphogenetic-protein (BMP) subfamily. We have cloned Smad1, a human homologue of Mad and Sma. Microinjection of Smad1 messenger RNA into Xenopus embryo animal caps mimics the mesoderm-ventralizing effects of BMP4. Smad1 moves into the nucleus in response to BMP4. Smad1 has transcriptional activity when fused to a heterologous DNA-binding domain, and this activity is increased by BMP4 acting through BMP-receptor types I and II. The transactivating activity resides in the conserved carboxy-terminal domain of Smad1 and is disrupted by a nonsense mutation that corresponds to null mutations found in Mad and in the related gene DPC4, a candidate tumour-suppressor gene in human pancreatic cancer(3), Additionally, we show that DPC4 contains a transcriptional activation domain. The results suggests that the Smad proteins are a new class of transcription factors that mediate responses to the TGF-beta family.	MEM SLOAN KETTERING CANC CTR,CELL BIOL PROGRAM,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,HOWARD HUGHES MED INST,NEW YORK,NY 10021; UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,DIV BIOCHEM & MOLEC BIOL,BERKELEY,CA 94709	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; University of California System; University of California Berkeley				Massague, Joan/0000-0001-9324-8408				CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; DALE L, 1992, DEVELOPMENT, V115, P573; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HARLAND RM, 1994, P NATL ACAD SCI USA, V91, P10243, DOI 10.1073/pnas.91.22.10243; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; JONES CM, 1992, DEVELOPMENT, V115, P639; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; LENNON GG, IN PRESS GENOMICS; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; LIU F, 1990, CELL, V61, P1217, DOI 10.1016/0092-8674(90)90686-9; LIU F, 1995, MOL CELL BIOL, V15, P3479; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; RUPP RAW, 1991, CELL, V65, P927, DOI 10.1016/0092-8674(91)90545-A; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; Savage C, 1996, P NATL ACAD SCI USA, V93, P790, DOI 10.1073/pnas.93.2.790; SEKELSKY JJ, 1995, GENETICS, V139, P1347; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; WILSON PA, 1994, CURR BIOL, V4, P676, DOI 10.1016/S0960-9822(00)00152-4; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0	23	570	601	1	31	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 13	1996	381	6583					620	623		10.1038/381620a0	http://dx.doi.org/10.1038/381620a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ657	8637600				2022-12-28	WOS:A1996UQ65700055
J	Wenthold, PG; Hrovat, DA; Borden, WT; Lineberger, WC				Wenthold, PG; Hrovat, DA; Borden, WT; Lineberger, WC			Transition-state spectroscopy of cyclooctatetraene	SCIENCE			English	Article							SINGLET GROUND-STATE; PHOTOELECTRON-SPECTROSCOPY; BOND ALTERNATION; RING INVERSION; 1,2,4,5-TETRAMETHYLENEBENZENE; ABINITIO; ANIONS; PHOTODETACHMENT; PLANARIZATION; DISTRIBUTIONS	The 351-nanometer photoelectron spectrum of the planar cyclooctatetraene radical anion (COT-) shows transitions to two electronic states of cyclooctatetraene (COT). These states correspond to the D-4h (1)A(1g) state, which is the transition slate for COT ring inversion, and the D-8h (3)A(2u) state. The electron binding energy of the (1)A(1g) transition state is 1.099 +/- 0.010 electron volts, which is lower by 12.1 +/- 0.3 kilocalories per mole than that of the (3)A(2u) state. The photoelectron spectrum shows that the singlet lies well below the triplet in D-8h COT and confirms ab initio predictions that the molecule violates Hund's rule. Vibrational structure is observed for both features and is readily assigned by use of a simple potential energy surface.	UNIV WASHINGTON,DEPT CHEM,SEATTLE,WA 98195; UNIV COLORADO,JOINT INST LAB ASTROPHYS,BOULDER,CO 80309; UNIV COLORADO,DEPT CHEM & BIOCHEM,BOULDER,CO 80309; NATL INST STAND & TECHNOL,BOULDER,CO 80309	University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA								ANET FAL, 1962, J AM CHEM SOC, V84, P671, DOI 10.1021/ja00863a033; ANET FAL, 1964, J AM CHEM SOC, V86, P3576, DOI 10.1021/ja01071a046; ARROWSMITH P, 1983, J CHEM PHYS, V79, P283, DOI 10.1063/1.445522; ARROWSMITH P, 1980, J CHEM PHYS, V73, P5895, DOI 10.1063/1.440033; Borden W. T., 1982, DIRADICALS, P1; BORDEN WT, 1994, ACCOUNTS CHEM RES, V27, P109, DOI 10.1021/ar00040a004; BORDEN WT, 1993, MOL CRYST LIQ CRYST, V232, P195, DOI 10.1080/10587259308035713; BORDEN WT, 1977, J AM CHEM SOC, V99, P4587, DOI 10.1021/ja00456a010; BROOKS PR, 1982, BER BUNSEN PHYS CHEM, V86, P401, DOI 10.1002/bbpc.19820860513; BROOKS PR, 1988, CHEM REV, V88, P407, DOI 10.1021/cr00084a004; BURNETT SM, 1983, CHEM PHYS LETT, V100, P124, DOI 10.1016/0009-2614(83)80698-8; Chen P., 1994, UNIMOLECULAR BIMOLEC, P371; DEWAR MJS, 1985, J PHYS CHEM-US, V89, P4739, DOI 10.1021/j100268a018; DU P, 1986, J AM CHEM SOC, V108, P5072, DOI 10.1021/ja00277a004; DVORAK V, 1976, J AM CHEM SOC, V98, P1080, DOI 10.1021/ja00421a004; ERMER O, 1986, J AM CHEM SOC, V108, P4908, DOI 10.1021/ja00276a034; ERVIN KM, 1992, ADV GAS PHASE ION CH, V1, P121; Fray G. I., 1978, CHEM CYCLOOCTATETRAE; GILLES MK, 1992, J PHYS CHEM-US, V96, P1130, DOI 10.1021/j100182a021; GYGAX R, 1979, J AM CHEM SOC, V101, P2567, DOI 10.1021/ja00504a011; HAMMONS JH, 1991, J AM CHEM SOC, V113, P4500, DOI 10.1021/ja00012a019; HERING P, 1980, PHYS REV LETT, V44, P687, DOI 10.1103/PhysRevLett.44.687; HROVAT DA, 1992, J AM CHEM SOC, V114, P5879, DOI 10.1021/ja00040a071; HROVAT DA, 1994, J AM CHEM SOC, V116, P6327, DOI 10.1021/ja00093a036; HROVAT DA, UNPUB; Hund F, 1928, Z PHYS, V51, P759, DOI 10.1007/BF01400239; Hund F., 1927, LINIENSPEKTREN PERIO; KATZ TJ, 1960, J AM CHEM SOC, V82, P3785, DOI 10.1021/ja01499a078; KATZ TJ, 1960, J CHEM PHYS, V32, P1873, DOI 10.1063/1.1731039; KIMMEL PI, 1968, J PHYS CHEM-US, V72, P2813, DOI 10.1021/j100854a021; LAHTI PM, 1985, J AM CHEM SOC, V107, P4362, DOI 10.1021/ja00300a063; LAHTI PM, 1989, J ORG CHEM, V54, P958, DOI 10.1021/jo00265a042; MANOLOPOULOS DE, 1993, SCIENCE, V262, P1852, DOI 10.1126/science.262.5141.1852; NEUMARK DM, 1993, ACCOUNTS CHEM RES, V26, P33, DOI 10.1021/ar00026a001; Oth J. F. M., 1971, PURE APPL CHEM, V25, P573, DOI DOI 10.1351/PAC197125030573; PAQUETTE LA, 1975, TETRAHEDRON, V31, P2855, DOI 10.1016/0040-4020(75)80303-6; PAQUETTE LA, 1982, PURE APPL CHEM, V54, P987, DOI 10.1351/pac198254050987; PAQUETTE LA, 1990, J AM CHEM SOC, V112, P239, DOI 10.1021/ja00157a038; PAQUETTE LA, 1990, J AM CHEM SOC, V112, P228, DOI 10.1021/ja00157a037; PAQUETTE LA, 1992, ACCOUNTS CHEM RES, V25, P57; PEDERSEN S, 1994, SCIENCE, V266, P1359, DOI 10.1126/science.266.5189.1359; POLANYI JC, 1995, ACCOUNTS CHEM RES, V28, P119, DOI 10.1021/ar00051a005; POPLE JA, 1993, ISR J CHEM, V33, P345; POPLE JA, 1989, J CHEM PHYS, V90, P5622, DOI 10.1063/1.456415; REYNOLDS JH, 1993, J AM CHEM SOC, V115, P8073, DOI 10.1021/ja00071a020; REYNOLDS JH, 1992, J AM CHEM SOC, V114, P763, DOI 10.1021/ja00028a055; REYNOLDS JH, 1992, J AM CHEM SOC, V114, P5866, DOI 10.1021/ja00040a062; STRAUSS HL, 1963, J AM CHEM SOC, V85, P2360, DOI 10.1021/ja00899a004; Wenthold PG, 1996, J PHYS CHEM-US, V100, P6920, DOI 10.1021/jp953401n; WENTWORT.WE, 1969, J PHYS CHEM-US, V73, P2126, DOI 10.1021/j100727a005; Zewail A. H., 1994, FEMTOCHEMISTRY ULTRA	51	221	224	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 7	1996	272	5267					1456	1459		10.1126/science.272.5267.1456	http://dx.doi.org/10.1126/science.272.5267.1456			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP899	8662467				2022-12-28	WOS:A1996UP89900039
J	Douglas, AS; Allan, TM; Helms, PJ				Douglas, AS; Allan, TM; Helms, PJ			Seasonality and the sudden infant death syndrome during 1987-9 and 1991-3 in Australia and Britain	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SLEEPING POSITION	Objective-To determine whether seasonality of the sudden infant death syndrome persists now that rates have fallen, mostly after widespread adoption of the ''face upwards' sleeping position. Design-Monthly data on the sudden infant death syndrome during 1987-9 were compared for seasonality with those of 1991-3; rates were studied as deaths per 1000 live births. Setting-Australia and Britain (England,Wales, and Scotland). Subjects-Infants under 1 year dying of the syndrome (2401 for Australia and 6630 for Britain). Main outcome measure-Extent of seasonal variation (amplitude) was established by cosinor analysis; amplitudes for the earlier and later years were compared. Results-The rate fell in every month, and, though it did so relatively more in winter than summer, seasonality remained a distinctive feature. In the comparison of amplitudes the ratio between the earlier and later years was 1.4 in both Australia and Britain. Some differences between the hemispheres were noted. Conclusions-Seasonality of the sudden infant death syndrome remains to be explained and continues to be an important aetiological lead. Studies from other countries are needed.	UNIV ABERDEEN, WELLCOME RES LIB, SCH MED, ABERDEEN AB9 2ZD, SCOTLAND; UNIV ABERDEEN, DEPT CHILD HLTH, SCH MED, ABERDEEN AB9 2ZD, SCOTLAND	University of Aberdeen; University of Aberdeen	Douglas, AS (corresponding author), UNIV ABERDEEN, DEPT MED & THERAPEUT, SCH MED, FORESTERHILL, ABERDEEN AB9 2ZD, SCOTLAND.							Abramson H, 1944, J PEDIATR-US, V25, P404, DOI 10.1016/S0022-3476(44)80005-1; ALLAN TM, 1994, SEASONAL VARIATION H; ARENDT J, 1995, MELATONIN MAMMALIAN, P207; Arrundale J., 1993, Health Bulletin (Edinburgh), V51, P106; BEAL S, 1994, MED J AUSTRALIA, V160, P660; BEAL SM, 1986, AUST PAEDIATR J, V22, P13; BOLTON DPG, 1993, ARCH DIS CHILD, V69, P187, DOI 10.1136/adc.69.2.187; CAMPBELL MJ, 1994, J ROY STAT SOC A STA, V157, P191, DOI 10.2307/2983358; DOUGLAS AS, 1991, LANCET, V337, P1393, DOI 10.1016/0140-6736(91)93069-L; ENGELBERTS AC, 1990, ARCH DIS CHILD, V65, P462, DOI 10.1136/adc.65.4.462; FLEMING PJ, 1990, BRIT MED J, V301, P85, DOI 10.1136/bmj.301.6743.85; FLEMING PJ, 1993, ACTA PAEDIATR, V82, P57, DOI 10.1111/j.1651-2227.1993.tb12878.x; GILMAN EA, 1995, BRIT MED J, V310, P631, DOI 10.1136/bmj.310.6980.631; KAADA B, 1994, ACTA PAEDIATR, V83, P548, DOI 10.1111/j.1651-2227.1994.tb13079.x; MINORS DS, 1989, BIOL RHYTHMS CLIN PR, P172; MITCHELL EA, 1991, NEW ZEAL MED J, V104, P71; MITCHELL EA, 1994, ARCH DIS CHILD, V70, P291, DOI 10.1136/adc.70.4.291; NELSON EAS, 1989, LANCET, V1, P199; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; PEARCE EA, 1993, WORLD WEATHER GUIDE; Sothern R., 1972, PHYSIOL TEACH, V1, P1; WAKLEY T, 1855, LANCET, V1, P103; WEISSBLUTH L, 1994, J THEOR BIOL, V167, P13, DOI 10.1006/jtbi.1994.1046; WIGFIELD R, 1994, EARLY HUM DEV, V38, P161, DOI 10.1016/0378-3782(94)90208-9; WIGFIELD RE, 1992, BRIT MED J, V304, P282, DOI 10.1136/bmj.304.6822.282	25	34	35	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	1996	312	7043					1381	1383						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP434	8646093	Green Published			2022-12-28	WOS:A1996UP43400017
J	Sales, BC; Mandrus, D; Williams, RK				Sales, BC; Mandrus, D; Williams, RK			Filled skutterudite antimonides: A new class of thermoelectric materials	SCIENCE			English	Article							THERMAL-CONDUCTIVITY; LAFE4P12	A class of thermoelectric materials has been synthesized with a thermoelectric figure of merit ZT(where T is temperature and Z is a function of thermopower, electrical resistivity, and thermal conductivity) near 1 at 800 kelvin. Although these materials have not been optimized, this Value is comparable to the best ZT values obtained for any previously studied thermoelectric material. Calculations indicate that the optimized material should have ZT values of 1.4. These ternary semiconductors have the general formula RM(4)X(12) (where R is lanthanum, cerium, praseodymium, neodymium, or europium; M is iron, ruthenium, or osmium; and X is phosphorus, arsenic, or antimony) and represent a new approach to creating improved thermoelectric materials. Several alloys in the compositionrange CeFe4-xCoxSb12 or LaFe4-xCoxSb12 (0 < x < 4) have large values of ZT.	OAK RIDGE NATL LAB,DIV MET & CERAM,OAK RIDGE,TN 37831	United States Department of Energy (DOE); Oak Ridge National Laboratory	Sales, BC (corresponding author), OAK RIDGE NATL LAB,DIV SOLID STATE,POB 2008,OAK RIDGE,TN 37831, USA.		Mandrus, David/H-3090-2014	Sales, Brian/0000-0002-6335-5912				BRAUN DJ, 1980, J LESS-COMMON MET, V72, P147, DOI 10.1016/0022-5088(80)90260-X; CAHILL DG, 1992, PHYS REV B, V46, P6131, DOI 10.1103/PhysRevB.46.6131; CHAKOUMAKOS BC, UNPUB; DELONG LE, 1985, SOLID STATE COMMUN, V53, P119, DOI 10.1016/0038-1098(85)90108-5; DUDKIN LD, 1959, SOV PHYS-SOL STATE, V1, P126; FISK Z, 1993, J ALLOY COMPD, V181, P369; FLEURIAL JP, 1995, AIP C P, V316, P40; Goldsmid H.J., 1986, ELECT REFRIGERATION; Hulliger F., 1961, HELV PHYS ACTA, V34, P782; JEITSCHKO W, 1977, ACTA CRYSTALLOGR B, V33, P3401, DOI 10.1107/S056774087701108X; JUNG DW, 1990, INORG CHEM, V29, P2252, DOI 10.1021/ic00337a015; MANDRUS D, 1995, PHYS REV B, V52, P4926, DOI 10.1103/PhysRevB.52.4926; MEISNER GP, 1981, PHYSICA B & C, V108, P763, DOI 10.1016/0378-4363(81)90686-0; MEISNER GP, 1985, J APPL PHYS, V57, P3073, DOI 10.1063/1.335217; MORELLI DT, 1995, PHYS REV B, V51, P9622, DOI 10.1103/PhysRevB.51.9622; MORELLI DT, 1995, J APPL PHYS, V77, P3777, DOI 10.1063/1.358552; NOLAS GS, IN PRESS J APPL PHYS; SALES BC, 1994, PHYS REV B, V50, P8207, DOI 10.1103/PhysRevB.50.8207; SALES BU, UNPUB; SHARP JW, 1995, J APPL PHYS, V78, P1013, DOI 10.1063/1.360402; SINGH DJ, 1994, PHYS REV B, V50, P11235, DOI 10.1103/PhysRevB.50.11235; SLACK GA, 1994, J APPL PHYS, V76, P1665, DOI 10.1063/1.357750; SLACK GA, THERMOELECTRIC HDB; STETSON NT, 1991, J SOLID STATE CHEM, V91, P140, DOI 10.1016/0022-4596(91)90067-R; VAILLAT T, 1993, P 11 INT C THERM, P98; WILLIAMS RK, 1983, J NUCL MATER, V115, P211, DOI 10.1016/0022-3115(83)90312-4; WOOD C, 1988, REP PROG PHYS, V51, P459, DOI 10.1088/0034-4885/51/4/001	27	1739	1809	22	649	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1325	1328		10.1126/science.272.5266.1325	http://dx.doi.org/10.1126/science.272.5266.1325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8662465				2022-12-28	WOS:A1996UN47200042
J	Zhu, X; Jiang, MS; Peyton, M; Boulay, G; Hurst, R; Stefani, E; Birnbaumer, L				Zhu, X; Jiang, MS; Peyton, M; Boulay, G; Hurst, R; Stefani, E; Birnbaumer, L			trp, a novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry	CELL			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; MOLECULAR-CLONING; DROSOPHILA PHOTORECEPTORS; INTRACELLULAR CALCIUM; ACINAR-CELLS; MAST-CELLS; INFLUX; PHOTOTRANSDUCTION; MOBILIZATION; EXCITATION	Capacitative calcium entry (CCE) describes Ca2+ influx into cells that replenishes Ca2+ stores emptied through the action of IP3 and other agents. It is an essential component of cellular responses to many hormones and growth factors. The molecular basis of this form of Ca2+ entry is complex and may involve more than one type of channel. Studies on visual signal transduction in Drosophila led to the hypothesis that a protein encoded in frp may be a component of CCE channels. We report the existence of six trp-related genes in the mouse genome. Expression in L cells of small portions of these genes in antisense orientation suppressed CCE. Expression in COS cells of two full-length cDNAs encoding human trp homologs, Htrp1 and Htrp3, increased CCE. This identifies mammalian gene products that participate in CCE. We propose that trp homologs are subunits of CCE channels, not unlike those of classical voltage-gated ion channels.			Zhu, X (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,INST MOLEC BIOL,DEPT ANESTHESIOL,DEPT BIOL CHEM,LOS ANGELES,CA 90095, USA.		Boulay, Guylain/D-9773-2010; Peyton, Michael/A-8728-2008		NHLBI NIH HHS [HL-45198] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045198] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERVEN LA, 1994, BIOCHEM J, V299, P399, DOI 10.1042/bj2990399; BERVEN LA, 1995, J BIOL CHEM, V270, P25893, DOI 10.1074/jbc.270.43.25893; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BROOKS RC, 1989, J BIOL CHEM, V264, P20147; BROWN JE, 1984, NATURE, V311, P160, DOI 10.1038/311160a0; BYRON KL, 1995, J PHYSIOL-LONDON, V485, P455, DOI 10.1113/jphysiol.1995.sp020742; CHIONO M, 1995, J BIOL CHEM, V270, P1149, DOI 10.1074/jbc.270.3.1149; CHOW TW, 1992, BLOOD, V80, P113; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; CLAPHAM DE, 1995, NATURE, V375, P634, DOI 10.1038/375634a0; CLEMENTI E, 1992, J BIOL CHEM, V267, P2164; DEVARY O, 1987, P NATL ACAD SCI USA, V84, P6939, DOI 10.1073/pnas.84.19.6939; DONG YJ, 1995, AM J PHYSIOL-CELL PH, V269, pC1332, DOI 10.1152/ajpcell.1995.269.5.C1332; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; FASOLATO C, 1994, TRENDS PHARMACOL SCI, V15, P77, DOI 10.1016/0165-6147(94)90282-8; FEIN A, 1984, NATURE, V311, P157, DOI 10.1038/311157a0; FOSKETT JK, 1994, J BIOL CHEM, V269, P31525; GILON P, 1995, J BIOL CHEM, V270, P8050, DOI 10.1074/jbc.270.14.8050; Grudt TJ, 1996, MOL BRAIN RES, V36, P93, DOI 10.1016/0169-328X(95)00248-Q; GUDERMANN T, 1992, J BIOL CHEM, V267, P4479; HARDIE RC, 1994, J GEN PHYSIOL, V103, P409, DOI 10.1085/jgp.103.3.409; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HARTENECK C, 1995, FEBS LETT, V358, P297, DOI 10.1016/0014-5793(94)01455-A; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; HU Y, 1994, BIOCHEM BIOPH RES CO, V132, P346; HU YF, 1995, BIOCHEM J, V305, P605, DOI 10.1042/bj3050605; JACONI MEE, 1993, J BIOL CHEM, V268, P26075; JAMESKRACKE MR, 1994, J PHARMACOL EXP THER, V271, P824; KASS GEN, 1993, BIOCHIM BIOPHYS ACTA, V1223, P226; KUHN LC, 1984, CELL, V37, P95, DOI 10.1016/0092-8674(84)90304-0; KWAN CY, 1990, AM J PHYSIOL, V258, pC1006, DOI 10.1152/ajpcell.1990.258.6.C1006; LEVY FO, 1992, J BIOL CHEM, V267, P7553; LIAO CF, 1989, J BIOL CHEM, V264, P7328; LIAO CF, 1990, J BIOL CHEM, V265, P11273; MATHES C, 1994, J GEN PHYSIOL, V104, P107, DOI 10.1085/jgp.104.1.107; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; MONTERO M, 1994, J BIOL CHEM, V269, P29451; PANDOL SJ, 1987, J BIOL CHEM, V262, P16963; PAREKH AB, 1993, NATURE, V364, P814, DOI 10.1038/364814a0; PETERSEN CCH, 1995, BIOCHEM J, V311, P41, DOI 10.1042/bj3110041; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; PUTNEY JW, 1993, ENDOCR REV, V14, P610, DOI 10.1210/er.14.5.610; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; RANDRIAMAMPITA C, 1994, J BIOL CHEM, V269, P29; RUDOLPH U, 1993, TRANSGENIC RES, V2, P345, DOI 10.1007/BF01976176; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHILLING WP, 1992, BIOCHEM J, V284, P521, DOI 10.1042/bj2840521; SELINGER Z, 1993, BIOCHIM BIOPHYS ACTA, V1179, P283, DOI 10.1016/0167-4889(93)90084-3; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; SUSS E, 1989, J GEN PHYSIOL, V94, P465, DOI 10.1085/jgp.94.3.465; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; VOSTAL JG, 1991, J BIOL CHEM, V266, P16911; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; YOSHIOKA T, 1985, J BIOCHEM-TOKYO, V97, P1251, DOI 10.1093/oxfordjournals.jbchem.a135171; Zhu X, 1996, P NATL ACAD SCI USA, V93, P2827, DOI 10.1073/pnas.93.7.2827; ZHU X, 1995, FEBS LETT, V373, P193, DOI 10.1016/0014-5793(95)01038-G; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445	64	580	610	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 31	1996	85	5					661	671		10.1016/S0092-8674(00)81233-7	http://dx.doi.org/10.1016/S0092-8674(00)81233-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UP344	8646775	Bronze			2022-12-28	WOS:A1996UP34400007
J	Sheehan, PE; Lieber, CM				Sheehan, PE; Lieber, CM			Nanotribology and nanofabrication of MoO3 structures by atomic force microscopy	SCIENCE			English	Article							SCALE FRICTION; TUNGSTEN TIP; SURFACES; DIAMOND; FILMS; ANISOTROPY	Atomic force microscopy was used to characterize the sliding of molybdenum oxide (MoO3) nanocrystals on single-crystal molybdenum disulfide (MoS2) surfaces. Highly anisotropic friction was observed whereby MoO3 nanocrystals moved only along specific directions of the MoS2 surface lattice. The energy per unit area to move the MoO3 nanocrystals along their preferred sliding direction was an order of magnitude less than required to slide macroscopic MoS2-bearing contacts. This extreme friction anisotropy was exploited to fabricate multicomponent MoO3 nanostructures. These reversibly interlocking structures could serve as the basis for devices such as mechanical logic gates.	HARVARD UNIV,DEPT CHEM,CAMBRIDGE,MA 02138; HARVARD UNIV,DIV APPL SCI,CAMBRIDGE,MA 02138	Harvard University; Harvard University			Sheehan, Paul E/B-4793-2010	Sheehan, Paul E/0000-0003-2668-4124				Amontons G., 1699, MEMOIRES ACAD ROYALE, VM.DC.XCIX, P206; BHUSHAN B, 1995, NATURE, V374, P607, DOI 10.1038/374607a0; BINGGELI M, 1994, APPL PHYS LETT, V65, P415, DOI 10.1063/1.113020; BLACKMAN GS, 1990, PHYS REV LETT, V65, P2270, DOI 10.1103/PhysRevLett.65.2270; BOWDEN FP, 1964, FRICTION LUBRICATI 2; BURNHAM NA, 1990, PHYS REV LETT, V64, P1931, DOI 10.1103/PhysRevLett.64.1931; DREXLER KE, 1992, NANOSYSTEMS, P364; ENOMOTO Y, 1981, PROC R SOC LON SER-A, V373, P405, DOI 10.1098/rspa.1981.0001; FRISBIE CD, 1994, SCIENCE, V265, P2071, DOI 10.1126/science.265.5181.2071; GERMANN GJ, 1993, J APPL PHYS, V73, P163, DOI 10.1063/1.353878; HARRISON JA, 1992, PHYS REV B, V46, P9700, DOI 10.1103/PhysRevB.46.9700; HIRANO M, 1991, PHYS REV LETT, V67, P2642, DOI 10.1103/PhysRevLett.67.2642; HU J, 1995, SURF SCI, V327, P358, DOI 10.1016/0039-6028(94)00846-9; KIM Y, 1992, SCIENCE, V257, P375, DOI 10.1126/science.257.5068.375; KIM Y, 1993, THESIS HARVARD U; LUTHI R, 1994, SCIENCE, V266, P1979, DOI 10.1126/science.266.5193.1979; MATE CM, 1987, PHYS REV LETT, V59, P1942, DOI 10.1103/PhysRevLett.59.1942; NOY A, 1995, J AM CHEM SOC, V117, P7943, DOI 10.1021/ja00135a012; OVERNEY RM, 1994, PHYS REV LETT, V72, P3546, DOI 10.1103/PhysRevLett.72.3546; OVERNEY RM, 1994, LANGMUIR, V10, P1281, DOI 10.1021/la00016a049; SHEEHAN PE, UNPUB; Singer I. L., 1992, FUNDAMENTALS FRICTIO; SINGER IL, 1994, J VAC SCI TECHNOL A, V12, P2605, DOI 10.1116/1.579079; SINGER IL, 1990, APPL PHYS LETT, V57, P995, DOI 10.1063/1.104276; WHITMAN LJ, 1991, SCIENCE, V251, P1206, DOI 10.1126/science.251.4998.1206	25	212	220	4	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 24	1996	272	5265					1158	1161		10.1126/science.272.5265.1158	http://dx.doi.org/10.1126/science.272.5265.1158			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8662451				2022-12-28	WOS:A1996UM88900046
J	Kleiman, RJ; Reichardt, LF				Kleiman, RJ; Reichardt, LF			Testing the agrin hypothesis	CELL			English	Review									UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Kleiman, RJ (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,NEUROSCI PROGRAM,SAN FRANCISCO,CA 94143, USA.							FALLON JR, 1994, TRENDS NEUROSCI, V17, P469, DOI 10.1016/0166-2236(94)90135-X; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; FERNS MJ, 1992, CELL, V70, P1, DOI 10.1016/0092-8674(92)90525-H; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; MARTIN PT, 1995, SCIENCE, V269, P413, DOI 10.1126/science.7618109; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MOSCOSO LM, 1995, MOL CELL NEUROSCI, V6, P80, DOI 10.1006/mcne.1995.1008; MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9	13	43	44	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 17	1996	85	4					461	464		10.1016/S0092-8674(00)81245-3	http://dx.doi.org/10.1016/S0092-8674(00)81245-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UM415	8653780	Bronze			2022-12-28	WOS:A1996UM41500002
J	Roggensack, K; Williams, SN; Schaefer, SJ; Parnell, RA				Roggensack, K; Williams, SN; Schaefer, SJ; Parnell, RA			Volatiles from the 1994 eruptions of Rabaul: Understanding large caldera systems	SCIENCE			English	Article							VOLCANO; GLASSES	The 1994 eruption of Rabaul, in Papua New Guinea, involved a small plinian eruption at Vulcan and a vulcanian eruption on the opposite side of the caldera at Tavurvur. Vulcan's ash leachates indicate seawater interaction that is consistent with earlier observations of low sulfur dioxide emissions and the presence of ice crystals in the initial plinian eruption cloud. In contrast, Tavurvur ash leachates indicate no seawater interaction, and later sulfur dioxide emissions remained high despite low-level eruptive activity. Silicic melt inclusions indicate that the andesitic melt contained about 2 weight percent water and negligible carbon dioxide. Mafic melt inclusions in Tavurvur ash have water and carbon dioxide contents that vary systematically over the course of the eruption. The mafic melt inclusions suggest that a mafic dike intruded from below the silicic chamber and provide further evidence that mafic intrusions drive caldera unrest.	NO ARIZONA UNIV,DEPT GEOL,FLAGSTAFF,AZ 86011	Northern Arizona University	Roggensack, K (corresponding author), ARIZONA STATE UNIV,DEPT GEOL,BOX 871404,TEMPE,AZ 85287, USA.							ANDERSON AT, 1993, AM MINERAL, V78, P794; Blong R, 1995, RABAUL ERUPTION 1994; BURNHAM CW, 1994, REV MINERAL, V30, P123; Dixon JE, 1995, J PETROL, V36, P1607; DOBSON PF, 1989, GEOCHIM COSMOCHIM AC, V53, P2723, DOI 10.1016/0016-7037(89)90143-9; EINARSSON P, 1980, J GEOPHYS-Z GEOPHYS, V47, P160; FINE G, 1986, EARTH PLANET SC LETT, V76, P263, DOI 10.1016/0012-821X(86)90078-6; GROVE TL, 1986, CONTRIB MINERAL PETR, V92, P281, DOI 10.1007/BF00572157; HEMING RF, 1974, GEOL SOC AM BULL, V85, P1253, DOI 10.1130/0016-7606(1974)85<1253:GAPORC>2.0.CO;2; HOLLOWAY JR, 1994, REV MINERAL, V30, P187; IHINGER PD, 1994, REV MINERAL, V30, P67; JOHNSON RW, 1995, EOS T AGU, V76, P171, DOI DOI 10.1029/95EO00093; KILINC A, 1983, CONTRIB MINERAL PETR, V83, P136, DOI 10.1007/BF00373086; MCBIRNEY AR, 1984, ANNU REV EARTH PL SC, V12, P337, DOI 10.1146/annurev.ea.12.050184.002005; MCKEE C, 1989, IAVCEI P VOLCANOLOGY, P399; MCKEE CO, 1994, GLOBAL VOLCAN NET B, V19, P2; Mori J, 1989, IAVCEI P VOLCANOLOGY, P429; QUIMBYHUNT MS, 1983, EOS T AM GEOPHYS UN, V64, P130; ROEDER PL, 1970, CONTRIB MINERAL PETR, V29, P275, DOI 10.1007/BF00371276; ROSE WI, 1977, GEOLOGY, V5, P621, DOI 10.1130/0091-7613(1977)5<621:SOVABA>2.0.CO;2; ROSE WI, 1988, J GEOPHYS RES-SOLID, V93, P4485, DOI 10.1029/JB093iB05p04485; ROSE WI, 1995, NATURE, V375, P477, DOI 10.1038/375477a0; SPERA FJ, 1980, PHYSICS MAGMATIC PRO, P265; SPROD IE, COMMUNICATION; STOIBER RE, 1981, J VOLCANOL GEOTH RES, V11, P203, DOI 10.1016/0377-0273(81)90023-8; TAYLOR PS, 1973, GEOL SOC AM BULL, V84, P1031, DOI 10.1130/0016-7606(1973)84<1031:SMOAFA>2.0.CO;2; WALLACE PJ, 1995, NATURE, V377, P612, DOI 10.1038/377612a0; Wood CP, 1995, J VOLCANOL GEOTH RES, V69, P285, DOI 10.1016/0377-0273(95)00034-8	28	46	46	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 26	1996	273	5274					490	493		10.1126/science.273.5274.490	http://dx.doi.org/10.1126/science.273.5274.490			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY983	8662536				2022-12-28	WOS:A1996UY98300038
J	Choi, JW; Chen, J; Schreiber, SL; Clardy, J				Choi, JW; Chen, J; Schreiber, SL; Clardy, J			Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP	SCIENCE			English	Article							PEPTIDYL-PROLYL ISOMERASE; IMMUNOSUPPRESSANT FK506; RAPAMYCIN AY-22,989; CYCLOPHILIN; CHEMISTRY; LIGANDS	Rapamycin, a potent immunosuppressive agent, binds two proteins: the FK506-binding protein (FKBP12) and the FKBP-rapamycin-associated protein (FRAP). A crystal structure of the ternary complex of human FKBP12, rapamycin, and the FKBP12-rapamycin-binding (FRB) domain of human FRAP at a resolution of 2.7 angstroms revealed the two proteins bound together as a result of the ability of rapamycin to occupy two different hydrophobic binding pockets simultaneously. The structure shows extensive interactions between rapamycin and both proteins, but fewer interactions between the proteins. The structure of the FRB domain of FRAP clarifies both rapamycin-independent and -dependent effects observed for mutants of FRAP and its homologs in the family of proteins related to the ataxia-telangiectasia mutant gene product, and it illustrates how a small cell-permeable molecule can mediate protein dimerization.	HARVARD UNIV,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02138; HARVARD UNIV,DEPT CHEM & BIOL CHEM,CAMBRIDGE,MA 02138	Harvard University; Howard Hughes Medical Institute; Harvard University	Choi, JW (corresponding author), CORNELL UNIV,BAKER LAB,DEPT CHEM,ITHACA,NY 14853, USA.			Chen, Jie/0000-0002-7887-3747	NATIONAL CANCER INSTITUTE [R01CA059021] Funding Source: NIH RePORTER; NCI NIH HHS [CA59021] Funding Source: Medline; NIGMS NIH HHS [GM38625] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Belshaw PJ, 1996, P NATL ACAD SCI USA, V93, P4604, DOI 10.1073/pnas.93.10.4604; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; FINDLAY JA, 1980, CAN J CHEM, V58, P579, DOI 10.1139/v80-090; FUREY W, 1990, AM CRYSTALLOGR ASS 2, V18, P73; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; HARRIS NL, 1994, J MOL BIOL, V236, P1356, DOI 10.1016/0022-2836(94)90063-9; HUNTER T, 1995, CELL, V83, P1, DOI 10.1016/0092-8674(95)90225-2; JACKSON SP, 1995, CURR BIOL, V5, P1210, DOI 10.1016/S0960-9822(95)00238-7; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; LEDERER F, 1981, J MOL BIOL, V148, P427, DOI 10.1016/0022-2836(81)90185-6; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LORENZ MC, 1995, J BIOL CHEM, V270, P27531, DOI 10.1074/jbc.270.46.27531; NICHOLLS A, 1992, GRASP MANUAL; RIVERA VM, IN PRESS NATURE MED; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sack J. S., 1988, J MOL GRAPHICS, V6, P244; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; SEHGAL SN, 1975, J ANTIBIOT, V28, P727, DOI 10.7164/antibiotics.28.727; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; SWINDELLS DCN, 1978, CAN J CHEM, V56, P2491, DOI 10.1139/v78-407; TANAKA H, 1987, J AM CHEM SOC, V109, P5031, DOI 10.1021/ja00250a050; VANDUYNE GD, 1991, J AM CHEM SOC, V113, P7433, DOI 10.1021/ja00019a057; VANDUYNE GD, 1991, SCIENCE, V252, P839, DOI 10.1126/science.1709302; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8; ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6	35	606	647	2	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 12	1996	273	5272					239	242		10.1126/science.273.5272.239	http://dx.doi.org/10.1126/science.273.5272.239			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW787	8662507				2022-12-28	WOS:A1996UW78700041
J	Miller, IJ; Telford, SR				Miller, IJ; Telford, SR			Placental malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									HARVARD UNIV,SCH PUBL HLTH,BOSTON,MA 02115	Harvard University; Harvard T.H. Chan School of Public Health	Miller, IJ (corresponding author), BRIGHAM & WOMENS HOSP,BOSTON,MA 02115, USA.								0	8	8	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	1996	335	2					98	98		10.1056/NEJM199607113350205	http://dx.doi.org/10.1056/NEJM199607113350205			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW353	8649496				2022-12-28	WOS:A1996UW35300005
J	Toglia, MR; Weg, JG				Toglia, MR; Weg, JG			Venous thromboembolism during pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; SERIAL IMPEDANCE PLETHYSMOGRAPHY; PROTEIN-C DEFICIENCY; VENA-CAVA FILTER; SUBCUTANEOUS HEPARIN; PULMONARY-EMBOLISM; UNITED-STATES; PUERPERIUM; THERAPY		UNIV MICHIGAN,MED CTR,DEPT INTERNAL MED,DIV PULM & CRIT CARE MED,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan	Toglia, MR (corresponding author), SUNY STONY BROOK,HLTH SCI CTR T9,DEPT OBSTET GYNECOL & REPROD MED,ROOM 033,STONY BROOK,NY 11794, USA.							ANDERSON DR, 1991, THROMB HAEMOSTASIS, V65, P248; ANDERSON DR, 1993, ARCH INTERN MED, V153, P841, DOI 10.1001/archinte.153.7.841; ANG CK, 1969, BRIT MED J, V4, P201, DOI 10.1136/bmj.4.5677.201; BADARACC.MA, 1974, BRIT MED J, V1, P215, DOI 10.1136/bmj.1.5901.215; BARSS VA, 1985, J REPROD MED, V30, P899; BERGQVIST A, 1983, ACTA OBSTET GYN SCAN, V62, P443, DOI 10.3109/00016348309154217; BERGQVIST D, 1983, ACTA OBSTET GYN SCAN, V62, P449, DOI 10.3109/00016348309154218; Bonnar J, 1987, HAEMOSTASIS THROMBOS, P570; BRANCH DW, 1985, NEW ENGL J MED, V313, P1322, DOI 10.1056/NEJM198511213132104; BRANDT P, 1981, THROMB RES, V22, P15, DOI 10.1016/0049-3848(81)90304-2; BREMME K, 1993, OBSTET GYNECOL, V81, P78; BREMME K, 1992, OBSTET GYNECOL, V80, P132; BRENNER B, 1987, AM J OBSTET GYNECOL, V157, P1160, DOI 10.1016/S0002-9378(87)80282-X; CLARKEPEARSON DL, 1981, SURGERY, V89, P594; COOK G, 1994, BRIT J HAEMATOL, V87, P873, DOI 10.1111/j.1365-2141.1994.tb06757.x; CRUICKSHANK MK, 1991, ARCH INTERN MED, V151, P333, DOI 10.1001/archinte.151.2.333; DAHLMAN T, 1990, BRIT J OBSTET GYNAEC, V97, P221, DOI 10.1111/j.1471-0528.1990.tb01785.x; DAHLMAN TC, 1989, AM J OBSTET GYNECOL, V161, P420, DOI 10.1016/0002-9378(89)90535-8; DAHLMAN TC, 1993, AM J OBSTET GYNECOL, V168, P1265, DOI 10.1016/0002-9378(93)90378-V; *DEP HLTH SOC SEC, 1982, REP CONF INQ MAT DEA; DESWIET M, 1981, ADV MED, P309; DIDOLKAR SM, 1983, OBSTET GYNECOL, V61, P363; Fagher B, 1990, ACTA OBSTET GYN SCAN, V69, P659, DOI 10.3109/00016349009028716; FAUGHT W, 1995, AM J OBSTET GYNECOL, V172, P147, DOI 10.1016/0002-9378(95)90104-3; FINAZZI G, 1994, THROMB HAEMOSTASIS, V71, P15; FRANKS AL, 1990, AM J PUBLIC HEALTH, V80, P720, DOI 10.2105/AJPH.80.6.720; GERBASI FR, 1990, OBSTET GYNECOL, V75, P385; GILLIS S, 1992, INT J GYNECOL OBSTET, V39, P297, DOI 10.1016/0020-7292(92)90261-G; GINSBERG JS, 1989, THROMB HAEMOSTASIS, V61, P189; GINSBERG JS, 1990, THROMB HAEMOSTASIS, V64, P286; GINSBERG JS, 1995, CHEST, V108, pS305, DOI 10.1378/chest.108.4_Supplement.305S; GINSBERG JS, 1989, ARCH INTERN MED, V149, P2233, DOI 10.1001/archinte.149.10.2233; GINSBERG JS, 1992, THROMB HAEMOSTASIS, V67, P519; GOODRICH SM, 1964, AM J OBSTET GYNECOL, V90, P740, DOI 10.1016/0002-9378(64)90935-4; GREENFIELD LJ, 1992, ARCH SURG-CHICAGO, V127, P969; HALL JG, 1980, AM J MED, V68, P122, DOI 10.1016/0002-9343(80)90181-3; HELLGREN M, 1981, GYNECOL OBSTET INVES, V12, P141, DOI 10.1159/000299596; HELLGREN M, 1982, GYNECOL OBSTET INVES, V14, P127, DOI 10.1159/000299460; HIILESMAA VILHO, 1960, ACTA OBSTET ET GYNECOL SCAND, V39, P5; HIRSH J, 1991, NEW ENGL J MED, V324, P1565; HORLOCKER TT, 1994, CLIN ANESTHESIA UPDA, V5, P1; HUISMAN MV, 1989, ARCH INTERN MED, V149, P511, DOI 10.1001/archinte.149.3.511; HULL R, 1982, NEW ENGL J MED, V306, P189, DOI 10.1056/NEJM198201283060401; HULL RD, 1992, ARCH INTERN MED, V152, P1589, DOI 10.1001/archinte.152.8.1589; HULL RD, 1985, ANN INTERN MED, V102, P21, DOI 10.7326/0003-4819-102-1-21; HULL RD, 1983, ANN INTERN MED, V98, P891, DOI 10.7326/0003-4819-98-6-891; HULL RD, 1990, ANN INTERN MED, V112, P663, DOI 10.7326/0003-4819-112-9-663; HYERS TM, 1995, CHEST, V108, pS335, DOI 10.1378/chest.108.4_Supplement.335S; JEFFCOATE T N A, 1968, British Medical Journal, V3, P19; KHAMASHTA MA, 1995, NEW ENGL J MED, V332, P993, DOI 10.1056/NEJM199504133321504; KRUITHOF EKO, 1987, BLOOD, V69, P460; MELISSARI E, 1992, THROMB HAEMOSTASIS, V68, P652; MONREAL M, 1994, THROMB HAEMOSTASIS, V71, P7; NARAYAN H, 1992, BRIT J OBSTET GYNAEC, V99, P637, DOI 10.1111/j.1471-0528.1992.tb13845.x; NARAYAN H, 1992, BRIT J OBSTET GYNAEC, V99, P726; NICHOLAS GG, 1985, SURG GYNECOL OBSTET, V161, P133; OMRI A, 1989, THROMB HAEMOSTASIS, V61, P55; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; ROCHAT RW, 1988, OBSTET GYNECOL, V72, P91; RUTHERFORD S, 1991, American Journal of Obstetrics and Gynecology, V164, P286; SPRITZER CE, 1995, OBSTET GYNECOL, V85, P603, DOI 10.1016/0029-7844(94)00426-E; TENGBORN L, 1989, AM J OBSTET GYNECOL, V160, P90, DOI 10.1016/0002-9378(89)90095-1; TRAUSCHTVANHORN JJ, 1992, AM J OBSTET GYNECOL, V167, P968, DOI 10.1016/S0002-9378(12)80021-4; WARKENTIN TE, 1995, NEW ENGL J MED, V332, P1330, DOI 10.1056/NEJM199505183322003; WEINER CP, 1984, OBSTET GYNECOL, V64, P46; WEINMANN EE, 1994, NEW ENGL J MED, V331, P1630, DOI 10.1056/NEJM199412153312407; WISE PH, 1980, BRIT MED J, V281, P110, DOI 10.1136/bmj.281.6233.110; WONG V, 1993, AM J MED GENET, V45, P17, DOI 10.1002/ajmg.1320450107; WOODHAMS BJ, 1989, THROMB RES, V55, P99, DOI 10.1016/0049-3848(89)90460-X; 1990, JAMA-J AM MED ASSOC, V263, P2753; 1986, JAMA-J AM MED ASSOC, V256, P744	71	253	262	1	7	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	1996	335	2					108	114		10.1056/NEJM199607113350207	http://dx.doi.org/10.1056/NEJM199607113350207			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW353	8649471				2022-12-28	WOS:A1996UW35300007
J	Wise, PM; Krajnak, KM; Kashon, ML				Wise, PM; Krajnak, KM; Kashon, ML			Menopause: The aging of multiple pacemakers	SCIENCE			English	Article							FOLLICLE-STIMULATING-HORMONE; AGE-RELATED-CHANGES; MICRODISSECTED BRAIN-AREAS; LUTEINIZING-HORMONE; SUPRACHIASMATIC NUCLEUS; INVITRO FERTILIZATION; PRIMORDIAL FOLLICLES; OVARIECTOMIZED RATS; MENSTRUAL CYCLES; PROLACTIN SURGES	Menopause signals the permanent and of menstrual cyclicity in a woman's life. Its impact reaches far beyond just the reproductive system. An understanding of the factors that interact and govern the process of aging In the reproductive system will help us to develop strategies for alleviating the negative aspects of menopause and may help us to better comprehend the process of biological aging.			Wise, PM (corresponding author), UNIV KENTUCKY, COLL MED, DEPT PHYSIOL, LEXINGTON, KY 40536 USA.							AVIOLI LV, 1994, EXP GERONTOL, V29, P391, DOI 10.1016/0531-5565(94)90019-1; BATISTA MC, 1995, FERTIL STERIL, V64, P492, DOI 10.1016/S0015-0282(16)57782-6; BROCK MA, 1991, J AM GERIATR SOC, V39, P74, DOI 10.1111/j.1532-5415.1991.tb05909.x; BUTCHER RL, 1985, BIOL REPROD, V32, P315, DOI 10.1095/biolreprod32.2.315; CAI A, IN PRESS AM J PHYSL; CASPER RF, 1988, FERTIL STERIL, V49, P644; COHEN IR, 1988, ENDOCRINOLOGY, V122, P2626, DOI 10.1210/endo-122-6-2626; COOPER RL, 1980, BIOL REPROD, V23, P611, DOI 10.1095/biolreprod23.3.611; COSTOFF A, 1975, J AM GERIATR SOC, V23, P193, DOI 10.1111/j.1532-5415.1975.tb00183.x; CZEISLER CA, 1990, SERONO S PUBLICATION, V80, P239; DEPAOLO LV, 1987, EXP AGING RES, V13, P3; DEPAOLO LV, 1986, ENDOCRINOLOGY, V118, P1127, DOI 10.1210/endo-118-3-1127; EVERETT JW, 1950, ENDOCRINOLOGY, V47, P198, DOI 10.1210/endo-47-3-198; FANTL JA, 1994, EXP GERONTOL, V29, P417, DOI 10.1016/0531-5565(94)90020-5; FILLIT H, 1994, ANN NY ACAD SCI, V743, P233, DOI 10.1111/j.1749-6632.1994.tb55795.x; FINCH CE, 1984, ENDOCR REV, V5, P467, DOI 10.1210/edrv-5-4-467; GOSDEN RG, 1983, BIOL REPROD, V28, P255, DOI 10.1095/biolreprod28.2.255; GOUGEON A, 1994, BIOL REPROD, V50, P653, DOI 10.1095/biolreprod50.3.653; Greenwald Gilbert S., 1994, P629; GROSS KM, 1987, J CLIN ENDOCR METAB, V64, P675, DOI 10.1210/jcem-64-4-675; HARNEY JP, IN PRESS ENDOCRINOLO; HEYMSFIELD SB, 1994, EXP GERONTOL, V29, P377, DOI 10.1016/0531-5565(94)90018-3; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43, DOI 10.1016/s0074-7696(08)61524-7; HIRSHFIELD AN, 1994, BIOL REPROD, V50, P421, DOI 10.1095/biolreprod50.2.421; HOOMEMAN EMD, 1982, BRAIN RES, V243, P235; HUGHES EG, 1990, J CLIN ENDOCR METAB, V70, P358, DOI 10.1210/jcem-70-2-358; JONES EC, 1960, J ENDOCRINOL, V20, P129, DOI 10.1677/joe.0.0200129; JUDD HL, 1982, ENDOCRINE ASPECTS AG, P163; KHOURY SA, 1987, J CLIN ENDOCR METAB, V64, P755, DOI 10.1210/jcem-64-4-755; Knobil E, 1980, Recent Prog Horm Res, V36, P53; Kordon Claude, 1994, P1621; KRARUP T, 1969, NATURE, V224, P187, DOI 10.1038/224187a0; KRONENBERG F, 1990, ANN NY ACAD SCI, V592, P52; LACKER HM, 1987, BIOL REPROD, V37, P570, DOI 10.1095/biolreprod37.3.570; LEE SJ, 1988, HUM REPROD, V3, P851, DOI 10.1093/oxfordjournals.humrep.a136796; LEGAN SJ, 1975, ENDOCRINOLOGY, V96, P57, DOI 10.1210/endo-96-1-57; LENTON EA, 1991, J CLIN ENDOCR METAB, V73, P1180, DOI 10.1210/jcem-73-6-1180; MACNAUGHTON J, 1992, CLIN ENDOCRINOL, V36, P339, DOI 10.1111/j.1365-2265.1992.tb01457.x; MATT DW, 1994, ENDOCRINE SOC, V76, P378; MCLACHIAN RI, 1992, CLIN ENDOCRINOL, V46, P175; MEREDITH S, 1985, BIOL REPROD, V32, P788, DOI 10.1095/biolreprod32.4.788; MEREDITH S, 1992, BIOL REPROD, V47, P162, DOI 10.1095/biolreprod47.2.162; METCALF MG, 1981, CLIN ENDOCRINOL, V14, P245, DOI 10.1111/j.1365-2265.1981.tb00193.x; NASS TE, 1984, J ENDOCRINOL, V100, P43, DOI 10.1677/joe.0.1000043; NELSON JF, 1987, REV BIOL RES AGING, V3, P359; PAGANINIHILL A, 1994, AM J EPIDEMIOL, V140, P256, DOI 10.1093/oxfordjournals.aje.a117244; PARKER CR, 1984, J CLIN ENDOCR METAB, V58, P488, DOI 10.1210/jcem-58-3-488; RICHARDSON GS, 1990, HDB BIOL AGING, P275; RICHARDSON SJ, 1987, J CLIN ENDOCR METAB, V65, P1231, DOI 10.1210/jcem-65-6-1231; SALISBURY RL, 1980, ACTA ENDOCRINOL-COP, V94, P166, DOI 10.1530/acta.0.0940166; SCARBROUGH K, 1990, ENDOCRINOLOGY, V126, P884, DOI 10.1210/endo-126-2-884; SCHWARTZ J, 1995, J CLIN PHARMACOL, V35, P314, DOI 10.1002/j.1552-4604.1995.tb04066.x; SHERMAN BM, 1976, J CLIN ENDOCR METAB, V42, P629, DOI 10.1210/jcem-42-4-629; SHERWIN BB, 1994, ANN NY ACAD SCI, V743, P213, DOI 10.1111/j.1749-6632.1994.tb55794.x; TESTART J, 1982, J CLIN ENDOCR METAB, V55, P374, DOI 10.1210/jcem-55-2-374; VANDERBEEK EM, 1993, J NEUROENDOCRINOL, V5, P137; Vom Saal FS, 1994, PHYSL REPRODUCTION, P1213; WEILAND NG, 1990, ENDOCRINOLOGY, V126, P2392, DOI 10.1210/endo-126-5-2392; WEILAND NG, 1992, ENDOCRINOLOGY, V131, P2959, DOI 10.1210/en.131.6.2959; WISE PM, 1988, P NATL ACAD SCI USA, V85, P5305, DOI 10.1073/pnas.85.14.5305; WISE PM, 1982, P SOC EXP BIOL MED, V169, P348, DOI 10.3181/00379727-169-41356; WISE PM, 1994, EXP GERONTOL, V29, P275, DOI 10.1016/0531-5565(94)90007-8; WISE PM, 1984, ENDOCRINOLOGY, V115, P801, DOI 10.1210/endo-115-2-801; WISE PM, 1991, FRONT NEUROENDOCRIN, V12, P323; WISE PM, 1982, BIOL REPROD, V27, P562, DOI 10.1095/biolreprod27.3.562; WISE PM, 1979, ENDOCRINOLOGY, V104, P940, DOI 10.1210/endo-104-4-940	66	164	168	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	1996	273	5271					67	70		10.1126/science.273.5271.67	http://dx.doi.org/10.1126/science.273.5271.67			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV478	8658198				2022-12-28	WOS:A1996UV47800035
J	Navarro, B; Kennedy, ME; Velimirovic, B; Bhat, D; Peterson, AS; Clapham, DE				Navarro, B; Kennedy, ME; Velimirovic, B; Bhat, D; Peterson, AS; Clapham, DE			Nonselective and G(beta gamma)-insensitive weaver K+ channels	SCIENCE			English	Article							MUTANT	Homozygous weaver mice are profoundly ataxic because of the loss of granule cell neurons during cerebellar development. This granule cell loss appears to be caused by a genetic defect in the pore region (Gly(156) --> Ser) of the heterotrimeric guanine nucleotide-binding protein (G protein)-gated inwardly rectifying potassium (K+) channel subunit (GIRK2). A related subunit, GIRK1, associates with GIRK2 to constitute a neuronal G protein-gated inward rectifier K+ channel. The weaver allele of the GIRK2 subunit (wvGIRK2) caused loss of K+ selectivity when expressed either as wvGIRK2 homomultimers or as GIRK1-wvGIRK2 heteromultimers. The mutation also led to loss of sensitivity to G protein beta gamma dimers. Expression of wvGIRK2 subunits led to increased cell death, presumably as a result of basal nonselective channel opening.	MAYO CLIN & MAYO FDN,DEPT PHARMACOL,ROCHESTER,MN 55905; DUKE UNIV,MED CTR,DEPT GENET,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT NEUROBIOL,DURHAM,NC 27710	Mayo Clinic; Duke University; Duke University			Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428				DUPRAT F, 1995, BIOCHEM BIOPH RES CO, V212, P657, DOI 10.1006/bbrc.1995.2019; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P28777, DOI 10.1074/jbc.270.48.28777; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; RAKIC P, 1973, J COMP NEUROL, V152, P103, DOI 10.1002/cne.901520202; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; SLESINGER PA, 1995, NEURON, V15, P1145, DOI 10.1016/0896-6273(95)90102-7; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; Velimirovic BM, 1996, FEBS LETT, V379, P31, DOI 10.1016/0014-5793(95)01465-9; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0	17	143	146	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1996	272	5270					1950	1953		10.1126/science.272.5270.1950	http://dx.doi.org/10.1126/science.272.5270.1950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8658170				2022-12-28	WOS:A1996UV29400052
J	English, M; Marsh, V; Amukoye, E; Lowe, B; Murphy, S; Marsh, K				English, M; Marsh, V; Amukoye, E; Lowe, B; Murphy, S; Marsh, K			Chronic salicylate poisoning and severe malaria	LANCET			English	Article							TOXICITY; CHILDREN	Background Salicylates continue to be marketed and to be used in developing countries as over-the-counter (OTC) antipyretics in children, whereas in developed countries they are no longer used in children because of safety concerns. The presenting signs of salicylate poisoning, especially chronic (repeated administration of therapeutic or excessive doses for longer than 12 h), can include metabolic acidosis, hypoglycaemia, lethargy, and coma and fits. These signs are also common in severe malaria in African children. Admission of two probable cases of chronic salicylate poisoning prompted us to look for other cases among children presenting to our hospital in Kenya, apparently with severe malaria. Methods All children admitted to Kilifi District Hospital between July and September, 1994, who had a positive blood film for Plasmodium falciparum, and one or more of coma, prostration, or respiratory distress were eligible, As well as routine tests for malaria and routine biochemistry, salicylate concentrations were measured, Management of children (aged 6 months to 10 years)in the community was assessed by a cross-sectional survey of 463 households and by interviews with mothers 2 days after they had bought OTC drugs for a child with fever. Findings Data were available for 143 of 154 children with initial primary diagnoses of severe malaria. 129 (90%) had detectable (>1 mg/dL) salicylate. Six of these had salicylate concentrations of 20 mg/dL or higher. All six had neurological impairment and metabolic acidosis and-four were, or became, hypoglycaemic. OTC drugs were the first line treatment in 188 (74%) of 254 fever episodes during the 2 weeks before the cross-sectional survey, Of 250 mothers who bought drugs for a febrile child, 236 (94%) bought a preparation containing salicylates and 50 (21%) gave a dose higher than the manufacturer's recommended maximum. Interpretation These cases suggest that in some children salicylate poisoning may cause or contribute to the development of metabolic acidosis and hypoglycaemia, complications of severe malaria associated with high mortality.	KENYA GOVT MED RES CTR,CLIN RES CTR,KILIFI UNIT,KILIFI,KENYA; JOHN RADCLIFFE HOSP,NUFFIELD DEPT MED,OXFORD OX3 9DU,ENGLAND	Kenya Medical Research Institute; University of Oxford				Marsh, Vicki/0000-0002-5178-4250; English, Michael/0000-0002-7427-0826; amukoye, Evans/0000-0003-0683-0585	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		English MC, 1996, ARCH DIS CHILD, V74, P201, DOI 10.1136/adc.74.3.201; FISHER CJ, 1985, AM J EMERG MED, V3, P33, DOI 10.1016/0735-6757(85)90009-9; GAUDREAULT P, 1982, PEDIATRICS, V70, P566; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; SLUTSKER L, 1994, TROP MED PARASITOL, V45, P61; SNODGRASS WR, 1986, PEDIATR CLIN N AM, V33, P381; TAYLOR TE, 1993, Q J MED, V86, P99; TEMPLE AR, 1981, ARCH INTERN MED, V141, P364, DOI 10.1001/archinte.141.3.364; TRINDER P, 1954, BIOCHEM J, V57, P301, DOI 10.1042/bj0570301	9	47	47	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 22	1996	347	9017					1736	1737		10.1016/S0140-6736(96)90809-0	http://dx.doi.org/10.1016/S0140-6736(96)90809-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT396	8656907				2022-12-28	WOS:A1996UT39600011
J	Freund, HJ				Freund, HJ			Remapping the brain	SCIENCE			English	Editorial Material											Freund, HJ (corresponding author), UNIV DUSSELDORF,DEPT NEUROL,MOORENSTR 5,D-40225 DUSSELDORF,GERMANY.							BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; DOMANN R, 1993, NEUROSCI LETT, V155, P69, DOI 10.1016/0304-3940(93)90675-B; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; KOZLOWSKI DA, IN PRESS J NEUROSCI; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; NUDO RJ, IN PRESS J NEUROPHYS; SEITZ RJ, 1995, NEUROREPORT, V6, P742, DOI 10.1097/00001756-199503270-00009	9	11	11	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1754	1754		10.1126/science.272.5269.1754	http://dx.doi.org/10.1126/science.272.5269.1754			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8650573				2022-12-28	WOS:A1996UT11000033
J	MunozJordan, JL; Davies, KP; Cross, GAM				MunozJordan, JL; Davies, KP; Cross, GAM			Stable expression of mosaic coats of variant surface glycoproteins in Trypanosoma brucei	SCIENCE			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; SITE-ASSOCIATED GENE; BLOOD-STREAM-FORM; ANTIGENIC VARIATION; AFRICAN TRYPANOSOMES; PHOSPHOLIPASE-C; MEMBRANE-FORM; VSG 117; PURIFICATION; SEQUENCE	The paradigm of antigenic variation in parasites is the variant surface glycoprotein (VSG) of Af rican trypanosomes. Only one VSG is expressed at any time, except for short periods during switching, The reasons for this pattern of expression and the consequences of expressing more than one VSG are unknown. Trypanosoma brucei was genetically manipulated to generate cell lines that expressed two VSGs simultaneously. These VSGs were produced in equal amounts and were homogeneously distributed on the trypanosome surface. The double-expressor cells had similar population doubling times and were as infective as wild-type cells. Thus, the simultaneous expression of two VSGs is not intrinsically harmful.	ROCKEFELLER UNIV,MOLEC PARASITOL LAB,NEW YORK,NY 10021	Rockefeller University			Cross, George A M/B-7444-2011	Cross, George A M/0000-0003-1374-6955; Davies, Kelvin/0000-0002-0201-9210	NIAID NIH HHS [AI 21531] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021531] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGUR Z, 1989, P NATL ACAD SCI USA, V86, P9626, DOI 10.1073/pnas.86.23.9626; AGUR Z, 1992, PARASITOL TODAY, V8, P128, DOI 10.1016/0169-4758(92)90280-F; AGUR Z, 1995, PARASITOL TODAY, V11, P24, DOI 10.1016/0169-4758(95)80103-0; ALARCON CM, 1994, MOL CELL BIOL, V14, P5579, DOI 10.1128/MCB.14.8.5579; ALINE RF, 1989, MOL BIOCHEM PARASIT, V32, P169, DOI 10.1016/0166-6851(89)90068-6; ALLEN G, 1982, J MOL BIOL, V157, P527, DOI 10.1016/0022-2836(82)90474-0; ALLEN G, 1983, BIOCHEM J, V209, P481, DOI 10.1042/bj2090481; BALTZ T, 1986, NATURE, V319, P602, DOI 10.1038/319602a0; BARRY D, 1992, PARASITOL TODAY, V8, P128; BERNARDS A, 1984, CELL, V36, P163, DOI 10.1016/0092-8674(84)90085-0; BLUM ML, 1993, NATURE, V362, P603, DOI 10.1038/362603a0; BOOTHROYD JC, 1982, J MOL BIOL, V157, P547, DOI 10.1016/0022-2836(82)90475-2; BORST P, 1994, SCIENCE, V264, P1872, DOI 10.1126/science.7516579; BULOW R, 1989, MOL BIOCHEM PARASIT, V32, P85, DOI 10.1016/0166-6851(89)90132-1; BULOW R, 1986, J BIOL CHEM, V261, P1918; CARRINGTON M, 1991, J MOL BIOL, V221, P823, DOI 10.1016/0022-2836(91)80178-W; CARRINGTON M, 1989, MOL BIOCHEM PARASIT, V33, P289, DOI 10.1016/0166-6851(89)90091-1; CARRUTHERS VB, 1992, P NATL ACAD SCI USA, V89, P8818, DOI 10.1073/pnas.89.18.8818; CARRUTHERS VB, 1993, NUCLEIC ACIDS RES, V21, P2537, DOI 10.1093/nar/21.10.2537; CORNELISSEN AWCA, 1985, CELL, V41, P825, DOI 10.1016/S0092-8674(85)80063-5; CROSS GAM, 1990, ANNU REV IMMUNOL, V8, P83, DOI 10.1146/annurev.iy.08.040190.000503; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Cross GAM, 1996, BIOESSAYS, V18, P283, DOI 10.1002/bies.950180406; CROSS GAM, 1984, J CELL BIOCHEM, V24, P79, DOI 10.1002/jcb.240240107; CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245; CROZATIER M, 1990, MOL BIOCHEM PARASIT, V42, P1, DOI 10.1016/0166-6851(90)90107-W; CULLY DF, 1985, CELL, V42, P173, DOI 10.1016/S0092-8674(85)80113-6; DEALMEIDA MLC, 1984, J PROTOZOOL, V31, P53, DOI 10.1111/j.1550-7408.1984.tb04289.x; DUSZENKO M, 1993, ADV CELL MOL BIOL M, V2, P227; EHLERS B, 1987, MOL CELL BIOL, V7, P1242, DOI 10.1128/MCB.7.3.1242; ESSER KM, 1985, SCIENCE, V229, P190, DOI 10.1126/science.3892689; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; FOX JA, 1986, J BIOL CHEM, V261, P5767; FREYMANN D, 1990, J MOL BIOL, V216, P141, DOI 10.1016/S0022-2836(05)80066-X; GRAHAM SV, 1995, PARASITOL TODAY, V11, P217, DOI 10.1016/0169-4758(95)80081-6; GRAHAM SV, 1991, MOL BIOCHEM PARASIT, V47, P31, DOI 10.1016/0166-6851(91)90145-V; GRAHAM SV, 1990, PARASITOLOGY, V101, P361, DOI 10.1017/S0031182000060558; GRAY AR, 1976, BIOLOGY KINETOPLASTI, V1, P493; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; HORN D, 1995, CELL, V83, P555, DOI 10.1016/0092-8674(95)90095-0; JOHNSON JG, 1977, J PROTOZOOL, V24, P587, DOI 10.1111/j.1550-7408.1977.tb01020.x; KOOTER JM, 1987, CELL, V51, P261, DOI 10.1016/0092-8674(87)90153-X; KOSINSKI RJ, 1980, PARASITOLOGY, V80, P343, DOI 10.1017/S0031182000000809; LAMONT GS, 1986, PARASITOLOGY, V92, P355, DOI 10.1017/S003118200006412X; LIGTENBERG MJL, 1994, EMBO J, V13, P2565, DOI 10.1002/j.1460-2075.1994.tb06546.x; LIPS S, 1993, MOL BIOCHEM PARASIT, V62, P135, DOI 10.1016/0166-6851(93)90189-5; LIU AYC, 1983, J MOL BIOL, V167, P57, DOI 10.1016/S0022-2836(83)80034-5; MILLER EN, 1981, PARASITOLOGY, V82, P63, DOI 10.1017/S0031182000041871; MYLER PJ, 1985, INFECT IMMUN, V47, P684, DOI 10.1128/IAI.47.3.684-690.1985; NAVARRO M, IN PRESS MOL CELL BI, V16; SALMON D, 1994, CELL, V78, P75, DOI 10.1016/0092-8674(94)90574-6; SCHOLLER JK, 1988, MOL BIOCHEM PARASIT, V29, P89, DOI 10.1016/0166-6851(88)90123-5; SEYFANG A, 1990, J PROTOZOOL, V37, P546, DOI 10.1111/j.1550-7408.1990.tb01263.x; STEVERDING D, 1995, J CELL BIOL, V131, P1173, DOI 10.1083/jcb.131.5.1173; STRANG AM, 1993, BIOCHEM BIOPH RES CO, V196, P1430, DOI 10.1006/bbrc.1993.2412; TIMMERS HTM, 1987, J MOL BIOL, V184, P81; TURNER CMR, 1989, PARASITOLOGY, V99, P67, DOI 10.1017/S0031182000061035; VANDERPLOEG LHT, 1982, NUCLEIC ACIDS RES, V10, P5905, DOI 10.1093/nar/10.19.5905; VANHAMME L, 1995, MICROBIOL REV, V59, P223, DOI 10.1128/MMBR.59.2.223-240.1995; WILLIAMS BG, 1995, TRYP LEISHM SEM GLAS; ZAMZE SE, 1991, J BIOL CHEM, V266, P20244; ZAMZE SE, 1990, EUR J BIOCHEM, V187, P657, DOI 10.1111/j.1432-1033.1990.tb15350.x	62	48	48	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1795	1797		10.1126/science.272.5269.1795	http://dx.doi.org/10.1126/science.272.5269.1795			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8650579				2022-12-28	WOS:A1996UT11000045
J	Nudo, RJ; Wise, BM; SiFuentes, F; Milliken, GW				Nudo, RJ; Wise, BM; SiFuentes, F; Milliken, GW			Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct	SCIENCE			English	Article							OWL MONKEYS; CORTEX; ORGANIZATION; AREA; REORGANIZATION; REPRESENTATION; STIMULATION; STROKE; HAND; MAPS	Substantial functional reorganization lakes place in the motor cortex of adult primates after a focal ischemic infarct, as might occur in stroke. A subtotal lesion confined to a small portion of the representation of one hand was previously shown to result in a further loss of hand territory in the adjacent, undamaged cortex of adult squirrel monkeys. In the present study, retraining of skilled hand use after similar infarcts resulted in prevention of the loss of hand territory adjacent to the infarct. In some instances, the hand representations expanded into regions formerly occupied by representations of the elbow and shoulder. Functional reorganization in the undamaged motor cortex was accompanied by behavioral recovery of skilled hand function. These results suggest that, after local damage to the motor cortex, rehabilitative training can shape subsequent reorganization in the adjacent intact cortex, and that the undamaged motor cortex may play an important role in motor recovery.			Nudo, RJ (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT NEUROBIOL & ANAT,HOUSTON,TX 77030, USA.		Nudo, Randolph/B-1623-2009		NINDS NIH HHS [NS27974, NS30853] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030853, R29NS027974] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bach-y-Rita P., 1980, RECOVERY FUNCTION TH, P225; BENECKE R, 1991, EXP BRAIN RES, V83, P419; Black P, 1970, Trans Am Neurol Assoc, V95, P207; BLACK P, 1975, OUTCOME SEVERE DAMAG, P65; BUCY PC, 1944, PRECENTRAL MOTOR COR, P353; CASTROALAMANCOS MA, 1992, EUR J NEUROSCI, V4, P853, DOI 10.1111/j.1460-9568.1992.tb00195.x; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; DONOGHUE JP, 1988, J NEUROSCI, V8, P3221; DONOGHUE JP, 1992, EXP BRAIN RES, V89, P1; GLEES P, 1950, J NEUROPHYSIOL, V13, P137, DOI 10.1152/jn.1950.13.2.137; GOULD HJ, 1986, J COMP NEUROL, V247, P297, DOI 10.1002/cne.902470303; Gowland C, 1987, STROKE REHABILITATIO, P217; HOFFMAN DS, 1995, J NEUROPHYSIOL, V73, P891, DOI 10.1152/jn.1995.73.2.891; Jenkins WM, 1987, PROG BRAIN RES <D>, V71, P249; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; KARNI A, 1995, NATURE, V377, P155; Lashley KS, 1924, ARCH NEURO PSYCHIATR, V12, P249, DOI 10.1001/archneurpsyc.1924.02200030002001; Nudo R. J., 1995, Society for Neuroscience Abstracts, V21, P517; NUDO RJ, 1992, J NEUROSCI, V12, P2918, DOI 10.1523/JNEUROSCI.12-08-02918.1992; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; Nudo RJ, 1996, J NEUROSCI, V16, P785; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; PASSINGHAM RE, 1983, BRAIN, V106, P675, DOI 10.1093/brain/106.3.675; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1015, DOI 10.1152/jn.1992.67.5.1015; RIDDING MC, 1995, CAN J PHYSIOL PHARM, V73, P218, DOI 10.1139/y95-032; SANES JN, 1995, SCIENCE, V268, P1775, DOI 10.1126/science.7792606; SCHLAUG G, 1994, EXP BRAIN RES, V98, P523; SEITZ RJ, 1995, NEUROREPORT, V6, P742, DOI 10.1097/00001756-199503270-00009; STRICK PL, 1982, J NEUROPHYSIOL, V48, P139, DOI 10.1152/jn.1982.48.1.139; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; TRAVIS A M, 1956, Am J Phys Med, V35, P273; TWITCHELL TE, 1951, BRAIN, V74, P443, DOI 10.1093/brain/74.4.443; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0	34	1313	1398	6	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1791	1794		10.1126/science.272.5269.1791	http://dx.doi.org/10.1126/science.272.5269.1791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8650578				2022-12-28	WOS:A1996UT11000044
J	Levin, LA				Levin, LA			Ophthalmology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANALOG; PHXA41				Levin, LA (corresponding author), UNIV WISCONSIN, SCH MED, MADISON, WI 53706 USA.							ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; Adamis AP, 1996, ARCH OPHTHALMOL-CHIC, V114, P66, DOI 10.1001/archopht.1996.01100130062010; AIELLO LP, 1995, ARCH OPHTHALMOL-CHIC, V113, P1538, DOI 10.1001/archopht.1995.01100120068012; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; ALM A, 1995, BRIT J OPHTHALMOL, V79, P12, DOI 10.1136/bjo.79.1.12; Alm A, 1995, OPHTHALMOLOGY, V102, P1743, DOI 10.1016/S0161-6420(95)30798-1; BASS EB, 1995, ARCH OPHTHALMOL-CHIC, V113, P1248, DOI 10.1001/archopht.1995.01100100036025; CHEW EY, 1995, ARCH OPHTHALMOL-CHIC, V113, P52, DOI 10.1001/archopht.1995.01100010054020; Diabet Control Complications Trial Res Grp, 1995, OPHTHALMOLOGY, V102, P647; DREW WL, 1995, NEW ENGL J MED, V333, P615, DOI 10.1056/NEJM199509073331002; GABELT BT, 1989, EXP EYE RES, V49, P389, DOI 10.1016/0014-4835(89)90049-3; MILLER JW, 1994, AM J PATHOL, V145, P574; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; RACZ P, 1993, ARCH OPHTHALMOL-CHIC, V111, P657, DOI 10.1001/archopht.1993.01090050091036; RULO AH, 1994, BRIT J OPHTHALMOL, V78, P899, DOI 10.1136/bjo.78.12.899; STRAHLMAN E, 1995, ARCH OPHTHALMOL-CHIC, V113, P1009, DOI 10.1001/archopht.1995.01100080061030; TORIS CB, 1993, OPHTHALMOLOGY, V100, P1297; 1996, ARCH OPHTHALMOL-CHIC, V114, P23; 1995, ARCH OPHTHALMOL-CHIC, V113, P36	19	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1834	1836		10.1001/jama.275.23.1834	http://dx.doi.org/10.1001/jama.275.23.1834			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642737				2022-12-28	WOS:A1996UQ15200036
J	Glickman, S; Kamm, MA				Glickman, S; Kamm, MA			Bowel dysfunction in spinal-card-injury patients	LANCET			English	Article							CORD INJURY; STIMULATION	Background This study aimed to determine the prevalence, nature, and effects-both physical and psychological-of spinal-cord-injury (SCI) on bower function. Methods 115 consecutive hospital outpatients (89 male, median age 38 years) with chronic SCI (median duration 62 months, range 9-491 months, 48% cervical, 47% thoracic, 5% lumbar) completed a questionnaire about pre and post injury bowel function, the Hospital Anxiety and Depression Scale (HADS), and self assessment of the impact of their disabilities and symptoms. Findings Nausea, diarrhoea, constipation, and faecal incontinence were all much more common (p<0 . 0001) after SCI. 95% of patients required at least one therapeutic method to initiate defaecation. Half the patients became dependent on others for toileting. 49% took more than 30 min to complete their toilet procedure. Bowel function was a source of distress in 54% of patients and this was significantly (p=0 . 005) associated with the time required for bowel management and frequency of incontinence (p=0 . 001). There was a highly significant correlation between the HADS scores and the time taken for bower management. On a scale of 0 (for no perceived problem) to 10 (maximum perceived problem), patients rated their loss of mobility as a mean of 6 . 8 (SD 3 . 3) and their bowel management as 5 . 1(SD 3 . 6). Interpretation Dowel function is a major physical and psychological problem in SCI patients.	CHARING CROSS HOSP,DEPT REHABIL MED,LONDON,ENGLAND; ST MARKS HOSP,MED PHYSIOL UNIT,LONDON EC1V 2PS,ENGLAND	Imperial College London; Imperial College London				Glickman, Scott/0000-0002-8084-9949				DEVROEDE G, 1979, GASTROENTEROLOGY, V77, P1258; FROST F, 1993, ARCH PHYS MED REHAB, V74, P696, DOI 10.1016/0003-9993(93)90027-8; GLICK ME, 1986, PARAPLEGIA, V24, P129, DOI 10.1038/sc.1986.17; HILL J, 1994, BRIT J SURG, V81, P1490, DOI 10.1002/bjs.1800811030; MACDONAGH RP, 1990, BRIT MED J, V300, P1494, DOI 10.1136/bmj.300.6738.1494; MACINTYRE AS, 1992, GUT, V33, P1062; MENARDO G, 1987, DIS COLON RECTUM, V30, P924, DOI 10.1007/BF02554277; STONE JM, 1990, ARCH PHYS MED REHAB, V71, P514; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	9	255	258	0	8	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 15	1996	347	9016					1651	1653		10.1016/S0140-6736(96)91487-7	http://dx.doi.org/10.1016/S0140-6736(96)91487-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ701	8642958				2022-12-28	WOS:A1996UQ70100010
J	Koop, T; Carslaw, KS				Koop, T; Carslaw, KS			Melting of H2SO4 center dot 4H2O particles upon cooling: Implications for polar stratospheric clouds	SCIENCE			English	Article							OZONE	Polar stratospheric clouds (PSCs) are important for the chemical activation of chlorine compounds and subsequent ozone depletion. Solid PSCs can form on sulfuric acid tetrahydrate (SAT) (H2SO4 . 4H(2)O) nuclei, but recent laboratory experiments have shown that PSC nucleation on SAT is strongly hindered. A PSC formation mechanism is proposed in which SAT particles melt upon cooling in the presence of HNO3 to form liquid HNO3-H2SO4-H2O droplets 2 to 3 kelvin above the ice frost point. This mechanism offers a PSC formation temperature that is defined by the ambient conditions and sets a temperature limit below which PSCs should form.			Koop, T (corresponding author), MAX PLANCK INST CHEM,POSTFACH 3060,D-55020 MAINZ,GERMANY.		Carslaw, Ken S/C-8514-2009; Koop, Thomas/B-7861-2008	Carslaw, Ken S/0000-0002-6800-154X; Koop, Thomas/0000-0002-7571-3684				ADRIANI A, 1995, J GEOPHYS RES, V100, P25977; CARSLAW KS, 1994, GEOPHYS RES LETT, V21, P2479, DOI 10.1029/94GL02799; CARSLAW KS, 1995, J PHYS CHEM-US, V99, P11557, DOI 10.1021/j100029a039; DRDLA K, 1994, GEOPHYS RES LETT, V21, P2475, DOI 10.1029/94GL02405; GABLE CM, 1950, J AM CHEM SOC, V72, P1445, DOI 10.1021/ja01160a005; HANSON DR, 1992, GEOPHYS RES LETT, V19, P2063, DOI 10.1029/92GL02182; IRACI LT, 1995, J GEOPHYS RES-ATMOS, V100, P20969, DOI 10.1029/95JD02267; KOOP T, 1995, GEOPHYS RES LETT, V22, P917, DOI 10.1029/95GL00814; MACKENZIE AR, 1995, J GEOPHYS RES-ATMOS, V100, P11275, DOI 10.1029/95JD00699; MARTI J, 1993, GEOPHYS RES LETT, V20, P359, DOI 10.1029/93GL00083; MEILINGER SK, 1995, GEOPHYS RES LETT, V22, P3031, DOI 10.1029/95GL03056; MIDDLEBROOK AM, 1993, J GEOPHYS RES-ATMOS, V98, P20473, DOI 10.1029/93JD02454; MOLINA MJ, 1993, SCIENCE, V261, P1418, DOI 10.1126/science.261.5127.1418; POOLE LR, 1988, J GEOPHYS RES-ATMOS, V93, P8423, DOI 10.1029/JD093iD07p08423; ROSEN JM, 1993, J GEOPHYS RES-ATMOS, V98, P12741, DOI 10.1029/93JD00880; TABAZADEH A, 1994, GEOPHYS RES LETT, V21, P1619, DOI 10.1029/94GL01368; TABAZADEH RP, 1994, J GEOPHYS RES, V99, P12897; TOLBERT MA, 1994, SCIENCE, V264, P527, DOI 10.1126/science.264.5158.527; ZHANG RY, 1995, J GEOPHYS RES-ATMOS, V100, P18845, DOI 10.1029/95JD01876	19	51	52	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1996	272	5268					1638	1641		10.1126/science.272.5268.1638	http://dx.doi.org/10.1126/science.272.5268.1638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8662477				2022-12-28	WOS:A1996UR09300042
J	Mayewski, PA; Twickler, MS; Whitlow, SI; Meeker, LD; Yang, Q; Thomas, J; Kreutz, K; Grootes, PM; Morse, DL; Steig, EJ; Waddington, ED; Saltzman, ES; Whung, PY; Taylor, KC				Mayewski, PA; Twickler, MS; Whitlow, SI; Meeker, LD; Yang, Q; Thomas, J; Kreutz, K; Grootes, PM; Morse, DL; Steig, EJ; Waddington, ED; Saltzman, ES; Whung, PY; Taylor, KC			Climate change during the last deglaciation in Antarctica	SCIENCE			English	Article							SNOW ACCUMULATION; YOUNGER DRYAS; ATLANTIC; OCEAN; BP	Greenland ice core records provide clear evidence of rapid changes in climate in a variety of climate indicators. In this work, rapid climate change events in the Northern and Southern hemispheres are compared on the basis of an examination of changes in atmospheric circulation developed from two ice cores. High-resolution glaciochemical series, covering the period 10,000 to 16,000 years ago, from a central Greenland ice core and anew site in east Antarctica display similar variability. These findings suggest that rapid climate change events occur more frequently in Antarctica than previously demonstrated.	UNIV NEW HAMPSHIRE, DEPT EARTH SCI, DURHAM, NH 03824 USA; UNIV NEW HAMPSHIRE, DEPT MATH, DURHAM, NH 03824 USA; UNIV WASHINGTON, QUATERNARY RES CTR AK60, SEATTLE, WA 98195 USA; UNIV WASHINGTON, GEOPHYS PROGRAM, SEATTLE, WA 98195 USA; UNIV MIAMI, ROSENSTIEL SCH MARINE & ATMOSPHER SCI, MIAMI, FL 33149 USA; UNIV MIAMI, NOAA, ATLANTIC OCEANOG & METEOROL LAB, OCEAN CHEM DIV, MIAMI, FL 33149 USA; UNIV & COMMUNITY COLL SYST NEVADA, DESERT RES INST, WATER RESOURCES CTR, RENO, NV 89506 USA	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); University of Miami; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Mayewski, PA (corresponding author), UNIV NEW HAMPSHIRE, INST STUDY EARTH OCEANS & SPACE, CLIMATE CHANGE RES CTR, DURHAM, NH 03824 USA.		Taylor, Kendrick/A-3469-2016; Steig, Eric J/G-9088-2015; Grootes, Pieter M/F-4952-2011	Taylor, Kendrick/0000-0001-8535-1261; Steig, Eric J/0000-0002-8191-5549; Grootes, Pieter/0000-0003-4265-3168				ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; BARD E, 1989, QUATERNARY RES, V31, P309, DOI 10.1016/0033-5894(89)90011-2; COOK E, 1991, SCIENCE, V253, P1266, DOI 10.1126/science.253.5025.1266; DEANGELIS M, 1992, J ATMOS CHEM, V14, P233, DOI 10.1007/BF00115236; DENTON GH, 1994, SCIENCE, V264, P1434, DOI 10.1126/science.264.5164.1434; ENOMOTO H, 1991, CLIMATIC CHANGE, V18, P67, DOI 10.1007/BF00142505; GASSE F, 1989, QUATERNARY RES, V32, P229, DOI 10.1016/0033-5894(89)90079-3; GASSE F, 1977, NATURE, V265, P42, DOI 10.1038/265042a0; GROOTES M, UNPUB; Grootes P. M., 1994, EOS, V75, P225; HEINE JT, 1993, QUATERNARY SCI REV, V12, P769, DOI 10.1016/0277-3791(93)90016-F; JOUZEL J, 1995, CLIM DYNAM, V11, P151, DOI 10.1007/BF00223498; JOUZEL J, 1992, NATO ASI SER, V1, P230; KEIGWIN LD, 1991, J GEOPHYS RES-OCEANS, V96, P16811, DOI 10.1029/91JC01624; LORIUS C, 1977, IAHS PUBLICATION, V118, P125; MALAIZE B, 1994, EOS, V75, P226; MAYEWSKI PA, 1994, SCIENCE, V263, P1747, DOI 10.1126/science.263.5154.1747; MAYEWSKI PA, 1993, SCIENCE, V261, P195, DOI 10.1126/science.261.5118.195; MEESE DA, 1994, 9401 COLD REG RES EN; Nilsson T., 1983, PLEISTOCENE GEOLOGY; OVERPECK JT, 1989, NATURE, V338, P553, DOI 10.1038/338553a0; PETIT JR, 1981, NATURE, V293, P391, DOI 10.1038/293391a0; RUDDIMAN WF, 1981, PALAEOGEOGR PALAEOCL, V35, P145; STAGER JC, 1988, QUATERNARY RES, V29, P54, DOI 10.1016/0033-5894(88)90071-3; STEIG EJ, UNPUB; Stuiver M, 1995, QUATERNARY RES, V44, P341, DOI 10.1006/qres.1995.1079; TAYLOR KC, 1993, NATURE, V361, P432, DOI 10.1038/361432a0; WADDINGTON ED, 1993, NATO ASI SER, V1, P499	28	91	97	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	1996	272	5268					1636	1638		10.1126/science.272.5268.1636	http://dx.doi.org/10.1126/science.272.5268.1636			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8662476	Green Submitted			2022-12-28	WOS:A1996UR09300041
J	Mellors, JW; Rinaldo, CR; Gupta, P; White, RM; Todd, JA; Kingsley, LA				Mellors, JW; Rinaldo, CR; Gupta, P; White, RM; Todd, JA; Kingsley, LA			Prognosis in HIV-1 infection predicted by the quantity of virus in plasma	SCIENCE			English	Article							MULTICENTER AIDS COHORT; TYPE-1	The relation between viremia and clinical outcome in individuals infected with human immunodeficiency virus-type 1 (HIV-1) has important implications for therapeutic research and clinical care. HIV-1 RNA in plasma was quantified with a branched-DNA signal amplification assay as a measure of viral load in a cohort of 180 seropositive men studied for more than 10 years. The risk of acquired immunodeficiency syndrome (AIDS) and death in study subjects, including those with normal numbers of CD4(+) T cells, was directly related to plasma viral load at study entry. Plasma viral load was a better predictor of progression to AIDS and death than was the number of CD4(+) T cells.	UNIV PITTSBURGH,SCH MED,DEPT MED,PITTSBURGH,PA 15213; VET AFFAIRS MED CTR,PITTSBURGH,PA 15240; UNIV PITTSBURGH,SCH MED,DEPT PATHOL,PITTSBURGH,PA 15261; CHIRON CORP,EMERYVILLE,CA 94608; UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT EPIDEMIOL,PITTSBURGH,PA 15261	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Novartis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mellors, JW (corresponding author), UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT INFECT DIS & MICROBIOL,403 PARRAN HALL,PITTSBURGH,PA 15261, USA.			Kingsley, Lawrence/0000-0002-7000-8556	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034301, U01AI035041, N01AI072632] Funding Source: NIH RePORTER; NIAID NIH HHS [U01-AI-35041, R01-AI34301-01, N01-AI-72632] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		COOMBS RW, 1989, NEW ENGL J MED, V321, P1626, DOI 10.1056/NEJM198912143212402; Cox D. R., 1984, ANAL SURVIVAL DATA; DEGRUTTOLA V, 1995, AIDS CLIN TRIALS, P129; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; FALTERMA.KW, 1974, CANCER, V34, P951, DOI 10.1002/1097-0142(197409)34:3+<951::AID-CNCR2820340725>3.0.CO;2-9; FREIMUTH W, 1996, 3 C RETR OPP INF INF; GIORGI JV, 1990, CLIN IMMUNOL IMMUNOP, V55, P173, DOI 10.1016/0090-1229(90)90096-9; GUPTA P, 1993, VIROLOGY, V196, P586, DOI 10.1006/viro.1993.1514; HENRARD DR, 1995, JAMA-J AM MED ASSOC, V274, P554, DOI 10.1001/jama.274.7.554; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HO DD, 1989, NEW ENGL J MED, V321, P1621, DOI 10.1056/NEJM198912143212401; HOGERVORST E, 1995, J INFECT DIS, V171, P811, DOI 10.1093/infdis/171.4.811; JURRIAANS S, 1994, VIROLOGY, V204, P223, DOI 10.1006/viro.1994.1526; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; KENNEDY BJ, 1985, CANCER, V56, P2547, DOI 10.1002/1097-0142(19851201)56:11<2547::AID-CNCR2820561102>3.0.CO;2-X; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; MUNOZ A, 1995, J ACQ IMMUN DEF SYND, V8, P496, DOI 10.1097/00042560-199504120-00010; MUNOZ A, 1989, AM J EPIDEMIOL, V130, P530, DOI 10.1093/oxfordjournals.aje.a115367; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; SAKSELA K, 1995, ANN INTERN MED, V123, P641, DOI 10.7326/0003-4819-123-9-199511010-00001; TODD J, 1995, J ACQ IMMUN DEF SYND, V10, pS35; TSOUKAS CM, 1994, CLIN MICROBIOL REV, V7, P14, DOI 10.1128/CMR.7.1.14-28.1994; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	25	2134	2212	4	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 24	1996	272	5265					1167	1170		10.1126/science.272.5265.1167	http://dx.doi.org/10.1126/science.272.5265.1167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8638160				2022-12-28	WOS:A1996UM88900049
J	Gautam, M; Noakes, PG; Moscoso, L; Rupp, F; Scheller, RH; Merlie, JP; Sanes, JR				Gautam, M; Noakes, PG; Moscoso, L; Rupp, F; Scheller, RH; Merlie, JP; Sanes, JR			Defective neuromuscular synaptogenesis in agrin-deficient mutant mice	CELL			English	Article							CULTURED MUSCLE-CELLS; ACETYLCHOLINE-RECEPTOR CLUSTERS; TORPEDO ELECTRIC ORGAN; EXTRACELLULAR-MATRIX; PROTEIN; MOLECULES; INDUCTION; JUNCTION; REDISTRIBUTION; LOCALIZATION	During neuromuscular synapse formation, motor axons induce clustering of acetylcholine receptors (AChRs) in the muscle fiber membrane. The protein agrin, originally isolated from the basal lamina of the synaptic cleft, is synthesized and secreted by motoneurons and triggers formation of AChR clusters on cultured myotubes. We show here that postsynaptic AChR aggregates are markedly reduced in number, size, and density in muscles of agrin-deficient mutant mice. These results support the hypothesis that agrin is a critical organizer of postsynaptic differentiation. However, some postsynaptic differentiation does occur in the mutant, suggesting the existence of a second nerve-derived synaptic organizing signal. In addition, we show that intramuscular nerve branching and presynaptic differentiation are abnormal in the mutant, phenotypes which may reflect either a distinct effect of agrin or impaired retrograde signaling from a defective postsynaptic apparatus.	WASHINGTON UNIV, SCH MED, DEPT MOLEC BIOL & PHARMACOL, ST LOUIS, MO 63110 USA; STANFORD UNIV, SCH MED, HOWARD HUGHES MED INST, DEPT MOL & CELLULAR PHYSIOL, STANFORD, CA 94305 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Stanford University	Gautam, M (corresponding author), WASHINGTON UNIV, SCH MED, DEPT ANAT & NEUROBIOL, ST LOUIS, MO 63110 USA.		Noakes, Peter/X-9825-2019	Noakes, Peter/0000-0001-9821-8478; Gautam, Medha/0000-0002-5418-4322				ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; BENNETT MR, 1975, COLD SPRING HARB SYM, V40, P409, DOI 10.1101/SQB.1976.040.01.039; BLOCH RJ, 1988, AM J PHYSIOL, V254, pC345, DOI 10.1152/ajpcell.1988.254.3.C345; BOWE MA, 1995, ANNU REV NEUROSCI, V18, P443; BROWN MC, 1981, ANNU REV NEUROSCI, V4, P17, DOI 10.1146/annurev.ne.04.030181.000313; BURG MA, 1995, J NEUROSCI RES, V41, P49, DOI 10.1002/jnr.490410107; Campagna JA, 1995, NEURON, V15, P1365, DOI 10.1016/0896-6273(95)90014-4; CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; COHEN MW, 1992, J NEUROSCI, V12, P2982, DOI 10.1523/JNEUROSCI.12-08-02982.1992; DAVEY DF, 1986, J NEUROSCI, V6, P673; DECHIARA TM, 1996, IN PRESS CELL; DUCLERT A, 1995, PHYSIOL REV, V75, P339, DOI 10.1152/physrev.1995.75.2.339; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; FRANK E, 1979, J CELL BIOL, V83, P143, DOI 10.1083/jcb.83.1.143; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; GODFREY EW, 1991, EXP CELL RES, V195, P99, DOI 10.1016/0014-4827(91)90504-N; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HARRIS A J, 1981, Philosophical Transactions of the Royal Society of London B Biological Sciences, V293, P287, DOI 10.1098/rstb.1981.0078; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; HOUENOU LJ, 1990, J NEUROBIOL, V21, P1249, DOI 10.1002/neu.480210809; KUROMI H, 1984, DEV BIOL, V103, P53, DOI 10.1016/0012-1606(84)90006-X; LUPA MT, 1989, J NEUROSCI, V9, P3937; MA E, 1994, J NEUROSCI, V14, P2943; MAGILLSOLC C, 1988, J CELL BIOL, V107, P1825, DOI 10.1083/jcb.107.5.1825; MARTIN PT, 1995, NEURON, V14, P743, DOI 10.1016/0896-6273(95)90218-X; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MERLIE JP, 1985, NATURE, V317, P66, DOI 10.1038/317066a0; MOSCOSO LM, 1995, MOL CELL NEUROSCI, V6, P80, DOI 10.1006/mcne.1995.1008; MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; PENG HB, 1995, J NEUROSCI, V15, P3027; PENG HB, 1991, NEURON, V6, P237; PENG HB, 1982, J NEUROSCI, V2, P1760; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1992, J NEUROSCI, V12, P3535; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; SANES JR, 1991, DEVELOPMENT, V113, P1181; SMITH MA, 1992, MOL CELL NEUROSCI, V3, P406, DOI 10.1016/1044-7431(92)90052-4; SMITH MA, 1994, NEURON, V12, P795, DOI 10.1016/0896-6273(94)90332-8; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WALLACE BG, 1989, J NEUROSCI, V9, P1294; ZISKINDCONHAIM L, 1984, J NEUROSCI, V4, P2346	53	756	771	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 17	1996	85	4					525	535		10.1016/S0092-8674(00)81253-2	http://dx.doi.org/10.1016/S0092-8674(00)81253-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UM415	8653788	hybrid			2022-12-28	WOS:A1996UM41500010
J	Mahon, BE; Mintz, ED; Greene, KD; Wells, JG; Tauxe, RV				Mahon, BE; Mintz, ED; Greene, KD; Wells, JG; Tauxe, RV			Reported cholera in the United States, 1992-1994 - A reflection of global changes in cholera epidemiology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VIBRIO-CHOLERAE; OUTBREAK; AMERICA; STRAIN; VCA-3	Objective.-To describe US cholera surveillance data from 1992 to 1994 and the domestic impact of the epidemics of Vibrio cholerae O1 in Latin America and V cholerae O139 in Asia. Design, Setting, and Participants.-Retrospective review of surveillance data from all cases of cholera reported to the Centers for Disease Control and Prevention (CDC) from January 1, 1992, through December 31, 1994, in the United States and its territories. Main Outcome Measures.-Clinical, epidemiologic, and laboratory surveillance data. Results.-From 1992 through 1994, 160 cases of cholera were reported to CDC by 20 states and 1 territory. This is a marked increase: only 136 cases were reported from 1965 through 1991. Outbreaks affecting 75 passengers on an airplane from Latin America and 5 passengers on a cruise ship in Southeast Asia accounted for 50% of cases. Vibrio cholerae O139 caused 6 cases (4%). The proportion of V cholerae O1 isolates resistant to at least 1 antimicrobial agent rose from 3% in 1992 to 93% in 1994. Of 158 patients whose location of exposure was known, 151 (96%) acquired infection abroad (125 in Latin America, 26 in Asia). Of 105 persons whose reason for travel was known, 31 (30%) were US residents who had returned to their country of origin to visit family or friends, and 65 (62%) were non-US residents visiting the United States from cholera-affected countries. The cholera rate among persons arriving in the United States from cholera-affected regions was 0.27 case per 100 000 air travelers, not substantially increased from earlier estimates. Conclusions.-Cholera has increased in the United States since 1991, reflecting global changes in cholera epidemiology, and is now primarily travel associated and antimicrobial resistant. Most travelers were not traditional tourists; reaching them with prevention measures may be difficult. The risk of cholera to the individual traveler remains extremely low.			Mahon, BE (corresponding author), CTR DIS CONTROL & PREVENT,FOODBORNE & DIARRHEAL DIS BRANCH,DIV BACTERIAL & MYCOT DIS,ATLANTA,GA 30333, USA.							ALBERT MJ, 1993, LANCET, V341, P704; ALMEIDA RJ, 1992, J CLIN MICROBIOL, V30, P300, DOI 10.1128/JCM.30.2.300-304.1992; BART KJ, 1970, J INFECT DIS, V121, pS17, DOI 10.1093/infdis/121.Supplement.S17; BESSER RE, 1994, JAMA-J AM MED ASSOC, V272, P1203, DOI 10.1001/jama.272.15.1203; BLAKE PA, 1980, NEW ENGL J MED, V302, P305, DOI 10.1056/NEJM198002073020601; BOYCE TG, 1995, J INFECT DIS, V172, P1401, DOI 10.1093/infdis/172.5.1401; *CDCP, 1995, HLTH INF INT TRAV 19; CHONGSANGUAN M, 1993, LANCET, V342, P430, DOI 10.1016/0140-6736(93)92841-G; EberhartPhillips J, 1996, EPIDEMIOL INFECT, V116, P9, DOI 10.1017/S0950268800058891; EVINS GM, 1995, J INFECT DIS, V172, P173, DOI 10.1093/infdis/172.1.173; FINELLI L, 1992, J INFECT DIS, V166, P1433, DOI 10.1093/infdis/166.6.1433; GOLDBERG S, 1983, INFECT IMMUN, V42, P224, DOI 10.1128/IAI.42.1.224-230.1983; JOHNSTON JM, 1983, NEW ENGL J MED, V309, P523, DOI 10.1056/NEJM198309013090903; KLONTZ KC, 1987, ANN INTERN MED, V107, P846, DOI 10.7326/0003-4819-107-6-846; Levine Myron M., 1994, P395; LOWRY PW, 1989, ARCH INTERN MED, V149, P2079, DOI 10.1001/archinte.149.9.2079; MACPHERSON DW, 1992, CAN MED ASSOC J, V146, P1947; MEKALANOS JJ, 1994, SCIENCE, V265, P1387, DOI 10.1126/science.8073279; *NAT COMM CLIN LAB, 1993, M2A5 NAT COMM CLIN L; RAMAMURTHY T, 1993, LANCET, V341, P703, DOI 10.1016/0140-6736(93)90480-5; SANCHEZ JL, 1994, LANCET, V344, P1273, DOI 10.1016/S0140-6736(94)90755-2; SHIMADA T, 1993, LANCET, V341, P1347; SNYDER JD, 1982, JAMA-J AM MED ASSOC, V247, P2268, DOI 10.1001/jama.1982.03320410050031; SWERDLOW DL, 1992, JAMA-J AM MED ASSOC, V267, P1495, DOI 10.1001/jama.267.11.1495; TAUXE RV, 1992, JAMA-J AM MED ASSOC, V267, P1388, DOI 10.1001/jama.267.10.1388; TAYLOR JL, 1993, J INFECT DIS, V167, P1330, DOI 10.1093/infdis/167.6.1330; *US DEP TRANSP, 1995, INT AIR TRAV STAT 19; WEBER JT, 1994, ARCH INTERN MED, V154, P551, DOI 10.1001/archinte.154.5.551; WEISSMAN JB, 1975, AM J EPIDEMIOL, V100, P487; *WHO, 1991, WHO PROGR CONTR DIAR; WOODWARD WE, 1970, J INFECT DIS, V121, pS10, DOI 10.1093/infdis/121.Supplement.S10; 1991, MMWR-MORBID MORTAL W, V40, P516; 1991, MMWR-MORBID MORTAL W, V40, P108; 1995, WKLY EPIDEMIOL REC, V70, P201; 1977, MMWR-MORBID MORTAL W, V26, P307; 1995, EPIDEMIOL B PAN AM H, V16, P11; 1993, LANCET, V342, P387; 1990, MMWR-MORBID MORTAL W, V39, P9; 1993, MMWR-MORBID MORTAL W, V42, P501; 1995, MMWR-MORBID MORTAL W, V44, P385; 1992, MMWR-MORBID MORTAL W, V41, P664; 1977, MMWR-MORBID MORTAL W, V26, P302; 1988, MMWR-MORBID MORTAL W, V37, P617; 1995, MMWR-MORBID MORTAL W, V44, P215	44	34	36	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1996	276	4					307	312		10.1001/jama.276.4.307	http://dx.doi.org/10.1001/jama.276.4.307			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UX583	8656543				2022-12-28	WOS:A1996UX58300036
J	Tough, DF; Borrow, P; Sprent, J				Tough, DF; Borrow, P; Sprent, J			Induction of bystander T cell proliferation by viruses and type I interferon in vivo	SCIENCE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; INFECTION; ANTIGEN; MEMORY; MICE; STIMULATION; EXPRESSION; EXPANSION; TOLERANCE; RESPONSES	T cell proliferation in vivo is presumed to reflect a T cell receptor (TCR)-mediated polyclonal response directed to various environmental antigens, However, the massive proliferation of T cells seen in viral infections is suggestive of a bystander reaction driven by cytokines instead of the TCR. In mice, T cell proliferation in viral infections preferentially affected the CD44(hi) subset of CD8(+) cells and was mimicked by injection of polyinosinic-polycytidylic acid [poly(I:C)], an inducer of type I interferon (IFN I), and also by purified IFN I; such proliferation was not associated with up-regulation of CD69 or CD25 expression, which implies that TCR signaling was not involved, IFN I [poly(I:C)]-stimulated CD8(+) cells survived for prolonged periods in vivo and displayed the same phenotype as did long-lived antigen-specific CD8(+) cells, IFN I also potentiated the clonal expansion and survival of CD8(+) cells responding to specific antigen, Production of IFN I may thus play an important role in the generation and maintenance of specific memory.	Scripps Res Inst, DEPT IMMUNOL, IMM4, LA JOLLA, CA 92037 USA; Scripps Res Inst, DEPT NEUROPHARMACOL, IMM6, LA JOLLA, CA 92037 USA	Scripps Research Institute; Scripps Research Institute				Borrow, Persephone/0000-0002-3877-9780	NCI NIH HHS [CA38355, CA25803] Funding Source: Medline; NIAID NIH HHS [AI21487] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA038355, P01CA025803, R37CA038355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021487] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BELL EB, 1987, J IMMUNOL, V139, P1379; BEVERLEY PCL, 1990, IMMUNOL TODAY, V11, P203, DOI 10.1016/0167-5699(90)90083-L; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; DUMONT FJ, 1986, EUR J IMMUNOL, V16, P735, DOI 10.1002/eji.1830160704; DUTKO FJ, 1983, J GEN VIROL, V64, P1689, DOI 10.1099/0022-1317-64-8-1689; FIELD AK, 1967, P NATL ACAD SCI USA, V58, P1004, DOI 10.1073/pnas.58.3.1004; GAO EK, 1990, J EXP MED, V171, P1101, DOI 10.1084/jem.171.4.1101; GRAY D, 1991, J EXP MED, V174, P969, DOI 10.1084/jem.174.5.969; GRESSER I, 1976, J EXP MED, V144, P1305, DOI 10.1084/jem.144.5.1305; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; KORNGOLD R, 1983, J IMMUNOL, V130, P2236; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P7922, DOI 10.1073/pnas.81.24.7922; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; MERIGAN TC, 1977, NATURE, V268, P67, DOI 10.1038/268067a0; MULLBACHER A, 1994, J EXP MED, V179, P317, DOI 10.1084/jem.179.1.317; OEHEN S, 1992, J EXP MED, V176, P1273, DOI 10.1084/jem.176.5.1273; RAZVI ES, 1995, ADV VIRUS RES, V45, P1, DOI 10.1016/S0065-3527(08)60057-3; ROCHA B, 1989, EUR J IMMUNOL, V19, P905, DOI 10.1002/eji.1830190518; ROEDERER M, 1995, NAT MED, V1, P621, DOI 10.1038/nm0795-621; SELIN LK, 1994, J EXP MED, V179, P1933, DOI 10.1084/jem.179.6.1933; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SPRENT J, 1985, J EXP MED, V162, P2068, DOI 10.1084/jem.162.6.2068; TANCHOT C, 1995, EUR J IMMUNOL, V25, P2127, DOI 10.1002/eji.1830250802; TOUGH D, UNPUB; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; TRIPP RA, 1995, J IMMUNOL, V154, P6013; TRIPP RA, 1995, J IMMUNOL, V154, P5870; VONBOEHMER H, 1993, J EXP MED, V177, P891, DOI 10.1084/jem.177.4.891; WHITTON JL, 1988, VIROLOGY, V162, P321, DOI 10.1016/0042-6822(88)90471-0; YANG HY, 1989, J IMMUNOL, V142, P1710; ZIJLSTRA M, 1989, NATURE, V342, P435, DOI 10.1038/342435a0	32	898	921	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1996	272	5270					1947	1950		10.1126/science.272.5270.1947	http://dx.doi.org/10.1126/science.272.5270.1947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8658169				2022-12-28	WOS:A1996UV29400051
J	Simon, GE; VonKorff, M; Heiligenstein, JH; Revicki, DA; Grothaus, L; Katon, W; Wagner, EH				Simon, GE; VonKorff, M; Heiligenstein, JH; Revicki, DA; Grothaus, L; Katon, W; Wagner, EH			Initial antidepressant choice in primary care - Effectiveness and cost of fluoxetine vs tricyclic antidepressants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-TRIALS; DEPRESSION; METAANALYSIS; EVENTS	Objective.-To compare the clinical, functional, and economic outcomes of initially prescribing fluoxetine with outcomes of initially selecting imipramine or desipramine. Design.-Randomized controlled trial. Setting.-Primary care clinics of a Seattle, Wash, area staff-model health maintenance organization from 1992 through 1994. Patients.-A total of 536 adults beginning antidepressant treatment for depression. Intervention.-Random assignment of initial antidepressant prescription (desipramine, fluoxetine, or imipramine), Subsequent antidepressant treatment (doses, medication changes or discontinuation, specialty referral) was managed by the primary care physician, Main Outcome Measures.-Assessments after 1, 3, and 6 months examined clinical outcomes (Hamilton Depression Rating Scale and the depression subscale of the Hopkins Symptom Checklist) and quality-of-life outcomes (Medical Outcomes Study SF-36), Medication use and health care costs were assessed using the health maintenance organization's computerized data. Results.-Patients assigned to receive fluoxetine reported fewer adverse effects, were more likely to continue the original medication, and were more likely to reach adequate doses than patients beginning treatment with either tricyclic drug, The fluoxetine group reported marginally better clinical outcomes after 1 month, but these differences were not statistically significant and disappeared by the 3-month assessment, Quality-of-life outcomes in the 3 groups did not differ. Total health care costs over 6 months were approximately equal for the 3 groups, with higher antidepressant costs in the fluoxetine group balanced by lower outpatient visit and inpatient costs, Conclusions.-Clinical outcomes, quality-of-life outcomes, and overall treatment costs provide no clear guidance on initial selection of fluoxetine or tricyclic drugs, Thus, patients' and physicians' preferences are an appropriate basis for treatment selection.	LILLY RES LABS,INDIANAPOLIS,IN; MEDTAP INT,ARLINGTON,VA; UNIV WASHINGTON,DEPT PSYCHIAT & BEHAV SCI,SEATTLE,WA 98195	Eli Lilly; University of Washington; University of Washington Seattle	Simon, GE (corresponding author), GRP HLTH COOPERAT PUGET SOUND,CTR HLTH STUDIES,1730 MINOR AVE,1600,SEATTLE,WA 98101, USA.			VonKorff, Michael/0000-0001-5386-8477				American Psychiatric Association, 1987, DIAGN STAT MAN MENT; BROWN DE, 1993, TIME, V142, P61; CLARK DO, 1995, MED CARE, V33, P783, DOI 10.1097/00005650-199508000-00004; COWLEY G, 1990, NEWSWEEK, V115, P385; *DEPR GUID PAN, 1993, DEPR PRIM CAR CLIN P; Derogatis L R, 1974, Mod Probl Pharmacopsychiatry, V7, P79; FEINSTEIN AR, 1983, ANN INTERN MED, V99, P544, DOI 10.7326/0003-4819-99-4-544; First M.B., 1990, USERS GUIDE STRUCTUR; GLASER M, 1995, DRUG TOPICS, V139, P43; GREENBERG RP, 1994, J NERV MENT DIS, V182, P547, DOI 10.1097/00005053-199410000-00003; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Huszonek J J, 1993, Ann Clin Psychiatry, V5, P7, DOI 10.3109/10401239309148918; JONSSON B, 1994, BRIT J PSYCHIAT, V164, P665, DOI 10.1192/bjp.164.5.665; KATON W, 1992, MED CARE, V30, P67, DOI 10.1097/00005650-199201000-00007; Kramer P. D., 1993, LISTENING PROZAC; LEPEN C, 1994, J AFFECT DISORDERS, V31, P1, DOI 10.1016/0165-0327(94)90122-8; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; MONTGOMERY SA, 1994, INT CLIN PSYCHOPHARM, V9, P47, DOI 10.1097/00004850-199400910-00008; OLFSON M, 1994, AM J PSYCHIAT, V151, P1281; OLFSON M, 1993, AM J PSYCHIAT, V150, P571; PANDE AC, 1993, INT CLIN PSYCHOPHARM, V8, P267, DOI 10.1097/00004850-199300840-00010; REVICKI DA, 1995, PHARMACOECONOMICS, V8, P524, DOI 10.2165/00019053-199508060-00007; REVICKI DA, 1995, PSYCHOPHARMACOL BULL, V31, P57; SACKETT DL, 1979, NEW ENGL J MED, V301, P1410, DOI 10.1056/NEJM197912273012602; SAUNDERS KW, 1994, PHARMACOEPIDEMIOLOGY; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; SCLAR DA, 1994, CLIN THER, V16, P715; SIMON G, 1995, J CLIN EPIDEMIOL, V48, P363, DOI 10.1016/0895-4356(94)00141-C; SIMON GE, 1993, J PSYCHIAT RES, V27, P247, DOI 10.1016/0022-3956(93)90035-Z; SIMON GE, 1995, ARCH GEN PSYCHIAT, V52, P850; Simon GE, 1995, J GEN INTERN MED, V10, P663, DOI 10.1007/BF02602759; SIMON GE, 1993, GEN HOSP PSYCHIAT, V15, P399, DOI 10.1016/0163-8343(93)90009-D; SONG FJ, 1993, BMJ-BRIT MED J, V306, P683, DOI 10.1136/bmj.306.6879.683; STOKES PE, 1993, CLIN THER, V15, P216; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G; WARE J, 1992, AM STAT, V39, P95; Ware J.E, 1994, PHYS MENTAL HLTH SUM; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; WOLFINGER R, 1992, SAS TECHNICAL SUPPOR; WORKMAN EA, 1993, J CLIN PSYCHIAT, V54, P5	41	287	287	1	24	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	1996	275	24					1897	1902		10.1001/jama.275.24.1897	http://dx.doi.org/10.1001/jama.275.24.1897			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UR975	8648870				2022-12-28	WOS:A1996UR97500035
J	Baker, JR; Baldwin, JL				Baker, JR; Baldwin, JL			Allergy and immunology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Baker, JR (corresponding author), UNIV MICHIGAN, SCH MED, ANN ARBOR, MI 48109 USA.							BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; CHIU VK, 1995, J IMMUNOL, V154, P2023; CLEMENT MV, 1994, J EXP MED, V180, P557, DOI 10.1084/jem.180.2.557; Evans R., 1993, ALLERGY PRINCIPLES P, P1109; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; HOLGATE ST, 1995, INT ARCH ALLERGY IMM, V107, P29, DOI 10.1159/000236921; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LIBLAU RS, 1995, IMMUNOL TODAY, V16, P34, DOI 10.1016/0167-5699(95)80068-9; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; MOLLER P, 1994, INT J CANCER, V57, P371, DOI 10.1002/ijc.2910570314; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255	15	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1794	1795		10.1001/jama.275.23.1794	http://dx.doi.org/10.1001/jama.275.23.1794			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642713				2022-12-28	WOS:A1996UQ15200012
J	Wesson, DR; Ling, W				Wesson, DR; Ling, W			Addiction medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALCOHOL DEPENDENCE; BUPRENORPHINE; NALTREXONE		SUMMIT MED CTR, OAKLAND, CA USA; UNIV CALIF LOS ANGELES, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles	Wesson, DR (corresponding author), UNIV CALIF SAN FRANCISCO, OAKLAND, CA USA.			, Walter/0000-0003-0664-5099				ALTERMAN AI, 1994, J NERV MENT DIS, V182, P157, DOI 10.1097/00005053-199403000-00005; CALHOUN S, IN PRESS PSYCHOACTIV; DOLE VP, 1995, JAMA-J AM MED ASSOC, V274, P1307; FRATTOLA L, 1990, DRUG EXP CLIN RES, V16, P371; HOLLANDER JE, 1995, ANN EMERG MED, V26, P671, DOI 10.1016/S0196-0644(95)70035-8; JOHNSON RE, 1992, JAMA-J AM MED ASSOC, V267, P2750, DOI 10.1001/jama.267.20.2750; LESHNER A, 1995, NIDA NOTES, V10, P3; Ling W, 1996, ARCH GEN PSYCHIAT, V53, P401; OMALLEY SS, 1992, ARCH GEN PSYCHIAT, V49, P881; ROBINSON GM, 1993, DRUG ALCOHOL DEPEN, V33, P81, DOI 10.1016/0376-8716(93)90036-P; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876	11	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1792	1793		10.1001/jama.275.23.1792	http://dx.doi.org/10.1001/jama.275.23.1792			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642712				2022-12-28	WOS:A1996UQ15200011
J	Davenport, RJ; Dennis, MS; Warlow, CP				Davenport, RJ; Dennis, MS; Warlow, CP			Effect of correcting outcome data for case mix: An example from stroke medicine	BRITISH MEDICAL JOURNAL			English	Article							INTENSIVE-CARE	Objective-To show the influence of variations in case mix on clinical outcome indicators for patients admitted to hospital with acute stroke. Design-''Before and after'' cohort study, with prospective, consecutive identification of patients and prospective follow up; multiple logistic regression analyses to correct for case mix variations. Setting-University teaching hospital. Subjects-216 patients with stroke identified before the introduction of an organised stroke service, and 252 patients with stroke identified after its introduction. Main outcome measures-Case fatality at 30 days and 12 months; for survivors at 12 months, proportions of patients who were independent (according to the Oxford handicap scale) and of those living at home. Results-Crude outcome data suggested that patients in the cohort identified after the introduction of the stroke service were significantly more likely to be alive, independent, and living at home than patients managed before the stroke service. After adjustment for age and sex these ''improvements'' were less impressive but still significant. After adjustment for many other possible prognostic indicators, however, the differences between the two groups for all four outcomes were non-significant, suggesting that the ''improvements'' may have been entirely due to differences in case mix between the two cohorts, rather than the new stroke service. Conclusions-Variations in case mix have a crucial influence on the interpretation of outcome data, and this is particularly important in non-randomised comparative studies. Such studies, comparing performance within and between different provider units, are likely to become increasingly common in the new reformed NHS. To allow meaningful interpretation, these studies must try to correct for case mix.			Davenport, RJ (corresponding author), UNIV EDINBURGH,WESTERN GEN HOSP,DEPT CLIN NEUROSCI,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.							BAMFORD J, 1988, J NEUROL NEUROSUR PS, V51, P1373, DOI 10.1136/jnnp.51.11.1373; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; BION J, 1993, BRIT MED J, V307, P953, DOI 10.1136/bmj.307.6910.953; Carstairs V, 1991, DEPRIVATION HLTH; GREEN J, 1990, JAMA-J AM MED ASSOC, V263, P241, DOI 10.1001/jama.263.2.241; KEELER EB, 1990, JAMA-J AM MED ASSOC, V264, P1962, DOI 10.1001/jama.264.15.1962; ORCHARD C, 1994, BRIT MED J, V308, P1493, DOI 10.1136/bmj.308.6942.1493; ROCKALL TA, 1995, LANCET, V346, P346, DOI 10.1016/S0140-6736(95)92227-X; ROWAN KM, 1993, BRIT MED J, V307, P972, DOI 10.1136/bmj.307.6910.972; *SCOTT OFF, 1994, CLIN OUTC IND; *SCOTT OFF, 1995, CLIN OUTC IND; WARLOW C, 1995, STROKE MODULE COCHRA; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539	15	87	87	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 15	1996	312	7045					1503	1505		10.1136/bmj.312.7045.1503	http://dx.doi.org/10.1136/bmj.312.7045.1503			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR823	8646140	Green Published			2022-12-28	WOS:A1996UR82300018
J	Brooks, PC; Stromblad, S; Sanders, LC; vonSchalscha, TL; Aimes, RT; StetlerStevenson, WG; Quigley, JP; Cheresh, DA				Brooks, PC; Stromblad, S; Sanders, LC; vonSchalscha, TL; Aimes, RT; StetlerStevenson, WG; Quigley, JP; Cheresh, DA			Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3	CELL			English	Article							EXTRACELLULAR-MATRIX; IV COLLAGENASE; ADHESION MOLECULES; UROKINASE RECEPTOR; TUMOR PROGRESSION; METASTASIS; VITRONECTIN; BINDING; EXPRESSION; INHIBITOR	Cellular invasion depends on cooperation between adhesive and proteolytic mechanisms. Evidence is provided that the matrix metalloproteinase MMP-2 can be localized in a proteolytically active form on the surface of invasive cells, based on its ability to bind directly integrin alpha v beta 3. MMP-2 and alpha v beta 3 were specifically colocalized on angiogenic blood vessels and melanoma cells in vivo. Expression of alpha v beta 3 on cultured melanoma cells enabled their binding to MMP-2 in a proteolytically active form, facilitating cell-mediated collagen degradation. In vitro, these proteins formed an SDS-stable complex that depended on the noncatalytic C-terminus of MMP-2, since a truncation mutant lost the ability to bind alpha v beta 3. These findings define a single cell-surface receptor that regulates both matrix degradation and motility, thereby facilitating directed cellular invasion.	Scripps Res Inst, DEPT VASC BIOL, LA JOLLA, CA 92037 USA; SUNY STONY BROOK, DEPT PATHOL, STONY BROOK, NY 11794 USA; NCI, PATHOL LAB, NIH, BETHESDA, MD 20892 USA	Scripps Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brooks, PC (corresponding author), Scripps Res Inst, DEPT IMMUNOL, IMM24 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.		Stetler-Stevenson, William/AAE-3501-2020; Stetler-Stevenson, William G/H-6956-2012	Stetler-Stevenson, William/0000-0002-5500-5808; Stetler-Stevenson, William G/0000-0002-5500-5808; Stromblad, Staffan/0000-0002-1236-6339	NCI NIH HHS [CA-45726, CA-50286] Funding Source: Medline; NHLBI NIH HHS [HL-54444] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA050286, R01CA045726, R01CA050286] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054444] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBELDA SM, 1993, LAB INVEST, V68, P4; ALBELDA SM, 1990, CANCER RES, V50, P6757; AMES RT, 1994, BIOCHEM J, V300, P729, DOI 10.1042/bj3000729; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; BLASI F, 1993, BIOESSAYS, V15, P105, DOI 10.1002/bies.950150206; BLOOD CH, 1990, BIOCHIM BIOPHYS ACTA, V1032, P89, DOI 10.1016/0304-419X(90)90014-R; BROOKS PC, 1993, J CELL BIOL, V122, P1351, DOI 10.1083/jcb.122.6.1351; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; BROWN PD, 1990, CANCER RES, V50, P6184; CAO J, 1995, J BIOL CHEM, V270, P801, DOI 10.1074/jbc.270.2.801; CHEN JM, 1991, J BIOL CHEM, V266, P5113; CROWLEY CW, 1993, P NATL ACAD SCI USA, V90, P5021, DOI 10.1073/pnas.90.11.5021; DAVIS GE, 1992, BIOCHEM BIOPH RES CO, V182, P1025, DOI 10.1016/0006-291X(92)91834-D; EMONARD HP, 1992, CANCER RES, V52, P5845; FILARDO EJ, 1995, J CELL BIOL, V130, P441, DOI 10.1083/jcb.130.2.441; FILARDO EJ, 1996, IN PRESS J CELL SCI; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; GLADSON CL, 1991, J CLIN INVEST, V88, P1924, DOI 10.1172/JCI115516; GREVIN D, 1993, INT J DEV BIOL, V37, P519; Habermann BF, 1993, CURR OPIN CELL BIOL, V5, P864, DOI 10.1016/0955-0674(93)90036-P; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; ITO A, 1995, BRIT J CANCER, V71, P1039, DOI 10.1038/bjc.1995.200; Kleiner DE, 1993, CURR OPIN CELL BIOL, V5, P891, DOI 10.1016/0955-0674(93)90040-W; KLEINER DE, 1993, BIOCHEMISTRY-US, V32, P1583, DOI 10.1021/bi00057a024; KNUDSEN KA, 1982, J CELL BIOCHEM, V18, P157, DOI 10.1002/jcb.1982.240180204; KOOK YH, 1994, EMBO J, V13, P3983, DOI 10.1002/j.1460-2075.1994.tb06714.x; LESTER BR, 1992, CANCER METAST REV, V11, P31, DOI 10.1007/BF00047601; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; MONSKY WL, 1993, CANCER RES, V53, P3159; MONTGOMERY AMP, 1993, CANCER RES, V53, P693; MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856; MOSES MA, 1991, J CELL BIOCHEM, V47, P230, DOI 10.1002/jcb.240470308; MOSES MA, 1990, SCIENCE, V248, P1408, DOI 10.1126/science.1694043; MUELLER SC, 1991, J CELL SCI, V99, P213; MURPHY G, 1992, BIOCHEM J, V283, P637, DOI 10.1042/bj2830637; NEWMAN PJ, 1985, BLOOD, V65, P227; ORLANDO RA, 1991, J BIOL CHEM, V266, P19543; PEPPER MS, 1994, J CELL BIOCHEM, V55, P419, DOI 10.1002/jcb.240550403; PFAFF M, 1994, J BIOL CHEM, V269, P20233; REINARTZ J, 1994, EXP CELL RES, V214, P486, DOI 10.1006/excr.1994.1286; RUCKLIDGE GJ, 1994, BIOCHEM SOC T, V22, P63, DOI 10.1042/bst0220063; RUOSLAHTI E, 1992, BRIT J CANCER, V66, P239, DOI 10.1038/bjc.1992.250; RUOSLAHTI E, 1989, CANCER CELL-MON REV, V1, P119; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; SMITH JW, 1990, J BIOL CHEM, V265, P11008; SMITH JW, 1988, J BIOL CHEM, V263, P18726; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; THOMAS L, 1993, J CELL SCI, V105, P191; WARD RV, 1991, BIOCHIM BIOPHYS ACTA, V1079, P242, DOI 10.1016/0167-4838(91)90132-J; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; WOLFSBERG TG, 1993, P NATL ACAD SCI USA, V90, P10783, DOI 10.1073/pnas.90.22.10783; WOLFSBERG TG, 1995, J CELL BIOL, V131, P275, DOI 10.1083/jcb.131.2.275; YAN HC, 1993, J CLIN INVEST, V91, P986, DOI 10.1172/JCI116320	59	1371	1414	0	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	1996	85	5					683	693		10.1016/S0092-8674(00)81235-0	http://dx.doi.org/10.1016/S0092-8674(00)81235-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UP344	8646777	Bronze			2022-12-28	WOS:A1996UP34400009
J	Fero, ML; Rivkin, M; Tasch, M; Porter, P; Carow, CE; Firpo, E; Polyak, K; Tsai, LH; Broudy, V; Perlmutter, RM; Kaushansky, K; Roberts, JM				Fero, ML; Rivkin, M; Tasch, M; Porter, P; Carow, CE; Firpo, E; Polyak, K; Tsai, LH; Broudy, V; Perlmutter, RM; Kaushansky, K; Roberts, JM			A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice	CELL			English	Article							CYCLIN-DEPENDENT KINASES; GROWTH FACTOR-I; TRANSGENIC MICE; FUSION GENES; INHIBITION; PROTOONCOGENE; FIBROBLASTS; DISRUPTION; SUBUNIT; HORMONE	Targeted disruption of the murine p27(Kip1) gene caused a gene dose-dependent increase in animal size without other gross morphologic abnormalities. All tissues were enlarged and contained more cells, although endocrine abnormalities were not evident. Thymic hyperplasia was associated with increased T lymphocyte proliferation, and T cells showed enhanced IL-2 responsiveness in vitro. Thus, p27 deficiency may cause a Cell-autonomous defect resulting in enhanced proliferation in response to mitogens. In the spleen, the absence of p27 selectively enhanced proliferation of hematopoietic progenitor cells. p27 deletion, like deletion of the Rb gene, uniquely caused neoplastic growth of the pituitary pars intermedia, Suggesting that p27 and Rb function in the same regulatory pathway. The absence of p27 also caused an ovulatory defect and female sterility. Maturation of secondary ovarian follicles into corpora lutea, which express high levels of p27, was markedly impaired.	FRED HUTCHINSON CANC RES CTR, PROGRAM CANC BIOL, DIV PUBL HLTH, SEATTLE, WA 98104 USA; HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA; UNIV WASHINGTON, DEPT MED, DIV HEMATOL, SEATTLE, WA 98195 USA; UNIV WASHINGTON, HOWARD HUGHES MED INST, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT IMMUNOL, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT BIOCHEM, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA; JOHNS HOPKINS ONCOL CTR, HOWARD HUGHES MED INST, BALTIMORE, MD 21231 USA	Fred Hutchinson Cancer Center; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine	Fero, ML (corresponding author), FRED HUTCHINSON CANC RES CTR, DEPT BASIC SCI, DIV PUBL HLTH, 1124 COLUMBIA ST, SEATTLE, WA 98104 USA.			Fero, Matthew/0000-0002-9967-4659	NCI NIH HHS [R01 CA 31615] Funding Source: Medline; NIDDK NIH HHS [R01 DK 49855] Funding Source: Medline; NIGMS NIH HHS [GM53049] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA031615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053049] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; BROUDY VC, 1995, BLOOD, V85, P1719, DOI 10.1182/blood.V85.7.1719.bloodjournal8571719; BROUDY VC, 1988, ARCH BIOCHEM BIOPHYS, V265, P329, DOI 10.1016/0003-9861(88)90135-X; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; CHRONWALL BM, 1987, ENDOCRINOLOGY, V120, P1201, DOI 10.1210/endo-120-3-1201; COATS S, 1996, IN PRESS SCIENCE; COOKE MP, 1991, CELL, V65, P281, DOI 10.1016/0092-8674(91)90162-R; CROSS FR, 1988, MOL CELL BIOL, V8, P4675, DOI 10.1128/MCB.8.11.4675; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FIRPO EJ, 1994, MOL CELL BIOL, V14, P4889, DOI 10.1128/MCB.14.7.4889; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; GARY KA, 1992, INT J DEV NEUROSCI, V10, P131, DOI 10.1016/0736-5748(92)90041-W; Gehlert D R, 1988, Peptides, V9 Suppl 1, P161, DOI 10.1016/0196-9781(88)90240-9; GERDES J, 1992, J PATHOL, V168, P85, DOI 10.1002/path.1711680114; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HARPER JW, 1993, CELL, V75, P805; HSU SM, 1981, AM J CLIN PATHOL, V75, P816, DOI 10.1093/ajcp/75.6.816; HSU SM, 1982, J HISTOCHEM CYTOCHEM, V30, P1079, DOI 10.1177/30.10.6182185; HU NP, 1994, ONCOGENE, V9, P1021; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; KAWAMATA N, 1995, CANCER RES, V55, P2266; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P2827, DOI 10.1210/endo-123-6-2827; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; PALMITER RD, 1983, SCIENCE, V222, P809, DOI 10.1126/science.6356363; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; PIETENPOL JA, 1995, CANCER RES, V55, P1206; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; PONCECASTANEDA MV, 1995, CANCER RES, V55, P1211; QUAIFE CJ, 1989, ENDOCRINOLOGY, V124, P40, DOI 10.1210/endo-124-1-40; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; ROBERTS JM, 1994, COLD SPRING HARB SYM, V59, P31, DOI 10.1101/SQB.1994.059.01.006; SATO Y, 1995, BLOOD, V86, P1525, DOI 10.1182/blood.V86.4.1525.bloodjournal8641525; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SLINGERLAND JM, 1994, MOL CELL BIOL, V14, P3683, DOI 10.1128/MCB.14.6.3683; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANBUULOFFERS SC, 1995, J ENDOCRINOL, V144, P491, DOI 10.1677/joe.0.1440491; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WARD A, 1994, P NATL ACAD SCI USA, V91, P10365, DOI 10.1073/pnas.91.22.10365; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; WOLF E, 1994, ENDOCRINOLOGY, V135, P1877, DOI 10.1210/en.135.5.1877; XIONG Y, 1993, GENE DEV, V7, P1572, DOI 10.1101/gad.7.8.1572; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	59	1304	1340	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	1996	85	5					733	744		10.1016/S0092-8674(00)81239-8	http://dx.doi.org/10.1016/S0092-8674(00)81239-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UP344	8646781	hybrid			2022-12-28	WOS:A1996UP34400013
J	Seol, W; Choi, HS; Moore, DD				Seol, W; Choi, HS; Moore, DD			An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors	SCIENCE			English	Article							RETINOIC ACID RECEPTORS; THYROID-HORMONE; RESPONSE ELEMENT; X-RECEPTOR; BETA-GENE; PROTEIN; ALPHA	SHP is an orphan member of the nuclear hormone receptor superfamily that contains the dimerization and ligand-binding domain found in other;family members but lacks the conserved DNA binding domain. In the yeast two-hybrid system, SHP interacted with several conventional and orphan members of the receptor superfamily, including retinoid receptors, the thyroid hormone receptor, and the orphan receptor MB67. SHP also interacted directly with these receptors in vitro. In mammalian cells, SHP specifically inhibited transactivation by the superfamily members with which it interacted. These results suggest that SHP functions as a negative regulator of receptor-dependent signaling pathways.	MASSACHUSETTS GEN HOSP, DEPT MOLEC BIOL, BOSTON, MA 02114 USA	Harvard University; Massachusetts General Hospital					NIDDK NIH HHS [DK46546] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046546] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUFLIEGNER M, 1993, MOL CELL BIOL, V13, P5725, DOI 10.1128/MCB.13.9.5725; BAES M, 1994, MOL CELL BIOL, V14, P1544, DOI 10.1128/MCB.14.3.1544; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; BUGGE TH, 1992, EMBO J, V11, P1409, DOI 10.1002/j.1460-2075.1992.tb05186.x; BURRIS TP, 1995, P NATL ACAD SCI USA, V92, P9525, DOI 10.1073/pnas.92.21.9525; Choi H. W., UNPUB; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HALLENBECK PL, 1992, P NATL ACAD SCI USA, V89, P5572, DOI 10.1073/pnas.89.12.5572; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LEE JW, 1994, MOL ENDOCRINOL, V8, P1245, DOI 10.1210/me.8.9.1245; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; LEE JW, 1995, NATURE, V374, P91, DOI 10.1038/374091a0; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; Moore DD, 1995, GLOB MOB SURV; ONATE SA, 1995, SCIENCE, V270, P1354; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; PESCE S, 1993, MOL CELL BIOL, V13, P7874, DOI 10.1128/MCB.13.12.7874; ROSEN ED, 1993, J BIOL CHEM, V268, P11534; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; SEOL WG, 1995, MOL ENDOCRINOL, V9, P72, DOI 10.1210/me.9.1.72; SUCOV HM, 1990, P NATL ACAD SCI USA, V87, P5392, DOI 10.1073/pnas.87.14.5392; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	33	431	448	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	1996	272	5266					1336	1339		10.1126/science.272.5266.1336	http://dx.doi.org/10.1126/science.272.5266.1336			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8650544				2022-12-28	WOS:A1996UN47200046
J	Yang, HY; Bard, M; Bruner, DA; Gleeson, A; Deckelbaum, RJ; Aljinovic, G; Pohl, TM; Rothstein, R; Sturley, SL				Yang, HY; Bard, M; Bruner, DA; Gleeson, A; Deckelbaum, RJ; Aljinovic, G; Pohl, TM; Rothstein, R; Sturley, SL			Sterol esterification in yeast: A two-gene process	SCIENCE			English	Article							ACYL-COENZYME-A; CHOLESTEROL ACYLTRANSFERASE; RAT-LIVER; TRANSFORMATION; METABOLISM; CELLS; DNA	Unesterified sterol modulates the function of eukaryotic membranes. In human cells, sterol is esterified to a storage form by acyl-coenzyme A (CoA): cholesterol acyl transferase (ACAT). Here, two genes are identified, ARE1 and ARE2, that encode ACAT-related enzymes in yeast. The yeast enzymes are 49 percent identical to each other and exhibit 23 percent identity to human ACAT. Deletion of ARE2 reduced sterol ester levels to approximately 25 percent of normal levels, whereas disruption of ARE1 did not affect sterol ester biosynthesis. Deletion of both genes resulted in a viable cell with undetectable esterified sterol. Measurements of [C-14]acetate incorporation into saponified lipids indicated down-regulation of sterol biosynthesis in the are1 are2 mutant cells. With the use of a consensus sequence to the yeast and human genes, an additional member of the ACAT gene family was identified in humans.	COLUMBIA UNIV COLL PHYS & SURG, INST HUMAN NUTR, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT PEDIAT, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT PHYSIOL, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT MOLEC BIOPHYS, NEW YORK, NY 10032 USA; INDIANA UNIV PURDUE UNIV, DEPT BIOL, INDIANAPOLIS, IN 46202 USA; GESELL ANAL TECH & CONSULTING MBH, D-78467 CONSTANCE, GERMANY; COLUMBIA UNIV COLL PHYS & SURG, DEPT GENET & DEV, NEW YORK, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Indiana University System; Indiana University-Purdue University Indianapolis; Columbia University			Yang, Hongyuan/AAR-1326-2020	Yang, Hongyuan/0000-0002-8482-6031	NHGRI NIH HHS [HG00861] Funding Source: Medline; NIAID NIH HHS [R01 AI38598] Funding Source: Medline; NIGMS NIH HHS [GM 50237] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050237, R37GM050237] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ausubel FM, 1987, CURRENT PROTOCOLS MO, V1-5; BASSON ME, 1986, P NATL ACAD SCI USA, V83, P5563, DOI 10.1073/pnas.83.15.5563; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BILLHEIMER JT, 1992, ADV CHOLESTEROL RES; BLOCH KE, 1983, CRC CR REV BIOCH MOL, V14, P47, DOI 10.3109/10409238309102790; CARR TP, 1992, ARTERIOSCLER THROMB, V12, P1274, DOI 10.1161/01.ATV.12.11.1274; CHANG CCY, 1995, J BIOL CHEM, V270, P29532; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; CHANG TY, 1983, ENZYMES, V16, P523; CHENG D, 1995, J BIOL CHEM, V270, P685, DOI 10.1074/jbc.270.2.685; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIMSTERDENK D, 1994, MOL BIOL CELL, V5, P655, DOI 10.1091/mbc.5.6.655; DOOLITTLE GM, 1982, BIOCHEMISTRY-US, V21, P674, DOI 10.1021/bi00533a014; ERICKSON SK, 1994, J LIPID RES, V35, P763; GOODMAN DS, 1964, J BIOL CHEM, V239, P1335; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KATZ S S, 1976, Journal of Clinical Investigation, V58, P200; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; OKPODU CM, 1994, BIOTECHNIQUES, V16, P154; PARKS LW, 1985, METHOD ENZYMOL, V111, P333; REINHART MP, 1987, J BIOL CHEM, V262, P9649; RUMSEY SC, 1995, J BIOL CHEM, V270, P10008, DOI 10.1074/jbc.270.17.10008; SHERMAN F, 1991, METHOD ENZYMOL, V194, P21; SHIRATOR.T, 1965, BIOCHIM BIOPHYS ACTA, V106, P625, DOI 10.1016/0005-2760(65)90078-0; STURLEY SL, 1994, J BIOL CHEM, V269, P21670; STURLEY SL, UNPUB; TABAS I, 1986, J BIOL CHEM, V261, P3147; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; THOMPSON SL, 1987, J BIOL CHEM, V262, P17420; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; WARNER GJ, 1995, J BIOL CHEM, V270, P5772, DOI 10.1074/jbc.270.11.5772; Yang H., UNPUB	36	215	228	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	1996	272	5266					1353	1356		10.1126/science.272.5266.1353	http://dx.doi.org/10.1126/science.272.5266.1353			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8650549				2022-12-28	WOS:A1996UN47200051
J	Yunus, MB; Aldag, JC				Yunus, MB; Aldag, JC			Restless legs syndrome and leg cramps in fibromyalgia syndrome: A controlled study	BRITISH MEDICAL JOURNAL			English	Article											Yunus, MB (corresponding author), UNIV ILLINOIS,COLL MED,DEPT MED,BOX 1649,PEORIA,IL 61656, USA.							CLOUGH C, 1987, BRIT MED J, V294, P262, DOI 10.1136/bmj.294.6567.262; MONTPLAISIR J, 1986, CLIN NEUROPHARMACOL, V9, P456, DOI 10.1097/00002826-198610000-00006; REYNOLDS G, 1986, BRIT MED J, V292, P659, DOI 10.1136/bmj.292.6521.659; YUNUS M, 1981, SEMIN ARTHRITIS RHEU, V11, P151, DOI 10.1016/0049-0172(81)90096-2; Yunus Muhammad B., 1993, P1383	5	108	114	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 25	1996	312	7042					1339	1339		10.1136/bmj.312.7042.1339	http://dx.doi.org/10.1136/bmj.312.7042.1339			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN476	8646049	Green Published			2022-12-28	WOS:A1996UN47600024
J	Hoodless, PA; Haerry, T; Abdollah, S; Stapleton, M; OConnor, MB; Attisano, L; Wrana, JL				Hoodless, PA; Haerry, T; Abdollah, S; Stapleton, M; OConnor, MB; Attisano, L; Wrana, JL			MADR1, a MAD-related protein that functions in BMP2 signaling pathways	CELL			English	Article							BONE MORPHOGENETIC PROTEINS; FACTOR-BETA FAMILY; GENE; EXPRESSION; RECEPTOR; COMPLEX; INDUCE; CELLS	Components of the signaling pathways that lie downstream of Ser/Thr kinase receptors and are required for signaling by the TGF beta superfamily have been poorly defined. The Drosophila gene Mothers against dpp (Mad) and the C. elegans sma genes are implicated in these signaling pathways. We show that MAD functions downstream of DPP receptors and is required for receptor signaling. Phosphorylation of MADR1, a human homolog of MAD, is tightly regulated and rapidly induced by BMP2, but not TGF beta or activin. This phosphorylation is necessary for function, since a point mutant that yields a null phenotype in Drosophila is not phosphorylated. BMP2 treatment results in accumulation of MADR1 in the nucleus. MAD proteins may thus define a novel class of signaling molecules with nuclear function in Ser/Thr kinase receptor signaling pathways.	HOSP SICK CHILDREN,PROGRAM DEV BIOL,TORONTO,ON M5G 1X8,CANADA; HOSP SICK CHILDREN,DIV GASTROENTEROL,TORONTO,ON M5G 1X8,CANADA; UNIV CALIF IRVINE,DEPT MOLEC BIOL & BIOCHEM,IRVINE,CA 92717; UNIV CALIF IRVINE,CTR DEV BIOL,IRVINE,CA 92717	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of California System; University of California Irvine; University of California System; University of California Irvine			Wrana, Jeffrey/F-8857-2013; O'Connor, Michael B/C-9977-2014	O'Connor, Michael B/0000-0002-3067-5506; Hoodless, Pamela/0000-0003-1371-0725	NIGMS NIH HHS [GM47462] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARORA K, 1995, CELL, V81, P781, DOI 10.1016/0092-8674(95)90539-1; ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Attisano L, 1996, MOL CELL BIOL, V16, P1066; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; CHAO MV, 1992, CELL, V68, P995, DOI 10.1016/0092-8674(92)90068-N; CHEN F, 1995, P NATL ACAD SCI USA, V92, P1565, DOI 10.1073/pnas.92.5.1565; CHEN RH, 1995, NATURE, V377, P548, DOI 10.1038/377548a0; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; GRIEDER NC, 1995, CELL, V81, P791, DOI 10.1016/0092-8674(95)90540-5; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HARLAND RM, 1994, P NATL ACAD SCI USA, V91, P10243, DOI 10.1073/pnas.91.22.10243; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; KAWABATA M, 1995, J BIOL CHEM, V270, P29628; KINGSLEY DM, 1994, TRENDS GENET, V10, P16, DOI 10.1016/0168-9525(94)90014-0; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; LENNON GG, 1996, IN PRESS GENOMICS; LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7; LIU F, 1995, MOL CELL BIOL, V15, P3479; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; MIYAZONO K, 1994, ADV IMMUNOL, V55, P181; NOHNO T, 1995, J BIOL CHEM, V270, P22522, DOI 10.1074/jbc.270.38.22522; NOLL R, 1994, DEVELOPMENT, V120, P2329; OHTA S, 1992, FEBS LETT, V314, P356, DOI 10.1016/0014-5793(92)81505-G; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; PADGETT RW, 1993, P NATL ACAD SCI USA, V90, P2905, DOI 10.1073/pnas.90.7.2905; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; RAFTERY LA, 1995, GENETICS, V139, P241; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; ROBERTSON HM, 1988, GENETICS, V118, P461; ROSEN V, 1992, TRENDS GENET, V8, P97, DOI 10.1016/0168-9525(92)90063-A; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; SAMPATH TK, 1993, P NATL ACAD SCI USA, V90, P6004, DOI 10.1073/pnas.90.13.6004; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; Savage C, 1996, P NATL ACAD SCI USA, V93, P790, DOI 10.1073/pnas.93.2.790; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SEKELSKY JJ, 1995, GENETICS, V139, P1347; STAEHLINGHAMPTON K, 1995, DEVELOPMENT, V121, P3393; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Wang TW, 1996, SCIENCE, V271, P1120, DOI 10.1126/science.271.5252.1120; WANG TW, 1994, SCIENCE, V265, P674, DOI 10.1126/science.7518616; WHARTON KA, 1991, P NATL ACAD SCI USA, V88, P9214, DOI 10.1073/pnas.88.20.9214; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217	57	628	665	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 17	1996	85	4					489	500		10.1016/S0092-8674(00)81250-7	http://dx.doi.org/10.1016/S0092-8674(00)81250-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UM415	8653785	Bronze			2022-12-28	WOS:A1996UM41500007
J	Sibai, BM				Sibai, BM			Drug therapy - Treatment of hypertension in pregnant women	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RANDOMIZED CONTROLLED TRIAL; MILD CHRONIC HYPERTENSION; PLACEBO-CONTROLLED TRIAL; ELEVATED LIVER-ENZYMES; LOW-DOSE ASPIRIN; SEVERE PREECLAMPSIA; ANTIHYPERTENSIVE TREATMENT; BED REST; COMPLICATING PREGNANCY; INTRAVENOUS LABETALOL				Sibai, BM (corresponding author), UNIV TENNESSEE, DEPT OBSTET & GYNECOL, DIV MATERNAL FETAL MED, 853 JEFFERSON AVE, RM E102, MEMPHIS, TN 38103 USA.							ALES KL, 1989, CLIN EXP HYPERTENS B, V8, P95, DOI 10.3109/10641958909023365; *AM COLL OBST GYN, 1986, TECHN B AM COLL OBST, V91; [Anonymous], 1990, AM J OBSTET GYNECOL, V163, P1691; ARIAS F, 1979, OBSTET GYNECOL, V53, P489; ASHE RG, 1987, S AFR MED J, V71, P354; BARTON JR, 1994, AM J OBSTET GYNECOL, V170, P765, DOI 10.1016/S0002-9378(94)70279-9; BELIZAN JM, 1980, AM J CLIN NUTR, V33, P2202, DOI 10.1093/ajcn/33.10.2202; BEROYZ G, 1994, LANCET, V343, P619; BLAKE S, 1991, BRIT J OBSTET GYNAEC, V98, P244, DOI 10.1111/j.1471-0528.1991.tb13387.x; BURROWS RF, 1995, AM J OBSTET GYNECOL, V173, P929, DOI 10.1016/0002-9378(95)90368-2; BUTTERS L, 1990, BMJ-BRIT MED J, V301, P587, DOI 10.1136/bmj.301.6752.587; CARROLI G, 1994, BRIT J OBSTET GYNAEC, V101, P753, DOI 10.1111/j.1471-0528.1994.tb11940.x; CHESLEY LC, 1947, AM J OBSTET GYNECOL, V53, P372, DOI 10.1016/0002-9378(47)90401-8; CHUA S, 1991, LANCET, V337, P250, DOI 10.1016/0140-6736(91)92227-S; COCKBURN J, 1982, LANCET, V1, P647; COLLINS R, 1985, BMJ-BRIT MED J, V290, P17, DOI 10.1136/bmj.290.6461.17; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; COPPER RL, 1994, OBSTET GYNECOL, V84, P490; CROWTHER CA, 1992, BRIT J OBSTET GYNAEC, V99, P13, DOI 10.1111/j.1471-0528.1992.tb14384.x; CRUICKSHANK D J, 1992, Journal of Obstetrics and Gynaecology (Abingdon), V12, P223, DOI 10.3109/01443619209004032; CRUICKSHANK DJ, 1991, CLIN EXP HYPERTENS B, V10, P333, DOI 10.3109/10641959109012919; CUNNINGHAM FG, 1993, WILLIAMS OBSTETRICS, P763; DAVEY DA, 1988, AM J OBSTET GYNECOL, V158, P892, DOI 10.1016/0002-9378(88)90090-7; DEKKER GA, 1993, AM J OBSTET GYNECOL, V168, P214, DOI 10.1016/S0002-9378(12)90917-5; DOUGLAS KA, 1994, BMJ-BRIT MED J, V309, P1395, DOI 10.1136/bmj.309.6966.1395; DUGGAN PM, 1992, AUST NZ J OBSTET GYN, V32, P335, DOI 10.1111/j.1479-828X.1992.tb02846.x; DULEY L, 1995, LANCET, V345, P1455; DULEY L, 1995, LANCET, V346, P1365, DOI 10.1016/S0140-6736(95)92377-2; ELLENBOGEN A, 1986, INT J GYNECOL OBSTET, V24, P3, DOI 10.1016/0020-7292(86)90015-9; FENAKEL K, 1991, OBSTET GYNECOL, V77, P331; FIDLER J, 1983, BMJ-BRIT MED J, V286, P1927, DOI 10.1136/bmj.286.6382.1927; GALLERY EDM, 1985, BMJ-BRIT MED J, V291, P563, DOI 10.1136/bmj.291.6495.563; GARDEN A, 1982, CLIN EXP HYPERTENS B, V1, P371, DOI 10.3109/10641958209139860; GIFFORD RW, 1993, ARCH INTERN MED, V153, P154; GILSTRAP LC, 1978, SEMIN PERINATOL, V2, P73; HOGSTEDT S, 1985, ACTA OBSTET GYN SCAN, V64, P505; HORVATH JS, 1985, OBSTET GYNECOL, V66, P634; HUGHES EC, 1972, OBSTETRIC GYNECOLOGI; ISMAIL AAA, 1993, INT J GYNECOL OBSTET, V40, P39, DOI 10.1016/0020-7292(93)90770-W; JANNET D, 1994, OBSTET GYNECOL, V84, P354; KINCAIDS.P, 1966, BRIT MED J, V1, P274, DOI 10.1136/bmj.1.5482.274; LANDESMAN R, 1955, OBSTET GYNECOL, V6, P354; LEATHER HM, 1968, LANCET, V2, P488; LOPEZLLERA M, 1992, AM J OBSTET GYNECOL, V166, P4, DOI 10.1016/0002-9378(92)91816-S; LUCAS MJ, 1995, NEW ENGL J MED, V333, P201, DOI 10.1056/NEJM199507273330401; MABIE WC, 1987, OBSTET GYNECOL, V70, P328; MARTINSCOSTA S, 1992, CLIN EXP HYPERTENS B, V11, P25, DOI 10.3109/10641959209031031; MATHEWS DD, 1977, BRIT J OBSTET GYNAEC, V84, P108, DOI 10.1111/j.1471-0528.1977.tb12535.x; MICHAEL CA, 1986, AUST NZ J OBSTET GYN, V26, P26, DOI 10.1111/j.1479-828X.1986.tb01523.x; MONTAN S, 1993, AM J OBSTET GYNECOL, V168, P152, DOI 10.1016/S0002-9378(12)90905-9; MONTAN S, 1992, BRIT MED J, V304, P946, DOI 10.1136/bmj.304.6832.946; MOODLEY J, 1994, HYPERTENS PREGNANCY, V13, P245, DOI 10.3109/10641959409072226; MOODLEY J, 1992, BRIT J OBSTET GYNAEC, V99, P727, DOI 10.1111/j.1471-0528.1992.tb13872.x; ODENDAAL HJ, 1987, S AFR MED J, V71, P555; ODENDAAL HJ, 1990, OBSTET GYNECOL, V76, P1070; PATERSONBROWN S, 1994, BRIT J OBSTET GYNAEC, V101, P409, DOI 10.1111/j.1471-0528.1994.tb11913.x; PHIPPARD AF, 1991, MED J AUSTRALIA, V154, P378, DOI 10.5694/j.1326-5377.1991.tb121126.x; PICKLES CJ, 1992, BRIT J OBSTET GYNAEC, V99, P964, DOI 10.1111/j.1471-0528.1992.tb13698.x; PICKLES CJ, 1989, BRIT J OBSTET GYNAEC, V96, P38, DOI 10.1111/j.1471-0528.1989.tb01574.x; PLOUIN PF, 1988, BRIT J OBSTET GYNAEC, V95, P868, DOI 10.1111/j.1471-0528.1988.tb06571.x; PLOUIN PF, 1990, BRIT J OBSTET GYNAEC, V97, P134, DOI 10.1111/j.1471-0528.1990.tb01738.x; REDMAN CWG, 1976, LANCET, V2, P753; REDMAN CWG, 1991, AM J KIDNEY DIS, V17, P149, DOI 10.1016/S0272-6386(12)81120-6; REDMAN CWG, 1988, LANCET, V1, P809; ROBERTS JM, 1993, LANCET, V342, P504; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; ROSA FW, 1989, OBSTET GYNECOL, V74, P371; ROSENFELD J, 1986, EUR J OBSTET GYN R B, V22, P197, DOI 10.1016/0028-2243(86)90066-3; ROSSOUW HJ, 1995, S AFR MED J, V85, P525; RUBIN PC, 1983, LANCET, V1, P431; SCHIFF E, 1994, OBSTET GYNECOL, V84, P626; Schoenfeld A, 1986, Obstet Gynecol Surv, V41, P67, DOI 10.1097/00006254-198602000-00001; SEABE SJ, 1989, S AFR MED J, V76, P248; Sibai B M, 1992, Int J Obstet Anesth, V1, P167, DOI 10.1016/0959-289X(92)90024-X; SIBAI BM, 1987, OBSTET GYNECOL, V70, P323; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P960, DOI 10.1016/0002-9378(90)91297-P; SIBAI BM, 1983, OBSTET GYNECOL, V61, P571; SIBAI BM, 1986, OBSTET GYNECOL, V67, P517; SIBAI BM, 1984, AM J OBSTET GYNECOL, V150, P831, DOI 10.1016/0002-9378(84)90458-7; SIBAI BM, 1990, AM J OBSTET GYNECOL, V163, P733, DOI 10.1016/0002-9378(90)91058-K; SIBAI BM, 1991, OBSTET GYNECOL, V78, P451; SIBAI BM, 1993, NEW ENGL J MED, V329, P1213, DOI 10.1056/NEJM199310213291701; SIBAI BM, 1994, AM J OBSTET GYNECOL, V171, P818, DOI 10.1016/0002-9378(94)90104-X; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P777, DOI 10.1016/0002-9378(90)91009-2; SIBAI BM, 1990, AM J OBSTET GYNECOL, V163, P1049, DOI 10.1016/0002-9378(90)91123-T; SIBAI BM, 1992, AM J OBSTET GYNECOL, V167, P879, DOI 10.1016/S0002-9378(12)80005-6; SIBAI BM, 1993, AM J OBSTET GYNECOL, V169, P1000, DOI 10.1016/0002-9378(93)90043-I; STEEGERS EAP, 1991, BRIT J OBSTET GYNAEC, V98, P980, DOI 10.1111/j.1471-0528.1991.tb15335.x; TUFFNELL DJ, 1992, LANCET, V339, P224, DOI 10.1016/0140-6736(92)90017-W; WALKER JJ, 1991, CLIN PERINATOL, V18, P845, DOI 10.1016/S0095-5108(18)30499-8; WEITZ C, 1987, INT J GYNECOL OBSTET, V25, P35, DOI 10.1016/0020-7292(87)90181-0; WICHMAN K, 1984, SCAND J CLIN LAB INV, V44, P90, DOI 10.3109/00365518409085385; WOODS JB, 1992, OBSTET GYNECOL, V80, P87; ZUSPAN FP, 1991, CLIN PERINATOL, V18, P653, DOI 10.1016/S0095-5108(18)30489-5	94	229	242	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 25	1996	335	4					257	265		10.1056/NEJM199607253350407	http://dx.doi.org/10.1056/NEJM199607253350407			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ532	8657243				2022-12-28	WOS:A1996UZ53200007
J	Hommel, M; Cornu, C; Boutitie, F; Boissel, JP; Viallet, F; BonnefoiKyriacou, D; Gayraud, D; Kiegel, P; Bissuel, JPB; Driencourt, JB; Ruel, H; Guillaume, L; Ruffie, C; Sirodot, M; Valon, P; MIchelBechet, L; Colin, B; Mourali, K; Olivier, P; Ziegler, B; Feissel, M; Cara, A; Faller, JP; Braun, JB; Chopard, JL; Berges, S; Berger, E; Rouanet, F; Orgogozo, JM; Devos, P; Testard, D; Bultel, J; Loubrieu, G; LeBolloch, A; Fallut, M; Bouniol, B; Pomet, E; Mocquard, Y; Rouhart, F; Diraison, P; Goas, JY; Zagnoli, F; Duriez, F; Riviere, B; Brault, JL; Colamarino, R; Claveloux, P; Deffond, D; Durieux, A; Tournilhac, M; Baldauf, E; RenglewiczDestgynder, C; Rondepierre, P; Brunet, JM; JulieCoaquette, V; Delefosse, F; Voisin, H; Alibert, M; Naviaux, S; Campagne, JB; Messin, R; Bakhache, E; Bouttement, C; Vanrenterghem, B; Masse, C; Lecat, N; Lenfant, F; Souyris, F; Lambert, P; Huttin, B; Gerard, D; Planque, E; Alexandre, JL; Gilet, B; Limousin, P; Kok, G; Lizeretti, J; Verier, A; Delisse, B; CaparrosLefebvre, D; DurieuCouade, I; Godefroy, O; Goldstein, P; Henon, H; Lestavel, P; Leys, D; Lucas, C; MounierVehier, F; Mathe, D; Clement, S; Ducluzeau, R; Meyran, S; Demaziere, J; Coppere, B; Ninet, J; Madoux, MHG; Gabollet, C; Laplace, S; Matas, O; Turkie, B; GavaudKennoz, C; Lafuma, H; Gallet, M; Lestrevel, M; Granger, J; Rozand, G; CrettetPousset, G; Savet, JF; Cavallaro, J; Mangola, B; Ribier, A; Rosolacci, T; Neuville, V; Chaussinand, JP; Chanwar, J; Courtois, S; Masson, C; Ille, O; Lees, KR; Woimant, F; Amarenco, P; Chabriat, H; Bousser, MG; Nouailhat, F; Outin, H; Merrer, J; Neau, JP; Tantot, AM; Visy, JM; Vaunaize, J; Pinel, JF; DeBrughgraeve, V; Deydier, A; Hermouet, M; AdnetBonte, C; Onnient, Y; GueganMassardier, E; Tardy, B; Bertrand, JC; Viallon, A; Lafond, P; Zeni, F; Page, Y; Cusey, I; Merienne, M; Legrand, S; Tranchant, C; Rodier, G; Faitg, R; Tavernier, D; Piot, P; Gillon, T; Sache, L; Schmidt, MH; Zerouali, Y; Feuchere, P; Chollet, F; GuiraudChaumeil, B; Saudeau, D; Devauchelle, H; Autret, A; Decombe, R; Rouques, C; Billaud, B; VanRechem, M; Kassiotis, P; LegalMeigne, B; BrunetBourgin, F; McInnes, GT; Muir, KW; Reid, JL; Semple, PF				Hommel, M; Cornu, C; Boutitie, F; Boissel, JP; Viallet, F; BonnefoiKyriacou, D; Gayraud, D; Kiegel, P; Bissuel, JPB; Driencourt, JB; Ruel, H; Guillaume, L; Ruffie, C; Sirodot, M; Valon, P; MIchelBechet, L; Colin, B; Mourali, K; Olivier, P; Ziegler, B; Feissel, M; Cara, A; Faller, JP; Braun, JB; Chopard, JL; Berges, S; Berger, E; Rouanet, F; Orgogozo, JM; Devos, P; Testard, D; Bultel, J; Loubrieu, G; LeBolloch, A; Fallut, M; Bouniol, B; Pomet, E; Mocquard, Y; Rouhart, F; Diraison, P; Goas, JY; Zagnoli, F; Duriez, F; Riviere, B; Brault, JL; Colamarino, R; Claveloux, P; Deffond, D; Durieux, A; Tournilhac, M; Baldauf, E; RenglewiczDestgynder, C; Rondepierre, P; Brunet, JM; JulieCoaquette, V; Delefosse, F; Voisin, H; Alibert, M; Naviaux, S; Campagne, JB; Messin, R; Bakhache, E; Bouttement, C; Vanrenterghem, B; Masse, C; Lecat, N; Lenfant, F; Souyris, F; Lambert, P; Huttin, B; Gerard, D; Planque, E; Alexandre, JL; Gilet, B; Limousin, P; Kok, G; Lizeretti, J; Verier, A; Delisse, B; CaparrosLefebvre, D; DurieuCouade, I; Godefroy, O; Goldstein, P; Henon, H; Lestavel, P; Leys, D; Lucas, C; MounierVehier, F; Mathe, D; Clement, S; Ducluzeau, R; Meyran, S; Demaziere, J; Coppere, B; Ninet, J; Madoux, MHG; Gabollet, C; Laplace, S; Matas, O; Turkie, B; GavaudKennoz, C; Lafuma, H; Gallet, M; Lestrevel, M; Granger, J; Rozand, G; CrettetPousset, G; Savet, JF; Cavallaro, J; Mangola, B; Ribier, A; Rosolacci, T; Neuville, V; Chaussinand, JP; Chanwar, J; Courtois, S; Masson, C; Ille, O; Lees, KR; Woimant, F; Amarenco, P; Chabriat, H; Bousser, MG; Nouailhat, F; Outin, H; Merrer, J; Neau, JP; Tantot, AM; Visy, JM; Vaunaize, J; Pinel, JF; DeBrughgraeve, V; Deydier, A; Hermouet, M; AdnetBonte, C; Onnient, Y; GueganMassardier, E; Tardy, B; Bertrand, JC; Viallon, A; Lafond, P; Zeni, F; Page, Y; Cusey, I; Merienne, M; Legrand, S; Tranchant, C; Rodier, G; Faitg, R; Tavernier, D; Piot, P; Gillon, T; Sache, L; Schmidt, MH; Zerouali, Y; Feuchere, P; Chollet, F; GuiraudChaumeil, B; Saudeau, D; Devauchelle, H; Autret, A; Decombe, R; Rouques, C; Billaud, B; VanRechem, M; Kassiotis, P; LegalMeigne, B; BrunetBourgin, F; McInnes, GT; Muir, KW; Reid, JL; Semple, PF			Thrombolytic therapy with streptokinase in acute ischemic stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CT; INFARCTION; SIGN	Background In patients with acute ischemic stroke, early treatment with thrombolytic agents is thought to permit reperfusion of ischemic neurons and to promote recovery of function. The Multicenter Acute Stroke-Trial - Europe (MAST-E) was designed to assess the efficacy and safety of streptokinase in patients with acute ischemic stroke. Methods Patients with moderate-to-severe ischemia in the territory of the middle cerebral artery were randomly assigned to receive streptokinase (1.5 million units over a period of one hour) or placebo within six hours after the onset of stroke. The primary efficacy outcome was a binary criterion combining mortality and severe disability at six months, with severe disability defined as a score of 3 or higher on the Rankin scale. The primary safety outcomes were mortality at 10 days and cerebral hemorrhage. Results All randomized patients (156 in the streptokinase group and 154 in the placebo group) were evaluated at six months. The incidence of the primary efficacy outcome was similar in the two groups (124 patients in the streptokinase group and 126 in the placebo group died or had a Rankin score greater than or equal to 3). However, the mortality rate at 10 days was significantly higher in the streptokinase group than in the placebo group (34.0 percent vs. 18.2 percent, P=0.002). The higher rate in the streptokinase group was mainly due to the hemorrhagic transformation of ischemic cerebral infarcts. At six months, more deaths had occurred in the streptokinase group than in the placebo group (73 vs. 59, P=0.06). Conclusions In patients with acute ischemic stroke, treatment with streptokinase resulted in an increase in mortality. The routine use of streptokinase cannot be recommended in acute ischemic stroke. (C) 1996, Massachusetts Medical Society.			Hommel, M (corresponding author), CHU GRENOBLE, NEUROL CLIN, STROKE UNIT, BP 217, F-38043 GRENOBLE 9, FRANCE.		Godefroy, Olivier/D-6117-2012; LEYS, Didier/G-2955-2016; Muir, Keith W/A-7670-2011; Chabriat, Hugues/G-5699-2010	LEYS, Didier/0000-0003-4408-4392; Muir, Keith W/0000-0001-9535-022X; Godefroy, Olivier/0000-0001-6789-6620; Chabriat, Hugues/0000-0001-8436-6074				[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1990, Lancet, V336, P65; BOISSEL JP, 1992, THROMB HAEMOSTASIS, V68, P752; CANDELISE L, 1995, LANCET, V346, P1509; CANDELISE L, 1994, CEREBROVASC DIS, V4, P341, DOI 10.1159/000108505; DONNAN GA, 1995, LANCET, V345, P578; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; HOMMEL M, 1995, LANCET, V345, P57, DOI 10.1016/S0140-6736(95)91179-0; HOMMEL M, 1994, EXPERT OPIN INV DRUG, V3, P1011; JAILLARDSERRADJ A, 1995, CEREBROVASC DIS, V5, P269; MAHONEY F I, 1965, Md State Med J, V14, P61; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MODAN B, 1992, STROKE, V23, P1230, DOI 10.1161/01.STR.23.9.1230; MOULIN T, 1994, EUR NEUROL, V34, P64; ORGOGOZO JM, 1992, STROKE, V23, P1678, DOI 10.1161/01.STR.23.11.1678; SOLOMON NA, 1994, STROKE, V25, P1721, DOI 10.1161/01.STR.25.9.1721; TOMSICK TA, 1990, AM J NEURORADIOL, V11, P473; TOMURA N, 1988, RADIOLOGY, V168, P463, DOI 10.1148/radiology.168.2.3393665; TRUWIT CL, 1990, RADIOLOGY, V176, P801, DOI 10.1148/radiology.176.3.2389039; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WAHLGREN NG, 1994, CEREBROVASC DIS, V4, P204, DOI 10.1159/000108483; WARDLAW JM, 1992, STROKE, V23, P1826, DOI 10.1161/01.STR.23.12.1826; 1994, STROKE, V25, P1317; 1994, CONTROL CLIN TRIALS, V15, P503; 1993, CLIN TRIALS METAANAL, V28, P329	25	447	454	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 18	1996	335	3					145	150						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW790	8657211				2022-12-28	WOS:A1996UW79000001
J	Cockett, NE; Jackson, SP; Shay, TL; Farnir, F; Berghmans, S; Snowder, GD; Nielsen, DM; Georges, M				Cockett, NE; Jackson, SP; Shay, TL; Farnir, F; Berghmans, S; Snowder, GD; Nielsen, DM; Georges, M			Polar overdominance at the Ovine callipyge locus	SCIENCE			English	Article							CHROMOSOME-14	An inheritable muscular hypertrophy was recently described in sheep and shown to be determined by the callipyge gene mapped to ovine chromosome 18. Here, the callipyge phenotype was found to be characterized by a nonmendelian inheritance pattern, referred to as polar overdominance, where only heterozygous individuals having inherited the callipyge mutation from their sire express the phenotype. The possible role of parental imprinting in the determinism of polar overdominance is envisaged.	UTAH STATE UNIV,DEPT ANIM DAIRY & VET SCI,LOGAN,UT 84322; TEXAS TECH UNIV,DEPT ANIM SCI & FOOD TECHNOL,LUBBOCK,TX 79409; UNIV LIEGE B43,FAC VET MED,DEPT GENET,B-4000 LIEGE,BELGIUM; ARS,USDA,US SHEEP EXPT STN,DUBOIS,ID 83423	Utah System of Higher Education; Utah State University; Texas Tech University System; Texas Tech University; University of Liege; United States Department of Agriculture (USDA)				Nielsen, Dahlia/0000-0003-0123-6085; Berghmans, Stephane/0000-0001-5414-8674; Georges, Michel/0000-0003-4124-2375				ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K; APIENZA C, 1990, DEV S, P107; BALDACCI PA, 1992, MAMM GENOME, V2, P100, DOI 10.1007/BF00353857; BEECHEY CV, 1994, MOUSE GENOME, V92, P505; BREGLIANO JC, 1983, MOBILE GENETIC ELEME, P363; CATTANACH BM, 1993, MOUSE GENOME, V91, P858; COCKETT NE, 1994, P NATL ACAD SCI USA, V91, P3019, DOI 10.1073/pnas.91.8.3019; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; FARNIR F, UNPUB; FOREJT J, 1992, CELL, V70, P443, DOI 10.1016/0092-8674(92)90168-C; GEORGES M, 1995, GENETICS, V139, P907; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MORTON NE, 1956, AM J HUM GENET, V8, P80; NIELSEN DJ, UNPUB; SAPIENZA C, 1992, GENETICS, V132, P241; SAPIENZA C, 1989, DEVELOPMENT, V107, P165; TARTOF KD, 1991, CELL, V65, P201, DOI 10.1016/0092-8674(91)90153-P; TEMPLE IK, 1991, J MED GENET, V28, P511, DOI 10.1136/jmg.28.8.511; WAKASUGI N, 1974, J REPROD FERTIL, V41, P85, DOI 10.1530/jrf.0.0410085; WANG JCC, 1991, AM J HUM GENET, V48, P1069	21	215	240	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 12	1996	273	5272					236	238		10.1126/science.273.5272.236	http://dx.doi.org/10.1126/science.273.5272.236			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW787	8662506				2022-12-28	WOS:A1996UW78700040
J	Carpenter, CCJ; Fischl, MA; Hammer, SM; Hirsch, MS; Jacobsen, DM; Katzenstein, DA; Montaner, JSG; Richman, DD; Saag, MS; Schooley, RT; Thompson, MA; Vella, S; Yeni, PG; Volberding, PA				Carpenter, CCJ; Fischl, MA; Hammer, SM; Hirsch, MS; Jacobsen, DM; Katzenstein, DA; Montaner, JSG; Richman, DD; Saag, MS; Schooley, RT; Thompson, MA; Vella, S; Yeni, PG; Volberding, PA			Antiretroviral therapy for HIV infection in 1996 - Recommendations of an international panel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; PLACEBO-CONTROLLED TRIAL; PROPHYLACTIC ZIDOVUDINE; TYPE-1 HIV-1; DOUBLE-BLIND; TRANSMISSION; 3'-AZIDO-3'-DEOXYTHYMIDINE; EXPOSURE; BLOOD; AIDS	Objective.-To provide clinical recommendations for antiretroviral therapy for human immunodeficiency virus (HIV) disease with currently (mid 1996) available drugs, When to start therapy, what to start with, when to change, and what to change to were addressed. Participants.-A 13-member panel representing international expertise in antiretroviral research and HIV patient care was selected by the International AIDS Society-USA. Evidence.-Available clinical and basic science data, including phase 3 controlled trials, clinical endpoint data, virologic and immunologic endpoint data, interim analyses, studies of HIV pathophysiology, and expert opinions of panel members were considered. Recommendations were limited to drugs available in mid 1996. Process.-For each question posed, 1 or more member(s) reviewed and presented available data. Recommendations were determined by group consensus (January 1996); revisions as warranted by new data were incorporated by group consensus (February-May 1996). Conclusions.-Recent data on HIV pathogenesis, methods to determine plasma HIV RNA, clinical trial data, and availability of new drugs point to the need for new approaches to treatment. Therapy is recommended based on CD4(+) cell count, plasma HIV RNA level, or clinical status, Preferred initial drug regimens include nucleoside combinations; at present protease inhibitors are probably best reserved for patients at higher progression risk. For treatment failure or drug intolerance, subsequent regimen considerations include reasons for changing therapy, available drug options, disease stage, underlying conditions, and concomitant medication(s). Therapy for primary (acute) infection, high-risk exposures to HIV, and maternal-to-fetal transmission are also addressed. Therapeutic approaches need to be updated as new data continue to emerge.	BROWN UNIV,SCH MED,PROVIDENCE,RI 02912; UNIV MIAMI,SCH MED,MIAMI,FL; HARVARD UNIV,SCH MED,BOSTON,MA; STANFORD UNIV,MED CTR,STANFORD,CA 94305; ST PAULS HOSP,VANCOUVER,BC V6Z 1Y6,CANADA; UNIV CALIF SAN DIEGO,LA JOLLA,CA; VET AFFAIRS MED CTR,SAN DIEGO,CA; UNIV ALABAMA,BIRMINGHAM,AL; UNIV COLORADO,SCH MED,DENVER,CO; AIDS RES CONSORTIUM ATLANTA,ATLANTA,GA; IST SUPER SANITA,I-00161 ROME,ITALY; HOP BICHAT CLAUDE BERNARD,X BICHAT MED SCH,PARIS,FRANCE; UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA	Brown University; University of Miami; Harvard University; Harvard Medical School; Stanford University; St. Paul's Hospital; University of Saskatchewan; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Alabama System; University of Alabama Birmingham; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Istituto Superiore di Sanita (ISS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco	Carpenter, CCJ (corresponding author), INT AIDS SOC USA,353 KEARNY ST,SAN FRANCISCO,CA 94108, USA.		Vella, Stefano/GZM-0519-2022; Montaner, Julio/K-7621-2012; VELLA, STEFANO/ABI-3368-2020; VELLA, STEFANO/D-4912-2015	katzenstein, david/0000-0002-8593-4560; VELLA, STEFANO/0000-0003-2347-5984				BARTLETT JA, 1996, 3 C RETR OPP INF WAS; BOYER PJ, 1994, JAMA-J AM MED ASSOC, V271, P1925, DOI 10.1001/jama.271.24.1925; BRYSON YJ, 1995, NEW ENGL J MED, V332, P833, DOI 10.1056/NEJM199503303321301; BRYSON YJ, 1996, 3 C RETR OPP INF WAS; CAMERON B, 1996, 3 C RETR OPP INF WAS; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; COFFIN JM, 1996, 3 C RETR OPP INF WAS; Collier AC, 1996, NEW ENGL J MED, V334, P1011, DOI 10.1056/NEJM199604183341602; COLLIER AC, 1993, ANN INTERN MED, V119, P786, DOI 10.7326/0003-4819-119-8-199310150-00003; CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0; CONDRA JH, 1995, 2 NAT C HUM RETR WAS; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; COOMBS RW, IN PRESS J INFECT DI; COOPER E, 1996, 3 C RETR OPP INF WAS; DANNER SA, 1995, NEW ENGL J MED, V333, P1528, DOI 10.1056/NEJM199512073332303; DAQUILA RT, 1995, ANN INTERN MED, V122, P401, DOI 10.7326/0003-4819-122-6-199503150-00001; DAquila RT, 1996, ANN INTERN MED, V124, P1019, DOI 10.7326/0003-4819-124-12-199606150-00001; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; DONEGAN E, 1990, ANN INTERN MED, V113, P733, DOI 10.7326/0003-4819-113-10-733; DUNN DT, 1992, LANCET, V340, P585, DOI 10.1016/0140-6736(92)92115-V; DURAND E, 1991, NEW ENGL J MED, V324, P1062; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; EMINI EA, 1996, 3 C RETR OPP INF WAS; ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502; ERON JJ, 1996, 3 C RETR OPP INF WAS; Fang GW, 1995, P NATL ACAD SCI USA, V92, P12100, DOI 10.1073/pnas.92.26.12100; FISCHL MA, 1990, ANN INTERN MED, V112, P727, DOI 10.7326/0003-4819-112-10-727; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; FISCHL MA, 1993, ANN INTERN MED, V118, P762, DOI 10.7326/0003-4819-118-10-199305150-00002; Fiscus SA, 1996, JAMA-J AM MED ASSOC, V275, P1483, DOI 10.1001/jama.275.19.1483; FOX R, 1987, AIDS, V1, P35; GAZZARD B, 1996, 3 C RETR OPP INF WAS; GERBERDING J, 1993, ANN INTERN MED, V118, P979, DOI 10.7326/0003-4819-118-12-199306150-00012; GERBERDING JL, 1995, NEW ENGL J MED, V332, P444, DOI 10.1056/NEJM199502163320707; GULICK R, 1996, 3 C RETR OPP INF WAS; HAMMER S, 1995, 35 INT C ANT AG CHEM; HAMMER SM, 1996, 3 C RETR OPP INF WAS; HAUBRICH RH, 1995, 2 NAT C HUM RETR REL; HAVLIR D, 1995, J INFECT DIS, V172, P1379, DOI 10.1093/infdis/172.5.1379; HAVLIR D, 1995, J INFECT DIS, V171, P537, DOI 10.1093/infdis/171.3.537; Havlir DV, 1996, ANN INTERN MED, V124, P984, DOI 10.7326/0003-4819-124-11-199606010-00006; HEATHCHIOZZI M, 1996, 3 C RETR OPP INF WAS; HENDERSON DK, 1990, ANN INTERN MED, V113, P740, DOI 10.7326/0003-4819-113-10-740; HENRARD DR, 1995, JAMA-J AM MED ASSOC, V274, P554, DOI 10.1001/jama.274.7.554; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; *HOFFM LAR, 1996, RAND DOUBL MULT PAR; HUGHES MD, 1994, J INFECT DIS, V169, P28, DOI 10.1093/infdis/169.1.28; Jacobsen H, 1996, J INFECT DIS, V173, P1379, DOI 10.1093/infdis/173.6.1379; JONES PD, 1991, LANCET, V338, P884, DOI 10.1016/0140-6736(91)91535-3; JURRIAANS S, 1994, VIROLOGY, V204, P223, DOI 10.1006/viro.1994.1526; KAHN JO, 1992, NEW ENGL J MED, V327, P581, DOI 10.1056/NEJM199208273270901; KATLAMA C, 1996, 3 C RETR OPP INF WAS; KATLAMA C, 1995, 2 NAT C HUM RETR REL; KINLOCHDELOES S, 1995, NEW ENGL J MED, V333, P408, DOI 10.1056/NEJM199508173330702; KITCHEN VS, 1995, LANCET, V345, P952, DOI 10.1016/S0140-6736(95)90699-1; KOUP RA, 1996, 3 C RETR OPP INF WAS; LAFEUILLADE A, 1996, 3 C RETR OPP INF WAS; LANDESMAN SH, 1994, 34 INT C ANT AG CHEM; LANGE JMA, 1990, NEW ENGL J MED, V322, P1375, DOI 10.1056/NEJM199005103221907; LOOKE DFM, 1990, LANCET, V335, P1280, DOI 10.1016/0140-6736(90)91343-9; LOVEDAY C, 1996, 3 C RETR OPP INF WAS; MARKOWITZ M, 1995, NEW ENGL J MED, V333, P1534, DOI 10.1056/NEJM199512073332304; MATHEZ D, 1996, 3 C RETR OPP INF WAS; MAYERS DL, 1994, 34 INT C ANT AG CHEM; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; MONTANER JSG, 1995, ANN INTERN MED, V123, P561, DOI 10.7326/0003-4819-123-8-199510150-00001; NEWELL ML, 1993, AIDS, V7, pS91, DOI 10.1097/00002030-199301001-00012; OBRIEN WA, 1995, BLOOD, V86, P1082; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; OLIVEIRA RH, 1996, 3 C RETR OPP INF WAS; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; PECKHAM C, 1995, NEW ENGL J MED, V333, P295; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; POLLARD R, 1996, 3 C RETR OPP INF WAS; PURO V, 1992, AIDS, V6, P963, DOI 10.1097/00002030-199209000-00009; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; RICHMAN KM, 1993, J ACQ IMMUN DEF SYND, V6, P402; RUPRECHT RM, 1986, NATURE, V323, P467, DOI 10.1038/323467a0; Saag MS, 1996, NAT MED, V2, P625, DOI 10.1038/nm0696-625; SAAG MS, 1993, NEW ENGL J MED, V329, P1065, DOI 10.1056/NEJM199310073291502; SANDE MA, 1993, JAMA-J AM MED ASSOC, V270, P2583, DOI 10.1001/jama.270.21.2583; SARAVOLATZ L, 1996, 3 C RETR OPP INF WAS; SCHACKER T, 1995, 35 INT C ANT AG CHEM; Schooley RT, 1996, J INFECT DIS, V173, P1354, DOI 10.1093/infdis/173.6.1354; SHIH CC, 1991, J INFECT DIS, V163, P625, DOI 10.1093/infdis/163.3.625; SPERLING R, 1996, 3 C RETR OPP INF WAS; SPRUANCE SL, 1994, ANN INTERN MED, V120, P360, DOI 10.7326/0003-4819-120-5-199403010-00002; STAPRANS SI, 1995, J EXP MED, V182, P1727, DOI 10.1084/jem.182.6.1727; STASZEWSKI S, 1995, 2 C RETR REL INF WAS; TAVARES L, 1987, CANCER RES, V47, P3190; TINDALL B, 1988, ARCH INTERN MED, V148, P945, DOI 10.1001/archinte.148.4.945; TOKARS JI, 1993, ANN INTERN MED, V118, P913, DOI 10.7326/0003-4819-118-12-199306150-00001; VANROMPAY KKA, 1992, ANTIMICROB AGENTS CH, V36, P2381, DOI 10.1128/AAC.36.11.2381; VELLA S, 1996, AIDS, V9, P21; VOLBERDING PA, 1994, JAMA-J AM MED ASSOC, V272, P437, DOI 10.1001/jama.272.6.437; VOLBERDING PA, 1995, NEW ENGL J MED, V333, P401, DOI 10.1056/NEJM199508173330701; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; WEISS SH, 1988, SCIENCE, V239, P68, DOI 10.1126/science.3336776; WELLES SI, IN PRESS J INFECT DI; YENI P, 1995, 5 EUR C CLIN ASP TRE; 1995, PEDIATRICS, V96, P977; 1990, AM J MED, V89, P335; 1994, MMWR-MORBID MORTAL W, V43, P1; 1995, MMWR-MORBID MORTAL W, V44, P929; 1996, MMWR-MORBID MORTAL W, V45, P468	109	544	549	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1996	276	2					146	154		10.1001/jama.276.2.146	http://dx.doi.org/10.1001/jama.276.2.146			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UV485	8656507				2022-12-28	WOS:A1996UV48500030
J	Pichel, JG; Shen, LY; Sheng, HZ; Granholm, AC; Drago, J; Grinberg, A; Lee, EJ; Huang, SP; Saarma, M; Hoffer, BJ; Sariola, H; Westphal, H				Pichel, JG; Shen, LY; Sheng, HZ; Granholm, AC; Drago, J; Grinberg, A; Lee, EJ; Huang, SP; Saarma, M; Hoffer, BJ; Sariola, H; Westphal, H			Defects in enteric innervation and kidney development in mice lacking GDNF	NATURE			English	Article							EMBRYONIC STEM-CELLS; LETHALITY; GENE	GLIAL-CELL-LINE-DERIVED neurotrophic factor (GDNF) has been isolated as a neurotrophic factor for midbrain dopaminergic neurons(1). Because of its neurotrophic activity on a wide range of neuronal populations in vitro and in vivo(2-11), GDNF is being considered as a potential therapeutic agent for neuronal disorders(2,3,12). During mammalian development, it is expressed not only in the nervous system, but also very prominently in the metanephric kidney and the gastrointestinal tract, suggesting possible functions during organogenesis(7,11,13,14). We have investigated the role of GDNF during development by generating a null mutation in the murine GDNF locus, and found that mutant mice show kidney agenesis or dysgenesis and defective enteric innervation. We demonstrate that GDNF induces ureter bud formation and branching during metanephros development, and is essential for proper innervation of the gastrointestinal tract.	NIH,LAB MAMMALIAN GENET & DEV,BETHESDA,MD 20892; UNIV COLORADO,HLTH SCI CTR,DEPT PHARMACOL,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT BASIC DENT SCI,DENVER,CO 80262; MONASH UNIV,DEPT ANAT,CLAYTON,VIC 3168,AUSTRALIA; UNIV HELSINKI,BIOCTR 1,PROGRAM MOL NEUROBIOL,FIN-00014 HELSINKI,FINLAND; UNIV HELSINKI,BIOCTR 1,PROGRAM DEV BIOL,FIN-00014 HELSINKI,FINLAND; UNIV HELSINKI,CHILDRENS HOSP,LAB PEDIAT PATHOL,FIN-00380 HELSINKI,FINLAND	National Institutes of Health (NIH) - USA; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Monash University; University of Helsinki; University of Helsinki; University of Helsinki			Pichel, Jose G/AAF-2255-2019	Pichel, Jose G/0000-0001-8580-0952				Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; Durbec PL, 1996, DEVELOPMENT, V122, P349; EKBLOM P, 1989, FASEB J, V3, P2141, DOI 10.1096/fasebj.3.10.2666230; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Harlow E., 1988, ANTIBODIES LAB MANUA; Hellmich HL, 1996, MECH DEVELOP, V54, P95, DOI 10.1016/0925-4773(95)00464-5; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; LEDOUARI.NM, 1973, J EMBRYOL EXP MORPH, V30, P31; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LOVE PE, 1992, P NATL ACAD SCI USA, V89, P9929, DOI 10.1073/pnas.89.20.9929; MOUNT HTJ, 1995, P NATL ACAD SCI USA, V92, P9092, DOI 10.1073/pnas.92.20.9092; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; OSATHANO.V, 1966, ARCH PATHOL, V82, P391; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Pasini B, 1996, TRENDS GENET, V12, P138, DOI 10.1016/0168-9525(96)10012-3; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; SARIOLA H, 1988, DEVELOPMENT, V104, P589; Saxen L., 1987, ORGANOGENESIS KIDNEY; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Suvanto P, 1996, EUR J NEUROSCI, V8, P816, DOI 10.1111/j.1460-9568.1996.tb01267.x; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; YNTEMA CL, 1954, J COMP NEUROL, V101, P515, DOI 10.1002/cne.901010212	30	949	977	0	17	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 4	1996	382	6586					73	76		10.1038/382073a0	http://dx.doi.org/10.1038/382073a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV473	8657307				2022-12-28	WOS:A1996UV47300056
J	Alpert, JS; Cheitlin, MD				Alpert, JS; Cheitlin, MD			Update in cardiology	ANNALS OF INTERNAL MEDICINE			English	Article									SAN FRANCISCO GEN HOSP, SAN FRANCISCO, CA 94110 USA	San Francisco General Hospital Medical Center	Alpert, JS (corresponding author), UNIV ARIZONA, ARIZONA HLTH SCI CTR, 1501 N CAMPBELL AVE, ROOM 6334, TUCSON, AZ 85724 USA.							Garber AM, 1996, ANN INTERN MED, V124, P515, DOI 10.7326/0003-4819-124-5-199603010-00013	1	6	6	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1996	125	1					40	46		10.7326/0003-4819-125-1-199607010-00007	http://dx.doi.org/10.7326/0003-4819-125-1-199607010-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT399	8644987				2022-12-28	WOS:A1996UT39900006
J	Spital, A				Spital, A			Mandated choice for organ donation: Time to give it a try	ANNALS OF INTERNAL MEDICINE			English	Article							PRESUMED CONSENT; PUBLIC-ATTITUDES; SHORTAGE; TRANSPLANTATION; DONORS	A severe shortage of organs greatly limits the ability to deliver the miracle of transplantation to people suffering from end-stage organ disease. Contributing to this shortage is a high rate of refusal among families who are asked for permission to remove organs from a recently deceased relative. Mandated choice offers an alternative to obtaining consent from the family by returning control to the individual. This plan would require all adults to record their wishes about posthumous organ donation and would consider those wishes binding. By moving the decision-making process to a relaxed setting and ensuring that a person's wishes would be honored, mandated choice would hopefully take advantage of favorable public attitudes toward donation and thereby facilitate organ procurement. Preliminary research suggests that public commitment to organ donation would increase under mandated choice. A pilot study of this promising proposal should be undertaken.	UNIV ROCHESTER, SCH MED, ROCHESTER, NY USA	University of Rochester								CAPLAN AL, 1983, HASTINGS CENT REP, V13, P23, DOI 10.2307/3560741; CHILDRESS JF, 1989, J HEALTH POLIT POLIC, V14, P87, DOI 10.1215/03616878-14-1-87; COHEN C, 1992, TRANSPLANT P, V24, P2168; CORLETT S, 1985, TRANSPLANT P, V17, P103; Dennis J Michael, 1994, UNOS Update, V10, P16; Fox M D, 1994, JAMA, V272, P1704, DOI 10.1001/jama.272.21.1704; GARRISON RN, 1991, SURG GYNECOL OBSTET, V173, P391; GLASSON J, 1994, JAMA-J AM MED ASSOC, V272, P809, DOI 10.1001/jama.1994.03520100071036; GLASSON J, 1995, JAMA-J AM MED ASSOC, V273, P1176, DOI 10.1001/jama.273.15.1176; HARRIS RJ, 1991, J APPL SOC PSYCHOL, V21, P3, DOI 10.1111/j.1559-1816.1991.tb00438.x; ISERSON KV, 1993, JAMA-J AM MED ASSOC, V270, P1930, DOI 10.1001/jama.1993.03510160048014; KATZ BJ, 1984, BEVERLY HILLS BAR J, V18, P152; KOKKEDEE W, 1992, SOC SCI MED, V35, P177, DOI 10.1016/0277-9536(92)90164-L; LEE PP, 1986, SURGERY, V100, P867; MANNINEN DL, 1985, JAMA-J AM MED ASSOC, V253, P3111, DOI 10.1001/jama.253.21.3111; MURRAY TH, 1994, JAMA-J AM MED ASSOC, V272, P814, DOI 10.1001/jama.272.10.814; OVERCAST TD, 1984, JAMA-J AM MED ASSOC, V251, P1559, DOI 10.1001/jama.251.12.1559; *PARTN ORG DON, 1993, AM PUBL ATT ORG DON; PERKINS KA, 1987, AM PSYCHOL, V42, P921, DOI 10.1037/0003-066X.42.10.921; Peters David A, 1988, J Law Health, V3, P157; PROTTAS J, 1995, JAMA-J AM MED ASSOC, V274, P942, DOI 10.1001/jama.274.12.942; PROTTAS JM, 1991, J HEALTH POLIT POLIC, V16, P121, DOI 10.1215/03616878-16-1-121; SIMINOFF LA, 1995, ANN INTERN MED, V123, P10, DOI 10.7326/0003-4819-123-1-199507010-00037; SPITAL A, 1995, JAMA-J AM MED ASSOC, V273, P504, DOI 10.1001/jama.273.6.504; SPITAL A, 1991, NEW ENGL J MED, V325, P1243, DOI 10.1056/NEJM199110243251710; SPITAL A, 1993, CLIN TRANSPLANT, V7, P525; SPITAL A, 1992, ARCH INTERN MED, V152, P2421, DOI 10.1001/archinte.152.12.2421; TYMSTRA T, 1992, FAM PRACT, V9, P141, DOI 10.1093/fampra/9.2.141; VEATCH RM, 1991, NEW ENGL J MED, V325, P1246, DOI 10.1056/NEJM199110243251711; VEATCH RM, 1995, TRANSPL P, V27, P1888; WAITHE ME, 1995, JAMA-J AM MED ASSOC, V273, P1177, DOI 10.1001/jama.1995.03520390034025; 1990, HARVARD LAW REV, V103, P1614; 1996, UNITED WORK ORGAN SH, V12, P26	33	53	54	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1996	125	1					66	69		10.7326/0003-4819-125-1-199607010-00010	http://dx.doi.org/10.7326/0003-4819-125-1-199607010-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UT399	8644990				2022-12-28	WOS:A1996UT39900009
J	Winkelmann, BR; Nauck, M; Klein, B; Russ, AP; Bohm, BO; Siekmeier, R; Ihnken, K; Verho, M; Gross, W; Marz, W				Winkelmann, BR; Nauck, M; Klein, B; Russ, AP; Bohm, BO; Siekmeier, R; Ihnken, K; Verho, M; Gross, W; Marz, W			Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease	ANNALS OF INTERNAL MEDICINE			English	Article						coronary disease; myocardial infarction; peptidyl-dipeptidase A; polymorphism (genetics)		Background: Previous research has shown that the insertion/deletion (I/D) polymorphism of the angiotensin I-converting enzyme (ACE) gene is a major determinant of plasma ACE activity. It has been suggested that persons with the DD genotype (those who express, on average, the highest levels of circulating ACE) have an increased risk for myocardial infarction and coronary artery disease, particularly if they are otherwise at low risk. Subsequent studies, however, have not confirmed that ACE I/D gene polymorphism is a risk factor for coronary artery disease and myocardial infarction. Objective: To investigate the association between the I/D polymorphism of the ACE gene and the risk for coronary artery disease and myocardial infarction in patients in whom coronary artery disease status was documented by angiography. Design: Cross-sectional study. Setting: University medical center. Patients: 209 male case-patients with coronary artery disease and 92 male controls without coronary artery disease, as documented by coronary angiography. Measurements: Assessment of the cardiac risk profile by questionnaire; classification of patients by the degree of coronary artery stenosis; levels of lipoproteins, apolipoproteins, and fibrinogen; and ACE I/D gene polymorphism assessed by polymerase chain reaction amplification. Results: Plasma ACE activity was significantly associated with ACE I/D gene polymorphism. The ACE genotype was not associated with the presence of coronary artery disease or myocardial infarction. If a recessive effect of the D allele was assumed (DD compared with DI and II), the relative risk was 1.00 (95% CI, 0.76 to 1.30) for coronary artery disease and 1.03 (CI, 0.77 to 1.38) for myocardial infarction. Results of analyses were also negative when a dominant effect of the D allele was assumed and when low-risk subgroups were examined. The established risk factors age and apolipoprotein B level emerged as the most important risk predictors in multivariate analyses, followed by diastolic blood pressure and fasting glucose levels. Conclusions: In an angiographically defined study sample, ACE I/D gene polymorphism was not associated with an increased risk for coronary artery disease or myocardial infarction, despite its effects on plasma ACE activity.	UNIV FRANKFURT, GUSTAV EMBDEN CTR BIOL CHEM, D-60590 FRANKFURT, GERMANY	Goethe University Frankfurt			Nauck, Michael Albrecht/ABA-9752-2021; Boehm, Bernhard Otto/F-8750-2015	Nauck, Michael Albrecht/0000-0002-5749-6954; 				AGERHOLMLARSEN B, 1996, CIRCULATION S1, V92, P800; AHNVE S, 1995, J AM COLL CARDIOL, V26, P277; Andersson B., 1995, European Heart Journal, V16, P113; ARBUSTINI E, 1995, BRIT HEART J, V74, P584; ASSMANN G, 1994, ATHEROSCLEROSIS, V110, pS11, DOI 10.1016/0021-9150(94)05386-W; Austen W G, 1975, Circulation, V51, P5; BEOHAR N, 1995, J INVEST MED, V43, P275; BOHN M, 1993, CLIN GENET, V44, P292; BOLIBAR I, 1995, ARTERIOSCL THROM VAS, V15, P1035, DOI 10.1161/01.ATV.15.8.1035; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; FRIEDL W, 1995, ATHEROSCLEROSIS, V112, P137, DOI 10.1016/0021-9150(94)05406-9; GARDEMANN A, 1995, CIRCULATION, V92, P2796, DOI 10.1161/01.CIR.92.10.2796; GLASER C, 1994, CIRCULATION, V90, P364; HARRAP SB, 1993, HYPERTENSION, V21, P455, DOI 10.1161/01.HYP.21.4.455; HUANG HM, 1994, CIRC RES, V75, P454, DOI 10.1161/01.RES.75.3.454; ITOH H, 1993, J CLIN INVEST, V91, P2268, DOI 10.1172/JCI116454; JAMIESON A, 1994, UNPUB COUNC ART 67 S, P120; KATSUYA T, 1995, LANCET, V345, P1600, DOI 10.1016/S0140-6736(95)90115-9; LACHURIE ML, 1995, CIRCULATION, V91, P2933, DOI 10.1161/01.CIR.91.12.2933; LEATHAM E, 1994, J HUM HYPERTENS, V8, P635; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; LUDWIG E, 1995, CIRCULATION, V91, P2120, DOI 10.1161/01.CIR.91.8.2120; MARSHALL HW, 1994, CIRCULATION, V89, P567, DOI 10.1161/01.CIR.89.2.567; MARZ W, 1986, CLIN CHIM ACTA, V160, P1, DOI 10.1016/0009-8981(86)90330-X; MATTU RK, 1995, CIRCULATION, V91, P270, DOI 10.1161/01.CIR.91.2.270; MIETTINEN HE, 1994, HUM GENET, V94, P189; MORRIS BJ, 1994, J CLIN INVEST, V94, P1085, DOI 10.1172/JCI117423; Moussard C., 1995, European Heart Journal, V16, P370; OKAMURA T, 1990, J CARDIOVASC PHARM, V15, P353, DOI 10.1097/00005344-199003000-00002; PAYNE MN, 1994, CIRCULATION, V90, P2566, DOI 10.1161/circ.90.5.7955223; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; ROBITAILLE NM, 1994, CIRCULATION, V90, P110; RUIZ J, 1994, P NATL ACAD SCI USA, V91, P3662, DOI 10.1073/pnas.91.9.3662; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SCHUNKERT H, 1993, CIRC RES, V72, P312, DOI 10.1161/01.RES.72.2.312; SHANMUGAM V, 1993, PCR METH APPL, V3, P120; SKEGGS LT, 1956, J EXP MED, V103, P295, DOI 10.1084/jem.103.3.295; SOUBRIER F, 1993, J HYPERTENS, V11, P471, DOI 10.1097/00004872-199305000-00001; TIRET L, 1992, AM J HUM GENET, V51, P197; URATA H, 1990, J BIOL CHEM, V265, P22348; WESOLOWSKA EB, 1994, UNPUB COUNC ART 67 S, P78; *WHO STUD GROUP DI, 1985, DIAB MELL	44	94	94	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1996	125	1					19	+		10.7326/0003-4819-125-1-199607010-00004	http://dx.doi.org/10.7326/0003-4819-125-1-199607010-00004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT399	8644984				2022-12-28	WOS:A1996UT39900003
J	Applegate, WB; Burns, R				Applegate, WB; Burns, R			Geriatric medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Applegate, WB (corresponding author), UNIV TENNESSEE,MEMPHIS,TN 38163, USA.							BARINAGA M, 1995, SCIENCE, V9, P178; BURNS R, 1995, ARCH INTERN MED, V155, P1313; GILL TM, 1995, J AM GERIATR SOC, V43, P603, DOI 10.1111/j.1532-5415.1995.tb07192.x; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; HODES RJ, 1994, J AM GERIATR SOC, V42, P679, DOI 10.1111/j.1532-5415.1994.tb06870.x; Hodes RJ, 1996, J AM GERIATR SOC, V44, P204, DOI 10.1111/j.1532-5415.1996.tb02441.x; KRAVITZ RL, 1994, J AM GERIATR SOC, V42, P1229, DOI 10.1111/j.1532-5415.1994.tb06502.x; LAHAD EL, 1995, SCIENCE, V269, P970; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; LUBITZ J, 1995, NEW ENGL J MED, V332, P999, DOI 10.1056/NEJM199504133321506; MANTON KG, 1995, NEW ENGL J MED, V333, P1232, DOI 10.1056/NEJM199511023331824; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; REUBEN DB, 1995, NEW ENGL J MED, V332, P1345, DOI 10.1056/NEJM199505183322007; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; SCHNEIDER EL, 1990, JAMA-J AM MED ASSOC, V263, P23335; SILVERMAN M, 1995, J AM GERIATR SOC, V43, P733, DOI 10.1111/j.1532-5415.1995.tb07041.x; STRITTMATTER WJ, 1994, EXP NEUROL, V125, P163, DOI 10.1006/exnr.1994.1019; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; STUCK AE, 1995, NEW ENGL J MED, V333, P1184, DOI 10.1056/NEJM199511023331805; TINETTI ME, 1995, JAMA-J AM MED ASSOC, V273, P1348, DOI 10.1001/jama.273.17.1348; 1995, JAMA-J AM MED ASSOC, V274, P1627	21	14	14	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1812	1813		10.1001/jama.275.23.1812	http://dx.doi.org/10.1001/jama.275.23.1812			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UQ152	8642724				2022-12-28	WOS:A1996UQ15200023
J	Pellegrino, ED				Pellegrino, ED			Ethics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONTEMPORARY				Pellegrino, ED (corresponding author), GEORGETOWN UNIV,MED CTR,WASHINGTON,DC 20007, USA.							BADRAN IG, 1988, J EGYPT MED ASSOC, V71, P463; BEECHAM L, 1995, BRIT MED J, V311, P196; Burleigh M, 1995, DEATH DELIVERANCE EU; CAMERON NMD, 1991, ETHICS MED, V73, P43; CARRICK P, 1985, MED ETHICS ANTIQUITY, P69; CASSILETH BR, 1995, JAMA-J AM MED ASSOC, V273, P1569, DOI 10.1001/jama.273.20.1569; CRAWSHAW R, 1995, JAMA-J AM MED ASSOC, V273, P1153; EDELSTEIN L, 1967, ANCIENT MED SELECTED, P319; ENGELHARDT HT, 1988, NEW ENGL J MED, V319, P1086, DOI 10.1056/NEJM198810203191610; Hall Mark A, 1994, Public Aff Q, V8, P33; KOTTEK SS, 1978, MED HIST, V22, P438, DOI 10.1017/S0025727300033469; MACKINNEY LC, 1977, LEGACIES ETHICS MED, P173; MERIKAS G, 1992, HUM MED, V8, P212; Pellegrino E D, 1994, J Contemp Health Law Policy, V10, P47; PELLEGRINO ED, 1985, MED ETHICS CODE I PE, P1; *REMM COMM, 1991, MED PRACT REG EUTH R; ROBIN ED, 1995, LANCET, V345, P1422, DOI 10.1016/S0140-6736(95)92604-6; *TASK FORC SEX AB, 1991, FIN REP 1991 TASK FO; TECHTCHENKO P, 1994, CAMB Q HEALTHC ETHIC, V3, P49; TEMKIN O, 1991, HIPPOCRATES WORLD CH; VEATCH RM, 1987, J RELIG ETHICS, V15, P86; WEISSLER AM, 1991, MAYO CLIN PROC, V66, P966, DOI 10.1016/S0025-6196(12)61587-0	22	11	12	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1807	1809		10.1001/jama.275.23.1807	http://dx.doi.org/10.1001/jama.275.23.1807			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642721				2022-12-28	WOS:A1996UQ15200020
J	Pitkin, RM				Pitkin, RM			Obstetrics and gynecology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Pitkin, RM (corresponding author), UNIV CALIF LOS ANGELES, LOS ANGELES, CA 90024 USA.							HARARI O, 1995, FERTIL STERIL, V64, P360, DOI 10.1016/S0015-0282(16)57736-X; HATCH KD, 1995, AM J OBSTET GYNECOL, V172, P1150, DOI 10.1016/0002-9378(95)91473-0; HELLEMANS P, 1995, BRIT J OBSTET GYNAEC, V102, P207, DOI 10.1111/j.1471-0528.1995.tb09095.x; IAMS JD, 1995, AM J OBSTET GYNECOL, V173, P141, DOI 10.1016/0002-9378(95)90182-5; KHANDELWAL M, 1995, AM J PERINAT, V12, P161, DOI 10.1055/s-2007-994441; LOCKWOOD CJ, 1991, NEW ENGL J MED, V325, P669, DOI 10.1056/NEJM199109053251001; LUNGU O, 1995, OBSTET GYNECOL, V85, P337, DOI 10.1016/0029-7844(94)00399-X; NAGEOTTE MP, 1994, AM J OBSTET GYNECOL, V170, P20; NAGY Z, 1995, FERTIL STERIL, V63, P808, DOI 10.1016/S0015-0282(16)57486-X; PALEFSKY J M, 1991, Current Opinion in Oncology, V3, P881, DOI 10.1097/00001622-199110000-00012; PALERMO GD, 1995, FERTIL STERIL, V63, P1231, DOI 10.1016/S0015-0282(16)57603-1; SUN XW, 1995, OBSTET GYNECOL, V85, P680, DOI 10.1016/0029-7844(95)00025-M; TARIN JJ, 1995, HUM REPROD, V10, P165, DOI 10.1093/humrep/10.1.165	13	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1829	1830		10.1001/jama.275.23.1829	http://dx.doi.org/10.1001/jama.275.23.1829			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642734				2022-12-28	WOS:A1996UQ15200033
J	Kimball, AM; Tant, M				Kimball, AM; Tant, M			A role for businesses in HIV prevention in Asia	LANCET			English	Editorial Material									ASIAN DEV BANK,MANILA,PHILIPPINES	Asian Development Bank	Kimball, AM (corresponding author), UNIV WASHINGTON,SCH PUBL HLTH & COMMUNITY MED,DEPT HLTH SERV,SEATTLE,WA 98195, USA.							ALBERS C, 1991, 10 INT C AIDS; BEHRAVESH N, 1993, DRI MCGRAW HILL INSI, P1; BLOOM DE, 1991, SCIENCE, V252, P1798, DOI 10.1126/science.1829547; CHEN D, 1991, NAT SEM AIDS SOC IMP; Goss D., 1993, EMPL RELAT, V15, P25, DOI [10.1108/01425459310031804, DOI 10.1108/01425459310031804]; HANKINS C, 1995, CAN MED ASSOC J, V153, P1613; JANJAREEON WS, 1995, REG AIDS C AS PAC CH; SINGH YN, 1994, INT J STD AIDS, V5, P137, DOI 10.1177/095646249400500212; TANG S, 1992, REPORT SURVEY AIDS W; *UN, 1993, DEM YB, P200; WEIL J, 1992, WALL STREET J   0702, pB1; *WHO, 1993, WORLD DEV REP EST HI; 1994, FAR E EC REV, V158, P5	13	2	2	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 15	1996	347	9016					1670	1672		10.1016/S0140-6736(96)91493-2	http://dx.doi.org/10.1016/S0140-6736(96)91493-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ701	8642964				2022-12-28	WOS:A1996UQ70100016
J	Moss, PJ; McKendrick, MW; Channer, KS; Read, RC				Moss, PJ; McKendrick, MW; Channer, KS; Read, RC			Persisting fever after gastroenteritis	LANCET			English	Article							VENTRICULAR ANEURYSM; INFECTION		ROYAL HALLAMSHIRE HOSP,DEPT INFECT & TROP MED,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND; ROYAL HALLAMSHIRE HOSP,DEPT MED,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND; ROYAL HALLAMSHIRE HOSP,DEPT MED MICROBIOL & INFECT DIS,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND	University of Sheffield; University of Sheffield; University of Sheffield				Read, Robert/0000-0002-4297-6728				COHEN JI, 1987, MEDICINE, V66, P349, DOI 10.1097/00005792-198709000-00003; LESTER A, 1991, EUR J CLIN MICROBIOL, V10, P486, DOI 10.1007/BF01963934; MANDAL BK, 1988, BRIT MED J, V297, P242; ONEILL DM, 1992, CLIN INFECT DIS, V14, P175, DOI 10.1093/clinids/14.1.175; SCHOFIELD PM, 1986, EUR HEART J, V7, P1077, DOI 10.1093/oxfordjournals.eurheartj.a062018	5	5	5	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 15	1996	347	9016					1662	1662		10.1016/S0140-6736(96)91490-7	http://dx.doi.org/10.1016/S0140-6736(96)91490-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ701	8642961				2022-12-28	WOS:A1996UQ70100013
J	Andres, RP; Bein, T; Dorogi, M; Feng, S; Henderson, JI; Kubiak, CP; Mahoney, W; Osifchin, RG; Reifenberger, R				Andres, RP; Bein, T; Dorogi, M; Feng, S; Henderson, JI; Kubiak, CP; Mahoney, W; Osifchin, RG; Reifenberger, R			''Coulomb staircase'' at room temperature in a self-assembled molecular nanostructure	SCIENCE			English	Article							GOLD; MONOLAYERS; CLUSTERS; DISULFIDES; SYSTEM	Double-ended aryl dithiols [alpha,alpha'-xylyldithiol (XYL) and 4,4'-biphenyldithiol] formed self assembled monolayers (SAMs) on gold(111) substrates and were used to tether nanometer-sized gold clusters deposited from a cluster beam, An ultrahigh-vacuum scanning tunneling microscope was used to image these nanostructures and to measure their current-voltage characteristics as a function of the separation between the probe tip and the metal cluster. At room temperature, when the tip was positioned over a cluster bonded to the XYL SAM, the current-voltage data showed ''Coulomb staircase'' behavior. These data are in good agreement with semiclassical predictions for correlated single-electron tunneling and permit estimation of the electrical resistance of a single XYL molecule (similar to 18 +/- 12 megohms).	PURDUE UNIV,SCH CHEM ENGN,W LAFAYETTE,IN 47907; PURDUE UNIV,DEPT CHEM,W LAFAYETTE,IN 47907; PURDUE UNIV,DEPT PHYS,W LAFAYETTE,IN 47907	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus			Bein, Thomas/G-7686-2014	Bein, Thomas/0000-0001-7248-5906				AMMAN M, 1991, PHYS REV B, V43, P1146, DOI 10.1103/PhysRevB.43.1146; BIEBUYCK HA, 1993, LANGMUIR, V9, P1766, DOI 10.1021/la00031a025; BOWLES RS, 1981, SURF SCI, V106, P117, DOI 10.1016/0039-6028(81)90188-6; CASTRO T, 1989, J VAC SCI TECHNOL A, V7, P2845, DOI 10.1116/1.576156; CHANG SC, 1994, J AM CHEM SOC, V116, P6792, DOI 10.1021/ja00094a038; CHAPMAN JA, 1957, PROC R SOC LON SER-A, V242, P96, DOI 10.1098/rspa.1957.0156; DOROGI M, 1995, PHYS REV B, V52, P9071, DOI 10.1103/PhysRevB.52.9071; GRABERT H, 1992, SINGLE CHARGE TUNNEL; HANNA AE, 1991, PHYS REV B, V44, P5919, DOI 10.1103/PhysRevB.44.5919; KIM YT, 1993, LANGMUIR, V9, P1941, DOI 10.1021/la00032a001; KULIK IO, 1975, ZH EKSP TEOR FIZ, V41, P308; MAHONEY W, 1995, MATER RES SOC SYMP P, V355, P83; MILLER TG, 1993, PHYS REV B, V48, P7499, DOI 10.1103/PhysRevB.48.7499; NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063; PARK SB, 1988, THESIS PURDUE U; PASHLEY DW, 1964, PHILOS MAG, V10, P127, DOI 10.1080/14786436408224212; PATIL AN, 1993, Z PHYS D ATOM MOL CL, V26, P135, DOI 10.1007/BF01429123; PINER R, 1989, REV SCI INSTRUM, V60, P3123, DOI 10.1063/1.1140589; RABOLT JF, 1983, J CHEM PHYS, V78, P946, DOI 10.1063/1.444799; Samanta MP, 1996, PHYS REV B, V53, pR7626, DOI 10.1103/PhysRevB.53.R7626; SNYDER RG, 1982, J PHYS CHEM-US, V86, P5145, DOI 10.1021/j100223a018; TOUR JM, 1995, J AM CHEM SOC, V117, P9529, DOI 10.1021/ja00142a021; Varsanyi G., 1974, ASSIGNMENTS VIBRATIO, V1; WASSERMAN SR, 1989, J MATER RES, V4, P886, DOI 10.1557/JMR.1989.0886	24	986	1012	5	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1323	1325		10.1126/science.272.5266.1323	http://dx.doi.org/10.1126/science.272.5266.1323			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8662464				2022-12-28	WOS:A1996UN47200041
J	Wang, XZ; Ron, D				Wang, XZ; Ron, D			Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase	SCIENCE			English	Article							PROTEIN-KINASE; GROWTH ARREST; DNA DAMAGE; AGENTS; ONCOGENE; C/EBP; CELLS	CHOP, a member of the C/EBP family of transcription factors, mediates effects of cellular stress on growth and differentiation, It accumulates under conditions of stress and undergoes inducible phosphorylation on two adjacent serine residues (78 and 81). In vitro, CHOP is phosphorylated on these residues by p38 mitogen-activated protein kinase (MAP kinase). A specific inhibitor of p38 MAP kinase, SB203580, abolished the stress-inducible in vivo phosphorylation of CHOP. Phosphorylation of CHOP on these residues enhanced its ability to function as a transcriptional activator and was also required for the full inhibitory effect of CHOP on adipose cell differentiation. CHOP thus serves as a link between a specific stress-activated protein kinase, p38, and cellular growth and differentiation.	NYU, MED CTR, SKIRBALL INST BIOMOL MED, DEPT MED, NEW YORK, NY 10016 USA; NYU, MED CTR, KAPLAN CANC CTR, NEW YORK, NY 10016 USA; NYU, MED CTR, DEPT CELL BIOL, NEW YORK, NY 10016 USA	New York University; New York University; New York University				Ron, David/0000-0002-3014-5636				BARONE MV, 1994, GENE DEV, V8, P453, DOI 10.1101/gad.8.4.453; BATCHVAROVA N, 1995, EMBO J, V14, P4654, DOI 10.1002/j.1460-2075.1995.tb00147.x; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736; CHEN Q, 1992, J BIOL CHEM, V267, P8207; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; DERLJARD B, 1994, CELL, V76, P1025; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HER JH, 1993, BIOCHEM J, V296, P25, DOI 10.1042/bj2960025; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LUETHY JD, 1992, CANCER RES, V52, P5; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; PRICE BD, 1992, CANCER RES, V52, P3814; ROBBINS DJ, 1994, ADV CANCER RES, V63, P93, DOI 10.1016/S0065-230X(08)60399-1; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SYLVESTER SL, 1994, J BIOL CHEM, V269, P20119; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; WANG X, UNPUB; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513	29	721	745	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	1996	272	5266					1347	1349		10.1126/science.272.5266.1347	http://dx.doi.org/10.1126/science.272.5266.1347			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8650547				2022-12-28	WOS:A1996UN47200049
J	Seymour, CA				Seymour, CA			Controversies in management - Screening asymptomatic people at high risk for hepatitis C - The case for	BRITISH MEDICAL JOURNAL			English	Article							VIRUS				Seymour, CA (corresponding author), UNIV LONDON ST GEORGES HOSP,SCH MED,LONDON SW17 0RE,ENGLAND.							ALTER HJ, 1995, SEMIN LIVER DIS, V15, P5; ASCHER NL, 1994, HEPATOLOGY, V20, P245; BRESTERS D, 1993, LANCET, V342, P210, DOI 10.1016/0140-6736(93)92300-I; BRUNO S, 1994, BRIT MED J, V308, P697, DOI 10.1136/bmj.308.6930.697; CUCKLE HS, 1995, BRIT MED J, V311, P1460, DOI 10.1136/bmj.311.7018.1460; DUSHEIKO G, 1994, HEPATOLOGY, V19, P13, DOI 10.1016/0270-9139(94)90046-9; GOODRICK MJ, 1994, TRANSFUSION MED, V4, P113, DOI 10.1111/j.1365-3148.1994.tb00251.x; MACLENNAN S, 1994, TRANSFUSION MED, V4, P130; MORADPOUR D, 1995, NEW ENGL J MED, V332, P1092, DOI 10.1056/NEJM199504203321610; POLYNARD T, 1995, NEW ENGL J MED, V332, P1457; SARACCO G, 1993, HEPATOLOGY, V18, P1300, DOI 10.1002/hep.1840180603; SEYMOUR CA, 1994, BRIT MED J, V308, P670, DOI 10.1136/bmj.308.6930.670; SHIELL A, 1994, MED J AUSTRALIA, V160, P268, DOI 10.5694/j.1326-5377.1994.tb125830.x; TERRAULT N, 1995, NEW ENGL J MED, V332, P1509, DOI 10.1056/NEJM199506013322211; TINE F, 1991, J HEPATOL, V13, P192, DOI 10.1016/0168-8278(91)90814-R; TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202; UYTTENDAELE S, 1994, VOX SANG, V66, P122, DOI 10.1111/j.1423-0410.1994.tb00293.x; VANDERPOEL CL, 1994, LANCET, V344, P1475, DOI 10.1016/S0140-6736(94)90293-3; Watson JP, 1996, GUT, V38, P269, DOI 10.1136/gut.38.2.269; ZAAIJER HL, 1993, LANCET, V341, P722, DOI 10.1016/0140-6736(93)90488-3	20	10	10	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 25	1996	312	7042					1347	1348		10.1136/bmj.312.7042.1347	http://dx.doi.org/10.1136/bmj.312.7042.1347			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN476	8646052	Green Published			2022-12-28	WOS:A1996UN47600027
J	Marengere, LEM; Waterhouse, P; Duncan, GS; Mittrucker, HW; Feng, GS; Mak, TW				Marengere, LEM; Waterhouse, P; Duncan, GS; Mittrucker, HW; Feng, GS; Mak, TW			Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4	SCIENCE			English	Article							ANTIGEN RECEPTOR; ZETA-CHAIN; LYMPHOCYTES-T; TCR ZETA; KINASE; CD28; PHOSPHORYLATION; CLONING; ZAP-70	The absence of CTLA-4 results in uncontrolled T cell proliferation. The T cell receptor-specific kinases FYN, LCK, and ZAP-70 as well as the RAS pathway were found to be activated in T cells of Ctla-4(-/-) mutant mice. In addition, CTLA-4 specifically associated with the tyrosine phosphatase SYP, an interaction mediated by the SRC homology 2 (SH2) domains SYP and phosphotyrosine sequence Tyr-Val-Lys-Met within the CTLA-4 cytoplasmic tail. The CTLA-4-associated SYP had phosphatase activity toward the RAS regulator p52(SHC). Thus, the RAS pathway and T cell activation through the T cell receptor are regulated by CTLA-4-associated SYP.	UNIV TORONTO, AMGEN INST, ONTARIO CANC INST, DEPT IMMUNOL, TORONTO, ON M5G 2C1, CANADA; UNIV TORONTO, AMGEN INST, ONTARIO CANC INST, DEPT MED BIOPHYS, TORONTO, ON M5G 2C1, CANADA; INDIANA UNIV, SCH MED, DEPT BIOCHEM & MOLEC BIOL, INDIANAPOLIS, IN 46202 USA; INDIANA UNIV, SCH MED, WALTHER ONCOL CTR, INDIANAPOLIS, IN 46202 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute			Duncan, Gordon/AIE-7011-2022	Waterhouse, Paul/0000-0001-8745-5224				ADACHI M, 1992, BIOCHEM BIOPH RES CO, V186, P1607, DOI 10.1016/S0006-291X(05)81592-X; ALLISON JP, 1994, CURR OPIN IMMUNOL, V6, P414, DOI 10.1016/0952-7915(94)90120-1; BOLEN JB, 1995, CURR OPIN IMMUNOL, V7, P306, DOI 10.1016/0952-7915(95)80103-0; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; BUDAY L, 1994, J BIOL CHEM, V269, P9019; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHAREST A, 1995, BIOCHEM J, V308, P425, DOI 10.1042/bj3080425; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; GROSS JA, 1992, J IMMUNOL, V149, P380; HUANG XM, 1995, P NATL ACAD SCI USA, V92, P11618, DOI 10.1073/pnas.92.25.11618; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JENKINS MK, 1994, IMMUNITY, V1, P443, DOI 10.1016/1074-7613(94)90086-8; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; MARENGERE LEM, 1994, NATURE, V369, P502, DOI 10.1038/369502a0; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MUSTELIN T, 1994, IMMUNITY, V1, P351, DOI 10.1016/1074-7613(94)90065-5; NEL AE, 1995, J BIOL CHEM, V270, P18428, DOI 10.1074/jbc.270.31.18428; OKUMURA M, 1995, CURR OPIN IMMUNOL, V7, P312, DOI 10.1016/0952-7915(95)80104-9; OSMAN N, 1995, J BIOL CHEM, V270, P13981, DOI 10.1074/jbc.270.23.13981; PLEIMAN CM, 1994, IMMUNOL TODAY, V15, P393, DOI 10.1016/0167-5699(94)90267-4; QUILLIAM LA, 1995, BIOESSAYS, V17, P395, DOI 10.1002/bies.950170507; RAVICHANDRAN KS, 1993, SCIENCE, V262, P902, DOI 10.1126/science.8235613; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; SIEH M, 1994, MOL CELL BIOL, V14, P4435, DOI 10.1128/MCB.14.7.4435; THOMAS ML, 1995, J EXP MED, V181, P1953, DOI 10.1084/jem.181.6.1953; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; VANOERS NSC, 1993, MOL CELL BIOL, V13, P5771, DOI 10.1128/MCB.13.9.5771; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WANG LM, 1995, STEM CELLS, V13, P360, DOI 10.1002/stem.5530130407; WANGE RL, 1992, J BIOL CHEM, V267, P11685; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; YI TL, 1995, BLOOD, V85, P87, DOI 10.1182/blood.V85.1.87.bloodjournal85187; YI TL, 1993, MOL CELL BIOL, V13, P7577, DOI 10.1128/MCB.13.12.7577; YI TL, 1993, MOL CELL BIOL, V13, P3350, DOI 10.1128/MCB.13.6.3350; ZANKE B, 1992, EUR J IMMUNOL, V22, P235, DOI 10.1002/eji.1830220134	53	438	449	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	1996	272	5265					1170	1173		10.1126/science.272.5265.1170	http://dx.doi.org/10.1126/science.272.5265.1170			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8638161				2022-12-28	WOS:A1996UM88900050
J	Li, W; Whaley, CD; Mondino, A; Mueller, DL				Li, W; Whaley, CD; Mondino, A; Mueller, DL			Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4(+) T cells	SCIENCE			English	Article							COSTIMULATORY SIGNAL; ANTIGEN RECEPTOR; MONOCLONAL-ANTIBODY; REGULATED KINASES; ACTIVATION DOMAIN; CLONAL ANERGY; GROWTH-FACTOR; C ACTIVATION; PROLIFERATION; STIMULATION	T cells activated by antigen receptor stimulation in the absence of accessory cell-derived costimulatory signals lose the capacity to synthesize the growth factor interleukin-2 (IL-2), a state called clonal anergy. An analysis of CD3- and CD28-induced signal transduction revealed reduced ERK and JNK enzyme activities in murine anergic T cells. The amounts of ERK and JNK proteins were unchanged, and the kinases could be fully activated in the presence of phorbol 12-myristrate 13-acetate. Dephosphorylation of the calcineurin substrate NFATp (preexisting nuclear factor of activated T cells) also remained inducible. These results suggest that a specific block in the activation of ERK and JNK contributes to defective IL-2 production in clonal anergy.	UNIV MINNESOTA, SCH MED, DEPT MED, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, SCH MED, DEPT MICROBIOL, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, SCH MED, CTR IMMUNOL, MINNEAPOLIS, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities			Mondino, Anna/K-9434-2016	Mondino, Anna/0000-0003-0833-6927; Mueller, Daniel/0000-0003-1621-0419	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI031669] Funding Source: NIH RePORTER; NIAID NIH HHS [R29 AI 31669] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; CHAO TSO, 1992, J BIOL CHEM, V267, P19876; CHO EA, 1993, J IMMUNOL, V151, P20; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; GAJEWSKI TF, 1994, P NATL ACAD SCI USA, V91, P38, DOI 10.1073/pnas.91.1.38; GIMMI CD, 1991, P NATL ACAD SCI USA, V88, P6575, DOI 10.1073/pnas.88.15.6575; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HECHT TT, 1983, J IMMUNOL, V131, P1049; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; IZQUIERDO M, 1993, J EXP MED, V178, P1199, DOI 10.1084/jem.178.4.1199; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JAIN JN, 1993, J IMMUNOL, V151, P837; JENKINS MK, 1990, J IMMUNOL, V144, P16; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; JENKINS MK, 1987, P NATL ACAD SCI USA, V84, P5409, DOI 10.1073/pnas.84.15.5409; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LI W, UNPUB; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MONDINO A, UNPUB; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MUELLER DL, 1991, J IMMUNOL, V147, P4118; MUELLER DL, 1990, J IMMUNOL, V144, P3701; MUELLER DL, 1995, CURR OPIN IMMUNOL, V7, P375, DOI 10.1016/0952-7915(95)80113-8; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; MUELLER DL, 1989, J IMMUNOL, V142, P2617; NEL AE, 1995, J BIOL CHEM, V270, P18428, DOI 10.1074/jbc.270.31.18428; OWAKI H, 1992, BIOCHEM BIOPH RES CO, V182, P1416, DOI 10.1016/0006-291X(92)91891-S; PASTOR MI, 1995, IMMUNOL TODAY, V16, P159, DOI 10.1016/0167-5699(95)80134-0; QUILL H, 1992, J IMMUNOL, V149, P2887; Sambrook J, 1989, MOL CLONING; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; WHALEY CD, UNPUB; WHITEHURST CE, 1992, J IMMUNOL, V148, P3230; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; YAN MH, 1994, NATURE, V372, P798	49	403	415	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	1996	271	5253					1272	1276		10.1126/science.271.5253.1272	http://dx.doi.org/10.1126/science.271.5253.1272			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TX695	8638107				2022-12-28	WOS:A1996TX69500034
J	Wang, Y; Herron, N				Wang, Y; Herron, N			X-ray photoconductive nanocomposites	SCIENCE			English	Article							SEMICONDUCTOR; CLUSTERS; SELENIUM	The successful development of digital radiography depends, to a large extent, on the availability of suitable x-ray photoconductors. The x-ray photoconductive nanocomposites reported here combine the advantages of both inorganic and organic compounds. An inorganic compound was finely dispersed in an organic polymer. The inorganic compound, with its large x-ray absorption efficiency, functioned as the x-ray absorber, and the polymer provided good dielectric properties and ease of thin-film preparation. The preparation procedures and the x-ray photoconductive properties of a specific example, a 50 percent by weight nanocomposite of bismuth triiodide and nylon-11, are discussed In detail.			Wang, Y (corresponding author), DUPONT CO INC,EXPTL STN,POB 80356,WILMINGTON,DE 19880, USA.							ALIG RC, 1975, PHYS REV LETT, V35, P1522, DOI 10.1103/PhysRevLett.35.1522; BASSLER H, 1993, PHYS STATUS SOLIDI B, V175, P15, DOI 10.1002/pssb.2221750102; CLEGG W, 1993, J CHEM SOC DALTON, P2579, DOI 10.1039/dt9930002579; DONOVAN JL, 1979, J APPL PHYS, V50, P6500, DOI 10.1063/1.325745; FENDLER JH, 1994, ADV POLYM SCI SERIES, V113; GLEITER H, 1992, ADV MATER, V4, P474, DOI 10.1002/adma.19920040704; Hillen W., 1988, Proceedings of the SPIE - The International Society for Optical Engineering, V914, P253, DOI 10.1117/12.968639; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; ROWLANDS JA, 1991, MED PHYS, V18, P421, DOI 10.1118/1.596689; Spinks J. W. T., 1976, INTRO RAD CHEM, V3rd; STEIGERWALD ML, 1990, ACCOUNTS CHEM RES, V23, P183, DOI 10.1021/ar00174a003; TOLBERT SH, 1994, SCIENCE, V265, P373, DOI 10.1126/science.265.5170.373; TROTTER J, 1966, Z KRISTALLOGR KRIST, V123, P67; WAGNER LK, 1989, IMAGING PROCESSES MA, P497; WANG Y, 1991, J PHYS CHEM-US, V95, P525, DOI 10.1021/j100155a009; WANG Y, 1990, J CHEM PHYS, V92, P6927, DOI 10.1063/1.458280; WANG Y, 1992, CHEM PHYS LETT, V200, P71, DOI 10.1016/0009-2614(92)87047-S; Wang Y., 1995, ADV PHOTOCHEM, V19, P179; WANG Y, 1996, KIRKOTHMER ENCY CHEM, P837; WELLER H, 1993, ANGEW CHEM, V105, P43; ZHAO W, 1992, EL SOC M TOR ONT CAN, P791	21	79	84	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 2	1996	273	5275					632	634		10.1126/science.273.5275.632	http://dx.doi.org/10.1126/science.273.5275.632			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VA249	8662550				2022-12-28	WOS:A1996VA24900042
J	Blower, SM; Small, PM; Hopewell, PC				Blower, SM; Small, PM; Hopewell, PC			Control strategies for tuberculosis epidemics: New models for old problems	SCIENCE			English	Article							PULMONARY TUBERCULOSIS; SAN-FRANCISCO; RESISTANT; RIFAMPIN; VACCINES; THERAPY; HIV	Tuberculosis, although preventable and curable, causes more adult deaths than any other infectious disease. A theoretical framework for designing effective control strategies is developed and used to determine treatment levels for eradication, to assess the effects of noneradicating control, and to examine the global goals of the World Health Organization. The theory is extended to assess how suboptimal control programs contribute to the evolution of drug resistance. A new evaluation criterion is defined and used to suggest how control strategies can be improved. In order to control tuberculosis, treatment failure rates must be lower in developing countries than in developed countries.	STANFORD UNIV, SCH MED, DEPT MED, STANFORD, CA 94305 USA; UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO GEN HOSP, SAN FRANCISCO, CA 94143 USA	Stanford University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Blower, SM (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT EPIDEMIOL & BIOSTAT, SAN FRANCISCO GEN HOSP, BOX 1347, SAN FRANCISCO, CA 94143 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033831, U01AI035969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R29DA008153] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33831, AI35969] Funding Source: Medline; NIDA NIH HHS [1R29DA08153] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ANDERSON R M, 1991; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; BLOWER SM, 1994, SCIENCE, V265, P1451, DOI 10.1126/science.8073289; BLOWER SM, UNPUB; BLOWR SM, 1996, P 1996 W MULT SIM ME, P71; BROEKMANS JF, 1993, TUBERCULOSIS COMPREH, P641; BRUDNEY K, 1991, AM REV RESPIR DIS, V144, P745, DOI 10.1164/ajrccm/144.4.745; CHAULET P, 1993, TUBERCULOSIS COMPREH, P601; COSTELLO HD, 1980, AM REV RESPIR DIS, V121, P313; Frost WH, 1937, AM J PUBLIC HEALTH N, V27, P759, DOI 10.2105/AJPH.27.8.759; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; GRZYBOWSKI S, 1978, Bulletin of the International Union Against Tuberculosis, V53, P70; ISEMAN MD, 1993, NEW ENGL J MED, V329, P784, DOI 10.1056/NEJM199309093291108; KOCHI A, 1991, TUBERCLE, V72, P1, DOI 10.1016/0041-3879(91)90017-M; LIETMAN TM, UNPUB; MCLEAN AR, 1993, P ROY SOC B-BIOL SCI, V253, P9, DOI 10.1098/rspb.1993.0075; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P419, DOI 10.1017/S0950268800067170; Park MM, 1996, AM J RESP CRIT CARE, V153, P317, DOI 10.1164/ajrccm.153.1.8542137; PORCO TC, UNPUB; SLUTKIN G, 1988, AM REV RESPIR DIS, V138, P1622, DOI 10.1164/ajrccm/138.6.1622; 1994, AM J RESP CRIT CARE, V149, P1623	22	257	266	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	1996	273	5274					497	500		10.1126/science.273.5274.497	http://dx.doi.org/10.1126/science.273.5274.497			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY983	8662538				2022-12-28	WOS:A1996UY98300040
J	Schneider, EC; Epstein, AM				Schneider, EC; Epstein, AM			Influence of cardiac-surgery performance reports on referral practices and access to care - A survey of cardiovascular specialists	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEW-YORK-STATE; QUALITY; REFORM; RATES; RISK	Background Reports on the comparative performance of physicians are becoming increasingly common. Little is known, however, about the credibility of these reports with target audiences or their influence on the delivery of medical services. Methods Since 1992, Pennsylvania has published the Consumer Guide to Coronary Artery Bypass Graft Surgery, which lists annual risk-adjusted mortality rates for all hospitals and surgeons providing such surgery in the state. In 1995, we surveyed a randomly selected sample of 50 percent of Pennsylvania cardiologists and cardiac surgeons to find out whether they were aware of the guide and, if so, to determine their views on its usefulness, limitations, and influence on providers. Results Eighty-two percent of the cardiologists and all the cardiac surgeons were aware of the guide, Only 10 percent of these respondents reported that its mortality rates were ''very important'' in assessing the performance of a cardiothoracic surgeon. Less than 10 percent reported discussing the guide with more than 10 percent of their patients who were candidates for a coronary-artery bypass graft (CABG). Eighty-seven percent of the cardiologists reported that the guide had a minimal influence or none on their referral recommendations. For both groups, the most important limitations of the guide were the absence of indicators of quality other than mortality (cited by 78 percent), inadequate risk adjustment (79 percent), and the unreliability of data provided by hospitals and surgeons (53 percent). Fifty-nine percent of the cardiologists reported increased difficulty in finding surgeons willing to perform CABG surgery in severely ill patients who required it, and 63 percent of the cardiac surgeons reported that they were less willing to operate on such patients. Conclusions The Consumer Guide to Coronary Artery Bypass Graft Surgery has limited credibility among cardiovascular specialists. It has little influence on referral recommendations and may introduce a barrier to care for severely ill patients. If publicly released performance reports are intended to guide the choice of providers without impeding access to medical care, strengthening the collaborative process involving physicians may enhance the credibility and usefulness of the reports. (C) 1996, Massachusetts Medical Society.	HARVARD UNIV,SCH MED,DEPT HLTH CARE POLICY,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DIV GEN MED,SECT HLTH SERV & POLICY RES,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,DEPT HLTH POLICY & MANAGEMENT,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health				Schneider, Eric/0000-0002-1132-5084	BHP HRSA HHS [5T 32 PE 11001-8] Funding Source: Medline	BHP HRSA HHS		ASCH DA, 1995, ANN INTERN MED, V122, P846, DOI 10.7326/0003-4819-122-11-199506010-00007; BROOK RH, 1994, ANN INTERN MED, V120, P84, DOI 10.7326/0003-4819-120-1-199401010-00015; *CA OFF STAT HLTH, 1993, ANN REP CAL HOSP OUT, V1; Chassin MR, 1996, NEW ENGL J MED, V334, P394, DOI 10.1056/NEJM199602083340611; CORRIGAN JM, 1995, MED CARE, V33, pJS18; EPSTEIN A, 1995, NEW ENGL J MED, V333, P57, DOI 10.1056/NEJM199507063330114; FREUDENHEIM M, 1995, NY TIMES        0917, P138; *GEN ACC OFF, 1995, GAOHEHS95201 GEN ACC; General Accounting Office, 1994, GAOHEHS94219 GEN ACC; GREEN J, 1995, NEW ENGL J MED, V332, P1229, DOI 10.1056/NEJM199505043321812; GRUMBACH K, 1995, AM J PUBLIC HEALTH, V85, P1402, DOI 10.2105/AJPH.85.10.1402; HANNAN EL, 1990, JAMA-J AM MED ASSOC, V264, P2768, DOI 10.1001/jama.264.21.2768; HANNAN EL, 1995, JAMA-J AM MED ASSOC, V273, P209, DOI 10.1001/jama.273.3.209; HANNAN EL, 1994, JAMA-J AM MED ASSOC, V271, P761, DOI 10.1001/jama.271.10.761; Iezzoni LI, 2012, RISK ADJUSTMENT MEAS, V4th; JOST TS, 1994, JAMA-J AM MED ASSOC, V271, P1508, DOI 10.1001/jama.271.19.1508; KASSIRER JP, 1994, NEW ENGL J MED, V330, P634, DOI 10.1056/NEJM199403033300910; LANDON B, IN PRESS INQUIRY; MCNEIL BJ, 1992, INQUIRY-J HEALTH CAR, V29, P298; *MEDICA, 1994, REP CARD HLTH CAR; OConnor GT, 1996, JAMA-J AM MED ASSOC, V275, P841, DOI 10.1001/jama.275.11.841; Omoigui NA, 1996, CIRCULATION, V93, P27, DOI 10.1161/01.CIR.93.1.27; *PA HLTH CAR COST, 1994, CONS GUID COR ART BY, V3; *PA HLTH CAR COST, 1994, COR ART BYP GRAFT SU, V2; *PA HLTH CAR COST, 1992, COR ART BYP GRAFT SU, V1; *PA HLTH CAR COST, 1992, CONS GUID COR ART BY, V1; *PA HLTH CAR COST, 1995, CONS GUID COR ART BY, V4; *PA HLTH CAR COST, 1995, COR ART BYP GRAFT SU, V4; *PA HLTH CAR COST, 1994, COR ART BYP GRAF SUR, V3; *PA HLTH CAR COST, 1994, CONS GUID COR ART BY, V2; PARK RE, 1990, JAMA-J AM MED ASSOC, V264, P484; PARSONNET V, 1989, CIRCULATION, V79, P3; PARSONNET V, 1990, CIRCULATION, V82, P1078; *QUAL INF MAN CORP, 1994, CLEV AR HOSP QUAL OU; TOPOL EJ, 1994, ANN INTERN MED, V120, P65, DOI 10.7326/0003-4819-120-1-199401010-00011; VLADECK BC, 1988, HEALTH AFFAIR, V7, P122, DOI 10.1377/hlthaff.7.1.122; WELCH HG, 1994, NEW ENGL J MED, V330, P607, DOI 10.1056/NEJM199403033300906; 1995, NY TIMES        0710, pA12; 1994, SURVEY OUTCOMES MANA	39	338	339	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	1996	335	4					251	256		10.1056/NEJM199607253350406	http://dx.doi.org/10.1056/NEJM199607253350406			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ532	8657242				2022-12-28	WOS:A1996UZ53200006
J	Tofler, IR; Stryer, BK; Micheli, LJ; Herman, LR				Tofler, IR; Stryer, BK; Micheli, LJ; Herman, LR			Physical and emotional problems of elite female gymnasts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ATHLETE TRIAD; AMENORRHEA; INJURIES; OSTEOPOROSIS; SWIMMERS; GROWTH		UNIV CALIF LOS ANGELES,LOS ANGELES,CA 90024; CHILDRENS HOSP,MED CTR,BOSTON,MA 02115; FLORIDA STATE UNIV,TALLAHASSEE,FL 32306	University of California System; University of California Los Angeles; Harvard University; Boston Children's Hospital; State University System of Florida; Florida State University	Tofler, IR (corresponding author), LOUISIANA STATE UNIV,CHILDRENS HOSP NEW ORLEANS,DEPT PSYCHIAT,200 HENRY CLAY AVE,NEW ORLEANS,LA 70118, USA.							BAKER R, 1996, NY TIMES        0420, pA17; CLAESSENS AL, 1992, MED SCI SPORT EXER, V24, P755; COAKLEY J, 1993, INTENSIVE PARTICIPATION IN CHILDRENS SPORTS, P77; COOK PC, 1995, ORTHOP CLIN N AM, V26, P453; DONNELLY P, 1993, INTENSIVE PARTICIPATION IN CHILDRENS SPORTS, P95; DRINKWATER BL, 1990, JAMA-J AM MED ASSOC, V263, P545, DOI 10.1001/jama.263.4.545; DUMMER GM, 1987, PHYSICIAN SPORTSMED, V15, P75, DOI 10.1080/00913847.1987.11709350; EMANS SJ, 1990, OBSTET GYNECOL, V76, P585; FRISCH RE, 1984, BIOL REV, V59, P161, DOI 10.1111/j.1469-185X.1984.tb00406.x; GARRICK JG, 1980, AM J SPORT MED, V8, P261, DOI 10.1177/036354658000800409; GOLDSTEIN JD, 1991, AM J SPORT MED, V19, P463, DOI 10.1177/036354659101900507; GOULD D, 1993, INTENSIVE PARTICIPATION IN CHILDRENS SPORTS, P19; KAPLAN HI, 1988, SYNOPSIS PSYCHIAT BE, P598; KIBLER WB, 1993, INTENSIVE PARTICIPATION IN CHILDRENS SPORTS, P203; LOUCKS AB, 1985, MED SCI SPORT EXER, V17, P56, DOI 10.1249/00005768-198502000-00010; MANDELBAUM BR, 1989, AM J SPORT MED, V17, P305, DOI 10.1177/036354658901700301; MANDELBAUM BR, 1993, INTENSIVE PARTICIPATION IN CHILDRENS SPORTS, P217; MICHELI LJ, 1989, PEDIAT EXERC SCI, V1, P329; NASH H L, 1987, Physician and Sportsmedicine, V15, P129; NATTIV A, 1994, CLIN SPORT MED, V13, P405; NATTIV A, 1993, PHYSICIAN SPORTSMED, V21, P66, DOI 10.1080/00913847.1993.11710401; OPIC H, 1995, REPORT INDEPENDENT I; OTIS CL, 1992, CLIN SPORT MED, V11, P351; PILLEMER FG, 1988, CLIN SPORT MED, V7, P679; POWERS SK, 1994, EXERCISE PHYSL THEOR, P480; ROBERTS GAF, 1992, ADVANCES IN CHITIN AND CHITOSAN, P179; ROSEN LW, 1986, PHYSICIAN SPORTSMED, V14, P79, DOI 10.1080/00913847.1986.11708966; ROSEN LW, 1988, PHYSICIAN SPORTSMED, V16, P140, DOI 10.1080/00913847.1988.11709603; ROWLAND TW, 1993, INTENSIVE PARTICIPAT, P177; Ryan J., 1995, LITTLE GIRLS PRETTY; Seefeldt V, 1978, J PHYS ED RECREATION, V49, P38; SINGER D, 1995, REHABIL MANAGE   DEC, P121; Skolnick AA, 1996, JAMA-J AM MED ASSOC, V275, P22, DOI 10.1001/jama.275.1.22; SKOLNICK AA, 1993, JAMA-J AM MED ASSOC, V270, P921, DOI 10.1001/jama.270.8.921; THEINTZ GE, 1993, J PEDIATR-US, V122, P306, DOI 10.1016/S0022-3476(06)80139-3; TOFLER I, 1995, INT J SPORTS PSYCHIA; TOFLER I, 1996, INT SOC SPORT SCI RE; TOFLER I, 1996, INT SOC SPORTS  0506; WEISS M, 1995, SPORTS PSYCHOL INTER, P41; Weiss M R, 1990, Exerc Sport Sci Rev, V18, P331; WILDER RT, 1992, J BONE JOINT SURG AM, V74A, P910, DOI 10.2106/00004623-199274060-00013; YEAGER KK, 1993, MED SCI SPORT EXER, V25, P775, DOI 10.1249/00005768-199307000-00003; 1996, NBS SPORTS      0302; 1994, TECHNIQUE, V15, P18; 1994, REUTERS NEWS SE 1128	45	94	94	0	15	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	1996	335	4					281	283		10.1056/NEJM199607253350412	http://dx.doi.org/10.1056/NEJM199607253350412			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ532	8657248				2022-12-28	WOS:A1996UZ53200012
J	Gitti, RK; Lee, BM; Walker, J; Summers, MF; Yoo, S; Sundquist, WI				Gitti, RK; Lee, BM; Walker, J; Summers, MF; Yoo, S; Sundquist, WI			Structure of the amino-terminal core domain of the HIV-1 capsid protein	SCIENCE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; TRIPLE-RESONANCE NMR; SIDE-CHAIN RESONANCES; ALPHA-CHYMOTRYPSIN; POSTTRANSLATIONAL MODIFICATIONS; 3-DIMENSIONAL STRUCTURE; SECONDARY STRUCTURE; C-13 MAGNETIZATION; PARTICLE FORMATION; LARGER PROTEINS	The three-dimensional structure of the amino-terminal core domain (residues 1 through 151) of the human immunodeficiency virus-type 1 (HIV-1) capsid protein has been solved by multidimensional heteronuclear magnetic resonance spectroscopy. The structure is unlike those of previously characterized viral coat proteins and is composed of seven alpha helices, two beta hairpins, and an exposed partially ordered loop. The domain is shaped like an arrowhead, with the beta hairpins and loop exposed at the trailing edge and the carboxyl-terminal helix projecting from the tip. The proline residue Pro(1) forms a salt bridge with a conserved, buried aspartate residue (Asp(51)), which suggests that the amino terminus of the protein rearranges upon proteolytic maturation. The binding site for cyclophilin A, a cellular rotamase that is packaged into the HIV-1 virion, is located on the exposed loop and encompasses the essential proline residue Pro(90). In the free monomeric domain, Pro(90) adopts kinetically trapped cis and trans conformations, raising the possibility that cyclophilin A catalyzes interconversion of the cis- and trans-Pro(90) loop structures.	UNIV MARYLAND BALTIMORE CTY,DEPT CHEM & BIOCHEM,BALTIMORE,MD 21228; UNIV UTAH,DEPT BIOCHEM,SALT LAKE CITY,UT 84132	University System of Maryland; University of Maryland Baltimore County; Utah System of Higher Education; University of Utah	Gitti, RK (corresponding author), UNIV MARYLAND BALTIMORE CTY,HOWARD HUGHES MED INST,BALTIMORE,MD 21228, USA.		Lee, Brian/F-8380-2013	Lee, Brian/0000-0002-0269-7812	NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030917, R01AI030917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM042561, R01GM042561] Funding Source: NIH RePORTER; NCI NIH HHS [CA 42014] Funding Source: Medline; NIAID NIH HHS [AI30917] Funding Source: Medline; NIGMS NIH HHS [GM 42561] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABADZAPATERO C, 1980, NATURE, V286, P33, DOI 10.1038/286033a0; Aberham C, 1996, J VIROL, V70, P3536, DOI 10.1128/JVI.70.6.3536-3544.1996; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ARGOS P, 1989, EMBO J, V8, P779, DOI 10.1002/j.1460-2075.1989.tb03438.x; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; Basak AK, 1996, J VIROL, V70, P3797, DOI 10.1128/JVI.70.6.3797-3806.1996; BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K; BILLICH A, 1995, J VIROL, V69, P2451, DOI 10.1128/JVI.69.4.2451-2461.1995; BIRKTOFT JJ, 1976, BIOCHEMISTRY-US, V15, P4481, DOI 10.1021/bi00665a023; Braaten D, 1996, J VIROL, V70, P3551, DOI 10.1128/JVI.70.6.3551-3560.1996; BRAATEN D, IN PRESS J VIROL; BROOKS I, 1994, METHOD ENZYMOL, V240, P459; CHAZAL N, 1994, J VIROL, V68, P111, DOI 10.1128/JVI.68.1.111-122.1994; COATES ARM, 1987, NATURE, V326, P549, DOI 10.1038/326549c0; DORFMAN T, 1994, J VIROL, V68, P8180, DOI 10.1128/JVI.68.12.8180-8187.1994; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; EHRLICH LS, 1994, VIROLOGY, V204, P515, DOI 10.1006/viro.1994.1565; FELHAMMER H, 1977, J MOL BIOL, V111, P415; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; FERSHT AR, 1972, J MOL BIOL, V64, P497, DOI 10.1016/0022-2836(72)90513-X; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FRANKE EK, 1994, J VIROL, V68, P5300, DOI 10.1128/JVI.68.8.5300-5305.1994; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; FREER ST, 1970, BIOCHEMISTRY-US, V9, P1997, DOI 10.1021/bi00811a022; GELDERBLOM HR, 1992, MEMBRANE INTERACTION, P33; GEMMECKER G, 1993, J AM CHEM SOC, V115, P11620, DOI 10.1021/ja00077a080; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; GRIMES J, 1995, NATURE, V373, P167, DOI 10.1038/373167a0; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; HARRISON SC, 1978, NATURE, V276, P368, DOI 10.1038/276368a0; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; HENDERSON LE, 1992, J VIROL, V66, P1856, DOI 10.1128/JVI.66.4.1856-1865.1992; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HONG SS, 1993, J VIROL, V67, P2787, DOI 10.1128/JVI.67.5.2787-2798.1993; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; HUNTER E, 1994, SEMIN VIROL, V5, P71, DOI 10.1006/smvy.1994.1008; IKURA M, 1990, J AM CHEM SOC, V112, P9020, DOI 10.1021/ja00180a080; IKURA M, 1991, Journal of Biomolecular NMR, V1, P299, DOI 10.1007/BF01875522; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; JOWETT JBM, 1992, J GEN VIROL, V73, P3079, DOI 10.1099/0022-1317-73-12-3079; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1990, SCIENCE, V249, P411, DOI 10.1126/science.2377896; KOIDE S, 1995, J BIOMOL NMR, V6, P306; KOLATKAR PR, 1992, ACTA CRYSTALLOGR B, V48, P191, DOI 10.1107/S0108768191012363; KOSSIAKOFF AA, 1977, BIOCHEMISTRY-US, V16, P654, DOI 10.1021/bi00623a016; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANGEDIJK JPM, 1990, J GEN VIROL, V71, P2609, DOI 10.1099/0022-1317-71-11-2609; LILJAS L, 1982, J MOL BIOL, V159, P93, DOI 10.1016/0022-2836(82)90033-X; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; MACURA S, 1980, MOL PHYS, V41, P95, DOI 10.1080/00268978000102601; MAMMANO F, 1994, J VIROL, V68, P4927, DOI 10.1128/JVI.68.8.4927-4936.1994; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; MATHEWS S, 1994, NATURE, V370, P666; MCCONN J, 1969, J MOL BIOL, V39, P551, DOI 10.1016/0022-2836(69)90145-4; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MERVIS RJ, 1988, J VIROL, V62, P3993, DOI 10.1128/JVI.62.11.3993-4002.1988; MEYERS R, 1995, HUAN RETROVIRUSES AI; MODROW S, 1994, MED MICROBIOL IMMUN, V184, P177; MUHANDIRAM DR, 1993, J BIOMOL NMR, V3, P463; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; OTT DE, 1995, AIDS RES HUM RETROV, V11, P1003, DOI 10.1089/aid.1995.11.1003; PFLUGL G, 1993, NATURE, V361, P91, DOI 10.1038/361091a0; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; PRONGAY AJ, 1990, P NATL ACAD SCI USA, V87, P9980, DOI 10.1073/pnas.87.24.9980; RAO ZH, 1995, NATURE, V378, P743, DOI 10.1038/378743a0; REICIN AS, 1995, J VIROL, V69, P642, DOI 10.1128/JVI.69.2.642-650.1995; ROBERTHEBMANN V, 1992, MOL IMMUNOL, V29, P729, DOI 10.1016/0161-5890(92)90183-X; ROSE S, 1992, PROTEINS, V13, P112, DOI 10.1002/prot.340130204; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533; ROSSMANN MG, 1988, P NATL ACAD SCI USA, V85, P4625, DOI 10.1073/pnas.85.13.4625; SIGLER PB, 1968, J MOL BIOL, V35, P143, DOI 10.1016/S0022-2836(68)80043-9; SPEARMAN P, 1994, J VIROL, V68, P3232, DOI 10.1128/JVI.68.5.3232-3242.1994; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; STEINKASSERER A, 1995, J VIROL, V69, P814, DOI 10.1128/JVI.69.2.814-824.1995; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; THERIAULT Y, 1993, NATURE, V361, P88, DOI 10.1038/361088a0; VALEGARD K, 1990, NATURE, V345, P36, DOI 10.1038/345036a0; VONPOBLOTZKI A, 1993, VIROLOGY, V193, P981, DOI 10.1006/viro.1993.1210; VUISTER GW, 1993, J MAGN RESON SER B, V101, P210, DOI 10.1006/jmrb.1993.1035; WANG CT, 1993, J VIROL, V67, P4264, DOI 10.1128/JVI.67.7.4264-4273.1993; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; WLODAWER A, 1993, ANNU REV BIOCHEM, V62, P543, DOI 10.1146/annurev.bi.62.070193.002551; Wuthrich K, 1986, NMR PROTEINS NUCL AC; YOO SJ, UNPUB; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	103	401	412	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 12	1996	273	5272					231	235		10.1126/science.273.5272.231	http://dx.doi.org/10.1126/science.273.5272.231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW787	8662505				2022-12-28	WOS:A1996UW78700039
J	Beymer, D; Poggio, T				Beymer, D; Poggio, T			Image representations for visual learning	SCIENCE			English	Article							OBJECT RECOGNITION; VISION; SHAPE	Computer vision researchers are developing new approaches to object recognition and detection that are based almost directly on images and avoid the use of intermediate three-dimensional models. Many of these techniques depend on a representation of images that induces a linear vector space structure and in principle requires dense feature correspondence. This image representation allows the use of learning techniques for the analysis of images (for computer vision) as well as for the synthesis of images (for computer graphics).	MIT, CTR BIOL & COMPUTAT LEARNING, DEPT BRAIN & COGNIT SCI, CAMBRIDGE, MA 02142 USA; MIT, ARTIFICIAL INTELLIGENCE LAB, CAMBRIDGE, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)								AKAMATSU S, 1992, 11TH IAPR INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION, PROCEEDINGS, VOL II, P217, DOI 10.1109/ICPR.1992.201758; ANANDAN P, 1996, P IM UND WORKSH PALM; Atick JJ, 1996, NETWORK-COMP NEURAL, V7, P1, DOI 10.1080/0954898X.1996.11978652; AVIDAN S, 1996, CIS9602 TECHN; BACHELDER I, 1991, THESIS MIT; BERGEN JR, 1992, P EUR C COMP VIS, P237; BEYMER D, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P500, DOI 10.1109/ICCV.1995.466898; BEYMER D, 1993, 1431 MIT ART INT LAB; BEYMER DI, 1995, 1537 MIT ART INT LAB; BLAKE A, 1993, INT J COMPUT VISION, V11, P127, DOI 10.1007/BF01469225; BLAKE A, 1994, SIGGRAPH 94 C P ORL, P185; Broomhead D. S., 1988, Complex Systems, V2, P321; BRUELE T, 1992, 1374 MIT ART INT LAB; BULTHOFF HH, 1992, P NATL ACAD SCI USA, V89, P60, DOI 10.1073/pnas.89.1.60; BURR DJ, 1981, IEEE T PATTERN ANAL, V3, P708, DOI 10.1109/TPAMI.1981.4767176; CHEN SE, 1993, SIGGRAPH 93, P279; COOTES TF, 1993, FOURTH INTERNATIONAL CONFERENCE ON COMPUTER VISION : PROCEEDINGS, P242; Cootes Timothy F, 1992, BMVC, DOI DOI 10.1007/978-1-4471-3201-1_28; CRAW I, 1991, 1991 BRIT MACH VIS C, P367; EVGENIOU T, 1996, THESIS MIT; EZZAT T, 1996, THESIS MIT; FAYYAD UM, 1993, P 10 INT C MACH LEAR, P112, DOI DOI 10.1016/B978-1-55860-307-3.50021-6; FISCHLER MA, 1973, IEEE T COMPUT, VC 22, P67, DOI 10.1109/T-C.1973.223602; Golomb BA, 1991, ADV NEURAL INFORMATI, V1, P572; Grenander U., 1991, HANDS PATTERN THEORE; Grimson W. E. L., 1990, OBJECT RECOGNITION C; HALLINAN PW, 1995, THESI SHARVARD U; HINTON GE, 1992, ADV NEUR IN, V4, P512; HURLBERT A, 1986, NATURE, V321, P651, DOI 10.1038/321651a0; JONES M, UNPUB; JONES MJ, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P531, DOI 10.1109/ICCV.1995.466894; KANADE T, 1995, IROS '95 - 1995 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS: HUMAN ROBOT INTERACTION AND COOPERATIVE ROBOTS, PROCEEDINGS, VOL 3, P95, DOI 10.1109/IROS.1995.525868; KASS M, 1987, P 1 INT C COMP VIS L; KIRBY M, 1990, IEEE T PATTERN ANAL, V12, P103, DOI 10.1109/34.41390; KOENDERINK JJ, 1979, BIOL CYBERN, V32, P211, DOI 10.1007/BF00337644; LADES M, 1993, IEEE T COMPUT, V42, P300, DOI 10.1109/12.210173; LANITIS A, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P368, DOI 10.1109/ICCV.1995.466919; LAVEAU S, 1994, 2205 I NAT RECH INF; LEE Y, 1995, SIGGRAPH 95 C P, P55; LIBRANDE S, 1992, THESIS MIT; LINES S, 1996, THESIS MIT; LIPSON P, 1993, THESIS MIT; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Lucas B.D., 1981, P 7 INT JOINT C ARTI, P674, DOI DOI 10.5555/1623264.1623280; McMillan L., 1995, Computer Graphics Proceedings. SIGGRAPH 95, P39, DOI 10.1145/218380.218398; MOGHADDAM B, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P786, DOI 10.1109/ICCV.1995.466858; MUKHERJEE S, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P794, DOI 10.1109/ICCV.1995.466857; MURASE H, 1993, PROCEEDINGS OF THE ELEVENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P836; MURASE H, 1995, INT J COMPUT VISION, V14, P5, DOI 10.1007/BF01421486; PENTLAND A, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P84, DOI 10.1109/CVPR.1994.323814; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P899; POGGIO T, 1985, NATURE, V317, P314, DOI 10.1038/317314a0; POGGIO T, 1990, SCIENCE, V247, P978, DOI 10.1126/science.247.4945.978; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; POGGIO T, 1992, 1347 MIT ART INT LAB; POGGIO T., 1989, 1140 MIT ART INT LAB; POGGIO T, 1990, 900503 I RIC SCI TEC; POGGIO T, 1992, 1354 MIT ART INT LAB; Pomerleau DA, 1991, NEURAL COMPUT, V3, P88, DOI 10.1162/neco.1991.3.1.88; ROWLEY H, 1995, CMUCS95158 CARN MELL; Seitz S. M., 1995, Proceedings IEEE Workshop on Representation of Visual Scenes (In Conjunction with ICCV'95) (Cat. No.95TB8126), P18, DOI 10.1109/WVRS.1995.476848; SHASHUA A, 1995, IEEE T PATTERN ANAL, V17, P779, DOI 10.1109/34.400567; SHASHUA A, 1992, 1401 MIT ART INT LAB; SUNG KK, 1994, P IM UND WORKSH MONT, P843; TOMASI C, 1992, INT J COMPUT VISION, V9, P137, DOI 10.1007/BF00129684; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; ULLMAN S, 1991, IEEE T PATTERN ANAL, V13, P992, DOI 10.1109/34.99234; VETTER T, 1995, CEREB CORTEX, V5, P261, DOI 10.1093/cercor/5.3.261; VETTER T, 1995, 1531 MIT ART INT LAB; WATERS K, 1993, 934 CRL DIG EQ CORP; WERNER T, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P957, DOI 10.1109/ICCV.1995.466831; WITKIN A, 1987, INT J COMPUT VISION, V1, P133, DOI 10.1007/BF00123162; Wolberg G, 1990, DIGITAL IMAGE WARPIN; YANG JYA, 1994, IEEE T IMAGE PROCESS, V3, P625; YUILLE A, COMMUNICATION; Yuille AL, 1990, NEURAL COMPUT, V2, P1, DOI 10.1162/neco.1990.2.1.1	77	175	185	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	1996	272	5270					1905	1909		10.1126/science.272.5270.1905	http://dx.doi.org/10.1126/science.272.5270.1905			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8658162				2022-12-28	WOS:A1996UV29400038
J	Waldor, MK; Mekalanos, JJ				Waldor, MK; Mekalanos, JJ			Lysogenic conversion by a filamentous phage encoding cholera toxin	SCIENCE			English	Article							VIBRIO-CHOLERAE; COLONIZATION FACTOR; COREGULATED PILI; VIRULENCE; ENTEROTOXIN; EXPRESSION; GENES	Vibrio cholerae, the causative agent of cholera, requires two coordinately regulated factors for full virulence: cholera toxin (CT), a patent enterotoxin, and toxin-coregulated pill (TCP), surface organelles required for intestinal colonization. The structural genes for CT are shown here to be encoded by a filamentous bacteriophage (designated CTX Phi), which is related to coliphage M13. The CTX Phi genome chromosomally integrated or replicated as a plasmid, CTX Phi used TCP as its receptor and infected V. cholerae cells within the gastrointestinal tracts of mice more efficiently than under laboratory conditions, Thus, the emergence of toxigenic V. cholerae involves horizontal gene transfer that may depend on in vivo gene expression.	HARVARD UNIV,SCH MED,SHIPLEY INST MED,DEPT MICROBIOL & MOLEC GENET,BOSTON,MA 02115	Harvard University; Harvard Medical School					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI018045, K08AI001321, R22AI018045] Funding Source: NIH RePORTER; NIAID NIH HHS [AI18045, AI01321] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BETLEY MJ, 1986, ANNU REV MICROBIOL, V40, P577, DOI 10.1146/annurev.mi.40.100186.003045; CHIANG SL, 1995, MOL MICROBIOL, V17, P1133, DOI 10.1111/j.1365-2958.1995.mmi_17061133.x; DIRITA VJ, 1992, MOL MICROBIOL, V6, P451, DOI 10.1111/j.1365-2958.1992.tb01489.x; DIRITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403, DOI 10.1073/pnas.88.12.5403; FASANO A, 1991, P NATL ACAD SCI USA, V88, P5242, DOI 10.1073/pnas.88.12.5242; Genetic Computer Group, 1994, PROGR MAN WISC PACK; GOLDBERG I, 1986, J BACTERIOL, V165, P723, DOI 10.1128/jb.165.3.723-731.1986; HALL RH, 1988, MICROB PATHOGENESIS, V4, P257, DOI 10.1016/0882-4010(88)90086-1; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; HILL DF, 1991, J MOL BIOL, V218, P349, DOI 10.1016/0022-2836(91)90717-K; HO ASY, 1990, J EXP MED, V172, P795, DOI 10.1084/jem.172.3.795; JONSON G, 1992, INFECT IMMUN, V60, P4278, DOI 10.1128/IAI.60.10.4278-4284.1992; KAPER JB, 1994, INFECT IMMUN, V62, P1480, DOI 10.1128/IAI.62.4.1480-1483.1994; KENNER JR, 1995, J INFECT DIS, V172, P1126, DOI 10.1093/infdis/172.4.1126; KOONIN EV, 1992, FEBS LETT, V312, P3, DOI 10.1016/0014-5793(92)81398-6; Mekalanos JJ, 1995, B I PASTEUR, V93, P255, DOI 10.1016/0020-2452(96)85759-9; MEKALANOS JJ, 1994, SCIENCE, V265, P1387, DOI 10.1126/science.8073279; MEKALANOS JJ, 1983, CELL, V35, P253, DOI 10.1016/0092-8674(83)90228-3; MILLER VL, 1984, P NATL ACAD SCI-BIOL, V81, P3471, DOI 10.1073/pnas.81.11.3471; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Model P., 1988, BACTERIOPHAGES, P375; MORSCHHAUSER J, 1994, MOL MICROBIOL, V11, P555, DOI 10.1111/j.1365-2958.1994.tb00336.x; PEARSON GDN, 1993, P NATL ACAD SCI USA, V90, P3750, DOI 10.1073/pnas.90.8.3750; PEARSON GDN, 1989, THESIS HARVARD U MED; Reidl J, 1995, MOL MICROBIOL, V18, P685, DOI 10.1111/j.1365-2958.1995.mmi_18040685.x; RUSSEL M, 1995, TRENDS MICROBIOL, V3, P223, DOI 10.1016/S0966-842X(00)88929-5; TAYLOR R, 1988, VACCINE, V6, P151, DOI 10.1016/S0264-410X(88)80019-7; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; TRUCKSIS M, 1993, P NATL ACAD SCI USA, V90, P5267, DOI 10.1073/pnas.90.11.5267; WALDOR MK, 1994, INFECT IMMUN, V62, P72, DOI 10.1128/IAI.62.1.72-78.1994; WALDOR MK, 1994, J INFECT DIS, V170, P278, DOI 10.1093/infdis/170.2.278	32	1261	1356	3	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1996	272	5270					1910	1914		10.1126/science.272.5270.1910	http://dx.doi.org/10.1126/science.272.5270.1910			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8658163				2022-12-28	WOS:A1996UV29400039
J	Elena, SF; Cooper, VS; Lenski, RE				Elena, SF; Cooper, VS; Lenski, RE			Punctuated evolution caused by selection of rare beneficial mutations	SCIENCE			English	Article							EQUILIBRIA; RATES	For more than two decades there has been intense debate over the hypothesis that most morphological evolution occurs during relatively brief episodes of rapid change that punctuate much longer periods of stasis, A clear and unambiguous case of punctuated evolution is presented for cell size in a population of Escherichia coli evolving for 3000 generations in a constant environment, The punctuation is caused by natural selection as rare, beneficial mutations sweep successively through the population, This experiment shows that the most elementary processes in population genetics can give rise to punctuated evolutionary dynamics.			Elena, SF (corresponding author), MICHIGAN STATE UNIV,CTR MICROBIAL ECOL,E LANSING,MI 48824, USA.		Elena, Santiago F./A-4191-2011	Elena, Santiago F./0000-0001-8249-5593; Cooper, Vaughn/0000-0001-7726-0765; Lenski, Richard/0000-0002-1064-8375				ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; BOOKSTEIN FL, 1978, PALEOBIOLOGY, V4, P120, DOI 10.1017/S0094837300005807; CHARLESWORTH B, 1982, EVOLUTION, V36, P474, DOI 10.1111/j.1558-5646.1982.tb05068.x; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; DYKHUIZEN DE, 1983, MICROBIOL REV, V47, P150, DOI 10.1128/MMBR.47.2.150-168.1983; Eldredge N., 1972, P82; Falconer D. S., 1981, INTRO QUANTITATIVE G; GINGERICH PD, 1984, SYST ZOOL, V33, P335, DOI 10.2307/2413079; GINGERICH PD, 1983, SCIENCE, V222, P159, DOI 10.1126/science.222.4620.159; GINZBURG LR, 1981, PALEOBIOLOGY, V7, P426, DOI 10.1017/S0094837300025483; Gould S.J., 1982, P83; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; JOHNSON PA, 1995, P ROY SOC B-BIOL SCI, V259, P125, DOI 10.1098/rspb.1995.0019; KLEINBAUM DJ, 1978, APPLIED REGRESSION A; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Levinton J. S., 1988, GENETICS PALEONTOLOG; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; NEWMAN CM, 1985, NATURE, V315, P400, DOI 10.1038/315400a0; Travisano M, 1996, GENETICS, V143, P15; Turner J., 1986, PATTERNS PROCESSES H, P183; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; WILLIAMSON PG, 1981, NATURE, V293, P437, DOI 10.1038/293437a0	25	198	205	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1802	1804		10.1126/science.272.5269.1802	http://dx.doi.org/10.1126/science.272.5269.1802			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8650581				2022-12-28	WOS:A1996UT11000047
J	Rhodes, JM				Rhodes, JM			Cholesterol crystal embolism: An important ''new'' diagnosis for the general physician	LANCET			English	Editorial Material							EMBOLIZATION				Rhodes, JM (corresponding author), UNIV LIVERPOOL,DEPT MED,LIVERPOOL L69 3BX,MERSEYSIDE,ENGLAND.		Rhodes, Jonathan M/C-2496-2009					BLANKENSHIP JC, 1995, CHEST, V107, P662, DOI 10.1378/chest.107.3.662; CABILI S, 1993, ANGIOLOGY, V44, P821, DOI 10.1177/000331979304401010; CROSS SS, 1991, J CLIN PATHOL, V44, P859, DOI 10.1136/jcp.44.10.859; DAHLBERG PJ, 1989, SURGERY, V105, P737; FINE MJ, 1987, ANGIOLOGY, V38, P769, DOI 10.1177/000331978703801007; GAINES PA, 1988, LANCET, V1, P168; Moolenaar W, 1996, GUT, V38, P196, DOI 10.1136/gut.38.2.196; RICHARDS AM, 1965, AM J CARDIOL, V15, P696, DOI 10.1016/0002-9149(65)90359-0; WONG FKM, 1995, AM J KIDNEY DIS, V26, P508	9	29	30	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 15	1996	347	9016					1641	1641		10.1016/S0140-6736(96)91482-8	http://dx.doi.org/10.1016/S0140-6736(96)91482-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ701	8642953				2022-12-28	WOS:A1996UQ70100005
J	Cascalho, M; Ma, A; Lee, S; Masat, L; Wabl, M				Cascalho, M; Ma, A; Lee, S; Masat, L; Wabl, M			A quasi-monoclonal mouse	SCIENCE			English	Article							LAMBDA-LIGHT CHAIN; B-CELL LYMPHOMA; GENE REPLACEMENT; VARIABLE REGION; VH; SEGMENTS; IMMUNOGLOBULINS; RECOMBINATION; REARRANGEMENT; ASSOCIATION	As a model for studying the generation of antibody diversity, a gene-targeted mouse was produced that is hemizygous for a rearranged V(D)J segment at the immunoglobulin (Ig) heavy chain locus, the other allele being nonfunctional. The mouse also has no functional kappa light chain allele. The heavy chain, when paired with any lambda light chain, is specific for the hapten (4-hydroxy-3-nitrophenyl) acetyl (NP). The primary repertoire of this quasi-monoclonal mouse is monospecific, but somatic hypermutation and secondary rearrangements change the specificity of 20 percent of the antigen receptors on B cells. The serum concentrations of the Ig isotypes are similar to those in nontransgenic littermates, but less than half of the serum IgM binds to NP, and none of the other isotypes do. Thus, neither network interactions nor random activation of a small fraction of the B cell population can account for serum is concentrations.			Cascalho, M (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT MICROBIOL & IMMUNOL, SAN FRANCISCO, CA 94143 USA.			Cascalho, Marilia/0000-0002-2695-3921	NIAMS NIH HHS [P60 AR20684] Funding Source: Medline; NIGMS NIH HHS [1R01 GM37699] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037699] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APPELLA E, 1971, P NATL ACAD SCI USA, V68, P590, DOI 10.1073/pnas.68.3.590; AZUMA T, 1981, P NATL ACAD SCI-BIOL, V78, P569, DOI 10.1073/pnas.78.1.569; BECKENGESER G, 1987, P NATL ACAD SCI USA, V84, P1060, DOI 10.1073/pnas.84.4.1060; BLOMBERG B, 1981, P NATL ACAD SCI-BIOL, V78, P3765, DOI 10.1073/pnas.78.6.3765; CARSON S, 1989, IMMUNOGENETICS, V29, P173, DOI 10.1007/BF00373642; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; CHEN JZ, 1993, EMBO J, V12, P821, DOI 10.1002/j.1460-2075.1993.tb05722.x; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; COUTINHO A, 1995, SCAND J IMMUNOL, V42, P3, DOI 10.1111/j.1365-3083.1995.tb03619.x; COVEY LR, 1990, INT IMMUNOL, V2, P579, DOI 10.1093/intimm/2.6.579; DILDROP R, 1987, EUR J IMMUNOL, V17, P731, DOI 10.1002/eji.1830170525; ELLIOTT BW, 1982, NATURE, V299, P559, DOI 10.1038/299559a0; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GROSSCHEDL R, 1984, CELL, V38, P67; IMANISHI T, 1974, J EXP MED, V140, P1498, DOI 10.1084/jem.140.6.1498; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Kabat EA, 1991, SEQUENCES PROTEINS I; KARJALAINEN K, 1980, EUR J IMMUNOL, V10, P132, DOI 10.1002/eji.1830100212; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; KLEINFIELD RW, 1989, J IMMUNOL, V142, P4475; KOMORI T, 1993, EUR J IMMUNOL, V23, P517, DOI 10.1002/eji.1830230233; LOH DY, 1983, CELL, V33, P85, DOI 10.1016/0092-8674(83)90337-9; MILLER J, 1981, P NATL ACAD SCI-BIOL, V78, P3829, DOI 10.1073/pnas.78.6.3829; RAMSDEN DA, 1991, P NATL ACAD SCI USA, V88, P10721, DOI 10.1073/pnas.88.23.10721; REILLY EB, 1984, P NATL ACAD SCI-BIOL, V81, P2484, DOI 10.1073/pnas.81.8.2484; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; SANCHEZ P, 1987, J EXP MED, V166, P265, DOI 10.1084/jem.166.1.265; SCHULENBERG EP, 1971, P NATL ACAD SCI USA, V66, P2623; SELSING E, 1982, P NATL ACAD SCI-BIOL, V79, P4681, DOI 10.1073/pnas.79.15.4681; SHIRASAWA T, 1992, J EXP MED, V176, P1209, DOI 10.1084/jem.176.4.1209; STEENBERGEN EJ, 1993, BLOOD, V82, P581, DOI 10.1182/blood.V82.2.581.bloodjournal822581; TAKI S, 1993, SCIENCE, V262, P1268, DOI 10.1126/science.8235657; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; USUDA S, 1992, EMBO J, V11, P611, DOI 10.1002/j.1460-2075.1992.tb05093.x; VARELA F, 1991, P NATL ACAD SCI USA, V88, P5917, DOI 10.1073/pnas.88.13.5917; WEISS S, 1985, EUR J IMMUNOL, V15, P765, DOI 10.1002/eji.1830150805; WHITESCHARF ME, 1981, EUR J IMMUNOL, V11, P897, DOI 10.1002/eji.1830111109; WHITESCHARF ME, 1982, EUR J IMMUNOL, V12, P935, DOI 10.1002/eji.1830121108	38	159	174	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 14	1996	272	5268					1649	1652		10.1126/science.272.5268.1649	http://dx.doi.org/10.1126/science.272.5268.1649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8658139				2022-12-28	WOS:A1996UR09300046
J	Lemmon, MA; Ferguson, KM; Schlessinger, J				Lemmon, MA; Ferguson, KM; Schlessinger, J			PH domains: Diverse sequences with a common fold recruit signaling molecules to the cell surface	CELL			English	Review									YALE UNIV,DEPT CHEM,NEW HAVEN,CT 06520	Yale University	Lemmon, MA (corresponding author), NYU,MED CTR,DEPT PHARMACOL,550 1ST AVE,NEW YORK,NY 10016, USA.			Lemmon, Mark/0000-0002-3379-5319				BATZER AG, 1995, MOL CELL BIOL, V15, P4403; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; CIFUENTES ME, 1994, J BIOL CHEM, V269, P1945; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; FERGUSON KM, 1995, NAT STRUCT BIOL, V2, P715, DOI 10.1038/nsb0995-715; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HASLAM RJ, 1993, NATURE, V363, P309, DOI 10.1038/363309b0; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; KAVANAUGH WM, 1995, SCIENCE, V268, P1177, DOI 10.1126/science.7539155; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; MCCOLLAM L, 1995, J BIOL CHEM, V270, P15954, DOI 10.1074/jbc.270.27.15954; Paterson HF, 1995, BIOCHEM J, V312, P661, DOI 10.1042/bj3120661; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; REBECCHI M, 1992, BIOCHEMISTRY-US, V31, P12742, DOI 10.1021/bi00166a005; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; YAGISAWA H, 1994, J BIOL CHEM, V269, P20179; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0	19	427	431	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 31	1996	85	5					621	624		10.1016/S0092-8674(00)81022-3	http://dx.doi.org/10.1016/S0092-8674(00)81022-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UP344	8646770	hybrid			2022-12-28	WOS:A1996UP34400002
J	Mochizuki, T; Wu, GQ; Hayashi, T; Xenophontos, SL; Veldhuisen, B; Saris, JJ; Reynolds, DM; Cai, YQ; Gabow, PA; Pierides, A; Kimberling, WJ; Breuning, MH; Deltas, CC; Peters, DJM; Somlo, S				Mochizuki, T; Wu, GQ; Hayashi, T; Xenophontos, SL; Veldhuisen, B; Saris, JJ; Reynolds, DM; Cai, YQ; Gabow, PA; Pierides, A; Kimberling, WJ; Breuning, MH; Deltas, CC; Peters, DJM; Somlo, S			PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein	SCIENCE			English	Article							INTRACRANIAL ANEURYSMS; FUNCTIONAL EXPRESSION; SPANNING PROTEINS; CALCIUM-CHANNEL; HETEROGENEITY; SEQUENCES	A second gene for autosomal dominant polycystic kidney disease was identified by positional cloning. Nonsense mutations in this gene (PKD2) segregated with the disease in three PKD2 families. The predicted 968-amino acid sequence of the PKD2 gene product has six transmembrane spans with intracellular amino- and carboxyl-termini. The PKD2 protein has amino acid similarity with PKD1, the Caenorhabditis elegans homolog of PKD1, and the family of voltage-activated calcium (and sodium) channels, and it contains a potential calcium-binding domain.	YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT MED & MOLEC GENET, DIV RENAL, BRONX, NY 10461 USA; CYPRUS INST NEUROL & GENET, AGIOS DHOMENTIOS 2012, NICOSIA, CYPRUS; LEIDEN UNIV, DEPT HUMAN GENET, SYLVIUS LABS, 2333 AL LEIDEN, NETHERLANDS; UNIV COLORADO, HLTH SCI CTR, DEPT INTERNAL MED, DENVER, CO 80220 USA; NICOSIA GEN HOSP, DEPT NEPHROL, NICOSIA 1311, CYPRUS; BOYS TOWN NATL RES HOSP, DEPT PATHOL, OMAHA, NE 68131 USA; BOYS TOWN NATL RES HOSP, DEPT OTOLARYNGOL, OMAHA, NE 68131 USA	Yeshiva University; Albert Einstein College of Medicine; Leiden University; Leiden University - Excl LUMC; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Boys Town National Research Hospital; Boys Town National Research Hospital			Deltas, Constantinos/A-4936-2013; Deltas, Constantinos/J-9345-2013; Breuning, Martijn H/E-3429-2010; Peters, Dorien/AFH-8507-2022	Deltas, Constantinos/0000-0001-5549-9169; Deltas, Constantinos/0000-0001-5549-9169; Peters, Dorien/0000-0001-6974-7143	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048383, K08DK002015] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK48383, DK02015] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; *BESTFIT, 1994, PROGR MAN WISC PACK; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; CHAPMAN AB, 1992, NEW ENGL J MED, V327, P916, DOI 10.1056/NEJM199209243271303; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; CONSTANTINOUDELTAS CD, 1995, HUM GENET, V95, P416; DAOUST MC, 1995, GENOMICS, V25, P733, DOI 10.1016/0888-7543(95)80020-M; DEALMEIDA S, 1995, HUM GENET, V96, P83, DOI 10.1007/BF00214191; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; GABOW PA, 1990, KIDNEY INT, V38, P1177, DOI 10.1038/ki.1990.330; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; GULATI J, 1992, J BIOL CHEM, V267, P25073; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; HILLE B, 1992, IONIC CHANNELS EXCIT, P250; HORNE WA, 1993, P NATL ACAD SCI USA, V90, P3787, DOI 10.1073/pnas.90.9.3787; HOSSACK KF, 1988, NEW ENGL J MED, V319, P907, DOI 10.1056/NEJM198810063191404; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; HUSTON J, 1993, J AM SOC NEPHROL, V3, P1871; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; KIMBERLING WJ, 1993, GENOMICS, V18, P467, DOI 10.1016/S0888-7543(11)80001-7; KIMBERLING WJ, 1988, NEW ENGL J MED, V319, P913, DOI 10.1056/NEJM198810063191405; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRETSINGER RH, 1987, COLD SPRING HARB SYM, V52, P499, DOI 10.1101/SQB.1987.052.01.057; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MOCHIZUKI T, UNPUB; MOCHIZUKI T, 1994, J AM SOC NEPHROL, V5, pA631; NAKASHIMA H, 1992, FEBS LETT, V303, P141, DOI 10.1016/0014-5793(92)80506-C; NAKAYAMA S, 1994, ANNU REV BIOPH BIOM, V23, P473, DOI 10.1146/annurev.bb.23.060194.002353; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PARFREY PS, 1990, NEW ENGL J MED, V323, P1085, DOI 10.1056/NEJM199010183231601; PETERS DJM, 1993, NAT GENET, V5, P359, DOI 10.1038/ng1293-359; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; PETERS DJM, 1995, AM J HUM GENET, V57, pA200; RAVINE D, 1992, LANCET, V340, P1330, DOI 10.1016/0140-6736(92)92503-8; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; RIESS O, 1994, CYTOGENET CELL GENET, V65, P238, DOI 10.1159/000133638; ROMEO G, 1988, LANCET, V2, P8; ROST B, 1995, PROTEIN SCI, V4, P521; SANMILLAN JL, 1995, AM J HUM GENET, V56, P248; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; SOMIO S, 1993, J AM SOC NEPHROL, V4, P1371; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; TORRES VE, 1993, AM J KIDNEY DIS, V22, P513, DOI 10.1016/S0272-6386(12)80922-X; VELDHUISEN B, UNPUB; WARD CJ, 1994, CELL, V77, P881; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1994, J BIOL CHEM, V269, P22347	54	1087	1141	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	1996	272	5266					1339	1342		10.1126/science.272.5266.1339	http://dx.doi.org/10.1126/science.272.5266.1339			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8650545				2022-12-28	WOS:A1996UN47200047
J	Halvorsen, PA; Kristiansen, IS				Halvorsen, PA; Kristiansen, IS			Radiology services for remote communities: Cost minimisation study of telemedicine	BRITISH MEDICAL JOURNAL			English	Article							SPATIAL-RESOLUTION REQUIREMENTS; OPERATING CHARACTERISTIC ANALYSIS; OBSERVER PERFORMANCE; DIGITAL RADIOGRAPHY; WORKSTATION IMAGES; CHEST RADIOGRAPHY; DISPLAY FORMATS; TELERADIOLOGY; FILM; ROC	Objectives-To determine the social costs of providing a rural population with radiology services under three different systems: the existing system (a small x ray unit at the remote site and all other examinations at the nearest radiology department (the host site)); a teleradiology system (most examinations at the remote site and more advanced examinations at the host site); and all examinations at the host site. Design-Cost minimisation study. Setting-Primary health care in a remote community in Norway. Subjects-A randomly selected sample (n=597) of all patients (n=1793) having radiological examinations in 1993. Main outcome measures-Annual direct medical costs, direct non-medical (travel) costs, and indirect costs (lost production) of the three options. Results-After exclusion of costs common to the three systems the direct medical, direct non-medical, and indirect costs of the three options were, respectively, pound 9000, pound 51 000, and pound 31 500 (total pound 91 500) for the existing system; pound 108 000, pound 2000, and pound 13 500 (total pound 123 500) for the teleradiology option; and pound 0, pound 75 000, and pound 42 000 (pound 117 000 in total) for the ''all at host'' option. Sensitivity analyses indicated that the existing system is the least costly option except when lost leisure is valued as highly as lost production. Conclusion-The teleradiology option did not seem to be cost saving in the study community. Such systems, however, may be justified on the grounds of equity of access and quality of care.	UNIV TROMSO,INST COMMUNITY MED,N-9037 TROMSO,NORWAY	UiT The Arctic University of Tromso				Halvorsen, Peder A./0000-0002-6519-9669				ACKERMAN MJ, 1993, RADIOGRAPHICS, V13, P1129, DOI 10.1148/radiographics.13.5.8210594; ACKERMAN SJ, 1993, RADIOLOGY, V186, P263, DOI 10.1148/radiology.186.1.8416576; ARRILDT WD, 1994, RADIOLOGY, V190, pA41, DOI 10.1148/radiology.190.2.41a; BARNES GT, 1993, RADIOGRAPHICS, V13, P673, DOI 10.1148/radiographics.13.3.8316673; BATNITZKY S, 1990, RADIOLOGY, V177, P11, DOI 10.1148/radiology.177.1.2204957; BIDGOOD WD, 1992, SEMIN ULTRASOUND CT, V13, P102; *CENTR BUR STAT, 1993, 1993 CENTR BUR STAT; CHAKRABORTY DP, 1986, RADIOLOGY, V158, P35, DOI 10.1148/radiology.158.1.3940394; COX GG, 1990, RADIOLOGY, V176, P771, DOI 10.1148/radiology.176.3.2389035; DWYER SJ, 1992, RADIOGRAPHICS, V12, P765, DOI 10.1148/radiographics.12.4.1636038; FRANKEN EA, 1992, INVEST RADIOL, V27, P732, DOI 10.1097/00004424-199209000-00016; FRASER RG, 1989, RADIOLOGY, V171, P297, DOI 10.1148/radiology.171.2.2649913; FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203; FRYBACK DG, 1983, J NEURORADIOLOGY, V10, P94; GITLIN JN, 1986, RADIOL CLIN N AM, V24, P55; GOLDBERG MA, 1993, RADIOLOGY, V186, P429, DOI 10.1148/radiology.186.2.8421746; GOODMAN LR, 1988, AM J ROENTGENOL, V150, P1241, DOI 10.2214/ajr.150.6.1241; GOODMAN LR, 1986, RADIOLOGY, V158, P27, DOI 10.1148/radiology.158.1.3940392; HAYRAPETIAN A, 1989, AM J ROENTGENOL, V152, P1113, DOI 10.2214/ajr.152.5.1113; HILLMAN BJ, 1994, RADIOLOGY, V193, P307, DOI 10.1148/radiology.193.2.7972731; HUEBENER KH, 1983, RADIOLOGY, V148, P363, DOI 10.1148/radiology.148.2.6867326; ILL SJD, 1991, AJR AM J ROENTGENOL, V156, P1279; KUNDEL HL, 1986, RADIOL CLIN N AM, V24, P69; LAMS PM, 1986, RADIOLOGY, V158, P11, DOI 10.1148/radiology.158.1.3940365; Larsen John Ludvig, 1994, Tidsskrift for den Norske Laegeforening, V114, P2934; Little AD., 1992, TELECOMMUNICATIONS C; MACMAHON H, 1986, RADIOLOGY, V158, P21, DOI 10.1148/radiology.158.1.3940383; MACMAHON H, 1988, RADIOLOGY, V168, P669, DOI 10.1148/radiology.168.3.3406396; Markivee C R, 1990, J Digit Imaging, V3, P170; MURPHEY MD, 1990, RADIOLOGY, V174, P865, DOI 10.1148/radiology.174.3.2305071; OLSEN JA, 1994, SCOT J POLIT ECON, V41, P69, DOI 10.1111/j.1467-9485.1994.tb01111.x; OSTENSEN H, 1994, A94002 SINTEF STF NO; SANE SM, 1992, EUR J RADIOL, V15, P276, DOI 10.1016/0720-048X(92)90122-P; SAXEBOL G, 1990, 3 SIS I RAD HYG; SCHAEFER CM, 1991, RADIOLOGY, V178, P733, DOI 10.1148/radiology.178.3.1994410; SCHROEDER SA, 1995, LANCET, V345, P1001, DOI 10.1016/S0140-6736(95)90753-X; SCOTT WW, 1993, RADIOLOGY, V187, P811, DOI 10.1148/radiology.187.3.8497636; SEELEY GW, 1987, AM J ROENTGENOL, V148, P421, DOI 10.2214/ajr.148.2.421; SHARP C, 1988, J TRANSP ECON POLICY, P235; SLASKY BS, 1990, RADIOLOGY, V174, P775, DOI 10.1148/radiology.174.3.2305061; SLOVIS TL, 1991, PEDIATR RADIOL, V21, P333, DOI 10.1007/BF02011480; TEMPLETON AW, 1991, AM J ROENTGENOL, V157, P1331, DOI 10.2214/ajr.157.6.1950884; Torrance GW, 1987, METHODS EC EVALUATIO; WEGRYN SA, 1990, RADIOLOGY, V175, P225, DOI 10.1148/radiology.175.1.2315485; YOSHINO MT, 1992, INVEST RADIOL, V27, P55, DOI 10.1097/00004424-199201000-00011; 1992, LAWS NORWAY	46	56	56	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 25	1996	312	7042					1333	1336		10.1136/bmj.312.7042.1333	http://dx.doi.org/10.1136/bmj.312.7042.1333			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN476	8646045	Green Published			2022-12-28	WOS:A1996UN47600020
J	Iijima, T; Witter, MP; Ichikawa, M; Tominaga, T; Kajiwara, R; Matsumoto, G				Iijima, T; Witter, MP; Ichikawa, M; Tominaga, T; Kajiwara, R; Matsumoto, G			Entorhinal-hippocampal interactions revealed by real-time imaging	SCIENCE			English	Article							FREQUENCY-DEPENDENT DEPRESSION; SUBICULAR COMPLEX; MEMORY SYSTEM; RAT; CONNECTIONS; CORTEX; INVITRO; ORGANIZATION; INHIBITION; IPSPS	The entorhinal cortex provides the major cortical input to the hippocampus, and both structures have been implicated in memory processes. The dynamics of neuronal circuits in the entorhinal-hippocampal system were studied in slices by optical imaging with high spatial and temporal resolution. Reverberation of neural activity was detected in the entorhinal cortex and was more prominent when the inhibition due to gamma-aminobutyric acid was slightly suppressed. Neural activity was transferred in a frequency-dependent way from the entorhinal cortex to the hippocampus. The entorhinal neuronal circuit could contribute to memory processes by holding information and selectively gating the entry of information into the hippocampus.	VRIJE UNIV AMSTERDAM,GRAD SCH NEUROSCI,NEUROSCI RES INST,DEPT ANAT & EMBRYOL,1081 BT AMSTERDAM,NETHERLANDS; TOHOKU UNIV,SENDAI,MIYAGI 980,JAPAN	Vrije Universiteit Amsterdam; Tohoku University	Iijima, T (corresponding author), ELECTROTECH LAB,MOL & CELLULAR NEUROSCI SECT,1-1-4 UMEZONO,TSUKUBA,IBARAKI 305,JAPAN.		Tominaga, Takashi/C-5332-2012	Tominaga, Takashi/0000-0003-1078-7989				BENARDO LS, 1993, BRAIN RES, V607, P81, DOI 10.1016/0006-8993(93)91491-A; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOULTON CL, 1992, HIPPOCAMPUS, V2, P99, DOI 10.1002/hipo.450020203; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; DEADWYLER SA, 1975, EXP NEUROL, V49, P35, DOI 10.1016/0014-4886(75)90194-6; DEISZ RA, 1989, J PHYSIOL-LONDON, V412, P513, DOI 10.1113/jphysiol.1989.sp017629; Edelman G.M., 1989, REMEMBERED PRESENT B; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; FINCH DM, 1988, J NEUROSCI, V8, P2213; FINCH DM, 1986, BRAIN RES, V397, P205, DOI 10.1016/0006-8993(86)90621-9; FRANESIC I, 1994, P NATL ACAD SCI USA, V91, P13014; GRINVALD A, 1988, PHYSIOL REV, V68, P1285, DOI 10.1152/physrev.1988.68.4.1285; HEBB DO, 1949, ORG BEHAVIOR; HEINEMANN U, 1992, DENTATE GYRUS ITS S, V7, P273; HUGUENARD JR, 1986, J NEUROPHYSIOL, V56, P1; ICHIKAWA M, 1993, BRAIN MECHANISMS OF PERCEPTION AND MEMORY: FROM NEURON TO BEHAVIOR, P638; IIJIMA T, 1992, NEUROSCIENCE, V51, P211, DOI 10.1016/0306-4522(92)90486-L; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; JONES RSG, 1995, HIPPOCAMPUS, V5, P125, DOI 10.1002/hipo.450050207; LOTHMAN EW, 1991, PROG NEUROBIOL, V37, P1, DOI 10.1016/0301-0082(91)90011-O; MALINOW R, 1994, SCIENCE, V266, P1195, DOI 10.1126/science.7973700; MCCARREN M, 1985, J NEUROPHYSIOL, V53, P557, DOI 10.1152/jn.1985.53.2.557; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MISHKIN M, 1978, NATURE, V273, P297, DOI 10.1038/273297a0; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P501, DOI 10.1152/jn.1989.61.3.501; TSUKAHARA N, 1972, BRAIN RES, V40, P67, DOI 10.1016/0006-8993(72)90108-4; VANHOESEN GW, 1982, TRENDS NEUROSCI, V5, P345, DOI 10.1016/0166-2236(82)90201-6; WITTER MP, 1993, HIPPOCAMPUS, V3, P33; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; ZOLAMORGAN S, 1994, HIPPOCAMPUS, V4, P483, DOI 10.1002/hipo.450040410; ZOLAMORGAN S, 1986, BEHAV NEUROSCI, V100, P155, DOI 10.1037/0735-7044.100.2.155	34	183	184	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 24	1996	272	5265					1176	1179		10.1126/science.272.5265.1176	http://dx.doi.org/10.1126/science.272.5265.1176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8638163				2022-12-28	WOS:A1996UM88900052
J	Lakowski, B; Hekimi, S				Lakowski, B; Hekimi, S			Determination of life-span in Caenorhabditis elegans by four clock genes	SCIENCE			English	Article							OXIDATIVE STRESS	The nematode worm Caenorhabditis elegans is a model system for the study of the genetic basis of aging. Maternal-effect mutations in four genes-clk-1, clk-2, clk-3, and gro-1-interact genetically to determine both the duration of development and life-span. Analysis of the phenotypes of these mutants suggests the existence of a general physiological clock in the worm. Mutations in certain genes involved in dauer formation (an alternative larval stage induced by adverse conditions in which development is arrested) can also extend life-span, but the life extension of Clock mutants appears to be independent of these genes. The daf-2(e1370) clk-1(e2519) worms, which carry life-span-extending mutations from two different pathways, live nearly five times as long as wild-type worms.	MCGILL UNIV,DEPT BIOL,MONTREAL,PQ H3A 1B1,CANADA	McGill University								BJORKSTEN J, 1968, J AM GERIATR SOC, V16, P408, DOI 10.1111/j.1532-5415.1968.tb02821.x; Comfort A., 1979, BIOL SENESCENCE; Curtis H.J., 1966, BIOL MECH AGING; DORMAN JB, 1995, GENETICS, V141, P1399; FINCH DL, 1990, LONGEVITY SENESCENCE; FLEMING JE, 1992, MUTAT RES, V275, P267, DOI 10.1016/0921-8734(92)90031-J; FRIEDMAN DB, 1988, GENETICS, V118, P75; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; HEKIMI S, 1995, GENETICS, V141, P1351; ISHII N, 1994, J GERONTOL, V49, pB117, DOI 10.1093/geronj/49.3.B117; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; LARSEN PK, COMMUNICATION; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; MEDVEDEV ZA, 1961, SOWJETWISS NATURWISS, V12, P1273; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Pearl R., 1928, RATE LIVING; Riddle DL., 1988, NEMATODE CAENORHABDI, P393; SACHER GA, 1966, PERSPECTIVES EXPT GE, pCH26; SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; VANVOORHIES WA, 1992, NATURE, V360, P456, DOI 10.1038/360456a0; WONG A, 1995, GENETICS, V139, P1247	25	401	425	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 17	1996	272	5264					1010	1013		10.1126/science.272.5264.1010	http://dx.doi.org/10.1126/science.272.5264.1010			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL619	8638122				2022-12-28	WOS:A1996UL61900045
J	Paris, N; Stanley, CM; Jones, RL; Rogers, JC				Paris, N; Stanley, CM; Jones, RL; Rogers, JC			Plant cells contain two functionally distinct vacuolar compartments	CELL			English	Article							TONOPLAST INTRINSIC PROTEIN; GRAIN ASPARTIC PROTEINASE; DEVELOPING PEA COTYLEDONS; THIOL PROTEASE; ARABIDOPSIS-THALIANA; STRUCTURAL ASPECTS; BARLEY LECTIN; ALEURAIN; ACCUMULATION; PRECURSOR	The plant cell vacuole has multiple functions, including storage of proteins and maintenance of an acidic pH where proteases will have maximal activity. It has been assumed that these diverse functions occur in the same compartment. Here, we demonstrate that antibodies to two different tonoplast intrinsic proteins, alpha-TIP and TIP-Ma27, label vacuole membranes of two different compartments within the same cell. These compartments are functionally distinct, because barley lectin, a protein stored in root tips, is exclusively contained within the alpha-TIP compartment, while aleurain, a protease that serves as a marker for an acidified vacuolar environment, is exclusively contained within the TIP-Ma27 compartment. As cells develop large vacuoles, the two compartments merge; this may represent a process by which storage products in the alpha-TIP compartment are exposed to the acidic lytic TIP-Ma27 compartment for degradation.	UNIV MISSOURI,DEPT BIOCHEM,COLUMBIA,MO 65211; UNIV MISSOURI,MOL CYTOL CORE FACIL,COLUMBIA,MO 65211; UNIV CALIF BERKELEY,DEPT PLANT BIOL,BERKELEY,CA 94720	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of California System; University of California Berkeley				PARIS, Nadine/0000-0001-5818-9318	NIGMS NIH HHS [GM52427] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052427] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bethke PC, 1996, PLANT PHYSIOL, V110, P521, DOI 10.1104/pp.110.2.521; BOLLER T, 1986, ANNU REV PLANT PHYS, V37, P137, DOI 10.1146/annurev.pp.37.060186.001033; CHRISPEELS MJ, 1992, CELL, V68, P613, DOI 10.1016/0092-8674(92)90134-X; CHRISPEELS MJ, 1991, PLANT MOL BIOL, V42, P21; CRAIG S, 1979, AUST J PLANT PHYSIOL, V6, P81, DOI 10.1071/PP9790081; CRAIG S, 1980, AUST J PLANT PHYSIOL, V7, P329, DOI 10.1071/PP9800329; GURUPRASAD K, 1994, FEBS LETT, V352, P131, DOI 10.1016/0014-5793(94)00935-X; Harlow E., 1988, ANTIBODIES LAB MANUA; HERMAN EM, 1994, PLANT PHYSIOL, V106, P1313, DOI 10.1104/pp.106.4.1313; HERMAN EM, 1994, ADV STRUCTURAL BIOL, P243; HOFTE H, 1992, PLANT PHYSIOL, V99, P561, DOI 10.1104/pp.99.2.561; HOH B, 1995, J CELL SCI, V108, P299; HOLWERDA BC, 1993, J EXP BOT, V44, P321; HOLWERDA BC, 1990, PLANT CELL, V2, P1091, DOI 10.1105/tpc.2.11.1091; HOLWERDA BC, 1992, PLANT CELL, V4, P307, DOI 10.1105/tpc.4.3.307; HOLWERDA BC, 1992, PLANT PHYSIOL, V99, P848, DOI 10.1104/pp.99.3.848; JOHNSON KD, 1989, PLANT PHYSIOL, V91, P1006, DOI 10.1104/pp.91.3.1006; KERVINEN J, 1993, PHYTOCHEMISTRY, V32, P799, DOI 10.1016/0031-9422(93)85208-9; KIRSCH T, 1994, P NATL ACAD SCI USA, V91, P3403, DOI 10.1073/pnas.91.8.3403; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LERNER DR, 1989, PLANT PHYSIOL, V91, P124, DOI 10.1104/pp.91.1.124; LUDEVID D, 1992, PLANT PHYSIOL, V100, P1633, DOI 10.1104/pp.100.4.1633; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; MARTYMAZARS D, 1995, EUR J CELL BIOL, V66, P106; MATSUOKA K, 1991, P NATL ACAD SCI USA, V88, P834, DOI 10.1073/pnas.88.3.834; MATSUOKA K, 1995, J CELL BIOL, V130, P1307, DOI 10.1083/jcb.130.6.1307; NAKAMURA K, 1993, J EXP BOT, V44, P331; NAKAMURA K, 1993, PLANT PHYSIOL, V101, P1, DOI 10.1104/pp.101.1.1; Okita TW, 1996, ANNU REV PLANT PHYS, V47, P327, DOI 10.1146/annurev.arplant.47.1.327; ROST TL, 1988, AM J BOT, V75, P1571, DOI 10.2307/2444707; RUNEBERGROOS P, 1994, PLANT PHYSIOL, V105, P321, DOI 10.1104/pp.105.1.321; RUNEBERGROOS P, 1991, EUR J BIOCHEM, V202, P1021, DOI 10.1111/j.1432-1033.1991.tb16465.x; SCHROEDER MR, 1993, PLANT PHYSIOL, V101, P451, DOI 10.1104/pp.101.2.451; STAAB JF, 1994, J BIOL CHEM, V269, P23736; TORMAKANGAS K, 1994, PLANTA, V195, P116, DOI 10.1007/BF00206299; WICK SM, 1985, PROTOPLASMA, V126, P198, DOI 10.1007/BF01281795; WINK M, 1993, J EXP BOT, V44, P231; ZHU Y, 1994, J BIOL CHEM, V269, P3846	38	335	346	0	39	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 17	1996	85	4					563	572		10.1016/S0092-8674(00)81256-8	http://dx.doi.org/10.1016/S0092-8674(00)81256-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UM415	8653791	Bronze			2022-12-28	WOS:A1996UM41500013
J	Kallberg, E; Jainandunsing, S; Gray, D; Leanderson, T				Kallberg, E; Jainandunsing, S; Gray, D; Leanderson, T			Somatic mutation of immunoglobulin V genes in vitro	SCIENCE			English	Article							GERMINAL-CENTERS; IMMUNE-RESPONSE; B-CELLS; T-CELLS; MATURATION; GENERATION; ANTIGEN; MEMORY	The molecular mechanism behind affinity maturation is the introduction of point mutations in immunoglobulin (Ig) V genes, followed by the selective proliferation of B cells expressing mutants with increased affinity for antigen. An in vitro culture system was developed in which somatic hypermutation of Ig V genes was sustained in primed B cells. Cognate T cell help and cross-linking of the surface Ig were required, whereas the addition of lipopolysaccharide or a CD40 ligand to drive proliferation was insufficient. This system should facilitate understanding of the molecular and cellular mechanisms that regulate somatic mutation and B cell selection.	LUND UNIV,IMMUNOL UNIT,S-22362 LUND,SWEDEN; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,LONDON W12 0NN,ENGLAND	Lund University; Imperial College London			Gray, David/L-8295-2013	Gray, David/0000-0003-3785-4934	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BETZ AG, 1993, IMMUNOL TODAY, V14, P405, DOI 10.1016/0167-5699(93)90144-A; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; DECKER DJ, 1995, IMMUNITY, V2, P195, DOI 10.1016/S1074-7613(95)80092-1; FULLER KA, 1993, J IMMUNOL, V151, P4505; GRAY D, 1993, ANNU REV IMMUNOL, V11, P49, DOI 10.1146/annurev.immunol.11.1.49; GRIFFITHS GM, 1984, NATURE, V312, P271, DOI 10.1038/312271a0; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; KAARTINEN M, 1983, NATURE, V304, P320, DOI 10.1038/304320a0; Kabat EA, 1983, SEQUENCES PROTEINS I; KALLBERG E, 1995, EUR J IMMUNOL, V25, P2349, DOI 10.1002/eji.1830250834; KALLBERG E, UNPUB; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KAWABE T, 1994, IMMUNITY, V1, P423; MANSER T, 1987, J IMMUNOL, V139, P234; MCHEYZERWILLIAMS MG, 1991, NATURE, V350, P502, DOI 10.1038/350502a0; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; RAJASEKAR R, 1988, SCAND J IMMUNOL, V27, P653, DOI 10.1111/j.1365-3083.1988.tb02398.x; RAZANAJAONA D, 1995, 9TH INT C IMM SAN FR; Siskind G W, 1969, Adv Immunol, V10, P1, DOI 10.1016/S0065-2776(08)60414-9; WOHLLEBEN G, IN PRESS INT IMMUNOL; YELTON DE, 1981, HYBRIDOMA, V1, P5, DOI 10.1089/hyb.1.1981.1.5	25	56	58	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 1	1996	271	5253					1285	1289		10.1126/science.271.5253.1285	http://dx.doi.org/10.1126/science.271.5253.1285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TX695	8638111				2022-12-28	WOS:A1996TX69500038
J	Matthews, KS				Matthews, KS			The whole lactose repressor	SCIENCE			English	Editorial Material							LAC REPRESSOR; TETRAMER				Matthews, KS (corresponding author), RICE UNIV, DEPT BIOCHEM & CELL BIOL, POB 1892, HOUSTON, TX 77251 USA.							ALBERTI S, 1993, EMBO J, V12, P3227, DOI 10.1002/j.1460-2075.1993.tb05992.x; ALBERTI S, 1991, NEW BIOL, V3, P57; CHAKERIAN AE, 1991, J BIOL CHEM, V266, P1371; CHEN J, 1992, J BIOL CHEM, V267, P13843; CHEN J, 1994, BIOCHEMISTRY-US, V33, P1234, DOI 10.1021/bi00171a025; CLORE GM, 1995, SCIENCE, V267, P1515, DOI 10.1126/science.7878474; CLORE GM, 1994, SCIENCE, V265, P386, DOI 10.1126/science.8023159; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; GILBERT W, 1967, P NATL ACAD SCI USA, V58, P2415, DOI 10.1073/pnas.58.6.2415; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; GRALLA JD, 1992, TRANSCRIPTIONAL REGU, P629; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JACOB F, 1970, LACTOSE OPERON, P1; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; LEE WT, 1994, NAT STRUCT BIOL, V1, P877, DOI 10.1038/nsb1294-877; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Miller J. H., 1980, OPERON; MILLER JH, 1970, LACTOSE OPERON, P343; MONOD J, 1951, BIOCHIM BIOPHYS ACTA, V7, P585, DOI 10.1016/0006-3002(51)90072-8; NICHOLS JC, 1993, J BIOL CHEM, V268, P17602; PACE HC, 1990, P NATL ACAD SCI USA, V87, P1870, DOI 10.1073/pnas.87.5.1870; RIGGS AD, 1968, J MOL BIOL, V34, P365, DOI 10.1016/0022-2836(68)90261-1; SCHMITZ A, 1976, J BIOL CHEM, V251, P3359; SCHUMACHER MA, 1995, CELL, V83, P147, DOI 10.1016/0092-8674(95)90243-0; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627	25	14	14	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	1996	271	5253					1245	1246		10.1126/science.271.5253.1245	http://dx.doi.org/10.1126/science.271.5253.1245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TX695	8638104				2022-12-28	WOS:A1996TX69500026
J	King, ML; Slobodin, SB				King, ML; Slobodin, SB			A fluted point from the Uptar site, northeastern Siberia	SCIENCE			English	Article							ALASKA; BERINGIA; WORLD	Lanceolate bifacial points, including one fluted specimen, have been collected from beneath an early Holocene tephra at the Uptar site, northeastern Siberia. Thus, the technology associated with the well-known Paleoindian tradition was not confined to the Americas. The Uptar collection does not compare readily with other Beringian complexes and demonstrates that there is greater diversity in the archaeological record of northeastern Siberia than traditional colonization models imply.	DESERT RES INST,QUATERNARY SCI CTR,LAS VEGAS,NV 89132; DEPT EDUC,MAGADAN 68500,RUSSIA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	King, ML (corresponding author), UNIV WASHINGTON,DEPT ANTHROPOL,SEATTLE,WA 98195, USA.							COOK JP, 1994, 21 ANN M AL ANTHR AS; Dikov N.N., 1977, ARKHEOLOGICHESKIE PA; DIKOV NN, 1983, AZIYA STYKE AM DREVN; DIXON EJ, 1990, QUEST ORIGINS 1 AM; DUMOND DE, 1980, SCIENCE, V209, P984, DOI 10.1126/science.209.4460.984; Dumond Don, 1987, ESKIMOS ALEUTS; ELIAS SA, 1992, QUATERNARY RES, V38, P371, DOI 10.1016/0033-5894(92)90045-K; Goebel T. E., 1991, CLOVIS ORIGINS ADAPT, P49; Haynes C.Vance., 1991, REV ARCHAEOL, V12, P8; Haynes Jr C.V., 1982, PALEOECOLOGY BERINGI, P383; HOFFECKER JF, 1993, SCIENCE, V259, P46, DOI 10.1126/science.259.5091.46; HOLMES CE, 1994, 21 ANN M AL ANTHR AS; Hopkins D.M., 1982, PALEOECOLOGY BERINGI, P3, DOI DOI 10.1016/B978-0-12-355860-2.50008-9; KUNZ ML, 1995, ARCTIC ANTHROPOL, V32, P5; LOZHKIN AV, 1993, QUATERNARY RES, V39, P314, DOI 10.1006/qres.1993.1038; LOZHKIN AV, 1989, RADIOUGLERODNOE DATI; MELTZER DJ, 1995, ANNU REV ANTHROPOL, V24, P21; Mochanov Y.A., 1977, DREVNEISHIE ETAPY ZA; POWERS WR, 1989, AM ANTIQUITY, V54, P263, DOI 10.2307/281707; SLOBODIN SB, 1990, DREVNIE PAMYATNIKI S, P65; SLOBODIN SB, IN PRESS AM BEGINNIN; YI SB, 1985, CURR ANTHROPOL, V26, P1, DOI 10.1086/203221	22	22	22	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 2	1996	273	5275					634	636		10.1126/science.273.5275.634	http://dx.doi.org/10.1126/science.273.5275.634			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	VA249	8662551				2022-12-28	WOS:A1996VA24900043
J	Schrock, E; duManoir, S; Veldman, T; Schoell, B; Wienberg, J; FergusonSmith, MA; Ning, Y; Ledbetter, DH; BarAm, I; Soenksen, D; Garini, Y; Ried, T				Schrock, E; duManoir, S; Veldman, T; Schoell, B; Wienberg, J; FergusonSmith, MA; Ning, Y; Ledbetter, DH; BarAm, I; Soenksen, D; Garini, Y; Ried, T			Multicolor spectral karyotyping of human chromosomes	SCIENCE			English	Article							HYBRIDIZATION	The simultaneous and unequivocal discernment of all human chromosomes in different colors would be of significant clinical and biologic importance. Whole-genome scanning by spectral karyotyping allowed instantaneous visualization of defined emission spectra for each human chromosome after fluorescence in situ hybridization, By means of computer separation (classification) of spectra, spectrally overlapping chromosome-specific DNA probes could be resolved, and all human chromosomes were simultaneously identified.	UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE CB2 1QP,ENGLAND; TEL AVIV UNIV,DEPT CELL RES & IMMUNOL,IL-69978 TEL AVIV,ISRAEL; APPL SPECTRAL IMAGING INC,CARLSBAD,CA 92009; APPL SPECTRAL IMAGING LTD,IL-10551 MIGDAL HAEMEQ,ISRAEL; NIH,DIAGNOST DEV BRANCH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892	University of Cambridge; Tel Aviv University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)			du manoir, stan p/O-8677-2017	du manoir, stan p/0000-0002-2200-2651; Garini, Yuval/0000-0002-8783-2015; Ferguson-Smith, Malcolm/0000-0001-9372-1381				KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; KOEHLER U, 1995, GENOMICS, V30, P287, DOI 10.1006/geno.1995.9875; Le Beau M M, 1993, Important Adv Oncol, P29; MALIK Z, 1996, FLUORESCENCE IMAGING, V137, P87; MELTZER P, 1992, NAT GENET, V1, P2; NING Y, IN PRESS NATURE GENE; Oran Brigham E., 1988, FAST FOURIER TRANSFO; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; SCHROCK E, UNPUB; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; Telenius H, 1992, GENE CHROMOSOME CANC, V4, P267; VANTUINEN P, 1983, AM J PHYS ANTHROPOL, V61, P453, DOI 10.1002/ajpa.1330610408	12	1348	1449	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 26	1996	273	5274					494	497		10.1126/science.273.5274.494	http://dx.doi.org/10.1126/science.273.5274.494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY983	8662537				2022-12-28	WOS:A1996UY98300039
J	Jones, DC; Hayslett, JP				Jones, DC; Hayslett, JP			Outcome of pregnancy in women with moderate or severe renal insufficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLOMERULAR-DISEASE; FAILURE	Background Pregnant women with mild preexisting renal disease have relatively few complications of pregnancy, but the risks of maternal and obstetrical complications in women with moderate or severe renal insufficiency remain uncertain. Methods We determined the frequency and types of maternal and obstetrical complications and the outcomes of pregnancy in 67 women with primary renal disease (82 pregnancies). All the women had initial serum creatinine concentrations of at least 1.4 mg per deciliter (124 mu mol per liter) and gestations that continued beyond the first trimester. Results The mean (+/-SD) serum creatinine con concentration increased from 1.9+/-0.8 mg per deciliter (168+/-71 mu mol per liter) in early pregnancy to 2.5+/-1.3 mg per deciliter (221+/-115 mu mol per liter) in the third trimester. The frequency of hypertension rose from 28 percent at base line to 48 percent in the third trimester, and that of high-grade proteinuria (urinary protein excretion, >3000 mg per liter) from 23 percent to 41 percent. For the 70 pregnancies (57 women) for which data were available during pregnancy and immediately post partum, pregnancy-related loss of maternal renal function occurred in 43 percent. Eight of these pregnancies (10 percent of the total) were associated with rapid acceleration of maternal renal insufficiency. Obstetrical complications included a high rate of preterm delivery (59 percent) and growth retardation (37 percent). The infant survival rate was 93 percent. Conclusions Among pregnant women with moderate or severe renal insufficiency, the rates of complications due to worsening renal function, hypertension, and obstetrical complications are increased, but fetal survival is high. (C) 1996, Massachusetts Medical Society.	YALE UNIV,DEPT INTERNAL MED,NEW HAVEN,CT 06520	Yale University	Jones, DC (corresponding author), YALE UNIV,SCH MED,DEPT OBSTET & GYNECOL,POB 208063,NEW HAVEN,CT 06520, USA.							ABE S, 1985, AM J OBSTET GYNECOL, V153, P508, DOI 10.1016/0002-9378(85)90463-6; AMINI SB, 1994, OBSTET GYNECOL, V83, P342; [Anonymous], 1975, LANCET, V2, P801; BARCELO P, 1986, KIDNEY INT, V30, P914, DOI 10.1038/ki.1986.272; BEAR RA, 1978, CAN MED ASSOC J, V118, P663; CUNNINGHAM FG, 1990, AM J OBSTET GYNECOL, V163, P453, DOI 10.1016/0002-9378(90)91175-C; HAYCOCK KA, 1994, STATVIEW; HOU S, 1985, NEW ENGL J MED, V312, P836, DOI 10.1056/NEJM198503283121306; Hughes EC, 1972, OBSTETRIC GYNECOLOGI, P423; IMBASCIATI E, 1986, AM J NEPHROL, V6, P193, DOI 10.1159/000167114; JUNGERS P, 1991, AM J KIDNEY DIS, V17, P116, DOI 10.1016/S0272-6386(12)81114-0; Jungers P, 1986, Adv Nephrol Necker Hosp, V15, P103; KATZ AI, 1980, KIDNEY INT, V18, P192, DOI 10.1038/ki.1980.128; Mackay EV, 1963, AUST NZ J OBSTET GYN, V3, P21; MITCH WE, 1976, LANCET, V2, P1326; PACKHAM DK, 1989, Q J MED, V71, P537; SURIAN M, 1984, NEPHRON, V36, P101, DOI 10.1159/000183126; WEINSTEIN L, 1982, AM J OBSTET GYNECOL, V142, P159, DOI 10.1016/S0002-9378(16)32330-4	18	236	258	0	9	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	1996	335	4					226	232		10.1056/NEJM199607253350402	http://dx.doi.org/10.1056/NEJM199607253350402			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ532	8657238				2022-12-28	WOS:A1996UZ53200002
J	Landauer, R				Landauer, R			Minimal energy requirements in communication	SCIENCE			English	Article							COMPUTATION	The literature describing the energy needs for a communications channel has been dominated by analyses of linear electromagnetic transmission, often without awareness that this is a special case. This case leads to the conclusion that an amount of energy equal to kTln 2, where kT is the thermal noise per unit bandwidth, is needed to transmit a bit, and more if quantized channels are used with photon energies h nu > kT: Alternative communication methods are proposed to show that there is no unavoidable minimal energy requirement per transmitted bit. These methods are Invoked as part of analysis of ultimate limits and not as practical procedures.			Landauer, R (corresponding author), IBM CORP, THOMAS J WATSON RES CTR, YORKTOWN HTS, NY 10598 USA.							BENNETT CH, 1988, IBM J RES DEV, V32, P16, DOI 10.1147/rd.321.0016; BENNETT CH, 1982, INT J THEOR PHYS, V21, P905, DOI 10.1007/BF02084158; BENNETT CH, 1973, IBM J RES DEV, V17, P525, DOI 10.1147/rd.176.0525; BENNETT CH, 1995, PHYS TODAY, V48, P24, DOI 10.1063/1.881452; BREMERMANN HJ, 1982, INT J THEOR PHYS, V21, P203, DOI 10.1007/BF01857726; BRILLOUIN L, 1956, SCI INFORMATION THEO, P162; Caves C, 1994, PHYSICAL ORIGINS TIM, P47; CAVES CM, 1994, REV MOD PHYS, V66, P481, DOI 10.1103/RevModPhys.66.481; CHAU HF, 1995, PHYS REV LETT, V75, P748, DOI 10.1103/PhysRevLett.75.748; DIVINCENZO DP, 1995, SCIENCE, V270, P255, DOI 10.1126/science.270.5234.255; FRANK D, 1994, P WORKSH PHYS COMP P; Frank D. J., 1995, Proceedings. 1995 International Symposium on Low Power Design, P197, DOI 10.1145/224081.224116; FREDKIN E, 1982, INT J THEOR PHYS, V21, P219, DOI 10.1007/BF01857727; FREDKIN E, 1990, PHYSICA D, V45, P254, DOI 10.1016/0167-2789(90)90186-S; GLANZ J, 1995, SCIENCE, V269, P28, DOI 10.1126/science.269.5220.28; GOTO E, 1955, J ELEC COMMUN ENG JA, V38, P770; Goto E., 1960, IRE T ELECT COMPUT, VEC -9, P25, DOI [10.1109/TEC.1960.5221600, DOI 10.1109/TEC.1960.5221600]; HAUSLADEN P, 1995, ANN NY ACAD SCI, V755, P698, DOI 10.1111/j.1749-6632.1995.tb39011.x; LANDAUER R, 1989, PR H ADV RE, P18; LANDAUER R, 1993, PHYSICA A, V194, P551, DOI 10.1016/0378-4371(93)90385-H; LANDAUER R, 1987, APPL PHYS LETT, V51, P2056, DOI 10.1063/1.98291; LANDAUER R, 1961, IBM J RES DEV, V5, P183, DOI 10.1147/rd.53.0183; Landauer R., 1994, Proceedings. Workshop on Physics and Computation PhysComp '94, P54, DOI 10.1109/PHYCMP.1994.363699; LANDAUER R, 1981, SPEC PUBL NBS, V614, P12; LANDAUER R, IN PRESS P DREX 4 S; LEFF HS, 1993, MAXWELLS DEMON ENTRO; Lent C. S., 1993, Nanotechnology, V4, P49, DOI 10.1088/0957-4484/4/1/004; LEVITIN LB, 1993, P WORKSH PHYS COMP P, P210; LIKHAREV KK, 1982, INT J THEOR PHYS, V21, P311, DOI 10.1007/BF01857733; LLOYD S, 1995, SCI AM, V273, P140, DOI 10.1038/scientificamerican1095-140; LLOYD S, 1993, SCIENCE, V261, P1569, DOI 10.1126/science.261.5128.1569; LLOYD S, 1994, SCIENCE, V263, P695, DOI 10.1126/science.263.5147.695; MARKO H, 1965, KYBERNETIK, V2, P274, DOI 10.1007/BF00274090; Merkle R. C., 1993, Nanotechnology, V4, P114, DOI 10.1088/0957-4484/4/2/007; SCHUMACHER B, 1995, PHYS REV A, V51, P2738, DOI 10.1103/PhysRevA.51.2738; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Szilard L, 1929, Z PHYS, V53, P840, DOI 10.1007/BF01341281; von Neumann J., 1957, U.S. Patent, Patent No. [2,815,488, 2815488]; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0; ZUREK WH, 1989, NATURE, V341, P119, DOI 10.1038/341119a0	41	106	107	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	1996	272	5270					1914	1918		10.1126/science.272.5270.1914	http://dx.doi.org/10.1126/science.272.5270.1914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8662490				2022-12-28	WOS:A1996UV29400040
J	Hehn, M; Ounadjela, K; Bucher, JP; Rousseaux, F; Decanini, D; Bartenlian, B; Chappert, C				Hehn, M; Ounadjela, K; Bucher, JP; Rousseaux, F; Decanini, D; Bartenlian, B; Chappert, C			Nanoscale magnetic domains in mesoscopic magnets	SCIENCE			English	Article							MICROMAGNETICS; PARTICLES	The basic magnetic properties of three-dimensional nanostructured materials can be drastically different from those of a continuous film. High-resolution magnetic force microscopy studies of magnetic submicrometer-sized cobalt dots with geometrical dimensions comparable to the width of magnetic domains reveal a variety of intricate domain patterns controlled by the details of the dot geometry. By changing the thickness of the dots, the width of the geometrically constrained magnetic domains can be tuned. Concentric rings and spirals with vortex configurations have been stabilized, with particular incidence in the magnetization reversal process as observed in the ensemble-averaged hysteresis loops.	INST PHYS & CHIM MAT STRASBOURG,F-67037 STRASBOURG,FRANCE; CNRS,L2M,F-92225 BAGNEUX,FRANCE; UNIV PARIS 11,INST ELECTR FONDAMENTALE,F-91405 ORSAY,FRANCE	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay			Bucher, Jean-Pierre/G-1108-2015; Bartenlian, Bernard/L-6093-2013; HEHN, Michel/N-1038-2015	Bucher, Jean-Pierre/0000-0002-9879-0252; HEHN, Michel/0000-0002-4240-5925				BUCHER JP, 1993, INT J MOD PHYS B, V7, P1079, DOI 10.1142/S0217979293002249; DONNET DM, 1995, J PHYS D APPL PHYS, V28, P1942, DOI 10.1088/0022-3727/28/9/023; FREDKIN DR, 1991, J APPL PHYS, V69, P5276, DOI 10.1063/1.348945; GIBSON GA, 1993, J APPL PHYS, V73, P4516, DOI 10.1063/1.352794; HEHN M, IN PRESS PHYS REV B; KENT AD, 1994, J APPL PHYS, V76, P6656, DOI 10.1063/1.358160; KITTEL C, 1946, PHYS REV, V70, P965, DOI 10.1103/PhysRev.70.965; Kooy C., 1960, PHILIPS RES REP, V15, P7; KRAUSS PR, 1994, J VAC SCI TECHNOL B, V12, P3639, DOI 10.1116/1.587630; MANALIS S, 1995, APPL PHYS LETT, V66, P2585, DOI 10.1063/1.113509; NAKATANI Y, 1989, JPN J APPL PHYS 1, V28, P2485, DOI 10.1143/JJAP.28.2485; NEW RMH, 1994, J VAC SCI TECHNOL B, V12, P3196, DOI 10.1116/1.587499; Rousseaux F, 1995, J VAC SCI TECHNOL B, V13, P2787, DOI 10.1116/1.588266; SEUL M, 1995, SCIENCE, V267, P476, DOI 10.1126/science.267.5197.476; Shi J, 1996, SCIENCE, V271, P937, DOI 10.1126/science.271.5251.937; SHI J, 1995, NATURE, V377, P707, DOI 10.1038/377707a0; WERNSDORFER W, 1995, J MAGN MAGN MATER, V145, P33, DOI 10.1016/0304-8853(94)01621-6; 1995, PHYS TODAY, V48	18	319	320	0	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1782	1785		10.1126/science.272.5269.1782	http://dx.doi.org/10.1126/science.272.5269.1782			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8662483				2022-12-28	WOS:A1996UT11000041
J	Waldman, T; Lengauer, C; Kinzler, KW; Vogelstein, B				Waldman, T; Lengauer, C; Kinzler, KW; Vogelstein, B			Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21	NATURE			English	Article							CYCLE; INSITU	PRECISE coordination of the S and M phases of the eukaryotic cell cycle is critical not only for normal cell division, but also for effective growth arrest under conditions of stress. When damaged, a cell must communicate signals to both the mitotic and DNA synthesis machineries so that a mitotic block is not followed by an extra S phase, or vice versa. The biochemical mechanisms regulating this coordination, termed checkpoints, have been identified in lower eukaryotes, but are largely unknown in mammalian cells(1-3). Here we show that p21(WAF1/CIP1), the prototype inhibitor of cyclin-dependent kinases (CDKs)(4), is required for this coordination in human cells. In the absence of p21, DNA-damaged cells arrest in a G2-like state, but then undergo additional S phases without intervening normal mitoses. They thereby acquire grossly deformed, polyploid nuclei and subsequently die through apoptosis. Perhaps not by coincidence, the DNA-damaging agents that can cause S/M uncoupling are used in the clinic to kill cancer cells preferentially.	JOHNS HOPKINS ONCOL CTR,HOWARD HUGHES MED INST,BALTIMORE,MD 21231; PROGRAM HUMAN GENET,BALTIMORE,MD 21231	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine								CARDER P, 1993, ONCOGENE, V8, P1397; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; ELDEIRY WS, 1995, CANCER RES, V55, P2910; GAO X, 1995, ONCOGENE, V11, P1395; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GIBERSON RT, 1995, MICROSC RES TECHNIQ, V32, P246, DOI 10.1002/jemt.1070320307; GORCZYCA W, 1993, CANCER RES, V53, P1945; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HARVEY M, 1993, ONCOGENE, V8, P2457; HEICHMAN KA, 1994, CELL, V79, P557, DOI 10.1016/0092-8674(94)90541-X; KUNG AL, 1990, CANCER RES, V50, P7307; KUNG AL, 1990, P NATL ACAD SCI USA, V87, P9553, DOI 10.1073/pnas.87.24.9553; LENGAUER C, 1994, GENET ANAL-BIOMOL E, V11, P140, DOI 10.1016/1050-3862(94)90034-5; LI JJ, 1993, CELL, V74, P223, DOI 10.1016/0092-8674(93)90413-K; LICHTER P, 1992, HUMAN CYTOGENETICS P, P157; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; METZ T, 1995, CELL, V82, P29, DOI 10.1016/0092-8674(95)90049-7; MORROW CS, 1993, CANCER MED, P618; MURRAY AW, 1992, NATURE, V359, P599, DOI 10.1038/359599a0; NASMYTH K, 1993, NATURE, V366, P634, DOI 10.1038/366634a0; NURSE P, 1994, CELL, V79, P5474; RIED T, 1992, GENE CHROMOSOME CANC, V4, P69, DOI 10.1002/gcc.2870040109; SHIBATA D, 1994, NAT GENET, V6, P273, DOI 10.1038/ng0394-273; WALDMAN T, 1995, CANCER RES, V55, P5187	28	708	732	0	15	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 20	1996	381	6584					713	716		10.1038/381713a0	http://dx.doi.org/10.1038/381713a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR979	8649519				2022-12-28	WOS:A1996UR97900057
J	Organ, CH; Bold, RJ				Organ, CH; Bold, RJ			Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Organ, CH (corresponding author), UNIV CALIF DAVIS E BAY, OAKLAND, CA USA.							BLAND KI, 1995, ANN SURG, V221, P706, DOI 10.1097/00000658-199506000-00010; COATES AS, 1995, J AM COLL SURGEONS, V180, P402; DECKER RA, 1995, SURGERY, V118, P257, DOI 10.1016/S0039-6060(05)80332-0; DUHAYLONGSOD FG, 1995, ANN SURG, V221, P677, DOI 10.1097/00000658-199506000-00007; FITZGIBBONS RJ, 1995, ANN SURG, V221, P3, DOI 10.1097/00000658-199501000-00002; FOITZIK T, 1995, ANN SURG, V222, P179, DOI 10.1097/00000658-199508000-00010; HERMANN RE, 1995, ANN SURG, V221, P459, DOI 10.1097/00000658-199505000-00003; LUITEN EJT, 1995, ANN SURG, V222, P57, DOI 10.1097/00000658-199507000-00010; MARTIN LC, 1995, ANN SURG, V222, P256, DOI 10.1097/00000658-199509000-00004; MCMAHON AJ, 1995, BRIT J SURG, V82, P307, DOI 10.1002/bjs.1800820308; MILLER RE, 1995, AM J SURG, V169, P273, DOI 10.1016/S0002-9610(99)80150-0; MONSON JRT, 1995, BRIT J SURG, V82, P150, DOI 10.1002/bjs.1800820205; NORMAN J, 1995, SURGERY, V117, P648, DOI 10.1016/S0039-6060(95)80008-5; ORLOFF MJ, 1995, J AM COLL SURGEONS, V180, P257; PEPLINSKI GR, 1995, SURGERY, V118, P185, DOI 10.1016/S0039-6060(05)80322-8; PETERS JH, 1995, J AM COLL SURGEONS, V180, P385; RUNKEL NSF, 1995, AM J SURG, V169, P227, DOI 10.1016/S0002-9610(99)80142-1; RUTLEDGE R, 1995, N CAROLINA STUDY CON, P16; STONE CA, 1995, BRIT J SURG, V82, P1015, DOI 10.1002/bjs.1800820806; TAKANISHI DM, 1995, ARCH SURG-CHICAGO, V130, P585	20	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1855	1857		10.1001/jama.275.23.1855	http://dx.doi.org/10.1001/jama.275.23.1855			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642750				2022-12-28	WOS:A1996UQ15200049
J	Pingleton, SK				Pingleton, SK			Pulmonary medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE RESPIRATORY-FAILURE; VENTILATION; ASTHMA				Pingleton, SK (corresponding author), UNIV KANSAS, MED CTR, KANSAS CITY, KS 66103 USA.							BONE RC, 1994, JAMA-J AM MED ASSOC, V271, P1447; BONE RC, 1995, JAMA-J AM MED ASSOC, V273, P967; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; COOPER JD, 1995, J THORAC CARDIOV SUR, V109, P106, DOI 10.1016/S0022-5223(95)70426-4; ELLIOTT MW, 1995, NEW ENGL J MED, V333, P870, DOI 10.1056/NEJM199509283331309; EUGENE J, 1995, AM SURGEON, V61, P934; JUNIPER EF, 1995, AM J RESP CRIT CARE, V151, P66, DOI 10.1164/ajrccm.151.1.7812574; LITTLE AG, 1995, ANN SURG, V222, P365, DOI 10.1097/00000658-199509000-00013; MEDURI GU, 1989, CHEST, V95, P865, DOI 10.1378/chest.95.4.865; PEARLMAN DS, 1992, NEW ENGL J MED, V327, P1420, DOI 10.1056/NEJM199211123272004; PINGLETON SK, 1988, AM REV RESPIR DIS, V137, P1463, DOI 10.1164/ajrccm/137.6.1463; RUTTENVANMOLKEN MPMH, 1995, AM J RESP CRIT CARE, V151, P975; WABABAYASHI A, 1995, ANN THORAC SURG, V60, P936; WEISS KB, 1992, NEW ENGL J MED, V326, P862, DOI 10.1056/NEJM199203263261304; WYSOCKI M, 1993, CHEST, V103, P907, DOI 10.1378/chest.103.3.907	15	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1849	1850		10.1001/jama.275.23.1849	http://dx.doi.org/10.1001/jama.275.23.1849			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642746				2022-12-28	WOS:A1996UQ15200045
J	Crisp, R; Hope, T; Ebbs, D				Crisp, R; Hope, T; Ebbs, D			The Asbury draft policy on ethical use of resources	BRITISH MEDICAL JOURNAL			English	Article								The general practice partners invited two medical ethicists (RC and TH) to meet them to develop the document. The partners met RC and TH for one and a half hours on eight occasions over one year and met without them on eight further occasions. The entire general practice also had an all day session to discuss in detail an advanced version of the draft. The developmental process was of great value to the partnership and has led to appreciable change in individuals' views. The draft policy presented here is intended to start the ball rolling, so that proper guidelines will be developed at whatever level in the NHS is most appropriate. Comments and feedback are welcomed.	UNIV OXFORD,ST ANNES COLL,OXFORD,ENGLAND; UNIV OXFORD,DEPT PUBL HLTH & PRIMARY CARE,OXFORD OX3 7LF,ENGLAND; DIDCOT HLTH CTR PRACTICE,DIDCOT,BERKS,ENGLAND	University of Oxford; University of Oxford								Bell J. M., 1988, PHILOS MED WELFARE; DANIELS N, 1985, JUST HLTH CARE; Harris J., 1985, VALUE LIFE; Lockwood M., 1988, ROY I PHILOS S, V23, P33; Rawls J., 1971, THEORY JUSTICE	5	17	17	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 15	1996	312	7045					1528	1531		10.1136/bmj.312.7045.1528	http://dx.doi.org/10.1136/bmj.312.7045.1528			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR823	8646149	Green Published			2022-12-28	WOS:A1996UR82300028
J	I, L; Juan, WT; Chiang, CH; Chu, JH				I, L; Juan, WT; Chiang, CH; Chu, JH			Microscopic particle motions in strongly coupled dusty plasmas	SCIENCE			English	Article								The microscopic particle motions from the crystal to the disordered slate of a dusty plasma with micrometer-sized silicon dioxide particle suspensions in a radio-frequency glow discharge system were studied through an optical microimaging system, Small-amplitude random motion around the lattice sites of the crystal state, relative domain motion with varying boundaries, cooperative hopping in the liquid state, and highly disordered motion with increasing radio-frequency power were observed. Chaotic states with different spatial scales under the coherent and stochastic coupling between dust particles and self-organized background plasma fluctuations were also demonstrated.			I, L (corresponding author), NATL CENT UNIV, DEPT PHYS, CHUNGLI 32054, TAIWAN.			Juan, Wen-Tau/0000-0002-7195-4384				CHOQUARD P, 1983, PHYS REV LETT, V50, P2086, DOI 10.1103/PhysRevLett.50.2086; CHU JH, 1989, PHYS REV A, V39, P233, DOI 10.1103/PhysRevA.39.233; CHU JH, 1994, PHYSICA A, V205, P183, DOI 10.1016/0378-4371(94)90498-7; CHU JH, 1994, PHYS REV LETT, V72, P4009, DOI 10.1103/PhysRevLett.72.4009; GOERTZ CK, 1989, REV GEOPHYS, V27, P271, DOI 10.1029/RG027i002p00271; HALPERIN BI, 1978, PHYS REV LETT, V41, P121, DOI 10.1103/PhysRevLett.41.121; HAYASHI Y, 1994, JPN J APPL PHYS 2, V33, pL804, DOI 10.1143/JJAP.33.L804; HURLEY MM, 1995, PHYS REV E, V52, P1694, DOI 10.1103/PhysRevE.52.1694; I L, 1994, PHYSICA A, V205, P443, DOI 10.1016/0378-4371(94)90522-3; I L, 1995, PHYS REV LETT, V74, P3161, DOI 10.1103/PhysRevLett.74.3161; ICHIMARU S, 1982, REV MOD PHYS, V54, P1017, DOI 10.1103/RevModPhys.54.1017; IKEZI H, 1986, PHYS FLUIDS, V29, P1764, DOI 10.1063/1.865653; JARZYNSKI C, 1995, PHYS REV LETT, V74, P2937, DOI 10.1103/PhysRevLett.74.2937; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; SCHWEIGERT VA, 1995, PHYS REV B, V51, P7700, DOI 10.1103/PhysRevB.51.7700; Strandburg KJ., 1992, BOND ORIENTATIONAL O, DOI 10.1007/978-1-4612-2812-7; THOMAS H, 1994, PHYS REV LETT, V73, P652, DOI 10.1103/PhysRevLett.73.652; VARMA RK, 1993, PHYS REV E, V47, P3612, DOI 10.1103/PhysRevE.47.3612; Wigner E, 1938, T FARADAY SOC, V34, P0678, DOI 10.1039/tf9383400678; YOUNG AP, 1979, PHYS REV B, V19, P1855, DOI 10.1103/PhysRevB.19.1855	20	78	80	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	1996	272	5268					1626	1628		10.1126/science.272.5268.1626	http://dx.doi.org/10.1126/science.272.5268.1626			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8662472				2022-12-28	WOS:A1996UR09300037
J	Zhu, XT; Zhao, X; Burkholder, WF; Gragerov, A; Ogata, CM; Gottesman, ME; Hendrickson, WA				Zhu, XT; Zhao, X; Burkholder, WF; Gragerov, A; Ogata, CM; Gottesman, ME; Hendrickson, WA			Structural analysis of substrate binding by the molecular chaperone DnaK	SCIENCE			English	Article							HEAT-SHOCK; 3-DIMENSIONAL STRUCTURE; PEPTIDE-BINDING; ANOMALOUS DIFFRACTION; UNCOATING PROTEIN; ESCHERICHIA-COLI; ATP HYDROLYSIS; CALMODULIN; HSP70; NUCLEOTIDES	DnaK and other members of the 70-kilodalton heat-shock protein (hsp70) family promote protein folding, interaction, and translocation, both constitutively and in response to stress, by binding to unfolded polypeptide segments. These proteins have two functional units: a substrate-binding portion binds the polypeptide, and an adenosine triphosphatase portion facilitates substrate exchange. The crystal structure of a peptide complex with the substrate-binding unit of DnaK has now been determined at 2.0 Angstrom resolution. The structure consists of a beta-sandwich subdomain followed by alpha-helical segments. The peptide is bound to DnaK in an extended conformation through a channel defined by loops from the beta sandwich. An alpha-helical domain stabilizes the complex, but does not contact the peptide directly. This domain is rotated in the molecules of a second crystal lattice, which suggests a model of conformation-dependent substrate binding that features a latch mechanism for maintaining long lifetime complexes.	COLUMBIA UNIV, HOWARD HUGHES MED INST, NEW YORK, NY 10032 USA; COLUMBIA UNIV, CANC RES INST, NEW YORK, NY 10032 USA; BROOKHAVEN NATL LAB, NATL SYNCHROTRON LIGHT SOURCE, HOWARD HUGHES MED INST, STONY BROOK, NY USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; United States Department of Energy (DOE); Brookhaven National Laboratory	Zhu, XT (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT BIOCHEM & MOLEC BIOPHYS, NEW YORK, NY 10032 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034102, R01GM037219, R56GM037219, R01GM034102] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 34102, R01 GM034102, GM 37219] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Athappilly FK, 1995, STRUCTURE, V3, P1407, DOI 10.1016/S0969-2126(01)00277-5; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; BUCHBERGER A, 1994, EMBO J, V13, P1687, DOI 10.1002/j.1460-2075.1994.tb06433.x; BURKHOLDER WF, UNPUB; CHAPPELL TG, 1987, J BIOL CHEM, V262, P746; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; DELUCAFLAHERTY C, 1990, CELL, V62, P875, DOI 10.1016/0092-8674(90)90263-E; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FARR CD, 1995, BIOCHEMISTRY-US, V34, P15574, DOI 10.1021/bi00047a024; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GRAGEROV A, 1994, J MOL BIOL, V241, P133, DOI 10.1006/jmbi.1994.1482; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; GREENE LE, 1995, J BIOL CHEM, V270, P2967, DOI 10.1074/jbc.270.7.2967; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; INOUE A, 1995, J BIOL CHEM, V270, P22571, DOI 10.1074/jbc.270.38.22571; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANDRY SJ, 1992, NATURE, V355, P455, DOI 10.1038/355455a0; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; MCKAY DBW, 1994, BIOL HEAT SHOCK PROT, P209; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MORIMOTO RI, 1994, BIOL HEAT SHOCK PROT; MORSHAUSER RC, 1995, BIOCHEMISTRY-US, V34, P6261, DOI 10.1021/bi00019a001; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; PALLEROS DR, 1994, J BIOL CHEM, V269, P13107; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; PALLEROS DR, 1992, J BIOL CHEM, V267, P5279; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; PRASA K, 1994, J BIOL CHEM, V269, P6831; Pratt William B., 1994, Seminars in Cell Biology, V5, P83; RENSING SA, 1994, J MOL EVOL, V39, P80, DOI 10.1007/BF00178252; RIPPMANN F, 1991, EMBO J, V10, P1053, DOI 10.1002/j.1460-2075.1991.tb08044.x; ROMAN E, 1994, EUR J BIOCHEM, V222, P65, DOI 10.1111/j.1432-1033.1994.tb18842.x; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; SAITO H, 1978, MOL GEN GENET, V164, P1, DOI 10.1007/BF00267592; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; Shi L, 1996, BIOCHEMISTRY-US, V35, P3297, DOI 10.1021/bi951984l; STANFIELD RL, 1995, CURR OPIN STRUC BIOL, V5, P103, DOI 10.1016/0959-440X(95)80015-S; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; TWERWILIGER T, 1979, CCP4 SUITE PROGRAMS; WANG TF, 1993, J BIOL CHEM, V268, P26409; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19300, DOI 10.1074/jbc.270.33.19300; WELCH WJ, 1985, MOL CELL BIOL, V5, P1229, DOI 10.1128/MCB.5.6.1229; WILBANKS SM, 1995, BIOCHEMISTRY-US, V34, P12095, DOI 10.1021/bi00038a002; YOCHEM J, 1978, MOL GEN GENET, V164, P9, DOI 10.1007/BF00267593; Zhao X., UNPUB; [No title captured]	68	1005	1059	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	1996	272	5268					1606	1614		10.1126/science.272.5268.1606	http://dx.doi.org/10.1126/science.272.5268.1606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8658133	Green Accepted			2022-12-28	WOS:A1996UR09300034
J	Torsi, L; Dodabalapur, A; Rothberg, LJ; Fung, AWP; Katz, HE				Torsi, L; Dodabalapur, A; Rothberg, LJ; Fung, AWP; Katz, HE			Intrinsic transport properties and performance limits of organic field-effect transistors	SCIENCE			English	Article								The field-effect mobility in thin-film transistors based on alpha-sexithiophene (alpha-6T) and related materials displays a temperature dependence that is remarkably nonmonotonic. Above a transition temperature T-T (specific to a given material) the transport is thermally activated, whereas below T-T there is a very steep enhancement of the mobility. In the activated regime, the results are well described by the theoretical predictions for small polaron motion made by Holstein in 1959. An analysis of the transistor characteristics shows that the hopping transport in these devices is intrinsic. Performance limits for devices based on alpha-6T and related materials were established; these limits point to the strong possibility that better molecular materials for transistor applications may be designed from first principles.	AT&T BELL LABS,LUCENT TECHNOL,MURRAY HILL,NJ 07974	Alcatel-Lucent; Lucent Technologies; AT&T; Nokia Corporation; Nokia Bell Labs			Torsi, Luisa/G-9065-2011; Dodabalapur, Ananth/H-3043-2012; Katz, Howard E/A-3352-2010	Torsi, Luisa/0000-0002-0798-0780; 				AUSTIN IG, 1972, J PHYS PART C SOLID, V5, P1687, DOI 10.1088/0022-3719/5/13/017; CONWELL EM, 1992, J PHYS CHEM-US, V96, P2827, DOI 10.1021/j100186a009; COWIE JMG, 1991, POLYM CHEM PHYSICS M, P256; DODABALAPUR A, 1995, SCIENCE, V268, P270, DOI 10.1126/science.268.5208.270; DODABALAPUR A, 1995, SCIENCE, V269, P1560, DOI 10.1126/science.269.5230.1560; FIRSOV YA, 1995, SEMICONDUCTORS+, V29, P515; GARNIER F, 1994, SCIENCE, V265, P1684, DOI 10.1126/science.265.5179.1684; HARRISON MG, 1994, SYNTHETIC MET, V67, P215, DOI 10.1016/0379-6779(94)90044-2; HOLSTEIN T, 1959, ANN PHYS-NEW YORK, V8, P343, DOI 10.1016/0003-4916(59)90003-X; HOROWITZ G, 1995, J PHYS III, V5, P355, DOI 10.1051/jp3:1995132; Katz HE, 1995, CHEM MATER, V7, P2238, DOI 10.1021/cm00060a008; KIEFL RF, 1989, PHYS REV LETT, V62, P792, DOI 10.1103/PhysRevLett.62.792; KOJIMA S, 1993, PHYS REV B, V47, P2924, DOI 10.1103/PhysRevB.47.2924; LOVINGER AJ, 1995, J MATER RES, V10, P2958, DOI 10.1557/JMR.1995.2958; MOTT NF, 1990, METAL INSULATOR TRAN, P59; SHLUGER AL, 1993, J PHYS-CONDENS MAT, V5, P3049, DOI 10.1088/0953-8984/5/19/007; SIEGRIST T, 1995, J MATER RES, V10, P2173; SZE SM, 1981, PHYSICS SEMICONDUCTO; Torsi L, 1995, CHEM MATER, V7, P2247, DOI 10.1021/cm00060a010; TORSI L, 1995, J APPL PHYS, V78, P1088, DOI 10.1063/1.360341; WARGAI K, 1995, PHYS REV B, V52, P1786; WARTA W, 1985, PHYS REV B, V32, P1172, DOI 10.1103/PhysRevB.32.1172; [No title captured]	23	233	235	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 7	1996	272	5267					1462	1464		10.1126/science.272.5267.1462	http://dx.doi.org/10.1126/science.272.5267.1462			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP899	8662468				2022-12-28	WOS:A1996UP89900041
J	Court, BV; Bradley, CP; Cheng, KK; Lancashire, RJ				Court, BV; Bradley, CP; Cheng, KK; Lancashire, RJ			Responding to out of hours requests for visits: A survey of general practitioner opinion	BRITISH MEDICAL JOURNAL			English	Article									UNIV BIRMINGHAM,SCH MED,DEPT PUBL HLTH & EPIDEMIOL,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND; UNIV BIRMINGHAM,DEPT GEN PRACTICE,BIRMINGHAM,W MIDLANDS,ENGLAND	University of Birmingham; University of Birmingham			Cheng, Kar/AAL-8899-2021	Cheng, Kar/0000-0002-1516-1857; Bradley, Colin/0000-0002-3595-9567				COURT B, 1995, BRIT MED J, V310, P263, DOI 10.1136/bmj.310.6974.263a; Court B. V., 1995, FAM PRACT, V12, P262; CUBITT T, 1983, BRIT MED J, V287, P28, DOI 10.1136/bmj.287.6384.28; Illife S., 1991, BRIT MED J, V302, P1584; *NAT HLTH SERV, 1995, 80 NAT HLTH SERV GEN	5	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 1	1996	312	7043					1401	1402						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP434	8646100				2022-12-28	WOS:A1996UP43400027
J	Dernburg, AF; Broman, KW; Fung, JC; Marshall, WF; Philips, J; Agard, DA; Sedat, JW				Dernburg, AF; Broman, KW; Fung, JC; Marshall, WF; Philips, J; Agard, DA; Sedat, JW			Perturbation of nuclear architecture by long-distance chromosome interactions	CELL			English	Article							SALIVARY-GLAND NUCLEI; DROSOPHILA-MELANOGASTER; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; EMBRYOGENESIS; DNA; HETEROCHROMATIN; RECOMBINATION; ORGANIZATION; MICROSCOPY	Position-effect variegation (PEV) describes the stochastic transcriptional silencing of a gene positioned adjacent to heterochromatin. Using FISH, we have tested whether variegated expression of the eye-color gene brown in Drosophila is influenced by its nuclear localization. In embryonic nuclei, a heterochromatic insertion at the brown locus is always spatially isolated from other heterochromatin. However, during larval development this insertion physically associates with other heterochromatic regions on the same chromosome in a stochastic manner. These observations indicate that the brown gene is silenced by specific contact with centromeric heterochromatin. Moreover, they provide direct evidence for long-range chromosome interactions and their impact on three-dimensional nuclear architecture, while providing a cohesive explanation for the phenomenon of PEV.	UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA; UNIV CALIF BERKELEY, DEPT STAT, BERKELEY, CA 94720 USA; UNIV CALIF SAN FRANCISCO, GRAD GRP BIOPHYS, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco				Dernburg, Abby/0000-0001-8037-1079; Broman, Karl/0000-0002-4914-6671				ABAD JP, 1992, P NATL ACAD SCI USA, V89, P4663, DOI 10.1073/pnas.89.10.4663; AGARD DA, 1989, METHOD CELL BIOL, V30, P353; ASHBRUNER M, 1989, DROSOPHILA LAB MANUA; BLACKMAN RK, 1987, CELL, V49, P497, DOI 10.1016/0092-8674(87)90452-1; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; CARMENA M, 1993, J CELL SCI, V105, P41; Chen H, 1996, J STRUCT BIOL, V116, P56, DOI 10.1006/jsbi.1996.0010; CREMER T, 1993, COLD SPRING HARB SYM, V58, P777, DOI 10.1101/SQB.1993.058.01.085; DERNBURG AF, 1996, IN PRESS GENETICS, V143; Doi M., 1988, THEORY POLYM DYNAMIC; DREESEN TD, 1988, MOL CELL BIOL, V8, P5206, DOI 10.1128/MCB.8.12.5206; DREESEN TD, 1991, GENE DEV, V5, P331, DOI 10.1101/gad.5.3.331; DREIBIN RA, 1986, COMPUT GRAPH, V22, P65; Efron B., 1994, MONOGRAPHS STAT APPL; ENGELS WR, 1994, SCIENCE, V263, P1623, DOI 10.1126/science.8128250; FOE VE, 1985, J CELL BIOL, V100, P1623, DOI 10.1083/jcb.100.5.1623; FOE VE, 1983, J CELL SCI, V61, P31; FREIFELDER D, 1976, PHYSICAL BIOCH; FUCHS JP, 1983, J CELL SCI, V64, P331; GODWIN AR, 1994, P NATL ACAD SCI USA, V91, P12554, DOI 10.1073/pnas.91.26.12554; GRAVES BJ, 1982, DEV BIOL, V93, P104, DOI 10.1016/0012-1606(82)90243-3; HAAF T, 1991, EXP CELL RES, V192, P325, DOI 10.1016/0014-4827(91)90048-Y; HABER JE, 1981, MOL CELL BIOL, V1, P1106, DOI 10.1128/MCB.1.12.1106; HARTL DL, 1994, P NATL ACAD SCI USA, V91, P6824, DOI 10.1073/pnas.91.15.6824; HAWLEY RS, 1992, DEV GENET, V13, P440, DOI 10.1002/dvg.1020130608; HELLGREN D, 1992, MUTAT RES, V284, P37, DOI 10.1016/0027-5107(92)90023-U; HENIKOFF S, 1995, GENETICS, V140, P1007; HENIKOFF S, 1994, GENETICS, V138, P1; HENIKOFF S, 1996, IN PRESS GENOMES; HILLIKER AJ, 1986, GENET RES, V47, P13, DOI 10.1017/S0016672300024459; HIRAOKA Y, 1993, J CELL BIOL, V120, P591, DOI 10.1083/jcb.120.3.591; HIRAOKA Y, 1990, BIOPHYS J, V57, P325, DOI 10.1016/S0006-3495(90)82534-0; HIRAOKA Y, 1990, J CELL BIOL, V111, P2815, DOI 10.1083/jcb.111.6.2815; HOCHSTRASSER M, 1986, J CELL BIOL, V102, P112, DOI 10.1083/jcb.102.1.112; HSIEH T, 1979, J MOL BIOL, V135, P465, DOI 10.1016/0022-2836(79)90447-9; KARPEN GH, 1990, CELL, V63, P97; KAUFFMAN BP, 1963, ACTA BIOL PORT, V7, P225; LICHTEN M, 1989, GENETICS, V123, P261; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; LOHE AR, 1993, GENETICS, V134, P1149; MAKUNIN IV, 1995, DOKL AKAD NAUK+, V344, P266; MANUELIDIS L, 1990, SCIENCE, V250, P1533, DOI 10.1126/science.2274784; MARSHALL WF, 1996, IN PRESS MOL CELL BI, V7; MATHOG D, 1984, NATURE, V308, P414, DOI 10.1038/308414a0; MCKEE BD, 1990, CELL, V61, P61, DOI 10.1016/0092-8674(90)90215-Z; Merriam J., 1968, DROS INFORM SERV, V43, P64; PALLADINO F, 1994, CURR OPIN CELL BIOL, V6, P373, DOI 10.1016/0955-0674(94)90029-9; Pardue ML, 1986, DROSOPHILA PRACTICAL, P111; RILES L, 1993, GENETICS, V134, P81; RINE J, 1980, MOL GEN GENET, V180, P99, DOI 10.1007/BF00267357; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; SLATIS HM, 1955, GENETICS, V40, P246; SMITH AV, 1991, DEVELOPMENT, V112, P997; SPOFFORD JB, 1976, GENETICS BIOL DROS C, V1, P955; TALBERT PB, 1994, GENETICS, V136, P559; TARTOF KD, 1991, CELL, V65, P201, DOI 10.1016/0092-8674(91)90153-P; Titterington D. M., 1985, STAT ANAL FINITE MIX; VANSCHAIK NW, 1959, GENETICS, V44, P725; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; WEILER KS, 1992, GENETICS, V132, P929; Wolff Tanya, 1993, P1277; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239	62	326	332	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	1996	85	5					745	759		10.1016/S0092-8674(00)81240-4	http://dx.doi.org/10.1016/S0092-8674(00)81240-4			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UP344	8646782	Bronze			2022-12-28	WOS:A1996UP34400014
J	Hathaway, DH; Gilman, PA; Harvey, JW; Hill, F; Howard, RF; Jones, HP; Kasher, JC; Leibacher, JW; Pintar, JA; Simon, GW				Hathaway, DH; Gilman, PA; Harvey, JW; Hill, F; Howard, RF; Jones, HP; Kasher, JC; Leibacher, JW; Pintar, JA; Simon, GW			GONG observations of solar surface flows	SCIENCE			English	Article							SPHERICAL HARMONIC-ANALYSIS; STEADY PHOTOSPHERIC FLOWS; VELOCITY-FIELDS; ROTATION; SUN; FEATURES; CONVECTION; SHELL	Doppler velocity observations obtained by the Global Oscillation Network Group (GONG) instruments directly measure the nearly steady flows in the solar photosphere. The sun's differential rotation is accurately determined from single observations. The rotation profile with respect to latitude agrees well with previous measures, but it also shows a slight north-south asymmetry. Rotation profiles averaged over 27-day rotations of the sun reveal the torsional oscillation signal-weak, jetlike features, with amplitudes of 5 meters per second, that are associated with the sunspot latitude activity belts. A meridional circulation with a poleward flow of about 20 meters per second is also evident, Several characteristics of the surface flows suggest the presence of large convection cells.	NATL CTR ATMOSPHER RES,HIGH ALTITUDE OBSERV,BOULDER,CO 80303; UNIV NEBRASKA,DEPT PHYS,OMAHA,NE 68182; NATL SOLAR OBSERV,SOLAR RES BRANCH,GEOPHYS DIRECTORATE,PHILLIPS LAB,USAF,MAT COMMAND,SUNSPOT,NM 88349; NATL OPT ASTRON OBSERV,NATL SOLAR OBSERV,NASA,GODDARD SPACE FLIGHT CTR,SW SOLAR STN,TUCSON,AZ 85726	National Center Atmospheric Research (NCAR) - USA; University of Nebraska System; United States Department of Defense; United States Air Force; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Optical Astronomy Observatory	Hathaway, DH (corresponding author), NASA,GEORGE C MARSHALL SPACE FLIGHT CTR,SPACE SCI LAB,SOLAR PHYS BRANCH,MAIL CODE ES82,HUNTSVILLE,AL 35812, USA.			Leibacher, John/0000-0001-7605-3684				BABCOCK HW, 1961, ASTROPHYS J, V133, P572, DOI 10.1086/147060; DURNEY BR, 1985, ASTROPHYS J, V292, P752, DOI 10.1086/163206; DUVALL TL, 1979, SOL PHYS, V63, P3, DOI 10.1007/BF00155690; ELSASSER WM, 1946, PHYS REV, V69, P202; Gilman P.A., 1977, GEOPHYS ASTRO FLUID, V8, P93, DOI [10.1080/03091927708240373, DOI 10.1080/03091927708240373]; GILMAN PA, 1986, ASTROPHYS J SUPPL S, V61, P585, DOI 10.1086/191125; GLATZMAIER GA, 1981, ASTROPHYS J SUPPL S, V45, P351, DOI 10.1086/190715; Harvey JW, 1996, SCIENCE, V272, P1284, DOI 10.1126/science.272.5266.1284; HATHAWAY DH, 1987, SOL PHYS, V108, P1, DOI 10.1007/BF00152073; HATHAWAY DH, 1982, SOL PHYS, V77, P341, DOI 10.1007/BF00156116; HATHAWAY DH, 1992, SOL PHYS, V137, P15, DOI 10.1007/BF00146573; Hathaway DH, 1996, ASTROPHYS J, V460, P1027, DOI 10.1086/177029; Hill F, 1996, SCIENCE, V272, P1292, DOI 10.1126/science.272.5266.1292; HOWARD R, 1979, ASTROPHYS J, V228, pL45, DOI 10.1086/182900; HOWARD R, 1980, ASTROPHYS J, V239, pL33, DOI 10.1086/183286; JONES HP, 1995, ESA, V2, P227; KOMM RW, 1993, SOL PHYS, V145, P1, DOI 10.1007/BF00627979; KUHN JR, 1983, ASTROPHYS J, V264, P689, DOI 10.1086/160642; LABONTE BJ, 1981, ASTROPHYS J, V250, P796, DOI 10.1086/159430; Latushko S, 1996, SOL PHYS, V163, P241, DOI 10.1007/BF00147998; LIBBRECHT KG, 1986, ASTROPHYS J, V308, P413, DOI 10.1086/164511; NOVEMBER LJ, 1981, ASTROPHYS J, V245, pL123, DOI 10.1086/183539; Parker E.N., 1979, COSMICAL MAGNETIC FI; ROBILLOT JM, 1984, ASTRON ASTROPHYS, V137, P43; SCHERRER PH, 1980, ASTROPHYS J, V241, P811, DOI 10.1086/158392; SIMON GW, 1968, Z ASTROPHYS, V69, P435; SIMON GW, 1991, MNRAS, V252, P1; SNODGRASS HB, 1984, ASTROPHYS J, V284, P848, DOI 10.1086/162468; SNODGRASS HB, 1985, ASTROPHYS J, V291, P339, DOI 10.1086/163073; SNODGRASS HB, 1990, ASTROPHYS J, V351, P309, DOI 10.1086/168467; Snodgrass HB, 1996, SOL PHYS, V163, P21, DOI 10.1007/BF00165454; STROUS LH, 1995, ESA, V2, P213; Thompson MJ, 1996, SCIENCE, V272, P1300, DOI 10.1126/science.272.5266.1300; ULRICH RK, 1988, SOL PHYS, V117, P291, DOI 10.1007/BF00147250; ULRICH RK, COMMUNICATION; WILSON PR, 1994, SOLAR STELLAR ACTIVI; YOSHIMURA H, 1983, ASTROPHYS J SUPPL S, V52, P363, DOI 10.1086/190872	37	117	117	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1306	1309		10.1126/science.272.5266.1306	http://dx.doi.org/10.1126/science.272.5266.1306			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8662460				2022-12-28	WOS:A1996UN47200036
J	Briggs, AH; Sculpher, MJ; Logan, RPH; Aldous, J; Ramsay, ME; Baron, JH				Briggs, AH; Sculpher, MJ; Logan, RPH; Aldous, J; Ramsay, ME; Baron, JH			Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age	BRITISH MEDICAL JOURNAL			English	Article							DUODENAL-ULCER; DISEASE	Objective-To assess the cost effectiveness of screening for and eradicating Helicobacter pylori in patients under 45 years of age presenting with dyspepsia. Design-A decision analytic model composed of a decision tree to represent the epidemiology of dyspepsia and a Markov process to model the outcomes of treatment. Patients-Patients under the age of 45 years presenting to their general practitioner with (peptic type) dyspepsia. Interventions-Conventional empirical treatment with healing and maintenance doses of cimetidine v eradication treatment solely in patients with confirmed peptic ulcer; and conventional empirical treatment for all dyspeptic patients compared with the use of a serology test to identify patients with H pylori, who then receive endoscopy to investigate the presence of peptic ulcer disease and, when disease is found, are given eradication treatment with a breath test to confirm successful eradication. Main outcome measures-Expected cumulative costs over a period of 10 years. The proportion of time patients spend without a recurrent ulcer. Results-After receiving eradication treatment, patients with confirmed ulcer spend an average of 99% of their time free fi om recurrent ulcer disease compared with 95% after treatment with cimetidine. Eradication treatment costs less than that with cimetidine. When the initial cost of identifying appropriate patients to receive eradication treatment is added to the analysis, however, these cost savings take almost eight years to accrue. Conclusions-Enthusiasm for introducing testing for and eradication of H pylori for dyspeptic patients in general practice should be tempered by an awareness that cost savings may take many years to realise.	UNIV NOTTINGHAM HOSP,QUEENS MED CTR,DEPT GASTROENTEROL,NOTTINGHAM NG7 2UH,ENGLAND; ST MARYS HOSP,SCH MED,ACAD DEPT PUBL HLTH,LONDON W2 1PG,ENGLAND; ST MARYS HOSP,DEPT GASTROENTEROL,LONDON W2 1NY,ENGLAND	University of Nottingham; Imperial College London; Imperial College London	Briggs, AH (corresponding author), BRUNEL UNIV,HLTH ECON RES GRP,UXBRIDGE UB8 3PH,MIDDX,ENGLAND.		Briggs, Andrew/ABA-9009-2020	Briggs, Andrew/0000-0002-0777-1997; Sculpher, Mark/0000-0003-3746-9913				ALDOUS J, 1994, PILOT STUDY EFFECTS; ATHERTON JC, 1994, GUT, V35, P723, DOI 10.1136/gut.35.6.723; AXON ATR, 1995, BMJ-BRIT MED J, V310, P853, DOI 10.1136/bmj.310.6983.853; BARDHAN KD, 1984, GUT, V25, P711, DOI 10.1136/gut.25.7.711; BECK JR, 1983, MED DECIS MAKING, V3, P411; BELL GD, 1993, Q J MED, V86, P375; BELL GD, 1993, BR J MED EC, V6, P45; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; *BRIT MED ASS ROYA, 1995, BRIT NAT FORM; CAMPBELL LM, 1994, BR J MED EC, V7, P147; *CHART I PUBL FIN, 1990, HLTH DAT HLTH SERV T, V2; CLAUSEN MR, 1992, SCAND J GASTROENTERO, V27, P421, DOI 10.3109/00365529209000099; Duggan A. E., 1995, Gut, V37, pA58; EDENHOLM M, 1985, SCAND J GASTROENTERO, V20, P163, DOI 10.3109/00365528509103953; FORRESTER E, 1994, GASTROENTEROL PR FEB, P6; GRIBBLE EJ, 1994, GASTROENTEROLOGY INT, V7, P90; HASTINGS L, 1995, GUT, V37, pA6; *HM TREAS, 1991, EC APPR CENTR GOV TE; KATZ KD, 1992, AM J SURG, V163, P349, DOI 10.1016/0002-9610(92)90021-I; KEMMER TP, 1994, EUR J GASTROEN HEPAT, V6, P571, DOI 10.1097/00042737-199407000-00002; LABENZ J, 1994, AM J GASTROENTEROL, V89, P1785; LOGAN RPH, 1992, HELICOBACTER PYLORI, P88; MOORE RA, 1995, HELICOBACTER PYLORI; NETTEN A, 1994, UNIT COSTS COMMUNITY; NOVELL, 1995, QUATTRO PRO V6 0; PATEL P, 1994, LANCET, V344, P511, DOI 10.1016/S0140-6736(94)91899-6; PYM B, 1990, GASTROENTEROLOGY, V99, P27, DOI 10.1016/0016-5085(90)91225-U; SOBALA GM, 1991, LANCET, V338, P94, DOI 10.1016/0140-6736(91)90085-4; SONNENBERG A, 1995, EUR J GASTROEN HEPAT, V7, P655; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; *TREEW SOFTW, 1995, DATA V2 6; TYTGAT GNJ, 1994, ALIMENT PHARM THERAP, V8, P359; VANZANTEN SJOV, 1994, CAN MED ASSOC J, V150, P189; WEBB PM, 1994, BRIT MED J, V308, P750, DOI 10.1136/bmj.308.6931.750; 1994, JAMA-J AM MED ASSOC, V272, P65; 1991, GUT, V32, P95	36	127	127	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 25	1996	312	7042					1321	1325		10.1136/bmj.312.7042.1321	http://dx.doi.org/10.1136/bmj.312.7042.1321			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN476	8646042	Green Published			2022-12-28	WOS:A1996UN47600016
J	Skinner, R; Cole, M; Pearson, ADJ; Coulthard, MG; Craft, AW				Skinner, R; Cole, M; Pearson, ADJ; Coulthard, MG; Craft, AW			Specificity of pH and osmolality of early morning urine sample in assessing distal renal tubular function in children: Results in healthy children	BRITISH MEDICAL JOURNAL			English	Article											Skinner, R (corresponding author), UNIV NEWCASTLE UPON TYNE,ROYAL VICTORIA INFIRM,SIR JAMES SPENCE INST CHILD HLTH,NEWCASTLE TYNE NE1 4LP,TYNE & WEAR,ENGLAND.							EDELMANN CM, 1967, AM J DIS CHILD, V114, P639, DOI 10.1001/archpedi.1967.02090270095009; RODRIGUEZSORIANO J, 1990, PEDIATR NEPHROL, V4, P268, DOI 10.1007/BF00857675; Silverman B., 1986, DENSITY ESTIMATION S, V175; SWIFT PGF, 1991, CURRENT PAEDIAT, V1, P177	4	10	10	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 25	1996	312	7042					1337	1338		10.1136/bmj.312.7042.1337	http://dx.doi.org/10.1136/bmj.312.7042.1337			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN476	8646047	Green Published			2022-12-28	WOS:A1996UN47600022
J	Patino, MM; Liu, JJ; Glover, JR; Lindquist, S				Patino, MM; Liu, JJ; Glover, JR; Lindquist, S			Support for the prion hypothesis for inheritance of a phenotypic trait in yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; SUP35 GENE; PROTEIN HSP104; DISEASES; BIOLOGY; PSI(+)	A cytoplasmically inherited genetic element in yeast, [PSI+], was confirmed to be a prionlike aggregate of the cellular protein Sup35 by differential centrifugation analysis and microscopic localization of a Sup35-green fluorescent protein fusion. Aggregation depended on the intracellular concentration and functional state of the chaperone protein Hsp104 in the same manner as did [PSI+] inheritance. The amino-terminal and carboxyterminal domains of Sup35 contributed to the unusual behavior of [PSI+]. [PSI+] altered the conformational slate of newly synthesized prion proteins, inducing them to aggregate as well, thus fulfilling a major tenet of the prion hypothesis.	UNIV CHICAGO, HOWARD HUGHES MED INST, CHICAGO, IL 60637 USA; UNIV CHICAGO, DEPT MOLEC GENET & CELL BIOL, CHICAGO, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025874, R37GM025874] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25874] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; COUGHEY B, 1995, CURR BIOL, V2, P807; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; DOEL SM, 1994, GENETICS, V137, P659; KAIN SR, 1995, BIOTECHNIQUES, V19, P650; LANSBURY PT, 1995, CHEM BIOL, V2, P1, DOI 10.1016/1074-5521(95)90074-8; Lindquist S, 1995, COLD SPRING HARB SYM, V60, P451, DOI 10.1101/SQB.1995.060.01.050; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; PATINO M, UNPUB; PRUSINER SB, 1994, ANNU REV MICROBIOL, V48, P655, DOI 10.1146/annurev.mi.48.100194.003255; SCHENA M, 1991, METHOD ENZYMOL, V194, P389; SCHIRMER E, UNPUB; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; THIELE DJ, 1988, MOL CELL BIOL, V8, P2745, DOI 10.1128/MCB.8.7.2745; TUITE M, IN PRESS TRENDS GENE; WARD WW, 1982, BIOCHEMISTRY-US, V21, P4535, DOI 10.1021/bi00262a003; WARD WW, 1980, PHOTOCHEM PHOTOBIOL, V31, P611, DOI 10.1111/j.1751-1097.1980.tb03755.x; Weissmann Charles, 1994, Trends in Cell Biology, V4, P10, DOI 10.1016/0962-8924(94)90032-9; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	26	558	567	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	1996	273	5275					622	626		10.1126/science.273.5275.622	http://dx.doi.org/10.1126/science.273.5275.622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VA249	8662547				2022-12-28	WOS:A1996VA24900039
J	Mathew, JP; Parks, R; Savino, JS; Friedman, AS; Koch, C; Mangano, DT; Browner, WS				Mathew, JP; Parks, R; Savino, JS; Friedman, AS; Koch, C; Mangano, DT; Browner, WS			Atrial fibrillation following coronary artery bypass graft surgery - Predictors, outcomes, and resource utilization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; FLUTTER; ARRHYTHMIAS; OPERATIONS; CONDUCTION; MUSCLE; AGE	Objective.-To determine the incidence, predictors, and cost of atrial fibrillation and flutter (AFIB) following coronary artery bypass graft (CABG) surgery. Design.-Prospective observational study (MultiCenter Study of Perioperative Ischemia). Setting.-Twenty-four university-affiliate hospitals in the United States from 1991 to 1993. Subjects.-A total of 2417 patients undergoing CABG with or without concurrent valvular surgery selected using a systematic sampling interval. Measurements.-Detailed preoperative, intraoperative, and postoperative data collected on standardized reporting forms. Results.-The overall incidence of postoperative AFIB was 27%. Independent predictors of postoperative AFIB included advanced age (odds ratio [OR], 1.24 per 5-year increase; 95% confidence interval [CI], 1.18-1.31); male sex (OR, 1.41; 95% CI, 1.09-1.81); a history of AFIB (OR, 2.28; 95% CI, 1.74-3.00); a history of congestive heart failure (OR, 1.31; 95% CI, 1.04-1.64); and a precardiopulmonary bypass heart rate of more than 100 beats per minute (OR, 1.59; 95% CI, 1.00-2.55). Surgical practices such as pulmonary vein venting (OR, 1.44; 95% CI, 1.13-1.83); bicaval venous cannulation (OR, 1.40; 95% CI, 1.04-1.89); postoperative atrial pacing (OR, 1.27; 95% CI, 1.00-1.62), and longer cross-clamp times (OR, 1.06 per 15 minutes; 95% CI, 1.00-1.11) also were identified as independent predictors of postoperative AFIB. Patients with postoperative AFIB remained an average of 13 hours longer in the intensive care unit and 2.0 days longer in the ward when compared with patients without AFIB. Conclusion-Postoperative AFIB is common after CABG surgery and has a significant effect on both intensive care unit and overall hospital length of stay. In addition to expected demographic factors, certain surgical practices increase the risk of postoperative AFIB. Randomized controlled trials are necessary to determine if modification of these surgical practices, especially in patients at high risk, would decrease the incidence of postoperative AFIB.	ISCHEMIA RES & EDUC FDN,DEPT EPIDEMIOL,SAN FRANCISCO,CA; UNIV PENN,MED CTR,DEPT ANESTHESIOL,PHILADELPHIA,PA 19104; CEDARS SINAI MED CTR,DEPT ANESTHESIOL,LOS ANGELES,CA 90048; CLEVELAND CLIN FDN,DEPT CARDIOTHORAC ANESTHESIOL,CLEVELAND,OH 44195; UNIV CALIF SAN FRANCISCO,DEPT ANESTHESIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,VET AFFAIRS MED CTR,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,VET AFFAIRS MED CTR,DEPT EPIDEMIOL & BIOSTAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,VET AFFAIRS MED CTR,DEPT ANESTHESIOL,SAN FRANCISCO,CA 94143	University of Pennsylvania; Cedars Sinai Medical Center; Cleveland Clinic Foundation; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Mathew, JP (corresponding author), YALE UNIV,SCH MED,DEPT ANESTHESIOL,333 CEDAR ST,TOMPKINS-3,NEW HAVEN,CT 06510, USA.			Mathew, Joseph/0000-0002-3815-4131				BHARATI S, 1988, CHEST, V94, P142, DOI 10.1378/chest.94.1.142; CHEN XZ, 1988, ANN THORAC SURG, V46, P406, DOI 10.1016/S0003-4975(10)64653-X; COOKE JP, 1990, CIRCULATION, V82, P1607, DOI 10.1161/01.CIR.82.5.1607; COX JL, 1993, ANN THORAC SURG, V56, P405, DOI 10.1016/0003-4975(93)90871-E; CRESWELL LL, 1993, ANN THORAC SURG, V56, P539, DOI 10.1016/0003-4975(93)90894-N; CROSBY LH, 1990, AM J CARDIOL, V66, P1520, DOI 10.1016/0002-9149(90)90550-K; FEUER JM, 1989, AM J CARDIOL, V64, P1376, DOI 10.1016/0002-9149(89)90586-9; FROST L, 1992, INT J CARDIOL, V36, P253, DOI 10.1016/0167-5273(92)90293-C; FULLER JA, 1989, J THORAC CARDIOV SUR, V97, P821; HARDER DR, 1979, J CELL PHYSIOL, V100, P375, DOI 10.1002/jcp.1041000218; KADISH AH, 1995, CARDIAC ELECTROPHYSI, P1268; KOPECKY SL, 1987, NEW ENGL J MED, V317, P669, DOI 10.1056/NEJM198709103171104; LAUER MS, 1989, PROG CARDIOVASC DIS, V31, P367, DOI 10.1016/0033-0620(89)90031-5; LEITCH JW, 1990, J THORAC CARDIOV SUR, V100, P338; NYSTROM U, 1993, THORAC CARDIOV SURG, V41, P34, DOI 10.1055/s-2007-1013817; ROBERTS SA, 1993, AM J CARDIOL, V72, P567, DOI 10.1016/0002-9149(93)90353-E; ROSENBLUETH A, 1947, AM HEART J, V33, P677, DOI 10.1016/0002-8703(47)90084-7; ROUSOU JA, 1985, CIRCULATION, V72, P259; RUBIN DA, 1987, J THORAC CARDIOV SUR, V94, P331; SATO S, 1992, J THORAC CARDIOV SUR, V104, P297; SCHUESSLER RB, 1993, CIRCULATION, V88, P250, DOI 10.1161/01.CIR.88.1.250; SCHUESSLER RB, 1995, CARDIAC ELECTROPHYSI, P543; SLOGOFF S, 1985, ANESTHESIOLOGY, V62, P107, DOI 10.1097/00000542-198502000-00002; SPACH MS, 1986, CIRC RES, V58, P356, DOI 10.1161/01.RES.58.3.356; WISTBACKA JOM, 1995, J CARDIOTHOR VASC AN, V9, P140, DOI 10.1016/S1053-0770(05)80184-3; YOUSIF H, 1990, INT J CARDIOL, V26, P313, DOI 10.1016/0167-5273(90)90087-L; 1990, NEW ENGL J MED, V322, P863; 1990, NEW ENGL J MED, V323, P1505	28	576	620	0	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1996	276	4					300	306		10.1001/jama.276.4.300	http://dx.doi.org/10.1001/jama.276.4.300			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UX583	8656542				2022-12-28	WOS:A1996UX58300035
J	Guarnieri, F; Fliss, M; Bancroft, C				Guarnieri, F; Fliss, M; Bancroft, C			Making DNA add	SCIENCE			English	Article								Recent studies have demonstrated the feasibility of using DNA-based experiments to compute solutions to combinatorial problems. However, a prerequisite for designing a computer useful in a wide range of applications is the ability to perform mathematical calculations. The development of a DNA-based algorithm for addition is presented. The DNA representation of two nonnegative binary numbers is presented in a form permitting a chain of primer extension reactions to carry out the addition operation. To demonstrate the feasibility of this algorithm, a simple example was executed biochemically.	MT SINAI SCH MED,DEPT PHYSIOL & BIOPHYS,NEW YORK,NY 10029	Icahn School of Medicine at Mount Sinai								ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; GUARNIERI F, 1996, IN PRESS P 2 ANN M D; LIPTON RJ, 1995, SCIENCE, V268, P542, DOI 10.1126/science.7725098; REIF JH, 1995, 7 ANN ACM S PAR ALG, P213; Sambrook J., 1989, MOL CLONING; YAN GZ, 1991, MOL ENDOCRINOL, V5, P535, DOI 10.1210/mend-5-4-535	7	125	157	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 12	1996	273	5272					220	223		10.1126/science.273.5272.220	http://dx.doi.org/10.1126/science.273.5272.220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW787	8662501				2022-12-28	WOS:A1996UW78700035
J	Sanchez, MP; SilosSantiago, I; Frisen, J; He, B; Lira, SA; Barbacid, M				Sanchez, MP; SilosSantiago, I; Frisen, J; He, B; Lira, SA; Barbacid, M			Renal agenesis and the absence of enteric neurons in mice lacking GDNF	NATURE			English	Article							LETHALITY	GLIAL-CELL-LINE-DERIVED neurotrophic factor (GDNF)(1) is a potent survival factor for dopaminergic neurons and motor neurons in culture(1,2). It also protects these neurons from degeneration in vitro(3-9), and improves symptoms like Parkinson's disease induced pharmacologically in rodents(10) and monkeys(11), Thus GDNF might have beneficial effects in the treatment of Parkinson's disease and amyotrophic lateral sclerosis, To examine the physiological role of GDNF in the development of the mammalian nervous system, we have generated mice defective in GDNF expression by using homologous recombination in embryonic stem cells to delete each of its two coding exons(1), GDNF-null mice, regardless of their targeted mutation, display complete renal agenesis owing to lack of induction of the ureteric bud, an early step in kidney development, These mice also have no enteric neurons, which probably explains the observed pyloric stenosis and dilation of their duodenum, However, ablation of the GDNF gene does not affect the differentiation and survival of dopaminergic neurons, at least during embryonic development.	BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT MOLEC ONCOL,PRINCETON,NJ 08543; BRISTOL MYERS SQUIBB PHARMACEUT RES INST,TRANSGEN UNIT,PRINCETON,NJ 08543	Bristol-Myers Squibb; Bristol-Myers Squibb			Sanchez, Marina P/A-2453-2011	Sanchez, Marina P/0000-0003-1905-3842				Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; Blaugrund E, 1996, DEVELOPMENT, V122, P309; BUTCHER LL, 1984, HDB CHEM NEUROANATOM, V2; Durbec PL, 1996, DEVELOPMENT, V122, P349; GASH MD, 1966, NATURE, V380, P252; GOSSLER A, 1995, GENE TARGETING PRACT, P181; Hellmich HL, 1996, MECH DEVELOP, V54, P95, DOI 10.1016/0925-4773(95)00464-5; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; PAPAIOANNOU V, 1995, GENE TARGETING PRACT, P107; Saxen L., 1987, ORGANOGENESIS KIDNEY, V19; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Torres M, 1995, DEVELOPMENT, V121, P4057; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WURST W, 1995, GENE TARGETING PRACT, P33; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; ZURN AD, 1994, NEUROREPORT, V6, P113, DOI 10.1097/00001756-199412300-00030	26	986	1011	0	42	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 4	1996	382	6586					70	73		10.1038/382070a0	http://dx.doi.org/10.1038/382070a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV473	8657306				2022-12-28	WOS:A1996UV47300055
J	White, RJ; Trouche, D; Martin, K; Jackson, SP; Kouzarides, T				White, RJ; Trouche, D; Martin, K; Jackson, SP; Kouzarides, T			Repression of RNA polymerase III transcription by the retinoblastoma protein	NATURE			English	Article							TRANSFORMED-CELLS; MESSENGER-RNA; GENE-PRODUCT; IN-VITRO; ACTIVATION; MOUSE; TBP; IDENTIFICATION; PROMOTERS; INVITRO	TRANSCRIPTION by RNA polymerase (pol) III is under cell-cycle control, being higher in S and G2 than in G0 and early G1 phases(1-4), Many transformed cell types have elevated pol III activity(4-9), presumably to sustain sufficient protein synthesis for unrestrained growth, The retinoblastoma tumour-suppressor protein (Rb) restricts cellular proliferation, and is often found mutated in transformed cells(10,11). Here we demonstrate that Rb can repress the level of transcription from pol III templates both in vitro and in vivo. Analysis of Rb-deficient SAOS2 cells and primary fibroblasts from Rb--/- mice demonstrates elevated levels of pol III activity in the abscence of functional Rb protein, Rb-induced repression of pol III activity is alleviated by mutations in the Rb pocket domain that occur naturally in tumours, and by viral transforming proteins that hind and inactivate Rb, These results implicate repression of pol III transcription as a mechanism for Rb-induced growth arrest, and suggest that restraining protein biosynthesis may be important in the prevention of tumour development.	UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE CB2 1QP,ENGLAND; WELLCOME CRC INST,CAMBRIDGE CB2 1QR,ENGLAND; UNIV CAMBRIDGE,DEPT ZOOL,CAMBRIDGE CB2 3EJ,ENGLAND	University of Cambridge; University of Cambridge			Jackson, Stephen Philip/R-4548-2019; Trouche, Didier/B-2854-2008; Dry, Kate/I-2328-2014	Jackson, Stephen Philip/0000-0001-9317-7937; Trouche, Didier/0000-0003-1398-6481; Kouzarides, Tony/0000-0002-8918-4162	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CAREY MF, 1986, MOL CELL BIOL, V6, P3068, DOI 10.1128/MCB.6.9.3068; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; HAGEMEIER C, 1993, P NATL ACAD SCI USA, V90, P1580, DOI 10.1073/pnas.90.4.1580; HAGEMEIER C, 1993, NUCLEIC ACIDS RES, V21, P4998, DOI 10.1093/nar/21.22.4998; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JOHNSON LF, 1974, CELL, V1, P95, DOI 10.1016/0092-8674(74)90068-3; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; KAYE FJ, 1990, P NATL ACAD SCI USA, V87, P6922, DOI 10.1073/pnas.87.17.6922; KOUZARIDES T, 1995, CANC BIOL, V6, P91; LOBO SM, 1992, CELL, V71, P1029, DOI 10.1016/0092-8674(92)90397-U; LOEKEN M, 1988, CELL, V55, P1171, DOI 10.1016/0092-8674(88)90261-9; MAJELLO B, 1985, NATURE, V314, P457, DOI 10.1038/314457a0; Marzluff W. F., 1984, TRANSCRIPTION TRANSL, P89; MAUCK JC, 1974, CELL, V3, P171, DOI 10.1016/0092-8674(74)90122-6; PATEL G, 1990, NUCLEIC ACIDS RES, V18, P2909, DOI 10.1093/nar/18.10.2909; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; RIGBY PWJ, 1993, CELL, V72, P7, DOI 10.1016/0092-8674(93)90042-O; SCOTT MRD, 1983, CELL, V34, P557, DOI 10.1016/0092-8674(83)90388-4; SINGH K, 1985, NATURE, V314, P553, DOI 10.1038/314553a0; TROUCHE D, 1993, BIOCHEM BIOPH RES CO, V196, P611, DOI 10.1006/bbrc.1993.2293; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WHITE RJ, 1990, EMBO J, V9, P3713, DOI 10.1002/j.1460-2075.1990.tb07584.x; WHITE RJ, 1995, MOL CELL BIOL, V15, P6653; WHITE RJ, 1995, MOL CELL BIOL, V15, P1983; WHITE RJ, 1994, RNA POLYMERASE 3 TRA	27	181	181	0	7	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 4	1996	382	6586					88	90		10.1038/382088a0	http://dx.doi.org/10.1038/382088a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV473	8657311				2022-12-28	WOS:A1996UV47300060
J	Wong, GT; Gannon, KS; Margolskee, RF				Wong, GT; Gannon, KS; Margolskee, RF			Transduction of bitter and sweet taste by gustducin	NATURE			English	Article							RECEPTOR-CELLS; MICE; DISRUPTION; EXPRESSION; RESPONSES	SFVERAL lines of evidence suggest that both sweet and bitter tastes are transduced via receptors coupled to heterotrimeric guanine-nucleotide-binding proteins (G proteins) (reviewed in refs 1, 2). Gustducin is a taste receptor cell (TRC)-specific G protein that is closely related to the transducins(3). Gustducin and rod transducin, which is also expressed in TRCs (ref. 4), have been proposed to couple bitter-responsive receptors to TRC-specific phosphodiesterases to regulate intracellular cyclic nucleotides(2-5). Here we investigate gustducin's role in taste transduction by generating and characterizing mice deficient in the gustducin alpha-subunit (alpha gustducin). As predicted, the mutant mice showed reduced behavioural and electrophysiological responses to bitter compounds, whereas they were indistinguishable from wild-type controls in their responses to salty and sour stimuli. Unexpectedly, mutant mice also exhibited reduced behavioural and electrophysiological responses to sweet compounds. Our results suggest that gustducin is a principal mediator of both bitter and sweet signal transduction.	CUNY MT SINAI SCH MED, DEPT PHYSIOL & BIOPHYS, NEW YORK, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai			Alshali, Rasha A/K-8051-2012	Margolskee, Robert/0000-0002-9572-2887				AKABAS MH, 1988, SCIENCE, V242, P1047, DOI 10.1126/science.3194756; AVENET P, 1987, J MEMBRANE BIOL, V97, P223, DOI 10.1007/BF01869225; AVENET P, 1988, NATURE, V331, P351, DOI 10.1038/331351a0; GANNON KS, 1995, PHYSIOL BEHAV, V57, P231, DOI 10.1016/0031-9384(94)00279-E; HARDER DB, 1989, CHEM SENSES, V14, P547, DOI 10.1093/chemse/14.4.547; KINNAMON SC, 1992, ANNU REV PHYSIOL, V54, P715, DOI 10.1146/annurev.physiol.54.1.715; KOLESNIKOV SS, 1995, NATURE, V376, P85, DOI 10.1038/376085a0; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; KWEE L, 1995, DEVELOPMENT, V121, P489; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LUGO DI, 1989, MOL ENDOCRINOL, V3, P1313, DOI 10.1210/mend-3-8-1313; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Margolskee Robert F., 1993, Current Opinion in Neurobiology, V3, P526, DOI 10.1016/0959-4388(93)90051-Y; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; MISTRETTA CM, 1991, SMELL TASTE HLTH DIS, P35; NAIM M, 1991, COMP BIOCHEM PHYS B, V100, P455, DOI 10.1016/0305-0491(91)90203-P; NAIM M, 1994, BIOCHEM J, V297, P451, DOI 10.1042/bj2970451; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; NINOMIYA Y, 1984, BRAIN RES, V302, P305, DOI 10.1016/0006-8993(84)90244-0; NINOMIYA Y, 1989, COMP BIOCHEM PHYS A, V92, P371; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Spielman AI, 1996, AM J PHYSIOL-CELL PH, V270, pC926, DOI 10.1152/ajpcell.1996.270.3.C926; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; STRIEM B J, 1991, Cellular Physiology and Biochemistry, V1, P46, DOI 10.1159/000154592; STRIEM BJ, 1989, BIOCHEM J, V260, P121, DOI 10.1042/bj2600121; SZABO P, 1994, DEVELOPMENT, V120, P1651; TINTI JM, 1991, ACS SYM SER, V450, P88; TONOSAKI K, 1988, NATURE, V331, P354, DOI 10.1038/331354a0; ZYLSTRA MLE, 1989, NATURE, V342, P435	30	525	568	5	51	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 27	1996	381	6585					796	800		10.1038/381796a0	http://dx.doi.org/10.1038/381796a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU356	8657284				2022-12-28	WOS:A1996UU35600063
J	Sadovnick, AD; Ebers, GC; Dyment, DA; Risch, NJ; Bulman, D; Rice, GPA; Hashimoto, SA; Paty, D; Oger, JJF; Metz, L; Bell, R; Warren, S; Hader, W; Auty, T; Nath, A; Gray, T; OConner, P; Nelson, R; Freedman, M; Brunet, D; Paulseth, R; Francis, G; Duquette, P; Murray, TJ; Bahn, V; PrysePhillips, W				Sadovnick, AD; Ebers, GC; Dyment, DA; Risch, NJ; Bulman, D; Rice, GPA; Hashimoto, SA; Paty, D; Oger, JJF; Metz, L; Bell, R; Warren, S; Hader, W; Auty, T; Nath, A; Gray, T; OConner, P; Nelson, R; Freedman, M; Brunet, D; Paulseth, R; Francis, G; Duquette, P; Murray, TJ; Bahn, V; PrysePhillips, W			Evidence for genetic basis of multiple sclerosis	LANCET			English	Article							EPIDEMIOLOGY; TWINS; RISKS; ONSET; AGE	Background Increased familial risks in multiple sclerosis (MS) range from 300-fold for monozygotic twins to 20-40-fold for biological first-degree relatives, suggesting a genetic influence. Yet if one identical twin has MS the other usually will not. One way of sorting out the contributions of genes and environment is to study half-sibs. Methods In a Canadian population-based sample of 16 000 is MS cases seen at 14 regional MS clinics one half-sib (or more) was reported by 939 index cases. By interview we elicited information on family structure and an illness in half-sibs and any full brothers or sisters. Findings The age-adjusted MS rate in the 1839 half-sibs of these index cases was 1.32% compared with 3.46% far the 1395 full sibs of the same cases (p<0.001; likelihood ratio test), There were no significant differences in risk for maternal versus paternal half-sibs (1.42% vs 1.19%) or for those raised together versus those raised apart from the index case (1.17% vs 1.47%). Interpretation Besides demonstrating the power and the feasiblity of using half-sib studies to throw light on the aetiology of complex disorders, our findings show that a shared environment does not account for familial risk in MS and that maternal effects (such as intrauterine and perinatal factors, breastfeeding, and genomic imprinting) have no demonstrable effect on familial risk. Halving the number of potentially contributory genes (by comparing full-sib and half-sib rates) lowers the risk of MS by a factor of 2.62, an observation consistent with a polygenic hypothesis.	UNIV WESTERN ONTARIO,DEPT CLIN NEUROL SCI,LONDON,ON,CANADA; STANFORD UNIV,SCH MED,DEPT GENET,STANFORD,CA; MONTREAL NEUROL INST,MONTREAL,PQ,CANADA; HOP NOTRE DAME DE BON SECOURS,MONTREAL,PQ,CANADA	Western University (University of Western Ontario); Stanford University; McGill University; Universite de Montreal	Sadovnick, AD (corresponding author), UNIV BRITISH COLUMBIA,DEPT MED GENET,222 WESBROOK BLDG,6174 UNIV BLVD,VANCOUVER,BC V6T 1Z3,CANADA.			Sadovnick, Dessa/0000-0003-2987-2008; Ebers, George/0000-0003-4771-4177				ALTER M, 1962, ARCH NEUROL-CHICAGO, V7, P253, DOI 10.1001/archneur.1962.04210040005001; BULMAN DE, 1991, BRAIN, V114, P937, DOI 10.1093/brain/114.2.937; DEAN G, 1967, BRIT MED J, V2, P724, DOI 10.1136/bmj.2.5554.724; DETELS R, 1977, AM J EPIDEMIOL, V105, P303, DOI 10.1093/oxfordjournals.aje.a112387; EBERS GC, 1986, NEW ENGL J MED, V315, P1638, DOI 10.1056/NEJM198612253152603; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; EBERS GC, 1994, J NEUROIMMUNOL, V53, P117, DOI 10.1016/0165-5728(94)90021-3; FINELLI PF, 1991, NEUROLOGY, V41, P1320, DOI 10.1212/WNL.41.8.1320-a; FREDRIKSON S, 1992, NEUROLOGY, V42, P577, DOI 10.1212/WNL.42.3.577; GAUDET JPC, 1995, NEUROEPIDEMIOLOGY, V14, P188, DOI 10.1159/000109795; GAUDET JPC, 1995, ACTA NEUROL SCAND, V91, P19; GRONNING M, 1985, ACTA NEUROL SCAND, V72, P321; HADER W J, 1985, Neurology, V35, P300; HAMMOND SR, 1988, BRAIN, V111, P1, DOI 10.1093/brain/111.1.1; KAUFMAN MD, 1992, NEUROLOGY, V42, P1644, DOI 10.1212/WNL.42.8.1644-b; KURTZKE JF, 1993, CLIN MICROBIOL REV, V6, P382, DOI 10.1128/CMR.6.4.382-427.1993; MCGUE M, 1987, BEHAV GENET, V16, P75; MUMFORD CJ, 1994, NEUROLOGY, V44, P11, DOI 10.1212/WNL.44.1.11; MYRIANTHOPOULOS NC, 1978, GENETIC EPIDEMIOLOGY, P363; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; RISCH N, 1983, BIOMETRICS, V39, P929, DOI 10.2307/2531328; ROBERTS DF, 1978, ANN HUM GENET, V42, P15, DOI 10.1111/j.1469-1809.1978.tb00928.x; SADOVNICK AD, 1993, CAN J NEUROL SCI, V20, P17, DOI 10.1017/S0317167100047351; SADOVNICK AD, 1988, AM J MED GENET, V29, P533, DOI 10.1002/ajmg.1320290310; SADOVNICK AD, 1993, ANN NEUROL, V33, P281, DOI 10.1002/ana.410330309; SADOVNICK AD, 1994, INT MS J, V1, P17; SADOVNICK AD, IN PRESS J NEUROIMMU; SCHAPIRA K, 1963, BRAIN, V86, P315, DOI 10.1093/brain/86.2.315; SCHUCKIT M, 1972, LIFE HIST RES PSYCHO, V2, P120; TIERNEY C, 1994, GENET EPIDEMIOL, V11, P523, DOI 10.1002/gepi.1370110608	30	285	288	0	13	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 22	1996	347	9017					1728	1730		10.1016/S0140-6736(96)90807-7	http://dx.doi.org/10.1016/S0140-6736(96)90807-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT396	8656905				2022-12-28	WOS:A1996UT39600009
J	Yusuf, SW; Booth, SA; Mishra, RM				Yusuf, SW; Booth, SA; Mishra, RM			Falls and urinary incontinence in a 66-year-old woman	LANCET			English	Article									DERBYSHIRE ROYAL INFIRM,DEPT MED ELDERLY,DERBY DE1 2QY,ENGLAND				Yusuf, Syed/AAE-9074-2022	Yusuf, Salim/0000-0003-4776-5601				KELLY R, 1951, BRAIN, V74, P23, DOI 10.1093/brain/74.1.23; LOBOSKY JM, 1984, J NEUROL NEUROSUR PS, V47, P1075, DOI 10.1136/jnnp.47.10.1075; SONIAT TLL, 1951, AM J PSYCHIAT, V108, P19, DOI 10.1176/ajp.108.1.19; WAGGONER RW, 1954, AM J PSYCHIAT, V110, P904, DOI 10.1176/ajp.110.12.904; WALTON J, 1993, BRAINS DIS NERVOUS S, P193	5	1	1	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 22	1996	347	9017					1738	1738		10.1016/S0140-6736(96)90810-7	http://dx.doi.org/10.1016/S0140-6736(96)90810-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT396	8656908				2022-12-28	WOS:A1996UT39600012
J	Kibota, TT; Lynch, M				Kibota, TT; Lynch, M			Estimate of the genomic mutation rate deleterious to overall fitness in E-coli	NATURE			English	Article							POPULATIONS; EVOLUTION	MUTATIONS are a double-edged sword: they are the ultimate source of genetic variation upon which evolution depends, yet most mutations affecting fitness (viability and reproductive success) appear to be harmful(1). Deleterious mutations of small effect can escape natural selection, and should accumulate in small populations(2-4). Reduced fitness from deleterious-mutation accumulation may be important in the evolution of sex(5-7), mate choice(8,9), and diploid life-cycles(10), and in the extinction of small populations(11,12). Few empirical data exist, however. Minimum estimates of the genomic deleterious-mutation rate for viability in Drosophila melanogaster are surprisingly high(1,13,14), leading to the conjecture that the rate for total fitness could exceed 1.0 mutation per individual per generation(5,6). Here we use Escherichia coli to provide an estimate of the genomic deleterious-mutation rate for total fitness in a microbe. We estimate that the per-microbe rate of deleterious mutations is in excess of 0.0002.	UNIV OREGON,DEPT BIOL,EUGENE,OR 97403	University of Oregon	Kibota, TT (corresponding author), CLARK COLL,DEPT BIOL,1800 E MCLOUGHLIN BLVD,VANCOUVER,WA 98663, USA.							BATEMAN AJ, 1959, INT J RADIAT BIOL, P170; Carlton BC, 1981, MANUAL METHODS GENER, P222; Cavalier-Smith T., 1985, P69; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; Charlesworth B, 1987, SEXUAL SELECTION TES, P21; CHARLESWORTH D, 1993, GENET RES, V61, P39, DOI 10.1017/S0016672300031086; Crow J.F., 1983, Genetics and Biology of Drosophila, V3c, P1; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; HALGH J, 1978, THEOR POPUL BIOL, V14, P251; HARTL DL, 1994, GENETICS, V138, P227; Herdman M., 1985, EVOLUTION GENOME SIZ, P37; JENKINS CD, 1995, EVOLUTION, V49, P512, DOI [10.1111/j.1558-5646.1995.tb02283.x, 10.2307/2410275]; KEIGHTLEY PD, 1994, GENETICS, V138, P1315; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; LANDE R, 1994, EVOLUTION, V48, P1460, DOI [10.2307/2410240, 10.1111/j.1558-5646.1994.tb02188.x]; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; LENSKI RE, 1991, AM NAT, V138, P315; LINDSLEY DL, 1980, GENETICS BIOL DROSOP, P226; LYNCH M, 1993, J HERED, V84, P339, DOI 10.1093/oxfordjournals.jhered.a111354; LYNCH M, 1990, EVOLUTION, V44, P1725, DOI 10.1111/j.1558-5646.1990.tb05244.x; Lynch Michael, 1994, P86; [No title captured]; [No title captured]	24	252	255	1	33	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 20	1996	381	6584					694	696		10.1038/381694a0	http://dx.doi.org/10.1038/381694a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR979	8649513				2022-12-28	WOS:A1996UR97900051
J	Joynt, RJ				Joynt, RJ			Neurology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Joynt, RJ (corresponding author), UNIV ROCHESTER, 601 ELMWOOD AVE, ROCHESTER, NY 14627 USA.							BIRD TD, 1995, ANN NEUROL, V38, P2, DOI 10.1002/ana.410380103; CHIMOWITZ MI, 1995, NEUROLOGY, V45, P1488, DOI 10.1212/WNL.45.8.1488; CLAES S, 1995, ARCH NEUROL-CHICAGO, V52, P749, DOI 10.1001/archneur.1995.00540320021009; DELZOPPO GJ, 1995, NEW ENGL J MED, V333, P1632, DOI 10.1056/NEJM199512143332410; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; GROTTA J, 1995, STROKE, V26, P1285, DOI 10.1161/01.STR.26.7.1285; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303; ROSES AD, 1995, ANN NEUROL, V38, P6, DOI 10.1002/ana.410380105; ROTHWELL PM, 1995, LANCET, V345, P209; SESHADRI S, 1995, ARCH NEUROL-CHICAGO, V52, P1074, DOI 10.1001/archneur.1995.00540350068018; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; 1995, JAMA-J AM MED ASSOC, V274, P1627	19	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1826	1827		10.1001/jama.275.23.1826	http://dx.doi.org/10.1001/jama.275.23.1826			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642732				2022-12-28	WOS:A1996UQ15200031
J	Wegman, DH; Fine, LJ				Wegman, DH; Fine, LJ			Occupational and environmental medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASTHMA		NIOSH, CINCINNATI, OH 45226 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Wegman, DH (corresponding author), UNIV MASSACHUSETTS, LOWELL, MA 01854 USA.							ANDERSSON GBJ, 1995, SPINE, V20, P1278, DOI 10.1097/00007632-199506000-00014; AXON EJ, 1995, OCCUP MED-OXFORD, V45, P109, DOI 10.1093/occmed/45.2.109; CANNON J, 1995, BRIT MED J, V311, P602, DOI 10.1136/bmj.311.7005.602; CHANYEUNG M, 1994, EUR RESPIR J, V7, P346, DOI 10.1183/09031936.94.07020346; CONTRERAS GR, 1994, OCCUP ENVIRON MED, V51, P710, DOI 10.1136/oem.51.10.710; FRANK JW, 1995, SCAND J WORK ENV HEA, V21, P3, DOI 10.5271/sjweh.2; GANNON PFG, 1993, BRIT J IND MED, V50, P491; GUO HR, 1995, AM J IND MED, V28, P591, DOI 10.1002/ajim.4700280504; LANES TC, 1995, SPINE, V20, P801, DOI 10.1097/00007632-199504000-00012; LIIRA JP, 1996, AM J PUBLIC HEALTH, V86, P387; MARRAS WS, 1995, ERGONOMICS, V38, P377, DOI 10.1080/00140139508925111; *NAT I OCC SAF HLT, 1994, 94127 NIOSH US DEP H; Needleman HL, 1996, JAMA-J AM MED ASSOC, V275, P363, DOI 10.1001/jama.275.5.363; PAGGIARO PL, 1994, EUR RESPIR J, V7, P761, DOI 10.1183/09031936.94.07040761; PIN T, 1994, AM J IND MED, V25, P709; PIRKLE JL, 1994, JAMA-J AM MED ASSOC, V272, P284, DOI 10.1001/jama.272.4.284; RAMAZZINI B, 1964, MORBIS ARTIFICUM; ROSS DJ, 1995, OCCUP MED-OXFORD, V45, P175, DOI 10.1093/occmed/45.4.175; SAAL JS, 1995, SPINE, V20, P1821, DOI 10.1097/00007632-199508150-00013; SEATON A, 1994, THORAX, V49, P171, DOI 10.1136/thx.49.2.171; TARLO SM, 1995, CHEST, V107, P634, DOI 10.1378/chest.107.3.634; WEISS KB, 1993, ANNU REV PUBL HEALTH, V14, P491, DOI 10.1146/annurev.pu.14.050193.002423; WOLLE JM, 1995, J ASTHMA, V32, P309, DOI 10.3109/02770909509044839	23	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1831	1832		10.1001/jama.275.23.1831	http://dx.doi.org/10.1001/jama.275.23.1831			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642735				2022-12-28	WOS:A1996UQ15200034
J	Offit, K; Gilewski, T; McGuire, P; Schluger, A; Hampel, H; Brown, K; Swensen, J; Neuhausen, S; Skolnick, M; Norton, L; Goldgar, D				Offit, K; Gilewski, T; McGuire, P; Schluger, A; Hampel, H; Brown, K; Swensen, J; Neuhausen, S; Skolnick, M; Norton, L; Goldgar, D			Germline BRCA1 185delAG mutations in Jewish women with breast cancer	LANCET			English	Article							POLYMERASE CHAIN-REACTION; ENZYMATIC AMPLIFICATION	Background We aimed to find out the proportion of breast cancers in Ashkenazi Jewish women attributable to the frameshift mutation at position 185 involving the deletion of adenine and guanine (185delAG) in the breast cancer gene BRCA1. Methods We studied 107 Ashkenazi Jewish women with breast cancer seen at medical oncology acid genetic counselling clinics in New York over a three and a half year period beginning in 1992. 80 of the women were diagnosed before age 42 years; the other 27 were diagnosed between 42 and 50 years and had a positive family history, Genomic DNA testing by PCR amplification was done to identify any 185delAG mutations of the BRCA1 gene. Findings Of the 80 women diagnosed before the age of 42 years, 16 (20%, 95% CI 11 . 2-28 . 8) were heterozygous for the mutation, All 16 women had at least one first-degree or second-degree relative with breast or ovarian cancer, Of 27 probands diagnosed with breast cancer between the ages of 42 and 50 years who had at least one first-degree relative affected with breast or ovarian cancer, 8 (30%, 95% CI 12-47) had 185delAG mutations, Interpretation These data suggest that screening for the 185delAG mutation may be useful in genetic counselling of these women where options for detection and prevention of possible cancers can be discussed.	MEM SLOAN KETTERING CANC CTR,DEPT MED,BREAST ONCOL SERV,NEW YORK,NY 10021; UNIV UTAH,SCH MED,DEPT MED INFORMAT,GENET EPIDEMIOL GRP,SALT LAKE CITY,UT; MYRIAD GENET INC,SALT LAKE CITY,UT; INT AGCY RES CANC,UNIT GENET EPIDEMIOL,F-69372 LYON,FRANCE	Memorial Sloan Kettering Cancer Center; Utah System of Higher Education; University of Utah; Myriad Genetics, Inc; World Health Organization; International Agency for Research on Cancer (IARC)	Offit, K (corresponding author), MEM SLOAN KETTERING CANC CTR,DEPT HUMAN GENET,CLIN GENET SERV,NEW YORK,NY 10021, USA.		Hampel, Heather/AAV-4041-2020	Hampel, Heather/0000-0001-7558-9794	NCI NIH HHS [P20 CA 58232, R01 CA 65673, R01 CA 55914] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA065673, P20CA058232, R01CA055914] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; OFFIT K, 1994, J CLIN ONCOL, V12, P1724, DOI 10.1200/JCO.1994.12.8.1724; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; TONIN P, 1995, AM J HUM GENET, V57, P189; WEBER JL, 1989, AM J HUM GENET, V44, P388	10	117	121	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 15	1996	347	9016					1643	1645		10.1016/S0140-6736(96)91484-1	http://dx.doi.org/10.1016/S0140-6736(96)91484-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ701	8642955				2022-12-28	WOS:A1996UQ70100007
J	Monroe, C; Meekhof, DM; King, BE; Wineland, DJ				Monroe, C; Meekhof, DM; King, BE; Wineland, DJ			A ''Schrodinger cat'' superposition state of an atom	SCIENCE			English	Article							JAYNES-CUMMINGS MODEL; QUANTUM COHERENCE; INTERFEROMETER; DISPERSION; GENERATION; COLLAPSE; REVIVAL	A ''Schrodinger cat''-like state of matter was generated at the single atom level. A trapped Be-9(+) ion was laser-cooled to the zero-point energy and then prepared ina superposition of spatially separated coherent harmonic oscillator states. This state was created by application of a sequence of laser pulses, which entangles internal (electronic) and external (motional) states of the ion. The Schrodinger cat superposition was verified by detection of the quantum mechanical interference between the localized wave packets. This mesoscopic system may provide insight into the fuzzy boundary between the classical and quantum worlds by allowing controlled studies of quantum measurement and quantum decoherence.			Monroe, C (corresponding author), NATL INST STAND & TECHNOL,DIV TIME & FREQUENCY,MS 847,BOULDER,CO 80303, USA.		Monroe, Christopher R/G-8105-2011					BENNETT CH, 1995, PHYS TODAY, V48, P24, DOI 10.1063/1.881452; Bohr N, 1935, PHYS REV, V48, P696, DOI 10.1103/PhysRev.48.696; Bohr N, 1928, NATURE, V121, P580, DOI 10.1038/121580a0; BRUNE M, 1992, PHYS REV A, V45, P5193, DOI 10.1103/PhysRevA.45.5193; BUZEK V, 1992, PHYS REV A, V45, P8190, DOI 10.1103/PhysRevA.45.8190; CHUANG IL, 1995, SCIENCE, V270, P1633, DOI 10.1126/science.270.5242.1633; CIRAC JI, UNPUB; COLLETT MJ, 1988, PHYS REV A, V38, P2233, DOI 10.1103/PhysRevA.38.2233; DAVIDOVICH L, 1993, PHYS REV LETT, V71, P2360, DOI 10.1103/PhysRevLett.71.2360; deMatos RL, 1996, PHYS REV LETT, V76, P608, DOI 10.1103/PhysRevLett.76.608; DIRAC PAM, 1984, PRINCIPLES QUANTUM M, P12; DIVINCENZO DP, 1995, SCIENCE, V270, P255, DOI 10.1126/science.270.5234.255; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; GEABANACLOCHE J, 1990, PHYS REV LETT, V65, P3385, DOI 10.1103/PhysRevLett.65.3385; GLAUBER RJ, 1963, PHYS REV, V131, P2766, DOI 10.1103/PhysRev.131.2766; GLAUBER RJ, 1963, PHYS REV, V130, P2529, DOI 10.1103/PhysRev.130.2529; GOETSCH P, 1995, PHYS REV A, V51, P136, DOI 10.1103/PhysRevA.51.136; Heisenberg W., 1927, Z PHYS J PHYS, V43, P172; JANSZKY J, 1994, PHYS REV A, V50, P1777, DOI 10.1103/PhysRevA.50.1777; JEFFERTS SR, 1995, PHYS REV A, V51, P3112, DOI 10.1103/PhysRevA.51.3112; JONES RR, 1993, PHYS REV LETT, V71, P2575, DOI 10.1103/PhysRevLett.71.2575; KASEVICH M, 1991, PHYS REV LETT, V67, P181, DOI 10.1103/PhysRevLett.67.181; LAWALL J, 1995, PHYS REV LETT, V75, P4194, DOI 10.1103/PhysRevLett.75.4194; LEGGETT AJ, 1985, PHYS REV LETT, V54, P857, DOI 10.1103/PhysRevLett.54.857; MAIERLEIBNITZ H, 1962, Z PHYS, V167, P368; MARTON L, 1954, PHYS REV, V90, P490; Meekhof DM, 1996, PHYS REV LETT, V76, P1796, DOI 10.1103/PhysRevLett.76.1796; MONROE C, 1995, PHYS REV LETT, V75, P4011, DOI 10.1103/PhysRevLett.75.4011; NOEL MW, 1995, PHYS REV LETT, V75, P1252, DOI 10.1103/PhysRevLett.75.1252; NOORDAM LD, 1992, PHYS REV A, V45, P4734, DOI 10.1103/PhysRevA.45.4734; PEINA J, 1984, QUANTUM STAT LINEAR; PHOENIX SJD, 1988, ANN PHYS-NEW YORK, V186, P381, DOI 10.1016/0003-4916(88)90006-1; POYATOS JF, UNPUB; SAVAGE CM, 1985, PHYS REV A, V32, P2316, DOI 10.1103/PhysRevA.32.2316; SAVAGE CM, 1990, OPT LETT, V15, P628, DOI 10.1364/OL.15.000628; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; SLOSSER JJ, 1990, OPT LETT, V15, P233, DOI 10.1364/OL.15.000233; SMITHEY DT, 1993, PHYS REV LETT, V70, P1244, DOI 10.1103/PhysRevLett.70.1244; VOGEL W, 1995, PHYS REV A, V52, P4214, DOI 10.1103/PhysRevA.52.4214; WALLENTOWITZ S, 1995, PHYS REV LETT, V75, P2932, DOI 10.1103/PhysRevLett.75.2932; WALLS DF, 1985, PHYS REV A, V31, P2403, DOI 10.1103/PhysRevA.31.2403; WALMSLEY IA, 1995, PHYS REV A, V52, P681, DOI 10.1103/PhysRevA.52.681; Wheeler J. A., 1983, QUANTUM THEORY MEASU; WINELAND DJ, 1992, LASER MANIPULATION A, P562; YURKE B, 1987, PHYS REV A, V36, P1955, DOI 10.1103/PhysRevA.36.1955; YURKE B, 1986, PHYS REV LETT, V57, P13, DOI 10.1103/PhysRevLett.57.13; YURKE B, 1987, PHYS REV A, V35, P4846, DOI 10.1103/PhysRevA.35.4846; [No title captured]	51	1101	1121	10	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 24	1996	272	5265					1131	1136		10.1126/science.272.5265.1131	http://dx.doi.org/10.1126/science.272.5265.1131			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8662445				2022-12-28	WOS:A1996UM88900039
J	Weinberg, RA				Weinberg, RA			E2F and cell proliferation: A world turned upside down	CELL			English	Review											Weinberg, RA (corresponding author), MIT,WHITEHEAD INST BIOMED RES,DEPT BIOL,CAMBRIDGE,MA 02142, USA.							Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; JOHNSON DG, 1994, P NATL ACAD SCI USA, V91, P12823, DOI 10.1073/pnas.91.26.12823; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; LATHANGUE NB, 1994, TRENDS BIOCHEM SCI, V19, P108, DOI 10.1016/0968-0004(94)90202-X; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; SINGH P, 1994, EMBO J, V13, P3329, DOI 10.1002/j.1460-2075.1994.tb06635.x; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; XU GF, 1995, P NATL ACAD SCI USA, V92, P1357, DOI 10.1073/pnas.92.5.1357	9	221	225	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 17	1996	85	4					457	459		10.1016/S0092-8674(00)81244-1	http://dx.doi.org/10.1016/S0092-8674(00)81244-1			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UM415	8653779	Bronze			2022-12-28	WOS:A1996UM41500001
J	FungLeung, WP; Surh, CD; Liljedahl, M; Pang, J; Leturcq, D; Peterson, PA; Webb, SR; Karlsson, L				FungLeung, WP; Surh, CD; Liljedahl, M; Pang, J; Leturcq, D; Peterson, PA; Webb, SR; Karlsson, L			Antigen presentation and T cell development in H2-M-deficient mice	SCIENCE			English	Article							INVARIANT CHAIN; I-A; PEPTIDE; MOLECULES; LACKING; REGION	HLA-DM (DM) facilitates peptide loading of major histocompatibility complex class II molecules in human cell lines. Mice lacking functional H2-M, the mouse equivalent of DM, have normal amounts of class II molecules at the cell surface, but most of these are associated with invariant chain-derived CLIP peptides. These mice contain large numbers of CD4(+) T cells, which is indicative of positive selection in the thymus. Their CD4(+) cells were unresponsive to self H2-M-deficient antigen-presenting cells (APCs) but were hyperreactive to wild-type APCs. H2-M-deficient APCs failed to elicit proliferative responses from wild-type T cells.	SCRIPPS RES INST, RW JOHNSON PHARMACEUT RES INST, LA JOLLA, CA 92037 USA; RW JOHNSON PHARMACEUT RES INST, SAN DIEGO, CA 92121 USA; Scripps Res Inst, DEPT IMMUNOL, LA JOLLA, CA 92037 USA	Johnson & Johnson; Johnson & Johnson USA; Scripps Research Institute; Johnson & Johnson; Johnson & Johnson USA; Scripps Research Institute			Pang, Jesse CS/H-3549-2013	Pang, Jesse CS/0000-0002-8716-4045; Fung-Leung, Wai-Ping/0000-0001-7013-8855				BHATTACHARYA A, 1981, J IMMUNOL, V127, P2488; BIJLMAKERS MJJE, 1994, EMBO J, V13, P2699, DOI 10.1002/j.1460-2075.1994.tb06560.x; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; BROOKS AG, 1994, J IMMUNOL, V153, P5382; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; DORNMAIR K, 1989, COLD SPRING HARB SYM, V54, P409; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; FUNGLEUNG WP, 1994, J EXP MED, V180, P959, DOI 10.1084/jem.180.3.959; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; HASENKRUG KJ, 1987, IMMUNOGENETICS, V25, P136, DOI 10.1007/BF00364282; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; KARLSSON L, UNPUB; MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0; MORKOWSKI S, 1995, J EXP MED, V182, P1403, DOI 10.1084/jem.182.5.1403; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; NELSON CA, 1994, NATURE, V371, P250, DOI 10.1038/371250a0; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STEBBINS CC, 1995, J EXP MED, V181, P223, DOI 10.1084/jem.181.1.223; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; SURH CD, 1992, J EXP MED, V176, P495, DOI 10.1084/jem.176.2.495; SURH CD, 1993, J EXP MED, V177, P379, DOI 10.1084/jem.177.2.379; SURH CD, UNPUB; SYMINGTON FW, 1981, IMMUNOGENETICS, V14, P53, DOI 10.1007/BF00344299; VIVILLE S, 1993, CELL, V72, P635, DOI 10.1016/0092-8674(93)90081-Z; WEBB SR, 1990, SCIENCE, V248, P1643	29	241	243	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 1	1996	271	5253					1278	1281		10.1126/science.271.5253.1278	http://dx.doi.org/10.1126/science.271.5253.1278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TX695	8638109				2022-12-28	WOS:A1996TX69500036
J	Umstadter, D; Chen, SY; Maksimchuk, A; Mourou, G; Wagner, R				Umstadter, D; Chen, SY; Maksimchuk, A; Mourou, G; Wagner, R			Nonlinear optics in relativistic plasmas and laser wake field acceleration of electrons	SCIENCE			English	Article							HIGH-INTENSITY LASERS; SELF-MODULATION; PULSES; SCATTERING; RAMAN	When a terawatt-peak-power laser beam is focused into a gas jet, an electron plasma wave, driven by forward Raman scattering, is observed to accelerate a naturally collimated beam of electrons to relativistic energies (up to 10(9) total electrons, with an energy distribution maximizing at 2 megaelectron volts, a transverse emittance as low as 1 millimeter-milliradian, and a field gradient of up to 2 gigaelectron volts per centimeter). Electron acceleration and the appearance of high-frequency modulations in the transmitted light spectrum were both found to have sharp thresholds in laser power and plasma density. A hole in the center of the electron beam may indicate that plasma electrons were expelled radially.			Umstadter, D (corresponding author), UNIV MICHIGAN,CTR ULTRAFAST OPT SCI,ANN ARBOR,MI 48109, USA.		Maksimchuk, Anatoly/AAA-1803-2020; Chen, Szu-yuan/F-7555-2012; Umstadter, Donald P/A-1581-2016	Chen, Szu-yuan/0000-0002-4474-674X; Umstadter, Donald P/0000-0002-2182-4346				AKHIEZER AI, 1956, ZH EKSP TEOR FIZ, V3, P696; ANDREEV NE, 1992, JETP LETT+, V55, P571; ANTONSEN TM, 1992, PHYS REV LETT, V69, P2204, DOI 10.1103/PhysRevLett.69.2204; BARNES DC, 1987, IEEE T PLASMA SCI, V15, P154, DOI 10.1109/TPS.1987.4316678; BORISOV AB, 1992, PHYS REV A, V45, P5830, DOI 10.1103/PhysRevA.45.5830; BULANOV SV, 1995, PHYS REV LETT, V74, P710, DOI 10.1103/PhysRevLett.74.710; COVERDALE CA, 1995, PHYS REV LETT, V74, P4659, DOI 10.1103/PhysRevLett.74.4659; DECKER CD, 1994, PHYS REV E, V50, pR3338, DOI 10.1103/PhysRevE.50.R3338; ESAREY E, 1994, PHYS REV LETT, V72, P2887, DOI 10.1103/PhysRevLett.72.2887; KRALL J, 1993, PHYS REV E, V48, P2157, DOI 10.1103/PhysRevE.48.2157; Mackinnon AJ, 1996, PHYS REV LETT, V76, P1473, DOI 10.1103/PhysRevLett.76.1473; MAINE P, 1988, IEEE J QUANTUM ELECT, V24, P398, DOI 10.1109/3.137; MAX CE, 1974, PHYS REV LETT, V33, P209, DOI 10.1103/PhysRevLett.33.209; MODENA A, 1995, NATURE, V377, P606, DOI 10.1038/377606a0; Mora P, 1996, PHYS REV E, V53, pR2068, DOI 10.1103/PhysRevE.53.R2068; MORI WB, 1994, PHYS REV LETT, V72, P1482, DOI 10.1103/PhysRevLett.72.1482; MOUROU G, 1992, PHYS FLUIDS B-PLASMA, V4, P2315, DOI 10.1063/1.860202; NAKAJIMA K, 1995, PHYS REV LETT, V74, P4428, DOI 10.1103/PhysRevLett.74.4428; Pukhov A, 1996, PHYS REV LETT, V76, P3975, DOI 10.1103/PhysRevLett.76.3975; SLUSHER RE, 1980, PHYS FLUIDS, V23, P472, DOI 10.1063/1.863016; SPRANGLE P, 1992, PHYS REV LETT, V69, P2200, DOI 10.1103/PhysRevLett.69.2200; SUN GZ, 1987, PHYS FLUIDS, V30, P526, DOI 10.1063/1.866349; TAJIMA T, 1979, PHYS REV LETT, V43, P267, DOI 10.1103/PhysRevLett.43.267; Tzeng KC, 1996, PHYS REV LETT, V76, P3332, DOI 10.1103/PhysRevLett.76.3332; WILKS SC, 1995, PHYS PLASMAS, V2, P274, DOI 10.1063/1.871097	25	401	405	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 26	1996	273	5274					472	475		10.1126/science.273.5274.472	http://dx.doi.org/10.1126/science.273.5274.472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY983	8662531				2022-12-28	WOS:A1996UY98300033
J	Hinnebusch, BJ; Perry, RD; Schwan, TG				Hinnebusch, BJ; Perry, RD; Schwan, TG			Role of the Yersinia pestis hemin storage (hms) locus in the transmission of plague by fleas	SCIENCE			English	Article							AGGREGATIVE FIMBRIAE; ESCHERICHIA-COLI; SIPHONAPTERA; FIBRONECTIN; PHENOTYPE; BACILLUS; PROTEINS; DELETION; CUTICLE; BINDING	Yersinia pestis, the cause of bubonic plague, is transmitted by the bites of infected fleas. Biological transmission of plague depends on blockage of the foregut of the flea by a mass of plague bacilli. Blockage was found to be dependent on the hemin storage (hms) locus. Yersinia pestis hms mutants established long-term infection of the flea's midgut but failed to colonize the proventriculus, the site in the foregut where blockage normally develops. Thus, the hms locus markedly alters the course of Y. pestis infection in its insect vector, leading ro a change in blood-feeding behavior and to efficient transmission of plague.	UNIV KENTUCKY,DEPT MICROBIOL & IMMUNOL,LEXINGTON,KY 40536	University of Kentucky	Hinnebusch, BJ (corresponding author), NIAID,ROCKY MT LABS,MICROBIAL STRUCT & FUNCT LAB,NIH,HAMILTON,MT 59840, USA.							Bacot A. W., 1914, Journal of Hygiene Cambridge Plague Suppl, V3; BACOT AW, 1915, J HYG PLAGUE CAMB S3, V4, P774; BIBIKOVA VA, 1977, ANNU REV ENTOMOL, V22, P23, DOI 10.1146/annurev.en.22.010177.000323; BREY PT, 1993, P NATL ACAD SCI USA, V90, P6275, DOI 10.1073/pnas.90.13.6275; CAVANAUGH DC, 1971, AM J TROP MED HYG, V20, P264, DOI 10.4269/ajtmh.1971.20.264; COLLINSON SK, 1992, J BACTERIOL, V174, P4490, DOI 10.1128/JB.174.13.4490-4495.1992; COLLINSON SK, 1993, J BACTERIOL, V175, P12, DOI 10.1128/JB.175.1.12-18.1993; ESKEY CR, 1940, PUBLIC HLTH B, V254; FETHERSTON JD, 1995, J BACTERIOL, V177, P1824, DOI 10.1128/jb.177.7.1824-1833.1995; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; FETHERSTON JD, 1994, MOL MICROBIOL, V13, P697, DOI 10.1111/j.1365-2958.1994.tb00463.x; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; JACKSON S, 1956, BRIT J EXP PATHOL, V37, P570; KARTMAN LEO, 1964, TRANS ROY SOC TROP MED HGY, V58, P363, DOI 10.1016/0035-9203(64)90206-8; KUTYREV VV, 1992, MICROB PATHOGENESIS, V12, P177, DOI 10.1016/0882-4010(92)90051-O; LILLARD JW, UNPUB; LUCIER TS, 1992, J BACTERIOL, V174, P2078, DOI 10.1128/JB.174.7.2078-2086.1992; MARMARAS VJ, 1993, ARCH INSECT BIOCHEM, V23, P169, DOI 10.1002/arch.940230404; MCDONOUGH KA, 1993, J MED ENTOMOL, V30, P772, DOI 10.1093/jmedent/30.4.772; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; PENDRAK ML, 1993, MOL MICROBIOL, V8, P857, DOI 10.1111/j.1365-2958.1993.tb01632.x; PERRY RD, 1993, INFECT IMMUN, V61, P32, DOI 10.1128/IAI.61.1.32-39.1993; Pollitzer R., 1954, WHO MONOGRAPH SERIES, V22; QUAN SF, 1954, SCIENCE, V120, P1101, DOI 10.1126/science.120.3131.1101; SURGALLA MJ, 1969, APPL MICROBIOL, V18, P834, DOI 10.1128/AEM.18.5.834-837.1969; TERTTI R, 1992, INFECT IMMUN, V60, P3021, DOI 10.1128/IAI.60.7.3021-3024.1992; WADE SE, 1988, J MED ENTOMOL, V25, P186, DOI 10.1093/jmedent/25.3.186	28	280	291	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 19	1996	273	5273					367	370		10.1126/science.273.5273.367	http://dx.doi.org/10.1126/science.273.5273.367			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY202	8662526				2022-12-28	WOS:A1996UY20200043
J	Wu, JY; Wen, L; Zhang, WJ; Rao, Y				Wu, JY; Wen, L; Zhang, WJ; Rao, Y			The secreted product of Xenopus gene lunatic Fringe, a vertebrate signaling molecule	SCIENCE			English	Article							BONE MORPHOGENETIC PROTEIN-4; MESODERM-INDUCING ACTIVITY; TGF-BETA; VENTRALIZING FACTOR; TRUNCATED ACTIVIN; AXIAL MESODERM; EARLY EMBRYOS; GROWTH-FACTOR; REQUIRES FGF; CELL-LINE	Signaling molecules are essential for vertebrate embryonic development. Here, two Xenopus homologs of the Drosophila gene fringe, lunatic Fringe (IFng) and radical Fringe (rFng), were identified and the protein product of IFng further characterized. The messenger RNA of IFng is supplied as a maternal message, Its product is a precursor protein consisting of pre-, pro-, and mature regions. The mature lunatic Fringe protein is secreted extracellularly, and it induced mesodermal tissue formation in animal cap assays. These results indicate that secreted lunatic Fringe can induce mesoderm and reveal that the Fringe proteins are a family of vertebrate signaling molecules.	ST LOUIS UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT PEDIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110	Saint Louis University; Washington University (WUSTL); Washington University (WUSTL)					NATIONAL CANCER INSTITUTE [R01CA114197] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070967] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA114197-01A2, R01 CA114197] Funding Source: Medline; NEI NIH HHS [R01 EY014576, R01 EY014576-03] Funding Source: Medline; NIGMS NIH HHS [R01 GM070967-02, R01 GM070967] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; ASASHIMA M, 1990, ROUX ARCH DEV BIOL, V198, P330, DOI 10.1007/BF00383771; CAMPBELL G, 1993, CELL, V74, P1113, DOI 10.1016/0092-8674(93)90732-6; CORNELL RA, 1994, DEVELOPMENT, V120, P453; DALE L, 1993, EMBO J, V12, P4471, DOI 10.1002/j.1460-2075.1993.tb06136.x; DALE L, 1992, DEVELOPMENT, V115, P573; DAWID IB, 1994, BIOESSAYS, V16, P385; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; JONES CM, 1995, CURR BIOL, V5, P574, DOI 10.1016/S0960-9822(95)00112-6; JONES CM, 1992, DEVELOPMENT, V115, P639; JONES CM, 1995, DEVELOPMENT, V121, P3651; KESSLER DS, 1994, SCIENCE, V265, P598; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; KLEIN PS, 1994, ENDOCR REV, V15, P326, DOI 10.1210/er.15.3.326; KOSTER M, 1991, MECH DEVELOP, V33, P191, DOI 10.1016/0925-4773(91)90027-4; LABONNE C, 1994, DEVELOPMENT, V120, P463; MATZUK MM, 1995, NATURE, V374, P354, DOI 10.1038/374354a0; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; RAO Y, 1994, GENE DEV, V8, P939, DOI 10.1101/gad.8.8.939; ROSA F, 1988, SCIENCE, V239, P783, DOI 10.1126/science.3422517; SCHULTEMERKER S, 1994, EMBO J, V13, P3533, DOI 10.1002/j.1460-2075.1994.tb06660.x; SLACK JMW, 1989, DEVELOPMENT, V107, P141; SLACK JMW, 1994, CURR BIOL, V4, P116, DOI 10.1016/S0960-9822(94)00027-8; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; SMITH JC, 1987, DEVELOPMENT, V99, P3; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; SOKOL S, 1990, SCIENCE, V249, P561, DOI 10.1126/science.2382134; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; THOMSEN G, 1990, CELL, V63, P485, DOI 10.1016/0092-8674(90)90445-K; THOMSEN GH, 1993, CELL, V74, P433, DOI 10.1016/0092-8674(93)80045-G; VANDENEIJNDENVANRAAIJ AJM, 1990, NATURE, V345, P732, DOI 10.1038/345732a0; VASSALLI A, 1994, GENE DEV, V8, P414, DOI 10.1101/gad.8.4.414; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7	38	57	62	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 19	1996	273	5273					355	358		10.1126/science.273.5273.355	http://dx.doi.org/10.1126/science.273.5273.355			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY202	8662522	Green Accepted			2022-12-28	WOS:A1996UY20200039
J	Osawa, M; Hanada, K; Hamada, H; Nakauchi, H				Osawa, M; Hanada, K; Hamada, H; Nakauchi, H			Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell	SCIENCE			English	Article							ANTIGEN; INVIVO; CD34	Hematopoietic stem cells (HSCs) supply all blood cells throughout life by making use of their self-renewal and multilineage differentiation capabilities. A monoclonal antibody raised to the mouse homolog of CD34 (mCD34) was used to purify mouse HSCs to near homogeneity. Unlike in humans, primitive adult mouse bone marrow HSCs were detected in the mCD34 low to negative fraction. Injection of a single mCD34(lo/-), c-Kit(+), Sca-1(+), lineage markers negative (Lin(-)) cell resulted in long-term reconstitution of the lymphohematopoietic system in 21 percent of recipients. Thus, the purified HSC population should enable analysis of the self-renewal and multilineage differentiation of individual HSCs.	UNIV TSUKUBA, CTR TSUKUBA ADV RES ALLIANCE, TSUKUBA, IBARAKI 305, JAPAN; JAPANESE FDN CANC RES, CTR CANC CHEMOTHERAPY, DEPT MOL BIOTHERAPY, TOKYO 170, JAPAN	University of Tsukuba; Japanese Foundation for Cancer Research	Osawa, M (corresponding author), UNIV TSUKUBA, INST BASIC MED SCI, DEPT IMMUNOL, TSUKUBA SCI CITY, TSUKUBA, IBARAKI 305, JAPAN.		Hanada, Ken-ichi/A-4642-2008; Hanada, Kenichi/L-2481-2013	Hanada, Kenichi/0000-0003-2959-1257; Osawa, Masatake/0000-0002-5318-9826				BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; BROWN J, 1991, INT IMMUNOL, V3, P175, DOI 10.1093/intimm/3.2.175; Cheng J, 1996, BLOOD, V87, P479, DOI 10.1182/blood.V87.2.479.bloodjournal872479; CIVIN CI, 1984, J IMMUNOL, V133, P157; JONES RJ, 1990, NATURE, V347, P188, DOI 10.1038/347188a0; KOHN DB, 1995, NAT MED, V1, P1017, DOI 10.1038/nm1095-1017; KRAUSE DS, 1994, BLOOD, V84, P691; OKADA S, 1993, BLOOD, V81, P1720; OKADA S, 1992, BLOOD, V80, P3044; ONISHI M, 1993, BLOOD, V81, P3217; Osawa M, 1996, J IMMUNOL, V156, P3207; OSAWA M, UNPUB; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SROUR EF, 1993, BLOOD, V82, P3333; SUDA J, 1992, BLOOD, V79, P2288; TJONNFJORD GE, 1994, BLOOD, V84, P3584; WINEMAN JP, 1992, BLOOD, V80, P1717	17	1607	1714	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 12	1996	273	5272					242	245		10.1126/science.273.5272.242	http://dx.doi.org/10.1126/science.273.5272.242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW787	8662508	Green Submitted			2022-12-28	WOS:A1996UW78700042
J	Kulczycki, A; Potts, M; Rosenfield, A				Kulczycki, A; Potts, M; Rosenfield, A			Abortion and fertility regulation	LANCET			English	Article							PUBLIC-HEALTH PERSPECTIVE; UNITED-STATES; RU-486	To achieve their desired fertility, women use a combination of contraception and abortion, and some societies also place constraints on marriage and sexual activity. The degree to which these means are adopted varies considerably, but for the foreseeable future abortion will remain an important element of fertility regulation. Globally, complications of unsafe abortion affect hundreds of thousands of women each year, and account for as many as 100 000 deaths annually (about two in ten maternal deaths), mainly in poor countries, where abortion typically remains illegal. Access to safe abortion is both essential and technically feasible and should be provided in combination with good quality family planning services.	FAMILY HLTH INT, LONDON EC1V 0AH, ENGLAND; UNIV MICHIGAN, SCH PUBL HLTH, ANN ARBOR, MI 48109 USA; COLUMBIA UNIV, SCH PUBL HLTH, NEW YORK, NY 10027 USA	University of Michigan System; University of Michigan; Columbia University								*A GUTTM I, 1994, CLAND AB LAT AM REAL; BAULIEU EE, 1989, SCIENCE, V245, P1351, DOI 10.1126/science.2781282; Brown S.S., 1995, BEST INTENTIONS UNIN; CHHABRA R, 1994, ABORTION INDIA OVERV; COEYTAUX FM, 1988, STUD FAMILY PLANN, V19, P186, DOI 10.2307/1966754; CREININ MD, 1993, CONTRACEPTION, V48, P339, DOI 10.1016/0010-7824(93)90079-M; DAVID HP, 1992, STUD FAMILY PLANN, V23, P1, DOI 10.2307/1966824; FREJKA T, 1985, FAM PLANN PERSPECT, V17, P230, DOI 10.2307/2135097; Greenslade FC, 1993, MANUAL VACUUM ASPIRA; GRIMES DA, 1995, MODERN METHODS INDUC, P95; Henshaw S K, 1994, J Public Health Policy, V15, P165, DOI 10.2307/3342987; HENSHAW SK, 1994, FAM PLANN PERSPECT, V26, P100, DOI 10.2307/2136033; HENSHAW SK, 1990, FAM PLANN PERSPECT, V22, P76, DOI 10.2307/2135512; HONG SB, 1989, INT HDB ABORTION, P302; JITSUKAWA M, 1994, SCIENCE, V265, P1048, DOI 10.1126/science.8066442; Jones E, 1989, PREGNANCY CONTRACEPT; KUBICKA L, 1995, ACTA PSYCHIAT SCAND, V91, P361, DOI 10.1111/j.1600-0447.1995.tb09795.x; KULCZYCKI A, 1995, POPUL DEV REV, V21, P471, DOI 10.2307/2137747; KUNINS H, 1991, ANNU REV PUBL HEALTH, V12, P361; LAWSON HW, 1994, AM J OBSTET GYNECOL, V171, P1365, DOI 10.1016/0002-9378(94)90162-7; MACKAY HT, 1995, FAM PLANN PERSPECT, V27, P112, DOI 10.2307/2136108; *OFF POP CENS SURV, 1995, OPCS SER AB, V20; POPOV AA, 1991, STUD FAMILY PLANN, V22, P368, DOI 10.2307/1966450; POTTS M, 1977, ABORTION; ROGO KO, 1993, E AFR MED J, V70, P386; Royston E, 1989, PREVENTING MATERNAL; RUSSO NF, 1992, J SOC ISSUES, V48, P183, DOI 10.1111/j.1540-4560.1992.tb00903.x; SERBANESCU F, 1995, STUD FAMILY PLANN, V26, P76, DOI 10.2307/2137933; SILVESTRE L, 1990, NEW ENGL J MED, V322, P645, DOI 10.1056/NEJM199003083221001; STEPHENSON P, 1992, AM J PUBLIC HEALTH, V82, P1328, DOI 10.2105/AJPH.82.10.1328; Tietze C, 1986, INDUCED ABORTION WOR; TRUSSELL J, 1990, STUD FAMILY PLANN, V21, P51, DOI 10.2307/1966591; *UN, 1992, LONG RANG WORLD POP; Westley S B, 1995, Asia Pac Pop Policy, P1; WHITEHEAD J, 1847, CAUSES TREAMTENT ABO; *WHO, 1995, COMPL AB TECHN MAN G; World Health Organization, 1994, AB TAB AV DAT FREQ M; Wrigley E.A., 1969, POPULATION HIST; 1990, FAM PLANN PERSPECT, V22, P36; 1992, JAMA-J AM MED ASSOC, V268, P3231; 1996, BRIT MED J, V312, P398	41	35	35	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 15	1996	347	9016					1663	1668		10.1016/S0140-6736(96)91491-9	http://dx.doi.org/10.1016/S0140-6736(96)91491-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UQ701	8642962	hybrid			2022-12-28	WOS:A1996UQ70100014
J	Calkins, DJ; Sterling, P				Calkins, DJ; Sterling, P			Absence of spectrally specific lateral inputs to midget ganglion cells in primate retina	NATURE			English	Article							GENICULATE-NUCLEUS; CONE CONNECTIONS; HORIZONTAL CELLS; MONKEY RETINA; MACAQUE; MECHANISMS; OPPONENT	VISUAL information is conveyed to the brain by retinal ganglion cells. Midget ganglion cells serve fine spatial vision(1,2) by summing excitation from a receptive field 'centre', receiving input from a single cone in the central retina, with lateral inhibition from a receptive field 'surround', receiving input from many surrounding cones, Midget ganglion cells are also thought to serve colour opponent vision(1-6) because the centre excitation is from a cone of one spectral type, while the surround inhibition is from cones of the other type(4,6). The two major cone types, middle(M)- and long(L)wavelength sensitive, are equally numerous and randomly distributed in the primate central retina(7-9), so a spectrally homogeneous surround requires that the cells mediating lateral interactions (horizontal or amacrine cells) receive selective input from only one cone type. Horizontal cells cannot do this because they receive input indiscriminately from M and L cones(10-12). Here we report that the amacrine cells connected to midget ganglion cells are similarly indiscriminate, The absence of spectral specificity in the inhibitory wiring raises doubt about the involvement of midget ganglion cells in colour vision and suggests that colour opponency may instead be conveyed by a different type of ganglion cell.	UNIV PENN, DEPT NEUROSCI, PHILADELPHIA, PA 19104 USA	University of Pennsylvania				Calkins, David/0000-0002-8475-9959				[Anonymous], 1991, COMPUTATIONAL MODELS, DOI [10.7551/mitpress/2002.003.0010, DOI 10.7551/MITPRESS/2002.003.0010]; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; BOYCOTT BB, 1987, PROC R SOC SER B-BIO, V229, P345, DOI 10.1098/rspb.1987.0001; CALKINS DJ, 1994, NATURE, V371, P70, DOI 10.1038/371070a0; CRONER LJ, 1995, VISION RES, V35, P7, DOI 10.1016/0042-6989(94)E0066-T; Dacey DM, 1996, SCIENCE, V271, P656, DOI 10.1126/science.271.5249.656; DEMONASTERIO FM, 1978, J NEUROPHYSIOL, V41, P1418, DOI 10.1152/jn.1978.41.6.1418; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; GRUNERT U, 1990, J COMP NEUROL, V297, P509, DOI 10.1002/cne.902970405; Kaplan E., 1990, Progress in Retinal Research, V9, P273, DOI 10.1016/0278-4327(90)90009-7; KLUG K, 1992, SOC NEUR ABSTR, V18; KLUG KY, 1993, INVEST OPHTH VIS SCI, V34, pA1398; KOLB H, 1991, J COMP NEUROL, V303, P617, DOI 10.1002/cne.903030408; Lee BB, 1996, VISION RES, V36, P631, DOI 10.1016/0042-6989(95)00167-0; MERIGAN WH, 1991, J NEUROSCI, V11, P994; MOLLON JD, 1992, NATURE, V360, P677, DOI 10.1038/360677a0; Packer OS, 1996, J NEUROSCI, V16, P2251; REID RC, 1992, NATURE, V356, P716, DOI 10.1038/356716a0; RODIECK RW, 1991, NATO ADV SCI I A-LIF, V203, P83; SCHILLER PH, 1990, NATURE, V343, P68, DOI 10.1038/343068a0; TSUKAMOTO Y, 1992, VISION RES, V32, P1809, DOI 10.1016/0042-6989(92)90042-H; VARDI N, 1994, VISION RES, V34, P1235, DOI 10.1016/0042-6989(94)90198-8; VARDI N, 1994, VISUAL NEUROSCI, V11, P135, DOI 10.1017/S0952523800011172; WASSLE H, 1989, EUR J NEUROSCI, V1, P421, DOI 10.1111/j.1460-9568.1989.tb00350.x; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115; ZRENNER E, 1983, NEUROPHYSIOLOGICAL A	28	81	82	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	1996	381	6583					613	615		10.1038/381613a0	http://dx.doi.org/10.1038/381613a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ657	8637598				2022-12-28	WOS:A1996UQ65700053
J	Ehrhardt, DW; Wais, R; Long, SR				Ehrhardt, DW; Wais, R; Long, SR			Calcium spiking in plant root hairs responding to Rhizobium nodulation signals	CELL			English	Article							LIPO-OLIGOSACCHARIDE SIGNALS; CYTOSOLIC FREE CALCIUM; CYTOPLASMIC CALCIUM; HOST SPECIFICITY; MELILOTI; ALFALFA; CELLS; ACID; OSCILLATIONS; CHANNELS	Rhizobium lipochitooligosaccharide signal molecules stimulate multiple responses in legume host plants, including changes in host gene expression, cell growth, and mitoses leading to root nodule development. The basis for signal transduction in the plant is not known. We examined cytoplasmic free calcium in host root hairs using calcium-sensitive reporter dyes. Image analysis of injected dyes revealed localized periodic spikes in cytoplasmic calcium levels that ensued after a characteristic lag following signal application. Structural features of the signal molecules required to cause nodulation responses in alfalfa are also essential for stimulating calcium spiking. A nonnodulating alfalfa mutant is defective in calcium spiking, consistent with the possibility that this mutant is blocked in an early stage of nodulation signal perception.			Ehrhardt, DW (corresponding author), STANFORD UNIV, HOWARD HUGHES MED INST, DEPT BIOL SCI, STANFORD, CA 94305 USA.							ALLEN NS, 1994, ADV MOL GENETICS PLA, V3, P107; ATKINSON EM, 1994, THESIS STANFORD U ST; BOLLER T, 1995, ANNU REV PLANT PHYS, V46, P189, DOI 10.1146/annurev.arplant.46.1.189; BOWLER C, 1994, CELL, V77, P73, DOI 10.1016/0092-8674(94)90236-4; BUSH DS, 1995, ANNU REV PLANT PHYS, V46, P95, DOI 10.1146/annurev.pp.46.060195.000523; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; CLARKSON DT, 1988, J CELL SCI, V91, P71; DENARIE J, 1993, CELL, V74, P951, DOI 10.1016/0092-8674(93)90717-5; DUDLEY ME, 1987, PLANTA, V171, P289, DOI 10.1007/BF00398674; DUDLEY ME, 1989, PLANT CELL, V1, P65, DOI 10.1105/tpc.1.1.65; EHRHARDT DW, 1995, J BACTERIOL, V177, P6237, DOI 10.1128/jb.177.21.6237-6245.1995; EHRHARDT DW, 1992, SCIENCE, V256, P998, DOI 10.1126/science.10744524; FELLE H, 1988, PLANTA, V174, P495, DOI 10.1007/BF00634478; FELLE HH, 1995, PLANT J, V7, P939, DOI 10.1046/j.1365-313X.1995.07060939.x; FEWTRELL C, 1993, ANNU REV PHYSIOL, V55, P427, DOI 10.1146/annurev.physiol.55.1.427; FISHER RF, 1992, NATURE, V357, P655, DOI 10.1038/357655a0; GILROY S, 1992, P NATL ACAD SCI USA, V89, P3591, DOI 10.1073/pnas.89.8.3591; GILROY S, 1990, NATURE, V346, P769, DOI 10.1038/346769a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HEPLER PK, 1985, ANNU REV PLANT PHYS, V36, P397, DOI 10.1146/annurev.pp.36.060185.002145; Kijne J.W., 1992, BIOL NITROGEN FIXATI, P349; KURKDJIAN AC, 1995, PLANT PHYSIOL, V107, P783, DOI 10.1104/pp.107.3.783; MCAINSH MR, 1995, PLANT CELL, V7, P1207, DOI 10.1105/tpc.7.8.1207; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; MILLER DD, 1992, J CELL SCI, V101, P7; MUNNS DN, 1970, PLANT SOIL, V32, P90, DOI 10.1007/BF01372849; MYLONA P, 1995, PLANT CELL, V7, P869, DOI 10.1105/tpc.7.7.869; NEUHAUS G, 1993, CELL, V73, P937, DOI 10.1016/0092-8674(93)90272-R; PETERSON MA, 1981, CROP SCI, V21, P611, DOI 10.2135/cropsci1981.0011183X002100040033x; READ ND, 1992, J MICROSC-OXFORD, V166, P57, DOI 10.1111/j.1365-2818.1992.tb01507.x; ROCHE P, 1991, CELL, V67, P1131, DOI 10.1016/0092-8674(91)90290-F; ROCHE P, 1991, J BIOL CHEM, V266, P10933; SAUNDERS MJ, 1982, SCIENCE, V217, P943, DOI 10.1126/science.217.4563.943; SAUNDERS MJ, 1983, DEV BIOL, V99, P41, DOI 10.1016/0012-1606(83)90252-X; SCHROEDER JI, 1990, P NATL ACAD SCI USA, V87, P9305, DOI 10.1073/pnas.87.23.9305; SMITH JT, 1993, ELECTROPHORESIS, V14, P396, DOI 10.1002/elps.1150140165; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435	39	447	481	3	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 31	1996	85	5					673	681		10.1016/S0092-8674(00)81234-9	http://dx.doi.org/10.1016/S0092-8674(00)81234-9			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UP344	8646776	Bronze			2022-12-28	WOS:A1996UP34400008
J	Ho, DD				Ho, DD			Viral counts count in HIV infection	SCIENCE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1				Ho, DD (corresponding author), ROCKEFELLER UNIV,AARON DIAMOND AIDS RES CTR,455 1ST AVE,NEW YORK,NY 10016, USA.							CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; CAO YZ, 1995, AIDS RES HUM RETROV, V11, P353, DOI 10.1089/aid.1995.11.353; CLARK SJ, 1994, J VIROL, V69, P4650; DAAR ES, 1991, NEW ENGL J MED, V324, P961, DOI 10.1056/NEJM199104043241405; Freimuth W. W., 1996, P162; Gulick R., 1996, P162; Hammer S. M., 1996, P175; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HO DD, 1989, NEW ENGL J MED, V321, P1621, DOI 10.1056/NEJM198912143212401; LEONARD JM, 1996, 3 C RETR OPP INF WAS, P162; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; OBRIEN T, 1996, 3 C RETR OPP INF WAS, P100; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; PACHL C, 1995, J ACQ IMMUN DEF SYND, V8, P446, DOI 10.1097/00042560-199504120-00003; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Phillips A. N., 1996, P58; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; SAKSELA K, 1995, ANN INTERN MED, V123, P641, DOI 10.7326/0003-4819-123-9-199511010-00001; SIMMONDS P, 1990, J VIROL, V64, P864, DOI 10.1128/JVI.64.2.864-872.1990; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	23	187	198	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 24	1996	272	5265					1124	1125		10.1126/science.272.5265.1124	http://dx.doi.org/10.1126/science.272.5265.1124			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8638155				2022-12-28	WOS:A1996UM88900036
J	DeChiara, TM; Bowen, DC; Valenzuela, DM; Simmons, MV; Poueymirou, WT; Thomas, S; Kinetz, E; Compton, DL; Rojas, E; Park, JS; Smith, C; DiStefano, PS; Glass, DJ; Burden, SJ; Yancopoulos, GD				DeChiara, TM; Bowen, DC; Valenzuela, DM; Simmons, MV; Poueymirou, WT; Thomas, S; Kinetz, E; Compton, DL; Rojas, E; Park, JS; Smith, C; DiStefano, PS; Glass, DJ; Burden, SJ; Yancopoulos, GD			The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo	CELL			English	Article							ORIGINAL SYNAPTIC SITES; TORPEDO ELECTRIC ORGAN; ACETYLCHOLINE-RECEPTORS; BASAL LAMINA; REGENERATING MUSCLE; GROWTH-FACTOR; AGRIN; NERVE; EXPRESSION; PROTEIN	Formation of neuromuscular synapses requires a series of inductive interactions between growing motor axons and differentiating muscle cells, culminating in the precise juxtaposition of a highly specialized nerve terminal with a complex molecular structure on the postsynaptic muscle surface. The receptors and signaling pathways mediating these inductive interactions are not known. We have generated mice with a targeted disruption of the gene encoding MuSK, a receptor tyrosine kinase selectively localized to the postsynaptic muscle surface. Neuromuscular synapses do not form in these mice, suggesting a failure in the induction of synapse formation. Together with the results of an accompanying manuscript, our findings indicate that MuSK responds to a critical nerve-derived signal (agrin), and in turn activates signaling cascades responsible for all aspects of synapse formation, including organization of the postsynaptic membrane, synapse-specific transcription, and presynaptic differentiation.	NYU,MED CTR,MOL NEUROBIOL PROGRAM,NEW YORK,NY 10016	New York University	DeChiara, TM (corresponding author), REGENERON PHARMACEUT INC,777 OLD SAW MILL RIVER RD,TARRYTOWN,NY 10591, USA.		Glass, David/AAI-3910-2021; Smith, Cynthia/AAY-6219-2020; Glass, David/C-4782-2012	Smith, Cynthia/0000-0003-3691-0324; Burden, Steven/0000-0002-3550-6891; Glass, David/0000-0001-6187-4164	NINDS NIH HHS [R01 NS036193, NS21579, NS27963, R01 NS036193-01A1S1] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036193, R01NS021579, R01NS027963] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTIOK N, 1995, EMBO J, V14, P4258, DOI 10.1002/j.1460-2075.1995.tb00100.x; APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; BARBACID M, 1993, ONCOGENE, V8, P2033; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; BOWE MA, 1995, ANNU REV NEUROSCI, V18, P443; BROWN MC, 1981, ANNU REV NEUROSCI, V4, P17, DOI 10.1146/annurev.ne.04.030181.000313; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; BURDEN SJ, 1979, J CELL BIOL, V82, P412, DOI 10.1083/jcb.82.2.412; Burden Steven J., 1995, Seminars in Developmental Biology, V6, P59, DOI 10.1016/S1044-5781(06)80085-X; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; CARTAUD J, 1993, EUR J NEUROSCI, V5, P191, DOI 10.1111/j.1460-9568.1993.tb00485.x; CHU GC, 1995, NEURON, V14, P329, DOI 10.1016/0896-6273(95)90289-9; CONOVER JC, 1995, NATURE, V375, P35; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; DUCLERT A, 1995, PHYSIOL REV, V75, P339, DOI 10.1152/physrev.1995.75.2.339; FALLS DL, 1990, COLD SPRING HARB SYM, V55, P397; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Ferns M, 1996, J CELL BIOL, V132, P937, DOI 10.1083/jcb.132.5.937; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; GANJU P, 1995, ONCOGENE, V11, P281; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Glass David J., 1993, Trends in Cell Biology, V3, P262, DOI 10.1016/0962-8924(93)90054-5; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; GOODEARL ADJ, 1995, J CELL BIOL, V130, P1423, DOI 10.1083/jcb.130.6.1423; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HARRIS DA, 1989, NATURE, V337, P173, DOI 10.1038/337173a0; HELGREN ME, 1994, CELL, V76, P493, DOI 10.1016/0092-8674(94)90113-9; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; JENNINGS CGB, 1993, P NATL ACAD SCI USA, V90, P2895, DOI 10.1073/pnas.90.7.2895; JESSELL TM, 1979, P NATL ACAD SCI USA, V76, P5397, DOI 10.1073/pnas.76.10.5397; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; KARNOVSKY MJ, 1964, J CELL BIOL, V23, P217, DOI 10.1083/jcb.23.2.217; KUFFLER DP, 1986, J COMP NEUROL, V250, P228, DOI 10.1002/cne.902500209; LETINSKY MS, 1976, J NEUROCYTOL, V5, P691, DOI 10.1007/BF01181582; MARTINOU JC, 1991, P NATL ACAD SCI USA, V88, P7669, DOI 10.1073/pnas.88.17.7669; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; MCMAHAN UJ, 1984, J CELL BIOL, V98, P1453, DOI 10.1083/jcb.98.4.1453; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; QU Z, 1994, J NEUROSCI, V14, P6834; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; SANES JR, 1978, J CELL BIOL, V78, P176, DOI 10.1083/jcb.78.1.176; SANES JR, 1995, DEV BIOL, V6, P163; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SEALOCK R, 1994, CELL, V77, P617, DOI 10.1016/0092-8674(94)90045-0; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SIMON AM, 1992, DEVELOPMENT, V114, P545; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SON YJ, 1995, NEURON, V14, P133, DOI 10.1016/0896-6273(95)90247-3; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WALLACE BG, 1995, J CELL BIOL, V128, P1121, DOI 10.1083/jcb.128.6.1121; WALLACE BG, 1989, J NEUROSCI, V9, P1294; WALLACE BG, 1994, J CELL BIOL, V125, P661, DOI 10.1083/jcb.125.3.661; ZHU XJ, 1995, EMBO J, V14, P5842, DOI 10.1002/j.1460-2075.1995.tb00272.x	65	715	732	1	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 17	1996	85	4					501	512		10.1016/S0092-8674(00)81251-9	http://dx.doi.org/10.1016/S0092-8674(00)81251-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UM415	8653786	hybrid			2022-12-28	WOS:A1996UM41500008
J	Sugita, M; Jackman, RM; vanDonselaar, E; Behar, SM; Rogers, RA; Peters, PJ; Brenner, MB; Porcelli, SA				Sugita, M; Jackman, RM; vanDonselaar, E; Behar, SM; Rogers, RA; Peters, PJ; Brenner, MB; Porcelli, SA			Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs	SCIENCE			English	Article							INTRACELLULAR-TRANSPORT; INVARIANT CHAIN; LYMPHOCYTES-T; HLA-DM; COMPARTMENTS; MEMBRANE; EXPRESSION; LYSOSOMES; CDNA	CD1 proteins have been implicated as antigen-presenting molecules for T cell-mediated immune responses, but their intracellular localization and trafficking remain uncharacterized. CD1b, a member of this family that presents microbial lipid antigens of exogenous origin, was found to localize to endocytic compartments that included the same specialized subset of endosomes in which major histocompatibility complex (MHC) class II molecules are proposed to bind endocytosed antigens. Unlike MHC class II molecules, which traffic to antigen-loading endosomal compartments [MHC class II compartments (MIICs)] primarily as a consequence of their association with the invariant chain, localization of CD1b to these compartments was dependent on a tyrosine-based motif in its own cytoplasmic tail.	HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,LYMPHOCYTE BIOL SECT,DIV RHEUMATOL & IMMUNOL,BOSTON,MA 02115; UNIV UTRECHT,FAC MED,DEPT CELL BIOL,UTRECHT,NETHERLANDS; UNIV UTRECHT,FAC MED,INST BIOMEMBRANES,UTRECHT,NETHERLANDS; HARVARD UNIV,SCH PUBL HLTH,DEPT ENVIRONM HLTH,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Utrecht University; Utrecht University; Harvard University; Harvard T.H. Chan School of Public Health			Behar, Samuel M/C-3541-2009	Sugita, Masahiko/0000-0001-5511-1304; Behar, Samuel/0000-0002-3374-6699				ARUFFO A, 1989, J IMMUNOL, V143, P1723; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BALK SP, 1989, P NATL ACAD SCI USA, V86, P252, DOI 10.1073/pnas.86.1.252; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BEHAR SM, 1995, J EXP MED, V182, P2007, DOI 10.1084/jem.182.6.2007; BENDELAC A, 1995, SCIENCE, V269, P185, DOI 10.1126/science.7542402; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; HONING S, 1995, J CELL BIOL, V128, P321, DOI 10.1083/jcb.128.3.321; HUMPHREY JS, 1993, J CELL BIOL, V120, P1123, DOI 10.1083/jcb.120.5.1123; LERCH PG, 1983, HUM IMMUNOL, V6, P13, DOI 10.1016/0198-8859(83)90070-8; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MARKS MS, 1995, J CELL BIOL, V131, P351, DOI 10.1083/jcb.131.2.351; NIJMAN HW, 1995, J EXP MED, V182, P163, DOI 10.1084/jem.182.1.163; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; OLIVE D, 1984, IMMUNOGENETICS, V20, P253, DOI 10.1007/BF00364207; PETERS PJ, 1995, J EXP MED, V182, P325, DOI 10.1084/jem.182.2.325; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; ROGERS RA, 1993, J CELL SCI, V106, P485; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; SUGITA M, 1995, J BIOL CHEM, V270, P1443, DOI 10.1074/jbc.270.3.1443; SUGITA M, UNPUB; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955	31	200	203	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 19	1996	273	5273					349	352		10.1126/science.273.5273.349	http://dx.doi.org/10.1126/science.273.5273.349			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY202	8662520				2022-12-28	WOS:A1996UY20200037
J	vandeSande, K; Pawlowski, K; Czaja, I; Wieneke, U; Schell, J; Schmidt, J; Walden, R; Matvienko, M; Wellink, J; vanKammen, A; Franssen, H; Bisseling, T				vandeSande, K; Pawlowski, K; Czaja, I; Wieneke, U; Schell, J; Schmidt, J; Walden, R; Matvienko, M; Wellink, J; vanKammen, A; Franssen, H; Bisseling, T			Modification of phytohormone response by a peptide encoded by ENOD40 of legumes and a nonlegume	SCIENCE			English	Article							SOYBEAN NODULE DEVELOPMENT; RHIZOBIUM-MELILOTI; GENES; EXPRESSION; PLANTS; ORGANOGENESIS; PROTOPLASTS; NODULATION; PROMOTER; ALFALFA	The gene ENOD40 is expressed during early stages of legume nodule development. A homolog was isolated from tobacco, which, as does ENOD40 from legumes, encodes an oligopeptide of about 10 amino acids. In tobacco protoplasts, these peptides change the response to auxin at concentrations as low as 10(-12) to 10(-16) M. The peptides encoded by ENOD40 appear to act as plant growth regulators.	MAX PLANCK INST ZUCHTUNGSFORSCH,D-50829 COLOGNE,GERMANY; AGR UNIV WAGENINGEN,DEPT MOLEC BIOL,NL-6703 HA WAGENINGEN,NETHERLANDS	Max Planck Society; Wageningen University & Research			Bisseling, Ton/A-2421-2013; Pawlowski, Katharina/U-9955-2017	Pawlowski, Katharina/0000-0003-2693-885X				ASAD S, 1994, PROTOPLASMA, V183, P10, DOI 10.1007/BF01276808; BISSELING T, UNPUB; COOPER JB, 1994, PLANT CELL, V6, P215, DOI 10.1105/tpc.6.2.215; CRESPI MD, 1994, EMBO J, V13, P5099, DOI 10.1002/j.1460-2075.1994.tb06839.x; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; GONZALEZPASTOR JE, 1994, NATURE, V369, P281, DOI 10.1038/369281a0; HASELOFF J, 1995, TRENDS GENET, V11, P328, DOI 10.1016/0168-9525(95)90186-8; HIRSCH AM, 1989, P NATL ACAD SCI USA, V86, P1244, DOI 10.1073/pnas.86.4.1244; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; KOUCHI H, 1993, MOL GEN GENET, V238, P106, DOI 10.1007/BF00279537; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; MALIGA P, 1973, NATURE-NEW BIOL, V244, P29, DOI 10.1038/newbio244029a0; MATVIENKO M, 1994, PLANT MOL BIOL, V26, P487, DOI 10.1007/BF00039559; NEGRUTIU I, 1987, PLANT MOL BIOL, V8, P363, DOI 10.1007/BF00015814; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; REISS B, 1994, PLANT PHYSL LIFE SCI, V13, P143; SCHERES B, 1990, CELL, V60, P281, DOI 10.1016/0092-8674(90)90743-X; SHEEN J, 1995, PLANT J, V8, P777, DOI 10.1046/j.1365-313X.1995.08050777.x; TOPFER R, 1993, METHOD ENZYMOL, V217, P66; TRUCHET G, 1991, NATURE, V351, P670, DOI 10.1038/351670a0; VANBOKHOVEN H, 1993, J GEN VIROL, V74, P2233, DOI 10.1099/0022-1317-74-10-2233; VIJN I, 1993, SCIENCE, V260, P1764, DOI 10.1126/science.8511583; VIJN I, 1995, PLANT MOL BIOL, V28, P1111, DOI 10.1007/BF00032671; WALDEN R, 1993, PLANT CELL REP, V12, P551, DOI 10.1007/BF00233058; YANG WC, 1993, PLANT J, V3, P573, DOI 10.1046/j.1365-313X.1993.03040573.x	26	143	149	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 19	1996	273	5273					370	373		10.1126/science.273.5273.370	http://dx.doi.org/10.1126/science.273.5273.370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY202	8662527				2022-12-28	WOS:A1996UY20200044
J	Semenza, JC; Rubin, CH; Falter, KH; Selanikio, JD; Flanders, WD; Howe, HL; Wilhelm, JL				Semenza, JC; Rubin, CH; Falter, KH; Selanikio, JD; Flanders, WD; Howe, HL; Wilhelm, JL			Heat-related deaths during the July 1995 heat wave in Chicago	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APPARENT TEMPERATURE; ST-LOUIS; SULTRINESS; MORTALITY	Background During a record-setting heat wave in Chicago in July 1995, there were at least 700 excess deaths, most of which were classified as heat-related. We sought to determine who was at greatest risk for heat-related death. Methods We conducted a case-control study in Chicago to identify risk factors associated with heat-related death and death from cardiovascular causes from July 14 through July 17, 1995. Beginning on July 21, we interviewed 339 relatives, neighbors, or friends of those who died and 339 controls matched to the case subjects according to neighborhood and age. Results The risk of heat-related death was increased for people with known medical problems who were confined to bed (odds ratio as compared with those who were not confined to bed, 5.5) or who were unable to care for themselves (odds ratio, 4.1). Also at increased risk were those who did not leave home each day (odds ratio, 6.7), who lived alone (odds ratio, 2.3), or who lived on the top floor of a building (odds ratio, 4.7). Having social contacts such as group activities or friends in the area was protective. In a multivariate analysis, the strongest risk factors for heat-related death were being confined to bed (odds ratio, 8.2) and living alone (odds ratio, 2.3); the risk of death was reduced for people with working air conditioners (odds ratio, 0.3) and those with access to transportation (odds ratio, 0.3). Deaths classified as due to cardiovascular causes had risk factors similar to those for heat-related death. Conclusions In this study of the 1995 Chicago heat wave, those at greatest risk of dying from the heat were people with medical illnesses who were socially isolated and did not have access to air conditioning. In future heat emergencies, interventions directed to such persons should reduce deaths related to the heat. (C) 1996, Massachusetts Medical Society.	CTR DIS CONTROL & PREVENT,EPIDEM INTELLIGENCE SERV,EPIDEMIOL PROGRAM OFF,ATLANTA,GA 30341; CTR DIS CONTROL & PREVENT,NATL CTR ENVIRONM HLTH,ATLANTA,GA 30341; ILLINOIS DEPT PUBL HLTH,SPRINGFIELD,IL 62761; DEPT PUBL HLTH,CHICAGO,IL	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Chicago Department of Public Health								AGRESTI A, 1990, CATEGORICAL DATA ANA, P56; ALDERSON MR, 1967, BRIT J PREV SOC MED, V21, P22; APPLEGATE WB, 1981, J AM GERIATR SOC, V29, P337, DOI 10.1111/j.1532-5415.1981.tb01238.x; BAROR O, 1969, J APPL PHYSIOL, V26, P403, DOI 10.1152/jappl.1969.26.4.403; BEADENKOPF WG, 1963, J CHRON DIS, V16, P249, DOI 10.1016/0021-9681(63)90030-4; Bridger C A, 1968, Int J Biometeorol, V12, P51, DOI 10.1007/BF01552978; CLARKE JF, 1972, ENVIRON RES, V5, P93, DOI 10.1016/0013-9351(72)90023-0; ELLIS FP, 1980, Q J MED, V49, P1; ELLIS FP, 1972, ENVIRON RES, V5, P1, DOI 10.1016/0013-9351(72)90019-9; GOVER MARY, 1938, PUBL HEALTH REPTS, V53, P1122, DOI 10.2307/4582590; GWYNNE JF, 1974, NEW ZEAL MED J, V80, P336; HAYMES EM, 1975, J APPL PHYSIOL, V39, P457, DOI 10.1152/jappl.1975.39.3.457; HENSCHEL A, 1969, AM J PUBLIC HEALTH N, V59, P2232, DOI 10.2105/AJPH.59.12.2232; JONES TS, 1982, JAMA-J AM MED ASSOC, V247, P3327, DOI 10.1001/jama.247.24.3327; KILBOURNE EM, 1982, JAMA-J AM MED ASSOC, V247, P3332, DOI 10.1001/jama.247.24.3332; KILBOURNE EM, 1986, MAXCY ROSENAU PUBLIC, P703; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; KOLLIAS J, 1964, J PHARMACOL EXP THER, V145, P373; MARTINEZ BF, 1989, JAMA-J AM MED ASSOC, V262, P2246, DOI 10.1001/jama.262.16.2246; *NAT CTR HLTH STAT, 1992, MORT PUBL US COMP DA; *NAT OC ATM ADM, 1995, 1995 NAT OC ATM ADM; ROGOT E, 1992, AM J EPIDEMIOL, V136, P106, DOI 10.1093/oxfordjournals.aje.a116413; SAS Institute, 1992, SAS STAT SOFTW CHANG; SCHUMAN SH, 1972, ENVIRON RES, V5, P59, DOI 10.1016/0013-9351(72)90020-5; SCHUMAN SH, 1964, JAMA-J AM MED ASSOC, V189, P733; STEADMAN RG, 1979, J APPL METEOROL, V18, P861, DOI 10.1175/1520-0450(1979)018<0861:TAOSPI>2.0.CO;2; STEADMAN RG, 1984, J CLIM APPL METEOROL, V23, P1674, DOI 10.1175/1520-0450(1984)023<1674:AUSOAT>2.0.CO;2; STEADMAN RG, 1979, J APPL METEOROL, V18, P874, DOI 10.1175/1520-0450(1979)018<0874:TAOSPI>2.0.CO;2; YAGLOU C. P., 1927, JOUR IND HYG, V9, P297; 1981, MMWR-MORBID MORTAL W, V30, P277; 1995, MMWR-MORBID MORTAL W, V44, P577	31	851	893	3	114	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	1996	335	2					84	90		10.1056/NEJM199607113350203	http://dx.doi.org/10.1056/NEJM199607113350203			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW353	8649494	Bronze			2022-12-28	WOS:A1996UW35300003
J	Lithgow, GJ; Kirkwood, TBL				Lithgow, GJ; Kirkwood, TBL			Mechanisms and evolution of aging	SCIENCE			English	Editorial Material							CAENORHABDITIS-ELEGANS; LIFE				Lithgow, GJ (corresponding author), UNIV MANCHESTER, BIOL GERONTOL GRP, 3239 STOPFORD BLDG, OXFORD RD, MANCHESTER M13 9PT, LANCS, ENGLAND.							Finch CE, 1990, LONGEVITY SENESCENCE; FRIEDMAN DB, 1988, GENETICS, V118, P75; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIRKWOOD TBL, 1992, ANN NY ACAD SCI, V663, P412, DOI 10.1111/j.1749-6632.1992.tb38685.x; KIRKWOOD TBL, 1982, HUM GENET, V60, P101, DOI 10.1007/BF00569695; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; LITHGOW GJ, 1994, J GERONTOL, V49, pB270, DOI 10.1093/geronj/49.6.B270; MELOV S, 1995, NUCLEIC ACIDS RES, V23, P1419, DOI 10.1093/nar/23.8.1419; MURAKAMI S, IN PRESS GENETICS; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; VANVOORHIES WA, 1992, NATURE, V360, P456, DOI 10.1038/360456a0; WONG A, 1995, GENETICS, V139, P1247	14	99	106	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	1996	273	5271					80	80		10.1126/science.273.5271.80	http://dx.doi.org/10.1126/science.273.5271.80			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV478	8658201				2022-12-28	WOS:A1996UV47800040
J	Sohal, RS; Weindruch, R				Sohal, RS; Weindruch, R			Oxidative stress, caloric restriction, and aging	SCIENCE			English	Article							AGE-RELATED-CHANGES; DIETARY RESTRICTION; FOOD RESTRICTION; LIPID-PEROXIDATION; PROTEIN OXIDATION; FREE-RADICALS; RATS; LONGEVITY; LIFE; MICE	Under normal physiological conditions, the use of oxygen by cells of aerobic organisms generates potentially deleterious reactive oxygen metabolites. A chronic state of oxidative stress exists In cells because of an imbalance between prooxidants and antioxidants. The amount of oxidative damage increases as an organism ages and is postulated to be a major causal factor of senescence. Support for this hypothesis includes the following observations: (i) Overexpression of antioxidative enzymes retards the age-related accrual of oxidative damage and extends the maximum life-span of transgenic Drosophila melanogaster. (ii) Variations in longevity among different species inversely correlate with the rates of mitochondrial generation of the superoxide anion radical (O-2(-)) and hydrogen peroxide, (iii) Restriction of caloric intake lowers steady-state levels of oxidative stress and damage, retards age-associated changes, and extends the maximum life-span in mammals.	UNIV WISCONSIN, DEPT MED, MADISON, WI 53705 USA; UNIV WISCONSIN, VET ADM GERIATR RES EDUC & CLIN CTR, MADISON, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; University of Wisconsin System; University of Wisconsin Madison	Sohal, RS (corresponding author), SO METHODIST UNIV, DEPT BIOL SCI, DALLAS, TX 75275 USA.				NIA NIH HHS [R01 AG013563-13, R01 AG013563, R01 AG007657-23, R01 AG007657] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG013563, R01AG007657] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABELSON PH, 1995, SCIENCE, V270, P215, DOI 10.1126/science.270.5234.215; Agarwal S, 1996, EXP GERONTOL, V31, P365, DOI 10.1016/0531-5565(95)02039-X; AGARWAL S, 1994, P NATL ACAD SCI USA, V91, P12332, DOI 10.1073/pnas.91.25.12332; AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; [Anonymous], COMMUNICATION; BARJA G, 1994, FREE RADICAL RES, V21, P317, DOI 10.3109/10715769409056584; BERTRAND HA, 1980, J GERONTOL, V35, P827, DOI 10.1093/geronj/35.6.827; BODKIN NL, 1995, J GERONTOL A-BIOL, V50, pB142, DOI 10.1093/gerona/50A.3.B142; CARTEE GD, 1994, AM J PHYSIOL, V266, pE946, DOI 10.1152/ajpendo.1994.266.6.E946; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8; CHOI JH, 1995, FREE RADICAL BIO MED, V18, P133, DOI 10.1016/0891-5849(94)00106-T; DAVIES KJA, 1995, BIOCH SOC S, V61, P1231; DUBEY A, IN PRESS ARCH BIOCH; DUFFY PH, 1990, CHRONOBIOL INT, V7, P113, DOI 10.3109/07420529009056963; FEIG DI, 1994, CANCER RES, V54, pS1890; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; GONZALESPACHECO DM, 1993, J NUTR, V123, P90, DOI 10.1093/jn/123.1.90; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; HANSEN BC, 1995, OBES RES, V3, pS199, DOI 10.1002/j.1550-8528.1995.tb00464.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hart R.W., 1995, DIETARY RESTRICTION; INGRAM DK, 1990, J GERONTOL, V45, pB148, DOI 10.1093/geronj/45.5.B148; JANSSEN YMW, 1993, LAB INVEST, V69, P261; KEMNITZ JW, 1993, J GERONTOL, V48, pB17, DOI 10.1093/geronj/48.1.B17; KEMNITZ JW, 1994, AM J PHYSIOL, V266, pE540, DOI 10.1152/ajpendo.1994.266.4.E540; KOIZUMI A, 1992, J NUTR, V122, P1446, DOI 10.1093/jn/122.7.1446; KU HH, 1993, MECH AGEING DEV, V72, P67, DOI 10.1016/0047-6374(93)90132-B; KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; LANE MA, 1995, AM J PHYSIOL-ENDOC M, V268, pE941, DOI 10.1152/ajpendo.1995.268.5.E941; Lane MA, 1996, P NATL ACAD SCI USA, V93, P4159, DOI 10.1073/pnas.93.9.4159; LYMAN CP, 1981, SCIENCE, V212, P668, DOI 10.1126/science.7221552; MASORO EJ, 1991, ANN NY ACAD SCI, V621, P337; MASORO EJ, 1982, P NATL ACAD SCI-BIOL, V79, P4239, DOI 10.1073/pnas.79.13.4239; MATSUO M, 1992, MECH AGEING DEV, V64, P273, DOI 10.1016/0047-6374(92)90084-Q; MATSUO M, 1993, J GERONTOL, V48, pB133, DOI 10.1093/geronj/48.4.B133; MCCORD JM, 1995, P SOC EXP BIOL MED, V209, P112; NOY N, 1985, MECH AGEING DEV, V29, P63, DOI 10.1016/0047-6374(85)90047-8; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Pearl R., 1928, RATE LIVING; Prosser C. L., 1973, Comparative animal physiology,, P362; PRYOR WA, 1978, PHOTOCHEM PHOTOBIOL, V28, P787, DOI 10.1111/j.1751-1097.1978.tb07020.x; RICHTER C, 1994, CURR TOP BIOENERG, V17, P1; RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K; Rubner M, 1908, PROBLEM LEBENSDAUER; SACHER GA, 1977, HDB BIOL AGING, P582; SAGAI M, 1980, LIFE SCI, V27, P731, DOI 10.1016/0024-3205(80)90326-4; Sohal R., UNPUB; SOHAL RS, 1993, FREE RADICAL BIO MED, V14, P583, DOI 10.1016/0891-5849(93)90139-L; SOHAL RS, 1993, BIOCHEM BIOPH RES CO, V196, P7, DOI 10.1006/bbrc.1993.2208; SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X; SOHAL RS, 1995, J BIOL CHEM, V270, P15671, DOI 10.1074/jbc.270.26.15671; SOHAL RS, 1992, MUTAT RES, V275, P295, DOI 10.1016/0921-8734(92)90033-L; SOHAL RS, 1986, MECH AGEING DEV, V36, P71, DOI 10.1016/0047-6374(86)90140-5; SOHAL RS, 1995, FREE RADICAL BIO MED, V19, P499, DOI 10.1016/0891-5849(95)00037-X; SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4; SOHAL RS, 1989, ADV MYOCHEM, V2, P21; SOHAL RS, 1993, AGING-CLIN EXP RES, V5, P3, DOI 10.1007/BF03324120; Sohal RS, 1995, LIFE SCI R, V56, P109; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5; TURRENS JF, 1990, FREE RADICALS LIPOPR, P203; Van Remmen Holly, 1995, P171; WARNER HR, 1995, J GERONTOL A-BIOL, V50, pB107, DOI 10.1093/gerona/50A.3.B107; WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Weindruch R., 1988, RETARDATION AGING DI; Weindruch R., 1993, FREE RADICALS AGING, P269; YU BP, 1994, MODULATION AGING PRO	71	2418	2509	10	472	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	1996	273	5271					59	63		10.1126/science.273.5271.59	http://dx.doi.org/10.1126/science.273.5271.59			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV478	8658196	Green Accepted			2022-12-28	WOS:A1996UV47800033
J	Stassinopoulos, A; Ji, J; Gao, XL; Goldberg, IH				Stassinopoulos, A; Ji, J; Gao, XL; Goldberg, IH			Solution structure of a two-base DNA bulge complexed with an enediyne cleaving analog	SCIENCE			English	Article							SITE-SPECIFIC CLEAVAGE; NEOCARZINOSTATIN CHROMOPHORE; TAT-PROTEIN; ACTIVATION; LOOP; NMR; CONFORMATION; SEQUENCES; BINDING; MODEL	Nucleic acid bulges have been implicated in a number of biological processes and are specific cleavage targets for the enediyne antitumor antibiotic neocarzinostatin chromophore in a base-catalyzed, radical-mediated reaction. The solution structure of the complex between an analog of the bulge-specific cleaving species and an oligodeoxynucleotide containing a two-base bulge was elucidated by nuclear magnetic resonance. An unusual binding mode involves major groove recognition by the drug carbohydrate unit and tight fitting of the wedge-shaped drug in the triangular prism pocket formed by the two looped-out bulge bases and the neighboring base pairs. The two drug rings mimic helical DNA bases, complementing the bent DNA structure. The putative abstracting drug radical is 2.2 +/- 0.1 angstroms from the pro-S H5' of the target bulge nucleotide. This structure clarifies the mechanism of bulge recognition and cleavage by a drug and provides insight into the design of bulge-specific nucleic acid binding molecules.	UNIV HOUSTON,DEPT CHEM,HOUSTON,TX 77204; HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115	University of Houston System; University of Houston; Harvard University; Harvard Medical School					NATIONAL CANCER INSTITUTE [R35CA044257] Funding Source: NIH RePORTER; NCI NIH HHS [CA44257] Funding Source: Medline; NIGMS NIH HHS [GM53793] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BHATTACHARYYA A, 1989, NUCLEIC ACIDS RES, V17, P6821, DOI 10.1093/nar/17.17.6821; BRUNGER AT, 1986, P NATL ACAD SCI USA, V83, P3801, DOI 10.1073/pnas.83.11.3801; CaceresCortes J, 1996, BIOCHEMISTRY-US, V35, P616, DOI 10.1021/bi9518398; CRIPPEN GM, 1981, DISTANCE GEOMETRY CO; DINGWALL C, 1990, EMBO J, V9, P4145, DOI 10.1002/j.1460-2075.1990.tb07637.x; DURAND M, 1990, NUCLEIC ACIDS RES, V18, P6353, DOI 10.1093/nar/18.21.6353; ECKEL LM, 1994, BIOCHEMISTRY-US, V33, P13611, DOI 10.1021/bi00250a012; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; GAIT MJ, 1993, TRENDS BIOCHEM SCI, V18, P255, DOI 10.1016/0968-0004(93)90176-N; GAO XL, 1995, BIOCHEMISTRY-US, V34, P40, DOI 10.1021/bi00001a006; GAO XL, 1989, Q REV BIOPHYS, V22, P93, DOI 10.1017/S0033583500003814; GOLDBERG IH, 1994, ENEDIYNE ANTIBIOTICS, P327; HANSEN M, 1995, CHEM BIOL, V2, P229, DOI 10.1016/1074-5521(95)90273-2; HENSENS OD, 1993, J AM CHEM SOC, V115, P11030, DOI 10.1021/ja00076a087; HENSENS OD, 1994, P NATL ACAD SCI USA, V91, P4534, DOI 10.1073/pnas.91.10.4534; HJAALT TAH, 1995, NUCLEIC ACIDS RES, V23, P580; JAMES TL, 1994, CURR OPIN STRUC BIOL, V4, P275, DOI 10.1016/S0959-440X(94)90320-4; KAPPEN LS, 1993, SCIENCE, V261, P1319, DOI 10.1126/science.8362243; KAPPEN LS, 1995, BIOCHEMISTRY-US, V34, P5997, DOI 10.1021/bi00017a029; KAPPEN LS, 1993, BIOCHEMISTRY-US, V32, P13138, DOI 10.1021/bi00211a024; KLEFF S, 1988, EMBO J, V7, P1527, DOI 10.1002/j.1460-2075.1988.tb02972.x; KUNKEL TA, 1993, NATURE, V365, P207, DOI 10.1038/365207a0; KUSZEWSKI J, 1992, J BIOMOL NMR, V2, P33, DOI 10.1007/BF02192799; LILLEY MJ, 1995, P NATL ACAD SCI USA, V92, P7140; Mao B, 1995, BIOCHEMISTRY-US, V34, P16641, DOI 10.1021/bi00051a012; MAO B, 1995, BIOCHEMISTRY-US, V34, P6226, DOI 10.1021/bi00018a027; NELSON JW, 1985, BIOCHEMISTRY-US, V24, P6416, DOI 10.1021/bi00344a016; NICOLAOU KC, 1992, SCIENCE, V256, P1172, DOI 10.1126/science.256.5060.1172; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; NILGES M, 1991, J MOL BIOL, V219, P499, DOI 10.1016/0022-2836(91)90189-D; QUIGLEY GJ, 1980, P NATL ACAD SCI-BIOL, V77, P7204, DOI 10.1073/pnas.77.12.7204; RICE JA, 1989, BIOCHEMISTRY-US, V28, P4512, DOI 10.1021/bi00436a058; RIPLEY LS, 1982, P NATL ACAD SCI-BIOL, V79, P4128, DOI 10.1073/pnas.79.13.4128; ROSEN MA, 1992, BIOCHEMISTRY-US, V31, P4004, DOI 10.1021/bi00131a016; SAENGER W, 1984, PRINCIPLES NUCLEIC A; SLAMA-SCHWOK A, 1995, J AM CHEM SOC, V117, P6822, DOI 10.1021/ja00131a003; STASSINOPOULOS A, 1995, BIOCHEMISTRY-US, V34, P15359, DOI 10.1021/bi00046a045; Turner DH, 1992, CURR OPIN STRUC BIOL, V2, P334; WHITE SA, 1987, NUCLEIC ACIDS RES, V15, P4049, DOI 10.1093/nar/15.10.4049; WILLIAMS LD, 1988, BIOCHEMISTRY-US, V27, P3004, DOI 10.1021/bi00408a051; WILSON WD, 1994, NEW J CHEM, V18, P419; WOODSON SA, 1988, BIOCHEMISTRY-US, V27, P3130, DOI 10.1021/bi00409a004; Wuthrich K, 1986, NMR PROTEINS NUCL AC; YANG CF, 1995, BIOCHEMISTRY-US, V34, P2267, DOI 10.1021/bi00007a022	44	63	68	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1996	272	5270					1943	1946		10.1126/science.272.5270.1943	http://dx.doi.org/10.1126/science.272.5270.1943			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8658168				2022-12-28	WOS:A1996UV29400050
J	Lerman, C; Narod, S; Schulman, K; Hughes, C; GomezCaminero, A; Bonney, G; Gold, K; Trock, B; Main, D; Lynch, J; Fulmore, C; Snyder, C; Lemon, SJ; Conway, T; Tonin, P; Lenoir, G; Lynch, H				Lerman, C; Narod, S; Schulman, K; Hughes, C; GomezCaminero, A; Bonney, G; Gold, K; Trock, B; Main, D; Lynch, J; Fulmore, C; Snyder, C; Lemon, SJ; Conway, T; Tonin, P; Lenoir, G; Lynch, H			BRCA1 testing in families with hereditary breast-ovarian cancer - A prospective study of patient decision making and outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUNTINGTONS-DISEASE; SUSCEPTIBILITY; RISK; MODELS	Objectives.-To identify predictors of utilization of breast-ovarian cancer susceptibility (BRCA1 gene) testing and to evaluate outcomes of participation in a testing program. Design.-Prospective cohort study with baseline interview assessment of predictor variables (eg, sociodemographic factors, knowledge about hereditary cancer and genetic testing, perceptions of testing benefits, limitations, and risks). BRCA1 test results were offered after an education and counseling session in a research setting. Outcome variables (including depression, functional health status, and prophylactic surgery plans [follow-up only]) were assessed at baseline and 1-month follow-up interviews. Participants.-Adult male and female members (n=279) of families with BRCA1-linked hereditary breast-ovarian cancer (HBOC). Results.-Of subjects who completed a baseline interview (n=192), 60% requested BRCA1 test results (43% of all study subjects requested results). Requests for results were more frequent for persons with health insurance (odds ratio [OR], 3.74; 95% confidence interval [CI], 2.06-6.80); more first-degree relatives affected with breast cancer (OR, 1.59; 95% CI, 1.16-2.16); more knowledge about BRCA1 testing (OR, 1.85; 95% CI, 1.36-2.50); and indicating that test benefits are important (OR, 1.45; 95% CI, 1.13-1.86). At follow-up, noncarriers of BRCA1 mutations showed statistically significant reductions in depressive symptoms and functional impairment compared with carriers and nontested individuals. individuals identified as mutation carriers did not exhibit increases in depression and functional impairment. Among unaffected women with no prior prophylactic surgery, 17% of carriers (2/12) intended to have mastectomies and 33% (4/12) to have oophorectomies. Conclusions.-Only a subset of HBOC family members are likely to request BRCA1 testing when available. Rates of test use may be higher in persons of a higher socioeconomic status and those with more relatives affected with breast cancer. For some high-risk individuals who receive test results in a research setting that includes counseling, there may be psychological benefits. More research is needed to assess the generalizability of these results and evaluate the long-term consequences of BRCA1 testing.	WOMENS COLL HOSP,DEPT MED,TORONTO,ON M5S 1B2,CANADA; FOX CHASE CANC CTR,DIV POPULAT SCI,PHILADELPHIA,PA 19111; CREIGHTON UNIV,MED CTR,DEPT PREVENT MED & PUBL HLTH,OMAHA,NE 68178; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ H3A 2T5,CANADA; INT AGCY RES CANC,UNIT MECHANISMS CARCINOGENESIS,F-69372 LYON,FRANCE	University of Toronto; University Toronto Affiliates; Womens College Hospital; Fox Chase Cancer Center; Creighton University; McGill University; World Health Organization; International Agency for Research on Cancer (IARC)	Lerman, C (corresponding author), GEORGETOWN UNIV,MED CTR,DEPT MED,LOMBARDI CANC CTR,DIV CANC PREVENT & CONTROL,WASHINGTON,DC 20007, USA.		Lerman, Caryn/AHC-5180-2022; Narod, Steven A/AAA-6112-2022	Gomez-Caminero, Andres/0000-0002-8728-3124	NCI NIH HHS [CA01604] Funding Source: Medline; NIMH NIH HHS [MH54435] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA001604] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ajzen I., 1980, UNDERSTANDING ATTITU; BEKKER H, 1993, BRIT MED J, V306, P14; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; BILLINGS PR, 1992, AM J HUM GENET, V50, P476; BLOCH M, 1992, AM J MED GENET, V42, P499, DOI 10.1002/ajmg.1320420416; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; BONNEY GE, 1992, HUM HERED, V42, P28, DOI 10.1159/000154044; CHALIKI H, 1995, AM J PUBLIC HEALTH, V85, P1133, DOI 10.2105/AJPH.85.8_Pt_1.1133; Collins FS, 1996, NEW ENGL J MED, V334, P186, DOI 10.1056/NEJM199601183340311; CRAUFURD D, 1989, LANCET, V2, P603; EASTON DF, 1993, AM J HUM GENET, V52, P678; ENGEL JF, 1995, CONSUMER BEHAVIOR; EVERSKIEBOOMS G, 1989, CLIN GENET, V35, P29; FEUNTEUN J, 1993, AM J HUM GENET, V52, P736; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; HOSKINS KF, 1995, JAMA-J AM MED ASSOC, V273, P577, DOI 10.1001/jama.273.7.577; KESSLER S, 1987, AM J MED GENET, V26, P259, DOI 10.1002/ajmg.1320260204; KING MC, 1993, JAMA-J AM MED ASSOC, V269, P1975, DOI 10.1001/jama.269.15.1975; LERMAN C, 1994, J CLIN ONCOL, V12, P843, DOI 10.1200/JCO.1994.12.4.843; LERMAN C, 1994, ARCH INTERN MED, V154, P609, DOI 10.1001/archinte.154.6.609; LERMAN C, 1995, AM J MED GENET, V57, P385, DOI 10.1002/ajmg.1320570304; LYNCH HT, 1994, CANCER, V74, P1184, DOI 10.1002/1097-0142(19940801)74:3+<1184::AID-CNCR2820741530>3.0.CO;2-4; LYNCH HT, 1992, CANCER, V69, P1404, DOI 10.1002/1097-0142(19920315)69:6<1404::AID-CNCR2820690616>3.0.CO;2-R; LYNCH HT, 1993, ARCH INTERN MED, V153, P1979; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1995, AM J HUM GENET, V56, P254; NELSON N, 1995, J NATL CANCER I, V88, P70; *OFF TECHN ASS, 1992, OTABPBA98 PUBL; QUAID KA, 1993, AM J MED GENET, V45, P41, DOI 10.1002/ajmg.1320450112; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; SEROVA O, 1996, AM J HUM GENET, V58, P51; Sherbourne CD, 1992, MEASURING FUNCTIONIN, P205; Sherbourne CD, 1992, MEASURING FUNCTIONIN, P194; STRUEWING JP, 1995, CANCER EPIDEM BIOMAR, V4, P169; STRUEWING JP, 1995, NAT GENET, V11, P196; TAMBOR ES, 1994, AM J HUM GENET, V55, P626; *US DEP HLTH HUM S, 1993, NIH PUBL; WIGGINS S, 1992, NEW ENGL J MED, V327, P1401, DOI 10.1056/NEJM199211123272001; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; 1994, JAMA-J AM MED ASSOC, V271, P785; 1994, AM J HUM GENET, V55, pR2	43	637	638	2	43	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	1996	275	24					1885	1892		10.1001/jama.275.24.1885	http://dx.doi.org/10.1001/jama.275.24.1885			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR975	8648868				2022-12-28	WOS:A1996UR97500033
J	Morrison, HI; Schaubel, D; Desmeules, M; Wigle, DT				Morrison, HI; Schaubel, D; Desmeules, M; Wigle, DT			Serum folate and risk of fatal coronary heart disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CAROTID ARTERIAL-DISEASE; CANADA SURVEY COHORT; FOLLOW-UP; DEFICIENCY; MORTALITY; ADULTS	Objective.-To assess the relationship between serum folate level and the risk of fatal coronary heart disease (CHD) among men and women. Design.-Retrospective cohort study with serum folate levels measured from September 1970 to December 1972, with follow-up through 1985. Setting.-Participants in the Nutrition Canada Survey. Participants.-A total of 5056 Canadian men and women aged 35 to 79 years with no history of self-reported CHD. Main Outcome Measure.-Fifteen-year CHD mortality. Results.-A total of 165 CHD deaths were observed. We found a statistically significant association between serum folate level and risk of fatal CHD, with rate ratios for individuals in the lowest serum folate level category (<6.8 nmol/L [3 ng/mL]) compared with the highest category (>13.6 nmol/L [6 ng/mL]) of 1.69 (95% confidence interval, 1.10-2.61). Conclusions.-These data indicate that low serum folate levels are associated with an increased risk of fatal CHD.			Morrison, HI (corresponding author), DEPT HLTH & WELF,CANC BUR,LAB CTR DIS CONTROL BLDG,TUNNEYS PASTURE,OTTAWA,ON K1A 0L2,CANADA.							ARONOW WS, 1992, NEW YORK STATE J MED, V92, P424; ARONOW WS, 1992, CORONARY ARTERY DIS, V3, P249, DOI 10.1097/00019501-199203000-00012; BAYLIS EM, 1971, LANCET, V1, P62; BLOCK G, 1993, J NATL CANCER I, V85, P846, DOI 10.1093/jnci/85.11.846; BUTTERWORTH CE, 1992, JAMA-J AM MED ASSOC, V267, P528, DOI 10.1001/jama.267.4.528; CHANARIN I, 1994, CLIN INVEST MED, V17, P253; *DEP NAT HLTH WELF, 1978, H58361973 DEP NAT HL; *DEP NAT HLTH WELF, 1973, H58361973 DEP NAT HL; FREUDENHEIM JL, 1991, INT J EPIDEMIOL, V20, P368, DOI 10.1093/ije/20.2.368; GABY SK, 1991, VITAMIN INTAKE HLTH; HOWE GR, 1981, COMPUT BIOMED RES, V14, P327, DOI 10.1016/0010-4809(81)90004-5; JOHANSEN H, 1987, CAN MED ASSOC J, V136, P823; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; KANG SS, 1987, METABOLISM, V36, P458, DOI 10.1016/0026-0495(87)90043-6; Kannel WB, 1983, PREVENTION CORONARY, P1; MARTIN M, 1986, LANCET, V2, P923; MOJONNIER L, 1968, J AM DIET ASSOC, V52, P288; *NAT CTR HLTH STAT, 1967, INT CLASS DIS AD US; *NAT RES COUNC, 1989, REC DIET ALL; OLEARY DH, 1992, STROKE, V23, P1752, DOI 10.1161/01.STR.23.12.1752; PANCHARUNITI N, 1994, AM J CLIN NUTR, V59, P940, DOI 10.1093/ajcn/59.4.940; ROMANO PS, 1995, AM J PUBLIC HEALTH, V85, P667, DOI 10.2105/AJPH.85.5.667; SALONEN JT, 1991, ARTERIOSCLER THROMB, V11, P1245, DOI 10.1161/01.ATV.11.5.1245; SAUBERLICH HE, 1987, AM J CLIN NUTR, V46, P1016, DOI 10.1093/ajcn/46.6.1016; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; SEMENCIW RM, 1988, INT J EPIDEMIOL, V17, P317, DOI 10.1093/ije/17.2.317; SHANNON HS, 1989, CAN J PUBLIC HEALTH, V80, P54; STAMPFER MJ, 1995, NEW ENGL J MED, V332, P328, DOI 10.1056/NEJM199502023320511; SUBAR AF, 1989, AM J CLIN NUTR, V50, P508, DOI 10.1093/ajcn/50.3.508; Ueland PM., 1992, ATHEROSCLEROTIC CARD, P183; [No title captured]; 1991, LANCET, V338, P131	32	263	271	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	1996	275	24					1893	1896		10.1001/jama.275.24.1893	http://dx.doi.org/10.1001/jama.275.24.1893			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR975	8648869				2022-12-28	WOS:A1996UR97500034
J	Wurman, J; Straka, JM; Rasmussen, EN				Wurman, J; Straka, JM; Rasmussen, EN			Fine-scale Doppler radar observations of tornadoes	SCIENCE			English	Article								Observations obtained with a mobile pencil-beam Doppler radar revealed many previously unresolved structures within tornadic storms and tornadoes and helped verify various aspects of conceptual models. Radar data from the parent circulations indicate the existence of spiral reflectivity bands, intense radial wind shear zones, and multiple larger-scale velocity maxima. Tornado structures observed include debris shields, clear axial (eye) regions, multiple reflectivity bands surrounding the center of the eye, and occasional reflectivity protrusions into the eye. Velocity and reflectivity data from tornado-scale circulations show evidence of axial downdrafts.	UNIV OKLAHOMA,COOPERAT INST MESOSCALE METEOROL STUDIES,NORMAN,OK 73019; NATL SEVERE STORMS LAB,NORMAN,OK 73069	University of Oklahoma System; University of Oklahoma - Norman; National Oceanic Atmospheric Admin (NOAA) - USA	Wurman, J (corresponding author), UNIV OKLAHOMA,SCH METEOROL,CTR ANAL & PREDICT STORMS,100 E BOYD ST,NORMAN,OK 73019, USA.							[Anonymous], 1993, DOPPLER RADAR WEATHE; [Anonymous], 1986, THUNDERSTORM MORPHOL; Bluestein H.B., 1993, GEOPHYS MONOGR AM GE, V79, P319, DOI [https://doi.org/10.1029/GM079p0319, DOI 10.1029/GM079P0319]; BLUESTEIN HB, 1993, MON WEATHER REV, V121, P2200, DOI 10.1175/1520-0493(1993)121<2200:DRWSOS>2.0.CO;2; CHURCH CR, 1977, B AM METEOROL SOC, V58, P900, DOI 10.1175/1520-0477(1977)058<0900:TVSAPU>2.0.CO;2; Lewellen W. S., 1993, GEOPHYS MONOGR SER, V79, P19; LEWELLEN WS, 1976, THEORETICAL MODELS T, P107; RASMUSSEN EN, 1994, B AM METEOROL SOC, V75, P995, DOI 10.1175/1520-0477(1994)075<0995:VOTOOR>2.0.CO;2; Ray P.S., 1986, MESOSCALE METEOROLOG, P414; SNOW JT, 1982, REV GEOPHYS, V20, P953, DOI 10.1029/RG020i004p00953; WURMAN J, 1995, 27 AM MET SOC INT C; WURMAN J, UNPUB	12	96	98	2	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1774	1777		10.1126/science.272.5269.1774	http://dx.doi.org/10.1126/science.272.5269.1774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8662481				2022-12-28	WOS:A1996UT11000038
J	Foege, WH				Foege, WH			Preventive medicine and public health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFECTION				Foege, WH (corresponding author), EMORY UNIV, CARTER CTR, ATLANTA, GA 30322 USA.							BELLAMY C, 1995, STATE WORLDS CHILDRE; BUCHBINDER SP, 1994, AIDS, V8, P1123, DOI 10.1097/00002030-199408000-00014; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HOPKINS DR, 1983, PRINCES PEASANTS, P97; Jenner E, 1798, INQUIRY CAUSES EFFEC; LEARMONT J, 1992, LANCET, V340, P863, DOI 10.1016/0140-6736(92)93281-Q; LEVINSON M, 1996, NEWSWEEK        0325, P38; MASON CJ, 1995, AIDS, V9, P1061, DOI 10.1097/00002030-199509000-00012; *ROCK FOUND, 1994, INT M MARCH 7 11 BEL; SIMONSEN JN, 1990, AIDS, V4, P139, DOI 10.1097/00002030-199002000-00007; TRAVERS K, 1995, SCIENCE, V268, P1612, DOI 10.1126/science.7539936; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; 1995, GLOBAL 2000      DEC	13	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1846	1847		10.1001/jama.275.23.1846	http://dx.doi.org/10.1001/jama.275.23.1846			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642744				2022-12-28	WOS:A1996UQ15200043
J	Gauda, EB; Gleason, CA				Gauda, EB; Gleason, CA			Neonatology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFANTS				Gauda, EB (corresponding author), JOHNS HOPKINS UNIV, SCH MED, BALTIMORE, MD 21205 USA.			Gauda, Estelle/0000-0002-3245-3421				[Anonymous], 1980, PEDIATRICS, V65, P651; BALLARD RA, 1992, LANCET, V339, P510, DOI 10.1016/0140-6736(92)90337-3; BRAVEMAN P, 1995, PEDIATRICS, V96, P716; COOPER WO, 1995, PEDIATRICS, V96, P957; CROWTHER CA, 1995, LANCET, V345, P877; GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031; HACK M, 1995, AM J OBSTET GYNECOL, V172, P457, DOI 10.1016/0002-9378(95)90557-X; HACK M, 1994, NEW ENGL J MED, V331, P753, DOI 10.1056/NEJM199409223311201; JOBE AH, 1993, AM J OBSTET GYNECOL, V168, P508, DOI 10.1016/0002-9378(93)90483-Y; KARI MA, 1994, PEDIATRICS, V93, P730; KESSEL W, 1995, PEDIATRICS, V96, P739; KNIGHT DB, 1994, AM J OBSTET GYNECOL, V171, P11, DOI 10.1016/S0002-9378(94)70070-2; KOTAGAL UR, 1995, J PEDIATR-US, V127, P285, DOI 10.1016/S0022-3476(95)70312-8; LIGGINS GC, 1972, PEDIATRICS, V50, P515; MACDONALD MG, 1995, PEDIATRICS, V96, P734; MAISELS MJ, 1995, PEDIATRICS, V96, P730; MAYA R, 1986, PEDIATR RES, V20, P982; OH W, 1995, PEDIATRICS, V96, P788; OH W, 1995, PEDIATRICS, V96, P974; SCHELLENBERG JC, 1988, J APPL PHYSIOL, V65, P94, DOI 10.1152/jappl.1988.65.1.94	20	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1823	1824		10.1001/jama.275.23.1823	http://dx.doi.org/10.1001/jama.275.23.1823			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642730				2022-12-28	WOS:A1996UQ15200029
J	Calder, SJ; Anderson, GH; Gregg, PJ				Calder, SJ; Anderson, GH; Gregg, PJ			Certification of cause of death in patients dying soon after proximal femoral fracture	BRITISH MEDICAL JOURNAL			English	Article							MORTALITY		UNIV LEICESTER,GLENFIELD GEN HOSP,DEPT ORTHOPAED SURG,LEICESTER LE3 9QP,LEICS,ENGLAND; LEICESTER ROYAL INFIRM,DEPT ORTHOPAED SURG,LEICESTER LE1 5WW,LEICS,ENGLAND	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Leicester					Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		PARKER MJ, 1991, PUBLIC HEALTH, V105, P443, DOI 10.1016/S0033-3506(05)80614-6; WOOD DJ, 1992, J BONE JOINT SURG BR, V74, P199, DOI 10.1302/0301-620X.74B2.1544951; 1992, RIGHTS RESPONSIBILIT, P79	3	19	19	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 15	1996	312	7045					1515	1515		10.1136/bmj.312.7045.1515	http://dx.doi.org/10.1136/bmj.312.7045.1515			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UR823	8646144	Green Published			2022-12-28	WOS:A1996UR82300022
J	Kammerling, RM; Kinnear, A				Kammerling, RM; Kinnear, A			The extent of the two tier service for fundholders	BRITISH MEDICAL JOURNAL			English	Article							PRACTITIONERS	Objective-To examine possible differential changes in outpatient referrals to orthopaedic clinics, attendances, and waiting times between fundholding and non-fundholding general practitioners. Design-observational controlled study of referrals by general practitioners to orthopaedic outpatients between April 1991 and March 1995. Setting-District health authority in south west England. Subjects-10 fundholding practices with 108 300 registered patients; 22 control practices with 159 900 registered patients. Main outcome measures-Changes in age standardised referral and outpatient attendance ratios for the year before and the two years after achieving fundholder status; changes in outpatient waiting times. Results-In the year before achieving fundholding status both groups were referring more patients than were being seen. Two years later, referral and attendance ratios had increased by 13% and 36% respectively for fundholders and 32% and 59% for controls, and both groups were referring fewer patients than were being seen. Attendances represented 112% of referrals for fundholders and 104% for controls. In 1991-2, a similar proportion of patients in the two groups was seen within three months of referral. The two hospitals that set up specific clinics exclusively for fundholders showed faster access for patients of fundholders by 1993-4, as did a third hospital without such clinics by 1994-5. Conclusions-Fundholders increased their orthopaedic referrals less than did controls and achieved a better balance between outpatient appointments and referrals. Their patients were likely to be seen more quickly, particularly if the hospital provided special clinics exclusively for fundholders. Lack of case mix information makes it impossible to judge whether these differences benefit or disadvantage patients.	AVON HLTH,BRISTOL BS2 8EE,AVON,ENGLAND									BAIN J, 1994, BRIT MED J, V309, P396, DOI 10.1136/bmj.309.6951.396; BEECHAM L, 1994, BRIT MED J, V308, P11, DOI 10.1136/bmj.308.6920.11; COULTER A, 1993, BRIT MED J, V306, P433, DOI 10.1136/bmj.306.6875.433; HICKS NR, 1991, BRIT MED J, V302, P991, DOI 10.1136/bmj.302.6783.991; *NHS EX, 1995, REV EXP PAT CHART IM; SAMUEL O, 1992, BRIT MED J, V305, P1497, DOI 10.1136/bmj.305.6867.1497; SURENDER R, 1995, BRIT MED J, V311, P1205, DOI 10.1136/bmj.311.7014.1205; [No title captured]	8	22	22	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 1	1996	312	7043					1399	1401						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP434	8646099				2022-12-28	WOS:A1996UP43400026
J	Novelli, MR; Williamson, JA; Tomlinson, IPM; Elia, G; Hodgson, SV; Talbot, IC; Bodmer, WF; Wright, NA				Novelli, MR; Williamson, JA; Tomlinson, IPM; Elia, G; Hodgson, SV; Talbot, IC; Bodmer, WF; Wright, NA			Polyclonal origin of colonic adenomas in an XO/XY patient with FAP	SCIENCE			English	Article							SOMATIC MUTATION; CLONAL ORIGIN; REPEAT FAMILY; Y-CHROMOSOME; X-CHROMOSOME; CELL; TUMORS; MARKER; MUCOSA	It is widely accepted that tumors are monoclonal in origin, arising from a mutation or series of mutations in a single cell and its descendants. The clonal origin of colonic adenomas and uninvolved intestinal mucosa from an XO/XY mosaic individual with familial adenomatous polyposis (FAP) was examined directly by in situ hybridization with Y chromosome probes. In this patient, the crypts of the small and large intestine were clonal, but at least 76 percent of the microadenomas were polyclonal in origin.	IMPERIAL CANC RES FUND,HUMAN CYTOGENET LAB,LONDON WC2A 3PX,ENGLAND; IMPERIAL CANC RES FUND,HISTOPATHOL UNIT,LONDON WC2A 3PX,ENGLAND; ST MARKS & NORTHWICK PK NATL HLTH SERV TRUST,IMPERIAL CANC RES FUND,COLORECTAL UNIT,HARROW HA1 3UJ,MIDDX,ENGLAND; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT HISTOPATHOL,LONDON W12 0HS,ENGLAND	Cancer Research UK; Cancer Research UK; Imperial College London	Novelli, MR (corresponding author), IMPERIAL CANC RES FUND,CANC GENET LAB,POB 123,44 LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND.		Wright, Nicholas/HHY-7227-2022	Wright, Nicholas/0000-0002-5525-3457; Bodmer, Walter/0000-0001-6244-9792				ALEXANDER P, 1985, BRIT J CANCER, V51, P453, DOI 10.1038/bjc.1985.65; ANDERSSON M, 1986, SCIENCE, V233, P786, DOI 10.1126/science.3738510; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; BEUTLER E, 1967, NEW ENGL J MED, V276, P389, DOI 10.1056/NEJM196702162760706; CARDER PJ, 1995, BRIT J CANCER, V71, P215, DOI 10.1038/bjc.1995.46; COTRAN RS, 1989, ROBBINS PATHOLOGICAL; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FIALKOW PJ, 1979, ANNU REV MED, V30, P135, DOI 10.1146/annurev.me.30.020179.001031; FULLER CE, 1990, BRIT J CANCER, V61, P382, DOI 10.1038/bjc.1990.83; GRIFFITHS DFR, 1988, NATURE, V333, P461, DOI 10.1038/333461a0; HSU SH, 1983, SCIENCE, V221, P951, DOI 10.1126/science.6879192; HUNTER S, 1993, GENE CHROMOSOME CANC, V8, P172, DOI 10.1002/gcc.2870080306; KERSTENS HMJ, 1994, HISTOCHEM CYTOCHEM, V42, P1971; Knudson A. G., 1973, ADV CANCER RES, V17, P317; KONIG JJ, 1994, PROSTATE, V25, P281, DOI 10.1002/pros.2990250602; KOVACS G, 1994, J PATHOL, V173, P39, DOI 10.1002/path.1711730107; PEARSE AGE, 1985, ENDOCRINE TUMOURS, P82; PONDER BAJ, 1985, NATURE, V313, P689, DOI 10.1038/313689a0; PONDER BAJ, 1986, J NATL CANCER I, V77, P967; PYKE R, 1965, J R STAT SOC B, V27, P395; RAGOUSSIS J, 1992, GENOMICS, V14, P673, DOI 10.1016/S0888-7543(05)80167-3; RAO PH, 1993, DIAGN MOL PATHOL, V2, P264, DOI 10.1097/00019606-199312000-00006; RAU D, 1992, HUM GENET, V89, P64, DOI 10.1007/BF00207044; RUBIN H, 1985, CANCER RES, V45, P2935; SANDBERG AA, 1992, J CELL BIOCH S, V161, P76; SCHMIDT GH, 1988, DEVELOPMENT, V103, P785; THOMPSON EM, 1990, DEVELOPMENT, V110, P477; VANDERLUIJT R, 1994, GENOMICS, V20, P1, DOI 10.1006/geno.1994.1119; WILLARD HF, 1983, NUCLEIC ACIDS RES, V11, P2017, DOI 10.1093/nar/11.7.2017; WILLIAMS ED, 1992, AM J PATHOL, V141, P773; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; WOLFE J, 1985, J MOL BIOL, V182, P477, DOI 10.1016/0022-2836(85)90234-7	32	199	201	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 24	1996	272	5265					1187	1190		10.1126/science.272.5265.1187	http://dx.doi.org/10.1126/science.272.5265.1187			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8638166				2022-12-28	WOS:A1996UM88900055
J	Raymond, JL; Lisberger, SG; Mauk, MD				Raymond, JL; Lisberger, SG; Mauk, MD			The cerebellum: A neuronal learning machine?	SCIENCE			English	Article							NICTITATING-MEMBRANE RESPONSE; VESTIBULO-OCULAR REFLEX; PURSUIT EYE-MOVEMENTS; ELECTRO-PHYSIOLOGICAL OBSERVATIONS; CLASSICALLY-CONDITIONED BEHAVIOR; PURKINJE-CELL ACTIVITY; TERM ADAPTIVE-CHANGES; INFERIOR OLIVE; INTERPOSITUS NUCLEUS; UNCONDITIONED STIMULUS	Comparison of two seemingly quite different behaviors yields a surprisingly consistent picture of the role of the cerebellum in motor learning, Behavioral and physiological data about classical conditioning of the eyelid response and motor learning in the vestibuloocular reflex suggest that (i) plasticity is distributed between the cerebellar cortex and the deep cerebellar nuclei; (ii) the cerebellar cortex plays a special role in learning the timing of movement; and (iii) the cerebellar cortex guides learning in the deep nuclei, which may allow learning to be transferred from the cortex to the deep nuclei. Because many of the similarities in the data from the two systems typify general features of cerebellar organization, the cerebellar mechanisms of learning in these two systems may represent principles that apply to many motor systems.	UNIV TEXAS, SCH MED, DEPT ANAT & NEUROBIOL, HOUSTON, TX 77030 USA; UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, WM KECK FDN CTR INTEGRAT NEUROSCI, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, SLOAN CTR THEORET NEUROBIOL, SAN FRANCISCO, CA 94143 USA	University of Texas System; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco				Raymond, Jennifer/0000-0002-8145-747X	NATIONAL EYE INSTITUTE [R01EY010198, R37EY003878, R01EY003878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046904, R29MH046904] Funding Source: NIH RePORTER; NEI NIH HHS [EY03878, EY10198] Funding Source: Medline; NIMH NIH HHS [MH46904] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ALLEY K, 1975, BRAIN RES, V98, P582, DOI 10.1016/0006-8993(75)90375-3; ARSHAVSKY YI, 1972, BRAIN RES, V43, P276, DOI 10.1016/0006-8993(72)90296-X; ARSHAVSKY YI, 1978, BRAIN RES, V151, P493, DOI 10.1016/0006-8993(78)91082-X; BARMACK NH, 1985, J NEUROPHYSIOL, V53, P481, DOI 10.1152/jn.1985.53.2.481; BARMACK NH, 1980, J NEUROPHYSIOL, V43, P182, DOI 10.1152/jn.1980.43.1.182; BERGER TW, 1976, SCIENCE, V192, P483, DOI 10.1126/science.1257783; BERTHIER NE, 1986, EXP BRAIN RES, V63, P341; BRINDLEY GS, 1964, INT BRAIN RES ORG B, V3, P30; BUONOMANO DV, 1994, NEURAL COMPUT, V6, P38, DOI 10.1162/neco.1994.6.1.38; CHAPMAN PF, 1990, BRAIN RES, V537, P149, DOI 10.1016/0006-8993(90)90351-B; CLARK GA, 1984, BRAIN RES, V291, P125, DOI 10.1016/0006-8993(84)90658-9; CLARK RE, 1993, BEHAV NEUROSCI, V107, P264, DOI 10.1037/0735-7044.107.2.264; CLARK RE, 1992, BEHAV NEUROSCI, V106, P879, DOI 10.1037/0735-7044.106.6.879; DAUM I, 1993, BEHAV NEUROSCI, V107, P748, DOI 10.1037/0735-7044.107.5.748; DESMOND JE, 1986, EXP BRAIN RES, V65, P59; DONEGAN NH, 1983, SOC NEUR ABSTR, V9, P331; DUFOSSE M, 1978, BRAIN RES, V150, P611, DOI 10.1016/0006-8993(78)90825-9; DULAC S, 1995, ANNU REV NEUROSCI, V18, P409, DOI 10.1146/annurev.neuro.18.1.409; EDDLES JC, 1967, CEREBELLUM NEURONAL; GALIANA HL, 1985, ADAPTIVE MECHANISMS, P327; Garcia Keith S., 1995, Society for Neuroscience Abstracts, V21, P1222; Gerrits NM, 1987, EXP BRAIN RES SUPPL, V17, P26; GRAF W, 1988, J NEUROPHYSIOL, V60, P2091, DOI 10.1152/jn.1988.60.6.2091; ITO M, 1972, BRAIN RES, V40, P81, DOI 10.1016/0006-8993(72)90110-2; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; ITO M, 1993, NATURE, V363, P24, DOI 10.1038/363024b0; Ito M, 1984, CEREBELLUM NEURAL CO; Ivry R B, 1992, Curr Opin Neurobiol, V2, P212, DOI 10.1016/0959-4388(92)90015-D; IVRY RB, 1988, EXP BRAIN RES, V73, P167, DOI 10.1007/BF00279670; KARAMIAN AI, 1969, NEUROBIOLOGY CEREBEL, P639; KEELE SW, 1990, ANN NY ACAD SCI, V608, P179, DOI 10.1111/j.1749-6632.1990.tb48897.x; KRUPA DJ, 1993, SCIENCE, V260, P989, DOI 10.1126/science.8493536; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LISBERGER SG, 1993, NATURE, V363, P25, DOI 10.1038/363025a0; LISBERGER SG, 1992, NATURE, V360, P159, DOI 10.1038/360159a0; LISBERGER SG, 1994, J NEUROPHYSIOL, V72, P954, DOI 10.1152/jn.1994.72.2.954; LISBERGER SG, 1994, J NEUROPHYSIOL, V72, P928, DOI 10.1152/jn.1994.72.2.928; LISBERGER SG, 1984, J NEUROPHYSIOL, V52, P1140, DOI 10.1152/jn.1984.52.6.1140; LISBERGER SG, 1988, SCIENCE, V242, P771, DOI 10.1126/science.3142040; LISBERGER SG, 1994, J NEUROPHYSIOL, V72, P974, DOI 10.1152/jn.1994.72.2.974; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P733, DOI 10.1152/jn.1978.41.3.733; Llinas R, 1993, Curr Opin Neurobiol, V3, P958, DOI 10.1016/0959-4388(93)90168-X; LUEBKE AE, 1994, EXP BRAIN RES, V98, P379; LUNDBERG A, 1971, EXP BRAIN RES, V12, P317; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MAUK MD, 1992, BEHAV NEUROSCI, V106, P666, DOI 10.1037/0735-7044.106.4.666; MAUK MD, 1986, P NATL ACAD SCI USA, V83, P5349, DOI 10.1073/pnas.83.14.5349; MCCORMICK DA, 1981, B PSYCHONOMIC SOC, V18, P103; MCCORMICK DA, 1984, J NEUROSCI, V4, P2811; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; MCCORMICK DA, 1985, BRAIN RES, V359, P120, DOI 10.1016/0006-8993(85)91419-2; MILES FA, 1980, J NEUROPHYSIOL, V43, P1477, DOI 10.1152/jn.1980.43.5.1477; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; MILES FA, 1980, J NEUROPHYSIOL, V43, P1437, DOI 10.1152/jn.1980.43.5.1437; NAGAO S, 1983, EXP BRAIN RES, V53, P36; OPTICAN LM, 1980, J NEUROPHYSIOL, V44, P1058, DOI 10.1152/jn.1980.44.6.1058; OPTICAN LM, 1985, J NEUROPHYSIOL, V54, P940, DOI 10.1152/jn.1985.54.4.940; PARTSALIS AM, 1995, J NEUROPHYSIOL, V73, P632, DOI 10.1152/jn.1995.73.2.632; PASTOR AM, 1994, J NEUROPHYSIOL, V72, P1383, DOI 10.1152/jn.1994.72.3.1383; PERRETT SP, 1993, J NEUROSCI, V13, P1708; PERRETT SP, 1995, B PSYCHONOMIC SOC, V15, P2074; PETERSON BW, 1991, ANN NY ACAD SCI, V627, P319; POPOV NF, 1929, HIGHER NERVOUS ACTIV, V1, P140; Raymond Jennifer L., 1995, Society for Neuroscience Abstracts, V21, P139; Raymond Jennifer L., 1994, Society for Neuroscience Abstracts, V20, P1194; ROBINSON DA, 1976, J NEUROPHYSIOL, V39, P954, DOI 10.1152/jn.1976.39.5.954; SEARS LL, 1991, BRAIN RES, V545, P114, DOI 10.1016/0006-8993(91)91276-7; STEINMETZ JE, 1989, SYNAPSE, V3, P225, DOI 10.1002/syn.890030308; STONE LS, 1990, J NEUROPHYSIOL, V63, P1241, DOI 10.1152/jn.1990.63.5.1241; STONE LS, 1990, J NEUROPHYSIOL, V63, P1262, DOI 10.1152/jn.1990.63.5.1262; TEMPIA F, 1991, EXP BRAIN RES, V86, P568; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; THOMPSON RF, 1980, PHYSIOL PSYCHOL, V8, P262; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; UEMURA T, 1973, ACTA OTO-LARYNGOL, P1; WATANABE E, 1984, BRAIN RES, V297, P169, DOI 10.1016/0006-8993(84)90555-9; WELSH JP, 1989, J NEUROSCI, V9, P299; WELSH JP, 1991, J PHYSIOL-LONDON, V444, P459, DOI 10.1113/jphysiol.1991.sp018888; WILSON VJ, 1976, J NEUROPHYSIOL, V39, P301, DOI 10.1152/jn.1976.39.2.301; YEO CH, 1992, EXP BRAIN RES, V88, P623; YEO CH, 1985, EXP BRAIN RES, V60, P87, DOI 10.1007/BF00237022; YEO CH, 1985, EXP BRAIN RES, V60, P99, DOI 10.1007/BF00237023; YEO CH, 1986, EXP BRAIN RES, V63, P81	85	462	465	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	1996	272	5265					1126	1131		10.1126/science.272.5265.1126	http://dx.doi.org/10.1126/science.272.5265.1126			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8638157				2022-12-28	WOS:A1996UM88900038
J	Danese, MD; Powe, NR; Sawin, CT; Ladenson, PW				Danese, MD; Powe, NR; Sawin, CT; Ladenson, PW			Screening for mild thyroid failure at the periodic health examination - A decision and cost-effectiveness analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							L-THYROXINE TREATMENT; QUALITY-OF-LIFE; SUBCLINICAL HYPOTHYROIDISM; AUTOIMMUNE-THYROIDITIS; MICROSOMAL ANTIBODIES; MYOCARDIAL-INFARCTION; REPLACEMENT THERAPY; DOUBLE-BLIND; FOLLOW-UP; DISEASE	Objective.-To estimate the cost-effectiveness of periodic screening for mild thyroid failure by measurement of serum thyroid stimulating hormone (TSH) concentration. Design.-Cost-utility analysis using a state-transition computer decision model that accounted for case finding, medical consequences of mild thyroid failure, and costs of care during 40 years of simulated follow-up. Setting.-Periodic health examinations in offices of primary care physicians. Patients.-Hypothetical cohorts of women and men screened every 5 years during the recommended periodic examination, beginning at age 35 years. Interventions.-Adding the serum TSH assay to total serum cholesterol screening was compared to cholesterol screening alone. Main Outcome Measures.-Discounted quality-adjusted life years (QALYs) and direct medical costs from a societal perspective. Results.-The cost-effectiveness of screening 35-year-old patients with a serum TSH assay every 5 years was $9223 per QALY for women and $22 595 per QALY for men. The cost-effectiveness became more favorable when age at first screening was increased for both sexes and was always more favorable for women than men. Reduced progression to overt hypothyroidism and relief of symptoms increased QALYs, but did not substantially reduce direct medical costs. Finding hypercholesterolemia induced by mild thyroid failure reduced direct medical costs, but did not substantially increase QALYs. The cost of a TSH assay and the importance to patients of symptoms associated with thyroid failure were the most influential factors in sensitivity analyses. Conclusions.-The cost-effectiveness of screening for mild thyroid failure compares favorably with other generally accepted preventive medical practices. Physicians should consider measuring serum TSH concentration in patients aged 35 years and older undergoing routine periodic health examinations. The cost-effectiveness of screening is most favorable in elderly women.	JOHNS HOPKINS MED INST,WELCH CTR PREVENT EPIDEMIOL & CLIN RES,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,BALTIMORE,MD; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT HLTH POLICY & MANAGEMENT,BALTIMORE,MD; JOHNS HOPKINS UNIV,SCH MED,DIV GEN INTERNAL MED,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,SCH MED,DIV ENDOCRINOL & METAB,BALTIMORE,MD 21218; DEPT VET AFFAIRS MED CTR,MED SERV,BOSTON,MA; BOSTON UNIV,SCH MED,DEPT MED,BOSTON,MA 02118	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Boston University					NEI NIH HHS [T32 EY07127] Funding Source: Medline; NIA NIH HHS [K01 AG000561] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY007127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG000561] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*AM MED ASS, 1994, PHYS CURR PROC TECHN; [Anonymous], 1994, Circulation, V89, P1333; Arem R, 1995, METABOLISM, V44, P1559, DOI 10.1016/0026-0495(95)90075-6; AREM R, 1990, ARCH INTERN MED, V150, P2097, DOI 10.1001/archinte.150.10.2097; BELL GM, 1985, CLIN ENDOCRINOL, V22, P83, DOI 10.1111/j.1365-2265.1985.tb01068.x; BOGNER U, 1993, ACTA ENDOCRINOL-COP, V128, P202, DOI 10.1530/acta.0.1280202; CHEUNG AP, 1992, MED J AUSTRALIA, V156, P312, DOI 10.5694/j.1326-5377.1992.tb139784.x; COOPER DS, 1984, ANN INTERN MED, V101, P18, DOI 10.7326/0003-4819-101-1-18; DEKONING HJ, 1991, INT J CANCER, V49, P531, DOI 10.1002/ijc.2910490410; DENKE MA, 1994, ARCH INTERN MED, V154, P317, DOI 10.1001/archinte.154.3.317; DIEKMAN T, 1995, ARCH INTERN MED, V155, P1490, DOI 10.1001/archinte.155.14.1490; DOSREMEDIOS LV, 1980, ARCH INTERN MED, V140, P1045, DOI 10.1001/archinte.140.8.1045; DOUBILET P, 1984, NEW ENGL J MED, V310, P95, DOI 10.1056/NEJM198401123100206; EPSTEIN KA, 1981, J CHRON DIS, V34, P175, DOI 10.1016/0021-9681(81)90063-1; FALKENBERG M, 1983, ACTA MED SCAND, V214, P361; FRANKLYN J, 1995, CLIN ENDOCRINOL, V43, P443, DOI 10.1111/j.1365-2265.1995.tb02615.x; FRANKLYN JA, 1993, CLIN ENDOCRINOL, V38, P453, DOI 10.1111/j.1365-2265.1993.tb00339.x; GEUL KW, 1993, CLIN ENDOCRINOL, V39, P275, DOI 10.1111/j.1365-2265.1993.tb02366.x; GORDIN A, 1981, CLIN ENDOCRINOL, V15, P537, DOI 10.1111/j.1365-2265.1981.tb00699.x; HATZIANDREU EI, 1988, AM J PUBLIC HEALTH, V78, P1417, DOI 10.2105/AJPH.78.11.1417; HELFAND M, 1990, ANN INTERN MED, V112, P840, DOI 10.7326/0003-4819-112-11-840; HUNINK MGM, 1994, J VASC SURG, V19, P632, DOI 10.1016/S0741-5214(94)70036-2; HUNNINGHAKE DB, 1993, NEW ENGL J MED, V328, P1213, DOI 10.1056/NEJM199304293281701; KEATING FR, 1961, PROG CARDIOVASC DIS, V3, P364, DOI 10.1016/S0033-0620(61)90004-4; LADENSON PW, 1994, THYROID, V4, P5; LITTENBERG B, 1990, ANN INTERN MED, V112, P192, DOI 10.7326/0003-4819-112-3-192; MILLER DK, 1994, MED DECIS MAKING, V14, P52, DOI 10.1177/0272989X9401400107; MIURA S, 1994, INTERNAL MED, V33, P413, DOI 10.2169/internalmedicine.33.413; MONZANI F, 1993, CLIN INVESTIGATOR, V71, P367; *NAT CTR HLTH STAT, 1993, VIT HLTH STAT, V11, P242; NYSTROM E, 1988, CLIN ENDOCRINOL, V29, P63, DOI 10.1111/j.1365-2265.1988.tb00250.x; NYSTROM E, 1981, ACTA MED SCAND, V210, P89; OLDRIDGE N, 1991, AM J CARDIOL, V67, P1084, DOI 10.1016/0002-9149(91)90870-Q; OSTER G, 1994, STROKE, V25, P1149, DOI 10.1161/01.STR.25.6.1149; PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77; RIDGWAY EC, 1981, J CLIN ENDOCR METAB, V53, P1238, DOI 10.1210/jcem-53-6-1238; RINIKER M, 1981, CLIN ENDOCRINOL, V14, P69, DOI 10.1111/j.1365-2265.1981.tb00366.x; ROSENTHAL MJ, 1987, JAMA-J AM MED ASSOC, V258, P209, DOI 10.1001/jama.258.2.209; SAWIN CT, 1985, ARCH INTERN MED, V145, P1386, DOI 10.1001/archinte.145.8.1386; SCHULMAN KA, 1990, JAMA-J AM MED ASSOC, V264, P3025, DOI 10.1001/jama.264.23.3025; SMURAWSKA LT, 1994, STROKE, V25, P1628, DOI 10.1161/01.STR.25.8.1628; SOLOMON NA, 1994, STROKE, V25, P1721, DOI 10.1161/01.STR.25.9.1721; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P170; STAUB JJ, 1992, AM J MED, V92, P631, DOI 10.1016/0002-9343(92)90782-7; TOFT AD, 1994, NEW ENGL J MED, V331, P174; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; TUNBRIDGE WMG, 1981, BRIT MED J, V282, P258, DOI 10.1136/bmj.282.6260.258; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; *US DEP HHS, 1988, FRAM STUD EP INV CAR; US Department of Health and Human Services National Institutes of Health, 1987, FRAM STUD EP INV CAR; *US DHEW, 1973, FRAM STUD EP INV CAR; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; WARTOFSKY L, 1991, THYROID FUNDAMENTAL, P1084; WITTELS EH, 1990, AM J CARDIOL, V65, P432, DOI 10.1016/0002-9149(90)90806-C; 1996, ANN INTERN MED, V124, P515; 1979, CAN MED ASSOC J, V121, P1; 1994, REDBOOK 1994; 1994, IMS AM; 1981, LANCET, V2, P128	61	161	168	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1996	276	4					285	292		10.1001/jama.276.4.285	http://dx.doi.org/10.1001/jama.276.4.285			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UX583	8656540				2022-12-28	WOS:A1996UX58300033
J	Smith, AR; Chao, KJ; Niu, Q; Shih, CK				Smith, AR; Chao, KJ; Niu, Q; Shih, CK			Formation of atomically flat silver films on GaAs with a ''silver mean'' quasi periodicity	SCIENCE			English	Article							SCANNING TUNNELING MICROSCOPY; BY-LAYER GROWTH; GAP STATES; GAAS(110); AG; MORPHOLOGY; FIBONACCI; CLUSTERS; SURFACE; MODEL	A flat epitaxial silver film on a gallium arsenide [GaAs(110)] surface was synthesized in a two-step process. Deposition of a critical thickness of silver at low temperature led to the formation of a dense nanocluster film. Upon annealing, all atoms rearranged themselves into an atomically flat film. This silver film has a close-packed (111) structure modulated by a ''silver mean'' quasi-periodic sequence. The ability to grow such epitaxial overlayers of metals on semiconductors enables the testing of theoretical models and provides a connection between metal and semiconductor technologies.	UNIV TEXAS,DEPT PHYS,AUSTIN,TX 78712	University of Texas System; University of Texas Austin			Niu, Qian/G-9908-2013	Smith, Arthur/0000-0003-4987-0931				EVANS DA, 1993, PHYS REV LETT, V70, P3483, DOI 10.1103/PhysRevLett.70.3483; FEENSTRA RM, 1989, PHYS REV LETT, V63, P112; FIRST PN, 1989, PHYS REV LETT, V63, P1416, DOI 10.1103/PhysRevLett.63.1416; FRITZ IJ, 1987, APPL PHYS LETT, V51, P1004, DOI 10.1063/1.98984; GUMBS G, 1988, PHYS REV LETT, V60, P1081, DOI 10.1103/PhysRevLett.60.1081; HAMERS RJ, 1990, J VAC SCI TECHNOL A, V8, P195, DOI 10.1116/1.577063; HOLZER M, 1988, PHYS REV B, V38, P1709, DOI 10.1103/PhysRevB.38.1709; JONKER BT, 1991, J VAC SCI TECHNOL B, V9, P2437, DOI 10.1116/1.585717; KUNKEL R, 1990, PHYS REV LETT, V65, P733, DOI 10.1103/PhysRevLett.65.733; LAGALLY MG, 1993, PHYS TODAY, V46, P24, DOI 10.1063/1.881367; MO YW, 1989, SURF SCI, V219, pL551, DOI 10.1016/0039-6028(89)90499-8; PRINZ GA, 1981, APPL PHYS LETT, V39; ROSENFELD G, 1993, PHYS REV LETT, V71, P895, DOI 10.1103/PhysRevLett.71.895; SHIH CK, 1990, J VAC SCI TECHNOL A, V8, P3379, DOI 10.1116/1.576562; SMITH AR, 1995, REV SCI INSTRUM, V66, P2499, DOI 10.1063/1.1145647; SPICER WE, 1980, PHYS REV LETT, V44, P420, DOI 10.1103/PhysRevLett.44.420; STROSCIO JA, 1993, PHYS REV LETT, V70, P3615, DOI 10.1103/PhysRevLett.70.3615; TERSOFF J, 1984, PHYS REV LETT, V52, P465, DOI 10.1103/PhysRevLett.52.465; TRAFAS BM, 1991, PHYS REV B, V43, P14107, DOI 10.1103/PhysRevB.43.14107; VRIJMOETH J, 1994, PHYS REV LETT, V72, P3843, DOI 10.1103/PhysRevLett.72.3843; WALDROP JR, 1979, APPL PHYS LETT, V34, P630, DOI 10.1063/1.90642; WILLIAMS ED, 1991, SCIENCE, V251, P393, DOI 10.1126/science.251.4992.393	22	260	266	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 12	1996	273	5272					226	228		10.1126/science.273.5272.226	http://dx.doi.org/10.1126/science.273.5272.226			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW787	8662503				2022-12-28	WOS:A1996UW78700037
J	Karon, JM; Rosenberg, PS; McQuillan, G; Khare, M; Gwinn, M; Petersen, LR				Karon, JM; Rosenberg, PS; McQuillan, G; Khare, M; Gwinn, M; Petersen, LR			Prevalence of HIV infection in the United States, 1984 to 1992	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS INFECTION; AIDS; BACKCALCULATION	Objective.-To estimate the number of persons infected with the human immunodeficiency virus (HIV) living in the United States and the change in HIV infection prevalence since 1984. Design.-We estimated HIV prevalence from 3 data sources. We estimated past HIV infection rates from a statistical procedure based on national acquired immunodeficiency syndrome (AIDS) case surveillance data and estimates of the time from HIV infection to AIDS diagnosis. We also analyzed HIV prevalence data from 2 national surveys, a survey of childbearing women and a household survey of current health status. We used other data sources to adjust these survey estimates to include groups not covered in the surveys. Results.-Approximately 0.3% of US residents (650 000-900 000 persons) were infected with HIV in 1992, Approximately 0.6% of men (including adolescent boys greater than or equal to 13 years of age) were infected, including approximately 2% of non-Hispanic black men and 1% of Hispanic men, Approximately 0.1% of women (including adolescent girls greater than or equal to 13 years of age) were infected, including approximately 0.6% of non-Hispanic black women. Approximately half of all infected persons were men who had sex with men, and one fourth were injecting drug users. The prevalence of HIV infection increased from 1984 to 1992, with a greater relative increase among women than men. Conclusions.-The 3 different data sources and methods are consistent in estimating that 650 000 to 900 000 persons were infected with HIV in the United States in 1992. Among adolescents and adults of both sexes, the proportion infected was substantially higher among non-Hispanic blacks and Hispanics than among non-Hispanic whites, HIV-related illness will be a major clinical and public health problem in the United States for years to come.	CTR DIS CONTROL & PREVENT,NATL CTR HLTH STAT,DIV HLTH EXAMINAT STAT,ATLANTA,GA 30333; NCI,NIH,ROCKVILLE,MD	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Karon, JM (corresponding author), CTR DIS CONTROL & PREVENT,DIV HIV AIDS PREVENT,NATL CTR HIV STD & TB PREVENT,MAILSTOP E-48,ATLANTA,GA 30333, USA.							BROOKMEYER R, 1991, SCIENCE, V253, P37, DOI 10.1126/science.2063206; Brookmeyer R., 1994, AIDS EPIDEMIOLOGY QU; *CDCP, 1993, HIVNCID1193036 PUBL, V3; Chu SY, 1996, OBSTET GYNECOL, V87, P195, DOI 10.1016/0029-7844(95)00399-1; DAVIS SF, 1995, JAMA-J AM MED ASSOC, V274, P952, DOI 10.1001/jama.274.12.952; EDLIN BR, 1995, 2 NAT C HUM RETR REL; FARIZO KM, 1992, JAMA-J AM MED ASSOC, V267, P1798, DOI 10.1001/jama.267.13.1798; GWINN M, 1991, JAMA-J AM MED ASSOC, V265, P1704, DOI 10.1001/jama.265.13.1704; HAY JW, 1994, APPL STAT-J ROY ST C, V43, P599, DOI 10.2307/2986260; HENDRIKS JCM, 1993, AIDS, V7, P231, DOI 10.1097/00002030-199302000-00012; Holmberg SD, 1996, AM J PUBLIC HEALTH, V86, P642, DOI 10.2105/AJPH.86.5.642; HOOVER DR, 1995, DRUGS, V49, P20, DOI 10.2165/00003495-199549010-00003; KARON JM, IN PRESS US DEP HL D, V821; MCQUILLAN GM, 1994, J ACQ IMMUN DEF SYND, V7, P1195; NELSON KE, 1994, AIDS RES HUM RETROV, V10, pS201; NWANYANWU OC, 1993, AM J PUBLIC HEALTH, V83, P571, DOI 10.2105/AJPH.83.4.571; OSMOND DH, 1994, AM J PUBLIC HEALTH, V84, P1933, DOI 10.2105/AJPH.84.12.1933; Prevots DR, 1996, AM J EPIDEMIOL, V143, P733, DOI 10.1093/oxfordjournals.aje.a008807; Rosenberg Philip S., 1990, Annals of Epidemiology, V1, P105; ROSENBERG PS, 1994, STAT MED, V13, P1975, DOI 10.1002/sim.4780131909; ROSENBERG PS, 1995, SCIENCE, V270, P1372, DOI 10.1126/science.270.5240.1372; ROSENBERG PS, 1991, STAT MED, V10, P1167, DOI 10.1002/sim.4780100802; ROSENBERG PS, 1991, APPL STAT-J ROY ST C, V40, P269; ROSENBLUM L, 1992, AM J PUBLIC HEALTH, V82, P1495, DOI 10.2105/AJPH.82.11.1495; VANHAASTRECHT HJA, 1994, AIDS, V8, P363, DOI 10.1097/00002030-199403000-00011; WEINSTOCK HS, 1995, J ACQ IMMUN DEF SYND, V9, P514; ZACCARELLI M, 1994, AIDS, V8, P345, DOI 10.1097/00002030-199403000-00008; 1990, MMWR-MORBID MORTAL W, V39, P1; 1987, MMWR MORB MORTAL S1S, V36, pS1; 1990, MMWR-MORBID MORTAL W, V39, P117; 1986, PUBLIC HLTH REP, V101, P342; 1991, MMWR-MORBID MORTAL W, V40, P1; 1990, MMWR-MORBID MORTAL W, V39, P110; 1992, MMWR-MORBID MORTAL W, V41, P1; 1994, MMWR-MORBID MORTAL W, V43, P826	35	183	184	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1996	276	2					126	131		10.1001/jama.276.2.126	http://dx.doi.org/10.1001/jama.276.2.126			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UV485	8656504				2022-12-28	WOS:A1996UV48500027
J	Miller, RA				Miller, RA			The aging immune system: Primer and prospectus	SCIENCE			English	Article							T-CELL SUBSETS; AGE-ASSOCIATED DECLINE; LYMPHOCYTES-T; ANTIBODY-RESPONSE; PERIPHERAL-BLOOD; OLD MICE; PHOSPHORYLCHOLINE-ANTIBODY; PROTEIN-PHOSPHORYLATION; REPERTOIRE DIVERSITY; ELDERLY POPULATION	Changes in T lymphocyte populations underlie much of the age related decline in the protective immune response. Aging leads to the replacement of virgin T cells by memory T cells and to the accumuiation of cells with signal transduction defects. Studies of antibody gene assembly, accessory cell function, post-thymic T cell development, skewed selection of T cell receptor repertoire, and the clinical concomitants of immune senescence will shed new light on the causes and consequences of age-dependent immune failure.	DEPT VET AFFAIRS MED CTR, ANN ARBOR, MI 48109 USA		Miller, RA (corresponding author), UNIV MICHIGAN, SCH MED, INST GERONTOL, ANN ARBOR, MI 48104 USA.							ALBRIGHT JW, 1990, J IMMUNOL, V144, P3970; ALBRIGHT JW, 1983, P NATL ACAD SCI-BIOL, V80, P6371, DOI 10.1073/pnas.80.20.6371; ALRAYES H, 1992, J ALLERGY CLIN IMMUN, V90, P630, DOI 10.1016/0091-6749(92)90136-P; BANGS LA, 1991, J IMMUNOL, V146, P1996; BENDER BS, 1986, J AM GERIATR SOC, V34, P649, DOI 10.1111/j.1532-5415.1986.tb04906.x; BOERSMA WJA, 1985, CELL IMMUNOL, V93, P417, DOI 10.1016/0008-8749(85)90146-7; BURTON GF, 1991, IMMUNOLOGY, V73, P271; CALLAHAN JE, 1993, J IMMUNOL, V151, P6657; CALLARD RE, 1978, EUR J IMMUNOL, V8, P552, DOI 10.1002/eji.1830080803; CEUPPENS JL, 1982, J IMMUNOL, V128, P2429; Chen Yifang, 1993, Aging Immunology and Infectious Disease, V4, P155; CHOPRA RK, 1989, CLIN IMMUNOL IMMUNOP, V53, P297, DOI 10.1016/0090-1229(89)90058-5; CHREST FJ, 1995, CYTOMETRY, V20, P33, DOI 10.1002/cyto.990200107; CLARKE GR, 1994, CLIN EXP IMMUNOL, V96, P364; COVELLI V, 1989, J IMMUNOL, V142, P1224; DAYNES RA, 1993, J IMMUNOL, V150, P5219; EFFROS RB, 1994, EXP GERONTOL, V29, P601, DOI 10.1016/0531-5565(94)90073-6; ERNST DN, 1990, J IMMUNOL, V145, P1295; FERGUSON FG, 1995, J GERONTOL A-BIOL, V50, pB378, DOI 10.1093/gerona/50A.6.B378; FULOP T, 1995, FEBS LETT, V375, P69, DOI 10.1016/0014-5793(95)01179-I; GAUCHAT J-F, 1988, Aging Immunology and Infectious Disease, V1, P191; GHOSH J, 1995, MECH AGEING DEV, V80, P171, DOI 10.1016/0047-6374(94)01568-7; GILLIS S, 1981, J CLIN INVEST, V67, P937, DOI 10.1172/JCI110143; GOIDL EA, 1976, J EXP MED, V144, P1037, DOI 10.1084/jem.144.4.1037; GONZALEZQUINTIAL R, 1992, J IMMUNOL, V149, P230; GROSSMANN A, 1990, J GERONTOL, V45, pB81, DOI 10.1093/geronj/45.3.B81; HAYASHI Y, 1989, CLIN EXP IMMUNOL, V78, P120; HINGORANI R, 1993, J IMMUNOL, V151, P5762; HOBBS MV, 1994, CELL IMMUNOL, V154, P264, DOI 10.1006/cimm.1994.1076; HOLMES KL, 1984, MECH AGEING DEV, V25, P243, DOI 10.1016/0047-6374(84)90145-3; Klinman Norman R., 1994, Aging Immunology and Infectious Disease, V5, P203; KROGSRUD RL, 1977, J IMMUNOL, V118, P1607; LANZA E, 1982, NK CELLS OTHER NATUR, P335; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; LERNER A, 1989, EUR J IMMUNOL, V19, P977, DOI 10.1002/eji.1830190604; Li Shaokang P., 1995, Aging Immunology and Infectious Disease, V6, P79; LI SP, 1993, CELL IMMUNOL, V151, P187, DOI 10.1006/cimm.1993.1230; LYNGBYE J, 1971, CLIN CHEM, V17, P495; MANOUSSAKIS MN, 1987, CLIN EXP IMMUNOL, V69, P557; MCCARRON M, 1987, MECH AGEING DEV, V41, P211, DOI 10.1016/0047-6374(87)90041-8; MCELHANEY JE, 1992, J GERONTOL, V47, pM3, DOI 10.1093/geronj/47.1.M3; MILLER C, 1995, J IMMUNOL, V155, P3377; Miller Carla, 1994, Aging Immunology and Infectious Disease, V5, P249; MILLER RA, 1994, J GERONTOL, V49, pB255, DOI 10.1093/geronj/49.6.B255; MILLER RA, 1981, EUR J IMMUNOL, V11, P751, DOI 10.1002/eji.1830111004; MILLER RA, 1984, J IMMUNOL, V133, P2925; MILLER RA, 1987, J CELL PHYSIOL, V132, P337, DOI 10.1002/jcp.1041320220; Miller Richard A., 1995, P555; Murasko D M, 1990, Annu Rev Gerontol Geriatr, V10, P71; MURASKO DM, 1986, AM J MED, V81, P612, DOI 10.1016/0002-9343(86)90546-2; NEGORO S, 1986, MECH AGEING DEV, V36, P223, DOI 10.1016/0047-6374(86)90089-8; NICOLETTI C, 1993, J IMMUNOL, V150, P543; NICOLETTI C, 1991, J IMMUNOL, V147, P2750; PATEL HR, 1992, EUR J IMMUNOL, V22, P253, DOI 10.1002/eji.1830220137; PILARSKI LM, 1991, J IMMUNOL, V147, P830; POSNETT DN, 1994, J EXP MED, V179, P609, DOI 10.1084/jem.179.2.609; POWERS DC, 1993, J INFECT DIS, V167, P584, DOI 10.1093/infdis/167.3.584; PROSS HF, 1982, INT J CANCER, V29, P383, DOI 10.1002/ijc.2910290404; PUEL A, 1995, J IMMUNOL, V154, P5799; RILEY SC, 1989, J IMMUNOL, V143, P3798; ROBERTST.IC, 1974, LANCET, V2, P368; ROCHA B, 1983, J IMMUNOL, V131, P2158; ROCHA B, 1989, EUR J IMMUNOL, V19, P905, DOI 10.1002/eji.1830190518; SCHULZE D H, 1992, Aging Immunology and Infectious Disease, V3, P127; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; SHI J, 1992, J GERONTOL, V47, pB147, DOI 10.1093/geronj/47.5.B147; SMITH GS, 1977, NATURE, V270, P727, DOI 10.1038/270727a0; THOMAN ML, 1989, ADV IMMUNOL, V46, P221, DOI 10.1016/S0065-2776(08)60655-0; THOMAN ML, 1981, J IMMUNOL, V127, P2102; UTSUYAMA M, 1992, MECH AGEING DEV, V63, P57, DOI 10.1016/0047-6374(92)90016-7; WAYNE SJ, 1990, J GERONTOL, V45, pM45, DOI 10.1093/geronj/45.2.M45; WEINDRUCH R, 1983, J IMMUNOL, V130, P993; WENG NP, 1995, P NATL ACAD SCI USA, V92, P11091, DOI 10.1073/pnas.92.24.11091; WHISLER RL, 1995, MECH AGEING DEV, V77, P197, DOI 10.1016/0047-6374(94)01526-R; WITKOWSKI JM, 1993, J IMMUNOL, V150, P1296; Yang XH, 1996, J EXP MED, V183, P959, DOI 10.1084/jem.183.3.959; ZHOU T, 1995, J EXP MED, V182, P129, DOI 10.1084/jem.182.1.129	77	894	919	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	1996	273	5271					70	74		10.1126/science.273.5271.70	http://dx.doi.org/10.1126/science.273.5271.70			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV478	8658199				2022-12-28	WOS:A1996UV47800036
J	Ceska, TA; Sayers, JR; Stier, G; Suck, D				Ceska, TA; Sayers, JR; Stier, G; Suck, D			A helical arch allowing single-stranded DNA to thread through T5 5'-exonuclease	NATURE			English	Article							POLYMERASE-I; 5'-3' EXONUCLEASE; D15 EXONUCLEASE; MECHANISM; PROTEIN; MODELS	THE 5'-exonucleases are enzymes that are essential for DNA replication and repair(1). As well as their exonucleolytic action, removing nucleotides from the 5'-end of nucleic acid molecules such as Okazaki fragments(2), many 5'-3'-exonucleases have been Shown to possess endonucleolytic activities(3,4), T5 5'-3'-exonuclease shares many similarities with the amino termini of eubacterial DNA polymerases(5), although, unlike eubacteria, phages such as T5, T4 and T7 express polymerase and 5'-exonuclease proteins from separate genes, Here we report the 2.5-Angstrom crystal structure of the phage T5 5'-exonuclease, which reveals a helical arch for binding DNA, We propose a model consistent with a threading mechanism in which single-stranded DNA could slide through the arch, which is formed by two helices, one containing positively charged, and the other hydrophobic, residues. The active site is at the base of the arch, and contains two metal-binding sites.	UNIV SHEFFIELD,ROYAL HALLAMSHIRE HOSP,DEPT MED & PHARMACOL,KREBS INST,SECT MOL MED,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND	University of Sheffield	Ceska, TA (corresponding author), EUROPEAN MOLEC BIOL LAB,STRUCT BIOL PROGRAMME,MEYERHOFSTR 1,D-69117 HEIDELBERG,GERMANY.		Sayers, Jon R/I-8974-2012; Sayers, Jon R/AAP-6179-2020	Sayers, Jon R/0000-0002-5082-1443; Sayers, Jon R/0000-0002-5082-1443				[Anonymous], 1993, ACTA CRYSTALLOGR D, V50, P760; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; BRUNGER AT, 1993, X PLOR VERSION 3 1; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; CESKA TA, 1993, J MOL BIOL, V233, P179, DOI 10.1006/jmbi.1993.1496; FUREY W, 1990, AM CRYSTALLOGR ASS 2, V18, P73; GUTMAN PD, 1993, NUCLEIC ACIDS RES, V21, P4406, DOI 10.1093/nar/21.18.4406; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; Kornberg A., 1992, DNA REPLICATION; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; LYAMICHEV V, 1993, SCIENCE, V260, P778, DOI 10.1126/science.7683443; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; NICHOLLS A, 1991, PROTEIN-STRUCT FUNCT, V11, P282; OKAZAKI R, 1971, P NATL ACAD SCI USA, V68, P2954, DOI 10.1073/pnas.68.12.2954; OTWINOWSKI Z, 1993, DENZO; ROBINS P, 1994, J BIOL CHEM, V269, P28535; SAYERS JR, 1990, J BIOL CHEM, V265, P18311; SAYERS JR, 1994, J THEOR BIOL, V170, P415, DOI 10.1006/jtbi.1994.1202; SAYERS JR, 1991, NUCLEIC ACIDS RES, V19, P4127, DOI 10.1093/nar/19.15.4127; SAYERS JR, 1992, BIOTECHNIQUES, V13, P592; SKINNER MM, 1994, P NATL ACAD SCI USA, V91, P2071, DOI 10.1073/pnas.91.6.2071; VELLIEUX FMDAP, 1995, J APPL CRYSTALLOGR, V28, P347, DOI 10.1107/S0021889894012355; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0	26	166	173	1	34	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 4	1996	382	6586					90	93		10.1038/382090a0	http://dx.doi.org/10.1038/382090a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV473	8657312				2022-12-28	WOS:A1996UV47300061
J	Eden, GF; VanMeter, JW; Rumsey, JM; Maisog, JM; Woods, RP; Zeffiro, TA				Eden, GF; VanMeter, JW; Rumsey, JM; Maisog, JM; Woods, RP; Zeffiro, TA			Abnormal processing of visual motion In dyslexia revealed by functional brain imaging	NATURE			English	Article							DEVELOPMENTAL DYSLEXIA; CORTEX; ORGANIZATION; COLOR; CONNECTIONS; PERCEPTION; MOVEMENT; VISION	IT is widely accepted that dyslexics have deficits in reading and phonological awareness(1,2), but there is increasing evidence that they also exhibit visual processing abnormalities that may be confined to particular portions of the visual system(3,4). In primate visual pathways, inputs from parvocellular or magnocellular layers of the lateral geniculate nucleus remain partly segregated in projections to extrastriate cortical areas specialized for processing colour and form versus motion(5-10), In studies of dyslexia, psychophysical(3) and anatomical(4) evidence indicate an anomaly in the magnocellular visual subsystem, To investigate the pathophysiology of dyslexia, we used functional magnetic resonance imaging (fMRI) to study visual motion processing in normal and dyslexic men, In all dyslexics, presentation of moving stimuli failed to produce the same task-related functional activation in area V5/MT (part of the magnocellular visual subsystem) observed in controls, In contrast, presentation of stationary patterns resulted in equivalent activations in V1/V2 and extrastriate cortex in both groups, Although previous studies have emphasized language deficits, our data reveal differences in the regional functional organization of the cortical visual system in dyslexia.	NIMH, CHILD PSYCHIAT BRANCH, NIH, BETHESDA, MD 20892 USA; NIH, LAB DIAGNOST RADIOL RES, OD, BETHESDA, MD 20892 USA; SENSOR SYST INC, STERLING, VA 20164 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT NEUROL, LOS ANGELES, CA 90098 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Eden, GF (corresponding author), NIMH, SECT FUNCT BRAIN IMAGING, NIH, BETHESDA, MD 20892 USA.		Zeffiro, Thomas/AAE-3441-2019; VanMeter, John W/D-2589-2018	Zeffiro, Thomas/0000-0002-0846-4577; VanMeter, John W/0000-0002-7012-5197				BRADLEY L, 1978, NATURE, V271, P746, DOI 10.1038/271746a0; CHENG K, 1995, J NEUROPHYSIOL, V74, P413, DOI 10.1152/jn.1995.74.1.413; CLARKE S, 1990, J COMP NEUROL, V298, P188, DOI 10.1002/cne.902980205; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; CORNELISSEN P, 1995, VISION RES, V35, P1483, DOI 10.1016/0042-6989(95)98728-R; EDEN GF, 1994, VISION RES, V34, P1345, DOI 10.1016/0042-6989(94)90209-7; EDEN GF, 1995, CORTEX, V31, P451, DOI 10.1016/S0010-9452(13)80059-7; KAPLAN E, 1982, J PHYSIOL-LONDON, V330, P125, DOI 10.1113/jphysiol.1982.sp014333; KULIKOWSKI JJ, 1973, J PHYSIOL-LONDON, V232, P149, DOI 10.1113/jphysiol.1973.sp010261; KWONG A, 1992, SOC NEUR ABSTR, V80, P5676; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1991, P NATL ACAD SCI USA, V88, P7943, DOI 10.1073/pnas.88.18.7943; LOVEGROVE WJ, 1980, SCIENCE, V210, P439, DOI 10.1126/science.7433985; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SHAPLEY R, 1986, TRENDS NEUROSCI, V9, P229, DOI 10.1016/0166-2236(86)90064-0; SNOWLING MJ, 1981, PSYCHOL RES-PSYCH FO, V43, P219, DOI 10.1007/BF00309831; Talairach J., 1988, COPLANAR STEREOTAXIC; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; VANESSEN DC, 1983, TRENDS NEUROSCI, V6, P370, DOI 10.1016/0166-2236(83)90167-4; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; ZEFFIRO TA, IN PRESS ADV EXP MED; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0; ZEKI SM, 1973, BRAIN RES, V53, P422, DOI 10.1016/0006-8993(73)90227-8; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313	29	493	505	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	1996	382	6586					66	69		10.1038/382066a0	http://dx.doi.org/10.1038/382066a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV473	8657305				2022-12-28	WOS:A1996UV47300054
J	Marley, MS; Saumon, D; Guillot, T; Freedman, RS; Hubbard, WB; Burrows, A; Lunine, JI				Marley, MS; Saumon, D; Guillot, T; Freedman, RS; Hubbard, WB; Burrows, A; Lunine, JI			Atmospheric, evolutionary, and spectral models of the brown dwarf Gliese 229 B	SCIENCE			English	Article							ABSORPTION	Theoretical spectra and evolutionary models that span the giant planet-brown dwarf continuum have been computed based on the recent discovery of the brown dwarf Gliese 229 B. A flux enhancement in the 4- to 5-micrometer wavelength window is a universal feature from jovian planets to brown dwarfs, Model results confirm the existence of methane and water in the spectrum of Gliese 229 B and indicate that its mass is 30 to 55 jovian masses, Although these calculations focus on Gliese 229 B, they are also meant to guide future searches for extrasolar giant planets and brown dwarfs.	UNIV ARIZONA,LUNAR & PLANETARY LAB,TUCSON,AZ 85721; NASA,AMES RES CTR,MOFFETT FIELD,CA 94035; UNIV ARIZONA,DEPT PHYS,TUCSON,AZ 85721; UNIV ARIZONA,DEPT ASTRON,TUCSON,AZ 85721	University of Arizona; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Arizona; University of Arizona	Marley, MS (corresponding author), NEW MEXICO STATE UNIV,DEPT ASTRON,BOX 30001,DEPT 4500,LAS CRUCES,NM 88003, USA.		Marley, Mark S/I-4704-2013	Guillot, Tristan/0000-0002-7188-8428				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; BELL KL, 1980, J PHYS B-AT MOL OPT, V13, P1859, DOI 10.1088/0022-3700/13/9/016; BERGERON P, 1991, ASTROPHYS J, V367, P253, DOI 10.1086/169624; BORYSOW A, 1990, ASTROPHYS J, V348, pL41, DOI 10.1086/185626; BURROWS A, 1995, NATURE, V375, P299, DOI 10.1038/375299a0; BURROWS A, 1993, ASTROPHYS J, V406, P158, DOI 10.1086/172427; BUTLER RP, IN PRESS ASTROPHYS J; FEGLEY B, 1994, ICARUS, V110, P117, DOI 10.1006/icar.1994.1111; Gatewood G., 1996, B AM ASTRON SOC, V28, P885; GOODY R, 1989, J QUANT SPECTROSC RA, V42, P539, DOI 10.1016/0022-4073(89)90044-7; GUILLOT T, 1994, ICARUS, V112, P337, DOI 10.1006/icar.1994.1188; HILICO JC, 1992, J MOL SPECTROSC, V152, P229, DOI 10.1016/0022-2852(92)90134-A; JOHN TL, 1988, ASTRON ASTROPHYS, V193, P189; LINDAL GF, 1992, ASTRON J, V103, P967, DOI 10.1086/116119; LODDERS K, COMMUNICATION; LUNINE JI, 1986, ASTROPHYS J, V310, P238, DOI 10.1086/164678; MARCY GW, IN PRESS ASTROPHYS J; MARLEY MS, UNPUB; MATTHEWS K, IN PRESS ASTROPHYS J; MATTHEWS K, 1995, 6280 INT ASTR UN; MCKAY CP, 1989, ICARUS, V80, P23, DOI 10.1016/0019-1035(89)90160-7; NAKAJIMA T, 1995, NATURE, V378, P463, DOI 10.1038/378463a0; OPPENHEIMER BR, 1995, SCIENCE, V270, P1478, DOI 10.1126/science.270.5241.1478; POLLACK JB, 1993, ICARUS, V103, P1, DOI 10.1006/icar.1993.1055; Saumon D, 1996, ASTROPHYS J, V460, P993, DOI 10.1086/177027; STRONG K, 1993, J QUANT SPECTROSC RA, V50, P363, DOI 10.1016/0022-4073(93)90072-P; WATTSON RB, 1992, J QUANT SPECTROSC RA, V48, P763, DOI 10.1016/0022-4073(92)90140-Y; WATTSON RB, COMMUNICATION; ZHENG C, 1995, ICARUS, V113, P84, DOI 10.1006/icar.1995.1006	30	238	238	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1996	272	5270					1919	1921		10.1126/science.272.5270.1919	http://dx.doi.org/10.1126/science.272.5270.1919			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8658164	Green Submitted			2022-12-28	WOS:A1996UV29400041
J	Schrag, DP; Hampt, G; Murray, DW				Schrag, DP; Hampt, G; Murray, DW			Pore fluid constraints on the temperature and oxygen isotopic composition of the glacial ocean	SCIENCE			English	Article							DEEP-OCEAN; SEA-LEVEL; BARBADOS; RECORD; AGES	Pore fluids from the upper 60 meters of sediment 3000 meters below the surface of the tropical Atlantic indicate that the oxygen isotopic composition (delta(18)O) of seawater at this site during the last glacial maximum was 0.8 +/- 0.1 per mil higher than it is today. Combined with the delta(18)O change in benthic foraminifera from this region, the elevated ratio indicates that the temperature of deep water in the tropical Atlantic Ocean was 4 degrees C colder during the last glacial maximum. Extrapolation from this site to a global average suggests that the ice volume contribution to the change in delta(18)O of foraminifera is 1.0 per mil, which partially reconciles the foraminiferal oxygen isotope record of tropical sea surface temperatures with estimates from Barbados corals and terrestrial climate proxies.	UNIV CALIF SANTA CRUZ,INST MARINE SCI,SANTA CRUZ,CA 95064; BROWN UNIV,DEPT GEOL SCI,PROVIDENCE,RI 02912	University of California System; University of California Santa Cruz; Brown University	Schrag, DP (corresponding author), PRINCETON UNIV,DEPT GEOL & GEOPHYS SCI,PRINCETON,NJ 08544, USA.							BAINBRIDGE AE, 1976, GEOSECS PACIFIC FINA; BARD E, 1990, NATURE, V345, P405, DOI 10.1038/345405a0; BROECKER WS, 1993, PALEOCEANOGRAPHY, V8, P137, DOI 10.1029/93PA00262; BROECKER WS, 1986, QUATERNARY RES, V26, P121, DOI 10.1016/0033-5894(86)90087-6; *CLIMAP PROJ MEMB, 1981, GEOL SOC AM MAP SER; Curry WB, 1990, PALEOCEANOGRAPHY, V5, P487, DOI 10.1029/PA005i004p00487; CURRY WB, 1995, P OCEAN DRILLING PRO, V154; DANSGAARD W, 1969, SCIENCE, V166, P499, DOI 10.1126/science.166.3904.499; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; FAIRBANKS RG, 1978, QUATERNARY RES, V10, P181, DOI 10.1016/0033-5894(78)90100-X; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; GUILDERSON TP, 1994, SCIENCE, V263, P663, DOI 10.1126/science.263.5147.663; HILLAIREMARCEL C, 1989, QUATERNARY RES, V32, P132; Levitus S., 1982, 13 NOAA; MIX AC, 1984, QUATERNARY RES, V21, P1, DOI 10.1016/0033-5894(84)90085-1; OLAUSSON ERIC, 1965, PROGR OCEANOGR, V3, P221; ONEIL JR, 1969, J CHEM PHYS, V51, P5547, DOI 10.1063/1.1671982; Oppo DW, 1990, PALEOCEANOGRAPHY, V5, P43, DOI 10.1029/PA005i001p00043; Oppo DW, 1990, PALEOCEANOGRAPHY, V5, P277, DOI 10.1029/PA005i003p00277; PORTER SC, 1979, QUATERNARY RES, V12, P161, DOI 10.1016/0033-5894(79)90055-3; SCHRAG DP, 1993, PALEOCEANOGRAPHY, V8, P1, DOI 10.1029/92PA02796; SHACKLETON N, 1967, NATURE, V215, P15, DOI 10.1038/215015a0; Shackleton N.J., 1989, Proceedings of the Ocean Drilling Program Scientific Results, V111, P295, DOI 10.2973/odp.proc.sr.111.150.1989; SHACKLETON NJ, 1987, QUATERNARY SCI REV, V6, P183, DOI 10.1016/0277-3791(87)90003-5; SHACKLETON NJ, 1985, CARBON CYCLE ATMOSPH, P303; SHEMESH A, 1992, SCIENCE, V256, P1434, DOI 10.1126/science.256.5062.1434; SIMPSON JH, 1958, PHYS REV, V111, P1201, DOI 10.1103/PhysRev.111.1201; STUTE M, 1992, SCIENCE, V256, P1000, DOI 10.1126/science.256.5059.1000; SUNDQUIST ET, 1985, AGU MONOGRAPH, P303; Van der Hammen T., 1974, J BIOGEOGR, V1, P3, DOI [10.2307/3038066, DOI 10.2307/3038066]; WEBSTER PJ, 1978, QUATERNARY RES, V10, P279, DOI 10.1016/0033-5894(78)90024-8	31	328	335	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1996	272	5270					1930	1932		10.1126/science.272.5270.1930	http://dx.doi.org/10.1126/science.272.5270.1930			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8662495				2022-12-28	WOS:A1996UV29400046
J	Gu, JG; Albuquerque, C; Lee, CJ; MacDermott, AB				Gu, JG; Albuquerque, C; Lee, CJ; MacDermott, AB			Synaptic strengthening through activation of Ca2+-permeable AMPA receptors	NATURE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; CHANNELS; CALCIUM; CURRENTS; ENTRY	POSTSYNAPTIC Ca2+ elevation during synaptic transmission is an important trigger for short- and long-term changes in synaptic strength in the vertebrate central nervous system(1). The AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate) receptors, a subfamily of glutamate receptors, mediate much of the excitatory synaptic transmission in the brain and spinal cord(2). It has been shown that a subtype of the AMPA receptor is Ca2+ -permeable(3-6) and is present in subpopulations of neurons(7-12). When synaptically localized(13), these receptors should mediate postsynaptic Ca2+ influx, providing a trigger for changes in synaptic strength. Here we show that Ca2+-permeable AMPA receptors are synaptically localized on a subpopulation of dorsal horn neurons, that they provide a synaptically gated route of Ca2+ entry, and that activation of these receptors strengthens synaptic transmission mediated by AMPA receptors. This pathway for postsynaptic Ca2+ influx may provide a new form of activity-dependent modulation of synaptic strength.	COLUMBIA UNIV, DEPT PHYSIOL & CELLULAR BIOPHYS, NEW YORK, NY 10032 USA; COLUMBIA UNIV, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA	Columbia University; Columbia University				Lee, C Justin/0000-0002-3555-0980				ABE T, 1983, J PHYSIOL-LONDON, V339, P243, DOI 10.1113/jphysiol.1983.sp014714; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOCHET P, 1994, NEURON, V12, P383, DOI 10.1016/0896-6273(94)90279-8; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GOLDSTEIN PA, 1995, J NEUROPHYSIOL, V73, P2522, DOI 10.1152/jn.1995.73.6.2522; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Jonas Peter, 1994, Current Opinion in Neurobiology, V4, P366, DOI 10.1016/0959-4388(94)90098-1; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; KYROZIS A, 1995, J PHYSIOL-LONDON, V485, P373, DOI 10.1113/jphysiol.1995.sp020736; LERMA J, 1994, EUR J NEUROSCI, V6, P1080, DOI 10.1111/j.1460-9568.1994.tb00605.x; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MAYER ML, 1987, J NEUROSCI, V7, P3230; MURPHY TH, 1995, NEURON, V15, P159, DOI 10.1016/0896-6273(95)90073-X; OTIS TS, 1995, J PHYSIOL-LONDON, V482, P309, DOI 10.1113/jphysiol.1995.sp020519; REICHLING DB, 1993, J PHYSIOL-LONDON, V469, P67, DOI 10.1113/jphysiol.1993.sp019805; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; SMITH SJ, 1988, CALCIUM ION CHANNEL, P147; WYLLIE DJA, 1994, NEURON, V12, P127, DOI 10.1016/0896-6273(94)90158-9; Yin H z, 1994, Neurobiol Dis, V1, P43, DOI 10.1006/nbdi.1994.0006	28	206	210	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	1996	381	6585					793	796		10.1038/381793a0	http://dx.doi.org/10.1038/381793a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU356	8657283				2022-12-28	WOS:A1996UU35600062
J	Shim, J; Lee, H; Park, J; Kim, H; Choi, EJ				Shim, J; Lee, H; Park, J; Kim, H; Choi, EJ			A non-enzymatic p21 protein inhibitor of stress-activated protein kinases	NATURE			English	Article							TRANSFORMATION; CELLS; JUN	THE stress-activated protein kinases (SAPKs), which are identical to the c-Jun amino-terminal kinases (JNKs), are activated in response to a variety of cellular stresses, including DNA damage, heat shock or tumour-necrosis factor-alpha(1,2). SAPK, a subfamily of the mitogen-activated protein (MAP) kinases, is a major protein kinase that phosphorylates c-Jun and other transcription factors(2-5). SAPK phosphorylation of transcription factors is important in stress-activated signalling cascades(1-6). Here we report that the protein p21(WAF1/CIP1/Sdi1), a DNA-damage-inducible cell-cycle inhibitor(7-10), acts as an inhibitor of the SAPK group of mammalian MAP kinases. This highlights a new biochemical activity of p21, which may provide the first evidence for a non-enzymatic inhibitory protein for SAPK. We suggest that p21, by inhibiting SAPK, may participate in regulating signalling cascades that are activated by cellular stresses such as DNA damage.	HANHYO INST TECHNOL,CELL BIOL LAB,SIHUNG SHI 429010,KYONGKI DO,SOUTH KOREA									AKASHI M, 1995, J BIOL CHEM, V270, P19181, DOI 10.1074/jbc.270.32.19181; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HARPER JW, 1993, CELL, V75, P805; HERRLICH P, 1992, REV PHYSIOL BIOCH P, V119, P187; HILBERG F, 1992, ONCOGENE, V7, P2371; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; NAKANISHI M, 1995, EMBO J, V14, P555, DOI 10.1002/j.1460-2075.1995.tb07031.x; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; OSAWA Y, 1995, BIOCHEM BIOPH RES CO, V216, P429, DOI 10.1006/bbrc.1995.2641; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Vogt P K, 1990, Adv Cancer Res, V55, P1, DOI 10.1016/S0065-230X(08)60466-2; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	29	239	244	0	4	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 27	1996	381	6585					804	807		10.1038/381804a0	http://dx.doi.org/10.1038/381804a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU356	8657286				2022-12-28	WOS:A1996UU35600065
J	LennardJones, JE				LennardJones, JE			Defining ulcer depth in colitis	LANCET			English	Editorial Material											LennardJones, JE (corresponding author), ST MARKS HOSP, HARROW HA1 3UJ, MIDDX, ENGLAND.							ALEMAYEHU G, 1991, AM J GASTROENTEROL, V86, P187; BARTRAM CI, 1983, GASTROINTEST RADIOL, V8, P61, DOI 10.1007/BF01948090; BOERR LAR, 1995, FALK SYMP, V76, P245; BUCKELL NA, 1980, GASTROENTEROLOGY, V79, P19; CARBONNEL F, 1994, DIGEST DIS SCI, V39, P1550, DOI 10.1007/BF02088063; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; Travis SPL, 1996, GUT, V38, P905, DOI 10.1136/gut.38.6.905; TRUELOVE SC, 1978, LANCET, V2, P1086; YOUNG AC, 1963, P ROY SOC MED, V56, P491, DOI 10.1177/003591576305600621	9	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 22	1996	347	9017					1708	1709		10.1016/S0140-6736(96)90800-4	http://dx.doi.org/10.1016/S0140-6736(96)90800-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT396	8656898				2022-12-28	WOS:A1996UT39600002
J	Nickel, JC; Siemens, DR; Lundie, MJ				Nickel, JC; Siemens, DR; Lundie, MJ			Allopurinol for prostatitis: Where is the evidence?	LANCET			English	Editorial Material											Nickel, JC (corresponding author), QUEENS UNIV,DEPT UROL,KINGSTON,ON,CANADA.							DOBLE A, 1991, BR J UROL, V65, P598; NEAL DE, 1994, UROLOGY, V43, P460, DOI 10.1016/0090-4295(94)90231-3; Nickel JC, 1996, J UROLOGY, V155, P1950, DOI 10.1016/S0022-5347(01)66056-7; NICKEL JC, 1996, CURR OPIN UROL, V6, P53; Persson BE, 1996, J UROLOGY, V155, P961, DOI 10.1016/S0022-5347(01)66358-4; Persson BE, 1996, J UROLOGY, V155, P958, DOI 10.1016/S0022-5347(01)66357-2	6	10	10	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 22	1996	347	9017					1711	1712						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT396	8656902				2022-12-28	WOS:A1996UT39600006
J	Rintala, E; Seppala, OP; Kotilainen, P; Rasi, V				Rintala, E; Seppala, OP; Kotilainen, P; Rasi, V			Protein C in the treatment of coagulopathy in meningococcal disease	LANCET			English	Letter							PURPURA		FINNISH RED CROSS & BLOOD TRANSFUS SERV,BLOOD TRANSFUS SERV,DEPT HAEMOSTASIS,HELSINKI,FINLAND		Rintala, E (corresponding author), UNIV TURKU,CENT HOSP,DEPT MED,FIN-20520 TURKU,FINLAND.			Rintala, Esa/0000-0002-9289-8043				ESMON CT, 1995, TRENDS CARDIOVAS MED, V5, P141, DOI 10.1016/1050-1738(95)00054-D; GERSON WT, 1993, PEDIATRICS, V91, P418; GIRAUD T, 1991, ARCH INTERN MED, V151, P310, DOI 10.1001/archinte.151.2.310; RIVARD GE, 1995, J PEDIATR-US, V126, P646, DOI 10.1016/S0022-3476(95)70369-1; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902	5	23	28	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 22	1996	347	9017					1767	1767		10.1016/S0140-6736(96)90845-4	http://dx.doi.org/10.1016/S0140-6736(96)90845-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT396	8656927				2022-12-28	WOS:A1996UT39600051
J	Lindberg, DAB; Humphreys, BL				Lindberg, DAB; Humphreys, BL			Medical informatics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Lindberg, DAB (corresponding author), NATL LIB MED, BETHESDA, MD 20894 USA.							BALL MJ, 1992, ASPECTS COMPUTER BAS, P262; BARBER B, 1994, INT J BIOMED COMPU S, P1; BENSON DA, 1994, NUCLEIC ACIDS RES, V22, P3441, DOI 10.1093/nar/22.17.3441; BLOOM FE, 1995, SCIENCE, V270, P715, DOI 10.1126/science.270.5237.715; Detmer D E, 1995, Yearb Med Inform, P55; GLOWNIAK JV, 1995, ANN INTERN MED, V123, P123, DOI 10.7326/0003-4819-123-2-199507150-00008; LINDBERG DAB, 1995, JAMA-J AM MED ASSOC, V273, P1667, DOI 10.1001/jama.273.21.1667; LINDBERG DAB, 1995, J AM MED INFORM ASSN, V2, P156, DOI 10.1136/jamia.1995.95338868; McCray A T, 1995, Medinfo, V8 Pt 1, P144; MCDONALD CJ, 1995, M D COMPUT, V12, P180; PEREDNIA DA, 1995, JAMA-J AM MED ASSOC, V273, P483, DOI 10.1001/jama.273.6.483; Sanders J H, 1995, Telemed J, V1, P115, DOI 10.1089/tmj.1.1995.1.115; 1995, MD COMPUT, V12, P442; [No title captured]	14	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1821	1822		10.1001/jama.275.23.1821	http://dx.doi.org/10.1001/jama.275.23.1821			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642729				2022-12-28	WOS:A1996UQ15200028
J	Start, RD; Sherwood, SJ; Kent, G; Angel, CA				Start, RD; Sherwood, SJ; Kent, G; Angel, CA			Audit study of next of kin's satisfaction with clinical necropsy service	BRITISH MEDICAL JOURNAL			English	Article									UNIV SHEFFIELD,SHEFFIELD CTR HLTH & RELATED RES,DEPT PSYCHIAT,SHEFFIELD S1 4DA,S YORKSHIRE,ENGLAND	University of Sheffield	Start, RD (corresponding author), UNIV SHEFFIELD,SCH MED,DEPT PATHOL,SHEFFIELD S10 2RX,S YORKSHIRE,ENGLAND.							*DEP HLTH NHS EX, 1995, REP HLTH SERV COMM; SHERWOOD SJ, 1995, POSTGRAD MED J, V71, P269, DOI 10.1136/pgmj.71.835.269; START RD, 1995, J CLIN PATHOL, V48, P497, DOI 10.1136/jcp.48.6.497	3	15	15	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 15	1996	312	7045					1516	1516		10.1136/bmj.312.7045.1516	http://dx.doi.org/10.1136/bmj.312.7045.1516			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR823	8646145	Green Published			2022-12-28	WOS:A1996UR82300023
J	Hill, F; Stark, PB; Stebbins, RT; Anderson, ER; Antia, HM; Brown, TM; Duvall, TL; Haber, DA; Harvey, JW; Hathaway, DH; Howe, R; Hubbard, RP; Jones, HP; Kennedy, JR; Korzennik, SG; Kosovichev, AG; Leibacher, JW; Libbrecht, KG; Pintar, JA; Rhodes, EJ; Schou, J; Thompson, MJ; Tomczyk, S; Toner, CG; Toussaint, R; Williams, WE				Hill, F; Stark, PB; Stebbins, RT; Anderson, ER; Antia, HM; Brown, TM; Duvall, TL; Haber, DA; Harvey, JW; Hathaway, DH; Howe, R; Hubbard, RP; Jones, HP; Kennedy, JR; Korzennik, SG; Kosovichev, AG; Leibacher, JW; Libbrecht, KG; Pintar, JA; Rhodes, EJ; Schou, J; Thompson, MJ; Tomczyk, S; Toner, CG; Toussaint, R; Williams, WE			The solar acoustic spectrum and eigenmode parameters	SCIENCE			English	Article							FREQUENCIES; OSCILLATIONS; CYCLE	The Global Oscillation Network Group (GONG) project estimates the frequencies, amplitudes, acid linewidths of more than 250,000 acoustic resonances of the sun from data sets lasting 36 days. The frequency resolution of a single data set is 0.321 microhertz. For frequencies averaged over the azimuthal order m, the median formal error is 0.044 microhertz, and the associated median fractional error is 1.6 x 10(-5). For a 3-year data set, the fractional error is expected to be 3 x 10(-6). The GONG m-averaged frequency measurements differ from other helioseismic data sets by 0.03 to 0.08 microhertz. The differences arise from a combination of systematic errors, random errors, and possible changes in solar structure.	UNIV CALIF BERKELEY,DEPT STAT,BERKELEY,CA 94720; UNIV CALIF BERKELEY,SPACE SCI LAB,BERKELEY,CA 94720; UNIV COLORADO,JOINT INST LAB ASTROPHYS,BOULDER,CO 80309; TATA INST FUNDAMENTAL RES,BOMBAY 400005,MAHARASHTRA,INDIA; NATL CTR ATMOSPHER RES,HIGH ALTITUDE OBSERV,BOULDER,CO 80307; STANFORD UNIV,NASA,GODDARD SPACE FLIGHT CTR,CTR ASTROPHYS & SPACE SCI,STANFORD,CA; NASA,GEORGE C MARSHALL SPACE FLIGHT CTR,HUNTSVILLE,AL 35812; UNIV LONDON QUEEN MARY & WESTFIELD COLL,ASTRON UNIT,LONDON E1 4NS,ENGLAND; NATL OPT ASTRON OBSERV,NASA,GODDARD SPACE FLIGHT CTR,TUCSON,AZ 85726; HARVARD SMITHSONIAN CTR ASTROPHYS,CAMBRIDGE,MA 02138; CALTECH,PASADENA,CA 91125; UNIV SO CALIF,DEPT PHYS & ASTRON,LOS ANGELES,CA 90089	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Colorado System; University of Colorado Boulder; Tata Institute of Fundamental Research (TIFR); National Center Atmospheric Research (NCAR) - USA; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Stanford University; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; University of London; Queen Mary University London; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Optical Astronomy Observatory; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; California Institute of Technology; University of Southern California	Hill, F (corresponding author), NATL OPT ASTRON OBSERV,NATL SOLAR OBSERV,POB 26732,TUCSON,AZ 85726, USA.		Antia, H./AAV-4222-2021; Duvall, Thomas L/C-9998-2012; Stebbins, Robin/G-5009-2013	Antia, H. M./0000-0001-7549-9684; Tomczyk, Steven/0000-0001-7399-3013; Leibacher, John/0000-0001-7605-3684; Stark, Philip/0000-0002-3771-9604				ANDERSON ER, 1990, ASTROPHYS J, V364, P699, DOI 10.1086/169452; BACHMANN KT, 1993, ASTROPHYS J, V411, pL45, DOI 10.1086/186908; BACHMANN KT, 1995, ASTROPHYS J, V443, P837, DOI 10.1086/175573; BACHMANN KT, 1993, ASTROPHYS J, V412, P870, DOI 10.1086/172969; CHOU DY, 1995, SOL PHYS, V160, P237, DOI 10.1007/BF00732806; DUVALL TL, 1988, ASTROPHYS J, V324, P1158, DOI 10.1086/165971; DUVALL TL, 1993, ASTROPHYS J, V410, P829, DOI 10.1086/172800; ELSWORTH Y, 1990, NATURE, V345, P322, DOI 10.1038/345322a0; ELSWORTH Y, 1993, MON NOT R ASTRON SOC, V265, P888, DOI 10.1093/mnras/265.4.888; ELSWORTH Y, 1994, ASTROPHYS J, V434, P801, DOI 10.1086/174783; GABRIEL M, 1995, ASTRON ASTROPHYS, V299, P245; Gough DO, 1996, SCIENCE, V272, P1296, DOI 10.1126/science.272.5266.1296; GUBAU MA, 1992, ASTRON ASTROPHYS, V255, P363; JEFFERIES SM, 1991, ASTROPHYS J, V377, P330, DOI 10.1086/170362; KORZENNIK SG, 1990, THESIS U CALIFORNIA; LIBBRECHT KG, 1990, NATURE, V345, P779, DOI 10.1038/345779a0; LIBBRECHT KG, 1990, ASTROPHYS J SUPPL S, V74, P1129, DOI 10.1086/191528; LOUDAGH S, 1993, ASTRON ASTROPHYS, V275, pL25; PATRON J, 1994, THESIS U LA LAGUNA; RHODES EJ, 1988, ASTROPHYS J, V326, P479, DOI 10.1086/166109; RHODES EJ, 1991, ADV SPACE RES-SERIES, V11, P17, DOI 10.1016/0273-1177(91)90435-M; RONAN RS, 1994, SOL PHYS, V149, P1, DOI 10.1007/BF00645174; Scherrer PH, 1995, SOL PHYS, V162, P129, DOI 10.1007/BF00733429; SCHOU J, 1992, THESIS U AARHUS; Thompson MJ, 1996, SCIENCE, V272, P1300, DOI 10.1126/science.272.5266.1300; TOMCZYK S, 1995, SOL PHYS, V159, P1, DOI 10.1007/BF00733027; WOODARD MF, 1985, NATURE, V318, P449, DOI 10.1038/318449a0	27	150	150	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1292	1295		10.1126/science.272.5266.1292	http://dx.doi.org/10.1126/science.272.5266.1292			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8662457				2022-12-28	WOS:A1996UN47200033
J	Hoppe, P; Strebel, R; Eberhardt, P; Amari, S; Lewis, RS				Hoppe, P; Strebel, R; Eberhardt, P; Amari, S; Lewis, RS			Type II supernova matter in a silicon carbide grain from the Murchison meteorite	SCIENCE			English	Article							RAY LINE EMISSION; SN-1987A; ANOMALIES; OXYGEN; EJECTA	The circumstellar silicon carbide (SiC) grain X57 from the Murchison meteorite contains large amounts of radiogenic calcium-44 (20 times its solar system abundance) and has an anomalous silicon isotopic composition, different from other circumstellar SiC grains. Its inferred initial Ti-44/Si and Ti-44/Ti-48 ratios are 1.6 x 10(-4) and 0.37. In addition, it contains radiogenic magnesium-26; the inferred initial Al-26/Al-27 ratio is 0.11. The isotopic and elemental data of X57 can be explained by selective mixing of matter from different zones of a typical type II supernova of 25 solar masses during its explosion. The high Ti-44/Si ratio requires contributions from the innermost nickel zone of the supernova to the SiC condensation site, as similarly suggested by astronomical observations.	UNIV CHICAGO,ENRICO FERMI INST,CHICAGO,IL 60637	University of Chicago	Hoppe, P (corresponding author), UNIV BERN,INST PHYS,SIDLERSTR 5,CH-3012 BERN,SWITZERLAND.		Hoppe, Peter/B-3032-2015	Hoppe, Peter/0000-0003-3681-050X				AMARI S, 1992, ASTROPHYS J, V394, pL43, DOI 10.1086/186468; AMARI S, 1995, METEORITICS, V30, P679, DOI 10.1111/j.1945-5100.1995.tb01165.x; AMARI S, 1994, GEOCHIM COSMOCHIM AC, V58, P459, DOI 10.1016/0016-7037(94)90477-4; AMETT D, 1989, ASTROPHYS J, V341, pL63; ANDERS E, 1993, METEORITICS, V28, P490, DOI 10.1111/j.1945-5100.1993.tb00274.x; CLAYTON DD, 1975, NATURE, V257, P36, DOI 10.1038/257036b0; DOTANI T, 1987, NATURE, V330, P230, DOI 10.1038/330230a0; EBLSUZAKI T, 1989, ASTROPHYS J, V344, pL65; FRYXELL B, 1991, ASTROPHYS J, V367, P619, DOI 10.1086/169657; HERANT M, 1992, ASTROPHYS J, V387, P294, DOI 10.1086/171081; HERANT M, 1994, ASTROPHYS J, V425, P814, DOI 10.1086/174026; Hoppe P., 1995, LUNAR PLANET SCI, V26, P621; LARIMER JW, 1979, GEOCHIM COSMOCHIM AC, V43, P1455, DOI 10.1016/0016-7037(79)90140-6; LATTIMER JM, 1978, ASTROPHYS J, V219, P230, DOI 10.1086/155771; MATZ SM, 1988, NATURE, V331, P416, DOI 10.1038/331416a0; MEYER BS, 1995, METEORITICS, V30, P325, DOI 10.1111/j.1945-5100.1995.tb01131.x; MULLER E, 1991, ASTRON ASTROPHYS, V251, P505; NITTLER L, 1995, LUNAR PLANET SCI, V26, P1057; NITTLER LR, IN PRESS ASTROPHYS J; SANDIE WG, 1988, ASTROPHYS J, V334, pL91, DOI 10.1086/185319; SHIGEYAMA T, 1990, ASTROPHYS J, V360, P242, DOI 10.1086/169114; WEAVER TA, 1993, PHYS REP, V227, P65, DOI 10.1016/0370-1573(93)90058-L; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; WOOSLEY SE, 1973, ASTROPHYS J SUPPL S, V26, P231, DOI 10.1086/190282	24	77	77	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1314	1316		10.1126/science.272.5266.1314	http://dx.doi.org/10.1126/science.272.5266.1314			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8662461				2022-12-28	WOS:A1996UN47200038
J	Snell, WJ; White, JM				Snell, WJ; White, JM			The molecules of mammalian fertilization	CELL			English	Review							EGG ZONA PELLUCIDA; TYROSINE KINASE; SPERM RECEPTOR; BINDING; PROTEIN; IDENTIFICATION; FUSION; PURIFICATION; DOMAIN; ZP3		UNIV VIRGINIA,HLTH SCI CTR,DEPT CELL BIOL,CHARLOTTESVILLE,VA 22908	University of Virginia	Snell, WJ (corresponding author), UNIV TEXAS,SW MED CTR,DEPT CELL BIOL & NEUROSCI,DALLAS,TX 75235, USA.				NIGMS NIH HHS [R01 GM025661, GM 25661, GM 48739] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025661, R01GM048739] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN CA, 1995, J CELL SCI, V108, P767; ALMEIDA EAC, 1995, CELL, V81, P1095, DOI 10.1016/S0092-8674(05)80014-5; Berditchevski F, 1996, MOL BIOL CELL, V7, P193, DOI 10.1091/mbc.7.2.193; BLEIL JD, 1988, DEV BIOL, V128, P376, DOI 10.1016/0012-1606(88)90299-0; BLEIL JD, 1990, P NATL ACAD SCI USA, V87, P5563, DOI 10.1073/pnas.87.14.5563; BLOBEL CP, 1992, NATURE, V356, P248, DOI 10.1038/356248a0; BOOKBINDER LH, 1995, SCIENCE, V269, P86, DOI 10.1126/science.7604284; BRONSON RA, 1995, FERTIL STERIL, V64, P414, DOI 10.1016/S0015-0282(16)57744-9; BURKS DJ, 1995, SCIENCE, V269, P83, DOI 10.1126/science.7541556; CARDULLO RA, 1995, BIOCHEMISTRY-US, V34, P10027, DOI 10.1021/bi00031a026; CHENG A, 1994, J CELL BIOL, V125, P867, DOI 10.1083/jcb.125.4.867; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; ELION EA, 1995, J CELL BIOL, V130, P1283, DOI 10.1083/jcb.130.6.1283; EVANS JP, 1995, J CELL SCI, V108, P3267; FLORMAN HM, 1994, DEV BIOL, V165, P152, DOI 10.1006/dbio.1994.1242; FOLTZ KR, 1993, SCIENCE, V259, P1421, DOI 10.1126/science.8383878; FRASER LR, 1994, INT REV CYTOL, V149, P1, DOI 10.1016/S0074-7696(08)62085-9; GONG XH, 1995, SCIENCE, V269, P1718, DOI 10.1126/science.7569899; GOODENOUGH UW, 1995, ANNU REV PLANT PHYS, V46, P21; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; HARDY DM, 1995, J BIOL CHEM, V270, P26025, DOI 10.1074/jbc.270.44.26025; HERRERO P, 1989, J GEN MICROBIOL, V135, P1209; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JAFFE LA, 1996, MOL BIOL MEMBRANE TR; KALAB P, 1994, J BIOL CHEM, V269, P3810; KURVARI V, 1996, P NATL ACAD SCI USA, V193, P39; LECLERC P, 1995, BIOL REPROD, V52, P1227, DOI 10.1095/biolreprod52.6.1227; LEYTON L, 1989, CELL, V57, P1123, DOI 10.1016/0092-8674(89)90049-4; LEYTON L, 1992, P NATL ACAD SCI USA, V89, P11692, DOI 10.1073/pnas.89.24.11692; LEYTON L, 1995, MOL REPROD DEV, V42, P347, DOI 10.1002/mrd.1080420312; LIN Y, 1994, J CELL BIOL, V125, P1157, DOI 10.1083/jcb.125.5.1157; LINDER B, 1995, EXP CELL RES, V221, P66, DOI 10.1006/excr.1995.1353; LIU CF, IN PRESS P NATL ACAD; MILLER DJ, 1993, J CELL BIOL, V123, P1431, DOI 10.1083/jcb.123.6.1431; MILLER DJ, 1992, NATURE, V357, P589, DOI 10.1038/357589a0; MUGA A, 1994, BIOCHEMISTRY-US, V33, P4444, DOI 10.1021/bi00181a002; MYLES DG, 1993, DEV BIOL, V158, P35, DOI 10.1006/dbio.1993.1166; MYLES DG, 1994, P NATL ACAD SCI USA, V91, P4195, DOI 10.1073/pnas.91.10.4195; NIEVA JL, 1994, BIOCHEMISTRY-US, V33, P3201, DOI 10.1021/bi00177a009; OldsClarke P, 1996, MOL REPROD DEV, V43, P94, DOI 10.1002/(SICI)1098-2795(199601)43:1&lt;94::AID-MRD12&gt;3.0.CO;2-4; Parrington J, 1996, NATURE, V379, P364, DOI 10.1038/379364a0; PRIMAKOFF P, 1985, J CELL BIOL, V101, P2239, DOI 10.1083/jcb.101.6.2239; PRIMAKOFF P, 1987, J CELL BIOL, V104, P141, DOI 10.1083/jcb.104.1.141; RALT D, 1991, P NATL ACAD SCI USA, V88, P2840, DOI 10.1073/pnas.88.7.2840; ROLDAN ERS, 1994, SCIENCE, V266, P1578, DOI 10.1126/science.7985030; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; SHUR BD, 1988, J BIOL CHEM, V263, P17706; SHUR BD, 1979, DEV BIOL, V71, P243, DOI 10.1016/0012-1606(79)90167-2; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; SWANSON WJ, 1995, P NATL ACAD SCI USA, V92, P4957, DOI 10.1073/pnas.92.11.4957; THALER CD, 1995, BIOCHEMISTRY-US, V34, P7788, DOI 10.1021/bi00024a002; THALL AD, 1995, J BIOL CHEM, V270, P21437, DOI 10.1074/jbc.270.37.21437; TONG ZB, 1995, J BIOL CHEM, V270, P849, DOI 10.1074/jbc.270.2.849; TOPFERPETERSEN E, 1993, BIOL CHEM H-S, V374, P411, DOI 10.1515/bchm3.1993.374.7-12.411; VANDERHAEGHEN P, 1993, J CELL BIOL, V123, P1441, DOI 10.1083/jcb.123.6.1441; Visconti PE, 1996, MOL REPROD DEV, V43, P82; WALENSKY LD, 1995, J CELL BIOL, V130, P857, DOI 10.1083/jcb.130.4.857; WARD CR, 1994, J BIOL CHEM, V269, P13254; WARD CR, 1993, DEV BIOL, V158, P9, DOI 10.1006/dbio.1993.1165; WASSARMAN PM, 1995, CURR OPIN CELL BIOL, V7, P658, DOI 10.1016/0955-0674(95)80107-3; WASSARMAN PM, 1995, CURR TOP DEV BIOL, V30, P1, DOI 10.1016/S0070-2153(08)60562-1; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; WHITE JM, 1996, IN PRESS COLD SPRING, V60; WOLFSBERG TG, 1995, J CELL BIOL, V131, P275, DOI 10.1083/jcb.131.2.275; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0; Yanagimachi R., 1994, P189; YOUAKIM A, 1994, J CELL BIOL, V126, P1573, DOI 10.1083/jcb.126.6.1573; ZHANG YH, 1991, J BIOL CHEM, V266, P22954	70	212	217	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 31	1996	85	5					629	637		10.1016/S0092-8674(00)81230-1	http://dx.doi.org/10.1016/S0092-8674(00)81230-1			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UP344	8646772	Bronze			2022-12-28	WOS:A1996UP34400004
J	Wignall, PB; Twitchett, RJ				Wignall, PB; Twitchett, RJ			Oceanic anoxia and the end Permian mass extinction	SCIENCE			English	Article							CARBON	Data on rocks from Spitsbergen and the equatorial sections of Italy and Slovenia indicate that the world's oceans became anoxic at both low and high paleolatitudes in the Late Permian. Such conditions may have been responsible for the mass extinction at this time. This event affected a wide range of shelf depths and extended into shallow water well above the storm wave base.			Wignall, PB (corresponding author), UNIV LEEDS,DEPT EARTH SCI,LEEDS LS2 9JT,W YORKSHIRE,ENGLAND.							Adams J.A.S., 1958, AM ASS PET GEOL B, V42, P387, DOI DOI 10.1306/0BDA5A89-16BD-11D7-8645000102C1865D; BALME BE, 1970, U KANS DEP GEOL SPEC, V4, P305; Bottjer D.J., 1988, GEOL SOC AM ABSTR, V20, pA106; BRANDNER R, 1988, BER GEOL BUND WIEN, V15, P3; Broglio Loriga C., 1988, MEM SOC GEOL ITAL, P5; Ding M., 1992, PERMOTRIASSIC EVENTS, P109; DOBRUSKINA IA, 1987, PALAEOGEOGR PALAEOCL, V58, P75, DOI 10.1016/0031-0182(87)90007-1; DROSER ML, 1986, J SEDIMENT PETROL, V56, P558, DOI 10.1306/212F89C2-2B24-11D7-8648000102C1865D; Erwin D. H, 1993, GREAT PALEOZOIC CRIS; GRUSZCZYNSKI M, 1989, NATURE, V337, P64, DOI 10.1038/337064a0; Hallam A., 1994, Canadian Society of Petroleum Geologists Memoir, V17, P797; Hallam A., 1991, Historical Biology, V5, P257; He Jinwen, 1989, Historical Biology, V2, P73; Hochachka P. W., 1984, BIOCH ADAPTATION; Holser W.T., 1991, ABH GEOL BUNDESANSTA, V45, P213; INGALL ED, 1993, GEOCHIM COSMOCHIM AC, V56, P3323; ISHIBASHI T, 1989, Memoirs of the Faculty of Science Kyushu University Series D Geology, V26, P215; Isozaki Yukio, 1994, Canadian Society of Petroleum Geologists Memoir, V17, P805; Jin Y.G., 1994, PERMIAN STRATIGRAPHY, V4, P138; KOZUR H, 1989, ZENTRALBL GEOL PAL 1, V11, P1245; MAGARITZ M, 1992, AM J SCI, V292, P727, DOI 10.2475/ajs.292.10.727; MEYEN SV, 1973, CAN SOC PET GEOL MEM, V2, P662; MYERS KJ, 1987, MARINE CLASTIC ENV N; NAKAZAWA K, 1987, P JPN ACAD B-PHYS, V63, P171, DOI 10.2183/pjab.63.171; Noe S.U., 1987, Facies, V16, P89, DOI 10.1007/BF02536749; Noe Sibylle, 1994, Jahrbuch der Geologischen Bundesanstalt, V137, P297; PAULL RK, 1994, LETHAIA, V27, P271, DOI 10.1111/j.1502-3931.1994.tb01421.x; RENNE PR, 1995, SCIENCE, V269, P1413, DOI 10.1126/science.269.5229.1413; RETALLACK G, IN PRESS INT GEOL C; RETALLACK GJ, 1995, SCIENCE, V267, P77, DOI 10.1126/science.267.5194.77; STANLEY SM, 1994, SCIENCE, V266, P1340, DOI 10.1126/science.266.5189.1340; TWITCHETT RJ, IN PRESS PALAEOGEOGR; VANCAPPELLEN P, 1994, PALEOCEANOGRAPHY, V9, P677, DOI 10.1029/94PA01455; Veevers J.J., 1994, GEOL SOC AM SPEC PAP, V288, P187; WANG K, 1994, GEOLOGY, V22, P580, DOI 10.1130/0091-7613(1994)022<0580:PTEOCE>2.3.CO;2; Wignall P.B., 1995, Historical Biology, V10, P175; WIGNALL PB, 1992, PALAEOGEOGR PALAEOCL, V93, P21, DOI 10.1016/0031-0182(92)90182-5; WIGNALL PB, 1993, PALAEOGEOGR PALAEOCL, V102, P215, DOI 10.1016/0031-0182(93)90068-T; WIGNALL PB, IN PRESS HIST BIOL; WIGNALL PB, IN PRESS PALAIOS; Yang Z. Y., 1992, PERMOTRIASSIC EVENTS, P9; YIN HF, 1988, MEMORIE SOC GEOLOGIC, V34, P329; ZELT FB, 1985, SOC EC PAL MIN FIELD, V4, P49	43	811	946	8	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 24	1996	272	5265					1155	1158		10.1126/science.272.5265.1155	http://dx.doi.org/10.1126/science.272.5265.1155			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8662450				2022-12-28	WOS:A1996UM88900045
J	Higgins, J; Callegari, C; Reho, J; Stienkemeier, F; Ernst, WE; Lehmann, KK; Gutowski, M; Scoles, G				Higgins, J; Callegari, C; Reho, J; Stienkemeier, F; Ernst, WE; Lehmann, KK; Gutowski, M; Scoles, G			Photoinduced chemical dynamics of high-spin alkali trimers	SCIENCE			English	Article							HELIUM CLUSTERS; EXCITED-STATES; SPECTROSCOPY; NA-3; SF6	Nanometer-sized helium droplets, each containing about 10(4) helium atoms, were used as an inert substrate on which to form previously unobserved, spin-3/2 (quartet state) alkali trimers. Dispersed fluorescence measurements reveal that, upon electronic excitation, the quartet trimers undergo intersystem crossing to the doublet manifold, followed by dissociation of the doublet trimer into an atom and a covalently bound singlet dimer. As shown by this work, aggregates of spin-polarized alkali metals represent ideal species for the optical study of fundamental chemical dynamics processes including nonadiabatic spin conversion, change of bonding nature, and unimolecular dissociation.	PRINCETON UNIV, DEPT CHEM, PRINCETON, NJ 08544 USA; UNIV BIELEFELD, FAK PHYS, D-33615 BIELEFELD, GERMANY; PENN STATE UNIV, DEPT PHYS, UNIVERSITY PK, PA 16802 USA; PACIFIC NW LAB, ENVIRONM MOL SCI LAB, RICHLAND, WA 99352 USA; UNIV GDANSK, DEPT CHEM, PL-80952 GDANSK, POLAND	Princeton University; University of Bielefeld; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Fahrenheit Universities; University of Gdansk			Gutowski, Maciej/G-9283-2019; Lehmann, Kevin K./K-6106-2017; Ernst, Wolfgang E/B-3257-2016; Stienkemeier, Frank/P-2527-2019; Stienkemeier, Frank/C-2865-2016	Gutowski, Maciej/0000-0001-5523-7388; Lehmann, Kevin K./0000-0003-3528-8641; Ernst, Wolfgang E/0000-0001-8849-5658; Stienkemeier, Frank/0000-0001-6014-8013; Callegari, Carlo/0000-0001-5491-7752				ANCILOTTO F, 1995, Z PHYS B, V98, P823; BERNSTEIN RB, 1982, CHEM DYNAMICS VIA MO, P168; BONACICKOUTECKY V, 1991, CHEM REV, V91, P1035, DOI 10.1021/cr00005a016; BROYER M, 1988, CHEM PHYS LETT, V145, P232, DOI 10.1016/0009-2614(88)80185-4; BROYER M, 1986, PHYS REV LETT, V57, P1851, DOI 10.1103/PhysRevLett.57.1851; BROYER M, 1989, PHYS REV LETT, V62, P2100, DOI 10.1103/PhysRevLett.62.2100; BUHLER B, 1992, CHEM PHYS LETT, V188, P247, DOI 10.1016/0009-2614(92)90017-H; COCCHINI F, 1988, J CHEM PHYS, V88, P6068, DOI 10.1063/1.454499; ERNST WE, 1995, PHYS REV LETT, V74, P58, DOI 10.1103/PhysRevLett.74.58; FOTH HJ, 1991, Z PHYS D ATOM MOL CL, V18, P257, DOI 10.1007/BF01437080; GOUGH TE, 1985, J CHEM PHYS, V83, P4958, DOI 10.1063/1.449757; HARTMANN M, 1995, PHYS REV LETT, V75, P1566, DOI 10.1103/PhysRevLett.75.1566; HERMANN A, 1979, CHEM PHYS LETT, V62, P216; HIGGINS JB, UNPUB; KUSCH P, 1978, J CHEM PHYS, V68, P2591, DOI 10.1063/1.436117; LEROY RJ, 1995, CP5550 U WAT; LEVINE RD, 1987, MOL REACTION DYNAMIC; PASCALE J, 1983, SERVICE PHYSIQUE ATO; SCHREIBER E, 1995, CHEM PHYS LETT, V242, P106, DOI 10.1016/0009-2614(95)00724-I; STIENKEMEIER F, 1995, PHYS REV LETT, V74, P3592, DOI 10.1103/PhysRevLett.74.3592; STIENKEMEIER F, UNPUB; THOMPSON TC, 1985, J CHEM PHYS, V82, P5597, DOI 10.1063/1.448594; WANG CRC, 1990, J CHEM PHYS, V93, P3787, DOI 10.1063/1.458765; ZURHEYDE MM, 1992, CHEM PHYS LETT, V199, P590	24	128	128	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 2	1996	273	5275					629	631		10.1126/science.273.5275.629	http://dx.doi.org/10.1126/science.273.5275.629			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VA249	8662549				2022-12-28	WOS:A1996VA24900041
J	Huerta, AD; Royden, LH; Hodges, KV				Huerta, AD; Royden, LH; Hodges, KV			The interdependence of deformational and thermal processes in mountain belts	SCIENCE			English	Article							EASTERN NEPAL HIMALAYA; CENTRAL THRUST ZONE; TIBETAN SLAB; METAMORPHISM; CONSTRAINTS; EVOLUTION; GRANITES; MODELS; BUDGET; PATHS	Crustal temperatures within collisional orogens are anomalously high compared with temperatures at comparable depths in stable continents, which is evidence of thermal processes that are fundamental to orogenesis. These temperatures can be explained by the redistribution of crust enriched in heat-producing elements through the accretion of crust from the down-going plate to the upper plate and surface erosion. With the use of geologically reasonable rates, the model results predict high temperatures (over 600 degrees C) and inverted upper-plate geotherms (about 100 degrees C over 20 kilometers) at shallow depths (20 to 40 kilometers) by 25 to 35 million years after collision, This study emphasizes the interdependence of deformational, surficial, and thermal processes.			Huerta, AD (corresponding author), MIT,DEPT EARTH ATMOSPHER & PLANETARY SCI,CAMBRIDGE,MA 02139, USA.		Huerta, Audrey/A-8680-2009; Hodges, Kip/A-7992-2009	Hodges, Kip/0000-0003-2805-8899; Huerta, Audrey/0000-0002-0252-8496				BARR TD, 1989, J GEOPHYS RES-SOLID, V94, P3923, DOI 10.1029/JB094iB04p03923; BIRD P, 1975, J GEOPHYS RES, V80, P4405, DOI 10.1029/JB080i032p04405; BRUNEL M, 1986, CAN J EARTH SCI, V23, P1117, DOI 10.1139/e86-111; DAHLEN FA, 1989, J GEOPHYS RES-SOLID, V94, P3906, DOI 10.1029/JB094iB04p03906; ENGLAND PC, 1986, GEOL SOC LOND SPEC P, V19, P83, DOI DOI 10.1144/GSL.SP.1986.019.01.05; Gansser A., 1964, GEOLOGY HIMALAYA; Hatcher Jr R. D., 1989, APPALACHIAN OUACHITA, VF-2, P233; HODGES KV, 1988, GEOLOGY, V16, P707, DOI 10.1130/0091-7613(1988)016<0707:PTBBCA>2.3.CO;2; HODGES KV, 1988, PHILOS T R SOC A, V326, P257, DOI 10.1098/rsta.1988.0087; HODGES KV, 1994, CONTRIB MINERAL PETR, V117, P151, DOI 10.1007/BF00286839; HOUSEMAN GA, 1981, J GEOPHYS RES, V86, P6115, DOI 10.1029/JB086iB07p06115; HUBBARD MS, 1989, J METAMORPH GEOL, V7, P19, DOI 10.1111/j.1525-1314.1989.tb00572.x; HUBBARD MS, 1989, TECTONICS, V8, P865, DOI 10.1029/TC008i004p00865; KARABINOS P, 1988, J METAMORPH GEOL, V6, P559, DOI 10.1111/j.1525-1314.1988.tb00440.x; LEFORT P, 1975, AM J SCI, VA275, P1; LYONCAEN H, 1985, TECTONICS, V4, P513, DOI 10.1029/TC004i006p00513; MACFARLANE AM, 1992, THESIS MIT; MOLNAR P, 1990, J GEOPHYS RES-SOLID, V95, P4833, DOI 10.1029/JB095iB04p04833; OXBURGH ER, 1974, SCHWEIZ MINER PETROG, V54, P641; PEACOCK M, 1987, METAMORPHISM CRUSTAL, P953; PECHER A, 1989, J METAMORPH GEOL, V7, P31, DOI 10.1111/j.1525-1314.1989.tb00573.x; PINET C, 1987, EARTH PLANET SC LETT, V84, P87, DOI 10.1016/0012-821X(87)90179-8; PITCHER WS, 1987, GEOL RUNDSCH, V76, P51, DOI 10.1007/BF01820573; ROYDEN LH, 1993, J GEOPHYS RES-SOL EA, V98, P4487, DOI 10.1029/92JB01954; RUPPEL C, 1994, TECTONICS, V13, P17, DOI 10.1029/93TC01824; SCAILLET B, 1990, J VOLCANOL GEOTH RES, V44, P163, DOI 10.1016/0377-0273(90)90017-A; SEARLE MP, 1989, J METAMORPH GEOL, V7, P127, DOI 10.1111/j.1525-1314.1989.tb00579.x; SEARLE MP, 1988, TECTONIC EVOLUTION H, P117; SHI YL, 1987, GEOLOGY, V15, P1048, DOI 10.1130/0091-7613(1987)15<1048:TMOTPP>2.0.CO;2; VIDAL P, 1982, GEOCHIM COSMOCHIM AC, V46, P2279, DOI 10.1016/0016-7037(82)90201-0	30	63	64	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 2	1996	273	5275					637	639		10.1126/science.273.5275.637	http://dx.doi.org/10.1126/science.273.5275.637			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VA249	8662552				2022-12-28	WOS:A1996VA24900044
J	Alderman, EL; Andrews, K; Bost, J; Bourassa, M; Chaitman, BR; Detre, K; Faxon, DP; Follmann, D; Frye, RL; Hlatky, M; Jones, RH; Kelsey, SF; Rogers, WJ; Rosen, AD; Schaff, H; Sellers, MA; Sopko, G; Tyrrell, KS; Williams, DO				Alderman, EL; Andrews, K; Bost, J; Bourassa, M; Chaitman, BR; Detre, K; Faxon, DP; Follmann, D; Frye, RL; Hlatky, M; Jones, RH; Kelsey, SF; Rogers, WJ; Rosen, AD; Schaff, H; Sellers, MA; Sopko, G; Tyrrell, KS; Williams, DO			Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; THROMBOLYTIC THERAPY; BALLOON ANGIOPLASTY; RANDOMIZED TRIAL; ARTERY DISEASE; FOLLOW-UP; SURVIVAL; SUBGROUPS	Background Coronary-artery bypass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA) are alternative methods of revascularization in patients with coronary artery disease. We tested the hypothesis that in selected patients with multivessel disease suitable for treatment with either procedure, an initial strategy of PTCA does not result in a poorer five-year clinical outcome than CABG. Methods Patients with multivessel disease were randomly assigned to an initial treatment strategy of CABG (n=914) or PTCA (n=915) and were followed for an average of 5.4 years. Analysis of outcome events was performed according to the intention to treat. Results The respective in-hospital event rates for CABG and PTCA were 1.3 percent and 1.1 percent for mortality, 4.6 percent and 2.1 percent for Q-wave myocardial infarction (P<0.01), and 0.8 percent and 0.2 percent for stroke. The five-year survival rate was 89.3 percent for those assigned to CABG and 86.3 percent for those assigned to PTCA (P=0.19; 95 percent confidence interval of the difference in survival, -0.2 percent to 6.0 percent). The respective five-year survival rates free from Q-wave myocardial infarction were 80.4 percent and 78.7 percent. By five years after study entry, 8 percent of the patients assigned to CABG had undergone additional revascularization procedures, as compared with 54 percent of those as signed to PTCA; 69 percent of those assigned to PTCA did not subsequently undergo CABG. Among diabetic patients who were being treated with insulin or oral hypoglycemic agents at base line, a subgroup not specified by the protocol, five-year survival was 80.6 percent for the CABG group as compared with 65.5 percent for the PTCA group (P=0.003). Conclusions As compared with CABG, an initial strategy of PTCA did not significantly compromise five-year survival in patients with multivessel disease, although subsequent revascularization was required more often with this strategy. For treated diabetics, five-year survival was significantly better after CABG than after PTCA. (C) 1996, Massachusetts Medical Society.	UNIV PITTSBURGH,BARI COORDINATING CTR,PITTSBURGH,PA 15261	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh				Hlatky, Mark/0000-0003-4686-9441; Bourassa, Martial G./0000-0002-4439-8650; Schaff, Hartzell/0000-0003-0994-027X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL038509, U01HL038504, U01HL038493] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL38493, HL38509, HL38504] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALDERMAN EL, 1992, CORONARY ARTERY DIS, V3, P1189; ALDERMAN EL, 1990, CIRCULATION, V82, P1629, DOI 10.1161/01.CIR.82.5.1629; BENETTI FJ, 1995, J CARDIOVASC SURG, V36, P159; BERTRAND M, 1995, 68 SCI SESS PLEN SES; BOURASSA MG, 1995, AM J CARDIOL, V75, pC3, DOI 10.1016/S0002-9149(99)80389-0; BOURASSA MG, 1984, AM J CARDIOL, V53, pC102, DOI 10.1016/0002-9149(84)90759-8; CAMPEAU L, 1978, CIRCULATION, V58, P170; COX DR, 1972, J R STAT SOC B, V34, P187; DETRE K, 1981, CIRCULATION, V63, P1329, DOI 10.1161/01.CIR.63.6.1329; DETRE KM, IN PRESS J AM COLL C; ELLIS SG, 1995, J AM COLL CARDIOL, V25, P1137, DOI 10.1016/0735-1097(94)00541-W; Favaloro R G, 1968, Ann Thorac Surg, V5, P334; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; GRUNTZIG AR, 1979, NEW ENGL J MED, V301, P61, DOI 10.1056/NEJM197907123010201; HLATKY MA, 1995, AM J CARDIOL, V75, pC34; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KING SB, 1994, NEW ENGL J MED, V331, P1044, DOI 10.1056/NEJM199410203311602; KOSINSKI AS, 1995, CIRCULATION S1, V91, P543; MANTEL N, 1959, J NATL CANCER I, V22, P719; MUELLER HS, 1992, CIRCULATION, V85, P1254, DOI 10.1161/01.CIR.85.4.1254; PASSAMANI E, 1985, NEW ENGL J MED, V312, P1665, DOI 10.1056/NEJM198506273122603; POCOCK SJ, 1995, LANCET, V346, P1184, DOI 10.1016/S0140-6736(95)92897-9; Principal Investigators of CASS and Associates, 1981, CIRCULATION S1, V63, pI1; Prineas R., 1982, MINNESOTA CODE MANUA; RAUTAHARJU PM, 1991, J ELECTROCARDIOL S, V24, P179; ROGERS WJ, 1995, AM J CARDIOL, V75, pC9; RYAN T J, 1988, Journal of the American College of Cardiology, V12, P529; SCHAFF HV, 1995, AM J CARDIOL, V75, pC18; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; SHEEHAN FH, 1987, CIRCULATION, V75, P817, DOI 10.1161/01.CIR.75.4.817; TAKARO T, 1976, CIRCULATION, V54, P107; VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603; WILLIAMS DO, 1995, AM J CARDIOL, V75, pC27; 1991, CIRCULATION S5, V84, P1; 1984, NEW ENGL J MED, V311, P1333	35	1269	1315	4	12	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	1996	335	4					217	225						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ532	8657237				2022-12-28	WOS:A1996UZ53200001
J	Chen, JT; Thomas, EL; Ober, CK; Mao, GP				Chen, JT; Thomas, EL; Ober, CK; Mao, GP			Self-assembled smectic phases in rod-coil block copolymers	SCIENCE			English	Article							RIGID BACKBONE POLYMERS; LIQUID-CRYSTAL; POLYISOCYANATES; AGGREGATION; BEHAVIOR	Rod-coil block copolymers are self-assembling polymers that combine the physics of orientational ordering of rodlike polymers and the microphase separation of coil-coil block copolymers. Several new solid-state morphologies were observed in a series of anionically synthesized model poly(hexyl isocyanate-b-styrene) rod-coil diblock copolymers examined by transmission electron microscopy and selected-area electron diffraction. The rod-coils formed smectic C-like and O-like morphologies with domain sizes ranging from tens of nanometers to almost 1 micrometer, Both structural and orientational changes were found for increasing rod volume fractions. In addition, some morphologies exhibited spontaneous long-range orientational order over many tens of micrometers.	MIT,DEPT MAT SCI & ENGN,CAMBRIDGE,MA 02139; CORNELL UNIV,DEPT MAT SCI & ENGN,ITHACA,NY 14853	Massachusetts Institute of Technology (MIT); Cornell University			Ober, Christopher/AAI-1568-2019	Ober, Christopher/0000-0002-3805-3314; Thomas, Edwin/0000-0001-5911-6524				AHARONI SM, 1979, MACROMOLECULES, V12, P94, DOI 10.1021/ma60067a021; AHARONI SM, 1980, J POLYM SCI POL PHYS, V18, P1439, DOI 10.1002/pol.1980.180180622; AHARONI SM, 1979, MACROMOLECULES, V12, P271, DOI 10.1021/ma60068a021; BARENBERG S, 1981, INT J BIOL MACROMOL, V3, P82, DOI 10.1016/0141-8130(81)90072-6; BERGER MN, 1973, J MACROMOL SCI R M C, VC  9, P269, DOI 10.1080/15583727308545900; BUR AJ, 1976, CHEM REV, V76, P727, DOI 10.1021/cr60304a003; CHANDANI ADL, 1989, JPN J APPL PHYS 2, V28, pL1265, DOI 10.1143/JJAP.28.L1265; CHEN JT, 1995, MACROMOLECULES, V28, P1688, DOI 10.1021/ma00109a048; CLOUGH SB, 1975, CHARACTERIZATION MAT, P417; DOUY A, 1977, POLYM ENG SCI, V17, P523, DOI 10.1002/pen.760170807; DOUY A, 1987, POLYMER, V28, P147, DOI 10.1016/0032-3861(87)90329-6; FLORY PJ, 1956, PROC R SOC LON SER-A, V234, P73, DOI 10.1098/rspa.1956.0016; FREDRICKSON GH, 1990, ANNU REV PHYS CHEM, V41, P525; GALERNE Y, 1990, PHYS REV LETT, V64, P906, DOI 10.1103/PhysRevLett.64.906; GALERNE Y, 1991, PHYS REV LETT, V66, P2891, DOI 10.1103/PhysRevLett.66.2891; GUROVICH E, IN PRESS MACROMOLECU; HALPERIN A, 1990, MACROMOLECULES, V23, P2724, DOI 10.1021/ma00212a023; HALPERIN A, 1989, EUROPHYS LETT, V10, P549, DOI 10.1209/0295-5075/10/6/008; HAMELIN P, 1993, J PHYS II, V3, P681, DOI 10.1051/jp2:1993160; HOLYST R, 1992, J CHEM PHYS, V26, P730; LEIBLER L, 1980, MACROMOLECULES, V13, P1602, DOI 10.1021/ma60078a047; LEVELUT AM, 1983, J PHYS-PARIS, V44, P623, DOI 10.1051/jphys:01983004405062300; NAKAJIMA A, 1979, MACROMOLECULES, V12, P840, DOI 10.1021/ma60071a010; PERLY B, 1976, MAKROMOL CHEM, V177, P2569; RADZILOWSKI LH, 1993, MACROMOLECULES, V26, P879, DOI 10.1021/ma00056a053; RADZILOWSKI LH, 1994, MACROMOLECULES, V27, P7747, DOI 10.1021/ma00104a033; RAPHAEL E, 1991, PHYSICA A, V177, P294, DOI 10.1016/0378-4371(91)90166-A; RAPHAEL E, 1992, MAKROMOL CHEM-M SYMP, V62, P1, DOI 10.1002/masy.19920620104; SEMENOV AN, 1986, SOV PHYS JETP, V63, P1; WILLIAMS DRM, 1992, MACROMOLECULES, V25, P3561, DOI 10.1021/ma00039a040	30	406	416	4	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 19	1996	273	5273					343	346		10.1126/science.273.5273.343	http://dx.doi.org/10.1126/science.273.5273.343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY202	8662518				2022-12-28	WOS:A1996UY20200035
J	Kivelson, MG; Khurana, KK; Walker, RJ; Russell, CT; Linker, JA; Southwood, DJ; Polanskey, C				Kivelson, MG; Khurana, KK; Walker, RJ; Russell, CT; Linker, JA; Southwood, DJ; Polanskey, C			A magnetic signature at Io: Initial report from the Galileo magnetometer	SCIENCE			English	Article							FLOW PAST IO; MHD SIMULATION; CURRENT SYSTEM; PLASMA TORUS; JUPITER; ALFVEN; MAGNETOSPHERE; SATELLITES; ATMOSPHERE; FIELD	During the inbound pass of the Galileo spacecraft, the magnetometer acquired 1 minute averaged measurements of the magnetic field along the trajectory as the spacecraft flew by lo. A field decrease, of nearly 40 percent of the background jovan field at closest approach to lo, was recorded. Plasma sources alone appear incapable of generating perturbations as large as those observed and an induced source for the observed moment implies an amount of free iron in the mantle much greater than expected. On the other hand, an intrinsic magnetic field of amplitude consistent with dynamo action at lo would explain the observations. It seems plausible that lo, like Earth and Mercury, is a magnetized solid planet.	SCI APPLICAT INT CORP,SAN DIEGO,CA 92171; UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,DEPT PHYS,LONDON SW7 2BZ,ENGLAND; CALTECH,JET PROP LAB,PASADENA,CA 91109	Science Applications International Corporation (SAIC); Imperial College London; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Kivelson, MG (corresponding author), UNIV CALIF LOS ANGELES,INST GEOPHYS & PLANETARY PHYS,LOS ANGELES,CA 90095, USA.		Russell, Christopher T/E-7745-2012; Kivelson, Margaret G/I-9019-2012	Russell, Christopher T/0000-0003-1639-8298; Kivelson, Margaret G/0000-0003-3859-8581; Khurana, Krishan/0000-0002-2856-1171				Anderson JD, 1996, SCIENCE, V272, P709, DOI 10.1126/science.272.5262.709; BIGG EK, 1964, NATURE, V203, P1088; BLACKETT PMS, 1947, NATURE, V159, P658, DOI 10.1038/159658a0; Brown R. A., 1974, EXPLORATION PLANETAR, P527; CARMICHAEL RS, 1989, PRACTICAL HDB PHYSIC; Carr T.D., 1983, PHYS JOVIAN MAGNETOS, P226, DOI [10.1017/cbo9780511564574.009, DOI 10.1017/CBO9780511564574.009]; CONNERNEY JEP, 1981, J GEOPHYS RES-SPACE, V86, P7679, DOI 10.1029/JA086iA09p07679; CONNERNEY JEP, 1981, J GEOPHYS RES-SPACE, V86, P8370, DOI 10.1029/JA086iA10p08370; CONNERNEY JEP, 1993, SCIENCE, V262, P1035, DOI 10.1126/science.262.5136.1035; CONSOLMAGNO GJ, 1981, ICARUS, V47, P36, DOI 10.1016/0019-1035(81)90089-0; GOERTZ CK, 1980, J GEOPHYS RES-SPACE, V85, P2949, DOI 10.1029/JA085iA06p02949; GOLDREICH P, 1969, ASTROPHYS J, V156, P59, DOI 10.1086/149947; HERBERT F, 1985, J GEOPHYS RES-SPACE, V90, P8241, DOI 10.1029/JA090iA09p08241; Hill T. W., 1983, PHYSICS JOVIAN MAGNE, P353, DOI DOI 10.1017/CBO9780511564574.012; KHURANA KK, UNPUB; KIVELSON MG, 1979, SCIENCE, V205, P491, DOI 10.1126/science.205.4405.491; KIVELSON MG, 1992, SPACE SCI REV, V60, P357, DOI 10.1007/BF00216862; KLIORE A, 1974, SCIENCE, V183, P323, DOI 10.1126/science.183.4122.323; KUPO I, 1976, ASTROPHYS J, V205, pL51, DOI 10.1086/182088; LEVY EH, 1979, P LUNAR PLANET SCI C, V10, P2335; LINKER JA, 1988, GEOPHYS RES LETT, V15, P1311, DOI 10.1029/GL015i011p01311; LINKER JA, 1989, GEOPHYS RES LETT, V16, P763, DOI 10.1029/GL016i007p00763; LINKER JA, 1991, J GEOPHYS RES-SPACE, V96, P21037, DOI 10.1029/91JA02132; LINKER JA, IN PRESS ADV SPACE R; LINKER JA, 1995, EOS, V76, pF343; MORABITO LA, 1979, SCIENCE, V204, P972, DOI 10.1126/science.204.4396.972; NESS NF, 1979, SCIENCE, V204, P982, DOI 10.1126/science.204.4396.982; NEUBAUER FM, 1978, GEOPHYS RES LETT, V5, P905, DOI 10.1029/GL005i011p00905; NEUBAUER FM, 1980, J GEOPHYS RES-SPACE, V85, P1171, DOI 10.1029/JA085iA03p01171; PEALE SJ, 1979, SCIENCE, V203, P892, DOI 10.1126/science.203.4383.892; PIDDINGTON JH, 1968, NATURE, V217, P935, DOI 10.1038/217935a0; Prange R, 1996, NATURE, V379, P323, DOI 10.1038/379323a0; RUSSELL CT, 1978, NATURE, V272, P147, DOI 10.1038/272147a0; SCHNEIDER NM, 1991, ASTROPHYS J, V368, P298, DOI 10.1086/169694; SMYTH WH, 1992, ADV SPACE RES-SERIES, V12, P337, DOI 10.1016/0273-1177(92)90408-P; SMYTH WH, 1991, J GEOPHYS RES-PLANET, V96, P22711, DOI 10.1029/91JE02505; SOUTHWOOD DJ, 1980, J GEOPHYS RES-SPACE, V85, P5959, DOI 10.1029/JA085iA11p05959; STROBEL DF, 1994, ICARUS, V111, P18, DOI 10.1006/icar.1994.1130; WIENBRUCH U, 1995, PLANET SPACE SCI, V43, P1045, DOI 10.1016/0032-0633(95)00039-8; WOLFGLADROW DA, 1987, J GEOPHYS RES, V92, P9949, DOI 10.1029/JA092iA09p09949	40	90	93	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 19	1996	273	5273					337	340		10.1126/science.273.5273.337	http://dx.doi.org/10.1126/science.273.5273.337			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY202	8662516				2022-12-28	WOS:A1996UY20200033
J	OConnor, H; Magos, A				OConnor, H; Magos, A			Endometrial resection for the treatment of menorrhagia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYSTEROSCOPIC TREATMENT; ABDOMINAL HYSTERECTOMY; YAG LASER; ABLATION; MANAGEMENT; LEIOMYOMAS	Background Endometrial resection is an alternative to hysterectomy in the treatment of women with menorrhagia, but it may not control the condition. We sought to evaluate the effectiveness of such resection. Methods We followed 525 consecutive women (mean age at initial surgery, 42 years) for up to five years after endometrial resection. The women were examined 6 to 12 weeks after the operation and were then sent yearly questionnaires seeking information about their condition. The mean duration of followup was 31 months. Thirty-seven women (86 percent of the 43 women available for five years of follow-up) were followed for the entire period. Results Endometrial resection was completed successfully in 95 percent of the women, with operative complications in 6 percent. Forty-eight women underwent subsequent resection. The yearly questionnaires indicated that 85 to 100 percent of the women (depending on the year of follow-up) had adequately controlled menorrhagia, 26 to 40 percent had amenorrhea, 71 to 80 percent reported either a lessening of menstrual pain or no pain, and 79 to 87 percent were satisfied with the results of their surgery. No further surgery was needed by 80 percent of the women, and only 9 percent underwent hysterectomy during the five years of follow-up, with 98 percent of those operations being performed in the first three postoperative years. Conclusions Endometrial resection is an effective alternative to hysterectomy in women with menorrhagia. (C) 1996, Massachusetts Medical Society.	UNIV LONDON,ROYAL FREE HOSP,DEPT OBSTET & GYNAECOL,MINIMALLY INVAS THERAPY UNIT,LONDON NW3 2QG,ENGLAND; UNIV LONDON,ROYAL FREE HOSP,DEPT OBSTET & GYNAECOL,ENDOSCOPY TRAINING CTR,LONDON NW3 2QG,ENGLAND	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School								ANDERSSON JK, 1990, BRIT J OBSTET GYNAEC, V97, P690, DOI 10.1111/j.1471-0528.1990.tb16240.x; ARMITAGE P, 1987, STATISTICAL METHODS, P408; BAUMANN R, 1990, BRIT MED J, V300, P304, DOI 10.1136/bmj.300.6720.304; BROADBENT JAM, 1992, BRIT J OBSTET GYNAEC, V99, P1018; BROOKS PG, 1991, AM J OBSTET GYNECOL, V164, P1601, DOI 10.1016/0002-9378(91)91443-Z; COOPER MJW, 1992, GYNAECOL ENDOSC, V1, P195; COULTER A, 1994, LANCET, V344, P1367, DOI 10.1016/S0140-6736(94)90727-7; DANIELL JF, 1992, OBSTET GYNECOL, V80, P329; DAVIS JA, 1989, BRIT J OBSTET GYNAEC, V96, P928, DOI 10.1111/j.1471-0528.1989.tb03347.x; DERMAN SG, 1991, OBSTET GYNECOL, V77, P591; DWYER N, 1993, BRIT J OBSTET GYNAEC, V100, P237, DOI 10.1111/j.1471-0528.1993.tb15237.x; EWEN SP, 1994, GYNAECOL ENDOSC, V3, P167; GANNON MJ, 1991, BRIT MED J, V303, P1362, DOI 10.1136/bmj.303.6814.1362; GARRY R, 1991, BRIT J OBSTET GYNAEC, V98, P357, DOI 10.1111/j.1471-0528.1991.tb13425.x; GIMPELSON RJ, 1992, J REPROD MED, V37, P629; GOLDRATH MH, 1981, AM J OBSTET GYNECOL, V140, P14, DOI 10.1016/0002-9378(81)90251-9; HILL D, 1992, GYNAECOL ENDOSC, V1, P185; INDMAN PD, 1993, OBSTET GYNECOL, V81, P716; LOCKWOOD M, 1990, BRIT J OBSTET GYNAEC, V97, P656, DOI 10.1111/j.1471-0528.1990.tb02562.x; MAGOS AL, 1990, BRIT MED J, V300, P1537, DOI 10.1136/bmj.300.6739.1537; MAGOS AL, 1991, LANCET, V337, P1074, DOI 10.1016/0140-6736(91)91718-A; MAGOS AL, 1989, LANCET, V2, P925; MAGOS AL, 1989, BRIT MED J, V298, P1428; MAGOS AL, 1989, BRIT MED J, V298, P1209, DOI 10.1136/bmj.298.6682.1209; MAGOS AL, 1991, LANCET, V337, P1362; MAHER PJ, 1990, AUST NZ J OBSTET GYN, V30, P357, DOI 10.1111/j.1479-828X.1990.tb02029.x; MARSH M, 1994, MISTLETOE UPDATE; NEUWIRTH RS, 1978, AM J OBSTET GYNECOL, V131, P91, DOI 10.1016/0002-9378(78)90481-7; PHIPPS JH, 1990, LANCET, V335, P374, DOI 10.1016/0140-6736(90)90207-L; PINION SB, 1994, BRIT MED J, V309, P979, DOI 10.1136/bmj.309.6960.979; SINGER A, 1994, OBSTET GYNECOL, V83, P732; VANCAILLIE TG, 1989, OBSTET GYNECOL, V74, P425; WORTMAN M, 1994, OBSTET GYNECOL, V83, P295	33	175	177	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	1996	335	3					151	156		10.1056/NEJM199607183350302	http://dx.doi.org/10.1056/NEJM199607183350302			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW790	8657212				2022-12-28	WOS:A1996UW79000002
J	Ramsey, BW				Ramsey, BW			Drug therapy - Management of pulmonary disease in patients with cystic fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PSEUDOMONAS-AERUGINOSA INFECTION; ALTERNATE-DAY PREDNISONE; MEDIATED GENE-TRANSFER; CHEST PHYSIOTHERAPY; AIRWAY EPITHELIA; LUNG; CIPROFLOXACIN; TOBRAMYCIN; ACTIVATION; SPUTUM				Ramsey, BW (corresponding author), UNIV WASHINGTON,SCH MED,DEPT PEDIAT,CYST FIBROSIS RES CTR,BOX 359301,SEATTLE,WA 98195, USA.				NIDDK NIH HHS [P50 NIH DK 47754] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK047754] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABMAN SH, 1991, J PEDIATR-US, V119, P211, DOI 10.1016/S0022-3476(05)80729-2; ABRAMOWSKY CR, 1982, HUM PATHOL, V13, P934, DOI 10.1016/S0046-8177(82)80056-7; ALTON EWFW, 1995, GENE THER, V2, P88; ARENS R, 1994, AM J RESP CRIT CARE, V150, P1154, DOI 10.1164/ajrccm.150.4.7921452; ARONOFF SC, 1994, J PEDIATR-US, V125, P992, DOI 10.1016/S0022-3476(05)82022-0; AUERBACH HS, 1985, LANCET, V2, P686; BEARDSMORE CS, 1994, ARCH DIS CHILD, V71, P133, DOI 10.1136/adc.71.2.133; BERGER M, 1989, J CLIN INVEST, V84, P1302, DOI 10.1172/JCI114298; BLUMBERG HM, 1991, J INFECT DIS, V163, P1279, DOI 10.1093/infdis/163.6.1279; BOSSO JA, 1987, AM J MED, V82, P180; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; BOUCHER RC, 1992, DRUGS, V43, P431, DOI 10.2165/00003495-199243040-00001; BRAGGION C, 1995, PEDIATR PULM, V19, P16, DOI 10.1002/ppul.1950190104; BRUCE MC, 1985, AM REV RESPIR DIS, V132, P529; BRUMMETT RE, 1980, DRUGS, V19, P412, DOI 10.2165/00003495-198019060-00002; BURKHARDT JE, 1990, VET PATHOL, V27, P162, DOI 10.1177/030098589002700303; BURNSTOCK G, 1990, ANN NY ACAD SCI, V603, P1; CAPLEN NJ, 1995, NAT MED, V1, P39, DOI 10.1038/nm0195-39; CHYSKY V, 1991, INFECTION, V19, P289, DOI 10.1007/BF01644970; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; CRYSTAL RG, 1994, NAT GENET, V8, P42, DOI 10.1038/ng0994-42; DAVIS PB, 1994, NEW ENGL J MED, V331, P672, DOI 10.1056/NEJM199409083311011; DEGROOT R, 1987, CLIN PHARMACOKINET, V13, P228, DOI 10.2165/00003088-198713040-00002; DESMOND KJ, 1983, J PEDIATR-US, V103, P538, DOI 10.1016/S0022-3476(83)80579-4; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; DRUMM ML, 1993, CELL, V74, P215; EGGLESTON PA, 1988, CHEST, V94, P360, DOI 10.1378/chest.94.2.360; EIGEN H, 1995, J PEDIATR-US, V126, P515, DOI 10.1016/S0022-3476(95)70343-8; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; HARPER TB, 1980, LUNG, V157, P219; HODSON ME, 1987, LANCET, V1, P235; ISLES A, 1983, AM REV RESPIR DIS, V127, P417, DOI 10.1164/arrd.1983.127.4.417; Jensen T, 1989, Antibiot Chemother (1971), V42, P237; JENSEN T, 1987, J ANTIMICROB CHEMOTH, V19, P831, DOI 10.1093/jac/19.6.831; JOHNSON LG, 1992, NAT GENET, V2, P21, DOI 10.1038/ng0992-21; KNOWLES MR, 1995, NEW ENGL J MED, V333, P823, DOI 10.1056/NEJM199509283331302; KNOWLES MR, 1995, HUM GENE THER, V6, P445, DOI 10.1089/hum.1995.6.4-445; KNOWLES MR, 1990, NEW ENGL J MED, V322, P1189, DOI 10.1056/NEJM199004263221704; KNOWLES MR, 1991, NEW ENGL J MED, V325, P533, DOI 10.1056/NEJM199108223250802; KONSTAN MW, 1995, AM J RESP CRIT CARE, V151, P260; KONSTAN MW, 1994, J PEDIATR-US, V124, P689, DOI 10.1016/S0022-3476(05)81356-3; KONSTAN MW, 1995, NEW ENGL J MED, V332, P848, DOI 10.1056/NEJM199503303321303; KONSTAN MW, 1994, AM J RESP CRIT CARE, V150, P448, DOI 10.1164/ajrccm.150.2.8049828; KONSTAN MW, 1990, AM REV RESPIR DIS, V141, P186, DOI 10.1164/ajrccm/141.1.186; KONSTAN MW, 1993, CYSTIC FIBROSIS, V64, P219; KORST RJ, 1995, AM J RESP CRIT CARE, V151, pS75, DOI 10.1164/ajrccm/151.3_Pt_2.S75; LARSEN GL, 1980, AM J DIS CHILD, V134, P1143, DOI 10.1001/archpedi.1980.02130240027009; LARSEN GL, 1979, AM REV RESPIR DIS, V119, P399; MACLUSKY IB, 1989, PEDIATR PULM, V7, P42, DOI 10.1002/ppul.1950070110; MCELVANEY NG, 1992, J CLIN INVEST, V90, P1296, DOI 10.1172/JCI115994; MCELVANEY NG, 1991, LANCET, V337, P392, DOI 10.1016/0140-6736(91)91167-S; MELLIS CM, 1978, PEDIATRICS, V61, P446; MENDELMAN PM, 1985, AM REV RESPIR DIS, V132, P761; MORTENSEN J, 1993, CHEST, V103, P805, DOI 10.1378/chest.103.3.805; MORTENSEN J, 1991, CHEST, V100, P1350, DOI 10.1378/chest.100.5.1350; MOSS RB, 1986, AM REV RESPIR DIS, V133, P648; NORRBY SR, 1991, EUR J CLIN MICROBIOL, V10, P378, DOI 10.1007/BF01967014; Oppenheimer E H, 1975, Perspect Pediatr Pathol, V2, P241; ORENSTEIN DM, 1990, CHEST, V98, P1081, DOI 10.1378/chest.98.5.1081; PANTIN CFA, 1986, THORAX, V41, P34, DOI 10.1136/thx.41.1.34; PATTISHALL EN, 1990, PEDIATR PULM, V9, P80, DOI 10.1002/ppul.1950090204; PFLEGER A, 1992, LUNG, V170, P323; PHILLIPS BM, 1986, J ROY SOC MED, V79, P44; POTTER JL, 1969, AM REV RESPIR DIS, V99, P909; PRASAD SA, 1993, J ROY SOC MED, V86, P23; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RADBERG G, 1990, ANTIMICROB AGENTS CH, V34, P2142, DOI 10.1128/AAC.34.11.2142; RAMSEY BW, 1991, AM REV RESPIR DIS, V144, P331, DOI 10.1164/ajrccm/144.2.331; RAMSEY BW, 1993, NEW ENGL J MED, V328, P1740, DOI 10.1056/NEJM199306173282403; RAMSEY BW, 1994, PEDIATR PULM, V17, P404, DOI 10.1002/ppul.1950170613; RAMSEY BW, 1993, AM REV RESPIR DIS, V148, P145, DOI 10.1164/ajrccm/148.1.145; RAMSEY BW, 1992, AM J CLIN NUTR, V55, P108, DOI 10.1093/ajcn/55.1.108; REDDING GJ, 1982, AM REV RESPIR DIS, V126, P31; REGELMANN WE, 1990, AM REV RESPIR DIS, V141, P914, DOI 10.1164/ajrccm/141.4_Pt_1.914; RIORDAN JR, 1993, ANNU REV PHYSIOL, V55, P609, DOI 10.1146/annurev.ph.55.030193.003141; ROSENSTEIN BJ, 1991, PEDIATRICS, V87, P245; SANCHEZ I, 1993, CHEST, V104, P842, DOI 10.1378/chest.104.3.842; SANTOS II, 1984, IMMUNOLOGIC ASPECTS, P29; SCHWIEBERT EM, 1995, CELL, V81, P1063, DOI 10.1016/S0092-8674(05)80011-X; SHAK S, 1990, P NATL ACAD SCI USA, V87, P9188, DOI 10.1073/pnas.87.23.9188; SHIMANUKI T, 1985, INFLAMMATION, V9, P285, DOI 10.1007/BF00916277; STEINKAMP G, 1989, PEDIATR PULM, V6, P91, DOI 10.1002/ppul.1950060207; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; SZAFF M, 1983, ACTA PAEDIATR SCAND, V72, P651, DOI 10.1111/j.1651-2227.1983.tb09789.x; TABLAN OC, 1987, CHEST, V91, P527, DOI 10.1378/chest.91.4.527; THOMASSEN MJ, 1984, J PEDIATR-US, V104, P352, DOI 10.1016/S0022-3476(84)81094-X; TURPIN SV, 1993, CYSTIC FIBROSIS, V64, P277; VALERIUS NH, 1991, LANCET, V338, P726; WELSH MJ, 1995, METABOLIC MOL BASES, V3, P3799; WILLUMSEN NJ, 1989, AM J PHYSIOL, V256, pC226, DOI 10.1152/ajpcell.1989.256.2.C226; WILSON FE, 1981, CHEST, V79, P237, DOI 10.1378/chest.79.2.237; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995; ZABNER J, 1993, CELL, V75, P207, DOI 10.1016/0092-8674(93)80063-K; ZACH MS, 1987, INFECTION, V15, P381, DOI 10.1007/BF01647750; ZACH MS, 1985, AM REV RESPIR DIS, V131, P537, DOI 10.1164/arrd.1985.131.4.537; 1991, J ALLERGY CLIN IMMUN, V88, P473; 1990, AM J DIS CHILD, V144, P1311	98	371	381	0	15	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	1996	335	3					179	188		10.1056/NEJM199607183350307	http://dx.doi.org/10.1056/NEJM199607183350307			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW790	8657217				2022-12-28	WOS:A1996UW79000007
J	Gibril, F; Reynolds, JC; Doppman, JL; Chen, CC; Venzon, DJ; Termanini, B; Weber, C; Stewart, CA; Jensen, RT				Gibril, F; Reynolds, JC; Doppman, JL; Chen, CC; Venzon, DJ; Termanini, B; Weber, C; Stewart, CA; Jensen, RT			Somatostatin receptor scintigraphy: Its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas - A prospective study	ANNALS OF INTERNAL MEDICINE			English	Article						receptors, somatostatin; neoplasm metastasis; gastrinoma; radionuclide imaging; Zollinger-Ellison syndrome	ZOLLINGER-ELLISON SYNDROME; IN-111 OCTREOTIDE SCINTIGRAPHY; ISLET CELL TUMORS; ENDOCRINE TUMORS; GASTROENTEROPANCREATIC TUMORS; NEUROENDOCRINE TUMORS; AGGRESSIVE RESECTION; MALIGNANT GASTRINOMA; LOCALIZATION; MANAGEMENT	Objective: To compare the sensitivity of somatostatin receptor scintigraphy done using [In-111-DTPA-DPhe(1)]octreotide with that of other imaging methods in the localization of gastrinomas in patients with the Zollinger-Ellison syndrome. Design: Prospective study. Setting: Referral-based clinical research center. Patients: 80 consecutive patients with the Zollinger-Ellison syndrome. Interventions: Conventional tumor localization studies (ultrasonography, computed tomography [CT], magnetic resonance imaging [MRI], selective angiography, and bone scanning) and somatostatin receptor scintigraphy done using [In-111-DTPA-DPhe(1)]octreotide with single-photon emission CT imaging at 4 and 24 hours. Patients with possible liver metastases had biopsies done for confirmation, and 15 patients had exploratory laparotomies done to assess primary tumor localization. Results: Extrahepatic gastrinomas or liver metastases were identified by ultrasonography in 19% of patients, by CT in 38% of patients, by MRI in 45% of patients, by angiography in 40% of patients, and by somatostatin receptor scintigraphy in 70% of patients. Somatostatin receptor scintigraphy was as sensitive as the other tests combined (59%), and when the results of all other tests were added to the somatostatin receptor scintigraphy results, tumors were localized in 75% of patients. Among patients with a possible primary tumor, the results of ultrasonography were positive in 9%, the results of CT were positive in 31%, the results of MRI were positive in 30%, the results of angiography were positive in 28%, and the results of somatostatin receptor scintigraphy were positive in 58%. Somatostatin receptor scintigraphy was as sensitive as all of the other imaging studies combined; when the results of scintigraphy were added to the results of the other studies, possible primary tumors were identified in 68% of patients. In 24 patients who had histologically proven metastatic liver disease, sensitivities for the detection of any metastatic liver lesions were 46% for ultrasonography, 42% for CT, 71% for MRI, 62% for angiography, and 92% for somatostatin receptor scintigraphy. Somatostatin receptor scintigraphy was significantly better than all of the conventional imaging methods in the identification of gastrinomas later found at surgery (P = 0.004), but it still missed 20% of gastrinomas. Conclusions: Somatostatin receptor scintigraphy is the single most sensitive method for imaging either primary or metastatic liver lesions in patients with the Zollinger-Ellison syndrome. Because of its sensitivity, simplicity, and cost-effectiveness, it should be the first imaging method used in these patients. For patients with negative results on somatostatin receptor scintigraphy, guidelines about the use of other imaging studies are proposed.	NIDDK, NIH, DIGEST DIS BRANCH, BETHESDA, MD 20892 USA; NCI, BIOSTAT & DATA MANAGEMENT SECT, NIH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Venzon, David J/B-3078-2008	Weber, Horst Christian/0000-0001-9005-6988				ARNOLD R, 1995, ENDOCRINE TUMORS PAN, P431; AZOULAY D, 1995, ENDOCRINE TUMORS PAN, P461; BARTON JC, 1986, GASTROENTEROLOGY, V91, P1179, DOI 10.1016/S0016-5085(86)80014-2; BENYA RV, 1994, AM J MED, V97, P436, DOI 10.1016/0002-9343(94)90323-9; CARTY SE, 1992, SURGERY, V112, P1024; Corleto VD, 1996, WORLD J SURG, V20, P241, DOI 10.1007/s002689900038; DEKERVILER E, 1994, EUR J NUCL MED, V21, P1191, DOI 10.1007/BF00182352; DOPPMAN JL, 1989, GASTROENTEROL CLIN N, V18, P793; ELLISON EH, 1964, ANN SURG, V160, P512, DOI 10.1097/00000658-196409000-00013; ERIKSSON B, 1989, ACTA ONCOL, V28, P373, DOI 10.3109/02841868909111209; FISHBEYN VA, 1993, ANN INTERN MED, V119, P199, DOI 10.7326/0003-4819-119-3-199308010-00004; FRAKER DL, 1994, ANN SURG, V220, P320, DOI 10.1097/00000658-199409000-00008; HAMMOND PJ, 1994, Q J MED, V87, P83; Jensen Robert T., 1993, P931; JENSEN RT, 1993, GASTRIN, P373; JENSEN RT, 1994, JAMA-J AM MED ASSOC, V271, P1; JOSEPH K, 1993, HORM METAB RES, V27, P28; KLOPPEL G, 1995, ENDOCRINE TUMORS PAN, P99; KRENNING EP, 1993, EUR J NUCL MED, V20, P716, DOI 10.1007/BF00181765; KRENNING EP, 1994, ANN NY ACAD SCI, V733, P416, DOI 10.1111/j.1749-6632.1994.tb17291.x; KRENNING EP, 1993, DIGESTION, V54, P84, DOI 10.1159/000201083; KRENNING EP, 1992, METABOLISM, V41, P83, DOI 10.1016/0026-0495(92)90038-C; KVOLS LK, 1993, GASTROENTEROLOGY, V105, P1909, DOI 10.1016/0016-5085(93)91091-U; KVOLS LK, 1993, RADIOLOGY, V187, P129, DOI 10.1148/radiology.187.1.8383865; KWEKKEBOOM DJ, 1995, ENDOCRINE TUMORS PAN, P298; LAMBERTS SWJ, 1993, ACTA ONCOL, V32, P167, DOI 10.3109/02841869309083907; LAMBERTS SWJ, 1990, NEW ENGL J MED, V323, P1246, DOI 10.1056/NEJM199011013231805; LONDON JF, 1991, RADIOLOGY, V178, P763, DOI 10.1148/radiology.178.3.1994415; *MALL MED INC, 1994, SOM REC IM NEUR TUM, P1; MATON PN, 1987, GASTROENTEROLOGY, V92, P913, DOI 10.1016/0016-5085(87)90964-4; METZ DC, 1993, WORLD J SURG, V17, P468, DOI 10.1007/BF01655106; METZ DC, 1995, ENDOCRINE TUMORS PAN, P240; MIGNON M, 1995, ENDOCRINE TUMORS PAN, P223; NAGORNEY DM, 1975, ENDOCRINE TUMORS PAN, P416; Norton J A, 1994, Adv Surg, V27, P129; NORTON JA, 1986, ANN SURG, V203, P352, DOI 10.1097/00000658-198604000-00003; NORTON JA, 1991, WORLD J SURG, V15, P151, DOI 10.1007/BF01658992; NORTON JA, 1994, CURR PROB SURG, V31, P82; ORBUCH M, 1995, ENDOCRINE TUMORS PAN, P268; ORLOFF SL, 1995, SURG CLIN N AM, V75, P511, DOI 10.1016/S0039-6109(16)46637-5; PISEGNA JR, 1993, DIGEST DIS SCI, V38, P1318, DOI 10.1007/BF01296084; REUBI JC, 1993, BLOOD, V82, P2143; REUBI JC, 1992, J STEROID BIOCHEM, V43, P27, DOI 10.1016/0960-0760(92)90184-K; SCHERUBL H, 1993, GASTROENTEROLOGY, V105, P1705, DOI 10.1016/0016-5085(93)91066-Q; SOLCIA E, 1989, GASTROENTEROL CLIN N, V18, P671; STRADER DB, 1995, ENDOCRINE TUMORS PAN, P282; SUGG SL, 1993, ANN SURG, V218, P138, DOI 10.1097/00000658-199308000-00004; UR E, 1993, CLIN ENDOCRINOL, V38, P501, DOI 10.1111/j.1365-2265.1993.tb00346.x; WECKBECKER G, 1993, PHARMACOL THERAPEUT, V60, P245, DOI 10.1016/0163-7258(93)90009-3; WEINEL RJ, 1993, ANN SURG, V218, P640, DOI 10.1097/00000658-199321850-00009; WESTLIN JE, 1993, ACTA ONCOL, V32, P783, DOI 10.3109/02841869309096136; WOLFE MM, 1987, NEW ENGL J MED, V317, P1200, DOI 10.1056/NEJM198711053171907; ZIMMER T, 1994, GUT, V35, P471, DOI 10.1136/gut.35.4.471	53	353	359	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1996	125	1					26	+		10.7326/0003-4819-125-1-199607010-00005	http://dx.doi.org/10.7326/0003-4819-125-1-199607010-00005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT399	8644985				2022-12-28	WOS:A1996UT39900004
J	Richman, DD				Richman, DD			HIV therapeutics	SCIENCE			English	Editorial Material									UNIV CALIF SAN DIEGO,DEPT PATHOL,LA JOLLA,CA 92092; UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92092	University of California System; University of California San Diego; University of California System; University of California San Diego	Richman, DD (corresponding author), SAN DIEGO VET AFFAIRS MED CTR,CLIN SCI BLDG,ROOM 327,9500 GILMAN DR,LA JOLLA,CA 92092, USA.							CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; CARPENTER CCJ, IN PRESS J AM MED AS; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0; COOMBS RW, IN PRESS J INFECT DI; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; Gazzard Brian, 1996, P161; Gulick R., 1996, P162; HAMMER S, 1995, 35 INT C ANT AG CHEM; Havlir DV, 1996, ANN INTERN MED, V124, P984, DOI 10.7326/0003-4819-124-11-199606010-00006; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MOUTOUH L, IN PRESS P NATL ACAD; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; RICHMAN DD, 1996, IN PRESS ANTIVIRAL D	18	75	78	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1996	272	5270					1886	1888		10.1126/science.272.5270.1886	http://dx.doi.org/10.1126/science.272.5270.1886			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8658159				2022-12-28	WOS:A1996UV29400028
J	Roth, PE; DeFranco, AL				Roth, PE; DeFranco, AL			Receptor tails unlock developmental checkpoints for B lymphocytes	SCIENCE			English	Editorial Material											Roth, PE (corresponding author), UNIV CALIF SAN FRANCISCO,GEORGE WILLIAMS HOOPER FDN,513 PARNASUSS AVE,SAN FRANCISCO,CA 94143, USA.							AOKI Y, 1994, P NATL ACAD SCI USA, V91, P10606, DOI 10.1073/pnas.91.22.10606; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; ROTH PE, 1995, CURR BIOL, V5, P349, DOI 10.1016/S0960-9822(95)00069-8; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804	7	12	12	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1752	1754		10.1126/science.272.5269.1752	http://dx.doi.org/10.1126/science.272.5269.1752			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8650572				2022-12-28	WOS:A1996UT11000032
J	Hellman, S; Weichselbaum, RR				Hellman, S; Weichselbaum, RR			Radiation oncology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Hellman, S (corresponding author), UNIV CHICAGO, CHICAGO, IL 60637 USA.							AKAKURA K, 1993, CANCER, V71, P2782, DOI 10.1002/1097-0142(19930501)71:9<2782::AID-CNCR2820710916>3.0.CO;2-Z; DATTA R, 1992, P NATL ACAD SCI USA, V89, P10149, DOI 10.1073/pnas.89.21.10149; HALLAHAN DE, 1995, NAT MED, V1, P786, DOI 10.1038/nm0895-786; HANKS GE, 1995, CANCER, V75, P1972, DOI 10.1002/1097-0142(19950401)75:7+<1972::AID-CNCR2820751636>3.0.CO;2-P; PILEPICH MV, 1995, UROLOGY, V45, P616, DOI 10.1016/S0090-4295(99)80053-3; SANDLER HM, 1995, INT J RADIAT ONCOL, V33, P797, DOI 10.1016/0360-3016(95)00219-7; Zelefsky M J, 1995, Cancer J Sci Am, V1, P142	7	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1852	1853		10.1001/jama.275.23.1852	http://dx.doi.org/10.1001/jama.275.23.1852			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642748				2022-12-28	WOS:A1996UQ15200047
J	Reinhardt, UE				Reinhardt, UE			Economics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Reinhardt, UE (corresponding author), PRINCETON UNIV,PRINCETON,NJ 08544, USA.							BATOR FM, 1958, Q J ECON, V72, P351, DOI 10.2307/1882231; BAUMOL WJ, 1977, EC THEORY OPERATIONS, pCH21; FRIEDMAN LS, 1984, MICROECONOMIC POLICY, P64; Fuchs VR, 1996, AM ECON REV, V86, P1; Kaldor N, 1939, ECON J, V49, P549, DOI 10.2307/2224835; KEARL JR, 1993, PRINCIPLES MICROECON, P418; KRUEGER AB, 1994, HLTH AFFAIRS     SPR, P34; NELSON R, 1977, MOON GHETTO, P15; PHELPS CE, 1992, HLTH EC, pCH4; Reinhardt U., 1996, STRATEGIC CHOICES CH; REINHARDT UE, 1992, YALE LAW POLICY REV, V10, P302; ROSEN HS, 1991, MICROECONOMICS, P15	12	15	15	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1802	1804		10.1001/jama.275.23.1802	http://dx.doi.org/10.1001/jama.275.23.1802			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UQ152	8642718				2022-12-28	WOS:A1996UQ15200017
J	Obaro, SK; Monteil, MA; Henderson, DC				Obaro, SK; Monteil, MA; Henderson, DC			The pneumococcal problem	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESPIRATORY-TRACT INFECTIONS; STREPTOCOCCUS-PNEUMONIAE; ANTIBODY-RESPONSE; CHILDREN; VACCINE; COMMUNITY; EFFICACY		CHELSEA & WESTMINSTER HOSP, CHARING CROSS & WESTMINSTER MED SCH, DEPT IMMUNOL, LONDON SW10 9NH, ENGLAND	Imperial College London								ANDREWS BE, 1987, Q J MED, V62, P195; AUSTRIAN R, 1986, J ANTIMICROB CHEMOTH, V18, P35, DOI 10.1093/jac/18.Supplement_A.35; CUNDELL DR, 1994, MICROB PATHOGENESIS, V17, P361, DOI 10.1006/mpat.1994.1082; *DEP HLTH, 1992, IMM INF DIS, P100; DOUGLAS RM, 1983, J INFECT DIS, V148, P131, DOI 10.1093/infdis/148.1.131; Fedson DS, 1994, VACCINES, P517; FORGIE IM, 1992, PEDIATR INFECT DIS J, V11, P466, DOI 10.1097/00006454-199206000-00009; FRIEDLAND IR, 1992, AM J DIS CHILD, V146, P920, DOI 10.1001/archpedi.1992.02160200042023; GEORGE RC, 1992, CDR REV, V2, P37; GLECKMAN R, 1988, J CLIN MICROBIOL, V26, P846, DOI 10.1128/JCM.26.5.846-849.1988; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; GUCKIAN JC, 1980, J INFECT DIS, V142, P175, DOI 10.1093/infdis/142.2.175; GWALTNEY JM, 1975, J INFECT DIS, V132, P62, DOI 10.1093/infdis/132.1.62; HAKANSSON A, 1994, INFECT IMMUN, V62, P2707; HAMMARSTROM V, 1993, SUPPORT CARE CANCER, V1, P195, DOI 10.1007/BF00366446; HANSMAN D, 1971, NEW ENGL J MED, V284, P175, DOI 10.1056/NEJM197101282840403; HASSANKING M, 1994, J CLIN MICROBIOL, V32, P1721, DOI 10.1128/JCM.32.7.1721-1724.1994; HOSEA SW, 1981, NEW ENGL J MED, V304, P245, DOI 10.1056/NEJM198101293040501; *I MED, 1985, NEW VACC DEV EST PRI, V2, P44; JOHNSTON RB, 1991, REV INFECT DIS, V13, pS509; KAUFMAN P, 1947, ARCH INTERN MED, V79, P518, DOI 10.1001/archinte.1947.00220110058004; KLEIN JO, 1982, PNEUMOCOCCUS PNEUMOC, P64; KNECHT JC, 1970, J EXP MED, V132, P475, DOI 10.1084/jem.132.3.475; KRAMER MR, 1987, ISRAEL J MED SCI, V23, P174; KRIVIT W, 1979, SURG CLIN N AM, V59, P223; Leowski J, 1986, World Health Stat Q, V39, P138; LINARES J, 1992, CLIN INFECT DIS, V15, P99, DOI 10.1093/clinids/15.1.99; LISTER PD, 1995, EUR J CLIN MICROBIOL, V14, pS18; LORTAN JE, 1993, CLIN EXP IMMUNOL, V91, P54; MARKIEWICZ Z, 1989, J CLIN MICROBIOL, V27, P405, DOI 10.1128/JCM.27.3.405-410.1989; MAYONWHITE R, 1994, PRESCRIBERS J, V34, P165; MCMULLIN M, 1993, BRIT MED J, V307, P1372, DOI 10.1136/bmj.307.6916.1372; MEYER RD, 1992, J HOSP INFECT, V22, P51, DOI 10.1016/S0195-6701(05)80007-6; NATHAN EA, 1907, TRANSVAAL MED J, V2, P154; PALLARES R, 1995, NEW ENGL J MED, V333, P474, DOI 10.1056/NEJM199508243330802; PRASAD AB, 1995, BRIT NATL FORMULARY; Rake G, 1936, J EXP MED, V63, P191, DOI 10.1084/jem.63.2.191; RILEY ID, 1986, LANCET, V2, P877; ROBINS JB, 1983, J INFECT DIS, V38, P64; SCHLECH WF, 1985, JAMA-J AM MED ASSOC, V253, P1749, DOI 10.1001/jama.253.12.1749; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; SIBER GR, 1994, SCIENCE, V265, P1385, DOI 10.1126/science.8073278; SIBER GR, 1980, NEW ENGL J MED, V303, P178, DOI 10.1056/NEJM198007243030402; SIMBERKOFF MS, 1986, NEW ENGL J MED, V315, P1318, DOI 10.1056/NEJM198611203152104; SUMMERFIELD G, 1994, BRIT MED J, V308, P598, DOI 10.1136/bmj.308.6928.598; VANDEWINKEL JGJ, 1993, IMMUNOL TODAY, V14, P215, DOI 10.1016/0167-5699(93)90166-I; WARA DW, 1982, PNEUMOCOCCUS PNEUMOC, P117; WARD J, 1981, REV INFECT DIS, V3, P254; WINKELSTEIN JA, 1981, REV INFECT DIS, V3, P289	49	80	82	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	1996	312	7045					1521	1525		10.1136/bmj.312.7045.1521	http://dx.doi.org/10.1136/bmj.312.7045.1521			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR823	8646147	Green Published			2022-12-28	WOS:A1996UR82300025
J	Radestad, I; Steineck, G; Nordin, C; Sjogren, B				Radestad, I; Steineck, G; Nordin, C; Sjogren, B			Psychological complications after stillbirth - Influence of memories and immediate management: Population based study	BRITISH MEDICAL JOURNAL			English	Article							PERINATAL DEATH; FOLLOW-UP; GRIEF; FAMILIES	Objective-To identify factors that may predict long term psychological complications among women who have had a stillborn child, Design-Nationwide population based study using epidemiological methods, Subjects-380 subjects and 379 controls who had had a stillborn or non-deformed live child in Sweden in 1991. Results-Information was provided by 636 (84%) women, The ratio (95% confidence interval) of proportions of women with symptoms related to anxiety above the 90th centile for women who had had a stillborn child compared with those who had not was 2.1 (1.2 to 3.9), An interval of 25 hours or more from the diagnosis of death in utero to the start of delivery gave a ratio of 4.8 (1.5 to 15.9). The ratio was 2.3 (1.1 to 5.3) for not seeing the child as long as the mother had wished and 3.1 (1.6 to 6.0) for no possession of a token of remembrance, Conclusion-It is advisable to induce the delivery as soon as feasible after the diagnosis of death in utero, A calm environment for the woman to spend as much time as she wants with her stillborn child is beneficial, and tokens of remembrance should be collected.	KAROLINSKA INST,CTR CARING SCI N,STOCKHOLM,SWEDEN; KAROLINSKA INST,RADIUMHEMMET,CANC EPIDEMIOL UNIT,STOCKHOLM,SWEDEN; KAROLINSKA INST,DEPT WOMENS & CHILDRENS HLTH,STOCKHOLM,SWEDEN; LINKOPING UNIV HOSP,DEPT PSYCHIAT,S-58185 LINKOPING,SWEDEN	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Linkoping University			Steineck, Gunnar/W-1515-2019	Steineck, Gunnar/0000-0002-0787-3969				Beckey R D, 1985, J Obstet Gynecol Neonatal Nurs, V14, P194, DOI 10.1111/j.1552-6909.1985.tb02227.x; BOURNE P, 1983, BRIT MED J, V286, P144; Bourne S, 1968, J R Coll Gen Pract, V16, P103; COHEN L, 1978, AM J ORTHOPSYCHIAT, V48, P727, DOI 10.1111/j.1939-0025.1978.tb02577.x; Cullberg J, 1966, Lakartidningen, V63, P3980; GILES PFH, 1970, AUST NZ J OBSTET GYN, V10, P207, DOI 10.1111/j.1479-828X.1970.tb00431.x; KELLNER KR, 1981, DEATH EDUC, V5, P29, DOI 10.1080/07481188108252075; Kennel JH, 1978, CONTEMP OBSTET GYNEC, V12, P53; KENNELL JH, 1970, NEW ENGL J MED, V283, P344, DOI 10.1056/NEJM197008132830706; KIRKLEYBEST E, 1982, AM J ORTHOPSYCHIAT, V52, P420, DOI 10.1111/j.1939-0025.1982.tb01428.x; KOWALSKI K, 1980, Clinical Obstetrics and Gynecology, V23, P1113, DOI 10.1097/00003081-198012000-00015; LAROCHE C, 1984, CAN J PSYCHIAT, V29, P14, DOI 10.1177/070674378402900104; LEON IG, 1992, CLIN PEDIATR, V31, P366, DOI 10.1177/000992289203100611; LEWIS E, 1976, LANCET, V2, P619; Long J, 1992, Midwives Chron, V105, P51; NICOL MT, 1986, MED J AUSTRALIA, V144, P287, DOI 10.5694/j.1326-5377.1986.tb128375.x; RADLOFF LS, 1994, APPL PSYCH MEAS, V1, P385; ROWE J, 1978, PEDIATRICS, V62, P166; *SAS I, 1993, P243 SAS; SPECK WT, 1980, PEDIATR REV, V2, P59; SPIELBERGER CD, 1983, MANUAL STATE TRAIT A; TOEDTER LJ, 1988, AM J ORTHOPSYCHIAT, V58, P435, DOI 10.1111/j.1939-0025.1988.tb01604.x; TUDEHOPE DI, 1986, MED J AUSTRALIA, V144, P290, DOI 10.5694/j.1326-5377.1986.tb128376.x; Welch I D, 1991, Neonatal Netw, V9, P53; ZEANAH CH, 1989, J AM ACAD CHILD PSY, V28, P467, DOI 10.1097/00004583-198907000-00001	25	136	138	1	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 15	1996	312	7045					1505	1508		10.1136/bmj.312.7045.1505	http://dx.doi.org/10.1136/bmj.312.7045.1505			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UR823	8646141	Green Published			2022-12-28	WOS:A1996UR82300019
J	Levings, CS				Levings, CS			Infertility treatment: A nuclear restorer gene in maize	SCIENCE			English	Editorial Material							CYTOPLASMIC MALE-STERILITY; CMS-T-MAIZE; MITOCHONDRIAL PROTEIN; TEXAS-CYTOPLASM; DISEASE SUSCEPTIBILITY; CONFERS SENSITIVITY; RECOMBINATION; EXPRESSION; FERTILITY; T-URF13				Levings, CS (corresponding author), N CAROLINA STATE UNIV,DEPT GENET,BOX 7614,RALEIGH,NC 27695, USA.							CHAUMONT F, 1995, P NATL ACAD SCI USA, V92, P1167, DOI 10.1073/pnas.92.4.1167; CHO D, UNPUB; Cui XQ, 1996, SCIENCE, V272, P1334, DOI 10.1126/science.272.5266.1334; DEWEY RE, 1987, P NATL ACAD SCI USA, V84, P5374, DOI 10.1073/pnas.84.15.5374; DEWEY RE, 1988, SCIENCE, V239, P293, DOI 10.1126/science.3276005; DEWEY RE, 1986, CELL, V44, P439, DOI 10.1016/0092-8674(86)90465-4; DUVICK DONALD N., 1965, ADVANCE GENET, V13, P1, DOI 10.1016/S0065-2660(08)60046-2; FAURON CMR, 1990, GENETICS, V124, P423; FLAVELL R, 1974, PLANT SCI LETT, V3, P259, DOI 10.1016/0304-4211(74)90096-0; FORDE BG, 1980, P NATL ACAD SCI-BIOL, V77, P418, DOI 10.1073/pnas.77.1.418; HUANG J, 1990, EMBO J, V9, P339, DOI 10.1002/j.1460-2075.1990.tb08116.x; KENNELL JC, 1987, MOL GEN GENET, V210, P399, DOI 10.1007/BF00327189; KENNELL JC, 1989, MOL GEN GENET, V216, P16, DOI 10.1007/BF00332225; KORTH KL, 1993, P NATL ACAD SCI USA, V90, P3388, DOI 10.1073/pnas.90.8.3388; LAUGHNAN JR, 1983, ANNU REV GENET, V17, P27, DOI 10.1146/annurev.ge.17.120183.000331; LEVINGS CS, 1992, PLANT MOL BIOL, V19, P135, DOI 10.1007/BF00015611; LEVINGS CS, 1990, SCIENCE, V250, P942, DOI 10.1126/science.250.4983.942; LEVINGS CS, 1993, PLANT CELL, V5, P1285, DOI 10.2307/3869781; LEVINGS CS, 1995, MOL BIOL PLANT MITOC; RHOADS DM, 1994, P NATL ACAD SCI USA, V91, P8253, DOI 10.1073/pnas.91.17.8253; ROTTMANN WH, 1987, EMBO J, V6, P1541, DOI 10.1002/j.1460-2075.1987.tb02398.x; ULLSTRUP AJ, 1972, ANNU REV PHYTOPATHOL, V10, P37, DOI 10.1146/annurev.py.10.090172.000345; WARMKE HE, 1977, J HERED, V68, P213, DOI 10.1093/oxfordjournals.jhered.a108817; WISE RP, 1987, P NATL ACAD SCI USA, V84, P2858, DOI 10.1073/pnas.84.9.2858	24	5	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1279	1280		10.1126/science.272.5266.1279	http://dx.doi.org/10.1126/science.272.5266.1279			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8650539				2022-12-28	WOS:A1996UN47200029
J	Dale, J; Lang, H; Roberts, JA; Green, J; Glucksman, E				Dale, J; Lang, H; Roberts, JA; Green, J; Glucksman, E			Cost effectiveness of treating primary care patients in accident and emergency: A comparison between general practitioners, senior house officers, and registrars	BRITISH MEDICAL JOURNAL			English	Article							MEDICAL-CARE	Objectives-To compare outcome and costs of general practitioners, senior house officers, and registrars treating patients who attended accident and emergency department with problems assessed at triage as being of primary care type. Design-Prospective intervention study which was later costed. Setting-inner city accident and emergency department in south east London. Subjects-4631 patients presenting with primary care problems: 1702 were seen by general practitioners, 2382 by senior house officers, and 557 by registrars. Main outcome measures-Satisfaction and outcome assessed in subsample of 565 patients 7-10 days after hospital attendance and aggregate costs of hospital care provided. Results-Most patients expressed high levels of satisfaction with clinical assessment (430/562 (77%)), treatment (418/557 (75%)), and consulting doctor's manner (434/492 (88%)). Patients' reported outcome and use of general practice in 7-10 days after attendance were similar: 206/241 (85%), 224/263 (85%), and 52/59 (88%) of those seen by general practitioners, senior house officers, and registrars respectively were fully recovered or improving chi(2)=0.35, P=0.830), while 48/240 (20%), 48/268 (18%), and 12/57 (21%) respectively consulted a general practitioner or practice nurse (chi(2)=0.51, P=0.774). Excluding costs of admissions, the average costs per case were pound 19.30, pound 17.97, and pound 11.70 for senior house officers, registrars, and general practitioners respectively. With cost of admissions included, these costs were pound 58.25, pound 44.68, and pound 32.30 respectively. Conclusion-Management of patients with primary care needs in accident and emergency department by general practitioners reduced costs with no apparent detrimental effect on outcome. These results support new role for general practitioners.	UNIV LONDON KINGS COLL,SCH MED & DENT,DEPT ACCID & EMERGENCY MED,LONDON SE5 9JP,ENGLAND; UNIV LONDON LONDON SCH HYG & TROP MED,DEPT PUBL HLTH & POLICY,HLTH SERV RES UNIT,LONDON WC1E 7HT,ENGLAND; UNIV LONDON KINGS COLL HOSP,DEPT ACCID & EMERGENCY,LONDON SE5 9RS,ENGLAND	University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Dale, J (corresponding author), UNIV LONDON KINGS COLL,SCH MED & DENT,DEPT GEN PRACTICE & PRIMARY CARE,LONDON SE5 9JP,ENGLAND.			Green, Judith/0000-0002-2315-5326; Dale, Jeremy/0000-0001-9256-3553				DALE J, 1995, BRIT MED J, V311, P427, DOI 10.1136/bmj.311.7002.427; DALE J, 1995, BRIT MED J, V311, P423, DOI 10.1136/bmj.311.7002.423; DALE J, 1992, PRIMARY CARE A E EST; DALE J, 1991, PROVODING PRIMARY CA; *DEP HLTH, 1992, REP INQ LOND HLTH SE; GREEN J, 1992, SOC SCI MED, V35, P987, DOI 10.1016/0277-9536(92)90238-L; HALL JA, 1988, SOC SCI MED, V27, P637, DOI 10.1016/0277-9536(88)90012-3; MUSCOVICE I, 1977, MED CARE, V15, P1024; *NAT AUD OFF, 1992, REP COMPTR AUD GEN N; NOREN J, 1980, NEW ENGL J MED, V302, P11, DOI 10.1056/NEJM198001033020103; Williams RM, 1996, NEW ENGL J MED, V334, P642, DOI 10.1056/NEJM199603073341007	11	91	94	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 25	1996	312	7042					1340	1344		10.1136/bmj.312.7042.1340	http://dx.doi.org/10.1136/bmj.312.7042.1340			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UN476	8646050	Green Published			2022-12-28	WOS:A1996UN47600025
J	Dawson, C; Whitfield, H				Dawson, C; Whitfield, H			ABC of urology - Urological trauma and bladder reconstruction	BRITISH MEDICAL JOURNAL			English	Article									CENT MIDDLESEX HOSP,LONDON NW10 7NS,ENGLAND; INST UROL & NEPHROL,LONDON,ENGLAND	Imperial College London; University of London; University College London	Dawson, C (corresponding author), EDITH CAVELL HOSP,PETERBOROUGH,ENGLAND.							GHONEIM MA, 1993, ADV UROLOGY ANDROLOG, V6; Matthews L A, 1995, Semin Urol, V13, P77; WEBSTER GD, 1993, ADV UROLOGY ANDROLOG, V6; WOODHOUSE CRJ, 1994, BRIT J UROL, V73, P55, DOI 10.1111/j.1464-410X.1994.tb07456.x	4	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 25	1996	312	7042					1352	1354		10.1136/bmj.312.7042.1352	http://dx.doi.org/10.1136/bmj.312.7042.1352			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN476	8646055	Green Published			2022-12-28	WOS:A1996UN47600031
J	Chou, MM; Blenis, J				Chou, MM; Blenis, J			The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1	CELL			English	Article							DISTINCT MECHANISMS; RAF-1 KINASE; RAPAMYCIN; DOMAIN; RAS; FIBROBLASTS; INHIBITION; ONCOGENE; LYMPHOMA; MEMBRANE	The 70 kDa ribosomal S6 kinase (pp70(S6k)) plays an important role in the progression of cells through G1 phase of the cell cycle. However, little is known of the signaling molecules that mediate its activation. We demonstrate that Rho family G proteins regulate pp70(S6k) activity in vivo. Activated alleles of Cdc42 and Rac1, but not RhoA, stimulate pp70(S6k) activity in multiple cell types. Activation requires an intact effector domain and isoprenylation of Cdc42 and Rac1. Coexpression of Dbl, an exchange factor for Cdc42, also activates pp70(S6k). Growth factor-induced activation of pp70(S6k) is abrogated by dominant negative alleles of Cdc42 and Rad. In addition, Cdc42 and Rad form a GTP-dependent complex with the catalytically inactive form of pp70(S6k) in vitro and in vivo, suggesting a mechanism by which these G proteins activate pp70(S6k).	HARVARD UNIV,SCH MED,DEPT CELL BIOL,BOSTON,MA 02115	Harvard University; Harvard Medical School								BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; BARFOD ET, 1993, J BIOL CHEM, V268, P26059; BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231; BLENIS J, 1991, CELL GROWTH DIFFER, V2, P279; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CALVO V, 1992, P NATL ACAD SCI USA, V89, P7571, DOI 10.1073/pnas.89.16.7571; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; CHEATHAM L, 1995, P NATL ACAD SCI USA, V92, P11696, DOI 10.1073/pnas.92.25.11696; CHOU MM, 1995, CURR OPIN CELL BIOL, V7, P806, DOI 10.1016/0955-0674(95)80064-6; CHOU MM, 1992, MOL CELL BIOL, V12, P5834, DOI 10.1128/MCB.12.12.5834; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; DIEKMANN D, 1995, EMBO J, V14, P5297, DOI 10.1002/j.1460-2075.1995.tb00214.x; DUMONT FJ, 1990, J IMMUNOL, V144, P251; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; FERRARI S, 1994, CRIT REV BIOCHEM MOL, V29, P385, DOI 10.3109/10409239409083485; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; HAN JW, 1995, J BIOL CHEM, V270, P21396, DOI 10.1074/jbc.270.36.21396; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HART MJ, 1994, J BIOL CHEM, V269, P62; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; KUO CJ, 1992, NATURE, V358, P70, DOI 10.1038/358070a0; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MONFAR M, 1995, MOL CELL BIOL, V15, P326, DOI 10.1128/MCB.15.1.326; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, J CELL SCI, V108, P225; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; REED JC, 1991, CELL GROWTH DIFFER, V2, P235; REINHARD C, 1994, EMBO J, V13, P1557, DOI 10.1002/j.1460-2075.1994.tb06418.x; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; SELF AJ, 1993, ONCOGENE, V8, P655; STAAL SP, 1988, J EXP MED, V167, P1259, DOI 10.1084/jem.167.3.1259; TOKER A, 1994, J BIOL CHEM, V269, P32358; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; WENG QP, 1995, P NATL ACAD SCI USA, V92, P5744, DOI 10.1073/pnas.92.12.5744; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; WILLIAMS NG, 1992, P NATL ACAD SCI USA, V89, P2922, DOI 10.1073/pnas.89.7.2922; ZHANG K, 1990, SCIENCE, V249, P162, DOI 10.1126/science.2115210; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	61	261	263	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 17	1996	85	4					573	583		10.1016/S0092-8674(00)81257-X	http://dx.doi.org/10.1016/S0092-8674(00)81257-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UM415	8653792	Bronze			2022-12-28	WOS:A1996UM41500014
J	Livnah, O; Stura, EA; Johnson, DL; Middleton, SA; Mulcahy, LS; Wrighton, NC; Dower, WJ; Jolliffe, LK; Wilson, IA				Livnah, O; Stura, EA; Johnson, DL; Middleton, SA; Mulcahy, LS; Wrighton, NC; Dower, WJ; Jolliffe, LK; Wilson, IA			Functional mimicry of a protein hormone by a peptide agonist: The EPO receptor complex at 2.8 angstrom	SCIENCE			English	Article							HUMAN GROWTH-HORMONE; ANTIBODY-ANTIGEN COMPLEXES; HUMAN TISSUE FACTOR; CRYSTAL-STRUCTURE; ERYTHROPOIETIN RECEPTOR; LIGAND-BINDING; EXTRACELLULAR DOMAIN; IMMUNOGLOBULIN FOLD; SIGNAL TRANSDUCTION; HUMAN CD4	The functional mimicry of a protein by an unrelated small molecule has been a formidable challenge. Now, however, th biological activity of a 166-residue hematopoietic growth hormone, erythropoietin (EPO), with is class 1 cytokine receptor has been mimicked by a 20-residue cyclic peptide unrelated in sequence to the natural ligand. The crystal structure at 2.8 Angstrom resolution of a complex of this agonist peptide with the extracellular domain of EPO receptor reveals that a peptide dimer induces an almost perfect twofold dimerization of the receptor. The dimer assembly differs from that of the human growth hormone (hGH) receptor complex and suggests that more than one mode of dimerization may be able to indue signal transduction and cell proliferation. The EPO receptor binding site, defined by peptide interaction, corresponds to the smaller functional epitope identified for hGH receptor. Similarly, the EPO mimetic peptide ligand can be considered as a minimal hormone, and suggests the design of nonpeptidic small molecule mimetics for EPO and other cytokines may indeed be achievable.	Scripps Res Inst, DEPT MOL BIOL, LA JOLLA, CA 92037 USA; RW JOHNSON PHARMACEUT RES INST, DRUG DISCOVERY RES, RARITAN, NJ 08869 USA; AFFYMAX RES INST, PALO ALTO, CA 94304 USA; Scripps Res Inst, SKAGGS INST CHEM BIOL, LA JOLLA, CA 92037 USA	Scripps Research Institute; Johnson & Johnson; Johnson & Johnson USA; Scripps Research Institute			Stura, Enrico A./A-2793-2010	Stura, Enrico A./0000-0001-6718-2118	NIGMS NIH HHS [GM-49497] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADZHUBEI AA, 1993, J MOL BIOL, V229, P472, DOI 10.1006/jmbi.1993.1047; BASS SH, 1991, P NATL ACAD SCI USA, V88, P4498, DOI 10.1073/pnas.88.10.4498; BAUMGARTNER JW, 1994, J BIOL CHEM, V269, P29094; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BERNSTEIN FC, 1978, ARCH BIOCHEM BIOPHYS, V185, P584, DOI 10.1016/0003-9861(78)90204-7; BOISSEL JP, 1993, J BIOL CHEM, V268, P15983; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585, DOI 10.1107/S0108767390002355; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; FLOCCO MM, 1994, J MOL BIOL, V235, P709, DOI 10.1006/jmbi.1994.1022; FOA P, 1991, ACTA HAEMATOL-BASEL, V86, P162, DOI 10.1159/000204826; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; FUREY WJ, 1990, AM CRYST ASS 40 ANN; GUSTCHINA A, 1995, PROTEINS, V21, P140, DOI 10.1002/prot.340210208; HANSEN JN, 1993, ANNU REV MICROBIOL, V47, P535, DOI 10.1146/annurev.micro.47.1.535; HARLOS K, 1994, NATURE, V370, P662, DOI 10.1038/370662a0; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HILTON DJ, 1995, P NATL ACAD SCI USA, V92, P190, DOI 10.1073/pnas.92.1.190; Hilton DJ, 1996, J BIOL CHEM, V271, P4699; HOLMGREN A, 1989, NATURE, V342, P248, DOI 10.1038/342248a0; HOWARD AJ, 1987, J APPL CRYSTALLOGR, V20, P383, DOI 10.1107/S0021889887086436; HUBER AH, 1994, NEURON, V12, P717, DOI 10.1016/0896-6273(94)90326-3; Ihle J N, 1993, Semin Immunol, V5, P375, DOI 10.1006/smim.1993.1043; JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; JACOBSON LO, 1957, NATURE, V179, P633, DOI 10.1038/179633a0; Johnson D. B., UNPUB; Johnson DL, 1996, PROTEIN EXPRES PURIF, V7, P104, DOI 10.1006/prep.1996.0014; JOLLIFFE LK, 1995, NEPHROL DIAL TRANSPL, V10, P28, DOI 10.1093/ndt/10.supp2.28; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM H, 1993, BIOCHEMISTRY-US, V32, P8465, DOI 10.1021/bi00084a011; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; KRANTZ SB, 1991, BLOOD, V77, P419; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUMPF RA, 1993, SCIENCE, V261, P1708, DOI 10.1126/science.8378771; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Middleton SA, 1996, J BIOL CHEM, V271, P14045, DOI 10.1074/jbc.271.24.14045; MIYAZAKI T, 1991, EMBO J, V10, P3191, DOI 10.1002/j.1460-2075.1991.tb04881.x; MULLER YA, 1994, BIOCHEMISTRY-US, V33, P10864, DOI 10.1021/bi00202a003; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Philo JS, 1996, BIOCHEMISTRY-US, V35, P1681, DOI 10.1021/bi9524272; QUELLE DE, 1992, MOL CELL BIOL, V12, P4553, DOI 10.1128/MCB.12.10.4553; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RONCO LV, 1994, J BIOL CHEM, V269, P277; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; SPIVAK JL, 1994, ERYTHROPOIETIN BASIC, V8, P863; STURA EA, UNPUB; WALTER MR, 1995, NATURE, V376, P230, DOI 10.1038/376230a0; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; WATOWICH SS, 1994, MOL CELL BIOL, V14, P3535, DOI 10.1128/MCB.14.6.3535; WATOWICH SS, 1992, P NATL ACAD SCI USA, V89, P2140, DOI 10.1073/pnas.89.6.2140; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1; WELLS JA, 1994, CURR OPIN CELL BIOL, V6, P163, DOI 10.1016/0955-0674(94)90132-5; WILSON IA, 1991, CIBA F SYMP, V159, P13; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; YOSHIMURA A, 1992, J BIOL CHEM, V267, P11619	69	533	605	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	1996	273	5274					464	471		10.1126/science.273.5274.464	http://dx.doi.org/10.1126/science.273.5274.464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY983	8662530				2022-12-28	WOS:A1996UY98300032
J	Uchino, T; Yoko, T				Uchino, T; Yoko, T			Low-frequency Raman scattering and the fast relaxation process in glycerol	SCIENCE			English	Article							LIQUID-GLASS TRANSITION; WATER TRIMER; SUPERCOOLED GLYCEROL; LIGHT-SCATTERING; DYNAMICS; FORMERS; NEUTRON; MODE	Ab initio molecular orbital calculations were used to determine the structure and vibrational frequencies of the cyclic glycerol trimer, which represents the region of medium-range ordering in liquid and supercooled glycerol. The calculations reproduced the experimentally observed low-frequency Raman scattering peak (or the ''boson peak'') at similar to 50 per centimeter, which suggests that the peak results from the localized collective motions of the cooperatively hydrogen-bonded hydroxyl groups. The calculations also suggest that the fast relaxation process may result from the translational motion of each glycerol molecule in the cyclic structure. On the basis of these results, a model of the glass transition was developed.			Uchino, T (corresponding author), KYOTO UNIV, CHEM RES INST, UJI, KYOTO 611, JAPAN.		Uchino, Takashi/C-4082-2016	Uchino, Takashi/0000-0002-4899-3078				ANGELL CA, 1988, J PHYS CHEM SOLIDS, V49, P863, DOI 10.1016/0022-3697(88)90002-9; ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; FRICK B, 1995, SCIENCE, V267, P1939, DOI 10.1126/science.267.5206.1939; FRISCH MJ, 1986, J CHEM PHYS, V84, P531, DOI 10.1063/1.450121; FUJARA F, 1991, EUROPHYS LETT, V14, P563, DOI 10.1209/0295-5075/14/6/011; GARAWI M, 1987, MOL PHYS, V62, P475, DOI 10.1080/00268978700102341; GOCHIYAEV VZ, 1991, PHILOS MAG B, V63, P777, DOI 10.1080/13642819108225986; GOTZE W, 1991, LES HOUCH S, V51, P287; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; HEHRE WJ, 1986, AB INITIO MOL ORBITA, P233; HUISKEN F, 1988, CHEM PHYS LETT, V144, P391, DOI 10.1016/0009-2614(88)87135-5; KOJIMA S, 1993, J MOL STRUCT, V294, P193, DOI 10.1016/0022-2860(93)80347-X; KOJIMA S, 1993, PHYS REV B, V47, P2924, DOI 10.1103/PhysRevB.47.2924; KRUGER M, 1992, J CHEM PHYS, V96, P7352, DOI 10.1063/1.462438; Mo O., 1994, J MOL STRUC-THEOCHEM, V314, P73; NOVIKOV VN, 1995, J CHEM PHYS, V102, P4691, DOI 10.1063/1.469517; PAN ZD, 1994, J CHEM PHYS, V101, P1767, DOI 10.1063/1.467755; PEETERS D, 1994, J MOL STRUC-THEOCHEM, V314, P39; PUGLIANO N, 1992, SCIENCE, V257, P1937, DOI 10.1126/science.1411509; PULAY P, 1969, MOL PHYS, V17, P197, DOI 10.1080/00268976900100941; ROSSLER E, 1994, PHYS REV B, V49, P14967, DOI 10.1103/PhysRevB.49.14967; Schlegel HB., 2009, GAUSSIAN 09 REVISION; SCHUTZ M, 1993, J CHEM PHYS, V99, P5228, DOI 10.1063/1.465991; SOKOLOV AP, 1994, J NON-CRYST SOLIDS, V172, P138, DOI 10.1016/0022-3093(94)90426-X; STILLINGER FH, 1995, SCIENCE, V267, P1935, DOI 10.1126/science.267.5206.1935; UCHINO T, IN PRESS J CHEM PHYS; WANG CH, 1971, J CHEM PHYS, V55, P1617, DOI 10.1063/1.1676288; WILLIAMS DE, 1993, ACTA CRYSTALLOGR A, V49, P1, DOI 10.1107/S0108767392005518; WUTTKE J, 1994, PHYS REV LETT, V72, P3052, DOI 10.1103/PhysRevLett.72.3052; XANTHEAS SS, 1993, J CHEM PHYS, V98, P8037, DOI 10.1063/1.464558	30	30	30	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	1996	273	5274					480	483		10.1126/science.273.5274.480	http://dx.doi.org/10.1126/science.273.5274.480			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY983	8662533				2022-12-28	WOS:A1996UY98300035
J	Lyons, SF				Lyons, SF			Shadow bands	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1996	276	2					98	98						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UV485	8656519				2022-12-28	WOS:A1996UV48500009
J	OBrien, TR; Blattner, WA; Waters, D; Eyster, ME; Hilgartner, MW; Cohen, AR; Luban, N; Hatzakis, A; Aledort, LM; Rosenberg, PS; Miley, WJ; Kroner, BL; Goedert, JJ				OBrien, TR; Blattner, WA; Waters, D; Eyster, ME; Hilgartner, MW; Cohen, AR; Luban, N; Hatzakis, A; Aledort, LM; Rosenberg, PS; Miley, WJ; Kroner, BL; Goedert, JJ			Serum HIV-1 RNA levels and time to development of AIDS in the multicenter hemophilia cohort study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VIRUS TYPE-1 INFECTION; CONTROLLED TRIAL; IMMUNODEFICIENCY; PROPORTIONS; ZIDOVUDINE; CELLS	Objective.-To determine if the long-term incidence of the acquired immunodeficiency syndrome (AIDS) is related to human immunodeficiency virus type 1 (HIV-1) RNA levels measured early in HIV-1 infection. Design.-Epidemiologic cohort study. Setting.-Five hemophilia treatment centers in the United States. Subjects.-A total of 165 subjects with hemophilia and HIV-1 infection (age at HIV-1 seroconversion, 1-66 years) followed from 1979 to 1995. Methods.-The HIV-1 RNA level was measured by polymerase chain reaction over a range of 200 to 1 million or more HIV-1 RNA copies/mL. in archived serum specimens collected 12 to 36 months (median, 27 months) after the estimated date of HIV-1 seroconversion. Kaplan-Meier methods were used to examine the risk of AIDS and proportional hazards models were used to estimate relative hazards. Results.-The HIV-1 RNA values were similar in subjects younger than 17 years at seroconversion (median, 5214 copies/mL) and those 18 to 34 years old (median, 4693 copies/mL), but higher in those 35 years or older (median, 12 069 copies/mL) (P=.02 compared with each younger group). At 10 years after seroconversion, the proportions of subjects with AIDS were 72% among subjects with 100 000 or more HIV-1 RNA copies/mL measured 12 to 36 months after HIV-1 seroconversion (n=9), 52% among subjects with 10 000 to 99 999 copies/mL (n=55), 22% among subjects with 1000 to 9999 copies/mL (n=82), and 0% among subjects with fewer than 1000 copies/mL (n=19) (P<.001). The age-adjusted relative hazard for AIDS for subjects with 10 000 or more copies/mL was 14.3 (95% confidence interval, 1.9-105.6) compared with subjects with fewer than 1000 copies/mL. Conclusions.-The HIV-1 RNA level during early chronic HIV-1 infection is a strong, age-independent predictor of clinical outcome; low revels define persons with a high probability of long-term AIDS-free survival.	PRI,FREDERICK,MD; MILTON S HERSHEY MED CTR,HERSHEY,PA; CORNELL UNIV,MED CTR,NEW YORK,NY 10021; CHILDRENS HOSP PHILADELPHIA,PHILADELPHIA,PA 19104; CHILDRENS HOSP,NATL MED CTR,WASHINGTON,DC 20010; MT SINAI MED CTR,NEW YORK,NY 10029; UNIV ATHENS,SCH MED,GR-11527 ATHENS,GREECE; NCI,BIOSTAT BRANCH,ROCKVILLE,MD; RES TRIANGLE INST,ROCKVILLE,MD	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Cornell University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's National Health System; Icahn School of Medicine at Mount Sinai; Athens Medical School; National & Kapodistrian University of Athens; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Research Triangle Institute	OBrien, TR (corresponding author), NCI,VIRAL EPIDEMIOL BRANCH,PUBL HLTH SERV,US DEPT HHS,EPN 434,6130 EXECUT BLVD,ROCKVILLE,MD 20852, USA.			Kroner, Barbara/0000-0001-6985-8222	NCI NIH HHS [N01-CP-85649] Funding Source: Medline; DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP085649] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics)		ARMITAGE P, 1971, STATISTICAL METHODS, P396; COX DR, 1972, J R STAT SOC B, V34, P187; DAAR ES, 1991, NEW ENGL J MED, V324, P961, DOI 10.1056/NEJM199104043241405; Dean A. G., 1990, EPI INFO VERSION 5 W; DUESBERG PH, 1995, LANCET, V346, P1371, DOI 10.1016/S0140-6736(95)92389-6; EYSTER ME, 1987, ANN INTERN MED, V107, P1, DOI 10.7326/0003-4819-107-1-1; FISCHL MA, 1990, ANN INTERN MED, V112, P727, DOI 10.7326/0003-4819-112-10-727; FLETCHER MA, 1987, DIAGN CLIN IMMUNOL, V5, P69; GOEDERT JJ, 1989, NEW ENGL J MED, V321, P1141, DOI 10.1056/NEJM198910263211701; GOEDERT JJ, 1994, LANCET, V344, P791, DOI 10.1016/S0140-6736(94)92345-0; Haynes BF, 1996, SCIENCE, V271, P324, DOI 10.1126/science.271.5247.324; HENRARD DR, 1995, JAMA-J AM MED ASSOC, V274, P554, DOI 10.1001/jama.274.7.554; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HORTON R, 1995, LANCET, V346, P656, DOI 10.1016/S0140-6736(95)92277-6; JURRIAANS S, 1994, VIROLOGY, V204, P223, DOI 10.1006/viro.1994.1526; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; KRONER BL, 1995, AIDS, V9, P275, DOI 10.1097/00002030-199509030-00009; KRONER BL, 1994, J ACQ IMMUN DEF SYND, V7, P279; LIN HJ, 1994, J INFECT DIS, V170, P553, DOI 10.1093/infdis/170.3.553; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; MULDER J, 1994, J CLIN MICROBIOL, V32, P292, DOI 10.1128/JCM.32.2.292-300.1994; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P94; *SAS I INC, 1992, P229 SAS I INC, P433; THOMAS DG, 1977, COMPUT BIOMED RES, V10, P373, DOI 10.1016/0010-4809(77)90006-4; TOLLERUD DJ, 1991, J CLIN LAB ANAL, V5, P255; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; 1987, MMWR MORB MORTAL S1S, V36, pS1	28	278	281	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1996	276	2					105	110		10.1001/jama.276.2.105	http://dx.doi.org/10.1001/jama.276.2.105			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UV485	8656501				2022-12-28	WOS:A1996UV48500024
J	Harvey, RP; McSween, HY				Harvey, RP; McSween, HY			A possible high-temperature origin for the carbonates in the Martian meteorite ALH84001	NATURE			English	Article							NORWAY	THE meteorite Allan Hills (ALH) 84001, commonly accepted to be of martian origin, is unique among known martian meteorites in containing abundant, zoned, pre-terrestrial carbonate minerals(1-9). Previous studies of the oxygen isotope compositions of these minerals(5,6,8) have suggested that they precipitated from a low-temperature (0-80 degrees C) aqueous fluid in the martian crust-perhaps in a near-surface hydrothermal system, Here we report analyses of the major-element compositions of the carbonates, which provide an independent constraint on the composition and temperature of the fluid from which they formed. We argue that the most likely explanation for the observed compositions, and for the absence of co-existing hydrous minerals, is that the carbonates were formed by reactions between hot (>650 degrees C), CO2-rich fluids and the ultramafic host rock during an impact event, Impact processes on the martian surface can produce both the hot, CO2-rich fluid (by volatilization of surface carbonates or other CO2 sources) and-by brecciation-the conduits through which it flowed, Impact metasomatism is also consistent with the observed oxygen isotope disequilibrium, sequence of mineral formation, and carbonate mineral zoning, reflecting carbonate formation during rapid cooling from high temperatures rather than prolonged exposure to low-temperature fluids(6,8).	UNIV TENNESSEE,DEPT GEOL SCI,KNOXVILLE,TN 37996	University of Tennessee System; University of Tennessee Knoxville	Harvey, RP (corresponding author), CASE WESTERN RESERVE UNIV,DEPT GEOL SCI,CLEVELAND,OH 44106, USA.							ANOVITZ LM, 1987, J PETROL, V28, P389, DOI 10.1093/petrology/28.2.389; ASH RA, 1995, METEORITICS, V30, P485; Baker V.R., 1992, CHANNELS VALLEY NETW, P493; CRIBB SJ, 1982, NORSK GEOL TIDSSKR, V62, P161; GRIFFITH LL, 1995, NATURE, V377, P406, DOI 10.1038/377406a0; HARVEY RP, 1994, METEORITICS, V29, P472; JAMES PB, 1992, MARS, P934; JOHANNES W, 1969, AM J SCI, V267, P1083, DOI 10.2475/ajs.267.9.1083; JULL AJT, 1995, METEORITICS, V30, P311, DOI 10.1111/j.1945-5100.1995.tb01129.x; MARTINEZ I, 1994, EARTH PLANET SC LETT, V121, P559, DOI 10.1016/0012-821X(94)90091-4; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; MITTLEFEHLDT DW, 1994, METEORITICS, V29, P214, DOI 10.1111/j.1945-5100.1994.tb00673.x; OHNMACHT W, 1974, J PETROL, V15, P303, DOI 10.1093/petrology/15.2.303; RIDLEY WI, 1995, METEORITICS, V30, P565; ROMANEK CS, 1995, METEORITICS, V30, P567; ROMANEK CS, 1994, NATURE, V372, P655, DOI 10.1038/372655a0; Schreyer W, 1972, LITHOS, V5, P345, DOI 10.1016/0024-4937(72)90089-8; SCORE R, 1995, ANT METEORITE NEWSL, V18, P20; TREIMAN AH, 1995, METEORITICS, V30, P294, DOI 10.1111/j.1945-5100.1995.tb01127.x; TROMMSDORFF V, 1990, CONTRIB MINERAL PETR, V104, P1, DOI 10.1007/BF00310641; WENTWORTH SJ, 1995, P LUN PLAN SCI C, V26, P1489; WOODS TL, 1992, GEOCHIM COSMOCHIM AC, V56, P3031, DOI 10.1016/0016-7037(92)90288-T	22	160	164	0	37	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 4	1996	382	6586					49	51		10.1038/382049a0	http://dx.doi.org/10.1038/382049a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV473	8657303				2022-12-28	WOS:A1996UV47300048
J	Tanaka, K; Oikawa, K; Ohta, N; Kuroiwa, H; Kuroiwa, T; Takahashi, H				Tanaka, K; Oikawa, K; Ohta, N; Kuroiwa, H; Kuroiwa, T; Takahashi, H			Nuclear encoding of a chloroplast RNA polymerase sigma subunit in a red alga	SCIENCE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; SP STRAIN PCC-7120; EVOLUTIONARY RELATIONSHIPS; GENE ORGANIZATION; RPOC1 GENE; DNA; EUBACTERIA; GENOME; CYANOBACTERIA; POLYPEPTIDES	A chloroplast RNA polymerase sigma factor is encoded by a nuclear gene, sigA, in the red alga Cyanidium caldarium RK-1. The encoded protein functions as an RNA polymerase sigma factor in vitro and it is localized to the chloroplast in vivo. SigA shows high sequence similarity to the sigma factors of cyanobacteria, which is indicative of the ancestral endosymbiotic event and subsequent transfer of the sigA gene to the nuclear genome.	UNIV TOKYO, INST MOL & CELLULAR BIOSCI, BUNKYO KU, TOKYO 113, JAPAN; WASEDA UNIV, DEPT BASIC HUMAN SCI, TOKOROZAWA, SAITAMA 359, JAPAN; UNIV TOKYO, GRAD SCH SCI, DEPT PLANT SCI, BUNKYO KU, TOKYO 113, JAPAN	University of Tokyo; Waseda University; University of Tokyo			Tanaka, Kan/E-3724-2015	Tanaka, Kan/0000-0001-7560-7884				BERGSLAND KJ, 1991, J BACTERIOL, V173, P3446, DOI 10.1128/jb.173.11.3446-3455.1991; BRAHAMSHA B, 1991, J BACTERIOL, V173, P2442, DOI 10.1128/jb.173.8.2442-2450.1991; HALLICK RB, 1993, NUCLEIC ACIDS RES, V21, P3537, DOI 10.1093/nar/21.15.3537; HARLOW H, 1988, ANTIBODIES LAB MANUA; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; HU J, 1991, NUCLEIC ACIDS RES, V19, P3431, DOI 10.1093/nar/19.12.3431; HU J, 1990, P NATL ACAD SCI USA, V87, P1531, DOI 10.1073/pnas.87.4.1531; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; JOHNSON KA, 1990, CELL, V62, P615, DOI 10.1016/0092-8674(90)90105-N; KEEGSTRA K, 1989, ANNU REV PLANT PHYS, V40, P471, DOI 10.1146/annurev.pp.40.060189.002351; LERBS S, 1988, MOL GEN GENET, V211, P459, DOI 10.1007/BF00425701; Liu B, 1996, P NATL ACAD SCI USA, V93, P3313, DOI 10.1073/pnas.93.8.3313; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; NOMURA T, 1986, NUCLEIC ACIDS RES, V14, P6857, DOI 10.1093/nar/14.17.6857; NOZAKI H, 1994, J PHYCOL, V30, P279, DOI 10.1111/j.0022-3646.1994.00279.x; OHTA N, 1992, PLANT CELL PHYSIOL, V33, P657; OHTA N, 1994, CURR GENET, V25, P357, DOI 10.1007/BF00351490; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; REITH M, 1995, ANNU REV PLANT PHYS, V46, P549, DOI 10.1146/annurev.arplant.46.1.549; REITH M, 1993, PLANT CELL, V5, P465, DOI 10.1105/tpc.5.4.465; SCHNEIDER GJ, 1988, J BACTERIOL, V170, P4136, DOI 10.1128/jb.170.9.4136-4140.1988; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TANAKA K, 1991, BIOCHIM BIOPHYS ACTA, V1089, P113, DOI 10.1016/0167-4781(91)90092-Z; TANAKA K, 1992, BIOCHIM BIOPHYS ACTA, V1132, P94, DOI 10.1016/0167-4781(92)90060-D; TANAKA K, 1988, SCIENCE, V242, P1040, DOI 10.1126/science.3194753; TILLER K, 1991, EUR J BIOCHEM, V198, P93, DOI 10.1111/j.1432-1033.1991.tb15990.x; TROXLER RF, 1994, PLANT PHYSIOL, V104, P753, DOI 10.1104/pp.104.2.753	29	98	100	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	1996	272	5270					1932	1935		10.1126/science.272.5270.1932	http://dx.doi.org/10.1126/science.272.5270.1932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8658165				2022-12-28	WOS:A1996UV29400047
J	Legge, JS				Legge, JS			Peak-expiratory-flow meters and asthma self-management	LANCET			English	Editorial Material											Legge, JS (corresponding author), ABERDEEN ROYAL INFIRM,DEPT THORAC MED,ABERDEEN AB9 2ZB,SCOTLAND.							BOULET LP, 1994, THORAX, V49, P965, DOI 10.1136/thx.49.10.965; GIBSON PG, 1995, ANN INTERN MED, V123, P488, DOI 10.7326/0003-4819-123-7-199510010-00002; JONES KP, 1995, THORAX, V50, P851, DOI 10.1136/thx.50.8.851; KENDRICK AH, 1993, BRIT MED J, V307, P422, DOI 10.1136/bmj.307.6901.422; MALO JL, 1993, J ALLERGY CLIN IMMUN, V91, P702, DOI 10.1016/0091-6749(93)90189-M; Miles JF, 1996, THORAX, V51, P403, DOI 10.1136/thx.51.4.403; VERSCHELDEN P, 1996, AM J RESP CRIT CARE, V153, pA777; 1994, BRIT MED J, V308, P564	8	13	13	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 22	1996	347	9017					1709	1710		10.1016/S0140-6736(96)90802-8	http://dx.doi.org/10.1016/S0140-6736(96)90802-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT396	8656900				2022-12-28	WOS:A1996UT39600004
J	Nichols, CG; Shyng, SL; Nestorowicz, A; Glaser, B; Clement, JP; Gonzalez, G; AguilarBryan, L; Permutt, MA; Bryan, J				Nichols, CG; Shyng, SL; Nestorowicz, A; Glaser, B; Clement, JP; Gonzalez, G; AguilarBryan, L; Permutt, MA; Bryan, J			Adenosine diphosphate as an intracellular regulator of insulin secretion	SCIENCE			English	Article							ISOLATED MEMBRANE PATCHES; POTASSIUM CHANNELS; K+ CHANNELS; ATP; CELLS; ADP	Adenosine triphosphate (ATP)-sensitive potassium (K-ATP) channels couple the cellular metabolic state to electrical activity and are a critical link between blood glucose concentration and pancreatic insulin secretion. A mutation in the second nucleotide-binding fold (NBF2) of the sulfonylurea receptor (SUR) of an individual diagnosed with persistent hyperinsulinemic hypoglycemia of infancy generated K-ATP channels that could be opened by diazoxide but not in response to metabolic inhibition. The hamster SUR, containing the analogous mutation, had normal ATP sensitivity, but unlike wild-type channels, inhibition by ATP was not antagonized by adenosine diphosphate (ADP). Additional mutations in NBF2 resulted in the same phenotype, whereas an equivalent mutation in NBF1 showed normal sensitivity to MgADP. Thus, by binding to SUR NBF2 and antagonizing ATP inhibition of K-ATP channels, intracellular MgADP may regulate insulin secretion.	WASHINGTON UNIV,SCH MED,DIV ENDOCRINOL & METAB,ST LOUIS,MO 63110; HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DIV ENDOCRINOL & METAB,IL-91010 JERUSALEM,ISRAEL; BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030	Washington University (WUSTL); Hebrew University of Jerusalem; Baylor College of Medicine; Baylor College of Medicine	Nichols, CG (corresponding author), WASHINGTON UNIV,SCH MED,DEPT CELL BIOL,ST LOUIS,MO 63110, USA.		Nichols, Colin/D-6336-2012; Glaser, Benjamin/F-8411-2017	Glaser, Benjamin/0000-0003-4711-5000				AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; BAUBICHONCORTAY H, 1994, J BIOL CHEM, V269, P22983; DUNNE MJ, 1986, FEBS LETT, V208, P59, DOI 10.1016/0014-5793(86)81532-0; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; HOPKINS WF, 1992, J MEMBRANE BIOL, V129, P287; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; MISLER S, 1986, P NATL ACAD SCI USA, V83, P7119, DOI 10.1073/pnas.83.18.7119; NICHOLS CG, 1991, BIOPHYS J, V60, P1164, DOI 10.1016/S0006-3495(91)82152-X; RAJAN AS, 1993, J BIOL CHEM, V268, P15221; SMIT LS, 1993, P NATL ACAD SCI USA, V90, P9963, DOI 10.1073/pnas.90.21.9963; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Zuppinger K, 1983, Prog Pediatr Surg, V16, P51	17	453	463	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1785	1787		10.1126/science.272.5269.1785	http://dx.doi.org/10.1126/science.272.5269.1785			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8650576				2022-12-28	WOS:A1996UT11000042
J	Richtsmeier, WJ; Johns, ME				Richtsmeier, WJ; Johns, ME			Otolaryngology head and neck surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									JOHNS HOPKINS UNIV, SCH MED, BALTIMORE, MD USA	Johns Hopkins University	Richtsmeier, WJ (corresponding author), DUKE UNIV, MED CTR, DURHAM, NC 27710 USA.							ANDREA M, 1995, ANN OTO RHINOL LARYN, V104, P333, DOI 10.1177/000348949510400501; BRENNAN JA, 1995, NEW ENGL J MED, V332, P712, DOI 10.1056/NEJM199503163321104; BRENNAN JA, 1995, NEW ENGL J MED, V332, P429, DOI 10.1056/NEJM199502163320704; ETCHASON J, 1995, NEW ENGL J MED, V332, P719, DOI 10.1056/NEJM199503163321106; HARRIS JP, 1995, ARCH OTOLARYNGOL, V121, P398; REDMOND DE, 1970, NEW ENGL J MED, V282, P18, DOI 10.1056/NEJM197001012820105; RODRIQUEZ WJ, 1995, LARYNGOSCOPE, V105, P300, DOI 10.1288/00005537-199503000-00014; TUCCI DL, 1995, ARCH OTOLARYNGOL, V121, P833; WEBER RS, 1995, LARYNGOSCOPE, V105, P1, DOI 10.1288/00005537-199508001-00001; WYATT JR, 1995, AM J OTOL, V16, P52	10	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1838	1839		10.1001/jama.275.23.1838	http://dx.doi.org/10.1001/jama.275.23.1838			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642739				2022-12-28	WOS:A1996UQ15200038
J	Price, RN; Nosten, F; Luxemburger, C; terKuile, FO; Paiphun, L; Chongsuphajaisiddhi, T; White, NJ				Price, RN; Nosten, F; Luxemburger, C; terKuile, FO; Paiphun, L; Chongsuphajaisiddhi, T; White, NJ			Effects of artemisinin derivatives on malaria transmissibility	LANCET			English	Article							RESISTANT FALCIPARUM-MALARIA; THAI-BURMESE BORDER; PLASMODIUM-FALCIPARUM; MEFLOQUINE; PYRIMETHAMINE; SULFADOXINE; GAMETOCYTES	Background On the western border of Thailand the efficacy of mefloquine in the treatment of falciparum malaria has declined while gametocyte carriage rates have increased, which suggests increased transmissibility of these resistant infections. We compared the following antimalarial drugs in relation to subsequent Plasmodium falciparum gametocyte carriage: mefloquine, halofantrine, quinine, and the artemisinin derivatives. Methods Between 1990 and 1995 we assessed gametocytaemia in a series of prospective studies of antimalarial drug treatment in 5193 adults and children with acute uncomplicated falciparum malaria in an area of malarious hill forest on the western border of Thailand, Weekly parasite counts from thick and thin blood films were done during the 4-week (1990-93) or 9-week (1993-95) follow-up period, Gametocyte positivity rates and person gametocyte week (PGW) rates were calculated to measure gametocyte carriage and transmission potential. Findings In primary P falciparum infections the gametocyte carriage rate was significantly higher after treatment with mefloquine than after treatment with the artemisinin (PGW 34 . 1 [95% CI 25 . 2-42 . 9] vs 3 . 9 [1 . 9-5 . 9] per 1000 person weeks; relative risk 8 . 0 [41-156]; p<00001). Recrudescent infections were associated with increased gametocyte carrier rates (relative risk 2 . 2 [1 . 6-3 . 0]; p<0 . 0001), but retreatment with artemisinin derivatives reduced subsequent gametocyte carriage 18 . 5 fold [3 . 5-98] compared with mefloquine retreatment and 6 . 8 fold (3 . 1-15 . 1) compared with quinine retreatment (p<0 . 001). The introduction of the artemisinin derivatives in routine treatment at this study site in mid 1994 was associated with a reduction in the subsequent incidence of falciparum malaria of 47 (25-69)%. Interpretation Although environmental changes affect. vector numbers, and hence malaria incidence, artemisinin derivatives were found to reduce the transmission potential of falciparum malaria. Widespread introduction of artemisinin derivatives in the treatment of falciparum malaria may prevent the spread of multidrug resistance.	MAHIDOL UNIV,FAC TROP MED,BANGKOK 10400,THAILAND; SHOKLO MALARIA RES UNIT,TAK PROV,THAILAND; JOHN RADCLIFFE HOSP,CTR TROP MED,OXFORD OX3 9DU,ENGLAND; UNIV AMSTERDAM,UNIT INFECT DIS & TROP MED,AMSTERDAM,NETHERLANDS	Mahidol University; Mahidol University; University of Oxford; University of Amsterdam			Kuile, Feiko ter/ABD-6681-2020; White, Nicholas J/I-4629-2012; Nosten, Francois/AAC-5509-2019; White, Nick/AAC-6527-2019	Kuile, Feiko ter/0000-0003-3663-5617; Nosten, Francois/0000-0002-7951-0745; White, Nick/0000-0002-1897-1978; Price, Richard/0000-0003-2000-2874	Wellcome Trust [091625] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CHEN PQ, 1994, CHINESE MED J-PEKING, V107, P709; HAWKING F, 1971, T ROY SOC TROP MED H, V65, P549, DOI 10.1016/0035-9203(71)90036-8; JEFFERY GM, 1956, AM J HYG, V64, P1; JEFFERY GM, 1955, AM J TROP MED HYG, V4, P781, DOI 10.4269/ajtmh.1955.4.781; KUMAR N, 1990, PARASITOL RES, V76, P214, DOI 10.1007/BF00930817; LOOAREESUWAN S, 1992, LANCET, V339, P821, DOI 10.1016/0140-6736(92)90276-9; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; MEHRA N, 1993, JPN J MED SCI BIOL, V46, P37, DOI 10.7883/yoken1952.46.37; NOSTEN F, 1994, J INFECT DIS, V170, P971, DOI 10.1093/infdis/170.4.971; NOSTEN F, 1987, B WORLD HEALTH ORGAN, V65, P891; NOSTEN F, 1991, LANCET, V337, P1140, DOI 10.1016/0140-6736(91)92798-7; RIECKMANN KH, 1969, MIL MED, V134, P802; SMALLEY ME, 1977, PARASITOLOGY, V74, P1, DOI 10.1017/S0031182000047478; SMALLEY ME, 1981, T ROY SOC TROP MED H, V75, P318, DOI 10.1016/0035-9203(81)90349-7; STRICKLAND GT, 1986, AM J TROP MED HYG, V35, P259, DOI 10.4269/ajtmh.1986.35.259; TERKUILE FO, 1993, LANCET, V341, P1044, DOI 10.1016/0140-6736(93)92409-M; Thomson David, 1911, Annals of Tropical Medicine and Parasitology, V5; WHITE NJ, IN PRESS PARASITOL T	18	372	379	0	40	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 15	1996	347	9016					1654	1658		10.1016/S0140-6736(96)91488-9	http://dx.doi.org/10.1016/S0140-6736(96)91488-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ701	8642959				2022-12-28	WOS:A1996UQ70100011
J	Spruch, L				Spruch, L			Long-range (Casimir) interactions	SCIENCE			English	Article							VAN-DER-WAALS; HE-HE; RETARDATION; ELECTRON; VACUUM; FORCES; POTENTIALS; ENERGY; LIGHT	Normally, nonrelativistic electromagnetic theory with two-particle Coulombic interactions adequately determines the interaction potential of systems A and B if the systems are composed of particles with characteristic velocities much less than the speed of light. If, however, the time it takes light to travel between A and B exceeds a characteristic oscillation period of A or B, the way in which the potential function depends on the separation of the systems can be altered. Called the Casimir effect, it has only recently been confirmed, and it arises in physics, chemistry, and biology. It is the dearest physical manifestation of the fact that, even in a vacuum, electromagnetic fields cannot all vanish.			Spruch, L (corresponding author), NYU, DEPT PHYS, 4 WASHINGTON PL, NEW YORK, NY 10003 USA.							AU CK, 1984, PHYS REV LETT, V53, P1145, DOI 10.1103/PhysRevLett.53.1145; BABB JF, 1987, PHYS REV A, V36, P456, DOI 10.1103/PhysRevA.36.456; BARTON G, 1977, J PHYS A-MATH GEN, V10, P601, DOI 10.1088/0305-4470/10/4/022; BARTON G, 1990, PHYS LETT B, V237, P559, DOI 10.1016/0370-2693(90)91224-Y; BENMENAHEM S, 1990, PHYS LETT B, V250, P133, DOI 10.1016/0370-2693(90)91167-A; BERNABEU J, 1976, ANN PHYS-NEW YORK, V102, P323, DOI 10.1016/0003-4916(76)90265-7; Casimir H. B. G., 1948, P KON NED AKAD WET, V51, P793; CASIMIR HBG, 1949, J CHIM PHYS PCB, V46, P407, DOI 10.1051/jcp/1949460407; CASIMIR HBG, 1948, PHYS REV, V73, P360, DOI 10.1103/PhysRev.73.360; DERJAGUIN BV, 1957, SOV PHYS JETP, V3, P819; DZYALOSHINSKII IE, 1961, ADV PHYS, V10, P165, DOI 10.1080/00018736100101281; FEINBERG G, 1989, PHYS REP, V180, P83, DOI 10.1016/0370-1573(89)90111-7; FEINBERG G, 1983, PHYS REV A, V27, P1958, DOI 10.1103/PhysRevA.27.1958; GINZBURG VF, 1979, THEORETICAL PHYSICS, pCH13; HINDS E, 1994, ADV ATOMIC MOL OPT S, pCH1; ISRAELAC.JN, 1972, PROC R SOC LON SER-A, V331, P19, DOI 10.1098/rspa.1972.0162; JAMIESON MJ, 1995, PHYS REV A, V51, P2626, DOI 10.1103/PhysRevA.51.2626; JANZEN AR, 1995, J CHEM PHYS, V103, P9626, DOI 10.1063/1.469978; KELSEY EJ, 1978, PHYS REV A, V18, P15, DOI 10.1103/PhysRevA.18.15; Landau L. D., 1975, COURSE THEORETICAL P, V2; LEVIN FS, 1993, LONG RANGE CASIMIR F; Lifshits E.M., 1955, ZH EKSP TEOR FIZ+, V29, P94; LUNDEEN SR, 1993, LONG RANGE CASIMIR F, pCH2; Luo F, 1996, J CHEM PHYS, V104, P1151, DOI 10.1063/1.470771; LUO F, 1994, J CHEM PHYS, V100, P4023, DOI 10.1063/1.466339; LUO F, 1993, J CHEM PHYS, V98, P3564, DOI 10.1063/1.464079; MILONNI PW, 1988, PHYS REV A, V38, P1621, DOI 10.1103/PhysRevA.38.1621; MILONNI PW, 1990, PHYS LETT B, V248, P437, DOI 10.1016/0370-2693(90)90317-Y; MILONNI PW, 1992, CONTEMP PHYS, V33, P313, DOI 10.1080/00107519208223981; MILONNI PW, 1993, QUANTUM VACUUM, pCH7; MOSTEPANENKO VM, 1988, USP FIZ NAUK+, V156, P385, DOI 10.1070/PU1988v031n11ABEH005641; NIR S, 1977, PROG SURF SCI, V8, P1, DOI 10.1016/0079-6816(77)90007-7; Power E., 1964, INTRO QUANTUM ELECTR; RAITHEL G, 1994, ADV ATOMIC MOL OPT S, pCH2; SCHARNHORST K, 1990, PHYS LETT B, V236, P354, DOI 10.1016/0370-2693(90)90997-K; SCHOLLKOPF W, 1994, SCIENCE, V266, P1345, DOI 10.1126/science.266.5189.1345; SHAKESHAFT R, 1980, PHYS REV A, V22, P811, DOI 10.1103/PhysRevA.22.811; Sparnaay M.J., 1989, PHYS MAKING, P247; Sparnaay M.J, 1989, PHYS MAKING ESSAYS D, P235; SPARNAAY MJ, 1958, PHYSICA, V24, P751, DOI 10.1016/S0031-8914(58)80090-7; SPRUCH L, 1978, PHYS REV A, V18, P845, DOI 10.1103/PhysRevA.18.845; SPRUCH L, 1994, PHYS REV A, V49, P2476, DOI 10.1103/PhysRevA.49.2476; SPRUCH L, 1986, PHYS TODAY, V39, P37, DOI 10.1063/1.881043; SPRUCH L, 1993, PHYS REV A, V48, P4213, DOI 10.1103/PhysRevA.48.4213; TIKOCHINSKY Y, 1993, PHYS REV A, V48, P4223, DOI 10.1103/PhysRevA.48.4223; VANKAMPEN NG, 1993, QUANTUM VACUUM, pCH7; Verwey E.J., 1948, THEORY STABILITY LYO; WILLIAMS HL, UNPUB; YABLONOVITCH E, 1990, RESONANCES : A VOLUME IN HONOR OF THE 70TH BIRTHDAY OF NICOLAAS BLOEMBERGEN, P112; ZHOU F, 1995, PHYS REV A, V52, P297, DOI 10.1103/PhysRevA.52.297	50	45	46	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	1996	272	5267					1452	1455		10.1126/science.272.5267.1452	http://dx.doi.org/10.1126/science.272.5267.1452			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP899	8662466				2022-12-28	WOS:A1996UP89900038
J	Hiley, CMH; Morley, CJ				Hiley, CMH; Morley, CJ			Risk factors for sudden infant death syndrome: Further change in 1992-3	BRITISH MEDICAL JOURNAL			English	Article									UNIV CAMBRIDGE,ADDENBROOKES HOSP,DEPT PAEDIAT,CAMBRIDGE CB2 2QQ,ENGLAND	Addenbrooke's Hospital; University of Cambridge				Morley, Colin/0000-0001-5388-0214				HILEY CMH, 1994, BRIT MED J, V309, P703, DOI 10.1136/bmj.309.6956.703; 1994, OPCS MONITOR	2	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 1	1996	312	7043					1397	1398						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP434	8646098	Green Published			2022-12-28	WOS:A1996UP43400025
J	Mamode, N; Scott, RN; McLaughlin, SC; McLelland, A; Pollock, JG				Mamode, N; Scott, RN; McLaughlin, SC; McLelland, A; Pollock, JG			Perioperative myocardial infarction in peripheral vascular surgery	BRITISH MEDICAL JOURNAL			English	Article									GLASGOW ROYAL INFIRM,DEPT MED CARDIOL,GLASGOW G31 2ER,LANARK,SCOTLAND; GLASGOW ROYAL INFIRM,DEPT BIOCHEM,GLASGOW G31 2ER,LANARK,SCOTLAND	University of Glasgow; University of Glasgow	Mamode, N (corresponding author), GLASGOW ROYAL INFIRM,PERIPHERAL VASC UNIT,GLASGOW G31 2ER,LANARK,SCOTLAND.							KALRA M, 1993, BRIT J SURG, V80, P28, DOI 10.1002/bjs.1800800110; MAMODE N, 1995, BMJ-BRIT MED J, V310, P1215, DOI 10.1136/bmj.310.6989.1215; MANGANO DT, 1990, ANESTHESIOLOGY, V72, P153, DOI 10.1097/00000542-199001000-00025; TAYLOR LM, 1991, J VASC SURG, V15, P52; WONG T, 1992, ANN INTERN MED, V116, P743, DOI 10.7326/0003-4819-116-9-743	5	14	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 1	1996	312	7043					1396	1397		10.1136/bmj.312.7043.1396	http://dx.doi.org/10.1136/bmj.312.7043.1396			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP434	8646097	Green Published			2022-12-28	WOS:A1996UP43400024
J	Greshake, A; Bischoff, A; Putnis, A; Palme, H				Greshake, A; Bischoff, A; Putnis, A; Palme, H			Corundum, rutile, periclase, and CaO in Ca,Al-rich inclusions from carbonaceous chondrites	SCIENCE			English	Article							ALLENDE METEORITE; SOLAR NEBULA; RICH; CONDENSATION	Four calcium, aluminum-rich inclusions from four carbonaceous chondrites-Allende, Acfer 082, Acfer 086, and Acfer 094-were studied by transmission electron microscopy, All inclusions contained at least two of the oxides periclase (MgO), rutile (TiO2), calcium oxide (CaO), and corundum (Al2O3). The oxides (50 to 200 nanometers in size) were found inside and at grain boundaries of the constituent minerals of the inclusions. Determining how these oxides formed may provide insight about condensation processes in the early solar nebula and the origin of refractory inclusions in chondrites. Formation of these oxides by exsolution is considered unlikely. An origin by kinetically controlled condensation appears more probable.	UNIV MUNSTER, INST MINERAL, D-48149 MUNSTER, GERMANY; UNIV COLOGNE, MINERAL PETROG INST, D-50674 COLOGNE, GERMANY	University of Munster; University of Cologne	Greshake, A (corresponding author), UNIV MUNSTER, INST PLANETOL, WILHELM KLEMM STR 10, D-48149 MUNSTER, GERMANY.		Putnis, Andrew/R-6388-2019	Putnis, Andrew/0000-0003-2232-9942				BARMATTHEWS M, 1982, GEOCHIM COSMOCHIM AC, V46, P31, DOI 10.1016/0016-7037(82)90288-5; Bischoff A., 1987, LUNAR PLANET SCI, V18, P81; BISCHOFF A, 1994, LUNAR PLANET SCI, V25, P1309; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; CLIFF G, 1975, J MICROSC-OXFORD, V103, P203, DOI 10.1111/j.1365-2818.1975.tb03895.x; GRAY CM, 1974, NATURE, V251, P495, DOI 10.1038/251495a0; KURAT G, 1970, EARTH PLANET SC LETT, V9, P225, DOI 10.1016/0012-821X(70)90032-4; MacPherson G.J., 1988, METEORITES EARLY SOL, P746; MACPHERSON GJ, 1984, GEOCHIM COSMOCHIM AC, V48, P29, DOI 10.1016/0016-7037(84)90347-8; MACPHERSON GJ, 1984, P LUNAR PLANET SCI C, V15, pC229; NEWTON J, 1995, METEORITICS, V30, P47, DOI 10.1111/j.1945-5100.1995.tb01211.x; PALME H, 1990, EARTH PLANET SC LETT, V101, P180, DOI 10.1016/0012-821X(90)90152-N; PALME H, 1993, LANDOLDTBORNSTEIN GR, V3, P196; ROLIE RA, 1979, US GEOL SURV B, V1452; Sears D.W.G., 1988, METEORITES EARLY SOL, P3; SIMON SB, 1993, LUNAR PLANET SCI, V24, P115; Tilton G. G., 1988, METEORITES EARLY SOL, P259	18	18	18	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	1996	272	5266					1316	1318		10.1126/science.272.5266.1316	http://dx.doi.org/10.1126/science.272.5266.1316			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8662462				2022-12-28	WOS:A1996UN47200039
J	Niemeyer, BA; Suzuki, E; Scott, K; Jalink, K; Zuker, CS				Niemeyer, BA; Suzuki, E; Scott, K; Jalink, K; Zuker, CS			The Drosophila light-activated conductance is composed of the two channels TRP and TRPL	CELL			English	Article							RETINAL-DEGENERATION; PHOTORECEPTOR DEACTIVATION; PROTEIN; GENE; MUTANT; PHOTOTRANSDUCTION; MELANOGASTER; RHODOPSIN; CA2+; MEMBRANE	Drosophila phototransduction is a G protein-coupled, calcium-regulated signaling cascade that serves as a model system for the dissection of phospholipase C (PLC) signaling in vivo. The Drosophila light-activated conductance is constituted in part by the transient receptor potential (trp) ion channel, yet trp mutants still display a robust response demonstrating the presence of additional channels. The transient receptor potential-like (trpl) gene encodes a protein displaying 40% amino acid identity with TRP. Mammalian homologs of TRP and TRPL recently have been isolated and postulated to encode components of the elusive I-crac conductance. We now show that TRP and TRPL localize to the membrane of the transducing organelle, together with rhodopsin and PLC, consistent with a role in PLC signaling during phototransduction. To determine the function of TRPL in vivo, we isolated trpl mutants and characterized them physiologically and genetically. We demonstrate that the light-activated conductance is composed of TRP and TRPL ion channels and that each can be activated on its own. We also use genetic and electrophysiological tools to study the contribution of each channel type to the light response and show that TRP and TRPL can serve partially overlapping functions.	UNIV TOKYO, INST MED SCI, TOKYO, JAPAN	University of Tokyo	Niemeyer, BA (corresponding author), UNIV CALIF SAN DIEGO, HOWARD HUGHES MED INST, DEPT NEUROSCI, DEPT BIOL, LA JOLLA, CA 92093 USA.		Niemeyer, Barbara A./AAL-8972-2021	Jalink, Kees/0000-0001-7019-3440; Niemeyer, Barbara A./0000-0002-6963-0575; Suzuki, Emiko/0000-0002-4005-0542				BACIGALUPO J, 1990, SER CENT ES, P27; BACIGALUPO J, 1995, J NEUROSCI, V15, P7196; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; BARASH S, 1988, J GEN PHYSIOL, V92, P307, DOI 10.1085/jgp.92.3.307; BAUMANN A, 1994, EMBO J, V13, P5040, DOI 10.1002/j.1460-2075.1994.tb06833.x; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; DECOUET HG, 1987, EUR J CELL BIOL, V44, P50; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; DOLPH PJ, 1994, NATURE, V370, P59, DOI 10.1038/370059a0; DONG YJ, 1995, AM J PHYSIOL-CELL PH, V269, pC1332, DOI 10.1152/ajpcell.1995.269.5.C1332; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; HARDIE RC, 1993, P ROY SOC B-BIOL SCI, V252, P223, DOI 10.1098/rspb.1993.0069; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; HOCHSTRATE P, 1989, J COMP PHYSIOL A, V166, P179, DOI 10.1007/BF00193462; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; HU YF, 1995, BIOCHEM J, V305, P605, DOI 10.1042/bj3050605; HU YF, 1994, BIOCHEM BIOPH RES CO, V201, P1050, DOI 10.1006/bbrc.1994.1808; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Kumar JP, 1995, DEVELOPMENT, V121, P4359; LARRIVEE DC, 1981, J GEN PHYSIOL, V78, P521, DOI 10.1085/jgp.78.5.521; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; MINKE B, 1975, NATURE, V258, P84, DOI 10.1038/258084a0; MINKE B, 1991, PROG RETIN RES, V11, P99, DOI 10.1016/0278-4327(91)90026-X; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Pak W.L., 1979, P67; PAK WL, 1976, SCIENCE, V194, P956, DOI 10.1126/science.824732; PAREKH AB, 1993, NATURE, V364, P814, DOI 10.1038/364814a0; PERETZ A, 1994, J GEN PHYSIOL, V104, P1057, DOI 10.1085/jgp.104.6.1057; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; POLLOCK JA, 1995, J NEUROSCI, V15, P3747; PORTER JA, 1993, SCIENCE, V262, P1038, DOI 10.1126/science.8235618; PORTER JA, 1993, J CELL BIOL, V122, P601, DOI 10.1083/jcb.122.3.601; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; RANGANATHAN R, 1995, ANNU REV NEUROSCI, V18, P283; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; SHIEH BH, 1995, NEURON, V14, P201, DOI 10.1016/0896-6273(95)90255-4; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; STIEVE H, 1986, MOL MECHANISM PHOTOR, P199; SUZUKI E, 1993, J ELECTRON MICROSC, V42, P178; SUZUKI E, 1994, J ELECTRON MICROSC, V43, P183; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; VIHTELIC TS, 1991, GENETICS, V127, P761; Wolff Tanya, 1993, P1277; WU L, 1995, NATURE, V373, P216, DOI 10.1038/373216a0; YEANDLE S, 1957, THESIS J HOPKINS U; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	59	290	295	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 31	1996	85	5					651	659		10.1016/S0092-8674(00)81232-5	http://dx.doi.org/10.1016/S0092-8674(00)81232-5			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UP344	8646774	Bronze			2022-12-28	WOS:A1996UP34400006
J	Subramaniam, VN; Peter, F; Philp, R; Wong, SH; Hong, WJ				Subramaniam, VN; Peter, F; Philp, R; Wong, SH; Hong, WJ			GS28, a 28-kilodalton Golgi SNARE that participates in ER-Golgi transport	SCIENCE			English	Article							VESICULAR TRANSPORT; ENDOPLASMIC-RETICULUM; FUSION; RECEPTORS; PROTEIN; FAMILY	Little is known about the integral membrane proteins that participate in the early secretory pathway of mammalian cells. The complementary DNA encoding a 28-kilodalton protein (p28) of the cis-Golgi was cloned and sequenced. The protein was predicted to contain a central coiled-coil domain with a carboxyl-terminal membrane anchor. An in vitro assay for endoplasmic reticulum-Golgi transport was used to show that p28 participates in the docking and fusion stage of this transport event. Biochemical studies established that p28 is a core component of the Golgi SNAP receptor (SNARE) complex.	NATL UNIV SINGAPORE,INST MOLEC & CELL BIOL,MEMBRANE BIOL LAB,SINGAPORE 119260,SINGAPORE	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore			Subramaniam, V. Nathan/A-1901-2010; HONG, Wanjin/E-9927-2010	Subramaniam, V. Nathan/0000-0002-4583-7790; 				ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; BANFIELD DK, 1995, NATURE, V375, P806, DOI 10.1038/375806a0; BECKERS CJM, 1987, CELL, V50, P523, DOI 10.1016/0092-8674(87)90025-0; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; CLARY DO, 1990, J BIOL CHEM, V265, P10109; DASCHER C, 1994, J BIOL CHEM, V269, P29363; DAVIDSON HW, 1993, J BIOL CHEM, V268, P4216; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; MCMAHON HT, 1994, J CELL BIOL, V125, P1015; PIND SN, 1994, J CELL BIOL, V125, P239, DOI 10.1083/jcb.125.2.239; PRYER NK, 1992, ANNU REV BIOCHEM, V61, P471; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SOGAARD M, 1994, CELL, V78, P936; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUBRAMANIAM VN, 1995, J CELL SCI, V108, P2405; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; TANG BL, 1994, EUR J CELL BIOL, V65, P298; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531	22	122	127	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 24	1996	272	5265					1161	1163		10.1126/science.272.5265.1161	http://dx.doi.org/10.1126/science.272.5265.1161			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8638159				2022-12-28	WOS:A1996UM88900047
J	Subramanya, HS; Doherty, AJ; Ashford, SR; Wigley, DB				Subramanya, HS; Doherty, AJ; Ashford, SR; Wigley, DB			Crystal structure of an ATP-dependent DNA ligase from bacteriophage T7	CELL			English	Article							RNA CAPPING ENZYME; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL EXPRESSION; ESCHERICHIA-COLI; GENE; GUANYLYLTRANSFERASE; DOMAIN; CDNA	The crystal structure of the ATP-dependent DNA ligase from bacteriophage T7 has been solved at 2.6 Angstrom resolution. The protein comprises two domains with a deep cleft running between them. The structure of a complex with ATP reveals that the nucleotide binding pocket is situated on the larger N-terminal domain, at the base of the cleft between the two domains of the enzyme. Comparison of the overall domain structure with that of DNA methyltransferases, coupled with other evidence, suggests that DNA also binds in this cleft. Since this structure is the first of the nucleotidyl-transferase superfamily, which includes the eukaryotic mRNA capping enzymes, the relationship between the structure of DNA ligase and that of other nucleotidyl-transferases is also discussed.			Subramanya, HS (corresponding author), UNIV OXFORD,MOLEC BIOPHYS LAB,OXFORD OX1 3QU,ENGLAND.			Doherty, Aidan/0000-0002-6370-1109	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BARNES DE, 1990, P NATL ACAD SCI USA, V87, P6679, DOI 10.1073/pnas.87.17.6679; BAYMILLER J, 1994, GENE, V142, P129, DOI 10.1016/0378-1119(94)90367-0; BRUNGER AT, 1989, ACTA CRYSTALLOGR A, V45, P50, DOI 10.1107/S0108767388009195; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CHENG XD, 1995, CURR OPIN STRUC BIOL, V5, P4, DOI 10.1016/0959-440X(95)80003-J; CONG PJ, 1995, MOL CELL BIOL, V15, P6222; CONG PJ, 1993, J BIOL CHEM, V268, P7256; DOHERTY AJ, 1996, IN PRESS J BIOL CHEM; DOHERTY AJ, 1996, IN PRESS NUCL ACIDS; DUNN JJ, 1981, J MOL BIOL, V148, P303, DOI 10.1016/0022-2836(81)90178-9; Engler M.J., 1982, ENZYMES, V15, P3, DOI [10.1016/S1874-6047(08)60273-5, DOI 10.1016/S1874-6047(08)60273-5]; GELLERT M, 1967, P NATL ACAD SCI USA, V57, P148, DOI 10.1073/pnas.57.1.148; HAMMOND JM, 1992, NUCLEIC ACIDS RES, V20, P2667, DOI 10.1093/nar/20.11.2667; HEAPHY S, 1987, BIOCHEMISTRY-US, V26, P1688, DOI 10.1021/bi00380a030; HYNES TR, 1991, PROTEINS, V10, P92, DOI 10.1002/prot.340100203; KLETZIN A, 1992, NUCLEIC ACIDS RES, V20, P5389, DOI 10.1093/nar/20.20.5389; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; KODAMA K, 1991, NUCLEIC ACIDS RES, V19, P6093, DOI 10.1093/nar/19.22.6093; LI Y, 1995, VIROLOGY, V212, P134, DOI 10.1006/viro.1995.1462; LINDAHL T, 1992, ANNU REV BIOCHEM, V61, P251, DOI 10.1146/annurev.bi.61.070192.001343; MODRICH P, 1973, J BIOL CHEM, V248, P7502; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; OKAZAKI R, 1968, P NATL ACAD SCI USA, V59, P598, DOI 10.1073/pnas.59.2.598; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; ROBERTS RJ, 1995, CELL, V82, P9, DOI 10.1016/0092-8674(95)90046-2; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; SANCAR A, 1994, SCIENCE, V266, P1954, DOI 10.1126/science.7801120; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; SCHINDELIN H, 1993, NATURE, V364, P164, DOI 10.1038/364164a0; Sheldrick G. M., 1991, CRYSTALLOGRAPHIC COM, V5, P145; SHIBAGAKI Y, 1992, J BIOL CHEM, V267, P9521; SHUMAN S, 1981, P NATL ACAD SCI-BIOL, V78, P187, DOI 10.1073/pnas.78.1.187; SHUMAN S, 1995, VIROLOGY, V211, P73, DOI 10.1006/viro.1995.1380; SHUMAN S, 1994, P NATL ACAD SCI USA, V91, P12046, DOI 10.1073/pnas.91.25.12046; SHUMAN S, 1995, MOL MICROBIOL, V17, P405, DOI 10.1111/j.1365-2958.1995.mmi_17030405.x; SKINNER MM, 1994, P NATL ACAD SCI USA, V91, P2071, DOI 10.1073/pnas.91.6.2071; SODERHALL S, 1976, NATURE, V260, P640, DOI 10.1038/260640a0; Tan GT, 1996, BIOCHEM J, V314, P993, DOI 10.1042/bj3140993; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Wilson AJC, 1942, NATURE, V150, P151, DOI 10.1038/150152a0	44	206	209	1	26	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 17	1996	85	4					607	615		10.1016/S0092-8674(00)81260-X	http://dx.doi.org/10.1016/S0092-8674(00)81260-X			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UM415	8653795	Bronze			2022-12-28	WOS:A1996UM41500017
J	Sato, Y; Roman, M; Tighe, H; Lee, D; Corr, M; Nguyen, MD; Silverman, GJ; Lotz, M; Carson, DA; Raz, E				Sato, Y; Roman, M; Tighe, H; Lee, D; Corr, M; Nguyen, MD; Silverman, GJ; Lotz, M; Carson, DA; Raz, E			Immunostimulatory DNA sequences necessary for effective intradermal gene immunization	SCIENCE			English	Article							MYCOBACTERIUM-BOVIS BCG; NATURAL-KILLER ACTIVITY; CD4+ T-CELLS; SYNTHETIC OLIGONUCLEOTIDES; INTERFERON-PRODUCTION; ALPHA; PROTEINS; IFN; TH1	Vaccination with naked DNA elicits cellular and humoral immune responses that have a T helper cell type 1 bias. However, plasmid vectors expressing large amounts of gene product do not necessarily induce immune responses to the encoded antigens. instead, the immunogenicity of plasmid DNA (pDNA) requires short immunostimulatory DNA sequences (ISS) that contain a CpG dinucleotide in a particular base context. Human monocytes transfected with pDNA or double-stranded oligonucleotides containing the ISS, but not those transfected with ISS-deficient pDNA or oligonucleotides, transcribed large amounts of interferon-alpha, interferon-beta, and interleukin-12. Although ISS are necessary for gene vaccination, they down-regulate gene expression and thus may interfere with gene replacement therapy by inducing proinflammatory cytokines.	UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,SAM & ROSE STEIN INST RES AGING,LA JOLLA,CA 92093	University of California System; University of California San Diego; University of California System; University of California San Diego					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214, R01AI037305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR041897] Funding Source: NIH RePORTER; NIAID NIH HHS [AI37305, AI36214] Funding Source: Medline; NIAMS NIH HHS [AR41897] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; BRINKMANN V, 1993, J EXP MED, V178, P1655, DOI 10.1084/jem.178.5.1655; FINKELMAN FD, 1991, J EXP MED, V174, P1179, DOI 10.1084/jem.174.5.1179; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; GAVIN MA, 1993, J IMMUNOL, V151, P3971; Halpern MD, 1996, CELL IMMUNOL, V167, P72, DOI 10.1006/cimm.1996.0009; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; KIMURA Y, 1994, J BIOCHEM-TOKYO, V116, P991, DOI 10.1093/oxfordjournals.jbchem.a124658; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; MANETTI R, 1995, EUR J IMMUNOL, V25, P2656, DOI 10.1002/eji.1830250938; MANICKAN E, 1995, J IMMUNOL, V155, P259; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; PARRONCHI P, 1992, J IMMUNOL, V149, P2977; Raz E, 1996, P NATL ACAD SCI USA, V93, P5141, DOI 10.1073/pnas.93.10.5141; RAZ E, 1994, P NATL ACAD SCI USA, V91, P9519, DOI 10.1073/pnas.91.20.9519; SATO Y, UNPUB; TOKUNAGA T, 1984, J NATL CANCER I, V72, P955; TOKUNAGA T, 1992, MICROBIOL IMMUNOL, V36, P55, DOI 10.1111/j.1348-0421.1992.tb01642.x; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; WANG B, 1993, P NATL ACAD SCI USA, V90, P4156, DOI 10.1073/pnas.90.9.4156; WANG JC, 1992, AM J HEMATOL, V40, P81, DOI 10.1002/ajh.2830400202; XIANG ZQ, 1995, IMMUNITY, V2, P129, DOI 10.1016/S1074-7613(95)80001-8; YAMAMOTO S, 1992, J IMMUNOL, V148, P4072; YAMAMOTO T, 1994, JPN J CANCER RES, V85, P775, DOI 10.1111/j.1349-7006.1994.tb02947.x; YAMAMOTO T, 1994, MICROBIOL IMMUNOL, V38, P831, DOI 10.1111/j.1348-0421.1994.tb01867.x; Yi AK, 1996, J IMMUNOL, V156, P558	27	903	1146	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 19	1996	273	5273					352	354		10.1126/science.273.5273.352	http://dx.doi.org/10.1126/science.273.5273.352			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY202	8662521				2022-12-28	WOS:A1996UY20200038
J	Xia, YN; Kim, E; Zhao, XM; Rogers, JA; Prentiss, M; Whitesides, GM				Xia, YN; Kim, E; Zhao, XM; Rogers, JA; Prentiss, M; Whitesides, GM			Complex optical surfaces formed by replica molding against elastomeric masters	SCIENCE			English	Article							GOLD	Complex, optically functional surfaces in organic polymers can be fabricated by replicating relief structures present on the surface of an elastomeric master with an ultraviolet or thermally curable organic polymer, while the master is deformed by compression, bending, or stretching, The versatility of this procedure for fabricating surfaces with complex, micrometer- and submicrometer-scale patterns was demonstrated by the production of (i) diffraction gratings with periods smaller than the original grating; (ii) chirped, blazed diffraction gratings (where the period of a chirped grating changes continuously with position) on planar and curved surfaces; (iii) patterned microfeatures on the surfaces of approximately hemispherical objects (for example, an optical surface similar to a fly's eye); and (iv) arrays of rhombic microlenses, These topologically complex, micropatterned surfaces are difficult to fabricate with other techniques.	HARVARD UNIV,DEPT CHEM,CAMBRIDGE,MA 02138; HARVARD UNIV,DEPT PHYS,CAMBRIDGE,MA 02138	Harvard University; Harvard University			Xia, Younan/E-8499-2011; Rogers, John/L-2798-2016					[Anonymous], 1991, FUNDAMENTALS ADHESIO; BIEBUYCK HA, 1994, LANGMUIR, V10, P2790, DOI 10.1021/la00020a047; BRYZEK J, 1994, IEEE SPECTRUM    MAY, P20; CALRSON SJ, 1993, SILOXANE POLYM; CLARK P, 1990, DEVELOPMENT, V108, P635; GIBSONS WM, 1994, APPL PHYS LETT, V65, P2542; HEINZE J, 1993, ANGEW CHEM INT EDIT, V32, P1268, DOI 10.1002/anie.199312681; HUGHES RC, 1991, SCIENCE, V254, P74, DOI 10.1126/science.254.5028.74; Hutley M. C., 1982, DIFFRACTION GRATINGS; KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628; LEHMANN HW, 1983, J VAC SCI TECHNOL B, V1, P1207, DOI 10.1116/1.582747; LIVANOS AC, 1976, OPT COMMUN, V20, P179; SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320; VANRIJSEWIJK HCH, 1982, PHILIPS TECH REV, V40, P287; WISE KD, 1991, SCIENCE, V254, P1335, DOI 10.1126/science.1962192; XIA J, 1995, J AM CHEM SOC, V117, P9576; Xia YN, 1996, J ELECTROCHEM SOC, V143, P1070, DOI 10.1149/1.1836585; XIA YN, 1995, ADV MATER, V7, P471, DOI 10.1002/adma.19950070513; Xia YN, 1996, CHEM MATER, V8, P601, DOI 10.1021/cm950464+	19	534	646	4	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 19	1996	273	5273					347	349		10.1126/science.273.5273.347	http://dx.doi.org/10.1126/science.273.5273.347			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY202	8662519				2022-12-28	WOS:A1996UY20200036
J	Staszewski, S; Loveday, C; Picazo, JJ; Dellamonica, P; Skinhoj, P; Johnson, MA; Danner, SA; Harrigan, PR; Hill, AM; Verity, L; McDade, H				Staszewski, S; Loveday, C; Picazo, JJ; Dellamonica, P; Skinhoj, P; Johnson, MA; Danner, SA; Harrigan, PR; Hill, AM; Verity, L; McDade, H			Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients - A randomized controlled comparison with zidovudine monotherapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS INFECTION; PLACEBO-CONTROLLED TRIAL; CUBIC MILLIMETER; HIV-INFECTION; DOUBLE-BLIND; MUTATION; AZT	Objective.-To compare the safety and efficacy of 2 doses of lamivudine given in combination with zidovudine with continued zidovudine monotherapy. Design.-Double-blind, randomized, multicenter, comparative trial of 223 patients treated for 24 weeks. Setting.-Patients from 32 hospitals in Europe were enrolled th roughout a 1-year period. Patients.-Adult human immunodeficiency virus type 1 (HIV-1)-positive, zidovudine-experienced (greater than or equal to 24 weeks prior zidovudine) patients with CD4(+) cell counts between 0.10 and 0.40x10(9)/L (100-400 cells/mu L). Intervention.-Patients received either 200 mg of zidovudine every 8 hours, 150 mg of lamivudine every 12 hours plus zidovudine, or 300 mg of lamivudine every 12 hours plus zidovudine for 24 weeks. All patients were then allowed to receive zidovudine and open-label lamivudine combination therapy. Twelve patients withdrew because of adverse events during the 24-week treatment period. Main Outcome Measures.-Efficacy was measured by evaluating immunological and viral load changes, and safety was assessed by evaluating clinical manifestations and laboratory indexes of toxic effects. Results.-Patients receiving low- or high-dose combination therapy had greater treatment effects compared with patients receiving continued zidovudine monotherapy during the first 24 weeks as documented by changes in CD4(+) cell counts (+0.04 vs +0.03 vs -0.02x10(9)/L, respectively; P<.001); log,, HIV-I RNA as measured by the Roche assay (-0.96 vs -0.77 vs +0.07 copies/mL, respectively; P<.001) or log(10) HIV-1 RNA measured by the quantitative nucleic acid sequence-based amplification assay (-0.59 vs -1.06 vs -0.02 copies/mL, respectively; P<.011); and immune-complex dissociated (ICD) p24 antigen (-74% vs -68% vs +27%, respectively; P<.001). There were no statistically significant differences in viral measurements, in CD4(+) cell counts, or in safety profile between the groups receiving 2 doses of lamivudine in combination with zidovudine. The effects on CD4(+) cell counts and ICD p24 antigen were sustained throughout 48 weeks for patients continuing combination therapy. Patients switching to combination therapy at week 24 showed improvement. Conclusions.-In zidovudine-experienced HIV-1-infected patients, combination treatment with lamivudine and zidovudine is well tolerated and provides greate; and more sustained increases in CD4(+) cell counts and decreases in viral load than continued zidovudine monotherapy.	UCL, SCH MED, LONDON W1N 8AA, ENGLAND; HOSP UNIV SAN CARLOS, MADRID, SPAIN; HOP LARCHEL, NICE, FRANCE; RIGSHOSP, DK-2100 COPENHAGEN, DENMARK; ROYAL FREE HOSP, LONDON NW3 2QG, ENGLAND; UNIV AMSTERDAM, ACAD MED CTR, 1105 AZ AMSTERDAM, NETHERLANDS; WELLCOME RES LABS, ANTIVIRAL THERAPEUT RES UNIT, BECKENHAM BR3 3BS, KENT, ENGLAND; GLAXO WELLCOME RES & DEV, DIV BIOSTAT & REPORTING, GREENFORD, MIDDX, ENGLAND; GLAXO WELLCOME RES & DEV, DIV EUROPEAN ANTIVIRAL CLIN RES, GREENFORD, MIDDX, ENGLAND	University of London; University College London; UCL Medical School; CHU Nice; Rigshospitalet; University of Copenhagen; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Amsterdam; Academic Medical Center Amsterdam; GlaxoSmithKline; Wellcome Research Laboratories; GlaxoSmithKline; GlaxoSmithKline	Staszewski, S (corresponding author), UNIV FRANKFURT KLINIKUM, ZENTRUM INNEREN MED, INFEKT AMBULANZ HAUS 68, THEODOR STERN KAI 7, D-60590 FRANKFURT, GERMANY.							[Anonymous], 1992, MMWR Recomm Rep, V41, P1; BOYER PL, 1995, ANTIMICROB AGENTS CH, V39, P1624, DOI 10.1128/AAC.39.7.1624; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; COOPER DA, 1993, NEW ENGL J MED, V329, P297, DOI 10.1056/NEJM199307293290501; DAQUILA RT, 1995, ANN INTERN MED, V122, P401, DOI 10.7326/0003-4819-122-6-199503150-00001; ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502; FISCHL MA, 1995, ANN INTERN MED, V122, P24, DOI 10.7326/0003-4819-122-1-199501010-00004; FISCHL MA, 1990, ANN INTERN MED, V112, P727, DOI 10.7326/0003-4819-112-10-727; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; GAZZARD B, 1996, 3 C RETR OPP INF JAN; HAMMER S, 1996, 3 C RETR OPP INF JAN; JACKSON B, 1995, 2 NAT C HUM RETR REL; KAHN JO, 1992, NEW ENGL J MED, V327, P581, DOI 10.1056/NEJM199208273270901; KAYE S, 1992, J MED VIROL, V37, P241, DOI 10.1002/jmv.1890370402; LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804; LIN HJ, 1994, J INFECT DIS, V170, P553, DOI 10.1093/infdis/170.3.553; LOVEDAY C, 1995, LANCET, V345, P790, DOI 10.1016/S0140-6736(95)90668-1; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; MENG TC, 1992, ANN INTERN MED, V116, P13, DOI 10.7326/0003-4819-116-1-13; MULDER J, 1994, J CLIN MICROBIOL, V32, P292, DOI 10.1128/JCM.32.2.292-300.1994; *NAT I ALL INF DIS, 1992, TABL GRAD SEV AD ADV; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; Pandey VN, 1996, BIOCHEMISTRY-US, V35, P2168, DOI 10.1021/bi9516642; PLUDA JM, 1995, J INFECT DIS, V171, P1438, DOI 10.1093/infdis/171.6.1438; RANA KZ, 1994, 34 INT C ANT AG CHEM; Schooley RT, 1996, J INFECT DIS, V173, P1354, DOI 10.1093/infdis/173.6.1354; SCHUURMAN R, 1995, J INFECT DIS, V171, P1411, DOI 10.1093/infdis/171.6.1411; SMALDONE L, 1995, ANN INTERN MED, V122, P24; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; VANELTEREN P, 1960, B INT STATIST INST, V37, P351; VANGEMEN B, 1994, J VIROL METHODS, V49, P157, DOI 10.1016/0166-0934(94)90040-X; VANLEEUWEN R, 1995, J INFECT DIS, V171, P1166, DOI 10.1093/infdis/171.5.1166; VINER KC, 1993, 9 INT C AIDS JUN BER; VOLBERDING PA, 1994, JAMA-J AM MED ASSOC, V272, P437, DOI 10.1001/jama.272.6.437; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282; WAINBERG MA, 1995, NAT MED, V1, P628, DOI 10.1038/nm0795-628; 1994, LANCET, V348, P871; [No title captured]	39	107	107	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1996	276	2					111	117		10.1001/jama.276.2.111	http://dx.doi.org/10.1001/jama.276.2.111			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UV485	8656502				2022-12-28	WOS:A1996UV48500025
J	Viola, A; Lanzavecchia, A				Viola, A; Lanzavecchia, A			T cell activation determined by T cell receptor number and tunable thresholds	SCIENCE			English	Article							MONOCLONAL-ANTIBODIES; ANTIGEN; REQUIREMENTS; SUPERANTIGEN; RECOGNITION; STIMULATION; MOLECULES; INVITRO; BINDING; PEPTIDE	The requirements for T cell activation have been reported io vary widely depending on the state of the T cell, the type of antigen-presenting cell, and the nature of the T cell receptor (TCR) ligand. A unitary requirement for T cell responses was revealed by measurement of the number of triggered TCRs. Irrespective of the nature of the triggering ligand, T cells ''counted'' the number of triggered TCRs and responded when a threshold of similar to 8000 TCRs was reached. The capacity to reach the activation threshold was severely compromised by a reduction in the number of TCRs. Costimulatory signals lowered the activation threshold to similar to 1500 TCRs, thus making T cells more sensitive to antigenic stimulation.	BASEL INST IMMUNOL,CH-4005 BASEL,SWITZERLAND				Agatea, Lisa/L-8267-2016; Viola, Antonella/A-4321-2015	Viola, Antonella/0000-0002-0125-9271				BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; BHARDWAJ N, 1993, J EXP MED, V178, P633, DOI 10.1084/jem.178.2.633; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; CROFT M, 1992, J EXP MED, V176, P1431, DOI 10.1084/jem.176.5.1431; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DOHRING C, 1994, INT J CANCER, V57, P754, DOI 10.1002/ijc.2910570524; FERBER I, 1994, SCIENCE, V263, P674, DOI 10.1126/science.8303275; FISCHER H, 1992, J IMMUNOL, V148, P1993; INABA K, 1984, J EXP MED, V160, P1717, DOI 10.1084/jem.160.6.1717; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LANZAVECCHIA A, 1986, TOL WORKSH 1986, P293; LUQMAN M, 1992, J IMMUNOL, V149, P2300; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MEUER SC, 1983, J EXP MED, V158, P988, DOI 10.1084/jem.158.3.988; PADOVAN E, 1995, J EXP MED, V181, P1587, DOI 10.1084/jem.181.4.1587; PANINABORDIGNON P, 1992, J EXP MED, V176, P1779, DOI 10.1084/jem.176.6.1779; ROOSNEK E, 1989, J EXP MED, V170, P297, DOI 10.1084/jem.170.1.297; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; TAX WJM, 1983, NATURE, V304, P445, DOI 10.1038/304445a0; THIBODEAU J, 1994, SCIENCE, V266, P1874, DOI 10.1126/science.7997881; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; VIOLA A, UNPUB; WEBER S, 1992, NATURE, V356, P793, DOI 10.1038/356793a0	28	860	881	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 5	1996	273	5271					104	106		10.1126/science.273.5271.104	http://dx.doi.org/10.1126/science.273.5271.104			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV478	8658175				2022-12-28	WOS:A1996UV47800049
J	Treanor, JJS; Goodman, L; deSauvage, F; Stone, DM; Poulsen, KT; Beck, CD; Gray, C; Armanini, MP; Pollock, RA; Hefti, F; Phillips, HS; Goddard, A; Moore, MW; BujBello, A; Davies, AM; Asai, N; Takahashi, M; Vandlen, R; Henderson, CE; Rosenthal, A				Treanor, JJS; Goodman, L; deSauvage, F; Stone, DM; Poulsen, KT; Beck, CD; Gray, C; Armanini, MP; Pollock, RA; Hefti, F; Phillips, HS; Goddard, A; Moore, MW; BujBello, A; Davies, AM; Asai, N; Takahashi, M; Vandlen, R; Henderson, CE; Rosenthal, A			Characterization of a multicomponent receptor for GDNF	NATURE			English	Article							TRANSFORMING GENE; SUPERFAMILY; ACTIVATION; RESPONSES; PROTEIN; CELLS; CD14; RET	GLIAL-CELL-LINE-DERIVED neurotrophic factor (GDNF)(1) is a potent survival factor for central and peripheral neurons(2-6), and is essential for the development of kidneys and the enteric nervous system(7-9). Despite the potential clinical and physiological importance of GDNF, its mechanism of action is unknown. Here we show that physiological responses to GDNF require the presence of a novel glycosyl-phosphatidylinositol (GPI)-linked protein (designated GDNFR-alpha) that is expressed on GDNF-responsive cells and binds GDNF with a high affinity. We further demonstrate that GDNF promotes the formation of a physical complex between GDNFR-alpha and the orphan tyrosine kinase receptor Ret(10-12), thereby inducing its tyrosine phosphorylation. These findings support the hypothesis that GDNF uses a multi-subunit receptor system in which GDNFR-alpha and Ret function as the ligand-binding and signalling components, respectively.	GENENTECH INC,DEPT NEUROSCI,S SAN FRANCISCO,CA 94080; GENENTECH INC,DEPT MOLEC BIOL,S SAN FRANCISCO,CA 94080; GENENTECH INC,DEPT PROT BIOCHEM,S SAN FRANCISCO,CA 94080; GENENTECH INC,DEPT MOL CANC RES,S SAN FRANCISCO,CA 94080; IBDM,INSERM,U382,F-13288 MARSEILLE 09,FRANCE; UNIV ST ANDREWS,ST ANDREWS KY16 9AT,FIFE,SCOTLAND; NAGOYA UNIV,DEPT PATHOL,NAGOYA,AICHI 466,JAPAN	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of St Andrews; Nagoya University			Davies, Alun M/A-4334-2010; BUJ-BELLO, Anna/J-7556-2013; Takahashi, Masahide/AAN-4770-2020; TAKAHASHI, Masahide/I-7244-2014; ASAI, Naoya/I-7377-2014	Davies, Alun M/0000-0001-5841-8176; Takahashi, Masahide/0000-0002-2803-2683; Henderson, Christopher/0000-0002-9936-3279	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; ATTISANO L, 1994, BIOCHIM BIOPHYS ACTA, V1222, P21; AVANTAGGIATO V, 1994, CELL GROWTH DIFFER, V5, P305; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BROWN D, 1993, CURR OPIN IMMUNOL, V5, P349, DOI 10.1016/0952-7915(93)90052-T; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; Durbec PL, 1996, DEVELOPMENT, V122, P349; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Koke J A, 1991, Protein Expr Purif, V2, P51, DOI 10.1016/1046-5928(91)90009-8; LEE JD, 1993, P NATL ACAD SCI USA, V90, P9930, DOI 10.1073/pnas.90.21.9930; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; MICANOVIC R, 1990, P NATL ACAD SCI USA, V87, P157, DOI 10.1073/pnas.87.1.157; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; TAKAHASHI M, 1995, CRIT REV ONCOGENESIS, V6, P35, DOI 10.1615/CritRevOncog.v6.i1.30; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; TSUZUKI T, 1995, ONCOGENE, V10, P191	30	925	992	0	17	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 4	1996	382	6586					80	83		10.1038/382080a0	http://dx.doi.org/10.1038/382080a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV473	8657309				2022-12-28	WOS:A1996UV47300058
J	Klassen, AC; Klassen, DK				Klassen, AC; Klassen, DK			Who are the donors in organ donation? The family's perspective in mandated choice	ANNALS OF INTERNAL MEDICINE			English	Article							TRANSPLANTATION; CONSENT	Evidence that families requested to permit organ donation refuse half the time has led to proposals for mandated choice. Under mandated choice, a person's donation wishes would be collected and retrieved at death, and requests to families would be avoided. There are both ethical and logistic problems with mandated choice. The view of the family should be respected in organ requests, even when patient wishes are known. Public sentiment against overriding family wishes could cause low rates of pro-donation registration. Caregivers have usually refused to take organs when families oppose donation. Logistic issues with mandated choice include the cost and complexity of maintaining a national database on donors and the enforcement of registration. No such database of adults currently exists, even for tax purposes. Two states that have mandated choice programs through departments of motor vehicles report relatively low numbers of pro-donation registrants compared with nondonors or undecided persons. Public education and voluntary donor identification hold more potential to increase donation.	UNIV MARYLAND, SCH MED, BALTIMORE, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Klassen, AC (corresponding author), JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, 615 N WOLFE ST, ROOM 729, BALTIMORE, MD 21205 USA.							DUKEMINI.J, 1968, NEW ENGL J MED, V279, P413, DOI 10.1056/NEJM196808222790807; FOX RC, 1992, SPARE PARTS ORGAN E; JORALEMON D, 1995, MED ANTHROPOL Q, V9, P335, DOI 10.1525/maq.1995.9.3.02a00040; KLASSEN AC, 1994, STUDY DESIGN EVALUAT; LOCK M, 1995, MED ANTHROPOL Q, V9, P390, DOI 10.1525/maq.1995.9.3.02a00060; OVERCAST TD, 1984, JAMA-J AM MED ASSOC, V251, P1559, DOI 10.1001/jama.251.12.1559; PROTTAS JM, 1983, MILBANK FUND Q, V61, P278, DOI 10.2307/3349908; SIMINOFF LA, 1995, ANN INTERN MED, V123, P10, DOI 10.7326/0003-4819-123-1-199507010-00037; SPITAL A, 1995, JAMA-J AM MED ASSOC, V273, P504, DOI 10.1001/jama.273.6.504; SPITAL A, 1991, NEW ENGL J MED, V325, P1243, DOI 10.1056/NEJM199110243251710; Spital A, 1996, ANN INTERN MED, V125, P66, DOI 10.7326/0003-4819-125-1-199607010-00010; STUART FP, 1981, TRANSPLANTATION, V31, P238, DOI 10.1097/00007890-198104000-00002; *US SCI REG ORG TR, 1993, ANN REP; VEATCH RM, 1991, NEW ENGL J MED, V325, P1246, DOI 10.1056/NEJM199110243251711	14	54	54	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1996	125	1					70	73		10.7326/0003-4819-125-1-199607010-00011	http://dx.doi.org/10.7326/0003-4819-125-1-199607010-00011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UT399	8644991				2022-12-28	WOS:A1996UT39900010
J	Rowen, L; Koop, BF; Hood, L				Rowen, L; Koop, BF; Hood, L			The complete 685-kilobase DNA sequence of the human beta T cell receptor locus	SCIENCE			English	Article							VARIABLE REGION GENES; V-BETA; ANTIGEN RECEPTOR; ALPHA-CHAIN; ORGANIZATION; DIVERSITY; REPERTOIRE; POLYMORPHISM; FAMILIES; IDENTIFICATION	The human beta T cell receptor (TCR) locus, comprising a complex family of genes, has been sequenced, The locus contains two types of coding elements-TCR elements (65 variable gene segments and two clusters of diversity, joining, and constant segments) and eight trypsinogen genes-that constitute 4.6 percent of the DNA. Genome-wide interspersed repeats and locus-specific repeats span 30 and 47 percent, respectively, of the 685-kilobase sequence. A comparison of the germline variable elements with their approximately 300 complementary DNA counterparts reveals marked differential patterns of variable gene expression, the importance of exonuclease activity in generating TCR diversity, and the predominant tendency for only functional variable elements to be present in complementary DNA libraries.	UNIV VICTORIA, DEPT BIOL, CTR ENVIRONM HLTH, VICTORIA, BC V8W 2Y2, CANADA	University of Victoria	Rowen, L (corresponding author), UNIV WASHINGTON, DEPT MOLEC BIOTECHNOL, SEATTLE, WA 98195 USA.		Koop, Ben F./A-8151-2008	Koop, Ben F./0000-0003-0045-5200				Adams M. D., 1994, AUTOMATED DNA SEQUEN; ADAMS MD, 1995, NATURE, V377, P3; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDERSON SJ, 1989, MOL CELL BIOL, V9, P4835, DOI 10.1128/MCB.9.11.4835; Arden Bernhard, 1995, Immunogenetics, V42, P455; BOLLUM FJ, 1986, ADV CANCER RES, V47, P37, DOI 10.1016/S0065-230X(08)60197-9; CHARMLEY P, 1993, J EXP MED, V177, P135, DOI 10.1084/jem.177.1.135; CHARMLEY P, 1990, TISSUE ANTIGENS, V35, P157, DOI 10.1111/j.1399-0039.1990.tb01773.x; CHARMLEY P, 1995, GENOMICS, V29, P760, DOI 10.1006/geno.1995.9940; CONCANNON P, 1986, COLD SPRING HARB SYM, V51, P785, DOI 10.1101/SQB.1986.051.01.091; CONCANNON P, 1986, P NATL ACAD SCI USA, V83, P6598, DOI 10.1073/pnas.83.17.6598; CONCANNON P, 1992, MANUAL CLIN LABORATO, P885; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DEININGER PL, 1993, EVOL BIOL, V27, P157; DOHERTY PJ, 1991, MOL IMMUNOL, V28, P607, DOI 10.1016/0161-5890(91)90129-8; EMI M, 1986, GENE, V41, P305; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FUNKHOUSER SW, 1992, ARTHRITIS RHEUM, V35, P465, DOI 10.1002/art.1780350417; Green Paul, COMMUNICATION; HALL MA, 1995, HUM IMMUNOL, V43, P207, DOI 10.1016/0198-8859(95)00013-T; HESSE JE, 1989, GENE DEV, V3, P1053, DOI 10.1101/gad.3.7.1053; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; HOOD L, 1975, ANNU REV GENET, V9, P305, DOI 10.1146/annurev.ge.09.120175.001513; HUNKAPILLER T, 1989, ADV IMMUNOL, V44, P1; JORES R, 1993, J IMMUNOL, V151, P6110; JORGENSEN JL, 1992, ANNU REV IMMUNOL, V10, P835, DOI 10.1146/annurev.iy.10.040192.004155; KIMURA N, 1987, EUR J IMMUNOL, V17, P375, DOI 10.1002/eji.1830170312; KOOP BF, 1994, GENOMICS, V19, P478, DOI 10.1006/geno.1994.1097; LEVITT MH, COMMUNICATION; LI YX, 1991, J EXP MED, V174, P1537, DOI 10.1084/jem.174.6.1537; LIEBER MR, 1991, FASEB J, V5, P2934, DOI 10.1096/fasebj.5.14.1752360; MAK TW, 1984, IMMUNOL REV, V81, P221, DOI 10.1111/j.1600-065X.1984.tb01112.x; MALHOTRA U, 1992, J IMMUNOL, V149, P1802; POSNETT DN, 1994, J EXP MED, V179, P1707, DOI 10.1084/jem.179.5.1707; ROACH J, COMMUNICATION; ROBINSON MA, 1985, HUM IMMUNOL, V14, P195, DOI 10.1016/0198-8859(85)90228-9; ROBINSON MA, 1993, P NATL ACAD SCI USA, V90, P2433, DOI 10.1073/pnas.90.6.2433; ROSENBERG WMC, 1992, EUR J IMMUNOL, V22, P541, DOI 10.1002/eji.1830220237; ROWEN L, UNPUB; ROYER HD, 1987, P NATL ACAD SCI USA, V84, P232, DOI 10.1073/pnas.84.1.232; SEBOUN E, 1989, J EXP MED, V170, P1263, DOI 10.1084/jem.170.4.1263; SIU G, 1986, J EXP MED, V164, P1600, DOI 10.1084/jem.164.5.1600; SLIGHTOM JL, 1994, GENOMICS, V20, P149, DOI 10.1006/geno.1994.1149; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; Smit AFA, 1996, P NATL ACAD SCI USA, V93, P1443, DOI 10.1073/pnas.93.4.1443; SMIT AFA, 1995, NUCLEIC ACIDS RES, V23, P98, DOI 10.1093/nar/23.1.98; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; SMIT AFA, COMMUNICATION; TANI T, 1990, NUCLEIC ACIDS RES, V18, P1631, DOI 10.1093/nar/18.6.1631; TILLINGHAST JP, 1986, SCIENCE, V233, P879, DOI 10.1126/science.3755549; TOYONAGA B, 1985, P NATL ACAD SCI USA, V82, P8624, DOI 10.1073/pnas.82.24.8624; VERLINDE CLM, COMMUNICATION; Wang K., COMMUNICATION; WEI S, 1994, IMMUNOGENETICS, V40, P27, DOI 10.1007/BF00163961; WIEGAND U, 1993, GENE, V136, P167, DOI 10.1016/0378-1119(93)90460-K; WILKINSON DA, 1994, RETROVIRIDAE, V3, P465; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; WILSON RK, 1988, IMMUNOL REV, V101, P149, DOI 10.1111/j.1600-065X.1988.tb00736.x; ZHAO TM, 1994, J EXP MED, V180, P1405, DOI 10.1084/jem.180.4.1405	59	361	424	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	1996	272	5269					1755	1762		10.1126/science.272.5269.1755	http://dx.doi.org/10.1126/science.272.5269.1755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8650574				2022-12-28	WOS:A1996UT11000034
J	Zhang, LF; Yu, K; Eisenberg, A				Zhang, LF; Yu, K; Eisenberg, A			Ion-induced morphological changes in ''crew-cut'' aggregates of amphiphilic block copolymers	SCIENCE			English	Article							MICELLE FORMATION; SURFACTANTS	The addition of ions in micromolar (CaCl2 or HCl) or millimolar (NaCl) concentrations can change the morphology of ''crew-cut'' aggregates of amphiphilic block copolymers in dilute solutions, In addition to spherical, rodlike, and univesicular or lamellar aggregates, an unusual large compound vesicle morphology can be obtained from a single block copolymer. Some features of the spontaneously formed large compound vesicles may make them especially useful as vehicles for delivering drugs and as models of biological cells. Gelation of a dilute spherical micelle solution can also be induced by ions as the result of the formation of a cross-linked ''pearl necklace'' morphology.	MCGILL UNIV,DEPT CHEM,MONTREAL,PQ H3A 2K6,CANADA	McGill University			ye, bin/K-7828-2012; 牛, 开心/C-3081-2014; Eisenberg, Adi/B-8676-2008					ANTONETTI M, 1994, MACROMOLECULES, V27, P2376; ASTAFIEVA I, 1993, MACROMOLECULES, V26, P7339, DOI 10.1021/ma00078a034; BRASHER LL, 1995, LANGMUIR, V11, P4267, DOI 10.1021/la00011a017; CHIRUVOLU S, 1994, SCIENCE, V264, P1753, DOI 10.1126/science.8209255; GAST AP, 1993, MACROMOLECULES, V26, P1774, DOI 10.1021/ma00059a043; GLATTER O, 1994, MACROMOLECULES, V27, P6046, DOI 10.1021/ma00099a017; HALPERIN A, 1987, MACROMOLECULES, V20, P2943, DOI 10.1021/ma00177a051; HILFIKER R, 1990, J COLLOID INTERF SCI, V135, P573, DOI 10.1016/0021-9797(90)90028-M; MILLER DD, 1987, J COLLOID INTERF SCI, V116, P598, DOI 10.1016/0021-9797(87)90156-1; MIYAGISHI S, 1995, LANGMUIR, V11, P2951, DOI 10.1021/la00008a018; NAGARAJAN R, 1989, J CHEM PHYS, V90, P5843, DOI 10.1063/1.456390; OZEKI S, 1982, J COLLOID INTERF SCI, V87, P424, DOI 10.1016/0021-9797(82)90339-3; Price C., 1982, DEV BLOCK COPOLYMERS, V1, P39; QIN AW, 1994, MACROMOLECULES, V27, P120, DOI 10.1021/ma00079a018; RAVOO BJ, 1994, LANGMUIR, V10, P1735, DOI 10.1021/la00018a020; SCHEPERS FJ, 1993, LANGMUIR, V9, P956, DOI 10.1021/la00028a014; SEIN A, 1995, LANGMUIR, V11, P455, DOI 10.1021/la00002a015; SELB J, 1985, DEV BLOCK COPOLYMERS, V2, P27; Shen H., UNPUB; TALMON Y, 1983, SCIENCE, V221, P1047, DOI 10.1126/science.221.4615.1047; TUZAR Z, 1993, SURF COLLOID SCI, V15, P1; WHITMORE MD, 1985, MACROMOLECULES, V18, P657, DOI 10.1021/ma00146a014; YU KM, UNPUB; Zhang L., UNPUB; ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728; ZHANG LF, 1995, MACROMOLECULES, V28, P6055, DOI 10.1021/ma00122a010; Zhang LF, 1996, J AM CHEM SOC, V118, P3168, DOI 10.1021/ja953709s	27	840	867	4	302	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1777	1779		10.1126/science.272.5269.1777	http://dx.doi.org/10.1126/science.272.5269.1777			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8662482				2022-12-28	WOS:A1996UT11000039
J	Bichot, NP; Schall, JD; Thompson, KG				Bichot, NP; Schall, JD; Thompson, KG			Visual feature selectivity In frontal eye fields induced by experience in mature macaques	NATURE			English	Article							STRIATE CORTEX; SACCADES; MONKEY; ENHANCEMENT; ATTENTION; RESPONSES; NEURONS; SEARCH	WHEN examining a complex image, the eye movements of expert observers differ from those of novices; experts have learned to ignore features that are visually salient but are not relevant to the interpretation of the image(1-3). We have studied the neural basis of this form of perceptual-motor learning using monkeys that have learned to search for a visual target among distracters, Monkeys trained to search only for, say, a red stimulus among green distracters will ignore green stimuli even if they subsequently appear as targets in a complementary search array, that is, among red distracters, We recorded from neurons in the frontal eye field (FEF), a cortical area that responds to visual stimuli and controls purposive eye movements(4-6). Normally, FEF neurons do not exhibit feature selectivity, but their activity evolves to signal the target for an incipient eye movement(7). In monkeys trained exclusively on targets of one colour, however, FEF neurons show selectivity for stimuli of that colour, Because this selective response occurs so soon after presentation of the stimulus array, and is independent of location within the visual field, we propose that it reflects a form of experience-dependent plasticity that mediates the learning of arbitrary stimulus-response associations.	VANDERBILT UNIV, DEPT PSYCHOL, VANDERBILT VIS RES CTR, NASHVILLE, TN 37240 USA	Vanderbilt University								BRAVO MJ, 1992, PERCEPT PSYCHOPHYS, V51, P465, DOI 10.3758/BF03211642; BRUCE CJ, 1990, NEUROSCI IN, P261; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; FISHER D, 1981, EYE MOVEMENTS COGNIT; GOLDBERG ME, 1981, J NEUROPHYSIOL, V46, P773, DOI 10.1152/jn.1981.46.4.773; GOLDBERG ME, 1989, NEUROBIOLOGY SACCADI, V3, P283; GRONER R, 1985, EYE MOVEMENTS HUMAN; HANES DP, 1995, EXP BRAIN RES, V103, P85; LAMME VAF, 1995, J NEUROSCI, V15, P1605; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; MAUNSELL JHR, 1995, SCIENCE, V270, P764, DOI 10.1126/science.270.5237.764; MOHLER CW, 1973, BRAIN RES, V61, P385, DOI 10.1016/0006-8993(73)90543-X; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1994, J NEUROSCI, V14, P2178; NOWAK LG, 1995, VISUAL NEUROSCI, V12, P371, DOI 10.1017/S095252380000804X; OREGAN JK, 1987, EYE MOVEMENTS PHYSL; SCHALL JD, 1995, J NEUROSCI, V15, P6905; SCHALL JD, 1991, J NEUROPHYSIOL, V66, P559, DOI 10.1152/jn.1991.66.2.559; SCHALL JD, 1995, J NEUROSCI, V15, P4464; SCHALL JD, 1991, NEURAL BASIS VISUAL, P388; Thompson K. G., 1995, Society for Neuroscience Abstracts, V21, P1270; WEINBERGER NM, 1995, ANNU REV NEUROSCI, V18, P129; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P766, DOI 10.1152/jn.1976.39.4.766	24	179	180	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	1996	381	6584					697	699		10.1038/381697a0	http://dx.doi.org/10.1038/381697a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR979	8649514				2022-12-28	WOS:A1996UR97900052
J	Figurov, A; PozzoMiller, LD; Olafsson, P; Wang, T; Lu, B				Figurov, A; PozzoMiller, LD; Olafsson, P; Wang, T; Lu, B			Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus	NATURE			English	Article							LONG-TERM POTENTIATION; POSTNATAL RAT-BRAIN; MESSENGER-RNA; AREA CA1; BDNF; NT-3; ENHANCEMENT; EXPRESSION; PLASTICITY; INDUCTION	NEUROTROPHINS promote neuronal survival and differentiation, but the fact that their expression is modified by neuronal activity, suggests a role in regulating synapse development and plasticity(1-3). In developing hippocampus, the expression of brain-derived neurotrophic factor (BDNF) and its receptor TrkB(4-7) increases in parallel with the ability to undergo long-term potentiation (LTP)(8-10). Here me report a mechanism by which BDNF modulates hippocampal LTP. Exogenous BDNF promoted the induction of LTP by tetanic stimulation in young (postnatal day 12-13) hippocampal slices, which in the absence of BDNF show only short-term potentiation (STP), This effect was due to an enhanced ability of hippocampal synapses to respond to tetanic stimulation, rather than to a direct modulation of the LTP-triggering mechanism. A TrkB-IgG fusion protein, which scavenges endogenous BDNF11, reduced the synaptic responses to tetanus as well as the magnitude of LTP in adult hippocampus.	NICHHD,DEV NEUROBIOL LAB,NIH,BETHESDA,MD 20892; ROCHE INST MOLEC BIOL,NUTLEY,NJ 07110	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)			Lu, Bai/A-4018-2012	Lu, Bai/0000-0001-5418-9759; Pozzo-Miller, Lucas/0000-0001-6085-5527				ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CASTREN E, 1993, NEUROREPORT, V4, P895, DOI 10.1097/00001756-199307000-00014; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; DUGICHDJORDJEVIC MM, 1993, NEUROREPORT, V4, P1091; FIGUROV A, 1993, EUR J NEUROSCI, V5, P1035, DOI 10.1111/j.1460-9568.1993.tb00956.x; FRIEDMAN WJ, 1991, EUR J NEUROSCI, V3, P688, DOI 10.1111/j.1460-9568.1991.tb00854.x; HARRIS KM, 1984, J PHYSIOL-LONDON, V346, P27, DOI 10.1113/jphysiol.1984.sp015005; HUANG YY, 1993, J NEUROSCI, V13, P568; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; ISACKSON PJ, 1995, CURR OPIN NEUROBIOL, V5, P350, DOI 10.1016/0959-4388(95)80048-4; JACKSON PS, 1993, J NEUROPHYSIOL, V70, P1412, DOI 10.1152/jn.1993.70.4.1412; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KIM HG, 1994, P NATL ACAD SCI USA, V91, P12341, DOI 10.1073/pnas.91.25.12341; KNIPPER M, 1994, NEUROREPORT, V5, P2433, DOI 10.1097/00001756-199412000-00007; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MULLER D, 1989, DEV BRAIN RES, V49, P105, DOI 10.1016/0165-3806(89)90063-1; PATTERSON S, 1992, NEURON, V9, P1981; PETROZZINO JJ, 1994, HIPPOCAMPUS, V4, P546, DOI 10.1002/hipo.450040504; RIDDLE DR, 1995, NATURE, V378, P189, DOI 10.1038/378189a0; RINGSTEDT T, 1993, DEV BRAIN RES, V72, P119, DOI 10.1016/0165-3806(93)90165-7; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; WANG T, 1995, J NEUROSCI, V15, P4796; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	30	925	948	1	24	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 20	1996	381	6584					706	709		10.1038/381706a0	http://dx.doi.org/10.1038/381706a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR979	8649517				2022-12-28	WOS:A1996UR97900055
J	Lusher, JM; Sarnaik, S				Lusher, JM; Sarnaik, S			Hematology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISEASE				Lusher, JM (corresponding author), WAYNE STATE UNIV, SCH MED, DETROIT, MI 48202 USA.							CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; EATON WA, 1987, BLOOD, V70, P1245; LETHAGEN S, 1993, CRIT REV ONCOL HEMAT, V15, P1, DOI 10.1016/1040-8428(93)90016-W; LETVIN NL, 1984, NEW ENGL J MED, V310, P869, DOI 10.1056/NEJM198404053101401; LUSHER J, 1994, LANCET, V344, P405; LUSHER JM, 1994, HAEMOSTASIS, V24, P276; POWARS DR, 1989, ANN NY ACAD SCI, V565, P262, DOI 10.1111/j.1749-6632.1989.tb24174.x; RICK ME, 1994, MED CLIN N AM, V78, P609, DOI 10.1016/S0025-7125(16)30149-3; ROGERS GP, 1992, SEMIN ONCOL       S9, V19, P67; RUGGERI ZM, 1980, J CLIN INVEST, V65, P1318, DOI 10.1172/JCI109795; RUGGERI ZM, 1994, HAEMOSTASIS, V24, P265; VOSKARIDOU E, 1995, BRIT J HAEMATOL, V89, P479, DOI 10.1111/j.1365-2141.1995.tb08352.x; ZENG YT, 1995, BRIT J HAEMATOL, V90, P557, DOI 10.1111/j.1365-2141.1995.tb05584.x; 1996, MMWR-MORBID MORTAL W, V45, P29	14	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1814	1815		10.1001/jama.275.23.1814	http://dx.doi.org/10.1001/jama.275.23.1814			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642725				2022-12-28	WOS:A1996UQ15200024
J	Rosch, P; Willbold, D				Rosch, P; Willbold, D			Is EIAV tat protein a homeodomain?	SCIENCE			English	Article							ANEMIA VIRUS TAT				Rosch, P (corresponding author), UNIV BAYREUTH,DEPT BIOPOLYMERS,D-95440 BAYREUTH,GERMANY.		Rösch, Paul/I-5445-2014; Willbold, Dieter/A-6280-2013	Rösch, Paul/0000-0003-3330-2446; Willbold, Dieter/0000-0002-0065-7366				ADES SE, 1995, BIOCHEMISTRY-US, V34, P14601, DOI 10.1021/bi00044a040; BAYER P, 1995, J MOL BIOL, V247, P529, DOI 10.1016/S0022-2836(05)80133-0; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; Higgins D G, 1994, Methods Mol Biol, V25, P307; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; LAUGHON A, 1991, BIOCHEMISTRY-US, V30, P11357, DOI 10.1021/bi00112a001; Metzger AU, 1996, FEBS LETT, V384, P255, DOI 10.1016/0014-5793(96)00314-6; NOIMAN S, 1990, VIROLOGY, V176, P280, DOI 10.1016/0042-6822(90)90254-O; PUGLISI JD, 1995, SCIENCE, V270, P1200, DOI 10.1126/science.270.5239.1200; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0; STEPHENS RM, 1990, J VIROL, V64, P3716, DOI 10.1128/JVI.64.8.3716-3725.1990; STICHT H, 1994, EUR J BIOCHEM, V225, P855, DOI 10.1111/j.1432-1033.1994.0855b.x; STICHT H, 1993, EUR J BIOCHEM, V218, P973, DOI 10.1111/j.1432-1033.1993.tb18455.x; WILLBOLD D, 1994, SCIENCE, V264, P1584, DOI 10.1126/science.7515512; Ye XM, 1995, CHEM BIOL, V2, P827, DOI 10.1016/1074-5521(95)90089-6	17	10	10	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1996	272	5268					1672	1672						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8658146				2022-12-28	WOS:A1996UR09300053
J	Garrity, PA; Rao, Y; Salecker, I; McGlade, J; Pawson, T; Zipursky, SL				Garrity, PA; Rao, Y; Salecker, I; McGlade, J; Pawson, T; Zipursky, SL			Drosophila photoreceptor axon guidance and targeting requires the dreadlocks SH2/SH3 adapter protein	CELL			English	Article							AFFINITY PHOSPHOTYROSYL PEPTIDE; 1ST OPTIC GANGLION; TYROSINE PHOSPHORYLATION; INSERTIONAL MUTAGENESIS; GENETIC MOSAICS; NERVOUS-SYSTEM; COMPOUND EYE; MELANOGASTER; SH2; DOMAIN	Mutations in the Drosophila gene dreadlocks (dock) disrupt photoreceptor cell (R cell) axon guidance and targeting. Genetic mosaic analysis and cell-type-specific expression of dock transgenes demonstrate dock is required in R cells for proper innervation. Dock protein contains one SH2 and three SH3 domains, implicating it in tyrosine kinase signaling, and is highly related to the human proto-oncogene Nck. Dock expression is detected in R cell growth cones in the target region. We propose Dock transmits signals in the growth cone in response to guidance and targeting cues. These findings provide an important step for dissection of signaling pathways regulating growth cone motility.	UNIV CALIF LOS ANGELES, SCH MED, HOWARD HUGHES MED INST, LOS ANGELES, CA 90024 USA; MT SINAI HOSP, SAMUEL LUNENFELD RES INST, PROGRAM MOL BIOL & CANC, TORONTO, ON M5G 1X5, CANADA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Garrity, PA (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, INST MOLEC BIOL, DEPT BIOL CHEM, LOS ANGELES, CA 90024 USA.		Pawson, Tony J/E-4578-2013; Salecker, Iris/V-1228-2018	Zipursky, Stephen/0000-0001-5630-7181; Salecker, Iris/0000-0003-3775-7763; Garrity, Paul/0000-0002-8274-6564				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ASHBRUNER M, 1989, DROSOPHILA LAB MANUA; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; BIGGS WH, 1992, P NATL ACAD SCI USA, V89, P6295, DOI 10.1073/pnas.89.14.6295; BURNS ME, 1995, CELL, V83, P187, DOI 10.1016/0092-8674(95)90160-4; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; CAMPOS AR, 1992, DEVELOPMENT, V114, P355; CHANT J, 1995, CELL, V81, P1, DOI 10.1016/0092-8674(95)90363-1; CHENEVERT J, 1994, MOL BIOL CELL, V5, P1169, DOI 10.1091/mbc.5.11.1169; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; DOWNWARD J, 1994, FEBS LETT, V338, P113, DOI 10.1016/0014-5793(94)80346-3; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; EBENS AJ, 1993, CELL, V74, P15, DOI 10.1016/0092-8674(93)90291-W; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; GARRITY PA, 1995, CELL, V83, P177, DOI 10.1016/0092-8674(95)90159-0; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HAY BA, 1994, DEVELOPMENT, V120, P2121; HU QJ, 1995, MOL CELL BIOL, V15, P1169; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; KANKEL DR, 1976, DEV BIOL, V48, P1, DOI 10.1016/0012-1606(76)90041-5; KARPEN GH, 1992, GENETICS, V132, P737; KEYNES R, 1995, CELL, V83, P161, DOI 10.1016/0092-8674(95)90157-4; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; LEHMANN JM, 1990, NUCLEIC ACIDS RES, V18, P1048, DOI 10.1093/nar/18.4.1048; LETOURNEAU PC, 1991, NERVE GROWTH CONE; LI W, 1992, MOL CELL BIOL, V12, P5824, DOI 10.1128/MCB.12.12.5824; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MARDON G, 1994, DEVELOPMENT, V120, P3473; MARTIN KA, 1995, NEURON, V14, P229, DOI 10.1016/0896-6273(95)90281-3; MCFARLANE S, 1995, NEURON, V15, P1017, DOI 10.1016/0896-6273(95)90091-8; MELNERTZHAGEN IA, 1993, DEV DROSOPHILA MELAN, P1363; MISMER D, 1987, GENETICS, V116, P565; NISHIMURA R, 1993, MOL CELL BIOL, V13, P6889, DOI 10.1128/MCB.13.11.6889; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PALAZZOLO MJ, 1990, GENE, V88, P25, DOI 10.1016/0378-1119(90)90056-W; PAWSON T, 1993, PHILOS T R SOC B, V340, P279, DOI 10.1098/rstb.1993.0069; SALECKER I, 1995, J COMP NEUROL, V352, P33, DOI 10.1002/cne.903520104; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHLAEPFER DD, 1994, NATURE, V372, P786; SELLECK SB, 1991, NEURON, V6, P83, DOI 10.1016/0896-6273(91)90124-I; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; TOROK T, 1993, GENETICS, V135, P71; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; WINBERG ML, 1992, DEVELOPMENT, V115, P903; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; WU DY, 1993, J CELL BIOL, V123, P653, DOI 10.1083/jcb.123.3.653; XU T, 1993, DEVELOPMENT, V117, P1223; YAO KM, 1994, J NEUROCHEM, V63, P41	59	229	231	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	1996	85	5					639	650		10.1016/S0092-8674(00)81231-3	http://dx.doi.org/10.1016/S0092-8674(00)81231-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UP344	8646773	Bronze			2022-12-28	WOS:A1996UP34400005
J	Mumma, MJ; DiSanti, MA; DelloRusso, N; Fomenkova, M; MageeSauer, K; Kaminski, CD; Xie, DX				Mumma, MJ; DiSanti, MA; DelloRusso, N; Fomenkova, M; MageeSauer, K; Kaminski, CD; Xie, DX			Detection of abundant ethane and methane, along with carbon monoxide and water, in comet C/1996 B2 Hyakutake: Evidence for interstellar origin	SCIENCE			English	Article							MONOCARBOXYLIC ACIDS; HALLEYS-COMET; AUSTIN 1989C1; P-HALLEY; P/HALLEY; FORMALDEHYDE; EMISSION; IDENTIFICATION; EXCITATION; METEORITE	The saturated hydrocarbons ethane (C2H6) and methane (CH4) along with carbon monoxide (GO) and water (H2O) were detected in comet C/1996 B2 Hyakutake with the use of high-resolution infrared spectroscopy at the NASA Infrared Telescope Facility on Mauna Kea, Hawaii. The inferred production rates of molecular gases from the icy, cometary nucleus (in molecules per second) are 6.4 x 10(26) for C2H6, 1.2 x 10(27) for CH4, 9.8 x 10(27) for CO, and 1.7 x 10(29) for H2O. An abundance of C2H6 comparable to that of CH4 implies that ices in C/1996 B2 Hyakutake did not originate in a thermochemically equilibrated region of the solar nebula. The abundances are consistent with a kinetically controlled production process, but production of C2H6 by gas-phase ion molecule reactions in the natal cloud core is energetically forbidden. The high C2H6/CH4 ratio is consistent with production of C2H6 in icy grain mantles in the natal cloud, either by photolysis of CH4-rich ice or by hydrogen-addition reactions to acetylene condensed from the gas phase.	CATHOLIC UNIV AMER,DEPT PHYS,WASHINGTON,DC 20064; NASA,GODDARD SPACE FLIGHT CTR,WASHINGTON,DC 20064; UNIV CALIF SAN DIEGO,CTR ASTROPHYS & SPACE SCI,LA JOLLA,CA 92093; ROWAN COLL,DEPT CHEM & PHYS,GLASSBORO,NJ 08028; NASA,INFRARED TELESCOPE FACIL,HILO,HI 96720	Catholic University of America; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of California System; University of California San Diego; Rowan University; National Aeronautics & Space Administration (NASA)	Mumma, MJ (corresponding author), NASA,GODDARD SPACE FLIGHT CTR,GREENBELT,MD 20771, USA.		Russo, Neil Dello/G-2727-2015; mumma, michael j/I-2764-2013; Magee-Sauer, Karen/K-6061-2015	Russo, Neil Dello/0000-0002-8379-7304; mumma, michael j/0000-0003-4627-750X; Magee-Sauer, Karen/0000-0002-4979-9875				ALLAMANDOLA LJ, 1988, ICARUS, V76, P225, DOI 10.1016/0019-1035(88)90070-X; ALLEN M, 1987, ASTRON ASTROPHYS, V187, P502; [Anonymous], 2006, MOL SPECTRA MOL STRU; BOCKELEEMORVAN D, 1987, ASTRON ASTROPHYS, V187, P425; BOCKELEEMORVAN D, 1994, PLANET SPACE SCI, V42, P655, DOI 10.1016/0032-0633(94)90043-4; BOCKELEEMORVAN D, 1991, NATURE, V350, P318, DOI 10.1038/350318a0; BOICE DC, 1990, GEOPHYS RES LETT, V17, P1813, DOI 10.1029/GL017i011p01813; BROOKE TY, 1991, ASTROPHYS J, V372, pL113, DOI 10.1086/186036; CHAMLEY SB, 1995, ASTROPHYS J, V448, P232; Charlesby A., 1960, ATOMIC RAD POLYM; CHIN G, 1984, ASTROPHYS J, V285, P858, DOI 10.1086/162565; COMBES M, 1988, ICARUS, V76, P404, DOI 10.1016/0019-1035(88)90013-9; Cronin JR., 1988, ORGANIC MATTER CARBO, P819; CROVISIER J, 1983, ASTRON ASTROPHYS, V126, P170; DAYHOFF MO, 1964, SCIENCE, V164, P1461; DELLORUSSO N, UNPUB; DISANTI MA, 1992, ICARUS, V96, P151, DOI 10.1016/0019-1035(92)90068-I; DISANTI MA, 1996, 6374 IAU; DRAPATZ S, 1987, ASTRON ASTROPHYS, V187, P497; EBERHARDT P, 1987, ASTRON ASTROPHYS, V187, P481; ECK RV, 1966, SCIENCE, V153, P628, DOI 10.1126/science.153.3736.628; Fegley B.J., 1989, FORMATION EVOLUTION, P171; FELDMAN PD, 1996, 6370 IAU; FESTOU M, 1996, 6355 IAU; GERAKINES PA, IN PRESS ASTRON ASTR; GOLDMAN A, 1989, J QUANT SPECTROSC RA, V41, P17, DOI 10.1016/0022-4073(89)90016-2; GREENE TP, 1993, P SOC PHOTO-OPT INS, V1946, P311; HERBST E, 1983, ASTROPHYS J, V269, P329, DOI 10.1086/161046; Herzberg G., 1945, INFRARED RAMAN SPECT, V2; HOBAN S, 1991, ICARUS, V93, P122, DOI 10.1016/0019-1035(91)90168-S; KAWARA K, 1988, ASTRON ASTROPHYS, V207, P174; LACY JH, 1991, ASTROPHYS J, V376, P556, DOI 10.1086/170304; LAMMERZAHL P, 1987, ASTRON ASTROPHYS, V187, P169; LARSON HP, 1989, ASTROPHYS J, V338, P1106, DOI 10.1086/167260; LAWLESS JG, 1979, NATURE, V282, P396, DOI 10.1038/282396a0; LII JH, 1992, J COMPUT CHEM, V13, P1138, DOI 10.1002/jcc.540130914; LIVINGSTON W, 1991, 91001 NSO; MATTHEWS HE, 1996, 6353 IAU; MEIER R, 1993, ASTRON ASTROPHYS, V277, P677; MOORE MH, 1992, ASTROPHYS J, V401, P353, DOI 10.1086/172065; Mumma M. J., 1993, PROTOSTARS PLANETS, P1177; MUMMA MJ, 1986, SCIENCE, V232, P1523, DOI 10.1126/science.232.4757.1523; MUMMA MJ, 1989, ASTROPHYS J, V344, P940, DOI 10.1086/167862; MUMMA MJ, 1995, B AM ASTRON SOC, V27, P1144; MUMMA MJ, 1996, 6366 IAU; Prinn R.G.P., 1989, ORIGIN EVOLUTION PLA, P78; ROTHMAN LS, 1992, J QUANT SPECTROSC RA, V48, P469, DOI 10.1016/0022-4073(92)90115-K; SCHLEICHER D, 1996, 6372 IAU; SCHLOERB FP, 1986, ASTROPHYS J, V310, pL55, DOI 10.1086/184781; SCHUTTE WA, 1991, ASTRON ASTROPHYS, V244, P190; SENAY M, 1996, 6335 IAU; SNYDER LE, 1989, ASTRON J, V97, P246, DOI 10.1086/114976; Stief LJ, 1965, J CHEM PHYS, V43, P2490, DOI 10.1063/1.1697148; STUDIER MH, 1965, SCIENCE, V149, P1455, DOI 10.1126/science.149.3691.1455; Tielens A.G.G.M., 1987, INTERSTELLAR PROCESS, P397; TOKUNAGA AT, 1996, 6378 IAU; van Dishoeck E. F., 1993, PROTOSTARS PLANETS, P163; WEAVER HA, 1984, ASTROPHYS J, V276, P782, DOI 10.1086/161664; WEAVER HA, 1984, ASTROPHYS J, V285, P872, DOI 10.1086/162567; WEAVER HA, 1996, 6374 IAU; WEGMANN R, 1987, ASTRON ASTROPHYS, V187, P339; WOMACK M, 6345 IAU; YUEN G, 1984, NATURE, V307, P252, DOI 10.1038/307252a0	64	271	272	3	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1310	1314		10.1126/science.272.5266.1310	http://dx.doi.org/10.1126/science.272.5266.1310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8650540				2022-12-28	WOS:A1996UN47200037
J	Perry, RJ; Moore, CA; Morgan, BDG; Plummer, DL				Perry, RJ; Moore, CA; Morgan, BDG; Plummer, DL			Determining the approximate area of a burn: An inconsistency investigated and re-evaluated	BRITISH MEDICAL JOURNAL			English	Article									UCL HOSP, DEPT PLAST SURG, LONDON WC1E 6BT, ENGLAND; UCL, DEPT MED PHYS & BIOENGN, LONDON WC1E 6BT, ENGLAND	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Perry, RJ (corresponding author), UCL, SCH MED, CIN SCI OFF, ADM, LONDON WC1E 6BT, ENGLAND.							Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; ELLIS H, 1993, LECT NOTES GEN SURG, P12; GEHAN EA, 1970, CANCER CHEMOTH REP 1, V54, P225; Plummer DL., 1992, REV NEU RORADIOL, V5, P489, DOI 10.1177/197140099200500413; Proctor HJ., 1993, ADV TRAUMA LIFE SUPP	5	29	30	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 25	1996	312	7042					1338	1338		10.1136/bmj.312.7042.1338	http://dx.doi.org/10.1136/bmj.312.7042.1338			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN476	8646048	Green Published			2022-12-28	WOS:A1996UN47600023
J	Archibald, JD				Archibald, JD			Fossil evidence for a Late Cretaceous origin of ''hoofed'' mammals	SCIENCE			English	Article							PHYLOGENY	Seventeen of eighteen orders of living placental mammals are not known before 65 million years ago. The monophyly of each order is well established, but interrelations have been less certain. A superordinal grouping of up to seven extant orders plus a variety of extinct orders, all included within Ungulata (''hoofed'' mammals), can be linked to Late Cretaceous mammals from the 85-million-year-old Bissekty Formation, Uzbekistan (and, less certainly, North America and Europe), thus pushing the origin of this major clade back by 20 million years. Ungulatomorphs are not closely related to primates, rodents, or rabbits.			Archibald, JD (corresponding author), SAN DIEGO STATE UNIV,DEPT BIOL,SAN DIEGO,CA 92182, USA.							ARCHIBALD JD, IN PRESS EVOLUTION T; BEARD K.C., 1993, MAMMAL PHYLOGENY, P129; Butler P.M., 1992, P125; BUTLER PM, 1990, BIOL REV, V65, P529, DOI 10.1111/j.1469-185X.1990.tb01237.x; Carroll RL, 1988, VERTEBRATE PALEONTOL; de Muizon Christian, 1991, Revista Tecnica de Yacimientos Petroliferos Fiscales Bolivianos, V12, P575; DIVELLI RL, 1993, MAMMAL PHYLOGENY, V2, P195; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Gingerich Philip D., 1994, Contributions from the Museum of Paleontology University of Michigan, V29, P41; GREAVES WS, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P99; IRWIN DM, 1993, MAMMAL PHYLOGENY, V2, P257; JANIS CM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P76; KIELANJAWOROWSK.Z, 1978, MESOZOIC MAMMALS 1 2, P99; LILLEGRAVEN JA, 1987, BIOL J LINN SOC, V32, P281, DOI 10.1111/j.1095-8312.1987.tb00434.x; LUCAS S. G., 1993, MAMMAL PHYLOGENY, V2, P182; MARSHALL LG, 1992, LETHAIA, V25, P353; Nessov L.A., 1994, Trudy Zoologicheskogo Instituta, V249, P105; NESSOV LA, 1984, VESTNIK ZOOLOGII KIE, V2, P60; NESSOV LA, 1982, EZHEGODNIK VSESOIUZN, V25, P228; NESSOV LA, 1985, VESTNIK LENINGRADSKO, V17, P8; NESSOV LA, IN PRESS B CARNEGIE; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; Prothero D. R., 1993, MAMMAL PHYLOGENY, V2, P173; RENFREE MB, 1993, MAMMAL PHYLOGENY, V1, P4; STUCKY RK, 1993, FOSS REC, V2, P739; SWOFFORD DL, 1993, PAUP PHYLOGENETIC AN	26	105	110	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 24	1996	272	5265					1150	1153		10.1126/science.272.5265.1150	http://dx.doi.org/10.1126/science.272.5265.1150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8662448				2022-12-28	WOS:A1996UM88900043
J	Sun, DZ; Liu, ZY				Sun, DZ; Liu, ZY			Dynamic ocean-atmosphere coupling: A thermostat for the tropics	SCIENCE			English	Article							SEA-SURFACE TEMPERATURE; CONVERGENCE	The ocean currents connecting the western tropical Pacific Ocean with the eastern tropical Pacific Ocean are driven by surface winds, The surface winds are in turn driven by the sea-surface temperature (SST) differences between these two regions. This dynamic coupling between the atmosphere and ocean may limit the SST in the tropical Pacific Ocean to below 305 kelvin even in the absence of cloud feedbacks.	UNIV WISCONSIN,DEPT ATMOSPHER & OCEAN SCI,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison	Sun, DZ (corresponding author), NATL CTR ATMOSPHER RES,BOULDER,CO 80307, USA.							BRYAN K, 1984, J PHYS OCEANOGR, V14, P666, DOI 10.1175/1520-0485(1984)014<0666:ATCTEO>2.0.CO;2; Crowley T. J., 1991, PALEOCLIMATOLOGY; FU R, 1992, NATURE, V358, P394, DOI 10.1038/358394a0; HARTMANN DL, 1993, J CLIMATE, V6, P2049, DOI 10.1175/1520-0442(1993)006<2049:LSEOTR>2.0.CO;2; LINDZEN RS, 1987, J ATMOS SCI, V44, P2418, DOI 10.1175/1520-0469(1987)044<2418:OTROSS>2.0.CO;2; LIU ZG, 1994, J PHYS OCEANOGR, V24, P2606, DOI 10.1175/1520-0485(1994)024<2606:AGSOTU>2.0.CO;2; MCCREARY JP, 1994, J PHYS OCEANOGR, V24, P466; MCWILLIAMS JC, 1978, J ATMOS SCI, V35, P963; PACANOWSKI R, 1991, 2 GFDL OC GROUP; PHILANDER SGH, 1989, EL NINO LA NINO SO O; PIERREHUMBERT RT, 1995, J ATMOS SCI, V52, P1784, DOI 10.1175/1520-0469(1995)052<1784:TRFATL>2.0.CO;2; RAMANATHAN V, 1991, NATURE, V351, P27, DOI 10.1038/351027a0; SUN DZ, 1995, J CLIMATE, V8, P1974, DOI 10.1175/1520-0442(1995)008<1974:HRITTT>2.0.CO;2; WALISER DE, 1993, J GEOPHYS RES-ATMOS, V98, P12881, DOI 10.1029/93JD00872; WALLACE JM, 1992, NATURE, V357, P230, DOI 10.1038/357230a0	15	105	109	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 24	1996	272	5265					1148	1150		10.1126/science.272.5265.1148	http://dx.doi.org/10.1126/science.272.5265.1148			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8662447				2022-12-28	WOS:A1996UM88900042
J	Peifer, M				Peifer, M			Regulating cell proliferation: As easy as APC	SCIENCE			English	Editorial Material							DROSOPHILA; ASSOCIATION; GENE				Peifer, M (corresponding author), UNIV N CAROLINA,DEPT BIOL,CB 3280,CHAPEL HILL,NC 27599, USA.		Peifer, Mark/A-1152-2010	Peifer, Mark/0000-0003-1412-3987	NIGMS NIH HHS [GM47857] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047857] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DICKINSON ME, 1994, DEVELOPMENT, V120, P1453; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; KIM SK, 1995, CURR OPIN CELL BIOL, V7, P641, DOI 10.1016/0955-0674(95)80105-7; KLYMKOWSKY MW, 1995, CELL, V83, P5, DOI 10.1016/0092-8674(95)90226-0; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; MUNEMITSU S, 1994, CANCER RES, V54, P3676; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; NATHKE IS, IN PRESS J CELL BIOL; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1995, TRENDS CELL BIOL, V5, P224, DOI 10.1016/S0962-8924(00)89015-7; PERRIMON N, 1994, CELL, V76, P781, DOI 10.1016/0092-8674(94)90351-4; PERRIMON N, 1989, GENETICS, V121, P333; POLAKIS P, 1995, CURR OPIN GENET DEV, V5, P66, DOI 10.1016/S0959-437X(95)90055-1; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; RUBINFELD B, 1995, J BIOL CHEM, V270, P5549, DOI 10.1074/jbc.270.10.5549; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; SMITH KJ, 1994, CANCER RES, V54, P3672; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; SU LK, 1995, CANCER RES, V55, P2972; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; WHITEHEAD I, 1995, MOL CELL BIOL, V15, P704; Woods D F, 1993, J Cell Sci Suppl, V17, P171; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087	27	78	80	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 17	1996	272	5264					974	975		10.1126/science.272.5264.974	http://dx.doi.org/10.1126/science.272.5264.974			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL619	8638142				2022-12-28	WOS:A1996UL61900033
J	SotoRamirez, LE; Renjifo, B; McLane, MF; Marlink, R; OHara, C; Sutthent, R; Wasi, C; Vithayasai, P; Vithayasai, V; Apichartpiyakul, C; Auewarakul, P; Cruz, VP; Chui, DS; Osathanondh, R; Mayer, K; Lee, TH; Essex, M				SotoRamirez, LE; Renjifo, B; McLane, MF; Marlink, R; OHara, C; Sutthent, R; Wasi, C; Vithayasai, P; Vithayasai, V; Apichartpiyakul, C; Auewarakul, P; Cruz, VP; Chui, DS; Osathanondh, R; Mayer, K; Lee, TH; Essex, M			HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MUCOSAL TRANSMISSION; SEXUAL TRANSMISSION; REPLICATION; INFECTION; TYPE-1; PCR	Heterosexual transmission by vaginal intercourse accounts for most transmission of human immunodeficiency virus-type 1 (HIV-1) in Africa and Asia but is less important in the HIV-1 epidemics of the United States and Western Europe. Epithelial Langerhans' cells (LCs) represent a possible source of initial cell contact for vaginal infection. Fifteen primary isolates of HIV-1 from U.S. homosexuals and 18 HIV-1 isolates from Thailand heterosexuals were evaluated for growth in LCs of U.S. origin. All the viruses from the Thai heterosexuals, which were subtype E, grew more efficiently in the LCs than any of the viruses from the U.S. homosexuals, which are subtype B. These results suggest that LC tropism is associated with the efficiency of heterosexual transmission of HIV.	HARVARD AIDS INST,BOSTON,MA 02115; MALLORY INST PATHOL,BOSTON,MA 02118; MAHIDOL UNIV,SIRIRAJ HOSP,FAC MED,DEPT MICROBIOL,BANGKOK 10700,THAILAND; CHIANG MAI UNIV,FAC MED,DEPT MICROBIOL,CHIANG MAI 50002,THAILAND; BRIGHAM & WOMENS HOSP,DEPT OBSTET & GYNECOL,BOSTON,MA 02115; FENWAY COMMUNITY HLTH CTR,RES DEPT,BOSTON,MA 02115; MEM HOSP RHODE ISL,DEPT MED,DIV INFECT DIS,PAWTUCKET,RI 02860; BROWN UNIV,SCH MED,PROVIDENCE,RI 02912	Harvard University; Harvard T.H. Chan School of Public Health; Mahidol University; Chiang Mai University; Harvard University; Brigham & Women's Hospital; Brown University			Auewarakul, Prasert/D-6015-2011	Auewarakul, Prasert/0000-0002-4745-4291	FIC NIH HHS [5 D43 TW0004] Funding Source: Medline; NCI NIH HHS [CA 39805] Funding Source: Medline; NHLBI NIH HHS [HL 33774] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW000004] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R35CA039805] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL033774] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRAATHEN LR, 1987, LANCET, V2, P1904; CHU SY, 1992, AIDS ETIOLOGY DIAGNO, P99; DELORME P, 1993, RES VIROLOGY, V144, P53, DOI 10.1016/S0923-2516(06)80012-9; DUSSERRE N, 1992, J INVEST DERMATOL, V99, pS99, DOI 10.1111/1523-1747.ep12669977; GIANNETTI A, 1993, J ACQ IMMUN DEF SYND, V6, P329; HENRY M, 1994, J INVEST DERMATOL, V103, P593, DOI 10.1111/1523-1747.ep12396918; KUNANUSONT C, 1995, LANCET, V345, P1078, DOI 10.1016/S0140-6736(95)90818-8; LANDOR M, 1989, AM J MED, V87, P489, DOI 10.1016/0002-9343(89)90682-7; LEHNER T, 1991, NATURE, V353, P709, DOI 10.1038/353709c0; LIU HN, 1994, CLIN EXP DERMATOL, V19, P113, DOI 10.1111/j.1365-2230.1994.tb01136.x; LOUWAGIE J, 1993, AIDS RES HUM RETROV, V9, pS147; LOUWAGIE J, 1995, J VIROL, V69, P263, DOI 10.1128/JVI.69.1.263-271.1995; MILLER CJ, 1992, AM J PATHOL, V141, P655; MILLER CJ, 1989, J VIROL, V63, P4277, DOI 10.1128/JVI.63.10.4277-4284.1989; MILLER CJ, 1994, LAB INVEST, V70, P225; NICOLOSI A, 1994, J ACQ IMMUN DEF SYND, V7, P296; NUOVO GJ, 1993, AM J PATHOL, V143, P40; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; PALACIO J, 1994, RES VIROLOGY, V145, P155, DOI 10.1016/S0923-2516(07)80017-3; PETERMAN TA, 1992, AIDS ETIOLOGY DIAGNO, P443; PIOT P, 1994, TXB AIDS MED, P109; PLUMMER FA, 1991, J INFECT DIS, V163, P233, DOI 10.1093/infdis/163.2.233; RAPPERSBERGER K, 1988, INTERVIROLOGY, V29, P185; SOTORAMIREZ L, UNPUB; TAN X, 1993, J VIROL, V67, P6447, DOI 10.1128/JVI.67.11.6447-6452.1993; TEUNISSEN MBM, 1988, J INVEST DERMATOL, V91, P358, DOI 10.1111/1523-1747.ep12475770; WANG WK, 1995, AIDS RES HUM RETROV, V11, P185, DOI 10.1089/aid.1995.11.185; WENIGER BG, 1994, AIDS, V8, pS13; 1986, MMWR-MORBID MORTAL W, V35, P334; 1992, BRIT MED J, V304, P809	30	289	294	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 1	1996	271	5253					1291	1293		10.1126/science.271.5253.1291	http://dx.doi.org/10.1126/science.271.5253.1291			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TX695	8638113				2022-12-28	WOS:A1996TX69500040
J	Almer, S; Bodemar, G; Franzen, L; Lindstrom, E; Nystrom, PO; Strom, M				Almer, S; Bodemar, G; Franzen, L; Lindstrom, E; Nystrom, PO; Strom, M			Use of air enema radiography to assess depth of ulceration during acute attacks of ulcerative colitis	LANCET			English	Article								Background Acute colitis is usually assessed by means of plain abdominal radiographs, the diagnostic utility of which can be enhanced by barium enema. Colonoscopy can also be useful. The latter methods may be laborious and carry risk, We describe a radiographic technique using air as the contrast medium to show mucosal or deeper ulceration. Methods Of 60 patients undergoing colectomy for acute ulcerative colitis, 35 had air enema radiography and 14 had plain films with sufficient amount of spontaneously occurring gas to allow visualisation of the mucosa, during the 10 days before surgery. The degree of inflammation on air enema films and the extent of histopathological ulceration in colectomy specimens were independently graded and compared with each other. Depth of ulceration was compared with clinical data including a preoperative risk stratification, the APACHE II score. Findings The degree of inflammation on air enema radiography correlated significantly with depth of ulceration at histopathological examination (r(s) 0.61, p < 0.001). Presence of mucosal changes had a close association with deep ulceration extending into the muscularis propria layer or beyond (p < 0.001). Air enema radiography had a high sensitivity (0.91) for presence of and specificity (0.75) in the exclusion of deep ulceration, with positive and negative predictive values of 0.88 and 0.80. 42 of 49 patients were correctly classified as regards deep ulcers. The correlation between higher preoperative APACHE II scores and severity of histopathological colitis was weak (r(s) 0.30, p < 0.05). Interpretation Air enema radiography reliably assesses the presence of colonic ulceration in patients with an acute attack of ulcerative colitis. It is a first-line investigation to assess the presence of deeper ulceration in acute colitis.	LINKOPING UNIV,FAC HLTH SCI,DEPT INTERNAL MED,LINKOPING,SWEDEN; LINKOPING UNIV HOSP,DEPT MED SURG GASTROENTEROL,S-58185 LINKOPING,SWEDEN; LINKOPING UNIV,FAC HLTH SCI,DEPT PATHOL 2,LINKOPING,SWEDEN; RYHOV HOSP,DEPT PATHOL,JONKOPING,SWEDEN	Linkoping University; Linkoping University; Linkoping University				Almer, Sven/0000-0001-9334-1821				ALEMAYEHU G, 1991, AM J GASTROENTEROL, V86, P187; ALMER S, 1995, EUR J GASTROEN HEPAT, V7, P59; ALMER S, 1995, DIGESTION, V56, P528, DOI 10.1159/000201287; BARTRAM CI, 1977, GASTROINTEST RADIOL, V1, P383; BARTRAM CI, 1983, GASTROINTEST RADIOL, V8, P61, DOI 10.1007/BF01948090; BARTRAM CI, 1967, P ROY SOC MED, V69, P617; BUCKELL NA, 1980, GASTROENTEROLOGY, V79, P19; CARBONNEL F, 1994, DIGEST DIS SCI, V39, P1550, DOI 10.1007/BF02088063; HALLS J, 1964, P ROY SOC MED, V57, P893; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LINDSTROM E, 1992, ACTA RADIOL, V33, P1; MCCONNELL F, 1958, RADIOLOGY, V71, P674, DOI 10.1148/71.5.674; MORAN A, 1995, SCAND J GASTROENTERO, V30, P356, DOI 10.3109/00365529509093290; PRANTERA C, 1991, J CLIN GASTROENTEROL, V13, P231; SIMPSON SA, 1960, RADIOLOGY, V84, P306; TRAVIS SPL, 1994, GASTROENTEROLOGY S, V106, P784; WELIN S, 1958, BRIT J RADIOL, V31, P453, DOI 10.1259/0007-1285-31-369-453; WELIN S, 1961, ACTA RADIOL, V55, P257, DOI 10.3109/00016926109175119; YOUNG AC, 1963, P ROY SOC MED, V56, P491, DOI 10.1177/003591576305600621	19	29	33	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 22	1996	347	9017					1731	1735		10.1016/S0140-6736(96)90808-9	http://dx.doi.org/10.1016/S0140-6736(96)90808-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT396	8656906				2022-12-28	WOS:A1996UT39600010
J	Volk, CM; Elkins, JW; Fahey, DW; Salawitch, RJ; Dutton, GS; Gilligan, JM; Proffitt, MH; Loewenstein, M; Podolske, JR; Minschwaner, K; Margitan, JJ; Chan, KR				Volk, CM; Elkins, JW; Fahey, DW; Salawitch, RJ; Dutton, GS; Gilligan, JM; Proffitt, MH; Loewenstein, M; Podolske, JR; Minschwaner, K; Margitan, JJ; Chan, KR			Quantifying transport between the tropical and mid-latitude lower stratosphere	SCIENCE			English	Article							MOUNT-PINATUBO; INSITU MEASUREMENTS; OZONE DEPLETION; AEROSOL; N2O; CONSTITUENTS; SIMULATIONS; ABSORPTION; CF2CL2; CFCL3	Airborne in situ observations of molecules with a wide range of lifetimes (methane, nitrous oxide, reactive nitrogen, ozone, chlorinated halocarbons, and halon-1211), used in a tropical tracer model, show that mid-latitude air is entrained into the tropical lower stratosphere within about 13.5 months; transport is faster in the reverse direction, Because exchange with the tropics is slower than global photochemical models generally assume, ozone at mid-latitudes appears to be more sensitive to elevated levels of industrial chlorine than is currently predicted, Nevertheless, about 45 percent of air in the tropical ascent region at 21 kilometers is of mid-latitude origin, implying that emissions from supersonic aircraft could reach the middle stratosphere.	UNIV COLORADO,COOPERAT INST RES ENVIRONM SCI,BOULDER,CO 80309; NOAA,AERON LAB,BOULDER,CO 80303; CALTECH,JET PROP LAB,PASADENA,CA 91109; NASA,AMES RES CTR,MOFFETT FIELD,CA 94035; NEW MEXICO INST MIN & TECHNOL,DEPT PHYS,SOCORRO,NM 87801	University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; New Mexico Institute of Mining Technology	Volk, CM (corresponding author), NOAA,CLIMATE MONITORING & DIAGNOST LAB,BOULDER,CO 80303, USA.		Gilligan, Jonathan/I-8938-2014; Gilligan, Jonathan/AAZ-5377-2021; Fahey, David W/G-4499-2013; Salawitch, Ross/B-4605-2009; Dutton, Geoffrey/V-9977-2019	Gilligan, Jonathan/0000-0003-1375-6686; Gilligan, Jonathan/0000-0003-1375-6686; Fahey, David W/0000-0003-1720-0634; Salawitch, Ross/0000-0001-8597-5832; Dutton, Geoffrey/0000-0001-7777-9268				Avallone LM, 1996, J GEOPHYS RES-ATMOS, V101, P1457, DOI 10.1029/95JD03010; BOERING KA, 1994, GEOPHYS RES LETT, V21, P2567, DOI 10.1029/94GL01985; BOERING KA, 1995, GEOPHYS RES LETT, V22, P2737, DOI 10.1029/95GL02337; BRASSEUR G, 1992, SCIENCE, V257, P1239, DOI 10.1126/science.257.5074.1239; BROCK CA, 1995, SCIENCE, V270, P1650, DOI 10.1126/science.270.5242.1650; CHEN P, 1994, J ATMOS SCI, V51, P3006, DOI 10.1175/1520-0469(1994)051<3006:IMEBTT>2.0.CO;2; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dessler AE, 1996, J ATMOS CHEM, V23, P209, DOI 10.1007/BF00048261; DLUGOKENCKY EJ, 1994, J GEOPHYS RES-ATMOS, V99, P17021, DOI 10.1029/94JD01245; EHHALT DH, 1983, J ATMOS CHEM, V1, P27, DOI 10.1007/BF00113978; Elkins JW, 1996, GEOPHYS RES LETT, V23, P347, DOI 10.1029/96GL00244; ELKINS JW, 1993, NATURE, V364, P780, DOI 10.1038/364780a0; Eluszkiewicz J, 1996, J ATMOS SCI, V53, P217, DOI 10.1175/1520-0469(1996)053<0217:RCITSA>2.0.CO;2; FAHEY DW, 1989, J GEOPHYS RES-ATMOS, V94, P11299, DOI 10.1029/JD094iD09p11299; FAHEY DW, 1993, NATURE, V363, P509, DOI 10.1038/363509a0; FAHEY DW, IN PRESS GEOPHYS RES; GOLDAN PD, 1980, J GEOPHYS RES-OCEANS, V85, P413, DOI 10.1029/JC085iC01p00413; Grant WB, 1996, J GEOPHYS RES-ATMOS, V101, P3973, DOI 10.1029/95JD03164; HINTSA EJ, 1994, GEOPHYS RES LETT, V21, P2559, DOI 10.1029/94GL01279; HITCHMAN MH, 1994, J GEOPHYS RES-ATMOS, V99, P20689, DOI 10.1029/94JD01525; HOLTON JR, 1986, J GEOPHYS RES-ATMOS, V91, P2681, DOI 10.1029/JD091iD02p02681; Ko Maw Ko, COMMUNICATION; KO MKW, 1985, J GEOPHYS RES-ATMOS, V90, P2313, DOI 10.1029/JD090iD01p02313; MAHLMAN JD, 1986, J GEOPHYS RES-ATMOS, V91, P2687, DOI 10.1029/JD091iD02p02687; MCCORMICK MP, 1993, J GEOPHYS RES-ATMOS, V98, P4867, DOI 10.1029/92JD02218; MCINTYRE ME, 1983, NATURE, V305, P593, DOI 10.1038/305593a0; Minschwaner K, 1996, J GEOPHYS RES-ATMOS, V101, P9433, DOI 10.1029/96JD00335; MINSCHWANER K, 1993, J GEOPHYS RES-ATMOS, V98, P10543, DOI 10.1029/93JD00223; MONTZKA SA, IN PRESS SCIENCE; Mote PW, 1996, J GEOPHYS RES-ATMOS, V101, P3989, DOI 10.1029/95JD03422; MURPHY DM, 1993, J GEOPHYS RES-ATMOS, V98, P8751, DOI 10.1029/92JD00681; Plumb RA, 1996, J GEOPHYS RES-ATMOS, V101, P3957, DOI 10.1029/95JD03002; PLUMB RA, 1992, J GEOPHYS RES-ATMOS, V97, P10145, DOI 10.1029/92JD00450; PODOLSKE J, 1993, APPL OPTICS, V32, P5324, DOI 10.1364/AO.32.005324; PRATHER MJ, 1993, NASA REF PUBL, V1292; PROFFITT MH, 1983, REV SCI INSTRUM, V54, P1719, DOI 10.1063/1.1137316; PROFFITT MH, 1989, NATURE, V342, P233, DOI 10.1038/342233a0; RANDEL WJ, 1993, NATURE, V365, P533, DOI 10.1038/365533a0; ROOD R, 1992, GEOPHYS RES LETT, V19, P805, DOI 10.1029/92GL00526; ROSENLOF KH, 1995, J GEOPHYS RES-ATMOS, V100, P5173, DOI 10.1029/94JD03122; SALAWITCH RJ, 1994, GEOPHYS RES LETT, V21, P2551, DOI 10.1029/94GL02782; STOLARSKI RS, 1995, NASA REF PUBL, V1381; TREPTE CR, 1993, J GEOPHYS RES-ATMOS, V98, P18563, DOI 10.1029/93JD01362; TREPTE CR, 1992, NATURE, V355, P626, DOI 10.1038/355626a0; Waugh DW, 1996, J GEOPHYS RES-ATMOS, V101, P4007, DOI 10.1029/95JD03160; Weisenstein DK, 1996, GEOPHYS RES LETT, V23, P161, DOI 10.1029/95GL03781; WENNBERG PO, 1994, SCIENCE, V266, P398, DOI 10.1126/science.266.5184.398; WILSON JC, 1993, SCIENCE, V261, P1140, DOI 10.1126/science.261.5125.1140; *WORLD MET ORG, 1995, 37 WORLD MET ORG; 1994, JPL PUBL, V9426	50	135	136	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1763	1768		10.1126/science.272.5269.1763	http://dx.doi.org/10.1126/science.272.5269.1763			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8662478				2022-12-28	WOS:A1996UT11000035
J	Zenke, FT; Engels, R; Vollenbroich, V; Meyer, J; Hollenberg, CP; Breunig, KD				Zenke, FT; Engels, R; Vollenbroich, V; Meyer, J; Hollenberg, CP; Breunig, KD			Activation of Gal4p by galactose-dependent interaction of galactokinase and Gal80p	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; KLUYVEROMYCES-LACTIS; GLUCOSE REPRESSION; ESCHERICHIA-COLI; GENE-EXPRESSION; PROTEIN; YEAST; INDUCTION; REGULON; PHENOTYPE	Yeast galactokinase (Gal1p) is an enzyme and a regulator of transcription. In addition to phosphorylating galactose, Gal1p activates Gal4p, the activator of GAL genes, but the mechanism of this regulation has been unclear. Here, biochemical and genetic evidence is presented to show that Gal1p activates Gal4p by direct interaction with the Gal4p inhibitor Gal80p. interaction requires galactose, adenosine triphosphate, and the regulatory function of Gal1p. These data indicate that Gal1p-Gal80p complex formation results in the inactivation of Gal80p, thereby transmitting the galactose signal to Gal4p.	UNIV DUSSELDORF,INST MIKROBIOL,D-40225 DUSSELDORF,GERMANY	Heinrich Heine University Dusseldorf			Breunig, Karin D./B-1929-2009	Zenke, Frank/0000-0002-2226-3755				AMMERER G, 1983, METHOD ENZYMOL, V101, P192; BAJWA W, 1988, MOL CELL BIOL, V8, P3439, DOI 10.1128/MCB.8.8.3439; BHAT PJ, 1990, GENETICS, V125, P281; BHAT PJ, 1992, MOL CELL BIOL, V12, P2701, DOI 10.1128/MCB.12.6.2701; BIANCHI MM, 1987, CURR GENET, V12, P185, DOI 10.1007/BF00436877; CROWE J, 1990, METHOD MOL BIOL, P371; FISHER JA, 1988, NATURE, V332, P853; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; KAKIDANI H, 1988, CELL, V52, P161, DOI 10.1016/0092-8674(88)90504-1; LEUTHER KK, 1992, SCIENCE, V256, P1333, DOI 10.1126/science.1598579; MA J, 1988, NATURE, V334, P631, DOI 10.1038/334631a0; MEYER J, 1991, MOL CELL BIOL, V11, P5454, DOI 10.1128/MCB.11.11.5454; MEYER J, 1993, THESIS H HEINE U DUS; MEYER JMM, UNPUB; RILEY MI, 1987, MOL CELL BIOL, V7, P780, DOI 10.1128/MCB.7.2.780; ROSE M, 1991, EUR J BIOCHEM, V199, P511, DOI 10.1111/j.1432-1033.1991.tb16149.x; SALMERON JM, 1986, NUCLEIC ACIDS RES, V14, P7767, DOI 10.1093/nar/14.19.7767; SALMERON JM, 1989, MOL CELL BIOL, V9, P2950, DOI 10.1128/MCB.9.7.2950; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; ZACHARIAE W, 1994, THESIS H HEINE U DUS; ZENKE FT, 1993, MOL CELL BIOL, V13, P7566, DOI 10.1128/MCB.13.12.7566; ZENKE FT, 1995, THESIS H HEINE U DUS	23	127	131	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1996	272	5268					1662	1665		10.1126/science.272.5268.1662	http://dx.doi.org/10.1126/science.272.5268.1662			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8658143				2022-12-28	WOS:A1996UR09300050
J	Kiyokawa, H; Kineman, RD; ManovaTodorova, KO; Soares, VC; Hoffman, ES; Ono, M; Khanam, D; Hayday, AC; Frohman, LA; Koff, A				Kiyokawa, H; Kineman, RD; ManovaTodorova, KO; Soares, VC; Hoffman, ES; Ono, M; Khanam, D; Hayday, AC; Frohman, LA; Koff, A			Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)	CELL			English	Article							MOUSE; FIBROBLASTS; THYMOCYTES; APOPTOSIS; MUTATION; G(1); P21	Disruption of the cyclin-dependent kinase-inhibitory domain of p27 enhances growth of mice. Growth is attributed to an increase in cell number, due to increased cell proliferation, most obviously in tissues that ordinarily express p27 at the highest levels. Disruption of p27 function leads to nodular hyperplasia in the intermediate lobe of the pituitary. However, increased growth occurs without an increase in the amounts of either growth hormone or IGF-I. In addition, female mice were infertile. Luteal cell differentiation is impaired, and a disordered estrus cycle is detected. These results reflect a disturbance of the hypothalamic-pituitary-ovarian axis. The phenotypes of these mice suggest that loss of p27 causes an alteration in cell proliferation that can lead to specific endocrine dysfunction.	UNIV ILLINOIS,DEPT MED,CHICAGO,IL 60612; YALE UNIV,DEPT BIOL,IMMUNOBIOL SECT,NEW HAVEN,CT 06511	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Yale University	Kiyokawa, H (corresponding author), MEM SLOAN KETTERING CANC CTR,PROGRAM MOLEC BIOL,1275 YORK AVE,NEW YORK,NY 10021, USA.		Kineman, Rhonda D/H-2221-2011	Kineman, Rhonda D/0000-0001-7322-1152; Kiyokawa, Hiroaki/0000-0002-7942-6455	NIDDK NIH HHS [NIDDK30667] Funding Source: Medline; NIGMS NIH HHS [GM37759, GM52597] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030667, R01DK030667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM052597, R01GM052597, R01GM037759] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen IT, 1996, ONCOGENE, V12, P595; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; COATS S, 1996, IN PRESS SCIENCE; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; EWEN ME, 1993, CELL, V74, P1009, DOI 10.1016/0092-8674(93)90723-4; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; HARPER JW, 1993, CELL, V75, P805; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; HU NP, 1994, ONCOGENE, V9, P1021; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Koff A, 1995, Prog Cell Cycle Res, V1, P141; KRANENBURG O, 1995, J CELL BIOL, V131, P227, DOI 10.1083/jcb.131.1.227; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P2827, DOI 10.1210/endo-123-6-2827; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MORSTYN G, 1983, J CLIN INVEST, V72, P1877; NAKANISHI M, 1995, EMBO J, V14, P555, DOI 10.1002/j.1460-2075.1995.tb07031.x; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; SLINGERLAND JM, 1994, MOL CELL BIOL, V14, P3683, DOI 10.1128/MCB.14.6.3683; SOSS TJ, 1996, CELL GROWTH DIFFER, V7, P135; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; WILSON A, 1988, J IMMUNOL, V140, P1461; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750; [No title captured]	43	1129	1153	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 31	1996	85	5					721	732		10.1016/S0092-8674(00)81238-6	http://dx.doi.org/10.1016/S0092-8674(00)81238-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UP344	8646780	hybrid			2022-12-28	WOS:A1996UP34400012
J	Wilkinson, P; Sayer, J; Laji, K; Grundy, C; Marchant, B; Kopelman, P; Timmis, AD				Wilkinson, P; Sayer, J; Laji, K; Grundy, C; Marchant, B; Kopelman, P; Timmis, AD			Comparison of case fatality in south Asian and white patients after acute myocardial infarction: Observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; RISK-FACTORS; MORTALITY; LONDON; MEN; HYPERINSULINEMIA; BANGLADESHIS; PROGNOSIS; ENGLAND; WALES	Objective-To compare mortality in south Asian (Indian, Pakistani, and Bangladeshi) and white patients in the six months after hospital admission for acute myocardial infarction. Design-Observational study. Setting-District general hospital in east London. Patients-149 south Asian and 313 white patients aged <65 years admitted to the coronary care unit with acute myocardial infarction from. 1 December 1988 to 31 December 1992. Main outcome measure-All cause mortality in the first six months after myocardial infarction. Results-The admission rate in the south Asians was estimated to be 2.04 times that in the white patients. Most aspects of treatment were similar in the two groups, except that a higher proportion of the south Asians received thrombolytic drugs (81.2% v 73.8%). After adjustment for age, sex, previous myocardial infarction, and treatment with thrombolysis or aspirin, or both, the south Asians had a poorer survival over the six months from myocardial infarction (hazard ratio 2.02 (95% cofidence interval 1.14 to 3.56), P=0.018), but a substantially higher proportion were diabetic (38% v 11%, P<0.001), and additional adjustment for diabetes removed much of their excess risk (adjusted hazard ratio 1.26 (0.68 to 2.33), P=0.47). Conclusion-South Asian patients had a higher risk of admission with myocardial infarction and a higher risk of death over the ensuing six months than the white patients. The higher case fatality among the south Asians, largely attributable to diabetes, may contribute to the increased risk of death from coronary heart disease in south Asians living in Britain.	LONDON CHEST HOSP, DEPT CARDIOL, LONDON, ENGLAND; NEWHAM DIST GEN HOSP, DEPT CARDIOL, LONDON, ENGLAND; NEWHAM DIST GEN HOSP, DEPT DIABET, LONDON, ENGLAND	University of London; Queen Mary University London	Wilkinson, P (corresponding author), UNIV LONDON LONDON SCH HYG & TROP MED, ENVIRONM EPIDEMIOL UNIT, LONDON WC1E 7HT, ENGLAND.			Wilkinson, Paul/0000-0001-7456-259X				[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, Lancet, V1, P397; BALARAJAN R, 1984, BRIT MED J, V289, P1185, DOI 10.1136/bmj.289.6453.1185; BALARAJAN R, 1991, BMJ-BRIT MED J, V302, P560, DOI 10.1136/bmj.302.6776.560; BECKLES GLA, 1986, LANCET, V1, P1298; BHATNAGAR D, 1995, LANCET, V345, P405; BRESLOW NE, 1987, STATISTICAL METHODS, V2, P109; COX DR, 1972, J R STAT SOC B, V34, P187; HUGHES LO, 1989, BRIT MED J, V298, P1345, DOI 10.1136/bmj.298.6684.1345; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI, P10; LOWTY PJ, 1984, BRIT HEART J, V52, P610; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; MCKEIGUE PM, 1988, BRIT MED J, V297, P903, DOI 10.1136/bmj.297.6653.903; MCKEIGUE PM, 1988, BRIT HEART J, V60, P390; MCKEIGUE PM, 1989, J CLIN EPIDEMIOL, V42, P597, DOI 10.1016/0895-4356(89)90002-4; MCKEIGUE PM, 1992, BRIT HEART J, V67, P341, DOI 10.1136/hrt.67.5.341; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; MCKEIGUE PM, 1985, LANCET, V2, P1086; MCKEIGUE PM, 1989, BRIT MED J, V299, P179, DOI 10.1136/bmj.299.6692.179-a; MUKHTAR HT, 1995, BRIT HEART J, V73, P122; STEVENSON R, 1993, BMJ-BRIT MED J, V307, P349, DOI 10.1136/bmj.307.6900.349; STONE PH, 1989, J AM COLL CARDIOL, V14, P49, DOI 10.1016/0735-1097(89)90053-3; TUNSTALLPEDOE H, 1975, LANCET, V2, P833; 1986, LANCET, V1, P1307	24	94	95	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	1996	312	7042					1330	1333		10.1136/bmj.312.7042.1330	http://dx.doi.org/10.1136/bmj.312.7042.1330			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN476	8646044	Green Published			2022-12-28	WOS:A1996UN47600019
J	Yamasaki, L; Jacks, T; Bronson, R; Goillot, E; Harlow, E; Dyson, NJ				Yamasaki, L; Jacks, T; Bronson, R; Goillot, E; Harlow, E; Dyson, NJ			Tumor induction and tissue atrophy in mice lacking E2F-1	CELL			English	Article							TRANSCRIPTION FACTOR E2F; RETINOBLASTOMA PROTEIN; BINDING PROTEIN; GENE; EXPRESSION; CLONING; MOUSE; CELLS; SITE; TRANSACTIVATION	The retinoblastoma tumor suppressor protein (pRB) is a transcriptional repressor that regulates gene expression by physically associating with transcription factors such as E2F family members. Although pRB and its upstream regulators are commonly mutated in human cancer, the physiological role of the pRB-E2F pathway is unknown. To address the function of E2F-1 and pRB/E2F-1 complexes in vivo, we have produced mice homozygous for a nonfunctional E2F-1 allele. Mice lacking E2F-1 are viable and fertile, yet experience testicular atrophy and exocrine gland dysplasia. Surprisingly, mice lacking E2F-1 develop a broad and unusual spectrum of tumors. Although overexpression of E2F-1 in tissue culture cells can stimulate cell proliferation and be oncogenic, loss of E2F-1 in mice results in tumorigenesis, demonstrating that E2F-1 also functions as a tumor suppressor.	MIT,CTR CANC RES,HOWARD HUGHES MED INST,DEPT BIOL,CAMBRIDGE,MA 02139; TUFTS UNIV,SCH VET MED,USDA,HUMAN NUTR RES CTR AGING,DEPT PATHOL,BOSTON,MA 02111	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Tufts University; United States Department of Agriculture (USDA)	Yamasaki, L (corresponding author), MASSACHUSETTS GEN HOSP,CTR CANC,BLDG 49,13TH ST,CHARLESTOWN,MA 02129, USA.			Goillot, Evelyne/0000-0003-0026-4690	NATIONAL CANCER INSTITUTE [P01CA042063, R01CA064402, R01CA060636] Funding Source: NIH RePORTER; NCI NIH HHS [CA64402, CA60636, CA42063] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADNANE J, 1995, J BIOL CHEM, V270, P8837, DOI 10.1074/jbc.270.15.8837; BEIJERSBERGEN RL, 1994, GENE DEV, V8, P2680, DOI 10.1101/gad.8.22.2680; BLAKE MC, 1989, MOL CELL BIOL, V9, P4994, DOI 10.1128/MCB.9.11.4994; BREMNER R, 1995, MOL CELL BIOL, V15, P3256; Bronson R., 1990, GENETIC EFFECTS AGIN, VII, P279; BRONSON RT, 1991, GROWTH DEVELOP AGING, V55, P169; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; DOBROWOLSKI SF, 1994, ONCOGENE, V9, P2605; DUHL DMJ, 1994, DEVELOPMENT, V120, P1695; DURONIO RJ, 1995, GENE DEV, V9, P1445, DOI 10.1101/gad.9.12.1445; DYNLACHT BD, 1994, GENE DEV, V8, P1772, DOI 10.1101/gad.8.15.1772; DYNLACHT BD, 1994, P NATL ACAD SCI USA, V91, P6359, DOI 10.1073/pnas.91.14.6359; FLEMINGTON EK, 1993, P NATL ACAD SCI USA, V90, P6914, DOI 10.1073/pnas.90.15.6914; GINSBERG D, 1994, GENE DEV, V8, P2665, DOI 10.1101/gad.8.22.2665; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; Harlow E., 1988, ANTIBODIES LAB MANUA; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; HIJMANS EM, 1995, MOL CELL BIOL, V15, P3082; HOROWITZ JM, 1996, IN PRESS MOL CELL DI; HSIAO KM, 1994, GENE DEV, V8, P1526, DOI 10.1101/gad.8.13.1526; HU NP, 1994, ONCOGENE, V9, P1021; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; IVEYHOYLE M, 1993, MOL CELL BIOL, V13, P7802, DOI 10.1128/MCB.13.12.7802; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; JOHNSON DG, 1994, P NATL ACAD SCI USA, V91, P12823, DOI 10.1073/pnas.91.26.12823; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; JOOSS K, 1995, ONCOGENE, V10, P1529; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KAMB A, 1995, TRENDS GENET, V11, P136, DOI 10.1016/S0168-9525(00)89027-7; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; LATHANGUE NB, 1994, TRENDS BIOCHEM SCI, V19, P108, DOI 10.1016/0968-0004(94)90202-X; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LEE EYHP, 1994, GENE DEV, V8, P2008, DOI 10.1101/gad.8.17.2008; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; LI Y, 1994, MOL CELL BIOL, V14, P1861, DOI 10.1128/MCB.14.3.1861; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MEANS AL, 1992, MOL CELL BIOL, V12, P1054, DOI 10.1128/MCB.12.3.1054; MICHAUD EJ, 1994, P NATL ACAD SCI USA, V91, P2562, DOI 10.1073/pnas.91.7.2562; MULLER R, 1995, TRENDS GENET, V11, P173, DOI 10.1016/S0168-9525(00)89039-3; NEUMAN E, 1994, MOL CELL BIOL, V14, P6607, DOI 10.1128/MCB.14.10.6607; NEVINS JR, 1992, SCIENCE, V258, P424; OHTANI K, 1994, MOL CELL BIOL, V14, P1603, DOI 10.1128/MCB.14.3.1603; QIN XQ, 1995, MOL CELL BIOL, V15, P742; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; RILEY DJ, 1994, ANNU REV CELL BIOL, V10, P1, DOI 10.1146/annurev.cb.10.110194.000245; Russell L. D., 1990, HISTOLOGICAL HISTOPA; SAITO M, 1995, GENOMICS, V25, P130, DOI 10.1016/0888-7543(95)80118-6; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; SELLERS WR, 1995, P NATL ACAD SCI USA, V92, P11544, DOI 10.1073/pnas.92.25.11544; SHAN B, 1992, MOL CELL BIOL, V12, P5620, DOI 10.1128/MCB.12.12.5620; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; SINGH P, 1994, EMBO J, V13, P3329, DOI 10.1002/j.1460-2075.1994.tb06635.x; SLACK RS, 1993, ONCOGENE, V8, P1585; SLANSKY JE, 1995, TRANSCRIPTIONAL CONT; STEVENS LC, 1973, J NATL CANCER I, V50, P235, DOI 10.1093/jnci/50.1.235; Turusov V., 1994, PATHOLOGY TUMORS LAB; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VAIRO G, 1995, GENE DEV, V9, P869, DOI 10.1101/gad.9.7.869; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; WILLIAMS BO, 1994, NAT GENET, V7, P480, DOI 10.1038/ng0894-480; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; XU GF, 1995, P NATL ACAD SCI USA, V92, P1357, DOI 10.1073/pnas.92.5.1357; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420	75	636	648	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 17	1996	85	4					537	548		10.1016/S0092-8674(00)81254-4	http://dx.doi.org/10.1016/S0092-8674(00)81254-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UM415	8653789	Bronze			2022-12-28	WOS:A1996UM41500011
J	Wu, JR; Gilbert, DM				Wu, JR; Gilbert, DM			A distinct G(1) step required to specify the Chinese hamster DHFR replication origin	SCIENCE			English	Article							DNA-REPLICATION	Nuclei isolated from Chinese hamster ovary (CHO) cells at various times during the G(1) phase of the cell cycle were stimulated to enter S phase by incubation in Xenopus egg cytosol. Replication of DNA initiated within the dihydrofolate reductase (DHFR) origin locus in nuclei isolated late in G(1), but at random sites in nuclei isolated early in G(1). A discrete transition point occurred 3 to 4 hours after metaphase. Neither replication licensing nor nuclear assembly was sufficient for origin recognition. Thus, a distinct cell cycle-regulated event in the nucleus restricts the initiation of replication to specific sites downstream of the DHFR gene.	SUNY HLTH SCI CTR,DEPT BIOCHEM & MOLEC BIOL,SYRACUSE,NY 13210	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center								BURHANS WC, 1994, SCIENCE, V263, P639, DOI 10.1126/science.8303270; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; COVERLEY D, 1994, ANNU REV BIOCHEM, V63, P745, DOI 10.1146/annurev.bi.63.070194.003525; DEPAMPHILIS ML, 1993, J BIOL CHEM, V268, P1; DEPAMPHILIS ML, 1993, ANNU REV BIOCHEM, V62, P29; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; DIJKWEL PA, 1995, MOL CELL BIOL, V15, P3023; GILBERT DM, 1995, MOL CELL BIOL, V15, P2942; HAMLIN JL, 1994, BBA-REV CANCER, V1198, P85, DOI 10.1016/0304-419X(94)90008-6; KUBOTA Y, 1995, CELL, V81, P601, DOI 10.1016/0092-8674(95)90081-0; LENO GH, 1992, CELL, V69, P151, DOI 10.1016/0092-8674(92)90126-W; MADINE MA, 1995, CURR BIOL, V5, P1270, DOI 10.1016/S0960-9822(95)00253-3; MADINE MA, 1995, NATURE, V375, P4221; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075	14	110	111	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 1	1996	271	5253					1270	1272		10.1126/science.271.5253.1270	http://dx.doi.org/10.1126/science.271.5253.1270			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TX695	8638106				2022-12-28	WOS:A1996TX69500033
J	Liu, JD; Schrank, B; Waterston, RH				Liu, JD; Schrank, B; Waterston, RH			Interaction between a putative mechanosensory membrane channel and a collagen	SCIENCE			English	Article							SENSITIVE NA+ CHANNEL; CAENORHABDITIS-ELEGANS; HAIR-CELLS; C-ELEGANS; MUTATIONS; SEQUENCE; GENE; IDENTIFICATION; CLONING; MUSCLE	The degenerin family of proteins in Caenorhabditis elegans is homologous to subunits of the mammalian amiloride-sensitive epithelial sodium channels. Mutations in nematode degenerins cause cell death, probably because of defects in channel function. Genetic evidence was obtained that the unc-105 gene product represents a degenerin homolog affecting C. elegans muscles and that this putative channel interacts with type IV collagen in the extracellular matrix underlying the muscle cell. This interaction may serve as a mechanism of stretch-activated muscle contraction, and this system could provide a molecular model for the activation of mechanosensitive ion channels.			Liu, JD (corresponding author), WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023883, R37GM023883] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM23883] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Crofton H. D., 1966, NEMATODES; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Du HP, 1996, NEURON, V16, P183, DOI 10.1016/S0896-6273(00)80035-5; EIDE D, 1985, GENETICS, V109, P67; FIRE A, COMMUNICATION; GARCIAANOVEROS J, 1995, CURR BIOL, V5, P441, DOI 10.1016/S0960-9822(95)00085-6; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3; KAO G, COMMUNICATION; KRAMER JG, COMMUNICATION; KRAMER JM, 1994, ANNU REV GENET, V28, P95; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; LINGUEGLIA E, 1993, FEBS LETT, V318, P95, DOI 10.1016/0014-5793(93)81336-X; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MOERMAN DG, 1986, P NATL ACAD SCI USA, V83, P2579, DOI 10.1073/pnas.83.8.2579; PARK EC, 1986, GENETICS, V113, P821; PARK EC, 1986, GENETICS, V113, P853; PICKLES JO, 1992, TRENDS NEUROSCI, V15, P254, DOI 10.1016/0166-2236(92)90066-H; SHREFFLER W, 1995, GENETICS, V139, P1261; SIBLEY MH, 1994, EMBO J, V13, P3278, DOI 10.1002/j.1460-2075.1994.tb06629.x; SIBLEY MH, 1993, J CELL BIOL, V123, P255, DOI 10.1083/jcb.123.1.255; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; TSILIBARY EC, 1990, J CELL BIOL, V111, P1583, DOI 10.1083/jcb.111.4.1583; WATERSTON RH, 1988, NEMATODE CAENORHABDI, P261; WHITE JG, 1976, PHILOS R SOC LONDO B, V275, P326; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; WILLIAMS BD, 1992, GENETICS, V131, P609; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0	38	124	135	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 19	1996	273	5273					361	364		10.1126/science.273.5273.361	http://dx.doi.org/10.1126/science.273.5273.361			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY202	8662524				2022-12-28	WOS:A1996UY20200041
J	Perkins, WR; Dause, RB; Parente, RA; Minchey, SR; Neuman, KC; Gruner, SM; Taraschi, TF; Janoff, AS				Perkins, WR; Dause, RB; Parente, RA; Minchey, SR; Neuman, KC; Gruner, SM; Taraschi, TF; Janoff, AS			Role of lipid polymorphism in pulmonary surfactant	SCIENCE			English	Article							RESPIRATORY-DISTRESS SYNDROME; PREMATURE BABIES; ALEC; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPIDS; VESICLES; THERAPY; PHASE	The development of artificial surfactants for the treatment of respiratory distress syndrome (RDS) requires lipid systems that can spread rapidly from solution to the air-water interface, Because hydration-repulsion forces stabilize liposomal bilayers and oppose spreading, liposome systems that undergo geometric rearrangement from the bilayer (lamellar) phase to the hexagonal II (H-II) phase could hasten lipid transfer to the air-water interface through unstable transition intermediates. A liposome system containing dipalmitoylphosphatidylcholine was designed; the system is stable at 23 degrees C but undergoes transformation to the H-II phase as the temperature increases to 37 degrees C. The spreading of lipid from this system to the air-water interface was rapid at 37 degrees C but slow at 23 degrees C, When tested in vivo in a neonatal rabbit model, such systems elicited an onset of action equal to that of native human surfactant. These findings suggest that lipid polymorphic phase behavior may have a crucial role in the effective functioning of pulmonary surfactant.	LIPOSOME CO INC, PRINCETON, NJ 08540 USA; PRINCETON UNIV, DEPT PHYS, PRINCETON, NJ 08544 USA; THOMAS JEFFERSON UNIV, DEPT PATHOL & CELL BIOL, PHILADELPHIA, PA 19107 USA	Princeton University; Jefferson University			Neuman, Keir C./F-7400-2011; Gruner, Sol/G-2924-2010	Neuman, Keir C./0000-0002-0863-5671; Gruner, Sol/0000-0002-1171-4426				AHLUWALIA JS, 1995, ARCH DIS CHILD-FETAL, V72, pF121, DOI 10.1136/fn.72.2.F121; AMIRKHANIAN JD, 1995, LUNG, V173, P243; BARROW RE, 1979, J PHYSIOL-LONDON, V295, P217, DOI 10.1113/jphysiol.1979.sp012963; BOONMAN A, 1987, J COLLOID INTERF SCI, V120, P456, DOI 10.1016/0021-9797(87)90372-9; Bourbon J.R., 1991, PULMONARY SURFACTANT; BOURBON JR, 1991, PULMONARY SURFACTANT, P257; BOURBON JR, 1991, PULMONARY SURFACTANT, P143; CASIRO O, 1995, J PEDIATR-US, V126, pS53, DOI 10.1016/S0022-3476(95)70008-0; CHUNG JB, 1990, LANGMUIR, V6, P1647, DOI 10.1021/la00101a005; CLEMENTS JA, 1977, AM REV RESPIR DIS, V115, P67; CORBET A, 1995, J PEDIATR-US, V126, pS5, DOI 10.1016/S0022-3476(95)70002-1; DEHAN M, 1991, PULMONARY SURFACTANT, P333; ENHORNING G, 1995, AM J RESP CRIT CARE, V151, P554, DOI 10.1164/ajrccm.151.2.7842219; EPAND RM, 1985, CHEM PHYS LIPIDS, V36, P387, DOI 10.1016/0009-3084(85)90046-5; GAULTIER C, 1991, PULMONARY SURFACTANT, P359; GIBSON AT, 1994, EUR J PEDIATR, V153, P495, DOI 10.1007/s004310050179; GRUNER SM, 1985, BIOCHEMISTRY-US, V24, P2833, DOI 10.1021/bi00333a004; HALLMAN M, 1977, PEDIATR RES, V11, P714, DOI 10.1203/00006450-197706000-00003; HILLS BA, 1990, BIOL SURFACTANT, P184; HOEKSTRA RE, 1994, EUR J PEDIATR, V153, pS12, DOI 10.1007/BF02179667; JANOFF AS, 1992, Patent No. 6703; KUINT J, 1994, ARCH DIS CHILD-FETAL, V71, pF170, DOI 10.1136/fn.71.3.F170; LI W, 1986, BIOCHEMISTRY-US, V25, P7477, DOI 10.1021/bi00371a033; MARSH D, 1990, HDB LIPID BILAYERS, P265; MICHAELSON DM, 1974, BIOCHEMISTRY-US, V13, P2605, DOI 10.1021/bi00709a021; MORLEY CJ, 1989, DEV PHARMACOL THERAP, V13, P182, DOI 10.1159/000457602; MORLEY CJ, 1991, ARCH DIS CHILD, V66, P467, DOI 10.1136/adc.66.4.467; MORLEY CJ, 1988, EARLY HUM DEV, V17, P41, DOI 10.1016/S0378-3782(88)80056-2; MORLEY CJ, 1990, ARCH DIS CHILD-FETAL, V65, P667, DOI 10.1136/adc.65.7_Spec_No.667; MOYA FR, 1994, AM J RESP CRIT CARE, V150, P1672, DOI 10.1164/ajrccm.150.6.7952631; PERKINS W R, 1992, Biophysical Journal, V61, pA239; PHILLIPS MC, 1970, BIOCHIM BIOPHYS ACTA, V196, P35, DOI 10.1016/0005-2736(70)90163-X; PLOTZ FB, 1995, PEDIATR RES, V37, P476; RAND RP, 1972, BIOCHIM BIOPHYS ACTA, V225, P484, DOI 10.1016/0005-2736(72)90152-6; REVAK SD, 1986, AM REV RESPIR DIS, V134, P1258; SAIGAL S, 1995, J PEDIATR-US, V126, pS61, DOI 10.1016/S0022-3476(95)70009-9; SCHURCH S, 1994, J APPL PHYSIOL, V77, P974, DOI 10.1152/jappl.1994.77.2.974; WATKINS JC, 1968, BIOCHIM BIOPHYS ACTA, V152, P293, DOI 10.1016/0005-2760(68)90037-4; WISEMAN LR, 1994, DRUGS, V48, P386, DOI 10.2165/00003495-199448030-00006; YU SH, 1984, BIOCHIM BIOPHYS ACTA, V776, P37, DOI 10.1016/0005-2736(84)90248-7	40	65	73	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	1996	273	5273					330	332		10.1126/science.273.5273.330	http://dx.doi.org/10.1126/science.273.5273.330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY202	8662513				2022-12-28	WOS:A1996UY20200030
J	JoseYacaman, M; Rendon, L; Arenas, J; Puche, MCS				JoseYacaman, M; Rendon, L; Arenas, J; Puche, MCS			Maya blue paint: An ancient nanostructured material	SCIENCE			English	Article								Maya blue paint was often used in Mesoamerica. The origin of its color and its resistance to acids and biocorrosion have not been fully understood. High-resolution transmission electron microscopy, electron energy loss spectroscopy, and x-ray microanalysis studies of authentic samples show that palygorskite crystals in the paint form a superlattice that probably occurs as a result of mixing with indigo molecules. An amorphous silicate substrate contains inclusions of metal nanoparticles encapsulated in the substrate and oxide nanoparticles on the surface. The beautiful tone of the color is obtained only when both the particles and the superlattice are present.	INST NACL INVEST NUCL,SALAZAR 52045,MEXICO; INST NACL ANTROPOL & HIST,MUSEO NACL ANTROPOL,MEXICO CITY 11560,DF,MEXICO		JoseYacaman, M (corresponding author), UNIV NACL AUTONOMA MEXICO,INST FIS,APARTADO POSTAL 20-364,DELEGAC ALVARO OBREGON,MEXICO CITY 01000,DF,MEXICO.		yacaman, miguel jose/B-5622-2009; Yacaman, Miguel Jose/B-8150-2013					ARNOLD DE, 1975, ARCHAEOLOGY, V28, P23; BLOEMER MJ, 1990, J OPT SOC AM B, V7, P790, DOI 10.1364/JOSAB.7.000790; Faraday M., 1857, PHILOS T ROY SOC LON, V147, P145, DOI [10.1098/rstl.1857.001, DOI 10.1098/RSTL.1857.0011]; GETTENS P, 1962, AM ANTIQUITY, V27, P557; JOSEYACAMAN M, 1970, J CRYST GROWTH, V7, P3; LITTMANN ER, 1982, AM ANTIQUITY, V47, P404, DOI 10.2307/279911; MEWIN HW, 1931, PUBLICATION CARNEGIE, V606; REPETTO B, 1975, B INAH, V14, P51; Reyes Valerio Constantino, 1993, BONAMPAK TEMPLO MAYO; TORRES L, 1968, MATER RES SOC S P, V123, P123; van de Hulst H.C., 1981, LIGHT SCATTERING SMA; VANOLPHEN H, 1966, SCIENCE, V154, P645, DOI 10.1126/science.154.3749.645; [No title captured]	13	172	176	2	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 12	1996	273	5272					223	225		10.1126/science.273.5272.223	http://dx.doi.org/10.1126/science.273.5272.223			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UW787	8662502				2022-12-28	WOS:A1996UW78700036
J	Karp, CL; Wysocka, M; Wahl, LM; Ahearn, JM; Cuomo, PJ; Sherry, B; Trinchieri, G; Griffin, DE				Karp, CL; Wysocka, M; Wahl, LM; Ahearn, JM; Cuomo, PJ; Sherry, B; Trinchieri, G; Griffin, DE			Mechanism of suppression of cell-mediated immunity by measles virus	SCIENCE			English	Article							PERMEABILITY-INCREASING PROTEIN; HUMAN-IMMUNODEFICIENCY-VIRUS; COMPLEMENT-SYSTEM; INFECTED-CELLS; INTERFERON-GAMMA; ACTIVATION; CD46; INDUCTION; HIV-1; INTERLEUKIN-12	The mechanisms underlying the profound suppression of cell-mediated immunity (CMI) accompanying measles are unclear. Interleukin-12 (IL-12), derived principally from monocytes and macrophages, is critical for the generation of CMI. Measles virus (MV) infection of primary human monocytes specifically down-regulated IL-12 production. Cross-linking of CD46, a complement regulatory protein that is the cellular receptor for MV, with antibody or with the complement activation product C3b similarly inhibited monocyte IL-12 production, providing a plausible mechanism for MV-induced immunosuppression. CD46 provides a regulatory link between the complement system and cellular Immune responses.	WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104; NIDR,IMMUNOL LAB,NIH,BETHESDA,MD 20892; PICOWER INST MED RES,MANHASSET,NY 11030; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT MOLEC MICROBIOL & IMMUNOL,BALTIMORE,MD 21205	The Wistar Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Northwell Health; Johns Hopkins University	Karp, CL (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21287, USA.		Sherry, Barbara/GSD-7179-2022; Trinchieri, Giorgio/F-9369-2015	Sherry, Barbara/0000-0003-3119-1463; Trinchieri, Giorgio/0000-0001-5892-7464; Karp, Christopher/0000-0002-0832-2659	NIAID NIH HHS [AI23047, AI01223, AI35149] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035149, R01AI023047] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS EM, 1991, J IMMUNOL, V147, P3005; ARNEBORN P, 1983, INFECT IMMUN, V39, P29, DOI 10.1128/IAI.39.1.29-37.1983; ASSAAD F, 1983, REV INFECT DIS, V5, P452; BLOOM BR, 1989, NATURE, V342, P115, DOI 10.1038/342115a0; CHEHIMI J, 1994, J EXP MED, V179, P1361, DOI 10.1084/jem.179.4.1361; CHO SW, 1991, CLIN EXP IMMUNOL, V83, P257; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; DENTENER MA, 1993, J IMMUNOL, V151, P4258; DIERICH MP, 1993, IMMUNOL TODAY, V14, P435, DOI 10.1016/0167-5699(93)90246-H; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Durum Scott K., 1993, P801; EBENBICHLER CF, 1991, J EXP MED, V174, P1417, DOI 10.1084/jem.174.6.1417; ESOLEN LM, 1993, J INFECT DIS, V168, P47, DOI 10.1093/infdis/168.1.47; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; GAZZINELLI RT, 1993, P NATL ACAD SCI USA, V90, P6115, DOI 10.1073/pnas.90.13.6115; GERLIER D, 1994, J GEN VIROL, V75, P2163, DOI 10.1099/0022-1317-75-9-2163; GRANT JP, 1990, STATE WORLDS CHILDRE; GRIFFIN DE, 1990, CLIN EXP IMMUNOL, V81, P218; GRIFFIN DE, 1993, J INFECT DIS, V168, P275, DOI 10.1093/infdis/168.2.275; HIRSCH MS, 1996, VIROLOGY, P1953; HIRSCH RL, 1981, CLIN IMMUNOL IMMUNOP, V21, P341, DOI 10.1016/0090-1229(81)90223-3; HIRSCH RL, 1984, CLIN IMMUNOL IMMUNOP, V31, P1, DOI 10.1016/0090-1229(84)90184-3; JAMES SL, 1995, MICROBIOL REV, V59, P533, DOI 10.1128/MMBR.59.4.533-547.1995; KALLI KR, 1991, J EXP MED, V174, P1451, DOI 10.1084/jem.174.6.1451; KARP CL, 1993, J CLIN INVEST, V91, P1644, DOI 10.1172/JCI116372; KARP CL, UNPUB; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; MANCHESTER M, 1995, P NATL ACAD SCI USA, V92, P2303, DOI 10.1073/pnas.92.6.2303; MARRA MN, 1990, J IMMUNOL, V144, P662; MARSCHANG P, 1993, AIDS, V7, P903, DOI 10.1097/00002030-199307000-00001; MAYERNIK DG, 1984, J LEUKOCYTE BIOL, V36, P551, DOI 10.1002/jlb.36.4.551; MERTZ PM, 1994, J BIOL CHEM, V269, P21322; MESZAROS K, 1993, J LEUKOCYTE BIOL, V54, P558, DOI 10.1002/jlb.54.6.558; MOENCH TR, 1988, J INFECT DIS, V158, P433, DOI 10.1093/infdis/158.2.433; MULLER G, 1995, J IMMUNOL, V155, P4661; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; NUSSBAUM O, 1995, J VIROL, V69, P3341, DOI 10.1128/JVI.69.6.3341-3349.1995; Schmidtmayerova H, 1996, P NATL ACAD SCI USA, V93, P700, DOI 10.1073/pnas.93.2.700; SOLDER BM, 1989, IMMUNOL LETT, V22, P135, DOI 10.1016/0165-2478(89)90180-6; SPEAR GT, 1990, J IMMUNOL, V144, P1490; STOIBER H, 1995, IMMUNOBIOLOGY, V193, P98, DOI 10.1016/S0171-2985(11)80158-0; TAMASHIRO VG, 1987, PEDIATR INFECT DIS J, V6, P451, DOI 10.1097/00006454-198705000-00007; THIEBLEMONT N, 1993, AIDS RES HUM RETROV, V9, P229, DOI 10.1089/aid.1993.9.229; THIELENS NM, 1993, J IMMUNOL, V151, P6583; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; TRINCHIERI G, 1994, BLOOD, V84, P4008, DOI 10.1182/blood.V84.12.4008.bloodjournal84124008; VAINIONPAA R, 1978, ACTA PATH MICRO IM B, V86, P379; VONPIRQUET C, 1908, DEUT MED WOCHENSCHR, V30, P1297; WAHL LM, 1984, CELL IMMUNOL, V85, P373, DOI 10.1016/0008-8749(84)90251-X; WAHL LM, 1981, MANUAL MACROPHAGE ME, P423; WARD BJ, 1993, CLIN IMMUNOL IMMUNOP, V67, P171, DOI 10.1006/clin.1993.1061; WEISS J, 1978, J BIOL CHEM, V253, P2664; WHITTLE HC, 1978, J CLIN INVEST, V62, P678, DOI 10.1172/JCI109175; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3; ZWEIMAN B, 1971, INT ARCH ALLER A IMM, V40, P834, DOI 10.1159/000230466	55	451	454	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 12	1996	273	5272					228	231		10.1126/science.273.5272.228	http://dx.doi.org/10.1126/science.273.5272.228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW787	8662504				2022-12-28	WOS:A1996UW78700038
J	Levine, BL; Mosca, JD; Riley, JL; Carroll, RG; Vahey, MT; Jagodzinski, LL; Wagner, KF; Mayers, DL; Burke, DS; Weislow, OS; StLouis, DC; June, CH				Levine, BL; Mosca, JD; Riley, JL; Carroll, RG; Vahey, MT; Jagodzinski, LL; Wagner, KF; Mayers, DL; Burke, DS; Weislow, OS; StLouis, DC; June, CH			Antiviral effect and ex vivo CD4(+) T cell proliferation in HIV-positive patients as a result of CD28 costimulation	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LYMPHOCYTES-T; REPLICATION; INFECTION; INDIVIDUALS; ACTIVATION; EXPRESSION; AIDS; INTERLEUKIN-2; RESPONSES	Because stimulation of CD4(+) lymphocytes leads to activation of human immunodeficiency virus-type 1 (HIV-1) replication, viral spread, and cell death, adoptive CD4(+) T cell therapy has not been possible. When antigen and CD28 receptors on cultured T cells were stimulated by monoclonal antibodies (mAbs) to CD3 and CD28 that had been immobilized, there was an increase in the number of polyclonal CD4(+) T cells from HIV-infected donors. Activated cells predominantly secreted cytokines associated with T helper cell type 1 function, The HIV-1 viral load declined in the absence of antiretroviral agents, Moreover, CD28 stimulation of CD4(+) T cells from uninfected donors rendered these cells highly resistant to HIV-I infection, Immobilization of CD28 mAb was crucial to the development of HIV resistance, as cells stimulated with soluble CD28 mAb were highly susceptible to HIV infection, The CD28-mediated antiviral effect occurred early in the viral life cycle, before HIV-1 DNA integration. These data may facilitate immune reconstitution and gene therapy approaches in persons with HIV infection.	USN,MED RES INST,BETHESDA,MD 20889; HENRY M JACKSON FDN ADVANCEMENT MIL MED,ROCKVILLE,MD 20850; WALTER REED ARMY INST RES,DIV RETROVIROL,ROCKVILLE,MD 20850; SRA TECHNOL,DIV LIFE SCI,ROCKVILLE,MD 20850	Naval Medical Research Center (NMRC); United States Department of Defense; United States Navy; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)			Riley, James L/D-1255-2009; Levine, Bruce L/D-1688-2009	June, Carl/0000-0003-0241-3557; Riley, James/0000-0002-1057-576X; /0000-0002-5704-8094	NIAID NIH HHS [AI29331] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029331] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASJO B, 1993, J VIROL, V67, P4395; BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; BORTHWICK NJ, 1994, AIDS, V8, P431, DOI 10.1097/00002030-199404000-00004; BRINCHMANN JE, 1994, J INFECT DIS, V169, P730, DOI 10.1093/infdis/169.4.730; CAYOTA A, 1993, CLIN EXP IMMUNOL, V91, P241; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; COSTELLO R, 1993, EUR J IMMUNOL, V23, P608, DOI 10.1002/eji.1830230304; DOBRESCU D, 1995, P NATL ACAD SCI USA, V92, P5563, DOI 10.1073/pnas.92.12.5563; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GROUX H, 1992, J EXP MED, V175, P331, DOI 10.1084/jem.175.2.331; HOLTER W, 1992, EUR J IMMUNOL, V22, P2765, DOI 10.1002/eji.1830221047; JOHNSTON MI, 1993, SCIENCE, V260, P1286, DOI 10.1126/science.7684163; JUNE CH, 1987, MOL CELL BIOL, V7, P4472, DOI 10.1128/MCB.7.12.4472; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KING CL, 1995, EUR J IMMUNOL, V25, P587, DOI 10.1002/eji.1830250242; LAURENCE J, 1992, NATURE, V358, P255, DOI 10.1038/358255a0; LEDBETTER JA, 1990, BLOOD, V75, P1531; LEVINE B, UNPUB; LEVINE BL, 1995, INT IMMUNOL, V7, P891, DOI 10.1093/intimm/7.6.891; LEWIS DE, 1994, J IMMUNOL, V153, P412; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; MAGGI E, 1987, EUR J IMMUNOL, V17, P1685, DOI 10.1002/eji.1830171202; MAGGI E, 1994, SCIENCE, V265, P244, DOI 10.1126/science.8023142; MARGOLICK JB, 1985, J CLIN INVEST, V76, P709, DOI 10.1172/JCI112025; MASCOLA JR, 1994, J INFECT DIS, V169, P48, DOI 10.1093/infdis/169.1.48; MICHAEL NL, 1992, J VIROL, V66, P310, DOI 10.1128/JVI.66.1.310-316.1992; NUNES JA, 1994, J EXP MED, V180, P1067, DOI 10.1084/jem.180.3.1067; PANTALEO G, 1990, J IMMUNOL, V144, P1696; PINCHUK LM, 1994, IMMUNITY, V1, P317, DOI 10.1016/1074-7613(94)90083-3; SAYEGH MH, 1995, J EXP MED, V181, P1869, DOI 10.1084/jem.181.5.1869; SCHNITTMAN SM, 1990, P NATL ACAD SCI USA, V87, P6058, DOI 10.1073/pnas.87.16.6058; SESHAMMA T, 1992, P NATL ACAD SCI USA, V89, P10663, DOI 10.1073/pnas.89.22.10663; SMITHGALL MD, 1995, AIDS RES HUM RETROV, V11, P885, DOI 10.1089/aid.1995.11.885; STEIN DS, 1993, CLIN INFECT DIS, V17, P749, DOI 10.1093/clinids/17.4.749; THOMPSON CB, 1995, CELL, V81, P979, DOI 10.1016/S0092-8674(05)80001-7; Vahey Maryanne T., 1995, P17; VANDERPOUWKRAAN T, 1993, EUR J IMMUNOL, V23, P1, DOI 10.1002/eji.1830230102; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; WENG NP, 1995, P NATL ACAD SCI USA, V92, P11091, DOI 10.1073/pnas.92.24.11091; WILSON CC, 1995, J INFECT DIS, V172, P88, DOI 10.1093/infdis/172.1.88	41	198	221	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1996	272	5270					1939	1943		10.1126/science.272.5270.1939	http://dx.doi.org/10.1126/science.272.5270.1939			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8658167				2022-12-28	WOS:A1996UV29400049
J	Wang, ZX; Moran, MF				Wang, ZX; Moran, MF			Requirement for the adapter protein GRB2 in EGF receptor endocytosis	SCIENCE			English	Article							EPIDERMAL GROWTH-FACTOR; GUANINE-NUCLEOTIDE EXCHANGE; LIGAND-INDUCED INTERNALIZATION; SH3 DOMAINS; TYROSINE KINASE; DOWN-REGULATION; BINDING-SITE; RAS; DYNAMIN; SOS	Activated epidermal growth factor (EGF) receptors induce the formation of various complexes of intracellular signaling proteins that are mediated by SRC homology 2 (SH2) and SH3 domains. The activated receptors are also rapidly internalized into the endocytotic compartment and degraded in lysosomes. EGF stimulation of canine epithelial cells induced a rapid and transient association of the SH3-SH2-SH3 protein GRB2 with dynamin, a guanosine triphosphatase that regulates endocytosis. Disruption of GRB2 interactions by microinjection of a peptide corresponding to the GRB2 SH2 domain or its phosphopeptide ligand blocked EGF receptor endocytosis; other SH2 domains that bind EGF receptors or antibodies that neutralize RAS did not. Both activation and termination of EGF signaling appear to be regulated by the diverse interactions of GRB2.	UNIV TORONTO,BANTING & BEST DEPT MED RES,TORONTO,ON M5G 1L6,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON M5G 1L6,CANADA	University of Toronto; University of Toronto			Moran, Michael/GYD-3631-2022					ANDO A, 1994, EMBO J, V13, P3033, DOI 10.1002/j.1460-2075.1994.tb06602.x; BARSAGI D, 1993, CELL, V74, P83, DOI 10.1016/0092-8674(93)90296-3; BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CHANG CP, 1993, J BIOL CHEM, V268, P19312; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; CUSSAC D, 1994, EMBO J, V13, P4011, DOI 10.1002/j.1460-2075.1994.tb06717.x; DAMKE H, 1994, J CELL BIOL, V127, P925; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; DECKER SJ, 1992, J BIOL CHEM, V267, P1104; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; DONOVAN JA, 1994, J BIOL CHEM, V269, P22925; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; FELDER S, 1992, J CELL BIOL, V117, P203, DOI 10.1083/jcb.117.1.203; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GLENNEY JR, 1988, CELL, V52, P675, DOI 10.1016/0092-8674(88)90405-9; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; HELIN K, 1991, J BIOL CHEM, V266, P8363; HERSKOVITS JS, 1993, P NATL ACAD SCI USA, V90, P11468, DOI 10.1073/pnas.90.24.11468; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; HONEGGER AM, 1989, P NATL ACAD SCI USA, V86, P925, DOI 10.1073/pnas.86.3.925; HONEGGER AM, 1990, J CELL BIOL, V110, P1541, DOI 10.1083/jcb.110.5.1541; JOLY M, 1995, J BIOL CHEM, V270, P13225, DOI 10.1074/jbc.270.22.13225; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; LAMAZE C, 1995, J CELL BIOL, V129, P47, DOI 10.1083/jcb.129.1.47; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MCPHERSON PS, 1994, J BIOL CHEM, V269, P30132; MEISNER H, 1995, J BIOL CHEM, V270, P25332, DOI 10.1074/jbc.270.43.25332; MIKI H, 1994, J BIOL CHEM, V269, P5489; NESTEROV A, 1995, P NATL ACAD SCI USA, V92, P8719, DOI 10.1073/pnas.92.19.8719; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; RAABE T, 1995, EMBO J, V14, P2509, DOI 10.1002/j.1460-2075.1995.tb07248.x; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; SCAIFE R, 1994, EMBO J, V13, P2574, DOI 10.1002/j.1460-2075.1994.tb06547.x; SEEDORF K, 1994, J BIOL CHEM, V269, P16009; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; SOLER C, 1994, J BIOL CHEM, V269, P12320; SORKIN A, 1992, J BIOL CHEM, V267, P8672; SORKIN A, 1993, SCIENCE, V261, P612, DOI 10.1126/science.8342026; TAKEI K, 1995, NATURE, V374, P86; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; WANG Z, UNPUB; Wang ZX, 1996, CELL GROWTH DIFFER, V7, P123; WILEY HS, 1991, J BIOL CHEM, V266, P11083; YU HT, 1992, SCIENCE, V258, P1665, DOI 10.1126/science.1280858	52	151	155	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1996	272	5270					1935	1939		10.1126/science.272.5270.1935	http://dx.doi.org/10.1126/science.272.5270.1935			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8658166				2022-12-28	WOS:A1996UV29400048
J	Dragic, T; Litwin, V; Allaway, GP; Martin, SR; Huang, YX; Nagashima, KA; Cayanan, C; Maddon, PJ; Koup, RA; Moore, JP; Paxton, WA				Dragic, T; Litwin, V; Allaway, GP; Martin, SR; Huang, YX; Nagashima, KA; Cayanan, C; Maddon, PJ; Koup, RA; Moore, JP; Paxton, WA			HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS; FUNCTIONAL EXPRESSION; CD4-MEDIATED FUSION	The beta-chemokines MIP-1 alpha, MIP-1 beta and RANTES inhibit infection of CD4(+) T cells by primary, non-syncytium-inducing (NSI) HIV-1 strains at the virus entry stage, and also block env-mediated cell-cell membrane fusion. CD4(+) T cells from some HIV-1-exposed uninfected individuals cannot fuse with NSI HIV-1 strains and secrete high levels of beta-chemokines. Expression of the beta-chemokine receptor CC-CKR-5 in CD4(+), non-permissive human and non-human cells renders them susceptible to infection by NSI strains, and allows env-mediated membrane fusion. CC-CKR-5 is a second receptor for NSI primary viruses.	ROCKEFELLER UNIV,AARON DIAMOND AIDS RES CTR,NEW YORK,NY 10016; PROGEN PHARMACEUT INC,TARRYTOWN,NY 10591	Rockefeller University			paxton, william/R-9747-2019	Paxton, William/0000-0002-2654-5186; Paxton, William/0000-0001-5200-0801				ASHORN PA, 1990, J VIROL, V64, P2149, DOI 10.1128/JVI.64.5.2149-2156.1990; BACON KB, 1995, SCIENCE, V269, P1727, DOI 10.1126/science.7569902; BENBARUCH A, 1995, J BIOL CHEM, V270, P22123, DOI 10.1074/jbc.270.38.22123; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; CHAUDHURI A, 1994, J BIOL CHEM, V269, P7835; CHEN BK, 1994, J VIROL, V68, P654, DOI 10.1128/JVI.68.2.654-660.1994; CLAPHAM PR, 1991, VIROLOGY, V181, P703, DOI 10.1016/0042-6822(91)90904-P; COMBADIERE C, 1995, J BIOL CHEM, V270, P29671; CONNOR RI, 1994, J VIROL, V68, P4400, DOI 10.1128/JVI.68.7.4400-4408.1994; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; COOCHI F, 1995, SCIENCE, V270, P1811; DRAGIC T, 1992, J VIROL, V66, P4794, DOI 10.1128/JVI.66.8.4794-4802.1992; DRAGIC T, 1995, J VIROL, V69, P1013, DOI 10.1128/JVI.69.2.1013-1018.1995; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; GAO JL, 1993, J EXP MED, V177, P1421, DOI 10.1084/jem.177.5.1421; Levy JA, 1996, IMMUNOL TODAY, V17, P217, DOI 10.1016/0167-5699(96)10011-6; LITWIN V, IN PRESS J VIROL; LOETSCHER M, 1994, J BIOL CHEM, V269, P232; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Moore J P, 1995, AIDS, V9 Suppl A, pS117; MOORE JP, 1993, VIRAL FUSION MECHANI, P233; NEOTE K, 1994, BLOOD, V84, P44; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412; Puri A, 1996, VIROLOGY, V219, P262, DOI 10.1006/viro.1996.0244; Raport CJ, 1996, J LEUKOCYTE BIOL, V59, P18, DOI 10.1002/jlb.59.1.18; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Wells TNC, 1996, J LEUKOCYTE BIOL, V59, P53, DOI 10.1002/jlb.59.1.53	29	2782	2926	0	162	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 20	1996	381	6584					667	673		10.1038/381667a0	http://dx.doi.org/10.1038/381667a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR979	8649512	Bronze			2022-12-28	WOS:A1996UR97900042
J	Hickok, G; Bellugi, U; Klima, ES				Hickok, G; Bellugi, U; Klima, ES			The neurobiology of sign language and its implications for the neural basis of language	NATURE			English	Article								THE left cerebral hemisphere is dominant for language, and many aspects of language use are more impaired by damage to the left than the right hemisphere, The basis for this asymmetry, however, is a matter of debate; the left hemisphere may be specialized for processing linguistic information(1-3) or for some more general function on which language depends, such as the processing of rapidly changing temporal information(4) or execution of complex motor patterns(5). To investigate these possibilities, we examined the linguistic abilities of 23 sign-language users with unilateral brain lesions. Despite the fact that sign language relies on visuospatial rather than rapid temporal information, the same left-hemispheric dominance emerged. Correlation analyses of the production of sign language versus non-linguistic hand gestures suggest that these processes are largely independent, Our findings support the view that the left-hemisphere dominance for language is not reducible solely to more general sensory or motor processes.	UNIV CALIF SAN DIEGO,SAN DIEGO,CA 92186	University of California System; University of California San Diego	Hickok, G (corresponding author), SALK INST BIOL STUDIES,10010 N TORREY PINES RD,LA JOLLA,CA 92037, USA.							BELIUGI U, 1989, TRENDS NEUROSCI, V10, P380; CHIARELLO C, 1982, BRAIN, V105, P29, DOI 10.1093/brain/105.1.29; Corina D., 1993, PHONOLOGY, V10, P165, DOI [10.1017/S0952675700000038, DOI 10.1017/S0952675700000038]; Corina David P., 1993, PHONETICS PHONOLOGY, P63; CORINA DP, 1992, SCIENCE, V255, P1258, DOI 10.1126/science.1546327; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; GOODGLASS H, 1976, ASSESSMENT APHASIA R; KIMURA D, 1982, PHILOS T ROY SOC B, V298, P135, DOI 10.1098/rstb.1982.0077; Kimura D., 1993, NEUROMOTOR MECH HUMA; Klima E., 1979, SIGNS LANGUAGE; Liddell S.K., 1980, AM SIGN LANGUAGE SYN, DOI 10.1515/9783112418260; Lillo-Martin Diane., 1991, UNIVERSAL GRAMMAR AM; Osterrieth P., 1944, ARCH PSYCHOL-GENEVE, V30, P206; PERLMUTTER DM, 1992, LINGUIST INQ, V23, P407; POIZNER H, 1993, ANN NY ACAD SCI, V682, P192, DOI 10.1111/j.1749-6632.1993.tb22969.x; Poizner H., 1987, LANGUAGE, DOI [10.2307/414579, DOI 10.2307/414579]; Siple Patricia, 1990, THEORETICAL ISSUES S, V1, P191, DOI DOI 10.1007/978-94-011-3468-2; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; [No title captured]	19	114	116	1	19	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 20	1996	381	6584					699	702		10.1038/381699a0	http://dx.doi.org/10.1038/381699a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR979	8649515				2022-12-28	WOS:A1996UR97900053
J	Gomaa, A; Shalaby, M; Osman, M; Eissa, M; Eizat, A; Mahmoud, M; Mikhail, N				Gomaa, A; Shalaby, M; Osman, M; Eissa, M; Eizat, A; Mahmoud, M; Mikhail, N			Topical treatment of erectile dysfunction: Randomised double blind placebo controlled trial of cream containing aminophylline, isosorbide dinitrate, and co-dergocrine mesylate	BRITISH MEDICAL JOURNAL			English	Article							INTRACAVERNOUS SELF-INJECTION; THERAPEUTIC APPLICATIONS; FACILITATING DRUGS; VASOACTIVE DRUGS; IC INJECTIONS; IMPOTENCE; NITROGLYCERIN; PAPAVERINE; MANAGEMENT; EXPERIENCE	Objective-To examine the effectiveness in treating impotence of topically applied cream containing three vasodilators-aminophylline, isosorbide dinitrate, and co-dergocrine mesylate-which act by different mechanisms. Design-Randomised double blinded placebo controlled crossover trial over two weeks. Subjects-36 men with erectile dysfunction randomly allocated to two equal groups. Interventions-Active cream containing aminophylline 3%, isosorbide dinitrate 0.25%, and co-dergocrine mesylate 0.05% for one week and placebo for another. Main outcome measures-Patients' reported experience of penile responses and side effects of treatment in questionnaires. Penile tumescence and arterial Row in the laboratory. Results-21 patients reported full erection and satisfactory intercourse with the active cream. Three men reported full erection and satisfactory intercourse with either cream. The active cream was more effective in psychogenic than organic impotence (eight out of nine men with psychogenic impotence achieved a full erection zi four out of eight with neurogenic impotence and two out of seven with arterial insufficiency). No major side effects were reported. In the laboratory the active cream increased penile arterial flow (0.19 (SD 0.08) m/s v 0.02 (0.15) m/s with placebo) and induced tumescence in 24 patients. Conclusions-Topical treatment with a cream containing three different vasodilators might be considered before intracavernous injection of vasoactive agents, particularly in psychogenic impotence.	UNIV ASSIUT,FAC MED,DEPT UROL,ASSIUT,EGYPT; UNIV ASSIUT,FAC MED,DEPT NEUROL,ASSIUT,EGYPT; UNIV ASSIUT,FAC MED,DEPT COMMUNITY MED,ASSIUT,EGYPT	Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Assiut University	Gomaa, A (corresponding author), UNIV ASSIUT,FAC MED,DEPT PHARMACOL,ASSIUT,EGYPT.		Eissa, Mamdouh M/K-9774-2015; Eissa, M M/S-4230-2019; Gomaa, Adel Abdel-Wadood/E-7326-2010	Eissa, Mamdouh M/0000-0001-8688-0843; Eissa, M M/0000-0003-4723-6427; Gomaa, Adel Abdel-Wadood/0000-0002-6462-0917				ABOSEIF SR, 1989, BRIT J UROL, V64, P183, DOI 10.1111/j.1464-410X.1989.tb05985.x; ABOZEID M, 1987, J UROLOGY, V138, P1263, DOI 10.1016/S0022-5347(17)43581-6; BLUM MD, 1985, J UROLOGY, V134, P479, DOI 10.1016/S0022-5347(17)47248-X; BRINDLEY GS, 1983, BRIT J PSYCHIAT, V143, P332, DOI 10.1192/bjp.143.4.332; BUCH PA, 1992, J UROLOGY, V147, P1650; BUVAT J, 1989, J UROLOGIE, V95, P89; BUVAT J, 1989, J UROLOGIE, V95, P33; CARTWRIGHT RG, 1990, BRIT J CLIN PHARMACO, V29, P533, DOI 10.1111/j.1365-2125.1990.tb03676.x; CAVALLINI G, 1991, J UROLOGY, V146, P50, DOI 10.1016/S0022-5347(17)37712-1; CLASS H, 1989, UROL INT, V44, P309; CONNER D P, 1989, Skin Pharmacology, V2, P153; DONATUCCI GF, 1993, PENIS, P20; GASSER TC, 1987, J UROLOGY, V137, P678, DOI 10.1016/S0022-5347(17)44172-3; GERBER GS, 1991, J UROLOGY, V146, P786, DOI 10.1016/S0022-5347(17)37921-1; GILMAN AG, 1990, PHARMACOL BASIS THER, P939; GIRDLEY FM, 1988, J UROLOGY, V140, P972, DOI 10.1016/S0022-5347(17)41902-1; GOMAA AA, 1994, J EGYPTIAN ACAD SCI, V145, P150; GOMAA AA, 1994, EUR J CLIN PHARMACOL, V47, pA101; HANDLER CE, 1985, INT J CARDIOL, V7, P149, DOI 10.1016/0167-5273(85)90356-0; HASHMAT AI, 1993, PENIS, P222; HEATON JPW, 1990, J UROLOGY, V143, P729, DOI 10.1016/S0022-5347(17)40074-7; KIRBY RS, 1991, IMPOTENCE DIAGNOSIS, P149; KRANE RJ, 1989, NEW ENGL J MED, V321, P1648, DOI 10.1056/NEJM198912143212406; LUE TF, 1987, J UROLOGY, V137, P829, DOI 10.1016/S0022-5347(17)44267-4; MEYHOFF HH, 1992, BRIT J UROL, V69, P88, DOI 10.1111/j.1464-410X.1992.tb15466.x; MORALES A, 1988, CONT MANAGEMENT IMPO, P178; NEGELEV S, 1990, J UROLOGY, V143, P586, DOI 10.1016/S0022-5347(17)40030-9; OWEN JA, 1989, J UROLOGY, V141, P546, DOI 10.1016/S0022-5347(17)40888-3; SIDI AA, 1986, J UROLOGY, V135, P704, DOI 10.1016/S0022-5347(17)45825-3; VIRAG R, 1984, ANGIOLOGY, V35, P79, DOI 10.1177/000331978403500203; WALTERS GR, 1988, BR J UROL, V62, P143	31	23	26	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 15	1996	312	7045					1512	1515		10.1136/bmj.312.7045.1512	http://dx.doi.org/10.1136/bmj.312.7045.1512			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR823	8646143	Green Published			2022-12-28	WOS:A1996UR82300021
J	Pearson, N; Brien, JO; Thomas, H; Ewings, P; Gallier, L; Bussey, A				Pearson, N; Brien, JO; Thomas, H; Ewings, P; Gallier, L; Bussey, A			Collecting morbidity data in general practice: The Somerset Morbidity Project	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective-To collect a valid, complete, continuous, and representative database of morbidity presenting to primary care and to use the data to help commission services on the basis of local need and effectiveness. Setting-Computerised general practices in Somerset. Methods-Participating general practices were selected to be representative of the district health authority population for general practice and population characteristics. All conditions presented at face to face consultations were assigned a Read code and episode type and the data were regularly validated. Data were sent by modem from the practices via a third party to the health authority each week. Main outcome measures-Proportion of consultations coded and accuracy of coding. Results-11 practices agreed to participate. Validations for completeness during April 1994 to March 1995 revealed that 96.4% of the records were coded; 94% of the 1090 records validated had appropriate episode types and 87% appropriate Read codes. The results have been used to help formulate the health authority's purchasing plans and have enabled a change in the local contracts for surgery for glue ear. Conclusions-The project has shown the feasibility of establishing a network of practices recording and reporting the morbidity seen in primary care. Early indications are that the data can be useful in evidence based purchasing.	KING EDWARD RD SURG, MINEHEAD, SOMERSET, ENGLAND		Pearson, N (corresponding author), SOMERSET HLTH AUTHOR, TAUNTON TA2 7PQ, SOMERSET, ENGLAND.							BOYDELL L, 1995, J EPIDEMIOL COMMUN H, V49, P22, DOI 10.1136/jech.49.Suppl_1.22; *DEP GEN PRACT, 1993, 1992 1993 DEP GEN PR; FLAMING DM, 1991, ANNUAL SEASONAL VARI; GRAY DP, 1991, ANNUAL SEASONAL VARI; KISH L, 1965, SURVEY SAMPLING, P187; LOGAN WPD, 1958, GEN STUDIES MED POPU, V14; MCCORMICK A, 1995, MORBIDITY STAT GEN P; PRINGLE M, 1991, BMJ-BRIT MED J, V302, P741, DOI 10.1136/bmj.302.6779.741; *ROYAL COLL GEN PR, 1974, STUD MED POP SUBJ, V26; Royal College of General Practitioners, 1986, MORB STAT GEN PRACT; SMITH N, 1995, BRIT MED J, V311, P313, DOI 10.1136/bmj.311.7000.313; WILSON AE, 1995, J EPIDEMIOL COMMUN H, V49, P227, DOI 10.1136/jech.49.3.227; 1992, EFFECTIVE HLTH CARE, V4, P3	13	37	37	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	1996	312	7045					1517	1520		10.1136/bmj.312.7045.1517	http://dx.doi.org/10.1136/bmj.312.7045.1517			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR823	8646146	Green Published			2022-12-28	WOS:A1996UR82300024
J	Roberts, I				Roberts, I			Safely to school?	LANCET			English	Editorial Material											Roberts, I (corresponding author), INST CHILD HLTH,DEPT EPIDEMIOL,CHILD HLTH MONITORING UNIT,LONDON WC1N 1EH,ENGLAND.							CHINN S, 1994, PAEDIATR PERINAT EP, V8, P90, DOI 10.1111/j.1365-3016.1994.tb00438.x; *DEP TRANSP, 1995, TRANSP STAT REP; Department of Health, 1996, STRAT STAT PHYS ACT; PRENTICE AM, 1995, BRIT MED J, V311, P437, DOI 10.1136/bmj.311.7002.437; Preston B., 1992, CUTTING PEDESTRIAN C; ROBERTS I, 1995, EPIDEMIOLOGY, V6, P169, DOI 10.1097/00001648-199503000-00014; WOODROFFE C, 1993, CHILDREN TEENAGERS H	7	19	19	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 15	1996	347	9016					1642	1642		10.1016/S0140-6736(96)91483-X	http://dx.doi.org/10.1016/S0140-6736(96)91483-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ701	8642954				2022-12-28	WOS:A1996UQ70100006
J	Yamatsuji, T; Matsui, T; Okamoto, T; Komatsuzaki, K; Takeda, S; Fukumoto, H; Iwatsubo, T; Suzuki, N; AsamiOdaka, A; Ireland, S; Kinane, TB; Giambarella, U; Nishimoto, I				Yamatsuji, T; Matsui, T; Okamoto, T; Komatsuzaki, K; Takeda, S; Fukumoto, H; Iwatsubo, T; Suzuki, N; AsamiOdaka, A; Ireland, S; Kinane, TB; Giambarella, U; Nishimoto, I			G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP	SCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; MISSENSE MUTATION; ALPHA-SUBUNIT; GENE; CELLS; APOPTOSIS; INDUCTION; DEATH	Missense mutations in the 595-amino acid form of the amyloid precursor protein (APP(695)) cosegregate with disease phenotype in families with dominantly inherited Alzheimer's disease. These mutations convert valine at position 642 to isoleucine, phenylalanine, or glycine. Expression of these mutant proteins, but not of normal APP(695), was shown to induce nucleosomal DNA fragmentation in neuronal cells. Induction of DNA fragmentation required the cytoplasmic domain of the mutants and appeared to be mediated by heterotrimeric guanosine triphosphate-binding proteins (G proteins).	HARVARD UNIV,SCH MED,MASSACHUSETTS GEN HOSP,CARDIVASC RES CTR,DEPT MED,CHARLESTOWN,MA 02129; UNIV TOKYO,FAC PHARMACEUT SCI,DEPT NEUROPATHOL & NEUROSCI,BUNKYO KU,TOKYO 113,JAPAN; TAKEDA CHEM IND LTD,TSUKUBA,IBARAKI 30042,JAPAN; ONCOR INC,GAITHERSBURG,MD 20877; HARVARD UNIV,SCH MED,MASSACHUSETTS GEN HOSP,DEPT PEDIAT,RENAL UNIT,CHARLESTOWN,MA 02129	Harvard University; Massachusetts General Hospital; University of Tokyo; Takeda Chemical Industries; Harvard University; Massachusetts General Hospital								ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CORRE I, 1995, BLOOD, V86, P1776, DOI 10.1182/blood.V86.5.1776.bloodjournal8651776; DRAGUNOW M, 1995, NEUROREPORT, V6, P1053, DOI 10.1097/00001756-199505090-00026; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HARDY J, 1992, NAT GENET, V1, P233, DOI 10.1038/ng0792-233; HERMOUET S, 1991, P NATL ACAD SCI USA, V88, P10455, DOI 10.1073/pnas.88.23.10455; IGARASHI M, 1993, SCIENCE, V259, P77, DOI 10.1126/science.8418498; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JOFFE I, 1993, CALCIFIED TISSUE INT, V53, P45, DOI 10.1007/BF01352014; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KARLINSKY H, 1992, NEUROLOGY, V42, P1445, DOI 10.1212/WNL.42.8.1445; KATZMAN R, 1986, NEW ENGL J MED, V314, P964, DOI 10.1056/NEJM198604103141506; KINANE TB, 1993, J BIOL CHEM, V268, P24669; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LANG J, 1995, EMBO J, V14, P3635, DOI 10.1002/j.1460-2075.1995.tb00033.x; LASSMANN H, 1995, ACTA NEUROPATHOL, V89, P35, DOI 10.1007/BF00294257; LEE VMY, 1986, J NEUROSCI, V6, P514; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; OKAMOTO T, 1995, J BIOL CHEM, V270, P4205, DOI 10.1074/jbc.270.9.4205; PLATIKA D, 1985, P NATL ACAD SCI USA, V82, P3499, DOI 10.1073/pnas.82.10.3499; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; SANDBRINK R, 1994, J BIOL CHEM, V269, P1510; SLEPAK VZ, 1993, J BIOL CHEM, V268, P1414; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; SU JH, 1994, NEUROREPORT, V5, P2529, DOI 10.1097/00001756-199412000-00031; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; YAMATSUJI T, UNPUB; YOSHIOKA K, 1991, BIOCHEM BIOPH RES CO, V178, P1141, DOI 10.1016/0006-291X(91)91011-Z; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	40	218	229	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1349	1352		10.1126/science.272.5266.1349	http://dx.doi.org/10.1126/science.272.5266.1349			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8650548				2022-12-28	WOS:A1996UN47200050
J	FergusonMiller, S				FergusonMiller, S			Update - Mammalian cytochrome c oxidase, a molecular monster subdued	SCIENCE			English	Editorial Material																		CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; FETTER JR, 1995, P NATL ACAD SCI USA, V92, P1604, DOI 10.1073/pnas.92.5.1604; GARCIAHORSMAN JA, 1995, BIOCHEMISTRY-US, V34, P4428, DOI 10.1021/bi00013a035; GENNIS R, 1995, SCIENCE, V269, P1063, DOI 10.1126/science.7652553; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; KADENBACH B, 1983, ANAL BIOCHEM, V129, P517, DOI 10.1016/0003-2697(83)90586-9; ROBINSON N, 1977, BIOCHEMISTRY-US, V16, P380; ROBINSON NC, 1993, J BIOENERG BIOMEMBR, V25, P153, DOI 10.1007/BF00762857; SUAREZ MD, 1984, J BIOL CHEM, V259, P3791; THOMPSON DA, 1983, BIOCHEMISTRY-US, V22, P3178, DOI 10.1021/bi00282a022; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; WILSON MT, 1980, J BIOL CHEM, V255, P2722	13	7	7	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 24	1996	272	5265					1125	1125		10.1126/science.272.5265.1125	http://dx.doi.org/10.1126/science.272.5265.1125			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8638156				2022-12-28	WOS:A1996UM88900037
J	Poirier, GE; Pylant, ED				Poirier, GE; Pylant, ED			The self-assembly mechanism of alkanethiols on Au(111)	SCIENCE			English	Article							SCANNING TUNNELING MICROSCOPY; N-ALKANETHIOLS; MONOLAYERS; GOLD; SURFACE; SPECTROSCOPY; ADSORPTION; THIOLS	The self-assembly mechanism of alkanethiol monolayers on the (111) surface of gold was discovered with the use of an ultrahigh-vacuum scanning tunneling microscope. Monolayer formation follows a two-step process that begins with condensation of low-density crystalline islands, characterized by surface-aligned molecular axes, from a lower density lattice-gas phase. At saturation coverage of this phase, the monolayer undergoes a phase transition to a denser phase by realignment of the molecular axes with the surface normal. These studies reveal the important role of molecule-substrate and molecule-molecule interactions in the self-assembly of these technologically important material systems.	UNIV TEXAS,DEPT CHEM & BIOCHEM,AUSTIN,TX 78712; NATL INST STAND & TECHNOL,GAITHERSBURG,MD 20899	University of Texas System; University of Texas Austin; National Institute of Standards & Technology (NIST) - USA								Adam NK, 1922, P R SOC LOND A-CONTA, V101, P516, DOI 10.1098/rspa.1922.0063; BAIN CD, 1989, J AM CHEM SOC, V111, P7164, DOI 10.1021/ja00200a040; BLACKMAN LCF, 1957, J CHEM SOC, P162, DOI 10.1039/jr9570000162; BUCK M, 1992, J VAC SCI TECHNOL A, V10, P926, DOI 10.1116/1.577879; CAMILLONE N, 1993, J CHEM PHYS, V98, P3503, DOI 10.1063/1.464071; CAMILLONE N, IN PRESS LANGMUIR; CHAILAPAKUL O, 1993, J AM CHEM SOC, V115, P12459, DOI 10.1021/ja00079a029; CHAMBLISS DD, 1991, J VAC SCI TECHNOL B, V9, P933, DOI 10.1116/1.585498; DIMILLA PA, 1994, J AM CHEM SOC, V116, P2225, DOI 10.1021/ja00084a105; DUBOIS LH, 1992, ANNU REV PHYS CHEM, V43, P437, DOI 10.1146/annurev.pc.43.100192.002253; EDINGER K, 1993, LANGMUIR, V9, P4, DOI 10.1021/la00025a002; FENTER P, 1994, SCIENCE, V266, P1216, DOI 10.1126/science.266.5188.1216; HAHNER G, 1993, LANGMUIR, V9, P1955; Harkins WD, 1941, J PHYS CHEM-US, V45, P20, DOI 10.1021/j150406a003; HAUSSLING L, 1991, MAKROMOL CHEM-M SYMP, V46, P145, DOI 10.1002/masy.19910460118; KARPFEN A, 1981, J CHEM PHYS, V75, P238, DOI 10.1063/1.441831; KARPOVICH DS, 1994, LANGMUIR, V10, P3315, DOI 10.1021/la00021a066; PALLAS NR, 1985, LANGMUIR, V1, P509, DOI 10.1021/la00064a019; POIRIER GE, 1995, J PHYS CHEM-US, V99, P10966, DOI 10.1021/j100027a042; POIRIER GE, 1994, LANGMUIR, V10, P2853, DOI 10.1021/la00021a001; POIRIER GE, IN PRESS J CHEM PHYS; SANDY AR, 1991, PHYS REV B, V43, P4667, DOI 10.1103/PhysRevB.43.4667; SELLERS H, 1993, J AM CHEM SOC, V70, P2447; STROSCIO JA, 1992, J VAC SCI TECHNOL A, V10, P1981, DOI 10.1116/1.578013; THOMAS RC, 1991, LANGMUIR, V7, P620, DOI 10.1021/la00052a004; WOLF C, 1989, PHYS REV B, V39, P7988; ZINKEALLMANG M, 1992, SURF SCI REP, V16, P378; ZUBRAGEL C, 1994, CHEM PHYS LETT, V219, P127, DOI 10.1016/0009-2614(94)00057-3	28	749	756	3	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 24	1996	272	5265					1145	1148		10.1126/science.272.5265.1145	http://dx.doi.org/10.1126/science.272.5265.1145			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8662446				2022-12-28	WOS:A1996UM88900041
J	Graff, JM; Bansal, A; Melton, DA				Graff, JM; Bansal, A; Melton, DA			Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily	CELL			English	Article							BONE MORPHOGENETIC PROTEIN-4; MESODERM-INDUCING ACTIVITY; VENTRALIZING FACTOR; AXIAL MESODERM; EARLY RESPONSE; INDUCTION; EMBRYOS; RNA; EXPRESSION; EMBRYOGENESIS	Xenopus cDNAs homologous to the Drosophila Mad gene and C. elegans CEM genes have been cloned and functionally analyzed by microinjection into frog embryos. The results show that these genes (Xmad) encode intracellular proteins that act downstream of TGF beta superfamily ligands. Most interesting is the fact that different Xmad proteins produce distinct biological responses. Xmad1 produces ventral mesoderm, apparently transducing a signal for BMP2 and BMP4, whereas Xmad2 induces dorsal mesoderm like Vg1, activin, and nodal. These results suggest that an individual Xmad protein waits poised in the cytoplasm for instruction from a distinct subset of TGF beta ligands and then conveys specific information to the nucleus.	HARVARD UNIV,HOWARD HUGHES MED INST,DEPT MOLEC & CELLULAR BIOL,CAMBRIDGE,MA 02138	Harvard University; Howard Hughes Medical Institute			Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647				AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; CHEN RH, 1995, NATURE, V377, P548, DOI 10.1038/377548a0; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; DALE L, 1993, EMBO J, V12, P4471, DOI 10.1002/j.1460-2075.1993.tb06136.x; DALE L, 1992, DEVELOPMENT, V115, P573; DERYNCK R, 1994, TRENDS BIOCHEM SCI, V19, P548, DOI 10.1016/0968-0004(94)90059-0; EVANS JP, 1991, METHOD CELL BIOL, V36, P133; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; GREEN JBA, 1990, DEVELOPMENT, V108, P173; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; HEMMATIBRIVANLOU A, 1995, DEV GENET, V17, P78, DOI 10.1002/dvg.1020170109; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; JONES CM, 1992, DEVELOPMENT, V115, P639; JONES CM, 1995, DEVELOPMENT, V121, P3651; KESSLER DS, 1995, DEVELOPMENT, V121, P2155; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; KINTNER CR, 1987, DEVELOPMENT, V99, P311; KOSTER M, 1991, MECH DEVELOP, V33, P191, DOI 10.1016/0925-4773(91)90027-4; KRIEG PA, 1989, DEV BIOL, V133, P93, DOI 10.1016/0012-1606(89)90300-X; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; MATHEWS LS, 1994, ENDOCR REV, V15, P310, DOI 10.1210/er.15.3.310; MOHUN TJ, 1984, NATURE, V311, P716, DOI 10.1038/311716a0; NEWFELD SJ, 1996, IN PRESS DEVELOPMENT; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; PIERCE SB, 1995, DEVELOPMENT, V121, P755; RAFTERY LA, 1995, GENETICS, V139, P241; REBAGLIATI MR, 1985, CELL, V42, P769, DOI 10.1016/0092-8674(85)90273-9; ROSA F, 1988, SCIENCE, V239, P783, DOI 10.1126/science.3422517; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; SAVAGE C, 1996, P NATL ACAD SCI USA, V93, P7790; SCHMIDT JE, 1995, DEV BIOL, V169, P37, DOI 10.1006/dbio.1995.1124; SCHULTEMERKER S, 1994, EMBO J, V13, P3533, DOI 10.1002/j.1460-2075.1994.tb06660.x; SEKELSKY JJ, 1995, GENETICS, V139, P1347; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; SMITH LD, 1991, METHOD CELL BIOL, V36, P45; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; SOKOL SY, 1995, DEVELOPMENT, V121, P1637; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; THOMSEN G, 1990, CELL, V63, P485, DOI 10.1016/0092-8674(90)90445-K; THOMSEN GH, 1993, CELL, V74, P433, DOI 10.1016/0092-8674(93)80045-G; UMBHAUER M, 1995, NATURE, V376, P58, DOI 10.1038/376058a0; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; WALL NA, 1994, CURR OPIN GENET DEV, V4, P517, DOI 10.1016/0959-437X(94)90066-C; WANG TW, 1994, SCIENCE, V265, P674, DOI 10.1126/science.7518616; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; WILSON PA, 1994, CURR BIOL, V4, P676, DOI 10.1016/S0960-9822(00)00152-4; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	56	396	409	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 17	1996	85	4					479	487		10.1016/S0092-8674(00)81249-0	http://dx.doi.org/10.1016/S0092-8674(00)81249-0			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UM415	8653784	Bronze			2022-12-28	WOS:A1996UM41500006
J	Tsang, SH; Gouras, P; Yamashita, CK; Kjeldbye, H; Fisher, J; Farber, DB; Goff, SP				Tsang, SH; Gouras, P; Yamashita, CK; Kjeldbye, H; Fisher, J; Farber, DB; Goff, SP			Retinal degeneration in mice lacking the gamma subunit of the rod cGMP phosphodiesterase	SCIENCE			English	Article							CYCLIC-GMP PHOSPHODIESTERASE; DOMINANT RETINITIS-PIGMENTOSA; BETA-SUBUNIT; OUTER SEGMENTS; RHODOPSIN MUTATIONS; PHOTORECEPTOR CELLS; NONSENSE MUTATION; MOUSE RETINA; G-PROTEIN; RDS GENE	The retinal cyclic guanosine 3',5'-monophosphate (cGMP) phosphodiesterase (PDE) is a key regulator of phototransduction in the vertebrate visual system, PDE consists of a catalytic core of alpha and beta subunits associated with two inhibitory gamma subunits. A gene-targeting approach was used to disrupt the mouse PDE gamma gene, This mutation resulted in a rapid retinal degeneration resembling human retinitis pigmentosa. In homozygous mutant mice, reduced rather than increased PDE activity was apparent; the PDE alpha beta dimer was formed but lacked hydrolytic activity, Thus, the inhibitory gamma subunit appears to be necessary for integrity of the photoreceptors and expression of PDE activity in vivo.	COLUMBIA UNIV COLL PHYS & SURG,DEPT BIOCHEM & MOLEC BIOPHYS,HOWARD HUGHES MED INST,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT OPHTHALMOL,EDWARD HARKNESS EYE INST,NEW YORK,NY 10032; UNIV CALIF LOS ANGELES,SCH MED,JULES STEIN EYE INST,INST MOLEC BIOL,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,SCH MED,DEPT OPHTHALMOL,LOS ANGELES,CA 90095	Columbia University; Howard Hughes Medical Institute; Columbia University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA			Goff, Stephen P/K-6337-2014	Goff, Stephen P/0000-0003-0693-5547; Farber, Debora/0000-0002-3207-697X	NEI NIH HHS [R01 EY008285, K08 EY000408, K08 EY000408-01, EY08285] Funding Source: Medline; NIGMS NIH HHS [T32 GM 073667-14] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008285, K08EY000408] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARSHAVSKY VY, 1992, NATURE, V357, P416, DOI 10.1038/357416a0; BAEHR W, 1979, J BIOL CHEM, V254, P1669; BAYES M, 1995, HUM MUTAT, V5, P228, DOI 10.1002/humu.1380050307; BOWES C, 1993, P NATL ACAD SCI USA, V90, P2955, DOI 10.1073/pnas.90.7.2955; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; DANCIGER M, 1995, GENOMICS, V3, P1; DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; FARBER DB, 1976, J CYCLIC NUCL PROT, V2, P139; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; FARBER DB, 1992, NEURON, V9, P349, DOI 10.1016/0896-6273(92)90173-B; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; FUNG BKK, 1990, BIOCHEMISTRY-US, V29, P2657, DOI 10.1021/bi00463a006; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; GILLESPIE PG, 1989, J BIOL CHEM, V264, P12187; GOURAS P, 1994, INVEST OPHTH VIS SCI, V35, P3145; HANH LB, 1994, INVEST OPHTH VIS SCI, V35, P1077; HUANG SH, 1995, INVEST OPHTH VIS SCI, V36, pS825; HUMPHRIES P, 1992, SCIENCE, V256, P804, DOI 10.1126/science.1589761; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; KROLL S, 1989, J BIOL CHEM, V264, P4490; KUHN H, 1981, BIOCHEMISTRY-US, V20, P2410; LIPKIN VM, 1988, FEBS LETT, V234, P287, DOI 10.1016/0014-5793(88)80100-5; MCINNES RR, 1992, NAT GENET, V1, P155, DOI 10.1038/ng0692-155; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; MIKI N, 1975, J BIOL CHEM, V250, P6320; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Papaioannou V., 1993, Gene targeting: a practical approach., P107; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; RAY K, 1994, INVEST OPHTH VIS SCI, V35, P4291; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; SHEFFIELD VC, 1991, AM J HUM GENET, V49, P699; SITARAMAYYA A, 1986, BIOCHEMISTRY-US, V25, P651, DOI 10.1021/bi00351a021; SKIBA NP, 1995, J BIOL CHEM, V270, P13210, DOI 10.1074/jbc.270.22.13210; STRYER L, 1991, J BIOL CHEM, V266, P10711; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; TAKEMOTO DJ, 1992, BIOCHEM J, V281, P637, DOI 10.1042/bj2810637; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G; TSANG S, UNPUB; TUTEJA N, 1988, FEBS LETT, V232, P182, DOI 10.1016/0014-5793(88)80413-7; WENSEL T G, 1986, Proteins Structure Function and Genetics, V1, P90, DOI 10.1002/prot.340010114; YAMAMOTO S, 1993, INVEST OPHTH VIS SCI, V34, P3068; YARFITZ S, 1994, J BIOL CHEM, V269, P14329; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9	49	148	151	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 17	1996	272	5264					1026	1029		10.1126/science.272.5264.1026	http://dx.doi.org/10.1126/science.272.5264.1026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL619	8638127	Green Accepted			2022-12-28	WOS:A1996UL61900050
J	Houk, KN; Nakamura, K; Sheu, CM; Keating, AE				Houk, KN; Nakamura, K; Sheu, CM; Keating, AE			Gating as a control element in constrictive binding and guest release by hemicarcerands	SCIENCE			English	Article							PROTEINS; COMPLEXATION	Theoretical modeling of the dynamics of complexation and decomplexation of guest molecules by container molecules reveals that gating has a critical influence on the ease of formation and stability of host-guest complexes. Hosts equipped with gates can form very stable complexes with a variety of guests under readily achievable conditions. Gating involves conformational processes of the host molecule that alter the size of the portals through which guest molecules pass. ''French door'' and ''sliding door'' mechanisms of gate opening are identified.			Houk, KN (corresponding author), UNIV CALIF LOS ANGELES,DEPT CHEM & BIOCHEM,LOS ANGELES,CA 90095, USA.			Keating, Amy/0000-0003-4074-8980				BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; BYUN YS, 1995, J CHEM SOC CHEM COMM, P1825, DOI 10.1039/c39950001825; CHAPMAN RG, 1994, J AM CHEM SOC, V116, P369, DOI 10.1021/ja00080a042; Cram D.J., 1994, CONTAINER MOL THEIR, DOI 10.1039/9781847550620-00107; CRAM DJ, 1992, J AM CHEM SOC, V114, P7765, DOI 10.1021/ja00046a023; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Frisch M.J., GAUSSIAN; Kirchhoff PD, 1996, J AM CHEM SOC, V118, P3237, DOI 10.1021/ja953772h; LAM PYS, 1994, SCIENCE, V263, P380, DOI 10.1126/science.8278812; MCCAMMON JA, 1981, NATURE, V293, P316, DOI 10.1038/293316a0; MEISSNER RS, 1995, SCIENCE, V270, P1485, DOI 10.1126/science.270.5241.1485; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; NAKAMURA K, 1995, J AM CHEM SOC, V117, P1853, DOI 10.1021/ja00111a033; NORTHRUP SH, 1982, J PHYS CHEM-US, V86, P2314, DOI 10.1021/j100210a014; NORTHRUP SH, 1984, J AM CHEM SOC, V106, P930, DOI 10.1021/ja00316a018; ROBBINS TA, 1995, J CHEM SOC CHEM COMM, P1515; SHERMAN JC, 1991, J AM CHEM SOC, V113, P2194, DOI 10.1021/ja00006a043; SHEU C, IN PRESS J AM CHEM S; WADE RC, 1993, BIOPHYS J, V63, P9; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051	21	95	96	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 2	1996	273	5275					627	629		10.1126/science.273.5275.627	http://dx.doi.org/10.1126/science.273.5275.627			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VA249	8662548				2022-12-28	WOS:A1996VA24900040
J	Samuel, D				Samuel, D			Investigation of ancient Egyptian baking and brewing methods by correlative microscopy	SCIENCE			English	Article							SCANNING ELECTRON-MICROSCOPY; STARCH	Ancient Egyptian methods of baking and brewing are investigated by optical and scanning electron microscopy of desiccated bread loaves and beer remains. The results suggest that current conceptions about ancient Egyptian bread and beer making should be modified. Bread was made not only with flour from raw grain, but sometimes also with malt and with yeast. Brewing blended cooked and uncooked malt with water; the mixture was strained free of husk before inoculation with yeast.			Samuel, D (corresponding author), UNIV CAMBRIDGE, MCDONALD INST ARCHAEOL RES, DOWNING ST, CAMBRIDGE CB2 3ER, ENGLAND.							Darby W, 1977, FOOD GIFT OSIRIS, V2; DRENKHAHN R, 1975, LEXIKON AGYPTOLOGIE, V1, P871; DRONZEK BL, 1972, CEREAL CHEM, V49, P232; FALTINGS D, 1991, Z AEGYPT SPRACHE ALT, V115, P104; GRUSS J, 1929, TAGESZTG BRAU, V26, P679; GRUSS J, 1928, TAGESZTG BRAU, V26, P1123; GRUSS J, 1929, TAGESZTG BRAU, V27, P517; GRUSS J, 1929, TAGESZTG BRAU, V27, P275; HELCK W, 1971, BIER ALTEN AEGYPTEN; HELCK W., 1975, LEXIKON AGYPTOLOGIE, VI, P789; HOSENEY RC, 1977, CEREAL FOOD WORLD, V22, P56; KAWABATA A, 1994, STARCH-STARKE, V46, P463, DOI 10.1002/star.19940461204; NIMS CF, 1958, J EGYPT ARCHAEOL, V44, P56; PALMER GH, 1972, J I BREWING, V78, P326, DOI 10.1002/j.2050-0416.1972.tb03456.x; ROCKLAND LB, 1977, J FOOD SCI, V42, P1204, DOI 10.1111/j.1365-2621.1977.tb14460.x; ROCKLAND LB, 1977, J FOOD SCI, V42, P1212; Samuel D, 1996, J AM SOC BREW CHEM, V54, P3; Samuel D., 1995, Brewers' Guardian, V124, P26; Samuel D., 1994, EGYPTIAN ARCHAEOLOGY, V4, P9; Samuel D., 1993, CAMB ARCHAEOL J, V3, P276, DOI [10.1017/S0959774300000883, DOI 10.1017/S0959774300000883]; Strouhal E., 1992, LIFE ANCIENT EGYPT; SUN Z, 1990, PLANT PHYSIOL, V94, P320, DOI 10.1104/pp.94.1.320; Wilson H., 1988, EGYPTIAN FOOD DRINK; WINLOCK H. E., 1932, TOMB QUEEN MERYET AM; Wittmack L., 1905, T ACAD SCI ST LOUIS, V15, P1	25	99	100	5	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	1996	273	5274					488	490		10.1126/science.273.5274.488	http://dx.doi.org/10.1126/science.273.5274.488			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	UY983	8662535				2022-12-28	WOS:A1996UY98300037
J	Kurtzberg, J; Laughlin, M; Graham, ML; Smith, C; Olson, JF; Halperin, EC; Ciocci, G; Carrier, C; Stevens, CE; Rubinstein, P				Kurtzberg, J; Laughlin, M; Graham, ML; Smith, C; Olson, JF; Halperin, EC; Ciocci, G; Carrier, C; Stevens, CE; Rubinstein, P			Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW TRANSPLANTATION; UMBILICAL-CORD BLOOD; SEVERE APLASTIC-ANEMIA; TOTAL-BODY IRRADIATION; VERSUS-HOST DISEASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; FANCONIS ANEMIA; CYCLOPHOSPHAMIDE; MELPHALAN; RECONSTITUTION	Background Transplantation of bone marrow from unrelated donors is limited by a lack of HLA-matched donors and the risk of graft-versus-host disease (GVHD). Placental blood from sibling donors can reconstitute hematopoiesis. We report preliminary results of transplantation using partially HLA-mismatched placental blood from unrelated donors. Methods Twenty-five consecutive patients, primarily children, with a variety of malignant and nonmalignant conditions received placental blood from unrelated donors and were evaluated for hematologic and immunologic reconstitution and GVHD. HLA matching was performed before transplantation by serologic typing for class I HLA antigens and low-resolution molecular typing for class II HLA alleles. In donor-recipient pairs who differed by no more than one HLA antigen or allele, high-resolution class II HLA typing was done retrospectively. For donor-recipient pairs who were mismatched for two HLA antigens or alleles, high-resolution typing was used prospectively to select the best match for HLA-DRB1. Results Twenty-four of the 25 donor-recipient pairs were discordant for one to th ree HCA antigens. In 23 of the 25 transplant recipients, the infused hematopoietic stem cells engrafted. Acute grade III GVHD occurred in 2 of the 21 patients who could be evaluated, and 2 patients had chronic GVHD. In vitro proliferative responses of T cells and B cells to plant mitogens were detected 60 days after transplantation. With a median follow-up of 12 1/2 months and a minimal follow-up of 100 days, the overall 100-day survival rate among these patients was 64 percent, and the overall event-free survival was 48 percent. Conclusions HLA-mismatched placental blood from unrelated donors is an alternative source of stem cells for hematopoietic reconstitution in children. (C) 1996, Massachusetts Medical Society.	NEW YORK BLOOD CTR,PLACENTAL BLOOD PROGRAM,NEW YORK,NY 10021	New York Blood Center	Kurtzberg, J (corresponding author), DUKE UNIV,MED CTR,PEDIAT BONE MARROW TRANSPLANT PROGRAM,BOX 3350,DURHAM,NC 27710, USA.				NHLBI NIH HHS [1R18-HL48031] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R18HL048031] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALCAREK KB, 1993, J INFECT DIS, V167, P1433, DOI 10.1093/infdis/167.6.1433; BROXMEYER HE, 1991, BLOOD CELLS, V17, P282; BROXMEYER HE, 1992, P NATL ACAD SCI USA, V89, P4109, DOI 10.1073/pnas.89.9.4109; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; CAREY PJ, 1991, BLOOD, V77, P1593; CHAMPLIN RE, 1990, TRANSPLANTATION, V49, P720, DOI 10.1097/00007890-199004000-00013; CHAO NJ, 1993, NEW ENGL J MED, V329, P1225, DOI 10.1056/NEJM199310213291703; COHEN F, 1965, AM J OBSTET GYNECOL, V93, P566, DOI 10.1016/0002-9378(65)90517-X; EMANUEL D, 1988, ANN INTERN MED, V109, P777, DOI 10.7326/0003-4819-109-10-777; GABUTTI V, 1993, BONE MARROW TRANSPL, V12, P84; Gandola L, 1990, Radiother Oncol, V18 Suppl 1, P105, DOI 10.1016/0167-8140(90)90186-Z; GLUCKMAN E, 1991, BLOOD, V78, P2451; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; GLUCKMAN E, 1993, STEM CELLS, V11, P180; HIRAO A, 1994, EXP HEMATOL, V22, P521; HOWARD MR, 1994, BONE MARROW TRANSPL, V13, P389; HOWS JM, 1992, LANCET, V340, P73, DOI 10.1016/0140-6736(92)90396-K; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KEATING A, 1992, LEUKEMIA, V6, P90; KERNAN NA, 1993, NEW ENGL J MED, V328, P593, DOI 10.1056/NEJM199303043280901; KURTZBERG J, 1994, BLOOD CELLS, V20, P275; LU L, 1993, BLOOD, V81, P41; MCGLAVE PB, 1987, BLOOD, V70, P1325; MIGLIACCIO G, 1992, BLOOD, V79, P2620; OREILLY RJ, 1973, TRANSPLANTATION, V15, P505; PEACOCK JE, 1995, BONE MARROW TRANSPL, V15, P983; PHILLIPS GL, 1991, J CLIN ONCOL, V9, P1880, DOI 10.1200/JCO.1991.9.10.1880; POLLACK MS, 1982, NEW ENGL J MED, V307, P662, DOI 10.1056/NEJM198209093071106; POLLACK MS, 1980, TRANSPLANTATION, V30, P331, DOI 10.1097/00007890-198011000-00004; POWLES RL, 1989, TRANSPLANT P, V21, P2955; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; RISDON G, 1994, CELL IMMUNOL, V154, P14, DOI 10.1006/cimm.1994.1053; RUBINSTEIN P, 1995, P NATL ACAD SCI USA, V92, P10119, DOI 10.1073/pnas.92.22.10119; RUBINSTEIN P, 1993, BLOOD, V81, P1679; RUSSELL S, 1992, TRANSPLANT P, V24, P183; SAMUELS BL, 1995, J CLIN ONCOL, V13, P1786, DOI 10.1200/JCO.1995.13.7.1786; SCHROEDER H, 1991, BONE MARROW TRANSPL, V7, P11; STORB R, 1991, BLOOD, V78, P1144, DOI 10.1182/blood.V78.4.1144.bloodjournal7841144; STORB R, 1990, BLOOD, V76, P1037; STORB R, 1984, SEMIN HEMATOL, V21, P27; Vilmer E, 1991, Bone Marrow Transplant, V7 Suppl 2, P125; WAGNER JE, 1995, LANCET, V346, P214, DOI 10.1016/S0140-6736(95)91268-1; WANG XH, 1987, AM J CLIN PATHOL, V88, P346, DOI 10.1093/ajcp/88.3.346; WINGARD JR, 1992, BLOOD, V79, P1068	44	853	916	0	20	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	1996	335	3					157	166		10.1056/NEJM199607183350303	http://dx.doi.org/10.1056/NEJM199607183350303			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW790	8657213				2022-12-28	WOS:A1996UW79000003
J	Shao, XG; Davletov, BA; Sutton, RB; Sudhof, TC; Rizo, J				Shao, XG; Davletov, BA; Sutton, RB; Sudhof, TC; Rizo, J			Bipartite Ca2+-binding motif in C-2 domains of synaptotagmin and protein kinase C	SCIENCE			English	Article							PHOSPHOLIPID-BINDING; ACTIVATION	C-2 domains are found in many proteins involved in membrane traffic or signal transduction. Although C-2 domains are thought to bind calcium ions, the structural basis for calcium binding is unclear. Analysis of calcium binding to C-2 domains of synaptotagmin I and protein kinase C-beta by nuclear magnetic resonance spectroscopy revealed a bipartite calcium-binding motif that involves the coordination of two calcium ions by five aspartate residues located on two separate loops. Sequence comparisons indicated that this may be a widely used calcium-binding motif, designated here as the C-2 motif.	UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas			Davletov, Bazbek/ABA-8569-2021	Davletov, Bazbek/0000-0003-4658-3275	NIMH NIH HHS [R01-MH52804-01] Funding Source: Medline; NINDS NIH HHS [R29 NS33731-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS033731] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; DAVLETOV BA, 1994, J BIOL CHEM, V269, P28547; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GRONENBORN AM, 1990, ANAL CHEM, V62, P2, DOI 10.1021/ac00200a003; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LUO JH, 1993, J BIOL CHEM, V268, P23580; NEWTON AC, 1993, ANNU REV BIOPH BIOM, V22, P1, DOI 10.1146/annurev.bb.22.060193.000245; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; RIZO J, 1994, J BIOMOL NMR, V4, P741, DOI 10.1007/BF00398406; SHAO XF, UNPUB; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; ULLRICH B, 1994, NEURON, V13, P1281, DOI 10.1016/0896-6273(94)90415-4; YAMAGUCHI T, 1993, J BIOL CHEM, V268, P27164; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	22	284	296	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 12	1996	273	5272					248	251		10.1126/science.273.5272.248	http://dx.doi.org/10.1126/science.273.5272.248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW787	8662510				2022-12-28	WOS:A1996UW78700044
J	Svec, F; Frechet, JMJ				Svec, F; Frechet, JMJ			New designs of macroporous polymers and supports: From separation to biocatalysis	SCIENCE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; PERFUSION CHROMATOGRAPHY; STATIONARY-PHASE; DIRECT INJECTION; PARTICLES; MEDIA; POLYMERIZATION; MATRICES; PORE	Reactive polymers play many roles, from supports for solid-phase synthesis or catalysis to media for separations. Although macroporous polymer beads that provide high reactive capacities and excellent solvent tolerance are well established, approaches to monosized beads with optimized pore structures or multiple chemistries segregated within pores of different sizes have expanded their realm of application. Polymer monoliths containing intricate pore networks can be obtained in any desired shape by a simple molding process and provide unique advantages such as fast kinetics, high reactivity, and high throughput. Applications ranging from immobilized enzyme reactors to fast media for the separation of synthetic or biopolymers are presented.	CORNELL UNIV,BAKER LAB,DEPT CHEM,ITHACA,NY 14853	Cornell University			FRECHET, Jean M/P-1497-2016; Svec, Frantisek/HDO-3774-2022	Frechet, Jean/0000-0001-6419-0163	NIGMS NIH HHS [GM 48364-02, GM 44885-05] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048364, R01GM044885] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AFEYAN NB, 1990, J CHROMATOGR, V519, P1, DOI 10.1016/0021-9673(90)85132-F; ANDERSON DJ, 1993, ANAL CHEM, V65, pR434; Barrett K. E. J., 1975, DISPERSION POLYM ORG; Bayer E., 1992, POLY ETHYLENE GLYCOL, P325; BROOKS BW, 1990, MAKROMOL CHEM-M SYMP, V35-6, P121, DOI 10.1002/masy.19900350110; CHEETHAM PSJ, 1985, HDB ENZYME BIOTECHNO, P54; CHENG CM, 1992, J POLYM SCI POL CHEM, V30, P235, DOI 10.1002/pola.1992.080300208; CHENG CM, 1992, J POLYM SCI POL CHEM, V30, P245, DOI 10.1002/pola.1992.080300209; CROUCHER MD, 1987, NATO ASI SER E, V138, P209; FRECHET JMJ, 1993, MAKROMOL CHEM-M SYMP, V70-1, P289, DOI 10.1002/masy.19930700131; FRECHET JMJ, 1981, TETRAHEDRON, V37, P663, DOI 10.1016/S0040-4020(01)97683-5; GILBERT RG, 1995, EMULSION POLYM MECH, P95; Guyot A., 1982, PROG POLYM SCI, V8, P277, DOI [10.1016/0079-6700(82)90002-8., DOI 10.1016/0079-6700(82)90002-8]; HAGEN DF, 1990, ANAL CHIM ACTA, V236, P157, DOI 10.1016/S0003-2670(00)83309-7; HAGINAKA J, 1991, TRAC-TREND ANAL CHEM, V10, P17, DOI 10.1016/0165-9936(91)85040-X; HODGE P, 1989, SYNTHESES SEPARATION; HORAK D, 1995, J POLYM SCI POL CHEM, V33, P2961, DOI 10.1002/pola.1995.080331714; HOSOYA K, 1995, ANAL CHEM, V67, P1907, DOI 10.1021/ac00107a024; HOSOYA K, 1994, J CHROMATOGR A, V666, P449, DOI 10.1016/0021-9673(94)80405-2; HOSOYA K, 1995, J CHROMATOGR A, V690, P21, DOI 10.1016/0021-9673(94)00899-K; HSIAO YL, 1995, MACROMOLECULES, V28, P8159, DOI 10.1021/ma00128a028; KENNEDY JF, 1993, POLYM INT, V32, P71, DOI 10.1002/pi.4990320112; KIM JH, 1988, CHEM ENG SCI, V43, P2025, DOI 10.1016/0009-2509(88)87079-9; Kostner A, 1976, Methods Enzymol, V44, P191; KUN KA, 1968, J POLYM SCI A1, V6, P2689, DOI 10.1002/pol.1968.150061001; LEE DP, 1988, J CHROMATOGR, V443, P143, DOI 10.1016/S0021-9673(00)94789-7; LEWANDOWSKI K, IN PRESS J LIQ CHROM; Liapis A. I., 1993, MATH MODELLING SCI C, V1, P397; MANGANARO JL, 1993, BIOTECHNOL PROGR, V9, P285, DOI 10.1021/bp00021a007; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MOORE JC, 1962, J POLYM SCI A, V2, P842; MOSBACH K, 1976, METHOD ENZYMOL; NAKAZATO K, 1994, CHROMATOGRAPHIA, V39, P655, DOI 10.1007/BF02274579; NIR A, 1977, CHEM ENG SCI, V32, P35, DOI 10.1016/0009-2509(77)80192-9; OBER CK, 1990, MAKROMOL CHEM-M SYMP, V35-6, P87, DOI 10.1002/masy.19900350108; OGINO K, 1995, J CHROMATOGR A, V699, P67, DOI 10.1016/0021-9673(95)00035-L; OGINO K, 1995, J CHROMATOGR A, V699, P59, DOI 10.1016/0021-9673(95)00031-H; OMI S, 1995, J APPL POLYM SCI, V57, P1013, DOI 10.1002/app.1995.070570814; OMI S, 1994, J APPL POLYM SCI, V51, P1, DOI 10.1002/app.1994.070510101; Petro M, 1996, BIOTECHNOL BIOENG, V49, P355, DOI 10.1002/(SICI)1097-0290(19960220)49:4<355::AID-BIT1>3.0.CO;2-O; Petro M, 1996, ANAL CHEM, V68, P315, DOI 10.1021/ac950726r; PINKERTON TC, 1991, J CHROMATOGR, V544, P13, DOI 10.1016/S0021-9673(01)83975-3; PORATH J, 1959, NATURE, V183, P1657, DOI 10.1038/1831657a0; REGNIER FE, 1991, NATURE, V350, P634, DOI 10.1038/350634a0; RODRIGUES AE, 1993, J CHROMATOGR, V653, P93; ROPER DK, 1995, J CHROMATOGR A, V702, P3, DOI 10.1016/0021-9673(95)00010-K; RUCKENSTEIN E, 1995, POLYMER, V36, P2857, DOI 10.1016/0032-3861(95)93669-D; SCHUMMER P, 1982, GERM CHEM ENG, V5, P209; SEDEREL WL, 1973, J APPL POLYM SCI, V17, P2835, DOI 10.1002/app.1973.070170920; Seidl J, 1967, ADV POLYM SCI, V5, P11; SMIGOL V, 1994, ANAL CHEM, V66, P2129, DOI 10.1021/ac00085a031; SMIGOL V, 1994, J LIQ CHROMATOGR, V17, P259, DOI 10.1080/10826079408013350; SMIGOL V, 1994, ANAL CHEM, V66, P4308, DOI 10.1021/ac00095a030; SMIGOL V, 1993, MACROMOLECULES, V26, P5615, DOI 10.1021/ma00073a013; Smith K., 1992, SOLID SUPPORTS CATAL; Snyder L.R., 1979, INTRO MODERN LIQUID, V2nd ed.; SVEC F, 1995, CHEM MATER, V7, P707, DOI 10.1021/cm00052a016; SVEC F, 1992, ANAL CHEM, V64, P820, DOI 10.1021/ac00031a022; TENNIKOVA TB, 1993, J CHROMATOGR, V646, P279, DOI 10.1016/0021-9673(93)83340-X; TERRETT NK, 1995, TETRAHEDRON, V51, P8135, DOI 10.1016/0040-4020(95)00467-M; UGELSTAD J, 1992, PROG POLYM SCI, V17, P87, DOI 10.1016/0079-6700(92)90017-S; Unger K.K., 1990, PACKINGS STATIONARY; VANDEEMTER JJ, 1956, CHEM ENG SCI, V5, P271, DOI 10.1016/0009-2509(56)80003-1; WANDERHOFF JW, 1984, J DISPERSION SCI TEC, V5, P231; WANG QC, 1993, ANAL CHEM, V65, P2243, DOI 10.1021/ac00065a013; WANG QC, 1992, ANAL CHEM, V64, P1232, DOI 10.1021/ac00035a008; WANG QC, 1994, J POLYM SCI POL CHEM, V32, P2577, DOI 10.1002/pola.1994.080321321; WINNIK FM, 1987, EUR POLYM J, V23, P617, DOI 10.1016/0014-3057(87)90007-3; YANG YQ, 1992, J CHROMATOGR, V598, P169, DOI 10.1016/0021-9673(92)85045-U; YUAN HG, 1991, J MACROMOL SCI R M C, VC31, P215, DOI 10.1080/15321799108021924	70	563	584	13	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 12	1996	273	5272					205	211		10.1126/science.273.5272.205	http://dx.doi.org/10.1126/science.273.5272.205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW787	8662498				2022-12-28	WOS:A1996UW78700032
J	Gostin, LO; Lazzarini, Z; Neslund, VS; Osterholm, MT				Gostin, LO; Lazzarini, Z; Neslund, VS; Osterholm, MT			The public health information infrastructure - A national review of the law on health information privacy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SYSTEM	Our objectives were to review and analyze the laws in the 50 states, the District of Columbia, and Puerto Pico that regulate the acquisition, storage, and use of public health data and to offer proposals for reform of the laws on public health information privacy, Virtually all states reported some statutory protection for governmentally maintained health data for public health information in general (49 states), communicable diseases (42 states), and sexually transmitted diseases (43 states). State statutes permitted disclosure of data for statistical purposes (42 states), contact tracing (39 states), epidemiologic investigations (22 states), and subpoena or court order (14 states), The survey revealed significant problems that affect both the development of fair and effective public health information systems and the protection of privacy. Statutes may be silent about the degree of privacy protection afforded, confer weaker privacy protection to certain kinds of information, or grant health officials broad discretion to disseminate personal information. Our proposals for law reform are based on a meeting of experts at the Carter Presidential Center under the auspices of the Centers for Disease Control and Prevention and the Council of State and Territorial Epidemiologists: (1) an independent data protection commission should be established, (2) health authorities should justify the collection of personally identifiable information, (3) subjects should be given basic information about data practices, (4) data should be held and used in accordance with fair information practices, (5) legally binding privacy and security assurances should attach to identifiable health information with significant penalties for breach of these assurances, (6) disclosure of data should be made only for purposes consistent with the original collection, and (7) secondary uses beyond those originally intended by the data collector should be permitted only with informed consent.	GEORGETOWN JOHNS HOPKINS PROGRAM LAW & PUBL HLTH,WASHINGTON,DC; GEORGETOWN JOHNS HOPKINS PROGRAM LAW & PUBL HLTH,BALTIMORE,MD; HARVARD UNIV,SCH PUBL HLTH,BOSTON,MA 02115; US DEPT HHS,OFF GEN COUNSEL,WASHINGTON,DC 20201; MINNESOTA DEPT HLTH,ACUTE DIS EPIDEMIOL SECT,MINNEAPOLIS,MN 55414	Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard T.H. Chan School of Public Health; Minnesota Department of Health (MHD)								*AG HLTH CAR POL R, 1990, AHCPR PURP PROGR; ANNAS GJ, 1995, GENETIC PRIVACY ACT; [Anonymous], 1989, PRIVATE ACTS SOCIAL; Baker E L, 1995, J Public Health Manag Pract, V1, P43; BAYER R, 1992, AM J PUBLIC HEALTH, V82, P1158, DOI 10.2105/AJPH.82.8.1158; Beauchamp TL, 2009, PRINCIPLES BIOMEDICA; *CTR DIS CONTR PRE, 1994, NAT HIV SER SUMM RES, P3; FOX DM, 1986, HASTINGS CENT REP  S, V16, P11; FRANCIS DP, 1983, J NATL CANCER I, V71, P1; *GEN ACC OFF, 1990, GAOIMTEC9070BR; *GEN ACC OFF, 1993, GAOIMTEC9317; Gostin L. O., 1995, CORNELL LAW REV, V80, P101; Gostin Lawrence O, 1995, MD Law Rev, V54, P1; GOSTIN LO, 1995, JAMA-J AM MED ASSOC, V274, P1793, DOI 10.1001/jama.274.22.1793; Gostin LO, 1995, J LAW MED ETHICS, V23, P320, DOI 10.1111/j.1748-720X.1995.tb01374.x; GOSTIN LO, 1993, JAMA-J AM MED ASSOC, V270, P2487; GRAD FP, 1990, PUBLIC HLTH LAW MANU; GRAITCER PL, 1987, AM J PREV MED, V3, P123; HENDERSON DA, 1976, INT J EPIDEMIOL, V5, P19, DOI 10.1093/ije/5.1.19; Hinman AR, 1972, 100 ANN M AM PUBL HL; HJELLE B, 1994, WESTERN J MED, V161, P467; *I MED, 1994, HLTH DAT INF AG US D; Institute of Medicine Committee for the Study of the Future of Public Health, 1988, FUT PUBL HLTH; Jezek Z, 1988, HUMAN MONKEYPOX; LEE PR, 1994, JAMA-J AM MED ASSOC, V272, P1315, DOI 10.1001/jama.272.17.1315; MASUR H, 1981, NEW ENGL J MED, V305, P1431, DOI 10.1056/NEJM198112103052402; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; MENCK HR, 1993, CANC NEWS, V47, P1; MINKOFF H, 1995, JAMA-J AM MED ASSOC, V274, P1165, DOI 10.1001/jama.274.14.1165; *NAT CTR HLTH STAT, 1993, PUBL US DAT TAP NAT; *OFF VIT STAT, 1959, VIT STAT US 1958; PRIVACY PROTECTION STUDY COMMISSION, 1977, PERS PRIV INF SOC; REILLY PR, 1994, AM J HUM GENET, V55, P32; Siegel Paul Z, 1993, Morbidity and Mortality Weekly Report, V42, P23; SMITH S, 1993, PUBLIC HEALTH REP, V108, P408; THACKER SB, 1994, PRINCIPLES PRACTICE, P3; *US DEP HLTH HUM S, 1994, NAT HLTH NUTR EX SUR, V3; *US DEP HLTH HUM S, 1995, FIN REP TASK FORC PR; *US DEP HLTH HUM S, 1994, CHILDH IMM IN; *US DHEW SECR ADV, 1973, REC COMP RIGHTS CIT; Walzer M., 1983, SPHERES JUSTICE; *WORKGR EL DAT INT, 1992, OBST EDI CURR HLTH C; *WORLD MED ASS, 1968, DECL GEN 1948; World Medical Association, 1949, INT COD MED ETH; 1991, MMWR-MORBID MORTAL W, V40, P502; 1994, MMWR-MORBID MORTAL W, V43, P627; 1981, MMWR-MORBID MORTAL W, V30, P305	47	75	76	1	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	1996	275	24					1921	1927		10.1001/jama.275.24.1921	http://dx.doi.org/10.1001/jama.275.24.1921			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UR975	8648874				2022-12-28	WOS:A1996UR97500039
J	GalchevaGargova, Z; Konstantinov, KN; Wu, IH; Klier, FG; Barrett, T; Davis, RJ				GalchevaGargova, Z; Konstantinov, KN; Wu, IH; Klier, FG; Barrett, T; Davis, RJ			Binding of zinc finger protein ZPR1 to the epidermal growth factor receptor	SCIENCE			English	Article							SIGNAL TRANSDUCTION; TYROSINE KINASE; SH3 DOMAINS; A431 CELLS; MECHANISM; AFFINITY	ZPR1 is a zinc finger protein that binds to the cytoplasmic tyrosine kinase domain of the epidermal growth factor receptor (EGFR). Deletion analysis demonstrated that this binding interaction is mediated by the zinc fingers of ZPR1 and subdomains X and XI of the EGFR tyrosine kinase. Treatment of mammalian cells with EGF caused decreased binding of ZPR1 to the EGFR and the accumulation of ZPR1 in the nucleus. The effect of EGF to regulate ZPR1 binding is dependent on tyrosine phosphorylation of the EGFR. ZPR1 therefore represents a prototype for a class of molecule that binds to the EGFR and is released from the receptor after activation.	UNIV MASSACHUSETTS, SCH MED, DEPT BIOCHEM & MOLEC BIOL, PROGRAM MOLEC MED, WORCESTER, MA 01605 USA; HOWARD HUGHES MED INST, WORCESTER, MA 01605 USA; SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, LA JOLLA, CA 92037 USA; Scripps Res Inst, DEPT CELL BIOL, LA JOLLA, CA 92037 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Scripps Research Institute; Scripps Research Institute					NATIONAL CANCER INSTITUTE [R01CA058396] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA58396] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; COUNTAWAY JL, 1989, J BIOL CHEM, V264, P10828; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FRITZLER MJ, 1994, MOL BIOL CELL, V5, P1043; GALCHEVA Z, UNPUB; GREGORIOU M, 1994, EUR J BIOCHEM, V223, P455, DOI 10.1111/j.1432-1033.1994.tb19013.x; GRONOWSKI AM, 1995, ENDOCRINOLOGY, V136, P2198, DOI 10.1210/en.136.5.2198; GRONOWSKI AM, 1993, ENDOCRINOLOGY, V133, P2836; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HU HM, 1994, J BIOL CHEM, V269, P30069; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; KAVANAUGH WM, 1995, SCIENCE, V268, P1177, DOI 10.1126/science.7539155; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KONSTANTINOV KN, UNPUB; KOTZIN BL, 1984, J IMMUNOL, V133, P2554; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; ROY LM, 1991, J CELL PHYSIOL, V146, P63, DOI 10.1002/jcp.1041460109; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WU RY, 1994, J BIOL CHEM, V269, P25085	35	92	100	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1797	1802		10.1126/science.272.5269.1797	http://dx.doi.org/10.1126/science.272.5269.1797			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8650580				2022-12-28	WOS:A1996UT11000046
J	Xu, DM; Nouraini, S; Field, D; Tang, SJ; Friesen, JD				Xu, DM; Nouraini, S; Field, D; Tang, SJ; Friesen, JD			An RNA-dependent ATPase associated with U2/U6 snRNAs in pre-mRNA splicing	NATURE			English	Article							SMALL NUCLEAR-RNA; YEAST; PROTEIN; SPLICEOSOME; MECHANISM; SUGGESTS; FIDELITY; PATHWAY; ROLES; U2	THE hydrolysis of ATP by a group of RNA dependent ATPases (DEAD/H proteins(1)) is required for spliceosome assembly, but not for the subsequent transesterification reactions(2). Little is known about the function of these ATPases in relation to the RNA conformational changes that occur in formation of active structures, in which U2/U6 small nuclear RNA (snRNA) interactions(3,4) are essential for splicing to take place, Using a synthetic lethal genetic screen, we have isolated four yeast splicing factors involved in U2/U6 snRNA interactions (D.X. et al., manuscript in preparation). The RNA-dependent ATPase activity associated with one such factor, the Slt22 protein, is stimulated preferentially by annealed U2/U6 snRNAs. Both mutant slt22-1 and U2 snRNA cause a reduction in stimulation, The slt22-1 mutation blocks splicing at or before the first step, resulting in the accumulation of an unusual complex which lacks U5 snRNA. Our results indicate that the U2/U6 snRNA interactions facilitated by Slt22 are also Involved in the interaction of U5 snRNA with tire spliceosome.	HOSP SICK CHILDREN, RES INST, DEPT GENET, TORONTO, ON M5G 1X8, CANADA; UNIV TORONTO, DEPT MOLEC & MED GENET, TORONTO, ON M5G 1X8, CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto								BROWN JD, 1992, EMBO J, V11, P3721, DOI 10.1002/j.1460-2075.1992.tb05457.x; BURGESS SM, 1993, TRENDS BIOCHEM SCI, V18, P381, DOI 10.1016/0968-0004(93)90094-4; BURGESS SM, 1993, CELL, V73, P1377, DOI 10.1016/0092-8674(93)90363-U; CHENG SC, 1987, GENE DEV, V1, P1014, DOI 10.1101/gad.1.9.1014; FABRIZIO P, 1990, SCIENCE, V250, P404, DOI 10.1126/science.2145630; Field DJ, 1996, GENE DEV, V10, P489, DOI 10.1101/gad.10.4.489; FRANK D, 1992, MOL CELL BIOL, V12, P5197, DOI 10.1128/MCB.12.11.5197; FRANK DN, 1994, MOL CELL BIOL, V14, P2180, DOI 10.1128/MCB.14.3.2180; FULLERPACE FV, 1993, EMBO J, V12, P369; JONES MH, 1995, P NATL ACAD SCI USA, V92, P9687, DOI 10.1073/pnas.92.21.9687; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; LAUBER J, IN PRESS EMBO J; LIN RJ, 1985, J BIOL CHEM, V260, P4780; MADHANI HD, 1994, GENE DEV, V8, P1071, DOI 10.1101/gad.8.9.1071; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; MADHANI HD, 1990, GENE DEV, V4, P2264, DOI 10.1101/gad.4.12b.2264; MADHANI HD, 1994, ANNU REV GENET, V28, P1; MCPHEETERS DS, 1992, CELL, V71, P819, DOI 10.1016/0092-8674(92)90557-S; Moore M., 1993, RNA WORLD, P303; Newman AJ, 1995, RNA, V1, P968; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; SUN JS, 1995, GENE DEV, V9, P843, DOI 10.1101/gad.9.7.843; TAM WY, 1993, P NATL ACAD SCI USA, V90, P10821; [No title captured]	25	70	71	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	1996	381	6584					709	713		10.1038/381709a0	http://dx.doi.org/10.1038/381709a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR979	8649518				2022-12-28	WOS:A1996UR97900056
J	Evens, RG				Evens, RG			Radiology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Evens, RG (corresponding author), WASHINGTON UNIV, SCH MED, ST LOUIS, MO 63110 USA.							BAUM RA, 1995, JAMA-J AM MED ASSOC, V274, P875, DOI 10.1001/jama.274.11.875; BLAKELEY DD, 1995, ANN INTERN MED, V122, P360, DOI 10.7326/0003-4819-122-5-199503010-00007; CHANNIN DS, 1995, ACAD RADIOL, V2, P721; DINSMORE RE, 1995, CIRCULATION, V91, P1607, DOI 10.1161/01.CIR.91.5.1607; Evens RG, 1996, JAMA-J AM MED ASSOC, V275, P112; EVENS RG, 1995, JAMA-J AM MED ASSOC, V274, P912; FELLNER C, 1995, RADIOLOGY, V196, P681, DOI 10.1148/radiology.196.3.7644629; FISHER M, 1995, JAMA-J AM MED ASSOC, V274, P908; JAFFE CC, 1995, AM J ROENTGENOL, V164, P463, DOI 10.2214/ajr.164.2.7839990; MACIUNAS RJ, 1993, INTERACTIVE IMAGE GU, P278; MCENERY KW, 1995, AM J ROENTGENOL, V164, P469, DOI 10.2214/ajr.164.2.7839991; MCKINNEY WP, 1995, M D COMPUT, V12, P109; SILVERMAN JM, 1995, RADIOLOGY, V197, P147, DOI 10.1148/radiology.197.1.7568813; SILVERMAN SG, 1995, RADIOLOGY, V197, P175, DOI 10.1148/radiology.197.1.7568819; STOCK KW, 1995, RADIOLOGY, V195, P451, DOI 10.1148/radiology.195.2.7724765; TAYLOR RH, 1996, COMPUTER INTEGRATED, P736	16	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1854	1855		10.1001/jama.275.23.1854	http://dx.doi.org/10.1001/jama.275.23.1854			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642749				2022-12-28	WOS:A1996UQ15200048
J	Gostin, LO				Gostin, LO			Law and medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Gostin, LO (corresponding author), GEORGETOWN UNIV,CTR LAW,JOHNS HOPKINS PROGRAM LAW & PUBL HLTH,WASHINGTON,DC 20057, USA.							ANNAS GJ, 1995, NEW ENGL J MED, V333, P1647, DOI 10.1056/NEJM199512143332420; CONRAD RJ, 1995, DEFENSE COUNSEL J, V62, P191; GOLD MR, 1995, NEW ENGL J MED, V333, P1678, DOI 10.1056/NEJM199512213332505; 1995, NY TIMES        0506	4	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1817	1819		10.1001/jama.275.23.1817	http://dx.doi.org/10.1001/jama.275.23.1817			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642727				2022-12-28	WOS:A1996UQ15200026
J	Walker, AR; DeAngelis, CD				Walker, AR; DeAngelis, CD			Pediatrics and adolescent medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Walker, AR (corresponding author), JOHNS HOPKINS UNIV, SCH MED, BALTIMORE, MD 21205 USA.							CHESNEY PJ, 1995, J PEDIATR-US, V127, P526, DOI 10.1016/S0022-3476(95)70107-9; CUMMINS RO, 1991, ANN EMERG MED, V20, P861; DIECKMANN RA, 1995, PEDIATRICS, V95, P901; GRAF WD, 1995, ANN EMERG MED, V26, P312, DOI 10.1016/S0196-0644(95)70079-X; RONCO R, 1995, ARCH PEDIAT ADOL MED, V149, P210, DOI 10.1001/archpedi.1995.02170140092017; ROSENBERG NM, 1995, PEDIATR EMERG CARE, V11, P167, DOI 10.1097/00006565-199506000-00006; ZARITSKY A, 1995, PEDIATRICS, V96, P765; 1992, JAMA-J AM MED ASSOC, V268, P2262	8	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1841	1842		10.1001/jama.275.23.1841	http://dx.doi.org/10.1001/jama.275.23.1841			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642741				2022-12-28	WOS:A1996UQ15200040
J	Gough, DO; Leibacher, JW; Scherrer, PH; Toomre, J				Gough, DO; Leibacher, JW; Scherrer, PH; Toomre, J			Perspectives in helioseismology	SCIENCE			English	Article							B-TYPE STARS; OPACITY MECHANISM; SOLAR; MODELS	Helioseismology is probing the interior structure and dynamics of the sun with ever-increasing precision, providing a well-calibrated laboratory in which physical processes can be studied under conditions that are unattainable on Earth. Nearly 10 million resonant modes of oscillation are observable in the solar atmosphere, and their frequencies need to be known with great accuracy in order to gauge the sun's interior. The advent of nearly continuous imaged observations from the complementary ground-based Global Oscillation Network Group (GONG) observatories and the space-based Solar and Heliospheric Observatory instruments augurs a new era of discovery. The flow of early results from GONG resolves some issues and raises a number of theoretical questions whose answers are required for understanding how a seemingly ordinary star actually operates.	NATL OPT ASTRON OBSERV,NATL SOLAR OBSERV,TUCSON,AZ 85726; STANFORD UNIV,DEPT PHYS,STANFORD,CA 94305; UNIV COLORADO,JILA,BOULDER,CO 80309	National Optical Astronomy Observatory; Stanford University; University of Colorado System; University of Colorado Boulder	Gough, DO (corresponding author), UNIV CAMBRIDGE,INST ASTRON,MADINGLEY RD,CAMBRIDGE CB3 0HA,ENGLAND.			Leibacher, John/0000-0001-7605-3684; Scherrer, Philip/0000-0002-6937-6968				BACHMANN KT, 1995, ASTROPHYS J, V443, P837, DOI 10.1086/175573; BAHCALL JN, 1993, PHYS REV D, V47, P1298, DOI 10.1103/PhysRevD.47.1298; BATURIN VA, 1994, EQUATION STATE ASTRO, P545; BROWN TM, 1989, ASTROPHYS J, V343, P526, DOI 10.1086/167727; CHOU DY, 1995, SOL PHYS, V160, P237, DOI 10.1007/BF00732806; CHRISTENSENDALS.J, 1988, ESA SP286, P149; CHRISTENSENDALSGAARD J, 1993, ASTROPHYS J, V403, pL75, DOI 10.1086/186725; DUVALL TL, 1984, NATURE, V310, P22, DOI 10.1038/310022a0; DZIEMBOWSKI WA, 1993, MON NOT R ASTRON SOC, V262, P204, DOI 10.1093/mnras/262.1.204; DZIEMBOWSKI WA, 1993, MON NOT R ASTRON SOC, V265, P588, DOI 10.1093/mnras/265.3.588; DZIEMBOWSKI WA, 1992, ACTA ASTRON, V22, P5; ELSWORTH Y, 1995, NATURE, V376, P669, DOI 10.1038/376669a0; ELSWORTH Y, 1994, ASTROPHYS J, V434, P801, DOI 10.1086/174783; FOSSAT E, 1995, ASTR SOC P, V76, P387; FROHLICH C, 1995, SOL PHYS, V62, P101; GABRIEL AH, 1995, SOL PHYS, V62, P61; GHOSAL S, 1991, GEOPHYS ASTRO FLUID, V61, P161, DOI 10.1080/03091929108229042; GOUGH DO, 1991, ANN NY ACAD SCI, V647, P199; Gough DO, 1996, SCIENCE, V272, P1296, DOI 10.1126/science.272.5266.1296; GREC G, 1980, NATURE, V288, P541, DOI 10.1038/288541a0; IGLESIAS CA, 1992, ASTROPHYS J, V397, P717, DOI 10.1086/171827; KIRIAKIDIS M, 1992, MON NOT R ASTRON SOC, V255, pP1, DOI 10.1093/mnras/255.1.1P; KOSOVICHEV AG, 1992, MON NOT R ASTRON SOC, V259, P536, DOI 10.1093/mnras/259.3.536; MOSHALIK P, 1992, ASTROPHYS J, V385, P685; MOSHALIK P, 1992, ASTRON ASTROPHYS, V256, pL5; RHODES EJ, 1995, ASTR SOC P, V76, P398; Scherrer PH, 1995, SOL PHYS, V162, P129, DOI 10.1007/BF00733429; TOMCZYK S, 1995, ASTROPHYS J, V448, pL57, DOI 10.1086/309598; TOMCZYK S, 1995, ASTR SOC P, V76, P444; [No title captured]	30	56	56	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1281	1283		10.1126/science.272.5266.1281	http://dx.doi.org/10.1126/science.272.5266.1281			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8662454				2022-12-28	WOS:A1996UN47200030
J	Halperin, DS; Bouvier, P; Jaffe, PD; Mounoud, RL; Pawlak, CH; Laederach, J; Wicky, HR; Astie, F				Halperin, DS; Bouvier, P; Jaffe, PD; Mounoud, RL; Pawlak, CH; Laederach, J; Wicky, HR; Astie, F			Prevalence of child sexual abuse among adolescents in Geneva: Results of a cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article							IMPACT; PROSTITUTION	Objective-To measure the cumulative prevalence of child sexual abuse in a repr Design-Cross sectional survey with an anonymous self administered questionnaire centred on a factual description of sexual activities. Setting-68 classes (17 schools) randomly selected from the 201 ninth grade classes of the public school system in Geneva. Subjects-1193 adolescents aged 13-17 years, of whom 1116 (93.5%; 568 girls, 548 boys) consented to the study and returned completed questionnaires. Results-192 (33.8%) girls and 60 (10.9%) boys reported having experienced at least one sexually abusive event. The prevalence of abuse involving physical contact was 20.4% (116 cases) among girls and 3.3% (18) among boys, The prevalence of abuse involving some form of penetration was 5.6% (32 cases) among girls and 1.1% (six) among boys. One third of the abused adolescents had experienced more than one abusive event and 46.5% (92/198) had experienced the first event before age 12. Abuse by a family member was reported by 20.5% (36/176) of abused girls and 6.3% (3/48) of abused boys. Abusers were known to victims in two thirds of cases. Ninety per cent of abusers were male and 35.3% (71/201) came from the victims' peer group. Over 80% of participants found the questionnaire interesting, clearly formulated, and useful. Conclusions-Child sexual abuse is a universal social phenomenon. Adolescents themselves can contribute to research and so help in the search for more efficient prevention and intervention strategies.	CTR MED UNIV GENEVA, FAC MED, INST SOCIAL & PREVENT MED, CH-1211 GENEVA 14, SWITZERLAND; UNIV GENEVA, FAC PSYCHOL & EDUC SCI, CH-1227 CAROUGE, SWITZERLAND; SERV SANTE JEUNESSE, CH-1211 GENEVA 3, SWITZERLAND; SERV MED PEDAG, UNITE PSYCHIAT ADOLESCENT, CH-1201 GENEVA, SWITZERLAND	University of Geneva; University of Geneva; University of Geneva	Halperin, DS (corresponding author), HOP ENFANTS, FAC MED, PAEDIAT EMERGENCY UNIT, CH-1211 GENEVA 14, SWITZERLAND.			Bouvier, Paul/0000-0001-5198-9056				BROWNE A, 1986, PSYCHOL BULL, V99, P66, DOI 10.1037/0033-2909.99.1.66; CONTE JR, 1987, J INTERPERS VIOLENCE, V2, P380, DOI DOI 10.1177/088626058700200404; Dean A.G., 1994, EPI INFO VERSION 6 W; ERNST C, 1993, EUR ARCH PSY CLIN N, V242, P293, DOI 10.1007/BF02190389; Finkelhor, 1986, SOURCEBOOK CHILD SEX; FINKELHOR D, 1994, CHILD ABUSE NEGLECT, V18, P409, DOI 10.1016/0145-2134(94)90026-4; FINKELHOR D, 1994, PEDIATRICS, V94, P413; GOODWIN J, 1988, J TRAUMA STRESS, V1, P475, DOI DOI 10.1007/BF00980367; HAUGAARD JJ, 1989, CHILD ABUSE NEGLECT, V13, P89, DOI 10.1016/0145-2134(89)90032-X; KENDALLTACKETT KA, 1993, PSYCHOL BULL, V113, P164, DOI 10.1037/0033-2909.113.1.164; LOFTUS EF, 1993, HARVARD MED SCH MENT, V9, P4; MULLEN PE, 1988, LANCET, V1, P841; NARRING F, 1995, SOZ PRAVENTIV MED, V40, P172, DOI 10.1007/BF01318638; Peters S.D., 1986, SOURCEBOOK CHILD SEX, P15; Plunkett A, 1990, Paediatr Perinat Epidemiol, V4, P351, DOI 10.1111/j.1365-3016.1990.tb00657.x; ROWAN AB, 1993, J TRAUMA STRESS, V6, P3, DOI 10.1002/jts.2490060103; Rutter M, 1994, CHILD ADOL PSYCH CL, P230, DOI 10.1136/bmj.312.7042.1326; SALTER AC, 1992, SEXUAL ABUSE CHILDRE, V1, P108; Sariola H, 1996, CHILD ABUSE NEGLECT, V20, P843, DOI 10.1016/0145-2134(96)00072-5; SCOTT KD, 1992, CHILD ABUSE NEGLECT, V16, P285, DOI 10.1016/0145-2134(92)90035-P; SENG MJ, 1989, ADOLESCENCE, V24, P665; SIMONS RL, 1991, J FAM ISSUES, V12, P361, DOI 10.1177/019251391012003007; WIDOM CS, 1989, AM J ORTHOPSYCHIAT, V59, P355, DOI 10.1111/j.1939-0025.1989.tb01671.x; WYATT GE, 1986, CHILD ABUSE NEGLECT, V10, P241, DOI 10.1016/0145-2134(86)90085-2	24	85	86	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 25	1996	312	7042					1326	1329		10.1136/bmj.312.7042.1326	http://dx.doi.org/10.1136/bmj.312.7042.1326			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UN476	8646043	Green Published			2022-12-28	WOS:A1996UN47600018
J	Matsumine, A; Ogai, A; Senda, T; Okumura, N; Satoh, K; Baeg, GH; Kawahara, T; Kobayashi, S; Okada, M; Toyoshima, K; Akiyama, T				Matsumine, A; Ogai, A; Senda, T; Okumura, N; Satoh, K; Baeg, GH; Kawahara, T; Kobayashi, S; Okada, M; Toyoshima, K; Akiyama, T			Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein	SCIENCE			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; IMMUNOELECTRON MICROSCOPY; SEPTATE JUNCTIONS; MEMBRANE-PROTEIN; GENE-PRODUCT; IDENTIFICATION; MUTATIONS; CHROMOSOME-5Q21; ASSOCIATION; CANCER	The adenomatous polyposis coli gene (APC) is mutated in familial adenomatous polyposis and in sporadic colorectal tumors, and its product binds to the adherens junction protein beta-catenin. Overexpression of APC blocks cell cycle progression, The APC-beta-catenin complex was shown to bind to DLG, the human homolog of the Drosophila discs large tumor suppressor protein, This interaction required the carboxyl-terminal region of APC and the DLG homology repeat region of DLG. APC colocalized with DLG at the lateral cytoplasm in rat colon epithelial cells and at the synapse in cultured hippocampal neurons. These results suggest that the APC-DLG complex may participate in regulation of both cell cycle progression and neuronal function.	OSAKA UNIV,MICROBIAL DIS RES INST,DEPT ONCOGENE RES,SUITA,OSAKA 565,JAPAN; NAGOYA UNIV,SCH MED,DEPT ANAT 1,NAGOYA,AICHI 466,JAPAN; OSAKA UNIV,INST PROT RES,DIV PROT METAB,SUITA,OSAKA 565,JAPAN; CTR ADULT DIS,OSAKA 537,JAPAN	Osaka University; Nagoya University; Osaka University			Baeg, Gyeong-Hun/A-2951-2008; Satoh, Kiyotoshi/M-3653-2017	Satoh, Kiyotoshi/0000-0001-6029-6534				BAEG GH, 1995, EMBO J, V14, P5618, DOI 10.1002/j.1460-2075.1995.tb00249.x; Bartel PL, 1993, USING 2 HYBRID SYSTE, P153; BHAT RV, 1994, J NEUROSCI, V14, P3059; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; GEUZE HJ, 1981, J CELL BIOL, V89, P653, DOI 10.1083/jcb.89.3.653; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; MATSUMINE A, UNPUB; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; MIYASHIRO I, 1995, ONCOGENE, V11, P89; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; MUNEMITSU S, 1994, CANCER RES, V54, P3676; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; RUFF P, 1991, P NATL ACAD SCI USA, V88, P6595, DOI 10.1073/pnas.88.15.6595; SENDA T, UNPUB; SHIBATA T, 1994, BIOCHEM BIOPH RES CO, V203, P519, DOI 10.1006/bbrc.1994.2213; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH KJ, 1994, CANCER RES, V54, P3672; SMITH KJ, 1993, P NATL ACAD SCI USA, V90, P2846, DOI 10.1073/pnas.90.7.2846; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; SU LK, 1995, CANCER RES, V55, P2972; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	36	399	410	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 17	1996	272	5264					1020	1023		10.1126/science.272.5264.1020	http://dx.doi.org/10.1126/science.272.5264.1020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL619	8638125				2022-12-28	WOS:A1996UL61900048
J	Rubinfeld, B; Albert, I; Porfiri, E; Fiol, C; Munemitsu, S; Polakis, P				Rubinfeld, B; Albert, I; Porfiri, E; Fiol, C; Munemitsu, S; Polakis, P			Binding of GSK3 beta to the APC-beta-catenin complex and regulation of complex assembly	SCIENCE			English	Article							CYTOPLASMIC DOMAIN; GENE-PRODUCT; E-CADHERIN; MUTATIONS; IDENTIFICATION; PROTEIN; CHROMOSOME-5Q21; PHOSPHORYLATION; ASSOCIATION; ANTIBODIES	The adenomatous polyposis coli gene (APC) is mutated in most colon cancers. The APC protein binds lo the cellular adhesion molecule beta-catenin, which is a mammalian homolog of ARMADILLO, a component of the WINGLESS signaling pathway in Drosophila development. Here it is shown that when beta-catenin is present in excess, APC binds to another component of the WINGLESS pathway, glycogen synthase kinase 3 beta (GSK3 beta), a mammalian homolog of Drosophila ZESTE WHITE 3. APC was a good substrate for GSK3 beta in vitro, and the phosphorylation sites were mapped to the central region of APC. Binding of beta-catenin to this region was dependent on phosphorylation by GSK3 beta.	ONYX PHARMACEUT,RICHMOND,CA 94806; INDIANA UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOL,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis				Rubinfeld, Bonnee/0000-0001-9861-6775				BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; GRUSSENMEYER T, 1985, P NATL ACAD SCI USA, V82, P7952, DOI 10.1073/pnas.82.23.7952; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; HINCK L, 1994, J CELL BIOL, V124, P729, DOI 10.1083/jcb.124.5.729; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; MCCREA PD, 1993, J CELL BIOL, V123, P477, DOI 10.1083/jcb.123.2.477; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; MUNEMITSU S, 1994, CANCER RES, V54, P3676; MUNEMITSU S, UNPUB; MUNEMITSU S, 1995, P NATL ACAD SCI US, V92; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1995, TRENDS CELL BIOL, V5, P224, DOI 10.1016/S0962-8924(00)89015-7; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; RUBINFELD B, 1995, J BIOL CHEM, V270, P5549, DOI 10.1074/jbc.270.10.5549; RUBINFELD B, 1992, MOL CELL BIOL, V12, P4634, DOI 10.1128/MCB.12.10.4634; SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0; SMITH KJ, 1993, P NATL ACAD SCI USA, V90, P2846, DOI 10.1073/pnas.90.7.2846; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; WANG QM, 1994, ANAL BIOCHEM, V220, P397, DOI 10.1006/abio.1994.1356	30	1234	1280	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 17	1996	272	5264					1023	1026		10.1126/science.272.5264.1023	http://dx.doi.org/10.1126/science.272.5264.1023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL619	8638126				2022-12-28	WOS:A1996UL61900049
J	OwenHughes, T; Utley, RT; Cote, J; Peterson, CL; Workman, JL				OwenHughes, T; Utley, RT; Cote, J; Peterson, CL; Workman, JL			Persistent site-specific remodeling of a nucleosome array by transient action of the SWI/SNF complex	SCIENCE			English	Article							TRANSCRIPTION FACTOR-BINDING; FACILITATED BINDING; YEAST; DNA; DISRUPTION; HISTONES; GAL4; ENHANCEMENT; ACTIVATORS; PROTEINS	The SWI/SNF complex participates in the restructuring of chromatin for transcription. The function of the yeast SWI/SNF complex in the remodeling oi a nucleosome array has now been analyzed in vitro. Binding of the purified SWI/SNF complex to a nucleosome array disrupted multiple nucleosomes in an adenosine triphosphate-dependent reaction. However, removal of SWI/SNF left a deoxyribonuclease I-hypersensitive site specifically at a nucleosome that was bound by derivatives of the transcription factor Gal4p. Analysis of individual nucleosomes revealed that the SWI/SNF complex catalyzed eviction of histones from the Gal4-bound nucleosomes. Thus, the transient action of the SWI/SNF complex facilitated irreversible disruption of transcription factor-bound nucleosomes.	PENN STATE UNIV,DEPT BIOCHEM & MOLEC BIOL,UNIVERSITY PK,PA 16802; UNIV MASSACHUSETTS,MED CTR,DEPT BIOCHEM & MOLEC BIOL,WORCESTER,MA 01605; UNIV MASSACHUSETTS,MED CTR,PROGRAM MOLEC MED,WORCESTER,MA 01605	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester			Cote, Jacques/I-8901-2014	Cote, Jacques/0000-0001-6751-555X; Owen-Hughes, Tom/0000-0002-0618-8185	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047867, R01GM049650, R01GM047867, R37GM049650] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM049650, GM47867, R37 GM049650] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRESNICK EH, 1992, NUCLEIC ACIDS RES, V20, P273, DOI 10.1093/nar/20.2.273; CAIRNS BR, 1994, P NATL ACAD SCI USA, V91, P1950, DOI 10.1073/pnas.91.5.1950; CHEN H, 1994, EMBO J, V13, P380, DOI 10.1002/j.1460-2075.1994.tb06272.x; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; COTE J, UNPUB; HIRSCHHORN JN, 1992, GENE DEV, V6, P2288, DOI 10.1101/gad.6.12a.2288; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; KIM J, 1989, GENE, V85, P15, DOI 10.1016/0378-1119(89)90459-9; KRUDE T, 1993, MOL CELL BIOL, V13, P1059, DOI 10.1128/MCB.13.2.1059; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; LIN YS, 1988, CELL, V54, P659, DOI 10.1016/S0092-8674(88)80010-2; MEERSSEMAN G, 1991, J MOL BIOL, V220, P89, DOI 10.1016/0022-2836(91)90383-H; MORSE RH, 1993, SCIENCE, V262, P1563, DOI 10.1126/science.8248805; OWENHUGHES T, IN PRESS EMBO J; PAZIN MJ, 1994, SCIENCE, V266, P2007, DOI 10.1126/science.7801129; PETERSON CL, 1995, TRENDS BIOCHEM SCI, V20, P143, DOI 10.1016/S0968-0004(00)88990-2; Quinn J, 1996, NATURE, V379, P844, DOI 10.1038/379844a0; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Struhl K, 1996, CELL, V84, P179, DOI 10.1016/S0092-8674(00)80970-8; SVAREN J, 1993, CURR OPIN GENET DEV, V3, P219, DOI 10.1016/0959-437X(93)90026-L; TAYLOR ICA, 1991, GENE DEV, V5, P1285, DOI 10.1101/gad.5.7.1285; TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; VARGAWEISZ PD, 1995, EMBO J, V14, P2209, DOI 10.1002/j.1460-2075.1995.tb07215.x; VETTESEDADEY M, 1994, MOL CELL BIOL, V14, P970, DOI 10.1128/MCB.14.2.970; WALL G, 1995, EMBO J, V14, P1727, DOI 10.1002/j.1460-2075.1995.tb07162.x; WALLRATH LL, 1994, BIOESSAYS, V16, P165, DOI 10.1002/bies.950160306; WALTER PP, 1995, MOL CELL BIOL, V15, P6178; Wilson CJ, 1996, CELL, V84, P235, DOI 10.1016/S0092-8674(00)80978-2; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90167-3; WORKMAN JL, 1993, TRENDS BIOCHEM SCI, V18, P90, DOI 10.1016/0968-0004(93)90160-O; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613; YOSHINAGA SK, 1992, SCIENCE, V258, P1598, DOI 10.1126/science.1360703	35	195	198	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 26	1996	273	5274					513	516		10.1126/science.273.5274.513	http://dx.doi.org/10.1126/science.273.5274.513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY983	8662543				2022-12-28	WOS:A1996UY98300045
J	Cho, JYK; Polvani, LM				Cho, JYK; Polvani, LM			The morphogenesis of bands and zonal winds in the atmospheres on the giant outer planets	SCIENCE			English	Article							GREAT RED SPOT; BETA-PLANE; TURBULENCE; NEPTUNE; DYNAMICS	The atmospheres of Jupiter, Saturn, Uranus, and Neptune were modeled as shallow layers of turbulent fluid overlying a smooth, spherical interior. With only the observed values of radius, rotation rate, average wind velocity, and mean layer thickness as model parameters, bands and jets spontaneously emerged from random initial conditions. The number, width, and amplitude of the jets, as well as the dominance of anticyclonic vortices, are in good agreement with observations for all four planets.	COLUMBIA UNIV,DEPT APPL PHYS,NEW YORK,NY 10027	Columbia University	Cho, JYK (corresponding author), COLUMBIA UNIV,PROGRAM APPL MATH,NEW YORK,NY 10027, USA.		Polvani, Lorenzo M/E-5949-2011					ALLISON M, 1990, GEOPHYS RES LETT, V17, P2269, DOI 10.1029/GL017i012p02269; Beebe R, 1994, CHAOS, V4, P113, DOI 10.1063/1.165998; Chen Y Y, 2010, HYDRODYNAMICS, V42, P1; Cho JYK, 1996, PHYS FLUIDS, V8, P1531, DOI 10.1063/1.868929; DOWLING TE, 1989, J ATMOS SCI, V46, P3256, DOI 10.1175/1520-0469(1989)046<3256:JGRSAA>2.0.CO;2; GIERASCH PJ, 1993, J GEOPHYS RES-PLANET, V98, P5459, DOI 10.1029/92JE01897; HOSKINS BJ, 1985, Q J ROY METEOR SOC, V111, P877, DOI 10.1256/smsqj.47001; INGERSOLL AP, 1990, SCIENCE, V248, P308, DOI 10.1126/science.248.4953.308; Laplace P.S., 1775, MMOIRES ACAD ROYALE, V88; MALTRUD ME, 1991, J FLUID MECH, V228, P321, DOI 10.1017/S0022112091002720; MARCUS PS, 1988, NATURE, V331, P693, DOI 10.1038/331693a0; MCLOW MM, 1986, ICARUS, V65, P353; Pedlosky J., 1979, GEOPHYS FLUID DYN; POLVANI LM, 1990, SCIENCE, V249, P1393, DOI 10.1126/science.249.4975.1393; RHINES PB, 1975, J FLUID MECH, V69, P417, DOI 10.1017/S0022112075001504; SMITH BA, 1989, SCIENCE, V246, P1422, DOI 10.1126/science.246.4936.1422; WILLIAMS GP, 1978, J ATMOS SCI, V35, P1399, DOI 10.1175/1520-0469(1978)035<1399:PCBROJ>2.0.CO;2; YODEN S, 1993, J ATMOS SCI, V50, P631, DOI 10.1175/1520-0469(1993)050<0631:ANEOTD>2.0.CO;2	18	87	88	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 19	1996	273	5273					335	337		10.1126/science.273.5273.335	http://dx.doi.org/10.1126/science.273.5273.335			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY202	8662515				2022-12-28	WOS:A1996UY20200032
J	Wang, J; Walsh, K				Wang, J; Walsh, K			Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation	SCIENCE			English	Article							RETINOBLASTOMA PROTEIN; CELL-DEATH; COMMITMENT	Proliferating murine C2C12 myoblasts can undergo either terminal differentiation or programmed cell death under conditions of mitogen deprivation. Unlike myoblasts, differentiated myotubes were resistant to apoptosis. During myogenesis the appearance of the apoptosis-resistant phenotype was correlated with the induction of the cyclin-dependent kinase (Cdk) inhibitor p21(CIP1) but not with the appearance of myogenin, a marker expressed earlier in differentiation. Forced expression of the Cdk inhibitors p21(CIP1) or p16(INK4A) blocked apoptosis during myocyte differentiation. These data indicate that induction of Cdk inhibitors may serve to protect differentiating myocytes from programmed cell death as well as play a role in establishing the postmitotic state.	ST ELIZABETHS MED CTR,DIV CARDIOVASC RES,BOSTON,MA 02135; TUFTS UNIV,SCH MED,BOSTON,MA 02135	St. Elizabeth's Medical Center; Tufts University				Walsh, Kenneth/0000-0001-7580-2276	NHLBI NIH HHS [HL50692] Funding Source: Medline; NIAMS NIH HHS [R01 AR040197, AR40197] Funding Source: Medline; NIA NIH HHS [R01 AG015052] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015052] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; COLLINS MKL, 1993, TRENDS BIOCHEM SCI, V18, P307, DOI 10.1016/0968-0004(93)90042-L; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; GUO K, 1995, MOL CELL BIOL, V15, P3823; HAASKOGAN DA, 1995, EMBO J, V14, P461, DOI 10.1002/j.1460-2075.1995.tb07022.x; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HAUPT Y, 1995, ONCOGENE, V10, P1563; JEFFS P, 1992, ANAT EMBRYOL, V185, P589; JIANG HP, 1994, ONCOGENE, V9, P3397; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; LOIS AF, 1995, CANCER RES, V55, P4010; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; NADALGINARD B, 1978, CELL, V15, P855, DOI 10.1016/0092-8674(78)90270-2; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Poluha W, 1996, MOL CELL BIOL, V16, P1335; SERRANO M, 1995, SCIENCE, V267, P249, DOI 10.1126/science.7809631; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; STEINMAN RA, 1994, ONCOGENE, V9, P3389; STOCKDALE F, 1961, EXP CELL RES, V24, P508, DOI 10.1016/0014-4827(61)90450-5; TORNEI LD, 1993, P NATL ACAD SCI USA, V90, P853; WANG JC, UNPUB; WILLIAMS GT, 1993, CELL, V74, P777, DOI 10.1016/0092-8674(93)90457-2; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111	28	461	465	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 19	1996	273	5273					359	361		10.1126/science.273.5273.359	http://dx.doi.org/10.1126/science.273.5273.359			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY202	8662523	Green Accepted			2022-12-28	WOS:A1996UY20200040
J	Sze, G				Sze, G			Contrast enhancement for cranial CT scanning	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							BRAIN METASTASES; MR				Sze, G (corresponding author), YALE UNIV,SCH MED,NEURORADIOL SECT,NEW HAVEN,CT 06520, USA.							JINKINS JR, 1986, NEUROSURGERY, V18, P664, DOI 10.1227/00006123-198605000-00027; LATCHAW RE, 1978, RADIOLOGY, V126, P681, DOI 10.1148/126.3.681; LEMAY M, 1986, AM J ROENTGENOL, V147, P963, DOI 10.2214/ajr.147.5.963; MITCHELL WG, 1988, PEDIATRICS, V82, P76; PRICE HI, 1982, RADIOGRAPHICS, V2, P7; SEARS ES, 1982, NEUROLOGY, V32, P815, DOI 10.1212/WNL.32.8.815; SZE G, 1989, AM J NEURORADIOL, V10, P965; SZE G, 1990, AM J NEURORADIOL, V11, P785; SZE G, 1988, RADIOLOGY, V168, P187, DOI 10.1148/radiology.168.1.3380956; SZE G, 1992, CRANIAL MRI CT, P539; SZE G, 1989, AJR AM J ROENTGENOL, V154, P1039	11	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	1996	275	24					1875	1876						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR975	8648856				2022-12-28	WOS:A1996UR97500014
J	Calle, EE; Heath, CW; MiracleMcMahill, HL; Coates, RJ; Liff, JM; Franceschi, S; Talamini, R; Chantarakul, N; Koetsawang, S; Rachawat, D; Morabia, A; Schuman, L; Stewart, W; Szklo, M; Bain, C; Schofield, F; Siskind, V; Band, P; Coldman, AJ; Gallagher, RP; Hislop, TG; Yang, P; Duffy, SW; Kolonel, LM; Nomura, AMY; Oberle, MW; Ory, HW; Peterson, HB; Wilson, HG; Wingo, PA; Ebeling, K; Kunde, D; Nishan, P; Colditz, G; Martin, N; Pardthaisong, T; Silpisornkosol, S; Theetranont, C; Boosiri, B; Chutivongse, S; Jimakorn, P; Virutamasen, P; Wongsrichanalai, C; McMichael, AJ; Rohan, T; Ewertz, M; Paul, C; Skegg, DCG; Boyle, P; Evstifeeva, M; Daling, JR; Malone, K; Noonan, EA; Stanford, JL; Thomas, DB; Weiss, NS; White, E; Andrieu, N; Bremond, A; Clavel, F; Gairard, B; Lansac, J; Piana, L; Renaud, R; Cuevas, HR; Ontiveros, P; Palet, A; Salazar, SB; Aristizabel, N; Cuadros, A; Bachelot, A; Le, MG; Deacon, J; Peto, J; Taylor, CN; Alfandary, E; Modan, B; Ron, E; Friedman, GD; Hiatt, RA; Bishop, T; Kosmelj, J; PrimicZakelj, M; Ravnihar, B; Stare, J; Beeson, WL; Fraser, G; Allen, DS; Bulbrook, RD; Cuzick, J; Fentiman, IS; Hayward, JL; Wang, DY; Hanson, RL; Leske, MC; Mahoney, MC; Nasca, PC; Varma, AO; Weinstein, AL; Moller, TR; Olsson, H; Ranstam, J; Goldbohm, RA; vandenBrandt, PA; Apelo, RA; Baens, J; delaCruz, JR; Javier, B; Lacaya, LB; Ngelangel, CA; LaVecchia, C; Negri, E; Marubini, E; Ferraroni, M; Gerber, M; Richardson, S; Segala, C; Gatei, D; Kenya, P; Kungu, A; Mati, JG; Brinton, LA; Hoover, R; Schairer, C; Spirtas, R; Lee, HP; Rookus, MA; vanLeeuwen, FE; Schoenberg, JA; Gammon, MD; Clarke, EA; Jones, L; McPherson, K; Neil, A; Vessey, M; Yeates, D; Beral, V; Bull, D; Crossley, B; Hermon, C; Jones, S; Key, T; Lewis, C; Reeves, G; Smith, P; Collins, R; Doll, R; Peto, R; Hannaford, P; Kay, C; RoseroBixby, L; Gao, YT; Yuan, JM; Wei, HY; Yun, T; Zhiheng, C; Berry, G; Booth, JC; Jelihovsky, T; MacLennan, R; Shearman, R; Wang, QS; Baines, CJ; Miller, AB; Wall, C; Lund, E; Stalsberg, H; Dabancens, A; Martinez, L; Molina, R; Salas, O; Alexander, FE; Hulka, BS; Bernstein, L; Haile, RW; PaganiniHill, A; Pike, MC; Ross, RK; Ursin, G; Yu, MC; Adami, HO; Bergstrom, R; Longnecker, MP; Newcomb, P; Farley, TMN; Holck, S; Meirik, O				Calle, EE; Heath, CW; MiracleMcMahill, HL; Coates, RJ; Liff, JM; Franceschi, S; Talamini, R; Chantarakul, N; Koetsawang, S; Rachawat, D; Morabia, A; Schuman, L; Stewart, W; Szklo, M; Bain, C; Schofield, F; Siskind, V; Band, P; Coldman, AJ; Gallagher, RP; Hislop, TG; Yang, P; Duffy, SW; Kolonel, LM; Nomura, AMY; Oberle, MW; Ory, HW; Peterson, HB; Wilson, HG; Wingo, PA; Ebeling, K; Kunde, D; Nishan, P; Colditz, G; Martin, N; Pardthaisong, T; Silpisornkosol, S; Theetranont, C; Boosiri, B; Chutivongse, S; Jimakorn, P; Virutamasen, P; Wongsrichanalai, C; McMichael, AJ; Rohan, T; Ewertz, M; Paul, C; Skegg, DCG; Boyle, P; Evstifeeva, M; Daling, JR; Malone, K; Noonan, EA; Stanford, JL; Thomas, DB; Weiss, NS; White, E; Andrieu, N; Bremond, A; Clavel, F; Gairard, B; Lansac, J; Piana, L; Renaud, R; Cuevas, HR; Ontiveros, P; Palet, A; Salazar, SB; Aristizabel, N; Cuadros, A; Bachelot, A; Le, MG; Deacon, J; Peto, J; Taylor, CN; Alfandary, E; Modan, B; Ron, E; Friedman, GD; Hiatt, RA; Bishop, T; Kosmelj, J; PrimicZakelj, M; Ravnihar, B; Stare, J; Beeson, WL; Fraser, G; Allen, DS; Bulbrook, RD; Cuzick, J; Fentiman, IS; Hayward, JL; Wang, DY; Hanson, RL; Leske, MC; Mahoney, MC; Nasca, PC; Varma, AO; Weinstein, AL; Moller, TR; Olsson, H; Ranstam, J; Goldbohm, RA; vandenBrandt, PA; Apelo, RA; Baens, J; delaCruz, JR; Javier, B; Lacaya, LB; Ngelangel, CA; LaVecchia, C; Negri, E; Marubini, E; Ferraroni, M; Gerber, M; Richardson, S; Segala, C; Gatei, D; Kenya, P; Kungu, A; Mati, JG; Brinton, LA; Hoover, R; Schairer, C; Spirtas, R; Lee, HP; Rookus, MA; vanLeeuwen, FE; Schoenberg, JA; Gammon, MD; Clarke, EA; Jones, L; McPherson, K; Neil, A; Vessey, M; Yeates, D; Beral, V; Bull, D; Crossley, B; Hermon, C; Jones, S; Key, T; Lewis, C; Reeves, G; Smith, P; Collins, R; Doll, R; Peto, R; Hannaford, P; Kay, C; RoseroBixby, L; Gao, YT; Yuan, JM; Wei, HY; Yun, T; Zhiheng, C; Berry, G; Booth, JC; Jelihovsky, T; MacLennan, R; Shearman, R; Wang, QS; Baines, CJ; Miller, AB; Wall, C; Lund, E; Stalsberg, H; Dabancens, A; Martinez, L; Molina, R; Salas, O; Alexander, FE; Hulka, BS; Bernstein, L; Haile, RW; PaganiniHill, A; Pike, MC; Ross, RK; Ursin, G; Yu, MC; Adami, HO; Bergstrom, R; Longnecker, MP; Newcomb, P; Farley, TMN; Holck, S; Meirik, O		Collaborative Group on Hormonal Factors in Breast Cancer	Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies	LANCET			English	Article							ORAL-CONTRACEPTIVES; RISK-FACTORS; PREMENOPAUSAL WOMEN; FINAL REPORT; YOUNG-WOMEN; AGE; POPULATION; ESTROGEN; ASSOCIATION; PATTERNS	Background The Collaborative Group on Hormonal Factors in Breast Cancer has brought together and reanalysed the worldwide epidemiological evidence on the relation between breast cancer risk and use of hormonal contraceptives. Methods Individual data on 53297 women with breast cancer and 100 239 women without breast cancer from 54 studies conducted in 25 countries were collected, checked, and analysed centrally. Estimates of the relative risk for breast cancer were obtained by a modification of the Mantel-Haenszel method. All analyses were stratified by study, age at diagnosis, parity, and, where appropriate, the age a woman was when her first child was born, and the age she was when her risk of conception ceased. Findings The results provide strong evidence for two main conclusions. First, while women are taking combined oral contraceptives and in the 10 years after stopping there is a small increase in the relative risk of having breast cancer diagnosed (relative risk [95% CI] in current users 1.24 [1.15-1.33], 2p<0.00001; 1-4 years after stopping 1.16 [1.08-1.23], 2p=0.00001; 5-9 years after stopping 1.07 [1.02-1.13], 2p=0.009). Second, there is no significant excess risk of having breast cancer diagnosed 10 or more years after stopping use (relative risk 1.01 [0.96-1.05], NS). The cancers diagnosed in women who had used combined oral contraceptives were less advanced clinically than those diagnosed in women who had never used these contraceptives: for ever-users compared with never-users, the relative risk for tumours that had spread beyond the breast compared with localised tumours was 0.88 (0.81-0.95; 2p=0.002). There was no pronounced variation in the results for recency of use between women with different background risks of breast cancer, including women from different countries and ethnic groups, women with different reproductive histories, and those with or without a family history of breast cancer. The studies included in this collaboration represent about 90% of the epidemiological information on the topic, and what is known about the other studies suggests that their omission has not materially affected the main conclusions. Other features of hormonal contraceptive use such as duration of use, age at first use, and the dose and type of hormone within the contraceptives had little additional effect on breast cancer risk, once recency of use had been taken into account. Women who began use before age 20 had higher relative risks of having breast cancer diagnosed while they were using combined oral contraceptives and in the 5 years after stopping than women who began use at older ages, but the higher relative risks apply at ages when breast cancer is rare and, for a given duration of use, earlier use does not result in more cancers being diagnosed than use beginning at older ages. Because breast cancer incidence rises steeply with age, the estimated excess number of cancers diagnosed in the period between starting use and 10 years after stopping increases with age at last use: for example, among 10 000 women from Europe or North America who used oral contraceptives from age 16 to 19, from age 20 to 24, and from age 25 to 29, respectively, the estimated excess number of cancers diagnosed up to 10 years after stopping use is 0.5 (95% CI 0.3-0.7), 1.5 (0.7-2.3), and 4.7 (2.7-6.7). Up to 20 years after cessation of use the difference between ever-users and never-users is not so much in the total number of cancers diagnosed, but in their clinical presentation, with the breast cancers diagnosed in ever-users being less advanced clinically than those diagnosed in never-users. The relation observed between breast cancer risk and hormone exposure is unusual, and it is not possible to infer from these data whether it is due to an earlier diagnosis of breast cancer in ever-users, the biological effects of hormonal contraceptives, or a combination of reasons. Interpretation Women who are currently using combined oral contraceptives or have used them in the past 10 years are at a slightly increased risk of having breast cancer diagnosed, although the additional cancers diagnosed tend to be localised to the breast. There is no evidence of an increase in the risk of having breast cancer diagnosed 10 or more years after cessation of use, and the cancers diagnosed then are less advanced clinically than the cancers diagnosed in never-users.	AMER CANC SOC, NEW YORK, NY USA; EMORY UNIV, ATLANTA, GA 30322 USA; AVIANO CANC CTR, PORDENONE, ITALY; MAHIDOL UNIV, BANGKOK 10700, THAILAND; JOHNS HOPKINS UNIV, BREAST TUMOR COLLABORAT STUDY, BALTIMORE, MD 21218 USA; UNIV QUEENSLAND, ST LUCIA, QLD 4067, AUSTRALIA; BRITISH COLUMBIA CANC AGCY, VANCOUVER, BC V5Z 4E6, CANADA; MRC, BIOSTAT UNIT, LONDON W1N 4AL, ENGLAND; UNIV HAWAII, CANC RES CTR, HONOLULU, HI 96822 USA; CTR DIS CONTROL & PREVENT, ATLANTA, GA 30341 USA; CENT INST CANC RES, BERLIN, GERMANY; HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,CHANNING LAB, G COLDITZ NURSES HLTH STUDY RES GRP, CAMBRIDGE, MA 02138 USA; CHIANG MAI UNIV, CHIANG MAI 50000, THAILAND; CHULALONGKORN UNIV, BANGKOK 10330, THAILAND; CSIRO, DIV HUMAN NUTR, ADELAIDE, SA 5000, AUSTRALIA; DANISH CANC SOC, COPENHAGEN, DENMARK; UNIV OTAGO, DUNEDIN, NEW ZEALAND; EUROPEAN INST ONCOL, MILAN, ITALY; FRED HUTCHINSON CANC RES CTR, SEATTLE, WA 98104 USA; INSERM, FRENCH MULTICTR BREAST STUDY, PARIS, FRANCE; HOSP GEN MEXICO CITY, MEXICO CITY, DF, MEXICO; INST GUSTAVE ROUSSY, INSERM, F-94805 VILLEJUIF, FRANCE; INST CANC RES, SUTTON, SURREY, ENGLAND; ISRAEL CHAIM SHEBA MED CTR, TEL HASHOMER, ISRAEL; KAISER PERMANENTE, OAKLAND, CA 94612 USA; IMPERIAL CANC RES FUND, GENET EPIDEMIOL LAB, LONDON, ENGLAND; INST ONCOL, LJUBLJANA, SLOVENIA; LOMA LINDA UNIV, LOMA LINDA, CA 92350 USA; LONG ISL BREAST CANC STUDY, LONG ISL CITY, NY USA; UNIV LUND HOSP, S-22185 LUND, SWEDEN; UNIV LIMBURG, 6200 MD MAASTRICHT, NETHERLANDS; UNIV PHILIPPINES, MANILA, PHILIPPINES; IST MARIO NEGRI, MILAN, ITALY; IST NAZL TUMORI, DIV STAT MED & BIOMETRIA, MILAN, ITALY; MONTPELLIER CANC CTR, MONTPELLIER, FRANCE; INSERM, MONTPELLIER, FRANCE; NAIROBI CTR RES REPROD, NAIROBI, KENYA; NCI, BETHESDA, MD 20892 USA; NICHHD, BETHESDA, MD 20892 USA; NATL UNIV SINGAPORE, SINGAPORE 117548, SINGAPORE; NEW JERSEY STATE DEPT HLTH, TRENTON, NJ 08625 USA; COLUMBIA UNIV, SCH PUBL HLTH, NEW YORK, NY 10027 USA; ONTARIO CANC TREATMENT & RES FDN, TORONTO, ON, CANADA; UNIV OXFORD, DEPT PUBL HLTH & PRIMARY CARE, OXFORD OX3 7LF, ENGLAND; ROYAL COLL GEN PRACTITIONERS ORAL CONTRACEPT STUD, LONDON, ENGLAND; UNIV COSTA RICA, SAN JOSE, COSTA RICA; IMPERIAL CANC RES FUND, MRC, BHF, CLIN TRIAL SERV UNIT, OXFORD, ENGLAND; IMPERIAL CANC RES FUND, MRC, BHF, EPIDEMIOL STUDIES UNIT, OXFORD, ENGLAND; SHANGHAI CANC INST, SHANGHAI, PEOPLES R CHINA; SHANGHAI INST PLANNED PARENTHOOD RES, SHANGHAI, PEOPLES R CHINA; DEPT PUBL HLTH, SIDNEY, BC, CANADA; TIANJIN CANC INST, TIANJIN, PEOPLES R CHINA; UNIV TORONTO, DEPT PREVENT MED & BIOSTAT, TORONTO, ON, CANADA; UNIV TROMSO, TROMSO, NORWAY; UNIV CHILE, SANTIAGO, CHILE; UNIV EDINBURGH, EDINBURGH, MIDLOTHIAN, SCOTLAND; UNIV N CAROLINA, SCH PUBL HLTH, CHAPEL HILL, NC USA; UNIV NOTTINGHAM, NOTTINGHAM NG7 2RD, ENGLAND; UNIV SO CALIF, LOS ANGELES, CA 90089 USA; UNIV UPPSALA, UPPSALA, SWEDEN; UNIV WISCONSIN, CTR COMPREHENS CANC, MADISON, WI 53706 USA; UNDP, UNFPA,WHO,WORLD BANK, SPECIAL PROGRAMME RES DEV & TRAINING HUMAN REPROD, NEW YORK, NY USA	American Cancer Society; Emory University; Mahidol University; Johns Hopkins University; University of Queensland; British Columbia Cancer Agency; MRC Biostatistics Unit; Cancer Research Center of Hawaii; University of Hawaii System; Centers for Disease Control & Prevention - USA; Harvard University; Brigham & Women's Hospital; Chiang Mai University; Chulalongkorn University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Danish Cancer Society; University of Otago; IRCCS European Institute of Oncology (IEO); Fred Hutchinson Cancer Center; Institut National de la Sante et de la Recherche Medicale (Inserm); Hospital General de Mexico; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; University of London; Institute of Cancer Research - UK; Chaim Sheba Medical Center; Kaiser Permanente; Cancer Research UK; Institute of Oncology - Slovenia; Loma Linda University; Lund University; Skane University Hospital; Hasselt University; University of the Philippines System; University of the Philippines Manila; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Fondazione IRCCS Istituto Nazionale Tumori Milan; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National University of Singapore; New Jersey Department of Health & Senior Services; Columbia University; University of Oxford; Universidad Costa Rica; University of Oxford; University of Oxford; Shanghai Jiao Tong University; Tianjin Medical University; University of Toronto; UiT The Arctic University of Tromso; Universidad de Chile; University of Edinburgh; University of North Carolina; University of North Carolina Chapel Hill; University of Nottingham; University of Southern California; Uppsala University; University of Wisconsin System; University of Wisconsin Madison; The World Bank; United Nations Population Fund; World Health Organization	Calle, EE (corresponding author), RADCLIFFE INFIRM, IMPERIAL CANC RES FUND, CANC EPIDEMIOL UNIT, OXFORD OX2 6HE, ENGLAND.		Hiatt, Robert/AAQ-1537-2021; Fentiman, Ian S/I-7644-2019; Fentiman, Ian/AAB-9886-2020; Ferraroni, Monica/D-6548-2017; Hanson, Robert L/O-3238-2015; Bachelot, Anne/GQZ-0551-2022; Colditz, Graham/A-3963-2009; Gao, Yu/HGE-1937-2022; Brinton, Louise A/G-7486-2015; Negri, Eva Vanna Lorenza/AAC-5698-2019; Richardson, Sylvia T/G-4691-2015; Negri, Eva/B-7244-2013; Ursin, Giske/U-6637-2017; Boyle, Peter/A-4380-2014; Ranstam, Jonas/A-4386-2009; franceschi, silvia/M-2452-2014; Clavel-Chapelon, Francoise/G-6733-2014	Ferraroni, Monica/0000-0002-4542-4996; Hanson, Robert L/0000-0002-4252-7068; Colditz, Graham/0000-0002-7307-0291; Brinton, Louise A/0000-0003-3853-8562; Negri, Eva Vanna Lorenza/0000-0001-9712-8526; Richardson, Sylvia T/0000-0003-1998-492X; Negri, Eva/0000-0001-9712-8526; Ursin, Giske/0000-0002-0835-9507; Boyle, Peter/0000-0001-6251-0610; Ranstam, Jonas/0000-0002-8287-7273; franceschi, silvia/0000-0003-4181-8071; La Vecchia, Carlo/0000-0003-1441-897X; Lund, Eiliv/0000-0002-8071-8711; Yuan, Jian-Min/0000-0002-4620-3108; Ewertz, Marianne/0000-0002-5965-969X; Bishop, Tim/0000-0002-8752-8785; Szklo, Moyses/0000-0001-9433-6266				ALEXANDER FE, 1987, J EPIDEMIOL COMMUN H, V41, P101, DOI 10.1136/jech.41.2.101; [Anonymous], 1992, Lancet, V339, P1; BERNSTEIN L, 1990, ORAL CONTRACEPTIVES, P169; BRINTON LA, 1995, J NATL CANCER I, V87, P827, DOI 10.1093/jnci/87.11.827; BROWNSON RC, 1988, ARCH INTERN MED, V148, P140, DOI 10.1001/archinte.148.1.140; CALLE EE, 1993, AM J EPIDEMIOL, V138, P675, DOI 10.1093/oxfordjournals.aje.a116904; CLAVEL F, 1991, INT J EPIDEMIOL, V20, P32, DOI 10.1093/ije/20.1.32; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; EWERTZ M, 1992, EUR J CANCER, V28A, P1176, DOI 10.1016/0959-8049(92)90481-G; HARRIS NV, 1982, AM J EPIDEMIOL, V116, P643, DOI 10.1093/oxfordjournals.aje.a113447; HARRIS RE, 1990, INT J EPIDEMIOL, V19, P240, DOI 10.1093/ije/19.2.240; HIATT RA, 1984, CANCER, V54, P139, DOI 10.1002/1097-0142(19840701)54:1<139::AID-CNCR2820540128>3.0.CO;2-X; HISLOP TG, 1986, CANCER DETECT PREV, V9, P47; JANERICH DT, 1983, J CHRON DIS, V36, P639, DOI 10.1016/0021-9681(83)90080-2; JICK SS, 1989, BRIT J CANCER, V59, P618, DOI 10.1038/bjc.1989.125; KAY CR, 1988, BRIT J CANCER, V58, P675, DOI 10.1038/bjc.1988.285; KELSEY JL, 1978, AM J EPIDEMIOL, V107, P236, DOI 10.1093/oxfordjournals.aje.a112530; KLEINMAN EL, 1990, HORMONAL CONTRACEPTI; LAVECCHIA C, 1995, INT J CANCER, V60, P163, DOI 10.1002/ijc.2910600205; LE MG, 1984, HORMONES SEXUAL FACT; LEE HP, 1992, CANCER CAUSE CONTROL, V3, P313, DOI 10.1007/BF00146884; LEE NC, 1987, J NATL CANCER I, V79, P1247; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MARUBINI E, 1988, CANCER, V61, P173, DOI 10.1002/1097-0142(19880101)61:1&lt;173::AID-CNCR2820610129&gt;3.0.CO;2-P; MCPHERSON K, 1987, BRIT J CANCER, V56, P653, DOI 10.1038/bjc.1987.261; MEIRIK O, 1986, LANCET, V2, P650; MILLER AB, 1992, CAN MED ASSOC J, V147, P1459; MILLS PK, 1989, CANCER, V64, P591, DOI 10.1002/1097-0142(19890801)64:3<591::AID-CNCR2820640305>3.0.CO;2-U; MORABIA A, 1993, PREV MED, V22, P178, DOI 10.1006/pmed.1993.1015; NEWCOMB PA, 1994, NEW ENGL J MED, V330, P81, DOI 10.1056/NEJM199401133300201; NGELANGEL CA, 1994, PHILIPP J INTERN MED, V32, P231; NOMURA AMY, 1986, INT J CANCER, V37, P49, DOI 10.1002/ijc.2910370109; OLSSON H, 1989, J NATL CANCER I, V81, P1000, DOI 10.1093/jnci/81.13.1000; PAFFENBARGER RS, 1977, CANCER, V39, P1887, DOI 10.1002/1097-0142(197704)39:4+<1887::AID-CNCR2820390822>3.0.CO;2-I; PAUL C, 1990, INT J CANCER, V46, P366, DOI 10.1002/ijc.2910460305; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; PIKE MC, 1983, LANCET, V2, P926; PRIMICZAKELJ M, 1995, INT J CANCER, V62, P414, DOI 10.1002/ijc.2910620410; RAMCHARAN S, 1981, NIH PUBLICATION, V3, P43; RAVNIHAR B, 1988, NEOPLASMA, V35, P109; RAVNIHAR B, 1979, EUR J CANCER, V15, P395, DOI 10.1016/0014-2964(79)90074-4; ROHAN TE, 1988, MED J AUSTRALIA, V149, P520, DOI 10.5694/j.1326-5377.1988.tb120759.x; ROMIEU I, 1989, JNCI-J NATL CANCER I, V81, P1313, DOI 10.1093/jnci/81.17.1313; ROOKUS MA, 1994, LANCET, V344, P844, DOI 10.1016/S0140-6736(94)92826-6; Rosenberg L, 1996, AM J EPIDEMIOL, V143, P25; ROSENBERG L, 1992, AM J EPIDEMIOL, V136, P1437, DOI 10.1093/oxfordjournals.aje.a116464; ROSS RK, 1980, JAMA-J AM MED ASSOC, V243, P1635, DOI 10.1001/jama.243.16.1635; ROSSING MA, IN PRESS AM J EPIDEM; SARTWELL PE, 1977, JNCI-J NATL CANCER I, V59, P1589, DOI 10.1093/jnci/59.6.1589; SCHILDKRAUT JM, 1990, OBSTET GYNECOL, V76, P395; SCHUURMAN AG, 1995, CANCER CAUSE CONTROL, V6, P416, DOI 10.1007/BF00052181; SEGALA C, 1991, BRIT J CANCER, V64, P919, DOI 10.1038/bjc.1991.427; SISKIND V, 1989, AM J EPIDEMIOL, V130, P229; STANFORD JL, 1989, BRIT J CANCER, V60, P375, DOI 10.1038/bjc.1989.288; TALAMINI R, 1985, INT J EPIDEMIOL, V14, P70, DOI 10.1093/ije/14.1.70; TAVANI A, 1993, BRIT J CANCER, V68, P568, DOI 10.1038/bjc.1993.387; THOMAS DB, 1990, BRIT J CANCER, V61, P110; URSIN G, 1992, EPIDEMIOLOGY, V3, P414, DOI 10.1097/00001648-199209000-00006; VESSEY M, 1983, BRIT J CANCER, V47, P455, DOI 10.1038/bjc.1983.74; VESSEY MP, 1989, BRIT J CANCER, V59, P613, DOI 10.1038/bjc.1989.124; WANG DY, 1987, EUR J CANCER CLIN ON, V23, P1541, DOI 10.1016/0277-5379(87)90098-8; WANG QS, 1992, CANCER EPIDEM BIOMAR, V1, P435; WEINSTEIN AL, 1991, EPIDEMIOLOGY, V2, P353, DOI 10.1097/00001648-199109000-00007; WHITE E, 1994, JNCI-J NATL CANCER I, V86, P505, DOI 10.1093/jnci/86.7.505; WINGO PA, 1991, OBSTET GYNECOL, V78, P161; WYNDER EL, 1978, CANCER-AM CANCER SOC, V41, P2341, DOI 10.1002/1097-0142(197806)41:6<2341::AID-CNCR2820410637>3.0.CO;2-N; YANG CP, 1992, CANCER CAUSE CONTROL, V3, P475, DOI 10.1007/BF00051360; YUAN JM, 1988, CANCER RES, V48, P1949; 1989, LANCET, V1, P873; IN PRESS CONTRACEPTI	71	970	990	2	74	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 22	1996	347	9017					1713	1727						15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT396	8656904	Green Submitted, hybrid			2022-12-28	WOS:A1996UT39600008
J	Prakash, N; CohenCory, S; Frostig, RD				Prakash, N; CohenCory, S; Frostig, RD			Rapid and opposite effects of BDNF and NGF on the functional organization of the adult cortex in vivo	NATURE			English	Article							INTRINSIC SIGNALS; MESSENGER-RNA; VISUAL-CORTEX; ARCHITECTURE	THE adult cortex is thought to undergo plastic changes that are closely dependent on neuronal activity (reviewed in ref. 1), although it is not yet known what molecules are involved. Neurotrophins and their receptors have been implicated in several aspects of developmental plasticity(2-4), and their expression in the adult cortex suggests additional roles in adult plasticity(5-9). To examine these potential roles in viva, we used intrinsic-signal optical imaging to quantify the effects of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) on the functional representation of a stimulated whisker in the 'barrel' subdivision of the rat somatosensory cortex. Topical application of BDNF resulted in a rapid and long-lasting decrease in the size of a whisker representation, and a decrease in the amplitude of the activity-dependent intrinsic signal, In contrast, NGF application resulted in a rapid but transient increase in the size of a representation, and an increase in the amplitude of the activity-dependent intrinsic signal. These results demonstrate that neurotrophins can rapidly modulate stimulus-dependent activity in adult cortex, and suggest a role for neurotrophins in regulating adult cortical plasticity.	UNIV CALIF IRVINE, DEPT PSYCHOBIOL, IRVINE, CA 92717 USA; UNIV CALIF IRVINE, CTR LEARNING & MEMORY, IRVINE, CA 92717 USA; CALTECH, DIV BIOL, PASADENA, CA 91125 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; California Institute of Technology				Prakash, Neal/0000-0003-0288-6573				ALTAR CA, 1994, EXP NEUROL, V130, P31, DOI 10.1006/exnr.1994.1182; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; Cellerino A., 1995, Society for Neuroscience Abstracts, V21, P2010; CHEN C, IN PRESS J NEUROSCIM; CUELLO AC, 1992, MOL NEUROBIOL, V6, P451, DOI 10.1007/BF02757946; Frostig R. D., 1994, Society for Neuroscience Abstracts, V20, P1384; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; HOLTZMAN DM, 1995, J NEUROSCI, V15, P1567; Kaas Jon H., 1995, P51; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KNIPPER M, 1994, NEUROREPORT, V5, P2433, DOI 10.1097/00001756-199412000-00007; KNIPPER M, 1993, NEUROREPORT, V4, P483, DOI 10.1097/00001756-199305000-00005; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; LINDHOLM D, 1994, J NEUROBIOL, V25, P1362, DOI 10.1002/neu.480251105; MAFFEI L, 1992, J NEUROSCI, V12, P4651; MALONEK D, 1990, Society for Neuroscience Abstracts, V16, P292; MASANA Y, 1993, J NEUROSCI RES, V35, P468, DOI 10.1002/jnr.490350503; Masino SA, 1996, P NATL ACAD SCI USA, V93, P4942, DOI 10.1073/pnas.93.10.4942; MASINO SA, 1993, P NATL ACAD SCI USA, V90, P9998, DOI 10.1073/pnas.90.21.9998; MIZUNO K, 1994, DEV BIOL, V165, P243, DOI 10.1006/dbio.1994.1250; NAWA H, 1994, J NEUROSCI, V14, P3751; Pitts AF, 1995, SOMATOSENS MOT RES, V12, P329, DOI 10.3109/08990229509093666; RACAMORA N, 1993, SOC NEUR ABSTR, V19, P259; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; ZHOU XF, 1993, BRAIN RES, V622, P63, DOI 10.1016/0006-8993(93)90802-T	30	96	96	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	1996	381	6584					702	706		10.1038/381702a0	http://dx.doi.org/10.1038/381702a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR979	8649516				2022-12-28	WOS:A1996UR97900054
J	Palmer, RH				Palmer, RH			Quality health care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Palmer, RH (corresponding author), HARVARD UNIV, SCH PUBL HLTH, 665 HUNTINGTON AVE, BOSTON, MA 02115 USA.							*AG HLTH CAR POL R, 1995, US CLIN PRACT GUID B, V1; *AG HLTH CAR POL R, 1995, UND CHOOS CLIN PERF; *AG HLTH CAR POL R, 1995, US CLIN PRACT GUID E, V2; CLEARY PD, 1991, HEALTH AFFAIR, V10, P254, DOI 10.1377/hlthaff.10.4.254; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; JENCKS SF, 1995, JOINT COMM J QUAL IM, V21, P343, DOI 10.1016/S1070-3241(16)30160-2; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; Nadzam D M, 1993, Jt Comm J Qual Improv, V19, P492; *NAT COMM QUAL ASS, 1993, REP CARD PIL PROJ KE; Palmer RH, 1995, HEALTH AFFAIR, V14, P89, DOI 10.1377/hlthaff.14.4.89; *US GEN ACC OFF, 1994, HLTH CAR REF REP CAR; *US GEN ACC OFF, 1995, MED ENH HLTH CAR QUA; *US GEN ACC OFF, 1994, HLTH CAR EMPL URG HO; *US GEN ACC OFF, 1995, HLTH CAR EMPL IND CO; VLADECK BC, 1995, JAMA-J AM MED ASSOC, V273, P1483, DOI 10.1001/jama.273.19.1483; WEINER JP, 1995, JAMA-J AM MED ASSOC, V273, P1503, DOI 10.1001/jama.273.19.1503; Zapka J G, 1995, J Ambul Care Manage, V18, P73	17	9	10	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1851	1852		10.1001/jama.275.23.1851	http://dx.doi.org/10.1001/jama.275.23.1851			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642747				2022-12-28	WOS:A1996UQ15200046
J	Graham, RW; Lundelius, EL; Graham, MA; Schroeder, EK; Toomey, RS; Anderson, E; Barnosky, AD; Burns, JA; Churcher, CS; Grayson, DK; Guthrie, RD; Harington, CR; Jefferson, GT; Martin, LD; McDonald, HG; Morlan, RE; Semken, HA; Webb, SD; Werdelin, L; Wilson, MC				Graham, RW; Lundelius, EL; Graham, MA; Schroeder, EK; Toomey, RS; Anderson, E; Barnosky, AD; Burns, JA; Churcher, CS; Grayson, DK; Guthrie, RD; Harington, CR; Jefferson, GT; Martin, LD; McDonald, HG; Morlan, RE; Semken, HA; Webb, SD; Werdelin, L; Wilson, MC			Spatial response of mammals to late quaternary environmental fluctuations	SCIENCE			English	Article							CLIMATE CHANGE	Analyses of fossil mammal faunas from 2945 localities in the United States demonstrate that the geographic ranges of individual species shifted at different times, in different directions, and at different rates in response to late Quaternary environmental fluctuations. The geographic pattern of faunal provinces was similar for the late Pleistocene and late Holocene, but differing environmental gradients resulted in dissimilar species composition for these biogeographic regions. Modern community patterns emerged only in the last few thousand years, and many late Pleistocene communities do not have modern analogs. Faunal heterogeneity was greater in the late Pleistocene.	ILLINOIS STATE MUSEUM,RES & COLLECT CTR,SPRINGFIELD,IL 62703; UNIV TEXAS,DEPT GEOL SCI,AUSTIN,TX 78712; MONTANA STATE UNIV,MT RES CTR,BOZEMAN,MT 59715; PROV MUSEUM ALBERTA,EDMONTON,AB T5N 0M6,CANADA; UNIV TORONTO,DEPT ZOOL,TORONTO,ON M5S 1A1,CANADA; UNIV WASHINGTON,DEPT ANTHROPOL,SEATTLE,WA 98195; UNIV ALASKA,DEPT BIOL,FAIRBANKS,AK 99701; CANADIAN MUSEUM NAT,EARTH SCI SECT PALEOBIOL,OTTAWA,ON K1P 6P4,CANADA; ANZA BORREGO DESERT STATE PK,BORREGO SPRINGS,CA 92004; UNIV KANSAS,MUSEUM NAT HIST,LAWRENCE,KS 66045; HAGERMAN FOSSIL BEDS NATL MONUMENT,HAGERMAN,ID 83332; CANADIAN MUSEUM CIVILIZAT,HULL,PQ J8X 4H2,CANADA; UNIV IOWA,DEPT GEOL,IOWA CITY,IA 52242; UNIV FLORIDA,FLORIDA MUSEUM NAT HIST,GAINESVILLE,FL 32611; SWEDISH MUSEUM NAT HIST,DEPT PALAEOZOOL,S-10405 STOCKHOLM,SWEDEN; SIMON FRASER UNIV,DEPT ARCHAEOL,BURNABY,BC V5A 1S6,CANADA	University of Texas System; University of Texas Austin; Montana State University System; Montana State University Bozeman; University of Toronto; University of Washington; University of Washington Seattle; University of Alaska System; University of Alaska Fairbanks; University of Kansas; University of Iowa; State University System of Florida; University of Florida; Swedish Museum of Natural History; Simon Fraser University	Graham, RW (corresponding author), DENVER MUSEUM NAT HIST,2001 COLORADO BLVD,DENVER,CO 80205, USA.							BLAIR WF, 1958, ZOOGEOGRAPHY, P433; BOND GC, 1995, SCIENCE, V267, P1005, DOI 10.1126/science.267.5200.1005; CAMERON GN, 1981, MAMM SPECIES, V158, P1; Clements F. E., 1904, BOT SURVEY NEBRASKA, V7; Clements F.E, 1916, PLANT SUCCESSION ANA; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Davis M., 1976, GEOSCIENCE MAN, V13, P13; Davis MB, 1983, LATE QUATERNARY US V, V2, P166; Delcourt HR, 1988, LANDSCAPE ECOL, V2, P23, DOI 10.1007/BF00138906; *FAUNMAP WORK GROU, 1994, ILLINOIS STATE MUSEU, V25, P1; FLESSA KW, 1979, GEOLOGY, V7, P15, DOI 10.1130/0091-7613(1979)7<15:GIOTRB>2.0.CO;2; FLYNN JJ, 1986, CONTRIBUTIONS GEOLOG, V3, P317; FREY JK, 1992, J MAMMAL, V73, P43, DOI 10.2307/1381864; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Gleason HA, 1922, ANN ASSOC AM GEOGR, V12, P39, DOI 10.2307/2560590; Graham R.W., 1984, P223; Graham R.W., 1992, P76; Graham R. W., 1986, COMMUNITY ECOLOGY, P300; Graham Russell W., 1990, P54; Graham Russell W., 1979, PRELLANO CULTURES AM, P49; GRAHAM RW, 1988, CONSERV BIOL, V2, P391, DOI 10.1111/j.1523-1739.1988.tb00204.x; GRAHAM RW, 1990, TRENDS ECOL EVOL, V5, P289, DOI 10.1016/0169-5347(90)90083-P; GRAHAM RW, 1987, N AM ADJACENT OCEANS, P371; GRAYSON DK, 1993, DESERTS PAST NATURAL; GUTHRIE RD, 1979, PALEOECOLOGY BERINGI, P307; Hill M.O., 1979, TWINSPAN FORTRAN PRO; HUMPHREY SR, 1974, BIOSCIENCE, V24, P457, DOI 10.2307/1296853; JACOBSON GL, 1987, N AM ADJACENT OCEANS, P277; JONES JK, 1992, OCCAS PAPERS MUS TEX, V146, P1; KING JE, 1981, ECOL MONOGR, V51, P43, DOI 10.2307/2937306; KUCHLER AW, 1964, SPECIAL PUBLICATIONS, V36, P1; Kurten B., 1980, PLEISTOCENE MAMMALS; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Martin L.D., 1985, P15; Martin L.D., 1978, Transactions of the Nebraska Academy of Sciences, V6, P117; MARTIN LD, 1987, KANSAS GEOLOGICAL SU, V5, P159; MARTIN PS, 1958, ZOOGEOGRAPHY, P375; MAYEWSKI PA, 1993, SCIENCE, V261, P195, DOI 10.1126/science.261.5118.195; OVERPECK JT, 1992, GEOLOGY, V20, P1071, DOI 10.1130/0091-7613(1992)020<1071:MENAVC>2.3.CO;2; PETEET DM, 1993, QUATERNARY SCI REV, V12, P277; RHODES RS, 1984, ILLINOIS STATE MUSEU, V40, P1; ROGERS RA, 1990, J BIOGEOGR, V17, P131, DOI 10.2307/2845322; SEMKEN HA, IN PRESS ACTA ZOOL C; SHI GR, 1993, PALAEOGEOGR PALAEOCL, V105, P199, DOI 10.1016/0031-0182(93)90084-V; STANGL FB, 1987, TEX J SCI, V39, P292; TAYLOR KC, 1993, NATURE, V361, P432, DOI 10.1038/361432a0; Thompson Robert S., 1993, P468; TRANSEAU EN, 1935, ECOLOGY, V16, P422; TUTHRIE RD, 1984, QUATERNARY EXTINCTIO, P259; Webb Thompson Iii, 1993, P415; [No title captured]; 1993, Q SCI REV, V12, P1	52	442	454	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1996	272	5268					1601	1606						6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8662471				2022-12-28	WOS:A1996UR09300033
J	Eck, MJ; DhePaganon, S; Trub, T; Nolte, RT; Shoelson, SE				Eck, MJ; DhePaganon, S; Trub, T; Nolte, RT; Shoelson, SE			Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor	CELL			English	Article							AFFINITY PHOSPHOTYROSYL PEPTIDE; SH2 DOMAIN; PROTEIN; RECOGNITION; BINDING	Crystal structures of the insulin receptor substrate-1 (IRS-1) phosphotyrosine-binding (PTB) domain, alone and complexed with the juxtamembrane region of the insulin receptor, show how this domain recognizes phosphorylated ''NPXY'' sequence motifs. The domain is a 7-stranded beta sandwich capped by a C-terminal helix. The insulin receptor phosphopeptide fills an L-shaped cleft on the domain. The N-terminal residues of the bound peptide form an additional strand in the beta sandwich, stabilized by contacts with the C-terminal helix. These interactions explain why IRS-1 binds to the insulin receptor but not to NPXpY motifs in growth factor receptors. The PTB domains of IRS-1 and Shc share a common fold with pleckstrin homology domains. Overall, ligand binding by IRS-1 and Shc PTB domains is similar, but residues critical for phosphotyrosine recognition are not conserved.	HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; HARVARD UNIV,SCH MED,JOSLIN DIABET CTR,DIV RES,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Eck, MJ (corresponding author), HARVARD UNIV,CHILDRENS HOSP,SCH MED,MOLEC MED LAB,BOSTON,MA 02115, USA.				NIDDK NIH HHS [DK43123] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043123] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; ARAKI E, 1993, DIABETES, V42, P1041, DOI 10.2337/diabetes.42.7.1041; BLAIKIE P, 1994, J BIOL CHEM, V269, P32031; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; BRUNGER AT, 1992, XPLOR VERSION 3 1 SY, V24, P958; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DIKIC I, 1995, J BIOL CHEM, V270, P15125, DOI 10.1074/jbc.270.25.15125; ECK MJ, 1994, NATURE, V368, P764, DOI 10.1038/368764a0; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; HE WM, 1995, J BIOL CHEM, V270, P23258, DOI 10.1074/jbc.270.40.23258; He WM, 1996, J BIOL CHEM, V271, P11641, DOI 10.1074/jbc.271.20.11641; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; JONES TA, 1989, CRYSTALLOGRAPHIC COM; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KAVANAUGH WM, 1995, SCIENCE, V268, P1177, DOI 10.1126/science.7539155; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; MYERS MG, 1995, J BIOL CHEM, V270, P11715, DOI 10.1074/jbc.270.20.11715; NAVAZA J, 1992, P CCP4 STUDY WEEKEND, P87; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nolte RT, 1996, NAT STRUCT BIOL, V3, P364, DOI 10.1038/nsb0496-364; ONEILL TJ, 1994, MOL CELL BIOL, V14, P6433, DOI 10.1128/MCB.14.10.6433; Otwinowski Z, 1991, P CCP4 STUD WEEK IS, P80; PICCIONE E, 1993, BIOCHEMISTRY-US, V32, P3197, DOI 10.1021/bi00064a001; SawkaVerhelle D, 1996, J BIOL CHEM, V271, P5980, DOI 10.1074/jbc.271.11.5980; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; TERWILLIGER TC, 1988, ACTA CRYSTALLOGR A, V43, P6; TRUB T, 1995, J BIOL CHEM, V270, P18205; VANDERGEER P, 1995, CURR BIOL, V5, P404, DOI 10.1016/S0960-9822(95)00081-9; VOLIOVITCH H, 1995, J BIOL CHEM, V270, P18083, DOI 10.1074/jbc.270.30.18083; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; WHITE MF, 1988, CELL, V54, P641, DOI 10.1016/S0092-8674(88)80008-4; WHITE MF, 1988, J BIOL CHEM, V263, P2969; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; Zhou MM, 1996, NAT STRUCT BIOL, V3, P388, DOI 10.1038/nsb0496-388; ZHOU MM, 1995, NATURE, V92, P7784	49	255	261	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 31	1996	85	5					695	705		10.1016/S0092-8674(00)81236-2	http://dx.doi.org/10.1016/S0092-8674(00)81236-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UP344	8646778	Bronze			2022-12-28	WOS:A1996UP34400010
J	Kogoma, T				Kogoma, T			Recombination by replication	CELL			English	Review							ESCHERICHIA-COLI; LAMBDA				Kogoma, T (corresponding author), UNIV NEW MEXICO,HLTH SCI CTR,CANC RES & TREATMENT CTR,DEPT MICROBIOL,DEPT CELL BIOL,ALBUQUERQUE,NM 87131, USA.							ASAI T, 1994, CELL, V78, P1051, DOI 10.1016/0092-8674(94)90279-8; CAO Y, 1995, GENETICS, V139, P1483; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Eggleston AK, 1996, TRENDS GENET, V12, P20, DOI 10.1016/0168-9525(96)81384-9; JEGGO PA, 1995, BIOESSAYS, V17, P949, DOI 10.1002/bies.950171108; Kogoma T, 1996, J BACTERIOL, V178, P1258, DOI 10.1128/jb.178.5.1258-1264.1996; Kreuzer K. N., 1994, MOL BIOL BACTERIOP T, P28; KUZMINOV A, 1994, EMBO J, V13, P2764, DOI 10.1002/j.1460-2075.1994.tb06570.x; MASAI H, 1994, EMBO J, V13, P5338, DOI 10.1002/j.1460-2075.1994.tb06868.x; MASAI H, 1996, IN PRESS FRONTIERS B; Sandler SJ, 1996, GENETICS, V143, P5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SMITH GR, 1991, CELL, V64, P19, DOI 10.1016/0092-8674(91)90205-D; STAHL FW, 1972, P NATL ACAD SCI USA, V69, P3598, DOI 10.1073/pnas.69.12.3598; THALER DS, 1988, ANNU REV GENET, V22, P169, DOI 10.1146/annurev.ge.22.120188.001125; VIRET JF, 1991, MICROBIOL REV, V55, P675, DOI 10.1128/MMBR.55.4.675-683.1991; ZAVITZ KH, 1992, J BIOL CHEM, V267, P6933	17	109	113	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 31	1996	85	5					625	627		10.1016/S0092-8674(00)81229-5	http://dx.doi.org/10.1016/S0092-8674(00)81229-5			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UP344	8646771	Bronze			2022-12-28	WOS:A1996UP34400003
J	Yang, YS; Kochoyan, M; Burgstaller, P; Westhof, E; Famulok, M				Yang, YS; Kochoyan, M; Burgstaller, P; Westhof, E; Famulok, M			Structural basis of ligand discrimination by two related RNA aptamers resolved by NMR spectroscopy	SCIENCE			English	Article							CONFORMATION; HAIRPIN; LOOP; INVITRO; COMPLEX; DNA	In a previous study, an RNA aptamer for the specific recognition of arginine was evolved from a parent sequence that bound citrulline specifically. The two RNAs differ al only 3 positions out of 44. The solution structures df the two aptamers complexed to their cognate amino acids have now been determined by two-dimensional nuclear magnetic resonance spectroscopy, Both aptamers contain two asymmetrical internal loops that are not well ordered in the free RNA but that fold into a compact structure upon ligand binding. Those nucleotides common to both RNAs include a conserved cluster of purine residues, three of which form an uneven plane containing a G:G pair, and two other residues nearly perpendicular to that surface, Two of the three variant nucleotides are stacked on the cluster of purines and form a triple contact to the amino acid side chain, whereas the edge of the third variant nucleotide is capping the binding pocket.	CBS FAC PHARM,F-34060 MONTPELLIER,FRANCE; ECOLE POLYTECH,CNRS,UNITE RECH ASSOCIEE D1254,GRP BIOPHYS,F-91128 PALAISEAU,FRANCE; UNIV MUNICH,GENZENTRUM,INST BIOCHEM,D-81675 MUNICH,GERMANY; INST BIOL MOLEC & CELLULAIRE,CNRS,UNITE PROPRE RECH 9002,F-67084 STRASBOURG,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; University of Munich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg								ALLAIN FHT, 1995, J MOL BIOL, V250, P333, DOI 10.1006/jmbi.1995.0381; BLINGTON AD, 1994, CURR BIOL, V4, P427; BRUNGER AT, 1992, X PLOR USER MANUAL V; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Burgstaller P, 1995, NUCLEIC ACIDS RES, V23, P4769, DOI 10.1093/nar/23.23.4769; CHEN L, 1995, P NATL ACAD SCI USA, V92, P5077, DOI 10.1073/pnas.92.11.5077; CHEONG CJ, 1990, NATURE, V346, P680, DOI 10.1038/346680a0; ELINGTON AD, 1990, NATURE, V346, P818; FAMULOK M, 1994, J AM CHEM SOC, V116, P1698, DOI 10.1021/ja00084a010; GOLD L, 1995, J BIOL CHEM, V270, P13581, DOI 10.1074/jbc.270.23.13581; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; HEUS HA, 1991, SCIENCE, V253, P191, DOI 10.1126/science.1712983; HIRAO I, 1995, CURR BIOL, V5, P1017, DOI 10.1016/S0960-9822(95)00205-3; JOYCE GF, 1994, CURR OPIN STRUC BIOL, V4, P331, DOI 10.1016/S0959-440X(94)90100-7; KELLOGG G, 1993, FEBS LETT, V327, P261; KLUG SJ, 1994, MOL BIOL REP, V20, P97, DOI 10.1007/BF00996358; LAUGHLAN G, 1994, SCIENCE, V265, P520, DOI 10.1126/science.8036494; MASSIRE C, 1994, J MOL GRAPHICS, V12, P201, DOI 10.1016/0263-7855(94)80088-X; NAGAL K, 1994, RNA PROTEIN INTERACT; NIKONOWICZ EP, 1992, NUCLEIC ACIDS RES, V20, P4508; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PETERSON RD, 1994, BIOCHEMISTRY-US, V33, P5357, DOI 10.1021/bi00184a001; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; PRETTRE CG, 1976, BIOPOLYMERS, V15, P2277; PUGLISI EV, 1994, P NATL ACAD SCI USA, V91, P11467, DOI 10.1073/pnas.91.24.11467; PUGLISI JD, 1990, J MOL BIOL, V214, P437, DOI 10.1016/0022-2836(90)90192-O; PUGLISI JD, 1995, SCIENCE, V270, P1200, DOI 10.1126/science.270.5239.1200; PUGLISI JD, 1992, SCIENCE, V257, P76, DOI 10.1126/science.1621097; PUGLISI JD, 1990, BIOCHEMISTRY-US, V29, P4215, DOI 10.1021/bi00469a026; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; SANTALUCIA J, 1993, BIOCHEMISTRY-US, V32, P12612, DOI 10.1021/bi00210a009; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; SKLENAR V, 1987, J MAGN RESON, V74, P469, DOI 10.1016/0022-2364(87)90269-1; SZOSTAK JW, 1992, TRENDS BIOCHEM SCI, V17, P89, DOI 10.1016/0968-0004(92)90242-2; TAO JS, 1992, P NATL ACAD SCI USA, V89, P2723, DOI 10.1073/pnas.89.7.2723; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; VARANI G, 1989, BIOCHEMISTRY-US, V28, P7760, DOI 10.1021/bi00445a036; VARANI G, 1991, BIOCHEMISTRY-US, V30, P3280, DOI 10.1021/bi00227a016; WESTHOF E, 1985, J MOL BIOL, V184, P119, DOI 10.1016/0022-2836(85)90048-8; WIMBERLY B, 1993, BIOCHEMISTRY-US, V32, P1078, DOI 10.1021/bi00055a013; Wuthrich K, 1986, NMR PROTEINS NUCL AC; WYATT JR, 1991, BIOTECHNIQUES, V11, P764; Yang Y., UNPUB; Ye XM, 1995, CHEM BIOL, V2, P827, DOI 10.1016/1074-5521(95)90089-6	45	162	168	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1343	1347		10.1126/science.272.5266.1343	http://dx.doi.org/10.1126/science.272.5266.1343			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8650546				2022-12-28	WOS:A1996UN47200048
J	Wrighton, NC; Farrell, FX; Chang, R; Kashyap, AK; Barbone, FP; Mulcahy, LS; Johnson, DL; Barrett, RW; Jolliffe, LK; Dower, WJ				Wrighton, NC; Farrell, FX; Chang, R; Kashyap, AK; Barbone, FP; Mulcahy, LS; Johnson, DL; Barrett, RW; Jolliffe, LK; Dower, WJ			Small peptides as potent mimetics of the protein hormone erythropoietin	SCIENCE			English	Article							HUMAN GROWTH-HORMONE; TYROSINE PHOSPHORYLATION; CELL-LINE; COMBINATORIAL TECHNOLOGIES; EXTRACELLULAR DOMAIN; RECEPTOR SUPERFAMILY; DRUG DISCOVERY; GM-CSF; ACTIVATION; LIBRARY	Random phage display peptide libraries and affinity selective methods were used to isolate small peptides that bind to and activate the receptor for the cytokine erythropoietin (EPO). In a panel of in vitro biological assays, the peptides act as full agonists and they can also stimulate erythropoiesis in mice. These agonists are represented by a 14-amino acid disulfide-bonded, cyclic peptide with the minimum consensus sequence YXCXXGPXTWXCXP, where X represents positions allowing occupation by several amino acids. The amino acid sequences of these peptides are not found in the primary sequence of EPO. The signaling pathways activated by these peptides appear to be identical to those induced by the natural ligand. This discovery may form the basis for the design of small molecule mimetics of EPO.	RW JOHNSON PHARMACEUT RES INST, DEPT DRUG DISCOVERY RES, RARITAN, NJ 08869 USA	Johnson & Johnson; Johnson & Johnson USA	Wrighton, NC (corresponding author), AFFYMAX RES INST, 4001 MIRANDA AVE, PALO ALTO, CA 94304 USA.							AVANZI GC, 1988, BRIT J HAEMATOL, V69, P359, DOI 10.1111/j.1365-2141.1988.tb02374.x; BABU P, UNPUB; BARBONE AG, 1994, J PHARMACEUT BIOMED, V12, P515, DOI 10.1016/0731-7085(93)E0006-9; BARRETT RW, 1992, ANAL BIOCHEM, V204, P357, DOI 10.1016/0003-2697(92)90252-3; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; CARROLL MP, 1991, J BIOL CHEM, V266, P14964; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; COSMAN D, 1993, CYTOKINE, V5, P95, DOI 10.1016/1043-4666(93)90047-9; COTES PM, 1961, NATURE, V191, P1065, DOI 10.1038/1911065a0; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; DAMEN JE, 1993, BLOOD, V82, P2296; DANDREA AD, 1989, CELL, V57, P277, DOI 10.1016/0092-8674(89)90965-3; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DUSANTERFOURT I, 1992, J BIOL CHEM, V267, P10670; Farrell F., UNPUB; FAULDS D, 1989, DRUGS, V38, P863, DOI 10.2165/00003495-198938060-00004; FOA P, 1991, ACTA HAEMATOL-BASEL, V86, P162, DOI 10.1159/000204826; FREAKE HC, 1981, BIOCHEM BIOPH RES CO, V101, P1131, DOI 10.1016/0006-291X(81)91565-5; GALLOP MA, 1994, J MED CHEM, V37, P1233, DOI 10.1021/jm00035a001; GORDON EM, 1994, J MED CHEM, V37, P1385, DOI 10.1021/jm00036a001; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; GREENWOOD J, 1991, J MOL BIOL, V220, P821, DOI 10.1016/0022-2836(91)90354-9; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Howard M, 1994, GUIDEBOOK CYTOKINES; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Johnson D. B., UNPUB; Johnson DL, 1996, PROTEIN EXPRES PURIF, V7, P104, DOI 10.1006/prep.1996.0014; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Kodama HA., 1981, JPN J ORAL BIOL, V23, P899, DOI DOI 10.2330/JORALBIOSCI1965.23.899; KRANTZ SB, 1991, BLOOD, V77, P419; LANDSCHULZ KT, 1989, BLOOD, V73, P1476; LANGE B, 1987, BLOOD, V70, P192; MARTENS CL, 1995, J BIOL CHEM, V270, P21129, DOI 10.1074/jbc.270.36.21129; MIURA O, 1991, MOL CELL BIOL, V11, P4895, DOI 10.1128/MCB.11.10.4895; MIURA O, 1994, BLOOD, V84, P1501; MIURA O, 1994, BLOOD, V84, P4135, DOI 10.1182/blood.V84.12.4135.bloodjournal84124135; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Philo JS, 1996, BIOCHEMISTRY-US, V35, P1681, DOI 10.1021/bi9524272; QUELLE FW, 1991, J BIOL CHEM, V266, P609; ROSENBRONSON S, 1986, IMMUNOGENETICS, V23, P368, DOI 10.1007/BF00372669; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; WATOWICH SS, 1994, MOL CELL BIOL, V14, P3535, DOI 10.1128/MCB.14.6.3535; WHITEHORN EA, 1995, BIO-TECHNOL, V13, P1215, DOI 10.1038/nbt1195-1215; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; WRIGHTON NC, UNPUB; Yanofsky SD, 1996, P NATL ACAD SCI USA, V93, P7381, DOI 10.1073/pnas.93.14.7381; YMER S, 1985, NATURE, V317, P255, DOI 10.1038/317255a0; YOSHIMURA A, 1990, NATURE, V348, P647, DOI 10.1038/348647a0; YOUSSOUFIAN H, 1993, BLOOD, V81, P2223	53	629	762	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	1996	273	5274					458	463		10.1126/science.273.5274.458	http://dx.doi.org/10.1126/science.273.5274.458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY983	8662529				2022-12-28	WOS:A1996UY98300031
J	Levy, JA				Levy, JA			Surrogate markers in AIDS research - Is there truth in numbers?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIV; LYMPHOCYTES; INFECTION		UNIV CALIF SAN FRANCISCO,SCH MED,DEPT MED,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	Levy, JA (corresponding author), UNIV CALIF SAN FRANCISCO,SCH MED,CANC RES INST,SAN FRANCISCO,CA 94143, USA.							BARKER E, 1995, P NATL ACAD SCI USA, V92, P11135, DOI 10.1073/pnas.92.24.11135; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; CAMERON B, 1996, 3 C RETR OPP INF WAS; CHOI SS, 1993, ANN INTERN MED, V118, P674, DOI 10.7326/0003-4819-118-9-199305010-00003; CLERICI M, 1993, SCIENCE, V262, P1721, DOI 10.1126/science.7903123; DAQUILA RT, 1994, CLIN LAB MED, V14, P393, DOI 10.1016/S0272-2712(18)30385-8; DELOES SK, 1995, NEW ENGL J MED, V333, P408; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502; HENRARD DR, 1995, JAMA-J AM MED ASSOC, V274, P554, DOI 10.1001/jama.274.7.554; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; KOVACS JA, 1995, NEW ENGL J MED, V332, P567, DOI 10.1056/NEJM199503023320904; Lech WJ, 1996, J VIROL, V70, P2038, DOI 10.1128/JVI.70.3.2038-2043.1996; LEE TH, 1994, J ACQ IMMUN DEF SYND, V7, P381; LEVY JA, 1995, LANCET, V345, P1619, DOI 10.1016/S0140-6736(95)90121-3; Levy JA, 1996, SCIENCE, V271, P670, DOI 10.1126/science.271.5249.670; Levy JA, 1996, IMMUNOL TODAY, V17, P217, DOI 10.1016/0167-5699(96)10011-6; MACKEWICZ CE, 1994, LANCET, V344, P1671, DOI 10.1016/S0140-6736(94)90459-6; MACKEWICZ CE, 1994, CLIN IMMUNOL IMMUNOP, V73, P80, DOI 10.1006/clin.1994.1172; Mayaux MJ, 1996, JAMA-J AM MED ASSOC, V275, P606, DOI 10.1001/jama.275.8.606; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Pantaleo G, 1995, J ACQ IMMUN DEF SYND, V10, pS6; PHILLIPS AN, 1991, LANCET, V337, P389; Raboud JM, 1996, J ACQ IMMUN DEF SYND, V12, P46, DOI 10.1097/00042560-199605010-00007; RICHMAN DD, 1992, AIDS RES HUM RETROV, V8, P1065, DOI 10.1089/aid.1992.8.1065; STEIN DS, 1992, J INFECT DIS, V165, P352, DOI 10.1093/infdis/165.2.352; VOLBERDING PA, 1995, NEW ENGL J MED, V333, P401, DOI 10.1056/NEJM199508173330701; VOLBERDING PA, 1988, MED MANAGEMENT AIDS, P353; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; WESTERMANN J, 1990, IMMUNOL TODAY, V11, P406, DOI 10.1016/0167-5699(90)90160-B	31	17	17	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1996	276	2					161	162		10.1001/jama.276.2.161	http://dx.doi.org/10.1001/jama.276.2.161			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UV485	8656510				2022-12-28	WOS:A1996UV48500034
J	Ahmadi, TS; Wang, ZL; Green, TC; Henglein, A; ElSayed, MA				Ahmadi, TS; Wang, ZL; Green, TC; Henglein, A; ElSayed, MA			Shape-controlled synthesis of colloidal platinum nanoparticles	SCIENCE			English	Article							CATALYSTS	The shapes and sizes of platinum nanoparticles were controlled by changes in the ratio of the concentration of the capping polymer material to the concentration of the platinum cations used in the reductive synthesis of colloidal particles in solution at room temperature. Tetrahedral, cubic, irregular-prismatic, icosahedral, and cube-octahedral particle shapes were observed, whose distribution was dependent on the concentration ratio of the capping polymer material to the platinum cation. Controlling the shape of platinum nanoparticles is potentially important In the field of catalysis.	GEORGIA INST TECHNOL, SCH CHEM & BIOCHEM, ATLANTA, GA 30332 USA; GEORGIA INST TECHNOL, SCH MAT SCI & ENGN, ATLANTA, GA 30332 USA; HAHN MEITNER INST BERLIN GMBH, ABT KLEINTEILCHENFORSCH, D-14109 BERLIN, GERMANY	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)			Wang, Zhong Lin/E-2176-2011; wang, jie/GRS-0942-2022	Wang, Zhong Lin/0000-0002-5530-0380; 				AHMADI TS, UNPUB; BRUCHE B, 1960, KOLLOID Z, V170, P97; BRUGGER PA, 1981, J AM CHEM SOC, V103, P2923, DOI 10.1021/ja00401a002; Charles S. C., 1980, FERROMAGNETIC MAT FERROMAGNETIC MAT, V2; CLINT JH, 1993, FARADAY DISCUSS, V95, P219, DOI 10.1039/fd9939500219; CURTIS AC, 1988, ANGEW CHEM INT EDIT, V27, P1530, DOI 10.1002/anie.198815301; DUFF DG, 1995, J PHYS CHEM-US, V99, P15934, DOI 10.1021/j100043a036; HENGLEIN A, 1995, J PHYS CHEM-US, V99, P14129, DOI 10.1021/j100038a053; HIRAI H, 1983, CHEM LETT, P1047, DOI 10.1246/cl.1983.1047; Kirkland A. I., 1990, ANNU REP PROG CHEM C, V87, P247, DOI DOI 10.1039/PC9908700247; LEFF DV, 1995, J PHYS CHEM-US, V99, P7036, DOI 10.1021/j100018a041; MILLIGAN WO, 1964, J AM CHEM SOC, V86, P3461, DOI 10.1021/ja01071a012; Rampino LD, 1941, J AM CHEM SOC, V63, P2745, DOI 10.1021/ja01855a070; SCHON G, 1995, COLLOID POLYM SCI, V273, P202, DOI 10.1007/BF00657826; THOMAS JM, 1988, PURE APPL CHEM, V60, P1517, DOI 10.1351/pac198860101517; TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055	16	2202	2329	15	870	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	1996	272	5270					1924	1926		10.1126/science.272.5270.1924	http://dx.doi.org/10.1126/science.272.5270.1924			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8662492				2022-12-28	WOS:A1996UV29400043
J	Emanuel, EJ				Emanuel, EJ			Cost savings at the end of life - What do the data show?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVANCE DIRECTIVES; NATIONAL HOSPICE; CANCER-PATIENTS; CARE; DEATH; HOME; EXPENDITURES; SERVICES; TRIAL	Medical care at the end of life consumes 10% to 12% of the total health care budget and 27% of the Medicare budget. Many people claim that increased use of hospice and advance directives and lower use of high-technology interventions for terminally ill patients will produce significant cost savings. However, the studies on cost savings from hospice and advance directives are not definitive, The 3 randomized trials show no savings from these interventions, but either they are too small for confidence in their negative results or their intervention and cost accounting are flawed, The nonrandomized trials of hospice and advance directives show a wide range of savings, from 68% to none. Five methodological issues obscure the assessment of these studies: (1) selection bias in those patients who use hospice and advance directives, (2) the different time frames of assessing the costs, (3) the limited types of medical costs evaluated, (4) the variability of reporting the savings, and (5) the lack of generalizability of the findings to other patient populations, A more definitive study that assessed patients' end-of-life care preferences, use of hospice and advance directives, and direct and indirect costs would be desirable, In the absence of such a study, the existing data suggest that hospice and advance directives can save between 25% and 40% of health care costs during the last month of life, with savings decreasing to 10% to 17% over the last 6 months of life and decreasing further to 0% to 10% over the last 12 months of life. These savings are less than most people anticipate. Nevertheless, they do indicate that hospice and advance directives should be encouraged because they certainly do not cost more and they provide a means for patients to exercise their autonomy over end-of-life decisions.	HARVARD UNIV,SCH MED,DIV MED ETH,BOSTON,MA 02115	Harvard University; Harvard Medical School	Emanuel, EJ (corresponding author), DANA FARBER CANC INST,CTR OUTCOMES & POLICY RES,DIV CANC EPIDEMIOL & CONTROL,44 BINNEY ST,BOSTON,MA 02115, USA.							Amado A, 1979, Nurs Outlook, V27, P522; Berwick DM, 1995, HASTINGS CENT REP, V25, pS21, DOI 10.2307/3527853; BILLINGS JA, 1995, HARV MED SCH DIV MED; BLOOM BS, 1980, MED CARE, V18, P560, DOI 10.1097/00005650-198005000-00009; BROOKS CH, 1984, MED CARE, V22, P691, DOI 10.1097/00005650-198408000-00002; CHAMBERS CV, 1994, ARCH INTERN MED, V154, P541, DOI 10.1001/archinte.154.5.541; CLEMENS SL, 1959, AUTOBIOGRAPHY, pCH29; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; DORONZIO JC, 1993, NY TIMES        0608, pA25; EMANUEL EJ, 1993, AM J MED, V95, P619, DOI 10.1016/0002-9343(93)90358-V; EMANUEL EJ, 1994, NEW ENGL J MED, V330, P540, DOI 10.1056/NEJM199402243300806; EMANUEL EJ, 1994, NEW ENGL J MED, V331, P478; Emanuel LL, 1995, HASTINGS CENT REP, V25, pS14, DOI 10.2307/3527851; FAIRCLOUGH HR, 1929, SATIRES EPISTLES ARS, P246; FRIES JF, 1993, NEW ENGL J MED, V329, P321, DOI 10.1056/NEJM199307293290506; GRAY D, 1987, J CHRON DIS, V40, P801, DOI 10.1016/0021-9681(87)90132-9; GREER DS, 1986, J CHRON DIS, V39, P9, DOI 10.1016/0021-9681(86)90103-7; JAAKKIMAINEN L, 1990, J CLIN ONCOL, V8, P1301, DOI 10.1200/JCO.1990.8.8.1301; KANE RL, 1984, LANCET, V1, P890; KIDDER D, 1992, HEALTH SERV RES, V27, P195; LO B, 1995, JAMA-J AM MED ASSOC, V274, P1634, DOI 10.1001/jama.274.20.1634; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; LUNDBERG GD, 1993, JAMA-J AM MED ASSOC, V269, P2554, DOI 10.1001/jama.269.19.2554; MAKSOUD A, 1993, ARCH INTERN MED, V153, P1249, DOI 10.1001/archinte.153.10.1249; MITCHELL A, 1994, NEW ENGL J MED, V331, P478; MOINPOUR CM, 1989, AM J PUBLIC HEALTH, V79, P1549, DOI 10.2105/AJPH.79.11.1549; MOR V, 1985, HEALTH SERV RES, V20, P407; *NAT HOSP ORG, 1995, ANAL COST SAV MED HO; PAULOS JA, 1990, INNUMERACY MATH ILLI; RICE DP, 1993, HEALTH AFFAIR, V12, P164, DOI 10.1377/hlthaff.12.2.164; RILEY G, 1987, INQUIRY-J HEALTH CAR, V24, P233; SCHNEIDERMAN LJ, 1992, ANN INTERN MED, V117, P599, DOI 10.7326/0003-4819-117-7-599; SCITOVSKY AA, 1994, MILBANK Q, V72, P561, DOI 10.2307/3350356; SINGER PA, 1992, ARCH INTERN MED, V152, P478, DOI 10.1001/archinte.152.3.478; Solomon MZ, 1995, HASTINGS CENT REP, V25, pS28, DOI 10.2307/3527856; SPECTOR WD, 1984, INQUIRY-J HEALTH CAR, V21, P328; TENO J, 1993, CLIN RES, V41, pA551; TENO JM, 1995, J GEN INTERN MED, V10, P179, DOI 10.1007/BF02600252; WACHTER RM, 1989, ANN INTERN MED, V111, P525, DOI 10.7326/0003-4819-111-6-525; Waldo D R, 1989, Health Care Financ Rev, V10, P111; WEEKS WB, 1994, ARCH INTERN MED, V154, P2077, DOI 10.1001/archinte.154.18.2077; 1996, JAMA-J AM MED ASSOC, V275, P1232; 1995, JAMA-J AM MED ASSOC, V274, P1591	43	188	189	0	25	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	1996	275	24					1907	1914		10.1001/jama.275.24.1907	http://dx.doi.org/10.1001/jama.275.24.1907			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UR975	8648872				2022-12-28	WOS:A1996UR97500037
J	Graham, B				Graham, B			Diagnosis of closed wrist injuries	LANCET			English	Editorial Material											Graham, B (corresponding author), UNIV TORONTO,TORONTO HOSP,TORONTO,ON,CANADA.							BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P1178, DOI 10.2106/00004623-199072080-00008; Lichtman D., 1988, WRIST ITS DISORDERS; Thorpe AP, 1996, BRIT J RADIOL, V69, P109, DOI 10.1259/0007-1285-69-818-109; WILKENS EW, 1989, EMERGENCY MED SCI FD	5	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 22	1996	347	9017					1709	1709		10.1016/S0140-6736(96)90801-6	http://dx.doi.org/10.1016/S0140-6736(96)90801-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT396	8656899				2022-12-28	WOS:A1996UT39600003
J	Herman, CJ; Schwartz, DA				Herman, CJ; Schwartz, DA			Pathology and laboratory medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Herman, CJ (corresponding author), EMORY UNIV, SCH MED, ATLANTA, GA 30322 USA.							CHEN YM, 1995, SCIENCE, V270, P789, DOI 10.1126/science.270.5237.789; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FOUCAR K, 1994, AM J CLIN PATHOL, V101, pS1; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; GRODY WW, 1995, DIAGN MOL PATHOL, V4, P155, DOI 10.1097/00019606-199509000-00001; KLEINER DE, 1995, LANCET, V346, P945, DOI 10.1016/S0140-6736(95)91561-3; Lederberg J, 1996, JAMA-J AM MED ASSOC, V275, P243, DOI 10.1001/jama.275.3.243; LIU XY, 1995, DIAGN MOL PATHOL, V4, P191, DOI 10.1097/00019606-199509000-00006; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; LUNDBERG GD, IN PRESS ARCH PATHOL; NOLTE KB, 1995, HUM PATHOL, V26, P110, DOI 10.1016/0046-8177(95)90123-X; SCHWARTZ DA, 1992, ARCH PATHOL LAB MED, V116, P660; THOLEN D, 1995, ARCH PATHOL LAB MED, V119, P307; Zaki SR, 1996, ARCH PATHOL LAB MED, V120, P134; Zaki SR, 1996, LANCET, V347, P535, DOI 10.1016/S0140-6736(96)91167-8; ZAKI SR, 1995, AM J PATHOL, V146, P552	17	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1839	1841		10.1001/jama.275.23.1839	http://dx.doi.org/10.1001/jama.275.23.1839			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642740				2022-12-28	WOS:A1996UQ15200039
J	Hollenberg, SM; Parrillo, JE				Hollenberg, SM; Parrillo, JE			Critical care medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK SURGICAL PATIENTS; OXYGEN DELIVERY				Hollenberg, SM (corresponding author), RUSH MED COLL, CHICAGO, IL 60612 USA.		Hollenberg, Steven/AAR-4522-2020	Hollenberg, Steven/0000-0003-1293-8496				ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934; BONE RC, 1995, CRIT CARE MED, V23, P994, DOI 10.1097/00003246-199506000-00003; BOYD O, 1993, JAMA-J AM MED ASSOC, V270, P2699, DOI 10.1001/jama.270.22.2699; CIVETTA JM, 1990, ANN SURG, V212, P266, DOI 10.1097/00000658-199009000-00005; ESSERMAN L, 1995, JAMA-J AM MED ASSOC, V274, P1544, DOI 10.1001/jama.274.19.1544; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; GATTINONI L, 1995, NEW ENGL J MED, V333, P1025, DOI 10.1056/NEJM199510193331601; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; MCCLOSKEY RV, 1994, ANN INTERN MED, V121, P1, DOI 10.7326/0003-4819-121-1-199407010-00001; OYE RK, 1991, CHEST, V99, P685, DOI 10.1378/chest.99.3.685; SHOEMAKER WC, 1992, CHEST, V102, P208, DOI 10.1378/chest.102.1.208; SUFFREDINI AF, 1994, CRIT CARE MED, V22, pS12; TUCHSCHMIDT J, 1992, CHEST, V102, P216, DOI 10.1378/chest.102.1.216; 1996, JAMA-J AM MED ASSOC, V275, P1232	16	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1799	1800		10.1001/jama.275.23.1799	http://dx.doi.org/10.1001/jama.275.23.1799			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642716				2022-12-28	WOS:A1996UQ15200015
J	Schindelin, H; Kisker, C; Hilton, J; Rajagopalan, KV; Rees, DC				Schindelin, H; Kisker, C; Hilton, J; Rajagopalan, KV; Rees, DC			Crystal structure of DMSO reductase: Redox-linked changes in molybdopterin coordination	SCIENCE			English	Article							DIMETHYL-SULFOXIDE REDUCTASE; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; DIMETHYLSULFOXIDE REDUCTASE; MOLYBDENUM COFACTOR; RHODOBACTER-SPHAEROIDES; FORMATE DEHYDROGENASE; BIOGENIC SULFUR; PROTEIN; DENITRIFICANS	The molybdoenzyme dimethylsulfoxide (DMSO) reductase contributes to the release of dimethylsulfide, a compound that has been implicated in cloud nucleation and global climate regulation, The crystal structure of DMSO reductase from Rhodobacter sphaeroides reveals a monooxo molybdenum cofactor containing two molybdopterin guanine dinucleotides that asymmetrically coordinate the molybdenum through their dithiolene groups, One of the pterins exhibits different coordination modes to the molybdenum between the oxidized and reduced states, whereas the side chain oxygen of Ser(147) coordinates the metal in both states. The change in pterin coordination between the Mo(VI) and Mo(IV) forms suggests a mechanism for substrate binding and reduction by this enzyme. Sequence comparisons of DMSO reductase with a family of bacterial oxotransferases containing molybdopterin guanine dinucleotide indicate a similar polypeptide fold and active site with two molybdopterins within this family.	CALTECH, DIV CHEM & CHEM ENGN, PASADENA, CA 91125 USA; DUKE UNIV, MED CTR, DEPT BIOCHEM, DURHAM, NC 27710 USA	California Institute of Technology; Duke University			Kisker, Caroline/T-1724-2019; Schindelin, Hermann/Q-2697-2019	Kisker, Caroline/0000-0002-0216-6026	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050775] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50775, GM00091] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; ANEJA VP, 1989, ACS SYM SER, V393, P2; [Anonymous], 1993, ADV INORGANIC CHEM, DOI DOI 10.1016/S0898-8838(08)60181-6; AXELROD HL, 1994, ACTA CRYSTALLOGR D, V50, P596, DOI 10.1107/S0907444994001319; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASTIAN NR, 1991, J BIOL CHEM, V266, P45; BATES TS, 1987, NATURE, V329, P319, DOI 10.1038/329319a0; BERG BL, 1991, J BIOL CHEM, V266, P22380; BILOUS PT, 1988, MOL MICROBIOL, V2, P785, DOI 10.1111/j.1365-2958.1988.tb00090.x; BRUNGER AT, 1992, XPLOR VERSION 3 1 SY, P187; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; DACEY JWH, 1986, SCIENCE, V233, P1314, DOI 10.1126/science.233.4770.1314; Davies GJ, 1996, ACTA CRYSTALLOGR D, V52, P7, DOI 10.1107/S0907444995009280; DAVIES GJ, 1993, NATURE, V365, P362, DOI 10.1038/365362a0; FINNEGAN MG, 1993, INORG CHEM, V32, P2616, DOI 10.1021/ic00064a005; George GN, 1996, J AM CHEM SOC, V118, P1113, DOI 10.1021/ja953317l; GLADYSHEV VN, 1994, P NATL ACAD SCI USA, V91, P7708, DOI 10.1073/pnas.91.16.7708; HILLE R, 1994, BBA-BIOENERGETICS, V1184, P143, DOI 10.1016/0005-2728(94)90220-8; Hilton JC, 1996, ARCH BIOCHEM BIOPHYS, V325, P139, DOI 10.1006/abbi.1996.0017; JOHNSON JL, 1990, P NATL ACAD SCI USA, V87, P3190, DOI 10.1073/pnas.87.8.3190; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KILPATRICK L, 1995, BIOCHEMISTRY-US, V34, P3032, DOI 10.1021/bi00009a034; KRAFFT T, 1992, EUR J BIOCHEM, V206, P503, DOI 10.1111/j.1432-1033.1992.tb16953.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LUDVIGSEN S, 1992, BIOCHEMISTRY-US, V31, P8783, DOI 10.1021/bi00152a014; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MCEWAN AG, 1991, BIOCHEM J, V274, P305, DOI 10.1042/bj2740305; MCEWAN AG, 1989, BIOCHIM BIOPHYS ACTA, V973, P308, DOI 10.1016/S0005-2728(89)80437-2; MEJEAN V, 1994, MOL MICROBIOL, V11, P1169, DOI 10.1111/j.1365-2958.1994.tb00393.x; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NEVITT GA, 1995, NATURE, V376, P680, DOI 10.1038/376680ao; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; PIERSON DE, 1990, J BACTERIOL, V172, P2194, DOI 10.1128/jb.172.4.2194-2198.1990; POLLOCK VV, 1995, ARCH BIOCHEM BIOPHYS, V318, P322, DOI 10.1006/abbi.1995.1236; RAJAGOPALAN KV, 1991, ADV ENZYMOL RAMB, V64, P215; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; ROMAO MJ, 1995, SCIENCE, V270, P1170, DOI 10.1126/science.270.5239.1170; SATOH T, 1987, J BIOCHEM-TOKYO, V102, P191, DOI 10.1093/oxfordjournals.jbchem.a122032; SCHULTZ BE, 1995, J AM CHEM SOC, V117, P827, DOI 10.1021/ja00107a031; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; SHUBER AP, 1986, J BIOL CHEM, V261, P2942; STIEFEL EI, 1993, ACS SYM SER, V535, P1; STOWELL MHB, IN PRESS J APPL CRYS; TAYLOR BF, 1989, ACS SYM SER, V393, P202; WEINER JH, 1992, BIOCHIM BIOPHYS ACTA, V1102, P1, DOI 10.1016/0167-4838(92)90493-W; WOOTTON JC, 1991, BIOCHIM BIOPHYS ACTA, V1057, P157, DOI 10.1016/S0005-2728(05)80100-8; ZINONI F, 1986, P NATL ACAD SCI USA, V83, P4650, DOI 10.1073/pnas.83.13.4650	52	441	448	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	1996	272	5268					1615	1621		10.1126/science.272.5268.1615	http://dx.doi.org/10.1126/science.272.5268.1615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8658134				2022-12-28	WOS:A1996UR09300035
J	Koh, JY; Suh, SW; Gwag, BJ; He, YY; Hsu, CY; Choi, DW				Koh, JY; Suh, SW; Gwag, BJ; He, YY; Hsu, CY; Choi, DW			The role of zinc in selective neuronal death after transient global cerebral ischemia	SCIENCE			English	Article							HISTOCHEMICALLY REACTIVE ZINC; FOREBRAIN ISCHEMIA; RAT HIPPOCAMPUS; ENDOGENOUS ZN-2+; CORTICAL-NEURONS; TEMPORAL PROFILE; CELL LOSS; BRAIN; NMDA; RELEASE	Zinc is present in presynaptic nerve terminals throughout the mammalian central nervous system and likely serves as an endogenous signaling substance. However, excessive exposure to extracellular zinc can damage central neurons. After transient forebrain ischemia in rats, chelatable zinc accumulated specifically in degenerating neurons in the hippocampal hilus and CA1, as well as in the cerebral cortex, thalamus, striatum, and amygdala. This accumulation preceded neurodegeneration, which could be prevented by the intraventricular injection of a zinc chelating agent. The toxic influx of zinc may be a key mechanism underlying selective neuronal death after transient global ischemic insults.	WASHINGTON UNIV,SCH MED,DEPT NEUROL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,CTR STUDY NERVOUS SYST INJURY,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)			Koh, Jae-Young/C-9014-2011	Koh, Jae-Young/0000-0002-4318-495X; Hsu, Chung Y./0000-0002-5632-2733	NINDS NIH HHS [NS30337] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030337] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; BLOMQVIST P, 1985, J CEREBR BLOOD F MET, V5, P420, DOI 10.1038/jcbfm.1985.57; BUCHAN AM, 1991, NEUROSCI LETT, V132, P255, DOI 10.1016/0304-3940(91)90314-J; CHARTON G, 1985, EXP BRAIN RES, V58, P202; CHOI DW, 1988, NEUROSCIENCE, V24, P67, DOI 10.1016/0306-4522(88)90312-0; CHOW HS, 1994, BRAIN RES, V639, P102, DOI 10.1016/0006-8993(94)91769-8; CHRISTINE CW, 1990, J NEUROSCI, V10, P108; CHUNG SH, 1984, PROC R SOC SER B-BIO, V221, P145, DOI 10.1098/rspb.1984.0028; CSERMELY P, 1988, J BIOL CHEM, V263, P6487; DANSCHER G, 1985, HISTOCHEMISTRY, V83, P419, DOI 10.1007/BF00509203; DESHPANDE J, 1992, EXP BRAIN RES, V88, P91, DOI 10.1007/BF02259131; DIEMER NH, 1992, ACTA NEUROL SCAND, V86, P45, DOI 10.1111/j.1600-0404.1992.tb08052.x; FREDENS K, 1973, HISTOCHEMISTRY, V37, P321, DOI 10.1007/BF00274968; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; FREDERICKSON CJ, 1982, BRAIN RES, V246, P338, DOI 10.1016/0006-8993(82)91188-X; FREDERICKSON CJ, 1992, J CHEM NEUROANAT, V5, P521, DOI 10.1016/0891-0618(92)90007-D; FREDERICKSON CJ, 1988, BRAIN RES, V446, P383, DOI 10.1016/0006-8993(88)90899-2; FREDERICKSON CJ, 1984, MERITS DEMERITS ZINC, VA, P289; GILL R, 1987, J NEUROSCI, V7, P3343; Gwag B. J., 1995, Society for Neuroscience Abstracts, V21, P1585; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; JOHANSEN FF, 1990, ACTA NEUROPATHOL, V81, P14, DOI 10.1007/BF00662632; JOHANSEN FF, 1987, ACTA NEUROPATHOL, V73, P110, DOI 10.1007/BF00693775; KIRINO T, 1984, ACTA NEUROPATHOL, V64, P139, DOI 10.1007/BF00695577; KOH JY, 1994, NEUROSCIENCE, V60, P1049, DOI 10.1016/0306-4522(94)90282-8; KOH JY, 1995, EXP NEUROL, V135, P153, DOI 10.1006/exnr.1995.1074; KRESS Y, 1981, BRAIN RES, V220, P139, DOI 10.1016/0006-8993(81)90217-1; LEES GJ, 1989, ACTA NEUROPATHOL, V7, P519; NEVANDER G, 1985, ANN NEUROL, V18, P281, DOI 10.1002/ana.410180303; NOHL H, 1991, FREE RADICAL BIO MED, V11, P581, DOI 10.1016/0891-5849(91)90139-T; Perrin D.D., 1979, STABILITY CONSTANTS; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rose K, 1993, IN VITRO BIOL METHOD, P46; ROSS T, 1995, BRAIN RES, V683, P117; SANDSTROM BE, 1994, FREE RADICAL BIO MED, V16, P177, DOI 10.1016/0891-5849(94)90141-4; SLOVITER RS, 1985, BRAIN RES, V330, P150, DOI 10.1016/0006-8993(85)90017-4; SMART TG, 1994, PROG NEUROBIOL, V42, P393, DOI 10.1016/0301-0082(94)90082-5; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; SWAN JH, 1990, J CEREBR BLOOD F MET, V10, P343, DOI 10.1038/jcbfm.1990.63; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; WEISS JH, 1993, NEURON, V10, P43, DOI 10.1016/0896-6273(93)90240-R; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; WINEGAR BD, 1990, J PHYSIOL-LONDON, V425, P563, DOI 10.1113/jphysiol.1990.sp018118; YIM MB, 1994, J BIOL CHEM, V269, P1621	45	927	947	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 17	1996	272	5264					1013	1016		10.1126/science.272.5264.1013	http://dx.doi.org/10.1126/science.272.5264.1013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL619	8638123				2022-12-28	WOS:A1996UL61900046
J	Wainberg, MA; Drosopoulos, WC; Salomon, H; Hsu, M; Borkow, G; Parniak, MA; Gu, ZX; Song, QB; Manne, J; Islam, S; Castriota, G; Prasad, VR				Wainberg, MA; Drosopoulos, WC; Salomon, H; Hsu, M; Borkow, G; Parniak, MA; Gu, ZX; Song, QB; Manne, J; Islam, S; Castriota, G; Prasad, VR			Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE INSERTION FIDELITY; HIGH-LEVEL RESISTANCE; INVITRO SELECTION; TYPE-1 RESISTANT; DNA-REPLICATION; INHIBITORS; EXTENSION; MUTATION; RNA	Monotherapy with (-)2',3'-dideoxy-3'-thiacytidine (3TC) leads to the appearance of a drug-resistant variant of human immunodeficiency virus-type 1 (HIV-1) with the methionine-184 --> valine (M184V) substitution in the reverse transcriptase (RT). Despite resulting drug resistance, treatment for more than 48 weeks is associated with a lower plasma viral burden than that at baseline. Studies to investigate this apparent contradiction revealed the following. (i) Titers of HIV-neutralizing antibodies remained stable in 3TC-treated individuals in contrast to rapid declines in those treated with azidothymidine (AZT). (ii) Unlike wild-type HIV, growth of M184V HIV in cell culture in the presence of d4T, AZT, Nevirapine, Delavirdine, or Saquinavir did not select for variants displaying drug resistance. (iii) There was an increase in fidelity of nucleotide insertion by the M184V mutant compared with wild-type enzyme.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MICROBIOL & IMMUNOL,BRONX,NY 10461; MCGILL UNIV,JEWISH GEN HOSP,MCGILL AIDS CTR,MONTREAL,PQ H3T 1E2,CANADA	Yeshiva University; Albert Einstein College of Medicine; McGill University			Borkow, Gadi/W-4294-2019; Prasad, Vinayaka R./A-1029-2011	Prasad, Vinayaka/0000-0002-9461-0189	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030861, P30AI027741, U01AI024845] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI-27741, R01 AI0-30861, UO1AI-24845] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAKHANASHVILI M, 1992, BIOCHEMISTRY-US, V31, P9393, DOI 10.1021/bi00154a010; BEBENEK K, 1989, J BIOL CHEM, V264, P16948; Bebenek K, 1993, REVERSE TRANSCRIPTAS, P85; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; BOULERICE F, 1990, J VIROL, V64, P1745, DOI 10.1128/JVI.64.4.1745-1755.1990; Cleland W W, 1979, Methods Enzymol, V63, P103; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0; CREIGHTON S, 1995, J BIOL CHEM, V270, P4759, DOI 10.1074/jbc.270.9.4759; DROSOPOULOS W, UNPUB; GAO Q, 1992, J VIROL, V66, P12, DOI 10.1128/JVI.66.1.12-19.1992; GAO Q, 1993, ANTIMICROB AGENTS CH, V37, P1390, DOI 10.1128/AAC.37.6.1390; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; GU ZX, 1992, J VIROL, V66, P7128, DOI 10.1128/JVI.66.12.7128-7135.1992; GU ZX, 1994, ANTIMICROB AGENTS CH, V38, P275, DOI 10.1128/AAC.38.2.275; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HUBNER A, 1992, J MOL BIOL, V223, P595, DOI 10.1016/0022-2836(92)90975-P; INGRAND D, 1995, AIDS, V9, P1323, DOI 10.1097/00002030-199512000-00004; KAVLICK MF, 1995, ANTIVIR RES, V28, P133, DOI 10.1016/0166-3542(95)00044-M; KEY Y, 1994, J BIOL CHEM, V269, P15331; LARDER BA, 1991, J VIROL, V65, P5232, DOI 10.1128/JVI.65.10.5232-5236.1991; LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; MEIER UC, 1995, SCIENCE, V270, P1360, DOI 10.1126/science.270.5240.1360; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; NUNBERG JH, 1991, J VIROL, V65, P4887, DOI 10.1128/JVI.65.9.4887-4892.1991; OTTO MJ, 1993, P NATL ACAD SCI USA, V90, P7543, DOI 10.1073/pnas.90.16.7543; PERRINO FW, 1989, P NATL ACAD SCI USA, V86, P8343, DOI 10.1073/pnas.86.21.8343; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; PILLAY D, 1995, REV MED VIROL, V5, P23, DOI 10.1002/rmv.1980050104; PLUDA JM, 1995, J INFECT DIS, V171, P1438, DOI 10.1093/infdis/171.6.1438; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; PRESTON BD, 1992, PHARM TECHNOL, V16, P34; PRINCE AM, 1987, J INFECT DIS, V156, P268, DOI 10.1093/infdis/156.2.268; RICCHETTI M, 1990, EMBO J, V9, P1583, DOI 10.1002/j.1460-2075.1990.tb08278.x; RICHMAN D, 1991, P NATL ACAD SCI USA, V88, P11241, DOI 10.1073/pnas.88.24.11241; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; SAAG MS, 1988, NATURE, V334, P440, DOI 10.1038/334440a0; SALOMON H, 1995, ANTIVIR CHEM CHEMOTH, V6, P222, DOI 10.1177/095632029500600404; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; SCHUURMAN R, 1995, J INFECT DIS, V171, P1411, DOI 10.1093/infdis/171.6.1411; STCLAIR MH, 1991, SCIENCE, V253, P1557, DOI 10.1126/science.1716788; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; TREMBLAY M, 1990, J INFECT DIS, V162, P735, DOI 10.1093/infdis/162.3.735; WAINBERG MA, 1995, AIDS, V9, P351, DOI 10.1097/00002030-199509040-00006; WAINBERG MA, 1995, AIDS RES HUM RETROV, V11, pS169; WAINBERG MA, 1994, AIDS, V8, P169; WAINBERG MA, 1991, AIDS, V5, P1061; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; YU H, 1992, J BIOL CHEM, V267, P10888; ZHANG D, 1994, ANTIMICROB AGENTS CH, V38, P282, DOI 10.1128/AAC.38.2.282	54	281	286	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 1	1996	271	5253					1282	1285		10.1126/science.271.5253.1282	http://dx.doi.org/10.1126/science.271.5253.1282			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TX695	8638110				2022-12-28	WOS:A1996TX69500037
J	Hansson, LE; Nyren, O; Hsing, AW; Bergstrom, R; Josefsson, S; Chow, WH; Fraumeni, JF; Adami, HO				Hansson, LE; Nyren, O; Hsing, AW; Bergstrom, R; Josefsson, S; Chow, WH; Fraumeni, JF; Adami, HO			The risk of stomach cancer in patients with gastric or duodenal ulcer disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HELICOBACTER-PYLORI; PEPTIC-ULCER; ASCORBIC-ACID; ASPIRIN USE; CARCINOMA; ALCOHOL; DRUGS	Background Helicobacter pylori infection, now considered to be a cause of gastric cancer, is also strongly associated with gastric and duodenal ulcer disease. The discovery of these relations has brought the long-controversial connection between peptic ulcers and gastric cancer into focus. Methods We estimated the risk of stomach cancer in a large cohort of hospitalized patients with gastric or duodenal ulcers, as recorded in the Swedish Inpatient Register between 1965 and 1983. Altogether, 57,936 patients were followed through 1989, for an average of 9.1 years. The standardized incidence ratio - the ratio of the observed number of cancers to the number expected on the basis of the incidence in the Swedish population at large - was used as a measure of relative risk. Results After peaking in the first 3 years of followup, the standardized incidence ratio for gastric cancer among 29,287 patients with gastric ulcers leveled off at 1.8 (95 percent confidence interval, 1.6 to 2.0) and remained significantly increased throughout followup, which was as long as 24 years for some patients. Prepyloric ulcer, diagnosed in 8646 patients, was not associated with a significant excess risk (standardized incidence ratio, 1.2; 95 percent confidence interval, 0.8 to 1.6). In the cohort of patients with duodenal ulcers (24,456 patients), the incidence of gastric cancer was significantly lower than expected. After the second year of follow-up, the standardized incidence ratio was only 0.6 (95 percent confidence interval, 0.4 to 0.7) and remained stable thereafter. Conclusions Gastric ulcer disease and gastric cancer have etiologic factors in common. A likely cause of both is atrophic gastritis induced by H. pylori. By contrast, there appear to be factors associated with duodenal ulcer disease that protect against gastric cancer. (C) 1996, Massachusetts Medical Society.	UNIV UPPSALA HOSP,DEPT CANC EPIDEMIOL,S-75185 UPPSALA,SWEDEN; UNIV UPPSALA HOSP,DEPT STAT,S-75185 UPPSALA,SWEDEN; MORA HOSP,DEPT SURG,MORA,SWEDEN; NCI,DIV CANC EPIDEMIOL & GENET,BETHESDA,MD 20892; INT EPIDEMIOL INST,ROCKVILLE,MD; HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02115	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health					PHS HHS [85636-05] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADAMI HO, 1987, SCAND J GASTROENTERO, V22, P889, DOI 10.3109/00365528708991931; AGREUS L, 1995, SCAND J GASTROENTERO, V30, P752, DOI 10.3109/00365529509096323; BAILAR JC, 1964, BIOMETRICS, V20, P639; BARTSCH H, 1988, MUTAT RES, V202, P307, DOI 10.1016/0027-5107(88)90194-7; CAHILL RJ, 1993, ACTA GASTROENTER S61, V56; CAMELS S, 1991, IARC SCI PUBL, V105, P187; Cruveilhier J, 1835, ANATOMIE PATHOLOGIQU; DEKKER W, 1977, GASTROENTEROLOGY, V73, P710; DOOLEY CP, 1984, ANN INTERN MED, V101, P538, DOI 10.7326/0003-4819-101-4-538; DUTERTRE Y, 1993, ACTA GASTROENTEROL S, V56, P61; EIDT S, 1994, DIGESTION, V55, P13, DOI 10.1159/000201116; ELLIS DJ, 1979, BRIT J SURG, V66, P117, DOI 10.1002/bjs.1800660211; GRIDLEY G, 1993, JNCI-J NATL CANCER I, V85, P307, DOI 10.1093/jnci/85.4.307; HANSSON LE, 1994, INT J CANCER, V57, P26, DOI 10.1002/ijc.2910570106; HIROHATA T, 1968, J NATL CANCER I, V41, P895; HOLE DJ, 1987, SCAND J GASTROENTERO, V22, P17, DOI 10.3109/00365528708991850; HSING AW, 1993, CANCER, V71, P745, DOI 10.1002/1097-0142(19930201)71:3<745::AID-CNCR2820710316>3.0.CO;2-1; IHRE B. J. E., 1964, GASTROENTEROLOGIA, V102, P78; IYENGAR R, 1987, P NATL ACAD SCI USA, V84, P6369, DOI 10.1073/pnas.84.18.6369; JACKSON JH, 1989, J CLIN INVEST, V84, P1644, DOI 10.1172/JCI114342; KATO I, 1992, AM J EPIDEMIOL, V135, P521, DOI 10.1093/oxfordjournals.aje.a116319; Kawashima T, 1991, Nihon Shokakibyo Gakkai Zasshi, V88, P1161; KEKKI M, 1990, GASTROEN CLIN BIOL, V14, P217; KRAUSE U, 1963, ACTA CHIR SCAND    S, V310, P1; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; *KUNGL MED, 1965, INT STAT CLASS DIS I; LANAS A, 1992, GASTROENTEROLOGY, V103, P862, DOI 10.1016/0016-5085(92)90018-T; LECHAGO J, 1993, GASTROENTEROLOGY, V104, P1554, DOI 10.1016/0016-5085(93)90370-R; LEE S, 1990, SCAND J GASTROENTERO, V25, P1223, DOI 10.3109/00365529008998557; LEWIS JH, 1982, AM J GASTROENTEROL, V77, P368; LUNDEGARDH G, 1988, NEW ENGL J MED, V319, P195, DOI 10.1056/NEJM198807283190402; LUNDEGARDH G, 1994, GUT, V35, P946, DOI 10.1136/gut.35.7.946; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; MOLLER H, 1992, GUT, V33, P1166, DOI 10.1136/gut.33.9.1166; MUNOZ N, 1994, CANCER EPIDEM BIOMAR, V3, P445; NAGAYO T, 1986, HISTOGENESIS PRECURS, P115; *NAT BOARD HLTH WE, 1973, INT STAT CLASS DIS I; NORFLEET RG, 1989, J CLIN GASTROENTEROL, V11, P382, DOI 10.1097/00004836-198908000-00006; NYREN O, 1995, JNCI-J NATL CANCER I, V87, P28, DOI 10.1093/jnci/87.1.28; ROOD JC, 1994, NUTR CANCER, V22, P65, DOI 10.1080/01635589409514332; SCHRAGER J, 1967, GUT, V8, P497, DOI 10.1136/gut.8.5.497; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; SIPPONEN P, 1992, EUR J GASTROEN HEPAT, V4, pS25; SOBALA GM, 1989, GASTROENTEROLOGY, V97, P357, DOI 10.1016/0016-5085(89)90071-1; SOMERVILLE K, 1986, LANCET, V1, P462; SPIRO HM, 1993, CLIN GASTROENTEROLOG; TAYLOR DN, 1991, EPIDEMIOL REV, V13, P42, DOI 10.1093/oxfordjournals.epirev.a036078; THUN MJ, 1993, CANCER RES, V53, P1322; TSUGANE S, 1993, CANCER CAUSE CONTROL, V4, P297, DOI 10.1007/BF00051331; WESTLUND K, 1963, MORTALITY PEPTIC ULC; WONG J, 1980, J SURG RES, V29, P446, DOI 10.1016/0022-4804(80)90058-X; World Health Organization, 1994, IARC MON EV CARC RIS, P177; Yamagata S, 1979, World J Surg, V3, P671	53	495	515	2	23	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	1996	335	4					242	249		10.1056/NEJM199607253350404	http://dx.doi.org/10.1056/NEJM199607253350404			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ532	8657240	Bronze			2022-12-28	WOS:A1996UZ53200004
J	Diacovo, TG; Puri, KD; Warnock, RA; Springer, TA; vonAndrian, UH				Diacovo, TG; Puri, KD; Warnock, RA; Springer, TA; vonAndrian, UH			Platelet-mediated lymphocyte delivery to high endothelial venules	SCIENCE			English	Article							NODE VASCULAR ADDRESSIN; L-SELECTIN; P-SELECTIN; HOMING RECEPTOR; MESENTERIC VENULES; LIGAND; MOLECULE; IDENTIFICATION; RECOGNIZE; ADHESION	Circulating lymphocytes gain access to lymph nodes owing to their ability to initiate rolling along specialized high endothelial venules (HEVs). One mechanism of rolling involves L-selectin binding to peripheral node addressin (PNAd) on HEVs. Activated platelets are shown to bind to circulating lymphocytes and to mediate rolling in HEVs, in vivo, through another molecule, P-selectin, which also interacts with PNAd. In vitro, activated platelets enhanced tethering of lymphocytes to PNAd and sustained lymphocyte rolling, even in the absence of functional L-selectin. Thus, a platelet pathway operating through P-selectin provides a second mechanism for lymphocyte delivery to HEVs.	HARVARD UNIV,SCH MED,CTR BLOOD RES,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT CARDIOL,BOSTON,MA 02115; TUFTS UNIV,SCH MED,DEPT PEDIAT,DIV NEWBORN MED,BOSTON,MA 02111; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115; STANFORD UNIV,DEPT PATHOL,STANFORD,CA 94305	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Tufts University; Harvard University; Harvard Medical School; Stanford University			von Andrian, Ulrich H/A-5775-2008		NHLBI NIH HHS [HL48675, HL54936] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054936] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; BERG EL, 1991, J CELL BIOL, V114, P343, DOI 10.1083/jcb.114.2.343; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; BUTTRUM SM, 1993, BLOOD, V82, P1165; COLLINS CE, 1994, GASTROENTEROLOGY, V106, P840, DOI 10.1016/0016-5085(94)90741-2; Diacovo TG, 1996, BLOOD, V88, P146; Diacovo TG, 1996, J EXP MED, V183, P1193, DOI 10.1084/jem.183.3.1193; DIACOVO TG, 1994, J CLIN INVEST, V94, P1243, DOI 10.1172/JCI117442; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; FRENETTE PS, 1995, P NATL ACAD SCI USA, V92, P7450, DOI 10.1073/pnas.92.16.7450; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; IMAI Y, 1991, J CELL BIOL, V113, P1213, DOI 10.1083/jcb.113.5.1213; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; JUTILA MA, 1994, J IMMUNOL, V153, P3917; KISHIMOTO TK, 1990, P NATL ACAD SCI USA, V87, P2244, DOI 10.1073/pnas.87.6.2244; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; LAWRENCE MB, 1995, EUR J IMMUNOL, V25, P1025, DOI 10.1002/eji.1830250425; LEHR HA, 1994, P NATL ACAD SCI USA, V91, P7688, DOI 10.1073/pnas.91.16.7688; LEHR HA, 1994, LAB INVEST, V71, P380; LEY K, 1993, BLOOD, V82, P1632; LEY K, 1991, CIRC RES, V69, P1034, DOI 10.1161/01.RES.69.4.1034; LIAU F, 1995, J EXP MED, V182, P1337; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; MEBIUS RE, 1993, J IMMUNOL, V151, P3252; MICHIE SA, 1993, AM J PATHOL, V143, P1688; MOORE KL, 1992, BIOCHEM BIOPH RES CO, V186, P173, DOI 10.1016/S0006-291X(05)80790-9; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; NORGARDSUMNICHT KE, 1993, SCIENCE, V261, P480, DOI 10.1126/science.7687382; PALABRICA T, 1992, NATURE, V359, P848, DOI 10.1038/359848a0; PRIES AR, 1988, INT J MICROCIRC, V7, P327; PURI KD, 1995, J CELL BIOL, V131, P261, DOI 10.1083/jcb.131.1.261; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; SAVAGE B, 1996, CELL, V84; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; TURUNEN JP, 1994, EUR J IMMUNOL, V24, P1130, DOI 10.1002/eji.1830240518; VONADRIAN UH, 1995, CELL, V82, P1; VONADRIAN UH, 1992, AM J PHYSIOL, V263, pH1304; VONANDRIAN UH, 1993, BLOOD, V82, P182, DOI 10.1182/blood.V82.1.182.bloodjournal821182; VONANDRIAN UH, IN PRESS MICROCIRCUL; WARNOCK R, UNPUB	42	264	272	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 12	1996	273	5272					252	255		10.1126/science.273.5272.252	http://dx.doi.org/10.1126/science.273.5272.252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW787	8662511				2022-12-28	WOS:A1996UW78700045
J	Mansergh, G; Haddix, AC; Steketee, RW; Nieburg, PI; Hu, DJ; Simonds, RJ; Rogers, M				Mansergh, G; Haddix, AC; Steketee, RW; Nieburg, PI; Hu, DJ; Simonds, RJ; Rogers, M			Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African developing country setting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AIDS	Objective.-To evaluate the cost-effectiveness of a short-course zidovudine program to prevent perinatal transmission of human immunodeficiency virus (HIV) type 1 in sub-Saharan African country settings. Design and Setting.-Several clinical trials of short-course zidovudine during pregnancy for prevention of perinatal transmission of HIV are under way in developing countries in sub-Saharan Africa. A decision model was used to examine the cost-effectiveness of zidovudine programs in a hypothetical 1-year birth cohort in a sub-Saharan African setting from the perspective of the health care system and of society. A completed short course of zidovudine was assumed to reduce perinatal HIV transmission from 25% to 16.5%, approximately one half of the effect of the longer-course zidovudine. Estimates of program costs, lifetime HIV-related health care costs, and lost productivity costs were derived from the published literature and from preliminary data available from sites of planned clinical trials. Sensitivity analyses were conducted on all relevant parameters. Main Outcome Measures.-Medical costs, lost productivity costs, program costs, cost savings, and incremental cost-effectiveness, expressed as cost per infant HIV infection prevented. Results.-The model estimated that a national zidovudine program in a setting with 12.5% HIV seroprevalence would reduce perinatal HIV incidence by 12% (4.9 infections per 1000 births), The cost to the health care system would be $3748 per infant HIV infection prevented. When productivity losses were included in the model, the cost decreases to $1115 per infant HIV infection prevented. The cost to implement a national zidovudine program including the cost of counseling, testing, and drugs, would be $2 million per 100 000 births or $20 per pregnant woman. In the base case, decreases in the cost of counseling and testing and increases in maternal HIV prevalence, zidovudine efficacy, and medical and lost productivity costs improved cost-effectiveness of the zidovudine program. Conclusions.-Assuming demonstrable efficacy of short-course zidovudine prevention of perinatal HIV, a national perinatal HIV prevention program with zidovudine in most sub-Saharan African country settings would reduce the incidence of infant HIV infection and, in some settings, provide societal savings; however, substantial initial investment in such programs will be required. Where health care resources are limited, as in these regions, allocation of resources to a perinatal zidovudine program will need to be considered in the context of resources required for other pressing medical care needs.	CTR DIS CONTROL & PREVENT,OFF DIRECTOR,NATL CTR HIV AIDS STD & TB PREVENT,NCHSTP,ATLANTA,GA 30333; CTR DIS CONTROL & PREVENT,EPIDEMIOL PROGRAM OFF,ATLANTA,GA 30333	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Mansergh, G (corresponding author), CTR DIS CONTROL & PREVENT,EPIDEMIOL BRANCH,DIV HIV AIDS PREVENT,NCHSTP,MSE-45,1600 CLIFTON RD,ATLANTA,GA 30333, USA.							ADJORLOLOJOHNSON G, 1994, JAMA-J AM MED ASSOC, V272, P462, DOI 10.1001/jama.272.6.462; AISU T, 1995, AIDS, V9, P267, DOI 10.1097/00002030-199509030-00008; [Anonymous], 1992, Wkly Epidemiol Rec, V67, P145; CAMERON C, 1992, 8 INT C AIDS AMST; COHEN J, 1995, SCIENCE, V269, P624, DOI 10.1126/science.7624786; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; DATTA P, 1994, J INFECT DIS, V170, P1134, DOI 10.1093/infdis/170.5.1134; DUNN DT, 1992, LANCET, V340, P585, DOI 10.1016/0140-6736(92)92115-V; EKPINI E, 1994, 10TH INT C AIDS YOK; Gillespie S., 1989, Land Use Policy, V6, P301, DOI 10.1016/0264-8377(89)90022-7; Gorsky RD, 1996, PUBLIC HEALTH REP, V111, P335; HANSON K, 1992, HEALTH POLICY PLANN, V7, P315, DOI 10.1093/heapol/7.4.315; HEYMANN SJ, 1990, AM J PUBLIC HEALTH, V80, P1305, DOI 10.2105/AJPH.80.11.1305; HU DJ, 1992, AIDS, V6, P1505, DOI 10.1097/00002030-199212000-00014; *INT PROGR CTR POP, 1995, 20 INT PROGR CTR POP; *INT PROGR CTR POP, 1994, 15 US BUR CENS INT P; Mofenson LM, 1994, SEMIN PEDIAT INFECT, V5, P252; NORSE D, 1991, 7 INT C AIDS FLOR; OVER M, 1989, HEALTH POLICY, V11, P169, DOI 10.1016/0168-8510(89)90034-1; OVER M, 1988, GLOBAL IMPACT AIDS, P123; PARROTT RH, 1991, J ACQ IMMUN DEF SYND, V4, P122; SATO PA, 1994, B WORLD HEALTH ORGAN, V72, P129; SCITOVSKY AA, 1988, AIDS, V2, pS71, DOI 10.1097/00002030-198800001-00011; *UNICEF, 1995, STAT WORLDS CHILDR 1; VIRAVAIDYA M, 1993, EC IMPLICATIONS AIDS, P7; *WORLD BANK, 1994, 1994 WORLD BANK WORL; *WORLD BANK, 1992, TANZ AIDS ASS PLANN; 1995, MMWR-MORBID MORTAL W, V44, P1; 1994, MMWR-MORBID MORTAL W, V43, P1	29	63	63	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1996	276	2					139	145		10.1001/jama.276.2.139	http://dx.doi.org/10.1001/jama.276.2.139			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UV485	8656506				2022-12-28	WOS:A1996UV48500029
J	Shan, K; Lincoff, AM; Young, JB				Shan, K; Lincoff, AM; Young, JB			Anthracycline-induced cardiotoxicity	ANNALS OF INTERNAL MEDICINE			English	Review							CONGESTIVE-HEART-FAILURE; SERIAL RADIONUCLIDE ANGIOCARDIOGRAPHY; ADRIAMYCIN-INDUCED CARDIOTOXICITY; CARDIAC SARCOPLASMIC-RETICULUM; ACUTE LYMPHOBLASTIC-LEUKEMIA; LEFT-VENTRICULAR DYSFUNCTION; BETA-ADRENERGIC RECEPTORS; CALCIUM-RELEASE CHANNEL; MUSCLE GENE-EXPRESSION; ADVANCED BREAST-CANCER	Purpose: To review the current understanding of the clinical significance, detection, pathogenesis, and prevention of anthracycline-induced cardiotoxicity. Data Sources: A MEDLINE search of the English-language medical literature and a manual search of the bibliographies of relevant articles, including abstracts from national cardiology meetings. Study Selection: Pertinent clinical and experimental studies addressing the clinical relevance, pathogenesis, detection, and prevention of anthracycline cardiotoxicity were selected from peer-reviewed journals without judgments about study design. A total of 137 original studies and 9 other articles were chosen. Data Extraction: Data quality and validity were assessed by each author independently. Statistical analysis of combined data was inappropriate given the differences in patient selection, testing, and follow-up in the available studies. Data Synthesis: Anthracyline-induced cardiotoxicity limits effective cancer chemotherapy by causing early cardiomyopathy, and it can produce late-onset ventricular dysfunction years after treatment has ceased. Detection of subclinical anthracyline-induced cardiomyopathy through resting left ventricular ejection fraction or echocardiographic fractional shortening is suboptimal. Conventional doses of anthracycline often lead to permanent myocardial damage and reduced functional reserve. Underlying pathogenetic mechanisms may include free-radical-mediated myocyte damage, adrenergic dysfunction, intracellular calcium overload, and the release of cardiotoxic cytokines. Dexrazoxane is the only cardioprotectant clinically approved for use against anthracyclines, and it was only recently introduced for selected patients with breast cancer who are receiving anthracycline therapy. Conclusions: A rapidly growing number of persons, including an alarming fraction of the 150 000 or more adults in the United States who have survived childhood cancer, will have substantial morbidity and mortality because of anthracycline-related cardiac disease. The development of effective protection against anthracycline-induced cardiotoxicity will probably have a significant effect on the overall survival of these patients.	CLEVELAND CLIN FDN, DEPT CARDIOL, EXPT INTERVENT LAB, CLEVELAND, OH 44195 USA	Cleveland Clinic Foundation								AKIMOTO H, 1993, CANCER RES, V53, P4658; ALEXANDER J, 1979, NEW ENGL J MED, V300, P278, DOI 10.1056/NEJM197902083000603; ALI MK, 1994, CANCER-AM CANCER SOC, V74, P182, DOI 10.1002/1097-0142(19940701)74:1<182::AID-CNCR2820740129>3.0.CO;2-2; ANASTASOPOULOS E, 1992, ANTICANCER RES, V12, P489; ARMITAGE JM, 1990, J HEART TRANSPLANT, V9, P627; BECK AC, 1991, WESTERN J MED, V155, P293; BELARDINELLI R, 1995, CIRCULATION, V91, P2775, DOI 10.1161/01.CIR.91.11.2775; BENEDICT CR, 1993, J AM COLL CARDIOL, V22, pA146, DOI 10.1016/0735-1097(93)90480-O; BIELACK SS, 1989, EUR J CANCER CLIN ON, V25, P873, DOI 10.1016/0277-5379(89)90135-1; Billingham M., 1984, CANCER TREAT S, V3, P71; BLEYER WA, 1990, CA-CANCER J CLIN, V40, P355, DOI 10.3322/canjclin.40.6.355; BONADONNA G, 1995, JAMA-J AM MED ASSOC, V273, P542; BOROW KM, 1983, ANN INTERN MED, V99, P750, DOI 10.7326/0003-4819-99-6-750; BRISTOW MR, 1978, AM J MED, V65, P823, DOI 10.1016/0002-9343(78)90802-1; BRISTOW MR, 1978, ANN INTERN MED, V88, P168, DOI 10.7326/0003-4819-88-2-168; BRISTOW MR, 1978, CANCER TREAT REP, V62, P873; BRISTOW MR, 1983, J CARDIOVASC PHARM, V5, P913, DOI 10.1097/00005344-198311000-00002; BRISTOW MR, 1981, AM HEART J, V102, P709, DOI 10.1016/0002-8703(81)90096-X; BRISTOW MR, 1981, LAB INVEST, V45, P157; BRISTOW MR, 1980, J CARDIOVASC PHARM, V2, P487, DOI 10.1097/00005344-198009000-00002; BULOCK FA, 1995, BRIT HEART J, V73, P340; BULOCK FA, 1995, MED PEDIATR ONCOL, V24, P143, DOI 10.1002/mpo.2950240217; BULOCK FA, 1993, BRIT HEART J, V70, P185; BURTON KP, 1990, J MOL CELL CARDIOL, V22, P1035, DOI 10.1016/0022-2828(90)91043-7; CORTES EP, 1975, CANCER CHEMOTH REP 3, V6, P215; COTTIN Y, 1995, BRIT HEART J, V73, P61; CUTHBERTSON DD, 1994, CIRCULATION, V90, P50; DELLITALIA LJ, 1993, CURR PROB CARDIOLOGY, V18, P711; DIAMOND GA, 1989, J AM COLL CARDIOL, V14, pA12, DOI 10.1016/0735-1097(89)90157-5; DORENT R, 1995, TRANSPLANT P, V27, P1683; DOROSHOW JH, 1983, CANCER RES, V43, P460; DOROSHOW JH, 1980, J CLIN INVEST, V65, P128, DOI 10.1172/JCI109642; EDWARDS BS, 1990, AM J CARDIOL, V65, P501, DOI 10.1016/0002-9149(90)90818-L; EHRKE MJ, 1986, CANCER RES, V46, P54; ELBAZ O, 1994, LEUKEMIA LYMPHOMA, V12, P191, DOI 10.3109/10428199409059589; ETTINGHAUSEN SE, 1986, ARCH SURG-CHICAGO, V121, P1445; EWER MS, 1994, ACTA ONCOL, V33, P645, DOI 10.3109/02841869409121776; FERRANS VJ, 1978, CANCER TREAT REP, V62, P955; FERRARI R, 1995, CIRCULATION, V92, P1479, DOI 10.1161/01.CIR.92.6.1479; FISHER B, 1989, J CLIN ONCOL, V7, P572, DOI 10.1200/JCO.1989.7.5.572; FISHER ML, 1994, J AM COLL CARDIOL, V23, P943, DOI 10.1016/0735-1097(94)90641-6; FLORAS JS, 1993, J AM COLL CARDIOL, V22, pA72, DOI 10.1016/0735-1097(93)90466-E; FRIEDMAN MA, 1978, JAMA-J AM MED ASSOC, V240, P1603, DOI 10.1001/jama.240.15.1603; FU LX, 1991, BASIC RES CARDIOL, V86, P117, DOI 10.1007/BF02190544; FUJITA N, 1991, J CARDIOVASC PHARM, V17, P656, DOI 10.1097/00005344-199104000-00020; GAASCH WH, 1994, JAMA-J AM MED ASSOC, V271, P1276; GANZ WI, 1993, AM J CLIN ONCOL-CANC, V16, P109, DOI 10.1097/00000421-199304000-00005; GOORIN AM, 1981, CANCER, V47, P2810, DOI 10.1002/1097-0142(19810615)47:12<2810::AID-CNCR2820471210>3.0.CO;2-4; GOTTDIENER JS, 1981, ANN INTERN MED, V94, P430, DOI 10.7326/0003-4819-94-4-430; HAMIED TAA, 1987, INT J IMMUNOPHARMACO, V9, P355, DOI 10.1016/0192-0561(87)90061-0; HANCOCK SL, 1993, JAMA-J AM MED ASSOC, V270, P1949, DOI 10.1001/jama.270.16.1949; HAQ MM, 1985, CANCER-AM CANCER SOC, V56, P1361, DOI 10.1002/1097-0142(19850915)56:6<1361::AID-CNCR2820560624>3.0.CO;2-S; HAUSDORF G, 1988, BRIT HEART J, V60, P309; HEGEWISCH S, 1990, LANCET, V335, P294, DOI 10.1016/0140-6736(90)90115-L; HENDERSON IC, 1989, J CLIN ONCOL, V7, P560, DOI 10.1200/JCO.1989.7.5.560; HITCHCOCKBRYAN S, 1986, MED PEDIATR ONCOL, V14, P211, DOI 10.1002/mpo.2950140405; HOLMBERG SRM, 1990, CIRC RES, V67, P272, DOI 10.1161/01.RES.67.2.272; HOLMBERG SRM, 1991, CARDIOSCIENCE, V2, P19; ISNER JM, 1983, AM J CARDIOL, V51, P1167, DOI 10.1016/0002-9149(83)90364-8; ITO H, 1990, P NATL ACAD SCI USA, V87, P4275, DOI 10.1073/pnas.87.11.4275; JACKSON JA, 1984, AM J PATHOL, V117, P140; JAKACKI R, 1991, PEDIATR RES, V29, pA143; KLEWER SE, 1992, J AM COLL CARDIOL, V19, P394, DOI 10.1016/0735-1097(92)90497-B; KOLARIC K, 1995, ONCOLOGY, V52, P251; KRAMER JH, 1991, J MOL CELL CARDIOL, V23, P1231, DOI 10.1016/0022-2828(91)90081-V; KUSUOKA H, 1991, J CARDIOVASC PHARM, V18, P437, DOI 10.1097/00005344-199109000-00017; LAMONTE CS, 1986, CANCER TREAT REP, V70, P439; LARSEN RL, 1992, AM J CARDIOL, V70, P73, DOI 10.1016/0002-9149(92)91393-I; LEANDRO J, 1994, AM J CARDIOL, V74, P1152, DOI 10.1016/0002-9149(94)90470-7; LEE BH, 1987, J AM COLL CARDIOL, V9, P184, DOI 10.1016/S0735-1097(87)80099-2; LEE TH, 1989, J AM COLL CARDIOL, V14, pA44, DOI 10.1016/0735-1097(89)90161-7; LEFRAK EA, 1973, CANCER-AM CANCER SOC, V32, P302, DOI 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2; LEGHA SS, 1982, ANN INTERN MED, V96, P133, DOI 10.7326/0003-4819-96-2-133; LENAZ L, 1976, CANCER TREAT REV, V3, P111, DOI 10.1016/S0305-7372(76)80018-7; LEWIS AB, 1981, PEDIATRICS, V68, P67; LIPSHULTZ SE, 1991, NEW ENGL J MED, V324, P808, DOI 10.1056/NEJM199103213241205; LIPSHULTZ SE, 1994, PEDIATRICS, V93, P433; LIPSHULTZ SE, 1995, NEW ENGL J MED, V332, P1738, DOI 10.1056/NEJM199506293322602; LIPSHULTZ SE, 1995, J AM COLL CARDIOL, V25, pA54; LIU XK, 1991, J MOL CELL CARDIOL, V23, P1091, DOI 10.1016/0022-2828(91)90199-V; MAK IT, 1988, CIRC RES, V63, P262, DOI 10.1161/01.RES.63.1.262; MANN DL, 1994, CHEST, V105, P897, DOI 10.1378/chest.105.3.897; MARCHANDISE B, 1989, AM HEART J, V118, P92, DOI 10.1016/0002-8703(89)90077-X; MASON JW, 1978, CANCER TREAT REP, V62, P857; MATSUMORI A, 1994, BRIT HEART J, V72, P561; MCKILLOP JH, 1983, AM HEART J, V106, P1048, DOI 10.1016/0002-8703(83)90651-8; MILEI J, 1987, CANC DRUG DEL, V4, P129, DOI 10.1089/cdd.1987.4.129; MINOTTI G, 1995, J CLIN INVEST, V95, P1595, DOI 10.1172/JCI117833; MOREB JS, 1992, CANCER, V70, P2637, DOI 10.1002/1097-0142(19921201)70:11<2637::AID-CNCR2820701112>3.0.CO;2-P; MORTENSEN SA, 1986, BRIT HEART J, V55, P274; MOUCEK RJ, 1987, J BIOL CHEM, V62, P15851; MYERS CE, 1977, SCIENCE, V197, P165, DOI 10.1126/science.877547; OLMOS RAV, 1995, EUR J CANCER, V31A, P26, DOI 10.1016/0959-8049(94)00357-B; OLMOS RAV, 1992, CLIN NUCL MED, V17, P163; OLSON HM, 1974, AM J PATHOL, V77, P439; PAI RG, 1995, CURR PROB CARDIOLOGY, V20, P687; PEGELOW CH, 1984, J CLIN ONCOL, V2, P443, DOI 10.1200/JCO.1984.2.5.443; PIVER MS, 1985, CANCER, V56, P76, DOI 10.1002/1097-0142(19850701)56:1<76::AID-CNCR2820560113>3.0.CO;2-S; PRAGA C, 1979, CANCER TREAT REP, V63, P827; PRATT CB, 1978, CANCER TREAT REP, V62, P1381; RAJAGOPALAN S, 1988, CANCER RES, V48, P4766; RAZIUDDIN S, 1994, CANCER, V73, P2426, DOI 10.1002/1097-0142(19940501)73:9<2426::AID-CNCR2820730928>3.0.CO;2-K; RIHAL CS, 1994, CIRCULATION, V90, P2772, DOI 10.1161/01.CIR.90.6.2772; RITCHIE JL, 1980, CANCER, V46, P1109, DOI 10.1002/1097-0142(19800901)46:5<1109::AID-CNCR2820460506>3.0.CO;2-B; ROBISON TW, 1986, LIFE SCI, V39, P731, DOI 10.1016/0024-3205(86)90021-4; SANTOSTASI G, 1991, TOXICOL APPL PHARM, V108, P140, DOI 10.1016/0041-008X(91)90277-L; SCHMITT K, 1995, EUR J PEDIATR, V154, P201, DOI 10.1007/s004310050275; SCHWARTZ RG, 1987, AM J MED, V82, P1109, DOI 10.1016/0002-9343(87)90212-9; SEHESTED M, 1993, BIOCHEM PHARMACOL, V46, P389, DOI 10.1016/0006-2952(93)90514-W; SEIFERT CF, 1994, ANN PHARMACOTHER, V28, P1063, DOI 10.1177/106002809402800912; SHADDY RE, 1995, AM HEART J, V129, P197, DOI 10.1016/0002-8703(95)90061-6; SHI FS, 1993, CANCER RES, V53, P3986; SILBER JH, 1993, MED PEDIATR ONCOL, V21, P477, DOI 10.1002/mpo.2950210704; SINGAL PK, 1995, J MOL CELL CARDIOL, V27, P1055, DOI 10.1016/0022-2828(95)90074-8; SINGAL PK, 1986, AM J PHYSIOL, V250, pH419, DOI 10.1152/ajpheart.1986.250.3.H419; SIVESKIILISKOVIC N, 1995, CIRCULATION, V91, P10, DOI 10.1161/01.CIR.91.1.10; SIVESKIILISKOVIC N, 1994, CIRCULATION, V89, P2829, DOI 10.1161/01.CIR.89.6.2829; SORENSEN K, 1995, J CLIN ONCOL, V13, P1546, DOI 10.1200/JCO.1995.13.7.1546; SPEYER JL, 1988, NEW ENGL J MED, V319, P745, DOI 10.1056/NEJM198809223191203; SPEYER JL, 1992, J CLIN ONCOL, V10, P117, DOI 10.1200/JCO.1992.10.1.117; SPEYER JL, 1985, AM J MED, V78, P555, DOI 10.1016/0002-9343(85)90395-X; STEINBERG JS, 1987, CANCER, V60, P1213, DOI 10.1002/1097-0142(19870915)60:6<1213::AID-CNCR2820600609>3.0.CO;2-V; STEINHERZ L, 1991, Pediatrician, V18, P49; STEINHERZ LJ, 1992, PEDIATRICS, V89, P942; STEINHERZ LJ, 1994, PEDIATRICS, V94, P782; STEINHERZ LJ, 1991, JAMA-J AM MED ASSOC, V266, P1672, DOI 10.1001/jama.266.12.1672; STEINHERZ LJ, 1995, MED PEDIATR ONCOL, V24, P352, DOI 10.1002/mpo.2950240604; STODDARD MF, 1992, J AM COLL CARDIOL, V20, P62, DOI 10.1016/0735-1097(92)90138-D; TONG J, 1991, AM J PHYSIOL, V260, pH909, DOI 10.1152/ajpheart.1991.260.3.H909; TORREAMIONE G, 1995, CIRCULATION, V92, P1487, DOI 10.1161/01.CIR.92.6.1487; TORREAMIONE G, 1996, IN PRESS J AM COLL C; TORTI FM, 1983, ANN INTERN MED, V99, P745, DOI 10.7326/0003-4819-99-6-745; TREAT J, 1990, J NATL CANCER I, V82, P1706, DOI 10.1093/jnci/82.21.1706; VONHOFF DD, 1977, AM J MED, V62, P200, DOI 10.1016/0002-9343(77)90315-1; VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710; WAAGSTEIN F, 1993, LANCET, V342, P1441, DOI 10.1016/0140-6736(93)92930-R; WAKASUGI S, 1992, J NUCL MED, V33, P208; WANG YX, 1995, CIRC RES, V76, P645, DOI 10.1161/01.RES.76.4.645; WEESNER KM, 1991, CANCER, V68, P435, DOI 10.1002/1097-0142(19910715)68:2<435::AID-CNCR2820680237>3.0.CO;2-#; WERNER GS, 1994, AM J CARDIOL, V73, P792, DOI 10.1016/0002-9149(94)90883-4; WIKMANCOFFELT J, 1983, CARDIOVASC RES, V17, P43, DOI 10.1093/cvr/17.1.43; WINGO PA, 1995, CA-CANCER J CLIN, V45, P8, DOI 10.3322/canjclin.45.1.8; YEUNG ST, 1991, LANCET, V337, P816, DOI 10.1016/0140-6736(91)92516-5; YOSHIKAWA T, 1994, J AM COLL CARDIOL, V24, P210, DOI 10.1016/0735-1097(94)90565-7; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; ZARET BL, 1984, CANCER TREAT S, V3, P61	146	563	600	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1996	125	1					47	58		10.7326/0003-4819-125-1-199607010-00008	http://dx.doi.org/10.7326/0003-4819-125-1-199607010-00008			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT399	8644988				2022-12-28	WOS:A1996UT39900007
J	Alkhatib, G; Combadiere, C; Broder, CC; Feng, Y; Kennedy, PE; Murphy, PM; Berger, EA				Alkhatib, G; Combadiere, C; Broder, CC; Feng, Y; Kennedy, PE; Murphy, PM; Berger, EA			CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1	SCIENCE			English	Article							BACTERIOPHAGE-T7 RNA-POLYMERASE; IMMUNODEFICIENCY-VIRUS; CD4-MEDIATED FUSION; VACCINIA VIRUS; MURINE CELLS; EXPRESSION; INFECTION; SYSTEM; GENES; CD4	Human immunodeficiency virus-type 1 (HIV-1) entry requires fusion cofactors on the CD4(+) target cell. Fusin, a heterotrimeric GTP-binding protein (G protein)-coupled receptor, serves as a cofactor for T cell line-tropic isolates. The chemokines RANTES, MIP-1 alpha, and MIP-1 beta, which suppress infection by macrophage-tropic isolates, selectively inhibited cell fusion mediated by the corresponding envelope glycoproteins (Envs). Recombinant CC CKR5, a G protein-coupled receptor for these chemokines, rendered CD4-expressing nonhuman cells fusion-competent preferentially with macrophage-tropic Envs. CC CKR5 messenger RNA was detected selectively in cell types susceptible to macrophage-tropic isolates. CC CKR5 is thus a fusion cofactor for macrophage-tropic HIV-1 strains.	NIAID,HOST DEF LAB,NIH,BETHESDA,MD 20892; NIAID,VIRAL DIS LAB,NIH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)			Broder, Christopher/E-1169-2013; Combadiere, Christophe/I-5639-2013	Combadiere, Christophe/0000-0002-1755-4531				ALEXANDER WA, 1992, J VIROL, V66, P2934, DOI 10.1128/JVI.66.5.2934-2942.1992; Alkhatib G, 1996, J VIROL, V70, P5487, DOI 10.1128/JVI.70.8.5487-5494.1996; ASHORN PA, 1990, J VIROL, V64, P2149, DOI 10.1128/JVI.64.5.2149-2156.1990; BERGER EA, 1995, HIV PRACTICAL APPROA, V2, P123; BRODER CC, 1993, VIROLOGY, V193, P483, DOI 10.1006/viro.1993.1151; BRODER CC, 1995, P NATL ACAD SCI USA, V92, P9004, DOI 10.1073/pnas.92.19.9004; CALLEBAUT C, 1994, SCIENCE, V264, P1162, DOI 10.1126/science.264.5162.1162; CHAKRABARTI SK, COMMUNICATION; CLAPHAM PR, 1991, VIROLOGY, V181, P703, DOI 10.1016/0042-6822(91)90904-P; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; COMBADIERE C, 1995, J BIOL CHEM, V270, P30235; COMBADIERE C, 1995, J BIOL CHEM, V270, P16491, DOI 10.1074/jbc.270.28.16491; COMBADIERE C, 1995, MOL BIOL CELL, V6, P224; COMBADIERE SK, 1996, J LEUKOCYTE BIOL, V60, P147; DRAGIC T, 1992, J VIROL, V66, P4794, DOI 10.1128/JVI.66.8.4794-4802.1992; DRAGIC T, 1995, J VIROL, V69, P1013, DOI 10.1128/JVI.69.2.1013-1018.1995; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Goudsmit J, 1995, J ACQ IMMUN DEF SYND, V10, pS15; KLEIN MR, 1995, TRENDS MICROBIOL, V3, P386, DOI 10.1016/S0966-842X(00)88984-2; LAZDINS JK, 1990, AIDS RES HUM RETROV, V6, P1157, DOI 10.1089/aid.1990.6.1157; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MIEDEMA F, 1994, IMMUNOL REV, V140, P35, DOI 10.1111/j.1600-065X.1994.tb00864.x; MOORE JP, 1993, VIRAL FUSION MECHANI, P233; Murphy Philip M., 1996, Cytokine and Growth Factor Reviews, V7, P47, DOI 10.1016/1359-6101(96)00009-3; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412; Planelles Vincente, 1993, P17; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; SIMMONS G, 1995, VIROLOGY, V209, P696, DOI 10.1006/viro.1995.1307; VALENTIN A, 1994, J VIROL, V68, P6684, DOI 10.1128/JVI.68.10.6684-6689.1994; WEINER DB, 1991, PATHOBIOLOGY, V59, P361, DOI 10.1159/000163679	32	2390	2513	0	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1996	272	5270					1955	1958		10.1126/science.272.5270.1955	http://dx.doi.org/10.1126/science.272.5270.1955			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8658171				2022-12-28	WOS:A1996UV29400054
J	Olavarrieta, CD; Sotelo, J				Olavarrieta, CD; Sotelo, J			Domestic violence in Mexico	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INJURIES; ABUSE; CARE		NATL INST NEUROL & NEUROSURG MEXICO,DIV RES,MEXICO CITY 14269,DF,MEXICO									*AM PSYCH ASS, 1993, COMM VIOL YOUTH PSYC; American Medical Association, 1992, DIAGN TREATM GUID DO; AZAOLAGARRIDO E, 1994, PROGRAMA INTERDISCIP; BEDREGAL X., 1991, HILOS NUDOS COLORES; BREINES W, 1983, SIGNS, V8, P490, DOI 10.1086/493987; Buvinic Mayra, 1983, WOMEN POVERTY 3 WORL; Campbell J.C., 1992, RESPONSE VICTIMIZATI, V14, P18; *CECOVID AC, 1992, AUN LUN VEC TIEN MIE; CORSI J, 1994, VIOLENIA FAMILIAR UN; COUNTS DA, 1992, SANCTIONS SANCUARY C; *CTR AT VIOL INTR, 1995, SUBP DER HUM SERV CO; DUARTE AEP, 1994, DERECHO FAMILIA, P295; DUARTE P, 1994, LUCHA CONTRA VIOLENC; DURFEE MJ, 1992, JAMA-J AM MED ASSOC, V267, P3172, DOI 10.1001/jama.267.23.3172; GARCIA B, 1994, TRABAJO FEMENINO VID, P151; GOMEZ MI, 1995, REFORMA         0521, pB2; GONZALEX L, 1994, MUJERES DERECHOS HUM; GONZALEZ S, 1992, PROGRAMA INTERDISCIP; Gonzalez S., 1987, PRESENCIA TRANSPAREN, P111; HARREL RR, 1995, REFORMA         0125, pB5; HEISE L, 1995, SEXUAL COERCION REPR, P4; Heise L., 1994, 255 WORLD BANK; HERNANDEZ A, 1995, REFORMA         0806; HIJAR M, 1992, SALUD MENT, V15, P15; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; KOSHLAND DE, 1994, SCIENCE, V265, P455, DOI 10.1126/science.8036485; Koss M P, 1992, Arch Fam Med, V1, P53, DOI 10.1001/archfami.1.1.53; LARA A, 1994, INFO CLIN I MEXICANA, V5, P10; LARRAIN S, 1993, PUBLICACION CIENTIFI, V541, P202; Lewis O, 1949, AM ANTHROPOL, V51, P602, DOI 10.1525/aa.1949.51.4.02a00050; LOPEZAUSTIN A, 1980, CUERPO HUMANO IDEOLO, V1; LOVERA S, 1989, JORNADA         0604, P3; LUGO C, 1987, FEM MEXICO, V48, P16; MCFARLANE J, 1992, JAMA-J AM MED ASSOC, V267, P3176, DOI 10.1001/jama.267.23.3176; MONTES SG, 1987, ANTROPOLOGIA SOCIAL; MULLEN PE, 1988, LANCET, V1, P841; *PAN AM HLTH ORG, 1994, INT CONV PREV SANCT; RAMIREZRODRIGUEZ JC, 1993, SALUD PUBLICA MEXICO, V35, P148; RANDALL T, 1990, JAMA-J AM MED ASSOC, V264, P939, DOI 10.1001/jama.264.8.939; RIQUER F, 1996, MUJER SALUD REPRODUC; SALINAS L, 1994, DERECHOS HUMANOS MUJ; SAUCEDA JM, 1995, REV MED MEX I SOCIAL, V33, P283; SUGG NK, 1992, JAMA-J AM MED ASSOC, V267, P3157, DOI 10.1001/jama.267.23.3157; Torres S, 1991, Issues Ment Health Nurs, V12, P113, DOI 10.3109/01612849109058213; URBINA S, 1994, LATINO PROGRAMME; VELAZQUEZ SA, 1994, COMPENDIO LEYES PUER, P160	46	27	28	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	1996	275	24					1937	1941		10.1001/jama.1996.03530480079051	http://dx.doi.org/10.1001/jama.1996.03530480079051			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UR975	8648877				2022-12-28	WOS:A1996UR97500042
J	Hardy, IRB; Dittmann, S; Sutter, RW				Hardy, IRB; Dittmann, S; Sutter, RW			Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union	LANCET			English	Review							IMMUNITY; POPULATION	Since 1990, an epidemic of diphtheria has spread throughout the newly independent states of the former Soviet Union, and by 1995 a total of 47 808 cases were reported. During the early stages of the epidemic, adequate control measures were not taken and vaccine was in short supply; possible contributing factors to the spread of the epidemic are the presence of highly susceptible child and adult populations, socioeconomic instability, population movement, and a deteriorating health infrastructure. Although WHO views the epidemic as an international public-health emergency and, together with UNICEF and the International Red Cross, has formulated a strategy to combat the epidemic, the necessary funds have not been made fully available. Current vaccination recommendations also need to be reviewed to ensure that population immunity will be adequate to prevent any resurgence of diphtheria in Europe and North America.	CTR DIS CONTROL & PREVENT,NATL IMMUNIZATION PROGRAM,ATLANTA,GA 30333; WHO,REG OFF EUROPE,IMMUNIZAT & VACCINES PROGRAM,DK-2100 COPENHAGEN,DENMARK	Centers for Disease Control & Prevention - USA; World Health Organization								BOLOTOVSKY VM, 1992, ZH MIKROBIOL EPIDEMI, V69, P23; CELLESI C, 1989, VACCINE, V7, P417, DOI 10.1016/0264-410X(89)90155-2; CHRISTENSON B, 1986, SCAND J INFECT DIS, V18, P227, DOI 10.3109/00365548609032331; DEZOYSA A, 1993, LANCET, V342, P446; DEZOYSA A, 1995, J CLIN MICROBIOL, V33, P1080, DOI 10.1128/JCM.33.5.1080-1083.1995; Doull JA, 1925, AM J HYG, V5, P508, DOI 10.1093/oxfordjournals.aje.a119677; DOULL JAMES A., 1930, JOUR PREVENT MED, V4, P371; DUDLEY SF, 1934, MED RES COUNCIL SPEC, V195; FELDBLIUM IV, 1986, ZH MIKROBIOL EPIDEMI, V63, P89; FROST W. H., 1928, JOUR PREVENT MED, V2, P325; GALAZKA A, 1989, EPIDEMIOL INFECT, V103, P587, DOI 10.1017/S0950268800030983; GALAZKA AM, 1995, EUR J EPIDEMIOL, V11, P107, DOI 10.1007/BF01719955; GALAZKA AM, 1995, EUR J EPIDEMIOL, V11, P95, DOI 10.1007/BF01719954; HARDY I, 1993, P M DIPHTH EUR JUL 5, P118; HARDY I, 1995, 35 INT C ANT AG CHEM; IVCHENKO SI, 1986, ZH MIKROBIOL EPIDEM, V63, P15; LAISHENKO II, 1993, VOEN MED ZH, V10, P37; LUMIO J, 1993, LANCET, V342, P53, DOI 10.1016/0140-6736(93)91918-C; MAKSIMOVA NM, 1987, ZH MIKROBIOL EPIDEMI, V64, P36; MAPLE PA, 1995, LANCET, V345, P963, DOI 10.1016/S0140-6736(95)90705-X; MARKINA SS, 1994, ZISNO           1111, P10; MIKHAILOVICH VM, 1995, J CLIN MICROBIOL, V33, P3061, DOI 10.1128/JCM.33.11.3061-3063.1995; MILLER LW, 1972, AM J DIS CHILD, V123, P197, DOI 10.1001/archpedi.1972.02110090067004; PAPPENHEIMER AM, 1982, HARV LECT 76, P45; RIX BA, 1994, SCAND J INFECT DIS, V26, P459, DOI 10.3109/00365549409008620; RUSAKOVA EV, 1987, ZH MIKROBIOL EPIDEMI, V64, P53; SARGENT RK, 1984, AM J MED SCI, V287, P37, DOI 10.1097/00000441-198403000-00008; SCHWARTZ SA, 1987, ZH MIKROBIOL EPIDEMI, V64, P26; SIMONSEN O, 1987, ACTA PATH MICRO IM C, V95, P225; WEISS BP, 1983, AM J PUBLIC HEALTH, V73, P802, DOI 10.2105/AJPH.73.7.802; Zingher A, 1923, AM J DIS CHILD, V25, P392; 1993, MMWR-MORBID MORTAL W, V42, P840; 1993, WKLY EPIDEMIOL REC, V68, P261; 1995, MMWR-MORBID MORTAL W, V44, P243; 1995, MMWR-MORBID MORTAL W, V44, P177; 1995, MMWR-MORBID MORTAL W, V44, P237; 1993, MMWR-MORBID MORTAL W, V42, P847	37	133	136	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 22	1996	347	9017					1739	1744		10.1016/S0140-6736(96)90811-9	http://dx.doi.org/10.1016/S0140-6736(96)90811-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT396	8656909				2022-12-28	WOS:A1996UT39600013
J	Zablackis, E; York, WS; Pauly, M; Hantus, S; Reiter, WD; Chapple, CCS; Albersheim, P; Darvill, A				Zablackis, E; York, WS; Pauly, M; Hantus, S; Reiter, WD; Chapple, CCS; Albersheim, P; Darvill, A			Substitution of L-fucose by L-galactose in cell walls of Arabidopsis mur1	SCIENCE			English	Article							XYLOGLUCAN-OLIGOSACCHARIDES; STRUCTURAL-ANALYSIS; SEED XYLOGLUCAN; GROWTH; PLANTS	An Arabidopsis thaliana mutant (mur1) has less than 2 percent of the normal amounts of L-fucose in the primary cell walls of aerial portions of the plant. The survival of mur1 plants challenged the hypothesis that fucose is a required component of biologically active oligosaccharides derived from cell wall xyloglucan. However, the replacement of L-fucose (that is, 6-deoxy-L-galactose) by L-galactose does not detectably alter the biological activity of the oligosaccharides derived from xyloglucan. Thus, essential structural and conformational features of xyloglucan and xyloglucan-derived oligosaccharides are retained when L-galactose replaces L-fucose.	UNIV GEORGIA,COMPLEX CARBOHYDRATE RES CTR,ATHENS,GA 30602; UNIV GEORGIA,DEPT BIOCHEM & MOLEC BIOL,ATHENS,GA 30602; UNIV CONNECTICUT,DEPT MOLEC & CELL BIOL,STORRS,CT 06269; PURDUE UNIV,DEPT BIOCHEM,W LAFAYETTE,IN 47907	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Connecticut; Purdue University System; Purdue University; Purdue University West Lafayette Campus			Pauly, Markus/B-5895-2008; Chapple, Clint CS/Q-5456-2017	Pauly, Markus/0000-0002-3116-2198; Chapple, Clint CS/0000-0002-5195-562X				AUGUR C, 1992, PLANT PHYSIOL, V99, P180, DOI 10.1104/pp.99.1.180; BAUER WD, 1973, PLANT PHYSIOL, V51, P174, DOI 10.1104/pp.51.1.174; BAYDOUN EAH, 1988, J PLANT PHYSIOL, V132, P484, DOI 10.1016/S0176-1617(88)80068-3; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; DARVILL A, 1992, GLYCOBIOLOGY, V2, P181, DOI 10.1093/glycob/2.3.181; DARVILL A, 1980, BIOCH PLANTS, V1; Feingold D. S., 1982, ENCY PLANT PHYSL A, V13A, P3; FRY SC, 1993, PHYSIOL PLANTARUM, V89, P1; FRY SC, 1993, PLANT PHYSIOL, V103, P1, DOI 10.1104/pp.103.1.1; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; HALLGREN C, 1995, J CARBOHYD CHEM, V14, P453, DOI 10.1080/07328309508005350; HAYASHI T, 1984, PLANT PHYSIOL, V75, P596, DOI 10.1104/pp.75.3.596; LORENCES EP, 1990, PHYSIOL PLANTARUM, V80, P109; MCDOUGALL GJ, 1989, J EXP BOT, V40, P233, DOI 10.1093/jxb/40.2.233; MCDOUGALL GJ, 1991, J PLANT PHYSIOL, V137, P332, DOI 10.1016/S0176-1617(11)80141-0; Pauly M, 1996, CARBOHYD RES, V282, P1, DOI 10.1016/0008-6215(95)00362-2; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; ROBERTS RM, 1973, PHYTOCHEMISTRY, V12, P2679, DOI 10.1016/0031-9422(73)85079-4; ROBERTS RM, 1971, ARCH BIOCHEM BIOPHYS, V145, P685, DOI 10.1016/S0003-9861(71)80029-2; WATANABE T, 1980, AGR BIOL CHEM TOKYO, V44, P791, DOI 10.1080/00021369.1980.10864032; YORK WS, 1990, CARBOHYD RES, V200, P9, DOI 10.1016/0008-6215(90)84179-X; YORK WS, 1984, PLANT PHYSIOL, V75, P295, DOI 10.1104/pp.75.2.295; YORK WS, 1993, CARBOHYD RES, V248, P285, DOI 10.1016/0008-6215(93)84135-S; YORK WS, 1995, CARBOHYD RES, V267, P79, DOI 10.1016/0008-6215(94)00287-P; York WS, 1985, METHOD ENZYMOL, P3, DOI DOI 10.1016/0076-6879(86)18062-1; ZABLACKIS E, 1995, PLANT PHYSIOL, V107, P1129, DOI 10.1104/pp.107.4.1129	26	117	119	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1808	1810		10.1126/science.272.5269.1808	http://dx.doi.org/10.1126/science.272.5269.1808			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8650583				2022-12-28	WOS:A1996UT11000049
J	Bowman, MA; Schwenk, TL				Bowman, MA; Schwenk, TL			Family medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									UNIV MICHIGAN, SCH MED, ANN ARBOR, MI 48109 USA	University of Michigan System; University of Michigan	Bowman, MA (corresponding author), WAKE FOREST UNIV, BOWMAN GRAY SCH MED, 300 S HAWTHORNE RD, WINSTON SALEM, NC 27103 USA.		bowman, marjorie/F-7235-2013	bowman, marjorie/0000-0002-1945-9212				ANDERSON JW, 1995, NEW ENGL J MED, V333, P276, DOI 10.1056/NEJM199508033330502; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; BURTON LC, 1995, AM J PUBLIC HEALTH, V85, P387, DOI 10.2105/AJPH.85.3.387; CAREY TS, 1995, NEW ENGL J MED, V333, P913, DOI 10.1056/NEJM199510053331406; COLLINS R, 1995, LANCET, V345, P669; Deutchman M E, 1995, J Am Board Fam Pract, V8, P440; FREED GL, 1995, J FAM PRACTICE, V40, P263; GERMAN PS, 1995, AM J PUBLIC HEALTH, V85, P379, DOI 10.2105/AJPH.85.3.379; GILLMAN MW, 1995, JAMA-J AM MED ASSOC, V273, P1113, DOI 10.1001/jama.273.14.1113; GREENFIELD S, 1995, JAMA-J AM MED ASSOC, V274, P1436; HERTOG MGL, 1995, ARCH INTERN MED, V155, P381, DOI 10.1001/archinte.155.4.381; JUKEMA JW, 1995, CIRCULATION, V91, P2528, DOI 10.1161/01.CIR.91.10.2528; LUCKMANN R, 1995, J FAM PRACTICE, V40, P547; Miller E S, 1995, J Am Board Fam Pract, V8, P357; Schaff E A, 1995, Arch Fam Med, V4, P774, DOI 10.1001/archfami.4.9.774; WEBER JE, 1995, ANN EMERG MED, V26, P429, DOI 10.1016/S0196-0644(95)70109-5	17	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1809	1810		10.1001/jama.275.23.1809	http://dx.doi.org/10.1001/jama.275.23.1809			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642722				2022-12-28	WOS:A1996UQ15200021
J	Brandstater, ME; Brown, SE				Brandstater, ME; Brown, SE			Physical medicine and rehabilitation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-BACK-PAIN				Brandstater, ME (corresponding author), LOMA LINDA UNIV, MED CTR, LOMA LINDA, CA 92350 USA.							BRODERICK JP, 1989, STROKE, V20, P577, DOI 10.1161/01.STR.20.5.577; BURKE SA, 1994, SPINE, V19, P1880, DOI 10.1097/00007632-199409000-00002; CHAN CW, 1993, SPINE, V18, P1717, DOI 10.1097/00007632-199310000-00001; DIXON TP, 1995, ARCH PHYS MED REHAB, V76, pSC1; DREYFUSS P, 1994, SPINE, V19, P807, DOI 10.1097/00007632-199404000-00014; FINESTONE HM, 1995, ARCH PHYS MED REHAB, V76, P310, DOI 10.1016/S0003-9993(95)80655-5; FORTIN JD, 1994, SPINE, V19, P1475, DOI 10.1097/00007632-199407000-00010; FORTIN JD, 1994, SPINE, V19, P1483, DOI 10.1097/00007632-199407000-00011; FREDERICKSON M, 1995, ARCH PHYS MED REHAB, V76, pSC5; HAFFEY WJ, 1995, ARCH PHYS MED REHAB, V76, pSC2, DOI 10.1016/S0003--999(3()95)81395--0; HIRSCH G, 1991, SPINE, V16, P1039, DOI 10.1097/00007632-199109000-00004; KEITH RA, 1995, ARCH PHYS MED REHAB, V76, P495, DOI 10.1016/S0003-9993(95)80501-X; KILGORE KM, 1995, ARCH PHYS MED REHAB, V76, pSC21; RAINVILLE J, 1992, SPINE, V17, P1060, DOI 10.1097/00007632-199209000-00008; ROTH EJ, 1994, ARCH PHYS MED REHAB, V75, P94; ROTH EJ, 1994, ARCH PHYS MED REHAB, V75, pS42; SCHEER SJ, 1995, ARCH PHYS MED REHAB, V76, P966, DOI 10.1016/S0003-9993(95)80076-X	17	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1843	1844		10.1001/jama.275.23.1843	http://dx.doi.org/10.1001/jama.275.23.1843			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642742				2022-12-28	WOS:A1996UQ15200041
J	Kauffman, CA				Kauffman, CA			Quandary about treatment of aspergillomas persists	LANCET			English	Editorial Material							PULMONARY ASPERGILLOMA				Kauffman, CA (corresponding author), VET AFFAIRS MED CTR,INFECT DIS SECT,ANN ARBOR,MI 48105, USA.							DIOT P, 1995, EUR RESPIR J, V8, P1263, DOI 10.1183/09031936.95.08081263; ISRAEL HL, 1982, CHEST, V82, P430, DOI 10.1378/chest.82.4.430; JEWKES J, 1983, THORAX, V38, P572, DOI 10.1136/thx.38.8.572; MASSARD G, 1992, ANN THORAC SURG, V54, P1159, DOI 10.1016/0003-4975(92)90086-J; Rumbak M, 1996, THORAX, V51, P253, DOI 10.1136/thx.51.3.253; YAMADA H, 1993, CHEST, V103, P1421, DOI 10.1378/chest.103.5.1421	6	57	58	0	6	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 15	1996	347	9016					1640	1640		10.1016/S0140-6736(96)91481-6	http://dx.doi.org/10.1016/S0140-6736(96)91481-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ701	8642952				2022-12-28	WOS:A1996UQ70100004
J	Marks, MB; McKendry, RJR				Marks, MB; McKendry, RJR			Orthoses for rheumatoid feet: Does it matter what's underfoot?	LANCET			English	Editorial Material									UNIV OTTAWA,RHEUMAT DIS UNIT,FAC MED,OTTAWA,ON,CANADA	University of Ottawa	Marks, MB (corresponding author), UNIV OTTAWA,PHYS MED & REHABIL UNIT,FAC MED,OTTAWA,ON,CANADA.							Budiman-Mak E, 1995, J Clin Rheumatol, V1, P313, DOI 10.1097/00124743-199512000-00001; BUDIMANMAK E, 1991, J CLIN EPIDEMIOL, V44, P561, DOI 10.1016/0895-4356(91)90220-4; Conrad KJ, 1996, J CLIN EPIDEMIOL, V49, P1, DOI 10.1016/0895-4356(96)00534-3; CRACCHIOLO A, 1988, FOOT BOOK, P239; CRAXFORD AD, 1982, CLIN ORTHOP RELAT R, P121; LANG LMG, 1987, BAILLIERE CLIN RHEUM, V1, P215, DOI 10.1016/S0950-3579(87)80001-8; MERRITT JL, 1987, J RHEUMATOL, V14, P62; Philps JW, 1990, FUNCTIONAL FOOT ORTH; SMIDT L, 1987, BAILLIERE CLIN RHEUM, V1, P275, DOI 10.1016/S0950-3579(87)80004-3; TINLEY P, 1987, BAILLIERE CLIN RHEUM, V1, P383, DOI 10.1016/S0950-3579(87)80009-2	10	9	9	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 15	1996	347	9016					1639	1639		10.1016/S0140-6736(96)91480-4	http://dx.doi.org/10.1016/S0140-6736(96)91480-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ701	8642951				2022-12-28	WOS:A1996UQ70100003
J	Alam, SM; Travers, PJ; Wung, JL; Nasholds, W; Redpath, S; Jameson, SC; Gascoigne, NRJ				Alam, SM; Travers, PJ; Wung, JL; Nasholds, W; Redpath, S; Jameson, SC; Gascoigne, NRJ			T-cell-receptor affinity and thymocyte positive selection	NATURE			English	Article							MOLECULE	DEVELOPMENT Of thymocytes involves two distinct outcomes resulting from superficially similar events, Recognition by thymocytes of major histocompatibility complex (MHC) proteins plus peptide leads to their rescue from apoptosis (positive selection), and recognition of antigenic peptide induces cell death (negative selection)(1), Antigen analogues(1-3), and sometimes low concentrations of antigenic peptide(4,5), induce positive selection; such analogues are often antagonists of mature T-cell clones(1-3,6) Various models seek to explain how recognition of different peptide/MHC complexes leads to such different outcomes(1,7-10): quantitative models relate response to the affinity, avidity or kinetics of T cell-antigen receptor (TCR) binding, whereas qualitative models require conformational or spatial changes in the TCR or associated molecules to modulate signal transduction(7,9). We have used surface plasmon resonance(11) to measure the kinetics of TCR interactions with positively and negatively selecting ligands to distinguish between these models, and find that affinity correlates to the outcome of selection. A 'window' of affinity resulting in positive selection extends over a 1-log range starting threefold below the affinity for negative selection.	Scripps Res Inst, RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA; UNIV LONDON BIRKBECK COLL, DEPT CRYSTALLOG, LONDON WC1E 7HX, ENGLAND; UNIV MINNESOTA, SCH MED, DEPT LAB MED & PATHOL, MINNEAPOLIS, MN 55455 USA	Scripps Research Institute; University of London; Birkbeck University London; University of Minnesota System; University of Minnesota Twin Cities			Jameson, Stephen C/D-9892-2013; Alam, S. Munir/AAC-6711-2019	Jameson, Stephen C/0000-0001-9137-1146; 				AJITKUMAR P, 1988, CELL, V54, P47, DOI 10.1016/0092-8674(88)90178-X; ALRAMADI BK, 1995, J IMMUNOL, V155, P662; Arden Bernhard, 1995, Immunogenetics, V42, P501; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; GASCOIGNE NRJ, 1990, J BIOL CHEM, V265, P9296; GERMAIN RN, 1995, IMMUNOLOGIST, V3, P113; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; JANEWAY CA, 1995, IMMUNOL TODAY, V16, P223, DOI 10.1016/0167-5699(95)80163-4; KAPPLER J, 1994, P NATL ACAD SCI USA, V91, P8462, DOI 10.1073/pnas.91.18.8462; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; KELLY JM, 1993, EUR J IMMUNOL, V23, P3318, DOI 10.1002/eji.1830231239; KOOP BF, 1994, GENOMICS, V19, P478, DOI 10.1006/geno.1994.1097; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; MALCHIODI EL, 1995, J EXP MED, V182, P1833, DOI 10.1084/jem.182.6.1833; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; SCORER CA, 1994, BIO-TECHNOL, V12, P181, DOI 10.1038/nbt0294-181; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	29	519	524	0	18	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 13	1996	381	6583					616	620		10.1038/381616a0	http://dx.doi.org/10.1038/381616a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ657	8637599				2022-12-28	WOS:A1996UQ65700054
J	Ameisen, JC				Ameisen, JC			The origin of programmed cell death	SCIENCE			English	Editorial Material							CDC2				Ameisen, JC (corresponding author), HOP BICHAT,INSERM,U13,F-75018 PARIS,FRANCE.							AMEISEN JC, 1994, AIDS, V8, P1197, DOI 10.1097/00002030-199409000-00001; AMEISEN JC, 1995, CELL DEATH DIFFER, V2, P285; CHRISTENSEN ST, 1995, CELL DEATH DIFFER, V2, P301; CORNILLON S, 1994, J CELL SCI, V107, P2691; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; ENARI M, 1995, EMBO J, V14, P5201, DOI 10.1002/j.1460-2075.1995.tb00204.x; Evan Gerard I., 1994, Trends in Cell Biology, V4, P191, DOI 10.1016/0962-8924(94)90134-1; HARRINGTON EA, 1994, CURR OPIN GENET DEV, V4, P120, DOI 10.1016/0959-437X(94)90100-7; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; Sogin ML, 1991, CURR OPIN GENET DEV, V1, P457, DOI 10.1016/S0959-437X(05)80192-3; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; UCKER DS, 1991, NEW BIOL, V3, P103; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Welburn SC, 1996, CELL DEATH DIFFER, V3, P229; WILLIAMS GT, 1991, CELL, V65, P1097, DOI 10.1016/0092-8674(91)90002-G; YARMOLINSKY MB, 1995, SCIENCE, V267, P836, DOI 10.1126/science.7846528	20	213	219	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1278	1279		10.1126/science.272.5266.1278	http://dx.doi.org/10.1126/science.272.5266.1278			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8650538				2022-12-28	WOS:A1996UN47200028
J	Cui, XQ; Wise, RP; Schnable, PS				Cui, XQ; Wise, RP; Schnable, PS			The rf2 nuclear restorer gene of male-sterile T-cytoplasm maize	SCIENCE			English	Article							ZEA-MAYS L; PROTEIN; PLANTS; MITOCHONDRIA; MICROSPOROGENESIS; DEHYDROGENASE; LOCALIZATION; DISEASE; ENCODES; T-URF13	The T cytoplasm of maize serves as a model for the nuclear restoration of cytoplasmic male sterility. The rf2 gene, one of two nuclear genes required for fertility restoration in male-sterile T-cytoplasm (cmsT) maize, was cloned. The protein predicted by the rf2 sequence is a putative aldehyde dehydrogenase, which suggests several mechanisms that might explain Rf2-mediated fertility restoration in cmsT maize. Aldehyde dehydrogenase may be involved in the detoxification of acetaldehyde produced by ethanolic fermentation during pollen development, may play a role in energy metabolism or may interact with URF13, the mitochondrial protein associated with male sterility in cmsT maize.	IOWA STATE UNIV SCI & TECHNOL, DEPT AGRON, AMES, IA 50011 USA; IOWA STATE UNIV SCI & TECHNOL, DEPT ZOOL & GENET, AMES, IA 50011 USA; IOWA STATE UNIV SCI & TECHNOL, DEPT PLANT PATHOL, AMES, IA 50011 USA; IOWA STATE UNIV SCI & TECHNOL, USDA ARS, AMES, IA 50011 USA	Iowa State University; Iowa State University; Iowa State University; Iowa State University; United States Department of Agriculture (USDA)				Wise, Roger/0000-0001-7786-1528; Schnable, Patrick/0000-0001-9169-5204; Cui, Xiangqin/0000-0003-0621-9313				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMBROZIAK W, 1993, ADV EXP MED BIOL, V328, P5; ASKER H, 1985, PHYTOCHEMISTRY, V24, P689, DOI 10.1016/S0031-9422(00)84877-3; BARKAN A, COMMUNICATION; BUCHER M, 1994, EMBO J, V13, P2755, DOI 10.1002/j.1460-2075.1994.tb06569.x; BUCHER M, 1995, PLANT MOL BIOL, V28, P739, DOI 10.1007/BF00021197; COMSTOCK JC, 1973, PHYTOPATHOLOGY, V63, P1357, DOI 10.1094/Phyto-63-1357; DEAN C, 1985, EMBO J, V4, P3055, DOI 10.1002/j.1460-2075.1985.tb04045.x; DELONG A, 1993, CELL, V74, P757, DOI 10.1016/0092-8674(93)90522-R; DEWEY RE, 1987, P NATL ACAD SCI USA, V84, P5374, DOI 10.1073/pnas.84.15.5374; DEWEY RE, 1986, CELL, V44, P439, DOI 10.1016/0092-8674(86)90465-4; DUVICK DONALD N., 1965, ADVANCE GENET, V13, P1, DOI 10.1016/S0065-2660(08)60046-2; FLAVELL R, 1974, PLANT SCI LETT, V3, P259, DOI 10.1016/0304-4211(74)90096-0; FORDE BG, 1980, P NATL ACAD SCI-BIOL, V77, P418, DOI 10.1073/pnas.77.1.418; HACK E, 1991, PLANT PHYSIOL, V95, P861, DOI 10.1104/pp.95.3.861; HANSON MR, 1985, INT REV CYTOL, V94, P213, DOI 10.1016/S0074-7696(08)60398-8; HOOKER A L, 1970, Plant Disease Reporter, V54, P708; JAKOBY WB, 1990, J BIOL CHEM, V265, P20715; KENNELL JC, 1987, MOL GEN GENET, V210, P399, DOI 10.1007/BF00327189; KENNELL JC, 1989, MOL GEN GENET, V216, P16, DOI 10.1007/BF00332225; KORTH KL, 1991, P NATL ACAD SCI USA, V88, P10865, DOI 10.1073/pnas.88.23.10865; LASER KD, 1972, BOT REV, V38, P425, DOI 10.1007/BF02860010; LAUGHNAN JR, 1983, ANNU REV GENET, V17, P27, DOI 10.1146/annurev.ge.17.120183.000331; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LEVINGS CS, 1993, PLANT CELL, V5, P1285, DOI 10.2307/3869781; MACKENZIE S, 1994, PLANT PHYSIOL, V105, P775, DOI 10.1104/pp.105.3.775; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; PRING DR, 1989, ANNU REV PHYTOPATHOL, V27, P483; PRING DR, 1988, PHILOS T ROY SOC B, V319, P187, DOI 10.1098/rstb.1988.0042; SCHNABLE PS, 1994, GENETICS, V136, P1171; TASAYCO ML, 1990, ARCH BIOCHEM BIOPHYS, V278, P444, DOI 10.1016/0003-9861(90)90283-5; ULLSTRUP AJ, 1972, ANNU REV PHYTOPATHOL, V10, P37, DOI 10.1146/annurev.py.10.090172.000345; VILLEMUR R, 1992, J MOL BIOL, V227, P81, DOI 10.1016/0022-2836(92)90683-B; WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X; WARMKE HE, 1977, J HERED, V68, P213, DOI 10.1093/oxfordjournals.jhered.a108817; WISE RP, 1994, THEOR APPL GENET, V88, P785, DOI 10.1007/BF01253987; WISE RP, 1987, PLANT MOL BIOL, V9, P121, DOI 10.1007/BF00015644; WISE RP, IN PRESS GENETICS; YODER OC, 1973, PHYTOPATHOLOGY, V63, P1361, DOI 10.1094/Phyto-63-1361	39	301	381	3	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1334	1336		10.1126/science.272.5266.1334	http://dx.doi.org/10.1126/science.272.5266.1334			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8650543				2022-12-28	WOS:A1996UN47200045
J	Taggart, AKP; Pugh, BF				Taggart, AKP; Pugh, BF			Dimerization of TFIID when not bound to DNA	SCIENCE			English	Article							BINDING-PROTEIN; TRANSCRIPTION	For unknown reasons, the eukaryotic transcription factor TFIID inefficiently recognizes promoters. Human TFIID was found to form highly specific homodimers that must dissociate before DNA binding. TFIID dimers formed through self-association of the TATA-binding polypeptide (TBP) subunit and could be immunoprecipitated with antibodies to TAF(II)250, the core subunit of TFIID. Chemical cross-linking experiments in HeLa cells revealed the presence of TBP dimers in vivo. These findings suggest that dimerization through TBP is the physiological state of TFIID when not bound to DNA. Thus, the inefficiency of TFIID binding to a promoter may be partly attributable to the competitive effect of dimerization.	PENN STATE UNIV,CTR GENE REGULAT,DEPT BIOCHEM & MOLEC BIOL,UNIVERSITY PK,PA 16802	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park					NIGMS NIH HHS [GM47855] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel FM, 1994, CURRENT PROTOCOLS MO; CHATTERJEE S, 1995, NATURE, V374, P820, DOI 10.1038/374820a0; COLEMAN RA, 1995, J BIOL CHEM, V270, P13850, DOI 10.1074/jbc.270.23.13850; COLEMAN RA, 1995, J BIOL CHEM, V270, P13842, DOI 10.1074/jbc.270.23.13842; KLAGES N, 1995, NATURE, V374, P822, DOI 10.1038/374822a0; LIEBERMAN PM, 1991, GENE DEV, V5, P2441, DOI 10.1101/gad.5.12b.2441; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; NIKOLOV DB, 1994, NAT STRUCT BIOL, V1, P621, DOI 10.1038/nsb0994-621; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; PUGH BF, 1995, IN VITRO TRANSCRIPTI, V37, P359; TAGGART AK, 1994, NUCLEIC ACIDS RES, V22, P1179; TAGGART AKP, 1992, CELL, V71, P1015, DOI 10.1016/0092-8674(92)90396-T; TJIAN R, 1994, CELL, V77, P55; WANG WD, 1992, GENE DEV, V6, P1716, DOI 10.1101/gad.6.9.1716; WEINZIERL ROJ, 1993, NATURE, V362, P511, DOI 10.1038/362511a0; ZAWEL L, 1995, ANNU REV BIOCHEM, V64, P533	16	56	56	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1331	1333		10.1126/science.272.5266.1331	http://dx.doi.org/10.1126/science.272.5266.1331			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8650542				2022-12-28	WOS:A1996UN47200044
J	Magistrale, H; Zhou, HW				Magistrale, H; Zhou, HW			Lithologic control of the depth of earthquakes in southern California	SCIENCE			English	Article							EASTERN TRANSVERSE RANGES; SIERRA-NEVADA BATHOLITH; LOS-ANGELES BASIN; TEHACHAPI MOUNTAINS; CONTINENTAL-CRUST; FAULT ZONE; EXPOSURE	The depth distribution of southern California earthquakes indicates that areas underlain by schist basement rocks have a shallower (4 to 10 kilometers) maximum depth of earthquakes than do areas with other types of basement rocks. The predominant minerals in the schists become plastic at lower temperatures, and th us at shallower depths, than the minerals in the other basement rocks. The lateral variations in lithology will control the depth extent (and thus the magnitudes) of potential future earthquakes; these depths can be determined from the depth of the current background seismicity.	UNIV HOUSTON,DEPT GEOSCI,HOUSTON,TX 77204	University of Houston System; University of Houston	Magistrale, H (corresponding author), SAN DIEGO STATE UNIV,DEPT GEOL SCI,SAN DIEGO,CA 92182, USA.							BARTH AP, 1991, GEOLOGICAL EXCURSION, P186; BURCHFIEL BC, 1981, GEOTECTONIC DEV CALI, V1, pCH9; CHEADLE MJ, 1986, TECTONICS, V5, P293, DOI 10.1029/TC005i002p00293; CORBETT EJ, 1984, THESIS CALTECH; CROUCH JK, 1993, GEOL SOC AM BULL, V105, P1415, DOI 10.1130/0016-7606(1993)105<1415:LCTEOT>2.3.CO;2; CROWELL JC, 1981, GEOTECTONIC DEV CALI, V1, pCH18; DILLON JT, 1990, J GEOPHYS RES-SOLID, V95, P19953, DOI 10.1029/JB095iB12p19953; Dokka R.K., 1991, GEOLOGICAL EXCURSION, P1; DOLAN JF, 1995, SCIENCE, V267, P199, DOI 10.1126/science.267.5195.199; EHLIG PL, 1981, GEOTECTONIC DEV CALI, V1, pCH10; GREEN SM, 1983, THESIS U CALIFORNIA; HAMILTON W, 1988, METAMORPHISM CRUSTAL, V7, pCH1; HAXEL G, 1978, MESOZOIC PALEOGEOGRA, P453; HOWELL DG, 1981, GEOTECTONIC DEV CALI, V1, pCH16; JACKSON DD, 1996, SEISMOL RES LETT, V67, P3, DOI DOI 10.1785/GSSRL.67.1.3; JACOBSON CE, 1990, J GEOPHYS RES-SOLID, V95, P509, DOI 10.1029/JB095iB01p00509; JONES LM, 1993, SEISMOL RES LETT, V64, P22; LARSEN ES, 1948, GEOL SOC AM MEM, V29; MA D, 1982, EOS, V63, P1033; Magistrale H, 1996, J GEOPHYS RES-SOL EA, V101, P3031, DOI 10.1029/95JB03447; MALIN PE, 1995, J GEOPHYS RES-SOL EA, V100, P2069, DOI 10.1029/94JB02127; MATTI JC, 1985, 85355 US GEOL SURV O; MEISSNER R, 1982, TECTONICS, V1, P73, DOI 10.1029/TC001i001p00073; MORRIS RS, 1986, GEOL SOC AM ABSTR, V18, P160; MORRIS RS, 1990, THESIS STATE U SAN D; NICHOLSON C, 1986, J GEOPHYS RES-SOLID, V91, P4891, DOI 10.1029/JB091iB05p04891; PICKETT DA, 1993, J GEOPHYS RES-SOL EA, V98, P609, DOI 10.1029/92JB01889; SALEEBY JB, 1987, J GEOPHYS RES-SOLID, V92, P10443, DOI 10.1029/JB092iB10p10443; SALEEBY JB, 1993, GEOL SOC AM ABSTR, V25, P141; SCHIFFRIES CM, 1994, GEOTIMES, V39, P4; SCHOELLHAMER JE, 1951, OM117 US GEOL SURV O; Scholz C. H., 1990, MECH EARTHQUAKES FAU; SHARP RV, 1967, GEOL SOC AM BULL, V78, P705, DOI 10.1130/0016-7606(1967)78[705:SJFZIT]2.0.CO;2; SIBSON RH, 1984, J GEOPHYS RES, V89, P5791, DOI 10.1029/JB089iB07p05791; SIBSON RH, 1982, B SEISMOL SOC AM, V72, P151; SILVER LT, 1993, GEOL SOC AM ABSTR, V25, P147; SILVER LT, 1986, GEOL SOC AM ABSTR, V18, P185; SORENSEN S, 1988, METAMORPHISM CRYSTAL, V7, pCH36; SORENSEN SS, 1991, GEOLOGICAL EXCURSION, P272; SPONGBERG ME, 1987, GEOL SOC AM ABSTR, V19, P454; TSE ST, 1986, J GEOPHYS RES-SOLID, V91, P9452, DOI 10.1029/JB091iB09p09452; VEDDER JG, 1987, GEOLOGY RESOURCE POT, P403; WEBB TH, 1985, B SEISMOL SOC AM, V75, P737; Wright T.L., 1991, AAPG MEMOIR, V52, P35; YEATS RS, 1973, AM ASSOC PETR GEOL B, V57, P117; Zhou H., 1994, EOS T AGU S, V75, P483; ZHOU HW, 1994, J GEOPHYS RES-SOL EA, V99, P15439, DOI 10.1029/94JB00934; 1995, B SEISMOL SOC AM, V85, P379	48	42	42	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 2	1996	273	5275					639	642		10.1126/science.273.5275.639	http://dx.doi.org/10.1126/science.273.5275.639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VA249	8662553				2022-12-28	WOS:A1996VA24900045
J	Thomas, C; DeVries, P; Hardin, J; White, J				Thomas, C; DeVries, P; Hardin, J; White, J			Four-dimensional imaging: Computer visualization of 3D movements in living specimens	SCIENCE			English	Article							FLUORESCENCE MICROSCOPY; TIME-LAPSE; EMBRYOS; ELEGANS; CELLS	The study of many biological processes requires the analysis of three-dimensional (3D) structures that change over time. Optical sectioning techniques can provide 3D data from living specimens; however, when 3D data are collected over a period of time, the quantity of Image information produced leads to difficulties in interpretation. A computer-based system is described that permits the analysis and archiving of 3D image data taken over time, The system allows a user to roam through the full range of time points and focal planes in the data set. The user can animate images as an aid to visualization and can append multicolored labels and text notes to identified structures during data analysis, The system provides a valuable tool for the study of embryogenesis and cytoplasmic movements within cells and has considerable potential as an educational tool.	UNIV WISCONSIN, DEPT ZOOL, MADISON, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Thomas, C (corresponding author), UNIV WISCONSIN, INTEGRATED MICROSCOPY RESOURCE BIOMED RES, MADISON, WI 53706 USA.		DeVries, Peter/B-7014-2009	DeVries, Peter/0000-0003-4637-5281	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000570] Funding Source: NIH RePORTER; NCRR NIH HHS [P41-RR00570-26] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AGARD DA, 1989, METHOD CELL BIOL, V30, P353; CHALFIE M, 1995, PHOTOCHEM PHOTOBIOL, V62, P651, DOI 10.1111/j.1751-1097.1995.tb08712.x; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DRIEBIN RA, 1988, COMPUT GRAPH, V22, P65; FIRE A, 1994, COMPUT APPL BIOSCI, V10, P443; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; INOUE S, 1994, BIOL BULL, V187, P232, DOI 10.1086/BBLv187n2p232; MINDEN JS, 1989, J CELL BIOL, V109, P505, DOI 10.1083/jcb.109.2.505; SCHNABEL R, 1991, MECH DEVELOP, V34, P85, DOI 10.1016/0925-4773(91)90046-9; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; WHITE JG, 1987, J CELL BIOL, V105, P41, DOI 10.1083/jcb.105.1.41	11	95	97	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	1996	273	5275					603	607		10.1126/science.273.5275.603	http://dx.doi.org/10.1126/science.273.5275.603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VA249	8662545	Green Submitted			2022-12-28	WOS:A1996VA24900032
J	Thess, A; Lee, R; Nikolaev, P; Dai, HJ; Petit, P; Robert, J; Xu, CH; Lee, YH; Kim, SG; Rinzler, AG; Colbert, DT; Scuseria, GE; Tomanek, D; Fischer, JE; Smalley, RE				Thess, A; Lee, R; Nikolaev, P; Dai, HJ; Petit, P; Robert, J; Xu, CH; Lee, YH; Kim, SG; Rinzler, AG; Colbert, DT; Scuseria, GE; Tomanek, D; Fischer, JE; Smalley, RE			Crystalline ropes of metallic carbon nanotubes	SCIENCE			English	Article							GROWTH	Fullerene single-wall nanotubes (SWNTs) were produced in yields of more than 70 percent by condensation of a laser-vaporized carbon-nickel-cobalt mixture at 1200 degrees C. X-ray diffraction and electron microscopy showed that these SWNTs are nearly uniform in diameter and thai they self-organize into ''ropes,'' which consist of 100 to 500 SWNTs in a two-dimensional triangular lattice with a lattice constant of 17 angstroms. The x-ray form factor is consistent with that of uniformly charged cylinders 13.8 +/- 0.2 angstroms in diameter. The ropes were metallic, with a single-rope resistivity of <10(-4) ohm-centimeters at 300 kelvin. The uniformity of SWNT diameter is attributed to the efficient annealing of an initial fullerene tubelet kept open by a few metal atoms; the optimum diameter is determined by competition between the strain energy of curvature of the graphene sheet and the dangling-bond energy of the open edge, where growth occurs. These factors strongly favor the metallic (10,10) tube with C-5v symmetry and an open edge stabilized by triple bonds.	RICE UNIV, RICE QUANTUM INST, CTR NANOSCALE SCI & TECHNOL, HOUSTON, TX 77251 USA; RICE UNIV, DEPT CHEM, HOUSTON, TX 77251 USA; RICE UNIV, DEPT PHYS, HOUSTON, TX 77251 USA; UNIV PENN, DEPT MAT SCI & ENGN, PHILADELPHIA, PA 19104 USA; UNIV PENN, RES STRUCT MATTER LAB, PHILADELPHIA, PA 19104 USA; INST CHARLES SADRON, F-67000 STRASBOURG, FRANCE; MICHIGAN STATE UNIV, DEPT PHYS & ASTRON, E LANSING, MI 48824 USA	Rice University; Rice University; Rice University; University of Pennsylvania; University of Pennsylvania; Michigan State University			Nikolaev, Pavel/B-9960-2009; Scuseria, Gustavo E/F-6508-2011; Tomanek, David/B-3275-2009; Lee, Young Hee/A-5424-2013; Dai, Hongjie/ABC-4574-2021	Tomanek, David/0000-0003-1131-4788; Kim, Seong-Gon/0000-0002-1629-0319				AJAYAN PM, 1993, CHEM PHYS LETT, V215, P509, DOI 10.1016/0009-2614(93)85711-V; AMELINCKX S, 1994, SCIENCE, V265, P635, DOI 10.1126/science.265.5172.635; BETHUNE DS, 1993, NATURE, V363, P605, DOI 10.1038/363605a0; CHARLIER JC, 1995, EUROPHYS LETT, V29, P43, DOI 10.1209/0295-5075/29/1/008; CHAUVET O, 1995, PHYS REV B, V52, pR6963, DOI 10.1103/PhysRevB.52.R6963; Chico L, 1996, PHYS REV LETT, V76, P971, DOI 10.1103/PhysRevLett.76.971; COWLEY JM, UNPUB; Dai HJ, 1996, SCIENCE, V272, P523, DOI 10.1126/science.272.5261.523; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; DRESSELHAUS MS, 1988, SPRINGER SERIES MAT, V5, P188; Eggen BR, 1996, SCIENCE, V272, P87, DOI 10.1126/science.272.5258.87; Fowler P. W., 1995, INT SERIES MONOGRAPH, V30; GUO T, 1993, J CHEM PHYS, V99, P352, DOI 10.1063/1.465758; GUO T, 1995, CHEM PHYS LETT, V243, P49, DOI 10.1016/0009-2614(95)00825-O; HEINEY PA, 1992, J PHYS CHEM SOLIDS, V53, P1333, DOI 10.1016/0022-3697(92)90231-2; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Kiang CH, 1996, PHYS REV LETT, V76, P2515, DOI 10.1103/PhysRevLett.76.2515; KORAN G, 1990, APPL PHYS LETT, V56, P2144; Langer L, 1996, PHYS REV LETT, V76, P479, DOI 10.1103/PhysRevLett.76.479; Lee Y. H., UNPUB; REZNIK D, 1995, PHYS REV B, V52, P116, DOI 10.1103/PhysRevB.52.116; RINZLER AG, 1995, SCIENCE, V269, P1550, DOI 10.1126/science.269.5230.1550; RINZLER AG, IN PRESS ELECTROCHEM; ROBERTSON DH, 1992, PHYS REV B, V45, P12592, DOI 10.1103/PhysRevB.45.12592; TERSOFF J, 1994, PHYS REV LETT, V73, P676, DOI 10.1103/PhysRevLett.73.676; TIBBETTS GG, 1990, NATO ADV SCI I C-MAT, V177, P73; WITANACHCHI S, 1995, J VAC SCI TECHNOL A, V13, P1174; Xu C., UNPUB; XU CH, 1992, J PHYS-CONDENS MAT, V4, P6047, DOI 10.1088/0953-8984/4/28/006; ZHOU O, 1994, SCIENCE, V263, P1744, DOI 10.1126/science.263.5154.1744	31	4964	5330	43	1772	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	1996	273	5274					483	487		10.1126/science.273.5274.483	http://dx.doi.org/10.1126/science.273.5274.483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY983	8662534				2022-12-28	WOS:A1996UY98300036
J	Christakis, NA; Escarce, JJ				Christakis, NA; Escarce, JJ			Survival of Medicare patients after enrollment in hospice programs	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CANCER-PATIENTS; TERMINAL CARE; NATIONAL HOSPICE; COST SAVINGS; REIMBURSEMENT; DEATH	Background Each year more than 220,000 Medicare beneficiaries receive care from hospice programs designed to enhance the quality of the end of life. Enrollment requires certification by a physician that the patient has a life expectancy of less than six months. We examined how long before death patients enrolled in hospice programs. Methods Using 1990 Medicare claims data, we analyzed the characteristics and survival of 6451 hospice patients followed for a minimum of 27 months with respect to mortality. Results The patients' mean age was 76.4 years; 92.4 percent were white, Half the patients were women, and 80.2 percent had cancer of some type. The most common diagnoses were lung cancer (21.4 percent), colorectal cancer (10.5 percent), and prostate cancer (7.4 percent). The median survival after enrollment was only 36 days, and 15.6 percent of the patients died within 7 days. At the other extreme, 14.9 percent of the patients lived longer than six months. Survival varied substantially according to diagnosis, even after adjustment for age and coexisting conditions. The unadjusted survival after enrollment was shortest for those with renal failure, those with leukemia or lymphoma, and those with liver or biliary cancer; it was longest for those with chronic lung disease, those with dementia, and those with breast cancer. Patients at for-profit, larger, outpatient, or newer hospices lived longer after enrollment than those in other types of hospice programs. Conclusions Most patients who enter hospice care do so late in the course of their terminal illnesses, The timing of enrollment in hospice programs varies substantially with the characteristics of the patients and the hospices. (C) 1996, Massachusetts Medical Society.	UNIV CHICAGO, DEPT SOCIOL, CHICAGO, IL 60637 USA; UNIV PENN, DEPT MED, DIV GEN INTERNAL MED, PHILADELPHIA, PA 19104 USA; UNIV PENN, LEONARD DAVIS INST HLTH ECON, PHILADELPHIA, PA 19104 USA	University of Chicago; University of Pennsylvania; University of Pennsylvania	Christakis, NA (corresponding author), UNIV CHICAGO, MED CTR,GEN INTERNAL MED SECT,DEPT MED, 5841 S MARYLAND AVE, MC 6098, CHICAGO, IL 60637 USA.		Christakis, Nicholas A/C-3205-2009; Christakis, Nicholas A/B-6690-2008					ALLARD P, 1995, J PALLIAT CARE, V11, P20, DOI 10.1177/082585979501100305; [Anonymous], 1975, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441.; BRODY H, 1984, NEW ENGL J MED, V310, P920; BROOKS CH, 1984, MED CARE, V22, P691, DOI 10.1097/00005650-198408000-00002; BRUERA E, 1992, J PAIN SYMPTOM MANAG, V7, P82, DOI 10.1016/0885-3924(92)90118-2; BULKIN W, 1988, NEW ENGL J MED, V318, P376, DOI 10.1056/NEJM198802113180609; Carney K, 1989, Nurs Econ, V7, P41; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHRISTAKIS NA, 1994, J GEN INTERN MED, V9, P314, DOI 10.1007/BF02599178; Davis F A, 1988, Health Care Financ Rev, V9, P99; DAWSON NJ, 1991, SOC SCI MED, V32, P83, DOI 10.1016/0277-9536(91)90131-U; *DEP HLTH HUM SERV, 1980, ICD9CM DEP HLTH HUM, V1; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; EVANS C, 1984, J EPIDEMIOL COMMUN H, V38, P310, DOI 10.1136/jech.38.4.310; Forster L E, 1989, Am J Hosp Care, V6, P31; FORSTER LE, 1988, ARCH INTERN MED, V148, P2540, DOI 10.1001/archinte.148.12.2540; GREER DS, 1986, J CHRON DIS, V39, P9, DOI 10.1016/0021-9681(86)90103-7; HANNAN EL, 1984, INQUIRY-J HEALTH CAR, V21, P338; Hyman R B, 1990, Hosp J, V6, P39, DOI 10.1300/J011v06n04_04; IEZZONI LI, 1992, JAMA-J AM MED ASSOC, V267, P2197, DOI 10.1001/jama.267.16.2197; Infeld D L, 1990, Hosp J, V6, P81; KANE RL, 1985, MED CARE, V23, P189, DOI 10.1097/00005650-198503000-00001; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KIDDER D, 1992, HEALTH SERV RES, V27, P195; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; LYNN J, 1995, WESTERN J MED, V163, P250; MOINPOUR CM, 1989, AM J PUBLIC HEALTH, V79, P1549, DOI 10.2105/AJPH.79.11.1549; MOR V, 1983, J HEALTH SOC BEHAV, V24, P375, DOI 10.2307/2136403; MOR V, 1985, HEALTH SERV RES, V20, P407; MOR V, 1988, HOSPICE EXPT; *OFF RES DEM, 1994, HCFA PUBL; PARKES CM, 1972, BRIT MED J, V2, P29, DOI 10.1136/bmj.2.5804.29; PEARLMAN RA, 1988, ARCH INTERN MED, V148, P2537, DOI 10.1001/archinte.148.12.2537; POTTER JF, 1980, NEW ENGL J MED, V302, P53, DOI 10.1056/NEJM198001033020111; REUBEN DB, 1988, ARCH INTERN MED, V148, P1586, DOI 10.1001/archinte.148.7.1586; ROMANO PS, 1994, MED CARE, V32, P81, DOI 10.1097/00005650-199401000-00006; Rosenthal Mark A., 1993, Palliative Medicine, V7, P199, DOI 10.1177/026921639300700306; Schonwetter R S, 1990, Hosp J, V6, P65; SPECTOR WD, 1984, INQUIRY-J HEALTH CAR, V21, P328; STRAHAN GW, 1994, ADV DATA VITAL HLTH, V256; TEACHMAN JD, 1993, SOCIOL METHOD RES, V21, P340, DOI 10.1177/0049124193021003003; Tukey J. W., 1977, EXPLORATORY DATA ANA; WALLSTON KA, 1988, MED CARE, V26, P177, DOI 10.1097/00005650-198802000-00008; 1993, NHO NEWSLINE, V3, P1	44	368	372	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 18	1996	335	3					172	178		10.1056/NEJM199607183350306	http://dx.doi.org/10.1056/NEJM199607183350306			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UW790	8657216	Green Published, Green Submitted			2022-12-28	WOS:A1996UW79000006
J	Ahmed, R				Ahmed, R			Tickling memory T cells	SCIENCE			English	Editorial Material							INTERFERON; MICE; INDUCTION				Ahmed, R (corresponding author), EMORY UNIV,SCH MED,EMORY VACCINE CTR,G211 ROLLINS RES BLDG,ATLANTA,GA 30322, USA.							Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Asano MS, 1996, J EXP MED, V183, P2165, DOI 10.1084/jem.183.5.2165; BEVERLEY PCL, 1990, IMMUNOL TODAY, V11, P203, DOI 10.1016/0167-5699(90)90083-L; BIRON CA, 1984, J LEUKOCYTE BIOL, V35, P31, DOI 10.1002/jlb.35.1.31; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; CAO WX, 1995, NATURE, V378, P295, DOI 10.1038/378295a0; DEGRE M, 1974, INT J CANCER, V14, P699, DOI 10.1002/ijc.2910140602; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; GIDLUND M, 1978, NATURE, V273, P759, DOI 10.1038/273759a0; GRESSER I, 1981, J IMMUNOL, V127, P1569; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; ISHIKAWA R, 1993, J IMMUNOL, V150, P3713; KORNGOLD R, 1983, J IMMUNOL, V130, P2236; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; MATZINGER P, 1994, NATURE, V369, P605, DOI 10.1038/369605a0; MULLBACHER A, 1994, J EXP MED, V179, P317, DOI 10.1084/jem.179.1.317; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; UNUTMAZ D, 1994, J EXP MED, V180, P1159, DOI 10.1084/jem.180.3.1159; VILCEK J, 1996, FIELDS VIROLOGY, P375; Welsh RM, 1996, SEMIN VIROL, V7, P95, DOI 10.1006/smvy.1996.0012; Zimmermann C, 1996, J EXP MED, V183, P1367, DOI 10.1084/jem.183.4.1367; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173	23	24	24	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1996	272	5270					1904	1904		10.1126/science.272.5270.1904	http://dx.doi.org/10.1126/science.272.5270.1904			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8658161				2022-12-28	WOS:A1996UV29400037
J	Bloom, BR				Bloom, BR			A perspective on AIDS vaccines	SCIENCE			English	Editorial Material							IMMUNODEFICIENCY				Bloom, BR (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED,HOWARD HUGHES MED INST,DEPT MICROBIOL,BRONX,NY 10461, USA.							ALMOND N, 1995, LANCET, V345, P1342, DOI 10.1016/S0140-6736(95)92540-6; BAKSHI SS, 1995, PEDIATR INFECT DIS J, V14, P658, DOI 10.1097/00006454-199508000-00002; BRYSON YJ, 1995, NEW ENGL J MED, V332, P833, DOI 10.1056/NEJM199503303321301; BUCHBINDER SP, 1994, AIDS, V8, P1123, DOI 10.1097/00002030-199408000-00014; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; CLEMENTS ML, IN PRESS NEW GENERAT; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; DESROSIERS RC, 1994, AIDS RES HUM RETROV, V10, P331, DOI 10.1089/aid.1994.10.331; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; HAYNES BF, 1993, SCIENCE, V260, P1279, DOI 10.1126/science.8493572; Haynes BF, 1996, SCIENCE, V271, P324, DOI 10.1126/science.271.5247.324; KEET IPM, 1994, J INFECT DIS, V169, P1236, DOI 10.1093/infdis/169.6.1236; LOHMAN BL, 1994, J VIROL, V68, P7021, DOI 10.1128/JVI.68.11.7021-7029.1994; LONG RB, 1996, NY TIMES        0419, pA18; LURIE P, 1994, JAMA-J AM MED ASSOC, V271, P295, DOI 10.1001/jama.271.4.295; MARTIN HL, 1994, AIDS RES HUM RETROV, V10, pS235; MOORE J, 1994, NATURE, V372, P313, DOI 10.1038/372313a0; MORRIS OP, 1996, J INFECT DIS, V173, P68; MUNOZ A, 1989, AM J EPIDEMIOL, V130, P530, DOI 10.1093/oxfordjournals.aje.a115367; Newell ML, 1996, LANCET, V347, P213, DOI 10.1016/S0140-6736(96)90401-8; *NIH OFF AIDS RES, 1996, NIH AIDS RES PROGR E; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; PAUL WE, 1995, CELL, V82, P177, DOI 10.1016/0092-8674(95)90304-6; PLUMMER FA, 1993, 9 INT C AIDS STD WOR; ROQUES PA, 1995, AIDS, V9, pF19; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; ROWLANDJONES SL, 1995, CURR OPIN IMMUNOL, V7, P448, DOI 10.1016/0952-7915(95)80087-5; Ruprecht RM, 1996, AIDS RES HUM RETROV, V12, P459, DOI 10.1089/aid.1996.12.459; SHIRAMIZU B, 1994, CANCER RES, V54, P2069; TRAVERS K, 1995, SCIENCE, V268, P1612, DOI 10.1126/science.7539936; WALKER MC, 1994, AIDS S1, V8, pS213; Weiss RA, 1996, AIDS RES HUM RETROV, V12, P465, DOI 10.1089/aid.1996.12.465; *WORLD BANK, 1993, INV HLTH, P62; [No title captured]; 1991, J AM VET MED ASSOC, V10, P1392	35	26	30	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1996	272	5270					1888	1890		10.1126/science.272.5270.1888	http://dx.doi.org/10.1126/science.272.5270.1888			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8658160				2022-12-28	WOS:A1996UV29400029
J	Durbec, P; MarcosGutierrez, CV; Kilkenny, C; Grigoriou, M; Wartiovaara, K; Suvanto, P; Smith, D; Ponder, B; Costantini, F; Saarma, M; Sariola, H; Pachnis, V				Durbec, P; MarcosGutierrez, CV; Kilkenny, C; Grigoriou, M; Wartiovaara, K; Suvanto, P; Smith, D; Ponder, B; Costantini, F; Saarma, M; Sariola, H; Pachnis, V			GDNF signalling through the Ret receptor tyrosine kinase	NATURE			English	Article							EXPRESSION	MUTATIONAL analysis in humans and mice has demonstrated that Ret, the product of the c-ret proto-oncogene, a member of the receptor tyrosine kinase (RTK) superfamily(1), is essential for development of the enteric nervous system and kidney(2-6). Despite the established role of Ret in mammalian embryogenesis, its cognate ligand(s) is currently unknown. Here we demonstrate, by using a Xenopus embryo bioassay, that glial-cell-line-derived neurotrophic factor (GDNF)(7), a distant member of the transforming growth factor(TGF)-beta superfamily, signals through the Ret RTK. Furthermore, using explant cultures from wild-type and Ret-deficient mouse embryos(4), we show that normal c-ret function is necessary for GDNF signalling in the peripheral nervous system, Our data strongly suggest that Ret is a functional receptor for GDNF, and that GDNF, in addition to its potential role in the differentiation and survival of central nervous system neurons(8-12), has profound effects on kidney organogenesis and the development of the peripheral nervous system.	NATL INST MED RES, DIV DEV NEUROBIOL, LONDON NW7 1AA, ENGLAND; UNIV HELSINKI, BIOCTR 1, INST BIOTECHNOL, FIN-00014 HELSINKI, FINLAND; UNIV CAMBRIDGE, ADDENBROOKES HOSP, CRC, HUMAN CANC GENET RES GRP, CAMBRIDGE CB2 2QQ, ENGLAND; COLUMBIA UNIV COLL PHYS & SURG, DEPT GENET & DEV, NEW YORK, NY 10032 USA; HELSINKI UNIV, CHILDRENS HOSP, FIN-000290 HELSINKI, FINLAND	MRC National Institute for Medical Research; University of Helsinki; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Columbia University; University of Helsinki			Grigoriou, Maria/AAM-8332-2021	Grigoriou, Maria/0000-0001-6336-5523				BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; Borrello MG, 1995, ONCOGENE, V11, P2419; BRIVANLOU AH, 1994, CELL, V77, P283; Durbec PL, 1996, DEVELOPMENT, V122, P349; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; GOTOH Y, 1995, EMBO J, V14, P2491, DOI 10.1002/j.1460-2075.1995.tb07246.x; HEBENSTREIT PG, 1992, ONCOGENE, V7, P2499; Hellmich HL, 1996, MECH DEVELOP, V54, P95, DOI 10.1016/0925-4773(95)00464-5; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; LABONNE C, 1995, DEVELOPMENT, V121, P1475; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Nieuwkoop P. D., 1975, NORMAL TABLE XENOPUS; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; RATHJEN FG, 1984, EMBO J, V3, P1; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; SAIRIO K, 1994, INT J DEV BIOL, V38, P77; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Saxen L., 1987, ORGANOGENESIS KIDNEY; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Suvanto P, 1996, EUR J NEUROSCI, V8, P816, DOI 10.1111/j.1460-9568.1996.tb01267.x; TAKAHASHI M, 1993, ONCOGENE, V8, P2925; TAKAHASHI M, 1988, ONCOGENE, V3, P571; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; UMBHAUER M, 1995, NATURE, V376, P58, DOI 10.1038/376058a0; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0	30	682	725	0	13	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 27	1996	381	6585					789	793		10.1038/381789a0	http://dx.doi.org/10.1038/381789a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU356	8657282				2022-12-28	WOS:A1996UU35600061
J	Oldenbourg, R				Oldenbourg, R			A new view on polarization microscopy	NATURE			English	Article											Oldenbourg, R (corresponding author), MARINE BIOL LAB,WOODS HOLE,MA 02543, USA.							ALLEN RD, 1963, J CELL BIOL, V185, P223; CHARNOT EM, 1958, HDB CHEM MICROSCOPY; Hartshorne N. H., 1960, CRYSTALS POLARISING; Inoue S, 1966, MOL ARCHITECTURE CEL, P209; Inoue S, 1986, VIDEO MICROSCOPY; MCCRONE WC, 1991, LIGHT MICROSCOPY PHY, P343; OLDENBOURG R, 1995, J MICROSC-OXFORD, V180, P140, DOI 10.1111/j.1365-2818.1995.tb03669.x; OLDENBOURG R, 1993, BIOL BULL, V18, P288; Shurcliff W. A., 1962, POLARIZED LIGHT	9	168	184	3	41	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 27	1996	381	6585					811	812		10.1038/381811a0	http://dx.doi.org/10.1038/381811a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU356	8657288				2022-12-28	WOS:A1996UU35600070
J	Morahan, G; Huang, DX; Tait, BD; Colman, PG; Harrison, LC				Morahan, G; Huang, DX; Tait, BD; Colman, PG; Harrison, LC			Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus	SCIENCE			English	Article							GENETIC-ANALYSIS; LOCALIZATION; MICE; IDENTIFICATION; LINKAGE; RECEPTOR; PROTEIN; GENOME; LOCUS	Insulin-dependent diabetes mellitus (IDDM) is a multigenic autoimmune disease. An IDDM susceptibility gene was mapped to chromosome 2q34. This gene may act early in diabetogenesis, because ''preclinical'' individuals also showed linkage, Human leukocyte antigen (HLA)-disparate, but not HLA-identical, sibs showed linkage, which was even stronger in families with affected females. The genes encoding insulin-like growth factor-binding proteins 2 and 5 were mapped to a 4-megabase pair interval near this locus, These results indicate the existence of a gene that acts at an early stage in IDDM development, screening for which may identify a specific subset of at-risk individuals.			Morahan, G (corresponding author), ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIA.		Morahan, Grant/T-7501-2019	Colman, Peter/0000-0001-8718-6175				ALLANDER SV, 1994, J BIOL CHEM, V269, P10891; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BLUM WF, 1993, GROWTH REGULAT, V3, P100; BONIFACIO E, 1990, LANCET, V335, P147, DOI 10.1016/0140-6736(90)90013-U; BUONAVISTA N, 1992, GENOMICS, V13, P856, DOI 10.1016/0888-7543(92)90169-S; CARTER RE, 1995, GENOMICS, V27, P196, DOI 10.1006/geno.1995.1025; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; CORNALL RJ, 1991, NATURE, V353, P262, DOI 10.1038/353262a0; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DEGOUYON B, 1993, P NATL ACAD SCI USA, V90, P1877, DOI 10.1073/pnas.90.5.1877; DUNCAN AMV, 1992, CYTOGENET CELL GENET, V60, P212, DOI 10.1159/000133340; EHRENBORG E, 1991, BIOCHEM BIOPH RES CO, V176, P1250, DOI 10.1016/0006-291X(91)90420-C; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; GARCHON HJ, 1991, NATURE, V353, P260, DOI 10.1038/353260a0; GIANNINI S, 1994, J CLIN ENDOCR METAB, V79, P1824, DOI 10.1210/jc.79.6.1824; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HOLMANS P, 1993, AM J HUM GENET, V52, P362; HONEYMAN MC, 1993, SPRINGER SEMIN IMMUN, V14, P253; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; KRUGLYAK L, 1995, NAT GENET, V11, P241; LUERSSEN H, 1990, GENOMICS, V8, P324, DOI 10.1016/0888-7543(90)90289-7; LUO DF, 1995, AM J HUM GENET, V57, P911; LUO DF, IN PRESS HUM MOL GEN; MORAHAN G, 1994, P NATL ACAD SCI USA, V91, P5898, DOI 10.1073/pnas.91.13.5898; MORAHAN G, UNPUB; OWERBACH D, 1995, DIABETES, V44, P132, DOI 10.2337/diabetes.44.1.132; POCIOT F, 1994, AUTOIMMUNITY, V19, P169, DOI 10.3109/08916939408995692; PROCHAZKA M, 1987, SCIENCE, V237, P286, DOI 10.1126/science.2885918; SERREZE DV, 1994, J EXP MED, V180, P1553, DOI 10.1084/jem.180.4.1553; STOFFEL M, 1993, DIABETOLOGIA, V36, P335, DOI 10.1007/BF00400237; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; THOMSON G, 1994, NAT GENET, V8, P108, DOI 10.1038/ng1094-108; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; TODD JA, 1990, IMMUNOL TODAY, V11, P122, DOI 10.1016/0167-5699(90)90049-F; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHITE JK, 1994, GENOMICS, V24, P295, DOI 10.1006/geno.1994.1619; WILKIE TM, 1993, GENOMICS, V18, P175, DOI 10.1006/geno.1993.1452; WU BL, 1993, CYTOGENET CELL GENET, V63, P29, DOI 10.1159/000133495; YOUNG A, 1995, GAS MANUAL USER GUID; ZIMONJIC DB, 1995, ONCOGENE, V10, P1235	42	103	107	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1811	1813		10.1126/science.272.5269.1811	http://dx.doi.org/10.1126/science.272.5269.1811			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8650584				2022-12-28	WOS:A1996UT11000050
J	Kucan, JO; Lee, RC				Kucan, JO; Lee, RC			Plastic surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DYE-LASER		UNIV CHICAGO HOSP & CLIN, CHICAGO, IL USA	University of Chicago; University of Illinois System	Kucan, JO (corresponding author), SO ILLINOIS UNIV, SCH MED, SPRINGFIELD, IL 62708 USA.			Lee, Raphael C./0000-0002-6628-1867				ABBASE EA, 1995, PLAST RECONSTR SURG, V96, P1218, DOI 10.1097/00006534-199510000-00036; ACHAUER BM, 1995, PLAST RECONSTR SURG, V95, P607, DOI 10.1097/00006534-199503000-00053; BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197; EAVES FF, 1995, CLIN PLAST SURG, V22, P683; HOFFMAN SJ, 1993, J AM ACAD DERMATOL, V29, P790, DOI 10.1016/S0190-9622(08)81707-0; HUANG DH, 1989, J CELL BIOL, V107, P380; KHOURI RK, 1995, PLAST RECONSTR SURG, V95, P1007, DOI 10.1097/00006534-199505000-00008; KHOURI RK, 1994, J CLIN INVEST, V94, P1757, DOI 10.1172/JCI117523; PRIBAZ JJ, 1994, MICROSURG, V15, P618, DOI 10.1002/micr.1920150903; RAMIREZ OM, 1995, CLIN PLAST SURG, V22, P639; STAFFORD TJ, 1995, CLIN DERMATOL, V13, P69, DOI 10.1016/0738-081X(94)00032-W; STRAUSS RP, 1993, J PEDIATR-US, V122, P505, DOI 10.1016/S0022-3476(05)83527-9; VACANTI CA, 1994, CLIN PLAST SURG, V21, P445; VASCONEZ LO, 1994, J PLAST RECONSTR SUR, V4, P788	14	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1844	1845		10.1001/jama.275.23.1844	http://dx.doi.org/10.1001/jama.275.23.1844			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642743				2022-12-28	WOS:A1996UQ15200042
J	Harding, S; Balarajan, R				Harding, S; Balarajan, R			Patterns of mortality in second generation Irish living in England and Wales: Longitudinal study	BRITISH MEDICAL JOURNAL			English	Article							IMMIGRANTS	Objective-To examine the mortality of second generation Irish living in England and Wales. Design-Longitudinal study of 1% of the population of England and Wales (longitudinal study by the Office of Population Censuses and Surveys (now the Office for National Statistics)) followed up from 1971 to 1989. Subjects-3075 men and 3233 women aged 15 and over in 1971. Main outcome measures-Age and sex specific standardised mortality ratios for all causes, cancers, coronary heart disease, cerebrovascular diseases, respiratory diseases, and injuries and poisonings. Deaths were also analysed by socioeconomic indicators. Results-786 deaths were traced to men and 762 to women. At working ages (men, aged 15-64; women, 15-59) the mortality of men (standardised mortality ratio 126) and women (129) was significantly higher than that of all men and all women. At ages 15-44, relative disadvantages were even greater both for men (145) and for women (164). Mortality was raised for most major causes of death. Significant excess mortality from cancers was seen for men of working age (132) and for women aged 60 and over (122). At working ages mortality of the second generation Irish in every social class and in the categories of car access and housing tenure was higher than that of all men and all women in the corresponding categories. Adjusting for these socioeconomic indicators did not explain the excess mortality. Conclusion-Mortality of second generation Irish men and women was higher than that of all men and all women and for most major causes of death. While socioeconomic factors remain important, cultural and lifestyle factors are likely to contribute to this adverse mortality.	UNIV SURREY,INST PUBL HLTH,GUILDFORD GU2 5YL,SURREY,ENGLAND	University of Surrey	Harding, S (corresponding author), OFF NATL STAT,LONGITUDINAL STUDY UNIT,ST CATHERINES HOUSE,LONDON WC2B 6JP,ENGLAND.							ADELSTEIN AM, 1979, BRIT J CANCER, V40, P464, DOI 10.1038/bjc.1979.202; ADELSTEIN AM, 1986, IRISH MED J, V79, P185; BALARAJAN R, 1986, COMMUNITY MED, V8, P237; BALARAJAN R, 1990, MORTALITY GEOGRAPHY; FOX J, 1990, 1971 81 LONGITUDINAL; Garvey D., 1985, POPULATION TRENDS, V39, P22; GOLDBLATT P, 1990, 1971 81 LONGITUDINAL; HARDING S, 1995, IN PRESS BR J CANC; Hattersley L, 1995, LONGITUDINAL STUDY 1; HICKMAN M, 1995, IRISH STUDIES REV, V10, P16; Hickman Mary, 1995, RELIG CLASS IDENTITY; HORNSBYSMITH MP, 1988, BRIT J SOCIOL, V39, P519, DOI 10.2307/590499; HULL D, 1979, SOC SCI MED-MED SOC, VA13, P25, DOI 10.1016/0271-7123(79)90005-1; KELLAGHER D, 1996, IN PRESS RES CULTURA; MARMOT M, 1981, FDN PSYCHOSOMATICS; Marmot MG, 1984, IMMIGRANT MORTALITY; *OFF POP CENS SURV, 1993, 1991 CENS ETHN GROUP, V1; RAFTERY J, 1990, SOC SCI MED, V31, P577, DOI 10.1016/0277-9536(90)90093-8; SYME SL, 1975, AM J EPIDEMIOL, V102, P477, DOI 10.1093/oxfordjournals.aje.a112185; ULLAH P, 1985, NEW COMMUNITY, V10, P310; WILLIAMS R, 1994, SOC SCI MED, V39, P189, DOI 10.1016/0277-9536(94)90327-1	21	77	77	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 1	1996	312	7043					1389	1392		10.1136/bmj.312.7043.1389	http://dx.doi.org/10.1136/bmj.312.7043.1389			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP434	8646095	Green Published			2022-12-28	WOS:A1996UP43400020
J	Friel, DD				Friel, DD			TRP: Its role in phototransduction and store-operated Ca2+ entry	CELL			English	Review							DEPLETION; CELLS; GENE				Friel, DD (corresponding author), CASE WESTERN RESERVE UNIV,DEPT NEUROSCI,10900 EUCLID AVE,CLEVELAND,OH 44106, USA.							BENNETT DL, 1995, CURR BIOL, V5, P1225, DOI 10.1016/S0960-9822(95)00243-0; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; DONG YJ, 1995, AM J PHYSIOL-CELL PH, V269, pC1332, DOI 10.1152/ajpcell.1995.269.5.C1332; FASOLATO C, 1994, TRENDS PHARMACOL SCI, V15, P77, DOI 10.1016/0165-6147(94)90282-8; Hardie RC, 1996, J NEUROSCI, V16, P2924; HARDIE RC, 1995, CELL CALCIUM, V18, P256, DOI 10.1016/0143-4160(95)90023-3; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; LEWIS RS, 1996, SOC GEN PHYSL SERIES, V51; MINKE B, 1996, IN PRESS CURR OPIN N; NIEMEYER BA, 1996, IN PRESS CELL, V85; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; PUTNEY JW, 1993, ENDOCR REV, V14, P610, DOI 10.1210/er.14.5.610; RANGANATHAN R, 1995, ANNU REV NEUROSCI, V18, P283; SHIEH B, 1996, IN PRESS NEURON, V16; Sinkins WG, 1996, J BIOL CHEM, V271, P2955, DOI 10.1074/jbc.271.6.2955; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; ZHU X, 1996, IN PRESS CELL, V85; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	20	44	46	1	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 31	1996	85	5					617	619		10.1016/S0092-8674(00)81021-1	http://dx.doi.org/10.1016/S0092-8674(00)81021-1			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UP344	8646769	Bronze			2022-12-28	WOS:A1996UP34400001
J	Harvey, JW; Hill, F; Hubbard, RP; Kennedy, JR; Leibacher, JW; Pintar, JA; Gilman, PA; Noyes, RW; Title, AM; Toomre, J; Ulrich, RK; Bhatnagar, A; Kennewell, JA; Marquette, W; Patron, J; Saa, O; Yasukawa, E				Harvey, JW; Hill, F; Hubbard, RP; Kennedy, JR; Leibacher, JW; Pintar, JA; Gilman, PA; Noyes, RW; Title, AM; Toomre, J; Ulrich, RK; Bhatnagar, A; Kennewell, JA; Marquette, W; Patron, J; Saa, O; Yasukawa, E			The Global Oscillation Network Group (GONG) project	SCIENCE			English	Article							SOLAR	Helioseismology requires nearly continuous observations of the oscillations of the solar surface for long periods of time in order to obtain precise measurements of the sun's normal modes of oscillation. The GONG project acquires velocity images from a network of six identical instruments distributed around the world. The GONG network began full operation in October 1995. It has achieved a duty cycle of 89 percent and reduced the magnitude of spectral artifacts by a factor of 280 in power, compared with single-site observations. The instrumental noise is less than the observed solar background.	NATL CTR ATMOSPHER RES,HIGH ALTITUDE OBSERV,BOULDER,CO 80307; SMITHSONIAN ASTROPHYS OBSERV,CAMBRIDGE,MA 02138; LOCKHEED SOLAR & ASTROPHYS LAB,PALO ALTO,CA 94304; UNIV COLORADO,JILA,BOULDER,CO 80309; UNIV CALIF LOS ANGELES,DEPT PHYS & ASTRON,LOS ANGELES,CA 90024; PHYS RES LAB,UDAIPUR SOLAR OBSERV,UDAIPUR,INDIA; IPS RADIO & SPACE SERV,LEARMONTH SOLAR OBSERV,EXMOUTH,WA,AUSTRALIA; BIG BEAR SOLAR OBSERV,BIG BEAR CITY,CA 92314; CALTECH,PASADENA,CA 91125; INST ASTROFIS CANARIAS,OBSERV TEIDE,E-38200 LA LAGUNA,TENERIFE,SPAIN; NATL OPT ASTRON OBSERV,CERRO TOLOLO INTER AMER OBSERV,LA SERENA,CHILE; MAUNA LOA SOLAR OBSERV,HILO,HI 96720	National Center Atmospheric Research (NCAR) - USA; Harvard University; Smithsonian Institution; Lockheed Martin; University of Colorado System; University of Colorado Boulder; University of California System; University of California Los Angeles; Department of Space (DoS), Government of India; Physical Research Laboratory - India; California Institute of Technology; Instituto de Astrofisica de Canarias; National Optical Astronomy Observatory	Harvey, JW (corresponding author), NATL OPT ASTRON OBSERV,NATL SOLAR OBSERV,POB 26732,TUCSON,AZ 85726, USA.		Ulrich, Roger/AAE-6935-2020	Ulrich, Roger/0000-0003-4041-4657; Leibacher, John/0000-0001-7605-3684; Patron Recio, Jesus/0000-0001-7965-0484				BECKERS JM, 1978, OSSER MEM ASTROPHYS, V106, P189; BROWN T, 1988, ADV HELIO ASTEROSEIS, P453; CHOU DY, 1995, SOL PHYS, V160, P237, DOI 10.1007/BF00732806; COX AN, 1991, SOLAR INTERIOR ATMOS, P329; ELSWORTH Y, 1995, ASTR SOC P, V76, P392; FOSSAT E, 1992, ASTRON ASTROPHYS, V263, P443; FOSSAT E, 1991, SOL PHYS, V133, P1, DOI 10.1007/BF00149818; GOUGH D, 1991, ANNU REV ASTRON ASTR, V29, P627, DOI 10.1146/annurev.aa.29.090191.003211; HARVEY JW, 1989, AIP C P, V189, P227; HILL F, 1985, SOL PHYS, V95, P201, DOI 10.1007/BF00152398; Hill F, 1996, SCIENCE, V272, P1292, DOI 10.1126/science.272.5266.1292; HILL F, 1994, SOL PHYS, V152, P351, DOI 10.1007/BF00680444; HILL F, 1994, SOL PHYS, V152, P321, DOI 10.1007/BF00680443; Hill F. A., UNPUB; HOEKSEMA JT, 1995, 4 SOHO WORKSH HEL, V2, P185; LEIBACHER J, 1971, ASTROPHYS LETT COMM, V7, P191; RHODES EJ, 1995, ASTR SOC P, V76, P398; Scherrer PH, 1995, SOL PHYS, V162, P129, DOI 10.1007/BF00733429; TOUSSAINT R, 1995, ASTR SOC P, V76, P532; ULRICH RK, 1970, ASTROPHYS J, V162, P993, DOI 10.1086/150731; Unno W., 1989, NONRADIAL OSCILLATIO, V2nd ed.; WILLIAMS W, 1993, ASTR SOC P, V52, P494; WILLIAMS W, 1993, ASTR SOC P, V42, P441; WILLIAMS WE, 1995, ASTR SOC P, V76, P500; WOLFF CL, 1972, ASTROPHYS J, V177, pL87, DOI 10.1086/181058; [No title captured]	26	365	370	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1284	1286		10.1126/science.272.5266.1284	http://dx.doi.org/10.1126/science.272.5266.1284			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8662455	Green Submitted			2022-12-28	WOS:A1996UN47200031
J	Montzka, SA; Butler, JH; Myers, RC; Thompson, TM; Swanson, TH; Clarke, AD; Lock, LT; Elkins, JW				Montzka, SA; Butler, JH; Myers, RC; Thompson, TM; Swanson, TH; Clarke, AD; Lock, LT; Elkins, JW			Decline in the tropospheric abundance of halogen from halocarbons: Implications for stratospheric ozone depletion	SCIENCE			English	Article							HYDROGEN-CHLORIDE; ANTARCTIC OZONE; GROWTH-RATES; ATMOSPHERE; AIR; DESTRUCTION; RADICALS; LATITUDE; DECREASE; HCFC-22	Analyses of air sampled from remote locations across the globe reveal that tropospheric chlorine attributable to anthropogenic halocarbons peaked near the beginning of 1994 and was decreasing at a rate of 25 +/- 5 parts per trillion per year by mid-1995. Although bromine from halons was still increasing in mid-1995, the summed abundance of these halogens in the troposphere is decreasing. To assess the effect of this trend on stratospheric ozone, estimates of the future stratospheric abundance of ozone-depleting gases were made for mid-latitude and polar regions on the basis of these tropospheric measurements. These results suggest that the amount of reactive chlorine and bromine will reach a maximum in the stratosphere between 1997 and 1999 and will decline thereafter if limits outlined in the adjusted and amended Montreal Protocol on Substances That Deplete the Ozone Layer are not exceeded in future years.	UNIV COLORADO,COOPERAT INST RES ENVIRONM SCI,BOULDER,CO 80309	University of Colorado System; University of Colorado Boulder	Montzka, SA (corresponding author), NOAA,CLIMATE MONITORING & DIAGNOST LAB,BOULDER,CO 80303, USA.		montzka, stephen/V-6162-2019	montzka, stephen/0000-0002-9396-0400				*ALT FLUOR ENV ACC, 1995, PROD SAL ATM REL FLU; ANDERSON JG, 1989, J GEOPHYS RES-ATMOS, V94, P11465, DOI 10.1029/JD094iD09p11465; ANDREAE MO, IN PRESS J GEOPHYS R; ARRIS L, 1995, GLOBAL ENV CHANGE RE, P4; BOERING KA, 1994, GEOPHYS RES LETT, V21, P2567, DOI 10.1029/94GL01985; BUTLER JH, 1992, NATURE, V359, P403, DOI 10.1038/359403a0; CUNNOLD DM, 1994, J GEOPHYS RES-ATMOS, V99, P1107, DOI 10.1029/93JD02715; DANIEL JS, 1995, J GEOPHYS RES-ATMOS, V100, P1271, DOI 10.1029/94JD02516; ELKINS JW, 1993, NATURE, V364, P780, DOI 10.1038/364780a0; FAHEY DW, 1995, EOS S, V76, P130; FISHER DA, 1994, J GEOPHYS RES-ATMOS, V99, P16643, DOI 10.1029/94JD00738; FRASER P, 1994, BASELINE ATMOSPHERIC, P70; FRASER PJ, IN PRESS J GEOPHYS R; GARCIA RR, 1994, J GEOPHYS RES-ATMOS, V99, P12937, DOI 10.1029/94JD00725; GIBBS WW, 1995, SCI AM, V273, P18; GUNSON MR, 1994, GEOPHYS RES LETT, V21, P2223, DOI 10.1029/94GL02077; HALL TM, 1993, J GEOPHYS RES-ATMOS, V98, P10573, DOI 10.1029/93JD00325; HALL TM, 1994, J GEOPHYS RES-ATMOS, V99, P1059, DOI 10.1029/93JD03192; HANSON DR, 1993, J GEOPHYS RES-ATMOS, V98, P22931, DOI 10.1029/93JD01929; Kerr RA, 1996, SCIENCE, V271, P32; KHALIL MAK, 1993, J GEOPHYS RES-ATMOS, V98, P2887, DOI 10.1029/92JD02598; KHALIL MAK, 1985, ANTARCT J US, V20, P206; KOPPMANN R, 1993, J GEOPHYS RES-ATMOS, V98, P20517, DOI 10.1029/93JD01864; LAL S, 1985, NATURE, V316, P135, DOI 10.1038/316135a0; Lobert J. M., 1996, CMDL10 NOAA ERL; LOBERT JM, 1995, SCIENCE, V267, P1002, DOI 10.1126/science.267.5200.1002; MANKIN WG, 1992, GEOPHYS RES LETT, V19, P179, DOI 10.1029/91GL02942; MANKIN WG, 1984, SCIENCE, V226, P170, DOI 10.1126/science.226.4671.170; MCCULLOCH A, 1992, ATMOS ENVIRON A-GEN, V26, P1325, DOI 10.1016/0960-1686(92)90392-X; *METH BROM GLOB CO, 1994, METH BROM ANN PROD S; MIDGLEY PM, 1995, ATMOS ENVIRON, V29, P1601, DOI 10.1016/1352-2310(95)00078-D; MIDGLEY PM, 1993, ATMOS ENVIRON A-GEN, V27, P2215, DOI 10.1016/0960-1686(93)90051-Y; MOLINA MJ, 1974, NATURE, V249, P810, DOI 10.1038/249810a0; MONTZKA A, 1996, GEOPHYS RES LETT, V23, P169; MONTZKA SA, 1994, GEOPHYS RES LETT, V21, P2483, DOI 10.1029/94GL02342; MONTZKA SA, 1993, GEOPHYS RES LETT, V20, P703, DOI 10.1029/93GL00753; MONTZKA SA, 1995, EOS, V76, P160; ORAM DE, 1995, GEOPHYS RES LETT, V22, P2741, DOI 10.1029/95GL02849; POLLOCK WH, 1992, J GEOPHYS RES-ATMOS, V97, P12993, DOI 10.1029/92JD01029; PRATHER MJ, 1990, NATURE, V344, P729, DOI 10.1038/344729a0; PRINN RG, 1995, SCIENCE, V269, P187, DOI 10.1126/science.269.5221.187; Russell JM, 1996, NATURE, V379, P526, DOI 10.1038/379526a0; SCHAUFFLER SM, 1995, GEOPHYS RES LETT, V22, P819, DOI 10.1029/95GL00376; SCHAUFFLER SM, 1993, GEOPHYS RES LETT, V20, P2567, DOI 10.1029/93GL02840; SCHMIDT U, 1991, GEOPHYS RES LETT, V18, P763, DOI 10.1029/91GL00022; SINGH HB, 1983, J GEOPHYS RES-OCEANS, V88, P3675, DOI 10.1029/JC088iC06p03675; SINGH HB, 1983, J GEOPHYS RES, V88, P3648; SINGH ON, 1988, NATURE, V334, P593, DOI 10.1038/334593a0; SOLOMON S, 1992, J GEOPHYS RES-ATMOS, V97, P825, DOI 10.1029/91JD02613; SOLOMON S, 1990, NATURE, V347, P347, DOI 10.1038/347347a0; SOLOMON S, 1986, NATURE, V321, P755, DOI 10.1038/321755a0; STOLARSKI RS, 1974, CAN J CHEM, V52, P1610, DOI 10.1139/v74-233; TABAZADEH A, 1993, SCIENCE, V260, P1082, DOI 10.1126/science.260.5111.1082; VANDOREN JM, 1991, J PHYS CHEM-US, V95, P1684, DOI 10.1021/j100157a037; WALLACE L, 1992, GEOPHYS RES LETT, V19, P1209, DOI 10.1029/92GL01112; WOFSY SC, 1974, CAN J CHEM, V52, P1582, DOI 10.1139/v74-230; WOODBRIDGE EL, 1995, J GEOPHYS RES-ATMOS, V100, P3057, DOI 10.1029/94JD02744; *WORLD MET ORG, 1992, 25 WORLD MET ORG; *WORLD MET ORG, 1995, 37 WORLD MET ORG; ZANDER R, 1992, J ATMOS CHEM, V15, P171, DOI 10.1007/BF00053758; ZURER PS, 1995, CHEM ENG NEWS, V75, P26	61	270	277	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1318	1322		10.1126/science.272.5266.1318	http://dx.doi.org/10.1126/science.272.5266.1318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8662463				2022-12-28	WOS:A1996UN47200040
J	Yuvaniyama, J; Denu, JM; Dixon, JE; Saper, MA				Yuvaniyama, J; Denu, JM; Dixon, JE; Saper, MA			Crystal structure of the dual specificity protein phosphatase VHR	SCIENCE			English	Article							CDC25 PROTEIN; TYROSINE PHOSPHATASE; DETECTOR; P34CDC2	Dual specificity protein phosphatases (DSPs) regulate mitogenic signal transduction and control the cell cycle. Here, the crystal structure of a human DSP, vaccinia H1-related phosphatase (or VHR), was determined at 2.1 angstrom resolution. A shallow active site pocket in VHR allows for the hydrolysis of phosphorylated serine, threonine, or tyrosine protein residues, whereas the deeper active site of protein tyrosine phosphatases (PTPs) restricts substrate specificity to only phosphotyrosine. Positively charged crevices near the active site may explain the enzyme's preference for substrates with two phosphorylated residues. The VHR structure defines a conserved structural scaffold for both DSPs and PTPs. A ''recognition region,'' connecting helix alpha 1 to strand beta 1 may determine differences in substrate specificity between VHR, the PTPs, and other DSPs.	UNIV MICHIGAN,DIV BIOPHYS RES,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT BIOL CHEM,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan				Yuvaniyama, Jirundon/0000-0002-6800-8944	NIAID NIH HHS [AI 34095] Funding Source: Medline; NIDDK NIH HHS [DK18024, DK18849] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018849, R01DK018024, R37DK018024] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AROCA P, 1995, J BIOL CHEM, V270, P14229, DOI 10.1074/jbc.270.23.14229; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; DENU JM, 1995, P NATL ACAD SCI USA, V92, P5910, DOI 10.1073/pnas.92.13.5910; DENU JM, 1995, J BIOL CHEM, V270, P3796, DOI 10.1074/jbc.270.8.3796; DENU JM, 1995, BIOCHEMISTRY-US, V34, P3396, DOI 10.1021/bi00010a031; Denu JM, 1996, P NATL ACAD SCI USA, V93, P2493, DOI 10.1073/pnas.93.6.2493; DUNPHY WG, 1991, CELL, V67, P189, DOI 10.1016/0092-8674(91)90582-J; FUREY W, 1990, AM CRYSTALLOGR ASS 2, V18, P73; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; ISHIBASHI T, 1992, P NATL ACAD SCI USA, V89, P12170, DOI 10.1073/pnas.89.24.12170; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; KWAK SP, 1994, J BIOL CHEM, V269, P3596; MESSERSCHMIDT A, 1987, J APPL CRYSTALLOGR, V20, P306, DOI 10.1107/S002188988708662X; MORENO S, 1990, NATURE, V344, P549, DOI 10.1038/344549a0; MORENO S, 1991, NATURE, V351, P194, DOI 10.1038/351194b0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; READ RJ, 1990, ACTA CRYSTALLOGR A, V46, P140; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; SCHUBERT HL, 1995, PROTEIN SCI, V4, P1904, DOI 10.1002/pro.5560040924; STONE RL, 1994, J BIOL CHEM, V269, P31323; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0; STUCKEY JH, UNPUB; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; ZHOU GC, 1994, J BIOL CHEM, V269, P28084	35	299	306	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1328	1331		10.1126/science.272.5266.1328	http://dx.doi.org/10.1126/science.272.5266.1328			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8650541				2022-12-28	WOS:A1996UN47200043
J	Goncharov, AF; Struzhkin, VV; Somayazulu, MS; Hemley, RJ; Mao, HK				Goncharov, AF; Struzhkin, VV; Somayazulu, MS; Hemley, RJ; Mao, HK			Compression of ice to 210 gigapascals: Infrared evidence for a symmetric hydrogen-bonded phase	SCIENCE			English	Article							HIGH-PRESSURE; TRANSITION; VIII; GPA	Protonated and deuterated ices (H2O and D2O) compressed to a maximum pressure of 210 gigapascals at 85 to 300 kelvin exhibit a phase transition at 60 gigapascals in H2O ice (70 gigapascals in D2O ice) on the basis of their infrared reflectance spectra determined with synchrotron radiation. The transition is characterized by soft-mode behavior of the nu(3) O-H or O-D stretch below the transition, followed by a hardening (positive pressure shift) above it. This behavior is interpreted as the transformation of ice phase VII to a structure with symmetric hydrogen bonds. The spectroscopic features of the phase persisted to the maximum pressures (210 gigapascals) of the measurements,although changes in vibrational mode coupling were observed at 150 to 160 gigapascals.	CARNEGIE INST WASHINGTON,CTR HIGH PRESSURE RES,WASHINGTON,DC 20015	Carnegie Institution for Science	Goncharov, AF (corresponding author), CARNEGIE INST WASHINGTON,GEOPHYS LAB,5251 BROAD BRANCH RD NW,WASHINGTON,DC 20015, USA.		Struzhkin, Viktor V/J-9847-2013; Goncharov, Alexander F./AAX-9943-2020	Struzhkin, Viktor V/0000-0002-3468-0548; Goncharov, Alexander F./0000-0002-6422-8819				Aoki K, 1996, PHYS REV LETT, V76, P784, DOI 10.1103/PhysRevLett.76.784; AOKI K, 1995, SCIENCE, V268, P1322, DOI 10.1126/science.268.5215.1322; BARKER AS, 1964, PHYS REV, V135, P1732; Benoit M, 1996, PHYS REV LETT, V76, P2934, DOI 10.1103/PhysRevLett.76.2934; BESSON JM, 1994, PHYS REV B, V49, P12540, DOI 10.1103/PhysRevB.49.12540; CARR GL, 1995, REV SCI INSTRUM, V66, P1643, DOI 10.1063/1.1145870; DEMONTIS P, 1989, PHYS REV B, V40, P2716, DOI 10.1103/PhysRevB.40.2716; DEMORITIS P, 1989, PHYS REV LETT, V60, P2284; HAMA J, 1992, HIGH PRESSURE RES MI, P403; Hemley RJ, 1996, PHYS REV LETT, V76, P1667, DOI 10.1103/PhysRevLett.76.1667; HIRSCH KR, 1986, J CHEM PHYS, V84, P2771, DOI 10.1063/1.450302; HOLZAPFEL WB, 1972, J CHEM PHYS, V56, P712, DOI 10.1063/1.1677221; JAHODA FC, 1957, PHYS REV, V107, P1261, DOI 10.1103/PhysRev.107.1261; KLUG DD, 1984, J CHEM PHYS, V81, P1220, DOI 10.1063/1.447808; LEE C, 1992, PHYS REV LETT, V69, P462, DOI 10.1103/PhysRevLett.69.462; LEE CY, 1993, PHYS REV B, V47, P4863, DOI 10.1103/PhysRevB.47.4863; LINES ME, 1977, PRINCIPLES APPL FERR, P32; LOUBEYRE P, COMMUNICATION; MAO HK, 1986, J GEOPHYS RES-SOLID, V91, P4673, DOI 10.1029/JB091iB05p04673; NELMES RJ, 1993, PHYS REV LETT, V71, P1192, DOI 10.1103/PhysRevLett.71.1192; POLLAN A, 1984, PHYS REV LETT, V52, P1312; PRUZAN P, 1990, EUROPHYS LETT, V13, P81, DOI 10.1209/0295-5075/13/1/014; PRUZAN P, 1994, J MOL STRUCT, V322, P279, DOI 10.1016/0022-2860(94)87045-4; PRUZAN P, 1993, J CHEM PHYS, V99, P9642; PRUZAN P, 1994 1995 EUR SYNCHR, P12; SOMAYAZULU MS, UNPUB; STILLINGER FH, 1983, J PHYS CHEM-US, V87, P4281, DOI 10.1021/j100244a058; Struzhkin V. V., UNPUB	28	250	256	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 12	1996	273	5272					218	220		10.1126/science.273.5272.218	http://dx.doi.org/10.1126/science.273.5272.218			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW787	8662500				2022-12-28	WOS:A1996UW78700034
J	Katlama, C; Ingrand, D; Loveday, C; Clumeck, N; Mallolas, J; Staszewski, S; Johnson, M; Hill, AM; Pearce, G; McDade, H				Katlama, C; Ingrand, D; Loveday, C; Clumeck, N; Mallolas, J; Staszewski, S; Johnson, M; Hill, AM; Pearce, G; McDade, H			Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients - A randomized controlled comparison with zidovudine monotherapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIAL; INFECTED PATIENTS; DOUBLE-BLIND; 2',3'-DIDEOXY-3'-THIACYTIDINE; RESISTANCE; MUTATION; AZT	Objective.-To compare safety and efficacy of lamivudine-zidovudine combination therapy with zidovudine monotherapy in treating human immunodeficiency virus type 1 (HIV-1)-infected, antiretroviral therapy-naive patients. Design.-Double-blind, randomized, multicenter, comparative trial of 129 patients throughout 24 weeks followed by 24 weeks of open-label lamivudine in combination with zidovudine. Setting.-Outpatients from 14 hospitals in Belgium, France, Germany, Spain, and the United Kingdom were enrolled within 6 months. Patients.-HIV-1-positive, antiretroviral-naive (less than or equal to 4 weeks prior zidovudine use) patients aged at least 18 years with CD4(+) cell counts between 0.10 x 10(9)/L and 0.40 x 10(9)/L (100-400/mu L). Intervention.-Patients received either 300 mg of lamivudine every 12 hours in combination with 200 mg of zidovudine every 8 hours for 24 weeks or zidovudine monotherapy for 24 weeks. All patients were then allowed to receive zidovudine in combination with open-label lamivudine (300 mg every 12 hours). Main Outcome Measures.-Efficacy was assessed by changes in CD4(+) cell counts, beta(2)-microglobulin, neopterin, HIV-1 immune-complex dissociated (ICD) p24 antigenemia, and HIV-1 viral load. Safety was assessed by incidence of adverse clinical events and defined laboratory-measured toxic effects. Results.-Combination therapy showed superior treatment effects compared with monotherapy during the first 24 weeks as documented by changes in CD4(+) cell counts (increase of 0.08 x 10(9)/L vs 0.02 x 10(9)/L, P<.001), ICD p24 (-88% vs -49%; P=.04), cellular viremia (-1.27 vs -0.20 log(10) median tissue-culture infected dose [TCID50] per 10(6) peripheral blood mononuclear cells; P=.001), and viral load measured by HIV-1 RNA polymerase chain reaction using a Roche method (-1.33 vs -0.57 log(10) copies/mL; P=.001) or an immune-capture method (-0.6 vs -0.14 log,, copies/mL; P=.008). Observed changes were sustained to 48 weeks for patients continuing to receive combination therapy. Patients switching to receive combination therapy at week 24 showed improvements in CD4(+) cell count and viral load to week 48. Mutation results suggested that mutations associated with zidovudine resistance may have developed more slowly over the first 24 weeks in patients receiving combination therapy. In contrast, mutations associated with lamivudine resistance appeared to develop rapidly, despite sustained antiviral treatment effect. However, the number of patients evaluated for genotypic changes was small, and confirmation of these results is needed in larger studies. No statistically significant differences in incidence or severity of clinically manifested or laboratory-measured toxic effects were noted between treatment groups. Conclusions.-The combination of lamivudine and zidovudine results in a potent and sustained antiviral effect in antiretroviral-naive patients that is superior to that observed with zidovudine monotherapy.	UCL, SCH MED, LONDON W1N 8AA, ENGLAND; HOP UNIV ST PIERRE, BRUSSELS, BELGIUM; HOSP CLIN BARCELONA, BARCELONA, SPAIN; UNIV FRANKFURT KLINIKUM, W-6000 FRANKFURT, GERMANY; ROYAL FREE HOSP, LONDON NW3 2QG, ENGLAND; GLAXO WELLCOME RES & DEV, DIV BIOSTAT & REPORTING, GREENFORD, MIDDX, ENGLAND; GLAXO WELLCOME RES & DEV, DIV EUROPEAN ANTIVIRAL CLIN RES, GREENFORD, MIDDX, ENGLAND	University of London; University College London; UCL Medical School; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Barcelona; Hospital Clinic de Barcelona; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; GlaxoSmithKline; GlaxoSmithKline	Katlama, C (corresponding author), HOP LA PITIE SALPETRIERE, SERV MALAD INFECT PARASITAIRES & TROP, 47 BD HOP, F-75013 PARIS, FRANCE.			Mallolas Masferrer, Josep/0000-0002-8365-141X				BOYER PL, 1995, ANTIMICROB AGENTS CH, V39, P1624, DOI 10.1128/AAC.39.7.1624; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; CUI LX, 1995, J CLIN INVEST, V95, P555, DOI 10.1172/JCI117698; DOLIN R, 1993, 9 INT C AIDS BERL; ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502; FISCHL MA, 1990, ANN INTERN MED, V112, P727, DOI 10.7326/0003-4819-112-10-727; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; FOLLANSBEE S, 1993, 9 INT C AIDS BERL; GAO Q, 1993, ANTIMICROB AGENTS CH, V37, P1390, DOI 10.1128/AAC.37.6.1390; GU ZX, 1992, J VIROL, V66, P7128, DOI 10.1128/JVI.66.12.7128-7135.1992; HAMMER S, 1995, 5 EUR C CLIN ASP TRE; HART GJ, 1992, ANTIMICROB AGENTS CH, V36, P1688, DOI 10.1128/AAC.36.8.1688; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; JACKSON B, 1995, 2 NAT C HUM RETR REL; KAHN JO, 1992, NEW ENGL J MED, V327, P581, DOI 10.1056/NEJM199208273270901; KAYE S, 1992, J MED VIROL, V37, P241, DOI 10.1002/jmv.1890370402; LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804; MULDER J, 1994, J CLIN MICROBIOL, V32, P292, DOI 10.1128/JCM.32.2.292-300.1994; *NAT I ALL INF DIS, 1992, TABL GRAD AD ADV EXP; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; Pandey VN, 1996, BIOCHEMISTRY-US, V35, P2168, DOI 10.1021/bi9516642; PLUDA JM, 1995, J INFECT DIS, V171, P1438, DOI 10.1093/infdis/171.6.1438; RANA KZ, 1994, 34 INT C ANT AG CHEM; RUBIN M, 1995, FDA DIV ANT DRUG PRO; SANDE MA, 1993, JAMA-J AM MED ASSOC, V270, P2583, DOI 10.1001/jama.270.21.2583; SCHOOLEY R, 1994, 4 EUR C CLIN ASP TRE; SCHUURMAN R, 1995, J INFECT DIS, V171, P1411, DOI 10.1093/infdis/171.6.1411; SEMPLE MG, 1993, J VIROL METHODS, V41, P167, DOI 10.1016/0166-0934(93)90124-A; SHAFER R, 1993, 9 INT C AIDS BERL; SOMMADOSSI JP, 1992, BIOCHEM PHARMACOL, V44, P1921, DOI 10.1016/0006-2952(92)90093-X; VANELTEREN P, 1960, B INT STATIST INST, V37, P351; VANLEEUWEN R, 1995, J INFECT DIS, V171, P1166, DOI 10.1093/infdis/171.5.1166; VELLA S, 1994, 10 C AIDS YOK; VINER KC, 1993, 9 INT C AIDS BERL; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282; WAINBERG MA, 1995, NAT MED, V1, P628, DOI 10.1038/nm0795-628; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; YENI P, 1995, 5 EUR C CLIN ASP TRE; 1994, LANCET, V348, P871; [No title captured]; 1992, MMWR-MORBID MORTAL W, V41, P1	42	164	166	1	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1996	276	2					118	125		10.1001/jama.276.2.118	http://dx.doi.org/10.1001/jama.276.2.118			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UV485	8656503				2022-12-28	WOS:A1996UV48500026
J	Karpen, GH; Le, MH; Le, H				Karpen, GH; Le, MH; Le, H			Centric heterochromatin and the efficiency of achiasmate disjunction in Drosophila female meiosis	SCIENCE			English	Article							POSITION-EFFECT VARIEGATION; RNA GENES FUNCTION; CHROMOSOME SEGREGATION; MELANOGASTER FEMALES; SYNAPTONEMAL COMPLEX; WILD-TYPE; DNA; RECOMBINATION; PROTEINS; REPEATS	The chromosomal requirements for achiasmate (nonexchange) homolog disjunction in Drosophila female meiosis I have been identified with the use of a series of molecularly defined minichromosome deletion derivatives. Efficient disjunction requires 1000 kilobases of overlap in the centric heterochromatin and is not affected by homologous euchromatin or overall size differences. Disjunction efficiency decreases linearly as heterochromatic overlap is reduced from 1000 to 430 kilobases of overlap. Further observations, including rescue experiments with nod kinesin-like protein transgenes, demonstrate that heterochromatin does not act solely to promote chromosome movement or spindle attachment. Thus, it is proposed that centric heterochromatin contains multiple pairing elements that act additively to initiate or maintain the proper alignment of achiasmate chromosomes in meiosis I. How heterochromatin could act to promote chromosome pairing is discussed here.			Karpen, GH (corresponding author), SALK INST BIOL STUDIES,MOLEC BIOL & VIROL LAB,LA JOLLA,CA 92037, USA.							AFSHAR K, 1995, J CELL BIOL, V131, P833, DOI 10.1083/jcb.131.4.833; AFSHAR K, 1995, CELL, V81, P129, DOI 10.1016/0092-8674(95)90377-1; ASHBURNER M, 1990, DROSOPHILA LAB HDB; BENFANTE R, 1990, GENE, V94, P217, DOI 10.1016/0378-1119(90)90390-D; CABOT EL, 1993, GENETICS, V135, P477; CARPENTER ATC, 1975, CHROMOSOMA, V51, P157, DOI 10.1007/BF00319833; CARPENTER ATC, 1979, GENETICS, V92, P511; Cook K. J., UNPUB; Csink AK, 1996, NATURE, V381, P529, DOI 10.1038/381529a0; Dernburg AF, 1996, CELL, V85, P745, DOI 10.1016/S0092-8674(00)81240-4; DERNBURG AF, IN PRESS CELL; DONALDSON KD, UNPUB; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; Grell R. F., 1976, GENET BIOL DROSOPHIL, VIa, P435; GRIGLIATTI T, 1991, METHOD CELL BIOL, V35, P587; HASSOLD T, 1993, CURR OPIN GENET DEV, V3, P398, DOI 10.1016/0959-437X(93)90111-2; HAWLEY RS, 1993, ANNU REV GENET, V27, P281; HAWLEY RS, 1993, DEV GENET, V13, P440; HIRAOKA Y, 1993, J CELL BIOL, V120, P591, DOI 10.1083/jcb.120.3.591; HOCHSTRASSER M, 1986, J CELL BIOL, V102, P112, DOI 10.1083/jcb.102.1.112; KARPEN GH, 1992, GENETICS, V132, P737; KARPEN GH, 1994, CURR OPIN GENET DEV, V4, P281, DOI 10.1016/S0959-437X(05)80055-3; KARPEN GH, 1990, CELL, V63, P97; KARPEN GH, UNPUB; KERREBROCK AW, 1995, CELL, V83, P247, DOI 10.1016/0092-8674(95)90166-3; KLECKNER N, 1993, COLD SPRING HARB SYM, V58, P553, DOI 10.1101/SQB.1993.058.01.062; LE MH, 1995, GENETICS, V141, P283; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; LOHE AR, 1993, GENETICS, V134, P1149; LOIDL J, 1994, P NATL ACAD SCI USA, V91, P331, DOI 10.1073/pnas.91.1.331; MCKEE BD, 1992, GENETICS, V132, P529; MCKEE BD, 1990, CELL, V61, P61, DOI 10.1016/0092-8674(90)90215-Z; MIYAZAKI WY, 1994, ANNU REV GENET, V28, P167, DOI 10.1146/annurev.ge.28.120194.001123; MOENS PB, 1994, BIOESSAYS, V16, P101, DOI 10.1002/bies.950160206; MURPHY TD, 1995, CELL, V81, P139, DOI 10.1016/0092-8674(95)90378-X; MURPHY TD, 1995, CELL, V82, P599, DOI 10.1016/0092-8674(95)90032-2; NIEDENTHAL RK, 1993, NUCLEIC ACIDS RES, V21, P4726, DOI 10.1093/nar/21.20.4726; ORLANDO V, 1995, CURR OPIN GENET DEV, V5, P174, DOI 10.1016/0959-437X(95)80005-0; PIMPINELLI S, 1995, P NATL ACAD SCI USA, V92, P3804, DOI 10.1073/pnas.92.9.3804; PLUTA AF, 1995, SCIENCE, V270, P1591, DOI 10.1126/science.270.5242.1591; Rabl C, 1885, MORPHOL JB, V10, P214; REUTER G, 1992, BIOESSAYS, V14, P605, DOI 10.1002/bies.950140907; Ross LO, 1996, GENETICS, V142, P79; SUN X, UNPUB; THEURKAUF WE, 1992, J CELL BIOL, V118, P759; TOWER J, 1993, GENETICS, V133, P347; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3; WOLF KW, 1994, BIOESSAYS, V16, P107, DOI 10.1002/bies.950160207; WURGLICS G, 1993, NATURWISSENSCHAFTEN, V80, P174, DOI 10.1007/BF01226377; YOOK K, UNPUB; ZHANG P, 1990, CELL, V62, P1053, DOI 10.1016/0092-8674(90)90383-P	52	173	177	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 5	1996	273	5271					118	122		10.1126/science.273.5271.118	http://dx.doi.org/10.1126/science.273.5271.118			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV478	8658180				2022-12-28	WOS:A1996UV47800054
J	Xie, Y; Qian, YT; Wang, WZ; Zhang, SY; Zhang, YH				Xie, Y; Qian, YT; Wang, WZ; Zhang, SY; Zhang, YH			A benzene-thermal synthetic route to nanocrystalline GaN	SCIENCE			English	Article							GALLIUM NITRIDE; HIGH-PRESSURE; GROWTH	thermal reaction of Li3N and GaCl3 in which benzene was used as the solvent under pressure has been carried out for the preparation of 30-nanometer particles of gallium nitride (GaN) at 280 degrees C. This temperature is much lower than that of traditional methods, and the yield of GaN reached 80%. The x-ray powder diffraction pattern indicated that sample was mainly hexagonal-phase GaN with a small fraction of rocksalt-phase GaN, which has a lattice constant a = 4.100 angstroms. This rocksalt structure, which had been observed previously only under high pressure (at least 37 gigapascals) was observed directly with high-resolution electron microscopy.	UNIV SCI & TECHNOL CHINA,STRUCT RES LAB,HEFEI 230026,ANHUI,PEOPLES R CHINA; UNIV SCI & TECHNOL CHINA,DEPT APPL CHEM,HEFEI 230026,ANHUI,PEOPLES R CHINA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS			Qian, Yitai/F-9692-2010; Xie, Yi/B-5753-2009; 张, 裕恒/H-4377-2011; Wang, Wenzhong/C-4423-2009	Xie, Yi/0000-0002-1416-5557; Wang, Wenzhong/0000-0001-5983-3937				ADDAMIANO A, 1961, J ELECTROCHEM SOC, V108, P1072, DOI 10.1149/1.2427952; ANDREWS JE, 1975, J ELECTROCHEM SOC, V122, P1273, DOI 10.1149/1.2134442; BAILER JC, 1955, INORGANIC SYNTHESES, V4, P1; BOOTH HS, 1939, INORGANIC SYNTHESES, V1, P26; DINGLE R, 1971, APPL PHYS LETT, V19, P5, DOI 10.1063/1.1653730; EJDER E, 1974, J CRYST GROWTH, V22, P44, DOI 10.1016/0022-0248(74)90057-8; ELWELL D, 1984, J CRYST GROWTH, V66, P45, DOI 10.1016/0022-0248(84)90075-7; FITZMAURICE JC, 1994, POLYHEDRON, V13, P235, DOI 10.1016/S0277-5387(00)86597-3; HWANG JW, 1995, CHEM MATER, V7, P517, DOI 10.1021/cm00051a012; ISHERWOOD BJ, 1970, J MATER SCI, V5, P869, DOI 10.1007/BF00574858; Johnson W. C., 1932, J PHYS CHEM-US, V36, P2561; MARUSKA HP, 1969, APPL PHYS LETT, V15, P327, DOI 10.1063/1.1652845; MUNIR ZA, 1965, J CHEM PHYS, V42, P4223, DOI 10.1063/1.1695924; OGINO T, 1979, JPN J APPL PHYS, V18, P1049, DOI 10.1143/JJAP.18.1049; PERLIN P, 1992, PHYS REV B, V45, P83, DOI 10.1103/PhysRevB.45.83; PICHUGIN IG, 1970, INORG MATER, V6, P1732; Ridley B. K., 1982, QUANTUM PROCESS SEMI, P62; SCHMITTRINK S, 1987, PHYS REV B, V35, P8113, DOI 10.1103/PhysRevB.35.8113; WILEY JB, 1992, SCIENCE, V255, P1093, DOI 10.1126/science.255.5048.1093; XIA H, 1993, PHYS REV B, V47, P12925, DOI 10.1103/PhysRevB.47.12925	20	372	418	29	430	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1996	272	5270					1926	1927		10.1126/science.272.5270.1926	http://dx.doi.org/10.1126/science.272.5270.1926			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8662493				2022-12-28	WOS:A1996UV29400044
J	James, M				James, M			Isotretinoin for severe acne	LANCET			English	Article																			0	10	10	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 22	1996	347	9017					1749	1750		10.1016/S0140-6736(96)90814-4	http://dx.doi.org/10.1016/S0140-6736(96)90814-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT396	8656912				2022-12-28	WOS:A1996UT39600016
J	Deng, HK; Liu, R; Ellmeier, W; Choe, S; Unutmaz, D; Burkhart, M; DiMarzio, P; Marmon, S; Sutton, RE; Hill, CM; Davis, CB; Peiper, SC; Schall, TJ; Littman, DR; Landau, NR				Deng, HK; Liu, R; Ellmeier, W; Choe, S; Unutmaz, D; Burkhart, M; DiMarzio, P; Marmon, S; Sutton, RE; Hill, CM; Davis, CB; Peiper, SC; Schall, TJ; Littman, DR; Landau, NR			Identification of a major co-receptor for primary isolates of HIV-1	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; MONONUCLEAR PHAGOCYTES; AIDS VIRUS; INFECTION; TROPISM; DOMAIN; PHENOTYPE; SYSTEM; BRAIN	Entry of HIV-1 into target cells requires cell-surface CD4 and additional host cell cofactors. A cofactor required for infection with virus adapted for growth in transformed T-cell lines was recently identified and named fusin. However, fusin does not promote entry of macrophage-tropic viruses, which are believed to be the key pathogenic strains in vivo. The principal cofactor for entry mediated by the envelope glycoproteins of primary macrophage-tropic strains of HIV-1 is CC-CKR-5, a receptor for the beta-chemokines RANTES, MIP-1 alpha and MIP-1 beta.	NYU,MED CTR,SKIRBALL INST BIOMOL MED,NEW YORK,NY 10016; NYU,MED CTR,HOWARD HUGHES MED INST,NEW YORK,NY 10016; ROCKEFELLER UNIV,AARON DIAMOND AIDS RES CTR,NEW YORK,NY 10016; STANFORD UNIV,MED CTR,DEPT BIOCHEM,STANFORD,CA 94305; UNIV LOUISVILLE,SCH MED,JAMES GRAHAM BROWN CANC CTR,LOUISVILLE,KY 40207; DNAX RES INST MOLEC & CELLULAR BIOL INC,DEPT IMMUNOL,PALO ALTO,CA 94304	New York University; Howard Hughes Medical Institute; New York University; Rockefeller University; Stanford University; University of Louisville; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.				Ellmeier, Wilfried/0000-0001-8192-8481				ASHORN PA, 1990, J VIROL, V64, P2149, DOI 10.1128/JVI.64.5.2149-2156.1990; BENBARUCH A, 1995, J BIOL CHEM, V270, P22123, DOI 10.1074/jbc.270.38.22123; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; CHAUDHURI A, 1994, J BIOL CHEM, V269, P7835; CHENGMAYER C, 1989, P NATL ACAD SCI USA, V86, P8575, DOI 10.1073/pnas.86.21.8575; CLAPHAM PR, 1991, VIROLOGY, V181, P703, DOI 10.1016/0042-6822(91)90904-P; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; COMBADIERE C, 1995, J BIOL CHEM, V270, P16491, DOI 10.1074/jbc.270.28.16491; COMELISSEN M, 1995, J VIROL, V69, P1810; CONNOR RI, 1994, J VIROL, V68, P4400, DOI 10.1128/JVI.68.7.4400-4408.1994; CONNOR RI, 1995, VIROLOGY, V206, P936; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FISHER AG, 1988, NATURE, V334, P444, DOI 10.1038/334444a0; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; GAO JL, 1994, J BIOL CHEM, V269, P28539; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; HORUK R, 1994, TRENDS PHARMACOL SCI, V15, P159, DOI 10.1016/0165-6147(94)90077-9; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; JAZIN EE, 1993, REGUL PEPTIDES, V47, P247, DOI 10.1016/0167-0115(93)90392-L; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; LANDAU NR, 1988, NATURE, V334, P159, DOI 10.1038/334159a0; LANDAU NR, 1992, J VIROL, V66, P5110, DOI 10.1128/JVI.66.8.5110-5113.1992; LANDAU NR, 1991, J VIROL, V65, P162, DOI 10.1128/JVI.65.1.162-169.1991; LIU ZQ, 1990, J VIROL, V64, P6148, DOI 10.1128/JVI.64.12.6148-6153.1990; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; OBRIEN WA, 1990, NATURE, V348, P69, DOI 10.1038/348069a0; PAGE KA, 1990, J VIROL, V64, P5720; Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; POWER CA, 1995, J BIOL CHEM, V270, P19495, DOI 10.1074/jbc.270.33.19495; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; SATTENTAU QJ, 1993, J VIROL, V67, P7383, DOI 10.1128/JVI.67.12.7383-7393.1993; SATTENTAU QJ, 1988, CELL, V52, P631, DOI 10.1016/0092-8674(88)90397-2; SCHALL TJ, 1991, CYTOKINE, V3, P165, DOI 10.1016/1043-4666(91)90013-4; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; VEENSTRA J, 1995, CLIN INFECT DIS, V21, P556, DOI 10.1093/clinids/21.3.556; WESTERVELT P, 1991, P NATL ACAD SCI USA, V88, P3097, DOI 10.1073/pnas.88.8.3097; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	44	3118	3306	2	241	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 20	1996	381	6584					661	666		10.1038/381661a0	http://dx.doi.org/10.1038/381661a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR979	8649511				2022-12-28	WOS:A1996UR97900041
J	Barchas, JD; Marzuk, PM				Barchas, JD; Marzuk, PM			Psychiatry	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Barchas, JD (corresponding author), CORNELL UNIV, COLL MED, NEW YORK, NY 10021 USA.							AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; ANDREASEN NC, 1994, SCIENCE, V266, P294, DOI 10.1126/science.7939669; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; DOLAN RJ, 1995, NATURE, V378, P180, DOI 10.1038/378180a0; EISENBERG L, 1995, AM J PSYCHIAT, V152, P1563, DOI 10.1176/ajp.152.11.1563; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HAMBURG D, 1995, GREAT TRANSITIONS PR; HOROWITZ MJ, 1995, ARCH GEN PSYCHIAT, V52, P625; INGLEHART JK, 1996, NEW ENGL J MED, V334, P131; Kernberg O, 1995, LOVE RELATIONS NORMA; NELSON RJ, 1995, NATURE, V378, P383, DOI 10.1038/378383a0; OLNEY JW, 1995, ARCH GEN PSYCHIAT, V52, P998; PERSON ES, 1995, FORCE FANTASY WE MAK; REDEI E, 1995, ENDOCRINOLOGY, V136, P3557, DOI 10.1210/en.136.8.3557; Shore MF, 1996, NEW ENGL J MED, V334, P116, DOI 10.1056/NEJM199601113340211; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; SMITH GR, 1995, ARCH GEN PSYCHIAT, V52, P238; Stern D., 1995, MOTHERHOOD CONSTELLA; STINE OC, 1995, AM J HUM GENET, V57, P1384; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; TSAI GC, 1995, AM J PSYCHIAT, V152, P332; 1995, ARCH GEN PSYCHIAT, V52, P715	24	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1847	1849		10.1001/jama.275.23.1847	http://dx.doi.org/10.1001/jama.275.23.1847			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UQ152	8642745				2022-12-28	WOS:A1996UQ15200044
J	Stiefel, EI				Stiefel, EI			Molybdenum bolsters the bioinorganic brigade	SCIENCE			English	Editorial Material							ENZYMES				Stiefel, EI (corresponding author), EXXON RES & ENGN CO, ROUTE 22 E, ANNANDALE, NJ 08807 USA.							ADAMS MWW, 1993, ANNU REV MICROBIOL, V47, P627, DOI 10.1146/annurev.micro.47.1.627; [Anonymous], 1993, ADV INORGANIC CHEM, DOI DOI 10.1016/S0898-8838(08)60181-6; BATES TS, 1987, NATURE, V329, P319, DOI 10.1038/329319a0; Bertini I., 1994, BIOINORGANIC CHEM; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Coughlan M.P., 1980, MOLYBDENUM MOLYBDENU; COWAN JA, 1993, INORGANIC BIOCHEMIST; COX PA, 1995, ELEMENTS EARTH, P53; George GN, 1996, J AM CHEM SOC, V118, P1113, DOI 10.1021/ja953317l; HILLE R, 1994, BBA-BIOENERGETICS, V1184, P143, DOI 10.1016/0005-2728(94)90220-8; HILLE R, 1993, ACS S SERIES, V535; HOLM RH, 1990, COORDIN CHEM REV, V100, P183, DOI 10.1016/0010-8545(90)85010-P; JOHNSON JL, 1990, P NATL ACAD SCI USA, V87, P3190, DOI 10.1073/pnas.87.8.3190; Kaim W., 1994, BIOINORGANIC CHEM IN; KIRKPATRICK L, 1995, BIOCHEMISTRY-US, V34, P3032; Lippard S. J., 1994, PRINCIPLES BIOINORGA; LOVELOCK J, 1988, AGES GAIA, P141; *MERCK CO, 1989, MERCK IND, P513; NEVITT GA, 1995, NATURE, V376, P680, DOI 10.1038/376680ao; Pilato R. S., 1993, BIOINORGANIC CATALYS, P131; RAJAGOPALAN KV, 1993, ACS SYM SER, V535, P38; ROMAO MJ, 1995, SCIENCE, V270, P1170, DOI 10.1126/science.270.5239.1170; SALTZMAN ES, 1989, ACS S SERIES, V393; Schindelin H, 1996, SCIENCE, V272, P1615, DOI 10.1126/science.272.5268.1615; SCHULTZ BE, 1995, J AM CHEM SOC, V117, P827, DOI 10.1021/ja00107a031; STIEFEL EI, 1995, KIRKOTHMER ENCY CHEM, V16, P940; WILLIAMS RJP, 1991, BIOL CHEM ELEMENTS; WOOTTON JC, 1991, BIOCHIM BIOPHYS ACTA, V1057, P157, DOI 10.1016/S0005-2728(05)80100-8	29	74	75	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	1996	272	5268					1599	1600		10.1126/science.272.5268.1599	http://dx.doi.org/10.1126/science.272.5268.1599			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8658132				2022-12-28	WOS:A1996UR09300032
J	Kersting, AB; Arculus, RJ; Gust, DA				Kersting, AB; Arculus, RJ; Gust, DA			Lithospheric contributions to arc magmatism: Isotope variations along strike in volcanoes of Honshu, Japan	SCIENCE			English	Article							ISLAND-ARC; ROCKS; CRUSTAL; SR; GENERATION; GENESIS; BASALTS; PACIFIC; ANDES; CHILE	Major chemical exchange between the crust and mantle occurs in subduction zone environments, profoundly affecting the chemical evolution of Earth. The relative contributions of the subducting slab, mantle wedge, and are lithosphere to the generation of island are magmas, and ultimately new continental crust, are controversial. Isotopic data for lavas from a transect of volcanoes in a single are segment of northern Honshu, Japan, have distinct variations coincident with changes in crustal lithology. These data im ply that the relatively thin crustal lithosphere is an active geochemical filter for all traversing magmas and is responsible for significant modification of primary mantle melts.	LAWRENCE LIVERMORE NATL LAB,INST GEOPHYS & PLANETARY PHYS,LIVERMORE,CA 94551; AUSTRALIAN NATL UNIV,KEY CTR GEOCHEM EVOLUT & METALLOGENY CONTINENTS,DEPT GEOL,CANBERRA,ACT 0200,AUSTRALIA; QUEENSLAND UNIV TECHNOL,SCH GEOL,BRISBANE,QLD 4001,AUSTRALIA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Australian National University; Queensland University of Technology (QUT)	Kersting, AB (corresponding author), LAWRENCE LIVERMORE NATL LAB,DIV EARTH SCI,L-231,POB 808,LIVERMORE,CA 94551, USA.			Arculus, Richard/0000-0002-3432-392X; Kersting, Annie/0000-0001-5238-8260				BAILEY JC, 1987, CONTRIB MINERAL PETR, V95, P155, DOI 10.1007/BF00381265; BARLING J, 1990, NATURE, V348, P59, DOI 10.1038/348059a0; CHEN CH, 1993, NATURE, V362, P831, DOI 10.1038/362831a0; COUSENS BL, 1994, CONTRIB MINERAL PETR, V117, P421, DOI 10.1007/BF00307275; DAVIDSON JP, 1990, CONTRIB MINERAL PETR, V105, P412, DOI 10.1007/BF00286829; DEPAOLO DJ, 1992, T ROY SOC EDIN-EARTH, V83, P439, DOI 10.1017/S0263593300008117; FAURE M, 1992, TECTONOPHYSICS, V208, P397, DOI 10.1016/0040-1951(92)90437-B; Gill J., 1981, OROGENIC ANDESITES P; HILDRETH W, 1988, CONTRIB MINERAL PETR, V98, P455, DOI 10.1007/BF00372365; Ichikawa K., 1990, PRECRETACEOUS TERRAN, V224, P1; JARRARD RD, 1986, REV GEOPHYS, V24, P217, DOI 10.1029/RG024i002p00217; JOLIVET L, 1988, TECTONOPHYSICS, V149, P89, DOI 10.1016/0040-1951(88)90120-5; Jolivet L., 1992, PROC OCEAN DRILL SCI, V127/128, P1311, DOI [10.2973/odp.proc.sr.127128-2.239.1992, DOI 10.2973/ODP.PROC.SR.127128-2.239.1992, DOI 10.2973/0DP.PR0C.SR.127128-2.239.1992]; KAY RW, 1978, GEOCHIM COSMOCHIM AC, V42, P263, DOI 10.1016/0016-7037(78)90178-3; Kersting AB, 1995, EARTH PLANET SC LETT, V136, P133, DOI 10.1016/0012-821X(95)00196-J; LAN CY, 1995, GEOLOGY, V23, P249, DOI 10.1130/0091-7613(1995)023<0249:NISOPB>2.3.CO;2; MATSUHISA Y, 1979, J VOLCANOL GEOTH RES, V5, P271, DOI 10.1016/0377-0273(79)90020-9; Mizutani S., 1990, PRECRETACEOUS TERRAN, P121; MORRIS JD, 1990, NATURE, V344, P31, DOI 10.1038/344031a0; MUEHLENBACHS K, 1972, CAN J EARTH SCI, V9, P172, DOI 10.1139/e72-014; NASU N, 1980, INIT REP DEEP SEA 2, V56, P408; NOHDA S, 1981, EARTH PLANET SC LETT, V52, P264, DOI 10.1016/0012-821X(81)90181-3; NOTSU K, 1983, J VOLCANOL GEOTH RES, V18, P531, DOI 10.1016/0377-0273(83)90024-0; PLANK T, 1988, EARTH PLANET SC LETT, V90, P349, DOI 10.1016/0012-821X(88)90135-5; ROGERS G, 1989, EARTH PLANET SC LETT, V91, P271, DOI 10.1016/0012-821X(89)90003-4; SATO K, 1992, 7 GEOL ATL JPN; STERN CR, 1991, GEOLOGY, V19, P78, DOI 10.1130/0091-7613(1991)019<0078:ROSEIT>2.3.CO;2; TATSUMI Y, 1989, J GEOPHYS RES-SOLID, V94, P4697, DOI 10.1029/JB094iB04p04697; WHITE WM, 1987, J GEOPHYS RES-SOLID, V92, P4881, DOI 10.1029/JB092iB06p04881; WOODHEAD JD, 1985, GEOCHIM COSMOCHIM AC, V49, P1925, DOI 10.1016/0016-7037(85)90087-0; WORNER G, 1992, LARGE FINE SCALE GEO; ZHAO DP, 1994, J GEOPHYS RES-SOL EA, V99, P22313, DOI 10.1029/94JB01149; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.ea.14.050186.002425	33	68	70	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 7	1996	272	5267					1464	1468		10.1126/science.272.5267.1464	http://dx.doi.org/10.1126/science.272.5267.1464			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP899	8662469				2022-12-28	WOS:A1996UP89900042
J	Gore, SM; Bird, AG; Ross, AJ				Gore, SM; Bird, AG; Ross, AJ			Prison rights: Mandatory drugs tests and performance indicators for prisons	BRITISH MEDICAL JOURNAL			English	Article								Mandatory drugs testing of prisoners applies throughout England and Wales. Data from the 1995 pilot study in eight prisons show that the proportion testing positive for opiates or benzodiazepines rose from 4.1% to 7.4% between the first and second phase of random testing and that there was a 20% increase over 1993-4 in the provisional total of assaults for 1995. Interpretation of these data is difficult, but this is no excuse for prevarication over the danger that this policy may induce inmates to switch from cannabis (which has a negligible public health risk) to injectable class A drugs (a serious public health risk) in prison. The performance indicators for misuse of drugs that are based on the random mandatory drugs testing programme lack relevant covariate information about the individuals tested and are not reliable or timely for individual prisons.	CHURCHILL HOSP,DEPT IMMUNOL,OXFORD OX3 7LJ,ENGLAND; MRC,BIAS,CTR HIV RES,EDINBURGH EH9 3JN,MIDLOTHIAN,SCOTLAND	University of Oxford; University of Edinburgh	Gore, SM (corresponding author), INST PUBL HLTH,MRC,BIOSTAT UNIT,CAMBRIDGE CB2 2SR,ENGLAND.							BENNETTO J, 1996, INDEPENDENT     0206, P9; BIRD AG, 1995, AIDS, V9, P801, DOI 10.1097/00002030-199507000-00019; BIRD AG, 1996, HERALD          0122, P12; Court C, 1996, BRIT MED J, V312, P929; FORSYTH M, 1996, PARLIAMENTARY DEBATE, P26; FREEMAN J, 1996, HERALD          0115, P3; GILL ON, 1995, BRIT MED J, V310, P275, DOI 10.1136/bmj.310.6975.275; GOLDSTEIN H, 1996, IN PRESS J ROYAL STA; GORE SM, 1995, BRIT MED J, V311, P1135, DOI 10.1136/bmj.311.7013.1135; GORE SM, 1995, BRIT MED J, V310, P293, DOI 10.1136/bmj.310.6975.293; GORE SM, 1995, BRIT MED J, V310, P595, DOI 10.1136/bmj.310.6979.595; GORE SM, IN PRESS INT J STD A; GORE SM, 1995, AIDS NEWS SUPPLEMENT, V95, P1; *HM PRIS SERV, 1995, DRUG MIS PRIS POL ST, P7; PENMAN D, 1995, INDEPENDENT     1230, P2; Robertson JR, 1996, BRIT MED J, V312, P636; Smith T, 1996, BRIT MED J, V312, P127; *WHIT PAP, 1995, TACKL DRUGS TOG STRA; 1995, REPORT HER MAJESTYS, P3	19	16	16	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 1	1996	312	7043					1411	1413						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP434	8646103				2022-12-28	WOS:A1996UP43400033
J	Thompson, MJ; Toomre, J; Anderson, ER; Antia, HM; Berthomieu, G; Burtonclay, D; Chitre, SM; ChristensenDalsgaard, J; Corbard, T; DeRosa, M; Genovese, CR; Gough, DO; Haber, DA; Harvey, JW; Hill, F; Howe, R; Korzennik, SG; Kosovichev, AG; Leibacher, JW; Pijpers, FP; Provost, J; Rhodes, EJ; Schou, J; Sekii, T; Stark, PB; Wilson, PR				Thompson, MJ; Toomre, J; Anderson, ER; Antia, HM; Berthomieu, G; Burtonclay, D; Chitre, SM; ChristensenDalsgaard, J; Corbard, T; DeRosa, M; Genovese, CR; Gough, DO; Haber, DA; Harvey, JW; Hill, F; Howe, R; Korzennik, SG; Kosovichev, AG; Leibacher, JW; Pijpers, FP; Provost, J; Rhodes, EJ; Schou, J; Sekii, T; Stark, PB; Wilson, PR			Differential rotation and dynamics of the solar interior	SCIENCE			English	Review							STELLAR CONVECTIVE DYNAMOS; ANGULAR-MOMENTUM TRANSPORT; MODE FREQUENCY SPLITTINGS; MAIN-SEQUENCE STARS; MAGNETIC-FIELDS; NUMERICAL SIMULATIONS; LATITUDE DEPENDENCE; INTERNAL-ROTATION; RADIATIVE ZONES; SUNS ROTATION	Splitting of the sun's global oscillation frequencies by large-scale flows can be used to investigate how rotation varies with radius and latitude within the solar interior. The nearly uninterrupted observations by the Global Oscillation Network Group (GONG) yield oscillation power spectra with high duty cycles and high signal-to-noise ratios. Frequency splittings derived from GONG observations confirm that the variation of rotation rate with latitude seen at the surface carries through much of the convection zone, at the base of which is an adjustment layer leading to latitudinally independent rotation at greater depths. A distinctive shear layer just below the surface is discernible at low to mid-latitudes.	UNIV COLORADO, JOINT INST LAB ASTROPHYS, BOULDER, CO 80309 USA; NATL OPT ASTRON OBSERV, NATL SOLAR OBSERV, TUCSON, AZ 85726 USA; TATA INST FUNDAMENTAL RES, BOMBAY 400005, MAHARASHTRA, INDIA; OBSERV COTE AZUR, F-06304 NICE 4, FRANCE; UNIV SYDNEY, SCH MATH, SYDNEY, NSW 2006, AUSTRALIA; AARHUS UNIV, THEORET ASTROPHYS CTR, DK-8000 AARHUS C, DENMARK; CARNEGIE MELLON UNIV, DEPT STAT, PITTSBURGH, PA 15213 USA; UNIV CAMBRIDGE, INST ASTRON, CAMBRIDGE CB3 0HA, ENGLAND; HARVARD SMITHSONIAN CTR ASTROPHYS, CAMBRIDGE, MA USA; STANFORD UNIV, HANSEN EXPT PHYS LAB ANNEX, STANFORD, CA 94305 USA; UNIV SO CALIF, DEPT PHYS & ASTRON, LOS ANGELES, CA 90089 USA; UNIV CALIF BERKELEY, DEPT STAT, BERKELEY, CA 94720 USA	University of Colorado System; University of Colorado Boulder; National Optical Astronomy Observatory; Tata Institute of Fundamental Research (TIFR); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; University of Sydney; Aarhus University; Carnegie Mellon University; University of Cambridge; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Stanford University; University of Southern California; University of California System; University of California Berkeley	Thompson, MJ (corresponding author), UNIV LONDON QUEEN MARY & WESTFIELD COLL, ASTRON UNIT, MILE END RD, LONDON E1 4NS, ENGLAND.		Pijpers, Frank P/O-2940-2016; Pijpers, Frank P/A-1734-2009; Antia, H./AAV-4222-2021	Pijpers, Frank P/0000-0001-7572-9435; Stark, Philip/0000-0002-3771-9604; Leibacher, John/0000-0001-7605-3684; Corbard, Thierry/0000-0002-9615-9619; Antia, H. M./0000-0001-7549-9684				APPOURCHAUX T, 1995, ESA, V2, P265; BACHMANN KT, 1995, ASTROPHYS J, V443, P837, DOI 10.1086/175573; BACKUS G, 1970, PHILOS TR R SOC S-A, V266, P123, DOI 10.1098/rsta.1970.0005; BACKUS G, 1968, GEOPHYS J ROY ASTR S, V16, P169, DOI 10.1111/j.1365-246X.1968.tb00216.x; BELVEDERE G, 1980, ASTRON ASTROPHYS, V86, P40; BROWN TM, 1989, ASTROPHYS J, V343, P526, DOI 10.1086/167727; BROWN TM, 1985, NATURE, V317, P591, DOI 10.1038/317591a0; BROWN TM, 1987, ASTROPHYS J, V314, pL21, DOI 10.1086/184843; BRUMMELL N, 1995, SCIENCE, V269, P1370, DOI 10.1126/science.269.5229.1370; BRUMMELL NH, 1995, ASTR SOC P, V76, P192; BRUMMELL NH, IN PRESS ASTROPHYS J; CATTANEO F, 1993, SOLAR MAGNETIC FIELD, P261; CHABOYER B, 1995, ASTROPHYS J, V441, P865, DOI 10.1086/175408; CHARBONNEAU P, 1993, ASTROPHYS J, V417, P762, DOI 10.1086/173357; CHRISTENSENDALS.J, 1988, ESA SP, V286, P149; CHRISTENSENDALS.J, 1995, ESA, V2, P41; CHRISTENSENDALSGAARD J, 1995, ASTR SOC P, V76, P212; CLAVERIE A, 1981, NATURE, V293, P443, DOI 10.1038/293443a0; Craig I. J. D., 1986, INVERSE PROBLEMS AST; DUMEY BR, 1991, ASTROPHYS J, V378, P378; DUVALL TL, 1991, ASTROPHYS J, V373, P308, DOI 10.1086/170052; DUVALL TL, 1980, SOL PHYS, V66, P213, DOI 10.1007/BF00150578; DUVALL TL, 1988, ASTROPHYS J, V324, P1158, DOI 10.1086/165971; DUVALL TL, 1993, ASTROPHYS J, V410, P829, DOI 10.1086/172800; DUVALL TL, 1986, NATURE, V321, P500, DOI 10.1038/321500a0; DUVALL TL, 1993, NATURE, V362, P430, DOI 10.1038/362430a0; Duvall TL, 1996, NATURE, V379, P235, DOI 10.1038/379235a0; DUVALL TL, 1984, NATURE, V310, P19, DOI 10.1038/310019a0; DUVALL TL, 1984, NATURE, V310, P22, DOI 10.1038/310022a0; DZIEMBOWSKI WA, 1989, ASTROPHYS J, V337, pL53, DOI 10.1086/185377; DZIEMBOWSKI WA, 1993, ASTR SOC P, V42, P225; ELSWORTH Y, 1995, NATURE, V376, P669, DOI 10.1038/376669a0; ELSWORTH Y, 1995, ASTRON SOC PAC C SER, V76, P42; FOSSAT E, 1995, ASTR SOC P, V76, P24; FOUKAL P, 1977, ASTROPHYS J, V218, P539, DOI 10.1086/155707; FOUKAL P, 1975, ASTROPHYS J, V199, pL71, DOI 10.1086/181851; GHOSAL S, 1991, GEOPHYS ASTRO FLUID, V61, P161, DOI 10.1080/03091929108229042; Gilman P.A., 1986, PHYS OF THE SUN, V1, P95; GILMAN PA, 1989, ASTROPHYS J, V338, P528, DOI 10.1086/167215; GILMAN PA, 1986, ASTROPHYS J SUPPL S, V61, P585, DOI 10.1086/191125; GILMAN PA, 1979, ASTROPHYS J, V229, P1179, DOI 10.1086/157052; Glatzmaier G. A., 1987, INTERNAL SOLAR ANGUL, P263; GLATZMAIER GA, 1995, ASTR SOC P, V76, P200; GLATZMAIER GA, 1985, GEOPHYS ASTRO FLUID, V31, P137, DOI 10.1080/03091928508219267; GLATZMAIER GA, 1985, ASTROPHYS J, V291, P300, DOI 10.1086/163069; GOLUB L, 1981, ASTROPHYS J, V243, P309, DOI 10.1086/158599; GOODE PR, 1991, ASTROPHYS J, V367, P649, DOI 10.1086/169660; GOUGH D, 1991, ANNU REV ASTRON ASTR, V29, P627, DOI 10.1146/annurev.aa.29.090191.003211; GOUGH D, 1985, SOL PHYS, V100, P65, DOI 10.1007/BF00158422; Gough D. O., 1990, PROGR SEISMOLOGY SUN, P283; GOUGH DO, 1991, ANN NY ACAD SCI, V647, P199; GOUGH DO, 1993, ASTR SOC P, V40, P93; GOUGH DO, 1988, SOLAR TERRESTRIAL RE, P90; GREC G, 1983, SOL PHYS, V82, P55, DOI 10.1007/BF00145545; HATHAWAY DH, 1984, ASTROPHYS J, V276, P316, DOI 10.1086/161615; HILL F, 1990, SOL PHYS, V128, P321, DOI 10.1007/BF00154168; HILL F, 1988, ASTROPHYS J, V333, P996, DOI 10.1086/166807; HILL F, 1995, ASTR SOC P, V76, P484; HILL HA, 1982, PHYS REV LETT, V49, P1794, DOI 10.1103/PhysRevLett.49.1794; HOWARD R, 1984, ASTROPHYS J, V283, P373, DOI 10.1086/162315; JEFFERIES SM, 1991, ASTROPHYS J, V377, P330, DOI 10.1086/170362; JIMENEZ A, 1994, ASTROPHYS J, V435, P874, DOI 10.1086/174868; KORZENNIK SG, 1995, ASTR SOC P, V76, P12; KORZENNIK SG, 1993, ASTR SOC P, V42, P201; KORZENNIK SG, 1990, PROGR SEISMOLOGY SUN, P341; KORZENNIK SG, 1988, ESA SP286, P117; Kosovichev AG, 1996, ASTROPHYS J, V461, pL55, DOI 10.1086/309989; LAVELY EM, 1993, ASTROPHYS J, V403, P810, DOI 10.1086/172252; LIBBRECHT KG, 1989, ASTROPHYS J, V336, P1092, DOI 10.1086/167079; LIBBRECHT KG, 1990, NATURE, V345, P779, DOI 10.1038/345779a0; MERRYFIELD WJ, 1991, ASTROPHYS J, V367, P658, DOI 10.1086/169661; MESTEL L, 1987, MON NOT R ASTRON SOC, V226, P123, DOI 10.1093/mnras/226.1.123; NESMERIBES E, 1993, ASTRON ASTROPHYS, V274, P563; PATRON J, 1995, ASTROPHYS J, V455, P746, DOI 10.1086/176620; PIJPERS FP, 1992, ASTRON ASTROPHYS, V262, pL33; PIJPERS FP, 1993, ASTR SOC P, V42, P241; PINSONNEAULT MH, 1989, ASTROPHYS J, V338, P424, DOI 10.1086/167210; RHODES EJ, 1990, ASTROPHYS J, V351, P687, DOI 10.1086/168507; RITZWOLLER MH, 1991, ASTROPHYS J, V369, P557, DOI 10.1086/169785; ROSNER R, 1985, NATURE, V317, P790, DOI 10.1038/317790a0; Rosner R., 1980, Cool Stars, Stellar Systems and Sun. Proceedings of a Workshop (SAO-389), P79; RUDIGER G, 1980, GEOPHYS ASTRO FLUID, V16, P239, DOI 10.1080/03091928008243659; SCHATZMAN E, 1969, ASTROPHYS LETT, V3, P139; SCHATZMAN E, 1977, ASTRON ASTROPHYS, V56, P211; SCHMITT D, 1993, IAU SYMP, P1; SCHOU J, 1994, ASTROPHYS J, V433, P389, DOI 10.1086/174653; SCHROTER EH, 1985, SOL PHYS, V100, P141, DOI 10.1007/BF00158426; SEKII T, 1993, MON NOT R ASTRON SOC, V264, P1018, DOI 10.1093/mnras/264.4.1018; SEKII T, 1995, ESA, V2, P285; SOLANKI SK, 1993, SPACE SCI REV, V63, P1, DOI 10.1007/BF00749277; SPIEGEL EA, 1992, ASTRON ASTROPHYS, V265, P106; SPIEGEL EA, 1980, NATURE, V287, P616, DOI 10.1038/287616a0; THOMPSON MJ, 1990, SOL PHYS, V125, P1, DOI 10.1007/BF00154773; TOMCZYK S, 1995, ASTROPHYS J, V448, pL57, DOI 10.1086/309598; TOMCZYK S, 1995, SOL PHYS, V159, P1, DOI 10.1007/BF00733027; TOMCZYK S, 1988, ESA SP286, P141; TOMCZYK S, IN PRESS B ASTRON SO; TOOMRE J, 1995, ESA, V1, P47; TOUTAIN T, 1994, ASTRON ASTROPHYS, V284, P265; TOUTAIN T, 1995, ASTR SOC P, V76, P34; ULRICH RK, 1988, SOL PHYS, V117, P291, DOI 10.1007/BF00147250; WEISS NO, 1966, PROC R SOC LON SER-A, V293, P310, DOI 10.1098/rspa.1966.0173; WILSON PR, 1995, ASTROPHYS J, V438, P445, DOI 10.1086/175088; WILSON PR, 1994, SOLAR STELLAR ACTIVI; WOODARD MF, 1993, ASTROPHYS J, V402, pL77, DOI 10.1086/186704; WOODARD MF, 1993, SCIENCE, V260, P1778, DOI 10.1126/science.260.5115.1778; ZAHN JP, 1994, ASTRON ASTROPHYS, V288, P829; ZAHN JP, 1992, ASTRON ASTROPHYS, V265, P115	109	329	332	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	1996	272	5266					1300	1305		10.1126/science.272.5266.1300	http://dx.doi.org/10.1126/science.272.5266.1300			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8662459	Green Submitted			2022-12-28	WOS:A1996UN47200035
J	Sillitoe, RH; Folk, RL; Saric, N				Sillitoe, RH; Folk, RL; Saric, N			Bacteria as mediators of copper sulfide enrichment during weathering	SCIENCE			English	Article							SUPERGENE ENRICHMENT; ATACAMA DESERT; NORTHERN CHILE; LA-ESCONDIDA; EL-SALVADOR; CELL-WALLS; DEPOSIT; METALS	Supergene chalcocite enrichment during weathering is an economically vital natural process that may lead to severalfold increases in the copper content of sulfide deposits. A scanning electron microscope study of chalcocite (Cu2S) from major enriched copper deposits in northern Chile revealed myriad bacterioform bodies in original growth positions near replacement interfaces with remnant hypogene sulfide grains. These minute (0.03 to 0.2 micrometers) chalcocite bodies are interpreted as fossilized and metallized nannobacteria that promoted the fixation of mobilized copper ions. Bacterial activity may thus be a fundamental factor in supergene enrichment of copper deposits.	UNIV TEXAS, DEPT GEOL SCI, AUSTIN, TX 78712 USA; SOC MINERA PUDAHUEL LTDA, SANTIAGO, CHILE	University of Texas System; University of Texas Austin								AGUE JJ, 1989, ECON GEOL, V84, P506, DOI 10.2113/gsecongeo.84.3.506; ALPERS CN, 1988, GEOL SOC AM BULL, V100, P1640, DOI 10.1130/0016-7606(1988)100<1640:MMCCIT>2.3.CO;2; ALPERS CN, 1989, ECON GEOL, V84, P229, DOI 10.2113/gsecongeo.84.2.229; ANDREW RL, 1980, MINERAL SCI ENG, V12, P193; BEVERIDGE TJ, 1976, J BACTERIOL, V127, P1502, DOI 10.1128/JB.127.3.1502-1518.1976; BEVERIDGE TJ, 1985, CAN J EARTH SCI, V22, P1893, DOI 10.1139/e85-204; BRIERLEY CL, 1990, MICROBIAL MINERAL RE, P303; BRIMHALL GH, 1985, ECON GEOL, V80, P1227, DOI 10.2113/gsecongeo.80.5.1227; BUSTOS S, 1993, FEMS MICROBIOL REV, V11, P231, DOI 10.1111/j.1574-6976.1993.tb00289.x; CLARK AH, 1990, ECON GEOL BULL SOC, V85, P1604, DOI 10.2113/gsecongeo.85.7.1604; EMMONS W. H., 1917, US GEOL SURV B, V625; FIELD CW, 1976, ECON GEOL, V71, P1533, DOI 10.2113/gsecongeo.71.8.1533; FLORES R, 1985, 4 C GEOL CHIL ANT CH, V2, P228; FOLK RL, 1994, GEOGR PHYS QUATERN, V48, P233, DOI 10.7202/033005ar; FOLK RL, 1993, J SEDIMENT PETROL, V63, P990, DOI 10.1306/D4267C67-2B26-11D7-8648000102C1865D; GUSTAFSON LB, 1975, ECON GEOL, V70, P857, DOI 10.2113/gsecongeo.70.5.857; Hughes M.N., 1989, METALS MICROORGANISM; HUNT JP, 1983, MIN ENG-LITTLETON, V35, P636; Locke A., 1926, LEACHED OUTCROPS GUI; McLean RJC., 1990, MICROBIAL MINERAL RE, P185; MENDELSON NH, 1992, SCIENCE, V258, P1633, DOI 10.1126/science.1455245; MONTEALEGRE R, 1993, BIOHYDROMETALLURGICAL TECHNOLOGIES, VOL 1, P1; MULLEN MD, 1989, APPL ENVIRON MICROB, V55, P3143, DOI 10.1128/AEM.55.12.3143-3149.1989; MURR LE, 1980, MINER SCI ENG, V12, P121; PEDERSEN K, 1993, EARTH-SCI REV, V34, P243, DOI 10.1016/0012-8252(93)90058-F; Ralph BJ, 1985, COMPREHENSIVE BIOTEC, V4, P201; SILLITOE RH, 1968, I MIN METALL T, V77, P166; SOUTHAM G, 1994, GEOCHIM COSMOCHIM AC, V58, P4527, DOI 10.1016/0016-7037(94)90355-7; WATTERSON JR, 1992, GEOLOGY, V20, P315, DOI 10.1130/0091-7613(1991)020<0315:PEFTIO>2.3.CO;2; [No title captured]	30	72	76	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 24	1996	272	5265					1153	1155		10.1126/science.272.5265.1153	http://dx.doi.org/10.1126/science.272.5265.1153			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8662449				2022-12-28	WOS:A1996UM88900044
J	Field, SJ; Tsai, FY; Kuo, F; Zubiaga, AM; Kaelin, WG; Livingston, DM; Orkin, SH; Greenberg, ME				Field, SJ; Tsai, FY; Kuo, F; Zubiaga, AM; Kaelin, WG; Livingston, DM; Orkin, SH; Greenberg, ME			E2F-1 functions in mice to promote apoptosis and suppress proliferation	CELL			English	Article							TRANSCRIPTION FACTOR E2F; DNA-BINDING ACTIVITY; HUMAN MYC PROMOTER; RETINOBLASTOMA PROTEIN; CYCLIN-A; CELL-CYCLE; THYMIDINE KINASE; TRANS-ACTIVATION; S-PHASE; COMPLEX	Members of the E2F transcription factor family (E2F-1-E2F-5) are believed to be critical positive regulators of cell cycle progression in eukaryotes although the in vivo functions of the individual E2Fs have not been elucidated. Mice were generated that lack E2F-1 and, surprisingly, these mice develop and reproduce normally. However, E2F-1(-/-) mice exhibit a defect in T lymphocyte development leading to an excess of mature T cells due to a maturation stage-specific defect in thymocyte apoptosis. As E2F-1(-/-) mice age they exhibit a second phenotype marked by aberrant cell proliferation. These findings suggest that while certain members of the E2F family may positively regulate cell cycle progression, E2F-1 functions to regulate apoptosis and to suppress cell proliferation.	CHILDRENS HOSP,DIV NEUROSCI,BOSTON,MA 02115; CHILDRENS HOSP,DIV HEMATOL ONCOL,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT PATHOL,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115; DANA FARBER CANC INST,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute			zubiaga, ana/S-3457-2019	zubiaga, ana/0000-0002-2132-9708; Field, Seth/0000-0002-8893-4806	NIDDK NIH HHS [DK49216] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK049216, P30DK049216] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAMS PD, 1995, SEMIN CANCER BIOL, V6, P99, DOI 10.1006/scbi.1995.0013; BAGCHI S, 1991, CELL, V65, P1063, DOI 10.1016/0092-8674(91)90558-G; BANDARA LR, 1991, NATURE, V352, P249, DOI 10.1038/352249a0; BLAKE MC, 1989, MOL CELL BIOL, V9, P4994, DOI 10.1128/MCB.9.11.4994; CAO L, 1992, NATURE, V355, P176, DOI 10.1038/355176a0; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; CHITTENDEN T, 1991, CELL, V65, P1073, DOI 10.1016/0092-8674(91)90559-H; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COBRINIK D, 1993, GENE DEV, V7, P2392, DOI 10.1101/gad.7.12a.2392; CRESS WD, 1993, MOL CELL BIOL, V13, P6314, DOI 10.1128/MCB.13.10.6314; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; DEVOTO SH, 1992, CELL, V68, P167, DOI 10.1016/0092-8674(92)90215-X; DOU QP, 1992, P NATL ACAD SCI USA, V89, P3256, DOI 10.1073/pnas.89.8.3256; DURONIO RJ, 1995, GENE DEV, V9, P1445, DOI 10.1101/gad.9.12.1445; DURONIO RJ, 1995, GENE DEV, V9, P1456, DOI 10.1101/gad.9.12.1456; DYNLACHT BD, 1994, GENE DEV, V8, P1772, DOI 10.1101/gad.8.15.1772; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; FOWLKES BJ, 1988, NATURE, V334, P620, DOI 10.1038/334620a0; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GOLD R, 1993, J HISTOCHEM CYTOCHEM, V41, P1023, DOI 10.1177/41.7.8515045; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; HIEBERT SW, 1989, P NATL ACAD SCI USA, V86, P3594, DOI 10.1073/pnas.86.10.3594; HUANG MM, 1989, GENE DEV, V3, P1699, DOI 10.1101/gad.3.11.1699; JOHNSON DG, 1994, P NATL ACAD SCI USA, V91, P12823, DOI 10.1073/pnas.91.26.12823; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KISIELOW P, 1991, ADV EXP MED BIOL, V292, P31; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Krek W, 1995, CELL, V83, P1149, DOI 10.1016/0092-8674(95)90141-8; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LATHANGUE NB, 1994, TRENDS BIOCHEM SCI, V19, P108, DOI 10.1016/0968-0004(94)90202-X; LEES E, 1992, GENE DEV, V6, P1874, DOI 10.1101/gad.6.10.1874; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI Y, 1994, MOL CELL BIOL, V14, P1861, DOI 10.1128/MCB.14.3.1861; MOTOKURA T, 1993, GENE CHROMOSOME CANC, V7, P89, DOI 10.1002/gcc.2870070205; MUDRYJ M, 1990, EMBO J, V9, P2179, DOI 10.1002/j.1460-2075.1990.tb07387.x; NEUMAN E, 1995, MOL CELL BIOL, V15, P4660; OGRIS E, 1993, J VIROL, V67, P1765, DOI 10.1128/JVI.67.4.1765-1771.1993; OWEN JJT, 1988, IMMUNOLOGY, V63, P639; PAGANO M, 1992, SCIENCE, V255, P1144, DOI 10.1126/science.1312258; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PEARSON BE, 1991, MOL CELL BIOL, V11, P2081, DOI 10.1128/MCB.11.4.2081; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; ROBERTSON EJ, 1987, TERATOCARCINOMAS EMB, P104; SALA A, 1994, CANCER RES, V54, P1402; SCOLLAY R, 1988, IMMUNOL REV, V104, P81, DOI 10.1111/j.1600-065X.1988.tb00760.x; SELLERS WR, 1995, P NATL ACAD SCI USA, V92, P11544, DOI 10.1073/pnas.92.25.11544; SHAN B, 1992, MOL CELL BIOL, V12, P5620, DOI 10.1128/MCB.12.12.5620; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; SHI YF, 1991, J IMMUNOL, V146, P3340; SHIRODKAR S, 1992, CELL, V68, P157, DOI 10.1016/0092-8674(92)90214-W; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; THALMEIER K, 1989, GENE DEV, V3, P527, DOI 10.1101/gad.3.4.527; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; XU GF, 1995, P NATL ACAD SCI USA, V92, P1357, DOI 10.1073/pnas.92.5.1357; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Yang Xiao-He, 1995, Gene Expression, V4, P195	64	696	709	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 17	1996	85	4					549	561		10.1016/S0092-8674(00)81255-6	http://dx.doi.org/10.1016/S0092-8674(00)81255-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UM415	8653790	Bronze			2022-12-28	WOS:A1996UM41500012
J	Glass, DJ; Bowen, DC; Stitt, TN; Radziejewski, C; Bruno, J; Ryan, TE; Gies, DR; Shah, S; Mattsson, K; Burden, SJ; DiStefano, PS; Valenzuela, DM; DeChiara, TM; Yancopoulos, GD				Glass, DJ; Bowen, DC; Stitt, TN; Radziejewski, C; Bruno, J; Ryan, TE; Gies, DR; Shah, S; Mattsson, K; Burden, SJ; DiStefano, PS; Valenzuela, DM; DeChiara, TM; Yancopoulos, GD			Agrin acts via a MuSK receptor complex	CELL			English	Article							FIBROBLAST GROWTH-FACTOR; CULTURED MUSCLE-CELLS; ACETYLCHOLINE-RECEPTORS; NGF; PHOSPHORYLATION; AGGREGATION; COMPONENTS; PROTEINS; NEURONS; SURFACE	Formation of the neuromuscular junction depends upon reciprocal inductive interactions between the developing nerve and muscle, resulting in the precise juxtaposition of a differentiated nerve terminal with a highly specialized patch on the muscle membrane, termed the motor endplate. Agrin is a nerve-derived factor that can induce molecular reorganizations at the motor endplate, but the mechanism of action of agrin remains poorly understood. MuSK is a receptor tyrosine kinase localized to the motor endplate, seemingly well positioned to receive a key nerve-derived signal. Mice lacking either agrin or MUSK have recently been generated and exhibit similarly profound defects in their neuromuscular junctions. Here we demonstrate that agrin acts via a receptor complex that includes MuSK as well as a myotube-specific accessory component.	NYU,MED CTR,SKIRBALL INST,MOL NEUROBIOL PROGRAM,NEW YORK,NY 10016	New York University	Glass, DJ (corresponding author), REGENERON PHARMACEUT INC,777 OLD SAW MILL RIVER RD,TARRYTOWN,NY 10591, USA.		Glass, David/AAI-3910-2021; Glass, David/C-4782-2012	Burden, Steven/0000-0002-3550-6891; Glass, David/0000-0001-6187-4164	NINDS NIH HHS [R01 NS036193-01A1S1, R01 NS036193] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036193] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; BARBACID M, 1993, ONCOGENE, V8, P2033; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; BOWE MA, 1995, ANNU REV NEUROSCI, V18, P443; BURDEN SJ, 1995, DEV BIOL, V6, P59; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; FAGERSTAM L, 1991, TECHNIQUES PROTEIN C, V2, P65; FALLON JR, 1994, TRENDS NEUROSCI, V17, P469, DOI 10.1016/0166-2236(94)90135-X; Ferns M, 1996, J CELL BIOL, V132, P937, DOI 10.1083/jcb.132.5.937; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Glass David J., 1993, Trends in Cell Biology, V3, P262, DOI 10.1016/0962-8924(93)90054-5; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; GOLDFARB M, 1990, CELL GROWTH DIFFER, V1, P439; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HOCH W, 1994, EMBO J, V13, P2814, DOI 10.1002/j.1460-2075.1994.tb06575.x; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; MARTIN PT, 1995, NEURON, V14, P743, DOI 10.1016/0896-6273(95)90218-X; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; PENG HB, 1991, NEURON, V6, P237; QU Z, 1994, J NEUROSCI, V14, P6834; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SEALOCK R, 1994, CELL, V77, P617, DOI 10.1016/0092-8674(94)90045-0; STAHL N, 1993, CELL, V74, P587, DOI 10.1016/0092-8674(93)90506-L; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WALLACE BG, 1995, J CELL BIOL, V128, P1121, DOI 10.1083/jcb.128.6.1121; WALLACE BG, 1989, J NEUROSCI, V9, P1294; WALLACE BG, 1994, J CELL BIOL, V125, P661, DOI 10.1083/jcb.125.3.661	47	548	572	2	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 17	1996	85	4					513	523		10.1016/S0092-8674(00)81252-0	http://dx.doi.org/10.1016/S0092-8674(00)81252-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UM415	8653787	hybrid			2022-12-28	WOS:A1996UM41500009
J	Thibault, O; Landfield, PW				Thibault, O; Landfield, PW			Increase in single L-type calcium channels in hippocampal neurons during aging	SCIENCE			English	Article							CENTRAL NERVOUS-SYSTEM; CA2+ CHANNELS; AGED RATS; INTRACELLULAR CALCIUM; ALZHEIMERS-DISEASE; CEREBELLAR NEURONS; PYRAMIDAL NEURONS; CLAMP RECORDINGS; MULTIPLE TYPES; CELLS	Voltage-activated calcium (Ca2+) influx is increased in mammalian CA1 hippocampal neurons during aging. However, the molecular basis for this elevation is not known. The partially dissociated hippocampal (''zipper'') slice preparation was used to analyze single Ca2+ channel activity in CA1 neurons of adult and aged rats. Total L-type Ca2+ channel activity in patches was found to increase with aging, primarily because of an increase in the density of functional channels. Learning in aged animals was inversely correlated with channel density, This increase in functional Ca2+ channels with aging could underlie the vulnerability of neurons to age-associated neurodegenerative conditions.	UNIV KENTUCKY, COLL MED, DEPT PHARMACOL, LEXINGTON, KY 40536 USA	University of Kentucky					NIA NIH HHS [AG10836, AG04542] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG004542, R01AG004542, P01AG010836] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARMSTRONG D, 1987, P NATL ACAD SCI USA, V84, P2518, DOI 10.1073/pnas.84.8.2518; ARMSTRONG DL, 1991, ANN NY ACAD SCI, V635, P26, DOI 10.1111/j.1749-6632.1991.tb36478.x; ARTALEJO CR, 1992, NATURE, V358, P63, DOI 10.1038/358063a0; BEAN BP, 1986, CIRC RES, V59, P229, DOI 10.1161/01.RES.59.2.229; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BECHEM M, 1993, PFLUG ARCH EUR J PHY, V424, P343, DOI 10.1007/BF00384362; BROWN TH, 1994, ANN NY ACAD SCI, V747, P313; CATTERALL WA, 1993, ANN NY ACAD SCI, V681, P342, DOI 10.1111/j.1749-6632.1993.tb22913.x; Chen K. C., 1995, Society for Neuroscience Abstracts, V21, P573; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOI DW, 1987, J NEUROSCI, V7, P369; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; Corey D.P., 1983, SINGLE CHANNEL RECOR, P53; DEYO RA, 1989, SCIENCE, V243, P809, DOI 10.1126/science.2916127; DISTERHOFT JF, 1993, CLIN NEUROPHARMACOL, V16, pS12, DOI 10.1097/00002826-199316001-00003; DISTERHOFT JF, 1994, CALCIUM HYPOTHESIS A, P747; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; ELIOT LS, 1994, J NEUROPHYSIOL, V72, P762, DOI 10.1152/jn.1994.72.2.762; FISHER RE, 1990, J NEUROPHYSIOL, V64, P91, DOI 10.1152/jn.1990.64.1.91; FORTI L, 1993, NEURON, V10, P437, DOI 10.1016/0896-6273(93)90332-L; FRICK KM, 1995, NEUROBIOL AGING, V16, P149, DOI 10.1016/0197-4580(94)00155-3; GALLAGHER M, 1988, NEUROBIOL AGING, V9, P363, DOI 10.1016/S0197-4580(88)80082-4; GIBSON GE, 1987, NEUROBIOL AGING, V8, P329, DOI 10.1016/0197-4580(87)90072-8; GOVONI S, 1985, BRAIN RES, V333, P374, DOI 10.1016/0006-8993(85)91596-3; Gray R, 1990, PREPARATIONS VERTEBR, P3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTMANN H, 1993, NEUROSCI LETT, V152, P181, DOI 10.1016/0304-3940(93)90513-K; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HORN R, 1991, BIOPHYS J, V60, P433, DOI 10.1016/S0006-3495(91)82069-0; HUGUENARD JR, 1988, J NEUROPHYSIOL, V59, P778, DOI 10.1152/jn.1988.59.3.778; JAFFE DB, 1994, J NEUROBIOL, V25, P220, DOI 10.1002/neu.480250303; KATZMAN R, 1991, FASEB J, V5, P278, DOI 10.1096/fasebj.5.3.2001787; KAVALALI ET, 1994, J PHYSIOL-LONDON, V480, P475, DOI 10.1113/jphysiol.1994.sp020376; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; KERR DS, 1989, SCIENCE, V245, P1505, DOI 10.1126/science.2781293; Khachaturian Z S, 1989, Aging (Milano), V1, P17; Khachaturian Z.S., 1984, HDB STUDIES PSYCHIAT, P7; KIRISCHUK S, 1992, NEUROSCIENCE, V50, P947, DOI 10.1016/0306-4522(92)90217-P; KOSTYUK P, 1993, J PHYSIOL-LONDON, V461, P467, DOI 10.1113/jphysiol.1993.sp019523; LANDFIELD P W, 1989, Society for Neuroscience Abstracts, V15, P80; LANDFIELD PW, 1989, ANN NY ACAD SCI, V568, P95; LANDFIELD PW, 1984, SCIENCE, V226, P1089, DOI 10.1126/science.6494926; LANDFIELD PW, 1992, J NEUROBIOL, V23, P1247, DOI 10.1002/neu.480230914; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Magnoni M.S, 1992, REV NEUROSCIENCE, P249; MARTINEZSERRANO A, 1992, J BIOL CHEM, V267, P4672; MCMONAGLESTRUCKO K, 1993, PHARMACOL BIOCHEM BE, V44, P827, DOI 10.1016/0091-3057(93)90013-J; MICHAELIS ML, 1992, MECH AGEING DEV, V62, P291, DOI 10.1016/0047-6374(92)90114-S; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MODY I, 1989, NEUROSCI LETT, V96, P70, DOI 10.1016/0304-3940(89)90245-0; MOGUL DJ, 1991, J PHYSIOL-LONDON, V433, P259, DOI 10.1113/jphysiol.1991.sp018425; MOYER JR, 1992, J NEUROPHYSIOL, V68, P2100, DOI 10.1152/jn.1992.68.6.2100; MOYER JR, 1994, HIPPOCAMPUS, V4, P11, DOI 10.1002/hipo.450040104; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; OLNEY JW, 1994, NEUROBIOL AGING, V15, P259, DOI 10.1016/0197-4580(94)90127-9; PARFITT KD, 1991, P NATL ACAD SCI USA, V88, P2361, DOI 10.1073/pnas.88.6.2361; PITLER TA, 1990, BRAIN RES, V508, P1, DOI 10.1016/0006-8993(90)91109-T; RANDALL A, 1995, J NEUROSCI, V15, P2995; REYNOLDS JN, 1989, BRAIN RES, V479, P384, DOI 10.1016/0006-8993(89)91646-6; Sakmann B, 1983, SINGLE CHANNEL RECOR, P37; SANGUINETTI MC, 1986, J GEN PHYSIOL, V88, P369, DOI 10.1085/jgp.88.3.369; SCHWARTZ LM, 1985, NATURE, V314, P747, DOI 10.1038/314747a0; SCRIABINE A, 1989, FASEB J, V3, P1799, DOI 10.1096/fasebj.3.7.2565839; SCULPTOREANU A, 1993, NATURE, V364, P240, DOI 10.1038/364240a0; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; Sigworth F. J., 1992, V207, P746; SLESINGER PA, 1991, NEURON, V7, P755, DOI 10.1016/0896-6273(91)90278-8; SMITH DO, 1988, J NEUROPHYSIOL, V59, P1069, DOI 10.1152/jn.1988.59.4.1069; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; SWARTZ KJ, 1992, J NEUROSCI, V12, P4358; THIBAULT O, 1995, J NEUROSCI METH, V59, P77, DOI 10.1016/0165-0270(94)00196-N; THIBAULT O, 1993, P NATL ACAD SCI USA, V90, P11792, DOI 10.1073/pnas.90.24.11792; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4	75	385	396	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	1996	272	5264					1017	1020		10.1126/science.272.5264.1017	http://dx.doi.org/10.1126/science.272.5264.1017			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL619	8638124				2022-12-28	WOS:A1996UL61900047
J	Carson, SS; Stocking, C; Podsadecki, T; Christenson, J; Pohlman, A; MacRae, S; Jordan, J; Humphrey, H; Siegler, M; Hall, J				Carson, SS; Stocking, C; Podsadecki, T; Christenson, J; Pohlman, A; MacRae, S; Jordan, J; Humphrey, H; Siegler, M; Hall, J			Effects of organizational change in the medical intensive care unit of a teaching hospital - A comparison of 'open' and 'closed' formats	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MECHANICAL VENTILATION; IMPACT	Objective.-To compare the effects of change from an open to a closed intensive care unit (ICU) format on clinical outcomes, resource utilization, teaching, and perceptions regarding quality of care. Design.-Prospective cohort study; prospective economic evaluation. Setting.-Medical ICU at a university-based tertiary care center. For the open ICU, primary admitting physicians direct care of patients with input from critical care specialists via consultation. For the closed ICU, critical care specialists direct patient care. Patients.-Consecutive samples of 124 patients admitted under an open ICU format and 121 patients admitted after changing to a closed ICU format. Readmissions were excluded. Main Outcome Measures.-Comparison of hospital mortality with mortality predicted by the Acute Physiology and Chronic Health Evaluation II (APACHE II) system; duration of mechanical ventilation; length of stay; patient charges for radiology, laboratory, and pharmacy departments; vascular catheter use; number of interruptions of formal teaching rounds; and perceptions of patients, families, physicians, and nurses regarding quality of care and ICU function. Results.-Mean+/-SD APACHE II scores were 15.4+/-8.3 in the open ICU and 20.6+/-8.6 in the closed ICU (P=.001). In the closed ICU, the ratio of actual mortality (31.4%) to predicted mortality (40.1%) was 0.78. In the open ICU, the ratio of actual mortality (22.6%) to predicted mortality (25.2%) was 0.90. Mean length of stay for survivors in the open ICU was 3.9 days, and mean length of stay for survivors in the closed ICU was 3.7 days (P=.79). There were no significant differences between periods in patient charges for radiology, laboratory, or pharmacy resources. Nurses were more likely to say that they were very confident in the clinical judgment of the physician primarily responsible for patient care in the closed ICU compared with the open ICU (41 % vs 7%; P<.01), and nurses were the group most supportive of changing to a closed ICU format before and after the study. Conclusions.-Based on comparison of actual to predicted mortality, changing from an open to a closed ICU format improved clinical outcome. Although patients in the closed ICU had greater severity of illness, resource utilization did not increase.	UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637	University of Chicago	Carson, SS (corresponding author), UNIV CHICAGO,PULM & CRIT CARE MED SECT,MC 6026,5841 S MARYLAND AVE,CHICAGO,IL 60637, USA.							APTER A, 1988, J MED EDUC, V63, P900; BLUM NJ, 1992, AM J DIS CHILD, V146, P806, DOI 10.1001/archpedi.1992.02160190038016; BROWN JJ, 1989, CHEST, V96, P127, DOI 10.1378/chest.96.1.127; CARLSON R W, 1987, Acute Care, V13, P2; Gerteis M., 1993, PATIENTS EYES UNDERS; GROEGER JS, 1992, CRIT CARE MED, V20, P846, DOI 10.1097/00003246-199206000-00024; KNAUS W A, 1989, American Review of Respiratory Disease, V140, pS8; KNAUS WA, 1986, ANN INTERN MED, V104, P410, DOI 10.7326/0003-4819-104-3-410; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LI TCM, 1984, JAMA-J AM MED ASSOC, V252, P2023, DOI 10.1001/jama.252.15.2023; LUDWIGS UG, 1991, J INTERN MED, V229, P117, DOI 10.1111/j.1365-2796.1991.tb00318.x; NUNN JF, 1979, JAMA-J AM MED ASSOC, V243, P43; PAPADAKIS MA, 1993, WESTERN J MED, V159, P659; POLLACK MM, 1988, CRIT CARE MED, V16, P11, DOI 10.1097/00003246-198801000-00003; PRENDERGAST TJ, IN PRESS AM J RESP C; RAFKIN HS, 1994, CRIT CARE CLIN, V10, P157, DOI 10.1016/S0749-0704(18)30154-4; RALPH DD, 1992, PRINCIPLES CRITICAL, P465; REYNOLDS HN, 1988, JAMA-J AM MED ASSOC, V260, P3446, DOI 10.1001/jama.260.23.3446; SCHWENK TL, 1987, PHYSICIAN TEACHER, P5; STAUFFER JL, 1993, CHEST, V104, P1222, DOI 10.1378/chest.104.4.1222; Wagner D P, 1989, Am Rev Respir Dis, V140, pS14; WITEK TJ, 1985, ARCH INTERN MED, V145, P235, DOI 10.1001/archinte.145.2.235	22	256	261	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1996	276	4					322	328		10.1001/jama.276.4.322	http://dx.doi.org/10.1001/jama.276.4.322			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UX583	8656546				2022-12-28	WOS:A1996UX58300039
J	Kimura, K; Araki, T				Kimura, K; Araki, T			Nutcracker phenomenon	NEW ENGLAND JOURNAL OF MEDICINE			English	Article											Kimura, K (corresponding author), UNIV TOKYO,TOKYO,JAPAN.								0	3	3	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	1996	335	3					171	171		10.1056/NEJM199607183350305	http://dx.doi.org/10.1056/NEJM199607183350305			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW790	8657215				2022-12-28	WOS:A1996UW79000005
J	Kimura, K; Ito, M; Amano, M; Chihara, K; Fukata, Y; Nakafuku, M; Yamamori, B; Feng, JH; Nakano, T; Okawa, K; Iwamatsu, A; Kaibuchi, K				Kimura, K; Ito, M; Amano, M; Chihara, K; Fukata, Y; Nakafuku, M; Yamamori, B; Feng, JH; Nakano, T; Okawa, K; Iwamatsu, A; Kaibuchi, K			Regulation of myosin phosphatase by Rho and Rho-Associated kinase (Rho-kinase)	SCIENCE			English	Article							SMOOTH-MUSCLE; PHOSPHORYLATION; SENSITIVITY; SYSTEM; CELLS; RAS	The small guanosine triphosphatase Rho is implicated in myosin light chain (MLC) phosphorylation, which results in contraction of smooth muscle and interaction of actin and myosin in nonmuscle cells. The guanosine triphosphate (GTP)-bound, active form of RhoA (GTP . RhoA) specifically interacted with the myosin-binding subunit (MBS) of myosin phosphatase, which regulates the extent of phosphorylation of MLC. Rho-associated kinase (Rho-kinase), which is activated by GTP . RhoA, phosphorylated MBS and consequently inactivated myosin phosphatase. Overexpression of RhoA or activated RhoA in NIH 3T3 cells increased phosphorylation of MBS and MLC. Thus, Rho appears to inhibit myosin phosphatase through the action of Rho-kinase.	NARA INST SCI & TECHNOL,DIV SIGNAL TRANSDUCT,IKOMA 63001,JAPAN; MIE UNIV,SCH MED,DEPT INTERNAL MED 1,TSU,MIE 514,JAPAN; KIRIN BREWERY CO LTD,CENT LABS KEY TECHNOL,YOKOHAMA,KANAGAWA 236,JAPAN	Nara Institute of Science & Technology; Mie University; Kirin Brewery Company Limited			Nakafuku, Masato/J-3068-2013; Amano, Mutsuki/M-4820-2014; Kimura, Kazushi/ABB-4007-2020	Amano, Mutsuki/0000-0002-0662-1524; Fukata, Yuko/0000-0001-7724-8643; Nakafuku, Masato/0000-0001-7783-9005				Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; AMANO M, UNPUB; BRADLEY AB, 1987, J PHYSIOL-LONDON, V385, P437, DOI 10.1113/jphysiol.1987.sp016500; CHEN YH, 1994, FEBS LETT, V356, P51, DOI 10.1016/0014-5793(94)01231-8; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GIULIANO KA, 1995, CURR OPIN CELL BIOL, V7, P4, DOI 10.1016/0955-0674(95)80038-7; HARTSHORNE DJ, 1987, PHYSL GASTROINTESTIN, V1, P423; HIRATA K, 1992, J BIOL CHEM, V267, P8719; HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; KIMURA K, UNPUB; KITAZAWA T, 1991, P NATL ACAD SCI USA, V88, P9307, DOI 10.1073/pnas.88.20.9307; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; MCCORMICK F, 1994, CURR OPIN GENET DEV, V4, P71, DOI 10.1016/0959-437X(94)90093-0; MORELAND S, 1992, AM J PHYSIOL, V263, pC540, DOI 10.1152/ajpcell.1992.263.2.C540; MUKAI H, 1994, BIOCHEM BIOPH RES CO, V199, P897, DOI 10.1006/bbrc.1994.1313; NOBES C, 1994, CURR OPIN GENET DEV, V4, P77, DOI 10.1016/0959-437X(94)90094-9; NODA M, 1995, FEBS LETT, V367, P246, DOI 10.1016/0014-5793(95)00573-R; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SATOH T, 1992, J BIOL CHEM, V267, P24149; Sellers JR, 1987, ENZYMES, V18, ppp381, DOI 10.1016/S1874-6047(08)60264-4; SHIMIZU H, 1994, J BIOL CHEM, V269, P30407; TAKAI Y, 1995, TRENDS BIOCHEM SCI, V20, P227, DOI 10.1016/S0968-0004(00)89022-2; TAYLOR DA, 1988, J BIOL CHEM, V263, P14456; TRINKLEMULCAHY L, 1995, J BIOL CHEM, V270, P18191, DOI 10.1074/jbc.270.31.18191; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WYBORSKI DL, 1991, NUCLEIC ACIDS RES, V19, P4647, DOI 10.1093/nar/19.17.4647; YAMAMORI B, UNPUB; Yamamoto T, 1995, J BIOL CHEM, V270, P30557, DOI 10.1074/jbc.270.51.30557	32	2336	2406	0	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 12	1996	273	5272					245	248		10.1126/science.273.5272.245	http://dx.doi.org/10.1126/science.273.5272.245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW787	8662509				2022-12-28	WOS:A1996UW78700043
J	Hien, TT; Day, NPJ; Phu, NH; Mai, NTH; Chau, TTH; Loc, PP; Sinh, DX; Chuong, LV; Vinh, H; Waller, D; Peto, TEA; White, NJ				Hien, TT; Day, NPJ; Phu, NH; Mai, NTH; Chau, TTH; Loc, PP; Sinh, DX; Chuong, LV; Vinh, H; Waller, D; Peto, TEA; White, NJ			A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QINGHAOSU; CHILDREN	Background Artemisinin (qinghaosu) and its derivatives are rapidly effective antimalarial drugs derived from a Chinese plant. Preliminary studies suggest that these drugs may be more effective than quinine in the treatment of severe malaria. We studied artemether in Vietnam, where Plasmodium falciparum has reduced sensitivity to quinine. Methods We conducted a randomized, double-blind trial in 560 adults with severe falciparum malaria. Two hundred seventy-six received intramuscular quinine dihydrochloride (20 mg per kilogram of body weight followed by 10 mg per kilogram every eight hours), and 284 received intramuscular artemether (4 mg per kilogram followed by 2 mg per kilogram every eight hours). Both drugs were given for a minimum of 72 hours. Results There were 36 deaths in the artemether group (13 percent) and 47 in the quinine group (17 percent; P = 0.16; relative risk of death in the patients given artemether, 0.74; 95 percent confidence interval, 0.5 to 1.11). The parasites were cleared more quickly from the blood in the artemether group (mean, 72 vs. 90 hours; P < 0.001); however, in this group fever resolved more slowly (127 vs. 90 hours, P < 0.001), the time to recovery from coma was longer (66 vs. 48 hours, P = 0.003), and the hospitalization was longer (288 vs. 240 hours, P = 0.005). Quinine treatment was associated with a higher risk of hypoglycemia (relative risk, 2.7; 95 percent confidence interval, 1.7 to 4.4; P < 0.001), but there were no other serious side effects in either group. Conclusions Artemether is a satisfactory alternative to-quinine for the treatment of severe malaria in adults. (C) 1996, Massachusetts Medical Society.	CHO QUAN HOSP, CTR TROP DIS, WELLCOME TRUST CLIN RES UNIT, HO CHI MINH CITY, VIETNAM; UNIV OXFORD, NUFFIELD DEPT CLIN MED, CTR TROP MED, OXFORD, ENGLAND	University of Oxford			White, Nick/AAC-6527-2019; White, Nicholas J/I-4629-2012; Thi, Nguyen/AAM-7074-2020	White, Nick/0000-0002-1897-1978; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 1979, CHINESE MED J-PEKING, V92, P811; ARNOLD K, 1990, T ROY SOC TROP MED H, V84, P499, DOI 10.1016/0035-9203(90)90012-4; BREWER TG, 1994, T ROY SOC TROP MED H, V88, P33, DOI 10.1016/0035-9203(94)90469-3; BREWER TG, 1994, AM J TROP MED HYG, V51, P251, DOI 10.4269/ajtmh.1994.51.251; FLETCHER W, 1923, STUDIES I MED RES KU, P24; Hien T T, 1994, Trans R Soc Trop Med Hyg, V88 Suppl 1, pS7; HIEN TT, 1993, LANCET, V341, P603; Karbwang J, 1995, T ROY SOC TROP MED H, V89, P668, DOI 10.1016/0035-9203(95)90437-9; Karbwang Juntra, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P768; LI G, 1982, Journal of Traditional Chinese Medicine, V2, P125; Li G Q, 1994, Trans R Soc Trop Med Hyg, V88 Suppl 1, pS5; Looareesuwan S, 1994, Trans R Soc Trop Med Hyg, V88 Suppl 1, pS9; MURRAY CJL, 1990, T ROY SOC TROP MED H, V84, P1, DOI 10.1016/0035-9203(90)90364-K; PASVOL G, 1991, AM J TROP MED HYG, V45, P702, DOI 10.4269/ajtmh.1991.45.702; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; PUKRITTAYAKAMEE S, 1994, T ROY SOC TROP MED H, V88, P324, DOI 10.1016/0035-9203(94)90102-3; ROSS Ronald, 1914, Journal of Tropical Medicine and Hygiene, V17, P286; Silamut K, 1995, T ROY SOC TROP MED H, V89, P665, DOI 10.1016/0035-9203(95)90436-0; WALLER D, 1990, T ROY SOC TROP MED H, V84, P488, DOI 10.1016/0035-9203(90)90009-4; WHITE NJ, 1994, T ROY SOC TROP MED H, V88, P41, DOI 10.1016/0035-9203(94)90471-5; WHITE NJ, 1983, NEW ENGL J MED, V309, P61, DOI 10.1056/NEJM198307143090201; White NJ, 1994, T R SOC TROP MED S1, V88, pS3, DOI DOI 10.1016/0035-9203(94)90459-6; WIN K, 1992, B WORLD HEALTH ORGAN, V70, P777; YEN LM, 1994, LANCET, V344, P786, DOI 10.1016/S0140-6736(94)92342-6; 1994, WHO FEATURES    0415	25	319	325	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 11	1996	335	2					76	83		10.1056/NEJM199607113350202	http://dx.doi.org/10.1056/NEJM199607113350202			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW353	8649493	Bronze			2022-12-28	WOS:A1996UW35300002
J	Sarbu, SM; Kane, TC; Kinkle, BK				Sarbu, SM; Kane, TC; Kinkle, BK			A chemoautotrophically based cave ecosystem	SCIENCE			English	Article							STABLE ISOTOPES; CARBON ISOTOPES; FRACTIONATION	Microbial mats discovered in a ground-water ecosystem in southern Romania contain chemoautotrophic bacteria that fix inorganic carbon, using hydrogen sulfide as an energy source, Analysis of stable carbon and nitrogen isotopes showed that this chemoautotrophic production is the food base for 48 species of cave-adapted terrestrial and aquatic invertebrates, 33 of which are endemic to this ecosystem, This is the only cave ecosystem known to be supported by in situ autotrophic production, and it contains the only terrestrial community known to be chemoautotrophically based.	UNIV CINCINNATI,DEPT BIOL SCI,CINCINNATI,OH 45221	University System of Ohio; University of Cincinnati				sarbu, serban m/0000-0001-8126-7193				BALLARD RD, 1977, OCEANUS, V20, P34; Conway N.M., 1994, P158; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; Culver D. C., 1982, CAVE LIFE; DECU V, 1994, ANN ENTOMOL SOC AM, V87, P755, DOI 10.1093/aesa/87.6.755; Degens E.T., 1969, ORG GEOCHEM, P304, DOI DOI 10.1007/978-3-642-87734-6_14; Diaconu G, 1993, KARSTOLOGIA, V22, P15; EHLERINGER JR, 1986, TRENDS ECOL EVOL, V1, P42, DOI 10.1016/0169-5347(86)90072-8; FISHER CR, 1994, MAR ECOL PROG SER, V103, P45, DOI 10.3354/meps103045; Goericke R., 1994, STABLE ISOTOPES ECOL, P187; GRUIA M, 1994, P BIOL SOC WASH, V107, P599; JANNASCH HW, 1985, P ROY SOC LOND B BIO, V225, P227; Lascu C., 1989, Miscellanea Speologica Romanica, V1, P13; Macko S.A., 1994, STABLE ISOTOPES ECOL, P45; MACKO SA, 1990, ORG GEOCHEM, V16, P1129, DOI 10.1016/0146-6380(90)90148-S; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; PAULL CK, 1985, NATURE, V317, P709, DOI 10.1038/317709a0; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; RAU GH, 1990, DEEP-SEA RES, V37, P1669, DOI 10.1016/0198-0149(90)90070-C; RUBY EG, 1987, APPL ENVIRON MICROB, V53, P1940, DOI 10.1128/AEM.53.8.1940-1943.1987; Sarbu Serban M., 1995, NSS Bulletin, V57, P91; SARBU SM, 1994, GEOMICROBIOL J, V12, P175, DOI 10.1080/01490459409377984; SARBU SM, 1992, NATURAL HIST BIOSPEL, P638; Sarbu SM., 1994, MICROBIAL MATS, P45, DOI [10.1007/978-3-642-78991-5_4, DOI 10.1007/978-3-642-78991-5_4]; Steel R.G., 1980, PRINCIPLES PROCEDURE, P481; STEVENS TO, 1995, SCIENCE, V270, P450, DOI 10.1126/science.270.5235.450; TUNNICLIFFE V, 1992, AM SCI, V80, P336; Yoshinari T., 1994, STABLE ISOTOPES ECOL, P114	29	291	307	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1996	272	5270					1953	1955		10.1126/science.272.5270.1953	http://dx.doi.org/10.1126/science.272.5270.1953			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8662497				2022-12-28	WOS:A1996UV29400053
J	Weiss, RA				Weiss, RA			HIV receptors and the pathogenesis of AIDS	SCIENCE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; IMMUNE-SYSTEM; RETROVIRUS; INFECTION; TROPISM				Weiss, RA (corresponding author), INST CANC RES,CHESTER BEATTY LABS,237 FULHAM RD,LONDON SW3 6JB,ENGLAND.							Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; BOYD MT, 1993, J VIROL, V67, P3649, DOI 10.1128/JVI.67.6.3649-3652.1993; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CLAPHAM PR, 1991, VIROLOGY, V181, P703, DOI 10.1016/0042-6822(91)90904-P; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DELWART EL, 1994, J VIROL, V68, P6672, DOI 10.1128/JVI.68.10.6672-6683.1994; DENG HK, IN PRESS NATURE; DRAGIC T, IN PRESS NATURE; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Hilleman MR, 1995, VACCINE, V13, P1733, DOI 10.1016/0264-410X(95)00114-G; HILLEMAN MR, 1994, AIDS RES HUM RETROV, V10, P3, DOI 10.1089/aid.1994.10.3; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Levy JA, 1994, HIV PATHOGENESIS AID; LUBASHOV VV, 1995, J VIROL, V69, P6911; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MCKNIGHT A, 1995, TRENDS MICROBIOL, V3, P356, DOI 10.1016/S0966-842X(00)88975-1; MCKNIGHT A, 1994, VIROLOGY, V201, P8, DOI 10.1006/viro.1994.1260; MCKNIGHT A, 1995, J VIROL, V69, P3167, DOI 10.1128/JVI.69.5.3167-3170.1995; McKnight AJ, 1996, J BIOL CHEM, V271, P486, DOI 10.1074/jbc.271.1.486; McLean Angela R., 1993, Trends in Microbiology, V1, P9, DOI 10.1016/0966-842X(93)90018-M; Miedema F, 1996, SCIENCE, V272, P505, DOI 10.1126/science.272.5261.505; NARAYAN O, 1993, RETROVIRIDAE, V2, P229; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; NOWAK MA, 1991, SCIENCE, V254, P963, DOI 10.1126/science.1683006; Nowak MA, 1996, SCIENCE, V272, P74, DOI 10.1126/science.272.5258.74; NOWAK MA, 1993, AIDS, V7, P53; Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412; POPE M, 1994, CELL, V78, P389, DOI 10.1016/0092-8674(94)90418-9; SMITHERS DW, 1962, LANCET, V1, P493; SotoRamirez LE, 1996, SCIENCE, V271, P1291, DOI 10.1126/science.271.5253.1291; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; TSAI WP, 1992, AIDS RES HUM RETROV, V8, P1749, DOI 10.1089/aid.1992.8.1749; WEISS RA, 1995, CELL, V82, P531, DOI 10.1016/0092-8674(95)90024-1; WEISS RA, 1993, SCIENCE, V260, P1273, DOI 10.1126/science.8493571; WEISS RA, 1993, RETROVIRIDAE, V1, P1; WEISS RA, IN PRESS ADV NEW AGE; WILLIAMS LM, 1991, VIROLOGY, V184, P723, DOI 10.1016/0042-6822(91)90442-E; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537	40	53	61	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1996	272	5270					1885	1886		10.1126/science.272.5270.1885	http://dx.doi.org/10.1126/science.272.5270.1885			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8658158				2022-12-28	WOS:A1996UV29400027
J	Yazdani, A; Eigler, DM; Lang, ND				Yazdani, A; Eigler, DM; Lang, ND			Off-resonance conduction through atomic wires	SCIENCE			English	Article							SCANNING TUNNELING MICROSCOPE; RESISTANCE; CONTACT; SWITCH	The electrical resistance of wires consisting of either a single xenon atom or two xenon atoms in series was measured and calculated on the basis of an atom-jellium model. Both the measurement and the calculation yielded a resistance of 10(5) ohms for the single-xenon atom system and 10(7) ohms for the two-xenon atom system. These resistances greatly exceeded the 12,900-ohm resistance of an ideal one-dimensional conduction channel because conduction through the xenon atoms occurs through the tail of the xenon 6s resonance, which lies far above the Fermi level. This conduction process in an atom-sized system can now be understood in terms of the electronic states of individual atoms.	IBM CORP, DIV RES, THOMAS J WATSON RES CTR, YORKTOWN HTS, NY 10598 USA	International Business Machines (IBM)	Yazdani, A (corresponding author), IBM CORP, ALMADEN RES CTR, DIV RES, 650 HARRY RD, SAN JOSE, CA 95120 USA.		Lang, Norton D/ABD-3060-2021	Yazdani, Ali/0000-0003-4996-8904				BACHELET GB, 1982, PHYS REV B, V26, P4199, DOI 10.1103/PhysRevB.26.4199; BEENAKKER CWJ, 1991, SOLID STATE PHYS, V44, P1; BUTTIKER M, 1988, IBM J RES DEV, V32, P63, DOI 10.1147/rd.321.0063; EIGLER DM, 1991, NATURE, V352, P600, DOI 10.1038/352600a0; EIGLER DM, 1991, PHYS REV LETT, V66, P1189, DOI 10.1103/PhysRevLett.66.1189; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; EIGLER DM, UNPUB; GIMZEWSKI JK, 1987, PHYS REV B, V36, P1284, DOI 10.1103/PhysRevB.36.1284; HAMANN DR, 1979, PHYS REV LETT, V43, P1494, DOI 10.1103/PhysRevLett.43.1494; Imry Y., 1986, Directions in condensed matter physics. Memorial volume in honor of Sheng-keng Ma, P101; JOACHIM C, 1995, PHYS REV LETT, V74, P2102, DOI 10.1103/PhysRevLett.74.2102; JOACHIM C, 1992, EUROPHYS LETT, V20, P697, DOI 10.1209/0295-5075/20/8/006; KALMEYER V, 1987, PHYS REV B, V35, P9805, DOI 10.1103/PhysRevB.35.9805; Kane E. O., 1969, Tunneling phenomena in solids, P1; KRANS JM, 1995, NATURE, V375, P767, DOI 10.1038/375767a0; KRANS JM, 1994, PHYS REV B, V50, P17659, DOI 10.1103/PhysRevB.50.17659; LANDAUER R, 1992, PHYS SCRIPTA, VT42, P110, DOI 10.1088/0031-8949/1992/T42/020; LANDAUER R, 1989, J PHYS-CONDENS MAT, V1, P8099, DOI 10.1088/0953-8984/1/43/011; LANG ND, 1987, PHYS REV B, V36, P8173, DOI 10.1103/PhysRevB.36.8173; LANG ND, 1981, PHYS REV LETT, V46, P842, DOI 10.1103/PhysRevLett.46.842; LANG ND, 1995, PHYS REV B, V52, P5335, DOI 10.1103/PhysRevB.52.5335; Lang ND., 1973, SOLID STATE PHYS, V28, P225, DOI 10.1016/S0081-1947(08)60204-0; OLESEN L, 1994, PHYS REV LETT, V72, P2251, DOI 10.1103/PhysRevLett.72.2251; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848	24	212	212	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	1996	272	5270					1921	1924		10.1126/science.272.5270.1921	http://dx.doi.org/10.1126/science.272.5270.1921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8662491				2022-12-28	WOS:A1996UV29400042
J	Trupp, M; Arenas, E; Fainzilber, M; Nilsson, AS; Sieber, BA; Grigoriou, M; Kilkenny, C; SalazarGrueso, E; Pachnis, V; Arumae, U; Sariola, H; Saarma, M; Ibanez, CF				Trupp, M; Arenas, E; Fainzilber, M; Nilsson, AS; Sieber, BA; Grigoriou, M; Kilkenny, C; SalazarGrueso, E; Pachnis, V; Arumae, U; Sariola, H; Saarma, M; Ibanez, CF			Functional receptor for GDNF encoded by the c-ret proto-oncogene	NATURE			English	Article							LINE	GLIAL-CELL-LINE-DERIVED neurotrophic factor (GDNF) promotes the survival and phenotype of central dopaminergic(1,2), noradrenergic(3) and motor neurons(4-6), as well as various subpopulations of peripheral sensory and sympathetic neurons(7,8). GDNF is structurally related to members of the transforming growth factor (TGF)-beta superfamily(9), several members of which have well-characterized receptor systems(10,11); however, GDNF receptors still remain undefined. Here we show that GDNF binds to, and induces tyrosine phosphorylation of, the product of the c-ret proto-oncogene, an orphan receptor tyrosine kinase, in a GDNF-responsive motor-neuron cell line. Ret protein could also bind GDNF and mediate survival and growth responses to GDNF upon transfection into naive fibroblasts. Moreover, high levels of c-ret mRNA expression were found in dopaminergic neurons of the adult substantia nigra, where exogenous GDNF protected Ret-positive neurons from 6-hydroxydopamine-induced cell death, Thus the product of the c-ret proto-oncogene encodes a functional receptor for GDNF that may mediate its neurotrophic effects on motor and dopaminergic neurons.	KAROLINSKA INST,DEPT MED BIOCHEM & BIOPHYS,MOLEC NEUROBIOL LAB,S-17177 STOCKHOLM,SWEDEN; NATL INST MED RES,DIV DEV NEUROBIOL,LONDON NW7 1AA,ENGLAND; UNIV CHICAGO,BRAIN RES INST,DEPT NEUROL,CHICAGO,IL 60637; UNIV HELSINKI,INST BIOTECHNOL,PROGRAM MOL NEUROBIOL,FIN-00014 HELSINKI,FINLAND; UNIV HELSINKI,INST BIOTECHNOL,PROGRAM DEV BIOL,FIN-00014 HELSINKI,FINLAND	Karolinska Institutet; MRC National Institute for Medical Research; University of Chicago; University of Helsinki; University of Helsinki			Grigoriou, Maria/AAM-8332-2021; Arumäe, Urmas/E-8290-2016; Arenas, Ernest/AAO-5231-2020	Grigoriou, Maria/0000-0001-6336-5523; Arumäe, Urmas/0000-0003-3658-6464; Arenas, Ernest/0000-0003-0197-6577; Fainzilber, Mike/0000-0001-8173-8557; Pachnis, Vassilis/0000-0001-9733-7686				Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; ARENAS E, 1994, NATURE, V367, P368, DOI 10.1038/367368a0; ATTISANO L, 1994, BBA-MOL CELL RES, V1222, P71, DOI 10.1016/0167-4889(94)90026-4; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; DERYNCK R, 1994, TRENDS BIOCHEM SCI, V19, P548, DOI 10.1016/0968-0004(94)90059-0; DOW E, 1994, AM J MED GENET, V53, P75, DOI 10.1002/ajmg.1320530116; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; Neveu I, 1996, J CELL BIOL, V133, P631, DOI 10.1083/jcb.133.3.631; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; SALAZARGRUESO EF, 1991, NEUROREPORT, V2, P505, DOI 10.1097/00001756-199109000-00002; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SUVANTO P, 1996, EUR J NEUROSCI, V8, P116; TAKAHASHI M, 1988, ONCOGENE, V3, P571; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; TSUZUKI T, 1995, ONCOGENE, V10, P191; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0	24	686	718	0	16	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 27	1996	381	6585					785	789		10.1038/381785a0	http://dx.doi.org/10.1038/381785a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU356	8657281				2022-12-28	WOS:A1996UU35600060
J	Bhattacharya, I; Sack, EM				Bhattacharya, I; Sack, EM			Screening colonoscopy: The cost of common sense	LANCET			English	Editorial Material							OCCULT BLOOD-TESTS; COLORECTAL-CANCER; MORTALITY				Bhattacharya, I (corresponding author), MICHAEL REESE HOSP & MED CTR,2929 S ELLIS,CHICAGO,IL 60616, USA.							ALLISON JE, 1990, ANN INTERN MED, V112, P328, DOI 10.7326/0003-4819-112-5-328; BHATTACHARYA I, 1996, IN PRESS GASTROENTER; LANG CA, 1994, JAMA-J AM MED ASSOC, V271, P1011, DOI 10.1001/jama.271.13.1011; LIEBERMAN DA, 1995, GASTROENTEROLOGY, V109, P1781, DOI 10.1016/0016-5085(95)90744-0; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MULLER AD, 1995, ARCH INTERN MED, V108, P402; Parker S. L., 1996, CA CANC J CLIN, V65, P5; REX DK, 1991, GASTROENTEROLOGY, V100, P64, DOI 10.1016/0016-5085(91)90583-7; ROGGE JD, 1994, AM J GASTROENTEROL, V89, P1775; SACK EM, 1996, IN PRESS GASTROENTER; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; STJOHN DJB, 1993, GASTROENTEROLOGY, V104, P1661, DOI 10.1016/0016-5085(93)90643-Q; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	14	29	29	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 22	1996	347	9017					1744	1745		10.1016/S0140-6736(96)90812-0	http://dx.doi.org/10.1016/S0140-6736(96)90812-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT396	8656910				2022-12-28	WOS:A1996UT39600014
J	Virmani, R; Farb, A; Burke, A				Virmani, R; Farb, A; Burke, A			Contraction-band necrosis: New use for an old friend	LANCET			English	Editorial Material											Virmani, R (corresponding author), ARMED FORCES INST PATHOL,DEPT CARDIOVASC PATHOL,WASHINGTON,DC 20306, USA.							ARBUSTINI E, 1993, CORONARY ARTERY DIS, V4, P751, DOI 10.1097/00019501-199309000-00001; FARB A, 1995, CIRCULATION, V92, P1701, DOI 10.1161/01.CIR.92.7.1701; FARB A, 1993, J MOL CELL CARDIOL, V25, P343, DOI 10.1006/jmcc.1993.1041; Hopster DJ, 1996, J CLIN PATHOL, V49, P403, DOI 10.1136/jcp.49.5.403; KARCH SB, 1986, HUM PATHOL, V17, P9, DOI 10.1016/S0046-8177(86)80150-2	5	15	15	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 22	1996	347	9017					1710	1711		10.1016/S0140-6736(96)90803-X	http://dx.doi.org/10.1016/S0140-6736(96)90803-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT396	8656901				2022-12-28	WOS:A1996UT39600005
J	Hazen, RM; Downs, RT; Finger, LW				Hazen, RM; Downs, RT; Finger, LW			High-pressure framework silicates	SCIENCE			English	Article							6-COORDINATED SILICON; ZEOLITES	Recent syntheses of high-pressure alkali and alkaline earth silicates reveal a class of framework structures with corner-linked 4- and 6-coordinated silicon. These compounds possess the structural formula(A(4-2x)(1+)B(x)(2+))Si-m(IV)((SinO2(m+n)-O-IV+2)), where x, m, and n specify the amounts of alkaline earth, 6-coordinated silicon, and 4-coordinated silicon, respectively. Appropriate values of m and n yield a range of high-pressure structures, from fully 4-coordinated to fully 6-coordinated silicate frameworks. Recognition of this class of framework silicates leads to predictions of high-pressure structures as well as room-pressure isomorphs of high-pressure silicates.	CARNEGIE INST WASHINGTON,CTR HIGH PRESSURE RES,WASHINGTON,DC 20015	Carnegie Institution for Science	Hazen, RM (corresponding author), CARNEGIE INST WASHINGTON,GEOPHYS LAB,5251 BROAD BRANCH RD NW,WASHINGTON,DC 20015, USA.							AKPORIAYE DE, 1989, Z KRISTALLOGR, V188, P103, DOI 10.1524/zkri.1989.188.1-2.103; ANDRIES KJ, 1990, ACTA CRYSTALLOGR A, V46, P855, DOI 10.1107/S010876739000561X; BEYER H, 1975, ACTA CHIM HUNG, V84, P25; BRUNNER GO, 1989, NATURE, V337, P146, DOI 10.1038/337146a0; Deer W.A., 1963, ROCK FORMING MINERAL; DETREKOY EJ, 1974, J CATAL, V32, P442, DOI 10.1016/0021-9517(74)90095-5; FINGER LW, 1991, ACTA CRYSTALLOGR B, V47, P561, DOI 10.1107/S0108768191004214; FINGER LW, 1995, J PHYS CHEM SOLIDS, V56, P1389, DOI 10.1016/0022-3697(95)00075-5; FLEET ME, 1995, PHYS CHEM MINER, V22, P383, DOI 10.1007/BF00213335; FLEET ME, 1995, EOS, V76, pF710; FLEET ME, 1996, AM MINERAL, V81, P911; FYFE CA, 1989, NATURE, V341, P223, DOI 10.1038/341223a0; Gasparik T, 1995, AM MINERAL, V80, P1269; Hazen R. M., 1979, Phase Transitions, V1, P1, DOI 10.1080/01411597908213181; HAZEN RM, 1994, PHYS CHEM MINER, V21, P344; HAZEN RM, 1986, AM MINERAL, V71, P977; HAZEN RM, 1994, GEOL SOC AM ABSTR, V27, pA166; Heaney P.J., 1994, SILICA; ITA J, 1992, J GEOPHYS RES-SOL EA, V97, P6849, DOI 10.1029/92JB00068; KINOMURA N, 1975, MINERAL MAG, V40, P401, DOI 10.1180/minmag.1975.040.312.09; KRUGER MB, 1990, SCIENCE, V249, P647, DOI 10.1126/science.249.4969.647; LIEBAU F, 1986, ZEOLITES, V6, P373, DOI 10.1016/0144-2449(86)90065-5; MEIER WM, 1992, ZEOLITES, V12, P1, DOI 10.1016/0144-2449(92)90022-H; MUMPTON FA, 1981, REV MINERAL, V4, P177; NEVSKII NN, 1979, DOKL AKAD NAUK SSSR+, V245, P110; NEWSAM JM, 1986, SCIENCE, V231, P1093, DOI 10.1126/science.231.4742.1093; PAOALO REG, 1992, GEOPHYS RES LETT, V19, P1895; PAPP J, 1971, J CATAL, V23, P168, DOI 10.1016/0021-9517(71)90038-8; Parsons I., 1994, FELDSPARS THEIR REAC; RIBEIRO FR, 1984, NATO ASI SERIES E, V80; SMITH JV, 1989, 8TH P INT ZEOL C AMS, P29; STEBBINS JF, 1991, SCIENCE, V251, P294, DOI 10.1126/science.251.4991.294; SWANSON DK, 1983, AM MINERAL, V68, P581	33	43	44	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1769	1771		10.1126/science.272.5269.1769	http://dx.doi.org/10.1126/science.272.5269.1769			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8662479				2022-12-28	WOS:A1996UT11000036
J	Stoll, HM; Schrag, DP				Stoll, HM; Schrag, DP			Evidence for glacial control of rapid sea level changes in the early cretaceous	SCIENCE			English	Article							DIAGENESIS; HYPOTHESIS	Lower Cretaceous bulk carbonate from deep sea sediments records sudden inputs of strontium resulting from the exposure of continental shelves. Strontium data from an interval spanning 7 million years in the Berriasian-Valanginian imply that global sea level fluctuated about 50 meters over time scales of 200,000 to 500,000 years, which is in agreement with the Exxon sea level curve. Oxygen isotope measurements indicate that the growth of continental ice sheets caused these rapid sea level changes. If glaciation caused all the rapid sea level changes in the Cretaceous that are indicated by the Exxon curve, then an Antarctic ice sheet may have existed despite overall climatic warmth.			Stoll, HM (corresponding author), PRINCETON UNIV,DEPT GEOL & GEOPHYS SCI,PRINCETON,NJ 08544, USA.		Stoll, Heather M/G-9066-2012	Stoll, Heather M/0000-0002-2953-7835				ARCHER D, 1994, NATURE, V367, P260, DOI 10.1038/367260a0; BAKER P, 1982, J SEDIMENT PETROL, V52, P52; BARRON EJ, 1984, GEOLOGY, V12, P595, DOI 10.1130/0091-7613(1984)12<595:CIOTVO>2.0.CO;2; BARRON EJ, 1984, GEOLOGY, V12, P377, DOI 10.1130/0091-7613(1984)12<377:CC>2.0.CO;2; BRALOWER TJ, 1989, MAR MICROPALEONTOL, V14, P153, DOI 10.1016/0377-8398(89)90035-2; Frakes L. A, 1992, CLIMATE MODES PHANER; FRAKES LA, 1988, NATURE, V333, P547, DOI 10.1038/333547a0; GAVISH E, 1969, J SEDIMENT PETROL, V39, P980; Hallam A., 1992, PHANEROZOIC SEA LEVE; HAQ B, 1987, SCIENCE, V23, P1156; HARRIS WM, 1968, SCIENCE, V160, P77, DOI 10.1126/science.160.3823.77; MATTHEWS RK, 1987, GEOLOGY, V15, P673, DOI 10.1130/0091-7613(1987)15<673:FMOBCD>2.0.CO;2; MATTHEWS RK, 1991, J GEOPHYS RES-SOLID, V96, P6797, DOI 10.1029/90JB02633; OPDYKE BN, 1992, GEOLOGY, V20, P733, DOI 10.1130/0091-7613(1992)020<0733:ROTCRH>2.3.CO;2; Opdyke BN, 1988, PALEOCEANOGRAPHY, V3, P685, DOI 10.1029/PA003i006p00685; PALMER MR, 1989, EARTH PLANET SC LETT, V92, P11, DOI 10.1016/0012-821X(89)90017-4; PRENTICE ML, 1991, J GEOPHYS RES-SOLID, V96, P6811, DOI 10.1029/90JB01614; RICHTER FM, 1993, EARTH PLANET SC LETT, V117, P553, DOI 10.1016/0012-821X(93)90102-F; RICHTER FM, 1987, EARTH PLANET SC LETT, V83, P27, DOI 10.1016/0012-821X(87)90048-3; Schlanger S.O., 1988, PHYS CHEM WEATHERING, P323; SCHLANGER SO, 1986, MESOZOIC CENOZOIC OC, P61; SCHRAG DP, 1995, GEOCHIM COSMOCHIM AC, V59, P2265, DOI 10.1016/0016-7037(95)00105-9; SCHRAG DP, 1992, EARTH PLANET SC LETT, V111, P305, DOI 10.1016/0012-821X(92)90186-Y; SHACKLETON NJ, 1993, PALEOCEANOGRAPHY, V8, P141, DOI 10.1029/93PA00123; TUREKIAN KK, 1956, GEOCHIM COSMOCHIM AC, V10, P245, DOI 10.1016/0016-7037(56)90015-1	25	127	141	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1771	1774		10.1126/science.272.5269.1771	http://dx.doi.org/10.1126/science.272.5269.1771			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8662480				2022-12-28	WOS:A1996UT11000037
J	Torres, RM; Flaswinkel, H; Reth, M; Rajewsky, K				Torres, RM; Flaswinkel, H; Reth, M; Rajewsky, K			Aberrant B cell development and immune response in mice with a compromised BCR complex	SCIENCE			English	Review							X-LINKED AGAMMAGLOBULINEMIA; ANTIGEN RECEPTOR COMPLEX; PROTEIN-TYROSINE KINASES; IG-BETA COMPONENTS; MOUSE BONE-MARROW; SIGNAL-TRANSDUCTION; IMMUNOGLOBULIN HEAVY; SRC FAMILY; ALPHA; EXPRESSION	The immunoglobulin alpha (Ig-alpha)-Ig-beta heterodimer is the signaling component of the antigen receptor complex on B cells (BCR) and B cell progenitors (pre-BCR). A mouse mutant that lacks most of the Ig-alpha cytoplasmic tail exhibits only a small impairment in early B cell development but a severe block in the generation of the peripheral B cell pool, revealing a checkpoint in B cell maturation that ensures the expression of a functional BCR on mature B cells. B cells that do develop demonstrate a differential dependence on Ig-alpha signaling in antibody responses such that a signaling-competent Ig-alpha appears to be critical for the response to T-independent, but not T-dependent, antigens.	UNIV COLOGNE,INST GENET,D-50931 COLOGNE,GERMANY; MAX PLANCK INST IMMUNOBIOL,D-79108 FREIBURG,GERMANY	University of Cologne; Max Planck Society				Rajewsky, Klaus/0000-0002-6633-6370				ALLMAN DM, 1993, J IMMUNOL, V151, P4431; AOKI Y, 1994, P NATL ACAD SCI USA, V91, P10606, DOI 10.1073/pnas.91.22.10606; ASSENMACHER M, 1994, EUR J IMMUNOL, V24, P1097, DOI 10.1002/eji.1830240513; BLUM JH, 1993, J BIOL CHEM, V268, P27236; BONNEROT C, 1995, IMMUNITY, V3, P335, DOI 10.1016/1074-7613(95)90118-3; BROUNS GS, 1993, EUR J IMMUNOL, V23, P1088, DOI 10.1002/eji.1830230517; BROWN VK, 1994, J BIOL CHEM, V269, P17238; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; CLARK MR, 1992, SCIENCE, V258, P123, DOI 10.1126/science.1439759; CONLEY ME, 1992, J CLIN IMMUNOL, V12, P139, DOI 10.1007/BF00918144; CONLEY ME, 1994, IMMUNOL REV, V138, P5, DOI 10.1111/j.1600-065X.1994.tb00844.x; DEWEERS M, 1994, J BIOL CHEM, V269, P23857; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; FLASWINKEL H, 1994, EMBO J, V13, P83, DOI 10.1002/j.1460-2075.1994.tb06237.x; FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414; GILFILLAN S, 1994, INT IMMUNOL, V6, P1681, DOI 10.1093/intimm/6.11.1681; GRUPP SA, 1993, J BIOL CHEM, V268, P25776; HARDY RR, 1994, ADV IMMUNOL, V55, P297; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HINSHELWOOD S, 1995, EUR J IMMUNOL, V25, P1113, DOI 10.1002/eji.1830250439; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; HOMBACH J, 1990, EUR J IMMUNOL, V20, P2795, DOI 10.1002/eji.1830201239; JACK RS, 1977, EUR J IMMUNOL, V7, P559, DOI 10.1002/eji.1830070813; KAHN WN, 1995, IMMUNITY, V3, P283; KASHIWAMURA SI, 1990, J IMMUNOL, V145, P337; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KIM KM, 1993, EUR J IMMUNOL, V23, P911, DOI 10.1002/eji.1830230422; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; LAW DA, 1993, CURR BIOL, V3, P645, DOI 10.1016/0960-9822(93)90062-S; LEDERMANN B, 1991, EXP CELL RES, V197, P254, DOI 10.1016/0014-4827(91)90430-3; LIN JJ, 1992, J IMMUNOL, V149, P1548; Loffert D, 1996, IMMUNITY, V4, P133, DOI 10.1016/S1074-7613(00)80678-0; LOFFERT D, 1994, IMMUNOL REV, V137, P135, DOI 10.1111/j.1600-065X.1994.tb00662.x; MATSUO T, 1993, J IMMUNOL, V150, P3766; MATSUUCHI L, 1992, P NATL ACAD SCI USA, V89, P3404, DOI 10.1073/pnas.89.8.3404; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; OPSTELTEN D, 1983, J IMMUNOL, V131, P2635; PAPAVASILIOU F, 1995, SCIENCE, V268, P408, DOI 10.1126/science.7716544; PATEL KJ, 1993, CELL, V74, P939, DOI 10.1016/0092-8674(93)90473-4; RAJEWSKY K, 1992, CURR OPIN IMMUNOL, V4, P171, DOI 10.1016/0952-7915(92)90008-3; RAJEWSKY K, 1974, EUR J IMMUNOL, V4, P111, DOI 10.1002/eji.1830040210; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; ROWLEY RB, 1995, J BIOL CHEM, V270, P11590, DOI 10.1074/jbc.270.19.11590; SANCHEZ M, 1993, J EXP MED, V178, P1049, DOI 10.1084/jem.178.3.1049; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TORRES RM, 1996, IN PRESS LAB PROTOCO; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; WICKER LS, 1986, CURR TOP MICROBIOL, V124, P87; WIENANDS J, 1990, THESIS U FREIBURG GE; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043; [No title captured]	60	243	249	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1804	1808		10.1126/science.272.5269.1804	http://dx.doi.org/10.1126/science.272.5269.1804			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8650582				2022-12-28	WOS:A1996UT11000048
J	Stoeckle, MY; Douglas, RG				Stoeckle, MY; Douglas, RG			Infectious diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									MERCK & CO INC, WHITE HOUSE STN, NJ USA	Merck & Company	Stoeckle, MY (corresponding author), CORNELL UNIV MED COLL, NEW YORK, NY 10021 USA.							CAMERON B, 1996, 3 C RETR OPP INF WAS; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; CHANG YF, 1995, INFECT IMMUN, V63, P3543, DOI 10.1128/IAI.63.9.3543-3549.1995; ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502; GUIBERT M, 1995, ACTA PAEDIATR, V84, P831, DOI 10.1111/j.1651-2227.1995.tb13771.x; HOFMANN J, 1995, NEW ENGL J MED, V333, P481, DOI 10.1056/NEJM199508243330803; Lederberg J, 1996, JAMA-J AM MED ASSOC, V275, P243, DOI 10.1001/jama.275.3.243; LeDuc JW, 1996, JAMA-J AM MED ASSOC, V275, P318, DOI 10.1001/jama.275.4.318; MARWICK C, 1995, JAMA-J AM MED ASSOC, V274, P12, DOI 10.1001/jama.274.1.12; MORRIS JG, 1995, ANN INTERN MED, V123, P250, DOI 10.7326/0003-4819-123-4-199508150-00002; PALLARES R, 1995, NEW ENGL J MED, V333, P474, DOI 10.1056/NEJM199508243330802; Pinner RW, 1996, JAMA-J AM MED ASSOC, V275, P189, DOI 10.1001/jama.275.3.189; RAMSAY ME, 1994, PEDIATR INFECT DIS J, V13, P1117, DOI 10.1097/00006454-199412000-00009; 1995, MMWR-MORBID MORTAL W, V44, P273; 1995, AM SOC MICROBIOL NEW, V61, P620; 1995, MMWR-MORBID MORTAL W, V44, P399; 1995, MMWR-MORBID MORTAL W, V44, P468; 1995, MMWR-MORBID M      S, V44, P1; 1995, MMWR-MORBID MORTAL W, V44, P625	19	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1816	1817		10.1001/jama.275.23.1816	http://dx.doi.org/10.1001/jama.275.23.1816			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642726				2022-12-28	WOS:A1996UQ15200025
J	Tintinalli, JE				Tintinalli, JE			Emergency medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Tintinalli, JE (corresponding author), UNIV N CAROLINA, CHAPEL HILL, NC 27599 USA.							AUBLE TE, 1995, ANN EMERG MED, V25, P642, DOI 10.1016/S0196-0644(95)70178-8; BAKER DW, 1995, ANN EMERG MED, V25, P311, DOI 10.1016/S0196-0644(95)70285-7; BIROS MH, 1995, JAMA-J AM MED ASSOC, V273, P1283, DOI 10.1001/jama.273.16.1283; BRILLMAN JC, IN PRESS ANN INTERN; CHERPITEL CJ, 1995, ANN EMERG MED, V26, P158, DOI 10.1016/S0196-0644(95)70146-X; DELBECCARO MA, 1995, ANN EMERG MED, V26, P598, DOI 10.1016/S0196-0644(95)70011-0; DERLET RW, 1995, ANN EMERG MED, V25, P215, DOI 10.1016/S0196-0644(95)70327-6; *GEN ACC OFF, 1993, EM DEP UN AFF GROWTH; GIBLER WB, 1995, ANN EMERG MED, V25, P1, DOI 10.1016/S0196-0644(95)70347-0; LEDWITH CA, 1995, ANN EMERG MED, V25, P331, DOI 10.1016/S0196-0644(95)70290-3; MADDEN C, 1995, ANN EMERG MED, V26, P177, DOI 10.1016/S0196-0644(95)70148-6; MEROPOL SB, 1995, ANN EMERG MED, V26, P180, DOI 10.1016/S0196-0644(95)70149-4; Osborn HH, 1996, ANN EMERG MED, V27, P225, DOI 10.1016/S0196-0644(96)70327-X; SCHILLING CG, 1995, ANN EMERG MED, V25, P203, DOI 10.1016/S0196-0644(95)70325-X; SCHMIDT TA, 1995, ACAD EMERG MED, V2, P990; Steinbrook R, 1996, NEW ENGL J MED, V334, P657, DOI 10.1056/NEJM199603073341010; STIELL I, 1995, BRIT MED J, V311, P594, DOI 10.1136/bmj.311.7005.594; Stiell IG, 1996, JAMA-J AM MED ASSOC, V275, P611, DOI 10.1001/jama.275.8.611; WILLIAMS JM, 1995, ANN EMERG MED, V25, P686, DOI 10.1016/S0196-0644(95)70184-2; WILLIAMS MV, 1995, JAMA-J AM MED ASSOC, V274, P1677; Williams RM, 1996, NEW ENGL J MED, V334, P642, DOI 10.1056/NEJM199603073341007; 1995, ANN EMERG MED, V26, P487	22	2	2	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1804	1805		10.1001/jama.275.23.1804	http://dx.doi.org/10.1001/jama.275.23.1804			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642719				2022-12-28	WOS:A1996UQ15200018
J	Watts, NB; Blevins, LS				Watts, NB; Blevins, LS			Endocrinology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GRAVES HYPERTHYROIDISM; OPHTHALMOPATHY				Watts, NB (corresponding author), EMORY UNIV, SCH MED, ATLANTA, GA 30322 USA.							BARTALENA L, 1989, NEW ENGL J MED, V321, P1349, DOI 10.1056/NEJM198911163212001; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; PAK CYC, 1995, ANN INTERN MED, V123, P401, DOI 10.7326/0003-4819-123-6-199509150-00001; PATWARDHAN NA, 1993, SURGERY, V114, P1108; POTTS JT, 1991, ANN INTERN MED, V114, P593, DOI 10.7326/0003-4819-114-7-593; PRUMMEL MF, 1989, NEW ENGL J MED, V321, P1353, DOI 10.1056/NEJM198911163212002; RIGGS BL, 1990, NEW ENGL J MED, V322, P802, DOI 10.1056/NEJM199003223221203; SAITO JK, 1995, CALCIFIED TISSUE INT, V57, P115, DOI 10.1007/BF00298431; SILVERBERG SJ, 1995, J CLIN ENDOCR METAB, V80, P723, DOI 10.1210/jc.80.3.723; SILVERBERG SJ, 1995, J CLIN ENDOCR METAB, V80, P729, DOI 10.1210/jc.80.3.729; SOLIMAN M, 1995, J CLIN ENDOCR METAB, V80, P2312, DOI 10.1210/jc.80.8.2312; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; TALLSTEDT L, 1992, NEW ENGL J MED, V326, P1733, DOI 10.1056/NEJM199206253262603; TALLSTEDT L, 1994, EUR J ENDOCRINOL, V130, P494, DOI 10.1530/eje.0.1300494; ZELISSEN PMJ, 1994, ANN INTERN MED, V120, P207, DOI 10.7326/0003-4819-120-3-199402010-00005	16	0	0	2	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1806	1807		10.1001/jama.275.23.1806	http://dx.doi.org/10.1001/jama.275.23.1806			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642720				2022-12-28	WOS:A1996UQ15200019
J	Egan, KM; Newcomb, PA; Longnecker, MP; TrenthamDietz, A; Baron, JA; Trichopoulos, D; Stampfer, MJ; Willett, WC				Egan, KM; Newcomb, PA; Longnecker, MP; TrenthamDietz, A; Baron, JA; Trichopoulos, D; Stampfer, MJ; Willett, WC			Jewish religion and risk of breast cancer	LANCET			English	Article								Background The excess risk of breast cancer among Jewish women has been attributed to the effects of difference in lifestyle and reproductive patterns, but there is now evidence that Jewish women may be more likely than other women to inherit mutations in breast-cancer genes. We investigated whether any excessive risk among Jewish women is confined to those with a family history of breast cancer. Methods We assessed the effect of Jewish religion on breast cancer in a large population-based case-control study (6611 women with breast cancer and 9026 controls) in USA. Participants were given telephone interviews and asked about known and suspected risk factors for breast cancer. Findings Overall, Jewish women had only a slightly raised relative risk of breast cancer (1 . 10 [95% CI 0 . 84-1 . 44]; p=0 . 49). However, the relative risk was much higher for Jewish women with a first-degree relative who had breast cancer (3 . 78 [1 . 74-8 . 16]; p<0 . 001). The effect of family history was greater in Jewish women than in women of other religions (p interaction=0 . 05). Interpretation These results are consistent with data suggesting that certain groups of Jewish women have a higher than expected rate of mutation in the breast-cancer gene BRCA1.	UNIV WISCONSIN,CTR COMPREHENS CANC,MADISON,WI; NIEHS,EPIDEMIOL BRANCH,RES TRIANGLE PK,NC; DARTMOUTH COLL SCH MED,DEPT MED,HANOVER,NH; DARTMOUTH COLL SCH MED,DEPT FAMILY & COMMUNITY MED,HANOVER,NH; HARVARD UNIV,SCH PUBL HLTH,DEPT NUTR,BOSTON,MA 02115; HARVARD UNIV,SCH MED,CHANNING LAB,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,BOSTON,MA 02115	University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Dartmouth College; Dartmouth College; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Egan, KM (corresponding author), HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02115, USA.			Longnecker, Matthew/0000-0001-6073-5322	NATIONAL CANCER INSTITUTE [R01CA047305, R01CA047147] Funding Source: NIH RePORTER; NCI NIH HHS [CA 47147, CA 47305] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BISHOP DT, 1994, EUR J CANCER, V30A, P1738, DOI 10.1016/0959-8049(94)00455-E; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; KELSEY JL, 1993, EPIDEMIOL REV, V15, P7, DOI 10.1093/oxfordjournals.epirev.a036118; LONGNECKER MP, 1995, JNCI-J NATL CANCER I, V87, P923, DOI 10.1093/jnci/87.12.923; NEWCOMB PA, 1994, NEW ENGL J MED, V330, P81, DOI 10.1056/NEJM199401133300201; NEWILL VA, 1961, J NATL CANCER I, V26, P405; SALBER EJ, 1969, JNCI-J NATL CANCER I, V43, P1013; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198	8	51	51	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 15	1996	347	9016					1645	1646		10.1016/S0140-6736(96)91485-3	http://dx.doi.org/10.1016/S0140-6736(96)91485-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ701	8642956	hybrid			2022-12-28	WOS:A1996UQ70100008
J	More, MI; Finger, LD; Stryker, JL; Fuqua, C; Eberhard, A; Winans, SC				More, MI; Finger, LD; Stryker, JL; Fuqua, C; Eberhard, A; Winans, SC			Enzymatic synthesis of a quorum-sensing autoinducer through use of defined substrates	SCIENCE			English	Article							ACYL CARRIER PROTEIN; ESCHERICHIA-COLI; VIBRIO-FISCHERI; TI-PLASMID; LUMINESCENCE; BIOSYNTHESIS; CONJUGATION; THIOESTERS	Many bacteria, including several pathogens of plants and humans, use a pheromone called an autoinducer to regulate gene expression in a cell density-dependent manner. Agrobacterium autoinducer [AAI, N-(3-oxo-octanoyl)-L-homoserine lactone] of A. tumefaciens is synthesized by the TraI protein, which is encoded by the tumor-inducing plasmid. Purified hexahistidinyl-TraI (H-6-TraI) used S-adenosylmethionine to make the homoserine lactone moiety of AAI, but did not use related compounds. H-6-TraI used 3-oxo-octanoyl-acyl carrier protein to make the 3-oxo-octanoyl moiety of AAI, but did not use 3-oxo-octanoyl-coenzyme A. These results demonstrate the enzymatic synthesis of an autoinducer through the use of purified substrates.	CORNELL UNIV,MICROBIOL SECT,ITHACA,NY 14853; ITHACA COLL,DEPT CHEM,ITHACA,NY 14850; TRINITY UNIV,DEPT BIOL,SAN ANTONIO,TX 78212	Cornell University; Trinity University				Finger, L. David/0000-0002-2342-9569; More, Margret/0000-0002-3672-521X	NIGMS NIH HHS [GM42893] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042893, R29GM042893] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAR YY, 1993, J BIOLUM CHEMILUM, V8, P261, DOI 10.1002/bio.1170080506; BASSLER BL, 1995, 2 COMPONENT SIGNAL T, pCH28; CAO JG, 1993, J BACTERIOL, V175, P3856, DOI 10.1128/JB.175.12.3856-3862.1993; CRONAN JE, 1981, P NATL ACAD SCI-BIOL, V78, P5440, DOI 10.1073/pnas.78.9.5440; DAGNOLO G, 1973, BIOCHIM BIOPHYS ACTA, V326, P155, DOI 10.1016/0005-2760(73)90241-5; DAGNOLO G, 1975, J BIOL CHEM, V250, P5283; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; EBERHARD A, 1991, ARCH MICROBIOL, V155, P294, DOI 10.1007/BF00252215; Fuqua C, 1996, J BACTERIOL, V178, P435, DOI 10.1128/jb.178.2.435-440.1996; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; FUQUA WC, IN PRESS MOL MICROBI; HANZELKA BL, 1995, J BACTERIOL, V177, P815, DOI 10.1128/jb.177.3.815-817.1995; HUISMAN GW, 1994, SCIENCE, V265, P537, DOI 10.1126/science.7545940; HWANG IY, 1994, P NATL ACAD SCI USA, V91, P4639, DOI 10.1073/pnas.91.11.4639; KAPLAN HB, 1985, J BACTERIOL, V163, P1210, DOI 10.1128/JB.163.3.1210-1214.1985; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; MORE MB, UNPUB; OUYANG T, 1991, J ORG CHEM, V56, P3752, DOI 10.1021/jo00011a067; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; PIPER KR, 1993, NATURE, V362, P448, DOI 10.1038/362448a0; Rock C O, 1981, Methods Enzymol, V71 Pt C, P341; SALMOND GPC, 1995, MOL MICROBIOL, V16, P615, DOI 10.1111/j.1365-2958.1995.tb02424.x; SIGGAARDANDERSEN M, 1994, P NATL ACAD SCI USA, V91, P11027, DOI 10.1073/pnas.91.23.11027; SITNIKOV DM, 1995, MOL MICROBIOL, V17, P801, DOI 10.1111/j.1365-2958.1995.mmi_17050801.x; TEMPE J, 1977, P NATL ACAD SCI USA, V74, P2848, DOI 10.1073/pnas.74.7.2848; Wirth R, 1996, TRENDS MICROBIOL, V4, P96, DOI 10.1016/0966-842X(96)81525-3; ZHANG LH, 1993, NATURE, V362, P446, DOI 10.1038/362446a0	28	301	318	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1996	272	5268					1655	1658		10.1126/science.272.5268.1655	http://dx.doi.org/10.1126/science.272.5268.1655			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8658141				2022-12-28	WOS:A1996UR09300048
J	Irifune, T; Kuroda, K; Funamori, N; Uchida, T; Yagi, T; Inoue, T; Miyajima, N				Irifune, T; Kuroda, K; Funamori, N; Uchida, T; Yagi, T; Inoue, T; Miyajima, N			Amorphization of serpentine at high pressure and high temperature	SCIENCE			English	Article							DEEP-FOCUS EARTHQUAKES; MANTLE TRANSITION ZONE; MECHANISM	Pressure-induced amorphization of serpentine was observed at temperatures of 200 degrees to 300 degrees C and pressures of 14 to 27 gigapascals with a combination of a multianvil apparatus and synchrotron radiation. High-pressure phases then crystallized rapidly when the temperature was increased to 400 degrees C. These results suggest that amorphization of serpentine is an unlikely mechanism for generating deep-focus earthquakes, as the temperatures of subducting slabs are significantly higher than those of the rapid crystallization regime.	UNIV TOKYO,INST SOLID STATE PHYS,MINATO KU,TOKYO 106,JAPAN; SUNY STONY BROOK,CTR HIGH PRESSURE RES,STONY BROOK,NY 11794; HOKKAIDO UNIV,DEPT EARTH & PLANETARY SCI,SAPPORO,HOKKAIDO 060,JAPAN	University of Tokyo; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Hokkaido University	Irifune, T (corresponding author), EHIME UNIV,DEPT EARTH SCI,MATSUYAMA,EHIME 790,JAPAN.		FUNAMORI, NOBUMASA/F-1002-2010	FUNAMORI, NOBUMASA/0000-0002-1363-8463				ANDERSON OL, 1989, J APPL PHYS, V65, P1534, DOI 10.1063/1.342969; BRIDGMAN PW, 1945, AM J SCI, V243A, P90; CANNAT M, 1995, GEOLOGY, V23, P49, DOI 10.1130/0091-7613(1995)023<0049:TCUEAR>2.3.CO;2; GREEN HW, 1989, NATURE, V341, P733, DOI 10.1038/341733a0; GREEN HW, 1990, NATURE, V348, P720, DOI 10.1038/348720a0; GRIGGS DT, 1972, NATURE SOLID EARTH, P361; HELFFRICH GR, 1989, J GEOPHYS RES-SOLID, V94, P753, DOI 10.1029/JB094iB01p00753; IRIFUNE T, 1992, P JPN ACAD B-PHYS, V68, P161, DOI 10.2183/pjab.68.161; ITO E, 1989, GEOPHYS RES LETT, V16, P425, DOI 10.1029/GL016i005p00425; JEFFREYS H, 1936, P R SOC EDINBURGH, V56, P158; KANZAKI M, 1991, PHYS EARTH PLANET IN, V66, P307, DOI 10.1016/0031-9201(91)90085-V; KIRBY SH, 1991, SCIENCE, V252, P216, DOI 10.1126/science.252.5003.216; KIRBY SH, 1987, J GEOPHYS RES-SOLID, V92, P13789, DOI 10.1029/JB092iB13p13789; KUDOH Y, 1995, PHYS CHEM MINER, V22, P295, DOI 10.1007/BF00202769; LIU LG, 1987, PHYS EARTH PLANET IN, V49, P142, DOI 10.1016/0031-9201(87)90138-5; Manghani, 1992, HIGH PRESSURE RES AP, V67, P237; MEADE C, 1991, SCIENCE, V252, P68, DOI 10.1126/science.252.5002.68; OGAWA M, 1987, J GEOPHYS RES-SOLID, V92, P13801, DOI 10.1029/JB092iB13p13801; SHIMOMURA O, 1992, HIGH PRESSURE RES AP, P3; SILVER PG, 1995, SCIENCE, V268, P69, DOI 10.1126/science.268.5207.69; SUNG M, 1976, TECTONOPHYSICS, V92, P1; Turcotte D., 2014, GEODYNAMICS, V3rd edn.; ULMER P, 1995, SCIENCE, V268, P858, DOI 10.1126/science.268.5212.858; WU TC, 1993, J GEOPHYS RES-SOL EA, V98, P19767, DOI 10.1029/93JB01614	24	41	44	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 7	1996	272	5267					1468	1470		10.1126/science.272.5267.1468	http://dx.doi.org/10.1126/science.272.5267.1468			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP899	8662470				2022-12-28	WOS:A1996UP89900043
J	Lock, C				Lock, C			What value do computers provide to NHS hospitals?	BRITISH MEDICAL JOURNAL			English	Article							INFORMATION	As the NHS spends around pound 220 million a year on information technology for use by acute hospitals that are hard pressed for resources, it is reasonable to ask what value is provided. A review of rigorous scientific evidence for the value of information technology to NHS hospitals found that published evidence is scarce and far from conclusive. Information technology in NHS hospitals needs further assessment so that future decisions on such necessary and important investments are based on clear, well documented experience and research.			Lock, C (corresponding author), UNIV LONDON UNIV COLL,DEPT STAT SCI,CLIN OPERAT RES UNIT,TORRINGTON PL,LONDON WC1E 6BT,ENGLAND.							APPLEBY J, 1995, 17 NAT ASS HLTH AUTH; *AUD COMM, 1995, YOUR INF STUD INF MA; Audit Commission, 1995, SETT REC STRAIGHT ST; BAILEY A, 1992, BRIT J HEALTHCARE CO, P10; BEECH C, 1992, P HEALTHCARE COMPUTI, P310; BEECH CA, 1994, BRIT J HEALTHCARE CO, P174; BROWN A, 1995, 2 EUR C INF TECHN IN; BUCKINGHAM J, 1994, BRIT J HEALTHCARE CO, P311; COOK CA, 1993, BRIT J HEALTHCARE CO, P641; CORBETT WA, 1992, BRIT J HEALTHCARE CO, P140; DANGERFIELD PH, 1992, BRIT J HEALTHCARE CO, P319; DAVIES CA, 1995, BRIT J HEALTHCARE CO, P179; DAWSON DK, 1990, BRIT J HEALTHCARE CO, P195; DONALDSON LJ, 1992, INJURY, V232, P363; DORENFEST SI, 1994, BRIT J HEALTHCARE CO, P324; Drummond M., 1994, EC ANAL ALONGSIDE CO; EMBERTON M, 1972, BR J UROL, V70, P634; GAMLIN JM, 1993, BRIT J HEALTHCARE CO, P120; HARRISON GSM, 1991, BRIT J UROL, V67, P532, DOI 10.1111/j.1464-410X.1991.tb15201.x; HAYNES RF, 1994, BRIT J HEALTHCARE CO, P30; HEYMAN TD, 1995, BRIT J HEALTHCARE CO, P282; HIGGINSON BM, 1995, BRIT J HEALTHCARE CO, P289; *HLTH SERV MAN UN, 1993, EV CLWYD RES MAN PRO; JONES A, 1995, BRIT J HEALTHCARE CO, P199; JONES RB, 1995, BRIT J HEALTHCARE CO, P129; KELLY WF, 1993, BRIT J HEALTHCARE CO, P127; Landauer T.K., 1995, TROUBLE COMPUTERS US; LANGLEY JD, 1994, COMPUT METH PROG BIO, V41, P287, DOI 10.1016/0169-2607(94)90060-4; LENFESTEY RS, 1994, BRIT J HEALTHCARE CO, P606; LOCK C, 1995, ASSESSMENT IT NHS SE; MAHADEVAN C, 1992, BRIT J HEALTHCARE CO, P244; MCKINNON I, 1993, BRIT J HEALTHCARE CO, P135; MITCHELL S, 1994, BRIT J HEALTHCARE CO, P552; *NHS EX INF MAN GR, 1995, PUBL LIST; OBRIEN GJ, 1991, BRIT J HEALTHCARE CO, P249; PACKWOOD T, 1991, HOSPITALS TRANSITION; PARKIN A, 1990, J MED ENG TECHNOL, V14, P55, DOI 10.3109/03091909009019267; PEEL V, 1993, BRIT J HEALTHCARE CO, P309; PENN ZJ, 1993, BRIT J HEALTHCARE CO, P672; PETERS M, 1991, BRIT J HEALTHC COMP, P129; POWELL P, 1992, J OPER RES SOC, V43, P29, DOI 10.2307/2583696; RICHARDSON K, 1994, POST IMPLEMENTATION; RICKARDS AF, 1993, BRIT J HEALTHCARE CO, P321; ROBERTSON G, 1992, BRIT J HEALTHCARE CO, P276; ROBINS JB, 1994, SCOT MED J, V39, P180, DOI 10.1177/003693309403900609; ROBSON DJ, 1993, BRIT J HEALTHCARE CO, P329; ROYCE RG, 1994, BRIT J HEALTHCARE CO, P364; SCOTT S, 1994, LIFE WORK GREENWICH; *SIL BRIDG RES, 1993, COMP CAR PAT GREENW; SMITH MF, 1993, BRIT J HEALTHCARE CO, P335; SMITH RAJ, 1993, BRIT J HEALTHCARE CO, P149; SPOURS A, 1994, BRIT J HEALTHCARE CO, P370; SULLIVAN F, 1995, BMJ-BRIT MED J, V311, P848, DOI 10.1136/bmj.311.7009.848; THOMPSON BH, 1993, BRIT J HEALTHCARE CO, P434; VANDERLOO RP, 1995, ASSESSMENT EVALUATIO; VICKERY KJ, 1993, BRIT J HEALTHCARE CO, P159; WELLS IG, 1992, BRIT J HEALTHCARE CO, P213; WHITE DA, 1995, BRIT J HEALTHCARE CO, P428; WYATT JC, 1995, BRIT MED J, V311, P175, DOI 10.1136/bmj.311.6998.175; YOUNG D, 1994, BRIT J HEALTHCARE CO, P217; YOUNG RJ, 1995, BRIT J HEALTHCARE CO, P62	61	27	27	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 1	1996	312	7043					1407	1410						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP434	8646102				2022-12-28	WOS:A1996UP43400031
J	Nakayama, K; Ishida, N; Shirane, M; Inomata, A; Inoue, T; Shishido, N; Hori, I; Loh, DY; Nakayama, K				Nakayama, K; Ishida, N; Shirane, M; Inomata, A; Inoue, T; Shishido, N; Hori, I; Loh, DY; Nakayama, K			Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors	CELL			English	Article							GROWTH-FACTOR-BETA; CELL; MOUSE; DISRUPTION; INHIBITOR; ONCOGENE; MUTATIONS; KINASES; GENES; P21	Mice lacking p27(Kip1) have been created by gene targeting in embryonic stem cells. These mice are larger than the control animals, with thymus, pituitary, and adrenal glands and gonadal organs exhibiting striking enlargement. CDK2 activity is elevated about 10-fold in p27(-/-) thymocytes. Development of ovarian follicles seems to be impaired, resulting in female sterility. Similar to mice with the Rb mutation, the p27(-/-) mice often develop pituitary tumors spontaneously. The retinas of the mutant mice show a disturbed organization of the normal cellular layer pattern. These findings indicate that p27(Kip1) acts to regulate the growth of a variety of cells. Unexpectedly, the cell cycle arrest mediated by TGF beta, rapamycin, or contact inhibition remained intact in p27(-/-) cells, suggesting that p27(Kip1) is not required in these pathways.	NIPPON ROCHE RES CTR,DEPT TOXICOL & PATHOL,KAMAKURA,KANAGAWA 247,JAPAN; WASHINGTON UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT MED GENET & MOL MICROBIOL,ST LOUIS,MO 63110	Roche Holding; Howard Hughes Medical Institute; Washington University (WUSTL)	Nakayama, K (corresponding author), NIPPON ROCHE RES CTR,DEPT BIOL,KAMAKURA,KANAGAWA 247,JAPAN.			Shirane, Michiko/0000-0002-8297-9245				AHUJA SS, 1993, J IMMUNOL, V150, P3109; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; BULLRICH F, 1995, CANCER RES, V55, P1199; CHAN FKM, 1995, MOL CELL BIOL, V15, P2682; CHAN LC, 1992, CANCER GENET CYTOGEN, V62, P47, DOI 10.1016/0165-4608(92)90037-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DECKER HJH, 1990, CANCER GENET CYTOGEN, V46, P135, DOI 10.1016/0165-4608(90)90021-2; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; FIRPO EJ, 1994, MOL CELL BIOL, V14, P4889, DOI 10.1128/MCB.14.7.4889; GILLETT C, 1994, CANCER RES, V54, P1812; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HARPER JW, 1993, CELL, V75, P805; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JIANG HP, 1994, ONCOGENE, V9, P3397; KAWAMATA N, 1995, CANCER RES, V55, P2266; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; LAMMIE GA, 1991, ONCOGENE, V6, P439; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LEE KP, 1979, TOXICOL APPL PHARM, V51, P219, DOI 10.1016/0041-008X(79)90464-2; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; LI LX, 1988, EXP EYE RES, V47, P911, DOI 10.1016/0014-4835(88)90073-5; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MORI T, 1994, CANCER RES, V54, P3396; MOROSETTI R, 1995, BLOOD, V86, P1924, DOI 10.1182/blood.V86.5.1924.bloodjournal8651924; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; NAKAYAMA K, 1994, SCIENCE, V263, P1131, DOI 10.1126/science.8108731; NAKAYAMA K, 1993, SCIENCE, V261, P1584, DOI 10.1126/science.8372353; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; NOGUCHI E, 1993, BIOCHEM BIOPH RES CO, V197, P1524, DOI 10.1006/bbrc.1993.2650; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; PIETENPOL JA, 1995, CANCER RES, V55, P1206; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; PONCECASTANEDA MV, 1995, CANCER RES, V55, P1211; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; SHINOHARA M, 1994, BLOOD, V84, P3781; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; STEINMAN RA, 1994, ONCOGENE, V9, P3389; SWYRYD EA, 1974, J BIOL CHEM, V249, P6945; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WAHL SM, 1989, IMMUNOL TODAY, V10, P258, DOI 10.1016/0167-5699(89)90136-9; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	65	1362	1400	0	31	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 31	1996	85	5					707	720		10.1016/S0092-8674(00)81237-4	http://dx.doi.org/10.1016/S0092-8674(00)81237-4			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UP344	8646779	Bronze			2022-12-28	WOS:A1996UP34400011
J	Feller, MB; Wellis, DP; Stellwagen, D; Werblin, FS; Shatz, CJ				Feller, MB; Wellis, DP; Stellwagen, D; Werblin, FS; Shatz, CJ			Requirement for cholinergic synaptic transmission in the propagation of spontaneous retinal waves	SCIENCE			English	Article							GABA-LIKE IMMUNOREACTIVITY; GANGLION-CELL DENDRITES; MAMMALIAN RETINA; CAT RETINA; ACETYLCHOLINE; RESPONSES; BUNGAROTOXIN; PATTERNS; SYSTEMS	Highly correlated neural activity in the form of spontaneous waves of action potentials is present in the developing retina weeks before vision. Optical imaging revealed that these waves consist of spatially restricted domains of activity that form a mosaic pattern over the entire retinal ganglion cell layer. Whole-cell recordings indicate that wave generation requires synaptic activation of neuronal nicotinic acetylcholine receptors on ganglion cells. The only cholinergic cells in these immature retinas are a uniformly distributed, bistratified population of amacrine cells, as assessed by antibodies to choline acetyltransferase. The results indicate that the major source of synaptic input to retinal ganglion cells is a system of cholinergic amacrine cells, whose activity is required for wave propagation in the developing retina.	UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley	Feller, MB (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,221 LIFE SCI ADDIT,BERKELEY,CA 94720, USA.				NATIONAL EYE INSTITUTE [R01EY000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NEI NIH HHS [EY00561] Funding Source: Medline; NIGMS NIH HHS [GM07048] Funding Source: Medline; NIMH NIH HHS [NIMH 48108] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AIZENMAN E, 1990, BRAIN RES, V517, P209, DOI 10.1016/0006-8993(90)91028-F; BODNARENKO SR, 1993, NATURE, V364, P144, DOI 10.1038/364144a0; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; DONG CJ, 1994, J NEUROSCI, V14, P2648; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HAMASSAKIBRITTO DE, 1994, J COMP NEUROL, V347, P161, DOI 10.1002/cne.903470202; HEAULME M, 1986, BRAIN RES, V384, P224, DOI 10.1016/0006-8993(86)91158-3; Kandler Karl, 1995, Current Opinion in Neurobiology, V5, P98, DOI 10.1016/0959-4388(95)80093-X; KEYSER KT, 1993, J NEUROSCI, V13, P442; KITTILA CA, 1995, J NEUROPHYSIOL, V73, P703, DOI 10.1152/jn.1995.73.2.703; LEBEDA FJ, 1982, J NEUROPHYSIOL, V48, P622, DOI 10.1152/jn.1982.48.3.622; LINSKER R, 1986, P NATL ACAD SCI USA, V83, P8390, DOI 10.1073/pnas.83.21.8390; LIPPE WR, 1994, J NEUROSCI, V14, P1486, DOI 10.1523/JNEUROSCI.14-03-01486.1994; LUKASIEWICZ PD, 1990, J NEUROSCI, V10, P210; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; MASLAND RH, 1976, J NEUROPHYSIOL, V39, P1220, DOI 10.1152/jn.1976.39.6.1220; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Mooney R., UNPUB; MOSINGER JL, 1986, EXP EYE RES, V42, P631, DOI 10.1016/0014-4835(86)90052-7; ODONOVAN M, 1992, J EXP ZOOL, V261, P261, DOI 10.1002/jez.1402610306; PENN AA, 1994, J NEUROSCI, V14, P3805; Pourcho RG, 1980, BRAIN RES, V198, P33; RORIG B, 1994, NEUROREPORT, V5, P1197; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; Sernagor E., 1994, Society for Neuroscience Abstracts, V20, P1470; SERNAGOR E, 1994, INVEST OPHTH VIS SCI, V35, P2125; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SPITZER NC, 1994, TRENDS NEUROSCI, V17, P115, DOI 10.1016/0166-2236(94)90120-1; TOOTLE JS, 1993, J NEUROPHYSIOL, V69, P1645, DOI 10.1152/jn.1993.69.5.1645; von der Malsburg C, 1973, Kybernetik, V14, P85; WASSLE H, 1989, J COMP NEUROL, V279, P43, DOI 10.1002/cne.902790105; WELLIS DP, UNPUB; Wong R O, 1993, Curr Opin Neurobiol, V3, P595, DOI 10.1016/0959-4388(93)90061-3; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; WONG ROL, 1995, J NEUROSCI, V15, P2696; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; WOTRING VE, 1995, NEUROSCIENCE, V67, P293, DOI 10.1016/0306-4522(95)00011-7; Yazulla S, 1985, Neurosci Res Suppl, V2, pS147, DOI 10.1016/0921-8696(85)90014-3; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8; ZHANG ZW, 1994, NEURON, V12, P167, DOI 10.1016/0896-6273(94)90161-9; ZHANG ZW, 1991, BRIT J PHARMACOL, V102, P19, DOI 10.1111/j.1476-5381.1991.tb12125.x	47	419	425	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 24	1996	272	5265					1182	1187		10.1126/science.272.5265.1182	http://dx.doi.org/10.1126/science.272.5265.1182			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8638165				2022-12-28	WOS:A1996UM88900054
J	Lewis, M; Chang, G; Horton, NC; Kercher, MA; Pace, HC; Schumacher, MA; Brennan, RG; Lu, PZ				Lewis, M; Chang, G; Horton, NC; Kercher, MA; Pace, HC; Schumacher, MA; Brennan, RG; Lu, PZ			Crystal structure of the lactose operon repressor and its complexes with DNA and inducer	SCIENCE			English	Article							LAC REPRESSOR; ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; RNA-POLYMERASE; OPERATOR; PROTEIN; MUTATIONS; SEQUENCE; REGION; GENE	The lac operon of Escherichia coli is the paradigm for gene regulation. Its key component is the lac repressor, a product of the lad gene. The three-dimensional structures of the intact lac repressor, the lac repressor bound to the gratuitous inducer isopropyl-beta-D-1-thiogalactoside (IPTG) and the lac repressor complexed with a 21-base pair symmetric operator DNA have been determined. These three structures show the conformation of the molecule in both the induced and repressed states and provide a framework for understanding a wealth of biochemical and genetic information. The DNA sequence of the lac operon has three lac repressor recognition sites in a stretch of 500 base pairs. The crystallographic structure of the complex with DNA suggests that the tetrameric repressor functions synergistically with catabolite gene activator protein (CAP) and participates in the quaternary formation of repression loops in which one tetrameric repressor interacts simultaneously with two sites on the genomic DNA.	UNIV PENN,DEPT BIOCHEM & BIOPHYS,PHILADELPHIA,PA 19104; UNIV PENN,DEPT CHEM,PHILADELPHIA,PA 19104; OREGON HLTH SCI UNIV,DEPT BIOCHEM & MOLEC BIOL,PORTLAND,OR 97201	University of Pennsylvania; University of Pennsylvania; Oregon Health & Science University	Lewis, M (corresponding author), UNIV PENN,JOHNSON RES FDN,PHILADELPHIA,PA 19104, USA.		Horton, Nancy C/E-7881-2011	Horton, Nancy C/0000-0003-2710-8284; Brennan, Richard/0000-0001-7647-485X	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044617] Funding Source: NIH RePORTER; NCRR NIH HHS [P41-RR06017] Funding Source: Medline; NIGMS NIH HHS [GM44617, 2-T32-GM082745] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADHYA S, 1989, ANNU REV GENET, V23, P207; ALBERTI S, 1991, NEW BIOL, V3, P57; BELLOMY GR, 1988, BIOCHEMISTRY-US, V27, P3900, DOI 10.1021/bi00411a002; BETZ JL, 1986, GENE, V42, P283, DOI 10.1016/0378-1119(86)90232-5; BEYREUTHER K, 1973, P NATL ACAD SCI USA, V70, P3576, DOI 10.1073/pnas.70.12.3576; Bourgeois S, 1976, Adv Protein Chem, V30, P1, DOI 10.1016/S0065-3233(08)60478-7; BRENOWITZ M, 1991, BIOCHEMISTRY-US, V30, P5986, DOI 10.1021/bi00238a024; BRENOWITZ M, 1991, J BIOL CHEM, V286, P1281; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BURSTEIN C, 1965, BIOCHIM BIOPHYS ACTA, V95, P634, DOI 10.1016/0005-2787(65)90517-4; CARUTHERS MH, 1980, ACCOUNTS CHEM RES, V13, P155, DOI 10.1021/ar50149a005; CHAKERIAN AE, 1991, J BIOL CHEM, V266, P1371; CHAKERIAN AE, 1991, J BIOL CHEM, V266, P22206; CHANG G, 1994, ACTA CRYSTALLOGR D, V50, P667, DOI 10.1107/S0907444994000727; CHANG WI, 1993, J BIOL CHEM, V268, P17613; CHEN J, 1994, J BIOL CHEM, V269, P12482; CHEN J, 1994, BIOCHEMISTRY-US, V33, P8728, DOI 10.1021/bi00195a014; CHUPRINA VP, 1993, J MOL BIOL, V234, P446, DOI 10.1006/jmbi.1993.1598; EISMANN ER, 1990, J MOL BIOL, V213, P763, DOI 10.1016/S0022-2836(05)80262-1; FAIRMAN R, 1995, PROTEIN SCI, V4, P1457, DOI 10.1002/pro.5560040803; FARABAUGH PJ, 1978, NATURE, V274, P765, DOI 10.1038/274765a0; FICKERT R, 1992, J MOL BIOL, V226, P59, DOI 10.1016/0022-2836(92)90124-3; FLASHNER Y, 1988, P NATL ACAD SCI USA, V85, P8968, DOI 10.1073/pnas.85.23.8968; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; FUREY W, 1990, AM CRYSTALLOGR ASS 2, V18, P73; GEISLER N, 1978, FEBS LETT, V87, P215, DOI 10.1016/0014-5793(78)80335-4; GILBERT W, 1973, P NATL ACAD SCI USA, V70, P3581, DOI 10.1073/pnas.70.12.3581; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; GILBERT W, 1975, PROTEIN LIGAND INTER, P193; HARRISON SC, 1991, NATURE, V353, P715, DOI 10.1038/353715a0; HAUROWITZ F, 1938, HOPPESEYLERS Z PHYSL, V254, P268; HUDSON JM, 1990, J MOL BIOL, V214, P381, DOI 10.1016/0022-2836(90)90188-R; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; JAREMA MAC, 1981, P NATL ACAD SCI-BIOL, V78, P2707, DOI 10.1073/pnas.78.5.2707; JOBE A, 1972, J MOL BIOL, V69, P397, DOI 10.1016/0022-2836(72)90253-7; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KIM R, 1982, COLD SPRING HARB SYM, V47, P451, DOI 10.1101/SQB.1983.047.01.053; KORNBERG RD, 1981, SCI AM, V244, P48, DOI 10.1038/scientificamerican0281-52; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LEWIS MA, UNPUB; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; MESSERSCHMIDT A, 1987, J APPL CRYSTALLOGR, V20, P306, DOI 10.1107/S002188988708662X; Miller J. H., 1980, OPERON; MILLER JH, 1984, J MOL BIOL, V180, P205, DOI 10.1016/0022-2836(84)90438-8; MILLER JH, 1979, J MOL BIOL, V131, P191, DOI 10.1016/0022-2836(79)90073-1; MILLER JH, 1970, LACTOSE OPERON; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; MONOD J, 1942, THESIS U PARIS; MOSSING MC, 1986, SCIENCE, V233, P889, DOI 10.1126/science.3090685; MOWBRAY SL, 1992, J MOL BIOL, V225, P155, DOI 10.1016/0022-2836(92)91033-L; MULLERHILL B, 1964, J MOL BIOL, V10, P303, DOI 10.1016/S0022-2836(64)80049-8; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; OTWINOWSKI Z, UNPUB HKL PROGRAM SU; PACE HC, 1990, P NATL ACAD SCI USA, V87, P1870, DOI 10.1073/pnas.87.5.1870; PERUTZ MF, 1964, NATURE, V203, P687, DOI 10.1038/203687a0; PLATT T, 1973, J BIOL CHEM, V248, P110; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; ROYER CA, 1990, BIOCHEMISTRY-US, V29, P4959, DOI 10.1021/bi00472a028; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; SADLER JR, 1983, P NATL ACAD SCI-BIOL, V80, P6785, DOI 10.1073/pnas.80.22.6785; SCHLEIF R, 1988, SCIENCE, V240, P127, DOI 10.1126/science.3353710; SCHMITZ A, 1976, J BIOL CHEM, V251, P3359; SCHMITZ A, 1979, NUCLEIC ACIDS RES, V6, P111, DOI 10.1093/nar/6.1.111; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; SHIGETA R, 1994, ACTA CRYSTALLOGR D, V50, P71, DOI 10.1107/S0907444993009382; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; SIMONS A, 1984, P NATL ACAD SCI-BIOL, V81, P1624, DOI 10.1073/pnas.81.6.1624; STRANEY SB, 1987, CELL, V51, P699, DOI 10.1016/0092-8674(87)90093-6; Voet D VJ, 1990, BIOCHEMISTRY; WADEJARDETZKY N, 1978, J MOL BIOL, V128, P259; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; ZUBAY G, 1970, P NATL ACAD SCI USA, V66, P104, DOI 10.1073/pnas.66.1.104	75	651	666	1	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 1	1996	271	5253					1247	1254		10.1126/science.271.5253.1247	http://dx.doi.org/10.1126/science.271.5253.1247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TX695	8638105				2022-12-28	WOS:A1996TX69500027
J	Cuervo, AM; Dice, JF				Cuervo, AM; Dice, JF			A receptor for the selective uptake and degradation of proteins by lysosomes	SCIENCE			English	Article							RAT-LIVER LYSOSOMES; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE	Multiple pathways of protein degradation operate within cells, A selective protein import pathway exists for the uptake and degradation of particular cytosolic proteins by lysosomes. Here, the lysosomal membrane glycoprotein LGP96 was identified as a receptor for the selective import and degradation of proteins within lysosomes. Specific substrates of this proteolytic pathway bound to the cytosolic tail of a 96-kilodalton lysosomal membrane protein in two different binding assays, Overexpression of human LGP96 in Chinese hamster ovary cells increased the activity of the selective lysosomal proteolytic pathway in vivo and in vitro.	TUFTS UNIV,SCH MED,DEPT PHYSIOL,BOSTON,MA 02111	Tufts University				Cuervo, Ana Maria/0000-0002-0771-700X	NIA NIH HHS [AG06116] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG006116, R37AG006116] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANIENTO F, 1993, J BIOL CHEM, V268, P10463; AUTERI JS, 1983, J CELL PHYSL, V115, P159; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; CUERVO AM, 1994, J BIOL CHEM, V269, P26374; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; CUERVO AM, UNPUB; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; FUKUDA M, 1988, J BIOL CHEM, V263, P18920; GRATZER S, 1995, J CELL BIOL, V129, P25, DOI 10.1083/jcb.129.1.25; Hayes SA, 1996, J CELL BIOL, V132, P255, DOI 10.1083/jcb.132.3.255; NOGUCHI Y, 1989, BIOCHEM BIOPH RES CO, V164, P1113, DOI 10.1016/0006-291X(89)91784-1; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; TERLECKY L, UNPUB; TERLECKY SR, 1993, J BIOL CHEM, V268, P23490; TERLECKY SR, 1994, EXPERIENTIA, V50, P1021, DOI 10.1007/BF01923456	15	667	696	4	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 26	1996	273	5274					501	503		10.1126/science.273.5274.501	http://dx.doi.org/10.1126/science.273.5274.501			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY983	8662539				2022-12-28	WOS:A1996UY98300041
J	Genta, RM; Graham, DY				Genta, RM; Graham, DY			Helicobacter pylori in a gastric pit	NEW ENGLAND JOURNAL OF MEDICINE			English	Article											Genta, RM (corresponding author), VET AFFAIRS MED CTR,HOUSTON,TX 77030, USA.		Graham, David/AAL-2165-2021						0	1	1	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	1996	335	4					250	250		10.1056/NEJM199607253350405	http://dx.doi.org/10.1056/NEJM199607253350405			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ532	8657241				2022-12-28	WOS:A1996UZ53200005
J	Richmond, J; Berman, BM; Docherty, JP; Goldstein, LB; Kaplan, G; Keil, JE; Krippner, S; Lyne, S; Mosteller, F; OConnor, BB; Rudy, EB; Schatzberg, AF; Friedman, R; Altman, F; Benson, H; Elliott, JM; Ferguson, JH; Gracely, R; Greene, A; Haddox, JD; Hall, WH; Hauri, PJ; Helzner, EC; Kaufmann, PG; Kiley, JP; Leveck, MD; McCutchen, CB; Monjan, AA; Pillemer, SR; MacArthur, JD; Sherman, C; Spencer, J; Varricchio, CG				Richmond, J; Berman, BM; Docherty, JP; Goldstein, LB; Kaplan, G; Keil, JE; Krippner, S; Lyne, S; Mosteller, F; OConnor, BB; Rudy, EB; Schatzberg, AF; Friedman, R; Altman, F; Benson, H; Elliott, JM; Ferguson, JH; Gracely, R; Greene, A; Haddox, JD; Hall, WH; Hauri, PJ; Helzner, EC; Kaufmann, PG; Kiley, JP; Leveck, MD; McCutchen, CB; Monjan, AA; Pillemer, SR; MacArthur, JD; Sherman, C; Spencer, J; Varricchio, CG			Integration of behavioral and relaxation approaches into the treatment of chronic pain and insomnia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Objective.-To provide physicians with a responsible assessment of the integration of behavioral and relaxation approaches into the treatment of chronic pain and insomnia. Participants.-A nonfederal, nonadvocate, 12-member panel representing the fields of family medicine, social medicine, psychiatry, psychology, public health, nursing, and epidemiology. In addition, 23 experts in behavioral medicine, pain medicine, sleep medicine, psychiatry, nursing, psychology, neurology, and behavioral and neurosciences presented data to the panel and a conference audience of 528 during a 1 1/2-day public session. Questions and statements from conference attendees were considered during the open session. Closed deliberations by the panel occurred during the remainder of the second day and the morning of the third day. Evidence.-The literature was searched through MEDLINE, and an extensive bibliography of references was provided to the panel and the conference audience. Experts prepared abstracts with relevant citations from the literature. Scientific evidence was given precedence over clinical anecdotal experience. Assessment Process.-The panel, answering predefined questions, developed their conclusions based on the scientific evidence presented in open forum and the scientific literature. The panel composed a draft statement that was read in its entirety and circulated to the experts and the audience for comment. Thereafter, the panel resolved conflicting recommendations and released a revised statement at the end of the conference. The panel finalized the revisions within a few weeks after the conference. Conclusions.-A number of well-defined behavioral and relaxation interventions now exist and are effective in the treatment of chronic pain and insomnia. The panel found strong evidence for the use of relaxation techniques in reducing chronic pain in a variety of medical conditions as well as strong evidence for the use of hypnosis in alleviating pain associated with cancer. The evidence was moderate for the effectiveness of cognitive-behavioral techniques and biofeedback in relieving chronic pain. Regarding insomnia, behavioral techniques, particularly relaxation and biofeedback, produce improvements in some aspects of sleep, but it is questionable whether the magnitude of the improvement in sleep onset and total sleep time are clinically significant.	UNIV MARYLAND,SCH MED,DEPT FAMILY MED,DIV COMPLEMENTARY MED,BALTIMORE,MD 21201; CORNELL UNIV,NEW YORK HOSP,WHITE PLAINS,NY 10605; CORNELL UNIV,COLL MED,DEPT PSYCHIAT,WHITE PLAINS,NY 10605; DUKE UNIV,MED CTR,DURHAM VA MED CTR,DEPT MED,DIV NEUROL,DURHAM,NC; DUKE UNIV,MED CTR,DURHAM VA MED CTR,CTR HLTH POLICY RES & EDUC,DURHAM,NC; GEORGETOWN UNIV,SCH MED,DEPT FAMILY & COMMUNITY MED,WASHINGTON,DC 20057; FAMILY PRACTICE ASSOCIATES,ARLINGTON,VA; MED UNIV S CAROLINA,DEPT BIOSTAT EPIDEMIOL & SYST SCI,CHARLESTON,SC 29425; SAYBROOK INST GRAD SCH & RES CTR,SAN FRANCISCO,CA; CHICAGO DEPT PUBL HLTH,CHICAGO,IL; HARVARD UNIV,DEPT STAT,CAMBRIDGE,MA 02138; HARVARD UNIV,DEPT HLTH POLICY & MANAGEMENT,CAMBRIDGE,MA 02138; MED COLL PENN & HAHNEMANN UNIV,SCH MED,DEPT COMMUNITY & PREVENT MED,PHILADELPHIA,PA 19102; UNIV PITTSBURGH,SCH NURSING,PITTSBURGH,PA 15261; STANFORD UNIV,SCH MED,DEPT PSYCHIAT,STANFORD,CA 94305; SUNY STONY BROOK,DEPT PSYCHIAT,STONY BROOK,NY 11794; NIMH,MED RES BRANCH,DIV EPIDEMIOL & SERV RES,NIH,BETHESDA,MD 20892; DEACONESS HOSP,DIV BEHAV MED,BOSTON,MA; MIND BODY MED INST,BOSTON,MA; NIH,OFF MED APPLICAT RES,BETHESDA,MD 20892; NIDR,NEUROPATH & PAIN MEASUREMENT SECT,NEUROBIOL & ANESTHESIOL BRANCH,NIH,BETHESDA,MD 20892; NIH,OFF ALTERNAT MED,BETHESDA,MD 20892; EMORY UNIV,SCH MED,ATLANTA,GA; NIH,OFF MED APPLICAT RES,BETHESDA,MD 20892; MAYO CLIN & MAYO FDN,MAYO MED SCH,ROCHESTER,MN 55905; MAYO CLIN,INSOMNIA PROGRAM,DEPT PSYCHOL,SLEEP DISORDERS CTR,ROCHESTER,MI; NHLBI,BEHAV MED SCI RES GRP,BETHESDA,MD 20892; NHLBI,NATL CTR SLEEP DISORDERS CTR,NIH,BETHESDA,MD 20892; NINR,DIV EXTRAMURAL PROGRAMS,NIH,BETHESDA,MD; NINCDS,EPILEPSY BRANCH,DIV CONVULS DEV & NEUROMUSCULAR DISORDERS,NIH,BETHESDA,MD 20892; NIA,NEUROBIOL AGING PROGRAM,NIH,BETHESDA,MD 20892; NIA,NEUROSCI & NEUROPSYCHOL AGING PROGRAM,NIH,BETHESDA,MD 20892; NIAMSD,OFF PREVENT EPIDEMIOL & CLIN APPLICAT,NIH,BETHESDA,MD 20892; HARVARD UNIV,SCH MED,DEPT SOCIAL MED,BOSTON,MA 02115; NIH,OFF MED APPLICAT RES,BETHESDA,MD 20892; NIH,OFF ALTERNAT MED,BETHESDA,MD 20892; NCI,COMMUNITY ONCOL & REHABIL BRANCH,DIV CANC PREVENT & CONTROL,NIH,BETHESDA,MD 20892	University System of Maryland; University of Maryland Baltimore; Cornell University; NewYork-Presbyterian Hospital; Cornell University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Georgetown University; Medical University of South Carolina; Chicago Department of Public Health; Harvard University; Harvard University; Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; Emory University; National Institutes of Health (NIH) - USA; Mayo Clinic; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Nursing Research (NINR); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Richmond, J (corresponding author), HARVARD UNIV,SCH MED,DEPT SOCIAL MED,BOSTON,MA 02115, USA.			Bradley, Laurence/0000-0002-1206-2263					0	213	217	0	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1996	276	4					313	318						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UX583	8656544				2022-12-28	WOS:A1996UX58300037
J	Lee, JW; Tevault, CV; Owens, TG; Greenbaum, E				Lee, JW; Tevault, CV; Owens, TG; Greenbaum, E			Oxygenic photoautotrophic growth without photosystem I	SCIENCE			English	Article							PHOTON REQUIREMENT; REACTION CENTERS; CHLAMYDOMONAS; EFFICIENCY	Contrary to the prediction of the Z-scheme model of photosynthesis, experiments demonstrated that mutants of Chlamydomonas containing photosystem II (PSII) but lacking photosystem I (PSI) can grow photoautotrophically with O-2 evolution, using atmospheric CO2 as the sole carbon source. Autotrophic photosynthesis by PSI-deficient mutants was stable both under anaerobic conditions and in air (21 percent O-2) at an actinic intensity of 200 microeinsteins per square meter per second. This PSII photosynthesis, which was sufficient to support cell development and mobility, may also occur in wild-type green algae and higher plants. The mutants can survive under 2000 microeinsteins per square meter per second with air, although they have less resistance to photoinhibition.	OAK RIDGE NATL LAB,DIV CHEM TECHNOL,OAK RIDGE,TN 37831; CORNELL UNIV,PLANT BIOL SECT,ITHACA,NY 14853	United States Department of Energy (DOE); Oak Ridge National Laboratory; Cornell University								ARNON DI, 1965, NATURE, V207, P1367, DOI 10.1038/2071367a0; ARNON DI, 1990, P NATL ACAD SCI USA, V87, P5930, DOI 10.1073/pnas.87.15.5930; BAMBERGER ES, 1982, PLANT PHYSIOL, V69, P1268, DOI 10.1104/pp.69.6.1268; BELL LN, 1985, ENERGETICS PHOTOSYNT, pCH6; BENNOUN P, 1994, BBA-BIOENERGETICS, V1186, P59, DOI 10.1016/0005-2728(94)90135-X; GIRARD J, 1980, CURR GENET, V2, P215, DOI 10.1007/BF00435689; GREENBAUM E, 1995, NATURE, V376, P438, DOI 10.1038/376438a0; HILL R, 1960, NATURE, V186, P136, DOI 10.1038/186136a0; KOW YW, 1982, PLANT PHYSIOL, V69, P442, DOI 10.1104/pp.69.2.442; Lee J.-S., UNPUB; LEE JW, 1995, APPL BIOCHEM BIOTECH, V51-2, P379, DOI 10.1007/BF02933441; MYERS J, 1990, PRIMARY PRODUCTIVITY, P1; OSBORNE BA, 1987, NEW PHYTOL, V106, P631, DOI 10.1111/j.1469-8137.1987.tb00164.x; OSBORNE BA, 1987, PLANT CELL ENVIRON, V10, P141, DOI 10.1111/j.1365-3040.1987.tb02090.x; OSBORNE BA, 1994, PLANT CELL ENVIRON, V17, P143, DOI 10.1111/j.1365-3040.1994.tb00277.x; PIRT SJ, 1986, NEW PHYTOL, V102, P3, DOI 10.1111/j.1469-8137.1986.tb00794.x; PIRT SJ, 1980, J CHEM TECHNOL BIOT, V30, P25, DOI 10.1002/jctb.503300105; ROITGRUND C, 1990, CURR GENET, V17, P147, DOI 10.1007/BF00312860; SALISBURY FB, 1985, PLANT PHYSIOL, P191; STRYER L, 1995, BIOCHEMISTRY-US, P658; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83	21	26	29	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 19	1996	273	5273					364	367		10.1126/science.273.5273.364	http://dx.doi.org/10.1126/science.273.5273.364			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY202	8662525				2022-12-28	WOS:A1996UY20200042
J	Noll, KS; Johnson, RE; Lane, AL; Domingue, DL; Weaver, HA				Noll, KS; Johnson, RE; Lane, AL; Domingue, DL; Weaver, HA			Detection of ozone on Ganymede	SCIENCE			English	Article							ION-BOMBARDMENT; SATELLITES; LIFE; REFLECTANCE; SPECTRA; SEARCH; H2O	An absorption band at 260 nanometers on the trailing hemisphere of Ganymede, identified as the Hartley band of ozone (O-3), was measured with the Hubble Space Telescope, The column abundance of ozone, 4.5 x 10(16) per square centimeter, can be produced by ion impacts or by photochemical equilibrium with previously detected molecular oxygen (O-2). An estimated number density ratio of [O-3]/[O-2] approximate to 10(-4) to 10(-3) requires an atmospheric density orders of magnitude higher than upper limits from spacecraft occultation experiment's. Apparently, this O-2-O-3 ''atmosphere'' is trapped in Ganymede's surface ice, an inference consistent with the shift and broadening of the band compared with the gas-phase O-3 band.	UNIV VIRGINIA, CHARLOTTESVILLE, VA 22901 USA; CALTECH, JET PROP LAB, PASADENA, CA 91109 USA; LUNAR & PLANETARY INST, HOUSTON, TX 77058 USA; JOHNS HOPKINS UNIV, DEPT PHYS & ASTRON, BALTIMORE, MD 21218 USA	University of Virginia; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Johns Hopkins University	Noll, KS (corresponding author), SPACE TELESCOPE SCI INST, 3700 SAN MARTIN DR, BALTIMORE, MD 21218 USA.		Weaver, Harold A/D-9188-2016; Noll, Keith/C-8447-2012	Weaver, Harold A/0000-0003-0951-7762; 				BAGENAL F, 1992, GEOPHYS RES LETT, V19, P79, DOI 10.1029/92GL00070; BROADFOOT AL, 1979, SCIENCE, V204, P979, DOI 10.1126/science.204.4396.979; BURATTI BJ, 1990, ICARUS, V87, P339, DOI 10.1016/0019-1035(90)90138-Y; BURKE BF, 1986, NATURE, V322, P340, DOI 10.1038/322340a0; Calvin WM, 1996, GEOPHYS RES LETT, V23, P673, DOI 10.1029/96GL00450; CHAMBERLAIN J.W., 1987, THEORY PLANETARY ATM; CLARK RN, 1984, ICARUS, V58, P265, DOI 10.1016/0019-1035(84)90043-5; HALL DT, 1995, NATURE, V373, P677, DOI 10.1038/373677a0; HAMILTON DC, 1981, J GEOPHYS RES-SPACE, V86, P8301, DOI 10.1029/JA086iA10p08301; Johnson R.E., 1990, ENERGETIC CHARGED PA, DOI [10.1007/978-3-642-48375-2, DOI 10.1007/978-3-642-48375-2]; LANE AL, 1981, NATURE, V292, P38, DOI 10.1038/292038a0; LANE AL, 1994, B AM ASTRON SOC, V26, P1159; LEGER A, 1994, ASTROPHYS SPACE SCI, V212, P327, DOI 10.1007/BF00984536; MATICH AJ, 1993, J PHYS CHEM-US, V97, P10539, DOI 10.1021/j100143a007; NELSON RM, 1987, ICARUS, V72, P358, DOI 10.1016/0019-1035(87)90180-1; NOLL KS, 1995, J GEOPHYS RES-PLANET, V100, P19057, DOI 10.1029/94JE03294; ROTTMAN GJ, COMMUNICATION; ROUSH TL, 1995, VOLATILES EARTH SOLA, V341, P143; SACK NJ, 1992, ICARUS, V100, P534, DOI 10.1016/0019-1035(92)90116-O; SACK NJ, 1991, J GEOPHYS RES-PLANET, V96, P17535, DOI 10.1029/91JE01681; SAGAN C, 1993, NATURE, V365, P715, DOI 10.1038/365715a0; SCHLEICHER DG, 1988, ASTROPHYS J, V331, P1058, DOI 10.1086/166622; SEDLACEK AJ, 1989, J PHYS CHEM-US, V93, P509, DOI 10.1021/j100339a004; SPENCER JR, 1995, J GEOPHYS RES-PLANET, V100, P19049, DOI 10.1029/95JE01503; TAUBE H, 1957, T FARADAY SOC, V53, P656, DOI 10.1039/tf9575300656; VAIDA V, 1989, J PHYS CHEM-US, V93, P506, DOI 10.1021/j100339a003	26	139	141	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	1996	273	5273					341	343		10.1126/science.273.5273.341	http://dx.doi.org/10.1126/science.273.5273.341			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY202	8662517				2022-12-28	WOS:A1996UY20200034
J	Mauskopf, JA; Paul, JE; Wichman, DS; White, AD; Tilson, HH				Mauskopf, JA; Paul, JE; Wichman, DS; White, AD; Tilson, HH			Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine - Implications for HIV screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COST-BENEFIT-ANALYSIS; INFECTION; ANTIBODY; PERFORMANCE; KNOWLEDGE; CONTINUE; HEALTH; CARE	Objectives.-To estimate the economic impact of (1) treating pregnant women who are human immunodeficiency virus (HIV)-positive with zidovudine and (2) voluntary screening programs for pregnant women for HIV infection and offering treatment with zidovudine to those found to be HIV-positive. Main Outcome Measures.-Number of cases of pediatric HIV infection and costs of screening, zidovudine treatment, and pediatric HIV infection treatment. Design.-Health care costs associated with treatment of HIV-positive pregnant women and their newborns are estimated as the costs of zidovudine and its administration and the reduction in costs of treating pediatric HIV infection. The lifetime costs of pediatric HIV infection are derived from the published literature. Estimates of the reduction in maternal-to-fetal transmission rates are taken from the AIDS [acquired immunodeficiency syndrome] Clinical Trials Group (ACTG) Protocol 076, Costs of a voluntary screening program include costs of screening tests and counseling. Sensitivity and threshold analyses are performed to determine the impact of changes in input parameter values including zidovudine treatment costs, efficacy of treatment, costs of pediatric HIV infection, prevalence of HIV infection in pregnant women, screening test sensitivity and specificity, and pregnancy termination rates on the results. Results.-Assuming transmission rates are reduced from 25.5% to 8.3% as found in the ACTG 076 trial, treatment costs of $104 502 for 100 HIV-positive pregnant women and their newborns are offset by the reduction of $1 701 333 associated with fewer cases of pediatric HIV infection for a net savings of $1 596 831. The sensitivity and threshold analyses show that overall cost savings from treatment of HIV-positive pregnant women and their newborns are achieved for a wide range of possible maternal treatment costs, efficacy rates, and lifetime pediatric HIV treatment costs. In the base-case analysis for the voluntary screening program, overall cost savings are seen when the HIV prevalence rate among pregnant women is greater than 4.6 per 1000. However, this threshold prevalence rate is sensitive to changes in parameter values-especially pediatric HIV treatment costs, counseling costs, efficacy of treatment, and years of additional HIV treatment for the pregnant women. Conclusions.-Offering zidovudine treatment to pregnant women known to be HIV-positive will decrease the number of cases of pediatric HIV infection and reduce health care costs. Voluntary screening programs for pregnant women will further decrease the number of cases of pediatric HIV infection. The effect of a screening program on health care costs varies according to HIV prevalence and the costs associated with the screening program.			Mauskopf, JA (corresponding author), GLAXO WELLCOME INC,5 MOORE DR,RES TRIANGLE PK,NC 27709, USA.			Mauskopf, Josephine/0000-0002-6098-5548				ANDRULIS DP, 1992, JAMA-J AM MED ASSOC, V267, P2482, DOI 10.1001/jama.267.18.2482; BARBACCI M, 1991, LANCET, V337, P709, DOI 10.1016/0140-6736(91)90286-X; BARBACCI MB, 1990, SEX TRANSM DIS, V17, P122, DOI 10.1097/00007435-199007000-00002; BARNHART H, 1995, 2 C RETR OPP INF WAS; BLOOM DE, 1991, SCIENCE, V252, P1798, DOI 10.1126/science.1829547; BRANDEAU ML, 1992, ARCH INTERN MED, V152, P2229, DOI 10.1001/archinte.152.11.2229; BROWN AE, 1995, NEW ENGL J MED, V332, P963, DOI 10.1056/NEJM199504063321419; BURKE DS, 1988, NEW ENGL J MED, V319, P961, DOI 10.1056/NEJM198810133191501; *CDCP, 1994, NAT HIV SER SUMM RES, V3; CHAVEY WE, 1994, J FAM PRACTICE, V38, P249; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; COZEN W, 1993, J ACQ IMMUN DEF SYND, V6, P95; Faden R R, 1993, Womens Health Issues, V3, P216, DOI 10.1016/S1049-3867(05)80067-2; FEHRS LJ, 1991, AM J PUBLIC HEALTH, V81, P619, DOI 10.2105/AJPH.81.5.619; FREDERICK T, 1994, PEDIATR INFECT DIS J, V13, P1091, DOI 10.1097/00006454-199412000-00004; GARRETT HM, 1994, RED BOOK, P48; GWINN M, 1992, J ACQ IMMUN DEF SYND, V5, P505; GWINN M, 1993, 9TH INT C AIDS BERL; HARDY LM, 1991, HIV SCREENING PREGNA; HAVENS PL, 1996, 3 C ANT OPP INF WASH; HEDLUND K, 1990, 6 INT C AIDS SAN FRA; HEGARTY JD, 1988, JAMA-J AM MED ASSOC, V260, P1901; HELLINGER FJ, 1993, JAMA-J AM MED ASSOC, V270, P474, DOI 10.1001/jama.270.4.474; HOLTGRAVE DR, 1993, ARCH INTERN MED, V153, P1225, DOI 10.1001/archinte.153.10.1225; HSIA DC, 1995, ARCH PEDIAT ADOL MED, V149, P489, DOI 10.1001/archpedi.1995.02170180019003; JOHNSTONE FD, 1990, BRIT MED J, V300, P23, DOI 10.1136/bmj.300.6716.23; LINDSAY MK, 1991, OBSTET GYNECOL, V77, P599; LINDSAY MK, 1989, OBSTET GYNECOL, V78, P678; LURIE P, 1994, JAMA-J AM MED ASSOC, V272, P1832, DOI 10.1001/jama.272.23.1832; MACDONALD KL, 1989, ANN INTERN MED, V110, P617, DOI 10.7326/0003-4819-110-8-617; MCCARTHY BD, 1993, ARCH INTERN MED, V153, P1107, DOI 10.1001/archinte.153.9.1107; PARROTT RH, 1991, J ACQ IMMUN DEF SYND, V4, P122; PHILLIPS KA, 1994, JAMA-J AM MED ASSOC, V271, P851, DOI 10.1001/jama.271.11.851; SELWYN PA, 1989, JAMA-J AM MED ASSOC, V261, P3567, DOI 10.1001/jama.261.24.3567; STEIN Z, 1993, AM J PUBLIC HEALTH, V83, P1379, DOI 10.2105/AJPH.83.10.1379; The European Collaborative Study, 1994, PEDIATRICS, V94, P815; TURNOCK BJ, 1989, JAMA-J AM MED ASSOC, V261, P3415, DOI 10.1001/jama.261.23.3415; *US BUR CENS, 1995, 1995 STAT ABSTR US, P494; VENTURA SJ, 1995, VITAL HLTH STAT S, V3; WEBER B, 1993, J VIROL METHODS, V44, P251, DOI 10.1016/0166-0934(93)90060-5; YOGEV R, 1992, MANAGEMENT HIV INFEC, P8; 1994, MMWR-MORBID MORTAL W, V43, P1	42	63	63	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1996	276	2					132	138		10.1001/jama.276.2.132	http://dx.doi.org/10.1001/jama.276.2.132			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UV485	8656505				2022-12-28	WOS:A1996UV48500028
J	Prandoni, P; Lensing, AWA; Cogo, A; Cuppini, S; Villalta, S; Carta, M; Cattelan, AM; Polistena, P; Bernardi, E; Prins, MH				Prandoni, P; Lensing, AWA; Cogo, A; Cuppini, S; Villalta, S; Carta, M; Cattelan, AM; Polistena, P; Bernardi, E; Prins, MH			The long-term clinical course of acute deep venous thrombosis	ANNALS OF INTERNAL MEDICINE			English	Article						thrombophlebitis; thromboembolism; blood coagulation disorders; recurrence; neoplasms	VEIN THROMBOSIS; PULMONARY-EMBOLISM; LOWER-EXTREMITY; STANDARD; SEQUELAE	Background: In patients who have symptomatic deep venous thrombosis, the long-term risk for recurrent venous thromboembolism and the incidence and severity of post-thrombotic sequelae have not been well documented. Objective: To determine the clinical course of patients during the 8 years after their first episode of symptomatic deep venous thrombosis. Design: Prospective cohort study. Setting: University outpatient thrombosis clinic. Patients: 355 consecutive patients with a first episode of symptomatic deep venous thrombosis. Measurements: Recurrent venous thromboembolism, the post-thrombotic syndrome, and death. Potential risk factors for these outcomes were also evaluated. Results: The cumulative incidence of recurrent venous thromboembolism was 17.5% after 2 years of follow-up (95% CI, 13.6% to 22.2%), 24.6% after 5 years (CI, 19.6% to 29.7%), and 30.3% after 8 years (CI, 23.6% to 37.0%). The presence of cancer and of impaired coagulation inhibition increased the risk for recurrent venous thromboembolism (hazard ratios, 1.72 [CI, 1.31 to 2.25] and 1.44 [CI, 1.02 to 2.01], respectively). In contrast, surgery and recent trauma or fracture were associated with a decreased risk for recurrent venous thromboembolism (hazard ratios, 0.36 [CI, 0.21 to 0.62] and 0.51 [CI, 0.32 to 0.87], respectively). The cumulative incidence of the post-thrombotic syndrome was 22.8% after 2 years (CI, 18.0% to 27.5%), 28.0% after 5 years (CI, 22.7% to 33.3%), and 29.1% after 8 years (CI, 23.4% to 34.7%). The development of ipsilateral recurrent deep venous thrombosis was strongly associated with the risk for the post-thrombotic syndrome (hazard ratio, 6.4; CI, 3.1 to 13.3). Survival after 8 years was 70.2% (CI, 64.7% to 75.6%). The presence of cancer increased the risk for death (hazard ratio, 8.1; CI, 3.6 to 18.1). Conclusion: Patients with symptomatic deep venous thrombosis, especially those without transient risk factors for deep venous thrombosis, have a high risk for recurrent venous thromboembolism that persists for many years. The post-thrombotic syndrome occurs in almost one third of these patients and is strongly related to ipsilateral recurrent deep venous thrombosis. These findings challenge the widely adopted use of short-course anticoagulation therapy in patients with symptomatic deep venous thrombosis.	UNIV AMSTERDAM, ACAD MED CTR, DEPT CLIN EPIDEMIOL & BIOSTAT, 1105 AZ AMSTERDAM, NETHERLANDS; UNIV HOSP PADUA, PADUA, ITALY	University of Amsterdam; Academic Medical Center Amsterdam; University of Padua; Azienda Ospedaliera - Universita di Padova	Prandoni, P (corresponding author), UNIV AMSTERDAM, ACAD MED CTR, CTR HEMOSTASIS THROMBOSIS ATHEROSCLEROSIS & I, F-4, MEIBERGDREEF 9, 1105 AZ AMSTERDAM, NETHERLANDS.		Carta, Mariarosa/ABF-9677-2021	Carta, Mariarosa/0000-0002-7143-4928; Cattelan, Anna Maria/0000-0003-2869-2945				ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; [Anonymous], 1994, HAEMOSTASIS S1; BEYTH RJ, 1995, ARCH INTERN MED, V155, P1031, DOI 10.1001/archinte.155.10.1031; BRANDJES DPM, 1991, THROMB HAEMOSTASIS, V65, pA1568; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; GJORES J E, 1956, Acta Chir Scand Suppl, V206, P1; HELDAL M, 1993, J INTERN MED, V234, P71, DOI 10.1111/j.1365-2796.1993.tb00707.x; HIRSH J, 1993, HEMOSTASIS THROMBOSI, P1322; HIRSH J, 1993, HEMOSTASIS THROMBOSI, P1543; IMMELMAN EJ, 1984, CLIN CHEST MED, V5, P537; Kalbfleisch J.D., 1980, STAT ANAL FAILURE TI, P1; KIERKEGAARD A, 1980, ACTA CHIR SCAND, V146, P267; LENSING AWA, 1992, THROMB HAEMOSTASIS, V67, P8; LENSING AWA, 1995, ARCH INTERN MED, V155, P601, DOI 10.1001/archinte.155.6.601; LENSING AWA, 1989, NEW ENGL J MED, V320, P342, DOI 10.1056/NEJM198902093200602; LENSING AWA, 1993, HEMOSTASIS THROMBOSI, P1297; LINDNER DJ, 1986, J VASC SURG, V4, P436, DOI 10.1067/mva.1986.avs0040436; MONREAL M, 1993, J INTERN MED, V233, P233, DOI 10.1111/j.1365-2796.1993.tb00981.x; ODONNELL TF, 1977, J SURG RES, V22, P483, DOI 10.1016/0022-4804(77)90030-0; PRANDONI P, 1992, LANCET, V339, P441, DOI 10.1016/0140-6736(92)91054-C; PRANDONI P, 1992, NEW ENGL J MED, V327, P1128, DOI 10.1056/NEJM199210153271604; PRANDONI P, 1993, CIRCULATION, V88, P1730, DOI 10.1161/01.CIR.88.4.1730; Salzman E. X., 1993, HEMOSTASIS THROMBOSI, P1275; Salzmann E, 1993, HEMOSTASIS THROMBOSI, P1346; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; STRANDNESS DE, 1983, JAMA-J AM MED ASSOC, V250, P1289, DOI 10.1001/jama.250.10.1289; WIDMER LK, 1985, VASA-J VASCULAR DIS, V14, P264	27	1603	1658	0	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1996	125	1					1	+		10.7326/0003-4819-125-1-199607010-00001	http://dx.doi.org/10.7326/0003-4819-125-1-199607010-00001			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT399	8644983				2022-12-28	WOS:A1996UT39900001
J	Dover, JS; Arndt, KA				Dover, JS; Arndt, KA			Dermatology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SILICONE GEL; DAMAGE; SCARS		HARVARD UNIV, SCH MED, BOSTON, MA USA; BETH ISRAEL HOSP, BOSTON, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Dover, JS (corresponding author), NEW ENGLAND DEACONESS HOSP, BOSTON, MA 02215 USA.							AHN ST, 1991, ARCH SURG-CHICAGO, V126, P499; ALSTER TS, 1995, LANCET, V345, P1198, DOI 10.1016/S0140-6736(95)91989-9; ALSTER TS, IN PRESS PLAST RECON; ALT TH, 1989, J DERMATOL SURG ONC, V15, P980, DOI 10.1111/j.1524-4725.1989.tb03185.x; DAVEY RB, 1991, BURNS, V17, P313, DOI 10.1016/0305-4179(91)90047-K; DAVID LM, 1989, CUTIS, V43, P583; DOVER JS, IN PRESS PLAST RECON; FITZPATRICK RE, IN PRESS ARCH DERMAT; FULTON JE, 1995, DERMATOL SURG, V21, P947, DOI 10.1111/j.1524-4725.1995.tb00531.x; Gibbons Margot, 1994, Journal of Burn Care and Rehabilitation, V15, P69, DOI 10.1097/00004630-199401000-00013; Hruza GJ, 1996, ARCH DERMATOL, V132, P451, DOI 10.1001/archderm.132.4.451; LAYTON AM, 1994, BRIT J DERMATOL, V130, P498, DOI 10.1111/j.1365-2133.1994.tb03385.x; Lowe NJ, 1995, DERMATOL SURG, V21, P1025, DOI 10.1111/j.1524-4725.1995.tb00552.x; PERKINS K, 1983, BURNS, V9, P201, DOI 10.1016/0305-4179(83)90039-6; QUINN KJ, 1985, BURNS, V12, P102, DOI 10.1016/0305-4179(85)90035-X; SPROAT JE, 1992, PLAST RECONSTR SURG, V90, P988, DOI 10.1097/00006534-199212000-00008; WALDORF HA, 1995, DERMATOL SURG, V21, P940, DOI 10.1111/j.1524-4725.1995.tb00530.x; WALSH JT, 1988, LASER SURG MED, V8, P108, DOI 10.1002/lsm.1900080204; YARBOROUGH JM, 1987, J DERMATOL SURG ONC, V13, P610, DOI 10.1111/j.1524-4725.1987.tb00526.x	19	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1801	1802		10.1001/jama.275.23.1801	http://dx.doi.org/10.1001/jama.275.23.1801			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642717				2022-12-28	WOS:A1996UQ15200016
J	McCabe, ERB				McCabe, ERB			Medical genetics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											McCabe, ERB (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, LOS ANGELES, CA 90024 USA.							CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786; EPSTEIN CJ, 1995, P NATL ACAD SCI USA, V92, P8566, DOI 10.1073/pnas.92.19.8566; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; GOLDGAR DE, 1995, NAT GENET, V11, P113, DOI 10.1038/ng1095-113; GRODY WW, 1995, DIAGN MOL PATHOL, V4, P155, DOI 10.1097/00019606-199509000-00001; KAISER J, 1995, SCIENCE, V270, P728; Langston AA, 1996, NEW ENGL J MED, V334, P137, DOI 10.1056/NEJM199601183340301; MARSHALL E, 1995, SCIENCE, V269, P1050, DOI 10.1126/science.7652552; MARSHALL E, 1995, SCIENCE, V270, P1751, DOI 10.1126/science.270.5243.1751; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; PEARSON P, 1994, NUCLEIC ACIDS RES, V22, P3470, DOI 10.1093/nar/22.17.3470; PHILLIPS JA, 1995, AM J HUM GENET, V57, P1499; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; WARD CJ, 1994, CELL, V77, P881; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	19	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1819	1821		10.1001/jama.275.23.1819	http://dx.doi.org/10.1001/jama.275.23.1819			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642728				2022-12-28	WOS:A1996UQ15200027
J	Biggar, RJ; Miotti, PG; Taha, TE; Mtimavalye, L; Broadhead, R; Justesen, A; Yellin, F; Liomba, G; Miley, W; Waters, D; Chiphangwi, D; Goedert, JJ				Biggar, RJ; Miotti, PG; Taha, TE; Mtimavalye, L; Broadhead, R; Justesen, A; Yellin, F; Liomba, G; Miley, W; Waters, D; Chiphangwi, D; Goedert, JJ			Perinatal intervention trial in Africa: Effect of a birth canal cleansing intervention to prevent HIV transmission	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE CHAIN-REACTION; HIGH-RISK; INFECTION; CHLORHEXIDINE; CHILDREN; INUTERO; INFANTS; MOTHERS; KIGALI	Background Perinatal transmission of human immunodeficiency virus (HIV) type 1 contributes significantly to infant mortality. Exposure in the birth canal may account for some transmission. We examined the efficacy of a birth canal washing procedure in reducing perinatal transmission in Malawi. Methods The infection status of infants of 3327 control women (conventional delivery procedures) was compared with that of 3637 infants of intervention-delivered women. The infants' HIV status was determined by polymerase chain reaction on dried blood spots collected at 6 and 12 weeks of age. The intervention consisted of manual cleansing of the birth canal with a cotton pad soaked in 0 . 25% chlorhexidine, which was done on admission in labour and every 4 h until delivery. Findings No adverse reactions to the intervention procedure were seen. 2094 (30%) of the enrolled women were HIV-infected, and 59% of their infants were seen in follow-up. Among 982 vaginal vertex singleton deliveries to HIV-infected women, 269 (27%) infants were infected. The intervention had no significant impact on HIV transmission rates (27% in 505 intervention women compared With 28% in 477 control women), except when membranes were ruptured more than 4 h before delivery (transmission 25% in the intervention group vs 39% in the control group). Interpretation If birth canal exposure is an important risk factor, different or additional methods to reduce the risk of perinatal HIV transmission should be tested. Alternatively, perhaps birth canal exposure is not a major contributor to perinatal infection risk.	NCI,VIRAL EPIDEMIOL BRANCH,BETHESDA,MD 20892; JOHNS HOPKINS UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,MINIST HLTH,RES PROJECT,BLANTYRE,MALAWI; QUEEN ELIZABETH CENT HOSP,DEPT OBSTET & GYNAECOL,BLANTYRE,MALAWI; QUEEN ELIZABETH CENT HOSP,DEPT PEDIAT,BLANTYRE,MALAWI; COMP SCI CORP,ROCKVILLE,MD; QUEEN ELIZABETH CENT HOSP,DEPT PATHOL,BLANTYRE,MALAWI; FREDERICK CANC RES & DEV CTR,SAIC,FREDERICK,MD	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; University of Malawi; University of Malawi; University of Malawi; University of Malawi; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick				Taha, Taha/0000-0001-9814-4894	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP033005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI035173] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CP-33005] Funding Source: Medline; NIAID NIH HHS [N01-AI-35173-117] Funding Source: Medline	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLEN S, 1991, J INFECT DIS, V164, P67, DOI 10.1093/infdis/164.1.67; AMSTEY MS, 1974, OBSTET GYNECOL, V44, P394; BORKOWSKY W, 1992, PEDIATRICS, V90, P133; BOYAR PJ, 1994, JAMA-J AM MED ASSOC, V271, P1925; BRYSON YJ, 1992, NEW ENGL J MED, V327, P1246, DOI 10.1056/NEJM199210223271718; BURMAN LG, 1992, LANCET, V340, P65, DOI 10.1016/0140-6736(92)90393-H; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; COURGNAUD V, 1991, AIDS RES HUM RETROV, V7, P337, DOI 10.1089/aid.1991.7.337; DULIEGE AM, 1995, J PEDIATR-US, V126, P625, DOI 10.1016/S0022-3476(95)70365-9; DUNN DT, 1995, AIDS, V9, pF7, DOI 10.1097/00002030-199509000-00001; DUNN DT, 1992, LANCET, V340, P585, DOI 10.1016/0140-6736(92)92115-V; EDWARDS JR, 1989, J PEDIATR-US, V115, P200, DOI 10.1016/S0022-3476(89)80065-4; GOEDERT JJ, 1991, LANCET, V338, P1471, DOI 10.1016/0140-6736(91)92297-F; HARBISON MA, 1989, J ACQ IMMUN DEF SYND, V2, P16; HIRA SK, 1989, BRIT MED J, V299, P1250, DOI 10.1136/bmj.299.6710.1250; LEPAGE P, 1993, AM J EPIDEMIOL, V137, P589, DOI 10.1093/oxfordjournals.aje.a116716; MEHTA CR, 1985, J AM STAT ASSOC, V80, P969, DOI 10.2307/2288562; MINKOFF H, 1995, AM J OBSTET GYNECOL, V173, P585, DOI 10.1016/0002-9378(95)90286-4; MIOTTI PG, 1992, BAILLIERE CLIN OB GY, V6, P165, DOI 10.1016/S0950-3552(05)80124-5; PAPIERNIK M, 1992, PEDIATRICS, V89, P297; ROGERS MF, 1989, NEW ENGL J MED, V320, P1649, DOI 10.1056/NEJM198906223202503; SCARLATTI G, 1991, AIDS, V5, P1173, DOI 10.1097/00002030-199110000-00003; SIMONON A, 1994, J ACQ IMMUN DEF SYND, V7, P952; TAHA TE, 1994, E AFR MED J, V71, P712; TAHA TE, 1994, MALAWI MED J, V10, P6; YOURNO J, 1992, J CLIN MICROBIOL, V30, P2887, DOI 10.1128/JCM.30.11.2887-2892.1992; 1991, LANCET, V337, P253; 1995, J ACQ IMMUNO DEFIC S, V8, P161; 1995, J ACQ IMMUNO DEFIC S, V8, P506	29	172	175	0	6	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 15	1996	347	9016					1647	1650		10.1016/S0140-6736(96)91486-5	http://dx.doi.org/10.1016/S0140-6736(96)91486-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ701	8642957	hybrid			2022-12-28	WOS:A1996UQ70100009
J	Singh, D; Bentley, G; Trevino, SG				Singh, D; Bentley, G; Trevino, SG			Fortnightly review: Callosities, corns, and calluses	BRITISH MEDICAL JOURNAL			English	Article									BAYLOR COLL MED,HOUSTON,TX 77030	Baylor College of Medicine	Singh, D (corresponding author), ROYAL NATL ORTHOPAED HOSP,INST ORTHOPAED,STANMORE HA7 4LP,MIDDX,ENGLAND.							ARNOLD HL, 1990, ANDREWS DIS SKIN CLI, P44; BAKER H, 1991, FOOT ITS DISORDERS, P113; COUGHLIN MJ, 1993, SURG FOOT ANKLE, P341; GIANNESTRAS N J, 1954, Clin Orthop, V4, P225; KLENERMAN L, 1991, FOOT ITS DISORDERS, P93; Mann R A, 1973, Orthop Clin North Am, V4, P67; MANN RA, 1984, INTRACTABLE PLANTAR, P287; Mann RA, 1993, SURG FOOT ANKLE, P413; REGNAULD B, 1986, FOOT PATHOLOGY AETIO; RICHARDSON GE, 1992, CAMPBELLS OPERATIVE, P2729; YALE J, 1987, YALES PODIATRIC MED	11	46	47	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 1	1996	312	7043					1403	1406						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP434	8646101				2022-12-28	WOS:A1996UP43400029
J	Gough, DO; Kosovichev, AG; Toomre, J; Anderson, E; Antia, HM; Basu, S; Chaboyer, B; Chitre, SM; ChristensenDalsgaard, J; Dziembowski, WA; EffDarwich, A; Elliott, JR; Giles, PM; Goode, PR; Guzik, JA; Harvey, JW; Hill, F; Leibacher, JW; Monteiro, MJPFG; Richard, O; Sekii, T; Shibahashi, T; Takata, M; Thompson, MJ; Vauclair, S; Vorontsov, SV				Gough, DO; Kosovichev, AG; Toomre, J; Anderson, E; Antia, HM; Basu, S; Chaboyer, B; Chitre, SM; ChristensenDalsgaard, J; Dziembowski, WA; EffDarwich, A; Elliott, JR; Giles, PM; Goode, PR; Guzik, JA; Harvey, JW; Hill, F; Leibacher, JW; Monteiro, MJPFG; Richard, O; Sekii, T; Shibahashi, T; Takata, M; Thompson, MJ; Vauclair, S; Vorontsov, SV			The seismic structure of the sun	SCIENCE			English	Article							INVERTING HELIOSEISMIC DATA; SOLAR	Global Oscillation Network Group data reveal that the internal structure of the sun can be well represented by a calibrated standard model. However, immediately beneath the convection zone and at the edge of the energy-generating core, the sound-speed variation is somewhat smoother in the sun than it is in the model. This could be a consequence of chemical inhomogeneity that is too severe in the model, perhaps owing to inaccurate modeling of gravitational settling or to neglected macroscopic motion that may be present in the sun. Accurate knowledge of the sun's structure enables inferences to be made about the physics that controls the sun; for example, through the opacity, the equation of state, or wave motion. Those inferences can then be used elsewhere in astrophysics.	STANFORD UNIV, HEPL, STANFORD, CA USA; UNIV COLORADO, JOINT INST LAB ASTROPHYS, BOULDER, CO 80309 USA; NATL OPT ASTRON OBSERV, NATL SOLAR OBSERV, TUCSON, AZ 85726 USA; TATA INST FUNDAMENTAL RES, BOMBAY 400005, MAHARASHTRA, INDIA; AARHUS UNIV, THEORET ASTROPHYS CTR, AARHUS, DENMARK; CANADIAN INST THEORET ASTROPHYS, TORONTO, ON M5S 1A1, CANADA; COPERNICUS ASTRON CTR, WARSAW, POLAND; NEW JERSEY INST TECHNOL, NEWARK, NJ 07102 USA; LOS ALAMOS NATL LAB, LOS ALAMOS, NM USA; UNIV PORTO, OPORTO, PORTUGAL; OBSERV MIDI PYRENEES, F-31400 TOULOUSE, FRANCE; UNIV TOKYO, DEPT ASTRON, TOKYO 113, JAPAN; INST ASTROFIS CANARIAS, TENERIFE, TENERIFE, SPAIN; UNIV LONDON QUEEN MARY & WESTFIELD COLL, LONDON E1 4NS, ENGLAND	Stanford University; University of Colorado System; University of Colorado Boulder; National Optical Astronomy Observatory; Tata Institute of Fundamental Research (TIFR); Aarhus University; New Jersey Institute of Technology; United States Department of Energy (DOE); Los Alamos National Laboratory; Universidade do Porto; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Tokyo; Instituto de Astrofisica de Canarias; University of London; Queen Mary University London	Gough, DO (corresponding author), UNIV CAMBRIDGE, INST ASTRON, MADINGLEY RD, CAMBRIDGE CB3 0HA, ENGLAND.		Basu, Sarbani/B-8015-2014; Antia, H./AAV-4222-2021; Richard, Olivier A/B-9301-2012; Peña, Antonio M Eff-Darwich/M-7357-2018; Monteiro, Mario J. P. F. G./B-4715-2008	Basu, Sarbani/0000-0002-6163-3472; Richard, Olivier A/0000-0002-0342-5093; Monteiro, Mario J. P. F. G./0000-0003-0513-8116; Chaboyer, Brian/0000-0003-3096-4161; Antia, H. M./0000-0001-7549-9684; Leibacher, John/0000-0001-7605-3684				ANTIA HM, 1994, ASTROPHYS J, V426, P801, DOI 10.1086/174117; BAHCALL JN, 1993, PHYS REV D, V47, P1298, DOI 10.1103/PhysRevD.47.1298; BASU S, 1994, MON NOT R ASTRON SOC, V269, P1137, DOI 10.1093/mnras/269.4.1137; BASU S, 1994, MON NOT R ASTRON SOC, V267, P207; CHABOYER B, 1995, ASTROPHYS J, V441, P865, DOI 10.1086/175408; CHRISTENSENDALSGAARD J, 1985, NATURE, V315, P378, DOI 10.1038/315378a0; CHRISTENSENDALSGAARD J, 1995, MON NOT R ASTRON SOC, V276, P283; CHRISTENSENDALSGAARD J, 1991, ASTROPHYS J, V378, P413, DOI 10.1086/170441; ChristensenDalsgaard J, 1996, SCIENCE, V272, P1286, DOI 10.1126/science.272.5266.1286; CHRISTENSENDALSGAARD J, 1990, MON NOT R ASTRON SOC, V242, P353, DOI 10.1093/mnras/242.3.353; Dappen W., 1991, LECTURE NOTES PHYSIC, V388, P111, DOI DOI 10.1007/3-540-54420-8_; Duvall TL, 1996, NATURE, V379, P235, DOI 10.1038/379235a0; DZIEMBOWSKI WA, 1991, MON NOT R ASTRON SOC, V249, P602, DOI 10.1093/mnras/249.4.602; GOODE PR, 1990, ASTROPHYS J, V356, P310, DOI 10.1086/168841; GOUGH D, 1985, SOL PHYS, V100, P65, DOI 10.1007/BF00158422; Gough D.O., 1993, ASTROPHYSICAL FLUID, P399; Gough D.O., 1991, SOLAR INTERIOR ATMOS, P519; GOUGH DO, 1993, ASTR SOC P, V42, P177; GOUGH DO, 1988, ADV HELIO ASTEROSEIS, P175; GOUGH DO, 1988, SOLAR TERRESTRIAL RE, P90; GOUGH DO, 1990, P IAU C, V0121, P00327, DOI DOI 10.1017/S0252921100068032; GUZIK JA, 1995, ASTROPHYS J, V448, P905, DOI 10.1086/176019; KELLER JB, 1960, ANN PHYS-NEW YORK, V9, P24, DOI 10.1016/0003-4916(60)90061-0; KNOBLOCH E, 1992, ASTROPHYS J, V401, P196, DOI 10.1086/172052; Kosovichev A. G., 1991, Soviet Astronomy, V35, P507; Kosovichev A. G., 1986, Bulletin of the Crimean Astrophysical Observatory, V75, P36; KOSOVICHEV AG, 1995, ADV SPACE RES, V15, P95, DOI 10.1016/0273-1177(94)00026-W; Kosovichev AG, 1996, ASTROPHYS J, V461, pL55, DOI 10.1086/309989; KOSOVICHEV AG, 1992, MON NOT R ASTRON SOC, V259, P536, DOI 10.1093/mnras/259.3.536; KOSOVICHEV AG, 1994, LECT NOTE PHYS, V432, P47; KUHN JR, 1988, ASTROPHYS J, V331, pL131, DOI 10.1086/185251; LIBBRECHT KG, 1993, ASTROPHYS J, V402, pL77; MONTEIRO MJPFG, 1993, ASTR SOC P, V42, P253; MONTEIRO MJPFG, 1994, ASTRON ASTROPHYS, V283, P247; MORENOINSERTIS S, 1994, SUNSPOTS THEORY OBSE; MORROW CA, 1988, ESA, V2, P73; PATRON J, 1995, ASTROPHYS J, V455, P746, DOI 10.1086/176620; RICHARD O, IN PRESS ASTRON ASTR; ROXBURGH IW, 1994, MON NOT R ASTRON SOC, V268, P880, DOI 10.1093/mnras/268.4.880; SPIEGEL EA, 1992, ASTRON ASTROPHYS, V265, P106; SPIEGEL EA, 1980, NATURE, V287, P616, DOI 10.1038/287616a0; Thompson MJ, 1996, SCIENCE, V272, P1300, DOI 10.1126/science.272.5266.1300; ZAHN JP, 1992, ASTRON ASTROPHYS, V265, P115; ZWEIBEL EG, 1995, ESA SPECIAL PUBLICAT	44	199	199	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1296	1300		10.1126/science.272.5266.1296	http://dx.doi.org/10.1126/science.272.5266.1296			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8662458				2022-12-28	WOS:A1996UN47200034
J	Leuther, KK; Bushnell, DA; Kornberg, RD				Leuther, KK; Bushnell, DA; Kornberg, RD			Two-dimensional crystallography of TFIIB- and IIE-RNA polymerase II complexes: Implications for start site selection and initiation complex formation	CELL			English	Article							TRANSCRIPTION FACTOR-TFIIB; TATA-BINDING-PROTEIN; CRYSTAL-STRUCTURE; ELECTRON-MICROSCOPY; 3-DIMENSIONAL STRUCTURE; 2-DIMENSIONAL CRYSTALS; FUNCTIONAL DOMAINS; YEAST; DNA; RESOLUTION	Transcription factors IIB (TFIIB) and IIE (TFIIE) bound to RNA polymerase II have been revealed by electron crystallography in projection at 15.7 Angstrom resolution. The results lead to simple hypotheses for the roles of these factors in the initiation of transcription. TFIIB is suggested to define the distance from TATA box to transcription start site by bringing TATA DNA in contact with polymerase at that distance from the active center of the enzyme. TFIIE is suggested to participate in a key conformational switch occurring at the active center upon polymerase-DNA interaction.			Leuther, KK (corresponding author), STANFORD UNIV,SCH MED,DEPT BIOL STRUCT,STANFORD,CA 94305, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021144] Funding Source: NIH RePORTER; NIAID NIH HHS [AI21144] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; AMOS LA, 1983, PROG BIOPHYS MOL BIO, V39, P183, DOI 10.1016/0079-6107(83)90017-2; ASTURIAS FJ, 1995, J STRUCT BIOL, V114, P60, DOI 10.1006/jsbi.1995.1005; BAGBY S, 1995, CELL, V82, P857, DOI 10.1016/0092-8674(95)90483-2; BARBERIS A, 1993, P NATL ACAD SCI USA, V90, P5628, DOI 10.1073/pnas.90.12.5628; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; BERROTERAN RW, 1994, MOL CELL BIOL, V14, P226, DOI 10.1128/MCB.14.1.226; BRISSON A, 1994, BIOL CELL, V80, P221, DOI 10.1016/0248-4900(94)90045-0; BURATOWSKI S, 1991, P NATL ACAD SCI USA, V88, P7509, DOI 10.1073/pnas.88.17.7509; BURATOWSKI S, 1993, P NATL ACAD SCI USA, V90, P5633, DOI 10.1073/pnas.90.12.5633; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; BURTON ZF, 1988, MOL CELL BIOL, V8, P1602, DOI 10.1128/MCB.8.4.1602; CAVALLINI B, 1988, NATURE, V334, P77, DOI 10.1038/334077a0; CHASMAN DI, 1993, P NATL ACAD SCI USA, V90, P8174, DOI 10.1073/pnas.90.17.8174; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; CORDEN J, 1980, SCIENCE, V209, P1406, DOI 10.1126/science.6251548; DARST SA, 1989, NATURE, V340, P730, DOI 10.1038/340730a0; DARST SA, 1991, CELL, V66, P121, DOI 10.1016/0092-8674(91)90144-N; DARST SA, 1991, J MOL BIOL, V221, P347, DOI 10.1016/0022-2836(91)80223-H; DAVIES JF, 1994, CELL, V76, P1123, DOI 10.1016/0092-8674(94)90388-3; EDWARDS AM, 1990, P NATL ACAD SCI USA, V87, P2122, DOI 10.1073/pnas.87.6.2122; FEAVER WJ, 1994, J BIOL CHEM, V269, P27549; FURTERGRAVES EM, 1994, NUCLEIC ACIDS RES, V22, P4932, DOI 10.1093/nar/22.23.4932; HA I, 1993, GENE DEV, V7, P1021, DOI 10.1101/gad.7.6.1021; HAHN S, 1989, CELL, V58, P1173, DOI 10.1016/0092-8674(89)90515-1; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; HENRY NL, 1994, GENE DEV, V8, P2868, DOI 10.1101/gad.8.23.2868; HISATAKE K, 1993, NATURE, V363, P744, DOI 10.1038/363744a0; HOLSTEGE FCP, 1995, EMBO J, V14, P810, DOI 10.1002/j.1460-2075.1995.tb07059.x; HULL MW, 1995, GENE DEV, V9, P481, DOI 10.1101/gad.9.4.481; JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7; KELLEHER RJ, 1992, GENE DEV, V6, P296, DOI 10.1101/gad.6.2.296; KILLEEN MT, 1992, MOL CELL BIOL, V12, P30, DOI 10.1128/MCB.12.1.30; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; KOMBERG RD, 1991, CURR OPIN STRUC BIOL, V1, P642; KOROLEV S, 1995, P NATL ACAD SCI USA, V92, P9264, DOI 10.1073/pnas.92.20.9264; LEE S, 1995, NATURE, V376, P609, DOI 10.1038/376609a0; LI Y, 1994, SCIENCE, V263, P805, DOI 10.1126/science.8303296; MALDONADO E, 1995, CURR OPIN CELL BIOL, V7, P352, DOI 10.1016/0955-0674(95)80090-5; MALIK S, 1993, MOL CELL BIOL, V13, P6253, DOI 10.1128/MCB.13.10.6253; MAXON ME, 1994, GENE DEV, V8, P515, DOI 10.1101/gad.8.5.515; Meredith GD, 1996, J MOL BIOL, V258, P413, DOI 10.1006/jmbi.1996.0258; MILLIGAN RA, 1987, J CELL BIOL, V105, P29, DOI 10.1083/jcb.105.1.29; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; PINTO I, 1994, J BIOL CHEM, V269, P30569; POLYAKOV A, 1995, CELL, V83, P365, DOI 10.1016/0092-8674(95)90114-0; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; SAYRE MH, 1992, J BIOL CHEM, V267, P23383; SCHULTZ P, 1993, EMBO J, V12, P2601, DOI 10.1002/j.1460-2075.1993.tb05920.x; SCHULTZ P, 1990, J MOL BIOL, V216, P353, DOI 10.1016/S0022-2836(05)80326-2; SOPTA M, 1985, J BIOL CHEM, V260, P353; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; SOUSA R, 1994, J MOL BIOL, V244, P6, DOI 10.1006/jmbi.1994.1699; STRUHL K, 1987, CELL, V49, P295, DOI 10.1016/0092-8674(87)90277-7; SUN ZW, 1995, P NATL ACAD SCI USA, V92, P3127, DOI 10.1073/pnas.92.8.3127; SVEJSTRUP JQ, 1996, J BIOL CHEM, V2, P643; TAN SY, 1995, P NATL ACAD SCI USA, V92, P6042, DOI 10.1073/pnas.92.13.6042; TSCHOCHNER H, 1992, P NATL ACAD SCI USA, V89, P11292, DOI 10.1073/pnas.89.23.11292; XIAO H, 1994, MOL CELL BIOL, V14, P7507, DOI 10.1128/MCB.14.11.7507; YAMASHITA S, 1993, SCIENCE, V261, P463, DOI 10.1126/science.8332911; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479	69	87	86	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 31	1996	85	5					773	779		10.1016/S0092-8674(00)81242-8	http://dx.doi.org/10.1016/S0092-8674(00)81242-8			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UP344	8646784	Bronze			2022-12-28	WOS:A1996UP34400016
J	Rogan, MT; LeDoux, JE				Rogan, MT; LeDoux, JE			Emotion: Systems, cells, synaptic plasticity	CELL			English	Review							RECEPTIVE-FIELD PLASTICITY; MEDIAL GENICULATE-BODY; AUDITORY-CORTEX; AMYGDALA; FEAR; POTENTIATION; HIPPOCAMPUS; ACQUISITION; EXPRESSION				Rogan, MT (corresponding author), NYU, CTR NEURAL SCI, 6 WASHINGTON PL, ROOM 1066, NEW YORK, NY 10003 USA.							Amaral DG, 1992, AMYGDALA NEUROBIOLOG, P465; ARMONY JL, 1995, BEHAV NEUROSCI, V109, P246, DOI 10.1037/0735-7044.109.2.246; BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; BARNES CA, 1995, NEURON, V15, P751, DOI 10.1016/0896-6273(95)90166-3; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHAPMAN PF, 1990, SYNAPSE, V6, P271, DOI 10.1002/syn.890060306; CLUGNET MC, 1990, J NEUROSCI, V10, P2818; DAVIS M, 1992, P255; EDELINE JM, 1992, BEHAV NEUROSCI, V106, P81, DOI 10.1037/0735-7044.106.1.81; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Ekman Paul, 1994, NATURE EMOTION FUNDA; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; FARB CR, 1995, J COMP NEUROL, V362, P86, DOI 10.1002/cne.903620106; KAPP B S, 1992, P229; KIHLSTROM JF, 1987, SCIENCE, V237, P1445, DOI 10.1126/science.3629249; KIM JJ, 1991, BEHAV NEUROSCI, V105, P126, DOI 10.1037/0735-7044.105.1.126; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LABAR KS, 1995, J NEUROSCI, V15, P6846; LeDoux J.E., 1989, COGNITION EMOTION, V3, P267, DOI [10.1080/02699938908412709, DOI 10.1080/02699938908412709]; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; LeDoux JE., 1991, CONCEPTS NEUROSCIENC, V2, P169; LeDoux JE, 1994, SCI AM, V270, P32; LEDOUX JE, 1991, EXP BRAIN RES, V85, P677; LI XF, 1995, EXP BRAIN RES, V105, P87; MACLEAN PD, 1952, ELECTROEN CLIN NEURO, V4, P407, DOI 10.1016/0013-4694(52)90073-4; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MAREN S, 1995, J NEUROSCI, V15, P7548; Maren S, 1996, NEURON, V16, P237, DOI 10.1016/S0896-6273(00)80041-0; MCCABE PM, 1992, LEARNING AND MEMORY : THE BEHAVIORAL AND BIOLOGICAL SUBSTRATES, P321; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; O'Keefe J, 1993, Curr Opin Neurobiol, V3, P917, DOI 10.1016/0959-4388(93)90163-S; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PITKANEN A, 1995, J COMP NEUROL, V356, P288, DOI 10.1002/cne.903560211; Posner M. I., 1990, FDN COGNITIVE SCI; QUIRK GJ, 1995, J NEUROSCI, V15, P1029; ROGAN MT, 1995, NEURON, V15, P127, DOI 10.1016/0896-6273(95)90070-5; STAUBLI UV, 1995, BRAIN MEMORY MODULAT, P303; Weinberger Norman M., 1995, P1071	39	151	152	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 17	1996	85	4					469	475		10.1016/S0092-8674(00)81247-7	http://dx.doi.org/10.1016/S0092-8674(00)81247-7			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UM415	8653782	hybrid			2022-12-28	WOS:A1996UM41500004
J	Wilson, IA				Wilson, IA			Another twist to MHC-peptide recognition	SCIENCE			English	Editorial Material							VIRAL PEPTIDES				Wilson, IA (corresponding author), SCRIPPS RES INST, DEPT MOLEC BIOL, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.							BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; GUO HC, 1992, NATURE, V360, P364, DOI 10.1038/360364a0; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; SILVER ML, 1992, NATURE, V360, P367, DOI 10.1038/360367a0; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STANFIELD RL, 1995, CURR OPIN STRUC BIOL, V5, P103, DOI 10.1016/0959-440X(95)80015-S; STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3	20	13	13	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	1996	272	5264					973	974		10.1126/science.272.5264.973	http://dx.doi.org/10.1126/science.272.5264.973			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL619	8638141				2022-12-28	WOS:A1996UL61900032
J	Matsumoto, M; Mariathasan, S; Nahm, MH; Baranyay, F; Peschon, JJ; Chaplin, DD				Matsumoto, M; Mariathasan, S; Nahm, MH; Baranyay, F; Peschon, JJ; Chaplin, DD			Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers	SCIENCE			English	Article							TUMOR-NECROSIS-FACTOR; BETA; MONOCYTOGENES; ACTIVATION; RESOLUTION; RESPONSES; RESISTANT; INFECTION; SURFACE; COMPLEX	In mice deficient in either lymphotoxin-alpha (LT-alpha) or the type I tumor necrosis factor (TNF) receptor, but not the type II TNF receptor, germinal centers failed to develop in peripheral lymphoid organs. Germinal center formation was restored in LT-alpha-deficient mice by transplantation of normal bone marrow, indicating that the LT-alpha-expressing cells required to establish this lymphoid structure are derived from bone marrow.	WASHINGTON UNIV,SCH MED,CTR IMMUNOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,HOWARD HUGHES MED INST,ST LOUIS,MO 63110; IMMUNEX RES & DEV CORP,SEATTLE,WA 98101	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)				Chaplin, David/0000-0002-1354-3069; Nahm, Moon/0000-0002-6922-1042				BANKS TA, 1995, J IMMUNOL, V155, P1685; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BEUTLER BE, 1992, TUMOR NECROSIS FACTO; BROWNING J, 1989, J IMMUNOL, V143, P1859; BROWNING JL, 1991, J IMMUNOL, V147, P1230; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; BROWNING JL, 1995, J IMMUNOL, V154, P33; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; ECK MJ, 1992, J BIOL CHEM, V267, P2119; ECK MJ, 1989, J BIOL CHEM, V264, P17595; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; HAKOSHIMA T, 1988, J MOL BIOL, V201, P455, DOI 10.1016/0022-2836(88)90153-2; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KRAAL G, 1986, IMMUNOLOGY, V58, P665; MARIATHASAN S, 1995, J INFLAMM, V45, P72; PAUL NL, 1988, ANNU REV IMMUNOL, V6, P407, DOI 10.1146/annurev.iy.06.040188.002203; PESCHON JJ, UNPUB; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; RAMESH N, 1994, IMMUNOL REV, V138, P87, DOI 10.1111/j.1600-065X.1994.tb00848.x; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; ROSE ML, 1980, NATURE, V284, P364, DOI 10.1038/284364a0; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; RUDDLE NH, 1992, CURR OPIN IMMUNOL, V4, P327, DOI 10.1016/0952-7915(92)90084-R; SHEEHAN KCF, 1995, J EXP MED, V181, P607, DOI 10.1084/jem.181.2.607; STEFFEN M, 1988, J IMMUNOL, V140, P2621; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; TARTAGLIA LA, 1993, J IMMUNOL, V151, P4637; THOMA B, 1990, J EXP MED, V172, P1019, DOI 10.1084/jem.172.4.1019; WORM M, 1994, INT IMMUNOL, V6, P1883, DOI 10.1093/intimm/6.12.1883; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	33	332	348	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 1	1996	271	5253					1289	1291		10.1126/science.271.5253.1289	http://dx.doi.org/10.1126/science.271.5253.1289			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TX695	8638112				2022-12-28	WOS:A1996TX69500039
J	Vortkamp, A; Lee, K; Lanske, B; Segre, GV; Kronenberg, HM; Tabin, CJ				Vortkamp, A; Lee, K; Lanske, B; Segre, GV; Kronenberg, HM; Tabin, CJ			Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein	SCIENCE			English	Article							HORMONE-RELATED PEPTIDE; TERMINAL CLEAVAGE PRODUCT; DROSOPHILA PATCHED GENE; MOTOR-NEURON INDUCTION; SONIC-HEDGEHOG; PARATHYROID-HORMONE; SCLEROTOME INDUCTION; POLARIZING ACTIVITY; VERTEBRATE HOMOLOG; RETROVIRAL VECTORS	Proper regulation of chondrocyte differentiation is necessary for the morphogenesis of skeletal elements, yet little is known about the molecular regulation of this process, A chicken homolog of Indian hedgehog (Ihh), a member of the conserved Hedgehog family of secreted proteins that is expressed during bone formation, has now been isolated. Ihh has biological properties similar to those of Sonic hedgehog (Shh), including the ability to regulate the conserved targets Patched (Ptc) and Gli. Ihh is expressed in the prehypertrophic chondrocytes of cartilage elements, where it regulates the rate of hypertrophic differentiation, Misexpression of Ihh prevents proliferating chondrocytes from initiating the hypertrophic differentiation process, The direct target of Ihh signaling is the perichondrium, where Gli and Ptc flank the expression domain of Ihh, Ihh induces the expression of a second signal, parathyroid hormone-related protein (PTHrP), in the periarticular perichondrium, Analysis of PTHrP (-/-) mutant mice indicated that the PTHrP protein signals to its receptor in the prehypertrophic chondrocytes, thereby blocking hypertrophic differentiation, In vitro application of Hedgehog or PTHrP protein to normal or PTHrP (-/-) limb explants demonstrated that PTHrP mediates the effects of Ihh through the formation of a negative feedback loop that modulates the rate of chondrocyte differentiation.	HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,ENDOCRINE UNIT,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02114	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School				Lanske, Beate/0000-0003-4638-804X	NIDDK NIH HHS [DK47038, DK4723] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047038] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abou-Samra A B, 1994, Adv Nephrol Necker Hosp, V23, P247; AMIZUKA N, 1994, J CELL BIOL, V126, P1611, DOI 10.1083/jcb.126.6.1611; Ausubel FM, 1988, MOL REPROD DEV; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Broadus Arthur E., 1994, P259; BUMCROT DA, 1995, MOL CELL BIOL, V15, P2294; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CURRIE P, IN PRESS NATURE; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; FEKETE DM, 1993, P NATL ACAD SCI USA, V90, P2350, DOI 10.1073/pnas.90.6.2350; FEKETE DM, 1993, MOL CELL BIOL, V13, P2604, DOI 10.1128/MCB.13.4.2604; FORBES AJ, 1993, DEVELOPMENT, P115; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HINCHLIFFE JR, 1980, DEV VERTEBRATE LIMB, P76; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; JOHNSON RL, 1994, CELL, V79, P1165, DOI 10.1016/0092-8674(94)90008-6; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; KINGSLEY DM, 1994, TRENDS GENET, V10, P16, DOI 10.1016/0168-9525(94)90014-0; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; LEE K, ENDOCRINOLOGY; Lee K. T., UNPUB; LEE KC, 1995, ENDOCRINOLOGY, V136, P453, DOI 10.1210/en.136.2.453; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; LINSENMAYER TF, 1991, DEVELOPMENT, V111, P191; LUVALLE P, 1988, J BIOL CHEM, V263, P18378; MARIGO V, 1995, GENOMICS, V28, P44, DOI 10.1006/geno.1995.1104; Marigo V, 1996, DEVELOPMENT, V122, P1225; MARIGO V, IN PRESS P NATL ACAD; MARIGO V, UNPUB; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; MOHLER J, 1992, DEVELOPMENT, V115, P957; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; NISHIMURA I, 1989, J BIOL CHEM, V264, P20033; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; ORENIC T, 1990, GENE DEV, V124, P50; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; RUPPERT JM, 1988, MOL CELL BIOL, V8, P3104, DOI 10.1128/MCB.8.8.3104; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; TESSAROLLO L, 1992, DEVELOPMENT, V115, P11; THIEDE MA, 1990, NUCLEIC ACIDS RES, V18, P3062, DOI 10.1093/nar/18.10.3062; VORTKAMP A, UNPUB	65	1557	1632	2	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 2	1996	273	5275					613	622		10.1126/science.273.5275.613	http://dx.doi.org/10.1126/science.273.5275.613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VA249	8662546				2022-12-28	WOS:A1996VA24900038
J	Cheng, H; Cao, YH; Olson, L				Cheng, H; Cao, YH; Olson, L			Spinal cord repair in adult paraplegic rats: Partial restoration of hind limb function	SCIENCE			English	Article							FIBROBLAST GROWTH-FACTOR; CORTICOSPINAL TRACT; INJURY; REGENERATION; GRAFTS; ELONGATION; EXPRESSION; AXONS; BRAIN	Complete spinal cord gaps in adult rats were bridged with multiple intercostal nerve grafts that redirected specific pathways from white to gray matter. The grafted area was stabilized with fibrin glue containing acidic fibroblast growth factor and by compressive wiring of posterior spinal processes. Hind limb function improved progressively during the first 6 months, as assessed by two scoring systems. The corticospinal tract regenerated through the grafted area to the lumbar enlargement, as did several bulbospinal pathways. These data suggest a possible repair strategy for spinal cord injury.	NATL YANG MING UNIV, TAIPEI, TAIWAN; VET GEN HOSP, NEUROL INST, DEPT NEUROSURG, TAIPEI, TAIWAN; KAROLINSKA INST, DEPT MOLEC & CELL BIOL, S-17177 STOCKHOLM, SWEDEN	National Yang Ming Chiao Tung University; Karolinska Institutet	Cheng, H (corresponding author), KAROLINSKA INST, DEPT NEUROSCI, S-17177 STOCKHOLM, SWEDEN.							ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; BEATTIE MS, 1989, C P CRITERIA ASSESSI, P16; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; BROWN LT, 1971, EXP BRAIN RES, V13, P432; Bunge R P, 1993, Curr Opin Neurobiol, V3, P805, DOI 10.1016/0959-4388(93)90157-T; CAO Y, 1993, THESIS KAROLINSKA I; CHENG H, 1995, EXP NEUROL, V136, P149, DOI 10.1006/exnr.1995.1092; CHENG H, 1994, J NEURAL TRANSP PLAS, V5, P233, DOI 10.1155/NP.1994.233; CHENG H, 1995, EXP BRAIN RES, V104, P199; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; ELDE R, 1991, NEURON, V7, P349, DOI 10.1016/0896-6273(91)90288-B; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; GIACOBINI MMJ, 1991, EXP BRAIN RES, V86, P73; Grillner S., 1973, CONTROL POSTURE LOCO, P515; Heimer L, 1989, NEUROANATOMICAL TRAC; IWASHITA Y, 1994, NATURE, V367, P167, DOI 10.1038/367167a0; KOSHINAGA M, 1993, EXP NEUROL, V120, P32, DOI 10.1006/exnr.1993.1038; KUANG RZ, 1994, DEVELOPMENT, V120, P1937; MCNEIL PL, 1989, J CELL BIOL, V109, P811, DOI 10.1083/jcb.109.2.811; NYGREN LG, 1974, BRAIN RES, V78, P377, DOI 10.1016/0006-8993(74)90922-6; OLSON L, 1982, BRAIN RES BULL, V9, P519, DOI 10.1016/0361-9230(82)90160-5; PUCHALA E, 1977, EXP NEUROL, V55, P1, DOI 10.1016/0014-4886(77)90155-8; SAVIO T, 1990, P NATL ACAD SCI USA, V87, P4130, DOI 10.1073/pnas.87.11.4130; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; SCHWAB ME, 1990, TRENDS NEUROSCI, V13, P452, DOI 10.1016/0166-2236(90)90098-U	27	636	734	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	1996	273	5274					510	513		10.1126/science.273.5274.510	http://dx.doi.org/10.1126/science.273.5274.510			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY983	8662542				2022-12-28	WOS:A1996UY98300044
J	Khan, AA; Soloski, MJ; Sharp, AH; Schilling, G; Sabatini, DM; Li, SH; Ross, CA; Snyder, SH				Khan, AA; Soloski, MJ; Sharp, AH; Schilling, G; Sabatini, DM; Li, SH; Ross, CA; Snyder, SH			Lymphocyte apoptosis: Mediation by increased type 3 inositol 1,4,5-trisphosphate receptor	SCIENCE			English	Article							T-CELL ACTIVATION; CEREBELLAR PURKINJE-CELLS; PLASMA-MEMBRANE; FLOW-CYTOMETRY; ENDOPLASMIC-RETICULUM; SIGNAL TRANSDUCTION; DNA FRAGMENTATION; ANTIGEN RECEPTOR; CYTOSOLIC CA-2+; SUICIDE PROCESS	B and T lymphocytes undergoing apoptosis in response to anti-immunoglobulin M antibodies and dexamethasone, respectively, were found to have increased amounts of messenger RNA for the inositol 1,4,5-trisphosphate receptor (IP(3)R) and increased amounts of IP(3)R protein. Immunohistochemical analysis revealed that the augmented receptor population was localized to the plasma membrane. Type 3 IP(3)R (IP(3)R3) was selectively increased during apoptosis, with no enhancement of type 1 IP(3)R (IP(3)R1). Expression of IP(3)R3 antisense constructs in S49 T cells blocked dexamethasone-induced apoptosis, whereas IP(3)R3 sense, IP(3)R1 sense, or IP(3)R1 antisense control constructs did not block cell death. Thus, the increases in IP(3)R3 may be causally related to apoptosis.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PHARMACOL & MOL SCI,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI037934, R01AI020922, R23AI020922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043040, R29MH043040] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-37934, AI-20922] Funding Source: Medline; NIMH NIH HHS [MH43040] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ASHERSON GL, 1970, J PHYSIOL-LONDON, V206, P32; BENHAMOU LE, 1990, EUR J IMMUNOL, V20, P1405, DOI 10.1002/eji.1830200630; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; BOYD AW, 1981, J IMMUNOL, V126, P2466; CARONLESLIE LAM, 1991, MOL ENDOCRINOL, V5, P1169, DOI 10.1210/mend-5-8-1169; Cohen J J, 1992, Semin Immunol, V4, P363; COHEN JJ, 1984, J IMMUNOL, V132, P38; CUNNINGHAM AM, 1993, NEUROSCIENCE, V57, P339, DOI 10.1016/0306-4522(93)90067-P; DANIELSEN M, 1983, MOL CELL BIOL, V3, P1310, DOI 10.1128/MCB.3.7.1310; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; DEFFERT DM, 1986, BIOCHEM J, V236, P37; DEFRANCO AL, 1982, B T CELL TUMORS BIOL, P445; DIVE C, 1992, BIOCHIM BIOPHYS ACTA, V1133, P275, DOI 10.1016/0167-4889(92)90048-G; FADOOL DA, 1992, NEURON, V9, P907, DOI 10.1016/0896-6273(92)90243-7; FENG L, 1992, CELL CALCIUM, V13, P79, DOI 10.1016/0143-4160(92)90001-9; FUJIMOTO T, 1992, J CELL BIOL, V119, P1507, DOI 10.1083/jcb.119.6.1507; GARDNER P, 1990, ANNU REV IMMUNOL, V8, P231, DOI 10.1146/annurev.iy.08.040190.001311; GOLDSMITH MA, 1988, SCIENCE, V240, P1029, DOI 10.1126/science.3259335; GOUGEON ML, 1993, SCIENCE, V260, P1269, DOI 10.1126/science.8098552; GUILLEMETTE G, 1988, J BIOL CHEM, V263, P4541; Harlow E., 1988, ANTIBODIES LAB MANUA; HARMON JM, 1979, J CELL PHYSIOL, V98, P267, DOI 10.1002/jcp.1040980203; HARRIS AW, 1970, EXP CELL RES, V60, P341, DOI 10.1016/0014-4827(70)90527-6; HASBOLD J, 1990, EUR J IMMUNOL, V20, P1685, DOI 10.1002/eji.1830200810; JOSEPH SK, 1984, J BIOL CHEM, V259, P3077; KAISER N, 1977, P NATL ACAD SCI USA, V74, P638, DOI 10.1073/pnas.74.2.638; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KHAN AA, 1992, SCIENCE, V257, P815, DOI 10.1126/science.1323146; KHAN AA, 1992, P NATL ACAD SCI USA, V89, P2849, DOI 10.1073/pnas.89.7.2849; KHAN AT, UNPUB; KIZAKI H, 1989, J IMMUNOL, V143, P1790; KUNO M, 1987, NATURE, V326, P301, DOI 10.1038/326301a0; KUNO M, 1994, BIOCHEM BIOPH RES CO, V199, P1128, DOI 10.1006/bbrc.1994.1348; LEWIS RS, 1989, CELL REGUL, V1, P99, DOI 10.1091/mbc.1.1.99; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; LIEVREMONT JP, 1994, BIOCHEM J, V300, P419, DOI 10.1042/bj3000419; MAYRLEITNER M, 1995, CELL CALCIUM, V17, P141, DOI 10.1016/0143-4160(95)90083-7; MCCONKEY DJ, 1989, J IMMUNOL, V143, P1801; MCCONKEY DJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P365, DOI 10.1016/0003-9861(89)90119-7; MCCONKEY DJ, 1990, IMMUNOL TODAY, V11, P120, DOI 10.1016/0167-5699(90)90048-E; MEYAARD L, 1992, SCIENCE, V257, P217, DOI 10.1126/science.1352911; NICOTERA P, 1992, ANNU REV PHARMACOL, V32, P449, DOI 10.1146/annurev.pa.32.040192.002313; OTSU H, 1990, CELL STRUCT FUNCT, V15, P163, DOI 10.1247/csf.15.163; PENNER R, 1988, NATURE, V334, P499, DOI 10.1038/334499a0; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; RABINOVITCH PS, 1986, J IMMUNOL, V137, P952; RALPH P, 1973, BIOCHEM BIOPH RES CO, V55, P1085, DOI 10.1016/S0006-291X(73)80006-3; RESTREPO D, 1990, SCIENCE, V249, P1166, DOI 10.1126/science.2168580; ROSS CA, 1989, NATURE, V339, P468, DOI 10.1038/339468a0; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; SCOTT DW, 1987, J IMMUNOL, V139, P3924; SCREPANTI I, 1989, J IMMUNOL, V142, P3378; SHARP AH, 1992, J BIOL CHEM, V267, P7444; STREB H, 1984, J MEMBRANE BIOL, V81, P241, DOI 10.1007/BF01868717; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; SUN XM, 1992, BIOCHEM PHARMACOL, V44, P2131; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; VANDERBILT JN, 1982, J BIOL CHEM, V257, P3009; VEDECKIS WV, 1983, MOL CELL ENDOCRINOL, V30, P215, DOI 10.1016/0303-7207(83)90049-7; WARNER NL, 1975, MEMBRANE RECEPTORS L, P203; WEISS A, 1986, ANNU REV IMMUNOL, V4, P593, DOI 10.1146/annurev.iy.04.040186.003113; WEISS A, 1984, P NATL ACAD SCI-BIOL, V81, P4169, DOI 10.1073/pnas.81.13.4169; WHITFIELD JF, 1966, EXP CELL RES, V43, P602, DOI 10.1016/0014-4827(66)90031-0; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	66	230	233	3	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 26	1996	273	5274					503	507		10.1126/science.273.5274.503	http://dx.doi.org/10.1126/science.273.5274.503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY983	8662540				2022-12-28	WOS:A1996UY98300042
J	Ryan, TM; Thomas, R				Ryan, TM; Thomas, R			Trends in the supply of medical personnel in the Russian Federation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									OPEN UNIV,FAC SOCIAL SCI,MILTON KEYNES MK6 3DY,BUCKS,ENGLAND; UNIV COLL SWANSEA,DEPT POLIT,SWANSEA,W GLAM,WALES	Open University - UK; Swansea University								BARSUKOVA N, 1996, MED GAZETA, V6, P10; *GOSK ROSS, 1990, OKHR ZDOR SSSR STAT, P111; *GOSK ROSS, 1994, ROSS STAT EZH 1994, P161; *GOSK ROSS, 1995, ROSS STAT EZH 1995, P175; *MED ENTS, 1989, VSES SEZD VRACH MOSK, P18; *ROSS AK MED NAUK, 1993, GOS DOKL SOST ZDOR N, P111; RYAN M, 1989, DOCTORS STATE SOVIET, P16; SURKOV T, 1995, MED GAZETA, V29, P10; *WHO, 1974, WHO PUBLIC HLTH PAPE, V56, P19; YEVLANOVA V, 1994, MED GAZETA, V42, P5; 1987, PRAVDA          1127, P1; 1986, MED GAZETA, V11, P2	12	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1996	276	4					339	342		10.1001/jama.276.4.339	http://dx.doi.org/10.1001/jama.276.4.339			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UX583	8656548				2022-12-28	WOS:A1996UX58300044
J	Laporte, JP; Gorin, NC; Rubinstein, P; Lesage, S; Portnoi, MF; Barbu, V; Lopez, M; Douay, L; Najman, A				Laporte, JP; Gorin, NC; Rubinstein, P; Lesage, S; Portnoi, MF; Barbu, V; Lopez, M; Douay, L; Najman, A			Cord-blood transplantation from an unrelated donor in an adult with chronic myelogenous leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROGENITOR CELLS; PATIENT; RECONSTITUTION; INVITRO; GROWTH		HOP ST ANTOINE,DEPT HEMATOL,F-75012 PARIS,FRANCE; HOP ST ANTOINE,LAB CYTOGENET,F-75012 PARIS,FRANCE; HOP ST ANTOINE,DEPT BIOCHEM B,F-75012 PARIS,FRANCE; UNIV PARIS 06,FORMAT ASSOCIEE CLAUDE BERNARD UNITE RECH GREFFE,F-75012 PARIS,FRANCE; NEW YORK BLOOD CTR,IMMUNOGENET LAB,NEW YORK,NY 10021	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; New York Blood Center								ALLIERI MA, 1992, EXP HEMATOL, V20, P312; BERTHOU C, 1995, BLOOD, V85, P1540, DOI 10.1182/blood.V85.6.1540.bloodjournal8561540; BOGDANIC V, 1993, TRANSPLANTATION, V56, P477; BROXMEYER HE, 1992, P NATL ACAD SCI USA, V89, P4109, DOI 10.1073/pnas.89.9.4109; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; CARDOSO AA, 1993, P NATL ACAD SCI USA, V90, P8707, DOI 10.1073/pnas.90.18.8707; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; EAVES CJ, 1985, HEMATOLOGY, V2, P19; GADDY J, 1995, J INTERF CYTOK RES, V15, P527, DOI 10.1089/jir.1995.15.527; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; GLUCKMAN E, 1994, BLOOD CELLS, V20, P601; GORDON MY, 1995, BRIT J HAEMATOL, V90, P744, DOI 10.1111/j.1365-2141.1995.tb05191.x; HARRIS DT, 1992, P NATL ACAD SCI US, V89; HOWS JM, 1992, LANCET, V340, P73, DOI 10.1016/0140-6736(92)90396-K; ISSARAGRISIL S, 1995, NEW ENGL J MED, V332, P367, DOI 10.1056/NEJM199502093320605; KAWASAKI ES, 1988, P NATL ACAD SCI USA, V85, P5698, DOI 10.1073/pnas.85.15.5698; Kurtzberg J., 1995, Blood, V86, p290A; RISDON G, 1995, P NATL ACAD SCI USA, V92, P2413, DOI 10.1073/pnas.92.6.2413; RISDON G, 1994, CELL IMMUNOL, V154, P14, DOI 10.1006/cimm.1994.1053; RUBINSTEIN P, 1993, BLOOD, V81, P1679; SONNENBERG FA, 1989, BLOOD, V74, P2569; SUTHERLAND HJ, 1989, BLOOD, V74, P1563; THOMAS ED, 1986, ANN INTERN MED, V104, P155, DOI 10.7326/0003-4819-104-2-155; TKACHUK DC, 1990, SCIENCE, V250, P559, DOI 10.1126/science.2237408; VILMER E, 1992, TRANSPLANTATION, V53, P1155; WAGNER JE, 1992, BLOOD, V79, P1874; WAGNER JE, 1995, LANCET, V346, P214, DOI 10.1016/S0140-6736(95)91268-1	27	86	91	0	4	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	1996	335	3					167	170		10.1056/NEJM199607183350304	http://dx.doi.org/10.1056/NEJM199607183350304			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW790	8657214				2022-12-28	WOS:A1996UW79000004
J	Nudler, E; Avetissova, E; Markovtsov, V; Goldfarb, A				Nudler, E; Avetissova, E; Markovtsov, V; Goldfarb, A			Transcription processivity: Protein-DNA interactions holding together the elongation complex	SCIENCE			English	Article							COLI RNA-POLYMERASE; ESCHERICHIA-COLI; TERNARY COMPLEXES; CHAIN ELONGATION; GENE-EXPRESSION; TERMINATION; KINETICS; PROMOTER; SUBUNITS	The elongation of RNA chains during transcription occurs in a ternary complex containing RNA polymerase (RNAP), DNA template, and nascent RNA. It is shown here that elongating RNAP from Escherichia coli can switch DNA templates by means of end-to-end transposition without loss of the transcript. After the switch, transcription continues on the new template. With the use of defined short DNA fragments as switching templates, RNAP-DNA interactions were dissected into two spatially distinct components, each contributing to the stability of the elongating complex. The front (F) interaction occurs ahead of the growing end of RNA. This interaction is non-ionic and requires 7 to 9 base pairs of intact DNA duplex. The rear (R) interaction is ionic and requires approximately six nucleotides of the template DNA strand behind the active site and one nucleotide ahead of it. The nontemplate strand is not involved. With the use of protein DNA crosslinking, the F interaction was mapped to the conserved zinc finger motif in the NH2-terminus of the beta' subunit and the R interaction, to the COOH-terminal catalytic domain of the beta subunit. Mutational disruption of the zinc finger selectively destroyed the F interaction and produced a salt-sensitive ternary complex with diminished processivity. A model of the ternary complex is proposed here that suggests that trilateral contacts in the active center maintain the nonprocessive complex, whereas a front-end domain including the zinc finger ensures processivity.			Nudler, E (corresponding author), PUBL HLTH RES INST,NEW YORK,NY 10016, USA.			Nudler, Evgeny/0000-0002-8811-3071	NIGMS NIH HHS [GM49242] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049242] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNDT KM, 1990, J MOL BIOL, V213, P79, DOI 10.1016/S0022-2836(05)80123-8; ASO T, 1995, FASEB J, V9, P1419, DOI 10.1096/fasebj.9.14.7589983; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; BERGSLAND KJ, 1991, J BACTERIOL, V173, P3446, DOI 10.1128/jb.173.11.3446-3455.1991; BORUKHOV S, 1993, J BIOL CHEM, V268, P23477; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; CHAMBERLIN MJ, 1995, HARVEY LECT, V88, P1; CLERGET M, 1995, J MOL BIOL, V248, P768, DOI 10.1006/jmbi.1995.0259; DAS A, 1993, ANNU REV BIOCHEM, V62, P893; FRIEDMAN DI, 1987, ANNU REV GENET, V21, P453; GIEDROC DP, 1986, BIOCHEMISTRY-US, V25, P4969, DOI 10.1021/bi00365a037; GRACHEV MA, 1989, EUR J BIOCHEM, V180, P577, DOI 10.1111/j.1432-1033.1989.tb14684.x; GREENBLATT J, 1993, NATURE, V364, P401, DOI 10.1038/364401a0; KASHLEV M, 1993, GENE, V130, P9, DOI 10.1016/0378-1119(93)90340-9; KERPPOLA TK, 1991, FASEB J, V5, P2833, DOI 10.1096/fasebj.5.13.1916107; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; KRUMMEL B, 1992, J MOL BIOL, V225, P239, DOI 10.1016/0022-2836(92)90918-A; LIU B, 1993, NATURE, V366, P33, DOI 10.1038/366033a0; MARKOVTSOV V, 1996, P NATL ACAD SCI USA, V93, P3231; MUSTAEV A, 1993, J BIOL CHEM, V268, P19185; NUDLER E, 1994, SCIENCE, V265, P793, DOI 10.1126/science.8047884; NUDLER E, 1995, CELL, V81, P353; NUDLER E, UNPUB; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.bi.55.070186.002011; POLYAKOV A, 1995, CELL, V83, P365, DOI 10.1016/0092-8674(95)90114-0; PUHLER G, 1989, P NATL ACAD SCI USA, V86, P4569, DOI 10.1073/pnas.86.12.4569; RHODES G, 1974, J BIOL CHEM, V249, P6675; RICE GA, 1991, P NATL ACAD SCI USA, V88, P4245, DOI 10.1073/pnas.88.10.4245; ROBERTS J, 1992, TRANSCRIPTIONAL REGU, P389; ROE JH, 1984, J MOL BIOL, V176, P495, DOI 10.1016/0022-2836(84)90174-8; SEVERINOV K, 1995, P NATL ACAD SCI USA, V92, P4591, DOI 10.1073/pnas.92.10.4591; SEVERINOV K, 1994, J BIOL CHEM, V269, P31701; SWEETSER D, 1987, P NATL ACAD SCI USA, V84, P1192, DOI 10.1073/pnas.84.5.1192; TELESNITSKY APW, 1992, J MOL BIOL, V225, P239; TREICH I, 1991, J BIOL CHEM, V266, P21971; VONHIPPEL PH, 1992, SCIENCE, V255, P809, DOI 10.1126/science.1536005; WANG DG, 1995, CELL, V81, P341, DOI 10.1016/0092-8674(95)90387-9; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032; YAGER TD, 1987, ESCHERICHIA COLI SAL, P1241	40	175	177	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 12	1996	273	5272					211	217		10.1126/science.273.5272.211	http://dx.doi.org/10.1126/science.273.5272.211			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW787	8662499				2022-12-28	WOS:A1996UW78700033
J	Moore, MW; Klein, RD; Farinas, I; Sauer, H; Armanini, M; Phillips, H; Reichardt, LF; Ryan, AM; CarverMoore, K; Rosenthal, A				Moore, MW; Klein, RD; Farinas, I; Sauer, H; Armanini, M; Phillips, H; Reichardt, LF; Ryan, AM; CarverMoore, K; Rosenthal, A			Renal and neuronal abnormalities in mice lacking GDNF	NATURE			English	Article							DOPAMINERGIC-NEURONS	GLIAL cell-line derived neurotrophic factor (GDNF) is a potent survival factor for embryonic midbrain dopaminergic(1), spinal motor(2), cranial sensory(3), sympathetic, and hindbrain noradrenergic(4) neurons, and is available to these cells in vivo. It is therefore considered a physiological trophic factor and a potential therapeutic agent for Parkinson's disease(5,6), amyotrophic lateral sclerosis(7), and Alzheimer's disease(4). Here we show that at postnatal day 0 (P0), GDNF-deficient mice have deficits in dorsal root ganglion, sympathetic and nodose neurons, but not in hindbrain noradrenergic or midbrain dopaminergic neurons. These mice completely lack the enteric nervous system (ENS), ureters and kidneys. Thus GDNF is important for the development and/or survival of enteric, sympathetic and sensory neurons and the renal system, but is not essential for catecholaminergic neurons in the central nervous system (CNS).	GENENTECH INC, DEPT NEUROSCI, S SAN FRANCISCO, CA 94080 USA; GENENTECH INC, DEPT MOLEC BIOL, S SAN FRANCISCO, CA 94080 USA; GENENTECH INC, DEPT PATHOBIOL, S SAN FRANCISCO, CA 94080 USA; UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, SAN FRANCISCO, CA 94143 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco			Farinas, Isabel/L-7118-2014	Farinas, Isabel/0000-0003-2903-4960				Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; COYLE JT, 1976, J NEUROCHEM, V27, P673, DOI 10.1111/j.1471-4159.1976.tb10393.x; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Durbec PL, 1996, DEVELOPMENT, V122, P349; GERSHON MD, 1993, J NEUROBIOL, V24, P199, DOI 10.1002/neu.480240207; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Hellmich HL, 1996, MECH DEVELOP, V54, P95, DOI 10.1016/0925-4773(95)00464-5; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HIRANO A, 1991, ADV NEUROL, V56, P91; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; HORNYKIEWICZ O, 1988, MT SINAI J MED, V55, P11; HUMPEL C, 1994, NEUROSCIENCE, V59, P791, DOI 10.1016/0306-4522(94)90284-4; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LICHING L, 1995, NEURON, V15, P527; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; SAUER H, 1995, P NATL ACAD SCI USA, V92, P8935, DOI 10.1073/pnas.92.19.8935; Saxen L., 1987, ORGANOGENESIS KIDNEY, V19; SCHAAR DG, 1993, EXP NEUROL, V124, P368, DOI 10.1006/exnr.1993.1207; SCHMIDTKASTNER R, 1994, MOL BRAIN RES, V26, P325, DOI 10.1016/0169-328X(94)90106-6; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; STROMBERG I, 1993, EXP NEUROL, V124, P401, DOI 10.1006/exnr.1993.1214; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0	30	1036	1079	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	1996	382	6586					76	79		10.1038/382076a0	http://dx.doi.org/10.1038/382076a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV473	8657308				2022-12-28	WOS:A1996UV47300057
J	Orwar, O; Jardemark, K; Jacobson, I; Moscho, A; Fishman, HA; Scheller, RH; Zare, RN				Orwar, O; Jardemark, K; Jacobson, I; Moscho, A; Fishman, HA; Scheller, RH; Zare, RN			Patch-clamp detection of neurotransmitters in capillary electrophoresis	SCIENCE			English	Article							EXCITATORY AMINO-ACIDS; METHYL-D-ASPARTATE; CEREBELLAR GRANULE CELLS; FRESHLY ISOLATED NEURONS; RAT OLFACTORY-BULB; SYNAPTIC TRANSMISSION; GROWTH CONES; CURRENTS; GLUTAMATE; CHANNELS	Gamma-aminobutyrate acid, L-glutamate, and N-methyl-D-aspartate were separated by capillary electrophoresis and detected by the use of whole-cell and outside-out patch-clamp techniques on freshly dissociated rat olfactory interneurons. These neuroactive compounds could be identified from their electrophoretic migration times, unitary channel conductances, and power spectra that yielded corner frequencies and mean single-channel conductances characteristic for each of the different agonist-receptor interactions. This technique has the sensitivity to observe the opening of a single ion channel for agonists separated by capillary electrophoresis.	STANFORD UNIV,DEPT CHEM,STANFORD,CA 94305; GOTHENBURG UNIV,DEPT ANAT & CELL BIOL,S-41390 GOTHENBURG,SWEDEN; STANFORD UNIV,HOWARD HUGHES INST,DEPT MOL & CELLULAR PHYSIOL,STANFORD,CA 94305	Stanford University; University of Gothenburg; Howard Hughes Medical Institute; Stanford University			Zare, Richard N./A-8410-2009	Zare, Richard/0000-0001-5266-4253	NIDA NIH HHS [DA 09873-01] Funding Source: Medline; NIMH NIH HHS [R01 MH112188, MH 45423-06] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045423, R01MH112188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009873] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ANDERSON CR, 1973, J PHYSIOL-LONDON, V235, P655, DOI 10.1113/jphysiol.1973.sp010410; ANDINE P, 1991, J NEUROCHEM, V57, P230, DOI 10.1111/j.1471-4159.1991.tb02120.x; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P207; BUCH RM, 1989, ANAL CHEM, V61, pA533, DOI 10.1021/ac00183a001; BUFLER J, 1992, J COMP PHYSIOL A, V170, P153; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COLQUHOUN D, 1977, PROC R SOC SER B-BIO, V199, P231, DOI 10.1098/rspb.1977.0137; COPENHAGEN DR, 1989, NATURE, V341, P536, DOI 10.1038/341536a0; CULLCANDY S, 1995, CURR BIOL, V5, P841, DOI 10.1016/S0960-9822(95)00168-0; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; DO KQ, 1986, J NEUROCHEM, V46, P779, DOI 10.1111/j.1471-4159.1986.tb13040.x; FISHMAN HA, 1995, P NATL ACAD SCI USA, V92, P7877, DOI 10.1073/pnas.92.17.7877; HAGBERG H, 1985, J CEREBR BLOOD F MET, V5, P413, DOI 10.1038/jcbfm.1985.56; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOWE JR, 1991, J PHYSIOL-LONDON, V432, P143, DOI 10.1113/jphysiol.1991.sp018381; HU YB, 1994, BRAIN RES, V659, P117, DOI 10.1016/0006-8993(94)90870-2; HUME RI, 1983, NATURE, V305, P632, DOI 10.1038/305632a0; JACOBSON I, 1991, NEUROSCI RES COMMUN, V8, P11; JACOBSON I, 1992, NEUROSCI RES COMMUN, V10, P177; Jahr C E, 1992, Curr Opin Neurobiol, V2, P270, DOI 10.1016/0959-4388(92)90114-Z; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; KATZ B, 1972, J PHYSIOL-LONDON, V224, P665, DOI 10.1113/jphysiol.1972.sp009918; KILIC G, 1993, EUR J NEUROSCI, V5, P65, DOI 10.1111/j.1460-9568.1993.tb00206.x; KIMURA M, 1995, NEUROSCIENCE, V66, P609, DOI 10.1016/0306-4522(95)00023-C; LEAL WS, 1995, P NATL ACAD SCI USA, V92, P1033, DOI 10.1073/pnas.92.4.1033; LESTER RAJ, 1992, J NEUROSCI, V12, P635; LI XY, 1993, NEUROSCI LETT, V155, P42, DOI 10.1016/0304-3940(93)90669-C; MA GH, 1995, MOL PHARMACOL, V47, P1035; MAEDA T, 1995, NEURON, V15, P253, DOI 10.1016/0896-6273(95)90031-4; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199; MELDRUM B, 1995, DIVERSITY INTERACTIN, V757, P492; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; OLNEY JW, 1975, J NEUROPATH EXP NEUR, V34, P167, DOI 10.1097/00005072-197503000-00005; ORWAR O, 1994, J NEUROCHEM, V63, P1371; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; RECHNITZ GA, 1978, SCIENCE, V199, P440, DOI 10.1126/science.619467; Sakmann B., 1995, SINGLE CHANNEL RECOR; SANDBERG M, 1986, J NEUROCHEM, V47, P178; SCHONROCK B, 1993, EUR J NEUROSCI, V5, P1042, DOI 10.1111/j.1460-9568.1993.tb00957.x; SHEAR JB, 1995, SCIENCE, V267, P74, DOI 10.1126/science.7809609; SPENCER PS, 1987, SCIENCE, V237, P517, DOI 10.1126/science.3603037; Trombley P Q, 1993, Curr Opin Neurobiol, V3, P540, DOI 10.1016/0959-4388(93)90053-2; TROMBLEY PQ, 1994, J NEUROPHYSIOL, V71, P761, DOI 10.1152/jn.1994.71.2.761; TROMBLEY PQ, 1990, J NEUROPHYSIOL, V64, P598, DOI 10.1152/jn.1990.64.2.598; WALLINGFORD RA, 1987, ANAL CHEM, V59, P1762, DOI 10.1021/ac00141a005; WEISS JH, 1988, SCIENCE, V241, P973, DOI 10.1126/science.3136549; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; ZOLLINGER M, 1994, J NEUROCHEM, V63, P1133	51	39	42	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1779	1782		10.1126/science.272.5269.1779	http://dx.doi.org/10.1126/science.272.5269.1779			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8650575				2022-12-28	WOS:A1996UT11000040
J	Saidman, LJ				Saidman, LJ			Anesthesiology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Saidman, LJ (corresponding author), UNIV CALIF SAN DIEGO,LA JOLLA,CA 92093, USA.							ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; ENDOH H, 1994, STROKE, V25, P403, DOI 10.1161/01.STR.25.2.403; Gross JB, 1996, ANESTHESIOLOGY, V84, P459; GYULAI F, 1995, ANESTHESIOLOGY, V83, P163; LEE CM, 1995, ANESTHESIOLOGY, V83, P237, DOI 10.1097/00000542-199508000-00001; LIU S, 1995, ANESTHESIOLOGY, V82, P1474, DOI 10.1097/00000542-199506000-00019; MATTA BF, 1995, ANESTHESIOLOGY, V83, P980, DOI 10.1097/00000542-199511000-00011; NEGRE I, 1994, ANESTH ANALG, V79, P298; REINSTRUP P, 1995, ANESTHESIOLOGY, V82, P359, DOI 10.1097/00000542-199502000-00006; RICHMOND CE, 1993, LANCET, V342, P73, DOI 10.1016/0140-6736(93)91284-S; ROSENBERG P, 1995, ANN MED, V27, P209; SHIS Y, 1994, ANESTHESIOLOGY, V80, P49; THEIL A, 1995, ANESTHESIOLOGY, V82, P655; WERNER C, 1995, ANESTHESIOLOGY, V83, P721, DOI 10.1097/00000542-199510000-00011; WOOLF CJ, 1993, ANESTH ANALG, V77, P362, DOI 10.1213/00000539-199377020-00026	15	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1795	1797		10.1001/jama.275.23.1795	http://dx.doi.org/10.1001/jama.275.23.1795			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642714				2022-12-28	WOS:A1996UQ15200013
J	Sabbert, D; Engelbrecht, S; Junge, W				Sabbert, D; Engelbrecht, S; Junge, W			Intersubunit rotation in active F-ATPase	NATURE			English	Article							GAMMA-SUBUNIT; SYNTHASE; MECHANISM; DELTA	THE enzyme ATP synthase, or F-ATPase, is present in the membranes of bacteria, chloroplasts and mitochondria, Its structure is bipartite, with a proton-conducting, integral membrane portion, F-0, and a peripheral portion, F-1. Solubilized F-1 is composed of five different subunits, (alpha beta)(3) gamma delta epsilon, and is active as an ATPase(1,2). The function of F-ATPase is to couple proton translocation through F-0 with ATP synthesis in F-1 (ref. 3), Several fines of evidence support the spontaneous formation of ATP on F-1 (refs 4, 5) and its endergonic release(6) at cooperative and rotating (or at feast alternating) sites(7). The release of ATP at the expense of protonmotive force might involve mechanical energy transduction from F-0 into F-1 by rotation of the smaller subunits (mainly gamma) within (alpha beta)(3), the catalytic hexagon of F-1 as suggested by electron microscopy(8), by X-ray crystal structure analysis(9) and by the use of cleavable crosslinkers(10). Here we record an intersubunit rotation in real time in the functional enzyme by applying polarized absorption relaxation after photobleaching to immobilized F-1 with eosin-labelled gamma, We observe the rotation of gamma relative to immobilized (alpha beta)(3) in a timespan of 100 ms, compatible with the rate of ATP hydrolysis by immobilized F-1. Its angular range, which is of at least 200 degrees, favours a triple-site mechanism of catalysis(7,11), with gamma acting as a crankshaft in (alpha beta)(3). The rotation of gamma is blocked when ATP is substituted with its non-hydrolysable analogue AMP-PNP.	UNIV OSNABRUCK,FACHBEREICH BIOL CHEM,BIOPHYS ABT,D-49069 OSNABRUCK,GERMANY	University Osnabruck								ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; BOYER PD, 1973, P NATL ACAD SCI USA, V70, P2837, DOI 10.1073/pnas.70.10.2837; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; ENGELBRECHT S, 1989, EUR J BIOCHEM, V179, P117, DOI 10.1111/j.1432-1033.1989.tb14528.x; ENGELBRECHT S, 1986, EUR J BIOCHEM, V160, P635, DOI 10.1111/j.1432-1033.1986.tb10085.x; GOGOL EP, 1990, P NATL ACAD SCI USA, V87, P9585, DOI 10.1073/pnas.87.24.9585; GRUBMEYER C, 1982, J BIOL CHEM, V257, P2092; Jablonski A, 1935, Z PHYS, V96, P236, DOI 10.1007/BF01341525; JUNGE W, 1977, BIOCHIM BIOPHYS ACTA, V462, P73, DOI 10.1016/0005-2728(77)90190-6; LEBEL D, 1978, ANAL BIOCHEM, V85, P86, DOI 10.1016/0003-2697(78)90277-4; MIKI J, 1988, FEBS LETT, V232, P221, DOI 10.1016/0014-5793(88)80421-6; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; MORONEY JV, 1984, J BIOL CHEM, V259, P7281; PARKER CA, 1961, T FARADAY SOC, V57, P1894, DOI 10.1039/tf9615701894; PENEFSKY HS, 1985, P NATL ACAD SCI USA, V82, P1589, DOI 10.1073/pnas.82.6.1589; Perrin F, 1936, J PHYS-PARIS, V7, P1, DOI 10.1051/jphysrad:01936007010100; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; WAGNER R, 1982, BIOCHEMISTRY-US, V21, P1890, DOI 10.1021/bi00537a029; WAHL P, 1975, CHEM PHYS, V7, P210, DOI 10.1016/0301-0104(75)87003-0; WALKER JE, 1994, BIOCHEMIST, V16, P31; WEBER J, 1994, J BIOL CHEM, V269, P20462	22	458	466	1	44	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 13	1996	381	6583					623	625		10.1038/381623a0	http://dx.doi.org/10.1038/381623a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ657	8637601				2022-12-28	WOS:A1996UQ65700056
J	Jaegle, M; Mandemakers, W; Broos, L; Zwart, R; Karis, A; Visser, P; Grosveld, F; Meijer, D				Jaegle, M; Mandemakers, W; Broos, L; Zwart, R; Karis, A; Visser, P; Grosveld, F; Meijer, D			The POU factor Oct-6 and Schwann cell differentiation	SCIENCE			English	Article							TRANSCRIPTION FACTOR SCIP; EXPRESSION; GENE; MYELINATION; AXONS	The POU transcription factor Oct-6, also known as SCIP or Tst-1, has been implicated as a major transcriptional regulator in Schwann cell differentiation. Microscopic and immunochemical analysis of sciatic nerves of Oct-6(-/-) mice at different stages of postnatal development reveals a delay in Schwann cell differentiation, with a transient arrest at the promyelination stage. Thus, Oct-6 appears to be required for the transition of promyelin cells to myelinating cells. Once these cells progress past this point, Oct-6 is no longer required, and myelination occurs normally.	ERASMUS UNIV ROTTERDAM, DEPT CELL BIOL & GENET, NL-3000 DR ROTTERDAM, NETHERLANDS	Erasmus University Rotterdam			Meijer, Dies/C-7786-2012	Meijer, Dies/0000-0002-8461-6341; Mandemakers, Wim/0000-0003-2673-5972				HE X, 1991, MOL CELL BIOL, V11, P1739, DOI 10.1128/MCB.11.3.1739; Jessen K R, 1992, Curr Opin Neurobiol, V2, P575, DOI 10.1016/0959-4388(92)90021-C; JESSEN KR, 1994, NEURON, V12, P509, DOI 10.1016/0896-6273(94)90209-7; KIOUSSI C, 1995, NEURON, V15, P553, DOI 10.1016/0896-6273(95)90144-2; LEDOUARIN NM, 1993, DEV BIOL, V159, P24, DOI 10.1006/dbio.1993.1219; Lemke G., 1992, INTRO MOL NEUROBIOLO, P281; MEIJER D, 1990, NUCLEIC ACIDS RES, V18, P7357, DOI 10.1093/nar/18.24.7357; Mirsky R, 1996, CURR OPIN NEUROBIOL, V6, P89, DOI 10.1016/S0959-4388(96)80013-4; MONUKI ES, 1993, MECH DEVELOP, V42, P15, DOI 10.1016/0925-4773(93)90095-F; MONUKI ES, 1990, SCIENCE, V249, P1300, DOI 10.1126/science.1975954; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; SCHERER SS, 1994, J NEUROSCI, V14, P1930; SUZUKI N, 1990, EMBO J, V9, P3723, DOI 10.1002/j.1460-2075.1990.tb07585.x; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; WEINBERG HJ, 1975, J NEUROCYTOL, V4, P395, DOI 10.1007/BF01261372; WEINSTEIN DE, 1995, MOL CELL NEUROSCI, V6, P212, DOI 10.1006/mcne.1995.1018; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; Zwart R, 1996, MECH DEVELOP, V54, P185, DOI 10.1016/0925-4773(95)00472-6; ZWART R, 1996, THESIS ERASMUS U ROT	20	228	231	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	1996	273	5274					507	510		10.1126/science.273.5274.507	http://dx.doi.org/10.1126/science.273.5274.507			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY983	8662541				2022-12-28	WOS:A1996UY98300043
J	Greenberg, SM; Edgar, MA; Kunz, DP; HedleyWhyte, ET; Finklestein, SP; Segal, AZ; Vonsattel, JP				Greenberg, SM; Edgar, MA; Kunz, DP; HedleyWhyte, ET; Finklestein, SP; Segal, AZ; Vonsattel, JP			Cerebral hemorrhage in a 69-year-old woman receiving warfarin - Cerebral amyloid angiopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; CENTRAL NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; INTRACEREBRAL HEMORRHAGE; GRANULOMATOUS-ANGIITIS; THROMBOLYTIC THERAPY; CLINICAL SPECTRUM; LOBAR HEMORRHAGE; RISK-FACTORS; COMPLICATIONS		HARVARD UNIV,SCH MED,CAMBRIDGE,MA 02138	Harvard University	Greenberg, SM (corresponding author), MASSACHUSETTS GEN HOSP,BOSTON,MA 02114, USA.		Hedley-Whyte, E Tessa/AAJ-9975-2021	Hedley-Whyte, E Tessa/0000-0002-1687-8905				[Anonymous], 1994, ARCH INTERN MED, V154, P2254; [Anonymous], 1994, ARCH INTERN MED, V154, P1449; BOGOUSSLAVSKY J, 1991, NEUROLOGY, V41, P837, DOI 10.1212/WNL.41.6.837; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; BRODERICK J, 1993, STROKE, V24, P49, DOI 10.1161/01.STR.24.1.49; CORIA F, 1987, AM J PATHOL, V129, P422; DEJAEGERE PP, 1992, J AM COLL CARDIOL, V19, P289, DOI 10.1016/0735-1097(92)90480-B; FIHN SD, 1993, ANN INTERN MED, V118, P511, DOI 10.7326/0003-4819-118-7-199304010-00005; FISHER CM, 1971, J NEUROPATH EXP NEUR, V30, P536, DOI 10.1097/00005072-197107000-00015; FISHER CM, 1951, J NEUROPATH EXP NEUR, V10, P92; GORE JM, 1991, CIRCULATION, V83, P448, DOI 10.1161/01.CIR.83.2.448; GREENBERG SM, 1993, NEUROLOGY, V43, P2073, DOI 10.1212/WNL.43.10.2073; GREENBERG SM, 1995, ANN NEUROL, V38, P254, DOI 10.1002/ana.410380219; GUSTAFSSON C, 1992, BRIT MED J, V305, P1457, DOI 10.1136/bmj.305.6867.1457; HENDRICKS HT, 1990, NEUROLOGY, V40, P1308, DOI 10.1212/WNL.40.8.1308; HORNIG CR, 1993, STROKE, V24, P465, DOI 10.1161/01.STR.24.3.465; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; ISHII N, 1984, J NEUROL NEUROSUR PS, V47, P1203, DOI 10.1136/jnnp.47.11.1203; KASE CS, 1994, INTRACEREBRAL HEMORR, P179; KAWAI M, 1993, BRAIN RES, V623, P142, DOI 10.1016/0006-8993(93)90021-E; LANDEFELD CS, 1989, AM J MED, V87, P144; LANDEFELD CS, 1989, AM J MED, V87, P153; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; MANDYBUR TI, 1986, J NEUROPATH EXP NEUR, V45, P79, DOI 10.1097/00005072-198601000-00007; MASSARO AR, 1991, NEUROLOGY, V41, P1881, DOI 10.1212/WNL.41.12.1881; MAURY CPJ, 1995, LAB INVEST, V72, P4; MELO TP, 1993, EUR NEUROL, V33, P9, DOI 10.1159/000116890; MOLINARI GF, 1993, STROKE, V24, P523, DOI 10.1161/01.STR.24.4.523; OTT BR, 1986, STROKE, V17, P630, DOI 10.1161/01.STR.17.4.630; PARDRIDGE WM, 1987, J NEUROCHEM, V49, P1394, DOI 10.1111/j.1471-4159.1987.tb01005.x; PENDLEBURY WW, 1991, ANN NEUROL, V29, P210, DOI 10.1002/ana.410290216; PROBST A, 1985, CLIN NEUROPATHOL, V4, P250; ROPPER AH, 1980, ANN NEUROL, V8, P141, DOI 10.1002/ana.410080203; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; SHINTAKU M, 1986, ACTA NEUROPATHOL, V70, P340, DOI 10.1007/BF00686094; SLOAN MA, 1995, NEUROLOGY, V45, P649, DOI 10.1212/WNL.45.4.649; SMITH DB, 1985, J NEUROSURG, V63, P963, DOI 10.3171/jns.1985.63.6.0963; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; VINERS HV, 1992, NEUROIMAG CLIN N AM, V2, P153; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; VINTERS HV, 1992, J NEUROL SCI, V112, P1, DOI 10.1016/0022-510X(92)90124-4; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; WAGLE WA, 1984, AM J NEURORADIOL, V5, P171; WIJDICKS EFM, 1993, STROKE, V24, P554, DOI 10.1161/01.STR.24.4.554; WISNIEWSKI HM, 1992, ACTA NEUROPATHOL, V84, P117, DOI 10.1007/BF00311383; YAMAGUCHI H, 1992, AM J PATHOL, V141, P249; ZUBENKO GS, 1994, AM J MED GENET, V54, P199, DOI 10.1002/ajmg.1320540306	48	34	34	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	1996	335	3					189	196		10.1056/NEJM199607183350308	http://dx.doi.org/10.1056/NEJM199607183350308			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW790	8657218				2022-12-28	WOS:A1996UW79000008
J	Leape, LL; Hilborne, LH; Schwartz, JS; Bates, DW; Rubin, HR; Slavin, P; Park, RE; Witter, DM; Panzer, RJ; Brook, RH; Kelly, J; Bluth, E; KrouselWood, T; Komaroff, A; Matchar, D; Kahn, K; Tobacman, J				Leape, LL; Hilborne, LH; Schwartz, JS; Bates, DW; Rubin, HR; Slavin, P; Park, RE; Witter, DM; Panzer, RJ; Brook, RH; Kelly, J; Bluth, E; KrouselWood, T; Komaroff, A; Matchar, D; Kahn, K; Tobacman, J			The appropriateness of coronary artery bypass graft surgery in academic medical centers	ANNALS OF INTERNAL MEDICINE			English	Article						coronary artery bypass; academic medical centers; regional health planning; angina pectoris; coronary disease		Objective: To compare the appropriateness of use of coronary artery bypass graft (CABG) surgery in Academic Medical Center Consortium hospitals as judged 1) according to criteria developed by an expert panel, 2) according to revisions of those criteria made by cardiac surgeons from the Academic Medical Center Consortium, and 3) by review of cases by the surgeons responsible for those cases. Design: Retrospective, randomized medical record review. Setting: 12 Academic Medical Center Consortium hospitals. Patients: Random sample of 1156 patients who had had isolated CABG surgery in 1990. Main Outcome Measures: 1) Percentage of patients with indications for which CABG surgery was classified as appropriate, inappropriate, or of uncertain appropriateness and 2) percentage of cases in which CABG surgery was judged inappropriate or uncertain for which ratings changed after local case review. Results: Data were retrieved from medical records by trained abstractors using an explicit data collection instrument. Cases in which CABG surgery was judged to be inappropriate or uncertain were individually reviewed by the responsible surgeons. According to the expert panel ratings, 83% of the CABG operations (95% CI, 81% to 85%) were necessary, 9% (CI, 8% to 10%) were appropriate, 7% (CI, 5% to 8%) were uncertain, and 1.6% (CI, 0.6% to 2.5%) were inappropriate. These rates are almost identical to those found in a previous study that was done in New York State and that used the same criteria (in that study, 91% of operations were classified as necessary or appropriate, 7% were classified as uncertain, and 2.4% were classified as inappropriate). Rates of inappropriate procedures varied from 0% to 5% among the 12 member hospitals (P = 0.02). The Academic Medical Center Consortium cardiac surgeons revised 568 (24%) of the indications used by the expert panel. However, because those revisions altered the appropriateness ratings in both directions and affected only 50 cases (4%), the net effect of the revisions was slight: The rate of inappropriate CABG surgery increased from 1.6% to 1.9%. Local review found that data collection errors had caused erroneous ratings in 12.5% of 64 cases in which surgery had been classified as inappropriate or uncertain. Conclusions: The Academic Medical Center Consortium hospitals had low rates of inappropriate and uncertain use of CABG surgery, regardless of the criteria used for assessment. Even though surgeons from the Consortium revised the appropriateness ratings extensively, their revisions had a negligible effect on the overall assessment of appropriateness. However, because of potential data collection errors, appropriateness criteria should be used for individual case audits only if supplemented by subsequent physician review.	ACAD MED CTR CONSORTIUM, ROCHESTER, NY 14643 USA; AMER MED ASSOC, CHICAGO, IL 60610 USA; ALTON OCHSNER MED INST, NEW ORLEANS, LA USA; BRIGHAM & WOMENS HOSP, DEPT GEN MED, BOSTON, MA 02115 USA; DUKE UNIV, MED CTR, DURHAM, NC USA; JOHNS HOPKINS UNIV HOSP, BALTIMORE, MD 21205 USA; MASSACHUSETTS GEN HOSP, CTR EVALUAT MED PRACT, BOSTON, MA 02114 USA; MAYO CLIN & MAYO FDN, ROCHESTER, MI USA; UNIV CALIF LOS ANGELES, MED CTR, LOS ANGELES, CA 90024 USA; UNIV IOWA HOSP & CLIN, IOWA CITY, IA 52242 USA; UNIV PENN, MED CTR, PHILADELPHIA, PA 19104 USA; UNIV ROCHESTER, MED CTR, ROCHESTER, NY 14642 USA; RAND CORP, SANTA MONICA, CA 90406 USA	American Medical Association; Ochsner Health System; Harvard University; Brigham & Women's Hospital; Duke University; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Massachusetts General Hospital; Mayo Clinic; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Iowa; University of Pennsylvania; University of Rochester; RAND Corporation			Bluth, Edward I./A-8613-2011; Kahn, Katherine/AAE-2857-2020; Matchar, David/M-3951-2019	Kahn, Katherine/0000-0002-6605-1455; 				ALDERMAN E, 1990, CIRCULATION, V82, P1; CHASSIN MR, 1986, INDICATIONS SELECTED; FISHER L, 1983, CIRCULATION, V68, P951; KAHAN JP, IN PRESS MED CARE; LEAPE LL, 1993, JAMA-J AM MED ASSOC, V269, P753, DOI 10.1001/jama.269.6.753; LEAPE LL, 1991, CORONARY ARTERY BYPA; Mittman B S, 1992, QRB Qual Rev Bull, V18, P413; PARK RE, 1986, AM J PUBLIC HEALTH, V76, P766, DOI 10.2105/AJPH.76.7.766; PARSONNET V, 1989, CIRCULATION, V79, P3; *STAT CORP, 1993, STAT REF MAN REL 3 1; WINSLOW CM, 1988, JAMA-J AM MED ASSOC, V260, P505, DOI 10.1001/jama.260.4.505; [No title captured]	12	34	34	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1996	125	1					8	+		10.7326/0003-4819-125-1-199607010-00003	http://dx.doi.org/10.7326/0003-4819-125-1-199607010-00003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT399	8644996				2022-12-28	WOS:A1996UT39900002
J	Sharp, D				Sharp, D			Gun deaths in schools, in the USA	LANCET			English	Editorial Material																		Ash P, 1996, JAMA-J AM MED ASSOC, V275, P1754, DOI 10.1001/jama.275.22.1754; Burns R, 1996, JAMA-J AM MED ASSOC, V275, P1775; Kachur SP, 1996, JAMA-J AM MED ASSOC, V275, P1729, DOI 10.1001/jama.275.22.1729	3	2	2	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 22	1996	347	9017					1712	1712		10.1016/S0140-6736(96)90805-3	http://dx.doi.org/10.1016/S0140-6736(96)90805-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT396	8656903				2022-12-28	WOS:A1996UT39600007
J	Sieratzki, JS; Woll, B				Sieratzki, JS; Woll, B			Why do mothers cradle babies on their left?	LANCET			English	Article							CARRYING NEWBORN-INFANTS; LEFT-SIDE PREFERENCE; HANDEDNESS; LATERALITY; PERCEPTION; HEARTBEAT; LANGUAGE; CHILD	Many explanations have been put forward for the observed preference of mothers to cradle babies on the left side. These include handedness, the importance of the maternal heartbeat, left breast sensitivity, socio-psychological factors, and advantages in monitoring the infant. We propose that protection and facilitation of affective communication Is at the core of cradling; and explore the relation between left-cradling and the role of the right hemisphere in early mother-infant interaction. Left-cradling not only directs maternal communication to the infant's right hemisphere but also facilitates affective feedback to the maternal right brain. The underlying neuro-linguistic mechanisms proposed in this article may be important in the early course of child language development and may also serve to illuminate our understanding of the evolution of human language.	CITY UNIV LONDON, DEPT CLIN COMMUN STUDIES, LONDON EC1V 0HB, ENGLAND	City University London	Sieratzki, JS (corresponding author), HAMMERSMITH HOSP, DEPT PAEDIAT & NEONATOL, LONDON, ENGLAND.		Woll, Bencie/C-2040-2008	Woll, Bencie/0000-0002-3300-4775				BERTONCINI J, 1989, BRAIN LANG, V37, P591, DOI 10.1016/0093-934X(89)90113-2; BOGREN LY, 1984, ACTA PSYCHIAT SCAND, V69, P13, DOI 10.1111/j.1600-0447.1984.tb04512.x; BOROD JC, 1990, BRAIN COGNITION, V13, P167, DOI 10.1016/0278-2626(90)90048-S; BRYDEN MP, 1991, CORTEX, V27, P229, DOI 10.1016/S0010-9452(13)80127-X; CODE C, 1984, EXPT CLIN PHONETICS, P166; Cruttenden A., 1994, INPUT INTERACTION LA, P135, DOI 10.1017/cbo9780511620690.008; DAVIDSON RJ, 1995, CURR OPIN NEUROBIOL, V5, P217, DOI 10.1016/0959-4388(95)80029-8; DECHATEAU P, 1987, ACTA PSYCHIAT SCAND, V75, P283; DECHATEAU P, 1976, DEV MED CHILD NEUROL, V18, P738; DIENSKE H, 1995, BEHAVIOUR, V132, P801, DOI 10.1163/156853995X00153; FERNALD A, 1989, J CHILD LANG, V16, P477, DOI 10.1017/S0305000900010679; FIFER WP, 1994, ACTA PAEDIATR, V83, P86, DOI 10.1111/j.1651-2227.1994.tb13270.x; FINGER S, 1975, CHILD DEV, V46, P267; GINSBURG HJ, 1979, CHILD DEV, V50, P280, DOI 10.2307/1129073; Hellige J. B., 1993, HEMISPHERIC ASYMMETR; HUHEEY JE, 1977, BEHAV GENET, V7, P29; Kupfermann I., 1991, PRINCIPLES NEURAL SC, P823; LUCAS MD, 1993, J GENET PSYCHOL, V154, P347; MANNING JT, 1990, ANIM BEHAV, V39, P1224, DOI 10.1016/S0003-3472(05)80800-0; MANNING JT, 1994, J COMP PSYCHOL, V108, P262, DOI 10.1037/0735-7036.108.3.262; PALMQVIST H, 1975, CHILD DEV, V46, P292; ROSS ED, 1993, NEUROL CLIN, V11, P9, DOI 10.1016/S0733-8619(18)30168-3; SALING MM, 1984, CURR ANTHROPOL, V25, P333, DOI 10.1086/203140; SALK L, 1973, SCI AM, V228, P24, DOI 10.1038/scientificamerican0573-24; SHIPLEYBROWN F, 1988, BRAIN LANG, V33, P16, DOI 10.1016/0093-934X(88)90051-X; SOLMS KLK, 1988, PERCEPT MOTOR SKILL, V67, P55; THOMPSON AM, 1993, CORTEX, V29, P649, DOI 10.1016/S0010-9452(13)80288-2; TREHUB SE, 1993, ADV CHILD DEV BEHAV, V24, P1, DOI 10.1016/S0065-2407(08)60298-0; WEILAND JH, 1970, J GENET PSYCHOL, V117, P157; WEINSTEIN S, 1963, AM J PSYCHOL, V76, P475, DOI 10.2307/1419791; Woll B., 1989, SOCIAL COGNITIVE ASP, P129	31	67	69	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 22	1996	347	9017					1746	1748		10.1016/S0140-6736(96)90813-2	http://dx.doi.org/10.1016/S0140-6736(96)90813-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UT396	8656911				2022-12-28	WOS:A1996UT39600015
J	Bucholz, RW; Buckwalter, JA				Bucholz, RW; Buckwalter, JA			Orthopedic surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							KNEE		UNIV IOWA HOSP & CLIN, IOWA CITY, IA 52242 USA	University of Iowa	Bucholz, RW (corresponding author), UNIV TEXAS, SW MED SCH, DALLAS, TX 75230 USA.			Buckwalter, Joseph/0000-0003-4308-7583				BALLARD WT, 1995, J BONE JOINT SURG AM, V77A, P585, DOI 10.2106/00004623-199504000-00012; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; COBB TK, 1994, FOOT ANKLE, V15, P64, DOI 10.1177/107110079401500202; CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603; COOK SD, 1995, J BONE JOINT SURG AM, V77A, P734, DOI 10.2106/00004623-199505000-00010; GERHART TN, 1993, CLIN ORTHOP RELAT R, P317; HOMMINGA GN, 1990, J BONE JOINT SURG BR, V72, P1003, DOI 10.1302/0301-620X.72B6.2246280; MUCKLE DS, 1990, J BONE JOINT SURG BR, V72, P60, DOI 10.1302/0301-620X.72B1.2404987; MULROY RD, 1990, J BONE JOINT SURG BR, V72, P757, DOI 10.1302/0301-620X.72B5.2211749; MUSCHLER GF, 1994, CLIN ORTHOP RELAT R, P229; SCHMITZ MA, 1995, 62 ANN M AM AC ORTH; SCHULTE KR, 1993, J BONE JOINT SURG AM, V75A, P961, DOI 10.2106/00004623-199307000-00002; *US DEP HHS, 1994, TOT HIP REPL NIH CON, V12, P1; Wozney John M., 1993, P131	14	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1836	1837		10.1001/jama.275.23.1836	http://dx.doi.org/10.1001/jama.275.23.1836			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642738				2022-12-28	WOS:A1996UQ15200037
J	Petersen, LA; Daley, J				Petersen, LA; Daley, J			General internal medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									BRIGHAM & WOMENS HOSP, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA USA; BETH ISRAEL HOSP, BOSTON, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Petersen, LA (corresponding author), BROCKTON W ROXBURY VET AFFAIRS MED CTR, W ROXBURY, MA 02132 USA.							[Anonymous], 1995, BMJ, V310, P83; [Anonymous], 1995, JAMA-J AM MED ASSOC, V274, P1676; BYINGTON RP, 1995, CIRCULATION, V92, P2419, DOI 10.1161/01.CIR.92.9.2419; CAREY TS, 1995, NEW ENGL J MED, V333, P913, DOI 10.1056/NEJM199510053331406; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; DIABET CONTROL COMPLICATIONS TRIAL RES GRP, 1995, DIABETES CARE, V18, P1468; Diabet Control Complications Trial Res Grp, 1995, DIABETES CARE, V18, P1415; FURBERG CD, 1995, CIRCULATION, V92, P1326, DOI 10.1161/01.CIR.92.5.1326; Greenfield Sheldon, 1995, JAMA (Journal of the American Medical Association), V274, P1436, DOI 10.1001/jama.274.18.1436; KATTLOVE H, 1995, JAMA-J AM MED ASSOC, V273, P142, DOI 10.1001/jama.273.2.142; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; OPIE LH, 1995, CIRCULATION, V92, P1068, DOI 10.1161/01.CIR.92.5.1068; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; STANFORD JL, 1995, JAMA-J AM MED ASSOC, V274, P137, DOI 10.1001/jama.274.2.137; 1995, ANN INTERN MED, V122, P561; 1995, JAMA-J AM MED ASSOC, V273, P199	18	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1811	1812		10.1001/jama.275.23.1811	http://dx.doi.org/10.1001/jama.275.23.1811			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642723				2022-12-28	WOS:A1996UQ15200022
J	Bryant, H				Bryant, H			Genetic screening for breast cancer in Ashkenazi women	LANCET			English	Editorial Material											Bryant, H (corresponding author), ALBERTA CANC BOARD,DIV EPIDEMIOL PREVENT & SCREENING,3330 HOSP DR NW,CALGARY,AB TN2 4N1,CANADA.							Collins FS, 1996, NEW ENGL J MED, V334, P186, DOI 10.1056/NEJM199601183340311; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; HOSKINS KF, 1995, JAMA-J AM MED ASSOC, V273, P577, DOI 10.1001/jama.273.7.577; LERMAN C, 1994, ARCH INTERN MED, V154, P609, DOI 10.1001/archinte.154.6.609; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; 1994, JAMA-J AM MED ASSOC, V271, P785	6	1	1	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 15	1996	347	9016					1638	1639		10.1016/S0140-6736(96)91479-8	http://dx.doi.org/10.1016/S0140-6736(96)91479-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ701	8642950				2022-12-28	WOS:A1996UQ70100002
J	Jackson, SR; Avery, NC; Tarlton, JF; Echford, SD; Abrams, P; Bailey, AJ				Jackson, SR; Avery, NC; Tarlton, JF; Echford, SD; Abrams, P; Bailey, AJ			Changes in metabolism of collagen in genitourinary	LANCET			English	Article								Background Genitourinary prolapse is a common problem, the pathophysiology of which is unknown. Methods We analysed vaginal-epithelial tissue from premenopausal women with genitourinary prolapse and compared them with controls. Findings We found that genitourinary prolapse is associated with a reduction in total collagen content and a decrease in collagen solubility. Both intermediate intermolecular cross-links acid advanced glycation crosslinks were increased in prolapse tissue. Collagen turnover, as indicated by matrix metalloproteinase activity, was up to four times higher in prolapse tissue. Collagen-type ratios, mature cross-link pyridinoline and total elastin content were similar in both prolapse and control tissues. Increased collagenolytic activity causes loss of collagen from prolapse tissue. Interpretation Based on these findings, we have identified a probable mechanism for genitourinary prolapse. Development of agents to inhibit collagenolytic activity may help in the treatment of this condition.	UNIV BRISTOL, COLLLAGEN RES GRP, BRISTOL, AVON, ENGLAND	University of Bristol	Jackson, SR (corresponding author), SOUTHMEAD GEN HOSP, BRISTOL UROL INST, BRISTOL BS10 5NB, AVON, ENGLAND.							AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; BAILEY AJ, 1995, BIOCHEM J, V305, P385, DOI 10.1042/bj3050385; BAILEY AJ, 1994, J HAND SURG-BRIT EUR, V19B, P522, DOI 10.1016/0266-7681(94)90220-8; BANNISTER DW, 1970, ANALYST, V95, P596, DOI 10.1039/an9709500596; BRINCAT M, 1983, BRIT MED J, V287, P1337, DOI 10.1136/bmj.287.6402.1337; el-Kholi G Y, 1975, J Egypt Med Assoc, V58, P196; Keane D, 1992, NEUROUROL URODYNAM, V11, P308; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIGHT ND, 1982, BIOCHIM BIOPHYS ACTA, V702, P30, DOI 10.1016/0167-4838(82)90024-3; LIGHT ND, 1982, STRUCTURAL CONTRACTI; MAKINEN J, 1986, ARCH GYNECOL OBSTET, V239, P17, DOI 10.1007/BF02134283; MATRISIAN LM, 1994, CONTRIB NEPHROL, V107, P94; NAGASE H, 1994, CONTRIB NEPHROL, V107, P85; NORTON DP, 1990, MATER LETT, V9, P321, DOI 10.1016/0167-577X(90)90170-Q; SAYER TR, 1990, NEUROUROL URODYNAM, V9, P319; SELL DR, 1989, J BIOL CHEM, V264, P21597; SIMS TJ, 1992, J CHROMATOGR-BIOMED, V582, P49, DOI 10.1016/0378-4347(92)80301-6	17	273	286	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 15	1996	347	9016					1658	1661		10.1016/S0140-6736(96)91489-0	http://dx.doi.org/10.1016/S0140-6736(96)91489-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ701	8642960				2022-12-28	WOS:A1996UQ70100012
J	Wang, G; Tanaka, K; Tanifuji, M				Wang, G; Tanaka, K; Tanifuji, M			Optical imaging of functional organization in the monkey inferotemporal cortex	SCIENCE			English	Article							ORIENTATION SELECTIVITY; INTRINSIC SIGNALS; NEURONAL-ACTIVITY; STRIATE CORTEX; VISUAL-CORTEX; MACAQUE; ARCHITECTURE; OBJECTS	To investigate the functional organization of object recognition, the technique of optical imaging was applied to the primate inferotemporal cortex, which is thought to be essential for object recognition. The features critical for the activation of single cells were first determined in unit recordings with electrodes. In the subsequent optical imaging, presentation of the critical features activated patchy regions around 0.5 millimeters in diameter, covering the site of the electrode penetration at which the critical feature had been determined. Because signals in optical imaging reflect average neuronal activities in the regions, the result directly indicates the regional clustering of cells responding to similar features.	RIKEN,FRONTIER RES PROGRAM,LAB NEURAL INFORMAT PROC,WAKO,SAITAMA 35101,JAPAN; RIKEN,INFORMAT SCI LAB,WAKO,SAITAMA 35101,JAPAN; KAGOSHIMA UNIV,FAC MED,DEPT PHYSIOL 2,KAGOSHIMA 890,JAPAN; FUKUI UNIV,DEPT INFORMAT SCI,FUKUI 910,JAPAN; RES DEV CORP JAPAN,PRECURSORY RES EMBRYON SCI & TECHNOL,FUKUI 910,JAPAN	RIKEN; RIKEN; Kagoshima University; University of Fukui; Japan Science & Technology Agency (JST)			Tanifuji, Manabu/H-1744-2019; Wang, Gang/Y-4549-2019; Tanaka, Keiji/N-5917-2015	Tanifuji, Manabu/0000-0001-7754-7774; Wang, Gang/0000-0002-4512-634X; Tanaka, Keiji/0000-0002-1910-3427				BALLARD DH, 1986, BEHAV BRAIN SCI, V9, P67, DOI 10.1017/S0140525X00021555; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; BLASDEL GG, 1992, J NEUROSCI, V12, P3115, DOI 10.1523/JNEUROSCI.12-08-03115.1992; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; DESIMONE R, 1984, J NEUROSCI, V4, P2051; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GOCHIN PM, 1991, EXP BRAIN RES, V84, P505; GOCHIN PM, 1992, P NATL ACAD SCI USA, V89, P8381, DOI 10.1073/pnas.89.17.8381; GRINVALD A, 1988, PHYSIOL REV, V68, P1285, DOI 10.1152/physrev.1988.68.4.1285; GRINVALD A, 1991, P NATL ACAD SCI USA, V88, P11559, DOI 10.1073/pnas.88.24.11559; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HAGLUND MM, 1992, NATURE, V358, P668, DOI 10.1038/358668a0; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; ITO M, 1994, CEREB CORTEX, V5, P499; KIM DS, 1994, NATURE, V370, P370, DOI 10.1038/370370a0; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; MACVICAR BA, 1991, J NEUROSCI, V11, P1458; MALONEK D, 1994, P ROY SOC B-BIOL SCI, V258, P109, DOI 10.1098/rspb.1994.0150; MASINO SA, 1993, P NATL ACAD SCI USA, V90, P9998, DOI 10.1073/pnas.90.21.9998; Mountcastle V.B., 1978, MINDFUL BRAIN CORTIC, P7; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630	25	249	252	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1996	272	5268					1665	1668		10.1126/science.272.5268.1665	http://dx.doi.org/10.1126/science.272.5268.1665			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8658144				2022-12-28	WOS:A1996UR09300051
J	ChristensenDalsgaard, J; Dappen, W; Ajukov, SV; Anderson, ER; Antia, HM; Basu, S; Baturin, VA; Berthomieu, G; Chaboyer, B; Chitre, SM; Cox, AN; Demarque, P; Donatowicz, J; Dziembowski, WA; Gabriel, M; Gough, DO; Guenther, DB; Guzik, JA; Harvey, JW; Hill, F; Houdek, G; Iglesias, CA; Kosovichev, AG; Leibacher, JW; Morel, P; Proffitt, CR; Provost, J; Reiter, J; Rhodes, EJ; Rogers, FJ; Roxburgh, IW; Thompson, MJ; Ulrich, RK				ChristensenDalsgaard, J; Dappen, W; Ajukov, SV; Anderson, ER; Antia, HM; Basu, S; Baturin, VA; Berthomieu, G; Chaboyer, B; Chitre, SM; Cox, AN; Demarque, P; Donatowicz, J; Dziembowski, WA; Gabriel, M; Gough, DO; Guenther, DB; Guzik, JA; Harvey, JW; Hill, F; Houdek, G; Iglesias, CA; Kosovichev, AG; Leibacher, JW; Morel, P; Proffitt, CR; Provost, J; Reiter, J; Rhodes, EJ; Rogers, FJ; Roxburgh, IW; Thompson, MJ; Ulrich, RK			The current state of solar modeling	SCIENCE			English	Review							ROSSELAND OPACITY TABLES; STELLAR ENVELOPES; CONVECTION ZONE; OSCILLATION FREQUENCIES; PULSATIONAL STABILITY; EVOLUTIONARY MODELS; HELIUM ABUNDANCE; NEUTRINO PROBLEM; EQUATION; SUN	Data from the Global Oscillation Network Group (GONG) project and other helioseismic experiments provide a test for models of stellar interiors and for the thermodynamic and radiative properties, on which the models depend, of matter under the extreme conditions found in the sun. Current models are in agreement with the helioseismic inferences, which suggests, for example, that the disagreement between the predicted and observed fluxes of neutrinos from the sun is not caused by errors in the models. However, the GONG data reveal subtle errors in the models, such as an excess In sound speed just beneath the convection zone. These discrepancies indicate effects that have so far not been correctly accounted for; for example, it is plausible that the sound-speed differences reflect weak mixing in stellar interiors, of potential importance to the overall evolution of stars and ultimately to estimates of the age of the galaxy based on stellar evolution calculations.	AARHUS UNIV, INST PHYS & ASTRON, DK-8000 AARHUS C, DENMARK; UNIV SO CALIF, DEPT PHYS & ASTRON, LOS ANGELES, CA 90089 USA; MOSCOW MV LOMONOSOV STATE UNIV, STERNBERG ASTRON INST, Moscow, RUSSIA; NATL OPT ASTRON OBSERV, NATL SOLAR OBSERV, TUCSON, AZ 85726 USA; TATA INST FUNDAMENTAL RES, BOMBAY 400005, MAHARASHTRA, INDIA; UNIV LONDON QUEEN MARY & WESTFIELD COLL, ASTRON UNIT, LONDON E1 4NS, ENGLAND; OBSERV COTE AZUR, F-06003 NICE, FRANCE; UNIV TORONTO, CANADIAN INST THEORET ASTROPHYS, TORONTO, ON M5S 1A1, CANADA; LOS ALAMOS NATL LAB, LOS ALAMOS, NM 87545 USA; YALE UNIV, DEPT ASTRON, NEW HAVEN, CT 06520 USA; UNIV VIENNA, INST ASTRON, A-1180 VIENNA, AUSTRIA; COPERNICUS CTR, WARSAW, POLAND; UNIV LIEGE, INST ASTROPHYS, B-4000 LIEGE, BELGIUM; UNIV CAMBRIDGE, INST ASTRON, CAMBRIDGE, ENGLAND; ST MARYS UNIV, DEPT PHYS & ASTRON, HALIFAX, NS B3H 3C3, CANADA; LAWRENCE LIVERMORE NATL LAB, LIVERMORE, CA 94550 USA; STANFORD UNIV, CTR SPACE SCI & ASTROPHYS, STANFORD, CA 94305 USA; NASA, GODDARD SPACE FLIGHT CTR, COMP SCI CORP, GREENBELT, MD 20771 USA; TECH UNIV MUNICH, INST MATH, W-8000 MUNICH, GERMANY; UNIV CALIF LOS ANGELES, DEPT PHYS & ASTRON, LOS ANGELES, CA 90095 USA	Aarhus University; University of Southern California; Lomonosov Moscow State University; National Optical Astronomy Observatory; Tata Institute of Fundamental Research (TIFR); University of London; Queen Mary University London; UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; University of Toronto; United States Department of Energy (DOE); Los Alamos National Laboratory; Yale University; University of Vienna; University of Liege; University of Cambridge; Saint Marys University - Canada; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Stanford University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Technical University of Munich; University of California System; University of California Los Angeles	ChristensenDalsgaard, J (corresponding author), AARHUS UNIV, THEORET ASTROPHYS CTR, DK-8000 AARHUS C, DENMARK.		Basu, Sarbani/B-8015-2014; Ulrich, Roger/AAE-6935-2020; Antia, H./AAV-4222-2021	Basu, Sarbani/0000-0002-6163-3472; Ulrich, Roger/0000-0003-4041-4657; Chaboyer, Brian/0000-0003-3096-4161; Antia, H. M./0000-0001-7549-9684; Houdek, Gunter/0000-0003-1819-810X; Leibacher, John/0000-0001-7605-3684				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; ANTIA HM, 1995, MON NOT R ASTRON SOC, V274, P499, DOI 10.1093/mnras/274.2.499; ANTIA HM, 1994, ASTROPHYS J, V426, P801, DOI 10.1086/174117; ANTIA HM, 1995, ASTROPHYS J, V442, P434, DOI 10.1086/175451; Bahcall J N, 1989, NEUTRINO ASTROPHYSIC; BAHCALL JN, 1990, PHYS REV LETT, V65, P2233, DOI 10.1103/PhysRevLett.65.2233; BAHCALL JN, 1992, REV MOD PHYS, V64, P885, DOI 10.1103/RevModPhys.64.885; BAHCALL JN, 1994, PHYS LETT B, V338, P276, DOI 10.1016/0370-2693(94)91378-1; Bahcall JN, 1995, REV MOD PHYS, V67, P781, DOI 10.1103/RevModPhys.67.781; BALIUNAS S, 1990, NATURE, V348, P520, DOI 10.1038/348520a0; BALMFORTH NJ, 1992, MON NOT R ASTRON SOC, V255, P603, DOI 10.1093/mnras/255.4.603; BALMFORTH NJ, 1992, MON NOT R ASTRON SOC, V255, P632, DOI 10.1093/mnras/255.4.632; BASU S, 1994, MON NOT R ASTRON SOC, V267, P209, DOI 10.1093/mnras/267.1.209; BASU S, 1994, J ASTROPHYS ASTRON, V15, P143, DOI 10.1007/BF03012174; BATURIN VA, 1996, P 32 LIEG INT ASTR C, P33; BATURIN VA, 1995, ASTRON REP, V37, P489; Bethe HA, 1939, PHYS REV, V55, P0434, DOI 10.1103/PhysRev.55.434; Biermann L., 1932, Z ASTROPHYS, V5, P117; Bohm-Vitense E., 1958, Z ASTROPHYS, V46, P108; BOOTHROYD AI, 1991, ASTROPHYS J, V377, P318, DOI 10.1086/170361; BROWN TM, 1994, ANNU REV ASTRON ASTR, V32, P37; BRUMMELL N, 1995, SCIENCE, V269, P1370, DOI 10.1126/science.269.5229.1370; CANUTO VM, 1991, ASTROPHYS J, V370, P295, DOI 10.1086/169815; CHABOYER B, 1995, ASTROPHYS J, V441, P865, DOI 10.1086/175408; CHABOYER B, 1995, ASTROPHYS J, V446, P435, DOI 10.1086/175802; Christensen-Dalsgaard J., 1991, SOLAR INTERIOR ATMOS, P401; CHRISTENSENDALS.J, IN PRESS NUCL PHYS B; CHRISTENSENDALSGAARD J, 1985, NATURE, V315, P378, DOI 10.1038/315378a0; CHRISTENSENDALSGAARD J, 1995, ASTRON ASTROPHYS, V299, pL17; CHRISTENSENDALSGAARD J, 1983, SOL PHYS, V82, P165, DOI 10.1007/BF00145558; CHRISTENSENDALSGAARD J, 1993, ASTROPHYS J, V403, pL75, DOI 10.1086/186725; CHRISTENSENDALSGAARD J, 1991, ASTROPHYS J, V378, P413, DOI 10.1086/170441; CHRISTENSENDALSGAARD J, 1995, ASTR SOC P, V76, P136; CHRISTENSENDALSGAARD J, 1994, MON NOT R ASTRON SOC, V270, P921, DOI 10.1093/mnras/270.4.921; CHRISTENSENDALSGAARD J, 1988, NATURE, V336, P634, DOI 10.1038/336634a0; CHRISTENSENDALSGAARD J, 1992, ASTRON ASTROPHYS REV, V4, P267, DOI 10.1007/BF00872687; Cowling TG, 1935, MON NOT R ASTRON SOC, V96, P0042; Cox A.N., 1965, ASTROPHYS J SUPPL S, V11, P22; Cox A.N., 1965, AP J               S, V11, P1; COX AN, 1970, ASTROPHYS J SUPPL S, V19, P261, DOI 10.1086/190208; COX AN, 1976, ASTROPHYS J SUPPL S, V31, P271, DOI 10.1086/190383; COX AN, 1970, ASTROPHYS J SUPPL S, V19, P243, DOI 10.1086/190207; COX AN, 1989, ASTROPHYS J, V342, P1187, DOI 10.1086/167675; DAPPEN W, 1988, ASTROPHYS J, V332, P261, DOI 10.1086/166650; DEMARQUE P, 1988, ADV HELIO ASTEROSEIS, V123, P91; DEMARQUE PR, 1964, ASTROPHYS J, V140, P541, DOI 10.1086/147947; DZITKO H, 1995, ASTROPHYS J, V447, P428, DOI 10.1086/175887; Ebeling W., 1991, THERMODYNAMIC PROPER; Eddington A.S., 1926, INTERNAL CONSTITUTIO; EGGLETON PP, 1973, ASTRON ASTROPHYS, V23, P325; Emden R., 1907, GASKUGELN; ENDAL AS, 1981, ASTROPHYS J, V243, P625, DOI 10.1086/158628; FRICKE K, 1971, MON NOT R ASTRON SOC, V154, P23, DOI 10.1093/mnras/154.1.23; Gabriel M, 1991, LECT NOTE PHYS, V388, P51, DOI [10.1007/3-540-54420-8_50, DOI 10.1007/3-540-54420-8_50]; Gamow G, 1938, PHYS REV, V53, P595, DOI 10.1103/PhysRev.53.595; GOUGH D, 1991, ANNU REV ASTRON ASTR, V29, P627, DOI 10.1146/annurev.aa.29.090191.003211; Gough DO, 1996, SCIENCE, V272, P1281, DOI 10.1126/science.272.5266.1281; GOUGH DO, 1995, MON NOT R ASTRON SOC, V273, P573, DOI 10.1093/mnras/273.3.573; Gough DO, 1996, SCIENCE, V272, P1296, DOI 10.1126/science.272.5266.1296; Grevesse N., 1993, ORIGIN EVOLUTION ELE, P15; GUENTHER DB, 1992, ASTROPHYS J, V387, P372, DOI 10.1086/171090; GUENTHER DB, 1994, ASTROPHYS J, V422, P400, DOI 10.1086/173735; GUENTHER DB, 1989, ASTROPHYS J, V339, P1156, DOI 10.1086/167370; GUZIK JA, 1995, ASTROPHYS J, V448, P905, DOI 10.1086/176019; GUZIK JA, 1993, ASTROPHYS J, V411, P394, DOI 10.1086/172840; HASELGROVE CB, 1956, MON NOT R ASTRON SOC, V116, P515, DOI 10.1093/mnras/116.5.515; HERNANDEZ FP, 1994, MON NOT R ASTRON SOC, V269, P475; Hill F, 1996, SCIENCE, V272, P1292, DOI 10.1126/science.272.5266.1292; HUMMER DG, 1988, ASTROPHYS J, V331, P794, DOI 10.1086/166600; IGLESIAS CA, 1992, ASTROPHYS J, V397, P717, DOI 10.1086/171827; IGLESIAS CA, 1991, ASTROPHYS J, V371, pL73, DOI 10.1086/186005; KANBUR SM, 1994, ASTROPHYS J, V420, P880, DOI 10.1086/173611; KIM YC, 1995, ASTROPHYS J, V442, P422, DOI 10.1086/175450; KORZENNIK SG, 1989, ASTROPHYS J, V339, P1144, DOI 10.1086/167369; KOSOVICHEV AG, 1991, ASTRON ZH+, V68, P1015; KOSOVICHEV AG, 1995, ADV SPACE RES, V15, P95, DOI 10.1016/0273-1177(94)00026-W; KOSOVICHEV AG, 1992, MON NOT R ASTRON SOC, V259, P536, DOI 10.1093/mnras/259.3.536; KOSOVICHEV AG, 1995, ASTR SOC P, V76, P89; KOSOVICHEV AG, 1995, ESA, V1, P165; KOSOVICHEV AG, IN PRESS SUN 2E RENC; Lane J., 1870, AM J SCI, Vs2-50, P57, DOI DOI 10.2475/AJS.S2-50.148.57; Michaud G., 1993, IAU C, V137, P246; MICHAUD G, 1990, SPACE SCI REV, V57, P1; MIHALAS D, 1988, ASTROPHYS J, V331, P815, DOI 10.1086/166601; MONTEIRO MJPFG, 1994, ASTRON ASTROPHYS, V283, P247; MOSKALIK P, 1992, ASTROPHYS J, V385, P685, DOI 10.1086/170975; NOERDLINGER PD, 1977, ASTRON ASTROPHYS, V57, P407; OKE JB, 1950, J R ASTRON SOC CAN, V44, P135; PETERSEN JO, 1974, ASTRON ASTROPHYS, V34, P309; PINSONNEAULT MH, 1989, ASTROPHYS J, V338, P424, DOI 10.1086/167210; PROFFITT CR, 1991, ASTROPHYS J, V380, P238, DOI 10.1086/170580; RAGHAVAN RS, 1995, SCIENCE, V267, P45, DOI 10.1126/science.267.5194.45; RICHARD O, IN PRESS ASTRON ASTR; ROGERS FJ, 1986, ASTROPHYS J, V310, P723, DOI 10.1086/164725; ROGERS FJ, 1992, ASTROPHYS J SUPPL S, V79, P507, DOI 10.1086/191659; ROGERS FJ, 1992, ASTROPHYS J, V401, P361, DOI 10.1086/172066; Rogers FJ, 1996, ASTROPHYS J, V456, P902, DOI 10.1086/176705; ROSENTHAL CS, 1995, ESA, V2, P459; ROXBURGH IW, 1994, MON NOT R ASTRON SOC, V268, P880, DOI 10.1093/mnras/268.4.880; SCHMITT JHMM, 1984, ASTROPHYS J, V282, P316, DOI 10.1086/162205; Schwarzschild K., 1906, NACHRICHTEN KONIG MP, V195, P41; SCHWARZSCHILD M, 1957, ASTROPHYS J, V125, P233, DOI 10.1086/146297; Seaton M J, 1995, OPACITY PROJECT, V1; SEATON MJ, 1994, MON NOT R ASTRON SOC, V266, P805, DOI 10.1093/mnras/266.4.805; SIMON NR, 1982, ASTROPHYS J, V260, pL87, DOI 10.1086/183876; STEIN RF, 1989, ASTROPHYS J, V342, pL95, DOI 10.1086/185493; STELLINGWERF RF, 1978, ASTRON J, V83, P1184, DOI 10.1086/112308; Thompson MJ, 1996, SCIENCE, V272, P1300, DOI 10.1126/science.272.5266.1300; THOUL AA, 1994, ASTROPHYS J, V421, P828, DOI 10.1086/173695; TSYTOVICH VN, IN PRESS ASTROPART P; von Weizsacker CF, 1937, PHYS Z, V38, P176; VORONTSOV SV, 1991, NATURE, V349, P49, DOI 10.1038/349049a0; VORONTSOV SV, 1992, MON NOT R ASTRON SOC, V257, P32, DOI 10.1093/mnras/257.1.32; WILSON RC, 1988, NATURE, V332, P810; ZAHN JP, 1991, ASTRON ASTROPHYS, V252, P179	115	923	932	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	1996	272	5266					1286	1292		10.1126/science.272.5266.1286	http://dx.doi.org/10.1126/science.272.5266.1286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UN472	8662456				2022-12-28	WOS:A1996UN47200032
J	Nmadu, PT				Nmadu, PT			Trends in staffing an academic department of surgery in a tropical hospital: Past, present, any future?	BRITISH MEDICAL JOURNAL			English	Article								Objective-To evaluate the effect of staff mobility on student teaching, the training of young surgeons, and the volume of research in an academic department of surgery of a tropical teaching hospital. Design-Retrospective study of academic staffing in the department of surgery of the Ahmadu Bello University Teaching Hospital between 1975 and 1993. Setting-Zaria, Nigeria. Subjects-42 academic staff, 1190 medical students, and 110 registrars (trainee surgeons). Main outcome measures-Number of academic staff in post, medical students, and registrars; number of research papers in latter years of the study. Results-in 19 years, 42 academic staff worked for varying periods (1-15 years) in the university department of surgery in Zaria. These included six professors, 12 senior lecturers, and 24 lecturers. Although staff numbers diminished, numbers of students ani, registrars increased year by year. Average number of publications dropped from a peak of 14.4 to 7.1 a year. Conclusion-Staffing of the department has fallen steadily over the years and has adversely affected the department's primary responsibility of teaching students and training young surgeons.			Nmadu, PT (corresponding author), AHMADU BELLO UNIV,ACAD DEPT SURG,ZARIA,NIGERIA.							BLAMEY RW, 1984, BRIT J SURG, V71, P861, DOI 10.1002/bjs.1800711119; GIDDINGS AEB, 1993, BRIT J SURG, V80, P1377, DOI 10.1002/bjs.1800801106; *NAT POSTGR MED CO, 1982, GUID CAND FELL SURG; *NAT U COMM, 1979, COURS SYST GRAD POIN; PERHOFF GT, 1988, JAMA-J AM MED ASSOC, V259, P402; RITCHIE WP, 1989, AM J SURG, V157, P538, DOI 10.1016/0002-9610(89)90693-4; STEELE RJC, 1989, BRIT J SURG, V76, P1291, DOI 10.1002/bjs.1800761222; SUSSMAN L, 1992, AM J SURG, V164, P1, DOI 10.1016/S0002-9610(05)80635-X; *W AFR COLL SURG, 1979, PROSP; *WHO, 1986, INT HLTH, P45	10	6	6	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 25	1996	312	7042					1345	1347		10.1136/bmj.312.7042.1345	http://dx.doi.org/10.1136/bmj.312.7042.1345			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN476	8646051	Green Published			2022-12-28	WOS:A1996UN47600026
J	Plas, DR; Johnson, R; Pingel, JT; Matthews, RJ; Dalton, M; Roy, G; Chan, AC; Thomas, ML				Plas, DR; Johnson, R; Pingel, JT; Matthews, RJ; Dalton, M; Roy, G; Chan, AC; Thomas, ML			Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling	SCIENCE			English	Article							PHOSPHATASE; SPECIFICITY	The threshold at which antigen triggers lymphocyte activation is set by the enzymes that regulate tyrosine phosphorylation. Upon T cell activation, the protein tyrosine phosphatase SHP-1 was found to bind to the protein tyrosine kinase ZAP-70. This interaction resulted in an increase in SHP-1 phosphatase activity and a decrease in ZAP-70 kinase activity. Expression of a dominant negative mutant of SHP-1 in T cells increased the sensitivity of the antigen receptor. Thus, SHP-1 functions as a negative regulator of the T cell antigen receptor and in setting the threshold of activation.	WASHINGTON UNIV,SCH MED,HOWARD HUGHES MED INST,CTR IMMUNOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MOLEC MICROBIOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MED,ST LOUIS,MO 63110	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)			Roy, Garbiñe/AAG-2570-2021	Roy, Garbiñe/0000-0001-6124-7574				BLISKA JB, 1992, J EXP MED, V176, P1625, DOI 10.1084/jem.176.6.1625; CAMPBELL MA, 1995, EUR J IMMUNOL, V25, P1573, DOI 10.1002/eji.1830250616; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; DECHERT U, 1995, EUR J BIOCHEM, V231, P673, DOI 10.1111/j.1432-1033.1995.0673d.x; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; EVAVOLD BD, 1992, J IMMUNOL, V148, P3471; FUHLBRIGGE RC, 1988, P NATL ACAD SCI USA, V85, P5649, DOI 10.1073/pnas.85.15.5649; HOWE LR, 1995, TRENDS BIOCHEM SCI, V20, P59, DOI 10.1016/S0968-0004(00)88958-6; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; MCFARLAND EDC, 1995, J BIOL CHEM, V270, P28103; PEI DH, 1993, P NATL ACAD SCI USA, V90, P1092, DOI 10.1073/pnas.90.3.1092; PEI DH, 1994, BIOCHEMISTRY-US, V33, P15483, DOI 10.1021/bi00255a030; PLAS DR, UNPUB; ROY G, 1995, ADV PROTEIN PHOSPHAT, V9, P121; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; TOWNLEY R, 1993, BIOCHEMISTRY-US, V32, P13414, DOI 10.1021/bi00212a006; YI TL, 1995, BLOOD, V85, P87, DOI 10.1182/blood.V85.1.87.bloodjournal85187; YI TL, 1993, MOL CELL BIOL, V13, P7577, DOI 10.1128/MCB.13.12.7577; YI TL, 1993, MOL CELL BIOL, V13, P3350, DOI 10.1128/MCB.13.6.3350	22	327	333	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 24	1996	272	5265					1173	1176		10.1126/science.272.5265.1173	http://dx.doi.org/10.1126/science.272.5265.1173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8638162				2022-12-28	WOS:A1996UM88900051
J	Rivkin, RB; Legendre, L; Deibel, D; Tremblay, JE; Klein, B; Crocker, K; Roy, S; Silverberg, N; Lovejoy, C; Mesple, F; Romero, N; Anderson, MR; Matthews, P; Savenkoff, C; Vezina, A; Therriault, JC; Wesson, J; Berube, C; Ingram, RG				Rivkin, RB; Legendre, L; Deibel, D; Tremblay, JE; Klein, B; Crocker, K; Roy, S; Silverberg, N; Lovejoy, C; Mesple, F; Romero, N; Anderson, MR; Matthews, P; Savenkoff, C; Vezina, A; Therriault, JC; Wesson, J; Berube, C; Ingram, RG			Vertical flux of biogenic carbon in the ocean: Is there food web control?	SCIENCE			English	Article							MICROBIAL LOOP; ORGANIC-MATTER; PARTICLE-FLUX; PACIFIC-OCEAN; DEEP OCEAN; TEMPERATURE; BACTERIA; GROWTH; SIZE; SEA	Models of biogenic carbon (BC) flux assume that short herbivorous food chains lead to high export, whereas complex microbial or omnivorous food webs lead to recycling and low export, and that export of BC from the euphotic zone equals new production (NP). In the Gulf of St. Lawrence, particulate organic carbon fluxes were similar during the spring phytoplankton bloom, when herbivory dominated, and during nonbloom conditions, when microbial and omnivorous food webs dominated. In contrast, NP was 1.2 to 161 times greater during the bloom than after it. Thus, neither food web structure nor NP can predict the magnitude or patterns of BC export, particularly on time scales over which the ocean is in nonequilibrium conditions.	UNIV LAVAL, DEPT BIOL, QUEBEC CITY, PQ G1K 7P4, CANADA; INRS OCEANOL, RIMOUSKI, PQ G5L 3A1, CANADA; MINIST PECHES & OCEANS, INST MAURICE LAMONTAGNE, MONT JOLI, PQ G5H 3Z4, CANADA; FISHERIES & OCEANS CANADA, SCI BRANCH, MARINE HABITAT RES, ST JOHNS, NF A1C 5X1, CANADA; MCGILL UNIV, DEPT ATMOSPHER & OCEAN SCI, MONTREAL, PQ H3A 2K6, CANADA	Laval University; University of Quebec; Institut national de la recherche scientifique (INRS); Fisheries & Oceans Canada; Fisheries & Oceans Canada; McGill University	Rivkin, RB (corresponding author), MEM UNIV NEWFOUNDLAND, CTR OCEAN SCI, ST JOHNS, NF A1C 5S7, CANADA.		Lovejoy, Connie/A-3756-2008	Lovejoy, Connie/0000-0001-8027-2281; Klein, Bert/0000-0003-3672-5807				AELLON CM, 1985, J PLANK RES, V7, P821; ARISTEGUI J, 1995, J PLANKTON RES, V17, P1563, DOI 10.1093/plankt/17.7.1563; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; BUESSELER KO, 1991, NATURE, V353, P420, DOI 10.1038/353420a0; CARLSON CA, 1994, NATURE, V371, P405, DOI 10.1038/371405a0; CHOI JW, 1992, APPL ENVIRON MICROB, V58, P593, DOI 10.1128/AEM.58.2.593-599.1992; COLLOS Y, 1987, INT J RAD APPL I, V38; CORNER EDS, 1967, J MAR BIOL ASSOC UK, V47, P259, DOI 10.1017/S002531540005637X; CORNER EDS, 1976, J MAR BIOL ASSOC UK, V56, P345, DOI 10.1017/S0025315400018968; CROCKER K, UNPUB; DAUCHEZ S, IN PRESS MAR ECOL PR; DUGDALE RC, 1992, J GEOPHYS RES-OCEANS, V97, P681, DOI 10.1029/91JC01533; DUGDALE RC, 1989, J GEOPHYS RES-OCEANS, V94, P18119, DOI 10.1029/JC094iC12p18119; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; EPPLEY RW, 1989, LIFE SCI R, V44, P85; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; GIFFORD D J, 1991, Marine Microbial Food Webs, V5, P161; HAGSTROM A, 1988, MAR ECOL PROG SER, V49, P171, DOI 10.3354/meps049171; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; JUMARS PA, 1989, DEEP-SEA RES, V36, P483, DOI 10.1016/0198-0149(89)90001-0; KIRCHMAN D, 1982, APPL ENVIRON MICROB, V44, P1296, DOI 10.1128/AEM.44.6.1296-1307.1982; LANDRY MR, 1982, MAR BIOL, V67, P283, DOI 10.1007/BF00397668; LEGENDRE L, 1995, AQUAT MICROB ECOL, V9, P69, DOI 10.3354/ame009069; LEGENDRE L, 1989, LIMNOL OCEANOGR, V34, P1374, DOI 10.4319/lo.1989.34.7.1374; LEGENDRE L, 1995, OPHELIA, V41, P153, DOI 10.1080/00785236.1995.10422042; LOHRENZ SE, 1992, DEEP-SEA RES, V39, P1373, DOI 10.1016/0198-0149(92)90074-4; MICHAELS AF, 1994, DEEP-SEA RES PT I, V41, P1013, DOI 10.1016/0967-0637(94)90016-7; MICHAELS AF, 1994, NATURE, V372, P537, DOI 10.1038/372537a0; MICHAELS AF, 1988, DEEP-SEA RES, V35, P473, DOI 10.1016/0198-0149(88)90126-4; MULLIN MM, 1963, LIMNOL OCEANOGR, V8, P239, DOI 10.4319/lo.1963.8.2.0239; OHMAN MD, 1994, LIMNOL OCEANOGR, V39, P21, DOI 10.4319/lo.1994.39.1.0021; PACE ML, 1987, NATURE, V325, P803, DOI 10.1038/325803a0; PAUL B, 1996, EOS, V76, P6; PLATT T, 1989, MAR ECOL PROG SER, V52, P77; PLATT T, 1988, SCIENCE, V241, P1613, DOI 10.1126/science.241.4873.1613; RASSOULZADEGAN F, 1982, ANN I OCEANOGR PARIS, V58, P177; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; RIVKIN RB, 1991, ANTARCT J US, V26, P145; RIVKIN RB, UNPUB; SATHYENDRANATH S, 1991, NATURE, V353, P129, DOI 10.1038/353129a0; SHERR B F, 1991, Marine Microbial Food Webs, V5, P227; SMITH SV, 1993, REV GEOPHYS, V31, P75, DOI 10.1029/92RG02584; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; TAYLOR AH, 1990, MAR ECOL PROG SER, V59, P1, DOI 10.3354/meps059001; TREMBLAY JE, IN PRESS LIMNOL OCEA; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183; 1994, MICROBIAL ECOL, V28, P223	47	112	114	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	1996	272	5265					1163	1166		10.1126/science.272.5265.1163	http://dx.doi.org/10.1126/science.272.5265.1163			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8662452				2022-12-28	WOS:A1996UM88900048
J	Oliet, SHR; Malenka, RC; Nicoll, RA				Oliet, SHR; Malenka, RC; Nicoll, RA			Bidirectional control of quantal size by synaptic activity in the hippocampus	SCIENCE			English	Article							LONG-TERM POTENTIATION; TRANSMITTER RELEASE; NEUROMUSCULAR-JUNCTION; NEURONS; CA1; STRONTIUM; CURRENTS; SLICES; CA2+	Analysis of strontium-induced asynchronous release of quanta from stimulated synapses revealed that long-term potentiation and long-term depression in the CA1 region of the mammalian hippocampus are associated with an increase and a decrease, respectively, in quantal size. At a single set of synapses, the increase in quantal size seen with long-term potentiation was completely reversed by depotentiating stimuli. Long-term potentiation and depression are also associated with an increase and decrease, respectively, in the frequency of quantal events, consistent with an all-or-none regulation (up or down) of clusters of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, a change in the release of transmitter, or both.	UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Oliet, SHR (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT MOLEC & CELLULAR PHARMACOL,SAN FRANCISCO,CA 94143, USA.			Oliet, Stephane/0000-0003-0595-9029				ASZTELY F, 1991, BRAIN RES, V558, P153, DOI 10.1016/0006-8993(91)90734-D; BAIN AI, 1992, J PHYSIOL-LONDON, V450, P63, DOI 10.1113/jphysiol.1992.sp019116; BEKKERS JM, 1995, J NEUROPHYSIOL, V73, P1145, DOI 10.1152/jn.1995.73.3.1145; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DODGE FA, 1969, J PHYSIOL-LONDON, V200, P267, DOI 10.1113/jphysiol.1969.sp008692; EDWARDS F, 1991, NATURE, V350, P271, DOI 10.1038/350271a0; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; GROVER LM, 1995, SYNAPSE, V19, P121, DOI 10.1002/syn.890190208; HANSE E, 1994, J NEUROSCI, V14, P5028; HUBER KM, 1995, J NEUROPHYSIOL, V73, P270, DOI 10.1152/jn.1995.73.1.270; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Katz B., 1966, NERVE MUSCLE SYNAPSE; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LARKMAN A, 1992, NATURE, V360, P70, DOI 10.1038/360070a0; LARKMAN AU, 1995, CURR OPIN NEUROBIOL, V5, P324, DOI 10.1016/0959-4388(95)80045-X; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MANABE T, 1994, SCIENCE, V265, P1888, DOI 10.1126/science.7916483; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MEIRI U, 1971, J PHYSIOL-LONDON, V215, P709, DOI 10.1113/jphysiol.1971.sp009493; MILEDI R, 1966, NATURE, V212, P1233, DOI 10.1038/2121233a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; WYLLIE DJA, 1994, NEURON, V13, P635, DOI 10.1016/0896-6273(94)90031-0; ZENGEL JE, 1980, J GEN PHYSIOL, V76, P175, DOI 10.1085/jgp.76.2.175	34	171	171	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 1	1996	271	5253					1294	1297		10.1126/science.271.5253.1294	http://dx.doi.org/10.1126/science.271.5253.1294			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TX695	8638114				2022-12-28	WOS:A1996TX69500041
J	Loeser, AG; Shen, ZX; Dessau, DS; Marshall, DS; Park, CH; Fournier, P; Kapitulnik, A				Loeser, AG; Shen, ZX; Dessau, DS; Marshall, DS; Park, CH; Fournier, P; Kapitulnik, A			Excitation gap in the normal state of underdoped Bi2Sr2CaCu2O8+delta	SCIENCE			English	Article							A-B PLANE; HIGH-TC; SPIN DYNAMICS; SUPERCONDUCTIVITY; RELAXATION; ANISOTROPY; CU	Angle-resolved photoemission experiments reveal evidence of an energy gap in the normal state excitation spectrum of the cuprate superconductor Bi2Sr2CaCu2O8+delta. This gap exists only in underdoped samples and closes around the doping level at which the superconducting transition temperature T-c is a maximum. The momentum dependence and magnitude of the gap closely resemble those of the d(x2-y2) gap observed in the superconducting state. This observation is consistent with results from several other experimental techniques, which also indicate the presence of a gap in the normal stale. Some possible theoretical explanations for this effect are reviewed.	STANFORD UNIV, SOLID STATE LAB, STANFORD, CA 94305 USA; STANFORD UNIV, DEPT APPL PHYS, STANFORD, CA 94305 USA	Stanford University; Stanford University	Loeser, AG (corresponding author), STANFORD SYNCHROTRON RADIAT LAB, DEPT APPL PHYS, STANFORD, CA 94305 USA.			Fournier, Patrick/0000-0002-2620-6272; kapitulnik, aharon/0000-0002-2569-3582				Andersen OK, 1995, J PHYS CHEM SOLIDS, V56, P1573, DOI 10.1016/0022-3697(95)00269-3; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BARTLOGG B, 1991, PHYS TODAY, V44, P44, DOI 10.1063/1.881260; BATLOGG B, 1994, PHYSICA C, V235, P130, DOI 10.1016/0921-4534(94)91330-7; BORKOWSKI LS, 1994, PHYS REV B, V49, P15404, DOI 10.1103/PhysRevB.49.15404; DESSAU DS, 1992, PHYS REV B, V45, P5095, DOI 10.1103/PhysRevB.45.5095; DONIACH S, 1990, PHYS REV B, V41, P6668, DOI 10.1103/PhysRevB.41.6668; GROEN WA, 1990, PHYSICA C, V165, P55, DOI 10.1016/0921-4534(90)90431-D; Hufner S., 1995, PHOTOELECTRON SPECTR; HWANG HY, 1994, PHYS REV LETT, V72, P2636, DOI 10.1103/PhysRevLett.72.2636; IMAI T, 1989, PHYSICA C, V162, P169, DOI 10.1016/0921-4534(89)90971-4; Ioffe LB, 1995, J PHYS CHEM SOLIDS, V56, P1611, DOI 10.1016/0022-3697(95)00134-4; KOTLIAR G, 1988, PHYS REV B, V38, P5142, DOI 10.1103/PhysRevB.38.5142; LAUGHLIN RB, 1994, PHYSICA C, V234, P280, DOI 10.1016/0921-4534(94)90574-6; LORAM JW, 1994, PHYSICA C, V235, P134, DOI 10.1016/0921-4534(94)91331-5; MAHAN GD, 1993, PHYS REV LETT, V71, P4277, DOI 10.1103/PhysRevLett.71.4277; MARSHALL D, UNPUB; MARSHALL DS, 1996, THESIS STANFORD U; MASSIDDA S, 1988, PHYSICA C, V152, P251, DOI 10.1016/0921-4534(88)90136-0; MITZI DB, 1990, PHYS REV B, V41, P6564, DOI 10.1103/PhysRevB.41.6564; Norman MR, 1995, PHYS REV B, V52, P15107, DOI 10.1103/PhysRevB.52.15107; Nozieres P., 1990, THEORY QUANTUM LIQUI; RANDERIA M, 1992, PHYS REV LETT, V69, P2001, DOI 10.1103/PhysRevLett.69.2001; RICE TM, 1990, J LESS-COMMON MET, V164, P1439, DOI 10.1016/0022-5088(90)90567-4; ROSSATMIGNOD J, 1991, PHYSICA B, V169, P58, DOI 10.1016/0921-4526(91)90208-V; ROTTER LD, 1991, PHYS REV LETT, V67, P2741, DOI 10.1103/PhysRevLett.67.2741; Schrieffer JR, 1995, J PHYS CHEM SOLIDS, V56, P1673, DOI 10.1016/0022-3697(95)00227-8; SHEN ZX, 1993, PHYS REV LETT, V70, P1553, DOI 10.1103/PhysRevLett.70.1553; SMITH NV, 1993, PHYS REV B, V47, P15476, DOI 10.1103/PhysRevB.47.15476; TAKIGAWA M, 1994, PHYS REV B, V49, P4158, DOI 10.1103/PhysRevB.49.4158; TAKIGAWA M, 1991, PHYS REV B, V43, P247, DOI 10.1103/PhysRevB.43.247; TALLON JL, 1995, PHYS REV LETT, V75, P4114, DOI 10.1103/PhysRevLett.75.4114; TANAMOTO T, 1992, J PHYS SOC JPN, V61, P1886, DOI 10.1143/JPSJ.61.1886; TIMUSK T, COMMUNICATION; TRIVEDI N, 1995, PHYS REV LETT, V75, P312, DOI 10.1103/PhysRevLett.75.312; UEMURA YJ, 1989, PHYS REV LETT, V62, P2317, DOI 10.1103/PhysRevLett.62.2317; WELLS BO, 1995, PHYS REV LETT, V74, P964, DOI 10.1103/PhysRevLett.74.964; Wen XG, 1996, PHYS REV LETT, V76, P503, DOI 10.1103/PhysRevLett.76.503; 1995, J PHYS CHEM SOLIDS, V56	41	859	866	4	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	1996	273	5273					325	329		10.1126/science.273.5273.325	http://dx.doi.org/10.1126/science.273.5273.325			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY202	8662512				2022-12-28	WOS:A1996UY20200029
J	Leshner, AI				Leshner, AI			Molecular mechanisms of cocaine addiction	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											Leshner, AI (corresponding author), NIDA,ROCKVILLE,MD 20857, USA.							CARRERA MRA, 1995, NATURE, V378, P727, DOI 10.1038/378727a0; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586	3	31	32	0	4	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	1996	335	2					128	129		10.1056/NEJM199607113350211	http://dx.doi.org/10.1056/NEJM199607113350211			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW353	8649475				2022-12-28	WOS:A1996UW35300011
J	Deyton, L				Deyton, L			Importance of surrogate markers in evaluation of antiviral therapy for HIV infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; CLINICAL-TRIALS; END-POINTS; AIDS				Deyton, L (corresponding author), NIAID, DIV AIDS,HIV RES BRANCH,NIH,SOLAR BLDG ROOM 2C16, 6003 EXECUT BLVD MSC 7620, BETHESDA, MD 20892 USA.							CHOI SS, 1993, ANN INTERN MED, V118, P674, DOI 10.7326/0003-4819-118-9-199305010-00003; Collier AC, 1996, NEW ENGL J MED, V334, P1011, DOI 10.1056/NEJM199604183341602; COOMBS RW, 1989, NEW ENGL J MED, V321, P1626, DOI 10.1056/NEJM198912143212402; DAQUILA RT, 1995, P 2 NAT C HUM RETR R; DEGRUTTOLA V, 1994, J INFECT DIS, V169, P713, DOI 10.1093/infdis/169.4.713; DEWOLF F, 1987, BMJ-BRIT MED J, V295, P569, DOI 10.1136/bmj.295.6598.569; ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502; EYSTER ME, 1989, ANN INTERN MED, V110, P963, DOI 10.7326/0003-4819-110-12-963; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; FLEMING TR, 1994, STAT MED, V13, P955, DOI 10.1002/sim.4780130906; FLEMING TR, 1994, STAT MED, V13, P1423, DOI 10.1002/sim.4780131318; FREEDMAN LS, 1992, STAT MED, V11, P167, DOI 10.1002/sim.4780110204; GAZZARD B, 1996, P 3 C RETR OPP INF W; HAMMER SM, 1996, P 3 C RETR OPP INF W; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HO DD, 1989, NEW ENGL J MED, V321, P1621, DOI 10.1056/NEJM198912143212401; HUGHES MD, 1995, J ACQ IMMUN DEF SYND, V10, pS1; *I MED, 1990, SURR ENDP EV EFF DRU; KAPPES JC, 1995, J ACQ IMMUN DEF SYND, V10, P139, DOI 10.1097/00042560-199510020-00005; LIN DY, 1993, STAT MED, V12, P835, DOI 10.1002/sim.4780120904; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; PRENTICE RL, 1989, STAT MED, V8, P431, DOI 10.1002/sim.4780080407; REICHELDERFER PS, 1995, J ACQ IMMUN DEF SYND, V10, pS19; SARAVOLATZ L, 1996, P 3 C RETR OPP INF W; STEIN DS, 1992, J INFECT DIS, V165, P352, DOI 10.1093/infdis/165.2.352; THOMPSON M, 1995, CPCRA036 HIV RNA PRO; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	28	14	14	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1996	276	2					159	160		10.1001/jama.276.2.159	http://dx.doi.org/10.1001/jama.276.2.159			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UV485	8656509				2022-12-28	WOS:A1996UV48500033
J	Buxton, AE; Lee, KL; DiCarlo, L; Echt, DS; Fisher, JD; Greer, S; Josephson, ME; Packer, D; Prystowsky, EN; Talajic, M				Buxton, AE; Lee, KL; DiCarlo, L; Echt, DS; Fisher, JD; Greer, S; Josephson, ME; Packer, D; Prystowsky, EN; Talajic, M			Nonsustained ventricular tachycardia in coronary artery disease: Relation to inducible sustained ventricular tachycardia	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; LATE HOSPITAL PHASE; PREVALENCE; ARRHYTHMIAS; COMPLEXES; SURVIVAL; TRIAL	Background: Many physicians believe that electrocardiographic characteristics of nonsustained ventricular tachycardia correlate with the risk for sudden death in survivors of myocardial infarction. Sustained ventricular tachycardia induced by programmed electrical stimulation has also been shown to predict sudden death. Objective: To determine whether electrocardiographic characteristics of spontaneous nonsustained ventricular tachycardia can predict the inducibility of sustained ventricular tachycardia by programmed electrical stimulation in patients with coronary artery disease having abnormal ventricular function. Design: Observational cohort study. Setting: 70 clinical electrophysiology laboratories in the United States and Canada. Patients: 1480 consecutive patients with coronary artery disease, left ventricular ejection fraction of 0.40 or less, and asymptomatic nonsustained ventricular tachycardia. Intervention: Electrophysiologic study attempting to induce sustained monomorphic ventricular tachycardia. Measurements: Daily frequency, duration, and cycle length of spontaneous episodes of nonsustained ventricular tachycardia, measured by standard electrocardiographic recordings. Results: No statistically significant difference in the frequency or duration of spontaneous nonsustained ventricular tachycardia was seen between patients with and those without inducible sustained ventricular tachycardia. Rates of spontaneous tachycardia were slightly slower in patients with inducible ventricular tachycardia than in patients without inducible ventricular tachycardia (P = 0.047), but the difference was not clinically significant. Conclusion: Electrocardiographic characteristics of spontaneous nonsustained ventricular tachycardia do not predict which patients with coronary artery disease will have inducible sustained ventricular tachycardia.	DUKE UNIV, MED CTR, DATA COORDINATING CTR, DURHAM, NC 27710 USA; MICHIGAN HEART PC, YPSILANTI, MI 48197 USA; VANDERBILT UNIV, MED CTR, DIV CARDIOL, NASHVILLE, TN 37232 USA; MONTEFIORE MED CTR, DEPT CARDIOL, HENRY & LUCY MOSS HOSP DIV, BRONX, NY 10467 USA; ARKANSAS CARDIOL CLIN, LITTLE ROCK, AR 72205 USA; BETH ISRAEL HOSP, DIV CARDIOL, BOSTON, MA 02215 USA; MAYO CLIN & MAYO FDN, ROCHESTER, MN 55905 USA; NORTHSIDE CARDIOL, INDIANAPOLIS, IN 46260 USA; MONTREAL HEART INST, MONTREAL, PQ H1T 1C8, CANADA	Duke University; Vanderbilt University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Mayo Clinic; Universite de Montreal	Buxton, AE (corresponding author), TEMPLE UNIV, SCH MED, CARDIOVASC SECT, DEPT MED, 3401 N BROAD ST, PHILADELPHIA, PA 19140 USA.		Tang, Anthony S/E-6203-2014	Fisher, John/0000-0003-2748-8715; Talajic, Mario/0000-0001-8469-4748	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL045726, U01HL045700] Funding Source: NIH RePORTER; NHLBI NIH HHS [UO1 HL45726, UO1 HL45700] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON KP, 1978, CIRCULATION, V57, P890, DOI 10.1161/01.CIR.57.5.890; BIGGER JT, 1986, AM J CARDIOL, V58, P1151, DOI 10.1016/0002-9149(86)90374-7; BIGGER JT, 1984, CIRCULATION, V69, P250, DOI 10.1161/01.CIR.69.2.250; BIGGER JT, 1981, AM J CARDIOL, V48, P815, DOI 10.1016/0002-9149(81)90344-1; BUXTON AE, 1993, PROG CARDIOVASC DIS, V36, P215, DOI 10.1016/0033-0620(93)90015-6; BUXTON AE, 1987, CIRCULATION, V75, P1178, DOI 10.1161/01.CIR.75.6.1178; DENES P, 1991, AM J CARDIOL, V68, P887, DOI 10.1016/0002-9149(91)90404-9; DESOYZA N, 1978, AM J MED, V64, P377, DOI 10.1016/0002-9343(78)90215-2; GOMES JAC, 1984, CIRCULATION, V70, P43, DOI 10.1161/01.CIR.70.1.43; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; KLEIGER RE, 1981, CIRCULATION, V63, P64, DOI 10.1161/01.CIR.63.1.64; KLEIN RC, 1989, J AM COLL CARDIOL, V14, P155, DOI 10.1016/0735-1097(89)90066-1; LEHMANN EL, 1974, NONPARAMETRICS; MAGGIONI AP, 1993, CIRCULATION, V87, P312, DOI 10.1161/01.CIR.87.2.312; SMITH PL, 1979, AM STAT, V33, P57, DOI 10.2307/2683222; WILBER DJ, 1990, CIRCULATION, V82, P350, DOI 10.1161/01.CIR.82.2.350	17	33	36	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1996	125	1					35	39		10.7326/0003-4819-125-1-199607010-00006	http://dx.doi.org/10.7326/0003-4819-125-1-199607010-00006			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT399	8644986				2022-12-28	WOS:A1996UT39900005
J	Hofmann, E; Wrench, PM; Sharples, FP; Hiller, RG; Welte, W; Diederichs, K				Hofmann, E; Wrench, PM; Sharples, FP; Hiller, RG; Welte, W; Diederichs, K			Structural basis of light harvesting by carotenoids: Peridinin-chlorophyll-protein from Amphidinium carterae	SCIENCE			English	Article							BACTERIOCHLOROPHYLL-A-PROTEIN; PROSTHECOCHLORIS-AESTUARII; MARINE DINOFLAGELLATE; LOCATION; COMPLEX	Peridinin-chlorophyll-protein, a water-soluble light-harvesting complex that has a blue-green absorbing carotenoid as its main pigment, is present in most photosynthetic dinoflagellates, Its high-resolution (2.0 angstrom) x-ray structure reveals a noncrystallographic trimer in which each polypeptide contains an unusual jellyroll fold of the alpha-helical amino- and carboxyl-terminal domains, These domains constitute a scaffold with pseudo-twofold symmetry surrounding a hydrophobic cavity filled by two lipid, eight peridinin, and two chlorophyll a molecules, The structural basis for efficient excitonic energy transfer from peridinin to chlorophyll is found in the clustering of peridinins around the chlorophylls at van der Waals distances.	UNIV KONSTANZ,FAK BIOL,D-78434 CONSTANCE,GERMANY; MACQUARIE UNIV,SCH BIOL SCI,N RYDE,NSW 2109,AUSTRALIA	University of Konstanz; Macquarie University			Hofmann, Eckhard/GPF-5024-2022	Hofmann, Eckhard/0000-0003-4874-372X				BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1987, XPLOR VERSION 3 1; CARBONERA D, 1995, SPECTROCHIM ACTA A, V51, P115, DOI 10.1016/0584-8539(94)00204-O; DICKERSO.RE, 1968, ACTA CRYSTALL B-STRU, VB 24, P997, DOI 10.1107/S0567740868003626; DIEDERICHS K, 1995, PROTEINS, V23, P187, DOI 10.1002/prot.340230208; DIEDERICHS K, 1994, JT CCP4 ESF EACBM NE, V31, P23; Forster T., 1965, MODERN QUANTUM CHEM, V3, P93; Frank H. A., 1993, CAROTENOIDS PHOTOSYN; FUJIOSHI Y, 1994, NATURE, V367, P614; FUREY W, IN PRESS METHODS ENZ; GILLBRO T, 1993, PHOTOCHEM PHOTOBIOL, V57, P44, DOI 10.1111/j.1751-1097.1993.tb02253.x; HAXO FT, 1976, PLANT PHYSIOL, V57, P297, DOI 10.1104/pp.57.2.297; HILLER RG, 1995, FEBS LETT, V363, P175, DOI 10.1016/0014-5793(95)00297-M; HILLER RG, 1993, PHOTOCHEM PHOTOBIOL, V57, P125, DOI 10.1111/j.1751-1097.1993.tb02267.x; HILLER RG, 1995, PHOTOSYNTHESIS LIGHT, V1, P24; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; IGLESIASPRIETO R, 1991, P ROY SOC B-BIOL SCI, V246, P275, DOI 10.1098/rspb.1991.0155; IGLESIASPRIETO R, 1993, PHILOS T ROY SOC B, V340, P381, DOI 10.1098/rstb.1993.0080; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KOKA P, 1977, BIOCHIM BIOPHYS ACTA, V495, P220, DOI 10.1016/0005-2795(77)90379-8; Koyama Y, 1996, PHOTOCHEM PHOTOBIOL, V63, P243, DOI 10.1111/j.1751-1097.1996.tb03021.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUHLBRANDT W, 1991, NATURE, V350, P130, DOI 10.1038/350130a0; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P127; MATTHEWS BW, 1979, J MOL BIOL, V131, P259, DOI 10.1016/0022-2836(79)90076-7; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; MIMURO M, 1990, BIOCHIM BIOPHYS ACTA, V1016, P280, DOI 10.1016/0005-2728(90)90070-K; NORRIS BJ, 1994, PLANT MOL BIOL, V24, P673, DOI 10.1007/BF00023563; RAWLYER A, 1995, BIOCHIM BIOPHYS ACTA, V1233, P122; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; SCHIRMER T, 1985, J MOL BIOL, V184, P257, DOI 10.1016/0022-2836(85)90379-1; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; SONG PS, 1976, BIOCHEMISTRY-US, V15, P4422, DOI 10.1021/bi00665a012; STECK K, 1990, FEBS LETT, V268, P48, DOI 10.1016/0014-5793(90)80969-P; Triplett Edward L., 1993, Molecular Marine Biology and Biotechnology, V2, P246; TRONRUD DE, 1986, J MOL BIOL, V188, P443, DOI 10.1016/0022-2836(86)90167-1; [No title captured]	38	369	389	4	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1996	272	5269					1788	1791		10.1126/science.272.5269.1788	http://dx.doi.org/10.1126/science.272.5269.1788			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UT110	8650577	Green Submitted			2022-12-28	WOS:A1996UT11000043
J	Hartmann, M; Miller, RE; Toennies, JP; Vilesov, AF				Hartmann, M; Miller, RE; Toennies, JP; Vilesov, AF			High-resolution molecular spectroscopy of van der Waals clusters in liquid helium droplets	SCIENCE			English	Article							HE-4 CLUSTERS; SF6; PHASE; GAS	Small van der Waals clusters of sulfur hexafluoride (SF6) and mixed SF6-rare gas clusters were prepared inside large droplets of helium-4, with each droplet consisting of about 4000 helium atoms. A diode laser was used to measure the high-resolution infrared spectra of these clusters in the vicinity of the nu(3) vibrational mode. In all cases rotational structure was observed, indicating that the embedded species rotate nearly freely, although they had been cooled to a temperature of 0.37 kelvin. The results indicate that helium droplets are probably superfluid and thereby provide a uniquely cold yet gentle matrix for high-resolution spectroscopy.	MAX PLANCK INST STROMUNGSFORSCH,D-37073 GOTTINGEN,GERMANY; UNIV N CAROLINA,DEPT CHEM,CHAPEL HILL,NC 27599	Max Planck Society; University of North Carolina; University of North Carolina Chapel Hill								BARNETT RN, 1993, J CHEM PHYS, V99, P9730, DOI 10.1063/1.465455; DALFOVO F, 1994, Z PHYS D ATOM MOL CL, V29, P61, DOI 10.1007/BF01437166; FROCHTENICHT R, 1994, CHEM PHYS LETT, V229, P1, DOI 10.1016/0009-2614(94)01026-9; GERAEDTS J, 1982, FARADAY DISCUSS, V73, P375, DOI 10.1039/dc9827300375; GORDON EB, 1993, CHEM PHYS, V170, P411, DOI 10.1016/0301-0104(93)85122-O; GOUGH TE, 1985, J CHEM PHYS, V83, P4958, DOI 10.1063/1.449757; GOYAL S, 1992, PHYS REV LETT, V69, P933, DOI 10.1103/PhysRevLett.69.933; HARTMANN M, 1995, PHYS REV LETT, V75, P1566, DOI 10.1103/PhysRevLett.75.1566; HARTMANN M, IN PRESS; KIVELSON D, 1970, J CHEM PHYS, V52, P1810, DOI 10.1063/1.1673222; LAMB M, 1932, HYDRODYNAMICS, P152; LEVY DH, 1980, ANNU REV PHYS CHEM, V31, P197, DOI 10.1146/annurev.pc.31.100180.001213; LEWERENZ M, 1993, CHEM PHYS LETT, V206, P381, DOI 10.1016/0009-2614(93)85569-A; LEWERENZ M, 1995, J CHEM PHYS, V102, P8191, DOI 10.1063/1.469231; PACK RT, 1984, J CHEM PHYS, V80, P4940, DOI 10.1063/1.446516; PUTLITZ G, 1991, TOP APPL PHYS, V70, P237; SCHEIDEMANN A, 1993, J PHYS CHEM-US, V97, P2128, DOI 10.1021/j100112a012; SCHEIDEMANN A, 1990, PHYS REV LETT, V64, P1899, DOI 10.1103/PhysRevLett.64.1899; SCHWEIZER G, 1983, THESIS U BONN; SILVERA IF, 1984, PHYS REV B, V29, P3899, DOI 10.1103/PhysRevB.29.3899; SWANSON BI, 1981, J CHEM PHYS, V74, P3205, DOI 10.1063/1.441515; URBAN RD, 1995, J CHEM PHYS, V103, P9132, DOI 10.1063/1.470024; WHALEY KB, 1994, INT REV PHYS CHEM, V13, P41, DOI 10.1080/01442359409353290; Wilks J., 1967, PROPERTIES LIQUID SO; 1989, CHEM PHYSICS MATRIX	25	186	186	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1996	272	5268					1631	1634		10.1126/science.272.5268.1631	http://dx.doi.org/10.1126/science.272.5268.1631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8662474				2022-12-28	WOS:A1996UR09300039
J	Heilek, GM; Noller, HF				Heilek, GM; Noller, HF			Site-directed hydroxyl radical probing of the rRNA neighborhood of ribosomal protein S5	SCIENCE			English	Article							ESCHERICHIA-COLI; CROSS-LINKING; TRANSLATIONAL FIDELITY; ELECTRON-MICROSCOPY; PRIMER EXTENSION; SMALL SUBUNIT; 16S RNA; LOCALIZATION; NUCLEOTIDES; MUTATIONS	Cysteine residues were introduced into three different positions distributed on the surface of ribosomal protein S5, to serve as targets for derivatization with an Fe(II)-ethyl-enediaminetetraacetic acid linker, Hydroxyl radicals generated locally from the tethered Fe(II) in intermediate ribonucleoprotein particles or in 30S ribosomal subunits reconstituted from derivatized S5 caused cleavage of the RNA, resulting in characteristically different cleavage patterns for the three different tethering positions. These findings provide constraints for the three-dimensional folding of 16S ribosomal RNA (rRNA) and for the orientation of S5 in the 30S subunit, and they further suggest that antibiotic resistance and accuracy mutations in S5 may involve perturbation of 16S rRNA.			Heilek, GM (corresponding author), UNIV CALIF SANTA CRUZ, SINSHEIMER LABS, CTR MOL BIOL RNA, SANTA CRUZ, CA 95064 USA.							BILGIN N, 1990, EMBO J, V9, P735, DOI 10.1002/j.1460-2075.1990.tb08167.x; BRIMACOMBE R, 1988, J MOL BIOL, V199, P115, DOI 10.1016/0022-2836(88)90383-X; BRIMACOMBE R, 1990, RIBOSOME, P93; BRIMACOMBE R, 1992, BIOCHIMIE, V74, P319, DOI 10.1016/0300-9084(92)90109-R; BRIMACOMBE R, 1995, EUR J BIOCHEM, V230, P365; CAPEL MS, 1987, SCIENCE, V238, P1403, DOI 10.1126/science.3317832; CELANDER DW, 1990, BIOCHEMISTRY-US, V29, P1355, DOI 10.1021/bi00458a001; CERRETTI DP, 1983, NUCLEIC ACIDS RES, V11, P2599, DOI 10.1093/nar/11.9.2599; DERIEMER LH, 1981, J LABELLED COMPD RAD, V18, P1517, DOI 10.1002/jlcr.2580181017; GUTHRIE C, 1969, P NATL ACAD SCI USA, V63, P384, DOI 10.1073/pnas.63.2.384; HEILEK GM, 1995, P NATL ACAD SCI USA, V92, P1113, DOI 10.1073/pnas.92.4.1113; HELD WA, 1974, J BIOL CHEM, V249, P3103; JOHANSON U, 1995, NUCLEIC ACIDS RES, V23, P464, DOI 10.1093/nar/23.3.464; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KYRIATSOULIS A, 1986, NUCLEIC ACIDS RES, V14, P1171, DOI 10.1093/nar/14.3.1171; LASATER LS, 1990, NUCLEIC ACIDS RES, V18, P477, DOI 10.1093/nar/18.3.477; MALHOTRA A, 1994, J MOL BIOL, V240, P308, DOI 10.1006/jmbi.1994.1448; MARSH RC, 1973, P NATL ACAD SCI USA, V70, P151, DOI 10.1073/pnas.70.1.151; MATKOVIC B, 1980, MOL GEN GENET, V179, P135, DOI 10.1007/BF00268455; MIAN S, UNPUB; MOAZED D, 1986, J MOL BIOL, V187, P399, DOI 10.1016/0022-2836(86)90441-9; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; MONTANDON PE, 1986, EMBO J, V5, P3705, DOI 10.1002/j.1460-2075.1986.tb04703.x; NOLLER HF, UNPUB; OAKES MI, 1986, P NATL ACAD SCI USA, V83, P275, DOI 10.1073/pnas.83.2.275; OAKES MI, 1990, RIBOSOME, P180; OSSWALD M, 1987, NUCLEIC ACIDS RES, V15, P3221, DOI 10.1093/nar/15.8.3221; PIEPERSBERG W, 1975, MOL GEN GENET, V143, P43, DOI 10.1007/BF00269419; PIEPERSBERG W, 1975, MOL GEN GENET, V140, P91, DOI 10.1007/BF00329777; POWERS T, 1991, EMBO J, V10, P2203, DOI 10.1002/j.1460-2075.1991.tb07756.x; POWERS T, 1994, TRENDS GENET, V10, P27, DOI 10.1016/0168-9525(94)90016-7; RAMAKRISHNAN V, 1992, NATURE, V358, P768, DOI 10.1038/358768a0; RANA TM, 1991, P NATL ACAD SCI USA, V88, P10578, DOI 10.1073/pnas.88.23.10578; RINKEAPPEL J, 1991, EMBO J, V10, P2195, DOI 10.1002/j.1460-2075.1991.tb07755.x; SAMAHA RR, 1994, P NATL ACAD SCI USA, V91, P7884, DOI 10.1073/pnas.91.17.7884; SCHEINMAN A, 1992, BIOCHIMIE, V74, P307, DOI 10.1016/0300-9084(92)90108-Q; SIGMUND CD, 1984, NUCLEIC ACIDS RES, V12, P4653, DOI 10.1093/nar/12.11.4653; STERN S, 1988, METHOD ENZYMOL, V164, P481; STERN S, 1988, J MOL BIOL, V204, P447, DOI 10.1016/0022-2836(88)90588-8; STERN S, 1988, J MOL BIOL, V201, P683, DOI 10.1016/0022-2836(88)90467-6; STOFFLERMEILICKE M, 1990, RIBOSOME, P123; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TREMPE MR, 1982, J BIOL CHEM, V257, P9822; VONAHSEN U, 1995, SCIENCE, V267, P234, DOI 10.1126/science.7528943; WOESE CR, 1989, P NATL ACAD SCI USA, V86, P3119, DOI 10.1073/pnas.86.9.3119; ZWIEB C, 1978, NUCLEIC ACIDS RES, V5, P1189, DOI 10.1093/nar/5.4.1189	47	85	86	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	1996	272	5268					1659	1662		10.1126/science.272.5268.1659	http://dx.doi.org/10.1126/science.272.5268.1659			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8658142				2022-12-28	WOS:A1996UR09300049
J	Johnson, RL; Rothman, AL; Xie, JW; Goodrich, LV; Bare, JW; Bonifas, JM; Quinn, AG; Myers, RM; Cox, DR; Epstein, EH; Scott, MP				Johnson, RL; Rothman, AL; Xie, JW; Goodrich, LV; Bare, JW; Bonifas, JM; Quinn, AG; Myers, RM; Cox, DR; Epstein, EH; Scott, MP			Human homolog of patched, a candidate gene for the basal cell nevus syndrome	SCIENCE			English	Article							CARCINOMA SYNDROME; SEGMENT POLARITY; DROSOPHILA-TRITHORAX; ACUTE LEUKEMIAS; KRUPPEL FAMILY; GLI GENE; PROTEIN; MUTATIONS; SEQUENCES; SUNLIGHT	The basal cell nevus syndrome (BCNS) is characterized by developmental abnormalities and by the postnatal occurrence of cancers, especially basal cell carcinomas (BCCs), the most common human cancer. Heritable mutations in BCNS patients and a somatic mutation in a sporadic BCC were identified in a human homolog of the Drosophila patched (ptc) gene. The ptc gene encodes a transmembrane protein that in Drosophila acts in opposition to the Hedgehog signaling protein, controlling cell fates, patterning, and growth in numerous tissues. The human PTC gene appears to be crucial for proper embryonic development and for tumor suppression.	UNIV CALIF SAN FRANCISCO, SAN FRANCISCO GEN HOSP, DEPT DERMATOL, SAN FRANCISCO, CA 94110 USA; STANFORD UNIV, SCH MED, DEPT GENET & DEV BIOL, HOWARD HUGHES MED INST, STANFORD, CA 94305 USA; STANFORD UNIV, SCH MED, DEPT GENET, STANFORD, CA 94305 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Stanford University; Stanford University					NIAMS NIH HHS [AR3995] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARIAS AM, 1988, DEVELOPMENT, V103, P157; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BINKLEY GW, 1951, AMA ARCH DERM SYPH, V63, P73, DOI 10.1001/archderm.1951.01570010076006; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; BONIFAS JM, 1994, HUM MOL GENET, V3, P447, DOI 10.1093/hmg/3.3.447; BONIFAS JM, UNPUB; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; CAPDEVILA J, 1994, DEVELOPMENT, V120, P987; CHANG DT, 1994, DEVELOPMENT, V120, P3339; CHEN H, 1995, J INVEST DERMATOL, V105, P629, DOI 10.1111/1523-1747.ep12323846; CHENEVIXTRENCH G, 1993, AM J HUM GENET, V53, P760; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; FARNDON PA, 1994, GENOMICS, V23, P486, DOI 10.1006/geno.1994.1528; FELSENFELD AL, 1995, DEVELOPMENT, V121, P1; FORBES AJ, 1993, DEVELOPMENT, P115; GAILANI MR, 1992, CELL, V69, P111, DOI 10.1016/0092-8674(92)90122-S; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; GORLIN RJ, 1960, NEW ENGL J MED, V262, P908, DOI 10.1056/NEJM196005052621803; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; HABUCHI T, 1995, INCOGENE, V11, P1671; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; HOWELL JB, 1984, J AM ACAD DERMATOL, V11, P98, DOI 10.1016/S0190-9622(84)70141-1; HOWELL JB, 1959, ARCH DERMATOL, V79, P67, DOI 10.1001/archderm.1959.01560130069008; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; INGHAM PW, 1995, CURR BIOL, V5, P432, DOI 10.1016/S0960-9822(95)00084-4; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Johnson R. M., UNPUB; JOHNSON RL, 1994, CELL, V79, P1165, DOI 10.1016/0092-8674(94)90008-6; Johnson RL, 1995, DEVELOPMENT, V121, P4161; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; KOJIMA T, 1994, GENE, V148, P211; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; MARIGO V, 1995, GENOMICS, V28, P44, DOI 10.1006/geno.1995.1104; Marigo V, 1996, DEVELOPMENT, V122, P1225; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; MORRIS DJ, 1994, GENOMICS, V23, P23, DOI 10.1006/geno.1994.1454; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; RUPPERT JM, 1988, MOL CELL BIOL, V8, P3104, DOI 10.1128/MCB.8.8.3104; SAMPEDRO J, 1991, NATURE, V353, P187, DOI 10.1038/353187a0; SLUSARSKI DC, 1995, GENETICS, V139, P229; TANABE Y, 1995, CURR BIOL, V5, P651, DOI 10.1016/S0960-9822(95)00130-8; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; WICKING C, 1994, GENOMICS, V22, P505, DOI 10.1006/geno.1994.1423; Xie J., UNPUB; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216	65	1477	1553	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	1996	272	5268					1668	1671		10.1126/science.272.5268.1668	http://dx.doi.org/10.1126/science.272.5268.1668			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8658145				2022-12-28	WOS:A1996UR09300052
J	Oda, N; Levin, JD; Spoonde, AY; Frank, EG; Levine, AS; Woodgate, R; Ackerman, EJ				Oda, N; Levin, JD; Spoonde, AY; Frank, EG; Levine, AS; Woodgate, R; Ackerman, EJ			Arrested DNA replication in Xenopus and release by Escherichia coli mutagenesis proteins	SCIENCE			English	Article							REPAIR; OOCYTES; EXTRACT; GENES; UMUD'; EGGS; RECA	Xenopus oocytes and oocyte nuclear extracts repair ultraviolet photoproducts on double-stranded (ds) DNA and replicate single-stranded (ss) to ds DNA, M13 ss DNA molecules containing cyclobutane pyrimidine dimers were maintained but not replicated in Xenopus oocytes, yet were replicated in progesterone-matured oocytes, The replication arrest functioned only in cis, The replication arrest was alleviated by injection into oocytes of messenger RNAs encoding the prokaryotic mutagenesis proteins UmuD'C or MucA'B, These results may help explain how cells stabilize repair or replication events on DNA with unrepairable lesions.	NIDDKD,NIH,BETHESDA,MD 20892; NICHHD,SECT DNA REPLICAT REPAIR & MUTAGENESIS,NIH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)				Woodgate, Roger/0000-0001-5581-4616; Spunde, Alexander/0000-0001-8805-9100				BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; BJURSELL G, 1979, NATURE, V280, P420, DOI 10.1038/280420a0; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; CORTESE R, 1980, P NATL ACAD SCI-BIOL, V77, P4147, DOI 10.1073/pnas.77.7.4147; DOREE M, 1993, CELL CYCLE PRACTICAL, P285; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; FORD CC, 1975, DEV BIOL, V43, P189, DOI 10.1016/0012-1606(75)90140-2; FRANK EG, 1993, P NATL ACAD SCI USA, V90, P8169, DOI 10.1073/pnas.90.17.8169; FRIEDBERG EC, 1995, DNA REPAIR; HARLAND RM, 1980, CELL, V21, P761, DOI 10.1016/0092-8674(80)90439-0; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HEYER WD, 1994, EXPERIENTIA, V50, P223, DOI 10.1007/BF01924005; JENKINS TM, 1992, SCIENCE, V258, P475, DOI 10.1126/science.1411545; JOHNSON RD, 1995, MOL CELL BIOL, V15, P4843; KAISERMAN HB, 1990, EUKARYOTIC NUCLEUS M, V2, P783; KAY BK, 1991, PRACTICAL USES CELL, V36; LARIMER FW, 1989, J BACTERIOL, V171, P230, DOI 10.1128/jb.171.1.230-237.1989; MAESHIMA K, 1995, GENE, V160, P195, DOI 10.1016/0378-1119(95)00148-Y; MURLI S, 1993, CURR OPIN GENET DEV, V3, P719, DOI 10.1016/S0959-437X(05)80089-9; ODA N, UNPUB; ODA N, IN PRESS J BIOL CHEM; Peat TS, 1996, NATURE, V380, P727, DOI 10.1038/380727a0; RAJAGOPALAN M, 1992, P NATL ACAD SCI USA, V89, P10777, DOI 10.1073/pnas.89.22.10777; SAXENA JK, 1990, NUCLEIC ACIDS RES, V18, P7425, DOI 10.1093/nar/18.24.7425; SEDGWICK SG, 1991, J BACTERIOL, V173, P5604, DOI 10.1128/jb.173.18.5604-5611.1991; SEDGWICK SG, 1991, MOL GEN GENET, V229, P428, DOI 10.1007/BF00267466; THOMAS DC, 1991, BIOCHEMISTRY-US, V30, P11751, DOI 10.1021/bi00115a003; WALKER GC, 1984, MICROBIOL REV, V48, P60, DOI 10.1128/MMBR.48.1.60-93.1984; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; WITKIN EM, 1987, P NATL ACAD SCI USA, V84, P6805, DOI 10.1073/pnas.84.19.6805; WOODGATE R, 1992, MOL MICROBIOL, V6, P2213, DOI 10.1111/j.1365-2958.1992.tb01397.x	31	13	13	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1996	272	5268					1644	1646		10.1126/science.272.5268.1644	http://dx.doi.org/10.1126/science.272.5268.1644			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8658137				2022-12-28	WOS:A1996UR09300044
J	Allison, MC; Mills, PR				Allison, MC; Mills, PR			Controversies in management: Screening asymptomatic people at high risk for hepatitis C - The case against	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTTRANSFUSION HEPATITIS		GARTNAVEL ROYAL HOSP, GLASGOW G12 0YN, LANARK, SCOTLAND	Gartnavel Royal Hospital	Allison, MC (corresponding author), ROYAL GWENT HOSP, NEWPORT NP9 2UB, GWENT, WALES.							ALTER MJ, 1995, SEMIN LIVER DIS, V15, P5, DOI 10.1055/s-2007-1007259; BOOTH JCL, 1995, GUT, V37, P449, DOI 10.1136/gut.37.4.449; DIBISCEGLIE AM, 1991, HEPATOLOGY, V14, P969, DOI 10.1016/0270-9139(91)90113-A; DONAHUE JG, 1992, NEW ENGL J MED, V327, P369, DOI 10.1056/NEJM199208063270601; DUSHEIKO GM, 1994, ALIMENT PHARM THER, V8, P229; GORDON SC, 1993, HEPATOLOGY, V18, P1338, DOI 10.1002/hep.1840180609; LAU JYN, 1993, LANCET, V342, P1208, DOI 10.1016/0140-6736(93)92187-X; MCMAHON RFT, 1994, HISTOPATHOLOGY, V24, P517; NEUGUT AI, 1988, GASTROENTEROLOGY, V95, P492, DOI 10.1016/0016-5085(88)90511-2; POYNARD T, 1995, NEW ENGL J MED, V332, P1457, DOI 10.1056/NEJM199506013322201; SANGIOVANNI A, 1995, HEPATOLOGY, V22, P734; SEEFF LB, 1992, NEW ENGL J MED, V327, P1906, DOI 10.1056/NEJM199212313272703; SHIELL A, 1994, MED J AUSTRALIA, V160, P268, DOI 10.5694/j.1326-5377.1994.tb125830.x; THOMAS DL, 1995, J INFECT DIS, V171, P768, DOI 10.1093/infdis/171.4.768; TREMOLADA F, 1992, J HEPATOL, V16, P273, DOI 10.1016/S0168-8278(05)80657-9; ZANETTI AR, 1995, LANCET, V345, P289, DOI 10.1016/S0140-6736(95)90277-5	16	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	1996	312	7042					1349	1350		10.1136/bmj.312.7042.1349	http://dx.doi.org/10.1136/bmj.312.7042.1349			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN476	8646053	Green Published			2022-12-28	WOS:A1996UN47600028
J	Tsukihara, T; Aoyama, H; Yamashita, E; Tomizaki, T; Yamaguchi, H; ShinzawaItoh, K; Nakashima, R; Yaono, R; Yoshikawa, S				Tsukihara, T; Aoyama, H; Yamashita, E; Tomizaki, T; Yamaguchi, H; ShinzawaItoh, K; Nakashima, R; Yaono, R; Yoshikawa, S			The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 angstrom	SCIENCE			English	Article							CARBON-MONOXIDE BINDING; PARACOCCUS-DENITRIFICANS; SUBUNITS; RESOLUTION; CONFORMERS; PROTEINS; ENERGY	The crystal structure of bovine heart cytochrome c oxidase at 2.8 Angstrom resolution with an R Value of 19.9 percent reveals 13 subunits, each different from the other, five phosphatidyl ethanolamines, three phosphatidyl glycerols and two cholates, two hemes A, and three copper, one magnesium, and one zinc. Of 3606 amino acid residues in the dimer, 3560 have been converged to a reasonable structure by refinement, A hydrogen-bonded system, including a propionate of a heme A (heme a), part of peptide backbone, and an imidazole ligand of Cu-A, could provide an electron transfer pathway between Cu-A and heme a, Two possible proton pathways for pumping, each spanning from the matrix to the cytosolic surfaces, were identified, including hydrogen bonds, internal cavities likely to contain water molecules, and structures that could form hydrogen bonds with small possible conformational change of amino acid side chains. Possible channels for chemical protons to produce H2O, for removing the produced water, and for O-2, respectively, were identified.	OSAKA UNIV,INST PROT RES,SUITA,OSAKA 565,JAPAN; HIMEJI INST TECHNOL,DEPT LIFE SCI,KAMIGOHRI AKOH,HYOGO 67812,JAPAN	Osaka University; University of Hyogo			Yamashita, Eiki/V-6758-2019	Yamashita, Eiki/0000-0002-4278-0039; Aoyama, Hiroshi/0000-0001-7915-8975				ANDYMARK WH, 1994, NATURE, V367, P750; ANTHONY G, 1993, P NATL ACAD SCI USA, V90, P1652, DOI 10.1073/pnas.90.5.1652; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BERATAN DN, 1992, SCIENCE, V258, P1740, DOI 10.1126/science.1334572; BLOOMER AC, 1978, NATURE, V276, P362, DOI 10.1038/276362a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; CAUGHEY WS, 1981, P NATL ACAD SCI-BIOL, V78, P2903, DOI 10.1073/pnas.78.5.2903; CHOTHIA C, 1977, P NATL ACAD SCI USA, V74, P4130, DOI 10.1073/pnas.74.10.4130; FETTER JR, 1995, P NATL ACAD SCI USA, V92, P1604, DOI 10.1073/pnas.92.5.1604; GARAVITO R M, 1990, Methods (Orlando), V1, P57, DOI 10.1016/S1046-2023(05)80147-1; GARCIAHORSMAN JA, 1995, BIOCHEMISTRY-US, V34, P4428, DOI 10.1021/bi00013a035; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HILL BC, 1994, J BIOL CHEM, V269, P2419; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; KADENBACH B, 1981, FEBS LETT, V135, P1, DOI 10.1016/0014-5793(81)80932-5; KADENBACH B, 1983, TRENDS BIOCHEM SCI, V8, P398, DOI 10.1016/0968-0004(83)90302-X; MALMSTROM BG, 1990, CHEM REV, V90, P1247, DOI 10.1021/cr00105a008; MORGAN JE, 1994, J BIOENERG BIOMEMBR, V26, P599, DOI 10.1007/BF00831534; MULLER M, 1988, BIOCHEM BIOPH RES CO, V154, P1260, DOI 10.1016/0006-291X(88)90275-6; PALMER G, 1991, LONG RANGE ELECT TRA; Perutz M. F., 1990, MECH COOPERATIVITY; POTTER WT, 1990, BIOCHEMISTRY-US, V29, P6283, DOI 10.1021/bi00478a025; RAITIO M, 1987, EMBO J, V6, P2825, DOI 10.1002/j.1460-2075.1987.tb02579.x; ROBINSON NC, 1982, BIOCHEMISTRY-US, V21, P184, DOI 10.1021/bi00530a031; THOMAS JW, 1993, BIOCHEMISTRY-US, V32, P10923, DOI 10.1021/bi00091a048; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; VASSILEV AO, 1995, P NATL ACAD SCI USA, V92, P8680, DOI 10.1073/pnas.92.19.8680; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Warburg O, 1929, BIOCHEM Z, V214, P64; WIKSTROM MKF, 1976, FEBS LETT, V65, P259, DOI 10.1016/0014-5793(76)80127-5; YOSHIKAWA S, 1982, J BIOL CHEM, V257, P412; ZHANG YZ, 1991, BIOCHEMISTRY-US, V30, P3674, DOI 10.1021/bi00229a012	33	1884	1920	4	173	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 24	1996	272	5265					1136	1144		10.1126/science.272.5265.1136	http://dx.doi.org/10.1126/science.272.5265.1136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8638158				2022-12-28	WOS:A1996UM88900040
J	Kurten, RC; Cadena, DL; Gill, GN				Kurten, RC; Cadena, DL; Gill, GN			Enhanced degradation of EGF receptors by a sorting nexin, SNX1	SCIENCE			English	Article								The vectorial movement of proteins requires specific recognition by components of the vesicular trafficking machinery. A protein, sorting nexin-1 (SNX1), was identified in a human cell line that bound to a region of the epidermal growth factor receptor (EGFR) containing the lysosomal targeting code, SNX1 contains a region of homology to a yeast vacuolar sorting protein, and overexpression of SNX1 decreased the amount of EGFR on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation. Thus, SNX1 is likely to play a role in sorting EGFR to lysosomes.	UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093	University of California System; University of California San Diego					NCI NIH HHS [CA58689] Funding Source: Medline; NIDDK NIH HHS [F32DK08666] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA058689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK008666] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; CADENA DL, 1994, J BIOL CHEM, V269, P260; EKENA K, 1995, MOL CELL BIOL, V15, P1671; FRENCH AR, 1994, J BIOL CHEM, V269, P15749; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; KURTEN RC, UNPUB; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Moore DD, 1995, GLOB MOB SURV; NESTEROV A, 1995, J BIOL CHEM, V270, P6320, DOI 10.1074/jbc.270.11.6320; OPRESKO LK, 1995, J BIOL CHEM, V270, P4325, DOI 10.1074/jbc.270.9.4325; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	11	308	317	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 17	1996	272	5264					1008	1010		10.1126/science.272.5264.1008	http://dx.doi.org/10.1126/science.272.5264.1008			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL619	8638121				2022-12-28	WOS:A1996UL61900044
J	Li, KJ; Kaufman, TC				Li, KJ; Kaufman, TC			The homeotic target gene centrosomin encodes an essential centrosomal component	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; DROSOPHILA EMBRYO; SEGMENTAL DETERMINATION; BITHORAX COMPLEX; GAMMA-TUBULIN; ULTRABITHORAX; RECOMBINASE; EXPRESSION; MUTATIONS; PROTEINS	The centrosomin (cnn) gene encodes a protein associated with mitotic centrosomes in Drosophila melanogaster and is a target of homeotic gene regulation. Here we report that CNN is an essential component of the centrosome. Loss of zygotic cnn expression disrupts the development of the second midgut constriction, the gastric caeca, and the nervous system. Embryos that lack maternal as well as zygotic cnn expression display defects in nuclear division, chromosome alignment, and microtubule organization, while adult flies that are mosaic for cnn(-) cells exhibit defects indicative of a block in cell proliferation. We propose that cnn provides an example of homeotic genes directly regulating the accumulation of essential cellular proteins to carry out segment-specific morphogenetic functions.	INDIANA UNIV, HOWARD HUGHES MED INST, DEPT BIOL, BLOOMINGTON, IN 47405 USA	Howard Hughes Medical Institute; Indiana University System; Indiana University Bloomington								AFSHAR K, 1995, CELL, V81, P129, DOI 10.1016/0092-8674(95)90377-1; AHMAD FJ, 1994, NEURON, V12, P271, DOI 10.1016/0896-6273(94)90270-4; ANDREW DJ, 1992, NEW BIOL, V4, P5; Ashburner M., 1989, DROSOPHILA LAB HDB; BAAS PW, 1992, J CELL BIOL, V119, P171, DOI 10.1083/jcb.119.1.171; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BIENZ M, 1994, TRENDS GENET, V10, P22, DOI 10.1016/0168-9525(94)90015-9; BOOKER R, 1989, DEVELOPMENT, V105, P621; Botas J, 1993, CURR OPIN CELL BIOL, V5, P1015, DOI 10.1016/0955-0674(93)90086-6; BRYANT PJ, 1971, DEV BIOL, V26, P606, DOI 10.1016/0012-1606(71)90146-1; BRYANT PJ, 1973, GENETICS, V75, P623; CAPOVILLA M, 1994, CELL, V76, P461, DOI 10.1016/0092-8674(94)90111-2; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; CHOU TB, 1992, GENETICS, V131, P643; CHOU TB, 1993, DEVELOPMENT, V119, P1359; COOLEY L, 1994, SCIENCE, V266, P590, DOI 10.1126/science.7939713; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; Fuller M.T., 1993, SPERMATOGENESIS DEV; GHYSEN A, 1985, CELL, V40, P943, DOI 10.1016/0092-8674(85)90354-X; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; GONZALEZ C, 1990, J CELL SCI, V96, P605; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Goodman Corey S., 1993, P1131; GOULD AP, 1992, DEVELOPMENT, V116, P1163; GRABA Y, 1995, DEVELOPMENT, V121, P209; GRABA Y, 1992, EMBO J, V11, P3375, DOI 10.1002/j.1460-2075.1992.tb05416.x; HEUER JG, 1995, DEVELOPMENT, V121, P3861; HINZ U, 1992, DEVELOPMENT, V116, P543; JIJAKLI H, 1992, INT J DEV BIOL, V36, P93; JONES B, 1993, GENE DEV, V7, P229, DOI 10.1101/gad.7.2.229; Kalt Astrid, 1993, Trends in Cell Biology, V3, P118, DOI 10.1016/0962-8924(93)90174-Y; KELLOGG DR, 1995, MOL BIOL CELL, V6, P1673, DOI 10.1091/mbc.6.12.1673; KELLOGG DR, 1989, J CELL BIOL, V109, P2977, DOI 10.1083/jcb.109.6.2977; KELLOGG DR, 1994, ANNU REV BIOCHEM, V63, P639, DOI 10.1146/annurev.bi.63.070194.003231; LANE ME, 1994, GENE DEV, V8, P2986, DOI 10.1101/gad.8.24.2986; MASTICK GS, 1995, GENETICS, V139, P349; OEGEMA K, 1995, J CELL BIOL, V131, P1261, DOI 10.1083/jcb.131.5.1261; RAFF JW, 1993, J CELL BIOL, V121, P823, DOI 10.1083/jcb.121.4.823; REUTER R, 1990, DEVELOPMENT, V109, P289; RUSSELL MA, 1974, DEV BIOL, V40, P24, DOI 10.1016/0012-1606(74)90104-3; STEARNS T, 1994, CELL, V76, P623, DOI 10.1016/0092-8674(94)90503-7; SULLIVAN W, 1995, CURR OPIN CELL BIOL, V7, P18, DOI 10.1016/0955-0674(95)80040-9; SULLIVAN W, 1990, DEVELOPMENT, V110, P311; SUNKEL CE, 1988, J CELL SCI, V89, P25; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; THEURKAUF WE, 1994, DROSOPHILA MELANOGAS, P489; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C; VERHEYEN E, 1994, DROSOPHILA MELANOGAS, P545; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; WHITFIELD WGF, 1995, J CELL SCI, V108, P3377; XU T, 1993, DEVELOPMENT, V117, P1223; XU T, 1994, METHOD CELL BIOL, V44, P655, DOI 10.1016/S0091-679X(08)60937-1; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	56	111	113	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 17	1996	85	4					585	596		10.1016/S0092-8674(00)81258-1	http://dx.doi.org/10.1016/S0092-8674(00)81258-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UM415	8653793	Bronze			2022-12-28	WOS:A1996UM41500015
J	Sheng, HZ; Zhadanov, AB; Mosinger, B; Fujii, T; Bertuzzi, S; Grinberg, A; Lee, EJ; Huang, SP; Mahon, KA; Westphal, H				Sheng, HZ; Zhadanov, AB; Mosinger, B; Fujii, T; Bertuzzi, S; Grinberg, A; Lee, EJ; Huang, SP; Mahon, KA; Westphal, H			Specification of pituitary cell lineages by the LIM homeobox gene Lhx3	SCIENCE			English	Article							NUCLEOTIDE-SEQUENCE; EXPRESSION; ONTOGENESIS; MESENCHYME; LETHALITY; INVITRO	During pituitary organogenesis, the progressive differentiation of distinct pituitary-specific cell lineages from a common primordium involves a series of developmental decisions and inductive interactions. Targeted gene disruption in mice showed that Lhx3, a LIM homeobox gene expressed in the pituitary throughout development, is essential for differentiation and proliferation of pituitary cell lineages, In mice homozygous for the Lhx3 mutation, Rathke's pouch formed but failed to grow and differentiate; such mice lacked both the anterior and intermediate robes of the pituitary. The determination of all pituitary cell lineages, except the corticotrophs, was affected, suggesting that a distinct, Lhx3-independent ontogenetic pathway exists for the initial specification of this lineage.	NICHHD,LAB MAMMALIAN GENES & DEV,NIH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)								BACH I, 1995, P NATL ACAD SCI USA, V92, P2720, DOI 10.1073/pnas.92.7.2720; CAMPER SA, 1990, GENOMICS, V8, P586, DOI 10.1016/0888-7543(90)90050-5; CASTRILLO JL, 1991, SCIENCE, V253, P197, DOI 10.1126/science.1677216; CHIN WW, 1981, P NATL ACAD SCI-BIOL, V78, P5329, DOI 10.1073/pnas.78.9.5329; DAIKOKU S, 1983, DEV BIOL, V97, P81, DOI 10.1016/0012-1606(83)90065-9; DIAKOKU S, 1982, DEV BIOL, V90, P198; ELKABES S, 1989, DEV BRAIN RES, V46, P85, DOI 10.1016/0165-3806(89)90145-4; ETKIN W, 1967, NEUROENDOCRINOLOGY, P261; FERRAND R, 1972, Archives de Biologie, V83, P297; Hermesz E, 1996, DEVELOPMENT, V122, P41; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; KAWAMURA K, 1995, CELL TISSUE RES, V279, P233, DOI 10.1007/s004410050278; KENDALL SK, 1995, GENE DEV, V9, P2007, DOI 10.1101/gad.9.16.2007; KIKUYAMA S, 1993, J EXP ZOOL, V266, P216, DOI 10.1002/jez.1402660307; KUSAKABE M, 1984, DEV GROWTH DIFFER, V26, P263; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LINZER DIH, 1985, J BIOL CHEM, V260, P9574; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; OFFIELD MF, IN PRESS DEVELOPMENT; RHODES SJ, 1994, CURR OPIN GENET DEV, V4, P709, DOI 10.1016/0959-437X(94)90138-S; ROBINSON GW, 1991, NEW BIOL, V3, P1183; Schwind JL, 1928, AM J ANAT, V41, P295, DOI 10.1002/aja.1000410206; SEIDAH NG, 1994, DNA CELL BIOL, V13, P1163, DOI 10.1089/dna.1994.13.1163; SHENG H, UNPUB; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; TAIRA M, 1993, DEV BIOL, V159, P245, DOI 10.1006/dbio.1993.1237; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WATANABE YG, 1982, CELL TISSUE RES, V227, P257, DOI 10.1007/BF00210884; WOOD SA, 1993, NATURE, V365, P87, DOI 10.1038/365025a0; ZHADANOV AB, 1995, GENOMICS, V27, P27, DOI 10.1006/geno.1995.1004; ZHADANOV AB, 1995, DEV DYNAM, V202, P354, DOI 10.1002/aja.1002020405	33	370	376	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 17	1996	272	5264					1004	1007		10.1126/science.272.5264.1004	http://dx.doi.org/10.1126/science.272.5264.1004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL619	8638120				2022-12-28	WOS:A1996UL61900043
J	Fields, PE; Gajewski, TF; Fitch, FW				Fields, PE; Gajewski, TF; Fitch, FW			Blocked ras activation in anergic CD4(+) T cells	SCIENCE			English	Article							CLONAL ANERGY; ANTIGEN RECEPTOR; IL-2; STIMULATION; INVITRO; P21RAS	T cell anergy is a state of functional unresponsiveness characterized by the inability to produce interleukin-2 (IL-2) upon T cell receptor stimulation. The mitogen-activated protein kinases ERK-1 and ERK-2 and the guanosine triphosphate-binding protein p21(Ras) were found to remain unactivated upon stimulation of anergic murine T helper cell 1 clones. The inability to activate the Ras pathway did not result from a defect in association among Shc, Grb-2, and murine Son of Sevenless, nor from a defect in their tyrosine phosphorylation. This block in Ras activation may lead to defective transactivation at activator protein 1 sites in anergic cells and may enable T cells to shut down IL-2 production selectively during anergy.	UNIV CHICAGO,COMM IMMUNOL,BEN MAY INST,DEPT PATHOL,CHICAGO,IL 60637; UNIV CHICAGO,DEPT MED,HEMATOL ONCOL SECT,CHICAGO,IL 60637	University of Chicago; University of Chicago			Fields, Patrick E/G-4878-2012	Fields, Patrick/0000-0002-6797-4139				BEVERLY B, 1992, INT IMMUNOL, V4, P661, DOI 10.1093/intimm/4.6.661; BHANDOOLA A, 1993, J IMMUNOL, V151, P2355; CHERNIACK AD, 1995, J BIOL CHEM, V270, P1485, DOI 10.1074/jbc.270.4.1485; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; DOWNWARD J, 1992, IMMUNOL TODAY, V13, P89, DOI 10.1016/0167-5699(92)90148-Z; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; FIELDS PI, UNPUB; GAJEWSKI TF, 1995, EUR J IMMUNOL, V25, P1836, DOI 10.1002/eji.1830250707; GAJEWSKI TF, 1989, J IMMUNOL, V143, P15; GAJEWSKI TF, 1994, P NATL ACAD SCI USA, V91, P38, DOI 10.1073/pnas.91.1.38; GULBINS E, 1993, SCIENCE, V260, P822, DOI 10.1126/science.8484124; IZQUIERDO M, 1993, J EXP MED, V178, P1199, DOI 10.1084/jem.178.4.1199; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; LEEVERS S J, 1992, Trends in Cell Biology, V2, P283, DOI 10.1016/0962-8924(92)90105-V; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; QUILL H, 1992, J IMMUNOL, V149, P2887; RAVICHANDRAN KS, 1993, SCIENCE, V262, P902, DOI 10.1126/science.8235613; RAYTER SI, 1992, EMBO J, V11, P4549, DOI 10.1002/j.1460-2075.1992.tb05556.x; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; STACK RM, 1994, J IMMUNOL, V152, P5723; WATERS SB, 1995, MOL CELL BIOL, V15, P2791; WATERS SB, 1995, J BIOL CHEM, V270, P20883, DOI 10.1074/jbc.270.36.20883; WOODROW M, 1993, J IMMUNOL, V150, P1	26	352	359	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 1	1996	271	5253					1276	1278		10.1126/science.271.5253.1276	http://dx.doi.org/10.1126/science.271.5253.1276			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TX695	8638108				2022-12-28	WOS:A1996TX69500035
J	Arkin, MR; Stemp, EDA; Holmlin, RE; Barton, JK; Hormann, A; Olson, EJC; Barbara, PF				Arkin, MR; Stemp, EDA; Holmlin, RE; Barton, JK; Hormann, A; Olson, EJC; Barbara, PF			Rates of DNA-mediated electron transfer between metallointercalators	SCIENCE			English	Article							PHENANTHRENEQUINONE DIIMINE COMPLEXES; AQUEOUS-SOLUTION; MOLECULAR WIRES; INTERCALATED ETHIDIUM; DONOR PROPERTIES; METAL-COMPLEXES; LIGHT SWITCH; CHARGE; MIGRATION; DISTANCE	Ultrafast emission and absorption spectroscopies were used to measure the kinetics of DNA-mediated electron transfer reactions between metal complexes intercalated into DNA, In the presence of rhodium(III) acceptor, a substantial fraction of photoexcited donor exhibits fast oxidative quenching (>3 x 10(10) per second). Transient-absorption experiments indicate that, for a series of donors, the majority of back electron transfer is also very fast (similar to 10(10) per second). This rate is independent of the loading of accepters on the helix, but is sensitive to sequence and pi stacking. The cooperative binding of donor and acceptor is considered unlikely on the basis of structural models and DNA photocleavage studies of binding. These data show that the DNA double helix differs significantly from proteins as a bridge for electron transfer.	CALTECH,BECKMAN INST,PASADENA,CA 91125; UNIV MINNESOTA,DEPT CHEM,MINNEAPOLIS,MN 55455	California Institute of Technology; University of Minnesota System; University of Minnesota Twin Cities			Arkin, Michelle/AAO-2009-2021		NIGMS NIH HHS [GM49216] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049216] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amouyal E., 1990, J CHEM SOC DA, V6, DOI [10.1039/dt9900001841, DOI 10.1039/DT9900001841]; Arkin MR, 1996, J AM CHEM SOC, V118, P2267, DOI 10.1021/ja9532998; Arkin MR, 1995, ADV CHEM SER, V246, P449; ATHERTON SJ, 1987, J PHYS CHEM-US, V91, P3137, DOI 10.1021/j100296a008; ATHERTON SJ, 1995, J PHYS CHEM-US, V99, P12025, DOI 10.1021/j100031a035; ATHERTON SJ, 1987, J PHYS CHEM-US, V91, P3993, DOI 10.1021/j100299a014; BAGULEY BC, 1984, BIOCHEMISTRY-US, V23, P37; BARTON JK, 1986, J AM CHEM SOC, V108, P6391, DOI 10.1021/ja00280a047; BARTON JK, 1986, SCIENCE, V233, P727, DOI 10.1126/science.3016894; BOXER SG, 1990, ANNU REV BIOPHYS BIO, V19, P267; BRUN AM, 1992, J AM CHEM SOC, V114, P3656, DOI 10.1021/ja00036a013; BRUN AM, 1994, J AM CHEM SOC, V116, P10383, DOI 10.1021/ja00102a004; CANDEIAS LP, 1993, J AM CHEM SOC, V115, P2437, DOI 10.1021/ja00059a044; CHAMBRON JC, 1985, NOUV J CHIM, V9, P527; CHOW CS, 1992, METHOD ENZYMOL, V212, P219; CLOSS GL, 1988, SCIENCE, V240, P440, DOI 10.1126/science.240.4851.440; COLLINS JG, 1994, J AM CHEM SOC, V116, P9840, DOI 10.1021/ja00101a004; CREUTZ C, 1980, J AM CHEM SOC, V102, P1309, DOI 10.1021/ja00524a014; CROTHERS DM, 1968, BIOPOLYMERS, V6, P575, DOI 10.1002/bip.1968.360060411; CULLIS PM, 1990, J CHEM SOC FARADAY T, V86, P591, DOI 10.1039/ft9908600591; DAVID SS, 1993, J AM CHEM SOC, V115, P2984, DOI 10.1021/ja00060a060; DAVIS LM, 1987, CHEM-BIOL INTERACT, V62, P45, DOI 10.1016/0009-2797(87)90078-0; DEE D, 1974, J CHEM PHYS, V60, P541, DOI 10.1063/1.1681073; DUPUREUR CM, 1994, J AM CHEM SOC, V116, P10286, DOI 10.1021/ja00101a053; FARAGGI M, 1994, J CHIM PHYS PCB, V91, P1054, DOI 10.1051/jcp/1994911054; FELTS AK, 1995, J PHYS CHEM-US, V99, P2929, DOI 10.1021/j100009a057; FRIEDMAN AE, 1991, NUCLEIC ACIDS RES, V19, P2595; FRIEDMAN AE, 1990, J AM CHEM SOC, V112, P4960, DOI 10.1021/ja00168a052; FROMHERZ P, 1986, J AM CHEM SOC, V108, P5361, DOI 10.1021/ja00277a060; HARTSHORN RM, 1992, J AM CHEM SOC, V114, P919; HIORT C, 1993, J AM CHEM SOC, V115, P3448, DOI 10.1021/ja00062a007; HOLMLIN RE, 1995, INORG CHEM, V34, P7, DOI 10.1021/ic00105a004; Holmlin RE, 1996, J AM CHEM SOC, V118, P5236, DOI 10.1021/ja953941y; HORMANN A, UNPUB; HOUEELEVIN C, 1991, BIOCHEMISTRY-US, V30, P8216, DOI 10.1021/bi00247a018; HUDSON BP, 1995, J AM CHEM SOC, V117, P9379, DOI 10.1021/ja00141a041; HUNTER CA, 1993, J MOL BIOL, V230, P1025, DOI 10.1006/jmbi.1993.1217; HUSH NS, 1975, CHEM PHYS LETT, V34, P11, DOI 10.1016/0009-2614(75)80190-4; JENKINS Y, 1992, BIOCHEMISTRY-US, V31, P10809, DOI 10.1021/bi00159a023; JOVANOVIC SV, 1986, J PHYS CHEM-US, V90, P974, DOI 10.1021/j100277a053; KARTHA S, 1991, MET IONS BIOL SYST, V27, P323; KEMP M, 1994, J CHEM PHYS, V101, P5172, DOI 10.1063/1.467373; Kittler L., 1980, J ELECTROANAL CHEM I, V116, P503; LANGEN R, 1995, SCIENCE, V268, P1733, DOI 10.1126/science.7792598; Lipscomb LA, 1996, BIOCHEMISTRY-US, V35, P2818, DOI 10.1021/bi952443z; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MARKOVITSI D, 1992, J CHEM SOC FARADAY T, V88, P1275, DOI 10.1039/ft9928801275; MARKS TJ, 1990, ANGEW CHEM INT EDIT, V29, P857, DOI 10.1002/anie.199008571; MCCONNELL H, 1961, J CHEM PHYS, V35, P508, DOI 10.1063/1.1731961; MEADE TJ, 1995, ANGEW CHEM INT EDIT, V34, P352, DOI 10.1002/anie.199503521; MEADE TJ, 1996, MET IONS BIOL SYST, V33, P453; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; MUJICA V, 1994, J CHEM PHYS, V101, P6849, DOI 10.1063/1.468314; MUJICA V, 1994, J CHEM PHYS, V101, P6856, DOI 10.1063/1.468315; MURPHY CJ, 1994, P NATL ACAD SCI USA, V91, P5315, DOI 10.1073/pnas.91.12.5315; MURPHY CJ, 1993, SCIENCE, V262, P1025, DOI 10.1126/science.7802858; NALEWAY CA, 1991, J PHYS CHEM-US, V95, P8434, DOI 10.1021/j100175a005; O'KONSKI C. T., 1964, BIOPOLYMERS SYMP, V1, P479; Olson E. J., UNPUB; PURUGGANAN MD, 1988, SCIENCE, V241, P1645, DOI 10.1126/science.3420416; QUIRION G, 1991, SYNTHETIC MET, V42, P2653, DOI 10.1016/0379-6779(91)91445-G; RISSER SM, 1993, J AM CHEM SOC, V115, P2508, DOI 10.1021/ja00059a057; SCHMECHEL DE, 1971, BIOPOLYMERS, V10, P465, DOI 10.1002/bip.360100304; SCHOUTEN PG, 1994, J AM CHEM SOC, V116, P6880, DOI 10.1021/ja00094a048; SHIELDS TP, 1995, BIOCHEMISTRY-US, V34, P15049, DOI 10.1021/bi00046a010; SHIELDS TP, 1995, BIOCHEMISTRY-US, V34, P15037, DOI 10.1021/bi00046a009; SITLANI A, 1993, J AM CHEM SOC, V115, P12589, DOI 10.1021/ja00079a050; SITLANI A, 1992, J AM CHEM SOC, V114, P2303, DOI 10.1021/ja00033a003; SITLANI A, 1994, BIOCHEMISTRY-US, V33, P12100, DOI 10.1021/bi00206a013; SNART RS, 1973, BIOPOLYMERS, V12, P1493, DOI 10.1002/bip.1973.360120705; STEENKEN S, 1992, J AM CHEM SOC, V114, P4701, DOI 10.1021/ja00038a037; STEMP EDA, 1995, J AM CHEM SOC, V117, P2375, DOI 10.1021/ja00113a037; Stemp EDA, 1996, MET IONS BIOL SYST, V33, P325; SZENTGYORGYI A, 1960, P NATL ACAD SCI USA, V46, P1444, DOI 10.1073/pnas.46.11.1444; TERBRUEGGEN RH, 1995, BIOCHEMISTRY-US, V34, P8227, DOI 10.1021/bi00026a003; TURRO C, 1995, J AM CHEM SOC, V117, P9026, DOI 10.1021/ja00140a020; UCHIDA K, 1989, NUCLEIC ACIDS RES, V17, P10259, DOI 10.1093/nar/17.24.10259; ULLMANN GM, 1995, J AM CHEM SOC, V117, P4766, DOI 10.1021/ja00122a005; VORLICKOVA M, 1985, J BIOMOL STRUCT DYN, V3, P67, DOI 10.1080/07391102.1985.10508399; WARMAN JM, 1992, RAD RES 20TH CENTURY, V2, P93; WELCH TW, 1995, J PHYS CHEM-US, V99, P11757, DOI 10.1021/j100030a021; WHILLANS DW, 1975, BIOCHIM BIOPHYS ACTA, V414, P193, DOI 10.1016/0005-2787(75)90223-3; WUTTKE DS, 1992, SCIENCE, V256, P1007, DOI 10.1126/science.256.5059.1007; YANAGI K, 1991, J MOL BIOL, V217, P201, DOI 10.1016/0022-2836(91)90620-L; [No title captured]	85	422	434	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 26	1996	273	5274					475	480		10.1126/science.273.5274.475	http://dx.doi.org/10.1126/science.273.5274.475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY983	8662532				2022-12-28	WOS:A1996UY98300034
J	Klassen, JK; Nathanson, GM				Klassen, JK; Nathanson, GM			Hydrogen-bond breaking and proton exchange in collisions of gaseous formic acid with liquid sulfuric acid	SCIENCE			English	Article							SCATTERING; DESORPTION	Gas-liquid scattering experiments provide direct observations of the fate of hydrogen-bonding molecules striking the surfaces of acidic liquids. Collisions of gaseous formic acid with concentrated sulfuric acid show that impinging monomers (HCOOH and DCOOD) scatter inelastically from the interface or become trapped by surface H2SO4. Most trapped DCOOD molecules undergo proton exchange before desorbing from the acid, indicating that gas-surface accommodation almost always leads to reaction with H2SO4 molecules. This proton transfer is not inhibited by dimerization of the formic acid: The dimers readily undergo intramolecular hydrogen bond cleavage and D-H exchange before desorbing from the acid.	UNIV WISCONSIN, DEPT CHEM, MADISON, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison								ANDO K, 1995, J MOL LIQ, V64, P25, DOI 10.1016/0167-7322(95)92818-V; BENJAMIN I, 1995, CHEM PHYS LETT, V243, P222, DOI 10.1016/0009-2614(95)00857-Z; CHAO J, 1978, J PHYS CHEM REF DATA, V7, P363, DOI 10.1063/1.555571; CHAUDHURI SK, 1991, IND ENG CHEM RES, V30, P339, DOI 10.1021/ie00050a010; COX RA, 1974, J AM CHEM SOC, V96, P1059, DOI 10.1021/ja00811a018; EIGEN M, 1964, ANGEW CHEM INT EDIT, V3, P1, DOI 10.1002/anie.196400011; EISENTHAL KB, 1993, ACCOUNTS CHEM RES, V26, P636, DOI 10.1021/ar00036a005; FIEHRER KM, UNPUB; GOVONI ST, 1994, J AM CHEM SOC, V116, P779, DOI 10.1021/ja00081a053; GULDAN ED, 1995, J PHYS CHEM-US, V99, P16059, DOI 10.1021/j100043a054; HANSON DR, 1995, SCIENCE, V267, P1326, DOI 10.1126/science.267.5202.1326; HU JH, 1995, J PHYS CHEM-US, V99, P8768, DOI 10.1021/j100021a050; HURST JE, 1979, PHYS REV LETT, V43, P1175, DOI 10.1103/PhysRevLett.43.1175; LEDNOVICH SL, 1977, AICHE J, V23, P454, DOI 10.1002/aic.690230408; LILER M, 1971, REACTION MECH SULFUR, P256; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1016/0030-4018(75)90085-1; RETTNER CT, 1989, J CHEM PHYS, V90, P3800, DOI 10.1063/1.455838; SAECKER ME, 1993, J CHEM PHYS, V99, P7056, DOI 10.1063/1.465425; SMITH KW, 1983, J PHYS CHEM-US, V87, P1514, DOI 10.1021/j100232a013; Zhang RQ, 1996, J PHYS CHEM-US, V100, P960, DOI 10.1021/jp951843t	20	23	23	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	1996	273	5273					333	335		10.1126/science.273.5273.333	http://dx.doi.org/10.1126/science.273.5273.333			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UY202	8662514				2022-12-28	WOS:A1996UY20200031
J	vanHensbroek, MB; Onyiorah, E; Jaffar, S; Schneider, G; Palmer, A; Frenkel, J; Enwere, G; Forck, S; Nusmeijer, A; Bennett, S; Greenwood, B; Kwiatkowski, D				vanHensbroek, MB; Onyiorah, E; Jaffar, S; Schneider, G; Palmer, A; Frenkel, J; Enwere, G; Forck, S; Nusmeijer, A; Bennett, S; Greenwood, B; Kwiatkowski, D			A trial of artemether or quinine in children with cerebral malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE FALCIPARUM-MALARIA; MALAWIAN CHILDREN; HYPOGLYCEMIA	Background Cerebral malaria has a mortality rate of 10 to 30 percent despite treatment with parenteral quinine, a situation that may worsen with the spread of quinine resistance. Artemether is a new antimalarial agent that clears parasites from the circulation more rapidly than quinine, but its effect on mortality is unclear. Methods We conducted a randomized, unblinded comparison of intramuscular artemether and intramuscular quinine in 576 Gambian children with cerebral malaria. The primary end points of the study were mortality and residual neurologic sequelae. Results Fifty-nine of the 288 children treated with artemether died in the hospital (20.5 percent), as compared with 62 of the 288 treated with quinine (21.5 percent). Among the 418 children analyzed at approximately five months for neurologic disease, residual neurologic sequelae were detected in 7 of 209 survivors treated with artemether (3.3 percent) and 11 of 209 survivors treated with quinine (5.3 percent, P = 0.5). After adjustment for potential confounders, the odds ratio for death was 0.84 (95 percent confidence interval, 0.53 to 1.32) in the artemether group, and for residual neurologic sequelae, 0.51 (95 percent confidence interval, 0.17 to 1.47). There were fewer local reactions at the injection site with artemether than with quinine (0.7 percent vs. 5.9 percent, P = 0.001). Conclusions Artemether is as effective as quinine in the treatment of cerebral malaria in children. (C) 1996, Massachusetts Medical Society.	MRC LABS, FAJARA, GAMBIA; SIBANOR HLTH CTR, SIBANOR, SENEGAL; ROYAL VICTORIA HOSP, DEPT PEDIAT, BANJUL, GAMBIA; UNIV AMSTERDAM, ACAD MED CTR, DEPT PEDIAT, 1105 AZ AMSTERDAM, NETHERLANDS; LONDON SCH HYG & TROP MED, DEPT EPIDEMIOL & POPULAT SCI, LONDON WC1, ENGLAND; UNIV OXFORD, JOHN RADCLIFFE HOSP, DEPT PAEDIAT, OXFORD OX3 9DU, ENGLAND	MRC Laboratory Molecular Biology; University of Amsterdam; Academic Medical Center Amsterdam; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	vanHensbroek, MB (corresponding author), UNIV AMSTERDAM, ACAD MED CTR, DEPT TROP MED F4, MEIBERGDREEF 9, 1105 AZ AMSTERDAM, NETHERLANDS.		Nusmeier, Anneliese/P-9219-2015	Nusmeier, Anneliese/0000-0002-2668-3597; Jaffar, Shabbar/0000-0002-9615-1588; Boele van Hensbroek, Michael/0000-0003-1907-5427; Kwiatkowski, Dominic/0000-0002-5023-0176				BREWER TG, 1994, T ROY SOC TROP MED H, V88, P33, DOI 10.1016/0035-9203(94)90469-3; COLLINS R, 1995, LANCET, V345, P669; HIEN TT, 1993, LANCET, V341, P603; KWIATKOWSKI D, 1993, Q J MED, V86, P91; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; MOLYNEUX ME, 1989, Q J MED, V71, P441; NOSTEN F, 1993, T ROY SOC TROP MED H, V87, P305, DOI 10.1016/0035-9203(93)90139-H; PETO R, 1978, BIOMEDICINE, V28, P24; PUKRITTAYAKAMEE S, 1994, T ROY SOC TROP MED H, V88, P324, DOI 10.1016/0035-9203(94)90102-3; SALAKO LA, 1994, T ROY SOC TROP MED H, V88, P89, DOI 10.1016/0035-9203(94)90515-0; TAYLOR TE, 1993, LANCET, V341, P661, DOI 10.1016/0140-6736(93)90423-E; TAYLOR TE, 1988, NEW ENGL J MED, V319, P1040, DOI 10.1056/NEJM198810203191602; WALLER D, 1990, T ROY SOC TROP MED H, V84, P488, DOI 10.1016/0035-9203(90)90009-4; WHITE NJ, 1994, T ROY SOC TROP MED H, V88, P41, DOI 10.1016/0035-9203(94)90471-5; WHITE NJ, 1983, NEW ENGL J MED, V309, P61, DOI 10.1056/NEJM198307143090201; WHITE NJ, 1987, LANCET, V1, P708; *WHO, 1994, INT C EL LEPR WHO, P21; [No title captured]	18	214	215	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 11	1996	335	2					69	75		10.1056/NEJM199607113350201	http://dx.doi.org/10.1056/NEJM199607113350201			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW353	8649492	Green Accepted			2022-12-28	WOS:A1996UW35300001
J	Hubbard, EJA; Dong, Q; Greenwald, I				Hubbard, EJA; Dong, Q; Greenwald, I			Evidence for physical and functional association between EMB-5 and LIN-12 in Caenorhabditis elegans	SCIENCE			English	Article							C-ELEGANS; CELL LINEAGE; YEAST; GENE; EXPRESSION; MUTANTS; GLP-1; MUTATIONS; DECISION; PROTEINS	The Caenorhabditis elegans LIN-12 and GLP-1 proteins are members of the LIN-12/Notch family of receptors for intercellular signals that specify cell fate. Evidence presented here suggests that the intracellular domains of LIN-12 and GLP-1-interact with the C. elegans EMB-5 protein and that the emb-5 gene functions in the same pathway as the lin-12 and glp-1 genes. EMB-5 is similar in sequence to a yeast protein that controls chromatin structure. Hence, a direct consequence of LIN-12 or GLP-1 activation may be an alteration of chromatin structure that produces changes in transcriptional activity.	COLUMBIA UNIV COLL PHYS & SURG,DEPT BIOCHEM & MOLEC BIOPHYS,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032	Columbia University; Columbia University; Howard Hughes Medical Institute				Hubbard, E. Jane Albert/0000-0001-5893-7232	NIGMS NIH HHS [GM37602] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037602] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; BARSTEAD R, COMMUNICATION; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; CASSADA R, 1981, DEV BIOL, V84, P193, DOI 10.1016/0012-1606(81)90383-3; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Christensen S, 1996, DEVELOPMENT, V122, P1373; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; Dong Q., UNPUB; DURFEE T, 1993, GENE DEV, V7, P1; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FITZGERALD K, 1993, DEVELOPMENT, V119, P1019; Fitzgerald K, 1995, DEVELOPMENT, V121, P4275; FITZGERALD K, COMMUNICATION; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; GREENWALD I, 1990, NATURE, V346, P197, DOI 10.1038/346197a0; GREENWALD I, 1994, CURR OPIN GENET DEV, V4, P556, DOI 10.1016/0959-437X(94)90072-B; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; HEDGECOCK EM, 1995, GENETICS, V141, P989; HUBBARD EL, UNPUB; KENYON C, 1986, CELL, V46, P477, DOI 10.1016/0092-8674(86)90668-9; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; LAMBIE EJ, 1991, DEVELOPMENT, V112, P231; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; MACLENNAN AJ, 1993, TRENDS BIOCHEM SCI, V18, P464; Miller J.H., 1972, EXPT MOL GENETICS; MIWA J, 1980, DEV BIOL, V76, P160, DOI 10.1016/0012-1606(80)90369-3; NAGASE T, D79984 GEN BANK; NISHIWAKI K, 1993, MOL GEN GENET, V239, P313, DOI 10.1007/BF00276929; Poulson DF, 1940, J EXP ZOOL, V83, P271, DOI 10.1002/jez.1400830207; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; ROEHL H, 1993, NATURE, V364, P632, DOI 10.1038/364632a0; SCHWEISGUTH F, 1995, DEVELOPMENT, V121, P1875; SCHWEISGUTH F, 1994, CELL, V69, P199; SEYDOUX G, 1989, CELL, V57, P1237, DOI 10.1016/0092-8674(89)90060-3; SPENCE AM, 1990, CELL, V60, P981, DOI 10.1016/0092-8674(90)90346-G; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SUNDARAM M, 1993, GENETICS, V135, P755; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; WILKINSON HA, 1994, CELL, V79, P1187, DOI 10.1016/0092-8674(94)90010-8; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90167-3	46	52	60	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 5	1996	273	5271					112	115		10.1126/science.273.5271.112	http://dx.doi.org/10.1126/science.273.5271.112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV478	8658178				2022-12-28	WOS:A1996UV47800052
J	Rothenberg, EV				Rothenberg, EV			How T cells count	SCIENCE			English	Editorial Material							COMPLEXES; MHC; QUANTITATION; ACTIVATION				Rothenberg, EV (corresponding author), CALTECH,DIV BIOL,156-29,PASADENA,CA 91125, USA.			Rothenberg, Ellen/0000-0002-3901-347X				CHRISTINCK ER, 1991, NATURE, V352, P67, DOI 10.1038/352067a0; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; KUMAGAI N, 1987, J IMMUNOL, V139, P1393; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; MILLER JFAP, 1994, CURR OPIN IMMUNOL, V6, P892, DOI 10.1016/0952-7915(94)90010-8; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; vonHerrath MG, 1995, IMMUNITY, V3, P727, DOI 10.1016/1074-7613(95)90062-4; WEISS A, 1987, J IMMUNOL, V138, P2169	14	25	28	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 5	1996	273	5271					78	79		10.1126/science.273.5271.78	http://dx.doi.org/10.1126/science.273.5271.78			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV478	8658200				2022-12-28	WOS:A1996UV47800039
J	Zaychikov, E; Martin, E; Denissova, L; Kozlov, M; Markovtsov, V; Kashlev, M; Heumann, H; Nikiforov, V; Goldfarb, A; Mustaev, A				Zaychikov, E; Martin, E; Denissova, L; Kozlov, M; Markovtsov, V; Kashlev, M; Heumann, H; Nikiforov, V; Goldfarb, A; Mustaev, A			Mapping of catalytic residues in the RNA polymerase active center	SCIENCE			English	Article							3-DIMENSIONAL STRUCTURE; OPEN COMPLEXES; MG2+; SITE	When the Mg2+ ion in the catalytic center of Escherichia coli RNA polymerase (RNAP) is replaced with Fe2+, hydroxyl radicals are generated. In the promoter complex, such radicals cleave template DNA near the transcription start site, whereas the beta' subunit is cleaved at a conserved motif NADFDGD (Asn-Ala-Asp-Phe-Asp-Gly-Asp). Substitution of the three aspartate residues with alanine creates a dominant lethal mutation. The mutant RNAP is catalytically inactive but can bind promoters and form an open complex, The mutant fails to support Fe2+-induced cleavage of DNA or protein. Thus, the NADFDGD motif is involved in chelation of the active center Mg2+.	PUBL HLTH RES INST,NEW YORK,NY 10016; RUSSIAN ACAD SCI,INST LIMNOL,IRKUTSK 664033,RUSSIA; MAX PLANCK INST BIOCHEM,D-82152 MARTINSRIED,MUNCHEN,GERMANY	Irkutsk Science Centre of the Russian Academy of Sciences; Russian Academy of Sciences; Limnological Institute SB RAS; Max Planck Society			Kozlov, Maxim/GLN-3047-2022	Kozlov, Maxim/0000-0002-5994-9099				BORUKHOV S, 1993, PROTEIN EXPRES PURIF, V4, P503, DOI 10.1006/prep.1993.1066; BORUKHOV S, 1991, J BIOL CHEM, V266, P23932; CHOU WY, 1995, J BIOL CHEM, V270, P25935, DOI 10.1074/jbc.270.43.25935; DARST SA, 1989, NATURE, V340, P730, DOI 10.1038/340730a0; DARST SA, 1991, CELL, V66, P121, DOI 10.1016/0092-8674(91)90144-N; DIECI G, 1995, EMBO J, V14, P3766, DOI 10.1002/j.1460-2075.1995.tb00046.x; ETTNER N, 1995, BIOCHEMISTRY-US, V34, P22, DOI 10.1021/bi00001a004; FARBER JM, 1986, J BIOL CHEM, V261, P4574; GRACHEV MA, 1989, EUR J BIOCHEM, V180, P577, DOI 10.1111/j.1432-1033.1989.tb14684.x; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; KASHLEV M, 1993, GENE, V130, P9, DOI 10.1016/0378-1119(93)90340-9; KNORRE DG, 1993, RUSS CHEM REV, V62, P65; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; MARKOVTSOV V, UNPUB; MARTIN E, 1992, THESIS RUSSIAN ACAD; MUSTAEV A, 1991, J BIOL CHEM, V266, P23927; MUSTAEV A, 1994, P NATL ACAD SCI USA, V91, P12036, DOI 10.1073/pnas.91.25.12036; NUDLER E, 1994, SCIENCE, V265, P793, DOI 10.1126/science.8047884; PRICE MA, 1992, METHOD ENZYMOL, V212, P194; SCHULTZ P, 1993, EMBO J, V12, P2607; SEVERINOV K, 1995, J BIOL CHEM, V270, P29428, DOI 10.1074/jbc.270.49.29428; SUH WC, 1993, SCIENCE, V259, P358, DOI 10.1126/science.8420002; SUH WC, 1992, BIOCHEMISTRY-US, V31, P7815, DOI 10.1021/bi00149a011; WEI CH, 1994, BIOCHEMISTRY-US, V33, P7931, DOI 10.1021/bi00191a021; WEI CH, 1995, BIOCHEMISTRY-US, V34, P7949, DOI 10.1021/bi00024a020; ZAYCHIKOV E, 1995, P NATL ACAD SCI USA, V92, P1739, DOI 10.1073/pnas.92.5.1739	26	149	153	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 5	1996	273	5271					107	109		10.1126/science.273.5271.107	http://dx.doi.org/10.1126/science.273.5271.107			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV478	8658176				2022-12-28	WOS:A1996UV47800050
J	Liu, MY; Simon, MI				Liu, MY; Simon, MI			Regulation by cAMP-dependent protein kinase of a G-protein-mediated phospholipase C	NATURE			English	Article							TRACHEAL SMOOTH-MUSCLE; BETA-GAMMA; SUBUNITS; PHOSPHORYLATION; STIMULATION; ACTIVATION; FORSKOLIN; CALCIUM; ISOZYME	THE heterotrimeric G proteins mediate a variety of cellular processes by coupling transmembrane receptors to different effector molecules, including adenylyl cyclases and inositol-phospholipid-specific phospholipase C (PLC)(1-3). Activation of adenylyl cyclases results in the production of cyclic AMP and activation of cAMP-dependent protein kinase (PKA), Phospholipase C catalyses the hydrolysis of phosphatidylinositol-4,5-bisphosphate (PtdInsP(2)) to generate diacylglycerol and inositol-1,4,5-triphosphate (InsP(3)), leading to the activation of protein kinase C (PKC) and the mobilization of intracellular calcium(4). The various PLC isoforms appear to be activated by different receptors, and in some cases by different G-protein components(5). There are four well-characterized forms of PLC-beta and all of them are activated to various extents by the G alpha(q) family of G proteins(6-9). Specific activation of PLC isoforms beta 2 and beta 3 by G-protein beta gamma subunits has also been reported(10,11). Although it has been suggested that PLC activity might be modulated by the adenylyl cyclase pathway, no clear link has been established between the two pathways. Here we report that cAMP-dependent protein kinase specifically inhibits G beta gamma-activated PLC-beta 2 activity but not that of the G alpha-activated PLC isoforms, and that the effect of PKA is not mimicked by PKC isozymes. Furthermore, we show that PKA directly phosphorylates serine residues of the PLC-beta 2 protein both in vivo and in vitro. Our results provide an insight into the specificity and nature of the crosstalk between the two G-protein coupled signal transduction pathways.	CALTECH,DIV BIOL,PASADENA,CA 91125	California Institute of Technology				Liu, Mingyao/0000-0002-9188-8417				ANWER K, 1989, ENDOCRINOLOGY, V124, P2995, DOI 10.1210/endo-124-6-2995; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HALL IP, 1990, BRIT J PHARMACOL, V100, P646, DOI 10.1111/j.1476-5381.1990.tb15861.x; JHON DY, 1993, J BIOL CHEM, V268, P6654; JIANG HP, 1994, J BIOL CHEM, V269, P7593; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KIM UH, 1989, J BIOL CHEM, V264, P20167; MADISON JM, 1988, J CLIN INVEST, V82, P1462, DOI 10.1172/JCI113752; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; NEYLON CB, 1988, EUR J PHARMACOL, V148, P441, DOI 10.1016/0014-2999(88)90124-0; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; OKAJIMA F, 1995, J BIOL CHEM, V270, P26332, DOI 10.1074/jbc.270.44.26332; PERNEY TM, 1989, J BIOL CHEM, V264, P7317; RHEE SG, 1992, J BIOL CHEM, V267, P12393; RICHARDON RM, 1995, J BIOL CHEM, V270, P27829, DOI 10.1074/jbc.270.46.27829; RYU SH, 1990, J BIOL CHEM, V265, P17941; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SNYDERMAN R, 1990, ADP RIBOSYLATING TOX, P295; TAKENAWA T, 1986, J BIOL CHEM, V261, P1092; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; WATSON SP, 1984, J BIOL CHEM, V259, P3199; WEN YS, 1992, ENDOCRINOLOGY, V131, P1377, DOI 10.1210/en.131.3.1377; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; WU DQ, 1993, J BIOL CHEM, V268, P3704	30	184	195	0	10	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 4	1996	382	6586					83	87		10.1038/382083a0	http://dx.doi.org/10.1038/382083a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV473	8657310				2022-12-28	WOS:A1996UV47300059
J	Schmidt, MW				Schmidt, MW			Experimental constraints on recycling of potassium from subducted oceanic crust	SCIENCE			English	Article							MANTLE SOURCES; EXCESS WATER; WESTERN ALPS; ARC; MAGMAS; ZONES; TONALITE; KILOBARS; PRESSURE; ECLOGITE	Petrological experiments on oceanic crust samples characterize the recycling of potassium from mid-ocean ridge basalts and sediments. Metasomatism could develop directly and continuously from subducted potassium-bearing crust from shallow levels to a maximum depth of 300 kilometers. Phengite (a potassium-rich mica) is the principal potassium host at subsolidus conditions. It transports potassium and water to depths of up to 300 kilometers and could yield over the entire depth range potassium-rich fluids or melts (depending on the specific geotherm), which are likely to constitute one of the primary metasomatic agents for generation of calc-alkaline magmas.	BAYER GEOINST,D-95440 BAYREUTH,GERMANY	University of Bayreuth			Schmidt, Max/A-1676-2008	Schmidt, Max W./0000-0002-3870-5781				CHOPIN C, 1984, CONTRIB MINERAL PETR, V86, P107, DOI 10.1007/BF00381838; DAVIES JH, 1992, J GEOPHYS RES-SOL EA, V97, P2037, DOI 10.1029/91JB02571; DICKINSON WR, 1975, GEOLOGY, V3, P53, DOI 10.1130/0091-7613(1975)3<53:PKRICM>2.0.CO;2; DICKINSON WR, 1967, SCIENCE, V157, P801, DOI 10.1126/science.157.3790.801; DOMANIK KJ, 1993, GEOCHIM COSMOCHIM AC, V57, P4997, DOI 10.1016/S0016-7037(05)80005-5; DOMANIK KJ, 1994, EOS, V75, P744; EVANS BW, 1986, GEOL SOC AM MEM, V164; FURUKAWA Y, 1993, J GEOPHYS RES-SOL EA, V98, P8309, DOI 10.1029/93JB00350; HARLOW GE, 1992, GEOL SOC AM ABSTR, V24, P129; ISHIKAWA T, 1994, NATURE, V370, P205, DOI 10.1038/370205a0; LAMBERT IB, 1972, J GEOL, V80, P693, DOI 10.1086/627795; LAMBERT IB, 1974, J GEOL, V82, P88, DOI 10.1086/627938; MASSONNE HJ, 1987, CONTRIB MINERAL PETR, V96, P212, DOI 10.1007/BF00375235; MELSON WG, 1976, J AM GEOPHYS UNION T, V4, P351; MORRIS JD, 1990, NATURE, V344, P31, DOI 10.1038/344031a0; NICHOLLS IA, 1980, CHEM GEOL, V30, P177, DOI 10.1016/0009-2541(80)90105-9; NICHOLS GT, 1994, NATURE, V371, P785, DOI 10.1038/371785a0; PEACOCK SM, 1990, SCIENCE, V248, P329, DOI 10.1126/science.248.4953.329; PERFIT MR, 1980, CHEM GEOL, V30, P227, DOI 10.1016/0009-2541(80)90107-2; Pettijohn F.J., 1963, 440S US GEOL SURV; PLANK T, 1993, NATURE, V362, P739, DOI 10.1038/362739a0; POLI S, 1993, AM J SCI, V293, P1061, DOI 10.2475/ajs.293.10.1061; POLI S, 1995, J GEOPHYS RES-SOL EA, V100, P22299, DOI 10.1029/95JB01570; REINECKE T, 1991, EUR J MINERAL, V3, P7; SCHMIDT MW, 1993, AM J SCI, V293, P1011, DOI 10.2475/ajs.293.10.1011; SIGMARSSON O, 1990, NATURE, V346, P163, DOI 10.1038/346163a0; Smith D.C., 1988, ECLOGITES ECLOGITES, P1; SOBOLEV NV, 1990, NATURE, V343, P742, DOI 10.1038/343742a0; SWEENEY R, 1995, TERRA NOVA, V7, P145; TATSUMI T, 1995, SUBDUCTION ZONE MAGM, P80; TATSUMI Y, 1989, J GEOPHYS RES-SOLID, V94, P4697, DOI 10.1029/JB094iB04p04697; THOMPSON AB, 1992, NATURE, V358, P295, DOI 10.1038/358295a0; TOKSOZ MN, 1971, J GEOPHYS RES, V76, P1113, DOI 10.1029/JB076i005p01113; ZHANG RY, 1994, EUR J MINERAL, V6, P217	34	172	182	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1996	272	5270					1927	1930		10.1126/science.272.5270.1927	http://dx.doi.org/10.1126/science.272.5270.1927			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV294	8662494				2022-12-28	WOS:A1996UV29400045
J	Eberhart, CG; Maines, JZ; Wasserman, SA				Eberhart, CG; Maines, JZ; Wasserman, SA			Meiotic cell cycle requirement for a fly homologue of human Deleted in Azoospermia	NATURE			English	Article							CDC25 HOMOLOG; DROSOPHILA; SPERMATOGENESIS; TWINE; GENE	INFERTILITY resulting from a severe defect in sperm production affects 2% of men worldwide(1,2). Of these men with azoospermia, the absence of sperm in semen, one in eight carry de novo deletions for a specific region of the Y chromosome(3-5). A candidate gene for the Y-chromosome azoospermia factor (AZF) has been identified and named Deleted in Azoospermia (DAZ)(5). Here we describe the cloning and characterization of the Drosophila gene boule, which is a homologue of DAZ. The two genes encode closely related proteins that contain a predicted RNA-binding motif, and both loci are expressed exclusively in the testis. Loss of bottle function results in azoospermia; meiotic divisions are blocked, although limited spermatid differentiation occurs. Histological examination of boule testes with cell-cycle markers indicates that the primary defect is at the meiotic G2/M transition. These results support the hypothesis that DAZ is the human AZF, and indicate that Boule and DAZ have an essential meiotic function in fly and human spermatogenesis.	UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas								ALPHEY L, 1992, CELL, V69, P977, DOI 10.1016/0092-8674(92)90616-K; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; CASTRILLON DH, 1993, GENETICS, V135, P489; CENCI G, 1994, J CELL SCI, V107, P3521; COMHAIRE FH, 1987, INT J ANDROL S, V7, P3; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; COURTOT C, 1992, DEVELOPMENT, V116, P405; EBERHART CG, 1995, DEVELOPMENT, V121, P3477; FULLER M, 1993, DEV DROSOPHILA, P61; GONCZY P, 1994, CELL, V77, P1015, DOI 10.1016/0092-8674(94)90441-3; HECHT NB, 1995, DEV GENET, V16, P95, DOI 10.1002/dvg.1020160202; HEGER RW, 1914, GERM CELL CYCLE ANIM; HOYLE HD, 1990, J CELL BIOL, V111, P1009, DOI 10.1083/jcb.111.3.1009; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; KARSCHMIZRACHI I, 1993, NUCLEIC ACIDS RES, V21, P2229, DOI 10.1093/nar/21.9.2229; KIM YJ, 1993, MOL CELL BIOL, V13, P174, DOI 10.1128/MCB.13.1.174; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Lindsley D.L., 1980, Genetics and Biology of Drosophila, V2d, P225; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; NAGAI K, 1995, TRENDS BIOCHEM SCI, V20, P235, DOI 10.1016/S0968-0004(00)89024-6; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, LANCET, V347, P1290, DOI 10.1016/S0140-6736(96)90938-1; SILBER SJ, 1995, HUM REPROD, V10, P1031, DOI 10.1093/oxfordjournals.humrep.a136085; SODERSTROM KO, 1980, ARCH PATHOL LAB MED, V104, P476; STEM C, 1941, J EXP ZOOL, V87, P113; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; WHITECOOPER H, 1993, J CELL SCI, V106, P1035	30	337	361	0	9	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 27	1996	381	6585					783	785		10.1038/381783a0	http://dx.doi.org/10.1038/381783a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU356	8657280				2022-12-28	WOS:A1996UU35600059
J	Rajewsky, K				Rajewsky, K			Clonal selection and learning in the antibody system	NATURE			English	Review							PRE-B-CELLS; CHAIN GENE REARRANGEMENT; REACTIVE LYMPHOCYTES-B; IMMUNOGLOBULIN HEAVY-CHAINS; D-MU PROTEIN; IMMUNE-RESPONSE; GERMINAL-CENTERS; BONE-MARROW; SOMATIC HYPERMUTATION; TRANSGENIC MICE	Each antibody-producing B cell makes antibodies of unique specificity, reflecting a series of ordered gene rearrangements which must be successfully performed if the cell is to survive. A second selection process occurs during immune responses in which a new antibody repertoire is generated through somatic hypermutation. Here only mutants binding antigen with high affinity survive to become memory cells. Cells expressing autoreactive receptors are counter-selected at both stages. This stringent positive and negative selection allows the generation and diversification of cells while rigorously controlling their specificity.			Rajewsky, K (corresponding author), UNIV COLOGNE,INST GENET,WEYERTAL 121,D-50931 COLOGNE,GERMANY.			Rajewsky, Klaus/0000-0002-6633-6370				ALLEN D, 1987, IMMUNOL REV, V96, P5, DOI 10.1111/j.1600-065X.1987.tb00506.x; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; BANGS LA, 1991, J IMMUNOL, V146, P1996; BENHAMOU LE, 1990, EUR J IMMUNOL, V20, P1405, DOI 10.1002/eji.1830200630; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; BEREK C, 1988, IMMUNOL REV, V105, P5, DOI 10.1111/j.1600-065X.1988.tb00763.x; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385; BOS NA, 1989, EUR J IMMUNOL, V19, P2335, DOI 10.1002/eji.1830191223; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; BUCKTON KE, 1965, INT J RADIAT BIOL, V8, P439; BURNET FM, 1959, CLONAL SELECTION THE; BURROWS P, 1979, NATURE, V280, P838, DOI 10.1038/280838a0; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CARLSSON L, 1992, INT IMMUNOL, V4, P549, DOI 10.1093/intimm/4.5.549; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; COFFMAN RL, 1983, J MOL CELL IMMUNOL, V1, P31; COOPER MD, 1966, J EXP MED, V123, P75, DOI 10.1084/jem.123.1.75; Croonian lecture, 1900, P R SOC LOND, V66, P424, DOI [DOI 10.1098/RSPL.1899.0121, 10.1098/rspl.1899.0121]; Cunningham A J, 1974, Contemp Top Mol Immunol, V3, P1; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; DECKER DJ, 1991, J IMMUNOL, V147, P1406; DEOKAR JD, 1991, IMMUNOLOGY, V146, P350; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; ERA T, 1991, EMBO J, V10, P337, DOI 10.1002/j.1460-2075.1991.tb07954.x; ESSER C, 1990, ANNU REV IMMUNOL, V8, P717, DOI 10.1146/annurev.iy.08.040190.003441; FEARON DT, 1995, REV IMMUNOL, P127; FEDDERSEN RM, 1985, P NATL ACAD SCI USA, V82, P4793, DOI 10.1073/pnas.82.14.4793; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; FEULLARD J, 1995, INT IMMUN, V7, P121; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; FULLER KA, 1993, J IMMUNOL, V151, P4505; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GERSTEIN RM, 1993, NATURE, V363, P625, DOI 10.1038/363625a0; GHIA P, 1995, EUR J IMMUNOL, V25, P3108, DOI 10.1002/eji.1830251118; GOLD MR, 1994, ADV IMMUNOL, V55, P221; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; GREY HM, 1965, J EXP MED, V122, P619, DOI 10.1084/jem.122.3.619; GRIFFITHS GM, 1984, NATURE, V312, P271, DOI 10.1038/312271a0; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; GU H, 1991, CELL, V65, P47, DOI 10.1016/0092-8674(91)90406-O; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; HARADA K, 1991, J EXP MED, V173, P409, DOI 10.1084/jem.173.2.409; HARDY RR, 1994, IMMUNOL REV, V137, P91, DOI 10.1111/j.1600-065X.1994.tb00660.x; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HAYAKAWA K, 1987, P NATL ACAD SCI USA, V84, P1379, DOI 10.1073/pnas.84.5.1379; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x; HOLMBERG D, 1984, EUR J IMMUNOL, V14, P435, DOI 10.1002/eji.1830140510; HOMBACH J, 1988, EMBO J, V7, P3451, DOI 10.1002/j.1460-2075.1988.tb03219.x; IGLESIAS A, 1991, EMBO J, V10, P2147, DOI 10.1002/j.1460-2075.1991.tb07749.x; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JEME NK, 1951, ACTA PATH MICROBI S, V87, P1; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; JUSTEMENT LB, 1994, IMMUNOL TODAY, V15, P399, DOI 10.1016/0167-5699(94)90268-2; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KEARNEY JF, 1986, IMMUNOL REV, V94, P39, DOI 10.1111/j.1600-065X.1986.tb01163.x; Kisielow P, 1995, ADV IMMUNOL, V58, P187; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KLEIN R, 1993, EUR J IMMUNOL, V23, P3248, DOI 10.1002/eji.1830231231; KLEIN U, 1993, EUR J IMMUNOL, V23, P3272, DOI 10.1002/eji.1830231232; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; KNIGHT KL, 1994, ADV IMMUNOL, V56, P179, DOI 10.1016/S0065-2776(08)60452-6; KOCKS C, 1988, P NATL ACAD SCI USA, V85, P8206, DOI 10.1073/pnas.85.21.8206; KOCKS C, 1989, ANNU REV IMMUNOL, V7, P537, DOI 10.1146/annurev.iy.07.040189.002541; KUBAGAWA H, 1989, P NATL ACAD SCI USA, V86, P2356, DOI 10.1073/pnas.86.7.2356; KUDO A, 1987, EMBO J, V6, P2267, DOI 10.1002/j.1460-2075.1987.tb02500.x; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; LANDRETH KS, 1981, J IMMUNOL, V127, P2027; LANG J, 1994, J CELL BIOCH V S18D, V501, P387; LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; LINTON PJ, 1991, J IMMUNOL, V146, P4099; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; LIU YJ, 1995, IMMUNITY, V2, P239, DOI 10.1016/1074-7613(95)90048-9; Loffert D, 1996, IMMUNITY, V4, P133, DOI 10.1016/S1074-7613(00)80678-0; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; MANZ J, 1988, J EXP MED, V168, P1363, DOI 10.1084/jem.168.4.1363; MATTHEWS MB, 1984, NATURE, V309, P374; MCBLANE F, 1995, CELL, V83, P387; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; MELCHERS F, 1995, CURR OPIN IMMUNOL, V7, P214, DOI 10.1016/0952-7915(95)80006-9; MERINO R, 1994, EMBO J, V13, P683, DOI 10.1002/j.1460-2075.1994.tb06307.x; MOLLER G, 1961, J EXP MED, V114, P415, DOI 10.1084/jem.114.4.415; MOLLER G, 1991, SCAND J IMMUNOL, V33, P111, DOI 10.1111/j.1365-3083.1991.tb03740.x; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; NAMEN AE, 1988, J EXP MED, V167, P998; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NOSSAL GJV, 1992, ADV IMMUNOL, V52, P283, DOI 10.1016/S0065-2776(08)60878-0; Nunez C, 1996, J IMMUNOL, V156, P866; NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; OKUMURA K, 1976, EUR J IMMUNOL, V6, P467, DOI 10.1002/eji.1830060704; OSMOND DG, 1991, CURR OPIN IMMUNOL, V3, P179, DOI 10.1016/0952-7915(91)90047-5; PAPAVASILIOU F, 1995, SCIENCE, V268, P408, DOI 10.1126/science.7716544; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; PATEL KJ, 1993, CELL, V74, P939, DOI 10.1016/0092-8674(93)90473-4; PECH M, 1981, NATURE, V291, P668, DOI 10.1038/291668a0; PERNIS B, 1970, J EXP MED, V132, P1001, DOI 10.1084/jem.132.5.1001; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; PILLAI S, 1988, CURR TOP MICROBIOL, V137, P136; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; RADA C, 1991, P NATL ACAD SCI USA, V88, P5508, DOI 10.1073/pnas.88.13.5508; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; RAFF MC, 1976, NATURE, V259, P224, DOI 10.1038/259224a0; RAFF MC, 1970, NATURE, V225, P553, DOI 10.1038/225553a0; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; REICHMANFRIED M, 1990, P NATL ACAD SCI USA, V87, P27390; RETH M, 1987, EMBO J, V6, P3299, DOI 10.1002/j.1460-2075.1987.tb02649.x; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; RETH M, 1991, IMMUNOL TODAY, V12, P196, DOI 10.1016/0167-5699(91)90053-V; RETH MG, 1984, NATURE, V312, P418, DOI 10.1038/312418a0; REYNAUD CA, 1991, CELL, V64, P995, DOI 10.1016/0092-8674(91)90323-Q; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; REYNAUD CA, 1994, ADV IMMUNOL, V57, P353, DOI 10.1016/S0065-2776(08)60676-8; REYNOLDS JD, 1983, EUR J IMMUNOL, V13, P627, DOI 10.1002/eji.1830130805; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; ROTH DB, 1995, CURR BIOL, V5, P496, DOI 10.1016/S0960-9822(95)00101-1; RUSCONI S, 1985, NATURE, V314, P330, DOI 10.1038/314330a0; SAKAGUCHI N, 1986, NATURE, V324, P579, DOI 10.1038/324579a0; Schiff C, 1992, Int Rev Immunol, V8, P135, DOI 10.3109/08830189209055569; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SCHWAGER J, 1989, EMBO J, V8, P2989, DOI 10.1002/j.1460-2075.1989.tb08449.x; SCHWARTZ RS, 1994, IMMUNOL TODAY, V15, P27, DOI 10.1016/0167-5699(94)90022-1; SIEKEVITZ M, 1987, CELL, V48, P757, DOI 10.1016/0092-8674(87)90073-0; Siskind G W, 1969, Adv Immunol, V10, P1, DOI 10.1016/S0065-2776(08)60414-9; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; STEINER LA, 1967, J EXP MED, V126, P1161, DOI 10.1084/jem.126.6.1161; STRASSER A, 1995, CURR OPIN IMMUNOL, V7, P228, DOI 10.1016/0952-7915(95)80007-7; TAKEDA S, 1993, EMBO J, V12, P2329, DOI 10.1002/j.1460-2075.1993.tb05887.x; TAKI S, 1992, ANN NY ACAD SCI, V651, P328; TALMAGE DW, 1959, SCIENCE, V129, P1643, DOI 10.1126/science.129.3364.1643; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TORRES R, IN PRESS SCIENCE; TSUBATA T, 1991, EUR J IMMUNOL, V21, P1359, DOI 10.1002/eji.1830210605; TSUBATA T, 1992, INT IMMUNOL, V4, P637, DOI 10.1093/intimm/4.6.637; WABL M, 1985, P NATL ACAD SCI USA, V82, P479, DOI 10.1073/pnas.82.2.479; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0; WEAVER D, 1985, CELL, V42, P117, DOI 10.1016/S0092-8674(85)80107-0; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; WEISS U, 1992, EUR J IMMUNOL, V22, P511, DOI 10.1002/eji.1830220233; YELAMOS J, 1995, NATURE, V376, P225; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043; ZHENG B, 1994, NATURE, V372, P556, DOI 10.1038/372556a0; ZHU MH, 1995, P NATL ACAD SCI USA, V92, P2810, DOI 10.1073/pnas.92.7.2810; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; ZOU YR, 1993, EMBO J, V12, P811, DOI 10.1002/j.1460-2075.1993.tb05721.x; 1993, IMMUNOL TODAY, V14, P25	182	1330	1351	2	77	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 27	1996	381	6585					751	758		10.1038/381751a0	http://dx.doi.org/10.1038/381751a0			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU356	8657279				2022-12-28	WOS:A1996UU35600049
J	Gazmararian, JA; Lazorick, S; Spitz, AM; Ballard, TJ; Saltzman, LE; Marks, JS				Gazmararian, JA; Lazorick, S; Spitz, AM; Ballard, TJ; Saltzman, LE; Marks, JS			Prevalence of violence against pregnant women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CHILD SEXUAL ABUSE; PHYSICAL ABUSE; SUBSTANCE USE; RISK	Objectives.-To summarize the methods and findings of studies examining the prevalence of violence against pregnant women and to synthesize these findings by comparing study characteristics for studies with similar and dissimilar results, Data Sources.-MEDLINE, POPLINE, Psychological Abstracts, and Sociological Abstracts databases were searched for all articles pertaining to violence during pregnancy for the period 1963 through August 1995. Study Selection.-Thirteen studies were selected on the basis of specific criteria: a sample with initially unknown violence status; a clear statement of research question(s), with focus on measuring the prevalence of violence; descriptions of the sample, data source, and data collection methods, and data from the United States or another developed country, Data Extraction.-Relevant data were extracted to compare studies by study description, methods, and results, Data Synthesis.-Evidence from the studies we reviewed indicates that the prevalence of violence during pregnancy ranges from 0.9% to 20.1%. Measures of violence, populations sampled, and study methods varied considerably across studies, and these factors may affect prevalence estimates, Studies that asked about violence more than once during detailed in-person interviews or asked later in pregnancy (during the third trimester) reported higher prevalence rates (7.4%-20.1%). The lowest estimate was reported by women who attended a private clinic and responded to a self-administered questionnaire provided to them by a person who was not a health care provider. Conclusions.-Violence may be a more common problem for pregnant women than some conditions for which they are routinely screened and evaluated, Future research that more accurately measures physical violence during pregnancy would contribute to more effective design and implementation of prevention and intervention strategies.	UNIV N CAROLINA,SCH MED,DEPT PEDIAT,CHAPEL HILL,NC 27515; UNIV N CAROLINA,SCH MED,DEPT INTERNAL MED,CHAPEL HILL,NC 27515; UNIV N CAROLINA,SCH PUBL HLTH,DEPT MATERNAL & CHILD HLTH,CHAPEL HILL,NC 27515; CTR DIS CONTROL & PREVENT,DIV VIOLENCE PREVENT,NATL CTR INJURY PREVENT & CONTROL,ATLANTA,GA; CTR DIS CONTROL & PREVENT,DIV REPROD HLTH,NATL CTR CHRON DIS PREVENT & HLTH PROMOT,ATLANTA,GA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Gazmararian, JA (corresponding author), PRUDENTIAL CTR HLTH CARE RES,2859 PACES FERRY RD,SUITE 820,ATLANTA,GA 30339, USA.		Duran, Bonnie m/A-3029-2009	Lazorick, Suzanne/0000-0002-5578-1356				AMARO H, 1990, AM J PUBLIC HEALTH, V80, P575, DOI 10.2105/AJPH.80.5.575; BERENSON AB, 1992, J ADOLESCENT HEALTH, V13, P466, DOI 10.1016/1054-139X(92)90008-Y; BERENSON AB, 1992, J ADOLESCENT HEALTH, V13, P470, DOI 10.1016/1054-139X(92)90009-Z; BERENSON AB, 1991, AM J OBSTET GYNECOL, V164, P1491, DOI 10.1016/0002-9378(91)91428-Y; BOWKER L, 1983, BEATING WIFE BEATING; CAMPBELL JC, 1992, RES NURS HEALTH, V15, P219, DOI 10.1002/nur.4770150308; CAMPBELL JC, 1986, ADV NURS SCI, V8, P36, DOI 10.1097/00012272-198607000-00006; Cunningham FG, 1997, WILIAMS OBSTET, V20th; GAZMARARIAN JA, 1995, OBSTET GYNECOL, V85, P1031, DOI 10.1016/0029-7844(95)00057-X; Gelles R.J., 1988, INTIMATE VIOLENCE; GELLES RJ, 1988, J MARRIAGE FAM, V50, P841, DOI 10.2307/352652; GELLES RJ, 1975, FAM COORD, V14, P40; GIELEN AC, 1994, SOC SCI MED, V39, P781, DOI 10.1016/0277-9536(94)90039-6; HELTON AS, 1987, AM J PUBLIC HEALTH, V77, P1337, DOI 10.2105/AJPH.77.10.1337; HELTON AS, 1987, MARCH DIMES PROTOCOL; HILLARD PJA, 1985, OBSTET GYNECOL, V66, P185; HUDSON WW, 1981, J MARRIAGE FAM, V43, P873, DOI 10.2307/351344; KOSS MP, 1993, J INTERPERS VIOLENCE, V8, P198, DOI 10.1177/088626093008002004; *L HARR ASS, 1985, 2 NAT FAM VIOL SURV; MCFARLANE J, 1992, JAMA-J AM MED ASSOC, V267, P3176, DOI 10.1001/jama.267.23.3176; O'Campo P, 1994, Womens Health Issues, V4, P29, DOI 10.1016/S1049-3867(05)80107-0; PARKER B, 1993, NURS RES, V42, P173; PARKER B, 1994, OBSTET GYNECOL, V84, P323; SAMPSELLE CM, 1992, J NURSE-MIDWIFERY, V37, P269, DOI 10.1016/0091-2182(92)90131-L; Scott C J, 1994, Md Med J, V43, P891; Smith M D, 1987, Violence Vict, V2, P173; SORENSON SB, 1994, ANN EPIDEMIOL, P140; STARK E, 1991, VIOLENCE AM PUBLIC H, P138; STEWART DE, 1993, CAN MED ASSOC J, V149, P1257; STEWART DE, 1994, CAN MED ASSOC J, V151, P1602; Straus M.M.A., 1980, CLOSED DOORS VIOLENC; STRAUS MA, 1979, J MARRIAGE FAM, V41, P57; Strauss M.A., 1990, PHYS VIOLENCE AM FAM, P29; WEBSTER J, 1994, MED J AUSTRALIA, V161, P466, DOI 10.5694/j.1326-5377.1994.tb127557.x; WYATT GE, 1986, CHILD ABUSE NEGLECT, V10, P231, DOI 10.1016/0145-2134(86)90084-0; WYATT GE, 1986, CHILD ABUSE NEGLECT, V10, P241, DOI 10.1016/0145-2134(86)90085-2; 1992, JAMA-J AM MED ASSOC, V267, P3190; [No title captured]	38	490	496	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	1996	275	24					1915	1920		10.1001/jama.275.24.1915	http://dx.doi.org/10.1001/jama.275.24.1915			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UR975	8648873				2022-12-28	WOS:A1996UR97500038
J	Bloor, K; Freemantle, N				Bloor, K; Freemantle, N			Lessons from international experience in controlling pharmaceutical expenditure .2. Influencing doctors	BRITISH MEDICAL JOURNAL			English	Article							COSTS	This is the second of three papers that review international policies to control spending on drugs and to improve the efficiency of drug use. This paper reviews policies influencing doctors' prescribing of drugs-particularly the use of budgetary restrictions, information and feedback, and guidelines-and evaluates the impact of these policies. Studies evaluating incentive systems are Limited, but evidence suggests that providing information on its own will not lead to substantial changes in practice and that more active strategies should be evaluated.	UNIV YORK,CTR HLTH ECON,YORK YO1 5DD,N YORKSHIRE,ENGLAND	University of York - UK	Bloor, K (corresponding author), UNIV YORK,DEPT HLTH SCI & CLIN EVALUAT,YORK YO1 5DD,N YORKSHIRE,ENGLAND.			Freemantle, Nick/0000-0001-5807-5740; Bloor, Karen/0000-0003-4852-9854				*AG HLTH CAR POL R, 1992, CLIN PRACT GUID, V3; *AG HLTH CAR POL R, 1994, CLIN PRACT GUID, V8; [Anonymous], 1994, EFF HLTH CAR B; Bloor K, 1993, PURCHASING PROVIDING; BRADLOW J, 1993, BRIT MED J, V307, P1186, DOI 10.1136/bmj.307.6913.1186; BROWN SS, 1995, BRIT MED J, V311, P1543; Cook T.C., 1979, QUASIEXPERIMENTATION; MALING TJB, 1994, PHARMACOECONOMICS, V6, P5, DOI 10.2165/00019053-199406010-00002; MAXWELL M, 1993, BRIT MED J, V307, P1190, DOI 10.1136/bmj.307.6913.1190; Maynard A, 1996, NEW ENGL J MED, V334, P604, DOI 10.1056/NEJM199602293340918; *MIN WELF HLTH CUL, 1994, V8E MIN WELF HLTH CU; PELC A, 1994, PHARMACOECONOMICS, V6, P28, DOI 10.2165/00019053-199400061-00009; SCHULENBURG JM, 1994, HEALTH ECON, V3, P301; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; SOUMERAI SB, 1987, AM J PUBLIC HEALTH, V77, P1518, DOI 10.2105/AJPH.77.12.1518; SOUMERAI SB, 1989, MILBANK Q, V67, P296; Stryer D. B., 1995, JGIM, V10, P114; *U LEEDS, 1993, EFF HLTH CAR B, V5; 1994, SCRIP           1129, P3; 1995, SCRIP           0314, P3; 1995, SCRIP           0310, P3; 1995, SCRIP           0530, P16	22	77	78	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 15	1996	312	7045					1525	1527		10.1136/bmj.312.7045.1525	http://dx.doi.org/10.1136/bmj.312.7045.1525			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR823	8646148	Green Published			2022-12-28	WOS:A1996UR82300026
J	Pearce, JMS				Pearce, JMS			Remak, father and son	LANCET			English	Item About an Individual																			0	3	3	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 15	1996	347	9016					1669	1670		10.1016/S0140-6736(96)91492-0	http://dx.doi.org/10.1016/S0140-6736(96)91492-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ701	8642963				2022-12-28	WOS:A1996UQ70100015
J	Ding, K; Seyfried, WE				Ding, K; Seyfried, WE			Direct pH measurement of NaCl-bearing fluid with an in situ sensor at 400 degrees C and 40 megapascals	SCIENCE			English	Article							PARTIAL MOLAL PROPERTIES; THERMODYNAMIC PROPERTIES; HIGH-PRESSURES; TEMPERATURE; CHLORIDE; 1000-DEGREES-C; REGION; WATER	The pH of concentrated NaCl-HCl fluids (0.57 mole of NaCl per kilogram of water) has been measured at supercritical conditions of water with a yttria-stabilized zirconia sensor in a titanium flow reactor. At 400 degrees C and 40 megapascals, the in situ pH of the fluids, ranging from 3.3 to 6.2, differs greatly from its original value of 1.9 to 7.6 at ambient conditions. The measurements agree well with theoretical predictions, showing strong associations of HCl degrees and NaOH degrees complexes in high-temperature fluids. The pH sensor provides a powerful tool to investigate unambiguously the distribution of species in aqueous fluids at elevated temperatures and pressures.			Ding, K (corresponding author), UNIV MINNESOTA,DEPT GEOL & GEOPHYS,MINNEAPOLIS,MN 55455, USA.							[Anonymous], 1995, GEOPHYS MONOGR SER; BOURCIER WL, 1987, HYDROTHERMAL EXPT TE, P157; DING K, 1992, GEOCHIM COSMOCHIM AC, V56, P3681, DOI 10.1016/0016-7037(92)90161-B; DING K, 1995, GEOCHIM COSMOCHIM AC, V59, P4769, DOI 10.1016/0016-7037(95)00319-3; DING K, IN PRESS J SOLUTION; DING K, 1988, EOS T AM GEOPHYS UN, V69, P1488; FELLORCO PC, 1993, ACS SYM SER, V514, P248; FOURNIER RO, 1983, GEOCHIM COSMOCHIM AC, V47, P579, DOI 10.1016/0016-7037(83)90279-X; HETTIARACHCHI S, 1992, J ELECTROCHEM SOC, V139, pL3, DOI 10.1149/1.2069213; JOHNSON JW, 1992, COMPUT GEOSCI-UK, V18, P899, DOI 10.1016/0098-3004(92)90029-Q; MACDONAL.DD, 1973, CAN J CHEM, V51, P2747, DOI 10.1139/v73-410; MACDONALD DD, 1988, J SOLUTION CHEM, V17, P719, DOI 10.1007/BF00647418; MESMER RE, 1970, J PHYS CHEM-US, V74, P1937, DOI 10.1021/j100704a019; Naumov GB, 1974, HDB THERMODYNAMIC DA; NIEDRACH LW, 1980, SCIENCE, V207, P1200, DOI 10.1126/science.207.4436.1200; NIEDRACH LW, 1980, J ELECTROCHEM SOC, V127, P2122, DOI 10.1149/1.2129358; PALMER DA, 1993, GEOCHIM COSMOCHIM AC, V57, P1393, DOI 10.1016/0016-7037(93)90001-D; SENGERS JMHL, 1983, J PHYS CHEM REF DATA, V12, P1, DOI 10.1063/1.555676; SHOCK EL, 1992, J CHEM SOC FARADAY T, V88, P803, DOI 10.1039/ft9928800803; Sverjensky D. A., 1991, GEOCHIM COSMOCHIM AC, V55, P988; TANGER JC, 1988, AM J SCI, V288, P19, DOI 10.2475/ajs.288.1.19; Von Damm K. L., 1995, GEOPHYS MONOGR SER, P222, DOI [10.1029/GM091, DOI 10.1029/GM091]	22	61	85	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1996	272	5268					1634	1636		10.1126/science.272.5268.1634	http://dx.doi.org/10.1126/science.272.5268.1634			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8662475				2022-12-28	WOS:A1996UR09300040
J	Martyn, CN; Gale, CR; Sayer, AA; Fall, C				Martyn, CN; Gale, CR; Sayer, AA; Fall, C			Growth in utero and cognitive function in adult life: Follow up study of people born between 1920 and 1943	BRITISH MEDICAL JOURNAL			English	Article							WEIGHT; BIRTH; CIRCUMFERENCE; INFANTS; DISEASE; BRAIN; FETAL; DEATH; HEAD	Objectives-To examine the relation between fetal growth and cognitive function in adult life. Design-A follow up study of men and women whose birth weights and other measurements of body size had been recorded at birth. Setting-Hertfordshire, Preston, and Sheffield. Subjects-1576 men and women born in Hertfordshire, Sheffield, or Preston between 1920 and 1943. Main outcome measures-Intelligence quotient as measured by the AH4 test and amount of decline in cognitive function with age as estimated by the difference between score on the Mill Hill vocabulary test and score on the AH4 test. Results-Score on the intelligence test was higher in people who had a large biparietal head diameter at birth, but it was not related to any other measure of body size or proportions. No association was found between decline in cognitive function and any measure of size or proportions at birth. Conclusion-Impaired fetal growth was not associated with poorer cognitive performance in adult life. Adaptations made by the fetus in response to conditions that retard its growth seem to be largely successful in maintaining brain development.			Martyn, CN (corresponding author), UNIV SOUTHAMPTON,SOUTHAMPTON GEN HOSP,MRC,ENVIRONM EPIDEMIOL UNIT,SOUTHAMPTON SO16 6YD,HANTS,ENGLAND.		Sayer, Avan Aihie/A-4359-2012; Gale, Catharine R/B-1653-2012	Aihie Sayer, Avan/0000-0003-1283-6457; Gale, Catharine/0000-0002-3361-8638; Fall, Caroline/0000-0003-4402-5552	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], [No title captured]; Barker D. J. P., 1994, MOTHERS BABIES DIS L; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Barker DJP, 1992, FETAL INFANT ORIGINS; BERK LE, 1991, CHILD DEV; CAMPBELL S, 1977, BRIT J OBSTET GYNAEC, V84, P165, DOI 10.1111/j.1471-0528.1977.tb12550.x; COOKE RWI, 1977, EARLY HUM DEV, V1, P145, DOI 10.1016/0378-3782(77)90015-9; CRAVIOTO J, 1975, PERCEPTUAL LEARNING, V2, P3; DAVIES PA, 1975, BRIT MED BULL, V31, P85, DOI 10.1093/oxfordjournals.bmb.a071248; FANCOURT R, 1976, BMJ-BRIT MED J, V1, P1435, DOI 10.1136/bmj.1.6023.1435; FOULDS GA, 1948, J MENT SCI, V94, P133, DOI 10.1192/bjp.94.394.133; GORMAN KS, 1992, INFANT BEHAV DEV, V15, P279, DOI 10.1016/0163-6383(92)80001-B; HOLLAND CA, 1991, REV CLIN GERONTOLOGY, V1, P81, DOI DOI 10.1017/S0959259800002598; HORN JL, 1967, ACTA PSYCHOL, V26, P107, DOI 10.1016/0001-6918(67)90011-X; KLINE J, 1976, CONCEPTION BIRTH EPI; MORGANE PJ, 1993, NEUROSCI BIOBEHAV R, V17, P91, DOI 10.1016/S0149-7634(05)80234-9; MORGANE PJ, 1992, VULNERABLE BRAIN ENV, V1, P3; NELSON KB, 1970, DEV MED CHILD NEUROL, V12, P487; OSMOND C, 1993, BRIT MED J, V307, P1519, DOI 10.1136/bmj.307.6918.1519; Osofsky H J, 1975, Obstet Gynecol Surv, V30, P227, DOI 10.1097/00006254-197504000-00001; RABBITT P, 1993, Q J EXP PSYCHOL-A, V46, P385, DOI 10.1080/14640749308401055; RABBITT P, 1990, APPL COGNITIVE PSYCH, V4, P225, DOI 10.1002/acp.2350040402; RABBITT P, 1993, Z GERONTOL, V26, P176; SCHERJON SA, 1993, THESIS U AMSTERDAM A; SMART JL, 1977, GENETICS ENV INTELLI, P215; STEIN Z, 1975, PEDIATR RES, V9, P70, DOI 10.1203/00006450-197509020-00003; Stein Z., 1975, FAMINE HUM DEV DUTCH; VILLAR J, 1984, PEDIATRICS, V74, P783; WARSHAW JB, 1985, PEDIATRICS, V6, P998; WINICK M, 1966, J NUTR, V89, P300, DOI 10.1093/jn/89.3.300; Winick M., 1972, Lipids, malnutrition and the developing brain. A Ciba Foundation Symposium jointly with the Nestle Foundation in memory of Sir Norman Wright., P199	32	73	78	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 1	1996	312	7043					1393	1396						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UP434	8646096				2022-12-28	WOS:A1996UP43400023
J	Cash, S; Zucker, RS; Poo, MM				Cash, S; Zucker, RS; Poo, MM			Spread of synaptic depression mediated by presynaptic cytoplasmic signaling	SCIENCE			English	Article							LONG-TERM POTENTIATION; NEURONS; INVITRO; CULTURE; CELLS; INDUCTION; TRANSPORT; SYNAPSES; CURRENTS; RELEASE	Postsynaptic activity may modulate presynaptic functions by transsynaptic retrograde signals, At developing neuromuscular synapses in Xenopus nerve-muscle cultures, a brief increase in the cytosolic calcium ion (Ca2+) concentration in postsynaptic myocytes induced persistent depression of presynaptic transmitter secretion, This depression spread to distant synapses formed by the same neuron, Clearance of extracellular fluid did not prevent the spread of depression, and depression could not be induced by increasing the Ca2+ concentration in a nearby myocyte not in contact with the presynaptic neuron, Thus, the spread of depression is mediated by signaling in the presynaptic cytoplasm, rather than by a retrograde factor in the extracellular space.	COLUMBIA UNIV,DEPT BIOL SCI,NEW YORK,NY 10027; UNIV CALIF BERKELEY,DIV NEUROBIOL,BERKELEY,CA 94720	Columbia University; University of California System; University of California Berkeley			Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015114] Funding Source: NIH RePORTER; NINDS NIH HHS [NS15114] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAHAM WC, 1983, NATURE, V305, P717, DOI 10.1038/305717a0; ALLEN RD, 1982, SCIENCE, V218, P1127, DOI 10.1126/science.6183744; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; BOURNE HR, 1993, NEURON S, V10, P65; BRADLER JE, 1990, NEUROSCIENCE, V35, P265, DOI 10.1016/0306-4522(90)90080-N; CASH S, IN PRESS NEURON; CHOW I, 1984, J PHYSIOL-LONDON, V346, P181, DOI 10.1113/jphysiol.1984.sp015015; CHRISTIE BR, 1992, SYNAPSE, V10, P1, DOI 10.1002/syn.890100102; DAN Y, 1992, SCIENCE, V256, P1570, DOI 10.1126/science.1317971; EVERS J, 1989, J NEUROSCI, V9, P1523; GOODMAN CS, 1993, NEURON S, V10, P77; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HIRSCH JC, 1992, SYNAPSE, V12, P82, DOI 10.1002/syn.890120110; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; KAO JPY, 1989, J BIOL CHEM, V264, P8179; LANDO L, 1994, J NEUROPHYSIOL, V72, P825, DOI 10.1152/jn.1994.72.2.825; Linden D J, 1993, Curr Opin Neurobiol, V3, P401, DOI 10.1016/0959-4388(93)90133-J; LO YJ, 1994, J NEUROSCI, V14, P4684; LO YJ, 1991, SCIENCE, V254, P1019, DOI 10.1126/science.1658939; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; MARTY A, 1995, CURR OPIN NEUROBIOL, V5, P335, DOI 10.1016/0959-4388(95)80046-8; MULLER D, 1995, NEURON, V14, P599, DOI 10.1016/0896-6273(95)90316-X; NICOLL RA, 1995, NATURE, V377, P155; OTANI S, 1995, LEARN MEMORY, V2, P101, DOI 10.1101/lm.2.2.101; POPOV S, 1992, J NEUROSCI, V12, P77; PURVES D, 1985, PRINCIPLES NEURAL DE; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; Tabti N., 1991, CULTURING NERVE CELL, P137; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; WANG T, 1995, NATURE, V374, P262, DOI 10.1038/374262a0; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; ZUCKER RS, 1993, CELL CALCIUM, V14, P87, DOI 10.1016/0143-4160(93)90079-L	34	37	38	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 17	1996	272	5264					998	1001		10.1126/science.272.5264.998	http://dx.doi.org/10.1126/science.272.5264.998			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL619	8638143				2022-12-28	WOS:A1996UL61900041
J	Maizels, M; Scott, B; Cohen, W; Chen, W				Maizels, M; Scott, B; Cohen, W; Chen, W			Intranasal lidocaine for treatment of migraine - A randomized, double-blind, controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLUSTER HEADACHE; SPHENOPALATINE; NEUROPEPTIDE; HUMANS; PAIN; CATS	Objective.-To evaluate the effectiveness of intranasal lidocaine for treatment of acute migraine headache. Design.-Prospective, randomized, double-blind, placebo-controlled trial. Setting.-Commmunity urgent care department. Patients.-A total of 81 patients (67 women and 14 men; median age, 42 years; range, 19-68 years) with a chief complaint of headache who fulfilled criteria of the International Headache Society for migraine participated. Patients were excluded if headache had lasted more than 3 days or if the frequency of severe headache was more than once per week. Intervention.-Patients were randomized in a 2:1 ratio to receive a 4% solution of intranasal lidocaine or saline placebo, respectively. Main Outcome Measures.-The primary outcome measure was at least 50% reduction of headache within 15 minutes after treatment. Secondary measures include reduction in nausea and photophobia, use of rescue medication, relapse of headache, and change in headache disability scores. Results.-Of 53 patients who received intranasal lidocaine, 29 (55%) had at least a 50% reduction of headache compared with 6 (21 %) of 28 controls (P=.004). Nausea and photophobia were significantly reduced (P=.03 and P=.001, respectively). Rescue medication for headache relief was needed in 15 (28%) of 53 patients in the lidocaine group vs 20 (71%) of 28 controls (P<.001). Among those with initial relief of headache, relapse of headache occurred in 10 (42%) of 24 in the lidocaine group vs 5 (83%) of 6 in the control group (P=.17), usually within the first hour after treatment. Conclusions.-Intranasal lidocaine provides rapid relief of headache in approximately 55% of ambulatory patients with migraine. Relapse of headache is common and occurs early after treatment.	SO CALIF PERMANENTE MED GRP, DEPT URGENT CARE, WOODLAND HILLS, CA 91365 USA; SO CALIF PERMANENTE MED GRP, DEPT RES & EVALUAT, PASADENA, CA USA	Kaiser Permanente; Southern California Permanente Medical Group (SCPMG); Permanente Medical Groups; Kaiser Permanente; Southern California Permanente Medical Group (SCPMG); Permanente Medical Groups	Maizels, M (corresponding author), SO CALIF PERMANENTE MED GRP, DEPT FAMILY PRACTICE, 5601 DE SOTO AVE, WOODLAND HILLS, CA 91365 USA.							BARRE F, 1982, HEADACHE, V22, P69, DOI 10.1111/j.1526-4610.1982.hed2202069.x; EDVINSSON L, 1994, CEPHALALGIA, V14, P320, DOI 10.1046/j.1468-2982.1994.1405320.x; EDVINSSON L, 1994, CEPHALALGIA, V14, P88, DOI 10.1046/j.1468-2982.1994.1402088.x; EDVINSSON L, 1995, CEPHALALGIA S14, V15, P110; FERRARI MD, 1991, NEW ENGL J MED, V325, P316; GOADSBY PJ, 1993, ANN NEUROL, V33, P48, DOI 10.1002/ana.410330109; GOADSBY PJ, 1987, AM J PHYSIOL, V253, pR270, DOI 10.1152/ajpregu.1987.253.2.R270; GOADSBY PJ, 1991, HEADACHE, V31, P365, DOI 10.1111/j.1526-4610.1991.hed3106365.x; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; KITTRELLE JP, 1985, ARCH NEUROL-CHICAGO, V42, P496, DOI 10.1001/archneur.1985.04060050098017; KUDROW L, 1995, HEADACHE, V35, P79, DOI 10.1111/j.1526-4610.1995.hed3502079.x; LAMBERT GA, 1984, J NEUROSURG, V61, P307, DOI 10.3171/jns.1984.61.2.0307; MOSKOWITZ MA, 1993, NEUROLOGY, V43, P16; MOSKOWITZ MA, 1984, ANN NEUROL, V16, P157, DOI 10.1002/ana.410160202; MOSKOWITZ MA, 1979, LANCET, V2, P883; OLESEN J, 1995, CEPHALALGIA, V15, P94, DOI 10.1046/j.1468-2982.1995.015002094.x; Sluder G, 1908, N STATE JMED, V27, P8; Sluder G, 1909, N Y MED J, V28, P293; STEWART WF, 1994, NEUROLOGY, V44, P17; SUZUKI N, 1989, NEUROSCIENCE, V30, P595, DOI 10.1016/0306-4522(89)90154-1; WALTERS BB, 1986, STROKE, V17, P488, DOI 10.1161/01.STR.17.3.488; 1988, CEPHALALGIA S7, V8, P19	22	101	114	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1996	276	4					319	321		10.1001/jama.276.4.319	http://dx.doi.org/10.1001/jama.276.4.319			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UX583	8656545				2022-12-28	WOS:A1996UX58300038
J	Weissman, MM; Bland, RC; Canino, GJ; Faravelli, C; Greenwald, S; Hwu, HG; Joyce, PR; Karam, EG; Lee, CK; Lellouch, J; Lepine, JP; Newman, SC; RubioStipec, M; Wells, JE; Wickramaratne, PJ; Wittchen, HU; Yeh, EK				Weissman, MM; Bland, RC; Canino, GJ; Faravelli, C; Greenwald, S; Hwu, HG; Joyce, PR; Karam, EG; Lee, CK; Lellouch, J; Lepine, JP; Newman, SC; RubioStipec, M; Wells, JE; Wickramaratne, PJ; Wittchen, HU; Yeh, EK			Cross-national epidemiology of major depression and bipolar disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIAGNOSTIC INTERVIEW SCHEDULE; PSYCHIATRIC-DISORDERS; UNITED-STATES; PREVALENCE; LIFETIME; TAIWAN; KOREA	Objective.-To estimate the rates and patterns of major depression and bipolar disorder based on cross-national epidemiologic surveys. Design and Setting.-Population-based epidemiologic studies using similar methods from 10 countries: the United States, Canada, Puerto Rico, France, West Germany, Italy, Lebanon, Taiwan, Korea, and New Zealand. Participants.-Approximately 38 000 community subjects. Outcome Measures.-Rates, demographics, and age at onset of major depression and bipolar disorder. Symptom profiles, comorbidity, and marital status with major depression. Results.-The lifetime rates for major depression vary widely across countries, ranging from 1.5 cases per 100 adults in the sample in Taiwan to 19.0 cases per 100 adults in Beirut. The annual rates ranged from 0.8 cases per 100 adults in Taiwan to 5.8 cases per 100 adults in New Zealand. The mean age at onset shows less variation (range, 24.8-34.8 years). In every country, the rates of major depression were higher for women than men. By contrast, the lifetime rates of bipolar disorder are more consistent across countries (0.3/100 in Taiwan to 1.5/100 in New Zealand); the sex ratios are nearly equal; and the age at first onset is earlier (average, 6 years) than the onset of major depression. Insomnia and loss of energy occurred in most persons with major depression at each site. Persons with major depression were also at increased risk for comorbidity with substance abuse and anxiety disorders at all sites. Persons who were separated or divorced had significantly higher rates of major depression than married persons in most of the countries, and the risk was somewhat greater for divorced or separated men than women in most countries. Conclusions.-There are striking similarities across countries in patterns of major depression and of bipolar disorder. The differences in rates for major depression across countries suggest that cultural differences or different risk factors may affect the expression of the disorder.	COLUMBIA UNIV COLL PHYS & SURG, DEPT PSYCHIAT, NEW YORK, NY 10032 USA; UNIV ALBERTA, DEPT PSYCHIAT, EDMONTON, AB, CANADA; UNIV PUERTO RICO, BEHAV SCI RES INST, SAN JUAN, PR 00936 USA; DEPT NEUROL & PSYCHIAT, FLORENCE, ITALY; NATL TAIWAN UNIV HOSP, SCH MED, TAIPEI, TAIWAN; NATL TAIWAN UNIV HOSP, DEPT PSYCHIAT, TAIPEI, TAIWAN; TAIPEI MED COLL, TAIPEI, TAIWAN; CHRISTCHURCH SCH MED, DEPT PSYCHOL MED, CHRISTCHURCH, NEW ZEALAND; CHRISTCHURCH SCH MED, DEPT PUBL HLTH & GEN PRACTICE, CHRISTCHURCH, NEW ZEALAND; ST GEORGE HOSP, DEPT PSYCHIAT & PSYCHOL, BEIRUT, LEBANON; AMER UNIV BEIRUT, BEIRUT, LEBANON; LEBANESE UNIV, BEIRUT, LEBANON; ST JOSEPH UNIV, BEIRUT, LEBANON; KEYO PSYCHIAT INST, KYONGGI DO, SOUTH KOREA; INSERM, U19, VILLEJUIF, FRANCE; MAX PLANCK INST PSYCHIAT, INST CLIN, D-80804 MUNICH, GERMANY; HOP FERNAND WIDAL, PARIS, FRANCE	Columbia University; University of Alberta; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; University of Otago; University of Otago; American University of Beirut; Lebanese University; Institut National de la Sante et de la Recherche Medicale (Inserm); Max Planck Society; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Weissman, MM (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, NEW YORK STATE PSYCHIAT INST, DIV CLIN & GENET EPIDEMIOL, NEW YORK, NY 10032 USA.		anand, amit/A-7222-2009; Wittchen, Hans-Ulrich/A-8507-2014; Wittchen, Hans-Ulrich/ABA-8901-2020; Faravelli, Carlo/B-7961-2014	Wittchen, Hans-Ulrich/0000-0002-6311-7711; Faravelli, Carlo/0000-0002-8131-8031; Weissman, Myrna/0000-0003-3490-3075; HWU, HAI-GWO/0000-0002-2582-2807	NIMH NIH HHS [MH37592] Funding Source: Medline; PHS HHS [30906-12] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; BOYD JH, 1985, EPIDEMIOLOGIC FIELD; BRESLAU N, 1995, PSYCHIAT RES, V58, P1, DOI 10.1016/0165-1781(95)02765-O; Breslow NE, 1987, DESIGN ANAL COHORT S, VII; BRUCE ML, 1992, AM J PSYCHIAT, V149, P914; CANINO GJ, 1987, ARCH GEN PSYCHIAT, V44, P727; CHEN CN, 1993, ARCH GEN PSYCHIAT, V50, P125; COMPTON WM, 1991, AM J PSYCHIAT, V148, P1697; EATON WW, 1984, ARCH GEN PSYCHIAT, V41, P942; FARAVELLI C, 1990, J AFFECT DISORDERS, V20, P135, DOI 10.1016/0165-0327(90)90127-T; HELZER JE, 1985, ARCH GEN PSYCHIAT, V42, P657; HWU HG, 1989, ACTA PSYCHIAT SCAND, V79, P136, DOI 10.1111/j.1600-0447.1989.tb08581.x; KARAM E, 1992, ANN PSYCHOL SCI ED, P99; KESSLER R, 1995, WORLD PSYCH ASS MAY; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; LEAF P, 1991, PSYCHIAT DISORDERS A; LEE CK, 1990, J NERV MENT DIS, V178, P247, DOI 10.1097/00005053-199004000-00005; LEE CK, 1990, J NERV MENT DIS, V178, P242, DOI 10.1097/00005053-199004000-00004; LEPINE J P, 1989, Psychiatrie and Psychobiologie, V4, P267; MURPHY JM, 1985, PSYCHOL MED, V15, P99, DOI 10.1017/S0033291700020961; MURPHY JM, 1995, HARVARD REV PSYCHIAT, V3, P47, DOI 10.3109/10673229509017165; ORN H, 1988, ACTA PSYCHIAT SCAND, V77, P17, DOI 10.1111/j.1600-0447.1988.tb08543.x; POTTHOFF RF, 1992, J AM STAT ASSOC, V87, P383, DOI 10.2307/2290269; Robins L, 1985, EPIDEMIOLOGIC FIELD; ROBINS L, 1995, WORLD PSYCH ASS MAY; Robins L.N., 1991, PSYCHIAT DISORDERS A; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; SAS&REG; Procedures, 1990, VERSION 6; Smith A., 1992, HDB AFFECTIVE DISORD, P111; WEISSMAN MM, 1988, PSYCHOL MED, V18, P141, DOI 10.1017/S0033291700001975; WELLS JE, 1989, AUST NZ J PSYCHIAT, V23, P315, DOI 10.3109/00048678909068289; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; WITTCHEN HU, 1992, EUR ARCH PSY CLIN N, V241, P247, DOI 10.1007/BF02190261; Wolk S, 1995, REV PSYCHIAT, V14, P227; YEH EK, 1994, CHIANG CHING KUO FDN, V109; 1992, JAMA-J AM MED ASSOC, V268, P3098	41	1517	1584	8	271	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1996	276	4					293	299		10.1001/jama.276.4.293	http://dx.doi.org/10.1001/jama.276.4.293			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UX583	8656541				2022-12-28	WOS:A1996UX58300034
J	Jazwinski, SM				Jazwinski, SM			Longevity, genes, and aging	SCIENCE			English	Review							YEAST SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; LIFE-SPAN; CAENORHABDITIS-ELEGANS; POSTPONED SENESCENCE; STRESS RESISTANCE; COCKAYNE SYNDROME; LONG; AGE; EXPRESSION	Until recently, biogerontology was a backwater of biology, but progress in the qualitative and quantitative genetic analysis of longevity has led to a revolution in aging research. This research has revealed that extended longevity is frequently associated with enhanced metabolic capacity and response to stress. Moreover, it suggests that there are multiple mechanisms of aging. Because of its complexity, the aging process takes us into the realm of integrative biology, and thus, biogerontology should prove instrumental in deciphering the functional and regulatory circuitry of the sequenced genome.			Jazwinski, SM (corresponding author), LOUISIANA STATE UNIV, MED CTR, DEPT BIOCHEM & MOLEC BIOL, NEW ORLEANS, LA 70112 USA.							ARKING R, 1988, EXP GERONTOL, V23, P59, DOI 10.1016/0531-5565(88)90020-4; ARKING R, 1993, GENETICA, V91, P127, DOI 10.1007/BF01435993; AXELROD A, 1991, MOL CELL BIOL, V11, P1080, DOI 10.1128/MCB.11.2.1080; Broach J R, 1990, Adv Cancer Res, V54, P79, DOI 10.1016/S0065-230X(08)60809-X; BUCK S, 1993, HEREDITY, V71, P23, DOI 10.1038/hdy.1993.103; CATTANACH BM, 1974, GENET RES, V23, P291, DOI 10.1017/S0016672300014932; CHEN JB, 1990, MOL MICROBIOL, V4, P2081, DOI 10.1111/j.1365-2958.1990.tb00568.x; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; CLARE MJ, 1985, HEREDITY, V55, P19, DOI 10.1038/hdy.1985.67; CLARK AG, 1995, GENETICA, V96, P225, DOI 10.1007/BF01439576; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; COVELLI V, 1989, J IMMUNOL, V142, P1224; CURTSINGER JW, 1992, SCIENCE, V258, P461, DOI 10.1126/science.1411541; DMELLO NP, 1994, J BIOL CHEM, V269, P15451; DMELLO NP, 1991, J BACTERIOL, V173, P6709, DOI 10.1128/jb.173.21.6709-6713.1991; DORMAN JB, 1995, GENETICS, V141, P1399; DUDAS SP, 1995, J GERONTOL A-BIOL, V50, pB117, DOI 10.1093/gerona/50A.3.B117; Ebert RH, 1996, DEV GENET, V18, P131, DOI 10.1002/(SICI)1520-6408(1996)18:2&lt;131::AID-DVG6&gt;3.0.CO;2-A; EBERT RH, 1993, GENETICS, V135, P1003; EGILMEZ NK, 1989, J BIOL CHEM, V264, P14312; ENGELBERG D, 1994, CELL, V77, P381, DOI 10.1016/0092-8674(94)90153-8; ERSHLER WB, 1993, LYMPHOKINE CYTOK RES, V12, P225; Finch CE, 1990, LONGEVITY SENESCENCE; FLEMING JE, 1988, P NATL ACAD SCI USA, V85, P4099, DOI 10.1073/pnas.85.11.4099; FLEMING JE, 1996, HDB BIOL AGING, P75; FRIEDMAN DB, 1988, GENETICS, V118, P75; FUKUI HH, 1993, EXP GERONTOL, V28, P585, DOI 10.1016/0531-5565(93)90048-I; GELMAN R, 1988, GENETICS, V118, P693; Gems D, 1996, NATURE, V379, P723, DOI 10.1038/379723a0; GRAVES JL, 1988, J INSECT PHYSIOL, V34, P1021, DOI 10.1016/0022-1910(88)90201-6; GRAVES JL, 1992, PHYSIOL ZOOL, V65, P268, DOI 10.1086/physzool.65.2.30158253; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HARLEY CB, 1995, CURR OPIN GENET DEV, V5, P249, DOI 10.1016/0959-437X(95)80016-6; HURSTING SD, 1994, P NATL ACAD SCI USA, V91, P7036, DOI 10.1073/pnas.91.15.7036; Jazwinski S. Michal, 1996, P39; JAZWINSKI SM, 1993, GENETICA, V91, P35, DOI 10.1007/BF01435986; JAZWINSKI SM, 1990, J GERONTOL, V45, pB68, DOI 10.1093/geronj/45.3.B68; JAZWINSKI SM, 1990, MOL MICROBIOL, V4, P337, DOI 10.1111/j.1365-2958.1990.tb00601.x; JAZWINSKI SM, 1989, EXP GERONTOL, V24, P423; JOHNSON TE, 1987, P NATL ACAD SCI USA, V84, P3777, DOI 10.1073/pnas.84.11.3777; JOHNSON TE, 1990, GENETIC EFFECTS AGIN, P101; Kale SP, 1996, DEV GENET, V18, P154, DOI 10.1002/(SICI)1520-6408(1996)18:2<154::AID-DVG8>3.0.CO;2-8; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KHAZAELI AA, 1995, J GERONTOL A-BIOL, V50, pB262, DOI 10.1093/gerona/50A.5.B262; Kim S, 1996, BIOCHEM BIOPH RES CO, V219, P370, DOI 10.1006/bbrc.1996.0240; KIRCHMAN PA, UNPUB; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; KLEIN C, 1994, MOL CELL BIOL, V14, P1920, DOI 10.1128/MCB.14.3.1920; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; LARSEN PL, 1995, GENETICS, V139, P1567; LAURENSON P, 1992, MICROBIOL REV, V56, P543, DOI 10.1128/MMBR.56.4.543-560.1992; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; LITHGOW GJ, 1994, J GERONTOL, V49, pB270, DOI 10.1093/geronj/49.6.B270; Lithgow Gordon J., 1996, P55; LUCKINBILL LS, 1984, EVOLUTION, V38, P996, DOI 10.1111/j.1558-5646.1984.tb00369.x; MARCHLER G, 1993, EMBO J, V12, P1997, DOI 10.1002/j.1460-2075.1993.tb05849.x; Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5; MASORO EJ, 1995, EXP GERONTOL, V30, P291, DOI 10.1016/0531-5565(94)00028-2; MCCLUNG JK, 1995, EXP GERONTOL, V30, P99, DOI 10.1016/0531-5565(94)00069-7; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; MILMAN N, 1988, CLIN CHIM ACTA, V176, P59, DOI 10.1016/0009-8981(88)90174-X; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; MULLER I, 1980, MECH AGEING DEV, V12, P47, DOI 10.1016/0047-6374(80)90028-7; MULLER I, 1985, A VAN LEEUW J MICROB, V51, P1, DOI 10.1007/BF00444223; MURAKAMI S, IN PRESS GENETICS; ORR WC, 1992, ARCH BIOCHEM BIOPHYS, V297, P35, DOI 10.1016/0003-9861(92)90637-C; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761; POST DJ, 1991, ANN NY ACAD SCI, V621, P66; PROUST J, 1982, TISSUE ANTIGENS, V19, P168, DOI 10.1111/j.1399-0039.1982.tb01436.x; RICHARDSON S, 1994, GENETICS EVOLUTION A, P226; ROSE M. R., 1991, EVOLUTIONARY BIOL AG; ROSE MR, 1992, EXP GERONTOL, V27, P241, DOI 10.1016/0531-5565(92)90048-5; ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x; RUSSELL RL, 1990, GENETIC EFFECTS AGIN, P129; SALAZAR M, 1995, P NATL ACAD SCI USA, V92, P3992, DOI 10.1073/pnas.92.9.3992; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; SATO T, 1992, CANCER RES, V52, P1643; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SERVICE PM, 1987, PHYSIOL ZOOL, V60, P321, DOI 10.1086/physzool.60.3.30162285; SERVICE PM, 1985, PHYSIOL ZOOL, V58, P380, DOI 10.1086/physzool.58.4.30156013; Shook DR, 1996, GENETICS, V142, P801; SIERRA F, 1992, J BIOL CHEM, V267, P10665; SIERRA F, 1989, MOL CELL BIOL, V9, P5610, DOI 10.1128/MCB.9.12.5610; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; SNOW M, COMMUNICATION; SOHAL RS, 1995, J BIOL CHEM, V270, P15671, DOI 10.1074/jbc.270.26.15671; SUN JY, 1994, J BIOL CHEM, V269, P18638; TAKATA H, 1987, LANCET, V2, P824; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; VANVOORHIES WA, 1992, NATURE, V360, P456, DOI 10.1038/360456a0; VARKEY JP, 1995, GENE DEV, V9, P1074, DOI 10.1101/gad.9.9.1074; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; WAREHAM KA, 1987, NATURE, V327, P725, DOI 10.1038/327725a0; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; WHEELER JC, 1995, P NATL ACAD SCI USA, V92, P10408, DOI 10.1073/pnas.92.22.10408; WONG A, 1995, GENETICS, V139, P1247; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; YUNIS EJ, 1993, GENETICA, V91, P211, DOI 10.1007/BF01435999	104	277	300	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	1996	273	5271					54	59		10.1126/science.273.5271.54	http://dx.doi.org/10.1126/science.273.5271.54			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV478	8658195				2022-12-28	WOS:A1996UV47800032
J	Lau, HT; Yu, M; Fontana, A; Stoeckert, CJ				Lau, HT; Yu, M; Fontana, A; Stoeckert, CJ			Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice	SCIENCE			English	Article							SYSTEMIC DELIVERY	Allogeneic transplantation of islets of Langerhans was facilitated by the cotransplantation of syngeneic myoblasts genetically engineered to express the Fas ligand (FasL). Composite grafting of allogeneic islets with syngeneic myoblasts expressing Fast protected the islet graft from immune rejection and maintained normoglycemia for more than 80 days in mice with streptozotocin-induced diabetes. Graft survival was not prolonged with composite grafts of unmodified myoblasts or Fas-expressing myoblasts. Islet allografts transplanted separately from FasL-expressing myoblasts into the contralateral kidney were rejected, as were similarly transplanted third-party thyroid allografts. Thus, the FasL signal provided site- and immune-specific protection of islet allografts.	UNIV PENN,CHILDRENS HOSP PHILADELPHIA,DEPT PEDIAT SURG,PHILADELPHIA,PA 19104; UNIV ZURICH HOSP,DEPT INTERNAL MED,CLIN IMMUNOL SECT,CH-8044 ZURICH,SWITZERLAND; CHILDRENS HOSP PHILADELPHIA,DEPT HEMATOL,ABRAMSON CTR,PHILADELPHIA,PA 19104	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Zurich; University Zurich Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia								BARR E, 1991, SCIENCE, V254, P1507, DOI 10.1126/science.1962212; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; CANTINI M, 1994, IN VITRO CELL DEV-AN, V30A, P131; DHAWAN J, 1991, SCIENCE, V254, P1509, DOI 10.1126/science.1962213; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GOLSTEIN P, 1995, IMMUNOL REV, V146, P45, DOI 10.1111/j.1600-065X.1995.tb00683.x; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; LEITHAUSER F, 1993, LAB INVEST, V69, P415; LYNCH DH, 1995, IMMUNOL TODAY, V16, P570; MILLER RA, 1993, CURRENT PROTOCOLS IM, V1; NAGATA S, 1994, ADV IMMUNOL, V57, P129, DOI 10.1016/S0065-2776(08)60672-0; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; RAMSDELL F, 1994, INT IMMUNOL, V6, P1545, DOI 10.1093/intimm/6.10.1545; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; RENSINGEHL A, 1995, EUR J IMMUNOL, V25, P2253, DOI 10.1002/eji.1830250821; SUDA T, 1994, J EXP MED, V179, P873, DOI 10.1084/jem.179.3.873; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; VIGNAUX F, 1995, J EXP MED, V181, P781, DOI 10.1084/jem.181.2.781; YAGITA H, 1995, IMMUNOL REV, V146, P223, DOI 10.1111/j.1600-065X.1995.tb00691.x	19	407	443	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 5	1996	273	5271					109	112		10.1126/science.273.5271.109	http://dx.doi.org/10.1126/science.273.5271.109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV478	8658177				2022-12-28	WOS:A1996UV47800051
J	Smith, JR; PereiraSmith, OM				Smith, JR; PereiraSmith, OM			Replicative senescence: Implications for in vivo aging and tumor suppression	SCIENCE			English	Review							HUMAN-DIPLOID FIBROBLASTS; FINITE LIFE-SPAN; HUMAN-CELLS; CELLULAR SENESCENCE; INDEFINITE DIVISION; SIMIAN VIRUS-40; WERNER SYNDROME; DNA-SYNTHESIS; MALIGNANT TRANSFORMATION; SERIAL CULTIVATION	Normal cells have limited proliferative potential in culture, a fact that has been the basis of their use as a model for replicative senescence for many years. Recent molecular analyses have identified numerous changes in gene expression that occur as cells become senescent, and the results indicate that multiple levels of control contribute to the irreversible growth arrest. These include repression of growth stimulatory genes, overexpression of growth inhibitory genes, and interference with downstream pathways. Studies with cell types other than fibroblasts will better define the role of cell senescence in the aging process and in tumorigenesis.	BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine	Smith, JR (corresponding author), BAYLOR COLL MED,ROY M & PHYLLIS GOUGH HUFFINGTON CTR AGING,DIV MOLEC VIROL,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.							ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; BAI L, 1993, INT J CANCER, V53, P451, DOI 10.1002/ijc.2910530317; BLOMQUIST E, 1980, MECH AGEING DEV, V12, P173, DOI 10.1016/0047-6374(80)90093-7; BOND JA, 1995, CANCER RES, V55, P2404; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; BUNN CL, 1980, EXP CELL RES, V127, P385, DOI 10.1016/0014-4827(80)90443-7; CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; COUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900; deLange T, 1996, SEMIN CELL DEV BIOL, V7, P23, DOI 10.1006/scdb.1996.0005; DELLORCO RT, 1973, EXP CELL RES, V77, P356, DOI 10.1016/0014-4827(73)90588-0; DIMRI GP, 1994, EXP CELL RES, V212, P132, DOI 10.1006/excr.1994.1127; DIMRI GP, 1994, COLD SPRING HARB SYM, V59, P67, DOI 10.1101/SQB.1994.059.01.010; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DOGGETT DL, 1992, MECH AGEING DEV, V65, P239, DOI 10.1016/0047-6374(92)90039-G; DULIC V, 1993, P NATL ACAD SCI USA, V90, P11034, DOI 10.1073/pnas.90.23.11034; DUNCAN EL, 1993, EXP CELL RES, V205, P337, DOI 10.1006/excr.1993.1095; EFFROS RB, 1984, HUM IMMUNOL, V9, P49, DOI 10.1016/0198-8859(84)90006-5; ELDEIRY WS, 1993, CELL, V75, P815; FARAGHER RGA, 1993, P NATL ACAD SCI USA, V90, P12030, DOI 10.1073/pnas.90.24.12030; GIRARDI AJ, 1965, J CELL COMPAR PHYSL, V65, P69, DOI 10.1002/jcp.1030650110; GOLDSTEIN S, 1979, J INVEST DERMATOL, V73, P19, DOI 10.1111/1523-1747.ep12532754; GOLDSTEIN S, 1974, EXP CELL RES, V83, P297, DOI 10.1016/0014-4827(74)90342-5; GORMAN SD, 1985, J CELL PHYSIOL, V125, P122, DOI 10.1002/jcp.1041250116; GREIDER CW, 1990, BIOESSAYS, V12, P363, DOI 10.1002/bies.950120803; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; HARA E, 1991, BIOCHEM BIOPH RES CO, V179, P528, DOI 10.1016/0006-291X(91)91403-Y; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; HARPER JW, 1993, CELL, V75, P805; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HENSLER PJ, 1994, MOL CELL BIOL, V14, P2291, DOI 10.1128/MCB.14.4.2291; Holliday R, 1996, BIOESSAYS, V18, P3, DOI 10.1002/bies.950180103; HOLLIDAY R, 1989, CELL BIOPHYS, V15, P15, DOI 10.1007/BF02991575; HOLLIDAY R, 1986, EXP CELL RES, V166, P543, DOI 10.1016/0014-4827(86)90499-4; IDE T, 1983, EXP CELL RES, V143, P343, DOI 10.1016/0014-4827(83)90060-5; KAUL SC, 1993, BIOCHEM BIOPH RES CO, V193, P348, DOI 10.1006/bbrc.1993.1630; KLEIN CB, 1991, SCIENCE, V251, P796, DOI 10.1126/science.1990442; KOI M, 1993, SCIENCE, V260, P361, DOI 10.1126/science.8469989; KUBBIES M, 1985, J CELL PHYSIOL, V125, P229, DOI 10.1002/jcp.1041250209; KUMAZAKI T, 1991, EXP CELL RES, V195, P13, DOI 10.1016/0014-4827(91)90494-F; LEE MS, 1993, COLD SPRING HARB SYM, V58, P707, DOI 10.1101/SQB.1993.058.01.078; LINDSEY J, 1991, MUTAT RES, V256, P45, DOI 10.1016/0921-8734(91)90032-7; MAARTEN HK, 1995, NUCLEIC ACIDS RES, V23, P3244; MARTIN GM, 1970, LAB INVEST, V23, P86; MATSUMURA T, 1979, J GERONTOL, V34, P328, DOI 10.1093/geronj/34.3.328; MAYNE LV, 1986, EXP CELL RES, V162, P530, DOI 10.1016/0014-4827(86)90356-3; MCALLISTER JM, 1987, IN VITRO CELL DEV B, V23, P677; MEDRANO E, COMMUNICATION; MEDRANO EE, 1994, MOL BIOL CELL, V5, P497, DOI 10.1091/mbc.5.4.497; MIHARA K, 1992, INT J CANCER, V50, P639, DOI 10.1002/ijc.2910500426; MILLIS AJ, 1992, EXP CELL RES, V201, P379; MOYER AW, 1964, J NATL CANCER I, V33, P227; MURNANE JP, 1994, EMBO J, V13, P4953, DOI 10.1002/j.1460-2075.1994.tb06822.x; NEUFELD DS, 1987, MOL CELL BIOL, V7, P2794, DOI 10.1128/MCB.7.8.2794; NEWBOLD RF, 1982, NATURE, V299, P633, DOI 10.1038/299633a0; NING Y, 1991, MUTAT RES, V256, P303, DOI 10.1016/0921-8734(91)90021-3; NING Y, 1991, P NATL ACAD SCI USA, V88, P5635, DOI 10.1073/pnas.88.13.5635; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; NORWOOD TH, 1979, J INVEST DERMATOL, V73, P92, DOI 10.1111/1523-1747.ep12532778; OBRIEN W, 1986, P NATL ACAD SCI USA, V83, P8659; OGATA T, 1993, MOL CELL BIOL, V13, P6036, DOI 10.1128/MCB.13.10.6036; OGATA T, 1993, JPN J CANCER RES, V86, P35; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; OSHIMA J, 1995, J CELL PHYSIOL, V162, P277, DOI 10.1002/jcp.1041620213; PEREIRASMITH OM, 1983, SCIENCE, V221, P964, DOI 10.1126/science.6879195; PEREIRASMITH OM, 1988, P NATL ACAD SCI USA, V85, P6042, DOI 10.1073/pnas.85.16.6042; PEREIRASMITH OM, 1981, SOMAT CELL GENET, V7, P411, DOI 10.1007/BF01542986; PEREIRASMITH OM, 1990, J CELL PHYSIOL, V144, P546, DOI 10.1002/jcp.1041440324; Ponten J, 1971, Virol Monogr, V8, P1; PONTEN J, 1976, BIOCHIM BIOPHYS ACTA, V458, P397, DOI 10.1016/0304-419X(76)90009-3; RASOAMANANTENA P, 1994, EXP CELL RES, V213, P121, DOI 10.1006/excr.1994.1181; RAY FA, 1990, J CELL BIOCHEM, V42, P13, DOI 10.1002/jcb.240420103; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Robetorye RS, 1996, CAN J AGING, V15, P315, DOI 10.1017/S0714980800006772; Robetorye RS, 1996, MOL CELL DIFFER, V4, P113; ROHME D, 1981, P NATL ACAD SCI-BIOL, V78, P5009, DOI 10.1073/pnas.78.8.5009; SAGER R, 1991, ENVIRON HEALTH PERSP, V93, P59, DOI 10.2307/3431170; SAGER R, 1983, P NATL ACAD SCI-BIOL, V80, P7601, DOI 10.1073/pnas.80.24.7601; SAGER R, 1984, CANC CELLS, V2, P248; SAITO H, 1991, EXP CELL RES, V192, P373, DOI 10.1016/0014-4827(91)90054-X; SANDHU AK, 1994, P NATL ACAD SCI USA, V91, P5498, DOI 10.1073/pnas.91.12.5498; SASAKI M, 1994, CANCER RES, V54, P6090; SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680; SHAY JW, 1991, BIOCHIM BIOPHYS ACTA, V1072, P1, DOI 10.1016/0304-419X(91)90003-4; SHAY JW, 1989, EXP CELL RES, V184, P109, DOI 10.1016/0014-4827(89)90369-8; SMITH JR, 1974, J CELL BIOL, V62, P48, DOI 10.1083/jcb.62.1.48; SMITH JR, 1980, SCIENCE, V207, P82; STAIANOCOICO L, 1984, J IMMUNOL, V132, P1788; STEIN GH, 1995, BIOESSAYS, V17, P537, DOI 10.1002/bies.950170610; STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342; STEIN GH, 1991, P NATL ACAD SCI USA, V88, P11012, DOI 10.1073/pnas.88.24.11012; Strahl C, 1996, MOL CELL BIOL, V16, P53; SUGAWARA O, 1990, SCIENCE, V247, P707, DOI 10.1126/science.2300822; Sugihara S, 1996, HUM GENET, V97, P1; TASSIN J, 1979, EXP CELL RES, V123, P388, DOI 10.1016/0014-4827(79)90483-X; THORNTON SC, 1983, SCIENCE, V222, P623, DOI 10.1126/science.6635659; THWEATT R, 1992, EXP GERONTOL, V27, P433, DOI 10.1016/0531-5565(92)90078-E; VAZIRI H, 1993, AM J HUM GENET, V52, P661; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; WADHWA R, 1993, J BIOL CHEM, V268, P6615; WADHWA R, 1995, EXP CELL RES, V216, P101, DOI 10.1006/excr.1995.1013; WADHWA R, 1993, EXP CELL RES, V207, P442, DOI 10.1006/excr.1993.1213; WEST MD, 1989, EXP CELL RES, V184, P138, DOI 10.1016/0014-4827(89)90372-8; WHITAKER NJ, 1992, J VIROL, V66, P1202, DOI 10.1128/JVI.66.2.1202-1206.1992; WRIGHT WE, 1989, MOL CELL BIOL, V9, P3088, DOI 10.1128/MCB.9.7.3088; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; YANG LQ, 1995, EXP CELL RES, V221, P126, DOI 10.1006/excr.1995.1359; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zeng GY, 1996, EXP CELL RES, V222, P150, DOI 10.1006/excr.1996.0019	114	470	487	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 5	1996	273	5271					63	67		10.1126/science.273.5271.63	http://dx.doi.org/10.1126/science.273.5271.63			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV478	8658197				2022-12-28	WOS:A1996UV47800034
J	Merson, MH				Merson, MH			Returning home: Reflections on the USA's response to the HIV AIDS epidemic	LANCET			English	Editorial Material											Merson, MH (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,POB 20834,NEW HAVEN,CT 06520, USA.							BRANDT A, 1987, NO MAGIC BULLET; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; FRANCIS DP, 1992, JAMA-J AM MED ASSOC, V268, P1444, DOI 10.1001/jama.268.11.1444; GROSECLOSE SL, 1995, J ACQ IMMUN DEF SYND, V10, P82; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Holmberg SD, 1996, AM J PUBLIC HEALTH, V86, P642, DOI 10.2105/AJPH.86.5.642; KIRBY D, 1994, PUBLIC HEALTH REP, V109, P339; NORMAND J, 1995, PREVENTING HIV TRANS; *OFF TECHN ASS, 1995, EFF AIDS PREV EFF; PHILLIPS KA, 1995, NEW ENGL J MED, V332, P1308, DOI 10.1056/NEJM199505113321918; ROSENBERG PS, 1995, SCIENCE, V270, P1372, DOI 10.1126/science.270.5240.1372; STRYKER J, 1995, JAMA-J AM MED ASSOC, V273, P1143, DOI 10.1001/jama.273.14.1143; 1993, MMWR MORBID MORTAL W, V42, P337; 1993, INVESTING HLTH, P99; 1993, MMWR MORBID MORTAL W, V42, P329; 1995, MMWR MORBID MORTAL W, V44, P849	16	7	7	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 15	1996	347	9016					1673	1676		10.1016/S0140-6736(96)91494-4	http://dx.doi.org/10.1016/S0140-6736(96)91494-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ701	8642965	hybrid			2022-12-28	WOS:A1996UQ70100017
J	Brunet, A; Pouyssegur, J				Brunet, A; Pouyssegur, J			Identification of MAP kinase domains by redirecting stress signals into growth factor responses	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; PHOSPHORYLATION; PROLIFERATION; FAMILY; S6	Mitogen-activated protein kinase (MAPK) cascades, termed MAPK modules, channel extracellular signals into specific cellular responses. Chimeric molecules were constructed between p38 and p44 MAPKs, which transduce stress and growth factor signals, respectively. A discrete region of 40 residues located in the amino-terminal p38MAPK lobe directed the specificity of response to extracellular signals, whereas the carboxyl-terminal half of the molecule specified Substrate recognition. One p38-p44MAPK chimera, expressed in vivo, redirected stress signals into early mitogenic responses, demonstrating the functional independence of these domains.			Brunet, A (corresponding author), FAC SCI,CTR BIOCHIM,CNRS,UMR134,PARC VALROSE,F-06108 NICE 2,FRANCE.							ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRUNET A, 1994, ONCOGENE, V9, P3379; BRUNET A, UNPUB; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CHEN RH, 1990, MOL CELL BIOL, V10, P3204, DOI 10.1128/MCB.10.6.3204; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; GOLDSMITH EJ, 1994, CURR OPIN STRUC BIOL, V4, P833, DOI 10.1016/0959-440X(94)90264-X; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LAVOIE J, IN PRESS PROGR CELL, V2; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MELOCHE S, 1992, MOL BIOL CELL, V3, P63, DOI 10.1091/mbc.3.1.63; MORGAN DO, 1994, CURR OPIN CELL BIOL, V6, P239, DOI 10.1016/0955-0674(94)90142-2; NEIMAN AM, 1993, TRENDS GENET, V9, P390, DOI 10.1016/0168-9525(93)90139-9; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0	28	124	128	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1996	272	5268					1652	1655		10.1126/science.272.5268.1652	http://dx.doi.org/10.1126/science.272.5268.1652			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8658140				2022-12-28	WOS:A1996UR09300047
J	Dominguez, M; Brunner, M; Hafen, E; Basler, K				Dominguez, M; Brunner, M; Hafen, E; Basler, K			Sending and receiving the Hedgehog signal: Control by the Drosophila Gli protein Cubitus interruptus	SCIENCE			English	Article							ENGRAILED GENE; EXPRESSION; COMPARTMENT; DOMINANT; REGION; CELL; RECOMBINATION; TRANSCRIPTION; MELANOGASTER; REPRESSION	Drosophila limb development is organized by interactions between anterior and posterior compartment cells. Posterior cells continuously express and require engrailed (en) and secrete Hedgehog (Hh) protein. Anterior cells express the zinc-finger protein Cubitus interruptus (Ci). It is now shown that anterior cells lacking ci express hh and adopt posterior properties without expressing en. Increased levels of Ci can induce the expression of the Hh target gene decapentaplegic (dpp) in a Hh-independent manner. Thus, expression of Ci in anterior cells controls limb development (i) by restricting hh secretion to posterior cells and (ii) by conferring competence to respond to Hh by mediating the transduction of this signal.			Dominguez, M (corresponding author), UNIV ZURICH,INST ZOOL,WINTERTHURERSTR 190,CH-8057 ZURICH,SWITZERLAND.		Dominguez, Maria/G-2171-2014	Dominguez, Maria/0000-0002-3329-7862; Basler, Konrad/0000-0003-3534-1529				Ashburner M., 1989, DROSOPHILA LAB HDB; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWER DL, 1986, EMBO J, V5, P2649, DOI 10.1002/j.1460-2075.1986.tb04547.x; BROWER DL, 1984, NATURE, V319, P496; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; DESPLAN C, 1985, NATURE, V318, P630, DOI 10.1038/318630a0; DINARDO S, 1985, CELL, V43, P59, DOI 10.1016/0092-8674(85)90012-1; EATON S, 1990, GENE DEV, V4, P1068, DOI 10.1101/gad.4.6.1068; FJOSE A, 1985, NATURE, V313, P284, DOI 10.1038/313284a0; FORBES AJ, 1993, DEVELOPMENT, P115; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; GUBB D, 1985, Wilhelm Roux's Archives of Developmental Biology, V194, P236, DOI 10.1007/BF00848252; GUILLEN I, 1995, DEVELOPMENT, V121, P3447; HAMA C, 1990, GENE DEV, V4, P1079, DOI 10.1101/gad.4.7.1079; HIDALGO A, 1994, CURR BIOL, V4, P1087, DOI 10.1016/S0960-9822(00)00247-5; HOCHMAN B, 1973, COLD SPRING HARB SYM, V38, P581, DOI 10.1101/SQB.1974.038.01.062; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; Johnson RL, 1995, DEVELOPMENT, V121, P4161; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; KORNBERG T, 1985, CELL, V40, P45, DOI 10.1016/0092-8674(85)90307-1; KORNBERG T, 1981, P NATL ACAD SCI-BIOL, V78, P1095, DOI 10.1073/pnas.78.2.1095; LAWRENCE PA, 1976, DEV BIOL, V50, P321, DOI 10.1016/0012-1606(76)90155-X; LAWRENCE PA, 1982, EMBO J, V1, P827, DOI 10.1002/j.1460-2075.1982.tb01255.x; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; LEE TC, 1994, ONCOGENE, V9, P1047; LEPAGE T, 1995, NATURE, V373, P711, DOI 10.1038/373711a0; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; LOCKE J, 1994, MOL GEN GENET, V243, P234, DOI 10.1007/BF00280321; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; MOHLER J, 1992, DEVELOPMENT, V115, P957; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; ORENIC T, 1987, DEV BIOL, V124, P50, DOI 10.1016/0012-1606(87)90458-1; ORENIC TV, 1990, GENE DEV, V4, P1053, DOI 10.1101/gad.4.6.1053; PAN DJ, 1995, CELL, V80, P543, DOI 10.1016/0092-8674(95)90508-1; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; POOLE SJ, 1985, CELL, V40, P31; SANICOLA M, 1995, GENETICS, V139, P745; SAUER F, 1993, NATURE, V364, P454, DOI 10.1038/364454a0; SAUER F, 1991, NATURE, V353, P563, DOI 10.1038/353563a0; SCHIMMANG T, 1993, PROG CLIN BIOL RES, V383, P153; SCHWARTZ C, 1995, DEVELOPMENT, V121, P1625; SLUSARSKI DC, 1995, GENETICS, V139, P229; TABATA T, 1995, DEVELOPMENT, V121, P3359; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; ZECCA M, 1995, DEVELOPMENT, V121, P2265	58	268	278	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1996	272	5268					1621	1625		10.1126/science.272.5268.1621	http://dx.doi.org/10.1126/science.272.5268.1621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8658135				2022-12-28	WOS:A1996UR09300036
J	Kaiser, D				Kaiser, D			Bacteria also vote	SCIENCE			English	Editorial Material							FISCHERI LUMINESCENCE SYSTEM; MYXOCOCCUS-XANTHUS; BACILLUS-SUBTILIS; LUXR GENE; A-FACTOR; IDENTIFICATION; AUTOINDUCER; MUTUALISM; PROTEIN		STANFORD UNIV,DEPT DEV BIOL,STANFORD,CA 94305	Stanford University	Kaiser, D (corresponding author), STANFORD UNIV,DEPT BIOCHEM,STANFORD,CA 94305, USA.							BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; DUNNY GM, 1995, J BACTERIOL, V177, P871, DOI 10.1128/jb.177.4.871-876.1995; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; GROSSMAN AD, 1988, P NATL ACAD SCI USA, V85, P4369, DOI 10.1073/pnas.85.12.4369; HORINOUCHI S, 1992, GENE, V115, P167, DOI 10.1016/0378-1119(92)90555-4; KAPLAN HB, 1987, P NATL ACAD SCI USA, V84, P6639, DOI 10.1073/pnas.84.19.6639; KAPLAN HB, 1985, J BACTERIOL, V163, P1210, DOI 10.1128/JB.163.3.1210-1214.1985; KUSPA A, 1992, J BACTERIOL, V174, P7360, DOI 10.1128/jb.174.22.7360-7369.1992; KUSPA A, 1992, J BACTERIOL, V174, P3319, DOI 10.1128/jb.174.10.3319-3326.1992; LONG SR, 1993, CELL, V73, P921, DOI 10.1016/0092-8674(93)90271-Q; MAGNUSON R, 1994, CELL, V77, P207, DOI 10.1016/0092-8674(94)90313-1; MANOIL C, 1980, J BACTERIOL, V141, P305, DOI 10.1128/JB.141.1.305-315.1980; MCFALLNGAI MJ, 1991, SCIENCE, V254, P1491, DOI 10.1126/science.1962208; More MI, 1996, SCIENCE, V272, P1655, DOI 10.1126/science.272.5268.1655; NEALSON KH, 1979, MICROBIOL REV, V43, P496, DOI 10.1128/MMBR.43.4.496-518.1979; Perego M, 1996, P NATL ACAD SCI USA, V93, P1549, DOI 10.1073/pnas.93.4.1549; RUBY EG, 1992, J BACTERIOL, V174, P4865, DOI 10.1128/JB.174.15.4865-4870.1992; SHADEL GS, 1991, J BACTERIOL, V173, P568, DOI 10.1128/jb.173.2.568-574.1991; SINGER M, 1995, GENE DEV, V9, P1633, DOI 10.1101/gad.9.13.1633; SOLOMON JM, 1995, GENE DEV, V9, P547, DOI 10.1101/gad.9.5.547	21	45	45	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1996	272	5268					1598	1599		10.1126/science.272.5268.1598	http://dx.doi.org/10.1126/science.272.5268.1598			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8658131				2022-12-28	WOS:A1996UR09300031
J	Sherman, DR; Mdluli, K; Hickey, MJ; Arain, TM; Morris, SL; Barry, CE; Stover, CK				Sherman, DR; Mdluli, K; Hickey, MJ; Arain, TM; Morris, SL; Barry, CE; Stover, CK			Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis	SCIENCE			English	Article							OXIDATIVE STRESS	Mutations that eliminate KatG catalase-peroxidase activity prevent activation of isoniazid and are a major mechanism of resistance to this principal drug for the treatment of Mycobacterium tuberculosis infections. However, the loss of KatG activity in clinical isolates seemed paradoxical because KatG is considered an important factor for the survival of the organism. Expression of either KatG or the recently identified alkyl hydroperoxidase AhpC was sufficient to protect bacilli against the toxic effects of organic peroxides. To survive during infection, isoniazid-resistant KatG mutants have apparently compensated for the loss of KatG catalase-peroxidase activity by a second mutation, resulting in hyperexpression of AhpC.	PATHOGENESIS CORP, LAB TB & MOL MICROBIOL, SEATTLE, WA 98119 USA; NIAID, TB RES UNIT, INTRACELLULAR PARASITES LAB, ROCKY MT LABS, HAMILTON, MT 59840 USA; US FDA, LAB MYCOBACTERIA, CTR BIOL EVALUAT & RES, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); US Food & Drug Administration (FDA)			Barry, Clifton E/ABE-7992-2020; Barry, III, Clifton/H-3839-2012	Barry, Clifton E/0000-0002-2927-270X; Barry, III, Clifton/0000-0002-2927-270X; Stover, Charles/0000-0002-7406-1696	Intramural NIH HHS [Z01 AI000783-11] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHRISTMAN MF, 1985, CELL, V41, P753, DOI 10.1016/S0092-8674(85)80056-8; COLE ST, COMMUNICATION; DEMPLE B, 1983, NATURE, V304, P466, DOI 10.1038/304466a0; DERETIC V, 1995, MOL MICROBIOL, V17, P889, DOI 10.1111/j.1365-2958.1995.mmi_17050889.x; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HEYM B, 1995, MOL MICROBIOL, V15, P235, DOI 10.1111/j.1365-2958.1995.tb02238.x; Hickey MJ, 1996, ANTIMICROB AGENTS CH, V40, P400, DOI 10.1128/AAC.40.2.400; JOHNSSON K, 1994, J AM CHEM SOC, V116, P7425, DOI 10.1021/ja00095a063; MORRIS S, 1995, J INFECT DIS, V171, P954, DOI 10.1093/infdis/171.4.954; ROSNER JL, 1994, ANTIMICROB AGENTS CH, V38, P1829, DOI 10.1128/AAC.38.8.1829; SHERMAN DH, UNPUB; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; SHOEB HA, 1985, ANTIMICROB AGENTS CH, V27, P399, DOI 10.1128/AAC.27.3.399; SIES H, 1986, ANGEW CHEM INT EDIT, V25, P1058, DOI 10.1002/anie.198610581; TAKAYAMA K, 1972, ANTIMICROB AGENTS CH, V2, P29, DOI 10.1128/AAC.2.1.29; WIELES B, 1995, INFECT IMMUN, V63, P4946, DOI 10.1128/IAI.63.12.4946-4948.1995; WILSON TM, 1995, MOL MICROBIOL, V15, P1009, DOI 10.1111/j.1365-2958.1995.tb02276.x; YUAN Y, 1995, P NATL ACAD SCI USA, V92, P6630, DOI 10.1073/pnas.92.14.6630; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	21	341	362	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	1996	272	5268					1641	1643		10.1126/science.272.5268.1641	http://dx.doi.org/10.1126/science.272.5268.1641			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8658136				2022-12-28	WOS:A1996UR09300043
J	Wong, VS; Wreghitt, TG; Alexander, GJM				Wong, VS; Wreghitt, TG; Alexander, GJM			Prospective study of hepatitis B vaccination in patients with chronic hepatitis C	BRITISH MEDICAL JOURNAL			English	Article							STRATEGIES		UNIV CAMBRIDGE,SCH CLIN MED,ADDENBROOKES NHS TRUST,DEPT MED,CAMBRIDGE CB2 2QQ,ENGLAND; ADDENBROOKES NHS TRUST,DEPT VIROL,CAMBRIDGE,ENGLAND	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital								ALTER MJ, 1990, JAMA-J AM MED ASSOC, V263, P1218, DOI 10.1001/jama.263.9.1218; CATTERALL AP, 1992, GUT, V33, P576, DOI 10.1136/gut.33.5.576; ESTEBAN R, 1993, J HEPATOL, V17, P567; ILAN Y, 1994, ISRAEL J MED SCI, V30, P259; 1987, UPDATE HEPATITIS B P, V107, P353	5	21	22	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 25	1996	312	7042					1336	1337		10.1136/bmj.312.7042.1336	http://dx.doi.org/10.1136/bmj.312.7042.1336			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN476	8646046	Green Published			2022-12-28	WOS:A1996UN47600021
J	Bretscher, MS				Bretscher, MS			Moving membrane up to the front of migrating cells	CELL			English	Review							RECEPTORS; TRANSFERRIN; LOCOMOTION; NEURONS				Bretscher, MS (corresponding author), MRC,MOLEC BIOL LAB,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND.							BRETSCHER MS, 1984, SCIENCE, V224, P681, DOI 10.1126/science.6719108; BRETSCHER MS, 1983, P NATL ACAD SCI-BIOL, V80, P454, DOI 10.1073/pnas.80.2.454; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; CRAIG AM, 1995, NATURE, V375, P592, DOI 10.1038/375592a0; DAI JW, 1995, CELL, V83, P693; DOTTI CG, 1990, CELL, V62, P62; HEATH JP, 1991, CELL MOTIL CYTOSKEL, V18, P245, DOI 10.1002/cm.970180402; HOPKINS CR, 1985, CELL, V40, P199, DOI 10.1016/0092-8674(85)90323-X; HOPKINS CR, 1994, J CELL BIOL, V125, P1265, DOI 10.1083/jcb.125.6.1265; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; MARCUS PI, 1962, COLD SPRING HARB SYM, V27, P351, DOI 10.1101/SQB.1962.027.001.033; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; WINKLER B, 1996, NATURE, V379, P213	17	133	135	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 17	1996	85	4					465	467		10.1016/S0092-8674(00)81246-5	http://dx.doi.org/10.1016/S0092-8674(00)81246-5			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UM415	8653781	Bronze			2022-12-28	WOS:A1996UM41500003
J	Holm, L; Sander, C				Holm, L; Sander, C			Mapping the protein universe	SCIENCE			English	Article							DNA-POLYMERASE-BETA; CRYSTAL-STRUCTURE; DATA-BANK; STRUCTURE ALIGNMENT; SEQUENCE ALIGNMENT; ZINC-FINGER; CLASSIFICATION; RESOLUTION; PHOSPHORYLASE; CONFORMATION	The comparison of the three-dimensional shapes of protein molecules poses a complex algorithmic problem. Its solution provides biologists with computational tools to organize the rapidly growing set of thousands of known protein shapes, to identify new types of protein architecture, and to discover unexpected evolutionary relations, reaching back billions of years, between protein molecules. Protein shape comparison also improves tools for identifying gene functions in genome databases by defining the essential sequence-structure features of a protein family. Finally, an exhaustive all-on-all shape comparison provides a map of physical attractor regions in the abstract shape space of proteins, with implications for the processes of protein folding and evolution.			Holm, L (corresponding author), EUROPEAN MOLEC BIOL LAB, EUROPEAN BIOINFORMAT INST, HINXTON HALL, CAMBRIDGE CB10 1SD, ENGLAND.		Sander, Chris/H-1452-2011	Sander, Chris/0000-0001-6059-6270				ALEXANDROV NN, 1992, J MOL BIOL, V225, P5, DOI 10.1016/0022-2836(92)91021-G; ARTYMIUK PJ, 1995, NAT STRUCT BIOL, V2, P117, DOI 10.1038/nsb0295-117; BARAKAT MT, 1991, J COMPUT AID MOL DES, V5, P107, DOI 10.1007/BF00129750; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BORCHERT TV, 1994, FEBS LETT, V341, P79, DOI 10.1016/0014-5793(94)80244-0; Casari G, 1996, TRENDS GENET, V12, P244, DOI 10.1016/0168-9525(96)30057-7; CHOTHIA C, 1984, ANNU REV BIOCHEM, V53, P537; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; CRIPPEN GM, 1995, J MOL BIOL, V252, P144, DOI 10.1006/jmbi.1995.0481; DAVIES JF, 1994, CELL, V76, P1123, DOI 10.1016/0092-8674(94)90388-3; DIEDERICHS K, 1995, PROTEINS, V23, P187, DOI 10.1002/prot.340230208; EFIMOV AV, 1995, J MOL BIOL, V245, P402, DOI 10.1006/jmbi.1994.0033; FAIRALL L, 1993, NATURE, V366, P483, DOI 10.1038/366483a0; FINKELSTEIN AV, 1991, NATURE, V351, P497, DOI 10.1038/351497a0; FISCHER D, 1992, J BIOMOL STRUCT DYN, V9, P769, DOI 10.1080/07391102.1992.10507955; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, P1893, DOI 10.1093/nar/8.9.1893; GRINDLEY HM, 1993, J MOL BIOL, V229, P707, DOI 10.1006/jmbi.1993.1074; Hill M. O., 1974, Applied Statistics, V23, P340, DOI 10.2307/2347127; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOLM L, 1994, PROTEINS, V19, P256, DOI 10.1002/prot.340190309; HOLM L, 1994, NUCLEIC ACIDS RES, V22, P3600; HOLM L, 1993, NATURE, V361, P309, DOI 10.1038/361309a0; HOLM L, 1995, EMBO J, V14, P1287, DOI 10.1002/j.1460-2075.1995.tb07114.x; HOLM L, 1995, P 3 INT C INT SYST M, P179; JOHNSON MS, 1994, 27TH P HAW INT C SYS, V5, P296; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KATTI SK, 1989, J MOL BIOL, V205, P557, DOI 10.1016/0022-2836(89)90226-X; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LATHROP RH, 1994, PROTEIN ENG, V7, P1059, DOI 10.1093/protein/7.9.1059; Lathrop RH, 1996, J MOL BIOL, V255, P641, DOI 10.1006/jmbi.1996.0053; Lesk AM, 1995, LECT NOTES COMPUT SC, V937, P248; LESK AM, 1991, PROTEIN ARCHITECTURE; MURZIN AG, 1988, J MOL BIOL, V204, P749, DOI 10.1016/0022-2836(88)90366-X; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; OMICHINSKI JG, 1992, BIOCHEMISTRY-US, V31, P3907, DOI 10.1021/bi00131a004; ONESTI S, 1991, J MOL BIOL, V217, P153, DOI 10.1016/0022-2836(91)90618-G; ORENGO C, 1994, CURR OPIN STRUC BIOL, V4, P429, DOI 10.1016/S0959-440X(94)90113-9; ORENGO CA, 1992, PROTEINS, V14, P139, DOI 10.1002/prot.340140203; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PAULING L, 1951, P NATL ACAD SCI USA, V37, P729, DOI 10.1073/pnas.37.11.729; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; PICKERSGILL RW, 1992, ACTA CRYSTALLOGR B, V48, P59, DOI 10.1107/S0108768191006572; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; SALI A, 1990, J MOL BIOL, V212, P403, DOI 10.1016/0022-2836(90)90134-8; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; SIBANDA BL, 1991, METHOD ENZYMOL, V202, P59; STAMPF DR, 1995, NATURE, V374, P572, DOI 10.1038/374572a0; SUBBIAH S, 1993, CURR BIOL, V3, P141, DOI 10.1016/0960-9822(93)90255-M; TAYLOR WR, 1989, J MOL BIOL, V208, P1, DOI 10.1016/0022-2836(89)90084-3; VRIEND G, 1991, PROTEINS, V11, P52, DOI 10.1002/prot.340110107; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697	55	1229	1280	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	1996	273	5275					595	602		10.1126/science.273.5275.595	http://dx.doi.org/10.1126/science.273.5275.595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VA249	8662544				2022-12-28	WOS:A1996VA24900031
J	Gao, SJ; Kingsley, L; Hoover, DR; Spira, TJ; Rinaldo, CR; Saah, A; Phair, J; Detels, R; Parry, P; Chang, Y; Moore, PS				Gao, SJ; Kingsley, L; Hoover, DR; Spira, TJ; Rinaldo, CR; Saah, A; Phair, J; Detels, R; Parry, P; Chang, Y; Moore, PS			Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPSTEIN-BARR VIRUS; AIDS; INFECTION; SYPHILIS; HIV; RESPONSES; PROTEINS; MEN	Background If Kaposi's sarcoma-associated herpesvirus (KSHV) is the cause of Kaposi's sarcoma, serologic evidence of infection should be present in patients before the disease develops. M Methods Using an immunoblot assay for two latent nuclear antigens of KSHV, we tested serum samples from homosexual male patients with the acquired immunodeficiency syndrome (AIDS) with and without Kaposi's sarcoma, HIV-infected men with hemophilia, HIV-seronegative blood donors, and HIV-seronegative patients with high titers of antibodies against Epstein-Barr virus (EBV). Serial serum samples obtained from patients with Kaposi's sarcoma before the diagnosis of the disease were tested for evidence of seroconversion. Results Of 40 patients with Kaposi's sarcoma, 32 (80 percent) were positive for antibodies against KSHV antigens by the immunoblot assay, as compared with only 7 of 40 homosexual men (18 percent) without Kaposi's sarcoma immediately before the onset of AIDS. Of 122 blood donors, 22 EBV-infected patients, and 20 HIV-infected men with hemophilia, none were seropositive. When studied by the immunoblot assay over a period of 13 to 103 months, 21 of the 40 patients with Kaposi's sarcoma (52 percent) seroconverted 6 to 75 months before the clinical appearance of Kaposi's sarcoma. The median duration of antibody seropositivity for KSHV-related latent nuclear antigens before the diagnosis of Kaposi's sarcoma was 33 months. Conclusions In most patients with Kaposi's sarcoma and AIDS, seroconversion to positivity for antibodies against KSHV-related nuclear antigens occurs before the clinical appearance of Kaposi's sarcoma. This supports the hypothesis that Kaposi's sarcoma results from infection with KSHV. (C) 1996, Massachusetts Medical Society.	COLUMBIA UNIV,COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10027; UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT INFECT DIS & MICROBIOL,PITTSBURGH,PA 15260; JOHNS HOPKINS UNIV,SCH PUBL HLTH,DIV EPIDEMIOL,BALTIMORE,MD 21218; CTR DIS CONTROL & PREVENT,DIV AIDS SEXUALLY TRANSMITTED DIS,ATLANTA,GA 30341; CTR DIS CONTROL & PREVENT,TB LAB RES,NATL CTR INFECT DIS,ATLANTA,GA 30341; NORTHWESTERN UNIV,SCH MED,COMPREHENS AIDS CTR,CHICAGO,IL 60611; UNIV CALIF LOS ANGELES,SCH PUBL HLTH,DEPT EPIDEMIOL,LOS ANGELES,CA 90024	Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Northwestern University; University of California System; University of California Los Angeles	Gao, SJ (corresponding author), COLUMBIA UNIV,SCH PUBL HLTH,DIV EPIDEMIOL,P&S 14-442,630 W 168TH ST,NEW YORK,NY 10032, USA.		Moore, Patrick/GVR-8294-2022; Gao, Shou-Jiang/B-8641-2012; Chang, Yuan/F-4146-2011; Moore, Patrick S./F-3960-2011	Chang, Yuan/0000-0003-1125-4041; Moore, Patrick S./0000-0002-8132-858X; Gao, Shou-Jiang/0000-0001-6194-1742; Kingsley, Lawrence/0000-0002-7000-8556	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035040, U01AI035039] Funding Source: NIH RePORTER; NIAID NIH HHS [U01-AI35040, U01-AI35039] Funding Source: Medline; PHS HHS [U64CCU210852-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adams V, 1995, LANCET, V346, P1715, DOI 10.1016/S0140-6736(95)92887-1; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; BERAL V, 1992, LANCET, V339, P632, DOI 10.1016/0140-6736(92)90793-3; BOSHOFF C, 1995, LANCET, V345, P1043; Boshoff C, 1996, LANCET, V347, P338, DOI 10.1016/S0140-6736(96)90524-3; BOWEN DL, 1985, ANN INTERN MED, V103, P704, DOI 10.7326/0003-4819-103-5-704; CESARMAN E, 1995, BLOOD, V86, P2708, DOI 10.1182/blood.V86.7.2708.bloodjournal8672708; CESARMAN E, 1995, NEW ENGL J MED, V332, P186; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chang Y, 1996, ARCH INTERN MED, V156, P202, DOI 10.1001/archinte.156.2.202; DUPIN N, 1995, LANCET, V345, P761, DOI 10.1016/S0140-6736(95)90642-8; GUPTA P, IN PRESS AIDS; HENLE G, 1976, INT J CANCER, V17, P1, DOI 10.1002/ijc.2910170102; HENLE W, 1987, P NATL ACAD SCI USA, V84, P570, DOI 10.1073/pnas.84.2.570; HICKS CB, 1987, ANN INTERN MED, V107, P492, DOI 10.7326/0003-4819-107-4-492; HICKS CB, 1987, ANN INTERN MED, V107, P946, DOI 10.7326/0003-4819-107-6-946_4; JOHNSON PDR, 1991, AIDS, V5, P419, DOI 10.1097/00002030-199104000-00010; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENNETTE ET, 1993, EUR J CANCER, V29A, P1584, DOI 10.1016/0959-8049(93)90299-U; LEVY JA, 1995, LANCET, V346, P786, DOI 10.1016/S0140-6736(95)91611-3; Liebowitz David, 1993, P107; LIN JC, 1995, LANCET, V346, P1602; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; MILLER G, 1974, J INFECT DIS, V130, P187, DOI 10.1093/infdis/130.2.187; Miller G, 1996, NEW ENGL J MED, V334, P1292, DOI 10.1056/NEJM199605163342003; Monini P, 1996, NEW ENGL J MED, V334, P1168, DOI 10.1056/NEJM199605023341805; Moore PS, 1996, J VIROL, V70, P549, DOI 10.1128/JVI.70.1.549-558.1996; Moore PS, 1996, AIDS, V10, P175, DOI 10.1097/00002030-199602000-00007; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; PAGANO JS, 1995, ANTIVIRAL CHEMOTHERA, P155; RADY PL, 1995, LANCET, V345, P1339, DOI 10.1016/S0140-6736(95)92538-4; RAHMAN MA, 1989, J INFECT DIS, V159, P472, DOI 10.1093/infdis/159.3.472; RANGAN SRS, 1977, J NATL CANCER I, V59, P165, DOI 10.1093/jnci/59.1.165; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; ROIZMAN B, 1995, NEW ENGL J MED, V332, P1227, DOI 10.1056/NEJM199505043321810; SCHALLING M, 1995, NAT MED, V1, P707, DOI 10.1038/nm0795-707; SEIGNEURIN JM, 1987, INT J CANCER, V40, P349, DOI 10.1002/ijc.2910400311; Strathdee S A, 1996, AIDS, V10 Suppl A, pS51, DOI 10.1097/00002030-199601001-00008; TAPPERO JW, 1993, J AM ACAD DERMATOL, V28, P371, DOI 10.1016/0190-9622(93)70057-Z; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WHITBY D, 1995, LANCET, V346, P799, DOI 10.1016/S0140-6736(95)91619-9; ZALKA A, 1991, ANN INTERN MED, V114, P521, DOI 10.7326/0003-4819-114-6-521_2; ZURHAUSEN H, 1978, NATURE, V272, P373	44	482	494	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	1996	335	4					233	241		10.1056/NEJM199607253350403	http://dx.doi.org/10.1056/NEJM199607253350403			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ532	8657239				2022-12-28	WOS:A1996UZ53200003
J	Attal, M; Harousseau, JL; Stoppa, AM; Sotto, JJ; Fuzibet, JG; Rossi, JF; Casassus, P; Maisonneuve, H; Facon, T; Ifrah, N; Payen, C; Bataille, R				Attal, M; Harousseau, JL; Stoppa, AM; Sotto, JJ; Fuzibet, JG; Rossi, JF; Casassus, P; Maisonneuve, H; Facon, T; Ifrah, N; Payen, C; Bataille, R			A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELL TRANSPLANTATION; HIGH-DOSE CHEMORADIOTHERAPY; INTRAVENOUS MELPHALAN; THERAPY; LEUKEMIA	Background The median survival of patients with myeloma after conventional chemotherapy is three years or less. Promising results have been reported with high-dose therapy supported by autologous bone marrow transplantation. We conducted a randomized study comparing conventional chemotherapy and high-dose therapy. Methods Two hundred previously untreated patients under the age of 65 years who had myeloma were randomly assigned at the time of diagnosis to receive either conventional chemotherapy or high-dose therapy and autologous bone marrow transplantation. Results The response rate among the patients who received high-dose therapy was 81 percent (including complete responses in 22 percent and very good partial responses in 16 percent), whereas it was 57 percent (complete responses in 5 percent and very good partial responses in 9 percent) in the group treated with conventional chemotherapy (P < 0.001). The probability of event-free survival for five years was 28 percent in the high-dose group and 10 percent in the conventional-dose group (P = 0.01); the overall estimated rate of survival for five years was 52 percent in the high-dose group and 12 percent in the conventional-dose group (P = 0.03). Treatment-related mortality was similar in the two groups. Conclusions High-dose therapy combined with transplantation improves the response rate, event-free survival, and overall survival in patients with myeloma. (C) 1996, Massachusetts Medical Society.	HOP PURPAN, DEPT BIOSTAT, F-31059 TOULOUSE, FRANCE; INST J PAOLI I CALMETTES, F-13009 MARSEILLE, FRANCE; HOP HOTEL DIEU, NANTES, FRANCE; HOP CIMIEZ, F-06003 NICE, FRANCE; HOP ALBERT MICHALLON, GRENOBLE, FRANCE; HOP LAPEYRONIE, MONTPELLIER, FRANCE; HOP AVICENNE, F-93009 BOBIGNY, FRANCE; HOP ROCHE YON, LA ROCHE SUR YON, FRANCE; HOP C HURIEZ, LILLE, FRANCE; CHU ANGERS, ANGERS, FRANCE	CHU de Toulouse; UNICANCER; Institut Paoli-Calmette (IPC); Nantes Universite; CHU de Nantes; CHU Nice; CHU Grenoble Alpes; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; CHD Vendee; Universite de Lille - ISITE; CHU Lille; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Attal, M (corresponding author), HOP PURPAN, SERV HEMATOL, DEPT HEMATOL, PL DOCTEUR BAYLAC, F-31059 TOULOUSE, FRANCE.			IFRAH, Norbert/0000-0003-3063-850X				ALEXANIAN R, 1969, J AMER MED ASSOC, V208, P1680, DOI 10.1001/jama.208.9.1680; ALEXANIAN R, 1994, BLOOD, V84, P4278, DOI 10.1182/blood.V84.12.4278.bloodjournal84124278; ANDERSON KC, 1991, BLOOD, V77, P712; ATTAL M, 1992, BLOOD, V79, P1130, DOI 10.1182/blood.V79.5.1130.bloodjournal7951130; Barlogie B., 1995, Blood, V86, p207A; BARLOGIE B, 1987, BLOOD, V70, P869; BARLOGIE B, 1986, BLOOD, V67, P1298; BARLOGIE B, 1992, JAMA-J AM MED ASSOC, V268, P2946, DOI 10.1001/jama.268.20.2946; BARLOGIE B, 1991, BONE MARROW TRANSPL, V7, P71; BERGSAGEL DE, 1989, EUR J CANCER CLIN ON, V25, P159, DOI 10.1016/0277-5379(89)90001-1; BJORKSTRAND B, 1995, STEM CELLS, V13, P140; BJORKSTRAND B, 1995, BONE MARROW TRANSPL, V15, P367; Casassus P., 1995, Blood, V86, p441A; CUNNINGHAM D, 1994, J CLIN ONCOL, V12, P759, DOI 10.1200/JCO.1994.12.4.759; CUNNINGHAM D, 1994, J CLIN ONCOL, V12, P764, DOI 10.1200/JCO.1994.12.4.764; DIMOPOULOS MA, 1993, BLOOD, V82, P2324; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; Fermand J. P., 1995, Blood, V86, p205A; FERMAND JP, 1993, BLOOD, V82, P2005; GIANNI AM, 1994, J CLIN ONCOL, V12, P503, DOI 10.1200/JCO.1994.12.3.503; GISSELBRECHT C, 1994, LANCET, V343, P696, DOI 10.1016/S0140-6736(94)91579-2; GORE ME, 1989, LANCET, V2, P879; GREGORY WM, 1992, J CLIN ONCOL, V10, P334, DOI 10.1200/JCO.1992.10.2.334; HAROUSSEAU JL, 1992, BLOOD, V79, P2827; HAROUSSEAU JL, 1995, BLOOD, V85, P3077, DOI 10.1182/blood.V85.11.3077.bloodjournal85113077; JAGANNATH S, 1990, BLOOD, V76, P1860; LINK H, 1992, BLOOD, V80, P2188; LOKHORST HM, 1992, J CLIN ONCOL, V10, P47, DOI 10.1200/JCO.1992.10.1.47; LUDWIG H, 1995, ANN ONCOL, V6, P467, DOI 10.1093/oxfordjournals.annonc.a059217; MANDELLI F, 1990, NEW ENGL J MED, V322, P1430, DOI 10.1056/NEJM199005173222005; MARIT G, 1995, BONE MARROW TRANSPL, V15, P963; MCELWAIN TJ, 1983, LANCET, V2, P822; Oken M. M., 1995, Blood, V86, p441A; PEEST D, 1995, EUR J CANCER, V31A, P146, DOI 10.1016/0959-8049(94)00452-B; REECE DE, 1993, BONE MARROW TRANSPL, V11, P139; REIFFERS J, 1989, BRIT J HAEMATOL, V72, P296, DOI 10.1111/j.1365-2141.1989.tb07705.x; SALMON SE, 1994, J CLIN ONCOL, V12, P2405, DOI 10.1200/JCO.1994.12.11.2405; SAMSON D, 1989, LANCET, V2, P882; SELBY PJ, 1987, BRIT J HAEMATOL, V66, P55, DOI 10.1111/j.1365-2141.1987.tb06890.x; SPORN JR, 1986, SEMIN ONCOL, V13, P318; VESOLE DH, 1994, BLOOD, V84, P950; Westin J., 1995, Blood, V86, p441A	42	2272	2338	0	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 11	1996	335	2					91	97		10.1056/NEJM199607113350204	http://dx.doi.org/10.1056/NEJM199607113350204			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW353	8649495				2022-12-28	WOS:A1996UW35300004
J	Mittal, R; Ahmadian, MR; Goody, RS; Wittinghofer, A				Mittal, R; Ahmadian, MR; Goody, RS; Wittinghofer, A			Formation of a transition-state analog of the Ras GTPase reaction by Ras center dot GDP, tetrafluoroaluminate, and GTPase-activating proteins	SCIENCE			English	Article							ESCHERICHIA-COLI; MECHANISM; GAP; HYDROLYSIS; BINDING; DOMAIN; SITE; FLUORIDE; P21; FLUORESCENCE	Unlike the alpha subunits of heterotrimeric guanosine triphosphate (GTP)-binding proteins, Ras-related GTP-binding proteins have hitherto been considered not to bind or become activated by tetrafluoroaluminate (AlF4-). However, the product of the proto-oncogene ras in its guanosine diphosphate (GDP)-bound form interacted with AlF4- in the presence of stoichiometric amounts of either of the guanosine triphosphatase (GTPase)-activating proteins (GAPs) p120(GAP) and neurofibromin. Neither oncogenic Ras nor a GAP mutant without catalytic activity produced such a complex. Together with the finding that the Ras-binding domain of the protein kinase c-Raf, whose binding site on Ras overlaps that of the GAPs, did not induce formation of such a complex, this result suggests that GAP and neurofibromin stabilize the transition state of the GTPase reaction of Ras.	MAX PLANCK INST MOLEK PHYSIOL, ABT STRUKTURELLE BIOL, D-44139 DORTMUND, GERMANY; MAX PLANCK INST MOLEK PHYSIOL, PHYS BIOCHEM ABT, D-44139 DORTMUND, GERMANY	Max Planck Society; Max Planck Society			Goody, Roger S/J-8845-2014	Goody, Roger S/0000-0002-0772-0444				AHMADIAN MR, UNPUB; BIGAY J, 1985, FEBS LETT, V191, P181, DOI 10.1016/0014-5793(85)80004-1; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BROWNBRIDGE GG, 1993, J BIOL CHEM, V268, P10914; CARLIER MF, 1989, BIOCHEMISTRY-US, V28, P1783, DOI 10.1021/bi00430a054; CODINA J, 1994, J BIOL CHEM, V269, P29339; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; ECCLESTON JF, 1993, J BIOL CHEM, V268, P27012; FREISSMUTH M, 1989, J BIOL CHEM, V264, P21907; GIBBS JB, 1988, P NATL ACAD SCI USA, V85, P5026, DOI 10.1073/pnas.85.14.5026; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; GUPTA SK, 1992, MOL CELL BIOL, V12, P190, DOI 10.1128/MCB.12.1.190; GUTMANN DH, 1993, ONCOGENE, V8, P761; HAZLETT TL, 1991, FEBS LETT, V278, P225, DOI 10.1016/0014-5793(91)80122-J; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; HIGASHIJIMA T, 1991, J BIOL CHEM, V266, P3396; ISSARTEL JP, 1991, BIOCHEMISTRY-US, V30, P4726, DOI 10.1021/bi00233a013; JOHN J, 1989, NATO ADV SCI I A-LIF, V165, P209; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; KAHN RA, 1991, J BIOL CHEM, V266, P15595; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; MARKBY DW, 1993, SCIENCE, V262, P1895, DOI 10.1126/science.8266082; MARSHALL MS, 1993, TRENDS BIOCHEM SCI, V18, P250, DOI 10.1016/0968-0004(93)90175-M; MESTERS JR, 1993, FEBS LETT, V321, P149, DOI 10.1016/0014-5793(93)80097-E; MITTAL R, UNPUB; MOORE KJM, 1993, BIOCHEMISTRY-US, V32, P7451, DOI 10.1021/bi00080a016; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; NEAL SE, 1990, P NATL ACAD SCI USA, V87, P3562, DOI 10.1073/pnas.87.9.3562; POLAKIS P, 1993, J BIOL CHEM, V268, P9157; RENSLAND H, 1991, BIOCHEMISTRY-US, V30, P11181, DOI 10.1021/bi00110a023; RENSLAND H, 1992, THESIS RUPRECHT KARL; SCHLICHTING I, UNPUB; SCHWEINS T, 1995, NAT STRUCT BIOL, V2, P36, DOI 10.1038/nsb0195-36; SKINNER RH, 1991, J BIOL CHEM, V266, P14163; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; VANDOP C, 1984, J BIOL CHEM, V259, P696; WIESMULLER L, 1992, J BIOL CHEM, V267, P10207; WITTINGHOFER A, 1993, HDB EXPT PHARM, V108, P195	46	194	196	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	1996	273	5271					115	117		10.1126/science.273.5271.115	http://dx.doi.org/10.1126/science.273.5271.115			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV478	8658179				2022-12-28	WOS:A1996UV47800053
J	Cuvillier, O; Pirianov, G; Kleuser, B; Vanek, PG; Coso, OA; Gutkind, JS; Spiegel, S				Cuvillier, O; Pirianov, G; Kleuser, B; Vanek, PG; Coso, OA; Gutkind, JS; Spiegel, S			Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate	NATURE			English	Article							PROLIFERATION	CERAMIDE is an important regulatory participant of programmed cell death (apoptosis) induced by tumour-necrosis factor (TNF)-alpha and Fas ligand, members of the TNF superfamily(1-6). Conversely, sphingosine and sphingosine-1-phosphate, which are metabolites of ceramide, induce mitogenesis(7) and have been implicated as second messengers in cellular proliferation induced by platelet-derived growth factor and serum(8,9). Here we report that sphingosine-1-phosphate prevents the appearance of the key features of apoptosis, namely intranucleosomal DNA fragmentation and morphological changes, which result from increased concentrations of ceramide. Furthermore, inhibition of ceramide-mediated apoptosis by activation of protein kinase C results from stimulation of sphingosine kinase and the concomitant increase in intracellular sphingosine-l-phosphate. Finally sphingosine-1-phosphate not only stimulates the extracellular signal-regulated kinase (ERK) pathway(10), it counteracts the ceramide-induced activation of stress-activated protein kinase (SAPK/JNK). Thus, the balance between the intracellular levels of ceramide and sphingosine-1-phosphate and their regulatory effects on different family members of mitogen-activated protein kinases determines the fate of the cell.	GEORGETOWN UNIV,MED CTR,DEPT BIOCHEM & MOLEC BIOL,WASHINGTON,DC 20007; TREVIGEN INC,GAITHERSBURG,MD 20877; NIDR,CELLULAR DEV & ONCOL LAB,NIH,BETHESDA,MD 20892	Georgetown University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)			CUVILLIER, Olivier/B-2567-2009; Gutkind, J. Silvio/A-1053-2009; CUVILLIER, Olivier/S-1631-2019; Gutkind, J. Silvio/J-1201-2016	CUVILLIER, Olivier/0000-0003-3346-375X; CUVILLIER, Olivier/0000-0003-3346-375X; Gutkind, J. Silvio/0000-0002-5150-4482; Kleuser, Burkhard/0000-0002-1888-9595				BOMFELDT KE, 1995, J CELL BIOL, V130, P193; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; CIFONE MG, 1995, EMBO J, V14, P5859, DOI 10.1002/j.1460-2075.1995.tb00274.x; CORONEOS E, 1995, J BIOL CHEM, V270, P23305, DOI 10.1074/jbc.270.40.23305; COSO OA, 1995, J BIOL CHEM, V270, P5620, DOI 10.1074/jbc.270.10.5620; CRESPO P, 1994, J BIOL CHEM, V269, P21103; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; DUKE RC, 1992, CURRENT PROTOCOLS IM; GILL BM, 1994, IMMUNOL REV, V142, P113, DOI 10.1111/j.1600-065X.1994.tb00885.x; GULBINS E, 1995, IMMUNITY, V2, P1; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HELLER RA, 1994, J CELL BIOL, V126, P5, DOI 10.1083/jcb.126.1.5; JARVIS WD, 1994, J BIOL CHEM, V269, P31685; JARVIS WD, 1994, CANCER RES, V54, P1707; JAYADEV S, 1995, J BIOL CHEM, V270, P2047, DOI 10.1074/jbc.270.5.2047; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; OLIVERA A, 1994, ANAL BIOCHEM, V223, P306, DOI 10.1006/abio.1994.1589; SPIEGEL S, 1995, J MEMBRANE BIOL, V146, P225; TEPPER CG, 1995, P NATL ACAD SCI USA, V92, P8443, DOI 10.1073/pnas.92.18.8443; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; WESTWICK JK, 1995, J BIOL CHEM, V270, P22689, DOI 10.1074/jbc.270.39.22689; WU J, 1995, J BIOL CHEM, V270, P11484, DOI 10.1074/jbc.270.19.11484; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; YATOMI T, 1995, ANAL BIOCHEM, V230, P315; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155	30	1280	1330	2	62	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 27	1996	381	6585					800	803		10.1038/381800a0	http://dx.doi.org/10.1038/381800a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU356	8657285				2022-12-28	WOS:A1996UU35600064
J	deLahunta, EA; Tulsky, AA				deLahunta, EA; Tulsky, AA			Personal exposure of faculty and medical students to family violence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INJURIES; ABUSE; CARE	Objective.-To determine the prevalence of exposure to personal family violence among medical students and full-time faculty at a major medical center. Design.-Self-reported, double-mailing, anonymous survey conducted in September 1995. Participants.-Of 406 medical students and 917 full-time faculty surveyed, 787 (59%) responded, including 217 students and 559 faculty members who identified academic status and 292 women and 482 men who identified gender. Main Outcome Measure.-Self-reported personal experience with partner abuse, child abuse, physical abuse, and sexual abuse. Results.-Response rates were higher for women (69%) than men (54%) (P<.001) and were higher for faculty (61%) than students (53%) (P=.01). Of the 787 respondents, 99 (12.6%; 95% confidence interval [Cl], 10.9%-15.6%) reported physical abuse, sexual abuse, or both by a partner during their adult life, 118 (15.0%; 95% CI, 12.8%-17.8%) reported physical abuse, sexual abuse, or both as a child, and 188 (23.9%; 95% CI, 22.0%-28.1%) reported physical abuse, sexual abuse, or both in their lifetime. Based on positive responses, a minimum of 17% of the female medical students and faculty and 3% of the male medical students and faculty have experienced physical abuse or sexual abuse by a partner in their adult Conclusions.-Family violence is a pervasive problem that crosses into the personal experience of medical professionals. The conservative estimate of partner abuse for female medical students and faculty appears comparable with the general population national estimates. The acknowledgment by physicians that family violence is a potential risk for everyone, physicians and patients alike, is a step toward enhancing the identification of abuse and initiating interventions on behalf of survivors of family violence.	UNIV ROCHESTER,SCH MED & DENT,DEPT EMERGENCY MED,ROCHESTER,NY 14627; UNIV ROCHESTER,SCH MED & DENT,DEPT INTERNAL MED,ROCHESTER,NY 14627	University of Rochester; University of Rochester				/0000-0002-1867-6055				ABBOTT J, 1995, JAMA-J AM MED ASSOC, V273, P1763, DOI 10.1001/jama.273.22.1763; ATTALA JM, 1994, WOMEN HEALTH, V21, P125, DOI 10.1300/J013v21n02_08; Brendtro M, 1989, Issues Ment Health Nurs, V10, P169; CAMPBELL JC, 1993, NURSING CARE SURVIVO; Flitcraft A.H., 1992, DIAGNOSTIC TREATMENT; GRISSO JA, 1991, AM J EPIDEMIOL, V134, P59, DOI 10.1093/oxfordjournals.aje.a115993; HAUGAARD JJ, 1989, CHILD ABUSE NEGLECT, V13, P89, DOI 10.1016/0145-2134(89)90032-X; Hendricks-Matthews M K, 1991, Fam Med, V23, P194; HOLTZ HA, 1989, MMWR-MORBID MORTAL W, V38, P17; HUDSON WW, 1981, J MARRIAGE FAM, V43, P873, DOI 10.2307/351344; *JOINT COMM ACCR H, 1992, 1992 ACCR MAN HOSP, P23; KASSEBAUM DG, 1995, ACAD MED, V70, P961; MCCAULEY J, 1995, ANN INTERN MED, V123, P737, DOI 10.7326/0003-4819-123-10-199511150-00001; MCFARLANE J, 1992, JAMA-J AM MED ASSOC, V267, P3176, DOI 10.1001/jama.267.23.3176; NOVELLO AC, 1992, JAMA-J AM MED ASSOC, V267, P3132, DOI 10.1001/jama.267.23.3132; ROSENBERG ML, 1992, PUBLIC HLTH PREVENTI, P1035; STRAUS MA, 1986, B NEW YORK ACAD MED, V62, P556; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; SUGG NK, 1992, JAMA-J AM MED ASSOC, V267, P3157, DOI 10.1001/jama.267.23.3157; 1992, JAMA-J AM MED ASSOC, V267, P3184	20	55	56	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	1996	275	24					1903	1906		10.1001/jama.275.24.1903	http://dx.doi.org/10.1001/jama.275.24.1903			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UR975	8648871				2022-12-28	WOS:A1996UR97500036
J	Albertsen, PC				Albertsen, PC			Urology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Albertsen, PC (corresponding author), UNIV CONNECTICUT, CTR HLTH, FARMINGTON, CT 06032 USA.							ALBERTSEN PC, 1995, JAMA-J AM MED ASSOC, V274, P626, DOI 10.1001/jama.274.8.626; BARRY MJ, 1995, UROLOGY, V46, P445, DOI 10.1016/S0090-4295(99)80255-6; BRESLAU NA, 1995, J BONE MINER RES, V10, P394; CATALONA WJ, 1995, JAMA-J AM MED ASSOC, V274, P1214; ESRIG D, 1994, NEW ENGL J MED, V331, P1259, DOI 10.1056/NEJM199411103311903; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; HANLEY JA, 1995, CONSEIL EVALUATION T, P1; MIDDLETON RG, 1995, J UROLOGY, V154, P2144, DOI 10.1016/S0022-5347(01)66718-1; OESTERLING JE, 1995, J UROLOGY, V154, P1090, DOI 10.1016/S0022-5347(01)66984-2; POTOSKY AL, 1995, JAMA-J AM MED ASSOC, V273, P548, DOI 10.1001/jama.273.7.548; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; WASSON JH, 1995, NEW ENGL J MED, V332, P75, DOI 10.1056/NEJM199501123320202; WILT TJ, 1994, J UROLOGY, V152, P1910, DOI 10.1016/S0022-5347(17)32413-8; WINGO PA, 1995, CA-CANCER J CLIN, V45, P8, DOI 10.3322/canjclin.45.1.8; WOOLF SH, 1995, NEW ENGL J MED, V333, P1401, DOI 10.1056/NEJM199511233332107	15	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1857	1858		10.1001/jama.275.23.1857	http://dx.doi.org/10.1001/jama.275.23.1857			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642751				2022-12-28	WOS:A1996UQ15200050
J	Russell, RM				Russell, RM			Nutrition	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											Russell, RM (corresponding author), TUFTS UNIV,JEAN MAYER USDA HUMAN NUTR RES CTR AGING,BOSTON,MA 02111, USA.							BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; *DIET GUID ADV COM, 1996, REP DIET GUID ADV CO, P1; GIOVANNUCCI E, 1995, J NATL CANCER I, V87, P1767, DOI 10.1093/jnci/87.23.1767; Greenberg ER, 1996, JAMA-J AM MED ASSOC, V275, P699, DOI 10.1001/jama.275.9.699; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; IRIBARREN C, 1995, NEW ENGL J MED, V333, P686, DOI 10.1056/NEJM199509143331102; JHA P, 1995, ANN INTERN MED, V123, P860, DOI 10.7326/0003-4819-123-11-199512010-00009; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; MORGANTI CM, 1995, MED SCI SPORT EXER, V27, P906; NELSON ME, 1994, JAMA-J AM MED ASSOC, V272, P1909, DOI 10.1001/jama.272.24.1909; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; UBBINK JB, 1994, J NUTR, V124, P1927, DOI 10.1093/jn/124.10.1927; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461	16	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	1996	275	23					1828	1829		10.1001/jama.275.23.1828	http://dx.doi.org/10.1001/jama.275.23.1828			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ152	8642733				2022-12-28	WOS:A1996UQ15200032
J	Nelson, JR; Lawrence, CW; Hinkle, DC				Nelson, JR; Lawrence, CW; Hinkle, DC			Thymine-thymine dimer bypass by yeast DNA polymerase zeta	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CIS-SYN; INVITRO; GENE; MUTAGENESIS; REPLICATION; PROTEIN	The REV3 and REV7 genes of the yeast Saccharomyces cerevisiae are required for DNA damage-induced mutagenesis. The Rev3 and Rev7 proteins were shown to form a complex with DNA polymerase activity. This polymerase replicated past a thymine-thymine cis-syn cyclobutane dimer, a lesion that normally severely inhibits replication, with an efficiency of similar to 10 percent. In contrast, bypass replication efficiency with yeast DNA polymerase a was no more than 1 percent. The Rev3-Rev7 complex is the sixth eukaryotic DNA polymerase to be described, and is therefore called DNA polymerase zeta.	UNIV ROCHESTER,SCH MED & DENT,DEPT BIOPHYS,ROCHESTER,NY 14642; UNIV ROCHESTER,DEPT BIOL,ROCHESTER,NY 14627	University of Rochester; University of Rochester					NIGMS NIH HHS [GM21858, GM29686] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029686, R01GM021858] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHAN GL, 1985, BIOCHEMISTRY-US, V24, P5723, DOI 10.1021/bi00342a006; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FRIEDBERG EC, 1995, DNA REPAIR; GEITZ RD, 1988, GENE, V74, P527; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; HOVLAND P, 1989, GENE, V83, P57, DOI 10.1016/0378-1119(89)90403-4; LARIMER FW, 1989, J BACTERIOL, V171, P230, DOI 10.1128/jb.171.1.230-237.1989; LARSON KL, 1987, BIOCHEMISTRY-US, V26, P2471, DOI 10.1021/bi00383a011; MORRISON A, 1989, J BACTERIOL, V171, P5659, DOI 10.1128/jb.171.10.5659-5667.1989; NELSON J, UNPUB; ODAY CL, 1992, NUCLEIC ACIDS RES, V20, P5403, DOI 10.1093/nar/20.20.5403; PARK HO, 1993, NATURE, V365, P269, DOI 10.1038/365269a0; RABKIN SD, 1983, P NATL ACAD SCI-BIOL, V80, P1541, DOI 10.1073/pnas.80.6.1541; RAJAGOPALAN M, 1992, P NATL ACAD SCI USA, V89, P10777, DOI 10.1073/pnas.89.22.10777; SHIMIZU K, 1993, J BIOL CHEM, V268, P27148; TAYLOR JS, 1990, BIOCHEMISTRY-US, V29, P1624, DOI 10.1021/bi00458a038; TORPEY LE, 1994, YEAST, V10, P1503, DOI 10.1002/yea.320101115	17	583	598	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1996	272	5268					1646	1649		10.1126/science.272.5268.1646	http://dx.doi.org/10.1126/science.272.5268.1646			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR093	8658138				2022-12-28	WOS:A1996UR09300045
J	Shibuya, H; Yamaguchi, K; Shirakabe, K; Tonegawa, A; Gotoh, Y; Ueno, N; Irie, K; Nishida, E; Matsumoto, K				Shibuya, H; Yamaguchi, K; Shirakabe, K; Tonegawa, A; Gotoh, Y; Ueno, N; Irie, K; Nishida, E; Matsumoto, K			TAB1: An activator of the TAK1 MAPKKK in TGF-beta signal transduction	SCIENCE			English	Article							GENE	Transforming growth factor-beta (TGF-B) regulates many aspects of cellular function. A member of the mitogen-activated protein kinase kinase kinase (MAPKKK) family, TAK1, was previously identified as a mediator in the signaling pathway of TGF-beta superfamily members. The yeast two-hybrid system has now revealed two human proteins, termed TAB1 and TAB2 (for TAK1 binding protein), that interact with TAK1. TAB1 and TAK1 were co-immunoprecipitated from mammalian cells. Overproduction of TAB1 enhanced activity of the plasminogen activator inhibitor 1 gene promoter, which is regulated by TGF-beta, and increased the kinase activity of TAK1. TAB1 may function as an activator of the TAK1 MAPKKK in TGF-beta signal transduction.	NAGOYA UNIV, FAC SCI, DEPT MOLEC BIOL, CHIKUSA KU, NAGOYA, AICHI 46401, JAPAN; RES DEV CORP JAPAN, PRECURSORY RES EMBRYON SCI & TECHNOL, HIKARI, KYOTO 61902, JAPAN; HOKKAIDO UNIV, FAC PHARMACEUT SCI, SAPPORO, HOKKAIDO 060, JAPAN; KYOTO UNIV, INST VIRUS RES, DEPT GENET & MOL BIOL, SAKYO KU, KYOTO 60601, JAPAN	Nagoya University; Japan Science & Technology Agency (JST); Hokkaido University; Kyoto University				Ueno, Naoto/0000-0002-8375-2317				ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; BANNO H, 1993, MOL CELL BIOL, V13, P4745, DOI 10.1128/MCB.13.8.4745; BLUMER KJ, 1994, TRENDS BIOCHEM SCI, V19, P236, DOI 10.1016/0968-0004(94)90147-3; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; JOHNSON AD, 1994, GENE, V147, P223, DOI 10.1016/0378-1119(94)90070-1; KEETON MR, 1991, J BIOL CHEM, V266, P23048; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; KISHORE GM, 1988, ANNU REV BIOCHEM, V57, P627, DOI 10.1146/annurev.bi.57.070188.003211; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LEVIN DE, 1995, CURR OPIN CELL BIOL, V7, P197, DOI 10.1016/0955-0674(95)80028-X; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; OHTA S, 1992, FEBS LETT, V314, P356, DOI 10.1016/0014-5793(92)81505-G; SCHULTZ J, 1995, CURR OPIN GENET DEV, V5, P31, DOI 10.1016/S0959-437X(95)90050-0; SHIBUYA H, 1992, NATURE, V357, P700, DOI 10.1038/357700a0; SHIBUYA H, 1994, MOL CELL BIOL, V14, P5812, DOI 10.1128/MCB.14.9.5812; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; YAMAGUCHI K, UNPUB	24	509	538	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	1996	272	5265					1179	1182		10.1126/science.272.5265.1179	http://dx.doi.org/10.1126/science.272.5265.1179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UM889	8638164				2022-12-28	WOS:A1996UM88900053
J	Smith, RC; McClennan, BL				Smith, RC; McClennan, BL			Voiding cystourethrography	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							VESICOURETERAL REFLUX; CHILDREN; TRACT				Smith, RC (corresponding author), YALE UNIV,SCH MED,DEPT DIAGNOST IMAGING,NEW HAVEN,CT 06520, USA.							ALADJEM M, 1980, PEDIATRICS, V65, P78; CALDAMONE AA, 1985, UROL CLIN N AM, V12, P75; HERTZ M, 1992, CAMPBELLS UROLOGY, P435; KLEINMAN PK, 1994, AM J ROENTGENOL, V162, P1151, DOI 10.2214/ajr.162.5.8166001; LEBOWITZ RL, 1992, J UROLOGY, V148, P1640, DOI 10.1016/S0022-5347(17)36991-4; LEBOWITZ RL, 1987, RADIOLOGY, V165, P1; LEBOWITZ RL, 1985, PEDIATR RADIOL, V15, P105, DOI 10.1007/BF02388714; LEBOWITZ RL, 1986, INVEST RADIOL, V21, P519, DOI 10.1097/00004424-198607000-00003; MUSSURAKIS S, 1994, CLIN RADIOL, V49, P541, DOI 10.1016/S0009-9260(05)82933-2; PARROTT TS, 1985, UROL CLIN N AM, V12, P13; ROZENMAN J, 1979, CLIN RADIOL, V30, P471, DOI 10.1016/S0009-9260(79)80234-2; SCHMIDBAUER CP, 1990, CLIN UROGRAPHY, P2055	12	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	1996	275	24					1876	1876						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR975	8648857				2022-12-28	WOS:A1996UR97500015
J	Russell, R; Dundas, R; Reynolds, F				Russell, R; Dundas, R; Reynolds, F			Long term backache after childbirth: Prospective search for causative factors	BRITISH MEDICAL JOURNAL			English	Article							EPIDURAL-ANESTHESIA; PREGNANCY; PAIN; BUPIVACAINE; LABOR	Objectives-To assess in a prospective randomised study the association between motor block resulting from high and low dose epidural infusions of bupivacaine in labour and the incidence of long term backache after childbirth, and to compare the incidence of backache in women not receiving epidural analgesia. Design-Women requesting epidural analgesia in labour between October 1991 and March 1994 were randomised to receive infusions of either bupivacaine alone or low dose bupivacaine with opioid. Data were collected during labour and the immediate postpartum period from these women and from women recruited at random over the same time from those who had laboured without epidural analgesia. A postal questionnaire about symptoms was sent three months after childbirth to all women. Further data were collected one year after childbirth from those who had reported new backache at three months. Setting-St Thomas's Hospital, London. Subjects-599 women were recruited, of whom 450 (75%) replied to a follow up questionnaire. Results-152 women (33.8% of responders) reported backache lasting three months after delivery and, of these, 33 (7.3%) had not previously suffered with backache. There were no significant differences between the treatment groups in the incidence of postnatal backache overall or of new backache err any symptoms after childbirth, Among all demographic, obstetric, and epidural variables examined the only factors significantly associated with backache after childbirth were backache before and during pregnancy. Conclusions-The incidence of new long term backache was not significantly increased in women who received epidural analgesia in labour. Motor block resulting from epidural local anaesthetic administration was not a significant factor in the development of backache.	UNITED MED & DENT SCH,GUYS & ST THOMAS HOSP,DEPT PUBL HLTH MED,LONDON SE1 7EH,ENGLAND	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Russell, R (corresponding author), ST THOMAS HOSP,DEPT ANAESTHESIA,LONDON SE1 7EH,ENGLAND.			Dundas, Ruth/0000-0002-3836-4286; Russell, Robin/0000-0001-7294-6629				BERG G, 1988, OBSTET GYNECOL, V71, P71; BREEN TW, 1994, ANESTHESIOLOGY, V81, P29, DOI 10.1097/00000542-199407000-00006; FAST A, 1987, SPINE, V12, P368, DOI 10.1097/00007632-198705000-00011; MACARTHUR A, 1995, BRIT MED J, V311, P1336, DOI 10.1136/bmj.311.7016.1336; MACARTHUR C, 1990, BRIT MED J, V301, P9, DOI 10.1136/bmj.301.6742.9; MACARTHUR C, 1992, BRIT MED J, V304, P1279, DOI 10.1136/bmj.304.6837.1279; MANTLE MJ, 1977, RHEUMATOL REHABIL, V16, P95, DOI 10.1093/rheumatology/16.2.95; OSTGAARD HC, 1992, SPINE, V17, P53, DOI 10.1097/00007632-199201000-00008; PATEL M, 1995, INT J OBSTET ANESTH, V4, P187; PHILLIPS G, 1988, ANESTH ANALG, V67, P462; REYNOLDS F, 1992, LANCET, V339, P1234, DOI 10.1016/0140-6736(92)91177-A; RUSSELL R, 1993, BRIT MED J, V306, P1299, DOI 10.1136/bmj.306.6888.1299; Russell R, 1996, ANAESTHESIA, V51, P266, DOI 10.1111/j.1365-2044.1996.tb13645.x; RUSSELL R, 1993, ANAESTHESIA, V48, P856, DOI 10.1111/j.1365-2044.1993.tb07413.x; Russell R, 1995, Int J Obstet Anesth, V4, P82, DOI 10.1016/0959-289X(95)82997-O; VANZUNDERT A, 1984, OBSTET ANESTH DIGEST, V4, P31	16	63	64	1	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 1	1996	312	7043					1384	1388						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP434	8646094				2022-12-28	WOS:A1996UP43400018
J	Lavoie, BD; Shaw, GS; Millner, A; Chaconas, G				Lavoie, BD; Shaw, GS; Millner, A; Chaconas, G			Anatomy of a flexer-DNA complex inside a higher-order transposition intermediate	CELL			English	Article							HISTONE-LIKE PROTEIN; SITE-SPECIFIC RECOMBINATION; INTEGRATION HOST FACTOR; ESCHERICHIA-COLI; NUCLEOPROTEIN STRUCTURES; EDTA-IRON; HU-ALPHA; BINDING; IHF; REPLICATION	Escherichia coli HU, a nonsequence-specific histone- and HMG-like DNA-binding protein, was chemically converted into a series of HU-nucleases with an iron-EDTA-based cleavage moiety positioned at 16 rationally selected sites. Specific DNA cleavage patterns from each of these HU-nucleases allowed us to determine the precise localization, stoichiometry, and orientation of HU binding in the Mu transpososome, a multiprotein structure that mediates the chemical reactions in DNA transposition. Correlation of the DNA cleavage data with the position of the cleavage moiety in the HU three-dimensional structure indicates the presence of a dramatic DNA bend, for which the bend center, direction, and magnitude were assessed. The data, which directly localize selected HU amino acids with respect to DNA in the transpososome, were used as constraints for computer-based molecular modeling to derive the first snapshot of an HU-DNA interaction.			Lavoie, BD (corresponding author), UNIV WESTERN ONTARIO,DEPT BIOCHEM,LONDON,ON N6A 5C1,CANADA.		Shaw, Gary S./C-7656-2009	Shaw, Gary S./0000-0002-4685-9625				AKI T, 1996, IN PRESS GENES CELLS, V2; BAKER TA, 1993, CELL, V74, P723, DOI 10.1016/0092-8674(93)90519-V; BIANCHI ME, 1994, MOL MICROBIOL, V14, P1, DOI 10.1111/j.1365-2958.1994.tb01261.x; BONNEFOY E, 1994, J MOL BIOL, V242, P116, DOI 10.1006/jmbi.1994.1563; BONNEFOY E, 1991, EMBO J, V10, P687, DOI 10.1002/j.1460-2075.1991.tb07998.x; Calladine CR., 1992, UNDERSTANDING DNA; CASTAING B, 1995, J BIOL CHEM, V270, P10291, DOI 10.1074/jbc.270.17.10291; CRAIG NL, 1995, SCIENCE, V270, P253, DOI 10.1126/science.270.5234.253; DICKERSON RE, 1992, METHOD ENZYMOL, V211, P67; EBRIGHT YW, 1992, BIOCHEMISTRY-US, V31, P10664, DOI 10.1021/bi00159a004; ECHOLS H, 1990, J BIOL CHEM, V265, P14697; ERMACORA MR, 1992, P NATL ACAD SCI USA, V89, P6383, DOI 10.1073/pnas.89.14.6383; FUNNELL BE, 1987, J BIOL CHEM, V262, P10327; GOSHIMA N, 1990, GENE, V96, P141, DOI 10.1016/0378-1119(90)90355-U; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; GROSSCHEDL R, 1995, CURR OPIN CELL BIOL, V7, P362, DOI 10.1016/0955-0674(95)80091-3; HAYES JJ, 1993, P NATL ACAD SCI USA, V90, P6415, DOI 10.1073/pnas.90.14.6415; HAYKINSON MJ, 1993, EMBO J, V12, P2503, DOI 10.1002/j.1460-2075.1993.tb05905.x; HODGESGARCIA Y, 1989, J BIOL CHEM, V264, P14621; HWANG DS, 1992, J BIOL CHEM, V267, P23083; KAHN JD, 1992, P NATL ACAD SCI USA, V89, P6343, DOI 10.1073/pnas.89.14.6343; KAO LR, 1993, P NATL ACAD SCI USA, V90, P5598, DOI 10.1073/pnas.90.12.5598; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAVOIE BD, 1993, GENE DEV, V7, P2510, DOI 10.1101/gad.7.12b.2510; LAVOIE BD, 1991, EMBO J, V10, P3051, DOI 10.1002/j.1460-2075.1991.tb07856.x; LAVOIE BD, 1994, J BIOL CHEM, V269, P15571; LAVOIE BD, 1995, CURR TOP MICROBIOL I, V204, P83; LEE EC, 1992, EMBO J, V11, P305, DOI 10.1002/j.1460-2075.1992.tb05053.x; MAZZARELLI JM, 1993, BIOCHEMISTRY-US, V32, P2979, DOI 10.1021/bi00063a008; MEGRAW TL, 1993, J BIOL CHEM, V268, P12758; MIZUUCHI M, 1992, CELL, V70, P303, DOI 10.1016/0092-8674(92)90104-K; Nash Howard A., 1996, P149; NER SS, 1994, TRENDS BIOCHEM SCI, V19, P185, DOI 10.1016/0968-0004(94)90017-5; NUNESDUBY SE, 1995, J MOL BIOL, V253, P228, DOI 10.1006/jmbi.1995.0548; OBERTO J, 1994, BIOCHIMIE, V76, P901, DOI 10.1016/0300-9084(94)90014-0; ONATE SA, 1994, MOL CELL BIOL, V14, P3376, DOI 10.1128/MCB.14.5.3376; PARVIN JD, 1995, NATURE, V373, P724, DOI 10.1038/373724a0; PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521; PONTIGGIA A, 1993, MOL MICROBIOL, V7, P343, DOI 10.1111/j.1365-2958.1993.tb01126.x; SAVILAHTI H, 1995, EMBO J, V14, P4893, DOI 10.1002/j.1460-2075.1995.tb00170.x; SHINDO H, 1993, BIOL PHARM BULL, V16, P437; SHINDO H, 1992, NUCLEIC ACIDS RES, V20, P1553, DOI 10.1093/nar/20.7.1553; SHYKIND BM, 1995, GENE DEV, V9, P1354, DOI 10.1101/gad.9.11.1354; SKARSTAD K, 1990, EMBO J, V9, P2341, DOI 10.1002/j.1460-2075.1990.tb07406.x; SURETTE MG, 1989, J BIOL CHEM, V264, P3028; TANAKA H, 1993, J BIOCHEM-TOKYO, V113, P568, DOI 10.1093/oxfordjournals.jbchem.a124084; TANAKA I, 1984, NATURE, V310, P376, DOI 10.1038/310376a0; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; VIS H, 1995, J MOL BIOL, V254, P692, DOI 10.1006/jmbi.1995.0648; Wang ZG, 1996, J BIOL CHEM, V271, P9619, DOI 10.1074/jbc.271.16.9619; Watson MA, 1996, CELL, V85, P435, DOI 10.1016/S0092-8674(00)81121-6; Werner MH, 1996, SCIENCE, V271, P778, DOI 10.1126/science.271.5250.778; WERNER MH, 1994, CURR BIOL, V4, P477, DOI 10.1016/S0960-9822(00)00108-1; WHITE SW, 1989, PROTEINS, V5, P281, DOI 10.1002/prot.340050405; YANG CC, 1989, CELL, V57, P869, DOI 10.1016/0092-8674(89)90801-5	55	90	91	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 31	1996	85	5					761	771		10.1016/S0092-8674(00)81241-6	http://dx.doi.org/10.1016/S0092-8674(00)81241-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UP344	8646783	Bronze			2022-12-28	WOS:A1996UP34400015
J	Edwards, AT; Vig, S; Denvir, MA; Wood, A				Edwards, AT; Vig, S; Denvir, MA; Wood, A			Paradoxical embolism in a young woman	BRITISH MEDICAL JOURNAL			English	Article							DIAGNOSIS; LIFE		UNIV WALES HOSP,DEPT SURG,CARDIFF CF4 4XW,S GLAM,WALES; UNIV WALES HOSP,DEPT CARDIOL,CARDIFF CF4 4XW,S GLAM,WALES; UNIV WALES HOSP,DEPT RADIOL,CARDIFF CF4 4XW,S GLAM,WALES	Cardiff University; Cardiff University; Cardiff University			Denvir, Martin A/ABA-3141-2021					FERRIS EJ, 1993, RADIOLOGY, V188, P851, DOI 10.1148/radiology.188.3.8351361; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; LOSCALZO J, 1986, AM HEART J, V112, P141, DOI 10.1016/0002-8703(86)90692-7; LYNCH JJ, 1984, AM J CARDIOL, V53, P1478, DOI 10.1016/S0002-9149(84)91617-5; MEISTER SG, 1972, AM J MED, V53, P292, DOI 10.1016/0002-9343(72)90171-4; SPEECHLYDICK ME, 1991, BRIT HEART J, V65, P163	6	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 25	1996	312	7042					1350	1351		10.1136/bmj.312.7042.1350	http://dx.doi.org/10.1136/bmj.312.7042.1350			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN476	8646054	Green Published			2022-12-28	WOS:A1996UN47600029
J	Deshpande, AM; Newlon, CS				Deshpande, AM; Newlon, CS			DNA replication fork pause sites dependent on transcription	SCIENCE			English	Article							RNA POLYMERASE-III; SACCHAROMYCES-CEREVISIAE; CONSENSUS SEQUENCE; YEAST CHROMOSOME; GENE; INVIVO; INITIATION; ORIGIN	Replication fork pause (RFP) sites transiently arresting replication fork movement were mapped to transfer RNA (tRNA) genes of Saccharomyces cerevisiae in vivo, RFP sites are polar, stalling replication forks only when they oppose the direction of tRNA transcription, Mutant tRNA genes defective in assembly of transcription initiation complexes and a temperature-sensitive RNA polymerase III mutant (rpc160-41) defective in initiation of transcription do not stall replication forks, suggesting that transcription is required for RFP activity.	UNIV MED & DENT NEW JERSEY, SCH MED, DEPT MICROBIOL & MOLEC GENET, NEWARK, NJ 07103 USA; UNIV MED & DENT NEW JERSEY, GRAD SCH BIOMED SCI, NEWARK, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center					NIGMS NIH HHS [GM35679] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035679] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; BRAUN BR, 1992, J MOL BIOL, V228, P1063, DOI 10.1016/0022-2836(92)90315-B; BREWER BJ, 1993, SCIENCE, V262, P1728, DOI 10.1126/science.8259517; BREWER BJ, 1992, CELL, V71, P267, DOI 10.1016/0092-8674(92)90355-G; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Campbell JL, 1991, MOL CELLULAR BIOL YE, P41; CHALKER DL, 1992, GENE DEV, V6, P117, DOI 10.1101/gad.6.1.117; COLLINS I, 1994, MOL CELL BIOL, V14, P3524, DOI 10.1128/MCB.14.5.3524; DESHPANDE AM, 1992, MOL CELL BIOL, V12, P4305, DOI 10.1128/MCB.12.10.4305; DESHPANDE AS, UNPUB; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; FRIEDMAN KL, COMMUNICATION; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; GIAEVER GN, 1988, CELL, V55, P849, DOI 10.1016/0092-8674(88)90140-7; GREENFEDER SA, 1992, MOL BIOL CELL, V3, P999, DOI 10.1091/mbc.3.9.999; GUDENUS R, 1988, GENETICS, V119, P517; KIRCHNER J, 1995, SCIENCE, V267, P1488, DOI 10.1126/science.7878467; KOBAYASHI T, 1992, MOL GEN GENET, V233, P355, DOI 10.1007/BF00265431; LINSKENS MHK, 1988, MOL CELL BIOL, V8, P4927, DOI 10.1128/MCB.8.11.4927; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; LIU B, 1994, P NATL ACAD SCI USA, V91, P10660, DOI 10.1073/pnas.91.22.10660; LIU B, 1993, NATURE, V366, P33, DOI 10.1038/366033a0; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MATSUZAKI H, 1994, J MOL BIOL, V235, P1173, DOI 10.1006/jmbi.1994.1072; NEWLON CS, 1993, COLD SPRING HARB SYM, V58, P415, DOI 10.1101/SQB.1993.058.01.048; ROTHSTEIN R, 1987, MOL CELL BIOL, V7, P1198, DOI 10.1128/MCB.7.3.1198; SHAW KJ, 1984, MOL CELL BIOL, V4, P657, DOI 10.1128/MCB.4.4.657; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; STROBEL MC, 1986, MOL CELL BIOL, V6, P2663, DOI 10.1128/MCB.6.7.2663; THEIS JF, 1992, YEAST, V8, P223, DOI 10.1002/yea.320080308; THURIAUX P, 1992, MOL CELLULAR BIOL YE, P1; VANHOUTEN JV, 1990, MOL CELL BIOL, V10, P3917, DOI 10.1128/MCB.10.8.3917	34	275	279	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	1996	272	5264					1030	1033		10.1126/science.272.5264.1030	http://dx.doi.org/10.1126/science.272.5264.1030			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL619	8638128				2022-12-28	WOS:A1996UL61900051
J	Downing, AK; Knott, V; Werner, JM; Cardy, CM; Campbell, ID; Handford, PA				Downing, AK; Knott, V; Werner, JM; Cardy, CM; Campbell, ID; Handford, PA			Solution structure of a pair of calcium-binding epidermal growth factor-like domains: Implications for the Marfan syndrome and other genetic disorders	CELL			English	Article							HETERONUCLEAR NMR-SPECTROSCOPY; HUMAN FACTOR-IX; CONNECTIVE-TISSUE MICROFIBRILS; EGF-LIKE DOMAINS; COUPLING-CONSTANTS; FACTOR-X; PROTEINS; FIBRILLIN; ALPHA; RESIDUES	The nuclear magnetic resonance structure of a covalently linked pair of calcium-binding (cb) epidermal growth factor-like (EGF) domains from human fibrillin-1, the protein defective in the Marfan syndrome, is described. The two domains are in a rigid, rod-like arrangement, stabilized by interdomain calcium binding and hydrophobic interactions. We propose a model for the arrangement of fibrillin monomers in microfibrils that reconciles structural and antibody binding data, and we describe a set of disease-causing mutations that provide the first clues to the specificity of cbEGF interactions. The residues involved in stabilizing the domain linkage are highly conserved in fibrillin, fibulin, thrombomodulin, and the low density lipoprotein receptor. We propose that the relative orientation of tandem cbEGF domains in these proteins is similar, but that in others, including Notch, pairs adopt a completely different conformation.	UNIV OXFORD, SIR WILLIAM DUNN SCH PATHOL, OXFORD OX1 3RE, ENGLAND; UNIV OXFORD, OXFORD CTR MOLEC SCI, NEW CHEM LAB, OXFORD OX1 3QT, ENGLAND	University of Oxford; University of Oxford	Downing, AK (corresponding author), UNIV OXFORD, DEPT BIOCHEM, OXFORD OX1 3QU, ENGLAND.		Werner, Joern/E-1148-2013	Werner, Jorn/0000-0002-4712-1833	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2013, DOI 10.1093/nar/20.suppl.2013; BARON M, 1992, PROTEIN SCI, V1, P81; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BORK P, 1996, IN PRESS Q REV BIOPH; BRANDSTETTER H, 1995, P NATL ACAD SCI USA, V92, P9796, DOI 10.1073/pnas.92.21.9796; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BROWN SC, 1988, J MAGN RESON, V77, P166, DOI 10.1016/0022-2364(88)90042-X; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; CLORE GM, 1991, SCIENCE, V252, P1390, DOI 10.1126/science.2047852; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; DAHLBACK B, 1986, P NATL ACAD SCI USA, V83, P4199, DOI 10.1073/pnas.83.12.4199; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; GANDRILLE S, 1995, BLOOD, V85, P130, DOI 10.1182/blood.V85.1.130.bloodjournal851130; *GEN COMP GROUP, 1994, PROGR MAN GCG PACK; Giannelli F, 1996, NUCLEIC ACIDS RES, V24, P103, DOI 10.1093/nar/24.1.103; GLANVILLE RW, 1994, J BIOL CHEM, V269, P26630; HANDFORD P, 1995, J BIOL CHEM, V270, P6751, DOI 10.1074/jbc.270.12.6751; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HOMMEL U, 1992, J MOL BIOL, V227, P271, DOI 10.1016/0022-2836(92)90697-I; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KAY LE, 1989, J MAGN RESON, V84, P72, DOI 10.1016/0022-2364(89)90006-1; KAY LE, 1990, J MAGN RESON, V86, P110, DOI 10.1016/0022-2364(90)90215-U; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P441, DOI 10.1177/39.4.2005373; KIELTY CM, 1993, FEBS LETT, V336, P323, DOI 10.1016/0014-5793(93)80829-J; Knott V, 1996, J MOL BIOL, V255, P22, DOI 10.1006/jmbi.1996.0003; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MACURA S, 1981, J MAGN RESON, V43, P259, DOI 10.1016/0022-2364(81)90037-8; MADDOX BK, 1989, J BIOL CHEM, V264, P21381; MAYHEW M, 1992, PROTEIN ENG, V5, P489, DOI 10.1093/protein/5.6.489; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NILGES M, 1995, J MOL BIOL, V245, P645, DOI 10.1006/jmbi.1994.0053; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; PERSSON E, 1989, J BIOL CHEM, V264, P16897; RAO Z, 1995, CELL, V82, P131, DOI 10.1016/0092-8674(95)90059-4; REES DJG, 1988, EMBO J, V7, P2053, DOI 10.1002/j.1460-2075.1988.tb03045.x; Saharinen J, 1996, EMBO J, V15, P245, DOI 10.1002/j.1460-2075.1996.tb00355.x; SAKAI LY, 1994, METHOD ENZYMOL, V245, P29; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; SELANDERSUNNERHAGEN M, 1992, J BIOL CHEM, V267, P19642; STENFLO J, 1991, BLOOD, V78, P1637; THOMPSON JD, 1994, COMPUT APPL BIOSCI, V10, P19; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; WY US, 1995, CHEM BIOL, V2, P91; ZHU G, 1990, J MAGN RESON, V90, P405, DOI 10.1016/0022-2364(90)90150-8; [No title captured]	53	369	385	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 17	1996	85	4					597	605		10.1016/S0092-8674(00)81259-3	http://dx.doi.org/10.1016/S0092-8674(00)81259-3			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UM415	8653794	Bronze			2022-12-28	WOS:A1996UM41500016
J	Fremont, DH; Hendrickson, WA; Marrack, P; Kappler, J				Fremont, DH; Hendrickson, WA; Marrack, P; Kappler, J			Structures of an MHC class II molecule with covalently bound single peptides	SCIENCE			English	Article							PH; PROLIFERATION; T-HELPER-1; SEPARATION; BINDING	The high-resolution x-ray crystal structures of the murine major histocompatibility complex (MHC) class II molecule, I-E(k), occupied by either of two antigenic peptides were determined. They reveal the structural basis for the I-E(k) peptide binding motif and suggest general principles for additional alleles. A buried cluster of acidic amino acids in the binding groove predicted to be conserved among all murine I-E and human DR MHC class II molecules suggests how pH may influence MHC binding or exchange of peptides. These structures also complement mutational studies on the importance of individual peptide residues to T cell receptor recognition.	NATL JEWISH CTR IMMUNOL & RESP MED,HOWARD HUGHES MED INST,DIV BASIC IMMUNOL,DENVER,CO 80206	Howard Hughes Medical Institute; National Jewish Health	Fremont, DH (corresponding author), COLUMBIA UNIV,DEPT BIOCHEM & MOLEC BIOPHYS,HOWARD HUGHES MED INST,NEW YORK,NY 10032, USA.		Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687; Fremont, Daved/0000-0002-8544-2689				BENTAL N, UNPUB; BONIFACE JJ, 1993, BIOCHEMISTRY-US, V32, P11761, DOI 10.1021/bi00095a003; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Brunger A.T., 1992, X PLOR VERSION 3 1 M; BRUSIC V, 1994, NUCLEIC ACIDS RES, V22, P3663, DOI 10.1093/nar/22.17.3663; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; CONNOLLY ML, 1985, J MOL GRAPHICS, V3, P19, DOI 10.1016/0263-7855(85)80009-6; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; EVAVOLD BD, 1992, J IMMUNOL, V148, P347; EVAVOLD BD, 1993, J IMMUNOL, V150, P3131; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; IGNATOWICZ L, 1995, J IMMUNOL, V154, P3852; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; JENSEN PE, 1990, J EXP MED, V171, P1779, DOI 10.1084/jem.171.5.1779; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; KOZONO H, 1995, IMMUNITY, V3, P187, DOI 10.1016/1074-7613(95)90088-8; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; REAY PA, 1994, J IMMUNOL, V152, P3946; REAY PA, 1992, EMBO J, V11, P2829, DOI 10.1002/j.1460-2075.1992.tb05350.x; Schild H, 1995, INT IMMUNOL, V7, P1957, DOI 10.1093/intimm/7.12.1957; SETTE A, 1992, J IMMUNOL, V148, P844; SPAIN LM, 1994, J IMMUNOL, V152, P1709; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0	30	319	326	2	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 17	1996	272	5264					1001	1004		10.1126/science.272.5264.1001	http://dx.doi.org/10.1126/science.272.5264.1001			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL619	8638119				2022-12-28	WOS:A1996UL61900042
